Citrus Sinensis ID: 037160

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------57
Protein Sequence
ANADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECMELSHTSGFSRRQSSSAKILRV
Secondary Structure (PSIPRED)
cccccccccccccccccccccccHHHHHHHHHHHHHHcccccccEEEEEcccccccEEEEEEccccccHHHHHHHHHHHHHHHHcccccccEEEEccccEEEEcccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccEEEEEcccccEEEEEEccccccHHHHHHHHHHccccccccccHHHHHHHHEEEEEEEEcccccccccccccccccHHHHHHHccccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEccccccHHHHHHHHHHHHHHHcccccccccccccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHccccccccEEEccccccccccccccccccccccccccccccccccccccEEEccccccHHHHcccccccccccccccEEEEEEEccccccccccccccccHHHHHHHHccccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccHEEEccccccccccHHHHHHHHHHHHHHHHccccccccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHccccccEEEEEccEEEEEccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHccccccccccccccccccEEEEEEEccccccHHHHHHHHHHHHHHHHHHHccccEEEEEEEEEEEEEcccccccccccccccccccccccccccccccEEcHHHHHHHHHcccHHccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEccHHcccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEccccccccccHHHHHccccEEEEEcccccHHHHHcccEEEcccHEEEEEEEEEEEcccccccccccccHHHHHHHHHHHHHcccccEEEccccccccHHHHHHHHHHHHHHHcccHcccccHHHHEEEEcccccccccccccEEEEEccccccccccccccccccccccc
Coil and Loop (DISEMBL)
ANADARTNIIERhcqklppenssnylHNYHALLNLMRGEMykkkfaskefgippsrtyMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFlrlenysfygepfapfddmkcgvdaEQEQQDLFRRVVEEVVNKVsknapnengfathkyTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALtcipaiegRVLFAGCFLrysryefandfkphkddqgmeMDLSLLHKSLKFLQFKYstiekatdcfdesnklghggygeifkgTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLgccftkkdsFVVYEFVQnksldrilfdpkqkkeldwkkRHVIIIGTAEGleylhkdgqmqIVHRDIKASnilldlkhrpkiadfglarfssseksllpntaiagtlgymapeyiangqltekvdiYSFGVLVLEIVSGvqnnkfqsddgFETLVTHTWKHFQAKTVLEIIDKsieiedieEVKRVVWVGLLctqelptlrpsMTNVVQMLKQkditlptpskppftdecmelshtsgfsrrqsssakilrv
Flexible Loop (DISEMBL)
anadartniierhcqklppenssnYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKvsknapnengfatHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIfkgtlqdgrEIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVqnksldrilfdpkqkkeldwkkrHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLarfsssekslLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCtqelptlrpsMTNVVQMLKQKDITLPTPSKPPFTDECMELShtsgfsrrqsssakilrv
Low Complexity Region (SEG)
ANADARTNIIERHCQKLPPENSSnylhnyhallnlMRGEMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFrrvveevvnkvsknAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLeiidksieiedieeVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECMELSHTSGFSRRQSSSAKILRV
Disordered region (IsUnstruct)
***********************NYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKP******MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM******************************************
Disordered Region (DISOPRED)
***DARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAP****FATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFAN**********************KFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPF********************A*ILRV
Disordered Region (DISEMBL)
ANADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECME********************
Disordered Region (DISPRO)
******TNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFAND*******************SLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECM*********************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
ANADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECMELSHTSGFSRRQSSSAKILRV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	569	2.2.26 [Sep-21-2011]
Q9CAL3	649	Cysteine-rich receptor-li	yes	no	0.964	0.845	0.429	1e-135
Q9M0G5	625	Putative cysteine-rich re	no	no	0.940	0.856	0.429	1e-132
Q9FNE1	651	Cysteine-rich receptor-li	no	no	0.926	0.809	0.380	1e-107
Q9CAL2	646	Cysteine-rich receptor-li	no	no	0.943	0.831	0.354	1e-102
Q9LMB9	615	Cysteine-rich receptor-li	no	no	0.847	0.783	0.390	2e-99
Q9LDS6	656	Putative cysteine-rich re	no	no	0.910	0.789	0.341	5e-86
Q9LDN1	636	Putative cysteine-rich re	no	no	0.873	0.781	0.34	6e-85
Q9LDM5	666	Putative cysteine-rich re	no	no	0.583	0.498	0.475	4e-84
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.847	0.714	0.342	5e-83
O65483	636	Cysteine-rich receptor-li	no	no	0.852	0.762	0.336	4e-82

>sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1

 Score =  483 bits (1244), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 259/603 (42%), Positives = 353/603 (58%), Gaps = 54/603 (8%)

Query: 3   ADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
            DAR   ++  C  L   N + Y+ N+ A +  +  ++    F     G  P   Y L+Q
Sbjct: 29  GDARARAVKVTCSPLLEHNETAYVPNFVATMEKISTQVQTSGFGVALTGTGPDANYGLAQ 88

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCG 122
           C  DL L +C  C+A+   +L  C P     +FLDGCF+R ENYSFY E   P D + CG
Sbjct: 89  CYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYSFYNEYKGPEDSIVCG 148

Query: 123 VDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADV---SAYAMASCLKTLNHQ 179
               + +   F   V + +      A    G+A       +    SA+ +A+C +TL+  
Sbjct: 149 NTTRKNKT--FGDAVRQGLRNAVTEASGTGGYARASAKAGESESESAFVLANCWRTLSPD 206

Query: 180 MCSQCLTKA-ASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEM------ 232
            C QCL  A AS    C+P  EGR L  GCFLRYS  +F N    +   +G  +      
Sbjct: 207 SCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFLNKIPRNGRSRGSVVVIVVSV 266

Query: 233 -------------------------------DLSLLHKSLK--FLQFKYSTIEKATDCFD 259
                                          D+  + K+LK   L FKYST+EKAT  FD
Sbjct: 267 LSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNFKYSTLEKATGSFD 326

Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
            +NKLG GG+G ++KG L DGR+IAVKRLF + ++R  +  NE++++S   HKNLV+ LG
Sbjct: 327 NANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYNEVNMISTVEHKNLVRLLG 386

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
           C  +  +S +VYE++QNKSLDR +FD  + K LDW++R+ II+GTAEGL YLH+   ++I
Sbjct: 387 CSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEGLVYLHEQSSVKI 446

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRDIKASNILLD K + KIADFGLAR    +KS + +TAIAGTLGYMAPEY+A+GQLTE
Sbjct: 447 IHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHI-STAIAGTLGYMAPEYLAHGQLTE 505

Query: 440 KVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED--- 496
            VD+YSFGVLVLEIV+G QN K +  D  ++L+T  WKHFQ+  + +I D +++ +    
Sbjct: 506 MVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLITEAWKHFQSGELEKIYDPNLDWKSQYD 565

Query: 497 ----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDE-CMELS 551
                +E+ RVV +GLLCTQE+P+LRP M+ ++ MLK K+  LP PS PPF DE  MEL 
Sbjct: 566 SHIIKKEIARVVQIGLLCTQEIPSLRPPMSKLLHMLKNKEEVLPLPSNPPFMDERVMELR 625

Query: 552 HTS 554
             S
Sbjct: 626 DGS 628

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1

 Score =  473 bits (1217), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 261/608 (42%), Positives = 354/608 (58%), Gaps = 73/608 (12%)

Query: 5   ARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQCM 64
           +R +++   C      N   Y  +Y   L+ +RG+M   KF + E G PP R Y+LSQC+
Sbjct: 27  SRIDVLGYICNNGTVSNEEAYRRSYQINLDAIRGDMRHVKFGTHEHGDPPERMYVLSQCV 86

Query: 65  EDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGVD 124
            DL+  EC+ C+++   LL+ C PA      LDGCF+R +NYSFY EP +  D   C  D
Sbjct: 87  SDLSSDECSLCWSRATDLLSQCFPATGGWFHLDGCFVRADNYSFYQEPVSHQDTKICASD 146

Query: 125 AEQ--EQQDLFRRVVEEVVN---------------------------------------- 142
            E+  E + L + V + +V                                         
Sbjct: 147 KEKSAEFKGLVKEVTKSIVEAAPYSRGFSVAKMGIRDLTVYGLGVCWRTLNDELCKLCLA 206

Query: 143 ----KVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPA 198
                V+   P++ GFA +       S Y   +    L      + LT     ++  + A
Sbjct: 207 DGALSVTSCLPSKEGFALNAGCYLRYSNYTFYNERGLLAMSFTKENLTYIFVISMVGVLA 266

Query: 199 IEGRVLFAGCF-LRYS-----------RYEFANDFKPHKDDQGMEMDLSLLHKSLKFLQF 246
           I        CF +R S           ++      +  K+ + +  +  L+        F
Sbjct: 267 IAAGFWCGKCFYMRTSPKKKIKGTKTKKFHLFGHLRIEKESESICTESHLM-------SF 319

Query: 247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIM 306
           +YST++KAT+ F+ES KLG GGYGE+FKGTL DGREIA+KRL +S K    EI NE+D++
Sbjct: 320 EYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEIDVI 379

Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           SR  HKNLV+ LGCCFT  +SF+VYEF+ N SLD ILF+P++KKELDWKKR  II+GTAE
Sbjct: 380 SRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILGTAE 439

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN-----TAIA 421
           GLEYLH+    +I+HRDIKASNILLDLK++PKI+DFGLA+F       +P      ++IA
Sbjct: 440 GLEYLHE--TCKIIHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPSSIA 497

Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA 481
           GTLGYMAPEYI+ G+L+ K+D YSFGVLVLEI SG +NNKF+SD+  ETLVT  WK F +
Sbjct: 498 GTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNSLETLVTQVWKCFAS 557

Query: 482 KTVLEIIDKSI-EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSK 540
             + E+IDK + E  D +E+KRV+ +GLLCTQE P LRP+M+ V+QM+   DI LPTP+K
Sbjct: 558 NKMEEMIDKDMGEDTDKQEMKRVMQIGLLCTQESPQLRPTMSKVIQMVSSTDIVLPTPTK 617

Query: 541 PPFTDECM 548
           PPF  + M
Sbjct: 618 PPFLHDSM 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1

 Score =  388 bits (996), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 223/586 (38%), Positives = 322/586 (54%), Gaps = 59/586 (10%)

Query: 4   DARTNIIERHCQKLPPENSS-NYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
           D RT +    C      ++  NY+  +   ++ +  ++  ++FA++      S  Y L Q
Sbjct: 31  DQRTTVSGLFCGGRSKSSADPNYIPTFVEDMHSLSLKLTTRRFATESLNSTTS-IYALIQ 89

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFA-PFDDMKC 121
           C +DL+ ++C  C+A     +  CLP+ SA +FLDGCFLR E Y FY E  +   D   C
Sbjct: 90  CHDDLSPSDCQLCYAIARTRIPRCLPSSSARIFLDGCFLRYETYEFYDESVSDASDSFSC 149

Query: 122 GVDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMC 181
             D   + +  F+  V E   +V   A  + GF        +   +A+A C ++L  + C
Sbjct: 150 SNDTVLDPRFGFQ--VSETAARV---AVRKGGFGVA----GENGVHALAQCWESLGKEDC 200

Query: 182 SQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKD----DQGMEMDLSLL 237
             CL KA      C+   EGR +  GC+LRYS ++F N    HK     ++G+ + + L 
Sbjct: 201 RVCLEKAVKEVKRCVSRREGRAMNTGCYLRYSDHKFYNGDGHHKFHVLFNKGVIVAIVLT 260

Query: 238 HKSLKFL----------------------------------QFKYSTIEKATDCFDESNK 263
             +   L                                  +FKY T+EKATD F     
Sbjct: 261 TSAFVMLILLATYVIMTKVSKTKQEKRNLGLVSRKFNNSKTKFKYETLEKATDYFSHKKM 320

Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT 323
           LG GG G +F G L +G+ +AVKRL  + ++ ++E  NE++++S   HKNLV+ LGC   
Sbjct: 321 LGQGGNGTVFLGILPNGKNVAVKRLVFNTRDWVEEFFNEVNLISGIQHKNLVKLLGCSIE 380

Query: 324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRD 383
             +S +VYE+V NKSLD+ LFD  Q K L+W +R  II+GTAEGL YLH    ++I+HRD
Sbjct: 381 GPESLLVYEYVPNKSLDQFLFDESQSKVLNWSQRLNIILGTAEGLAYLHGGSPVRIIHRD 440

Query: 384 IKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDI 443
           IK SN+LLD +  PKIADFGLAR    +K+ L +T IAGTLGYMAPEY+  GQLTEK D+
Sbjct: 441 IKTSNVLLDDQLNPKIADFGLARCFGLDKTHL-STGIAGTLGYMAPEYVVRGQLTEKADV 499

Query: 444 YSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIE----- 498
           YSFGVLVLEI  G + N F  + G   L+   W  +    ++E +D  ++ E ++     
Sbjct: 500 YSFGVLVLEIACGTRINAFVPETGH--LLQRVWNLYTLNRLVEALDPCLKDEFLQVQGSE 557

Query: 499 -EVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPF 543
            E  +V+ VGLLCTQ  P+LRPSM  V++ML ++D  +P+P+ PPF
Sbjct: 558 AEACKVLRVGLLCTQASPSLRPSMEEVIRMLTERDYPIPSPTSPPF 603

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1

 Score =  373 bits (958), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 209/590 (35%), Positives = 326/590 (55%), Gaps = 53/590 (8%)

Query: 3   ADARTNIIERHC--QKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYML 60
           +D+R + + + C  +   P+  S ++ N+ A ++ +   +  K +     G      Y  
Sbjct: 20  SDSRGDTVAQICNNRTTTPQQRSLFVTNFLAAMDAVSPLVEAKGYGQVVNGTGNLTVYAY 79

Query: 61  SQCMEDLTLTECNTCFAQMNHLLADCLP----AISAHVFLDGCFLRLENYSFYGEPFAPF 116
            +C++DL   +C+ CFAQ+   +  CLP         VF DGC++R ++Y+FY E  +  
Sbjct: 80  GECIKDLDKKDCDLCFAQIKAKVPRCLPFQKGTRGGQVFSDGCYIRYDDYNFYNETLSLQ 139

Query: 117 DDMKCGV-DAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKT 175
           D   C   +     + +FR    E+V  +S  A    GF        +V+ + +A C +T
Sbjct: 140 DRTVCAPKEITGVNRTVFRDNAAELVKNMSVEAVRNGGFYAGFVDRHNVTVHGLAQCWET 199

Query: 176 LNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQ------- 228
           LN   C +CL+KA+    +C+   EGRVL AGC++R+S  +F N+      D        
Sbjct: 200 LNRSGCVECLSKASVRIGSCLVNEEGRVLSAGCYMRFSTQKFYNNSGNSTSDGNGGHNHL 259

Query: 229 GMEMDLS-------LLHKSLKFLQ---------------------------FKYSTIEKA 254
           G+ + ++       LL  +  FL                            F Y  +E+A
Sbjct: 260 GVILAVTSSVVAFVLLVSAAGFLLKKRHAKKQREKKQLGSLFMLANKSNLCFSYENLERA 319

Query: 255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL 314
           TD F + NKLG GG G ++KG L +G+ +AVKRLF + K  +    NE++++S+  HKNL
Sbjct: 320 TDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEVNLISQVDHKNL 379

Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ LGC  T  +S +VYE++ N+SL   LF  K  + L+W KR  II+GTAEG+ YLH++
Sbjct: 380 VKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWAKRFKIILGTAEGMAYLHEE 439

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
             ++I+HRDIK SNILL+    P+IADFGLAR    +K+ + +TAIAGTLGYMAPEY+  
Sbjct: 440 SNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHI-STAIAGTLGYMAPEYVVR 498

Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI 494
           G+LTEK D+YSFGVL++E+++G +NN F  D G  +++   W  ++   V E +D  +  
Sbjct: 499 GKLTEKADVYSFGVLMIEVITGKRNNAFVQDAG--SILQSVWSLYRTSNVEEAVDPILGD 556

Query: 495 E-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPF 543
             +  E  R++ +GLLC Q     RP+M+ VV+M+K   + + TP++PPF
Sbjct: 557 NFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMK-GSLEIHTPTQPPF 605

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2

 Score =  363 bits (932), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 208/533 (39%), Positives = 292/533 (54%), Gaps = 51/533 (9%)

Query: 53  PPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEP 112
           PP   Y+  QC EDL++++C  CF +    L          +  D CFLR ++  F  E 
Sbjct: 78  PP--IYVFLQCREDLSVSDCRHCFNESRLELERKCSGSGGRIHSDRCFLRFDDRDFSEEF 135

Query: 113 FAP-FDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMAS 171
             P FD   C        +  F R ++E +  V+  A    GF      +   + YA+A 
Sbjct: 136 VDPTFDKANCEETGTGFGE--FWRFLDEALVNVTLKAVKNGGFGAAS-VIKTEAVYALAQ 192

Query: 172 CLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFAND----------- 220
           C +TL+   C +CL  A S+   C    E R  F GC+L+YS ++F +D           
Sbjct: 193 CWQTLDENTCRECLVNARSSLRAC-DGHEARAFFTGCYLKYSTHKFFDDAAEHKPDADQR 251

Query: 221 ------FKPHKDDQGM------EMDLSLLHKSLKFL-----------------QFKYSTI 251
                 F PH  D+ +       + LS+L     F+                  FKY  +
Sbjct: 252 NFIRSSFFPHLSDRDVTRLAIAAISLSILTSLGAFISYRRVSRKRKAQVPSCVNFKYEML 311

Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHH 311
           EKAT+ F +S KLG GG G ++KG L DGR +AVK+LF + +    +  NE++++S   H
Sbjct: 312 EKATESFHDSMKLGQGGAGSVYKGILPDGRIVAVKKLFFNTREWADQFFNEVNLISGVQH 371

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
           KNLV+ LGC      S +VYE+V N+SLD+ILF       L WK+R  IIIG +EGLEYL
Sbjct: 372 KNLVRLLGCSIEGPKSLLVYEYVHNRSLDQILFMKNTVHILSWKQRFNIIIGISEGLEYL 431

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H+  +++I+HRDIK SNILLD    PKIADFGL R   ++K+   NT IAGTLGY+APEY
Sbjct: 432 HRGSEVKIIHRDIKTSNILLDRNLSPKIADFGLIRSMGTDKT-QTNTGIAGTLGYLAPEY 490

Query: 432 IANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS 491
           +  GQLTEK D+Y+FGVL++EIV+G +NN F    G  +++   W+HF+A T+   ID  
Sbjct: 491 LIKGQLTEKADVYAFGVLIIEIVTGKKNNAFT--QGTSSVLYSVWEHFKANTLDRSIDPR 548

Query: 492 IEIEDI-EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPF 543
           ++   + EE  +V+ +GLLC Q    LRPSM+ +V ML+ KD     P +PPF
Sbjct: 549 LKGSFVEEEALKVLQIGLLCVQSSVELRPSMSEIVFMLQNKDSKFEYPKQPPF 601

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LDS6|CRK32_ARATH Putative cysteine-rich receptor-like protein kinase 32 OS=Arabidopsis thaliana GN=CRK32 PE=3 SV=1

 Score =  318 bits (816), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 200/586 (34%), Positives = 287/586 (48%), Gaps = 68/586 (11%)

Query: 22  SSNYLHNYHALL-NLMRGEMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFA-QM 79
           +  Y  N H +L NL      +  + +   G  P R Y L  C+       C+ C     
Sbjct: 35  NGTYDTNRHLILSNLASNVSSRDGYYNGSVGEGPDRIYALGLCIPGTDPKVCDDCMQIAS 94

Query: 80  NHLLADCLPAISAHVFLDG---CFLRLENYSFYG----EPFAPFDDMKCGVDAEQEQQDL 132
             +L +C     ++ +      CF+R  N SF+     EP     D+  G+     Q DL
Sbjct: 95  TGILQNCPNQTDSYDWRSQKTLCFVRYSNSSFFNKMDLEPTMVIGDLNSGL----FQGDL 150

Query: 133 --FRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAAS 190
             + R  EE +N +          A     +     YA+  C++ ++   C  C+     
Sbjct: 151 AAYTRTWEEFMNSMITRVGRTRYLADISPRIGSARIYALMQCIRGISSMECETCIRDNVR 210

Query: 191 TALTCIPA-IEGRVLFAGCFLRYSRYEFANDF-------KPHKDDQGMEMDLSLL----- 237
              +C    I G +    CF R+   E+   F        P  D + +     +      
Sbjct: 211 MYQSCCNGFIGGTIRKPVCFFRWDGSEYLGAFGDTPSLPPPSPDGKTISTGAIVAVVVSV 270

Query: 238 -------------------HKSLK-----------FLQFKYSTIEKATDCFDESNKLGHG 267
                              +K+LK            LQF + T+E ATD F  +NKLG G
Sbjct: 271 VIFVVLLALVLVIRKRRQSYKTLKPKTDDDMTSPQSLQFDFMTLEAATDKFSRNNKLGKG 330

Query: 268 GYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS 327
           G+GE++KG L +  E+AVKRL  +     +E  NE+ I+++  HKNLV+ LG C  + + 
Sbjct: 331 GFGEVYKGMLPNETEVAVKRLSSNSGQGTQEFKNEVVIVAKLQHKNLVRLLGFCLERDEQ 390

Query: 328 FVVYEFVQNKSLDRILF--------DPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            +VYEFV NKSL+  LF        DP +K +LDWK+R+ II G   GL YLH+D ++ I
Sbjct: 391 ILVYEFVPNKSLNYFLFGNKQKHLLDPTKKSQLDWKRRYNIIGGITRGLLYLHQDSRLTI 450

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRDIKASNILLD    PKIADFG+AR    +++      + GT GYM PEY+ +GQ + 
Sbjct: 451 IHRDIKASNILLDADMNPKIADFGMARNFRVDQTEDNTRRVVGTFGYMPPEYVTHGQFST 510

Query: 440 KVDIYSFGVLVLEIVSGVQNNKF-QSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DI 497
           K D+YSFGVL+LEIV G +N+ F + DD    LVTH W+ +   + L++ID +IE   D 
Sbjct: 511 KSDVYSFGVLILEIVCGKKNSSFYKIDDSGGNLVTHVWRLWNNDSPLDLIDPAIEESCDN 570

Query: 498 EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPF 543
           ++V R + +GLLC QE P  RP M+ + QML    ITLP P  P F
Sbjct: 571 DKVIRCIHIGLLCVQETPVDRPEMSTIFQMLTNSSITLPVPRPPGF 616

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDN1|CRK33_ARATH Putative cysteine-rich receptor-like protein kinase 33 OS=Arabidopsis thaliana GN=CRK33 PE=2 SV=1

 Score =  315 bits (807), Expect = 6e-85,   Method: Compositional matrix adjust.
 Identities = 187/550 (34%), Positives = 283/550 (51%), Gaps = 53/550 (9%)

Query: 45  FASKEFGIPPSRTYMLSQCMEDLTLTECNTCF-AQMNHLLADCLPAISAHVFLDG---CF 100
           F +   G  P   +++  C++    T C+ C     + L  +C     A+ +      CF
Sbjct: 61  FYNSSIGKVPDEVHVMGMCIDGTEPTVCSDCLKVAADQLQENCPNQTEAYTWTPHKTLCF 120

Query: 101 LRLENYSFYGE-PFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNE--NGFATH 157
            R  N SF+      P       VD +     L   + E + +++  +A ++     ++ 
Sbjct: 121 ARYSNSSFFKRVGLHPLYMEHSNVDIKSNLTYL-NTIWEALTDRLMSDASSDYNASLSSR 179

Query: 158 KYTLADVS-------AYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFL 210
           +Y  A+V+        YA+  C   L    C  CL KA S     +    G V +  C  
Sbjct: 180 RYYAANVTNLTNFQNIYALMLCTPDLEKGACHNCLEKAVS-EYGNLRMQRGIVAWPSCCF 238

Query: 211 RYSRYEFANDFK-----PHKDDQGMEMDLSLL---------------------------- 237
           R+  Y F   F      P    + + +   +                             
Sbjct: 239 RWDLYPFIGAFNLTLSPPPGSKRNISVGFFVAIVVATGVVISVLSTLVVVLVCRKRKTDP 298

Query: 238 -HKSLKF-LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR 295
             +S K+ LQ+   TIE AT  F + N LG GG+GE+FKG LQDG EIAVKRL       
Sbjct: 299 PEESPKYSLQYDLKTIEAATCTFSKCNMLGQGGFGEVFKGVLQDGSEIAVKRLSKESAQG 358

Query: 296 IKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWK 355
           ++E  NE  ++++  H+NLV  LG C   ++  +VYEFV NKSLD+ LF+P +K +LDW 
Sbjct: 359 VQEFQNETSLVAKLQHRNLVGVLGFCMEGEEKILVYEFVPNKSLDQFLFEPTKKGQLDWA 418

Query: 356 KRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
           KR+ II+GTA G+ YLH D  ++I+HRD+KASNILLD +  PK+ADFG+AR    ++S  
Sbjct: 419 KRYKIIVGTARGILYLHHDSPLKIIHRDLKASNILLDAEMEPKVADFGMARIFRVDQSRA 478

Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKF-QSDDGFETLVTH 474
               + GT GY++PEY+ +GQ + K D+YSFGVLVLEI+SG +N+ F ++D+  + LVT+
Sbjct: 479 DTRRVVGTHGYISPEYLMHGQFSVKSDVYSFGVLVLEIISGKRNSNFHETDESGKNLVTY 538

Query: 475 TWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI 533
            W+H++  + LE++D  +E      EV R + + LLC Q  P  RP+++ ++ ML    I
Sbjct: 539 AWRHWRNGSPLELVDSELEKNYQSNEVFRCIHIALLCVQNDPEQRPNLSTIIMMLTSNSI 598

Query: 534 TLPTPSKPPF 543
           TLP P  P +
Sbjct: 599 TLPVPQSPVY 608

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDM5|CRK31_ARATH Putative cysteine-rich receptor-like protein kinase 31 OS=Arabidopsis thaliana GN=CRK31 PE=3 SV=1

 Score =  312 bits (800), Expect = 4e-84,   Method: Compositional matrix adjust.
 Identities = 163/343 (47%), Positives = 217/343 (63%), Gaps = 11/343 (3%)

Query: 203 VLFAGCFLRYSRYEFANDFKPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESN 262
           VL A   + + R +     K H DD     D++    S + LQF ++TIE ATD F  +N
Sbjct: 293 VLVALGLVIWKRRQSYKTLKYHTDD-----DMT----SPQSLQFDFTTIEVATDNFSRNN 343

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG GG+GE++KG L +  EIAVKRL  +     +E  NE+ I+++  HKNLV+ LG C 
Sbjct: 344 KLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQGTQEFKNEVVIVAKLQHKNLVRLLGFCI 403

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            + +  +VYEFV NKSLD  LFDPK K +LDWK+R+ II G   GL YLH+D ++ I+HR
Sbjct: 404 ERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWKRRYNIIGGVTRGLLYLHQDSRLTIIHR 463

Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVD 442
           DIKASNILLD    PKIADFG+AR    +++      + GT GYM PEY+ +GQ + K D
Sbjct: 464 DIKASNILLDADMNPKIADFGMARNFRVDQTEDQTGRVVGTFGYMPPEYVTHGQFSTKSD 523

Query: 443 IYSFGVLVLEIVSGVQNNK-FQSDDGFETLVTHTWKHFQAKTVLEIIDKSI-EIEDIEEV 500
           +YSFGVL+LEIV G +N+  FQ DD    LVTH W+ +   + L++ID +I E  D +EV
Sbjct: 524 VYSFGVLILEIVCGKKNSSFFQMDDSGGNLVTHVWRLWNNDSPLDLIDPAIKESYDNDEV 583

Query: 501 KRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPF 543
            R + +G+LC QE P  RP M+ + QML    ITLP P  P F
Sbjct: 584 IRCIHIGILCVQETPADRPEMSTIFQMLTNSSITLPVPRPPGF 626

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  309 bits (791), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 184/538 (34%), Positives = 280/538 (52%), Gaps = 56/538 (10%)

Query: 36  MRGEMYKKKFASKEFGIPPSRT-YMLSQCMEDLTLTECNTCFAQ-MNHLLADCLPAISAH 93
           ++  +  +KFA+++      +T Y L QC  DLT  +C +C  Q +N+L   C  ++   
Sbjct: 173 VKAALSSRKFATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGR 232

Query: 94  VFLDGCFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNENG 153
           V    C  R E Y FY E  A                          V     N P+E G
Sbjct: 233 VIAPSCSFRYELYPFYNETIA---------------AAPMAPPPSSTVTAPPLNIPSEKG 277

Query: 154 FATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYS 213
              +   +    A  ++ C+  L                             A C+L   
Sbjct: 278 KGKNLTVIVTAIAVPVSVCVLLLG----------------------------AMCWLLAR 309

Query: 214 RYEFANDFKPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIF 273
           R    N      +D    +D   +  S + LQF++S IE AT+ F ESNKLGHGG+GE++
Sbjct: 310 RRN--NKLSAETED----LDEDGI-TSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVY 362

Query: 274 KGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF 333
           KG L  G  +A+KRL        +E  NE+D++++  H+NL + LG C   ++  +VYEF
Sbjct: 363 KGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEF 422

Query: 334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL 393
           V NKSLD  LFD ++++ LDW++R+ II G A G+ YLH+D ++ I+HRD+KASNILLD 
Sbjct: 423 VPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDA 482

Query: 394 KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
              PKI+DFG+AR    +++      I GT GYM+PEY  +G+ + K D+YSFGVLVLE+
Sbjct: 483 DMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLEL 542

Query: 454 VSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQ 512
           ++G +N+ F  +DG   LVT+ WK +   + LE++D+++       EV R + + LLC Q
Sbjct: 543 ITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQ 602

Query: 513 ELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECMELS---HTSGFSRRQSSSAKIL 567
           E  + RPSM +++ M+    +TLP P +  F    M+ S    + G +   S+++K L
Sbjct: 603 EDSSERPSMDDILVMMNSFTVTLPIPKRSGFLLRTMKDSRDPRSGGSASDHSATSKSL 660

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65483|CRK24_ARATH Cysteine-rich receptor-like protein kinase 24 OS=Arabidopsis thaliana GN=CRK24 PE=3 SV=2

 Score =  306 bits (783), Expect = 4e-82,   Method: Compositional matrix adjust.
 Identities = 188/559 (33%), Positives = 278/559 (49%), Gaps = 74/559 (13%)

Query: 45  FASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMN-HLLADCLPAISAHVF-LDG--CF 100
           F +   G  P+R Y L  C+       C+ C    N  LL +C     A V+ +D   C 
Sbjct: 57  FYTTWIGEHPNRAYGLGMCVPGTDAHSCSDCIILANARLLQNCTNQTEAIVWRIDRTVCL 116

Query: 101 LRLENYSFY---GEPFAPFD----DMKCGV-DAEQEQQDLFRRVVEEVVNKVSKNAPNEN 152
           +R  N SFY   G      D    D +  + D E   + L  R++++             
Sbjct: 117 VRYSNRSFYSSLGMEILRSDNYTRDFQANLTDLEITWEALMIRMIDQ------------- 163

Query: 153 GFATHKYTLADVS--------AYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVL 204
             A++ Y  A +          Y    C + L+ Q C++CL +      +C    +G ++
Sbjct: 164 --ASYLYYAAGIRKLETSISRIYGFVQCSRDLSLQNCTKCLQQNVVEYRSCCRGRQGGII 221

Query: 205 F-AGCFLRYSRYEFANDF---KPHKDDQG-----------------MEMDLSLLHKSLKF 243
               CF+R+  Y F   F   +P + D                   + + + L  +   +
Sbjct: 222 LRPSCFIRWELYPFLGLFDNIRPRQKDGKSISTGAIVAIIVVPILLLALGVGLWKRRKAY 281

Query: 244 ----------------LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKR 287
                           LQF++  IE AT  F   NKLGHGG+GE++KGT  +G E+AVKR
Sbjct: 282 KTKTTKIADDITTSGSLQFEFKAIEAATCNFHNVNKLGHGGFGEVYKGTFPNGTEVAVKR 341

Query: 288 LFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPK 347
           L  +     +E  NE+ ++++  H+NLV+ LG      +  +VYEF+ NKSLD  LFDP 
Sbjct: 342 LSKTSGQGEEEFKNEVFLVAKLQHRNLVKLLGYAVKGDEKILVYEFLPNKSLDHFLFDPV 401

Query: 348 QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF 407
           +K +LDW +R+ II G   G+ YLH+D ++ I+HRD+KA NILLD    PKI DFG+AR 
Sbjct: 402 KKGQLDWTRRYNIINGITRGIVYLHQDSRLTIIHRDLKAGNILLDADMNPKIVDFGVARN 461

Query: 408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG 467
              +++      + GT+GYM PEY+ NGQ + K D+YSFGVL+LEI+ G +N+     DG
Sbjct: 462 FRVDQTEATTARVVGTIGYMPPEYVTNGQFSTKSDVYSFGVLILEIIGGKKNSSINETDG 521

Query: 468 -FETLVTHTWKHFQAKTVLEIIDKSI-EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVV 525
               LVT+ W+ +  + +LE++D  + E  D  EV R + +GLLC QE P  RP+M+ V 
Sbjct: 522 SISNLVTYVWRLWNNEPLLELVDAPMGENYDRNEVIRCIHIGLLCVQENPADRPTMSTVF 581

Query: 526 QMLKQKDITLPTPSKPPFT 544
            ML    ITL  P  P F 
Sbjct: 582 HMLTNTSITLHVPQPPGFV 600

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	569
359488826	635	PREDICTED: putative cysteine-rich recept	0.977	0.875	0.527	0.0
224074253	471	predicted protein [Populus trichocarpa]	0.822	0.993	0.58	1e-170
147765626	725	hypothetical protein VITISV_038881 [Viti	0.917	0.72	0.488	1e-163
296087633	1245	unnamed protein product [Vitis vinifera]	0.980	0.448	0.471	1e-158
224107811	634	predicted protein [Populus trichocarpa]	0.957	0.859	0.446	1e-139
225425609	654	PREDICTED: cysteine-rich receptor-like p	0.959	0.834	0.439	1e-139
147767573	654	hypothetical protein VITISV_005913 [Viti	0.959	0.834	0.439	1e-139
225425605	654	PREDICTED: cysteine-rich receptor-like p	0.959	0.834	0.439	1e-138
356497745	652	PREDICTED: cysteine-rich receptor-like p	0.966	0.843	0.435	1e-137
351720648	594	protein kinase family protein [Glycine m	0.903	0.865	0.454	1e-137

>gi|359488826|ref|XP_002273750.2| PREDICTED: putative cysteine-rich receptor-like protein kinase 43-like [Vitis vinifera]

 Score =  653 bits (1685), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/603 (52%), Positives = 418/603 (69%), Gaps = 47/603 (7%)

Query: 3   ADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
           A+ R +II R C      N SNYL +Y  ++  +R E+ K KFA KE G PP + Y+L+Q
Sbjct: 24  ANPRADIIARICSNDYAHNFSNYLDSYSKIITQLRDELPKTKFAFKEAGEPPDKIYVLAQ 83

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCG 122
           CM+DL+  +C  CF+Q++ L   C PA    V+LDGCFLR +NYSF+ +   P D ++C 
Sbjct: 84  CMDDLSFQDCQACFSQISSLFPGCFPATGGRVYLDGCFLRGDNYSFFQDTLTPMDYLRCS 143

Query: 123 VDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCS 182
                 Q   F  V + V++++ +  P+ +G+A +  +   ++ Y MASC KTL+   C+
Sbjct: 144 DSISGVQN--FDDVAKSVIDELVRMTPSRDGYAAYDESANGITVYGMASCWKTLDRDRCA 201

Query: 183 QCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFAND------------FKPH------ 224
            CL  AA +A  C P+ EGRVL AGCFLRYS Y+F ND            F  H      
Sbjct: 202 SCLASAAISAFACFPSAEGRVLNAGCFLRYSDYKFVNDPKWLAARDATLSFISHVVGVVS 261

Query: 225 -----------------------KDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDES 261
                                   +   +E+D S++ +SL   QFKY+T+EKATD F+E+
Sbjct: 262 VCILAIIIGFFIGKAAYQKRNQQNEANEIEVDSSVVKRSL---QFKYTTLEKATDYFNEA 318

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           NKLG GG+GE+FKGTL+DGREIA+KRLFI+ ++  +E+ NE+DI+  A HKNLV+FLGCC
Sbjct: 319 NKLGQGGFGEVFKGTLRDGREIAIKRLFITGQSGAQEVYNEIDIIGSACHKNLVRFLGCC 378

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
           FT+ DSF+VYEF+ N+SLDR+LFD ++KKEL WK R  II+GTAEGLEYLHKD  ++I+H
Sbjct: 379 FTRHDSFLVYEFLPNRSLDRVLFDTEKKKELPWKIRLGIIMGTAEGLEYLHKDCHVRIIH 438

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIKASN+LLD ++RPKIADFGLARF S++++ L  TAIAGTLGYMAPEY+A G+LT+KV
Sbjct: 439 RDIKASNVLLDFRYRPKIADFGLARFYSTDRA-LTGTAIAGTLGYMAPEYLAQGRLTDKV 497

Query: 442 DIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVK 501
           D+YS+GVL+LEIVSGVQNNKFQ DD   TL T TWKHFQ+ T+ EIIDK +EIED+EEV 
Sbjct: 498 DVYSYGVLILEIVSGVQNNKFQLDDSLNTLATATWKHFQSNTMTEIIDKGMEIEDMEEVT 557

Query: 502 RVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECMELSHTSGFSRRQS 561
           RV+ VGLLCTQE PTLRP+MT ++QMLKQKD++LP PSKPPFT+E + +S   G  RR +
Sbjct: 558 RVIQVGLLCTQESPTLRPAMTEIIQMLKQKDVSLPIPSKPPFTEENLTISPALGCPRRPA 617

Query: 562 SSA 564
             A
Sbjct: 618 VDA 620

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224074253|ref|XP_002304322.1| predicted protein [Populus trichocarpa] gi|222841754|gb|EEE79301.1| predicted protein [Populus trichocarpa]

 Score =  604 bits (1558), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 290/500 (58%), Positives = 371/500 (74%), Gaps = 32/500 (6%)

Query: 64  MEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCGV 123
           M+DLT  EC  CF+Q++ L+  C P+    V+ DGCF+R ENYSFY E  AP D      
Sbjct: 1   MDDLTNDECAMCFSQISTLIPSCFPSTGGRVYFDGCFIRAENYSFYREALAPED------ 54

Query: 124 DAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQ 183
                                   AP+  GFA+   T   +SAY MA+C K L+H +CS 
Sbjct: 55  ----------------------TKAPSFRGFASKHETSNGISAYGMANCWKILDHDLCSI 92

Query: 184 CLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEMDLSLLHKSLKF 243
           CL++A ++AL+CIP+ E RVL AGCFLRYS   FAND      +   E +  LL + +++
Sbjct: 93  CLSEAVASALSCIPSTEARVLNAGCFLRYSDASFAND---SNGEYSKETEDLLLEERVQY 149

Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEM 303
           +QFKY+T++ AT+ F E+N+LG GG+GE+FKGTL DGREIA+KRL+ISRK R++EI NEM
Sbjct: 150 MQFKYATLDTATESFSETNRLGCGGFGEVFKGTLPDGREIAIKRLYISRKFRVQEIRNEM 209

Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
           +I+ RA HKNLV+FLGCCFT  DSF+VYE++ N+SLD ILFDP +KKELDWK+R +II G
Sbjct: 210 EIIGRAQHKNLVRFLGCCFTSIDSFLVYEYLANRSLDLILFDPAKKKELDWKRRFLIIEG 269

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
           TAEGLEYLHK  Q++I+HRDIKASN+LLDL+HRPKI+DFGLARF S ++SL+ NTAIAGT
Sbjct: 270 TAEGLEYLHKYSQVRIIHRDIKASNVLLDLRHRPKISDFGLARFYSCDQSLV-NTAIAGT 328

Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT 483
           LGYMAPEYIA G+LTEKVD+YSFGVLV+E+++GVQNNK+QS+  +ETLVT  WKHFQ+ T
Sbjct: 329 LGYMAPEYIAKGRLTEKVDVYSFGVLVIEMITGVQNNKYQSEKTYETLVTCAWKHFQSNT 388

Query: 484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPF 543
           V EIID S+ IED EE++RVV +GLLCTQE P LRP+ T VVQML++KD+ L +PSKPPF
Sbjct: 389 VQEIIDTSMTIEDAEEIERVVQIGLLCTQESPNLRPTTTEVVQMLRKKDVELSSPSKPPF 448

Query: 544 TDECMELSHTSGFSRRQSSS 563
           TDE MEL +     ++  S+
Sbjct: 449 TDELMELHYLGSLDQQHPST 468

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147765626|emb|CAN69245.1| hypothetical protein VITISV_038881 [Vitis vinifera]

 Score =  582 bits (1501), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 294/602 (48%), Positives = 388/602 (64%), Gaps = 80/602 (13%)

Query: 3   ADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
           A+ R +II R C      N SNYL +Y  ++  +R E+ K KFA KE G PP + Y+L+Q
Sbjct: 24  ANPRADIIARICSNDYAHNFSNYLDSYSKIITQLRDELPKTKFAFKEAGEPPDKIYVLAQ 83

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCG 122
           CM+DL+  +C  CF+Q++ L   C PA    V+LDGCFLR +NYSF+ +   P D ++C 
Sbjct: 84  CMDDLSFQDCQACFSQISSLFPGCFPATGGRVYLDGCFLRGDNYSFFQDTLTPMDYLRCS 143

Query: 123 --VDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADVSAYAMASCLKTLNHQM 180
             +   Q   B+ + V++E+V    +  P+ +G+A +  +   ++ Y MASC KTL+   
Sbjct: 144 DSISGVQNFDBIAKSVIDELV----RMTPSRDGYAAYDESANGITVYGMASCWKTLDRDR 199

Query: 181 CSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFK------------------ 222
           C+ CL  AA +A  C P+ EGRVL AGCFLRYS Y+F ND K                  
Sbjct: 200 CASCLASAAISAFACFPSAEGRVLNAGCFLRYSDYKFVNDPKWLAARDATLSFISHVVGV 259

Query: 223 -----------------------PHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFD 259
                                     +   +E+D S++ +SL   QFKY+T+EKATD F+
Sbjct: 260 VSVCILAIIIGFFIGKAAYQKRNQQNEANEIEVDSSVVKRSL---QFKYTTLEKATDYFN 316

Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           E+NKLG GG+GE+FKGTL+DGREIA+KRLFI  ++  +E+ NE+DI+  A HKNL     
Sbjct: 317 EANKLGQGGFGEVFKGTLRDGREIAIKRLFIXGQSGAQEVYNEIDIIGSACHKNLK---- 372

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                                    D ++KKEL WK R  II+GTAEGLEYLHKD  ++I
Sbjct: 373 -------------------------DTEKKKELPWKIRLGIIMGTAEGLEYLHKDCHVRI 407

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRDIKASN+LLD ++RPKIADFGLARF S++++L   TAIAGTLGYMAPEY+A G+LT+
Sbjct: 408 IHRDIKASNVLLDFRYRPKIADFGLARFYSTDRALT-GTAIAGTLGYMAPEYLAQGRLTD 466

Query: 440 KVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE 499
           KVD+YS+GVL+LEIVSGVQNNKFQ DD   TL T TWKHFQ+ T+ EIIDK +EIED+EE
Sbjct: 467 KVDVYSYGVLILEIVSGVQNNKFQLDDSLNTLATATWKHFQSNTMTEIIDKGMEIEDMEE 526

Query: 500 VKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECMELSHTSGFSRR 559
           V RV+ VGLLCTQE PTLRP MT ++QMLKQKD++LP PSKPPFT+E + +S   G  RR
Sbjct: 527 VTRVIQVGLLCTQESPTLRPXMTEIIQMLKQKDVSLPIPSKPPFTEENLTISPALGCPRR 586

Query: 560 QS 561
            +
Sbjct: 587 PA 588

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296087633|emb|CBI34889.3| unnamed protein product [Vitis vinifera]

 Score =  566 bits (1458), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 303/642 (47%), Positives = 400/642 (62%), Gaps = 84/642 (13%)

Query: 3   ADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
           A+ R +II R C      N SNYL +Y  ++  +R E+ K KFA KE G PP + Y+L+Q
Sbjct: 24  ANPRADIIARICSNDYAHNFSNYLDSYSKIITQLRDELPKTKFAFKEAGEPPDKIYVLAQ 83

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDM--- 119
           CM+DL+  +C  CF+Q++ L   C PA    V+LDGCFLR +NYSF+ +   P D +   
Sbjct: 84  CMDDLSFQDCQACFSQISSLFPGCFPATGGRVYLDGCFLRGDNYSFFQDTLTPMDYLVTA 143

Query: 120 ----------KCGVDAEQEQQDLFRRVVEEVVNKV-----------SKNAPNENGFATHK 158
                        +   Q   D+ + V++E+V              S N     G A+  
Sbjct: 144 FVFLVFFFIFLADISGVQNFDDVAKSVIDELVRMTPSRDGYAAYDESANGITVYGMASCW 203

Query: 159 YTL-----------ADVSAYAM----------ASCL---------KTLNHQMCSQCLTKA 188
            TL           A +SA+A           A C          +  +    S      
Sbjct: 204 KTLDRDRCASCLASAAISAFACFPSAEGRVLNAGCFLRYSDYKFYQGFDFSFYSFSWGSL 263

Query: 189 ASTALTCIPAIEGRV------LFAGCFLRYSRYEFANDFKPHKDDQGM------------ 230
           A   L+ I  + G V      +  G F+  + Y+  N       +  M            
Sbjct: 264 ADATLSFISHVVGVVSVCILAIIIGFFIGKAAYQKRNQQNEANGNSIMRKFVMIEHIPQI 323

Query: 231 --------EMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGRE 282
                   E+D S++ +SL   QFKY+T+EKATD F+E+NKLG GG+GE+FKGTL+DGRE
Sbjct: 324 IFLINEEIEVDSSVVKRSL---QFKYTTLEKATDYFNEANKLGQGGFGEVFKGTLRDGRE 380

Query: 283 IAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRI 342
           IA+KRLFI+ ++  +E+ NE+DI+  A HKNLV+FLGCCFT+ DSF+VYEF+ N+SLDR+
Sbjct: 381 IAIKRLFITGQSGAQEVYNEIDIIGSACHKNLVRFLGCCFTRHDSFLVYEFLPNRSLDRV 440

Query: 343 LFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF 402
           LFD ++KKEL WK R  II+GTAEGLEYLHKD  ++I+HRDIKASN+LLD ++RPKIADF
Sbjct: 441 LFDTEKKKELPWKIRLGIIMGTAEGLEYLHKDCHVRIIHRDIKASNVLLDFRYRPKIADF 500

Query: 403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKF 462
           GLARF S++++ L  TAIAGTLGYMAPEY+A G+LT+KVD+YS+GVL+LEIVSGVQNNKF
Sbjct: 501 GLARFYSTDRA-LTGTAIAGTLGYMAPEYLAQGRLTDKVDVYSYGVLILEIVSGVQNNKF 559

Query: 463 QSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMT 522
           Q DD   TL T TWKHFQ+ T+ EIIDK +EIED+EEV RV+ VGLLCTQE PTLRP+MT
Sbjct: 560 QLDDSLNTLATATWKHFQSNTMTEIIDKGMEIEDMEEVTRVIQVGLLCTQESPTLRPAMT 619

Query: 523 NVVQMLKQKDITLPTPSKPPFTDECMELSHTSGFSRRQSSSA 564
            ++QMLKQKD++LP PSKPPFT+E + +S   G  RR +  A
Sbjct: 620 EIIQMLKQKDVSLPIPSKPPFTEENLTISPALGCPRRPAVDA 661

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224107811|ref|XP_002314609.1| predicted protein [Populus trichocarpa] gi|222863649|gb|EEF00780.1| predicted protein [Populus trichocarpa]

 Score =  501 bits (1289), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 259/580 (44%), Positives = 360/580 (62%), Gaps = 35/580 (6%)

Query: 3   ADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
            D R+  ++  C +    N++ ++ N+ A +  +  +M    F     G  P   Y L+Q
Sbjct: 30  GDPRSQTVQVMCGRQLEHNATIFVPNFVATMGNISDQMRASGFGVAVSGSGPDINYGLAQ 89

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCG 122
           C  DL+L +C  C+A+   +L  C P     ++LDGCF+R ENYSFY E   P D   CG
Sbjct: 90  CYGDLSLLDCVLCYAEARTVLPQCYPYNGGRIYLDGCFMRAENYSFYEEYLGPGDKAVCG 149

Query: 123 VDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADV--SAYAMASCLKTLNHQM 180
                 +   F     + V++   +A N  G+A  + T+     SAY +A+C KTLN   
Sbjct: 150 --NTTRKSSTFAESTRQAVSQAVTSASNNQGYARVQLTVPGTNESAYVLANCWKTLNASS 207

Query: 181 CSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEMDLSL---- 236
           C  CL  A ++ L C+P  EGR L+ GCF+RYS  +F ND   +   +G+ + + +    
Sbjct: 208 CRACLENATASILGCLPWSEGRALYTGCFMRYSDIDFLNDELGNGSSRGLGVSIGVYIWK 267

Query: 237 ----------------LHKSLK--FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ 278
                           L ++L    L FKYST+EK T  FDE+NKLG GG+G ++KG L 
Sbjct: 268 RRYIMKKRRGSNEAQKLARTLNDSSLNFKYSTLEKGTGSFDETNKLGQGGFGSVYKGALP 327

Query: 279 DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKS 338
           DGREIAVKRLF + ++R  +  NE++++S   HKNLV+ LGC  +  +S +VYEF+ N+S
Sbjct: 328 DGREIAVKRLFFNNRHRAADFYNEVNMISSVEHKNLVRLLGCSCSGPESLLVYEFLPNRS 387

Query: 339 LDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPK 398
           LDR +FD  + KEL W+KR+ II GTAEGL YLH +  ++I+HRDIKASNILLD + R K
Sbjct: 388 LDRFIFDQNKGKELTWEKRYEIITGTAEGLAYLHMNSSIRIIHRDIKASNILLDSRLRAK 447

Query: 399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQ 458
           IADFGLAR    +KS + +TAIAGTLGYMAPEY+A+GQLTEKVD+Y FGVL+LEIV+G Q
Sbjct: 448 IADFGLARSFQDDKSHI-STAIAGTLGYMAPEYLAHGQLTEKVDVYGFGVLLLEIVTGRQ 506

Query: 459 NNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED------IEEVKRVVWVGLLCTQ 512
           NN+ ++ +  E+LV  TWK FQA TV E+ D ++ + +      + +VKR V VGLLCTQ
Sbjct: 507 NNRSKNSEYTESLVILTWKKFQAGTVEELYDPNLMLHNHHDNNVMNDVKRAVHVGLLCTQ 566

Query: 513 ELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDE-CMELS 551
           E+P+LRP+M+  +QML  ++  LP PS PPF DE  MEL+
Sbjct: 567 EIPSLRPTMSKALQMLTTEE-HLPRPSNPPFIDEMTMELN 605

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225425609|ref|XP_002265910.1| PREDICTED: cysteine-rich receptor-like protein kinase 2 [Vitis vinifera] gi|297739089|emb|CBI28578.3| unnamed protein product [Vitis vinifera]

 Score =  500 bits (1288), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 263/598 (43%), Positives = 363/598 (60%), Gaps = 52/598 (8%)

Query: 3   ADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
            D R+  I+  C      NS+ ++ N+ A++  +  +M    F     G  P  TY L+Q
Sbjct: 31  GDPRSRTIQMMCGNQREHNSTIFVINFVAMMENISNQMRTSGFGVAVLGSAPDATYGLAQ 90

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCG 122
           C  DL+L +C  C+A+    L  C P  +  ++LDGCF+R +NYSF  E   P D   CG
Sbjct: 91  CYGDLSLLDCVLCYAEARTFLPQCFPFTTGRIYLDGCFMRAQNYSFIEEYTGPSDHALCG 150

Query: 123 VDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTL---ADVSAYAMASCLKTLNHQ 179
              E  +   F+    + + +   +APN NG+A  K  +   A+ SAY +A+C +TLN  
Sbjct: 151 --NETRKNSTFQESARQAIKQAVADAPNNNGYARSKVMVPGTANESAYVLANCWRTLNAI 208

Query: 180 MCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEM------- 232
            C  CL  A+S+ L C+P  EGR L  GCF+RYS  +F N    +   +G  +       
Sbjct: 209 SCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGSSRGTIIIIVVSAV 268

Query: 233 ------------------------------DLSLLHKSL--KFLQFKYSTIEKATDCFDE 260
                                         D   L K+L    L FKY+T+EKAT  FD 
Sbjct: 269 SAVIVLLVGGAIGVYILKQRKIQKKRRGSNDAIKLVKTLHDSSLNFKYATLEKATGSFDN 328

Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +NKLG GG+G ++KG L DGREIAVKRLF + ++R  +  NE++I+S   HKNLV+ LGC
Sbjct: 329 ANKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRAADFYNEVNIISSVEHKNLVRLLGC 388

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             +  +S ++YEF+ NKSLDR +FD  + K L+W+KR  II GTAEGL YLH++ +++I+
Sbjct: 389 SCSGPESLLIYEFLPNKSLDRFIFDTNRGKALNWEKRCEIITGTAEGLVYLHENSKIRII 448

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           HRDIKASNILLD K R KIADFGLAR    +KS + +TAIAGTLGYMAPEY+A+GQLTEK
Sbjct: 449 HRDIKASNILLDSKMRAKIADFGLARSFQEDKSHI-STAIAGTLGYMAPEYLAHGQLTEK 507

Query: 441 VDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIE-- 498
            D+YSFGVL+LEI +G QNN+ ++ +  ++LVT  WKHFQ  T+ E+ D ++ + + +  
Sbjct: 508 ADVYSFGVLLLEIATGRQNNRSKTAEYSDSLVTIAWKHFQLGTLEELFDPNLMLHNHDNG 567

Query: 499 ----EVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDE-CMELS 551
               EV RV+ +GLLCTQE+P+LRPSM+  +QML +KD  LPTP+ PPF DE  MEL+
Sbjct: 568 NIKNEVLRVMQIGLLCTQEVPSLRPSMSKALQMLTKKDEHLPTPTSPPFIDERTMELN 625

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147767573|emb|CAN64526.1| hypothetical protein VITISV_005913 [Vitis vinifera]

 Score =  500 bits (1288), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 263/598 (43%), Positives = 363/598 (60%), Gaps = 52/598 (8%)

Query: 3   ADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
            D R+  I+  C      NS+ ++ N+ A++  +  +M    F     G  P  TY L+Q
Sbjct: 31  GDPRSRTIQMMCGNQREHNSTIFVINFVAMMENISNQMRTSGFGVAVLGSAPDATYGLAQ 90

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCG 122
           C  DL+L +C  C+A+    L  C P  +  ++LDGCF+R +NYSF  E   P D   CG
Sbjct: 91  CYGDLSLLDCVLCYAEARTFLPQCFPFTTGRIYLDGCFMRAQNYSFIEEYTGPSDHALCG 150

Query: 123 VDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTL---ADVSAYAMASCLKTLNHQ 179
              E  +   F+    + + +   +APN NG+A  K  +   A+ SAY +A+C +TLN  
Sbjct: 151 --NETRKNSTFQESARQAIKQAVADAPNNNGYARSKVMVPGTANESAYVLANCWRTLNAI 208

Query: 180 MCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEM------- 232
            C  CL  A+S+ L C+P  EGR L  GCF+RYS  +F N    +   +G  +       
Sbjct: 209 SCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGSSRGTIIIIVVSAV 268

Query: 233 ------------------------------DLSLLHKSL--KFLQFKYSTIEKATDCFDE 260
                                         D   L K+L    L FKY+T+EKAT  FD 
Sbjct: 269 SAVIVLLVGGAIGVYILKQRKIQKKRRGSNDAIKLVKTLHDSSLNFKYATLEKATGSFDN 328

Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +NKLG GG+G ++KG L DGREIAVKRLF + ++R  +  NE++I+S   HKNLV+ LGC
Sbjct: 329 ANKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRAADFYNEVNIISSVEHKNLVRLLGC 388

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             +  +S ++YEF+ NKSLDR +FD  + K L+W+KR  II GTAEGL YLH++ +++I+
Sbjct: 389 SCSGPESLLIYEFLPNKSLDRFIFDTNRGKALNWEKRCEIITGTAEGLVYLHENSKIRII 448

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           HRDIKASNILLD K R KIADFGLAR    +KS + +TAIAGTLGYMAPEY+A+GQLTEK
Sbjct: 449 HRDIKASNILLDSKMRAKIADFGLARSFQEDKSHI-STAIAGTLGYMAPEYLAHGQLTEK 507

Query: 441 VDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIE-- 498
            D+YSFGVL+LEI +G QNN+ ++ +  ++LVT  WKHFQ  T+ E+ D ++ + + +  
Sbjct: 508 ADVYSFGVLLLEIXTGRQNNRSKTAEYSDSLVTIAWKHFQLGTLEELFDPNLMLHNHDNG 567

Query: 499 ----EVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDE-CMELS 551
               EV RV+ +GLLCTQE+P+LRPSM+  +QML +KD  LPTP+ PPF DE  MEL+
Sbjct: 568 NIKNEVLRVMQIGLLCTQEVPSLRPSMSKALQMLTKKDEHLPTPTSPPFIDERTMELN 625

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225425605|ref|XP_002265829.1| PREDICTED: cysteine-rich receptor-like protein kinase 2 [Vitis vinifera]

 Score =  498 bits (1283), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 263/598 (43%), Positives = 359/598 (60%), Gaps = 52/598 (8%)

Query: 3   ADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
            D R+ +I+  C   P  NS+ ++ N+ A++  +  ++    F     G  P   Y L+Q
Sbjct: 31  GDPRSRMIQITCANQPEHNSTIFVPNFVAMMENISNQVRTSGFGVAISGSGPDANYGLAQ 90

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCG 122
           C  DL+L +C  C+A+   +L  C P     ++LDGCF+R +NYSF  E   P D   CG
Sbjct: 91  CYGDLSLLDCVLCYAEARTVLPQCFPYNGGRIYLDGCFMRAQNYSFIEEYTGPSDHALCG 150

Query: 123 VDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTL---ADVSAYAMASCLKTLNHQ 179
              E  +   F+    + + +   +APN NG+A  K  +   A+ SAY +A C +TLN  
Sbjct: 151 --NETRKNSTFQESARQAIKQAVADAPNNNGYARSKVIVPGTANESAYVLADCWRTLNAS 208

Query: 180 MCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEM------- 232
            C  CL  A+S+ L C+P  EGR L  GCF+RYS  +F N    +   +G  +       
Sbjct: 209 SCRACLENASSSILGCLPWSEGRALNTGCFMRYSDTDFLNKEPDNGSSRGTVIIIVVPAV 268

Query: 233 ------------------------------DLSLLHKSL--KFLQFKYSTIEKATDCFDE 260
                                         D   L K+L    L FKY+T+EKAT  FD 
Sbjct: 269 SAVIVLLVLGAIGVYIWKQRKIQKKRRGSNDAIKLVKTLHDSSLNFKYATLEKATGSFDN 328

Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
            NKLG GG+G ++KG L DGREIAVKRLF + ++R  +  NE++I+S   HKNLV+ LGC
Sbjct: 329 ENKLGQGGFGTVYKGVLTDGREIAVKRLFFNNRHRAADFYNEVNIISSVEHKNLVRLLGC 388

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             +  +S +VYE++ NKSLDR +FD  + K L+W+KR  IIIGTAEGL YLH++   +I+
Sbjct: 389 SCSGPESLLVYEYLPNKSLDRFIFDTNRGKALNWEKRCEIIIGTAEGLAYLHENSTNRII 448

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           HRDIKASNILLD K R KIADFGLAR    +KS +  TAIAGTLGYMAPEY+A+GQLTEK
Sbjct: 449 HRDIKASNILLDSKMRAKIADFGLARSFQEDKSHI-TTAIAGTLGYMAPEYLAHGQLTEK 507

Query: 441 VDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDI--- 497
           VD+YSFGVL+LEIV+G QNN+ ++ +  +++VT  WKHFQ  T+ E+ D ++ + +    
Sbjct: 508 VDVYSFGVLLLEIVTGRQNNRSKTSEYSDSIVTIAWKHFQLGTLEELFDPNLMLHNYHNG 567

Query: 498 ---EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDE-CMELS 551
               EV RV+ + LLCTQE P+LRPSM+  +QML +KD  LPTP+ PPF DE  MEL+
Sbjct: 568 NIKNEVLRVMQIALLCTQEAPSLRPSMSKALQMLTKKDEHLPTPTNPPFIDERTMELN 625

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356497745|ref|XP_003517719.1| PREDICTED: cysteine-rich receptor-like protein kinase 2-like [Glycine max]

 Score =  496 bits (1276), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 263/604 (43%), Positives = 365/604 (60%), Gaps = 54/604 (8%)

Query: 3   ADARTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKKKFASKEFGIPPSRTYMLSQ 62
           A+ R   +   C      N++ ++ N+ A +  +  EM K  F +   G  P   Y L+Q
Sbjct: 29  AEPRAKTVLITCGHELEHNTTIFVPNFVATMEKISDEMRKTGFGTAIVGTGPDTNYGLAQ 88

Query: 63  CMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDDMKCG 122
           C  DL+L +C  C+A+   +L  C P  S  +FLDGCF+R ENYSF+ E   P D   CG
Sbjct: 89  CYGDLSLLDCVLCYAEARTVLPQCFPYNSGRIFLDGCFMRAENYSFFNEYTGPGDRAVCG 148

Query: 123 VDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTLADV---SAYAMASCLKTLNHQ 179
               +     F     + V +  ++APN  G+A     +A     SAY +A C +TL+  
Sbjct: 149 NTTRKNSS--FHAAAMQAVLRAVQDAPNNKGYAKGNVAVAGTTNQSAYVLADCWRTLDKS 206

Query: 180 MCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFANDFKPHKDDQGMEM------- 232
            C  CL  A+S+ L C+P  EGR L  GCF+RYS  +F N  + +   +G  +       
Sbjct: 207 SCKACLENASSSILGCLPWQEGRALNTGCFMRYSDTDFLNKEQENGSSRGNVVVIVIAVV 266

Query: 233 ------------------------------DLSLLHKSLKF--LQFKYSTIEKATDCFDE 260
                                         D   L K+L+   L FKYST++KAT+ F E
Sbjct: 267 SSVTVLVVGVTIGVYIWKQRYIQKKRRGSNDAKKLAKTLQNNNLNFKYSTLDKATESFHE 326

Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +NKLG GG+G ++KG L DGREIAVKRLF + ++R  +  NE++I+S   HKNLV+ LGC
Sbjct: 327 NNKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRAADFYNEVNIISSVEHKNLVRLLGC 386

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             +  +S +VYEF+ N+SLDR +FD  + KEL+W+ R+ IIIGTAEGL YLH++ + +I+
Sbjct: 387 SCSGPESLLVYEFLPNRSLDRYIFDKNKGKELNWENRYEIIIGTAEGLVYLHENSKTRII 446

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           HRDIKASNILLD K R KIADFGLAR    ++S + +TAIAGTLGYMAPEY+A+GQLTEK
Sbjct: 447 HRDIKASNILLDAKLRAKIADFGLARSFQEDQSHI-STAIAGTLGYMAPEYLAHGQLTEK 505

Query: 441 VDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED---- 496
            D+YSFGVL+LEIV+  QNN+ ++ +  ++LVT  WKHFQA T  ++ D ++++++    
Sbjct: 506 ADVYSFGVLLLEIVTARQNNRSKASEYSDSLVTVAWKHFQAGTSEQLFDPNLDLQEDHNS 565

Query: 497 ----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDE-CMELS 551
                +E+ RVV +GLLCTQE+P+LRPSM+  +QML +K+  L  PS PPF DE  MEL 
Sbjct: 566 NVNVKDEIIRVVHIGLLCTQEVPSLRPSMSKALQMLTKKEEHLDAPSNPPFLDESTMELH 625

Query: 552 HTSG 555
            TSG
Sbjct: 626 DTSG 629

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351720648|ref|NP_001235136.1| protein kinase family protein [Glycine max] gi|223452426|gb|ACM89540.1| protein kinase family protein [Glycine max]

 Score =  494 bits (1271), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 258/568 (45%), Positives = 351/568 (61%), Gaps = 54/568 (9%)

Query: 39  EMYKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDG 98
           EM K  F +   G  P   Y L+QC  DL+L +C  C+A+   +L  C P  S  +FLDG
Sbjct: 7   EMRKTGFGTAIVGTGPDTNYGLAQCYGDLSLLDCVLCYAEARTVLPQCFPYNSGRIFLDG 66

Query: 99  CFLRLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHK 158
           CF+R ENYSF+ E   P D   CG    +     F+    + V +  ++APN  G+A   
Sbjct: 67  CFMRAENYSFFNEYLGPGDRAVCGNTTRKNSS--FQAAARQAVLRAVQDAPNNKGYAKGN 124

Query: 159 YTLADV---SAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRY 215
             +A     SAY +A C +TL+ + C  CL  A+S+ L C+P  EGR L  GCF+RYS  
Sbjct: 125 VAVAGTTNQSAYVLADCWRTLDKRSCKACLENASSSILGCLPWSEGRALNTGCFMRYSDT 184

Query: 216 EFANDFKPHKDDQGMEM-------------------------------------DLSLLH 238
           +F N  + +    G  +                                     D   L 
Sbjct: 185 DFLNKEQENGSSSGNVVVIVIAVVSSVIVSVVGVTIGVYIWKQRNIQKKRRGSNDAEKLA 244

Query: 239 KSLKF--LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRI 296
           K+L+   L FKYST++KAT+ F E+NKLG GG+G ++KG L DGREIAVKRLF + ++R 
Sbjct: 245 KTLQNNNLNFKYSTLDKATESFHENNKLGQGGFGTVYKGVLADGREIAVKRLFFNNRHRA 304

Query: 297 KEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK 356
            +  NE++I+S   HKNLV+ LGC  +  +S +VYEF+ N+SLDR +FD  + KEL+W+K
Sbjct: 305 ADFYNEVNIISSVEHKNLVRLLGCSCSGPESLLVYEFLPNRSLDRYIFDKNKGKELNWEK 364

Query: 357 RHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP 416
           R+ IIIGTAEGL YLH++ + +I+HRDIKASNILLD K R KIADFGLAR    +KS + 
Sbjct: 365 RYEIIIGTAEGLVYLHENSKTRIIHRDIKASNILLDAKLRAKIADFGLARSFQEDKSHI- 423

Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW 476
           +TAIAGTLGYMAPEY+A+GQLTEK D+YSFGVL+LEIV+  QNN+ ++ +  ++LVT  W
Sbjct: 424 STAIAGTLGYMAPEYLAHGQLTEKADVYSFGVLLLEIVTARQNNRSKASEYSDSLVTVAW 483

Query: 477 KHFQAKTVLEIIDKSIEIED--------IEEVKRVVWVGLLCTQELPTLRPSMTNVVQML 528
           KHFQA T  ++ D ++++++         +E+ RVV +GLLCTQE+ +LRPSM+  +QML
Sbjct: 484 KHFQAGTAEQLFDPNLDLQEDHNSNVNVKDEILRVVHIGLLCTQEVSSLRPSMSKALQML 543

Query: 529 KQKDITLPTPSKPPFTDE-CMELSHTSG 555
            +K+  L  PS PPF DE  MEL  TSG
Sbjct: 544 TKKEEDLVAPSNPPFLDESTMELHDTSG 571

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	569
TAIR|locus:2026821	649	CRK2 "cysteine-rich RLK (RECEP	0.585	0.513	0.533	5.1e-121
TAIR|locus:2139845	625	AT4G28670 [Arabidopsis thalian	0.699	0.636	0.496	6.8e-95
TAIR|locus:2026785	646	CRK3 "cysteine-rich RLK (RECEP	0.520	0.458	0.451	7e-92
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.527	0.443	0.458	7.4e-82
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.523	0.445	0.471	1.1e-80
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.576	0.485	0.421	1.7e-80
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.565	0.481	0.443	1.2e-79
TAIR|locus:2123071	636	CRK33 "cysteine-rich RLK (RECE	0.536	0.479	0.454	2.5e-79
TAIR|locus:2123126	666	CRK31 "cysteine-rich RLK (RECE	0.622	0.531	0.447	3.2e-79
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.527	0.465	0.447	1.4e-76

TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 896 (320.5 bits), Expect = 5.1e-121, Sum P(2) = 5.1e-121
 Identities = 184/345 (53%), Positives = 241/345 (69%)

Query:   233 DLSLLHKSLK--FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFI 290
             D+  + K+LK   L FKYST+EKAT  FD +NKLG GG+G ++KG L DGR+IAVKRLF 
Sbjct:   298 DVEKMAKTLKDSSLNFKYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFF 357

Query:   291 SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKK 350
             + ++R  +  NE++++S   HKNLV+ LGC  +  +S +VYE++QNKSLDR +FD  + K
Sbjct:   358 NNRHRATDFYNEVNMISTVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGK 417

Query:   351 ELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS 410
              LDW++R+ II+GTAEGL YLH+   ++I+HRDIKASNILLD K + KIADFGLAR    
Sbjct:   418 TLDWQRRYTIIVGTAEGLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQD 477

Query:   411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET 470
             +KS + +TAIAGTLGYMAPEY+A+GQLTE VD+YSFGVLVLEIV+G QN K +  D  ++
Sbjct:   478 DKSHI-STAIAGTLGYMAPEYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDS 536

Query:   471 LVTHTWKHFQAKTV-------LXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTN 523
             L+T  WKHFQ+  +       L              + RVV +GLLCTQE+P+LRP M+ 
Sbjct:   537 LITEAWKHFQSGELEKIYDPNLDWKSQYDSHIIKKEIARVVQIGLLCTQEIPSLRPPMSK 596

Query:   524 VVQMLKQKDITLPTPSKPPFTDE-CMELSHTS-GFSRRQSSSAKI 566
             ++ MLK K+  LP PS PPF DE  MEL   S G S   +S A +
Sbjct:   597 LLHMLKNKEEVLPLPSNPPFMDERVMELRDGSDGDSAGCASLATV 641

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010193 "response to ozone" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006457 "protein folding" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0009408 "response to heat" evidence=RCA

GO:0009644 "response to high light intensity" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

GO:0042542 "response to hydrogen peroxide" evidence=RCA

TAIR|locus:2139845 AT4G28670 [Arabidopsis thaliana (taxid:3702)]

 Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
 Identities = 204/411 (49%), Positives = 263/411 (63%)

Query:   149 PNENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGC 208
             P++ GFA +       S Y   +    L      + LT     ++  + AI        C
Sbjct:   217 PSKEGFALNAGCYLRYSNYTFYNERGLLAMSFTKENLTYIFVISMVGVLAIAAGFWCGKC 276

Query:   209 F-LRYSRYEFANDFKPHK----DDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNK 263
             F +R S  +     K  K        +E +   +      + F+YST++KAT+ F+ES K
Sbjct:   277 FYMRTSPKKKIKGTKTKKFHLFGHLRIEKESESICTESHLMSFEYSTLKKATNNFNESCK 336

Query:   264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT 323
             LG GGYGE+FKGTL DGREIA+KRL +S K    EI NE+D++SR  HKNLV+ LGCCFT
Sbjct:   337 LGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEIDVISRCQHKNLVRLLGCCFT 396

Query:   324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRD 383
               +SF+VYEF+ N SLD ILF+P++KKELDWKKR  II+GTAEGLEYLH+    +I+HRD
Sbjct:   397 NMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILGTAEGLEYLHET--CKIIHRD 454

Query:   384 IKASNILLDLKHRPKIADFGLARF-----SSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
             IKASNILLDLK++PKI+DFGLA+F          S L  ++IAGTLGYMAPEYI+ G+L+
Sbjct:   455 IKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPSSIAGTLGYMAPEYISKGRLS 514

Query:   439 EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA-KTVLXXXXXXXXXXXX 497
              K+D YSFGVLVLEI SG +NNKF+SD+  ETLVT  WK F + K               
Sbjct:   515 NKIDAYSFGVLVLEITSGFRNNKFRSDNSLETLVTQVWKCFASNKMEEMIDKDMGEDTDK 574

Query:   498 XXVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECM 548
               +KRV+ +GLLCTQE P LRP+M+ V+QM+   DI LPTP+KPPF  + M
Sbjct:   575 QEMKRVMQIGLLCTQESPQLRPTMSKVIQMVSSTDIVLPTPTKPPFLHDSM 625

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 693 (249.0 bits), Expect = 7.0e-92, Sum P(2) = 7.0e-92
 Identities = 136/301 (45%), Positives = 197/301 (65%)

Query:   244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEM 303
             L F Y  +E+ATD F + NKLG GG G ++KG L +G+ +AVKRLF + K  +    NE+
Sbjct:   309 LCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEV 368

Query:   304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
             +++S+  HKNLV+ LGC  T  +S +VYE++ N+SL   LF  K  + L+W KR  II+G
Sbjct:   369 NLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWAKRFKIILG 428

Query:   364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
             TAEG+ YLH++  ++I+HRDIK SNILL+    P+IADFGLAR    +K+ + +TAIAGT
Sbjct:   429 TAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHI-STAIAGT 487

Query:   424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT 483
             LGYMAPEY+  G+LTEK D+YSFGVL++E+++G +NN F  D G  +++   W  ++   
Sbjct:   488 LGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAG--SILQSVWSLYRTSN 545

Query:   484 VLXXXX-XXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPP 542
             V                  R++ +GLLC Q     RP+M+ VV+M+K   + + TP++PP
Sbjct:   546 VEEAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMKGS-LEIHTPTQPP 604

Query:   543 F 543
             F
Sbjct:   605 F 605

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 709 (254.6 bits), Expect = 7.4e-82, Sum P(2) = 7.4e-82
 Identities = 138/301 (45%), Positives = 196/301 (65%)

Query:   244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEM 303
             LQ  Y TI+ AT+ F ESNK+G GG+GE++KGT  +G+E+AVKRL  + +    E   E+
Sbjct:   339 LQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEV 398

Query:   304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
              ++++  H+NLV+ LG     ++  +VYE++ NKSLD +LFDP ++ +LDW +R+ II G
Sbjct:   399 VVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGG 458

Query:   364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
              A G+ YLH+D ++ I+HRD+KASNILLD    PKIADFG+AR    +++    + I GT
Sbjct:   459 IARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGT 518

Query:   424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT 483
              GYMAPEY  +GQ + K D+YSFGVLVLEI+SG +N+ F   DG + L+THTW+ +  +T
Sbjct:   519 YGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTWRLWTNRT 578

Query:   484 VLXXXXXXXXXX-XXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPP 542
              L               V R + +GLLC QE P  RP+++ V  ML    +TLP P +P 
Sbjct:   579 ALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTLPVPRQPG 638

Query:   543 F 543
             F
Sbjct:   639 F 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 705 (253.2 bits), Expect = 1.1e-80, Sum P(2) = 1.1e-80
 Identities = 141/299 (47%), Positives = 192/299 (64%)

Query:   244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEM 303
             LQ  Y TI+ ATD F ESNK+G GG+GE++KGTL DG E+AVKRL  S      E  NE+
Sbjct:   334 LQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEV 393

Query:   304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
              ++++  H+NLV+ LG C   ++  +VYE+V NKSLD  LFDP +K +LDW +R+ II G
Sbjct:   394 VLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGG 453

Query:   364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
              A G+ YLH+D ++ I+HRD+KASNILLD    PKIADFG+AR    +++    + I GT
Sbjct:   454 VARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGT 513

Query:   424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ-AK 482
              GYM+PEY  +GQ + K D+YSFGVLVLEI+SG +N+ F   DG   LV++ W  +   +
Sbjct:   514 YGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGR 573

Query:   483 TVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKP 541
              +               V R V +GLLC QE P  RP+++ +V ML    +TLP P +P
Sbjct:   574 PLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQP 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 697 (250.4 bits), Expect = 1.7e-80, Sum P(2) = 1.7e-80
 Identities = 140/332 (42%), Positives = 207/332 (62%)

Query:   240 SLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEI 299
             S + LQF++S IE AT+ F ESNKLGHGG+GE++KG L  G  +A+KRL        +E 
Sbjct:   329 STETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEF 388

Query:   300 CNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
              NE+D++++  H+NL + LG C   ++  +VYEFV NKSLD  LFD ++++ LDW++R+ 
Sbjct:   389 KNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYK 448

Query:   360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA 419
             II G A G+ YLH+D ++ I+HRD+KASNILLD    PKI+DFG+AR    +++      
Sbjct:   449 IIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKR 508

Query:   420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF 479
             I GT GYM+PEY  +G+ + K D+YSFGVLVLE+++G +N+ F  +DG   LVT+ WK +
Sbjct:   509 IVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWKLW 568

Query:   480 QAKTVLXXXXXXXXXXXXXX-VKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTP 538
                + L               V R + + LLC QE  + RPSM +++ M+    +TLP P
Sbjct:   569 VENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTVTLPIP 628

Query:   539 SKPPFTDECMELSH---TSGFSRRQSSSAKIL 567
              +  F    M+ S    + G +   S+++K L
Sbjct:   629 KRSGFLLRTMKDSRDPRSGGSASDHSATSKSL 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 691 (248.3 bits), Expect = 1.2e-79, Sum P(2) = 1.2e-79
 Identities = 144/325 (44%), Positives = 193/325 (59%)

Query:   244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEM 303
             LQF + TIE ATD F +SN +G GG+GE+++G L  G E+AVKRL  +     +E  NE 
Sbjct:   331 LQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEA 390

Query:   304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
              ++S+  HKNLV+ LG C   ++  +VYEFV NKSLD  LFDP ++ ELDW +R+ II G
Sbjct:   391 VLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGG 450

Query:   364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
              A G+ YLH+D ++ I+HRD+KASNILLD    PKIADFG+AR    ++S      IAGT
Sbjct:   451 IARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGT 510

Query:   424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQS-DDGFETLVTHTWKHFQAK 482
              GYM+PEY   G  + K D+YSFGVLVLEI+SG +N+ F + DD    LVTH W+ ++  
Sbjct:   511 FGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNG 570

Query:   483 TVLXXXX-XXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKP 541
             + L                 R + + LLC QE P  RP +  ++ ML     TL  P  P
Sbjct:   571 SPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAP 630

Query:   542 PFTDECMELSHTSGFSRRQSSSAKI 566
              F     +L    G    +S+S  I
Sbjct:   631 GFCLSGRDLEQ-DGVEYTESTSRSI 654

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2123071 CRK33 "cysteine-rich RLK (RECEPTOR-like protein kinase) 33" [Arabidopsis thaliana (taxid:3702)]

 Score = 721 (258.9 bits), Expect = 2.5e-79, Sum P(2) = 2.5e-79
 Identities = 140/308 (45%), Positives = 199/308 (64%)

Query:   239 KSLKF-LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK 297
             +S K+ LQ+   TIE AT  F + N LG GG+GE+FKG LQDG EIAVKRL       ++
Sbjct:   301 ESPKYSLQYDLKTIEAATCTFSKCNMLGQGGFGEVFKGVLQDGSEIAVKRLSKESAQGVQ 360

Query:   298 EICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKR 357
             E  NE  ++++  H+NLV  LG C   ++  +VYEFV NKSLD+ LF+P +K +LDW KR
Sbjct:   361 EFQNETSLVAKLQHRNLVGVLGFCMEGEEKILVYEFVPNKSLDQFLFEPTKKGQLDWAKR 420

Query:   358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             + II+GTA G+ YLH D  ++I+HRD+KASNILLD +  PK+ADFG+AR    ++S    
Sbjct:   421 YKIIVGTARGILYLHHDSPLKIIHRDLKASNILLDAEMEPKVADFGMARIFRVDQSRADT 480

Query:   418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKF-QSDDGFETLVTHTW 476
               + GT GY++PEY+ +GQ + K D+YSFGVLVLEI+SG +N+ F ++D+  + LVT+ W
Sbjct:   481 RRVVGTHGYISPEYLMHGQFSVKSDVYSFGVLVLEIISGKRNSNFHETDESGKNLVTYAW 540

Query:   477 KHFQAKTVLXXXXXXXXXXXXXX-VKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL 535
             +H++  + L               V R + + LLC Q  P  RP+++ ++ ML    ITL
Sbjct:   541 RHWRNGSPLELVDSELEKNYQSNEVFRCIHIALLCVQNDPEQRPNLSTIIMMLTSNSITL 600

Query:   536 PTPSKPPF 543
             P P  P +
Sbjct:   601 PVPQSPVY 608

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)]

 Score = 733 (263.1 bits), Expect = 3.2e-79, Sum P(2) = 3.2e-79
 Identities = 165/369 (44%), Positives = 218/369 (59%)

Query:   203 VLFAGCFLRYSRYEFANDFKPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESN 262
             VL A   + + R +     K H DD     D++    S + LQF ++TIE ATD F  +N
Sbjct:   293 VLVALGLVIWKRRQSYKTLKYHTDD-----DMT----SPQSLQFDFTTIEVATDNFSRNN 343

Query:   263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
             KLG GG+GE++KG L +  EIAVKRL  +     +E  NE+ I+++  HKNLV+ LG C 
Sbjct:   344 KLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQGTQEFKNEVVIVAKLQHKNLVRLLGFCI 403

Query:   323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
              + +  +VYEFV NKSLD  LFDPK K +LDWK+R+ II G   GL YLH+D ++ I+HR
Sbjct:   404 ERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWKRRYNIIGGVTRGLLYLHQDSRLTIIHR 463

Query:   383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVD 442
             DIKASNILLD    PKIADFG+AR    +++      + GT GYM PEY+ +GQ + K D
Sbjct:   464 DIKASNILLDADMNPKIADFGMARNFRVDQTEDQTGRVVGTFGYMPPEYVTHGQFSTKSD 523

Query:   443 IYSFGVLVLEIVSGVQNNKF-QSDDGFETLVTHTWKHFQAKTVLXXXX-XXXXXXXXXXV 500
             +YSFGVL+LEIV G +N+ F Q DD    LVTH W+ +   + L               V
Sbjct:   524 VYSFGVLILEIVCGKKNSSFFQMDDSGGNLVTHVWRLWNNDSPLDLIDPAIKESYDNDEV 583

Query:   501 KRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPP--FTDECMELSH-TSGFS 557
              R + +G+LC QE P  RP M+ + QML    ITLP P +PP  F      L   T G  
Sbjct:   584 IRCIHIGILCVQETPADRPEMSTIFQMLTNSSITLPVP-RPPGFFFRNRPNLDPLTYGSE 642

Query:   558 RRQSSSAKI 566
             + QSSS  +
Sbjct:   643 QGQSSSMSV 651

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 667 (239.9 bits), Expect = 1.4e-76, Sum P(2) = 1.4e-76
 Identities = 135/302 (44%), Positives = 187/302 (61%)

Query:   244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEM 303
             LQF +  IE AT+CF   NKLG GG+GE++KGTL  G ++AVKRL  +     KE  NE+
Sbjct:   312 LQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEV 371

Query:   304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
              ++++  H+NLV+ LG C   ++  +VYEFV NKSLD  LFD   K +LDW +R+ II G
Sbjct:   372 VVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGG 431

Query:   364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
              A G+ YLH+D ++ I+HRD+KA NILLD    PKIADFG+AR    +++      + GT
Sbjct:   432 IARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGT 491

Query:   424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNK-FQSDDGFETLVTHTWKHFQAK 482
              GYM+PEY   GQ + K D+YSFGVLVLEI+SG++N+  +Q D+    LVT+TW+ +   
Sbjct:   492 YGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSNG 551

Query:   483 TVLXXXX-XXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKP 541
             +                 + R + + LLC QE    RP+M+++VQML    I L  P  P
Sbjct:   552 SPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLIALAEPRPP 611

Query:   542 PF 543
              F
Sbjct:   612 GF 613

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9CAL3	CRK2_ARATH	2, ., 7, ., 1, 1, ., -	0.4295	0.9648	0.8459	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_III000672 hypothetical protein (471 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	569
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-48
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-42
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-33
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-31
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-28
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-23
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-23
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-22
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-22
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-12
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	9e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	2e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	6e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	8e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.003
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  170 bits (433), Expect = 1e-49
 Identities = 67/194 (34%), Positives = 112/194 (57%), Gaps = 11/194 (5%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFLGCC 321
           LG GG+G ++     + G+++A+K +     + + E +  E++I+ + +H N+V+  G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
             +   ++V E+ +  SL  +L   + + +L   +   I++   EGLEYLH      I+H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 382 RDIKASNILLD-LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTE 439
           RD+K  NILLD    + K+ADFGL++  +S+KSLL    I GT  YMAPE +   G  +E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGKGYYSE 173

Query: 440 KVDIYSFGVLVLEI 453
           K DI+S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  169 bits (430), Expect = 1e-48
 Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 11/197 (5%)

Query: 262 NKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFLG 319
            KLG G +G+++     + G+ +A+K +   +  + +E I  E+ I+ +  H N+V+   
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
               +   ++V E+ +   L  +L   K++  L   +    +      LEYLH      I
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGI 118

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           VHRD+K  NILLD     K+ADFGLAR     + L   T   GT  YMAPE +      +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGYGK 175

Query: 440 KVDIYSFGVLVLEIVSG 456
            VDI+S GV++ E+++G
Sbjct: 176 AVDIWSLGVILYELLTG 192

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  161 bits (410), Expect = 9e-46
 Identities = 86/296 (29%), Positives = 133/296 (44%), Gaps = 62/296 (20%)

Query: 262 NKLGHGGYGEIFKGTLQDG----REIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNLV 315
            KLG G +GE++KG L+       E+AVK L    S + R K+   E  +M +  H N+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-KDFLKEARVMKKLGHPNVV 59

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLD------RILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           + LG C  ++  ++V E+++   L       R +F   +K  L  K      I  A+G+E
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG---- 425
           YL      + VHRD+ A N L+      KI+DFGL+R    +           T G    
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-----YRKKTGGKLPI 171

Query: 426 -YMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNNKFQSDDGFETLVTHTWK 477
            +MAPE + +G  T K D++SFGVL+ EI +       G+ N                  
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------------------ 213

Query: 478 HFQAKTVLEIIDKSIEIEDIE----EVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
               + VLE + K   +   E    E+  ++   L C Q  P  RP+ + +V+ L+
Sbjct: 214 ----EEVLEYLRKGYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (407), Expect = 2e-45
 Identities = 79/268 (29%), Positives = 122/268 (45%), Gaps = 21/268 (7%)

Query: 263 KLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEI--CNEMDIMSRAHHKNLVQFLG 319
           KLG G +G ++K   +  G+ +AVK L    +   K+     E+ I+ R  H N+V+ + 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
               K   ++V E+ +   L   L    +   L   +   I +    GLEYLH +G   I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSNG---I 119

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-T 438
           +HRD+K  NILLD     KIADFGLA+      S    T   GT  YMAPE +  G    
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS--SLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 439 EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIE 498
            KVD++S GV++ E+++G     F  ++  + L        +        D+       E
Sbjct: 178 PKVDVWSLGVILYELLTG--KPPFSGENILDQLQ----LIRRILGPPLEFDEPKWSSGSE 231

Query: 499 EVKRVVWVGLLCTQELPTLRPSMTNVVQ 526
           E K ++    L     P+ RP+   ++Q
Sbjct: 232 EAKDLI-KKCLNKD--PSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  156 bits (396), Expect = 8e-44
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 17/203 (8%)

Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFL 318
             LG G +G ++    +D G  +AVK + +S  +   ++ +  E+ I+S   H N+V++ 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 319 GCCFTKKDSF--VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA---EGLEYLHK 373
           G    ++ +   +  E+V   SL  +L   K+  +L      VI   T    EGL YLH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLP---EPVIRKYTRQILEGLAYLH- 118

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                IVHRDIK +NIL+D     K+ADFG A+     ++     ++ GT  +MAPE I 
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
             +     DI+S G  V+E+ +G
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  155 bits (394), Expect = 2e-43
 Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 263 KLGHGGYGEIFKGTLQDG-----REIAVKRLFISRKNR----IKEICNEMDIMSRAHHKN 313
           KLG G +GE++KGTL+        E+AVK L   +++     I+E   E  IM +  H N
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL---KEDASEQQIEEFLREARIMRKLDHPN 62

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ LG C  ++   +V E++    L   L   +  KEL         +  A G+EYL  
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLE- 120

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA---IAGTLGYMAPE 430
                 +HRD+ A N L+      KI+DFGL+R    +           I     +MAPE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPE 174

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVS 455
            +  G+ T K D++SFGVL+ EI +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  154 bits (392), Expect = 3e-43
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 46/282 (16%)

Query: 263 KLGHGGYGEIFKGTLQD-----GREIAVKRLFISRKNR----IKEICNEMDIMSRAHHKN 313
           KLG G +GE++KG L+        E+AVK L   +++     I+E   E  IM +  H N
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL---KEDASEQQIEEFLREARIMRKLDHPN 62

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ LG C  ++  ++V E+++   L   L   K + +L         +  A G+EYL  
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE- 119

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA---IAGTLGYMAPE 430
                 +HRD+ A N L+      KI+DFGL+R    +           I     +MAPE
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPE 173

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK 490
            +  G+ T K D++SFGVL+ EI +           G +      +     + VLE +  
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFT----------LGEQ-----PYPGMSNEEVLEYLKN 218

Query: 491 --SIEIEDI--EEVKRVVWVGLLCTQELPTLRPSMTNVVQML 528
              +        E+  ++   L C  E P  RP+ + +V++L
Sbjct: 219 GYRLPQPPNCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  153 bits (390), Expect = 7e-43
 Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 59/289 (20%)

Query: 263 KLGHGGYGEIFKGTL-----QDGREIAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           KLG G +GE++KGTL         ++AVK L   + +   +E   E  IM +  H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
            LG C   +  ++V E++    L   L   K  ++L  K    + +  A+G+EYL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARF-------SSSEKSLLPNTAIAGTLGYMAP 429
              VHRD+ A N L+      KI+DFGL+R               LP   I     +MAP
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP---IK----WMAP 173

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID 489
           E + +G+ T K D++SFGVL+ EI +  +                  + +   +  E+++
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGE------------------QPYPGMSNEEVLE 215

Query: 490 KSIEIEDI----------EEVKRVVWVGLLCTQELPTLRPSMTNVVQML 528
               +ED           +E+  ++   L C    P  RP+ + +V+ L
Sbjct: 216 L---LEDGYRLPRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  150 bits (382), Expect = 6e-42
 Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 9/201 (4%)

Query: 257 CFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
            F+   K+G GG+GE++K    + G+E+A+K + +  K + ++I NE+ I+ +  H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           ++ G    K + ++V EF    SL  +L    Q   L   +   +     +GLEYLH   
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT--LTESQIAYVCKELLKGLEYLHS-- 116

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
              I+HRDIKA+NILL      K+ DFGL+   S  K       + GT  +MAPE I   
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---ARNTMVGTPYWMAPEVINGK 172

Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
               K DI+S G+  +E+  G
Sbjct: 173 PYDYKADIWSLGITAIELAEG 193

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  135 bits (343), Expect = 5e-36
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 13/205 (6%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
            + +    K+G G  GE++K T    G+E+A+K++ + RK   + I NE+ IM    H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCKHPN 76

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV--IIIGTAEGLEYL 371
           +V +        + +VV E++   SL  I+     +  +   +  +  +     +GLEYL
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H      ++HRDIK+ NILL      K+ADFG A   + EKS     ++ GT  +MAPE 
Sbjct: 133 H---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEV 187

Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I       KVDI+S G++ +E+  G
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 2e-34
 Identities = 62/202 (30%), Positives = 111/202 (54%), Gaps = 17/202 (8%)

Query: 261 SNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQF 317
            + +G G +G ++KG  L+ G  +A+K++ + +     +K I  E+D++    H N+V++
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +G   T    +++ E+ +N SL +I+  F P  +  +      V +    +GL YLH+ G
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-----VYVYQVLQGLAYLHEQG 119

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              ++HRDIKA+NIL       K+ADFG+A + +   K    + ++ GT  +MAPE I  
Sbjct: 120 ---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK---DDASVVGTPYWMAPEVIEM 173

Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
              +   DI+S G  V+E+++G
Sbjct: 174 SGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (325), Expect = 6e-33
 Identities = 67/304 (22%), Positives = 119/304 (39%), Gaps = 20/304 (6%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSR-AHHKNLVQFL 318
           KLG G +GE++    +D + +A+K L     S+   ++    E+ I++   H  N+V+  
Sbjct: 7   KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
                +   ++V E+V   SL+ +L    +K  L   +   I+      LEYLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 379 IVHRDIKASNILLDLK-HRPKIADFGLARFSSSEKSLLPN----TAIAGTLGYMAPEYIA 433
           I+HRDIK  NILLD      K+ DFGLA+      S        +   GT GYMAPE + 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 434 ---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK 490
                  +   DI+S G+ + E+++G+   + + +    +            ++   +  
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECMEL 550
           S      +    ++        + P  R S ++ +       + L               
Sbjct: 242 SNPELISKAASDLL---KKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298

Query: 551 SHTS 554
               
Sbjct: 299 PLRL 302

Length = 384

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  121 bits (306), Expect = 3e-31
 Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 10/200 (5%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           FD   KLG G YG ++K    + G+ +A+K   +  +  ++EI  E+ I+ +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVK 62

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
           + G  F   D ++V E+    S+  I+      K L  ++   I+  T +GLEYLH    
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH---S 117

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
            + +HRDIKA NILL+ + + K+ADFG++    ++     NT I GT  +MAPE I    
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 175

Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              K DI+S G+  +E+  G
Sbjct: 176 YNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  119 bits (300), Expect = 2e-30
 Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 14/204 (6%)

Query: 261 SNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQF 317
            NK+G G +G+++    L  G  +AVK + I   +   IKEI +EM ++    H NLV++
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G    ++  ++  E+    +L+ +L   +  + LD     V  +   EGL YLH  G  
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLHSHG-- 119

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT--AIAGTLGYMAPEYIANG 435
            IVHRDIK +NI LD     K+ DFG A    +  + +     ++AGT  YMAPE I  G
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 436 QLTEK---VDIYSFGVLVLEIVSG 456
           +        DI+S G +VLE+ +G
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATG 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  115 bits (290), Expect = 5e-29
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 263 KLGHGGYGEIFKGTLQ-DGREIAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
            LG G  G ++K   +  G+  A+K++     +   K++  E+  +       +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKDGQM 377
            + + +  +V E++   SL  +L     KK     +  +  I   +   GL+YLH     
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYI-ARQILKGLDYLHTK--R 119

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
            I+HRDIK SN+L++ K   KIADFG+++    E +L       GT+ YM+PE I     
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGESY 177

Query: 438 TEKVDIYSFGVLVLEIVSGV 457
           +   DI+S G+ +LE   G 
Sbjct: 178 SYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  114 bits (287), Expect = 1e-28
 Identities = 71/284 (25%), Positives = 127/284 (44%), Gaps = 52/284 (18%)

Query: 262 NKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFL 318
            ++G G +G+++      DG+   +K + +S  +    ++  NE+ I+ + +H N++++ 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGTAEGLEYL 371
                K    +V E+     L + +   K++ +       LDW       +     L+YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FVQLCLALKYL 119

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H     +I+HRDIK  NI L      K+ DFG+++  SS   L   T + GT  Y++PE 
Sbjct: 120 HS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-KTVV-GTPYYLSPEL 174

Query: 432 IANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH-FQAKTVLEIIDK 490
             N     K DI+S G ++ E+                     T KH F+ + +LE+  K
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELC--------------------TLKHPFEGENLLELALK 214

Query: 491 SI--EIEDI-----EEVKRVVWVGLLCTQELPTLRPSMTNVVQM 527
            +  +   I      E++ +V   LL  Q+ P  RPS+  ++Q 
Sbjct: 215 ILKGQYPPIPSQYSSELRNLVS-SLL--QKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  114 bits (288), Expect = 1e-28
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 37/220 (16%)

Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRL---FISRKNRIKEICNEMDIMSR-AHHKNLVQFL 318
           +G G +  +     +   +E A+K L    + ++ ++K +  E ++++R   H  +++ L
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK-L 67

Query: 319 GCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKD 374
              F  +++ + V E+  N  L + +   ++   LD           AE    LEYLH  
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLD---EKCTRFYAAEILLALEYLHSK 121

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA------------- 421
           G   I+HRD+K  NILLD     KI DFG A+      S   N   A             
Sbjct: 122 G---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 422 -----GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
                GT  Y++PE +      +  D+++ G ++ ++++G
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (286), Expect = 2e-28
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 22/203 (10%)

Query: 262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRI-KEICNEMDIMSRAHHKNLVQFLG 319
            +LG G  G + K   +  G+ +AVK + +     I K+I  E+DI+ + +   +V F G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV---IIIGTAEGLEYLHKDGQ 376
             +   D  +  E++   SLD+IL     K+        +   I +   +GL YLH+  +
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKIL-----KEVQGRIPERILGKIAVAVLKGLTYLHE--K 119

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT---AIAGTLGYMAPEYIA 433
            +I+HRD+K SNIL++ + + K+ DFG++         L N+      GT  YMAPE I 
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-------LVNSLAKTFVGTSSYMAPERIQ 172

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
               + K DI+S G+ ++E+ +G
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 9e-28
 Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 15/194 (7%)

Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT 323
           +G G +G++  G  + G+++AVK L        +    E  +M+   H NLVQ LG    
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRD 383
               ++V E++   SL   L   + +  +   ++    +   EG+EYL +      VHRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 384 IKASNILLDLKHRPKIADFGLARFSSS--EKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           + A N+L+      K++DFGLA+ +S   +   LP       + + APE +   + + K 
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP-------VKWTAPEALREKKFSTKS 180

Query: 442 DIYSFGVLVLEIVS 455
           D++SFG+L+ EI S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  110 bits (277), Expect = 3e-27
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 29/211 (13%)

Query: 264 LGHGGYGEIFKG-TLQDGREIAVKRLFISR------KNRIKEIC----NEMDIMSRAHHK 312
           +G G YG ++    +  G  +AVK++ +         +R K++     +E++ +    H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----FDPKQKKELDWKKRHVIIIGTAEG 367
           N+VQ+LG   T++   +  E+V   S+   L     F+ +  +    +          EG
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           L YLH  G   I+HRD+KA N+L+D     KI+DFG+++ S        N ++ G++ +M
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 428 APEYIANGQ--LTEKVDIYSFGVLVLEIVSG 456
           APE I +     + KVDI+S G +VLE+ +G
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  109 bits (274), Expect = 1e-26
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 18/209 (8%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKN 313
           +   E ++LG G  G + K  L++   I   +   +  N    K+I  E++I        
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 314 LVQFLGCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE----G 367
           +V++ G    +  S   +  E+ +  SLD I    K+ K+   +    ++   AE    G
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           L YLH     +I+HRDIK SNILL  K + K+ DFG+    S E          GT  YM
Sbjct: 118 LSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGTFTGTSFYM 170

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE I     +   D++S G+ +LE+   
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQN 199

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 3e-26
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 36/209 (17%)

Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++     K T   G+  A+K L    I ++  ++    E +I+SR +H  +V+
Sbjct: 1   LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 317 FLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA--------EG 367
            L   F T++  ++V E+     L   L            K        A          
Sbjct: 58  -LHYAFQTEEKLYLVLEYAPGGELFSHL-----------SKEGRFSEERARFYAAEIVLA 105

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           LEYLH  G   I++RD+K  NILLD     K+ DFGLA+  SSE S        GT  Y+
Sbjct: 106 LEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYL 160

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE +      + VD +S GVL+ E+++G
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  105 bits (263), Expect = 2e-25
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 34/209 (16%)

Query: 264 LGHGGYGEIFKG-TLQDGREIAVKRLFI-----SRKNRIKEICNEMDIMSRAHHKNLVQF 317
           LG G +G +++G  L DG   AVK + +     + +  +K++  E+ ++S+  H N+VQ+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKD 374
           LG    + + ++  E V   SL ++L      K+       VI + T +   GLEYLH  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLL------KKYGSFPEPVIRLYTRQILLGLEYLHDR 121

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLA------RFSSSEKSLLPNTAIAGTLGYMA 428
                VHRDIK +NIL+D     K+ADFG+A       F+ S K         G+  +MA
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK---------GSPYWMA 169

Query: 429 PEYIA-NGQLTEKVDIYSFGVLVLEIVSG 456
           PE IA  G      DI+S G  VLE+ +G
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  105 bits (264), Expect = 2e-25
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 10/201 (4%)

Query: 262 NKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLG 319
             +G G    ++    L +  ++A+KR+ + +    + E+  E+  MS+ +H N+V++  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY- 65

Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
             F   D  ++V  ++   SL  I+     +  LD      ++    +GLEYLH +GQ  
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
            +HRDIKA NILL      KIADFG++       +++        GT  +MAPE +    
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 437 -LTEKVDIYSFGVLVLEIVSG 456
               K DI+SFG+  +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (262), Expect = 3e-25
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 10/200 (5%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           F    KLG G +GE+++G  ++   +A+K L      + ++   E+  + R  HK+L+  
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT--AEGLEYLHKDG 375
              C   +  +++ E ++  SL   L  P+ +         +I +    AEG+ YL +  
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL---PVASLIDMACQVAEGMAYLEEQ- 123

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
               +HRD+ A NIL+      K+ADFGLAR    +  L  +  I     + APE  ++G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHG 179

Query: 436 QLTEKVDIYSFGVLVLEIVS 455
             + K D++SFG+L+ E+ +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 5e-25
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 24/202 (11%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           KLG G +GE++ GT     ++AVK L    +S +  ++E      IM +  H  LVQ   
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEA----QIMKKLRHDKLVQLYA 68

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            C  ++  ++V E++   SL   L   + KK L   +   +    AEG+ YL        
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLE---SRNY 124

Query: 380 VHRDIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
           +HRD+ A NIL+      KIADFGLAR      +++ E +  P       + + APE   
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP-------IKWTAPEAAN 177

Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
            G+ T K D++SFG+L+ EIV+
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 7e-25
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)

Query: 258 FDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           ++   ++G G YG+++K   +  G  +A+K + +   +  + I  E+ ++    H N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRI---LFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           + G    +   ++V E+    SL  I      P  + ++ +  R      T +GL YLH 
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKGLAYLH- 118

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEY 431
             +   +HRDIK +NILL      K+ADFG++    ++  K     + I GT  +MAPE 
Sbjct: 119 --ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR---KSFI-GTPYWMAPEV 172

Query: 432 IA---NGQLTEKVDIYSFGVLVLE 452
            A    G    K DI++ G+  +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  103 bits (258), Expect = 9e-25
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)

Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 182

Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 18/204 (8%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            D   K+G G  G +   T    GR++AVK++ + ++ R + + NE+ IM    H N+V+
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                    + +VV EF++  +L  I+        ++ ++   + +   + L +LH  G 
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQG- 135

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE----KSLLPNTAIAGTLGYMAPEYI 432
             ++HRDIK+ +ILL    R K++DFG     S E    KSL+      GT  +MAPE I
Sbjct: 136 --VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVI 187

Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
           +      +VDI+S G++V+E+V G
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 16/200 (8%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           K+G G +G+++KG L+   E+AVK  R  +    + K    E +I+ +  H N+V+ +G 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  K+  ++V E V   SL  + F  K+K  L  KK   + +  A G+EYL        +
Sbjct: 61  CVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCI 115

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT----LGYMAPEYIANGQ 436
           HRD+ A N L+   +  KI+DFG++R    E+     T   G     + + APE +  G+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 437 LTEKVDIYSFGVLVLEIVSG 456
            T + D++S+G+L+ E  S 
Sbjct: 172 YTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 31/225 (13%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQDGR------EIAVKRL-FISRKNRIKEICNEMD 304
           E   D       LGHG +GE+++G  +         ++AVK L     +    +   E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD--PKQKKELDWKKRHVIII 362
           IMS+ +H+N+V+ +G  F +   F++ E +    L   L +  P+ ++      + ++  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSS 410
               A+G +YL ++     +HRDI A N LL  K      KIADFG+AR       +   
Sbjct: 122 ARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +++LP       + +M PE   +G  T K D++SFGVL+ EI S
Sbjct: 179 GRAMLP-------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 15/199 (7%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFI-SRKNRIKEICNEMDIMSRAHH---KNLVQFL 318
           +G G YG +++G  +  GR +A+K + + +  + + +I  E+ ++S+       N+ ++ 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G        +++ E+ +  S+ R L       E   K   VII      L+Y+HK G   
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAE---KYISVIIREVLVALKYIHKVG--- 121

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           ++HRDIKA+NIL+      K+ DFG+A  +   ++    +   GT  +MAPE I  G+  
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 439 E-KVDIYSFGVLVLEIVSG 456
           + K DI+S G+ + E+ +G
Sbjct: 180 DTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 28/211 (13%)

Query: 261 SNKLGHGGYGEIFKGTL-----QDGREIAVKRLFISRKNR-IKEICNEMDIMSRAHHKNL 314
             +LG G +G++            G ++AVK L  S + +   +   E++I+    H+N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 315 VQFLGCCF--TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           V++ G C     +   ++ E++ + SL   L   + + +++ K+  +      +G++YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYL- 125

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--------SSSEKSLLPNTAIAGTL 424
             G  + +HRD+ A NIL++ +   KI+DFGLA+            E    P       +
Sbjct: 126 --GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP-------I 176

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            + APE +   + +   D++SFGV + E+ +
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)

Query: 267 GGYGEIF---KGTLQDGREI-AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           G YG +F   K +  D   I  +K+  + RKN++ ++  E DI+S+A    +V+      
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            KK+ ++V E++    L  +L   +    LD     + I      LEYLH +G   I+HR
Sbjct: 64  GKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHR 117

Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLL------PNTAIAGTLGYMAPEYIANGQ 436
           D+K  NIL+D     K+ DFGL++     + +        +  I GT  Y+APE I    
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177

Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
            ++ VD +S G ++ E + G+
Sbjct: 178 HSKTVDWWSLGCILYEFLVGI 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 99.2 bits (247), Expect = 5e-23
 Identities = 58/195 (29%), Positives = 103/195 (52%), Gaps = 10/195 (5%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G ++    +  G+E+A+K++ + ++ + + I NE+ +M    H N+V +L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV E++   SL     D   +  +D  +   +     + LE+LH +   Q++H
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ NILL +    K+ DFG     + E+S    + + GT  +MAPE +       KV
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 99.0 bits (246), Expect = 5e-23
 Identities = 58/195 (29%), Positives = 104/195 (53%), Gaps = 10/195 (5%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G +F    +  G+E+A+K++ + ++ + + I NE+ +M    + N+V FL   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + FVV E++   SL  ++     +  +D  +   +     + LE+LH +   Q++H
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ N+LL +    K+ DFG     + E+S    + + GT  +MAPE +       KV
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 98.3 bits (245), Expect = 8e-23
 Identities = 72/223 (32%), Positives = 111/223 (49%), Gaps = 38/223 (17%)

Query: 264 LGHGGYGEIFKGTL--QDGRE----IAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQ 316
           LG G +G+++KG L   + R     +A+K L  + + +++ E   E ++MS   H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILF-------------DPKQKKELDWKKRHVIIIG 363
            LG C  ++ + +++E++ +  L   L              D   K  LD      I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSS-----EKSLLP 416
            A G+EYL        VHRD+ A N L+      KI+DFGL+R  +S+       KSLLP
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQ 458
                  + +M PE I  G+ T + DI+SFGV++ EI S G+Q
Sbjct: 190 -------VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ 225

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 18/202 (8%)

Query: 263 KLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICN----EMDIMSRAHHKNLVQF 317
           K+G G YG ++K      G  +A+K+  I  +   + I      E+ ++   +H N+++ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKK--IKLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
           L     K D ++V+EF+    L +++ D  +++ L        +    +GL + H  G  
Sbjct: 64  LDVFRHKGDLYLVFEFMD-TDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG-- 118

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIAN-G 435
            I+HRD+K  N+L++ +   K+ADFGLAR F S  +          T  Y APE +    
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV---TRWYRAPELLLGDK 174

Query: 436 QLTEKVDIYSFGVLVLEIVSGV 457
             +  VDI+S G +  E++S  
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)

Query: 263 KLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G +   T +  G+++AVK++ + ++ R + + NE+ IM   HH+N+V      
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV EF++  +L  I+   +  +E    +   + +     L YLH  G   ++H
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQG---VIH 141

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ +ILL    R K++DFG    +   K +    ++ GT  +MAPE I+      +V
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++V+E++ G
Sbjct: 200 DIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  101 bits (254), Expect = 2e-22
 Identities = 82/301 (27%), Positives = 146/301 (48%), Gaps = 35/301 (11%)

Query: 241 LKFLQFKYS---TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI 296
           L+F   K S   TI        E N +  G  G  +KG ++++G +  VK   I+  N I
Sbjct: 672 LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE--INDVNSI 729

Query: 297 KEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK 356
               +E+  M +  H N+V+ +G C ++K +++++E+++ K+L  +L      + L W++
Sbjct: 730 PS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWER 781

Query: 357 RHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP 416
           R  I IG A+ L +LH      +V  ++    I++D K  P +      R S        
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTD 835

Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF---ETLVT 473
                 +  Y+APE      +TEK DIY FG++++E+++G    K  +D  F    ++V 
Sbjct: 836 TKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTG----KSPADAEFGVHGSIV- 889

Query: 474 HTWKHF-QAKTVLEI-IDKSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML 528
             W  +  +   L++ ID SI  +   +  E+  V+ + L CT   PT RP   +V++ L
Sbjct: 890 -EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Query: 529 K 529
           +
Sbjct: 949 E 949

Length = 968

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 97.0 bits (241), Expect = 2e-22
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 10/195 (5%)

Query: 263 KLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G +        GR++AVK + + ++ R + + NE+ IM    H+N+V+     
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
              ++ +V+ EF+Q  +L  I+     +  L+ ++   +     + L YLH  G   ++H
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ +ILL L  R K++DFG    +   K +    ++ GT  +MAPE I+      +V
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++V+E+V G
Sbjct: 199 DIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 35/212 (16%)

Query: 262 NKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNR------IKEICNEMDIMSRAHHKNL 314
            ++G G YG+++K    + G  +A+K++ +  +        I+EI     ++ +  H N+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREI----KLLQKLRHPNI 60

Query: 315 VQFLGCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           V+      +K     ++V+E++ +  L  +L  P+ K      K ++  +   EGL+YLH
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQL--LEGLQYLH 117

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL-LPNTAIAGTLGYMAPE- 430
                 I+HRDIK SNIL++     K+ADFGLAR  +   S    N  I  TL Y  PE 
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPEL 172

Query: 431 ------YIANGQLTEKVDIYSFGVLVLEIVSG 456
                 Y        +VD++S G ++ E+  G
Sbjct: 173 LLGATRY------GPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 96.1 bits (239), Expect = 4e-22
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 32/216 (14%)

Query: 258 FDESNK---LGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
           +DE+ +   LG G YG ++    L     IA+K +       ++ +  E+ + S   H+N
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 314 LVQFLGCCFTKKDSFVVY-EFVQNKSLDRIL---FDPKQKKE--LDWKKRHVIIIGTAEG 367
           +VQ+LG   ++   F ++ E V   SL  +L   + P +  E  + +  + ++     EG
Sbjct: 67  IVQYLGSD-SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EG 120

Query: 368 LEYLHKDGQMQIVHRDIKASNILLD-LKHRPKIADFG----LARFSSSEKSLLPNTAIAG 422
           L+YLH     QIVHRDIK  N+L++      KI+DFG    LA  +   ++        G
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TG 171

Query: 423 TLGYMAPEYIANGQ--LTEKVDIYSFGVLVLEIVSG 456
           TL YMAPE I  G        DI+S G  ++E+ +G
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 95.3 bits (237), Expect = 5e-22
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 19/207 (9%)

Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNL 314
           F+  NK+G G +G +FK   + D R  A+K++ +S+ NR   +E  +E  ++++     +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKK-----ELDWKKRHVIIIGTAEGLE 369
           +++      K    +V E+ +N  L ++L    Q+      +  W+      I    GL 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWR----FFIQILLGLA 115

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           +LH     +I+HRDIK+ N+ LD     KI D G+A+   S+ +   NT I GT  Y++P
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANT-IVGTPYYLSP 170

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E   +    EK D+++ GV++ E  +G
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTG 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 95.9 bits (238), Expect = 6e-22
 Identities = 59/200 (29%), Positives = 106/200 (53%), Gaps = 10/200 (5%)

Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            D   K+G G  G +   T++  G+ +AVK++ + ++ R + + NE+ IM    H+N+V+
Sbjct: 22  LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                    + +VV EF++  +L  I+   +  +E    +   + +   + L  LH  G 
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLKALSVLHAQG- 136

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             ++HRDIK+ +ILL    R K++DFG    +   K +    ++ GT  +MAPE I+   
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLP 192

Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              +VDI+S G++V+E+V G
Sbjct: 193 YGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.0 bits (236), Expect = 9e-22
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 24/209 (11%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRI------KEICNEMDIMSRAHHKNLV 315
             LG G YG ++ G    G+ IAVK++ +   N +      +++  E+D++    H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           Q+LG C       +  EFV   S+  IL  F P  +       + ++     +G+ YLH 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYM 427
           +    +VHRDIK +N++L      K+ DFG AR         +  ++L   ++ GT  +M
Sbjct: 121 N---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWM 175

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE I       K DI+S G  V E+ +G
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG 204

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 24/209 (11%)

Query: 264 LGHGGYGEIFKG-TLQDGREIAVKRLFIS---------RKNRIKEICNEMDIMSRAHHKN 313
           +G G +G ++ G     G  +AVK++ +          +++ +  +  E+ ++    H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +VQ+LG         +  E+V   S+  +L +    +E   +     +    +GL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN---FVRQILKGLNYLHN 124

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT------AIAGTLGYM 427
            G   I+HRDIK +NIL+D K   KI+DFG+++    E + L         ++ G++ +M
Sbjct: 125 RG---IIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQGSVFWM 179

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE +     T K DI+S G LV+E+++G
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 19/199 (9%)

Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQFLGCCF 322
           LG G +GE+FKGTL+D   +AVK         +K +  +E  I+ +  H N+V+ +G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  ++V E V     D + F  K+K EL  K+     +  A G+ YL        +HR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHR 117

Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D+ A N L+   +  KI+DFG++R      +SSS    +P       + + APE +  G+
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP-------IKWTAPEALNYGR 170

Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + + D++S+G+L+ E  S
Sbjct: 171 YSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 19/200 (9%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFI-SRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
            +G G +GE++K    +  + +A+K + +   ++ I++I  E+  +S+     + ++ G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 321 CFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            F K    +++ E+    S      D  +  +LD      I+     GLEYLH++G+   
Sbjct: 68  -FLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEEGK--- 119

Query: 380 VHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           +HRDIKA+NILL  +   K+ADFG++     + S++    NT   GT  +MAPE I    
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR----NT-FVGTPFWMAPEVIKQSG 174

Query: 437 LTEKVDIYSFGVLVLEIVSG 456
             EK DI+S G+  +E+  G
Sbjct: 175 YDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 91.9 bits (228), Expect = 6e-21
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQF 317
             ++G G +G ++ G   + R++A+K +    +S ++ I+E      +M +  H  LVQ 
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEE----AQVMMKLSHPKLVQL 64

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G C  +    +V+EF+++  L   L    Q+ +   +    + +   EG+ YL      
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLE---SS 119

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEY 431
            ++HRD+ A N L+      K++DFG+ RF      +SS  +  P       + + +PE 
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP-------VKWSSPEV 172

Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
            +  + + K D++SFGVL+ E+ S
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 92.6 bits (230), Expect = 9e-21
 Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 19/199 (9%)

Query: 264 LGHGGYGEIFK-GTLQDGREIAVKRLFISRKNRI-KEICNEMDIMSRAHHKNLVQFLGCC 321
           LG G  G + K   +  G  +A K + I  K+ + K+I  E+ IM       +V F G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 322 FTKKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
             + +  +  EF+   SLDRI     P   + L       I +   EGL YL+     +I
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRI 125

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA--IAGTLGYMAPEYIANGQL 437
           +HRDIK SNIL++ + + K+ DFG+    S E  L+ + A    GT  YM+PE I  G+ 
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGV----SGE--LINSIADTFVGTSTYMSPERIQGGKY 179

Query: 438 TEKVDIYSFGVLVLEIVSG 456
           T K D++S G+ ++E+  G
Sbjct: 180 TVKSDVWSLGISIIELALG 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.8 bits (230), Expect = 1e-20
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 258 FDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKN---RIKEICNEMDIMSRAHHKN 313
           F +  ++GHG +G + F   ++    +A+K++  S K    + ++I  E+  + R  H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
            +++ GC   +  +++V E+    + D +    K  +E++      I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHS 143

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                ++HRDIKA NILL    + K+ADFG A  +S      P  +  GT  +MAPE I 
Sbjct: 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS------PANSFVGTPYWMAPEVIL 194

Query: 434 ---NGQLTEKVDIYSFGVLVLEI 453
               GQ   KVD++S G+  +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 91.5 bits (227), Expect = 1e-20
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 19/199 (9%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ G      ++A+K L        +    E ++M +  H  LV+ L    
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVR-LYAVV 70

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P+  K L   K   +    AEG+ ++    +   +HR
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKNYIHR 126

Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G 
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP-------IKWTAPEAINYGT 179

Query: 437 LTEKVDIYSFGVLVLEIVS 455
            T K D++SFG+L+ EIV+
Sbjct: 180 FTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 92.1 bits (228), Expect = 1e-20
 Identities = 55/195 (28%), Positives = 104/195 (53%), Gaps = 10/195 (5%)

Query: 263 KLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G ++    +  G+E+A+K++ + ++ + + I NE+ +M    + N+V +L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV E++   SL  ++     +  +D  +   +     + L++LH +   Q++H
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ NILL +    K+ DFG     + E+S    + + GT  +MAPE +       KV
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKN---RIKEICNEMDIMSRAHHKN 313
           F   +++GHG +G ++  T     E+ AVK++  S K    + ++I  E+  + +  H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
            +++ GC   +  +++V E+    + D +    K  +E++      I  G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHS 139

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                ++HRDIKA NILL    + K+ADFG A  SS      P  +  GT  +MAPE I 
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVIL 190

Query: 434 ---NGQLTEKVDIYSFGVLVLEI 453
               GQ   KVD++S G+  +E+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 28/221 (12%)

Query: 254 ATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHH 311
            T  F+    +G G YG+++K    + G+ +A+K + I  ++  +EI  E +I+ + ++H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62

Query: 312 KNLVQFLGCCFTKKDSFV-------VYEFVQNKS----LDRILFDPKQKKELDWKKRHVI 360
            N+  F G  F KK+          V E     S    +  +    K+ KE +W     I
Sbjct: 63  PNIATFYGA-FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EWIA--YI 118

Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
           +  T  GL YLH++   +++HRDIK  NILL      K+ DFG++    S      NT I
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST-LGRRNTFI 174

Query: 421 AGTLGYMAPEYIANGQLTE-----KVDIYSFGVLVLEIVSG 456
            GT  +MAPE IA  +  +     + D++S G+  +E+  G
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 71/219 (32%), Positives = 108/219 (49%), Gaps = 40/219 (18%)

Query: 264 LGHGGYGEIFKGTLQD----GRE---IAVKRLFISRKNRI----KEICNEMDIMSRAHHK 312
           LG G +GE+++GT  D    G     +AVK L   RK       KE   E  +MS  +H 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFNHP 59

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE----LDWKKRHVIIIGTAEGL 368
           N+V+ LG C   +  +++ E ++   L   L D + ++     L  K+   I +  A+G 
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRP-----KIADFGLAR-------FSSSEKSLLP 416
            YL    QM  +HRD+ A N L+  K        KI DFGLAR       +    + LLP
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                  + +MAPE + +G+ T + D++SFGVL+ EI++
Sbjct: 177 -------VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 91.3 bits (226), Expect = 3e-20
 Identities = 54/195 (27%), Positives = 104/195 (53%), Gaps = 10/195 (5%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G ++    +  G+E+A++++ + ++ + + I NE+ +M    + N+V +L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV E++   SL  ++     +  +D  +   +     + LE+LH +   Q++H
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ NILL +    K+ DFG     + E+S    + + GT  +MAPE +       KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++ +E++ G
Sbjct: 198 DIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.6 bits (226), Expect = 3e-20
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 32/208 (15%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEICNEMDIMSRAHHKNLV 315
           KLG G YG ++K    + G  +A+K++ +  +        ++EI     ++    H N+V
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELKHPNIV 61

Query: 316 QFLGCCFTKKDSFVVYEFVQN---KSLD--RILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           + L    T++  ++V+E+      K LD       P   K + ++     ++    GL Y
Sbjct: 62  KLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQ-----LL---RGLAY 113

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAP 429
            H     +I+HRD+K  NIL++     K+ADFGLAR F    ++         TL Y AP
Sbjct: 114 CH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWYRAP 167

Query: 430 EYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           E +   +  +  VDI+S G +  E+++G
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 57/198 (28%), Positives = 105/198 (53%), Gaps = 12/198 (6%)

Query: 264 LGHGGYGEIFKGTLQ-DGRE---IAVKRLFI--SRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+ +G L+  G++   +A+K L    S K R+ +   E  IM +  H N+++ 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPNIIRL 70

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     +   ++ E+++N SLD+ L   +   +    +   ++ G A G++YL +   M
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSE---M 125

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
             VHRD+ A NIL++     K++DFGL+R     ++          + + APE IA  + 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185

Query: 438 TEKVDIYSFGVLVLEIVS 455
           T   D++SFG+++ E++S
Sbjct: 186 TSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 15/200 (7%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISR-----KNRIKEICNEMDIMSRAHHKNLVQF 317
           LG G +G ++     D GRE+AVK++         K  +  +  E+ ++    H+ +VQ+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 318 LGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
            GC    +   +  E++   S+ D++       + +  K    I+    EG+EYLH +  
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN-- 123

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
             IVHRDIK +NIL D     K+ DFG + R  +   S     ++ GT  +M+PE I+  
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 436 QLTEKVDIYSFGVLVLEIVS 455
               K D++S G  V+E+++
Sbjct: 183 GYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)

Query: 264 LGHGGYGEIFKGT-LQDGR----EIAVKRLF--ISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G ++KG  + +G      +A+K L    S K   KEI +E  +M+   H ++V+
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA-NKEILDEAYVMASVDHPHVVR 73

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPK----QKKELDWKKRHVIIIGTAEGLEYLH 372
            LG C + +   +  + +    L   + + K     +  L+W  +       A+G+ YL 
Sbjct: 74  LLGICLSSQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
           +     +VHRD+ A N+L+      KI DFGLA+    ++           + +MA E I
Sbjct: 127 EKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
            +   T K D++S+GV V E+++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 35/215 (16%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRK------NRIKEICNEMDIMSRAH 310
           ++E  ++G G YG ++K   L  GR +A+K++ +         + ++EI   +  +    
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59

Query: 311 HKNLVQFLGCCFTKKDS-----FVVYEFVQNKSLDRIL-------FDPKQKKELDWKKRH 358
           H N+V+ L  C   +        +V+E V ++ L   L         P+  K+L  +   
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ--- 115

Query: 359 VIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
             ++    G+++LH     +IVHRD+K  NIL+    + KIADFGLAR  S E +L   T
Sbjct: 116 --LLR---GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---T 164

Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
           ++  TL Y APE +        VD++S G +  E+
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKN---RIKEICNEMDIMSRAHHKN 313
           F +  ++GHG +G ++        E+ A+K++  S K    + ++I  E+  + +  H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
            +++ GC   +  +++V E+    + D +    K  +E++      I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA---AICHGALQGLAYLHS 133

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
             +   +HRDIKA NILL      K+ADFG A   S      P  +  GT  +MAPE I 
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVS------PANSFVGTPYWMAPEVIL 184

Query: 434 ---NGQLTEKVDIYSFGVLVLEI 453
               GQ   KVD++S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 91.4 bits (227), Expect = 5e-20
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 25/205 (12%)

Query: 262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQFLG 319
           N++G G  G ++K   +  GR  A+K ++ + ++ ++ +IC E++I+   +H N+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 320 CCFTKKDSFVVYEFVQNKSLD--RILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
                 +  V+ EF+   SL+   I      ++ L    R ++      G+ YLH+    
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHI----ADEQFLADVARQIL-----SGIAYLHR---R 187

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
            IVHRDIK SN+L++     KIADFG++R  +  +++ P  +  GT+ YM+PE I N  L
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPERI-NTDL 244

Query: 438 TEKV------DIYSFGVLVLEIVSG 456
                     DI+S GV +LE   G
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLG 269

Length = 353

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 19/203 (9%)

Query: 262 NKLGHGGYGEIFKGTLQ--DGREI--AVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQ 316
            +LGHG +G + KG      G+E+  AVK L         KE   E  +M++  H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 317 FLGCCFTKKDSFV-VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            +G C  K +  + V E      L + L   ++    D K    +    A G+ YL    
Sbjct: 61  LIGVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLE--- 112

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR---FSSSEKSLLPNTAIAGTLGYMAPEYI 432
               VHRD+ A N+LL  +H+ KI+DFG++R     S        TA    L + APE I
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECI 170

Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
             G+ + K D++S+GV + E  S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 21/207 (10%)

Query: 264 LGHGGYGEIFKGTLQDGRE--IAVKRLFI----------SRKNRIKEICNEMDIMSRA-H 310
           LG G +G ++K   ++  +  +A+K + +           R   I +I +E+ I+     
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 311 HKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKE-LDWKKRHVIIIGTAEGL 368
           H N+V++    F + D  ++V + ++   L       K+KK+    ++   I +     L
Sbjct: 68  HPNIVRYYKT-FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMA 428
            YLHK  + +IVHRD+  +NI+L    +  I DFGLA+    E  L   T++ GT+ Y  
Sbjct: 127 RYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS 455
           PE + N    EK D+++FG ++ ++ +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 89.3 bits (221), Expect = 7e-20
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 21/210 (10%)

Query: 257 CFDESNKLGHGGYGEIFKGTLQ-DGRE---IAVKRLF--ISRKNRIKEICNEMDIMSRAH 310
              +   +G G +GE+F+G L+  GR+   +A+K L    + K R ++  +E  IM +  
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-QDFLSEASIMGQFS 64

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+++  G     K + ++ E+++N +LD+ L D     E    +   ++ G A G++Y
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKY 122

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG----- 425
           L     M  VHRD+ A NIL++     K++DFGL+R    +    P      + G     
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD----PEGTYTTSGGKIPIR 175

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           + APE IA  + T   D++SFG+++ E++S
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 11/198 (5%)

Query: 263 KLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLG 319
            +G G YG + K   +  G  +A+K+   S  +    K    E+ ++ +  H+N+V    
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
               K   ++V+E+V+   L+ +         L        I    + + Y H      I
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHS---HNI 121

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE-YIANGQLT 438
           +HRDIK  NIL+      K+ DFG AR     +   P T    T  Y APE  + +    
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARA-LRARPASPLTDYVATRWYRAPELLVGDTNYG 180

Query: 439 EKVDIYSFGVLVLEIVSG 456
           + VD+++ G ++ E++ G
Sbjct: 181 KPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 37/214 (17%)

Query: 262 NKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN-----EMDIMSRAHHKNLV 315
            KLG G Y  ++K    + GR +A+K++ +  +   K+  N     E+ ++    H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 316 QFLGCCFTKKDSF-VVYEF--------VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
             L   F  K +  +V+EF        +++KS   I+  P   K          ++ T  
Sbjct: 66  GLLDV-FGHKSNINLVFEFMETDLEKVIKDKS---IVLTPADIKS--------YMLMTLR 113

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLG 425
           GLEYLH +    I+HRD+K +N+L+      K+ADFGLAR F S  + +        T  
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV---TRW 167

Query: 426 YMAPE--YIANGQLTEKVDIYSFGVLVLEIVSGV 457
           Y APE  + A       VD++S G +  E++  V
Sbjct: 168 YRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 38/220 (17%)

Query: 264 LGHGGYGEIFKGTL-----QDGR-EIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKNLV 315
           LG G +G++ K         +    +AVK L      + + ++ +EM++M     HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT----------- 364
             LG C  +   +VV E+  + +L   L   +   E            T           
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 365 --AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLL 415
             A G+E+L      + +HRD+ A N+L+   H  KIADFGLAR       +  +    L
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           P       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 197 P-------VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 35/273 (12%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
            +G G +G + +G    G+++AVK   I      +    E  +M++ HHKNLV+ LG   
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
                ++V E +   +L   L   + +  +   +     +  AEG+EYL      ++VHR
Sbjct: 70  -HNGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124

Query: 383 DIKASNILLDLKHRPKIADFGLARFSS--SEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           D+ A NIL+      K++DFGLAR  S   + S LP       + + APE + + + + K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP-------VKWTAPEALKHKKFSSK 177

Query: 441 VDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE 499
            D++S+GVL+ E+ S G                   +     K V E ++K   +E  E 
Sbjct: 178 SDVWSYGVLLWEVFSYGRA----------------PYPKMSLKEVKECVEKGYRMEPPEG 221

Query: 500 VKRVVWVGLL-CTQELPTLRPSMTNVVQMLKQK 531
               V+V +  C +  P  RPS   + + L+++
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 24/202 (11%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE+++G   +   +AVK L     +  K+   E  IM +  H  L+Q    C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVII---IGTAEGLEYLHKDGQMQI 379
            ++  ++V E ++  SL   L    Q       K   +I      A G+ YL        
Sbjct: 72  LEEPIYIVTELMKYGSLLEYL----QGGAGRALKLPQLIDMAAQVASGMAYLE---AQNY 124

Query: 380 VHRDIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
           +HRD+ A N+L+   +  K+ADFGLAR      + + E +  P       + + APE   
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP-------IKWTAPEAAL 177

Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
             + + K D++SFG+L+ EIV+
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 258 FDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKN---RIKEICNEMDIMSRAHHKN 313
           F +  ++GHG +G + F   +++   +A+K++  S K    + ++I  E+  + +  H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
            +Q+ GC   +  +++V E+    + D +    K  +E++      +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHS 133

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                ++HRD+KA NILL      K+ DFG A   +      P     GT  +MAPE I 
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVIL 184

Query: 434 ---NGQLTEKVDIYSFGVLVLEI 453
               GQ   KVD++S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRL-FISRKNRIKE-ICNEMDIMSRAHHKNL 314
           ++    +G G +G + K     DG+ +  K + + +   + K+ + +E++I+    H N+
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 315 VQFLGCCF--TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVII---IGTAEGLE 369
           V++       + +  ++V E+ +   L +++   K KKE  + +   I          L 
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 370 YLH--KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
             H   D    ++HRD+K +NI LD  +  K+ DFGLA+    + S        GT  YM
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYM 177

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +PE + +    EK DI+S G L+ E+ + 
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCAL 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 21/204 (10%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEICNEMDIMSRAHHKNLV 315
           ++G G +G +FK    + G  +A+K++ + R         ++EI      +    H  +V
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62

Query: 316 QFLGCCFTKKDSFV-VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + L   F     FV V E++ +  L  +L D ++       K ++ ++   +G+ Y+H +
Sbjct: 63  KLLDV-FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHAN 118

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           G   I+HRD+K +N+L+      KIADFGLAR  S E+  L +  +A T  Y APE +  
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYG 174

Query: 435 GQ-LTEKVDIYSFGVLVLEIVSGV 457
            +     VD+++ G +  E+++G 
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 13/196 (6%)

Query: 264 LGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           LG G +G+++K    + G   A K + I  +  +++   E+DI+S   H N+V      F
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            +   +++ EF    +LD I+   + ++ L   +   +     E L +LH     +++HR
Sbjct: 73  YENKLWILIEFCDGGALDSIML--ELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHR 127

Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE--- 439
           D+KA NILL L    K+ADFG++  + S           GT  +MAPE +A     +   
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPY 185

Query: 440 --KVDIYSFGVLVLEI 453
             K DI+S G+ ++E+
Sbjct: 186 DYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 37/218 (16%)

Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+G +    ++   R  A+K +    I    + + I +E +I+   +H  +V+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 320 CCFTKKDSFVVY---EFVQNKSL-----DRILFDPKQKKELDWKKRHVI--IIGTAEGLE 369
              T KD   +Y   E+     L     DR LFD       ++  R  I  ++      E
Sbjct: 61  ---TFKDKKYIYMLMEYCLGGELWTILRDRGLFD-------EYTARFYIACVV---LAFE 107

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMA 428
           YLH  G   I++RD+K  N+LLD     K+ DFG A+   S +K+        GT  Y+A
Sbjct: 108 YLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFCGTPEYVA 160

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD 466
           PE I N      VD +S G+L+ E+++G     F  DD
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGRP--PFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 55/292 (18%)

Query: 264 LGHGGYGEIFKGTLQD------GREIAVKRLFI--SRKNRIKEICNEMDIMSRAHHKNLV 315
           LG G +G +++G  +          +A+K +    S + RI E  NE  +M   +  ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT----------A 365
           + LG   T + + VV E +    L   L   + ++        +               A
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYL---RSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNT 418
           +G+ YL      + VHRD+ A N ++      KI DFG+ R       +    K LLP  
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP-- 184

Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH 478
                + +MAPE + +G  T K D++SFGV++ E+                TL    ++ 
Sbjct: 185 -----VRWMAPESLKDGVFTTKSDVWSFGVVLWEMA---------------TLAEQPYQG 224

Query: 479 FQAKTVLE-IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
              + VL+ +ID            +++ +  +C Q  P +RP+   +V  LK
Sbjct: 225 LSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 69/294 (23%), Positives = 124/294 (42%), Gaps = 53/294 (18%)

Query: 264 LGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQ 316
           LG G +G++F G         D   +AVK L  +  N  ++    E ++++   H+N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLD----------RILFDPKQK-KELDWKKRHVIIIGTA 365
           F G C       +V+E++++  L+            L  P     EL   +   I +  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNT 418
            G+ YL        VHRD+   N L+      KI DFG++R       +     ++LP  
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP-- 187

Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWK 477
                + +M PE I   + T + D++SFGV++ EI + G Q                 W 
Sbjct: 188 -----IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ----------------PWY 226

Query: 478 HFQAKTVLEIIDKSIEIEDIEEVKRVVW-VGLLCTQELPTLRPSMTNVVQMLKQ 530
               + V+E I +   ++        V+ + L C +  P  R ++ ++ + L++
Sbjct: 227 GLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 20/204 (9%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR-IKEICNEMDI-MSRAHHKNLVQFLGC 320
           LG G YG + K   +  G  +AVKR+  +  ++  K +  ++DI M        V F G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 321 CFTKKDSFVVYEFVQNKSLDRI---LFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            F + D ++  E V + SLD+    ++D       D   +  I +   + LEYLH   ++
Sbjct: 69  LFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHS--KL 123

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
            ++HRD+K SN+L++   + K+ DFG+   S      +  T  AG   YMAPE I N +L
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGI---SGYLVDSVAKTIDAGCKPYMAPERI-NPEL 179

Query: 438 TE-----KVDIYSFGVLVLEIVSG 456
            +     K D++S G+ ++E+ +G
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 18/208 (8%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFI-------SRKNRIKEICNEMDIM 306
              F    K+G G +  ++K   L DGR +A+K++ I       +R++ +KEI    D++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEI----DLL 56

Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDR-ILFDPKQKKELDWKKRHVIIIGTA 365
            +  H N++++L       +  +V E      L R I    KQK+ +  +      +   
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
             LE++H     +I+HRDIK +N+ +      K+ D GL RF SS+ +     ++ GT  
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPY 171

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEI 453
           YM+PE I       K DI+S G L+ E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 35/210 (16%)

Query: 263 KLGHGGYGEIFK-GTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           KLG G YG ++K   L D +  A+K +    +S+K R   + NE+ I++  +H N++ + 
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISY- 64

Query: 319 GCCFTKKDSF-------VVYEFVQNKSLDRILFDPKQKK-----ELDWKKRHVIIIGTAE 366
                 K++F       +V E+     L + +   K+K+     +  W+    I I    
Sbjct: 65  ------KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLR 114

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           GL+ LH   + +I+HRD+K++NILL      KI D G+++     K  +  T I GT  Y
Sbjct: 115 GLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHY 167

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           MAPE       + K DI+S G L+ E+ + 
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 35/211 (16%)

Query: 264 LGHGGYGEIFKGTL-QDGRE---IAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +G G +GE+ +G L   G+    +A+K L   +  ++ R  +  +E  IM +  H N++ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNIIH 69

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRIL------FDPKQKKELDWKKRHVIIIGTAEGLEY 370
             G     +   ++ EF++N +LD  L      F   Q           ++ G A G++Y
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG--------MLRGIAAGMKY 121

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG----- 425
           L    +M  VHRD+ A NIL++     K++DFGL+RF   + S   +     +LG     
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS---DPTYTSSLGGKIPI 175

Query: 426 -YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            + APE IA  + T   D++S+G+++ E++S
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 29/204 (14%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++  T     ++AVK +     + ++    E ++M    H  LV+ L    
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVK-LHAVV 70

Query: 323 TKKDSFVVYEFVQNKSL-DRILFDPKQKKEL----DWKKRHVIIIGTAEGLEYLHKDGQM 377
           TK+  +++ EF+   SL D +  D   K+ L    D+  +       AEG+ ++    Q 
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIE---QR 121

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEY 431
             +HRD++A+NIL+      KIADFGLAR      +++ E +  P       + + APE 
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-------IKWTAPEA 174

Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
           I  G  T K D++SFG+L++EIV+
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 68/240 (28%), Positives = 117/240 (48%), Gaps = 35/240 (14%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKE-----ICNEMDI 305
           ++  D FD   ++G G YG+++K   +D G  +A+K++   R +  KE        E+ I
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKI 59

Query: 306 MSRAHHKNLVQFLGCCFTKKDS----------FVVYEFVQNKSLDRILFDPKQKKELDWK 355
           + + +H+N+V        K+D+          ++V+E++     D  L    +   + + 
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFS 114

Query: 356 KRHV--IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEK 412
           + H+   +    EGL Y HK      +HRDIK SNILL+ K + K+ADFGLAR ++S E 
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Query: 413 SLLPNTAIAGTLGYMAPE-YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               N  I  TL Y  PE  +   +    +D++S G ++ E+    +   FQ++     L
Sbjct: 172 RPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELF--TKKPIFQANQELAQL 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 28/204 (13%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ G   +  ++AVK L     + ++    E ++M    H  LV+      
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 323 TKKDSFVVYEFVQNKSL-DRILFDPKQK----KELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            ++  +++ E++   SL D +  D   K    K +D+  +       AEG+ Y+ +    
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIERK--- 122

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEY 431
             +HRD++A+N+L+      KIADFGLAR      +++ E +  P       + + APE 
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-------IKWTAPEA 175

Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
           I  G  T K D++SFG+L+ EIV+
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 27/207 (13%)

Query: 264 LGHGGYGEIFKGTL--QDGREI--AVKRLFISRKNRIKEI------CNEMDIMSRAHHKN 313
           +G G +G ++ GTL   DG++I  AVK L     NRI ++        E  IM    H N
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-----NRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 314 LVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG--TAEGLEY 370
           ++  LG C   + S  VV  ++++  L   +        +    + +I  G   A+G+EY
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV----KDLIGFGLQVAKGMEY 113

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMA 428
           L      + VHRD+ A N +LD     K+ADFGLAR  +     S+  +T     + +MA
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS 455
            E +   + T K D++SFGVL+ E+++
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 84.3 bits (208), Expect = 5e-18
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 45/286 (15%)

Query: 263 KLGHGGYGEIFKGTL-----QDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +LG   +G+I+KG L        + +A+K L  I+   +  E   E  +M+  HH N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILF--------------DPKQKKELDWKKRHVIII 362
            LG    ++   +++E++    L   L               D   K  LD      I I
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAI 420
             A G+EYL        VH+D+ A NIL+  +   KI+D GL+R  +S+    + P + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHF 479
              + +M PE I  G+ +   DI+SFGV++ EI S G+Q                 +  F
Sbjct: 189 P--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQ----------------PYYGF 230

Query: 480 QAKTVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNV 524
             + V+E++ K   +   E+   R+  +   C QE P+ RP   ++
Sbjct: 231 SNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 25/203 (12%)

Query: 265 GHGGYGEIFKGTLQDGREI-AVK---RLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           G G +G++     +D +++ A+K   +     K  ++ + NE  I+   +H  LV     
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL--- 65

Query: 321 CFTKKDSFVVYEFVQNKSLDRIL-----FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            ++ +D   +Y  V    +D +L     +   QK +   ++    I      LEYLH  G
Sbjct: 66  WYSFQDEENMY-LV----VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              I+HRDIK  NILLD +    I DF +A   +    +    T+ +GT GYMAPE +  
Sbjct: 121 ---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMAPEVLCR 173

Query: 435 GQLTEKVDIYSFGVLVLEIVSGV 457
              +  VD +S GV   E + G 
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 23/201 (11%)

Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLGCC 321
           LG G +G +  G  +   ++A+K +   R+  + E     E  +M +  H NLVQ  G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
             ++  F+V E++ N  L   L + K K   +W       +   E +EYL  +G    +H
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV--CEAMEYLESNG---FIH 123

Query: 382 RDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           RD+ A N L+   +  K++DFGLAR+      +SS+ +  P       + +  PE     
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP-------VKWAPPEVFDYS 176

Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
           + + K D++SFGVL+ E+ S 
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.1 bits (209), Expect = 6e-18
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 23/201 (11%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRLF---ISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G +     +   +  A+K L    I +  +++ + NE  I+    H  LV   G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKDGQ 376
                 + ++V E+V    L         +      +        A+    LEYLH    
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVAR-----FYAAQVVLALEYLH---S 119

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT-AIAGTLGYMAPEYIANG 435
           + IV+RD+K  N+LLD     KI DFG A      K +   T  + GT  Y+APE I + 
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFA------KRVKGRTYTLCGTPEYLAPEIILSK 173

Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
              + VD ++ G+L+ E+++G
Sbjct: 174 GYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.0 bits (207), Expect = 6e-18
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 17/206 (8%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGRE---IAVKRLFISR-KNRIKEICNEMDIMSRAHH 311
           + F +  K+G G +GE+FKG   D R    +A+K + +   ++ I++I  E+ ++S+   
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKS-LDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
             + ++ G        +++ E++   S LD  L +P     LD  +   I+    +GL+Y
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPG---PLDETQIATILREILKGLDY 116

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH + +   +HRDIKA+N+LL      K+ADFG+A       + +      GT  +MAPE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPE 171

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSG 456
            I       K DI+S G+  +E+  G
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 13/196 (6%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG+G +GE++ GT     ++AVK L     +  +    E  IM +  H  LVQ L    
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQ-LYAVV 70

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L D  + + L       +    A G+ Y+ +   M  +HR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++++NIL+      KIADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 182

Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+V+
Sbjct: 183 KSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 263 KLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNR-IKEIC-NEMDIMSRAHHKNLVQFLG 319
            +G G YG + K   ++ G+ +A+K+   S  ++ +K+I   E+ ++ +  H+NLV  + 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
               KK  ++V+EFV +  LD +   P     LD  +    +     G+E+ H      I
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSH---NI 121

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN---TAIAGTLGYMAPEY-IANG 435
           +HRDIK  NIL+      K+ DFG AR  ++     P    T    T  Y APE  + + 
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAA-----PGEVYTDYVATRWYRAPELLVGDT 176

Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
           +    VDI++ G LV E+++G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 50/197 (25%), Positives = 109/197 (55%), Gaps = 13/197 (6%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +LG G +G+++K   ++   +A  ++  ++ +  +++   E+DI++   H N+V+ L   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
           + + + +++ EF    ++D ++ +   ++ L   +  V+   T E L YLH++   +I+H
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI-----ANGQ 436
           RD+KA NIL  L    K+ADFG++  + + +++    +  GT  +MAPE +      +  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 437 LTEKVDIYSFGVLVLEI 453
              K D++S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 57/202 (28%), Positives = 109/202 (53%), Gaps = 13/202 (6%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISR-KNRIKEICNEMDIMSRAHHKNLV 315
           F +  ++G G +GE++KG     +E+ A+K + +   ++ I++I  E+ ++S+     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 316 QFLGCCFTKKDSFVVYEFVQNKS-LDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           ++ G        +++ E++   S LD +   P ++  +    R ++     +GL+YLH +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYLHSE 120

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
            +   +HRDIKA+N+LL  +   K+ADFG+A    ++  +  NT + GT  +MAPE I  
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFV-GTPFWMAPEVIKQ 175

Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
                K DI+S G+  +E+  G
Sbjct: 176 SAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 27/271 (9%)

Query: 263 KLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +GE+F G L+ D   +AVK    +    +K +   E  I+ +  H N+V+ +G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  K+  ++V E VQ    D + F   +   L  K+   ++   A G+EYL        +
Sbjct: 62  CTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCI 116

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL--GYMAPEYIANGQLT 438
           HRD+ A N L+  K+  KI+DFG++R    E  +  +T     +   + APE +  G+ +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 439 EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIE 498
            + D++SFG+L+ E  S               L    + +   +   E I++ + +   E
Sbjct: 175 SESDVWSFGILLWEAFS---------------LGAVPYANLSNQQTREAIEQGVRLPCPE 219

Query: 499 EVKRVVWVGLL-CTQELPTLRPSMTNVVQML 528
                V+  +  C +  P  RPS + V Q L
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 14/203 (6%)

Query: 262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           ++LG G YG ++K   +  G  +A+K + +   +++  +I  E+DI+ +A    +V F G
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
             F +   ++  E++   SLD++       + +       I     +GL++L K+ +  I
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KE-EHNI 124

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI------A 433
           +HRD+K +N+L++   + K+ DFG+   S +  + L  T I G   YMAPE I       
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGV---SGNLVASLAKTNI-GCQSYMAPERIKSGGPNQ 180

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
           N   T + D++S G+ +LE+  G
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 17/206 (8%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGRE---IAVKRLFISR-KNRIKEICNEMDIMSRAHH 311
           + F +  ++G G +GE+FKG   D R    +A+K + +   ++ I++I  E+ ++S+   
Sbjct: 4   ELFTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKS-LDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
             + ++ G        +++ E++   S LD +   P  + ++    + ++     +GL+Y
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-----KGLDY 116

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH + +   +HRDIKA+N+LL  +   K+ADFG+A       + +      GT  +MAPE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPE 171

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSG 456
            I       K DI+S G+  +E+  G
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 23/200 (11%)

Query: 264 LGHGGYGE--IFKGTLQDG-----REIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +GE  +++ T +D      +E+ + RL  S K R ++  NE+ I+S   H N++ 
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRL--SEKER-RDALNEIVILSLLQHPNIIA 63

Query: 317 FLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVI--IIGTAEGLEYLHK 373
           +           +  E+    +L D+I+   +QK +L +++  V+  +      + Y+HK
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIV---RQKGQL-FEEEMVLWYLFQIVSAVSYIHK 119

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
            G   I+HRDIK  NI L      K+ DFG+++   SE S+     + GT  YM+PE   
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQ 174

Query: 434 NGQLTEKVDIYSFGVLVLEI 453
             +   K DI++ G ++ E+
Sbjct: 175 GVKYNFKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 56/197 (28%), Positives = 106/197 (53%), Gaps = 13/197 (6%)

Query: 263 KLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +LG G +G+++K   ++ G   A K +    +  +++   E++I++  +H  +V+ LG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
           +     +++ EF    ++D I+ +    + L   +  VI     E L+YLH    M+I+H
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLH---SMKIIH 133

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE-- 439
           RD+KA N+LL L    K+ADFG++  + + K+L    +  GT  +MAPE +    + +  
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 440 ---KVDIYSFGVLVLEI 453
              K DI+S G+ ++E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 57/186 (30%), Positives = 96/186 (51%), Gaps = 19/186 (10%)

Query: 258 FDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEIC--NEMDIMSRAHHKNL 314
           +++  K+G G +GE+FK    +  + +A+K++ +  +     I    E+ I+    H+N+
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73

Query: 315 VQFLGCCFTKK--------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           V  +  C TK           ++V+EF ++  L  +L +   K  L   K+  ++     
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKMLLN 130

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN--TAIAGTL 424
           GL Y+H++   +I+HRD+KA+NIL+      K+ADFGLAR  S  K+  PN  T    TL
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 425 GYMAPE 430
            Y  PE
Sbjct: 188 WYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 264 LGHGGYGEIFKG--TLQDGREI--AVKRLFI--SRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G   L   REI  A+K L    + K R ++  +E  IM +  H N++  
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNIIHL 70

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYL---SDM 125

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + APE I
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTAPEAI 181

Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 34/215 (15%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRIKE-----ICNEMDIMSRAHH 311
           F++ N++G G YG +++       EI A+K++   R +  ++        E+ ++    H
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRH 65

Query: 312 KNLVQFLGCCFTKK-DS-FVVYEFVQNKSLDRIL------FDPKQKKELDWKKRHVIIIG 363
            N+V+       K  DS F+V E+ + + L  +L      F   Q K         +++ 
Sbjct: 66  PNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVK--------CLMLQ 116

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAG 422
              GL+YLH++    I+HRD+K SN+LL  K   KIADFGLAR +    K + P      
Sbjct: 117 LLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--- 170

Query: 423 TLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSG 456
           TL Y APE +      T  +D+++ G ++ E+++ 
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 4e-17
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 28/205 (13%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEM----DIMSRAHHKNLVQF 317
           +LG G +G ++     + G  +A+K++   +K    E C  +     +     H N+V+ 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKM--KKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 318 LGCCFTKKDSFVVYEFVQN------KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
                   + + V+E+++       K      F     +         II    +GL ++
Sbjct: 64  KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRS--------IIYQILQGLAHI 115

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           HK G     HRD+K  N+L+      KIADFGLAR     +S  P T    T  Y APE 
Sbjct: 116 HKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPEI 169

Query: 432 I-ANGQLTEKVDIYSFGVLVLEIVS 455
           +  +   +  VDI++ G ++ E+ +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.7 bits (199), Expect = 7e-17
 Identities = 52/180 (28%), Positives = 99/180 (55%), Gaps = 9/180 (5%)

Query: 280 GREIAVKRLFI-SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV--VYEFVQN 336
           G ++AVK L   S  N I ++  E++I+   +H+N+V++ G C     + +  + EF+ +
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR 396
            SL   L  P+ K +++ K++    +   +G++YL   G  Q VHRD+ A N+L++ +H+
Sbjct: 93  GSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQ 147

Query: 397 PKIADFGLARFSSSEKSLLP-NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            KI DFGL +   ++K        +   + + APE +   +     D++SFGV + E+++
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 80.3 bits (198), Expect = 7e-17
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 35/207 (16%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLGC 320
           +LG G +G +  G  +   ++A+K +   ++  + E     E  +M +  H+ LVQ  G 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 321 CFTKKDSFVVYEFVQNKSLDRIL------FDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           C  ++  ++V E++ N  L   L      F P Q  E+             EG+ YL   
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD--------VCEGMAYLESK 119

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMA 428
              Q +HRD+ A N L+D +   K++DFGL+R      ++SS  S  P       + +  
Sbjct: 120 ---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP-------VRWSP 169

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS 455
           PE +   + + K D+++FGVL+ E+ S
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 16/203 (7%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNR-IKEICNEMD-IMSRAHHKNLVQFLGC 320
           +G G +G + K   +  G  +AVKR+  +   +  K +  ++D +M  +    +V+F G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 321 CFTKKDSFVVYEFVQNKSLD---RILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            F + D ++  E + + SLD   + +++   K  +  +    I + T + L YL ++  +
Sbjct: 72  LFREGDCWICMELM-DISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEE--L 127

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
           +I+HRD+K SNILLD     K+ DFG+   S      +  T  AG   YMAPE I     
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGI---SGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 438 TE---KVDIYSFGVLVLEIVSGV 457
                + D++S G+ + E+ +G 
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 17/195 (8%)

Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT 323
           +G G +G++  G  + G ++AVK   I      +    E  +M++  H NLVQ LG    
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 324 KKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +K   ++V E++   SL   L   + +  L         +   E +EYL  +     VHR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126

Query: 383 DIKASNILLDLKHRPKIADFGLARFSSS--EKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           D+ A N+L+   +  K++DFGL + +SS  +   LP       + + APE +   + + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-------VKWTAPEALREKKFSTK 179

Query: 441 VDIYSFGVLVLEIVS 455
            D++SFG+L+ EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 81.5 bits (201), Expect = 8e-17
 Identities = 69/236 (29%), Positives = 108/236 (45%), Gaps = 23/236 (9%)

Query: 264 LGHGGYGEIFKGTL-QDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++    L + GR  AVK L    I + + ++    E  I+S A +   +  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           CCF   D  F V EFV    L   +F  ++ +  D  +           L +LH  G   
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG--- 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           I++RD+K  N+LLD +   K+ADFG+ +           +   GT  Y+APE +      
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLYG 174

Query: 439 EKVDIYSFGVLVLEIVSGVQNNKFQS---DDGFETL-----VTHTWKHFQAKTVLE 486
             VD ++ GVL+ E++ G  +  F++   DD FE +     V  TW    A  +L+
Sbjct: 175 PSVDWWAMGVLLYEMLCG--HAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILK 228

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI-KEICNEMDIMSRAHHKNLVQFLGCC 321
           LGHG  G ++K   L   R +AVK + +     + K+I +E++I+ +     ++ F G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV---IIIGTAEGLEYLHKDGQMQ 378
           F +    +  EF+   SLD     P+          HV   I +   +GL YL     ++
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPE----------HVLGRIAVAVVKGLTYLW---SLK 115

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           I+HRD+K SN+L++ + + K+ DFG++    +S  K+ +      GT  YMAPE I+  Q
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV------GTNAYMAPERISGEQ 169

Query: 437 LTEKVDIYSFGVLVLEIVSG-VQNNKFQSDDGF 468
                D++S G+  +E+  G     + Q + G 
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 56/220 (25%), Positives = 108/220 (49%), Gaps = 31/220 (14%)

Query: 264 LGHGGYGEIFKGTLQD--GR----EIAVKRLFI-SRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++ K T     GR     +AVK L   +  + ++++ +E +++ + +H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIG 363
             G C       ++ E+ +  SL   L + ++                LD      + +G
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 364 --------TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
                    + G++YL    +M++VHRD+ A N+L+    + KI+DFGL+R    E S +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             +     + +MA E + +   T + D++SFGVL+ EIV+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 17/202 (8%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHH-KNLVQFLGC 320
           +G G  G+++K    + G  +AVK++     K   K I  ++D++ ++H    +V+  G 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQK-KELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
             T  D F+  E +    LD++L   +    E    K  V I+   + L YL K+    +
Sbjct: 83  FITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIV---KALHYL-KEKH-GV 136

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI----ANG 435
           +HRD+K SNILLD     K+ DFG++      K+    T  AG   YMAPE I     N 
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNP 193

Query: 436 QLTEKVDIYSFGVLVLEIVSGV 457
           +   + D++S G+ ++E+ +G 
Sbjct: 194 KYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 26/211 (12%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFI-------SRKNRIKEICNEMDIMSRA 309
           F    K+G G + E+++ T L D + +A+K++ I       +R++ +KEI    D++ + 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEI----DLLKQL 59

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD-----WKKRHVIIIGT 364
           +H N++++L       +  +V E      L +++   K++K L      WK      +  
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK----YFVQL 115

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
              +E++H     +++HRDIK +N+ +      K+ D GL RF SS+ +     ++ GT 
Sbjct: 116 CSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTP 170

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            YM+PE I       K DI+S G L+ E+ +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 258 FDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEIC--NEMDIMSRAHHKNL 314
           ++   KLG G +GE++K   ++ GR +A+K++ +  +     I    E+ I+ +  H N+
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 315 VQFLGCCFTKKD-------SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEG 367
           V  +     + D       S  +     +  L  +L +P  K      K +++ +   EG
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL--LEG 127

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN---------T 418
           + YLH++    I+HRDIKA+NIL+D +   KIADFGLAR                    T
Sbjct: 128 INYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 419 AIAGTLGYMAPEYIANG-QLTEKVDIYSFG 447
            +  T  Y  PE +    + T  VDI+  G
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIG 214

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 70

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 182

Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 183 KSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 70/216 (32%), Positives = 112/216 (51%), Gaps = 21/216 (9%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIM-SRAHHK 312
           TD ++    +G G YG+++K T  +DG   AVK L     +  +EI  E +I+ S  +H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHP 79

Query: 313 NLVQFLGCCFTKKDSFV------VYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTA 365
           N+V+F G  F K D  V      V E     S+  ++       + LD      I+ G  
Sbjct: 80  NVVKFYGM-FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            GL++LH +   +I+HRD+K +NILL  +   K+ DFG++   +S + L  NT++ GT  
Sbjct: 139 LGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSV-GTPF 193

Query: 426 YMAPEYIANGQLTE-----KVDIYSFGVLVLEIVSG 456
           +MAPE IA  Q  +     + D++S G+  +E+  G
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 258 FDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           ++   ++G G YG+++K   L  G   AVK + +   +    I  E+ ++    H N+V 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRI--LFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + G   +++  ++  E+    SL  I  +  P  + ++ +  R      T +GL YLH  
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE-----TLQGLAYLHSK 125

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA- 433
           G+M   HRDIK +NILL      K+ADFG+A  +    ++    +  GT  +MAPE  A 
Sbjct: 126 GKM---HRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 434 --NGQLTEKVDIYSFGVLVLEI 453
             NG   +  DI++ G+  +E+
Sbjct: 181 EKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 26/211 (12%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFI-------SRKNRIKEICNEMDIMSRA 309
           F    K+G G + E+++ T L DG  +A+K++ I       +R + IKEI    D++ + 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEI----DLLKQL 59

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD-----WKKRHVIIIGT 364
           +H N++++        +  +V E      L R++   K++K L      WK      +  
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK----YFVQL 115

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
              LE++H     +++HRDIK +N+ +      K+ D GL RF SS+ +     ++ GT 
Sbjct: 116 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTP 170

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            YM+PE I       K DI+S G L+ E+ +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 58/206 (28%), Positives = 106/206 (51%), Gaps = 13/206 (6%)

Query: 264 LGHGGYGEIFK---GTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           LG G +G +       LQD  G  +AVK+L  S    +++   E++I+    H N+V++ 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 319 GCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
           G C++  +++  +V E++   SL   L   K ++ LD +K  +      +G+EYL   G 
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIANG 435
            + VHRD+   NIL++ ++R KI DFGL +    +K          + + + APE +   
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 436 QLTEKVDIYSFGVLVLEIVSGVQNNK 461
           + +   D++SFGV++ E+ +    + 
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSC 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 18/225 (8%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHHKN 313
           F    ++G GGYG++F    +D  EI A+KR+    + + N ++ +  E DI++    + 
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           LV+ L      +  ++  E+V       +L        L        +    E ++ LH 
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALH- 118

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
             ++  +HRD+K  N L+D     K+ DFGL    S       N+ + G+  YMAPE + 
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGL----SKGIVTYANSVV-GSPDYMAPEVLR 171

Query: 434 NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT-HTWK 477
                  VD +S G ++ E + G     F      ET      WK
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGF--PPFSGSTPNETWENLKYWK 214

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++    L+   E     A+K+  +   + ++    E  +++ A     +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 320 CCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           C F TK+  F V E++    L   +F  +     D  +          GL++LHK G   
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--- 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA--IAGTLGYMAPEYIANGQ 436
           I++RD+K  N+LLD     KIADFG+ +    E       A    GT  Y+APE +   +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCK----ENMNGEGKASTFCGTPDYIAPEILKGQK 172

Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDD 466
             E VD +SFGVL+ E++ G   + F  +D
Sbjct: 173 YNESVDWWSFGVLLYEMLIG--QSPFHGED 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT     ++A+K L        +    E  IM +  H  LV  L    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVP-LYAVV 70

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V EF+   SL   L +    K L   +   +    A+G+ Y+ +   M  +HR
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKE-GDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      KIADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 182

Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+V+
Sbjct: 183 KSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 22/221 (9%)

Query: 264 LGHGGYGEIF----KGTLQDGRE--IAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLV 315
           LG G +GE+F    KG  ++G E  + VK L    K  N   E   E+D+  +  HKN+V
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKAL-QKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE------LDWKKRHVIIIGTAEGLE 369
           + LG C   +  +++ E+     L + L   K K E      L  K++  +    A G++
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS-SSEKSLLPNTAIAGTLGYMA 428
           +L      + VHRD+ A N L+  +   K++   L++   +SE   L N  I   L ++A
Sbjct: 132 HLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--LRWLA 186

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGF 468
           PE +     + K D++SFGVL+ E+ + G       SD+  
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.2 bits (190), Expect = 9e-16
 Identities = 63/280 (22%), Positives = 124/280 (44%), Gaps = 49/280 (17%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLGC 320
           +LG G +G +  G  +   ++A+K +    +  + E     E  +M +  H  LVQ  G 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG----TAEGLEYLHKDGQ 376
           C  +K  ++V EF++N  L   L   +Q++    K    +++       EG+EYL ++  
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYL---RQRQG---KLSKDMLLSMCQDVCEGMEYLERNS- 120

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPE 430
              +HRD+ A N L+      K++DFG+ R+      +SS  +  P       + +  PE
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP-------VKWSPPE 171

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE--TLVTHTWKHFQAKTVLEII 488
                + + K D++SFGVL+ E+ +  +   F+    +E   +++  ++ ++ K     +
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMISRGFRLYRPKLASMTV 230

Query: 489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML 528
            +               V   C  E P  RP+   +++ +
Sbjct: 231 YE---------------VMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 78.3 bits (194), Expect = 9e-16
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 29/209 (13%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL-- 318
           +G G YG +      + GR++A+K++     + I  K I  E+ ++    H+N++  L  
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 319 -----GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
                   F   D ++V E ++   L +++   K  + L        +     GL+YLH 
Sbjct: 68  LRPPSPEDF--NDVYIVTELMET-DLHKVI---KSPQPLTDDHIQYFLYQILRGLKYLHS 121

Query: 374 DGQMQIVHRDIKASNILL----DLKHRPKIADFGLARFSSSEKSLLPN-TAIAGTLGYMA 428
                ++HRD+K SNIL+    DL    KI DFGLAR    ++      T    T  Y A
Sbjct: 122 AN---VIHRDLKPSNILVNSNCDL----KICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174

Query: 429 PEYIANGQ-LTEKVDIYSFGVLVLEIVSG 456
           PE + +    T+ +DI+S G +  E+++ 
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 77.6 bits (192), Expect = 9e-16
 Identities = 58/217 (26%), Positives = 111/217 (51%), Gaps = 34/217 (15%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEICNEMDIMSR 308
           D +++ N++  G YG +++    + G  +A+K+L + ++        ++EI    +I+ +
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI----NILLK 60

Query: 309 AHHKNLVQF----LGCCFTKKDS-FVVYEFVQN--KSLDRILFDPKQKKELDWKKRHVII 361
             H N+V      +G   +  D  ++V E+V++  KSL   +  P  + E        ++
Sbjct: 61  LQHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE-----VKCLM 112

Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAI 420
           +    G+ +LH +    I+HRD+K SN+LL+ +   KI DFGLAR + S  K     T +
Sbjct: 113 LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY---TQL 166

Query: 421 AGTLGYMAPE-YIANGQLTEKVDIYSFGVLVLEIVSG 456
             TL Y APE  +   + +  +D++S G +  E+++ 
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 68/239 (28%), Positives = 110/239 (46%), Gaps = 29/239 (12%)

Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++    L+   E     A+K+  +   + ++    E  +++ A     +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           C F  K+  F V EF+    L   +F  + K   D  +          GL++LH  G   
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--- 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLAR---FSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           I++RD+K  N++LD     KIADFG+ +   F  +  S        GT  Y+APE +   
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS-----TFCGTPDYIAPEILQGL 171

Query: 436 QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG---FETLVTHT-----WKHFQAKTVLE 486
           + T  VD +SFGVL+ E++ G   + F  DD    FE++   T     W   ++K +LE
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIG--QSPFHGDDEDELFESIRVDTPHYPRWITKESKDILE 228

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 264 LGHGGYGEIFKGTL-QDGREI--AVKRLF-ISRKNRIKEICNEMDIMSR-AHHKNLVQFL 318
           +G G +G++ K  + +DG  +  A+KR+   + K+  ++   E++++ +  HH N++  L
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 319 GCCFTKKDSFVVYEFVQNKSL------DRIL-FDP------KQKKELDWKKRHVIIIGTA 365
           G C  +   ++  E+  + +L       R+L  DP           L  ++        A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G++YL    Q Q +HRD+ A NIL+   +  KIADFGL+R    ++  +  T     + 
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 188

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MA E +     T   D++S+GVL+ EIVS
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 31/217 (14%)

Query: 263 KLGHGGYGEIFKGTLQDGR----EIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQF 317
            +G G +G++++G           +AVK         ++E    E  IM +  H ++V+ 
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
           +G   T+   ++V E      L   L     K  LD     +     +  L YL      
Sbjct: 73  IGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSE------KSLLPNTAIAGTLGYMAPEY 431
           + VHRDI A N+L+      K+ DFGL+R+   E      K  LP       + +MAPE 
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP-------IKWMAPES 179

Query: 432 IANGQLTEKVDIYSFGVLVLEIVS-------GVQNNK 461
           I   + T   D++ FGV + EI+        GV+NN 
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 23/203 (11%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKE------ICNEMDIMSRAHHKNLVQ 316
           LG GG+GE+    ++  G+  A K+L    K R+K+        NE  I+ +   + +V 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL---DKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHK 373
            L   F  KD   +   + N     + +      E  + +   I    A+   GLE+LH 
Sbjct: 58  -LAYAFETKDDLCLVMTLMNGG--DLKYHIYNVGEPGFPEARAIFY-AAQIICGLEHLH- 112

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
             Q +IV+RD+K  N+LLD     +I+D GLA      K        AGT GYMAPE + 
Sbjct: 113 --QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQ 167

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
                  VD ++ G  + E+++G
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 78/308 (25%), Positives = 134/308 (43%), Gaps = 65/308 (21%)

Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           EK T       +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 6   EKITMS----RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 60

Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE------LDWKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E          K+
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R       +  
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177

Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE 469
             K LLP       + +M+PE + +G  T   D++SFGV++ EI                
Sbjct: 178 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--------------- 215

Query: 470 TLVTHTWKHFQAKTVLE------IIDKSIEIED-IEEVKRVVWVGLLCTQELPTLRPSMT 522
           TL    ++    + VL       ++DK     D + E+ R+ W      Q  P +RPS  
Sbjct: 216 TLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCW------QYNPKMRPSFL 269

Query: 523 NVVQMLKQ 530
            ++  +K+
Sbjct: 270 EIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 12/206 (5%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKN-RIKEIC-NEMDIMSRAHHK 312
           + +++ +K+G G YG +FK   ++ G+ +A+K+   S  +  IK+I   E+ ++ +  H 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           NLV  +     K+   +V+E+  +  L+ +  +P+   E   KK   II  T + + + H
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCH 117

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
           K      +HRD+K  NIL+  + + K+ DFG AR  +        T    T  Y APE +
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELL 172

Query: 433 -ANGQLTEKVDIYSFGVLVLEIVSGV 457
             + Q    VD+++ G +  E+++G 
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 41/217 (18%)

Query: 293 KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKK- 350
           KN++  +  E  IM        V  L   F  KD  ++V E++       ++     K  
Sbjct: 37  KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI-----KTL 91

Query: 351 ---ELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF 407
                DW K++  I     G+E LH+ G   I+HRDIK  N+L+D     K+ DFGL+R 
Sbjct: 92  GGLPEDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146

Query: 408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG 467
                  L N    GT  Y+APE I      +  D +S G ++ E + G           
Sbjct: 147 G------LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG----------- 189

Query: 468 FETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVV 504
                   +  F A+T   + D  I    I   + V 
Sbjct: 190 --------YPPFHAETPDAVFDN-ILSRRINWPEEVK 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 264 LGHGGYGEIFKGTLQ-DGREI--AVKRLF-ISRKNRIKEICNEMDIMSR-AHHKNLVQFL 318
           +G G +G++ K  ++ DG  +  A+KR+   + K+  ++   E++++ +  HH N++  L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 319 GCCFTKKDSFVVYEFVQNKSL------DRIL-FDPKQKKE------LDWKKRHVIIIGTA 365
           G C  +   ++  E+  + +L       R+L  DP           L  ++        A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G++YL    Q Q +HRD+ A NIL+   +  KIADFGL+R    ++  +  T     + 
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MA E +     T   D++S+GVL+ EIVS
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 70/287 (24%), Positives = 103/287 (35%), Gaps = 54/287 (18%)

Query: 263 KLGHGGYGEIFKGTLQD--GREI--AVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           KLG G +G + +G      G+ I  AVK L      + + +   E  IM    H+NL++ 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G   T     +V E     SL   L                  +  A G+ YL      
Sbjct: 62  YGVVLTHP-LMMVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLE---SK 116

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLAR--------FSSSEKSLLPNTAIAGTLGYMAP 429
           + +HRD+ A NILL    + KI DFGL R        +   E   +P         + AP
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP-------FAWCAP 169

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID 489
           E +     +   D++ FGV + E+ +           G E      W       +L+ ID
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFT----------YGEE-----PWAGLSGSQILKKID 214

Query: 490 KSIEI--------EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML 528
           K  E         +DI  V    W         P  RP+   + + L
Sbjct: 215 KEGERLERPEACPQDIYNVMLQCW------AHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 31/239 (12%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRA-HHKNLVQFL 318
           LG G +G++    L+   E+ AVK L    I + + ++    E  +++ A  H  L Q L
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ-L 61

Query: 319 GCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
             CF  KD  F V E+V    L   +F  ++    D  +          GL++LH+ G  
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG-- 116

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP---NTAIAGTLGYMAPEYIAN 434
            I++RD+K  N+LLD +   KIADFG+      ++ +L     +   GT  Y+APE ++ 
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKIADFGM-----CKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG---FETLVTH-----TWKHFQAKTVL 485
                 VD ++ GVL+ E+++G   + F+ DD    F++++        W   +AK++L
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAG--QSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSIL 227

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 24/210 (11%)

Query: 264 LGHGGYGEIFKGTLQ-DGREI--AVKRLF-ISRKNRIKEICNEMDIMSR-AHHKNLVQFL 318
           +G G +G++ +  ++ DG ++  A+K L   + +N  ++   E++++ +  HH N++  L
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 319 GCCFTKKDSFVVYEFVQNKSL------DRIL-FDPKQKKE------LDWKKRHVIIIGTA 365
           G C  +   ++  E+    +L       R+L  DP   KE      L  ++        A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G++YL    + Q +HRD+ A N+L+      KIADFGL+R    E+  +  T     + 
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVR 183

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MA E +     T K D++SFGVL+ EIVS
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 16/202 (7%)

Query: 258 FDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           F+   ++G G YG+++K   +  G   A+K + +        +  E+ +M    H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRI--LFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + G    +   ++  EF    SL  I  +  P  + ++ +  R      T +GL YLH  
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE-----TLQGLYYLHSK 125

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA- 433
           G+M   HRDIK +NILL      K+ADFG++  +    ++    +  GT  +MAPE  A 
Sbjct: 126 GKM---HRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 434 --NGQLTEKVDIYSFGVLVLEI 453
              G   +  DI++ G+  +E+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 40/212 (18%)

Query: 262 NKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEI-----CNEMDIMSR-AHHKNL 314
            K+G G + E+ K  + + G+  A+K +    K   K +       E+  + R + H N+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 315 VQFLGCCF---TKKDSFV-------VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           ++ +   F   T + + V       +YE ++            +K+ L  K+    +   
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDMNLYELIKG-----------RKRPLPEKRVKSYMYQL 109

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
            + L+++H++G   I HRDIK  NIL+      K+ADFG  R      S  P T    T 
Sbjct: 110 LKSLDHMHRNG---IFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTR 162

Query: 425 GYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVS 455
            Y APE +  +G    K+DI++ G +  EI+S
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 59/290 (20%)

Query: 264 LGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKE-ICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T           ++AVK L  +  +  +E + +E+ IMS   +H+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
             LG C       V+ E+     L   L   K++  L  +         A+G+ +L    
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFL---A 158

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAIAGTLGYMA 428
               +HRD+ A N+LL      KI DFGLAR       +     + LP       + +MA
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP-------VKWMA 211

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS-GVQ-------NNKFQS--DDGFETLVTHTWKH 478
           PE I N   T + D++S+G+L+ EI S G         ++KF     +G+        + 
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA-----QP 266

Query: 479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML 528
             A   +  I K+                  C    P  RP+   +VQ++
Sbjct: 267 EHAPAEIYDIMKT------------------CWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 25/218 (11%)

Query: 264 LGHGGYGEIFKGTL--QDGR--EIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           LG G +G + +G L   DG   ++AVK  +L I   + I+E  +E   M    H N+++ 
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 318 LGCCFTKKDS------FVVYEFVQNKSLDRILFDPK---QKKELDWKKRHVIIIGTAEGL 368
           +G CF            V+  F+++  L   L   +     ++L  +     ++  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMA 428
           EYL        +HRD+ A N +L       +ADFGL++   S             + ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQN 459
            E +A+   T K D+++FGV + EI +       GV+N
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 72/291 (24%), Positives = 129/291 (44%), Gaps = 49/291 (16%)

Query: 263 KLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNL 314
           +LG G +G +++G  +D         +AVK +    S + RI E  NE  +M      ++
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 71

Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK-----RHVIIIGT--AEG 367
           V+ LG     + + VV E + +  L   L   + + E +  +     + +I +    A+G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           + YL+     + VHRD+ A N ++      KI DFG+ R       +    K LLP    
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP---- 184

Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ 480
              + +MAPE + +G  T   D++SFGV++ EI                +L    ++   
Sbjct: 185 ---VRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLS 226

Query: 481 AKTVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
            + VL+ +     ++  +   +RV  +  +C Q  P +RP+   +V +LK 
Sbjct: 227 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 40/222 (18%)

Query: 264 LGHGGYGEIFK----GTLQDGRE----IAVKRLFISRKNR-IKEICNEMDIMS-RAHHKN 313
           LG G +G++ +    G  +   +    +AVK L  +  ++ + ++ +EM++M     HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FD-PKQKKE-LDWKKRHVI 360
           ++  LG C  +   +V+ E+    +L   L           FD  K  +E L +K     
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFG+L+ EI +
Sbjct: 197 RLP-------VKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 50/205 (24%), Positives = 102/205 (49%), Gaps = 20/205 (9%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEICNEMDIMSRAHHKNLVQ 316
           LG G +   ++   ++ G  +AVK++   R         ++ +  E+ +M+R +H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
            LG         +  E++   S+  +L  +   ++  +      ++      GL YLH++
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL-----RGLSYLHEN 122

Query: 375 GQMQIVHRDIKASNILLD-LKHRPKIADFGLA-RFSSS-EKSLLPNTAIAGTLGYMAPEY 431
              QI+HRD+K +N+L+D    R +IADFG A R ++    +      + GT+ +MAPE 
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           +   Q     D++S G +++E+ + 
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATA 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 13/198 (6%)

Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++F    KGT Q     A+K+  +   + ++    E  ++S A     +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 320 CCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           C F TK++ F V E++    L   +F  +   + D  +          GL++LH  G   
Sbjct: 63  CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--- 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           IV+RD+K  NILLD     KIADFG+ + +    +        GT  Y+APE +   +  
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYN 174

Query: 439 EKVDIYSFGVLVLEIVSG 456
             VD +SFGVL+ E++ G
Sbjct: 175 TSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 40/154 (25%), Positives = 76/154 (49%), Gaps = 9/154 (5%)

Query: 302 EMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVII 361
           E  ++   +H ++++      +   + +V   + + S D   +  K+ + L   +  +I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA 421
               EGL YLH     +I+HRD+K  NI ++   +  I D G A+F     + L    +A
Sbjct: 164 KQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLA 217

Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           GT+   APE +A  +   K DI+S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 57/217 (26%), Positives = 114/217 (52%), Gaps = 30/217 (13%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLV 315
           F+    +G+G YG+++KG  ++ G+  A+K + ++     +EI  E++++ + +HH+N+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 316 QFLGCCFTKKDS-------FVVYEFVQNKSLDRILFDPK----QKKELDWKKRHVIIIGT 364
            + G  F KK+        ++V EF    S+  ++ + K    +++ + +  R ++    
Sbjct: 67  TYYGA-FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---- 121

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             GL +LH   Q +++HRDIK  N+LL      K+ DFG++  +  ++++       GT 
Sbjct: 122 -RGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTP 175

Query: 425 GYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSG 456
            +MAPE IA     +     K D++S G+  +E+  G
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 56/222 (25%), Positives = 106/222 (47%), Gaps = 36/222 (16%)

Query: 258 FDESNKLGHGGYGEIFKG---TLQDGREIAVKRLFISRKNRIKEI----CNEMDIMSRAH 310
           ++    +G G YG ++K      +DG+E A+K+ F   K +   I    C E+ ++    
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60

Query: 311 HKNLVQFLGCCFTKKDS--FVVYEFVQ---------NKSLDRILFDPKQKKELDWKKRHV 359
           H+N+V  +       D   ++++++ +         ++   R+   P   K L W+    
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ---- 116

Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILL----DLKHRPKIADFGLAR-FSSSEKSL 414
            I+    G+ YLH +    ++HRD+K +NIL+      +   KI D GLAR F++  K L
Sbjct: 117 -IL---NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 415 LPNTAIAGTLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVS 455
                +  T+ Y APE +   +  T+ +DI++ G +  E+++
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 40/221 (18%)

Query: 264 LGHGGYGEI----FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIM---SRAHHKN 313
           LG G +G++    +K T   G   A+K L    I  ++ ++ +  E  I    +   H  
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSL----DRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           LV    C  T+     V E+     L       +F   +     +    V++     GL+
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV---FYAACVVL-----GLQ 115

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR----FSSSEKSLLPNTAIAGTLG 425
           YLH++    IV+RD+K  N+LLD +   KIADFGL +    F          +   GT  
Sbjct: 116 YLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR------TSTFCGTPE 166

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD 466
           ++APE +     T  VD +  GVL+ E++  V  + F  DD
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEML--VGESPFPGDD 205

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 11/207 (5%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLF-ISRKNRIK-EICNEMDIMSRA 309
           E   D F+  ++LG G  G + K   +    I  ++L  +  K  I+ +I  E+ ++   
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           +   +V F G  ++  +  +  E +   SLD++L + K+  E    K   + I    GL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VSIAVLRGLA 117

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YL +  + QI+HRD+K SNIL++ +   K+ DFG+   S      + N+ + GT  YM+P
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFV-GTRSYMSP 171

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E +     + + DI+S G+ ++E+  G
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 38/223 (17%)

Query: 263 KLGHGGYGEI----------FKG---TLQDGRE--IAVKRLFIS-RKNRIKEICNEMDIM 306
           KLG G +GE+          F G      DG+   +AVK L     K    +   E+ IM
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV------- 359
           SR  + N+++ LG C +     ++ E+++N  L++ L     ++E++    H        
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL----SQREIESTFTHANNIPSVS 127

Query: 360 ------IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEK 412
                 + +  A G++YL     +  VHRD+   N L+   +  KIADFG++R   S + 
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             +   A+   + +MA E I  G+ T   D+++FGV + E+ +
Sbjct: 185 YRIQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 26/222 (11%)

Query: 263 KLGHGGYGEIFKGT------LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +LG G +G++F          +D   +AVK L        K+   E ++++   H+++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDR----------ILFD--PKQKK-ELDWKKRHVIIIG 363
           F G C       +V+E++++  L++          IL D  P+Q K EL   +   I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIA 421
            A G+ YL        VHRD+   N L+      KI DFG++R  +S+    +  +T + 
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQ 463
             + +M PE I   + T + D++SFGV++ EI +  +   FQ
Sbjct: 189 --IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 258 FDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNR------IKEICNEMDIMSRAH 310
           F +  K+G G YG ++K      G  +A+K++ +  +        I+EI     ++   +
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 57

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAP 429
            H     +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y AP
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAP 169

Query: 430 EYIANGQL-TEKVDIYSFGVLVLEIVS 455
           E +   +  +  VDI+S G +  E+V+
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 39/286 (13%)

Query: 263 KLGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +LG G +G++F          QD   +AVK L  +  N  K+   E ++++   H+++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRIL----------FDPKQKKELDWKKRHVIIIGTAE 366
           F G C       +V+E++++  L++ L           +  +  EL   +   I    A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTL 424
           G+ YL        VHRD+   N L+      KI DFG++R  +S+    +  +T +   +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP--I 186

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV 484
            +M PE I   + T + D++S GV++ EI                T     W       V
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIF---------------TYGKQPWYQLSNNEV 231

Query: 485 LEIIDKSIEIEDIEEVKRVVWVGLL-CTQELPTLRPSMTNVVQMLK 529
           +E I +   ++      + V+  +L C Q  P +R ++  +  +L+
Sbjct: 232 IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 72.2 bits (177), Expect = 9e-14
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 18/217 (8%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++    L+   E+ A+K L    I + + +     E  I++ A     +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           CCF  KD  F V E+V    L   +F  ++ ++ D  +           L +LH+ G   
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           +++RD+K  NILLD +   K+ADFG+ +           T   GT  Y+APE +   +  
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELEYG 174

Query: 439 EKVDIYSFGVLVLEIVSGVQNNKFQS---DDGFETLV 472
             VD ++ GVL+ E+++G     F++   DD FE+++
Sbjct: 175 PSVDWWALGVLMYEMMAG--QPPFEADNEDDLFESIL 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 22/208 (10%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNR------IKEICNEMDIMSRAH 310
           +++  K+G G YG +FK   ++  EI A+KR+ +   +       ++EIC    ++    
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELK 57

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           HKN+V+      + K   +V+E+  ++ L +  FD     ++D +     +    +GL +
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYC-DQDLKK-YFDSCNG-DIDPEIVKSFMFQLLKGLAF 114

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAP 429
            H      ++HRD+K  N+L++     K+ADFGLAR F    +     +A   TL Y  P
Sbjct: 115 CH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY---SAEVVTLWYRPP 168

Query: 430 EYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           + +   +L +  +D++S G +  E+ + 
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 40/222 (18%)

Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +   +++ +K     
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 200 RLP-------VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 40/222 (18%)

Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           ++P Q  E     + ++  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 203 RLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 57/207 (27%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSRA 309
           E   D F++ ++LG G  G +FK + +  G  +A K + +  K  I+ +I  E+ ++   
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           +   +V F G  ++  +  +  E +   SLD++L   K+   +  +    + I   +GL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 117

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YL +  + +I+HRD+K SNIL++ +   K+ DFG+   S      + N+ + GT  YM+P
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFV-GTRSYMSP 171

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E +     + + DI+S G+ ++E+  G
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 27/218 (12%)

Query: 251 IEKATDCFDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMD 304
           I K T+ F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKR 357
           +M+   + ++ + LG C T     +         LD +    ++ K+       L+W   
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW--- 114

Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
               +  A+G+ YL    + ++VHRD+ A N+L+      KI DFGLA+   +++     
Sbjct: 115 ---CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168

Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                 + +MA E I +   T + D++S+GV V E+++
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 29/206 (14%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG++        GR++A+K+L    ++ I  K    E+ ++    H+N++  L  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 321 CFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV--IIIGTAEGLEYL 371
            FT        +D ++V   +    L+ I+   K +K  D    H+  ++     GL+Y+
Sbjct: 83  -FTPASSLEDFQDVYLVTHLMG-ADLNNIV---KCQKLSD---DHIQFLVYQILRGLKYI 134

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H  G   I+HRD+K SNI ++     KI DFGLAR +  E      T    T  Y APE 
Sbjct: 135 HSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEI 186

Query: 432 IAN-GQLTEKVDIYSFGVLVLEIVSG 456
           + N     + VDI+S G ++ E+++G
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 18/148 (12%)

Query: 314 LVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT--AEGLEY 370
           L Q L  CF   D  + V E+V    L   ++  +Q  +  +K+ H +      A GL +
Sbjct: 63  LTQ-LHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGK--FKEPHAVFYAAEIAIGLFF 116

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA--IAGTLGYMA 428
           LH  G   I++RD+K  N++LD +   KIADFG+ +    E      T     GT  Y+A
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCGTPDYIA 169

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           PE IA     + VD ++FGVL+ E+++G
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.9 bits (179), Expect = 2e-13
 Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 51/231 (22%)

Query: 263 KLGHGGYGEIFKGTLQD---GREIAVKRLFISRKNRI------KEICNEMDIMSRAHHKN 313
            +G GG GE++     D    R +A+K++   R++        K    E  I +   H  
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKI---REDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 314 LVQFLGCCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHV----------I 360
           +V     C    D   VY    +++  +L  +L    QK+ L   K             I
Sbjct: 64  IVPVYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSI 118

Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL----- 415
                  +EY+H  G   ++HRD+K  NILL L     I D+G A F   E+  L     
Sbjct: 119 FHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 416 --PNTA---------IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              N           I GT  YMAPE +     +E  DIY+ GV++ ++++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 11/205 (5%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKN 313
           D +++  KLG G Y  ++KG  + +G+ +A+K + +  +         E  ++    H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V       TK+   +V+E+V     D   +  K    L  +   + +     GL Y+H 
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHT---DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH- 120

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE-YI 432
             Q  I+HRD+K  N+L+      K+ADFGLAR  S       N  +  TL Y  P+  +
Sbjct: 121 --QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLL 176

Query: 433 ANGQLTEKVDIYSFGVLVLEIVSGV 457
            + + +  +D++  G + +E++ GV
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGV 201

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 263 KLGHGGYGEIF---------KGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
           +LG G +G ++         +  L+  +EI V  L     N   +   E  ++S+  H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL---NPNETVQANQEAQLLSKLDHPA 63

Query: 314 LVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVI--IIGTAEGLEY 370
           +V+F    F ++D+F ++ E+ + + LD  L + K   +    +  V    I    G+ Y
Sbjct: 64  IVKFHAS-FLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFIQLLLGVHY 121

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           +H   Q +I+HRD+KA NI L   +  KI DFG++R       L   T   GT  YM+PE
Sbjct: 122 MH---QRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLA--TTFTGTPYYMSPE 175

Query: 431 YIANGQLTEKVDIYSFGVLVLEI 453
            + +     K DI+S G ++ E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 60/218 (27%), Positives = 113/218 (51%), Gaps = 32/218 (14%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLV 315
           F+    +G+G YG+++KG  ++ G+  A+K + ++ ++  +EI  E++++ + +HH+N+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76

Query: 316 QFLGCCFTKKDS-------FVVYEFVQNKSLDRILFDPKQK--KELDWKK---RHVIIIG 363
            + G  F KK         ++V EF    S+  ++ + K    KE DW     R ++   
Sbjct: 77  TYYGA-FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIAYICREIL--- 131

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
              GL +LH     +++HRDIK  N+LL      K+ DFG++  +  ++++       GT
Sbjct: 132 --RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGT 184

Query: 424 LGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSG 456
             +MAPE IA     +     + DI+S G+  +E+  G
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 23/209 (11%)

Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE------ICNEMDIMSRAH 310
           F +   LG GG+GE+    ++  G+  A K+L    K RIK+        NE  I+ + +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGESMALNEKQILEKVN 58

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---G 367
            + +V  L   +  KD+  +   + N     + F      E  +++   +    AE   G
Sbjct: 59  SRFVVS-LAYAYETKDALCLVLTLMNGG--DLKFHIYHMGEAGFEEGRAVFYA-AEICCG 114

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           LE LH++   +IV+RD+K  NILLD     +I+D GLA      +++       GT+GYM
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGYM 168

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE + N + T   D ++ G L+ E+++G
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 56/218 (25%), Positives = 104/218 (47%), Gaps = 35/218 (16%)

Query: 263 KLGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +LG G +G++F          QD   +AVK L  + ++  ++   E ++++   H+++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRIL-FDPKQKKELDWKK---------RHVIIIGT-- 364
           F G C   +   +V+E++++  L+R L       K L   +           ++ I +  
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPN 417
           A G+ YL     +  VHRD+   N L+      KI DFG++R       +    +++LP 
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 187

Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                 + +M PE I   + T + DI+SFGV++ EI +
Sbjct: 188 ------IRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 43/237 (18%)

Query: 252 EKATDCFDESNKLGHGGYGE--------IFKGTLQDGREIAVKR---LFISR-------K 293
           E      +   KLG G +GE        +   + +   E        L   +        
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 294 NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL--------FD 345
           N  ++   E+ I+SR    N+ + LG C       ++ E+++N  L++ L          
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 346 PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA 405
               K L +     +    A G+ YL     +  VHRD+   N L+   +  KIADFG++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 406 R-------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           R       +    ++ LP       + +MA E +  G+ T K D+++FGV + EI++
Sbjct: 178 RNLYSSDYYRVQGRAPLP-------IRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 20/201 (9%)

Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFI----SRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           +G G YGE+       DG++  +K+L +     R+ +  E   E  ++S+  H N+V + 
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIVAYR 65

Query: 319 GCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI--IIGTAEGLEYLHKD 374
              +  +D   ++V  F +   L   L   K++K     +  V+   +  A  L+YLH+ 
Sbjct: 66  ES-WEGEDGLLYIVMGFCEGGDLYHKL---KEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
               I+HRD+K  N+ L   +  K+ D G+AR   ++  +   + + GT  YM+PE  +N
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGTPYYMSPELFSN 176

Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
                K D+++ G  V E+ +
Sbjct: 177 KPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 25/204 (12%)

Query: 263 KLGHGGYGE-IFKGTLQDGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFL 318
           K+G G +G+ I   + +DG++  +K + IS+   K R +E   E+ ++S   H N+VQ+ 
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQYQ 65

Query: 319 GCCFTKKDSFVVYEFVQNKSLDR-------ILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
                  + ++V ++ +   L +       +LF   Q   LDW       +     L+++
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDW------FVQICLALKHV 117

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H     +I+HRDIK+ NI L      K+ DFG+AR  +S    L  T I GT  Y++PE 
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTCI-GTPYYLSPEI 172

Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
             N     K DI++ G ++ E+ +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 263 KLGHGGYGEIFKGTLQ---DGREIAVKRLFISRKNR-----IK-EICNEMDIMSRAHHKN 313
           +LG G +G + KG  +     + +AVK L    KN      +K E+  E ++M +  +  
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKIL----KNDNNDPALKDELLREANVMQQLDNPY 57

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ +G C   +   +V E  +   L++ L   ++ K +  K    ++   + G++YL +
Sbjct: 58  IVRMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEE 113

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE +
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 34/209 (16%)

Query: 264 LGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI----KEICNEMDIMSRAHHKNL 314
           LG G +G ++KG  + DG  +    A+K L   R+N      KEI +E  +M+      +
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVL---RENTSPKANKEILDEAYVMAGVGSPYV 71

Query: 315 VQFLGCCFTKKDSFV--------VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
            + LG C T     V        + ++V+    DRI      +  L+W       +  A+
Sbjct: 72  CRLLGICLTSTVQLVTQLMPYGCLLDYVRENK-DRI----GSQDLLNW------CVQIAK 120

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           G+ YL    ++++VHRD+ A N+L+   +  KI DFGLAR    +++          + +
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           MA E I + + T + D++S+GV V E+++
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 40/222 (18%)

Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K        +AVK L     ++ + ++ +EM++M     HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           FD  +  +++L +K     
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 197 RLP-------VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 18/215 (8%)

Query: 264 LGHGGYGEIF---KGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++F   K T  D  ++     +K+  +  ++R++    E DI++  +H  +V+
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK-MERDILAEVNHPFIVK 62

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T+   +++ +F++   L   L       E D K     +   A  L++LH  G 
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLAELALALDHLHSLG- 118

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I++RD+K  NILLD +   K+ DFGL++ S   +      +  GT+ YMAPE +    
Sbjct: 119 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG 174

Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
            T+  D +SFGVL+ E+++G  +  FQ  D  ET+
Sbjct: 175 HTQSADWWSFGVLMFEMLTG--SLPFQGKDRKETM 207

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 33/207 (15%)

Query: 263 KLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNR------IKEICNEMDIMSRAHHKNLV 315
           K+G G YG ++K      G  +A+K++ +  ++       I+EI     ++   +H N+V
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI----SLLKELNHPNIV 61

Query: 316 QFLGCCFTKKDSFVVYEFVQ---NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           + L    ++   ++V+EF+     K +D     P    +    K ++  +   +G+ Y H
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLDLKKYMDSS---PLTGLDPPLIKSYLYQL--LQGIAYCH 116

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLP---NTAIAGTLGYMA 428
                +++HRD+K  N+L+D +   K+ADFGLAR F       +P    T    TL Y A
Sbjct: 117 ---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG------VPVRTYTHEVVTLWYRA 167

Query: 429 PEYIANG-QLTEKVDIYSFGVLVLEIV 454
           PE +    Q +  VDI+S G +  E+V
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 16/205 (7%)

Query: 264 LGHGGYGEIFKGTLQD--------GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
           LG G + +IFKG  ++          E+ +K L  S +N  +       +MS+  HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
              G C    +S +V E+V+  SLD  L   K    + WK    +    A  L +L   G
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLEDKG 120

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL--LPNTAIAGTLGYMAPEYIA 433
              + H ++ A N+LL  +   K  +    + S    S+  LP   +   + ++ PE I 
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIE 177

Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSGV 457
           N Q L+   D +SFG  + EI SG 
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGG 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE------ICNEMDIMSRAH 310
           F +   LG GG+GE+    ++  G+  A KRL    K RIK+        NE  I+ + +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRL---EKKRIKKRKGESMALNEKQILEKVN 58

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---G 367
            + +V  L   +  KD+  +   + N     + F         +++   +    AE   G
Sbjct: 59  SQFVVN-LAYAYETKDALCLVLTIMNGG--DLKFHIYNMGNPGFEEERALFYA-AEILCG 114

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           LE LH++     V+RD+K  NILLD     +I+D GLA     E   +      GT+GYM
Sbjct: 115 LEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV--GTVGYM 168

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE + N + T   D +  G L+ E++ G
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.5 bits (171), Expect = 8e-13
 Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 32/212 (15%)

Query: 262 NKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNR------IKEICNEMDIMSRAHHKNL 314
            KLG G YG ++K   +  +E+ A+K++F + +N        +EI   M +     H N+
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREI---MFLQELGDHPNI 69

Query: 315 VQFLGC--CFTKKDSFVVYEFVQNKSLDRILFDPKQKKEL--DWKKRHVI--IIGTAEGL 368
           V+ L        KD ++V+E+++   L  ++     +  +  D  KR+++  ++     L
Sbjct: 70  VKLLNVIKAENDKDIYLVFEYMET-DLHAVI-----RANILEDVHKRYIMYQLLKA---L 120

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPN--TAIAGTLG 425
           +Y+H      ++HRD+K SNILL+   R K+ADFGLAR  S  E++      T    T  
Sbjct: 121 KYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 426 YMAPE-YIANGQLTEKVDIYSFGVLVLEIVSG 456
           Y APE  + + + T+ VD++S G ++ E++ G
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 17/155 (10%)

Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDP-KQKKELDWKKRHVIII 362
            +M    + N ++      T K   ++ ++++    D  LFD  K++ +L   +   II 
Sbjct: 63  QLMK--DNPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIR 116

Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLD-LKHRPKIADFGLARFSSSEKSLLPNTAIA 421
              E L  LHK     I+H DIK  N+L D  K R  + D+GL +   +           
Sbjct: 117 QLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY------D 167

Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           GTL Y +PE I         D ++ GVL  E+++G
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 59/183 (32%), Positives = 90/183 (49%), Gaps = 16/183 (8%)

Query: 280 GREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK 337
           G  +AVK+L    +N+   K    E+ ++   +HKN++  L   FT + S    E  Q+ 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV-FTPQKSL---EEFQDV 101

Query: 338 SLDRILFDPKQKK----ELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL 393
            L   L D    +    ELD ++   ++     G+++LH  G   I+HRD+K SNI++  
Sbjct: 102 YLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 158

Query: 394 KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
               KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E+
Sbjct: 159 DCTLKILDFGLARTACTNFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215

Query: 454 VSG 456
           V G
Sbjct: 216 VKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 17/202 (8%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFIS--RKNRIKEI----CNEMDIMSRAHHKNLVQ 316
           LG G +GE++     D GRE+AVK++      +   KE+    C E+ ++    H  +VQ
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC-EIQLLKNLRHDRIVQ 68

Query: 317 FLGCC--FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + GC     +K   +  E++   S+   L   K    L             +G+ YLH +
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHSN 125

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
               IVHRDIK +NIL D     K+ DFG + R  +   S     ++ GT  +M+PE I+
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
                 K D++S    V+E+++
Sbjct: 183 GEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 26/204 (12%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      + G ++A+K+L    ++ I  K    E+ ++    H+N++  L  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 321 CFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
            FT        +D ++V  ++Q   L +I+        L   K   ++     GL+Y+H 
Sbjct: 83  -FTSAVSGDEFQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHS 135

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
            G   I+HRD+K  N+ ++     KI DFGLAR + +E      T    T  Y APE I 
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVIL 187

Query: 434 NG-QLTEKVDIYSFGVLVLEIVSG 456
           N     + VDI+S G ++ E+++G
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 18/214 (8%)

Query: 248 YSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLF--ISRKNRIKEICNEMD 304
           + T+ + T+ + +   +G G +G +     Q  G+ +A+K++    S     K    E+ 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 305 IMSRAHHKNLVQFLGCCFT-KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
           ++    H+N++       +  +D + V E +    L R+L      + L+ +     +  
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTE-LLGTDLHRLL----TSRPLEKQFIQYFLYQ 116

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
              GL+Y+H  G   +VHRD+K SNIL++     KI DFGLAR    +      T    T
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVST 168

Query: 424 LGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSG 456
             Y APE +   Q    +VDI+S G +  E++ G
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 22/203 (10%)

Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE------ICNEMDIMSRAHHKNLVQ 316
           LG GG+GE+    ++  G+  A K+L    K R+K+         E  I+++ H + +V 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKL---NKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57

Query: 317 FLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLH 372
            L   F TK D  +V   +    L   +++  ++     + R      TA+   GLE+LH
Sbjct: 58  -LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY--TAQIISGLEHLH 114

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
              Q +I++RD+K  N+LLD     +I+D GLA      +S       AGT G+MAPE +
Sbjct: 115 ---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELL 169

Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              +    VD ++ GV + E+++
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIA 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 55/184 (29%), Positives = 94/184 (51%), Gaps = 20/184 (10%)

Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109

Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 110 LM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160

Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 453 IVSG 456
           ++ G
Sbjct: 218 MIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 31/213 (14%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRK-----NRIKEICNEMDIMSRAHH 311
           F +  KLG G Y  ++KG  +   EI A+K + +  +       I+EI     +M    H
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI----SLMKELKH 57

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQN---KSLD----RILFDPKQKKELDWKKRHVIIIGT 364
           +N+V+      T+    +V+E++     K +D    R   DP   K   ++         
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ--------L 109

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
            +G+ + H++    ++HRD+K  N+L++ +   K+ADFGLAR      +   N  +  TL
Sbjct: 110 LKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TL 164

Query: 425 GYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
            Y AP+ +   +  +  +DI+S G ++ E+++G
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKN-----RIKEICNEMDIMSRAHHKNLVQF 317
           LG G +G ++     D GRE+A K++    ++      +  +  E+ ++    H+ +VQ+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 318 LGCC--FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            GC     +K   +  E++   S+   L       E   +K    I+   EG+ YLH + 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL---EGMSYLHSN- 125

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              IVHRDIK +NIL D     K+ DFG + R  +   S     ++ GT  +M+PE I+ 
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
                K D++S G  V+E+++
Sbjct: 184 EGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 263 KLGHGGYGEIFKG-TLQDGREIAVK--RLFISRKNRIKEICNEMDIMSRAH---HKNLVQ 316
           ++G G YG ++K      G  +A+K  R+  +          E+ ++ R     H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 317 FLGCCFTKKDS-----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
            +  C T +        +V+E V ++ L R   D      L  +    ++     GL++L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDL-RTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H +    IVHRD+K  NIL+    + K+ADFGLAR  S + +L P   +  TL Y APE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP---VVVTLWYRAPEV 178

Query: 432 IANGQLTEKVDIYSFGVLVLEI 453
           +        VD++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 2e-12
 Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 18/191 (9%)

Query: 278 QDGREIAVKRLFI---SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEF 333
             G E+A+K L       +++      E  + +R +H N+V  L          F V+E+
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL-- 391
           V  ++L  +L        L   +   +++   + L   H  G   IVHRD+K  NI++  
Sbjct: 61  VPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114

Query: 392 -DLKHRPKIADFGLARFSS-----SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYS 445
             ++   K+ DFG+             +L   T + GT  Y APE +    +T   D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 446 FGVLVLEIVSG 456
           +G++ LE ++G
Sbjct: 175 WGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 267 GGYGEIFKGTLQDGREIAVKRLFI-SRKNRIKEI-----CNEMDIMSRAHHKNLVQFLGC 320
           G +G IF G L D +    + +F+ + K+   EI       E  ++    H+N++  L  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 321 CFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWK---KRHVIIIGT--AEGLEYLHKD 374
           C    +  FV+Y ++   +L   L   +  +  + +    + ++ +    A G+ YLHK 
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYI 432
           G   ++H+DI A N ++D + + KI D  L+R  F      L  N      + +MA E +
Sbjct: 137 G---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN--RPVKWMALESL 191

Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
            N + +   D++SFGVL+ E+++
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)

Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102

Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 103 LM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153

Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 453 IV 454
           +V
Sbjct: 211 MV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 44/229 (19%)

Query: 264 LGHGGYGEIFKGT---LQDGRE---IAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQ 316
           +G G +G +F+     L        +AVK L       ++ +   E  +M+   H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFD--PKQKKELDWKKRHV--------------- 359
            LG C   K   +++E++    L+  L    P+ +  L                      
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSS 410
             I    A G+ YL    + + VHRD+   N L+      KIADFGL+R       + +S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQ 458
           E   +P       + +M PE I   + T + D++++GV++ EI S G+Q
Sbjct: 190 ENDAIP-------IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 10/198 (5%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           +G G +G++++   +D R I A+K L    I  K  +     E +I+ R         +G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
             F+ +    +Y      S   + +  +++      +    I      LE+LHK     I
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DI 117

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ-LT 438
           V+RD+K  NILLD      + DFGL++ + +  +   NT   GT  Y+APE + + +  T
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLT-DNKTTNT-FCGTTEYLAPEVLLDEKGYT 175

Query: 439 EKVDIYSFGVLVLEIVSG 456
           + VD +S GVLV E+  G
Sbjct: 176 KHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 56/188 (29%), Positives = 95/188 (50%), Gaps = 26/188 (13%)

Query: 280 GREIAVKRLFISR----KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-------KDSF 328
           G+ +A+K+L  SR        K    E+ +M   +HKN++  L   FT        +D +
Sbjct: 41  GQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV-FTPQKSLEEFQDVY 97

Query: 329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASN 388
           +V E + + +L +++     + +LD ++   ++     G+++LH  G   I+HRD+K SN
Sbjct: 98  LVMELM-DANLCQVI-----QMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 148

Query: 389 ILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGV 448
           I++      KI DFGLAR + +   + P      T  Y APE I      E VDI+S G 
Sbjct: 149 IVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGC 205

Query: 449 LVLEIVSG 456
           ++ E++ G
Sbjct: 206 IMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKN-----RIKEICNEMDIMSRAHHKNLVQF 317
           LG G +G ++     D GRE+AVK++    ++      +  +  E+ ++    H+ +VQ+
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 318 LGCCF--TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            GC     ++   +  E +   S+   L       E   +K    I+   EG+ YLH + 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL---EGVSYLHSN- 125

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              IVHRDIK +NIL D     K+ DFG + R  +   S     ++ GT  +M+PE I+ 
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
                K DI+S G  V+E+++
Sbjct: 184 EGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 57/242 (23%), Positives = 113/242 (46%), Gaps = 30/242 (12%)

Query: 302 EMDIMSRAHHKNLVQFLGCCFTKKDSFV--VYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
           E++I+   +H+N+V++ GCC  +    +  + E+V   SL   L  PK K  L      +
Sbjct: 56  EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLA----QL 109

Query: 360 IIIGT--AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--------FSS 409
           ++      EG+ YLH       +HRD+ A N+LLD     KI DFGLA+        +  
Sbjct: 110 LLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 166

Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE 469
            E    P       + + A E +   + +   D++SFGV + E+++   ++K      FE
Sbjct: 167 REDGDSP-------VFWYAVECLKENKFSYASDVWSFGVTLYELLTHC-DSKQSPPKKFE 218

Query: 470 TLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLL-CTQELPTLRPSMTNVVQML 528
            ++           ++E++++ + +   +   + V++ +  C +     RP+  +++ +L
Sbjct: 219 EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Query: 529 KQ 530
           K+
Sbjct: 279 KE 280

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 28/207 (13%)

Query: 263 KLGHGGYGEIFKG-TLQD-GREIAVKRLFISRKNR------IKEICNEMDIMSRAHHKNL 314
           ++G G YG++FK   L++ GR +A+KR+ +           I+E+   +  +    H N+
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLETFEHPNV 66

Query: 315 VQFLGCCFTKKDS-----FVVYEFVQN---KSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           V+    C   +        +V+E V       LD++  +P    E        ++     
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTE----TIKDMMFQLLR 121

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           GL++LH     ++VHRD+K  NIL+    + K+ADFGLAR  S + +L   T++  TL Y
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 175

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEI 453
            APE +        VD++S G +  E+
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 41/220 (18%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKR-------LFISRKNRIKEICNEMDIMSRA 309
           +   + +G G YG +   T    G ++A+K+        F  R  R      E+ I+ R 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR------EIKILRRF 60

Query: 310 HHKNLVQFLG-------CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV--I 360
            H+N++  L          F   D ++V E ++   L +++      K       H+   
Sbjct: 61  KHENIIGILDIIRPPSFESF--NDVYIVQELMET-DLYKLI------KTQHLSNDHIQYF 111

Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE---KSLLPN 417
           +     GL+Y+H      ++HRD+K SN+LL+     KI DFGLAR +  E      L  
Sbjct: 112 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL-- 166

Query: 418 TAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N +  T+ +DI+S G ++ E++S 
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 60/218 (27%), Positives = 109/218 (50%), Gaps = 25/218 (11%)

Query: 250 TIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  D + +  ++G G YG +      + G ++A+K+L+   ++ +  K    E+ ++
Sbjct: 9   TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68

Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V  F+    L +++    + ++L   +   
Sbjct: 69  KHMKHENVIGLLDV-FTPDLSLDRFHDFYLVMPFM-GTDLGKLM----KHEKLSEDRIQF 122

Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA 419
           ++    +GL+Y+H  G   I+HRD+K  N+ ++     KI DFGLAR + SE      T 
Sbjct: 123 LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TG 174

Query: 420 IAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
              T  Y APE I N    T+ VDI+S G ++ E+++G
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.7 bits (160), Expect = 7e-12
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 30/212 (14%)

Query: 258 FDESNKLGHGGYGEIF--KGTLQDG----REIAVKRLFISRKNRIKEICNEMDIMSRAHH 311
           ++   K+G G +G+I+  K          +EI + ++ +  K   K    E+ ++++  H
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKH 58

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDR-------ILFDPKQKKELDWKKRHVIIIGT 364
            N+V F          F+V E+     L +       +LF   Q   L W       +  
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI--LSW------FVQI 110

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHR-PKIADFGLARFSSSEKSLLPNTAIAGT 423
           + GL+++H     +I+HRDIK+ NI L       K+ DFG+AR  +    L       GT
Sbjct: 111 SLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA--YTCVGT 165

Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             Y++PE   N     K DI+S G ++ E+ +
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 61.7 bits (150), Expect = 9e-12
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 4/92 (4%)

Query: 21  NSSNYLHNYHALLNLMRGEM---YKKKFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFA 77
            +S +  N +ALL+ +         K FA+   G  P   Y L+QC  DL+ ++C +C A
Sbjct: 15  ANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLA 74

Query: 78  Q-MNHLLADCLPAISAHVFLDGCFLRLENYSF 108
             ++ L   C       ++ D CFLR E+Y F
Sbjct: 75  TAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 45/228 (19%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           +G G +GE++    +D  ++ A+K L    + ++N+I  +  E DI++ A    +V+ L 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK-LY 67

Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKDG 375
             F  ++  ++V E++    L  +L   K     +  + +      AE    L+ +HK  
Sbjct: 68  YSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFY-----IAELVLALDSVHK-- 119

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLA--------RFSSSEKSLLPNT--------- 418
            +  +HRDIK  NIL+D     K+ADFGL         R      S              
Sbjct: 120 -LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178

Query: 419 ----------AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
                     +  GT  Y+APE +       + D +S GV++ E++ G
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 29/220 (13%)

Query: 255 TDCFDESNKLGHGGYGEIFK-GTLQDGREIAVKRLFISRKNRIKEICNEMD-----IMSR 308
           +D ++    +G G YG++FK    ++G + AVK L     + I +I  E++     + + 
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-----DPIHDIDEEIEAEYNILKAL 71

Query: 309 AHHKNLVQFLGCCFTKKDS------FVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVII 361
           + H N+V+F G  + KKD       ++V E     S+ D +    K+ + ++      I+
Sbjct: 72  SDHPNVVKFYGM-YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130

Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA 421
                GL++LH +   + +HRD+K +NILL  +   K+ DFG++   +S + L  NT++ 
Sbjct: 131 HEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSV- 185

Query: 422 GTLGYMAPEYIANGQ-----LTEKVDIYSFGVLVLEIVSG 456
           GT  +MAPE IA  Q        + D++S G+  +E+  G
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 39/215 (18%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISRKNRIKE---ICNEMDIMSRAHHKN 313
            +    +G G +G +     +      A+K + I    R+K+   + NE  ++    H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 314 LVQFLGCCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---- 366
           +++     +T+ D   +Y   E+V    L   L           +        T      
Sbjct: 63  IIRLF---WTEHDQRFLYMLMEYVPGGELFSYL-----------RNSGRFSNSTGLFYAS 108

Query: 367 ----GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT-AIA 421
                LEYLH     +IV+RD+K  NILLD +   K+ DFG A      K L   T  + 
Sbjct: 109 EIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFA------KKLRDRTWTLC 159

Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           GT  Y+APE I +    + VD ++ G+L+ E++ G
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 21/212 (9%)

Query: 260 ESNKLGHGGYGEIFKGTLQDG---REIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           E  K+G G YG ++K   +DG   +E A+K+  I         C E+ ++    H N++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQ--IEGTGISMSACREIALLRELKHPNVIA 62

Query: 317 FLGCCFTKKDS--FVVYEFVQNKSLDRILF---DPKQKKELDWKKRHV--IIIGTAEGLE 369
                 +  D   ++++++ ++     I F       KK +   +  V  ++    +G+ 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 370 YLHKDGQMQIVHRDIKASNILL----DLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTL 424
           YLH +    ++HRD+K +NIL+      + R KIAD G AR F+S  K L     +  T 
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 425 GYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVS 455
            Y APE +   +  T+ +DI++ G +  E+++
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 11/204 (5%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKN 313
           D F++  +LG G  G + K      G  +A K + +  K  I+ +I  E+ ++   +   
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V F G  ++  +  +  E +   SLD++L   K+   +       I I    GL YL +
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
             + +I+HRD+K SNIL++ +   K+ DFG+   S      + N+ + GT  YM+PE + 
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFV-GTRSYMSPERLQ 171

Query: 434 NGQLTEKVDIYSFGVLVLEIVSGV 457
               T + DI+S G+ ++E+  G 
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 20/202 (9%)

Query: 264 LGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQF 317
           LG G +G ++KG  + +G  +    A+K L  +   +   E  +E  IM+   H +LV+ 
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPK----QKKELDWKKRHVIIIGTAEGLEYLHK 373
           LG C +     V  + + +  L   + + K     +  L+W       +  A+G+ YL  
Sbjct: 75  LGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE- 126

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
             + ++VHRD+ A N+L+   +  KI DFGLAR    ++           + +MA E I 
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
             + T + D++S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 17/200 (8%)

Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE------ICNEMDIMSRAHHKNLVQ 316
           LG GG+GE+    ++  G+  A K+L    K RIK+        NE  I+ + + + +V 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
            L   +  KD+  +   + N    +           D ++          GLE L ++  
Sbjct: 65  -LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
            +IV+RD+K  NILLD +   +I+D GLA      +++       GT+GYMAPE I N +
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV---RGRVGTVGYMAPEVINNEK 177

Query: 437 LTEKVDIYSFGVLVLEIVSG 456
            T   D +  G L+ E++ G
Sbjct: 178 YTFSPDWWGLGCLIYEMIQG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 38/218 (17%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISRKNR------IKEICNEMDIMSR 308
           D +++  K+G G YG ++K   +   E IA+K++ + +++       I+EI     ++  
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREI----SLLKE 57

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD----WKKRHVII--- 361
             H N+V+      ++K  ++V+E++          D   KK +D    + K   +I   
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEYL----------DLDLKKHMDSSPDFAKNPRLIKTY 107

Query: 362 -IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLAR-FSSSEKSLLPNT 418
                 G+ Y H     +++HRD+K  N+L+D +    K+ADFGLAR F    ++    T
Sbjct: 108 LYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF---T 161

Query: 419 AIAGTLGYMAPE-YIANGQLTEKVDIYSFGVLVLEIVS 455
               TL Y APE  + +   +  VDI+S G +  E+V+
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 69/252 (27%)

Query: 263 KLGHGGYGEI---------------FKGTLQDGRE--IAVKRLFI-SRKNRIKEICNEMD 304
           KLG G +GE+               F   ++ GR   +AVK L   + KN   +   E+ 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+SR    N+++ LG C  +    ++ E+++N  L++ L              H +    
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL------------SSHHLDDKE 119

Query: 365 AEGLEYLHKDGQM-------------QI------------VHRDIKASNILLDLKHRPKI 399
             G + +     +             QI            VHRD+   N L+      KI
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKI 179

Query: 400 ADFGLAR-------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
           ADFG++R       +    +++LP       + +MA E I  G+ T   D+++FGV + E
Sbjct: 180 ADFGMSRNLYAGDYYRIQGRAVLP-------IRWMAWECILMGKFTTASDVWAFGVTLWE 232

Query: 453 IVSGVQNNKFQS 464
           I+   +   +  
Sbjct: 233 ILMLCKEQPYGE 244

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 24/204 (11%)

Query: 263 KLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNR------IKEICNEMDIMSRAHHKNLV 315
           K+G G YG ++KG   + G+ +A+K++ +  +        I+EI     ++    H N+V
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKELQHPNIV 62

Query: 316 QFLGCCFTKKDSFVVYEFVQ---NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                   +   ++++EF+     K LD +        EL     + I+    +G+ + H
Sbjct: 63  CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH 118

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
                +++HRD+K  N+L+D K   K+ADFGLAR       +  +  +  TL Y APE +
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVL 173

Query: 433 ANGQL-TEKVDIYSFGVLVLEIVS 455
                 +  VDI+S G +  E+ +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 67/266 (25%), Positives = 107/266 (40%), Gaps = 78/266 (29%)

Query: 264 LGHGGYGEIFKGT------LQDGREIAVKRLFI-SRKNRIKEICNEMDIMSR-AHHKNLV 315
           LG G +G++ +            R +AVK L   +  +  + + +E+ I+    HH N+V
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 316 QFLGCCF-----------------------TKKDSFVVYE-------------------- 332
             LG C                        +K+  FV Y+                    
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134

Query: 333 -----------------FVQNKSLDRILFDPKQKKELDWKK----RHVIIIG--TAEGLE 369
                            FV+ KSL  +  +  ++++L +KK      +I      A+G+E
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDL-YKKVLTLEDLICYSFQVAKGME 193

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           +L      + +HRD+ A NILL   +  KI DFGLAR    +   +        L +MAP
Sbjct: 194 FL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 250

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVS 455
           E I +   T + D++SFGVL+ EI S
Sbjct: 251 ETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 19/201 (9%)

Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFL 318
           +G G Y ++    L+    I     VK+  ++    I  +  E  +  +A +H  LV   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
            C  T+   F V E+V    L   +F  +++++L  +         +  L YLH+ G   
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP---NTAIAGTLGYMAPEYIANG 435
           I++RD+K  N+LLD +   K+ D+G+ +     + L P    +   GT  Y+APE +   
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
                VD ++ GVL+ E+++G
Sbjct: 172 DYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 47/229 (20%)

Query: 262 NKLGHGGYGEIFKG-TLQDGREIAVKRLFISR-KNRIKE-------------ICNEMDIM 306
             LG G YG++ K      G+ +A+K++ I    N + +                E+ IM
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKR----HV--I 360
           +   H+N++  +       D +V  +F+ N  +D  +     KK +D K R     V  I
Sbjct: 75  NEIKHENIMGLV-------DVYVEGDFI-NLVMD--IMASDLKKVVDRKIRLTESQVKCI 124

Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR---------FSSSE 411
           ++    GL  LHK      +HRD+  +NI ++ K   KIADFGLAR           S +
Sbjct: 125 LLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 412 KSLLPN---TAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSG 456
           +++      T+   TL Y APE +    +    VD++S G +  E+++G
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 28/219 (12%)

Query: 263 KLGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLV 315
           +LG   +G+++KG L      +  + +A+K L    +  ++E   +E  + SR  H N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILF-------------DPKQKKELDWKKRHVIII 362
             LG    ++   +++ +  +  L   L              D   K  L+      I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAI 420
             A G+E+L       +VH+D+   N+L+  K   KI+D GL R  +++    L+ N+ +
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQ 458
              + +M+PE I  G+ +   DI+S+GV++ E+ S G+Q
Sbjct: 189 P--IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 43/226 (19%)

Query: 263 KLGHGGYGEI-----------------FKGTLQDGREIAVKRLFI-SRKNRIKEICNEMD 304
           KLG G +GE+                    +      +AVK L   + KN   +   E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           IMSR    N+++ L  C T     ++ E+++N  L++ L   + ++  +      I   T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 365 --------AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
                   A G++YL     +  VHRD+   N L+   +  KIADFG++R       +  
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             +++LP       + +M+ E I  G+ T   D+++FGV + EI++
Sbjct: 189 QGRAVLP-------IRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 11  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFV------QNKSLDRILFDPKQKKELDWKKRHV- 359
               H+N++  L   FT   S   +  V          L+ I+   K +K  D    HV 
Sbjct: 71  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTD---DHVQ 123

Query: 360 -IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
            +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      T
Sbjct: 124 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----T 175

Query: 419 AIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
               T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 12/198 (6%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR-----IKEICNEMDIMSRAHHKNLVQF 317
           LG G +G + KG  + +G  I +     + ++R      +EI + M  M    H  +V+ 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
           LG C       V         LD +    + +  LD ++     +  A+G+ YL +    
Sbjct: 75  LGICPGASLQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNWCVQIAKGMYYLEEHR-- 129

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
            +VHR++ A NILL      +IADFG+A     +      +     + +MA E I  G+ 
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 438 TEKVDIYSFGVLVLEIVS 455
           T + D++S+GV V E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE-------ICNEMDIMSRAHHKNL 314
            KLG G Y  +FKG     R    + L   ++ R++           E+ ++    H N+
Sbjct: 12  EKLGEGTYATVFKG-----RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V       T K   +V+E++ +K L + + D      +   K  + +     GL Y H+ 
Sbjct: 67  VTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVK--IFLYQILRGLAYCHR- 122

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE-YIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR  S       N  +  TL Y  P+  + 
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
           + + + ++D++  G +  E+ SG
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 16/96 (16%)

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT-----AIAG 422
           L++LH   Q+ I++RDIK  NILLD +    + DFGL+      K  L        +  G
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLS------KEFLAEEEERAYSFCG 168

Query: 423 TLGYMAPEYIANGQL--TEKVDIYSFGVLVLEIVSG 456
           T+ YMAPE I  G     + VD +S GVL  E+++G
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 32/210 (15%)

Query: 264 LGHGGYGEIF---KGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GGYG++F   K T  D G+  A+K L   +K  I  + N+ D       +N+++ + 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVL---KKATI--VRNQKDTAHTKAERNILEAV- 57

Query: 320 CCFTKKDSFVV---YEFVQNKSLDRIL-FDPKQKKELDWKKRHVIIIGTAE--------G 367
                K  F+V   Y F     L  IL +    +  +  ++  + +  TA          
Sbjct: 58  -----KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           LE+LH+ G   I++RD+K  NILLD +   K+ DFGL + S  E ++       GT+ YM
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV--THTFCGTIEYM 167

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
           APE +      + VD +S G L+ ++++G 
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.0 bits (153), Expect = 4e-11
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 15/198 (7%)

Query: 264 LGHGGYGEIF--KGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLG 319
           +G G +G +   +    D + + +K++ + +  + +     NE  ++    H N++++  
Sbjct: 8   VGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                K   +V E+    +L   +    QK+         I+    + L  LH      I
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYI----QKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122

Query: 380 VHRDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
           +HRD+K  NILLD KH+   KI DFG+++  SS+        + GT  Y++PE       
Sbjct: 123 LHRDLKTQNILLD-KHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPY 178

Query: 438 TEKVDIYSFGVLVLEIVS 455
            +K DI++ G ++ E+ S
Sbjct: 179 NQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 21/212 (9%)

Query: 260 ESNKLGHGGYGEIFKGTLQDG---REIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           E  K+G G YG ++K   +DG   R+ A+K+  I         C E+ ++    H N++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQ--IEGTGISMSACREIALLRELKHPNVIS 62

Query: 317 FLGCCFTKKDS--FVVYEFVQNKSLDRILF---DPKQKKELDWKKRHV--IIIGTAEGLE 369
                 +  D   ++++++ ++     I F       KK +   +  V  ++    +G+ 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 370 YLHKDGQMQIVHRDIKASNILL----DLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTL 424
           YLH +    ++HRD+K +NIL+      + R KIAD G AR F+S  K L     +  T 
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 425 GYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVS 455
            Y APE +   +  T+ +DI++ G +  E+++
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 21/204 (10%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G+G +G ++  T  +DG+ +A+K++    +N    K +  E+ ++    H N++  L  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 321 -------CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
                   F  ++ +VV E +Q+  L +I+  P Q    D  K  V +     GL+YLH 
Sbjct: 68  LQPPHIDPF--EEIYVVTELMQS-DLHKIIVSP-QPLSSDHVK--VFLYQILRGLKYLHS 121

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
            G   I+HRDIK  N+L++     KI DFGLAR    ++S    T    T  Y APE + 
Sbjct: 122 AG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVTQYYRAPEILM 177

Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSG 456
             +  T  VDI+S G +  E++  
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A G+E+L      + +HRD+ A NILL   +  KI DFGLAR    +   +        L
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 41/91 (45%), Positives = 56/91 (61%), Gaps = 7/91 (7%)

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGY 426
           LE+LHK G   IV+RDIK  NILLD +    + DFGL++ F S EK      +  GT+ Y
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE--RTYSFCGTIEY 172

Query: 427 MAPEYI-ANGQLTEKVDIYSFGVLVLEIVSG 456
           MAPE I   G   + VD +S G+L+ E+++G
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 19/201 (9%)

Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE------ICNEMDIMSRAHHKNLVQ 316
           LG GG+GE+    ++  G+  A K+L    K RIK+        NE  I+ + + + +V 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 317 FLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            L   +  KD+  +V   +    L   +++       D ++          GLE LH++ 
Sbjct: 65  -LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLHRE- 121

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
             +IV+RD+K  NILLD     +I+D GLA                GT+GYMAPE + N 
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLA---VEIPEGETIRGRVGTVGYMAPEVVKNE 176

Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
           + T   D +  G L+ E++ G
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 11/198 (5%)

Query: 263 KLGHGGYGEIFKGTLQDGR---EIAVKRLFI-SRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           +LG G +G + KG  +  +   ++A+K L   + K+   E+  E +IM +  +  +V+ +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G C   +   +V E      L++ L    +K E+       ++   + G++YL       
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLE---GKN 115

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL-PNTAIAGTLGYMAPEYIANGQL 437
            VHRD+ A N+LL  +H  KI+DFGL++   ++ S     +A    L + APE I   + 
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 438 TEKVDIYSFGVLVLEIVS 455
           + + D++S+G+ + E  S
Sbjct: 176 SSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 40/104 (38%), Positives = 56/104 (53%), Gaps = 10/104 (9%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A G+E+L      + +HRD+ A NILL   +  KI DFGLAR    +   +   +    L
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNNK 461
            +MAPE I +   T + D++SFGVL+ EI S       GVQ N+
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 32/85 (37%), Positives = 49/85 (57%), Gaps = 3/85 (3%)

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           ++Y+H +G   I+HRDIK  N+L++      + DFG A F+    S   +  IAGT+   
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 428 APEYIANGQLTEKVDIYSFGVLVLE 452
           APE +A    T  VDI+S G+++ E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           +G G Y ++    L+   +I     VK+  +     I  +  E  +  +A     +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 320 CCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
            CF T    F+V E+V    L   +F  +++++L  +            L +LH+ G   
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG--- 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP---NTAIAGTLGYMAPEYIANG 435
           I++RD+K  N+LLD     K+ D+G+ +     + L P    +   GT  Y+APE +   
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
           +    VD ++ GVL+ E+++G
Sbjct: 172 EYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 22/221 (9%)

Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++     KGT +      +K+  + + + ++    E  +++ +     +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT--AEGLEYLHKDGQ 376
            CF   D  + V E+V    L   ++  +Q     +K+ H +      A GL +LH  G 
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDL---MYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKG- 121

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I++RD+K  N++LD +   KIADFG+ + +  +   +      GT  Y+APE IA   
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQP 177

Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG---FETLVTH 474
             + VD ++FGVL+ E+++G     F+ +D    F++++ H
Sbjct: 178 YGKSVDWWAFGVLLYEMLAG--QAPFEGEDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 57.8 bits (140), Expect = 2e-10
 Identities = 28/88 (31%), Positives = 39/88 (44%), Gaps = 3/88 (3%)

Query: 133 FRRVVEEVVNKVSKNAP--NENGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAAS 190
           F   +  +++ +S NA   +  GFA      A  + Y +A C   L+   C  CL  A S
Sbjct: 19  FESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLATAVS 78

Query: 191 TALTCIP-AIEGRVLFAGCFLRYSRYEF 217
               C P    GR+ +  CFLRY  Y F
Sbjct: 79  ELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 54/226 (23%), Positives = 106/226 (46%), Gaps = 38/226 (16%)

Query: 264 LGHGGYGEIFKGTL-QDGR--EIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           LG G +G + +G L QD    ++AVK  ++ I  ++ +++  +E   M    H N+++ +
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 319 GCCF--TKKDSF----VVYEFVQNKSLDRILFDPKQKKELDWKKRHVII---IGTAEGLE 369
           G C    + + +    V+  F+++  L   L   +      +    +++      A G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAIAG 422
           YL        +HRD+ A N +L+      +ADFGL++       +     + +P      
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP------ 177

Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNNK 461
            + ++A E +A+   T K D++SFGV + EI +       GV+N++
Sbjct: 178 -VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 13/199 (6%)

Query: 262 NKLGHGGYGEIFKG--TLQDGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQFL 318
           +KLG G Y  ++KG   L D   +A+K + +  +         E+ ++    H N+V   
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
               T+K   +V+E++ +K L + L D      +   K  + +     GL Y H+    +
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK--LFLFQLLRGLNYCHR---RK 124

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE-YIANGQL 437
           ++HRD+K  N+L++ +   K+ADFGLAR  S       N  +  TL Y  P+  + +   
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDY 182

Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + ++D++  G +  E+ +G
Sbjct: 183 STQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)

Query: 258 FDESNKLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
           F+    + +G YG ++    K T Q     A+K++    +  +N+I+++  E DI++ A 
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQ---RFAMKKINKQNLILRNQIQQVFVERDILTFAE 59

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +  +V       TK+   +V E+V+      +L   K    L      +    T   LEY
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALPVDMARMYFAETVLALEY 116

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS-------------SSEKSLLPN 417
           LH  G   IVHRD+K  N+L+      K+ DFGL++                 +     +
Sbjct: 117 LHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
             + GT  Y+APE I      + VD ++ G+++ E + G 
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 10/196 (5%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRLFISRKNR-IKEIC-NEMDIMSRAHHKNLVQFLGC 320
           +G G YG + K   ++ +EI A+K+   S +N  +KE    E+ ++     +N+V+    
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
              +   ++V+E+V+   L+ +   P        +K    I    + + + HK+    IV
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWCHKN---DIV 122

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           HRDIK  N+L+      K+ DFG AR + SE S    T    T  Y +PE +      + 
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 441 VDIYSFGVLVLEIVSG 456
           VD++S G ++ E+  G
Sbjct: 182 VDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 23/203 (11%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEM------DIMSRAHHKNLVQ 316
           LG GG+GE+    +++ G+  A K+L    K R+K+   E       +I+ + +   +V 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKL---DKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHK 373
                 +K    +V   +    L   +++  ++  L+ ++   +I  +A+   G+ +LH 
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMER---VIHYSAQITCGILHLH- 112

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              M IV+RD+K  N+LLD +   +++D GLA      K++   T  AGT GYMAPE + 
Sbjct: 113 --SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILK 167

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
               +  VD ++ G  + E+V+G
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 36/111 (32%), Positives = 64/111 (57%), Gaps = 6/111 (5%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           + GL +LH+ G   I++RD+K  N++LD +   KIADFG+ +    +   +      GT 
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTP 165

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG-FETLVTH 474
            Y+APE IA     + VD +++GVL+ E+++G      + +D  F++++ H
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQFLG 319
           +KLG G Y  +FKG  +     +A+K + +  +         E+ ++    H N+V    
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-----LDWKKRHVIIIGTAEGLEYLHKD 374
              T++   +V+E++ +        D KQ  +     +      + +     GL Y HK 
Sbjct: 71  IIHTERCLTLVFEYLDS--------DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK- 121

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE-YIA 433
              +I+HRD+K  N+L++ K   K+ADFGLAR  S       N  +  TL Y  P+  + 
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
           + + +  +D++  G ++ E+ +G
Sbjct: 178 STEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 8/93 (8%)

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLG 425
            LE+LHK G   I++RDIK  NILLD      + DFGL++ F   E       +  GT+ 
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA--YSFCGTIE 171

Query: 426 YMAPEYIANGQL--TEKVDIYSFGVLVLEIVSG 456
           YMAP+ +  G     + VD +S GVL+ E+++G
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 18/199 (9%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      +   ++A+K++  +  NRI  K    E+ ++    H+N++     
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 321 CF-----TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                     D ++VYE + +  L +I+   +  + L        +     GL+Y+H   
Sbjct: 73  MPPPHREAFNDVYIVYELM-DTDLHQII---RSSQTLSDDHCQYFLYQLLRGLKYIHSAN 128

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN- 434
              ++HRD+K SN+LL+     KI DFGLAR +S +   +  T    T  Y APE + N 
Sbjct: 129 ---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYRAPELLLNC 183

Query: 435 GQLTEKVDIYSFGVLVLEI 453
            + T  +D++S G +  E+
Sbjct: 184 SEYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 25/204 (12%)

Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           LG G +GE+ +G L+    RE+ V     R   S K R +    E   + +  H N+V+ 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNIVRL 71

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G         +V E++ N +LD  L   K + +L   +   ++ G A G++YL    +M
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG------YMAPEY 431
             VH+ + A  +L++     KI+ F   +   SE       AI  T+       + APE 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE-------AIYTTMSGKSPVLWAAPEA 179

Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
           I     +   D++SFG+++ E++S
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 37/199 (18%), Positives = 75/199 (37%), Gaps = 35/199 (17%)

Query: 280 GREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK 337
              +AVK++ +   +   +K +  E+    +  H N++ ++       + +VV   +   
Sbjct: 25  NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84

Query: 338 SLDRILFDPKQKKELDWKKRH-----------VIIIGTAEGLEYLHKDGQMQIVHRDIKA 386
           S + +L            K H            I+      L+Y+H       +HR +KA
Sbjct: 85  SCEDLL------------KTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKA 129

Query: 387 SNILLDLKHRPKIADFGLAR--FSSSEKSL---LPNTAIAGTLGYMAPEYIANGQL--TE 439
           S+ILL    +  ++    +       ++         +    L +++PE +        E
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNE 189

Query: 440 KVDIYSFGVLVLEIVSGVQ 458
           K DIYS G+   E+ +G  
Sbjct: 190 KSDIYSVGITACELANGHV 208

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 39/246 (15%)

Query: 264 LGHGGYGEIFKGTLQD---------GREIAVKRLFISRKNRIKEICNEM-DIMSRAHHKN 313
           LG G +  I+KG L+          G+E++V    +   +R      E   +MS+  HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           LV+  G C   ++  +V E+V+   LD  L   K    L WK    +    A  L YL  
Sbjct: 63  LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE- 118

Query: 374 DGQMQIVHRDIKASNILL---DLKHRP----KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
               ++VH ++   NIL+    L        K++D G+        ++L        + +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIPW 170

Query: 427 MAPEYIANGQ--LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF-QAKT 483
           +APE I NGQ  LT   D +SFG  +LEI S         ++   TL +   + F Q + 
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN-------GEEPLSTLSSSEKERFYQDQH 223

Query: 484 VLEIID 489
            L + D
Sbjct: 224 RLPMPD 229

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 15/200 (7%)

Query: 264 LGHGGYGEIFKGTLQ-DGREIAVK----RLFISRKNRIKEICNEMDIMSR-AHHKNLVQF 317
           +G G +G++     + DG+  AVK    ++ ++RK + K I  E +++ +   H  LV  
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ-KHIMAERNVLLKNVKHPFLVGL 61

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
                T +  + V +FV    L    F  ++++     +        A  L YLH    +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLH---SI 115

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
            IV+RD+K  NILLD +    + DFGL +   ++      T   GT  Y+APE I     
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPY 173

Query: 438 TEKVDIYSFGVLVLEIVSGV 457
              VD +  G ++ E++ G+
Sbjct: 174 DNTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 25/216 (11%)

Query: 253 KATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE-----ICNEMDIMS 307
           KA D +D    +G G +GE+     +  +++   +L +S+   IK         E DIM+
Sbjct: 41  KAED-YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL-LSKFEMIKRSDSAFFWEERDIMA 98

Query: 308 RAHHKNLVQFLGCCFT-KKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGT 364
            A+   +VQ L C F   K  ++V E++    L  ++  +D  +K    W K +     T
Sbjct: 99  FANSPWVVQ-LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----T 148

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           AE +  L     M ++HRD+K  N+LLD     K+ADFG          +  +TA+ GT 
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTP 207

Query: 425 GYMAPEYI----ANGQLTEKVDIYSFGVLVLEIVSG 456
            Y++PE +     +G    + D +S GV + E++ G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 14/199 (7%)

Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           +G G +G++ +   +D + I     +++  I  ++ +     E  ++++ +   +V    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKK-ELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
              + +  ++V  F+    L    F   Q++   D  +           LE LHK     
Sbjct: 61  SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHK---FN 113

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           +++RD+K  NILLD +    + DFGL + +        NT   GT  Y+APE +     T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMK-DDDKTNT-FCGTPEYLAPELLLGHGYT 171

Query: 439 EKVDIYSFGVLVLEIVSGV 457
           + VD ++ GVL+ E+++G+
Sbjct: 172 KAVDWWTLGVLLYEMLTGL 190

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 258 FDESNKLGHGGYGEI----FKGTLQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRAH 310
           F+    LG G +G +     KGT   G   A+K L    I +  +++ +  E  I+    
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 311 HKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H  +V  + C F  ++  + + EFV    L   L    +      K  H  ++      E
Sbjct: 77  HPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV---LAFE 132

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      I++RD+K  N+LLD K   K+ DFG A+    +++      + GT  Y+AP
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTF----TLCGTPEYLAP 184

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I +    + VD ++ GVL+ E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 60/240 (25%), Positives = 108/240 (45%), Gaps = 43/240 (17%)

Query: 256 DCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNR------IKEICNEMDIMSR 308
           D +++  K+G G YG+++K      G+ +A+K+  +           ++EI + + ++S 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI-SLLQMLSE 59

Query: 309 AHHKNLVQFLGCCFTKKDS-----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
           + +  +V+ L     ++ +     ++V+E+     LD    D K+  + + +     +  
Sbjct: 60  SIY--IVRLLDVEHVEEKNGKPSLYLVFEY-----LDS---DLKKFMDSNGRGPGRPLPA 109

Query: 364 TA---------EGLEYLHKDGQMQIVHRDIKASNILLD-LKHRPKIADFGLAR-FSSSEK 412
                      +G+ + HK G   ++HRD+K  N+L+D  K   KIAD GL R FS   K
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166

Query: 413 SLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
           S    T    TL Y APE +      +  VDI+S G +  E+        F  D   + L
Sbjct: 167 SY---THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK--QPLFPGDSELQQL 221

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 8/91 (8%)

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           GLE++H      +V+RD+K +NILLD     +I+D GLA   S +K   P+ ++ GT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGY 161

Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           MAPE +  G       D +S G ++ +++ G
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 7/98 (7%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           AE +  +H   QM  VHRDIK  N+L+D     K+ADFG A   ++ K +     + GT 
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTP 167

Query: 425 GYMAPEYI------ANGQLTEKVDIYSFGVLVLEIVSG 456
            Y+APE +        G    + D +S GV+  E++ G
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG 205

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 11/197 (5%)

Query: 263 KLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQFLGC 320
           KLG G Y  ++KG  + +G+ +A+K + +  +  +      E  ++    H N+V     
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK+    V+E++     D   +  +    L      + +     GL Y+H      I+
Sbjct: 72  IHTKETLTFVFEYMHT---DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HIL 125

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTE 439
           HRD+K  N+L+      K+ADFGLAR  S       +  +  TL Y  P+ +      + 
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSS 183

Query: 440 KVDIYSFGVLVLEIVSG 456
            +DI+  G + +E++ G
Sbjct: 184 ALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)

Query: 264 LGHGGYGEIFKGTLQ----DGREIAVKRLF--ISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           LG G +G + +  L+      +++AVK L   I   + I+E   E   M    H N+++ 
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 318 LGCCFTKKDS------FVVYEFVQNKSLDRILFDPKQKKE---LDWKKRHVIIIGTAEGL 368
           +G     +         V+  F+++  L   L   +  +E   L  +     +I  A G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMA 428
           EYL        +HRD+ A N +L+      +ADFGL++   S        A    + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQN 459
            E +A+   T   D+++FGV + EI++       GV+N
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 33/220 (15%)

Query: 253 KATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRIKE-----ICNEMDIM 306
           KA D FD    +G G +GE+     +  +++ A+K L  S+   IK         E DIM
Sbjct: 41  KAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL--SKFEMIKRSDSAFFWEERDIM 97

Query: 307 SRAHHKNLVQFLGCCFT-KKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIG 363
           + A+ + +VQ L   F   K  ++V E++    L  ++  +D  +K    W + +     
Sbjct: 98  AHANSEWIVQ-LHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WARFY----- 147

Query: 364 TAE---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
           TAE    L+ +H    M  +HRD+K  N+LLD     K+ADFG      +   +  +TA+
Sbjct: 148 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204

Query: 421 AGTLGYMAPEYI----ANGQLTEKVDIYSFGVLVLEIVSG 456
            GT  Y++PE +     +G    + D +S GV + E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.4 bits (143), Expect = 4e-09
 Identities = 67/258 (25%), Positives = 115/258 (44%), Gaps = 38/258 (14%)

Query: 247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIK-EICNEM 303
           KY   E   + ++   K+G+G +GE+F    +  +E    +    R  K R K ++  E+
Sbjct: 4   KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEV 63

Query: 304 DIMSRAHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVII 361
           ++M    HKN+V+++     K +   +++ EF     L R +   K  K     + H I+
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI--QKCYKMFGKIEEHAIV 121

Query: 362 IGTAE---GLEYLH--KDGQ--MQIVHRDIKASNILL---------------DLKHRP-- 397
             T +    L Y H  KDG    +++HRD+K  NI L               +L  RP  
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVS 455
           KI DFGL++    E       +  GT  Y +PE + +      +K D+++ G ++ E+ S
Sbjct: 182 KIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 456 GVQNNKFQSDDGFETLVT 473
           G     F   + F  L++
Sbjct: 239 G--KTPFHKANNFSQLIS 254

Length = 1021

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 19/201 (9%)

Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFL 318
           +G G Y ++    L+  R I     +K+  ++    I  +  E  +   A +H  LV   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
            C  T+   F V EFV    L   +F  +++++L  +         +  L +LH+ G   
Sbjct: 63  SCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG--- 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP---NTAIAGTLGYMAPEYIANG 435
           I++RD+K  N+LLD +   K+ D+G+ +     + + P    +   GT  Y+APE +   
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCK-----EGIRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
                VD ++ GVL+ E+++G
Sbjct: 172 DYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A G+E+L        VHRD+ A N+L+      KI DFGLAR    + + +   +    L
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MAPE I N   T   D++SFG+L+ EI +
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.0 bits (137), Expect = 9e-09
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 14/198 (7%)

Query: 264 LGHGGYGE-IFKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G+ I       G+  A+K L    I  K+ +     E  ++    H  L   L 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS-LK 61

Query: 320 CCFTKKDSFV-VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
             F  KD    V E+V    L    F   +++     +           L+YLH     +
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---K 115

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           IV+RD+K  N++LD     KI DFGL +   ++ + +      GT  Y+APE + +    
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM--KTFCGTPEYLAPEVLEDNDYG 173

Query: 439 EKVDIYSFGVLVLEIVSG 456
             VD +  GV++ E++ G
Sbjct: 174 RAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 30/213 (14%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           LG G  G +F     D  + +AVK++ ++    +K    E+ I+ R  H N+V+      
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 323 -------------TKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
                        T+ +S ++V E+++   L  +L    ++  L  +   + +     GL
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL----EQGPLSEEHARLFMYQLLRGL 127

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLARFSSSE---KSLLPNTAIAGTL 424
           +Y+H      ++HRD+K +N+ ++ +    KI DFGLAR        K  L    +  T 
Sbjct: 128 KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--TK 182

Query: 425 GYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSG 456
            Y +P  + +    T+ +D+++ G +  E+++G
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTL 424
           GL+Y+H      ++HRD+K SN+L++     +I DFG+AR   SS  +     T    T 
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 425 GYMAPEYI-ANGQLTEKVDIYSFGVLVLEIV 454
            Y APE + +  + T  +D++S G +  E++
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 11/95 (11%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT- 423
           A+G+++L        +HRD+ A N+LL      KI DFGLAR   ++     N  + G  
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS----NYVVKGNA 274

Query: 424 ---LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE I +   T + D++S+G+L+ EI S
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A G+E+L        VHRD+ A N+LL      KI DFGLAR    + + +   +    +
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MAPE I +   T   D++S+G+L+ EI S
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 26/209 (12%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGR--EIAVKRL---FISRKNRIKEICNEMDIMSRAHHK 312
           F+    LG G +G +   T ++     +A+KR     I ++ ++  + +E  I++  +H 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD-----WKKRHVIIIGTAEG 367
             V   G    +   ++V EFV        L   ++ K        +    +++I     
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGGEFFTFL---RRNKRFPNDVGCFYAAQIVLI----- 143

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
            EYL     + IV+RD+K  N+LLD     K+ DFG A+   +    L      GT  Y+
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL-----CGTPEYI 195

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE + N    +  D ++ G+ + EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 27/205 (13%)

Query: 264 LGHGGYGEIFKGTLQDGRE-IAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +        R+ +AVK+L    ++ I  +    E+ ++    H+N++  L  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 321 CFTKKDS---FVVYEFVQN---KSLDRILFDPKQKKELDWKKRHV--IIIGTAEGLEYLH 372
            FT   S   F     V N     L+ I+   K +K  D    HV  +I     GL+Y+H
Sbjct: 83  -FTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSD---EHVQFLIYQLLRGLKYIH 135

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SN+ ++     +I DFGLAR +  E      T    T  Y APE +
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIM 187

Query: 433 ANG-QLTEKVDIYSFGVLVLEIVSG 456
            N     + VDI+S G ++ E++ G
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 31/246 (12%)

Query: 231 EMDLSLLHKSL---KFLQFKYSTIEKATDC------FDESNKLGHGGYGEIFKGTLQDGR 281
           ++D   L K+     FL     TI K  D       ++    +G G +GE+     +  R
Sbjct: 9   DLDFPALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 68

Query: 282 EIAVKRLFISRKNRIKE-----ICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN 336
           ++   +L +S+   IK         E DIM+ A+   +VQ        +  ++V E++  
Sbjct: 69  KVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127

Query: 337 KSLDRIL--FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK 394
             L  ++  +D  +K    W + +     TAE +  L     M  +HRD+K  N+LLD  
Sbjct: 128 GDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 178

Query: 395 HRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI----ANGQLTEKVDIYSFGVLV 450
              K+ADFG     + E  +  +TA+ GT  Y++PE +     +G    + D +S GV +
Sbjct: 179 GHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 451 LEIVSG 456
            E++ G
Sbjct: 238 YEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 67/288 (23%)

Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +G GG+GE++     D G+  A+K L    K RIK    E   ++     +LV    C F
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 323 TKKDSFVVYEFVQNKSLDRIL---------FDPKQ-----KKELDWKKRHVIIIGTAEGL 368
                 + Y F     L  IL         +   Q     +KE+ +    +I+     GL
Sbjct: 59  I---VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-----GL 110

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMA 428
           E++H      +V+RD+K +NILLD     +I+D GLA   S +K   P+ ++ GT GYMA
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMA 163

Query: 429 PEYIANGQLTE-KVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI 487
           PE +  G   +   D +S G ++ +++ G  ++ F+                Q KT    
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG--HSPFR----------------QHKT---- 201

Query: 488 IDKSIEIEDIEEVKRVVWVGLLCTQELP-TLRPSMTNVVQMLKQKDIT 534
                  +D  E+ R+    L    ELP +  P + ++++ L Q+D++
Sbjct: 202 -------KDKHEIDRMT---LTVNVELPDSFSPELKSLLEGLLQRDVS 239

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 62/231 (26%), Positives = 93/231 (40%), Gaps = 47/231 (20%)

Query: 263 KLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLV 315
            LG G  G +F    KGT   G+  A+K L    + ++N++K +  E +I++   H  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLH 372
                  T+    +V ++     L R+L    Q++        V     AE    LEYLH
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLL----QRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 373 KDGQMQIVHRDIKASNILL-----------DL------KHRPKIADFGLARFSSSEKSLL 415
             G   IV+RD+K  NILL           DL      +  P           SS  S+ 
Sbjct: 121 LLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 416 PNTAIA----------GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             T             GT  Y+APE I+       VD ++ G+L+ E++ G
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 13/199 (6%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKEICNEMDIM-SRAHHKNLVQFL 318
           +G G +G++       DG+  AVK L    I +K   K I  E +++     H  LV   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
               T    + V ++V    L    F  ++++     +        A  L YLH    + 
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLH---SLN 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           I++RD+K  NILLD +    + DFGL +           +   GT  Y+APE +      
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYD 174

Query: 439 EKVDIYSFGVLVLEIVSGV 457
             VD +  G ++ E++ G+
Sbjct: 175 RTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ +L        +HRD+ A NILL      KI DFGLAR   ++ + +        +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MAPE I N   T + D++S+G+L+ EI S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           LEYLH      +V+RDIK  N++LD     KI DFGL +   S+ + +      GT  Y+
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYL 162

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE + +      VD +  GV++ E++ G
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           L YLH      +V+RD+K  N++LD     KI DFGL +   S+ + +      GT  Y+
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYL 162

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE + +      VD +  GV++ E++ G
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 43/238 (18%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLF----ISRKNRIKEICNEMDIMSRAHH 311
           D F+    +G G +GE+     +D   I   ++     +  K ++  I  E DI+  A  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             +V+       K++ +++ EF+    +  +L    +K  L  +     I  T   ++ +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAI 117

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGL------ARFSSSEKSLLPNT------- 418
           H   Q+  +HRDIK  N+LLD K   K++DFGL      A  +   ++L  N        
Sbjct: 118 H---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 419 --------------------AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
                               +  GT  Y+APE        +  D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 27/186 (14%)

Query: 302 EMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQK-----KELDWKK 356
           E  ++++  H N+V F          ++V E+     L + +   + K       L W  
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW-- 105

Query: 357 RHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP 416
                +    G++++H+    +++HRDIK+ NI L    + K+ DFG AR  +S  +   
Sbjct: 106 ----FVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA- 157

Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW 476
                GT  Y+ PE   N     K DI+S G ++ E+ +    + FQ++         +W
Sbjct: 158 -CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT--LKHPFQAN---------SW 205

Query: 477 KHFQAK 482
           K+   K
Sbjct: 206 KNLILK 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 9/100 (9%)

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT--AIAGTLG 425
           ++YLH++   +I+HRDIKA NI ++      + DFG A F      +  N     AGT+ 
Sbjct: 195 IQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD---INANKYYGWAGTIA 248

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD 465
             APE +A       VDI+S G+++ E+ +   ++ F+ D
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATC-HDSLFEKD 287

Length = 391

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 12/136 (8%)

Query: 325 KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDI 384
           KD +VV+E +++  L +++   K   +L  +     +      L+Y+H      + HRD+
Sbjct: 77  KDIYVVFELMES-DLHQVI---KANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDL 129

Query: 385 KASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIAN--GQLTEK 440
           K  NIL +   + KI DFGLAR  F+ +  ++     +A T  Y APE   +   + T  
Sbjct: 130 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-TRWYRAPELCGSFFSKYTPA 188

Query: 441 VDIYSFGVLVLEIVSG 456
           +DI+S G +  E+++G
Sbjct: 189 IDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 4/90 (4%)

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
            L+YLH   +  +V+RD+K  N++LD     KI DFGL +    + + +      GT  Y
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEY 162

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +APE + +      VD +  GV++ E++ G
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 20/207 (9%)

Query: 263 KLGHGGYGEI----FKGTLQDGREIAVKRL--FISRKNRIKEICNEMDIMSR-AHHKNLV 315
           +LG G YG +       T  +   +A+K++    S+K   K    E+ ++     HKN+ 
Sbjct: 7   ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 316 QFLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                      +F    +YE +    L +I+   +   +  ++     I     GL+Y+H
Sbjct: 66  CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQS---FIYQILCGLKYIH 122

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPN-TAIAGTLGYMAPE 430
                 ++HRD+K  N+L++     KI DFGLAR FS +        T    T  Y APE
Sbjct: 123 ---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVSG 456
            + + Q  T+ +D++S G ++ E++  
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGR 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 28/85 (32%), Positives = 47/85 (55%)

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           +H      ++HRDIK++NILL      K+ DFG ++  ++  S        GT  Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVS 455
                  ++K D++S GVL+ E+++
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 40/220 (18%)

Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEIC-------------------NEMD 304
           L  G +G+IF   L+   E A  R  ++  N+ K  C                   NE+ 
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL 215

Query: 305 IMSRAHHKNLVQFLGCC--------FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK 356
            + R +H+N+++              T+K  F +Y F+ +++ D       + + L  + 
Sbjct: 216 ALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW------KDRPLLKQT 269

Query: 357 RHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP 416
           R  I+      +EY+H     +++HRDIK  NI L+   +  + DFG A     EK    
Sbjct: 270 RA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTA--MPFEKEREA 323

Query: 417 -NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +    GT+   +PE +A     E  DI+S G+++L+++S
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 43/236 (18%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLF----ISRKNRIKEICNEMDIMSRAHHKN 313
           F+    +G G +GE+     +D   +   ++     +  K ++  I  E DI+  A    
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+       K + +++ EF+    +  +L    +K  L  ++    I  T   ++ +H 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIH- 118

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGL---------ARFSSSEKSLLPNT------ 418
             Q+  +HRDIK  N+LLD K   K++DFGL           F  +    LP+       
Sbjct: 119 --QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 419 ------------------AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
                             +  GT  Y+APE        +  D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 263 KLGHGGYGEIFKG-TLQDGREIAVKRLFISRK-----NRIKEICNEMDIMSRAHHKNLVQ 316
           KLG G Y  ++KG +   G+ +A+K + +  +       I+E      ++    H N+V 
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREA----SLLKDLKHANIVT 67

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-----LDWKKRHVIIIGTAEGLEYL 371
                 TKK   +V+E++          D KQ  +     L      + +     GL Y 
Sbjct: 68  LHDIIHTKKTLTLVFEYLDT--------DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE- 430
           H   Q +++HRD+K  N+L+  +   K+ADFGLAR  S       N  +  TL Y  P+ 
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDV 174

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSGV 457
            + + + +  +D++  G +  E+ +G 
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 8e-07
 Identities = 26/78 (33%), Positives = 48/78 (61%)

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
           +++HRD+K++NI L      K+ DFG ++  S   SL   ++  GT  Y+APE     + 
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 438 TEKVDIYSFGVLVLEIVS 455
           ++K D++S GV++ E+++
Sbjct: 249 SKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 31/208 (14%)

Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRL---FISRKNRIKEICNEMDIMSR-AHHKNLVQFL 318
           +G G +G++     + + +  AVK L    I +K   K I +E +++ +   H  LV   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 319 GCCFTKKDSFVVYEFVQNKSL------DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
               T    + V +++    L      +R   +P+ +               A  L YLH
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR---------FYAAEIASALGYLH 113

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN---TAIAGTLGYMAP 429
               + IV+RD+K  NILLD +    + DFGL +     +++  N   +   GT  Y+AP
Sbjct: 114 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNGTTSTFCGTPEYLAP 165

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSGV 457
           E +        VD +  G ++ E++ G+
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 46/157 (29%), Positives = 81/157 (51%), Gaps = 21/157 (13%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           AE +  +H   Q+  VHRDIK  N+LLD+    ++ADFG     + + ++  + A+ GT 
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTP 167

Query: 425 GYMAPEYI-----ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET---LVTHTW 476
            Y++PE +       G+   + D +S GV + E++ G     F ++   ET   ++ H  
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG--ETPFYAESLVETYGKIMNHE- 224

Query: 477 KHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQE 513
           + FQ  +   I D S E +D+  ++R     L+C++E
Sbjct: 225 ERFQFPS--HITDVSEEAKDL--IQR-----LICSRE 252

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 13/199 (6%)

Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRL---FISRKNRIKEICNEMDIMSRA-HHKNLVQFL 318
           +G G +G++     + DG   AVK L    I +K     I  E +++ +   H  LV   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
               T +  + V ++V    L    F  ++++     +        A  + YLH    + 
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLH---SLN 116

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           I++RD+K  NILLD +    + DFGL +     +     +   GT  Y+APE +      
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYD 174

Query: 439 EKVDIYSFGVLVLEIVSGV 457
             VD +  G ++ E++ G+
Sbjct: 175 RTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 57/245 (23%), Positives = 101/245 (41%), Gaps = 53/245 (21%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLF---ISRKNRIKEICNEMDIMSRAHHKN 313
           F +   +G G +GE+      D   + A+K L    +  +N+   +  E DI++ A ++ 
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 314 LVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           +V+ L   F  KD+ + V +++    +  +L       E D  + ++  +  A  +E +H
Sbjct: 63  VVK-LYYSFQDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCA--IESVH 118

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNT----------- 418
           K   M  +HRDIK  NIL+D     K+ DFGL    R++   K                 
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 419 ---------------------------AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVL 451
                                      ++ GT  Y+APE +     T+  D +S GV++ 
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 452 EIVSG 456
           E++ G
Sbjct: 236 EMLVG 240

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 30/239 (12%)

Query: 263 KLGHGGYGEIFKGTLQDG---REIAVKRLFISRKNRIKEICNEMDIMSRAH------HKN 313
           ++G+G +G++  G +  G    ++ VK L +S       +  +M  +  A       H N
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVS-----ASVQEQMKFLEEAQPYRSLQHSN 56

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKEL--DWKKRHVIIIGTAEGLEYL 371
           L+Q LG C       +V EF     L   L   ++ + +  D      +    A GL +L
Sbjct: 57  LLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           HK+     +H D+   N LL      KI D+GL+     E   +    +   L ++APE 
Sbjct: 117 HKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 432 I--ANGQL-----TEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAK 482
           +   +G L     T++ +++S GV + E+   G Q  +  SD   E ++T+T +  Q K
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD---EQVLTYTVREQQLK 229

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 19/145 (13%)

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI--- 432
           Q+  VHRDIK  N+LLD     ++ADFG      ++ ++  N A+ GT  Y++PE +   
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEILQAM 178

Query: 433 --ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL--VTHTWKHFQAKTVLEII 488
               G+   + D +S GV + E++ G     F ++   ET   + +  +HFQ        
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYG--ETPFYAESLVETYGKIMNHKEHFQFPP----- 231

Query: 489 DKSIEIEDIEEVKRVVWVGLLCTQE 513
               ++ D+ E  + +   L+C+ E
Sbjct: 232 ----DVTDVSEEAKDLIRRLICSPE 252

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 21/146 (14%)

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI--- 432
           Q+  VHRDIK  NIL+D+    ++ADFG +     E   + ++   GT  Y++PE +   
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 433 --ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET---LVTHTWKHFQAKTVLEI 487
               G+   + D +S GV + E++ G     F ++   ET   ++ H  + FQ       
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYG--ETPFYAESLVETYGKIMNHK-ERFQFPA---- 231

Query: 488 IDKSIEIEDIEEVKRVVWVGLLCTQE 513
                ++ D+ E  + +   L+C++E
Sbjct: 232 -----QVTDVSEDAKDLIRRLICSRE 252

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 20/207 (9%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIA---VKRLFISRKNRIKE---ICNEMDIMSRAHHKNLV 315
           +++G+G +G++  G    G   A   VK L  S      E      E+      +H N++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG--TAEGLEYLHK 373
           Q LG C       +V EF     L   L   +       +K  +  +    A GL +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH- 117

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
             Q   +H D+   N  L      KI D+GLA     E   +     A  L ++APE + 
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 434 NGQ-------LTEKVDIYSFGVLVLEI 453
                      T+K +I+S GV + E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 34/99 (34%), Positives = 47/99 (47%), Gaps = 11/99 (11%)

Query: 359 VIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
            I     E L YLH  G   I+HRD+K  NI LD      + DFG A     +    P+T
Sbjct: 189 TIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA----CKLDAHPDT 241

Query: 419 ----AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
                 +GTL   +PE +A      K DI+S G+++ E+
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 48.6 bits (116), Expect = 6e-06
 Identities = 59/259 (22%), Positives = 90/259 (34%), Gaps = 77/259 (29%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHHK 312
           D F    KLG G +G ++K +L + +     +  + +      +    NE   + RA   
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER--VRRACPN 189

Query: 313 NLVQFLGCCFTKKDS------FVVYEFVQNKSLDRILFDPKQKKELDWK----------- 355
           +   F+        S      ++V+ +    +L     D  Q KE  +            
Sbjct: 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTL----ADLMQSKEFPYNVEPYLLGKVQD 245

Query: 356 -----KRHVIIIGTA-----EGLEYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGL 404
                +R   II T        L+ LH  G   IVHRD+K  NI+        KI D G 
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGA 302

Query: 405 A-------RFSSSEKSLLPNTAIAGTLGYMAPE-YIANGQ-------------------- 436
           A        +   E  L P         Y APE YI + Q                    
Sbjct: 303 AADLRVGINYIPKEFLLDPR--------YAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 354

Query: 437 -LTEKVDIYSFGVLVLEIV 454
            L ++ DIYS G++ L++ 
Sbjct: 355 NLPDRFDIYSAGLIFLQMA 373

Length = 566

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 60/252 (23%), Positives = 106/252 (42%), Gaps = 63/252 (25%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLF---ISRKNRIKEICNEMDIMSRAHHKN 313
           F +   LG G +GE+      D   + A+K L    +  +N++  +  E DI++ A ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 314 LVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLE 369
           +V+ L   F  KD+ + V +++    +  +L        ++     +     AE    +E
Sbjct: 63  VVK-LYYSFQDKDNLYFVMDYIPGGDMMSLLI------RMEVFPEVLARFYIAELTLAIE 115

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEK-----------SLL 415
            +HK   M  +HRDIK  NIL+DL    K+ DFGL    R++ + K           S+ 
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172

Query: 416 PNT-------------------------------AIAGTLGYMAPEYIANGQLTEKVDIY 444
           P+                                ++ GT  Y+APE +     T+  D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232

Query: 445 SFGVLVLEIVSG 456
           S GV++ E++ G
Sbjct: 233 SVGVILFEMLVG 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 43/194 (22%), Positives = 87/194 (44%), Gaps = 20/194 (10%)

Query: 272 IFKGTLQDGREIAVKRLFISRKN--RIKEIC-NEMDIMSRAHHKNLVQFLGCCFTKKDSF 328
           I+KG   + +E+ ++      K    + +I  NE+  + R    N+++  G      D  
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 329 ----VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDI 384
               ++ E+     L  +L    ++K+L +K +  + I   +GL  L+K       ++++
Sbjct: 95  PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNL 149

Query: 385 KASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN--GQLTEKVD 442
            + + L+   ++ KI   GL +  SS      N      + Y + + + +   + T K D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF-----MVYFSYKMLNDIFSEYTIKDD 204

Query: 443 IYSFGVLVLEIVSG 456
           IYS GV++ EI +G
Sbjct: 205 IYSLGVVLWEIFTG 218

Length = 283

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 62/248 (25%), Positives = 107/248 (43%), Gaps = 50/248 (20%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           +G G +GE+     +D   I A+K+L  S    K ++  +  E DI++ A +  +V+ L 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK-LY 67

Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
             F  ++  +++ E++    +  +L    +K     ++    I  T   ++ +HK G   
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG--- 121

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLA-------------RFSSSEKSLLPNT------- 418
            +HRDIK  N+LLD K   K++DFGL                S +  S   +        
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181

Query: 419 ------------AIA----GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKF 462
                       A+A    GT  Y+APE        ++ D +S GV++ E++ G     F
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP--PF 239

Query: 463 QSDDGFET 470
            SD+  ET
Sbjct: 240 CSDNPQET 247

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 19/157 (12%)

Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           +MS+  H +L    G C    ++ +V EFV++  LD  L   K +  + WK    +    
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQQL 126

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLK-----HRP--KIADFGLARFSSSEKSLLPN 417
           A  L YL       +VH ++ A NILL          P  K++D G++  + S +  +  
Sbjct: 127 ASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVER 183

Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEI 453
                 + ++APE +  G  L+   D +SFG  +LEI
Sbjct: 184 ------IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 31/211 (14%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE-IAVKRLF--ISRKNRIKEICNEMDIMSRAHHKNLV--- 315
           N +G+G +G +++    D  E +A+K++      KNR      E+ IM   +H N++   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR------ELLIMKNLNHINIIFLK 125

Query: 316 -QFLGCCFTK--KDSF--VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
             +   CF K  K+ F  VV EF+       +    +    L      +        L Y
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 371 LHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLARFSSSEKSLLP---NTAIAGTLGY 426
           +H      I HRD+K  N+L+D   H  K+ DFG      S K+LL    + +   +  Y
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG------SAKNLLAGQRSVSYICSRFY 236

Query: 427 MAPE-YIANGQLTEKVDIYSFGVLVLEIVSG 456
            APE  +     T  +D++S G ++ E++ G
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 8/89 (8%)

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           L+ LH++G   IV RD+  +NILLD +   ++  F   R+S  E S     A+     Y 
Sbjct: 98  LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSC-DGEAVENM--YC 149

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE     + TE  D +S G ++ E+++G
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 57/249 (22%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLF---ISRKNRIKEICNEMDIMSRAHHKN 313
           F +   LG G +GE+      D + + A+K L    +  +N++  +  E DI++ A ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 314 LVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           +V+ L   F  KD+ + V +++    +  +L       E         I      +E +H
Sbjct: 63  VVR-LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE---DLARFYIAELTCAVESVH 118

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEK----------------- 412
           K   M  +HRDIK  NIL+D     K+ DFGL    R++   K                 
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 413 ------------SLLP-------------NTAIAGTLGYMAPEYIANGQLTEKVDIYSFG 447
                        L P               ++ GT  Y+APE +     T+  D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 448 VLVLEIVSG 456
           V++ E++ G
Sbjct: 236 VILYEMLVG 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 45/181 (24%), Positives = 71/181 (39%), Gaps = 38/181 (20%)

Query: 290 ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV--------QNKSLDR 341
           I   ++I    N  +I     H  + ++ GC   K+   + Y F+          +   R
Sbjct: 65  IYDIDKIALWKNIHNI----DHLGIPKYYGCGSFKRCR-MYYRFILLEKLVENTKEIFKR 119

Query: 342 ILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
           I    K       K    I+      LEY+H+ G   I H DIK  NI++D  +R  I D
Sbjct: 120 IKCKNK-------KLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIID 169

Query: 402 FGLA----------RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVL 451
           +G+A           +S  +K L       GTL Y   +      +T + D+ S G  +L
Sbjct: 170 YGIASHFIIHGKHIEYSKEQKDLH-----RGTLYYAGLDAHNGACVTRRGDLESLGYCML 224

Query: 452 E 452
           +
Sbjct: 225 K 225

Length = 294

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 18/42 (42%), Positives = 28/42 (66%), Gaps = 3/42 (7%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR 406
           A  L+YLH+ G   I+HRD+K  N+L+  +   K+ DFGL++
Sbjct: 114 ALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 8e-04
 Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 32/132 (24%)

Query: 346 PKQKKELDWKK---RHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF 402
           P+ K++++  K   R V+      GL  LH+ G   IVHRDIK  N+L+ +  + KI DF
Sbjct: 302 PQDKRDINVIKGVMRQVLT-----GLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDF 353

Query: 403 GLA------------------RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDI- 443
           G A                  R+S  E+ ++P +        MA        L  + D+ 
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413

Query: 444 --YSFGVLVLEI 453
             Y+ GVL++++
Sbjct: 414 DSYTAGVLLMQM 425

Length = 507

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.4 bits (97), Expect = 8e-04
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 22/152 (14%)

Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           +G G +GE+        G+  A+K L  S   +K+++  +  E D+++ +    +V    
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY- 67

Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHK 373
             ++ +D+  +Y   EF+    L  +L       + D     V     AE    +E +HK
Sbjct: 68  --YSFQDAQYLYLIMEFLPGGDLMTMLI------KYDTFSEDVTRFYMAECVLAIEAVHK 119

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLA 405
            G    +HRDIK  NIL+D     K++DFGL+
Sbjct: 120 LG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 40.3 bits (95), Expect = 0.001
 Identities = 19/41 (46%), Positives = 21/41 (51%), Gaps = 4/41 (9%)

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE 411
           LHK G   IVH D+  SNI+L    R    DFGL  FS   
Sbjct: 108 LHKAG---IVHGDLTTSNIILS-GGRIYFIDFGLGEFSDEV 144

Length = 204

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 28/113 (24%)

Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS----------S 409
           I+ G   GL YLH++G    +HR+IKAS+IL        I+  GL   S          +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154

Query: 410 SEKSL----LPNTAIAGTLGYMAPEYIANG--QLTEKVDIYSFGVLVLEIVSG 456
            +K+      P  + +  L +++PE +         K DIYS G+   E+ +G
Sbjct: 155 GQKAKVVYDFPQFSTS-VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 34/212 (16%)

Query: 264 LGHGGYGEIFKGTLQD-----------GREIAV--KRLFISRKNRIKEICNEMDIMSRAH 310
           LG G   +I+ G L              +EI V  K L  S ++          +M +  
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           HK++V   G C    ++ +V EFV+   LD  LF  ++   L    +  +    A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 371 LH-KDGQMQIVHRDIKASNILL-----DLKHRP--KIADFGLARFSSSEKSLLPNTAIAG 422
           L  KD    +VH ++   NILL     D +  P  K++D G+        ++L       
Sbjct: 121 LEDKD----LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP------ITVLSRQECVE 170

Query: 423 TLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEI 453
            + ++APE + + + L+   D +SFG  + EI
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	569
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
PRK10345	210	hypothetical protein; Provisional	99.8
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
smart00090	237	RIO RIO-like kinase.	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
KOG1243	690	consensus Protein kinase [General function predict	99.32
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.18
KOG3087	229	consensus Serine/threonine protein kinase [General	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.0
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.99
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.94
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.94
COG4248	637	Uncharacterized protein with protein kinase and he	98.81
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.8
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.72
PRK09902	216	hypothetical protein; Provisional	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.52
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.5
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.43
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.42
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.36
PF01636	239	APH: Phosphotransferase enzyme family This family	98.3
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.28
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.23
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.23
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.14
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.11
PLN02876	822	acyl-CoA dehydrogenase	98.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.01
PRK10593	297	hypothetical protein; Provisional	97.94
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.88
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.87
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.76
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.68
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.66
PRK05231	319	homoserine kinase; Provisional	97.55
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.43
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.34
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.34
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.33
KOG2270	520	consensus Serine/threonine protein kinase involved	97.28
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.21
PLN02236	344	choline kinase	96.99
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.96
PLN02756	418	S-methyl-5-thioribose kinase	96.77
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.67
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.65
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.51
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.25
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.14
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.01
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.01
COG2334	331	Putative homoserine kinase type II (protein kinase	95.95
PRK12396	409	5-methylribose kinase; Reviewed	95.85
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.51
PRK11768	325	serine/threonine protein kinase; Provisional	95.44
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.38
PRK06148	1013	hypothetical protein; Provisional	95.27
PTZ00384	383	choline kinase; Provisional	94.58

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-54  Score=442.92  Aligned_cols=288  Identities=40%  Similarity=0.676  Sum_probs=253.8

Q ss_pred             cccccchhHHHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeee
Q 037160          242 KFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC  321 (569)
Q Consensus       242 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  321 (569)
                      ....|.+.+++.+|++|...++||+|+||.||+|.+.+|+.||||++.....+..++|.+|++++.+++|||+|+++|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34568899999999999999999999999999999999999999988765443145699999999999999999999999


Q ss_pred             eeCC-ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          322 FTKK-DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       322 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                      .+.+ +.+||||||++|+|+++|+..... .++|..+++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 599999999999999999754433 89999999999999999999999988899999999999999999999999


Q ss_pred             ccCCCcccCCCCCCCCCccc-ccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhh
Q 037160          401 DFGLARFSSSEKSLLPNTAI-AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      |||+++..+....  ..... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.....+.....++.|.+..+
T Consensus       220 DFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            9999976654111  11222 89999999999999999999999999999999999998887665555556888999999


Q ss_pred             cccchhhhhcccCC-CC-CH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          480 QAKTVLEIIDKSIE-IE-DI-EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       480 ~~~~~~~~~~~~l~-~~-~~-~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ..+.+.+++|+.+. .. .. +++.++..++.+|++.+|++||+|.||+++|+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            99999999999986 34 33 68899999999999999999999999999996544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=374.95  Aligned_cols=247  Identities=26%  Similarity=0.393  Sum_probs=208.7

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCc-eEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD-SFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~  333 (569)
                      +.+..+.||+|..|+|||++++ +++-+|+|++... +....+++.+|++++++.+||+||+++|.|..+.. ..|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4556788999999999999998 6788999999544 44556789999999999999999999999999984 9999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |++|+|++++.   ..+.+++...-.|+.++++||.|||+ ++   ||||||||+|||++..|++||||||.++.+... 
T Consensus       160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            99999999994   33678999999999999999999996 65   999999999999999999999999999877654 


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                         .....+||..|||||.+.++.|+.++||||||+.++|+.+|+-|+....+..              ..+.++++...
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--------------~~~~~Ll~~Iv  295 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--------------LDIFELLCAIV  295 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC--------------CCHHHHHHHHh
Confidence               3457899999999999999999999999999999999999999887652211              11222222222


Q ss_pred             C----CCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 E----IEDI-EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~----~~~~-~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .    ..+. .....+.+++..||++||.+||++.|++++
T Consensus       296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1    1122 366789999999999999999999999965

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-47  Score=382.27  Aligned_cols=257  Identities=32%  Similarity=0.486  Sum_probs=211.5

Q ss_pred             cccccccccCceeEEEEEecCCceEEEEEEeecchh--hHHHHHHHHHHHHhccccccceeeeeeeeCC-ceEEEEeecC
Q 037160          259 DESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-DSFVVYEFVQ  335 (569)
Q Consensus       259 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~  335 (569)
                      .+.+.||+|+||+||+|.++....||||++......  ..+.|.+|+.+|.+++|||||+++|++.+.. ...|||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            344569999999999999985444999999765322  2568999999999999999999999999888 7999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCcccCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~~~~~~~~~  414 (569)
                      +|+|.+++... .+..+++..++.|+.+||+||.|||+.++  ||||||||+||||+.++ ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            99999999653 56789999999999999999999999974  99999999999999997 99999999998765532  


Q ss_pred             CCCcccccCCCcccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          415 LPNTAIAGTLGYMAPEYIA--NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~--~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      ...+...||+.|||||++.  ...++.|+||||||++||||+||+.||......+.               ...++....
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---------------~~~v~~~~~  263 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---------------ASAVVVGGL  263 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---------------HHHHHhcCC
Confidence            1334578999999999999  56999999999999999999999999875543211               111111222


Q ss_pred             CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          493 EIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       493 ~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                      ... +.+....+..++.+||+.+|+.||++.+|+..|+......
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            222 3336677888999999999999999999999998654433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-47  Score=368.39  Aligned_cols=203  Identities=28%  Similarity=0.508  Sum_probs=183.2

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..+|...++||+|.||+||+|+++ ++.+||||.+...  .+...+.+..|+.+|+.++|||||+++++++..+..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888899999999999999987 6899999999766  4556677889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC------CCeEEeccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK------HRPKIADFGLA  405 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~------~~~kl~Dfgla  405 (569)
                      |||+||+|.++|   ..++.+++..+..++.||+.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi---~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYI---RRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999   45568999999999999999999999999   9999999999999765      45899999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCc
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD  466 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~  466 (569)
                      +.+....   -....+|++-|||||++..++|+.|+|+||+|+||||+++|+.||.-....
T Consensus       163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            9887543   234789999999999999999999999999999999999999998855544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-46  Score=380.07  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=211.0

Q ss_pred             ccccccccccccCceeEEEEEe-cCCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..|...+.||+|||+.+|.++. ..|+.||+|++...   +....+.+.+|++|.+.|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688899999999999999997 68999999998653   3445677899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      |+|+.++|..++   +.++.+++.+++.++.||+.||.|||+++   |||||||-.|++|+++.++||+|||||......
T Consensus        98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            999999999999   46789999999999999999999999999   999999999999999999999999999988754


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..  .....+||+.|.|||++.....+..+||||+|||||-||.|++||+...-...                ...|...
T Consensus       172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket----------------y~~Ik~~  233 (592)
T KOG0575|consen  172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET----------------YNKIKLN  233 (592)
T ss_pred             cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH----------------HHHHHhc
Confidence            32  45688999999999999999999999999999999999999999875432211                0111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      -..-+........+++..+|+.||.+|||+++|+.+
T Consensus       234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            011122344456667889999999999999999954

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-47  Score=368.24  Aligned_cols=254  Identities=26%  Similarity=0.357  Sum_probs=207.0

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchh-------hHHHHHHHHHHHHhccccccceeeeeeee
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN-------RIKEICNEMDIMSRAHHKNLVQFLGCCFT  323 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~  323 (569)
                      +.+.+.|.+.+.||+|+||.|-+|..+ +|+.||||++......       ......+|+++|++|+|||||+++++++.
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            346677889999999999999999865 8999999998654211       12235799999999999999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC---CCeEEe
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIA  400 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl~  400 (569)
                      .+..|+||||++||+|.+.+.   .++.+.+.....++.|++.|+.|||++|   |+||||||+|||+..+   -.+||+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             CCceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence            999999999999999999984   4566777788889999999999999999   9999999999999766   569999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ---LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      |||+|+......   .....+||+.|.|||++.++.   +..++|+||+|||||-+++|.+||.....+           
T Consensus       322 DFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-----------  387 (475)
T KOG0615|consen  322 DFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-----------  387 (475)
T ss_pred             ccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-----------
Confidence            999999887433   456889999999999998764   234889999999999999999998754433           


Q ss_pred             hhcccchhhhhcccCC-CC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          478 HFQAKTVLEIIDKSIE-IE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~-~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                          ..+.+.+.+... ..   -.+...+.++++.++|..||++|||+.|+|++-.
T Consensus       388 ----~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  388 ----PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             ----ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence                222232222211 11   2234567788999999999999999999996543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=371.18  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=214.4

Q ss_pred             ccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      +...++||+|-||.||.|.+++...||+|.+.... ...+.|.+|+++|++|+|+|||+++++|..++.++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            44567899999999999999988899999987653 33467889999999999999999999999988999999999999


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCC
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN  417 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  417 (569)
                      +|.++|.. ..+..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+....+.+. ..
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~~  361 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-AS  361 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee-ec
Confidence            99999965 45677899999999999999999999999   999999999999999999999999999966555543 33


Q ss_pred             cccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-
Q 037160          418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-  495 (569)
Q Consensus       418 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-  495 (569)
                      ....-...|.|||.+..+.++.|||||||||+||||+| |+.|+.                ......+.+.++....-. 
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~----------------~msn~ev~~~le~GyRlp~  425 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP----------------GMSNEEVLELLERGYRLPR  425 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC----------------CCCHHHHHHHHhccCcCCC
Confidence            34445678999999999999999999999999999999 444433                223344556666555444 


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      +..+...+.+++..||..+|++|||+..+...|++..
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            5556677888999999999999999999998887654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-46  Score=343.29  Aligned_cols=257  Identities=25%  Similarity=0.355  Sum_probs=208.8

Q ss_pred             ccccccccccccCceeEEEEEe-cCCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeee-eeeeCCc-eEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLG-CCFTKKD-SFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv  330 (569)
                      .+|+++++||+|.||.||+++. .+|..+|.|.+...  +.........|+.+|++|+|||||++++ .+.++.+ .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3588889999999999999985 48999999988643  3455677899999999999999999998 4444444 8999


Q ss_pred             EeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          331 YEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQ-MQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      ||++.+|+|...++.. ..++.+++..+|+++.|+++||.++|++-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999998543 356678999999999999999999999421 24999999999999999999999999999988


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      .....  .....+|||.||+||.+.+.+|+.||||||+||++|||..-++||....      +.+          +.+.|
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~----------L~~KI  240 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLS----------LCKKI  240 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHH----------HHHHH
Confidence            77543  3457899999999999999999999999999999999999999987542      111          11111


Q ss_pred             cccCCC-CC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          489 DKSIEI-ED-IEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       489 ~~~l~~-~~-~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      ...-.. -+ .-.+..+..|+..|+..||+.||+...++..+..
T Consensus       241 ~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  241 EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            111111 12 4456788899999999999999997666655544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=348.65  Aligned_cols=242  Identities=23%  Similarity=0.356  Sum_probs=202.4

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      -++|++.++||+|+||.||.++.+ +++-+|+|++.+.   .....+..++|..+|.+++||.||+++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999976 6889999998654   234567789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      +||+.||.|..+|   .+.+.+++..+.-++.+|+.||.|||+++   ||||||||+|||||.+|+++|+||||++..-.
T Consensus       104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999   45567889999999999999999999999   99999999999999999999999999986554


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...  .....+||+.|||||++.+..++..+|.||||+++|||++|.+||.........               ..+...
T Consensus       178 ~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~---------------~~I~~~  240 (357)
T KOG0598|consen  178 DGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY---------------DKILKG  240 (357)
T ss_pred             CCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH---------------HHHhcC
Confidence            432  344689999999999999999999999999999999999999998755432211               111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRP  519 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP  519 (569)
                      .+...+.-.......++...++.+|++|-
T Consensus       241 k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  241 KLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             cCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            11111222345566777889999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.7e-44  Score=333.56  Aligned_cols=262  Identities=23%  Similarity=0.336  Sum_probs=209.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      +.|+.+.++|+|+||.|||++++ +|+-||||++..+..  ...+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45788899999999999999987 699999999976543  333457899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      ||+..-|+++=   .....++...+..++.|+++|+.|+|+++   +|||||||+||||+.+|.+||||||+|+.+....
T Consensus        82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99988887764   34456888999999999999999999999   9999999999999999999999999999887422


Q ss_pred             CCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc-
Q 037160          413 SLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK-  490 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  490 (569)
                      .  .-+..+.|.+|.|||.+.+ .+|...+|||++||++.||++|.+-|....+-+.-.++......+.... .+++.. 
T Consensus       156 d--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh-q~iF~~N  232 (396)
T KOG0593|consen  156 D--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH-QSIFSSN  232 (396)
T ss_pred             c--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH-HHHhccC
Confidence            1  3467789999999999987 5899999999999999999999998877665544333332222111111 111110 


Q ss_pred             ---------c------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          491 ---------S------IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       491 ---------~------l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                               .      +....+....-++.++..||+.||.+|++-++++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                     0      00112233345788999999999999999999984

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=347.60  Aligned_cols=267  Identities=22%  Similarity=0.266  Sum_probs=213.3

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhh-HHHHHHHHHHHHhcc-ccccceeeeeeeeCC-ceE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNR-IKEICNEMDIMSRAH-HKNLVQFLGCCFTKK-DSF  328 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~  328 (569)
                      .+.++|...++||.|.||.||+|+.+ .|+.||||+++..-... .-.-++|+..|++|+ |||||++.+++.+.+ .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            35678999999999999999999965 78999999886553322 123468999999998 999999999999888 999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||| ..+|..++++.  +..+++..+..|+.||++||+|+|++|   +.|||+||+|||+..+..+||+|||+|+..
T Consensus        87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            999999 56899999653  778999999999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCCCCCCcccccCCCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhh-----HhHhhhhccc
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV-----THTWKHFQAK  482 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~-----~~~~~~~~~~  482 (569)
                      .+..   +-+..+.|.+|.|||++ +.+.|+.+.|||++|||++|+.+-++-|....+-+.-.-+     ...++.|..+
T Consensus       161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            7655   55788899999999986 5678999999999999999999999887765543321111     1222333332


Q ss_pred             c-hhhhhcccC--------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          483 T-VLEIIDKSI--------EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       483 ~-~~~~~~~~l--------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      . +...+.-.+        ..--+......++++..|+++||.+|||+.|.+++-
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1 111111111        111233567788999999999999999999999764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.2e-42  Score=314.93  Aligned_cols=281  Identities=24%  Similarity=0.350  Sum_probs=217.9

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchh--hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|...++||+|.||.||+|+.. +|+.||||++...+..  ......+|++.|+.++|+||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            45777889999999999999964 8999999999776432  23467899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      || ..+|+..|++  +...+....+..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+++.+....
T Consensus        82 fm-~tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FM-PTDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ec-cccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            99 5689999854  4567888999999999999999999999   9999999999999999999999999999888755


Q ss_pred             CCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH--------hHhhhhccc-
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT--------HTWKHFQAK-  482 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~-  482 (569)
                      ..  .+..+-|.+|.|||.+.+. +|+..+||||.|||+.||+-|.+-+....+-+.-..+-        ..|+.+..- 
T Consensus       156 ~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             cc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            42  2334789999999998875 79999999999999999999988766555543332222        233332221 


Q ss_pred             chhhhh--c-ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCCCccc
Q 037160          483 TVLEII--D-KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDE  546 (569)
Q Consensus       483 ~~~~~~--~-~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p~~p~~~~~  546 (569)
                      +..++.  . +.+..--+......++++..++..||.+|+|++|.+++=--.+  .|.|..|.-.+.
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~--~P~pt~~~~lp~  298 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS--LPLPTPPSKLPI  298 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc--CCCCCChhhCcC
Confidence            111111  0 1111112334556688999999999999999999998744333  455554444433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.7e-43  Score=370.47  Aligned_cols=259  Identities=28%  Similarity=0.377  Sum_probs=215.3

Q ss_pred             hccccccccccccCceeEEEEEec------CCceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      ..+.+..++||+|.||.||+|+..      +.+.||||.++..... ..++|++|+++|..++|||||+++|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            445566788999999999999854      2457999999876544 778999999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCC-------C----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC
Q 037160          328 FVVYEFVQNKSLDRILFDPK-------Q----KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR  396 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~-------~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  396 (569)
                      ++|+|||..|+|.+||....       .    +.+++..+.+.|+.|||.||.||-++.   +|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999995322       1    334889999999999999999999998   999999999999999999


Q ss_pred             eEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhH
Q 037160          397 PKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       397 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  475 (569)
                      |||+||||++..-..+++.......-..+|||||.|..++||.+||||||||+|||+++ |+.|+....           
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-----------  710 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-----------  710 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----------
Confidence            99999999997766666544444455789999999999999999999999999999998 666654322           


Q ss_pred             hhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          476 WKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                           ...+.+.+...--- -+.....++..|+..||+.+|++||+++||-..|+.-.
T Consensus       711 -----n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  711 -----NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             -----hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence                 22333333332222 25566778899999999999999999999999998644

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-42  Score=342.97  Aligned_cols=267  Identities=25%  Similarity=0.357  Sum_probs=208.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeC--CceE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSF  328 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  328 (569)
                      ..+.|+.+++||+|.||.||+|+.. +|+.||+|++....  .....-..+||.||++|+||||+++.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            4456788889999999999999954 79999999997764  33445677999999999999999999999877  6889


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      ||+|||+. +|.-++.  ...-.++..++..++.||+.||.|+|.++   |+|||||.+|||||.+|.+||+|||||+++
T Consensus       195 lVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            99999965 6766663  33457899999999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh-----hhhccc
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW-----KHFQAK  482 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~  482 (569)
                      ...... ..+..+-|++|.|||.+.+. .|+.++|+||.||||.||+.|++.+....+-...+.+...-     ..|...
T Consensus       269 ~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            776544 45677889999999999876 79999999999999999999999887665433322222111     112211


Q ss_pred             chh--hhhcccCCCC------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVL--EIIDKSIEIE------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~--~~~~~~l~~~------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+.  ..+.+.....      ........++++..+|..||.+|.|+.++|+.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            111  1111111100      11122446778889999999999999999854

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=346.66  Aligned_cols=256  Identities=21%  Similarity=0.305  Sum_probs=210.4

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCce
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  327 (569)
                      +.-++|.+++.||+|.|++|++|+.+ .+++||||++.+.   +....+.+..|-+.|.+| .||.|++++..|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            44578999999999999999999965 7899999988543   223345677899999999 899999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      |+|+||+++|+|-++|   .+.+.+++...+.++.+|+.||+|||+.|   ||||||||+|||||++|++||+|||-|+.
T Consensus       150 YFvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999   45578999999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCC-----------CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh
Q 037160          408 SSSEKSL-----------LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       408 ~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  476 (569)
                      +......           .....++||..|.+||++..+..++.+|+|+||||||+|+.|++||...++-..        
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli--------  295 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI--------  295 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH--------
Confidence            7654332           112458999999999999999999999999999999999999999876543211        


Q ss_pred             hhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          477 KHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                              .+.|...-...++...+...+|+.+.|..+|.+|+|..+|-++.-.
T Consensus       296 --------FqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF  341 (604)
T KOG0592|consen  296 --------FQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF  341 (604)
T ss_pred             --------HHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence                    1111111111122233455667778889999999999999977543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1e-41  Score=350.25  Aligned_cols=260  Identities=28%  Similarity=0.403  Sum_probs=202.7

Q ss_pred             hccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeC-C
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK-K  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~  325 (569)
                      .++|++.++||+|+||.||+|.+.      .++.||||++.... ....+.+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467999999999999999999742      35689999886543 23446789999999999 899999999988764 4


Q ss_pred             ceEEEEeecCCCChhhHhhCCCC---------------------------------------------------------
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQ---------------------------------------------------------  348 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  348 (569)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999854211                                                         


Q ss_pred             --CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCc
Q 037160          349 --KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY  426 (569)
Q Consensus       349 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y  426 (569)
                        ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              234788899999999999999999998   999999999999999999999999999865443222122234567889


Q ss_pred             ccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHH
Q 037160          427 MAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVW  505 (569)
Q Consensus       427 ~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  505 (569)
                      +|||++.+..++.++||||||++||||++ |..|+........  +.    .....+.        ....+......+..
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~~--------~~~~~~~~~~~l~~  308 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDGT--------RMRAPENATPEIYR  308 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcCC--------CCCCCCCCCHHHHH
Confidence            99999999999999999999999999997 9888765332210  00    0000000        00011223346778


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          506 VGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       506 l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ++..||+.+|++|||+.||++.|++.
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=348.84  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=211.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      ..|....+||+|..|.||.+... +++.||||++........+.+.+|+.+|+..+|+|||++++.+...+++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            45777789999999999999854 78999999998887777788999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      +||+|.+++.    ...+++.++..|+.++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999983    345899999999999999999999999   99999999999999999999999999988776654 


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       .....+||+.|||||++....|++|+||||||++++||+-|++|+-...+-.-.      |.....+        ....
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------yLIa~ng--------~P~l  489 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG--------TPKL  489 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------HHHhhcC--------CCCc
Confidence             456778999999999999999999999999999999999999997653322110      0000000        0111


Q ss_pred             C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          495 E-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       495 ~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      . .......+.++..+||+.|++.||++.|+|++
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            1 33445667778899999999999999999976

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=338.39  Aligned_cols=257  Identities=27%  Similarity=0.364  Sum_probs=202.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCC--ceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK--DSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e  332 (569)
                      .+|...+.||+|.||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|.....+  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677889999999999999976 58999999887664444677899999999999999999999855544  6899999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcccCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSE  411 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~~~~~  411 (569)
                      |+++|+|.+++...+.  .+++..+..+..||++||.|||+++   ||||||||+||||+. ++.+||+|||+++.....
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999954332  6999999999999999999999999   999999999999999 799999999999877641


Q ss_pred             -CCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          412 -KSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       412 -~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                       ..........||+.|||||++..+ ....++|||||||++.||+||++||... .+.    ....+......       
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~----~~~~~~ig~~~-------  239 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEE----AEALLLIGRED-------  239 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cch----HHHHHHHhccC-------
Confidence             111233467899999999999864 3446999999999999999999998643 000    01111111111       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                       ....-+........+++.+|++.+|+.|||+.+++++.--
T Consensus       240 -~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  240 -SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             -CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence             0111122233455667789999999999999999987644

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=349.61  Aligned_cols=271  Identities=24%  Similarity=0.400  Sum_probs=215.2

Q ss_pred             HHHHhccccccccccccCceeEEEEEecCCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      .+.-.+.+.+..+||+|.||+||+|++.  .+||||++...  .....+.|++|+..+++-+|.||+-+.|++..... .
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            3444566778899999999999999987  38999999765  34577899999999999999999999999988877 9


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      ||+.+|+|.+|..+|..  .+..++....+.|+.||++||.|||.++   |||||||..||++.++++|||+||||+..-
T Consensus       464 IiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence            99999999999999954  3466888899999999999999999999   999999999999999999999999999754


Q ss_pred             CCCCCCCCCcccccCCCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANG---QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      .............|...|||||+++.+   +|+..+||||||+|+|||++|..|+.....+++...+.   +.+-..++.
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG---rG~l~pd~s  615 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG---RGYLMPDLS  615 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec---ccccCccch
Confidence            443222233355678899999999754   68999999999999999999999988444433211111   000001110


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCCC
Q 037160          486 EIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSK  540 (569)
Q Consensus       486 ~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p~~  540 (569)
                              ....+..+.+.+|+..||..++++||.+.+|+.+|+.....+|.-.+
T Consensus       616 --------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R  662 (678)
T KOG0193|consen  616 --------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR  662 (678)
T ss_pred             --------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence                    01223344566777899999999999999999999887766654444

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.7e-42  Score=345.08  Aligned_cols=260  Identities=27%  Similarity=0.376  Sum_probs=217.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+..  ....+.+.+|++|++.++|||||.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56888889999999999999876 68899999886643  3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+.| +|..+|   ...+.++++.+..++.++..||.|||+.+   |+|||+||.|||++.+|.+|++|||+|+.+..+.
T Consensus        82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9977 999999   45678999999999999999999999998   9999999999999999999999999999887754


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  ..+.+.||+.|||||.+.+++|+..+|+||+|||+||+++|++||...                   .+.+++...+
T Consensus       155 ~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------------------si~~Lv~~I~  213 (808)
T KOG0597|consen  155 S--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------------------SITQLVKSIL  213 (808)
T ss_pred             e--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------------------HHHHHHHHHh
Confidence            3  456788999999999999999999999999999999999999997522                   2223333222


Q ss_pred             CCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hccCCCCCCCCCCCCC
Q 037160          493 EIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQKDITLPTPSKPPF  543 (569)
Q Consensus       493 ~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~~~~~p~~p~~  543 (569)
                      .+.   +......+..++...|++||..|.|..+++.+  .++.-.-...|..|++
T Consensus       214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~  269 (808)
T KOG0597|consen  214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF  269 (808)
T ss_pred             cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence            222   34566678888889999999999999999954  2333333344444433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=344.04  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=206.2

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeec----ch-hhHHHHHHHHHHHHhcc-ccccceeeeeeeeCC
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS----RK-NRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKK  325 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  325 (569)
                      ...+.|.+.+.||+|+||.|+.|.+. +++.||+|.+...    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34568999999999999999999865 7899999966443    11 23456778999999998 999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-CCeEEeccCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGL  404 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~kl~Dfgl  404 (569)
                      ..++||||+.||+|.+.+.+   .+.+.+.++..++.|++.|++|||+++   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999943   577888999999999999999999999   9999999999999999 9999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ-LT-EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      +.......  ......+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||.......   +.    .     
T Consensus       168 s~~~~~~~--~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~----~-----  233 (370)
T KOG0583|consen  168 SAISPGED--GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LY----R-----  233 (370)
T ss_pred             ccccCCCC--CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HH----H-----
Confidence            99874111  1456789999999999999876 76 78999999999999999999988633221   10    0     


Q ss_pred             chhhhhcccCCCCCHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLEIIDKSIEIEDIEE-VKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~-~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                         .+....... +.-. ...+..++.+|++.+|..|+|+.+|+++
T Consensus       234 ---ki~~~~~~~-p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  234 ---KIRKGEFKI-PSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             ---HHhcCCccC-CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence               011111111 1111 6678889999999999999999999943

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=329.86  Aligned_cols=262  Identities=23%  Similarity=0.349  Sum_probs=208.1

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .+.|++...||.|..++||+|+.. .++.||||++.... ......+.+|+..|+.++||||++++..|..+..+|+||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            357889999999999999999854 67999999997654 3346889999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      ||.+|++.++++..-. ..+++..+..|+.++++||.|||.+|   .||||||+.||||+++|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999965433 34899999999999999999999999   9999999999999999999999999877554433


Q ss_pred             C-CCCC-cccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          413 S-LLPN-TAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       413 ~-~~~~-~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      . .... ..+.||+.|||||++..  ..|+.|+||||||+...||.+|..||....+-..  ++... +.-...  ..  
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tL-qn~pp~--~~--  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTL-QNDPPT--LL--  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHh-cCCCCC--cc--
Confidence            2 1112 46789999999999654  3699999999999999999999999876554321  11100 000000  00  


Q ss_pred             cccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      -..+..+ .......+.+++..||+.||++|||+++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            0011111 22334467889999999999999999999953

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-40  Score=336.77  Aligned_cols=266  Identities=23%  Similarity=0.327  Sum_probs=201.2

Q ss_pred             ccccccccccccCceeEEEEEecC-----------------CceEEEEEEeecc-hhhHHHHHHHHHHHHhcccccccee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQD-----------------GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQF  317 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~  317 (569)
                      ++|.+.++||+|+||.||++.+++                 +..||+|.+.... ......+.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568889999999999999998542                 3369999886542 3345679999999999999999999


Q ss_pred             eeeeeeCCceEEEEeecCCCChhhHhhCCC----------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 037160          318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPK----------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH  381 (569)
Q Consensus       318 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  381 (569)
                      ++++.+....++||||+++++|.+++....                ....+++..++.++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999884321                1234788899999999999999999998   999


Q ss_pred             CCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 037160          382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNK  461 (569)
Q Consensus       382 rDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~  461 (569)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||+++..+..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986544332212233456788999999988899999999999999999998644333


Q ss_pred             CCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          462 FQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      +...... ..+......+...     ........++.....+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       242 ~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDE-QVIENAGEFFRDQ-----GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHH-HHHHHHHHHhhhc-----cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            2221111 1111110000000     0000000122234567889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.7e-40  Score=330.78  Aligned_cols=243  Identities=20%  Similarity=0.280  Sum_probs=196.3

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchh---hHHHHHHHHHHHHhccccccceeeeeeee----CCceEEEEeec
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN---RIKEICNEMDIMSRAHHKNLVQFLGCCFT----KKDSFVVYEFV  334 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  334 (569)
                      ..||+|++|.||+|.+ +|+.||||++......   ..+.+.+|+.+|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 4889999998654332   25678899999999999999999999876    34678999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      ++|+|.+++.   ....+++...+.++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.....  
T Consensus       105 ~~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--  176 (283)
T PHA02988        105 TRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--  176 (283)
T ss_pred             CCCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence            9999999994   345788999999999999999999985 6   889999999999999999999999998865432  


Q ss_pred             CCCCcccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          414 LLPNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                         .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.........   ...            +...
T Consensus       177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~~i------------~~~~  238 (283)
T PHA02988        177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---DLI------------INKN  238 (283)
T ss_pred             ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---HHH------------HhcC
Confidence               123467899999999976  68999999999999999999999998644322111   000            0000


Q ss_pred             CCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          492 IEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       492 l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .... +......+.+++.+||+.+|++|||+.||++.|+..
T Consensus       239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            0001 112344677888999999999999999999999764

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-40  Score=337.35  Aligned_cols=265  Identities=22%  Similarity=0.336  Sum_probs=206.7

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .++|++.++||+|+||.||+++.+ ++..+|+|.+.... ......+.+|+++|++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999976 68889999887643 3345679999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.+++.   ....+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999984   3346889999999999999999999853  3999999999999999999999999998765432 


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh----------------
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW----------------  476 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----------------  476 (569)
                         ......|++.|+|||++.+..++.++|||||||++|||++|+.|+...........+....                
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence               2234568999999999999899999999999999999999999986443322211111000                


Q ss_pred             -----------hhhcccchhhhhcccCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          477 -----------KHFQAKTVLEIIDKSIEI-----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       477 -----------~~~~~~~~~~~~~~~l~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                                 .........+..+.....     ........+.+++.+||+.||++|||+.||+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                       000000011111111100     0112345688899999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.5e-40  Score=332.23  Aligned_cols=256  Identities=23%  Similarity=0.320  Sum_probs=206.2

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ...++|+.+++||+|+||.||+++.+ +|..+|+|++.++.   ..+.+.++.|-.+|....+|+||+++..|.+.+.+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            35689999999999999999999966 68999999998764   456677899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      |||||++||++-.+|   .....|++..+...+.+.+.||.-||+.|   +|||||||+|+|||..|++||+||||+..+
T Consensus       218 LiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence            999999999999999   56788999999999999999999999999   999999999999999999999999998632


Q ss_pred             CCCC--------------------CCCC-------------------------CcccccCCCcccccccccCCCCcccch
Q 037160          409 SSEK--------------------SLLP-------------------------NTAIAGTLGYMAPEYIANGQLTEKVDI  443 (569)
Q Consensus       409 ~~~~--------------------~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~ksDv  443 (569)
                      ....                    ....                         ....+|||.|||||++.+..|+..+|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            2100                    0000                         012479999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCCcch-hhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC--
Q 037160          444 YSFGVLVLEIVSGVQNNKFQSDDGF-ETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPS--  520 (569)
Q Consensus       444 ~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt--  520 (569)
                      ||||||+||||.|.+||....+... ..++.|.          +.+.   .+.......+..+++.+|+. ||+.|--  
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr----------~~l~---fP~~~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR----------ETLK---FPEEVDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh----------hhcc---CCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            9999999999999999987766532 2222222          0000   01111122455566677777 9999965  


Q ss_pred             -HHHHHHHh
Q 037160          521 -MTNVVQML  528 (569)
Q Consensus       521 -~~evl~~L  528 (569)
                       +.||-++-
T Consensus       438 G~~EIK~HP  446 (550)
T KOG0605|consen  438 GAEEIKKHP  446 (550)
T ss_pred             cHHHHhcCC
Confidence             66666543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=345.12  Aligned_cols=265  Identities=31%  Similarity=0.418  Sum_probs=208.8

Q ss_pred             HHHHhccccccccccccCceeEEEEEec--CC--ce-EEEEEEee---cchhhHHHHHHHHHHHHhccccccceeeeeee
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQ--DG--RE-IAVKRLFI---SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF  322 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  322 (569)
                      .+...++-...++||+|.||.||+|.++  ++  .. ||||....   ......+++.+|+++|++++|||||+++|+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3444556666789999999999999976  22  23 89998875   34677889999999999999999999999999


Q ss_pred             eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       323 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                      .++.++||||+|.||+|.++|...  ...++..+++.++.+.|.||+|||+++   +|||||..+|+|+..++.+||+||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence            999999999999999999999532  236999999999999999999999999   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      |+++.-.....  ......-...|+|||.+..+.++.++|||||||++||+++ |..|+......               
T Consensus       307 GLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------------  369 (474)
T KOG0194|consen  307 GLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------------  369 (474)
T ss_pred             ccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---------------
Confidence            99875442111  1112234678999999999999999999999999999999 66665433222               


Q ss_pred             cchhhhh-cccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 037160          482 KTVLEII-DKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTP  538 (569)
Q Consensus       482 ~~~~~~~-~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p  538 (569)
                       .+...+ ..... ..+......+..++..||..+|++||+|.+|.+.|+........+
T Consensus       370 -~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  370 -EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             -HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence             111111 11111 112233445555677999999999999999999998776655543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-41  Score=312.07  Aligned_cols=200  Identities=27%  Similarity=0.415  Sum_probs=183.2

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      -++|+..+.||.|+||.|.+++.+ +|..+|+|++.+..   ..+.+...+|..+|+.+.||+++++++.+.+....++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            357889999999999999999987 68899999997654   34456688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||++||.|..++   ++.+.+++..++-++.+|+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999999   55678999999999999999999999999   99999999999999999999999999997765


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD  465 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~  465 (569)
                           ..-..+||+.|+|||++....+..++|.|+|||++|||+.|.+||....+
T Consensus       197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence                 33478999999999999999999999999999999999999999987665

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=333.31  Aligned_cols=246  Identities=22%  Similarity=0.258  Sum_probs=201.9

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||++..+ +++.||+|++....   ....+.+.+|+.++++++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999976 68999999986542   234466889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999984   3456889999999999999999999998   999999999999999999999999998865432


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.|+.........       ..        +....
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-------~~--------i~~~~  214 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-------EK--------ILAGK  214 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HH--------HHhCC
Confidence                 22456899999999999888999999999999999999999998644322110       00        01111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQML  528 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~L  528 (569)
                      .. .+......+.+++.+||+.||.+||+     +.+++++-
T Consensus       215 ~~-~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         215 LE-FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             cC-CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence            11 01122345778899999999999995     89988664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.9e-40  Score=330.14  Aligned_cols=252  Identities=25%  Similarity=0.320  Sum_probs=201.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .|+..++||+|+||.||++... +|+.||+|.+....   ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677889999999999999865 78999999886542   2233467899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++|+|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998887432 2346889999999999999999999998   9999999999999999999999999998754332


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .   .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+.            ..+....
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~------------~~~~~~~  221 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD------------RRVKEDQ  221 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH------------HHhhccc
Confidence            1   234568999999999999999999999999999999999999987543321111100            0000000


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~  527 (569)
                      ..........+..++..||+.+|++||+     +++++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            0112223456778899999999999997     8888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.8e-40  Score=342.84  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=202.2

Q ss_pred             hccccccccccccCceeEEEEEe------cCCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTL------QDGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  326 (569)
                      .++|++.++||+|+||.||+|..      ..+..||||++.... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45688899999999999999973      245689999886432 33446788999999999 89999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCC----------------------------------------------------------
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQ----------------------------------------------------------  348 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  348 (569)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998853211                                                          


Q ss_pred             --------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          349 --------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       349 --------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                                    ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788999999999999999999998   999999999999999999999999999866543322


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.......  ..    ++.         +.....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~----~~~---------~~~~~~  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KF----YKM---------IKEGYR  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HH----HHH---------HHhCcc
Confidence            12223345678999999999999999999999999999998 777765432211  01    111         111100


Q ss_pred             CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          494 IE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       494 ~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .. +......+.+++.+||+.+|++||++.||+++|+.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            00 11123467789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=339.05  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=204.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|+.. +++.||||++....   ......+.+|++++.+++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999976 58899999987542   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999994   3456889999999999999999999998   99999999999999999999999999976543 


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc-
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK-  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  490 (569)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...........+    ..+.     ..+.. 
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i----~~~~-----~~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL----KYWK-----ETLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH----Hhcc-----ccccCC
Confidence                223557899999999999999999999999999999999999998654332211110    0000     00000 


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ............+.+++..||+.+|++||++.+++++-
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence            00000112345677888899999999999999999763

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6e-40  Score=335.61  Aligned_cols=245  Identities=22%  Similarity=0.297  Sum_probs=200.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++....   ......+.+|+.++++++||||+++++.+...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999976 68899999986542   234467889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999984   3456788899999999999999999998   999999999999999999999999999866432


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||........       +...        ....
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i--------~~~~  231 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKI--------LAGR  231 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHH--------hcCC
Confidence                 2245789999999999999999999999999999999999999864322110       1111        1111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~  527 (569)
                      +.. +......+.+++..||+.||++||+     +.+++.+
T Consensus       232 ~~~-p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 LKF-PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             cCC-CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            110 1112345678899999999999997     7888855

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=338.46  Aligned_cols=240  Identities=29%  Similarity=0.453  Sum_probs=198.8

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCChh
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLD  340 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  340 (569)
                      ++-||+|+.|.||+|+++ ++.||||++..-       -..+|+-|++|+||||+.+.|+|......+||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            456999999999999998 689999976422       225788899999999999999999999999999999999999


Q ss_pred             hHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCccc
Q 037160          341 RILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI  420 (569)
Q Consensus       341 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  420 (569)
                      .+|   +.+..+.......|..+||.||.|||.+.   |||||||.-||||..+..+||+|||.++......   ..-.+
T Consensus       201 ~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSF  271 (904)
T KOG4721|consen  201 EVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSF  271 (904)
T ss_pred             HHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhh
Confidence            999   45677888999999999999999999998   9999999999999999999999999998765542   23468


Q ss_pred             ccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-CHHH
Q 037160          421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEE  499 (569)
Q Consensus       421 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~  499 (569)
                      .||..|||||++++.+.++|+|||||||||||||||..|+.......+      .|.   -      -...+.-. +...
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwG---V------GsNsL~LpvPstc  336 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWG---V------GSNSLHLPVPSTC  336 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EEe---c------cCCcccccCcccC
Confidence            899999999999999999999999999999999999988754322211      110   0      01122222 2334


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          500 VKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       500 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ..-+.-++++||+..|..||++++|+.+|+=..
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            455667889999999999999999999996443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.1e-40  Score=328.90  Aligned_cols=265  Identities=20%  Similarity=0.252  Sum_probs=203.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999986 68899999986542  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |++++.+..+.   .....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99998887655   23456889999999999999999999998   9999999999999999999999999998764432


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--------hhhhcccc-
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT--------WKHFQAKT-  483 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-  483 (569)
                      .. ......|++.|+|||++.+..++.++|||||||++|||++|++||...........+...        +..+.... 
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            21 223457899999999999889999999999999999999999998754322111000000        00000000 


Q ss_pred             hhhhhcccCCC-C------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIEI-E------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~~-~------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......+.... .      .......+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000 0      01123458889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-40  Score=339.64  Aligned_cols=249  Identities=22%  Similarity=0.299  Sum_probs=208.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +-|+.++.||.|+-|.|-+|++. +|+.+|||++....   ......+.+|+-+|+.+.|||++++++++++..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            34778889999999999999976 89999999986542   233456889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|.|.+++   ..++.+.+.++.+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|..-..+
T Consensus        92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            999999999999   56788999999999999999999999999   999999999999999999999999999865443


Q ss_pred             CCCCCCcccccCCCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLT-EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      .   --...+|.+.|.+||++.+.+|+ .++||||+|||||.||+|+.||..   +.+..++.             .+..
T Consensus       166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLl-------------KV~~  226 (786)
T KOG0588|consen  166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLL-------------KVQR  226 (786)
T ss_pred             c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHH-------------HHHc
Confidence            3   23467899999999999999876 589999999999999999999873   33322221             1121


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ..-.-+........+++.+|+..||+.|.|+.||+++.-
T Consensus       227 G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  227 GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            111112333456677888999999999999999998753

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-41  Score=323.02  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=209.6

Q ss_pred             HhccccccccccccCceeEEEEEe-cCCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ...+|++.+.||+|.||.|-++.. ..|+.||||.+.+.   +.+..-.+++|++||..|+||||+.++++|+..+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            345688889999999999999985 68999999988654   44556678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||..+|.|.+++   ..++.+++.++..++.||..|+.|+|.++   ++|||||.+|||||.++++||+||||+.++.
T Consensus       131 vMEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence            99999999999999   45678999999999999999999999998   9999999999999999999999999999887


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLT-EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ...   ..+.++|++.|.+||++.+.+|. +.+|-|||||+||.|+.|.-||.....                ..+...+
T Consensus       205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----------------k~lvrQI  265 (668)
T KOG0611|consen  205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----------------KRLVRQI  265 (668)
T ss_pred             ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----------------HHHHHHh
Confidence            654   33578999999999999998775 789999999999999999888753321                1122222


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ...-.. .++......-++.|||..||++|-|+.+|..++.
T Consensus       266 s~GaYr-EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  266 SRGAYR-EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             hccccc-CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            221111 2222333445677999999999999999998774

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-40  Score=302.76  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=210.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      -++|++.+.||+|-||.||.|+.+ ++.-||+|++.++.   .....++.+|+++-..|+||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            467999999999999999999976 67789999997653   23456799999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      +||..+|+|...|.+ .....+++.....++.|+|.||.|+|.++   ||||||||+|+|++..+.+||+|||.+...+.
T Consensus       101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            999999999999954 34566888889999999999999999998   99999999999999999999999999876553


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      +    .....+||..|.+||+..+...+..+|+|++|++.||++.|.+||+....+.               ....+..-
T Consensus       177 ~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---------------tYkrI~k~  237 (281)
T KOG0580|consen  177 N----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---------------TYKRIRKV  237 (281)
T ss_pred             C----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---------------HHHHHHHc
Confidence            2    4567899999999999999999999999999999999999999987554221               11111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      .+. .+........+++..|+..+|.+|.+..|++.+-
T Consensus       238 ~~~-~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  238 DLK-FPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ccc-CCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            111 1233344567788899999999999999999763

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.7e-40  Score=340.75  Aligned_cols=258  Identities=25%  Similarity=0.385  Sum_probs=202.4

Q ss_pred             hccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  326 (569)
                      .++|++.++||+|+||.||+++..      ++..||+|++.... ......+.+|+.+++.+ +|+||+++++.+.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457999999999999999998842      34579999986543 33456788999999999 89999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCC-----------------------------------------------------------
Q 037160          327 SFVVYEFVQNKSLDRILFDPK-----------------------------------------------------------  347 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~-----------------------------------------------------------  347 (569)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999884321                                                           


Q ss_pred             --------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcc
Q 037160          348 --------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA  419 (569)
Q Consensus       348 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  419 (569)
                              ....+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788899999999999999999998   99999999999999999999999999986544322111223


Q ss_pred             cccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-CH
Q 037160          420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DI  497 (569)
Q Consensus       420 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~  497 (569)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||........               ....+....... +.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---------------~~~~~~~~~~~~~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---------------FYKMVKRGYQMSRPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---------------HHHHHHcccCccCCC
Confidence            345678999999988899999999999999999997 9988764332210               001111111100 11


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          498 EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       498 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .....+.+++..||+.+|++|||+.+|+++|++
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            123567788899999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2e-39  Score=319.61  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=201.6

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|++.++||+|+||.||++.++++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4588889999999999999998888899999876433 234678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++...  ...+++..+..++.+++.||.|||+.+   |+||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999988532  246889999999999999999999998   999999999999999999999999998765433221 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+........   ....    ....        ...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i----~~~~--------~~~  221 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMI----SRGF--------RLY  221 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HCCC--------CCC
Confidence            1123345668999999988889999999999999999999 8888754332111   1111    0000        000


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      .+......+..++.+||+.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            01112346788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.3e-39  Score=323.90  Aligned_cols=256  Identities=30%  Similarity=0.457  Sum_probs=205.8

Q ss_pred             ccccccccccccCceeEEEEEecC-C-----ceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQD-G-----REIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ++|++.+.||+|+||.||+|.... +     ..|++|.+.... ......+.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998652 2     579999886543 334567899999999999999999999999989999


Q ss_pred             EEEeecCCCChhhHhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC
Q 037160          329 VVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH  395 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~  395 (569)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999854221             145888999999999999999999998   99999999999999999


Q ss_pred             CeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHh
Q 037160          396 RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTH  474 (569)
Q Consensus       396 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  474 (569)
                      .+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..|+........      
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence            999999999986544332222334456889999999998899999999999999999998 9888754332211      


Q ss_pred             Hhhhhcccchhhhhcc-cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          475 TWKHFQAKTVLEIIDK-SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       475 ~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                                .+.+.. .....+......+.+++.+||+.+|.+||++.||+++|++
T Consensus       236 ----------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 ----------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ----------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                      111111 1111123345678889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-40  Score=315.77  Aligned_cols=277  Identities=21%  Similarity=0.311  Sum_probs=214.4

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEe--ecchhhHHHHHHHHHHHHhccccccceeeeeeee-----CCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLF--ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT-----KKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~  326 (569)
                      ...|...+.||+|.||.|+.+..+ +|+.||||++.  .......++..+|+.+|++++|+||+.+++.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345566788999999999999976 78999999997  4556677889999999999999999999999865     356


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .|+|+|+| +.+|..++   +..+.++...+..++.||++||.|+|+.+   |+||||||+|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            79999999 78999999   44556999999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh--------h
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW--------K  477 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~  477 (569)
                      ...........+..+.|.+|.|||++.. ..|+...||||.|||+.||++|++-|.....-..-.++....        .
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8865422223367788999999998754 589999999999999999999999887665433333332211        1


Q ss_pred             hhcccchhhhhcccCCCC-------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh--ccCCCCCCCC
Q 037160          478 HFQAKTVLEIIDKSIEIE-------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML--KQKDITLPTP  538 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~-------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L--~~~~~~~~~p  538 (569)
                      ...+..+...+.......       -+......+++..+||..||.+|+|++|.|++-  .........|
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            222222222222211111       112335577888999999999999999999653  3333333444

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.8e-40  Score=334.37  Aligned_cols=242  Identities=21%  Similarity=0.272  Sum_probs=196.3

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      +.||+|+||.||+++.+ +|+.||+|++....   ......+.+|+.++++++||||+++++.+......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999875 78999999987542   334456789999999999999999999999999999999999999


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCC
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN  417 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  417 (569)
                      +|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  152 (323)
T cd05571          81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence            9999884   3457899999999999999999999998   99999999999999999999999999875332211  22


Q ss_pred             cccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCH
Q 037160          418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDI  497 (569)
Q Consensus       418 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  497 (569)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ....            ...... .+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~~------------~~~~~~-~p~  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI------------LMEEIR-FPR  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HHHH------------HcCCCC-CCC
Confidence            356799999999999999999999999999999999999999864322211   0000            000000 112


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          498 EEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       498 ~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      .....+.+++.+||+.+|++||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            2344677888999999999999     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-41  Score=329.69  Aligned_cols=247  Identities=27%  Similarity=0.435  Sum_probs=207.7

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .|...+.||+|.||.||+|... .++.||+|++.... ....+.+..|+.+|.+++++||.++++.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            4666688999999999999965 78899999997653 456788999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      .||++.+.+   .....+++..+.-++.++..||.|||.++   .+|||||+.||||..+|.+||+|||++-....... 
T Consensus        94 ~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-  166 (467)
T KOG0201|consen   94 GGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-  166 (467)
T ss_pred             cCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence            999999999   34445577888889999999999999999   99999999999999999999999999987766544 


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       ....++||+.|||||++....|+.|+||||||++.+||++|.+|+..-.+.                +++-+|-+...+
T Consensus       167 -rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP  229 (467)
T KOG0201|consen  167 -RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPP  229 (467)
T ss_pred             -ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCC
Confidence             336789999999999999889999999999999999999999997654432                111122221111


Q ss_pred             C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          495 E-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       495 ~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      . +....+-+.+++..||..||+.||++.+++++
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            1 22445568889999999999999999999843

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-39  Score=322.15  Aligned_cols=254  Identities=21%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             hccccccccccccCceeEEEEEec----CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|+||.||+|.++    .+..||+|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356889999999999999999754    35689999887543 3334678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999998532  356899999999999999999999998   9999999999999999999999999876543


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ..... ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+........                .+.+
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~----------------~~~~  221 (266)
T cd05064         159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV----------------IKAV  221 (266)
T ss_pred             ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----------------HHHH
Confidence            22211 1112345678999999999999999999999999999775 9888754322211                1111


Q ss_pred             cccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          489 DKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       489 ~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      ..... ..+......+.+++..||+.+|++||++.+|++.|+.
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            11111 1122334567778999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-39  Score=332.39  Aligned_cols=264  Identities=22%  Similarity=0.332  Sum_probs=203.9

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .++|++.++||+|+||.||++.++ ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999977 67889999876542 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.+++.   ....+++..+..++.+++.||.|||+.+  +|+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            999999999984   3346888999999999999999999752  2999999999999999999999999998755332 


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhh-------------
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF-------------  479 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------  479 (569)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.|+...................             
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence               1234568999999999998899999999999999999999999986543322211111000000             


Q ss_pred             ------------cccchhhhhcccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          480 ------------QAKTVLEIIDKSIEIE-----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       480 ------------~~~~~~~~~~~~l~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                                  .......+.+......     .......+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                        0000001111111100     01123457789999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-39  Score=348.19  Aligned_cols=252  Identities=18%  Similarity=0.265  Sum_probs=204.5

Q ss_pred             cccccccccccCceeEEEEEec-C-CceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-D-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+|+.++|||||++++++...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888899999999999999865 4 6788999776665555667889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          335 QNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       335 ~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      ++|+|.+++... .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999888532 23456889999999999999999999998   99999999999999999999999999987655433


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.......   +..            ........
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~------------~~~~~~~~  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ------------QVLYGKYD  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH------------HHHhCCCC
Confidence            223345679999999999999999999999999999999999999985432211   100            00111111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      ..+......+.+++..||+.+|++||++.+++.
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            111223356788899999999999999999874

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.2e-40  Score=310.07  Aligned_cols=297  Identities=23%  Similarity=0.327  Sum_probs=218.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhh--HHHHHHHHHHHHhccccccceeeeeeeeC--CceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  329 (569)
                      -++|+.+++|++|.||.||+|+.+ +++.||+|+++......  --..++|+.+|.+++|||||.+-.+.+..  +..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356889999999999999999976 78899999997654221  23457899999999999999999988754  57899


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      |||||+. +|..++..  -++.+...++..+..|+++|++|||...   |+||||||+|+|++..|.+||+|||+|+.++
T Consensus       155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999954 88888843  3367888999999999999999999999   9999999999999999999999999999888


Q ss_pred             CCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH--------hHhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT--------HTWKHFQ  480 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~  480 (569)
                      +...  ..+..+-|++|.|||.+.+. .|+...|+||+|||+.||+++++-+....+-+.-+.+-        ..|+.+.
T Consensus       229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            7532  45678889999999998875 69999999999999999999998877655433222211        1233222


Q ss_pred             ccchhhhhcc------cCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCC--CCCCccccccc
Q 037160          481 AKTVLEIIDK------SIEIE--DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPS--KPPFTDECMEL  550 (569)
Q Consensus       481 ~~~~~~~~~~------~l~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p~--~p~~~~~~~~~  550 (569)
                      .-.....+..      .+...  .......-..+....|..||.+|-|++|.|++=--...++|.++  -|.|..++...
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~~~  386 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQ  386 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccccc
Confidence            2221111110      00000  00012334556678889999999999999976444443443322  36666655544


Q ss_pred             ccCCCCccc
Q 037160          551 SHTSGFSRR  559 (569)
Q Consensus       551 ~~~~~~~~~  559 (569)
                      ...++...+
T Consensus       387 ~~~~~~~~~  395 (419)
T KOG0663|consen  387 RVKRGTSPR  395 (419)
T ss_pred             cCCCCCCCC
Confidence            444444443

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-40  Score=358.90  Aligned_cols=261  Identities=28%  Similarity=0.438  Sum_probs=209.3

Q ss_pred             hccccccccccccCceeEEEEEec--CCc----eEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ--DGR----EIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      .++-+..+.||+|.||.||.|...  +|.    .||||.+... +.+...+|.+|..+|++++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345566788999999999999865  343    3889988654 456678899999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCC----CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          328 FVVYEFVQNKSLDRILFDPK----QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                      +|++|||++|+|..+|.+.+    ....+...+.+.++.+||+|+.||++++   +|||||..+|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999996542    2456889999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      ||+.....+++.....-.-...|||||.+..+.++.|+|||||||+|||++| |..|+......+.              
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--------------  913 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--------------  913 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--------------
Confidence            9995555444422222233468999999999999999999999999999999 5556553332211              


Q ss_pred             chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                       +........-..+..+..++.+++..||+.+|++||++..|++.+..+..
T Consensus       914 -~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  914 -LLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             -HHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence             11111111112244456677899999999999999999999998876543

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2e-39  Score=330.91  Aligned_cols=242  Identities=23%  Similarity=0.291  Sum_probs=195.4

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      +.||+|+||.||+++.+ +|+.||+|++....   ......+.+|+.++++++||||+++++.+......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36899999999999975 78999999987542   334556788999999999999999999999999999999999999


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCC
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN  417 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  417 (569)
                      +|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~  152 (323)
T cd05595          81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence            9998883   3456899999999999999999999998   99999999999999999999999999875322211  22


Q ss_pred             cccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCH
Q 037160          418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDI  497 (569)
Q Consensus       418 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  497 (569)
                      ....||+.|+|||++.++.++.++|||||||++|||++|+.|+.........   ..            +...... .+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~---~~------------~~~~~~~-~p~  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---EL------------ILMEEIR-FPR  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH---HH------------HhcCCCC-CCC
Confidence            3457899999999999999999999999999999999999998643322110   00            0000000 011


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          498 EEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       498 ~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      .....+.+++..||+.+|++||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            2234567788899999999998     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=336.35  Aligned_cols=240  Identities=26%  Similarity=0.397  Sum_probs=204.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  328 (569)
                      ..++|...++||+|.||.|+++.++ +++.+|||++++..   .+..+....|.+|+... +||.++.++..|.+.++.|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999999987 67899999997653   55677888999998887 5999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+.||++..++    ....+++..+.-++..|+.||.|||+++   ||+||||-+|||||.+|.+||+||||++.-
T Consensus       446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999965444    4567899999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      -....  ....++||+.|||||++.+..|+..+|.|+|||+|||||.|+.||..+.+++.                   +
T Consensus       519 m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-------------------F  577 (694)
T KOG0694|consen  519 MGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-------------------F  577 (694)
T ss_pred             CCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------------------H
Confidence            43222  45689999999999999999999999999999999999999999986655432                   2


Q ss_pred             cccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCH
Q 037160          489 DKSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSM  521 (569)
Q Consensus       489 ~~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~  521 (569)
                      +..+.++   +.-...+.+.|+.+.+..||++|.-+
T Consensus       578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            2222221   33445667788889999999999876

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-39  Score=322.49  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=205.6

Q ss_pred             ccccccccccccCceeEEEEEecC------CceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQD------GREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ++|.+.+.||+|+||.||+|...+      ++.||||.+...... ..+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468888999999999999998643      478999988765443 4578999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCC-----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          329 VVYEFVQNKSLDRILFDPK-----------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                      +||||+++++|.+++....           ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999985432           2345788999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..|+........   .... 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~-  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI-  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH-
Confidence            9999999875543322212233446788999999999999999999999999999998 9888754332211   1100 


Q ss_pred             hhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          477 KHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                         .        ..............+.+++..||+.+|++||++.||++.|++
T Consensus       238 ---~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 ---T--------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ---H--------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence               0        011111122234567789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-40  Score=332.42  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=214.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCc-eEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD-SFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  331 (569)
                      ++|...+++|+|.||.++..+++ +++.+++|.+....  ........+|+.++++++|||||.+.+.|++++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999987 67899999987653  2233467899999999999999999999999988 99999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      +|++||++.+.|...+ +..++++.++.++.|++.|+.|||+..   |+|||||+.||+++.++.+||+|||+|+.....
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999996533 567899999999999999999999887   999999999999999999999999999998876


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..  ......||+.||.||++.+.+|..|+|||||||++|||++-+++|.-.+....               +..+....
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---------------i~ki~~~~  222 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---------------ILKINRGL  222 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---------------HHHHhhcc
Confidence            53  34578899999999999999999999999999999999999998764432211               11222222


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+..+...+..++..|++.+|+.||++.++|.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            233356677788889999999999999999999965

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-39  Score=320.00  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=205.9

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .++|++.++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++.+......+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            357889999999999999999988888999998765432 3568899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++... ....+++..++.++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999998532 3456788999999999999999999998   999999999999999999999999999876543221


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                       ......++..|+|||++.++.++.++||||||+++|||++ |+.|+........   .......+         .   .
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~~---------~---~  223 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQRGY---------R---M  223 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHHcCC---------C---C
Confidence             2223345678999999998899999999999999999998 8888754332211   11100000         0   0


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .........+.+++.+||+.+|++||++++|++.|++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0111223467789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=301.72  Aligned_cols=262  Identities=22%  Similarity=0.297  Sum_probs=211.1

Q ss_pred             hccccccccccccCceeEEEEE-ecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCC-----ceE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-----DSF  328 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  328 (569)
                      .++|.+.++||+|||+-||+++ ..+++.+|+|++...+.+..+..++|++..++++|||+++++++...+.     +.|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4689999999999999999998 4478999999999888888899999999999999999999998876543     489


Q ss_pred             EEEeecCCCChhhHhhCCCC-CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          329 VVYEFVQNKSLDRILFDPKQ-KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      |+++|...|+|.+.+..... +..+++.++++|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            99999999999999855443 347999999999999999999999986 4799999999999999999999999999875


Q ss_pred             cCCCCCCC-------CCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          408 SSSEKSLL-------PNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       408 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      ..-.-...       .......|..|.|||.+.   +...++++|||||||+||+|+.|..||+...+.+.. +      
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-l------  251 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-L------  251 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-E------
Confidence            43221110       001235789999999874   446889999999999999999999998754332111 0      


Q ss_pred             hhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          478 HFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                            ...+....+.. +.......+.+++.+|++.+|.+||++.+++..+..
T Consensus       252 ------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  252 ------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             ------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                  01111112222 133367788999999999999999999999998865

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-39  Score=336.68  Aligned_cols=259  Identities=21%  Similarity=0.233  Sum_probs=196.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|++.++||+|+||.||++... .++.||+|...      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999975 68899999642      23567899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +. ++|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            95 67877773   3456889999999999999999999998   99999999999999999999999999975433211


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCc--------chhhhhHhHh---hhhc--
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD--------GFETLVTHTW---KHFQ--  480 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~--------~~~~~~~~~~---~~~~--  480 (569)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.|+......        ....++....   ..+.  
T Consensus       238 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 N-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             c-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            1 223567999999999999999999999999999999999999876432211        0000110000   0000  


Q ss_pred             -ccchhhhh----cc-cCC----CC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          481 -AKTVLEII----DK-SIE----IE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       481 -~~~~~~~~----~~-~l~----~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ...+.+..    .. ...    ..   .......+..++.+||+.||++|||+.|++++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             00000000    00 000    00   11233467789999999999999999999964

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.6e-39  Score=322.71  Aligned_cols=259  Identities=23%  Similarity=0.358  Sum_probs=202.6

Q ss_pred             HhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      .+++|++.++||+|+||.||+|.++      .+..||+|++.... .....++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999753      24679999875432 2344578899999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCC-------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEE
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQ-------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI  399 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  399 (569)
                      .++||||+++++|.+++.....       ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999854221       234678889999999999999999998   999999999999999999999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhh
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      +|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+.......   ...    .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~----~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLR----F  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----H
Confidence            99999876544332212223345778999999998899999999999999999999 677765332211   110    0


Q ss_pred             hcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .        ........+......+.+++.+||+.+|++|||+.|++++|++
T Consensus       234 ~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 V--------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             H--------HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            0        0111111112233467789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-39  Score=318.66  Aligned_cols=255  Identities=25%  Similarity=0.372  Sum_probs=205.7

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ..++|++.++||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++......+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            346789999999999999999998878899999886543 2356788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++.... ...+++..+..++.+++.||.+||+.+   |+||||||+||++++++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999985422 346899999999999999999999998   99999999999999999999999999987653221


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      . .......+..|+|||++.+..++.++||||||+++|||++ |+.|+.......   +.             ..++...
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-------------~~~~~~~  221 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VL-------------QQVDQGY  221 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH-------------HHHHcCC
Confidence            1 1122233468999999998899999999999999999999 888875332111   10             0111111


Q ss_pred             C-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          493 E-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       493 ~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      . .........+.+++.+|++.+|++||++.+|++.|++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0 0122334567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-39  Score=332.35  Aligned_cols=246  Identities=23%  Similarity=0.287  Sum_probs=200.6

Q ss_pred             hccccccccccccCceeEEEEEecC--CceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQD--GREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|+||.||+|.+++  +..||+|++....   ......+.+|+.+++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568999999999999999998653  3689999886532   2345678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++|+|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999984   3456889999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........       +..        +..
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~--------i~~  242 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQK--------ILE  242 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHH--------Hhc
Confidence            32     2345799999999999988899999999999999999999999864432211       011        111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      .... .+......+..++.+|++.+|++|+     ++.+++++
T Consensus       243 ~~~~-~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        243 GIIY-FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCC-CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1110 0111234567788999999999995     89999876

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.6e-39  Score=326.15  Aligned_cols=264  Identities=20%  Similarity=0.305  Sum_probs=199.8

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.++||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46889999999999999999876 68899999886543 22345678999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 88888742  2345788999999999999999999998   99999999999999999999999999876543221


Q ss_pred             CCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhhhhccc-c
Q 037160          414 LLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWKHFQAK-T  483 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~-~  483 (569)
                        ......+++.|+|||.+.+ ..++.++|||||||++|||++|++||...........+..        .|...... .
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence              2234567899999998865 4689999999999999999999999865443322111111        11111100 0


Q ss_pred             hhhhhcccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIEIE-----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......+.....     .+.......+++.+||+.||.+|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000000000     11123456789999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-39  Score=332.10  Aligned_cols=264  Identities=21%  Similarity=0.318  Sum_probs=197.0

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC-----CceE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----KDSF  328 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  328 (569)
                      +|++.++||+|+||.||+|+.. +|+.||||++...  .......+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999975 7899999988643  223345688999999999999999999988643     2479


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68888883   3456899999999999999999999998   999999999999999999999999999854


Q ss_pred             CCCCCC-CCCcccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhh
Q 037160          409 SSEKSL-LPNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWK  477 (569)
Q Consensus       409 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~  477 (569)
                      ...... .......||+.|+|||++.+  ..++.++|||||||++|||++|++||...........+..        .+.
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            332211 11234578999999999866  6789999999999999999999999865432211111100        000


Q ss_pred             hhcccchhhhhccc---CCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          478 HFQAKTVLEIIDKS---IEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       478 ~~~~~~~~~~~~~~---l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ........+.+...   ....    .+.....+.+++..||+.+|++|||+.|++++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            01111111111110   0000    01123456789999999999999999999965

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4e-39  Score=323.78  Aligned_cols=260  Identities=25%  Similarity=0.343  Sum_probs=208.8

Q ss_pred             ccccccccccccCceeEEEEEec------CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .+|.+.+.||+|+||.||++...      ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999743      345689998876666666789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC
Q 037160          330 VYEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR  396 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  396 (569)
                      ||||+++++|.+++....             ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985422             2345889999999999999999999998   999999999999999999


Q ss_pred             eEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhH
Q 037160          397 PKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       397 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  475 (569)
                      ++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.|+.......   .    
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~----  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V----  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----
Confidence            99999999976544332212234456788999999999999999999999999999999 888875433221   1    


Q ss_pred             hhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          476 WKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                      ++....+.        ...........+.+++.+||+.+|++||++.+|+++|+....
T Consensus       235 ~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGR--------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCC--------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11111111        101112234567889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.8e-39  Score=330.47  Aligned_cols=242  Identities=22%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      +.||+|+||.||+++.+ +|+.||+|++...   .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999975 6899999998654   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCC
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN  417 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  417 (569)
                      +|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~  152 (328)
T cd05593          81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM  152 (328)
T ss_pred             CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence            9998884   3456899999999999999999999998   99999999999999999999999999875432211  22


Q ss_pred             cccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCH
Q 037160          418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDI  497 (569)
Q Consensus       418 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  497 (569)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........   .            ..... ..+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~---~------------~~~~~-~~p~  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---I------------LMEDI-KFPR  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH---h------------ccCCc-cCCC
Confidence            345799999999999998999999999999999999999999864332211000   0            00000 0011


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          498 EEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       498 ~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      .....+.+++.+||+.+|++||     ++.|++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2334577788999999999997     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.1e-39  Score=318.12  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=210.6

Q ss_pred             HHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ....+|++.++||.|+||.||+|...+++.+++|.+..........+.+|+.+++.++|+||+++++++......++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567899999999999999999988899999999877666566789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.+++... ....+++..++.++.+++.||.|||+.+   |+||||||+||++++++.+||+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999999543 3456899999999999999999999998   9999999999999999999999999998664432


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .  ......++..|+|||.+.++.++.++||||||+++|+|++ |+.|+........   ...             +...
T Consensus       159 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~-------------~~~~  220 (261)
T cd05148         159 Y--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQ-------------ITAG  220 (261)
T ss_pred             c--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHH-------------HHhC
Confidence            2  1223345678999999988899999999999999999998 7888754332111   110             0011


Q ss_pred             CC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          492 IE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       492 l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .. .........+.+++.+||+.+|++|||+.++++.|+.
T Consensus       221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            00 1122334567789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.5e-39  Score=331.82  Aligned_cols=248  Identities=27%  Similarity=0.379  Sum_probs=195.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|+..++||+|+||.||++++. +++.||||++.... ......+.+|++++++++|+||+++++++......++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999976 68999999986543 33446789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|....       ...+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986532       3456778889999999999999998   99999999999999999999999999986644321


Q ss_pred             CCCCcccccCCCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          414 LLPNTAIAGTLGYMAPEYIAN-----GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                        ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+....            .
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------------~  289 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI------------C  289 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH------------h
Confidence              2234578999999998743     23456899999999999999999998743332221111100            0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..............+.+++.+||+.+|++|||+.||+++
T Consensus       290 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000001122334567889999999999999999999976

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.8e-39  Score=321.62  Aligned_cols=259  Identities=25%  Similarity=0.367  Sum_probs=206.3

Q ss_pred             ccccccccccccCceeEEEEEec------CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888999999999999999742      345689998876666666789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCC----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEE
Q 037160          330 VYEFVQNKSLDRILFDPK----------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI  399 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  399 (569)
                      ||||+++++|.+++....          ....+++..++.++.|++.+|.|||+.+   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999985322          2235899999999999999999999998   999999999999999999999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhh
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      +|||+++...............++..|+|||++.+..++.++||||||+++|||++ |.+|+........   .    ..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~----~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I----EC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HH
Confidence            99999986544322212223445778999999998899999999999999999998 8888653332111   0    00


Q ss_pred             hcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ...+.        ...........+.+++.+||+.+|.+|||+.||++.|+...
T Consensus       235 i~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         235 ITQGR--------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHcCC--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            01110        00011122346788999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=336.44  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=204.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+++.. +|+.||||++....   ......+.+|++++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999976 78999999987542   244567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999843   367899999999999999999999998   999999999999999999999999999866543


Q ss_pred             C---------------------------CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 037160          412 K---------------------------SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQS  464 (569)
Q Consensus       412 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~  464 (569)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            3                           0011234568999999999999999999999999999999999999986544


Q ss_pred             CcchhhhhHhHhhhhcccchhhhhc--ccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHh
Q 037160          465 DDGFETLVTHTWKHFQAKTVLEIID--KSIEI-EDIEEVKRVVWVGLLCTQELPTLRPS-MTNVVQML  528 (569)
Q Consensus       465 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt-~~evl~~L  528 (569)
                      .....       .        .+..  ..+.. ........+..++..|++ +|.+||+ +.+++++.
T Consensus       235 ~~~~~-------~--------~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         235 LQETY-------N--------KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             HHHHH-------H--------HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            22110       0        0000  00110 111134567778889997 9999999 99999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6e-39  Score=316.32  Aligned_cols=252  Identities=22%  Similarity=0.359  Sum_probs=202.1

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|.+.+.||+|+||.||++...++..+|+|.+..... ....+.+|+.++++++||||+++++++......+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            45788899999999999999988777899998764432 34678999999999999999999999998889999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999998532  236899999999999999999999998   999999999999999999999999998765443221 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.........       ..        +.......
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~--------~~~~~~~~  221 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV-------EK--------VSQGLRLY  221 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HH--------HhcCCCCC
Confidence            1122345678999999988889999999999999999998 88887543322110       00        00100001


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ........+.+++.+||+.+|.+||++.+|++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11123467788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3e-39  Score=346.50  Aligned_cols=260  Identities=20%  Similarity=0.249  Sum_probs=206.6

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCC-
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-  325 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  325 (569)
                      +.+...++|.+.++||+|+||.||+++.. +|+.||||++...  .......+.+|+.++..++|+||+++...+.... 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            34455678999999999999999999865 7899999998654  2344567889999999999999999887765432 


Q ss_pred             -------ceEEEEeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          326 -------DSFVVYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       326 -------~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                             ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence                   357999999999999998542 23456889999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      ||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..    .
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~----~  255 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VM----H  255 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HH----H
Confidence            9999999987654332223345679999999999999999999999999999999999999986432211   10    0


Q ss_pred             hhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          478 HFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                              ..+.......+......+..++..||+.+|.+||++.+++++
T Consensus       256 --------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 --------KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --------HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                    011111111122334567789999999999999999999865

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=328.06  Aligned_cols=240  Identities=20%  Similarity=0.322  Sum_probs=193.2

Q ss_pred             ccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          264 LGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ||+|+||.||+++.. +++.||+|++...   .......+.+|+.++++++||||+++++.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999976 6889999998653   233456788999999999999999999999999999999999999999


Q ss_pred             hhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcc
Q 037160          340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA  419 (569)
Q Consensus       340 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  419 (569)
                      .+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~  152 (312)
T cd05585          81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT  152 (312)
T ss_pred             HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence            99984   3456899999999999999999999998   99999999999999999999999999875433221  2235


Q ss_pred             cccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHH
Q 037160          420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE  499 (569)
Q Consensus       420 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  499 (569)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..    .        ........ .+...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~----~--------~~~~~~~~-~~~~~  216 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MY----R--------KILQEPLR-FPDGF  216 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HH----H--------HHHcCCCC-CCCcC
Confidence            679999999999999999999999999999999999999986432211   10    0        01111111 11223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 037160          500 VKRVVWVGLLCTQELPTLRPS---MTNVVQM  527 (569)
Q Consensus       500 ~~~~~~l~~~Cl~~~P~~RPt---~~evl~~  527 (569)
                      ...+.+++..||+.+|++||+   +.|++.+
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            345677889999999999985   5666644

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.6e-39  Score=335.46  Aligned_cols=261  Identities=25%  Similarity=0.368  Sum_probs=204.8

Q ss_pred             HHhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhcc-ccccceeeeeeeeC
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTK  324 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  324 (569)
                      .-.++|.+.++||+|+||.||+|.+.      .+..||||++.... ....+.+.+|+++|+++. ||||+++++++.+.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            33567889999999999999999853      23479999986543 333467899999999996 99999999999999


Q ss_pred             CceEEEEeecCCCChhhHhhCCC---------------------------------------------------------
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPK---------------------------------------------------------  347 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  347 (569)
                      ...++||||+++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999998874321                                                         


Q ss_pred             ------------------------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          348 ------------------------------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       348 ------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                                                          ....+++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                                0124788889999999999999999998   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~  470 (569)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+........  
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence            9999999999999986644332222334456788999999998899999999999999999997 8888754322110  


Q ss_pred             hhHhHhhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                          .+..         +...... ........+.+++.+||+.+|++||++.+|.++|+..
T Consensus       349 ----~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         349 ----FYNK---------IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             ----HHHH---------HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence                0010         0000000 1122345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.9e-39  Score=327.64  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=194.6

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHH---HhccccccceeeeeeeeCCceEEE
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIM---SRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      |++.++||+|+||.||++..+ +++.||||++....   ....+.+.+|++++   ++++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667889999999999999876 68999999987542   23345666776665   456899999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|...+.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988873    346899999999999999999999998   99999999999999999999999999875332


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...  ......|++.|+|||++.+..++.++|||||||++|||++|+.|+.........       ..        +...
T Consensus       154 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~-------~~--------i~~~  216 (324)
T cd05589         154 FGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF-------DS--------IVND  216 (324)
T ss_pred             CCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH-------HH--------HHhC
Confidence            221  223567899999999999999999999999999999999999998644322110       00        0000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      ... .+......+.+++.+||+.+|.+||     ++.+++++
T Consensus       217 ~~~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         217 EVR-YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCC-CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            000 1112234567889999999999999     57777764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.7e-39  Score=316.39  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=203.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .+|++.++||+|+||.||+|..+ .++.|++|.+... ......+.+|++++++++|+||+++++++......+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999976 5889999987644 334567899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999998532 3456899999999999999999999998   999999999999999999999999999866543221


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |..|+........       +...         .....
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~---------~~~~~  223 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELL---------EKGYR  223 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHH---------HCCCC
Confidence             1122334678999999998999999999999999999998 8888754322111       1111         11111


Q ss_pred             CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          494 IE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       494 ~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .. +......+.+++.+||+.+|++||++.+++++|+.
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            11 12233567778899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9e-39  Score=319.93  Aligned_cols=271  Identities=22%  Similarity=0.400  Sum_probs=203.7

Q ss_pred             ccccccccccccCceeEEEEEec-----CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee--CCceE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-----DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT--KKDSF  328 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~  328 (569)
                      +.|++.+.||+|+||.||++..+     +++.||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888899999999999999742     578999999877666667789999999999999999999998754  34678


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999999843  2346899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ....... ......++..|+|||++.+..++.++||||||+++|||++|..++.......................+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            5433211 111223445699999999889999999999999999999987664322111000000000000000111122


Q ss_pred             hcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          488 IDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       488 ~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      +...... ........+.+++.+||+.+|++|||+.||++.|+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            2211111 1222345688899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=344.09  Aligned_cols=258  Identities=21%  Similarity=0.315  Sum_probs=211.1

Q ss_pred             HHHhccccccccccccCceeEEEEEecCC-ceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeee-eee-----
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQDG-REIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGC-CFT-----  323 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~-----  323 (569)
                      +....+.++.+.|.+|||+.||.++...+ .+||+|++...+....+.+++|+++|++|+ |+|||.+++. ...     
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34456678889999999999999998755 999999999888899999999999999996 9999999993 321     


Q ss_pred             -CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          324 -KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       324 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                       .-+.+|.||||.||.|-+++....... |++.++++|+.++++|+.+||... ++|||||||-+||||..+|+.|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence             135689999999999999996544444 999999999999999999999985 78999999999999999999999999


Q ss_pred             CCCcccCCCCCCCC-------CcccccCCCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhh
Q 037160          403 GLARFSSSEKSLLP-------NTAIAGTLGYMAPEYI---ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV  472 (569)
Q Consensus       403 gla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~  472 (569)
                      |.+...-..-....       .-...-|+.|.|||++   .+...++|+|||+|||+||-|.....||+....       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            99864322211000       0023468999999987   566899999999999999999999999875422       


Q ss_pred             HhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          473 THTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                                  ..++....... .+....++..||..||+.||.+||++.+|++.+-.
T Consensus       264 ------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  264 ------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                        12333333333 36788889999999999999999999999987753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=318.24  Aligned_cols=257  Identities=23%  Similarity=0.319  Sum_probs=205.7

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch--------------hhHHHHHHHHHHHHhcccccccee
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--------------NRIKEICNEMDIMSRAHHKNLVQF  317 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~  317 (569)
                      +.-++|++.+.||+|.||.|-+|+.. +++.||||++.+...              ...+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            44578999999999999999999976 789999999854321              124578899999999999999999


Q ss_pred             eeeeee--CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC
Q 037160          318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH  395 (569)
Q Consensus       318 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~  395 (569)
                      +++..+  .+..|||+|||..|.+...-   ..+..++..+++.++..+..||+|||.++   ||||||||+|+||+++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            999865  46789999999999886533   22233899999999999999999999999   99999999999999999


Q ss_pred             CeEEeccCCCcccCCCCCCC---CCcccccCCCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 037160          396 RPKIADFGLARFSSSEKSLL---PNTAIAGTLGYMAPEYIANGQ----LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF  468 (569)
Q Consensus       396 ~~kl~Dfgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~SlGvil~elltg~~p~~~~~~~~~  468 (569)
                      ++||+|||.+..+.......   ......||+.|+|||...++.    -+.+.||||+||.||-|+.|+.||.....-  
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--  325 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--  325 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence            99999999998775442211   112468999999999987743    346889999999999999999997533211  


Q ss_pred             hhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          469 ETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       469 ~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                                   .....++...+... .++....+..+++++|.+||+.|.++.+|..+..-
T Consensus       326 -------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  326 -------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             -------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence                         11223333344333 45566777889999999999999999999987643

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.6e-39  Score=326.68  Aligned_cols=255  Identities=23%  Similarity=0.364  Sum_probs=201.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCc----eEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGR----EIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .+|++.+.||+|+||.||+|++. +++    .||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999864 343    38999886543 34456789999999999999999999998764 5789


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ++||+++|+|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            9999999999999853  2345889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ............++..|+|||++.+..++.++||||||+++|||++ |..|+.........                ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~----------------~~~  224 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------------SIL  224 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH----------------HHH
Confidence            4432212223334678999999999999999999999999999998 88887543222111                111


Q ss_pred             cccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          489 DKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       489 ~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ..... ..+......+..++..||+.+|++||++.+|+..|....
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         225 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11110 111223346778999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.7e-39  Score=327.87  Aligned_cols=259  Identities=27%  Similarity=0.400  Sum_probs=202.4

Q ss_pred             hccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeC-C
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK-K  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~  325 (569)
                      .++|++.++||+|+||.||+|+..      .++.||+|++.... ....+.+..|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999742      24789999886432 33446788899999999 899999999988654 5


Q ss_pred             ceEEEEeecCCCChhhHhhCCCC---------------------------------------------------------
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQ---------------------------------------------------------  348 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  348 (569)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999998843211                                                         


Q ss_pred             -CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcc
Q 037160          349 -KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM  427 (569)
Q Consensus       349 -~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  427 (569)
                       ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             136889999999999999999999998   9999999999999999999999999998764433222223445677899


Q ss_pred             cccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC-CCCHHHHHHHHH
Q 037160          428 APEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE-IEDIEEVKRVVW  505 (569)
Q Consensus       428 aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~  505 (569)
                      |||++.+..++.++|||||||++|||++ |..|+........  +             ...+..... ..+......+.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~-------------~~~~~~~~~~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F-------------CRRLKEGTRMRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H-------------HHHHhccCCCCCCccCCHHHHH
Confidence            9999999999999999999999999998 9888754322110  0             001111000 011223456788


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          506 VGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       506 l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ++.+||+.+|++||++.||+++|+..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=315.68  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=203.5

Q ss_pred             ccccccccccccCceeEEEEEecC----CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQD----GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|++.+.||+|+||.||+|.++.    ...||||.+.... ......+.+|+.++++++||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578899999999999999998752    3578999886543 33446788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999853  2347899999999999999999999998   99999999999999999999999999987753


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..|+.........       ....        +
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~--------~  223 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-------KAVE--------D  223 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-------HHHH--------c
Confidence            222111223345678999999998899999999999999999998 88886433221110       0000        0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .............+.+++.+||+.+|++||++.||+++|+.
T Consensus       224 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         224 GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            00001112234567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-39  Score=321.17  Aligned_cols=250  Identities=30%  Similarity=0.489  Sum_probs=192.0

Q ss_pred             ccccccccCceeEEEEEec-----CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          260 ESNKLGHGGYGEIFKGTLQ-----DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +.+.||.|.||.||+|.+.     .+..|+||.+.... ....+.+.+|++.+++++||||+++++++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4568999999999999876     35789999995532 33468899999999999999999999999988889999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++|+|.++|... ....+++..++.|+.||++||.|||+.+   ++|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999543 3467899999999999999999999998   99999999999999999999999999987633322


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      ............|+|||.+....++.++||||||+++|||++ |+.|+.......   +..            .+.+...
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~------------~~~~~~~  223 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIE------------KLKQGQR  223 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHH------------HHHTTEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc------------ccccccc
Confidence            222234456788999999999999999999999999999999 666654332111   110            0101111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ...+......+..++..||..+|++||++.+|++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            111222345677899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=319.90  Aligned_cols=252  Identities=24%  Similarity=0.316  Sum_probs=201.9

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      +|++.++||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+..+...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999975 68999999986532   2223457789999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999888532 3356899999999999999999999998   9999999999999999999999999998654332


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .   .....|++.|+|||++.+..++.++||||||+++|||++|+.||.........       .     .+...+....
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-------~-----~~~~~~~~~~  221 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------E-----EVERRVKEDQ  221 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-------H-----HHHHHhhhcc
Confidence            1   23456899999999999889999999999999999999999998643321110       0     0011111111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      ..........+..++..||+.||++||     ++.+++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            111223445677899999999999999     88899865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-38  Score=319.15  Aligned_cols=256  Identities=29%  Similarity=0.406  Sum_probs=202.4

Q ss_pred             ccccccccccccCceeEEEEEe-----cCCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTL-----QDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|++.++||+|+||.||+|..     ..+..+++|.+.... ......+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4578889999999999999984     245789999886433 3445678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCC--------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC
Q 037160          330 VYEFVQNKSLDRILFDPK--------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH  395 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~  395 (569)
                      ||||+++++|.+++....              ....+++..++.++.+++.||.|||+++   |+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999984321              1235788999999999999999999998   99999999999999999


Q ss_pred             CeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHh
Q 037160          396 RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTH  474 (569)
Q Consensus       396 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  474 (569)
                      .+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+........      
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~------  235 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV------  235 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence            999999999986644332222234446778999999988889999999999999999998 8877653322111      


Q ss_pred             HhhhhcccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          475 TWKHFQAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       475 ~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                                .+.+..... .........+.+++..||+.+|++||++.+|+++|..
T Consensus       236 ----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 ----------IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                      111111000 0111223567778899999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.9e-39  Score=333.59  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=195.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .|++.++||+|+||.||+|+.. +++.||||++....   ......+.+|++++++++||||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999865 68899999986542   3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999984   3456888899999999999999999998   9999999999999999999999999976432110


Q ss_pred             CC---------------------------------------------CCCcccccCCCcccccccccCCCCcccchhhHH
Q 037160          413 SL---------------------------------------------LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFG  447 (569)
Q Consensus       413 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlG  447 (569)
                      ..                                             .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00                                             001235799999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHH--hcCCCCCCCCCHHHH
Q 037160          448 VLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLL--CTQELPTLRPSMTNV  524 (569)
Q Consensus       448 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~--Cl~~~P~~RPt~~ev  524 (569)
                      |++|||++|+.||...........+ ..|            ...+... .......+.+++.+  |+..+|..||++.||
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i-~~~------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKV-INW------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHH-Hcc------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999998754332111000 000            0000000 11122344445544  667777789999999


Q ss_pred             HHH
Q 037160          525 VQM  527 (569)
Q Consensus       525 l~~  527 (569)
                      +.+
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.9e-39  Score=332.18  Aligned_cols=252  Identities=22%  Similarity=0.268  Sum_probs=200.8

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+++.+ +|+.||+|++....   ....+.+.+|+.+++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999976 78999999987542   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998532  356899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCCCcccccCCCcccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIA------NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      ... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........       +.....    
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~----  223 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------YNNIMN----  223 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------HHHHHc----
Confidence            322 223457899999999986      45678999999999999999999999864332211       000000    


Q ss_pred             hhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          486 EIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       486 ~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       . ...+. ...+.....+..++..|++ +|++||++.+++.+
T Consensus       224 -~-~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         224 -F-QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -C-CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence             0 00011 1112234456677788997 99999999999964

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9.5e-39  Score=322.99  Aligned_cols=263  Identities=22%  Similarity=0.353  Sum_probs=197.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .++|++.++||+|+||.||+|+.+ +++.||||++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999976 789999999865432 223457789999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+. ++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 567666632  3356888999999999999999999998   9999999999999999999999999987543322


Q ss_pred             CCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh--------hhcccc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK--------HFQAKT  483 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~  483 (569)
                      .  ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....+..  ..+.....        .|....
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence            1  2234568899999999865 458899999999999999999999987543211  11110000        000000


Q ss_pred             hhhhhc-ccC---CCCCH-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIID-KSI---EIEDI-------EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~-~~l---~~~~~-------~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...... ...   .....       .....+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            000000 000   00000       112356678899999999999999999964

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.1e-39  Score=328.74  Aligned_cols=252  Identities=24%  Similarity=0.325  Sum_probs=198.6

Q ss_pred             cccccccccccCceeEEEEEec----CCceEEEEEEeecc----hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCce
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFISR----KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  327 (569)
                      +|++.++||+|+||.||+++..    +++.||+|++....    ....+.+.+|+.++.++ +|+||+++++.+......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999998753    57899999986432    23345678899999999 599999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++++|.+++.   .+..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999984   3456889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.   ...     ..
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~---~~~-----~~  225 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS---RRI-----LK  225 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH---HHH-----hc
Confidence            5443222 22346799999999998765 47889999999999999999999986443321111110   000     00


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                       .+..+   .......+.+++.+||+.+|++||     ++.+++++
T Consensus       226 -~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 -CDPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             -CCCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence             01111   112334567788999999999999     78888865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2e-38  Score=311.66  Aligned_cols=247  Identities=28%  Similarity=0.420  Sum_probs=195.7

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ++||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999975 78999999875432 33456789999999999999999999999999999999999999999


Q ss_pred             hhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcc
Q 037160          340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA  419 (569)
Q Consensus       340 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  419 (569)
                      .+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999843  2346889999999999999999999998   99999999999999999999999999876543221111112


Q ss_pred             cccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-CH
Q 037160          420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DI  497 (569)
Q Consensus       420 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~  497 (569)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+........                ...+....... ..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~----------------~~~~~~~~~~~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----------------REAIEQGVRLPCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH----------------HHHHHcCCCCCCcc
Confidence            223467999999999999999999999999999998 7777643222111                11111111111 22


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          498 EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       498 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      .....+.+++.+||+.+|++|||+.+|+++|+
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            23456788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.1e-39  Score=332.22  Aligned_cols=203  Identities=26%  Similarity=0.398  Sum_probs=175.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||++... +++.||+|++....   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999876 68899999986532   233456889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++.   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999984   3457899999999999999999999998   999999999999999999999999998754321


Q ss_pred             CCC---------------------------------CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 037160          412 KSL---------------------------------LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQ  458 (569)
Q Consensus       412 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~  458 (569)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 037160          459 NNKFQS  464 (569)
Q Consensus       459 p~~~~~  464 (569)
                      ||....
T Consensus       235 Pf~~~~  240 (363)
T cd05628         235 PFCSET  240 (363)
T ss_pred             CCCCCC
Confidence            986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-38  Score=325.38  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=194.5

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      +.||+|+||.||+++.+ +++.||+|++...   .......+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 6789999998754   233445678899988877 899999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~  152 (329)
T cd05618          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence            99988883   3456899999999999999999999998   99999999999999999999999999875332211  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch--hhhhHhHhhhhcccchhhhhcccCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF--ETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||........  .....+.+...        ...... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~~~~~-  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEKQIR-  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--------hcCCCC-
Confidence            2346789999999999999999999999999999999999999853221110  00011111111        111111 


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPS------MTNVVQM  527 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt------~~evl~~  527 (569)
                      .+......+..++.+||+.+|++||+      +.+++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            12223455678889999999999998      5677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-38  Score=324.87  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=194.6

Q ss_pred             ccccccCceeEEEEEec----CCceEEEEEEeecc----hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQ----DGREIAVKRLFISR----KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++||+|+||.||+++..    .++.||+|++....    ......+.+|+.+|+.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999852    57899999986532    22345678999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++.   ....+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999883   3456788888999999999999999998   99999999999999999999999999875433222


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||........               ...+......
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---------------~~~~~~~~~~  218 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---------------IDKILKGKLN  218 (323)
T ss_pred             --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---------------HHHHHcCCCC
Confidence              22345799999999999988899999999999999999999999864332110               0011111111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                       .+......+.+++.+||+.+|++||     ++.+++++
T Consensus       219 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         219 -LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             1112234577888999999999999     88888864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-38  Score=323.38  Aligned_cols=241  Identities=26%  Similarity=0.348  Sum_probs=190.1

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+|+.+ +++.||+|++....   ....+.+..|..++..+ +||||+++++.+......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 57889999987542   23344556677777654 899999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~  152 (316)
T cd05592          81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence            99999884   3356889999999999999999999998   99999999999999999999999999975433221  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...             +.......+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~---~~~-------------i~~~~~~~~  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL---FDS-------------ILNDRPHFP  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH---HHH-------------HHcCCCCCC
Confidence            3356799999999999998999999999999999999999999864432211   000             000000011


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSMT-NVVQ  526 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~  526 (569)
                      ......+.+++..||+.+|++||++. ++++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            12234566788899999999999976 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-38  Score=317.95  Aligned_cols=266  Identities=23%  Similarity=0.407  Sum_probs=203.2

Q ss_pred             ccccccccccCceeEEEEEe-----cCCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeC--CceEE
Q 037160          258 FDESNKLGHGGYGEIFKGTL-----QDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSFV  329 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  329 (569)
                      |++.+.||+|+||.||++..     .+++.||+|.+.... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     357889999886543 23456788999999999999999999987654  35789


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      +|||+++++|.+++..    ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999842    35899999999999999999999998   9999999999999999999999999998665


Q ss_pred             CCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ................+.+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhh
Confidence            432211 112234566799999998889999999999999999999999887543221 111111111111122222222


Q ss_pred             cccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          489 DKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       489 ~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      +...... +......+.+++..||+.+|++|||+++|++.|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            2222211 222345788899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-38  Score=318.94  Aligned_cols=264  Identities=23%  Similarity=0.328  Sum_probs=195.1

Q ss_pred             ccccccccccccCceeEEEEEec--CCceEEEEEEeecc--hhhHHHHHHHHHHHHhc---cccccceeeeeee-----e
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ--DGREIAVKRLFISR--KNRIKEICNEMDIMSRA---HHKNLVQFLGCCF-----T  323 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~  323 (569)
                      ++|++.++||+|+||.||+|+..  +++.||+|++....  ......+.+|+.+++++   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  46889999886543  22234566788777766   6999999999885     2


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                      ....++||||+. ++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999996 5888888432 2345889999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-hhhHhHh----hh
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE-TLVTHTW----KH  478 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~----~~  478 (569)
                      +++......   ......||+.|+|||.+.+..++.++|||||||++|||++|++||......... .+.....    ..
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            998654432   233556899999999998889999999999999999999999998755432211 1111000    00


Q ss_pred             hccc-ch-hhhhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          479 FQAK-TV-LEIIDKSIEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       479 ~~~~-~~-~~~~~~~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +... .. ...+.......    .+.....+.+++.+||+.+|++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0000 00 00000000000    01123456689999999999999999999953

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.1e-39  Score=309.63  Aligned_cols=266  Identities=24%  Similarity=0.307  Sum_probs=203.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchh--hHHHHHHHHHHHHhccccc-cceeeeeeeeCC------
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKN-LVQFLGCCFTKK------  325 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------  325 (569)
                      ..|+..++||+|.||+||+|+.+ +|+.||+|++.....+  .-....+|+.+|++++|+| ||++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            44666778999999999999966 7899999999876542  3345679999999999999 999999998877      


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCC-ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQK-KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                      ..++|+||+ ..+|.+++...... ..++...+..++.||++||.|||+++   |+||||||.||||++.|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            788999999 56898888543322 45677889999999999999999999   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh-----hh
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW-----KH  478 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-----~~  478 (569)
                      |+.+.-...  ..+..++|.+|.|||++.+. .|+...||||+|||+.||+++++-|....+.+....+-...     +.
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            996653221  23466789999999999887 79999999999999999999988776655432211111111     11


Q ss_pred             hcccchhhhhcccCC----CC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          479 FQAKTVLEIIDKSIE----IE-----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~----~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      |+.-....-.+....    ..     .+.......+++.+|++.+|..|.|+..++++
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            211111111110000    00     11112467889999999999999999999987

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.4e-38  Score=312.63  Aligned_cols=257  Identities=24%  Similarity=0.382  Sum_probs=207.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|+.. +++.||||.+...   .......+.+|++++++++||||+++++++......++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999975 7899999987542   2344457889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          332 EFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998884322 2345788999999999999999999998   99999999999999999999999999887654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+........ .+             .+.+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~-------------~~~~~~  222 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SL-------------CQKIEQ  222 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HH-------------HHHHhc
Confidence            322  12234688899999999888899999999999999999999999754322110 01             011111


Q ss_pred             cC-CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          491 SI-EIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       491 ~l-~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .. ... .......+.+++.+||+.+|++||++.+|++.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11 111 123345678899999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-38  Score=312.85  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=200.8

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      .+|++.+.||+|+||.||++.++++..+|+|.+..... ....+.+|++++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35788899999999999999988777899998754332 23568889999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            99999998532  236899999999999999999999998   999999999999999999999999998765432211 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC-
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE-  493 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-  493 (569)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.........       ..         +..... 
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~---------~~~~~~~  220 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-------ES---------VSAGYRL  220 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-------HH---------HHcCCcC
Confidence            1122234567999999998899999999999999999999 77787543322110       00         111110 


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ..+......+.+++.+||+.+|++|||+.||++.|.
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            011223456888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-38  Score=318.27  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=201.2

Q ss_pred             cccccccccccCceeEEEEEec------CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      +|++.++||+|+||.||+|...      .++.||+|++..... .....+.+|+.++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4777889999999999999864      247899999875433 234668899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC
Q 037160          330 VYEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR  396 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  396 (569)
                      ++||+.+++|.+++....             ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999984211             1345788899999999999999999998   999999999999999999


Q ss_pred             eEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhH
Q 037160          397 PKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       397 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  475 (569)
                      +||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..|+........   .   
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~---  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---I---  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H---
Confidence            99999999886644332212233456789999999988899999999999999999998 7777653322111   0   


Q ss_pred             hhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          476 WKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                       .        .+.+.............+..++..||+.+|++||++.+|+..|+.
T Consensus       237 -~--------~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 -E--------MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -H--------HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             0        011111111122334457788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-38  Score=316.36  Aligned_cols=247  Identities=23%  Similarity=0.306  Sum_probs=196.7

Q ss_pred             ccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ||+|+||.||++..+ +++.||+|.+....   ....+.+..|+.++++++|+||+++.+++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999876 78899999986532   22345678899999999999999999999999999999999999999


Q ss_pred             hhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCc
Q 037160          340 DRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT  418 (569)
Q Consensus       340 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  418 (569)
                      ...+... .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8887432 23456899999999999999999999998   99999999999999999999999999976654332  223


Q ss_pred             ccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHH
Q 037160          419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIE  498 (569)
Q Consensus       419 ~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  498 (569)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||...........   ..        ........ .....
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~---~~--------~~~~~~~~-~~~~~  223 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE---LK--------QRILNDSV-TYPDK  223 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH---HH--------HhhcccCC-CCccc
Confidence            45789999999999999999999999999999999999999865432210000   00        00011101 11223


Q ss_pred             HHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          499 EVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       499 ~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      ....+.+++..||+.+|++||     ++++++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            445677888999999999999     77888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.4e-38  Score=323.73  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=195.5

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+++++ +++.||+|++....   ......+.+|..++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999976 68899999987532   23345688999999998 799999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~  152 (329)
T cd05588          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence            99998883   3457899999999999999999999998   99999999999999999999999999874322111  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc--hhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG--FETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.+..        +...... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~-  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQIR-  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCCCC-
Confidence            235679999999999999999999999999999999999999986432211  00000111111        1111111 


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPS------MTNVVQM  527 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt------~~evl~~  527 (569)
                      .+......+..++..||+.+|.+||+      +.+++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            11123345778889999999999997      6788754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-39  Score=333.47  Aligned_cols=253  Identities=20%  Similarity=0.279  Sum_probs=196.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||++... +++.||||++....   ......+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999865 78999999986532   334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999984   3456888999999999999999999998   999999999999999999999999998643221


Q ss_pred             CCC------------C---------------------------------CCcccccCCCcccccccccCCCCcccchhhH
Q 037160          412 KSL------------L---------------------------------PNTAIAGTLGYMAPEYIANGQLTEKVDIYSF  446 (569)
Q Consensus       412 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~Sl  446 (569)
                      ...            .                                 ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012469999999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCC---CCHH
Q 037160          447 GVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLR---PSMT  522 (569)
Q Consensus       447 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~R---Pt~~  522 (569)
                      ||++|||++|+.||.........   .... .+.         ..+.. ........+.+++..|++ +|.+|   |++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~---~~i~-~~~---------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETY---RKII-NWR---------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHH---HHHH-ccC---------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999999998654332110   0000 000         00000 011122345667778887 66654   6999


Q ss_pred             HHHHHh
Q 037160          523 NVVQML  528 (569)
Q Consensus       523 evl~~L  528 (569)
                      |++.+-
T Consensus       301 ~~l~hp  306 (377)
T cd05629         301 EIKSHP  306 (377)
T ss_pred             HHhcCC
Confidence            999763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-38  Score=318.20  Aligned_cols=264  Identities=24%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             ccccccccccccCceeEEEEEecC---------------CceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQD---------------GREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLG  319 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~  319 (569)
                      ++|++.++||+|+||.||+++..+               ...||+|.+... .......+.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987642               124899988654 2334467899999999999999999999


Q ss_pred             eeeeCCceEEEEeecCCCChhhHhhCCC---------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeE
Q 037160          320 CCFTKKDSFVVYEFVQNKSLDRILFDPK---------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNIL  390 (569)
Q Consensus       320 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIl  390 (569)
                      ++......++||||+++++|.+++....         ....+++..++.++.+++.||.|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999984321         1124688899999999999999999998   999999999999


Q ss_pred             ECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCC--CCCCCCCCcch
Q 037160          391 LDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV--QNNKFQSDDGF  468 (569)
Q Consensus       391 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~--~p~~~~~~~~~  468 (569)
                      +++++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||+++.  .|+........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            9999999999999987654332221222334577899999999899999999999999999999854  44443222211


Q ss_pred             hhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          469 ETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       469 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                         +......+....     ..............+.+++.+||+.+|++||++.+|++.|++
T Consensus       242 ---~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 ---IENTGEFFRNQG-----RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ---HHHHHHhhhhcc-----ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence               111000000000     000000112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-38  Score=323.60  Aligned_cols=242  Identities=25%  Similarity=0.372  Sum_probs=194.4

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+|+.+ +++.||+|++....   ......+..|.+++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 57899999986542   23445677899998876 899999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|...+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  152 (321)
T cd05591          81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T  152 (321)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence            99998884   3456889999999999999999999998   99999999999999999999999999875433221  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   ..    .        +...... .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~----~--------i~~~~~~-~p  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FE----S--------ILHDDVL-YP  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HH----H--------HHcCCCC-CC
Confidence            2345789999999999988999999999999999999999999875433211   10    0        0000000 01


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRP-------SMTNVVQM  527 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RP-------t~~evl~~  527 (569)
                      ......+..++..||+.+|++||       ++.+++++
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11234567788999999999999       88888855

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.8e-39  Score=327.86  Aligned_cols=242  Identities=22%  Similarity=0.290  Sum_probs=195.1

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      +.||+|+||.||++... +|+.||+|++....   ......+.+|+++++.++||||+++++.+......++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999865 78999999986532   334566788999999999999999999999999999999999999


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      +|.+++.   ....+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  152 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T  152 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence            9998883   34568999999999999999999997 67   99999999999999999999999999875432221  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+               ...... .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---------------~~~~~~-~p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------------LMEEIR-FP  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH---------------hcCCCC-CC
Confidence            23456999999999999999999999999999999999999998644322111110               000000 01


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      ......+.+++.+||+.+|++|+     ++.+++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            12234567788999999999996     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-38  Score=312.30  Aligned_cols=256  Identities=23%  Similarity=0.376  Sum_probs=201.0

Q ss_pred             ccccccccccCceeEEEEEec-C---CceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCc-----
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-D---GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD-----  326 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  326 (569)
                      |.+.+.||+|+||.||+|... +   +..||+|++....  ......+.+|++.++.++||||+++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999865 2   3679999887542  3445678999999999999999999998876554     


Q ss_pred             -eEEEEeecCCCChhhHhhCCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          327 -SFVVYEFVQNKSLDRILFDPK---QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       327 -~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                       .++++||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999999884432   2346899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.......   +....      
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~------  228 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL------  228 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH------
Confidence            99986654433222223345678999999988899999999999999999999 777765432211   11111      


Q ss_pred             cchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          482 KTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       482 ~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                            ........+......+.+++.+||+.+|++|||+.||++.|++.
T Consensus       229 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 ------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  00000011223445788889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-38  Score=324.04  Aligned_cols=242  Identities=26%  Similarity=0.393  Sum_probs=193.5

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+++.+ +++.||||++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999976 68899999986532   23456677888888876 799999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|.+++.   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~  152 (320)
T cd05590          81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T  152 (320)
T ss_pred             chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence            99998884   3356889999999999999999999998   99999999999999999999999999875432221  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..    ..        ..... ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~----~i--------~~~~~-~~~  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE----AI--------LNDEV-VYP  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH----HH--------hcCCC-CCC
Confidence            2345799999999999988999999999999999999999999865432211   00    00        00000 011


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSM------TNVVQM  527 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~------~evl~~  527 (569)
                      ......+.+++..||+.+|++||++      .+++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            1223456778899999999999998      666644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-39  Score=299.46  Aligned_cols=251  Identities=25%  Similarity=0.319  Sum_probs=205.8

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--------hhhHHHHHHHHHHHHhc-cccccceeeeee
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--------KNRIKEICNEMDIMSRA-HHKNLVQFLGCC  321 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  321 (569)
                      ..+-+.|+..+.||+|..+.|.++.++ +|+++|+|++....        ....+.-..|+.||+++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            345567888889999999999999876 78999999885432        12235567899999998 799999999999


Q ss_pred             eeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEec
Q 037160          322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD  401 (569)
Q Consensus       322 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  401 (569)
                      +.....++|+|.|+.|.|.|+|   ...-.+++++..+|+.|+.+|+.|||..+   ||||||||+|||++++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            9999999999999999999999   55678999999999999999999999999   99999999999999999999999


Q ss_pred             cCCCcccCCCCCCCCCcccccCCCcccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH
Q 037160          402 FGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA------NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       402 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  475 (569)
                      ||++..+..+..   ....+||++|+|||.+.      ...|+..+|+|++|||||.|+.|.+||....+          
T Consensus       167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----------  233 (411)
T KOG0599|consen  167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----------  233 (411)
T ss_pred             cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----------
Confidence            999998887653   35789999999999884      34688899999999999999999999753211          


Q ss_pred             hhhhcccchhhhhcccC---CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          476 WKHFQAKTVLEIIDKSI---EIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l---~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                            --++.++....   ..+ =.+.....-+++.+||+.||..|.|++|+|.+
T Consensus       234 ------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  234 ------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence                  11222222211   111 12334455668889999999999999999965

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-39  Score=332.80  Aligned_cols=252  Identities=21%  Similarity=0.313  Sum_probs=198.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+++.. +|+.||||++....   ......+.+|+.+++.++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999976 68999999987542   334456889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999984   3456899999999999999999999998   999999999999999999999999998754322


Q ss_pred             CCCC------------------------------------CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh
Q 037160          412 KSLL------------------------------------PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS  455 (569)
Q Consensus       412 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt  455 (569)
                      ....                                    ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0012469999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 037160          456 GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPS---MTNVVQM  527 (569)
Q Consensus       456 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt---~~evl~~  527 (569)
                      |..||.........   ... ..+.         ..+. .........+.+++..|+. +|.+|++   +.|++++
T Consensus       235 G~~Pf~~~~~~~~~---~~i-~~~~---------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQETY---RKI-INWK---------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHHHH---HHH-HcCC---------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99998654322110   000 0000         0000 0011122345566777886 8999998   9999865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.7e-38  Score=309.39  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=205.1

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|++.+.||+|++|.||++..+ +++.|++|.+...  .......+.+|++++++++||||+++++.+......++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778889999999999999976 6899999988643  334567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++... ....+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998543 2457889999999999999999999998   99999999999999999999999999886654332


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......|++.|+|||++.+..++.++||||||++++||++|+.|+.......   ...            ........
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~------------~~~~~~~~  219 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL------------KIIRGVFP  219 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH------------HHHcCCCC
Confidence              2234568899999999999999999999999999999999999986443211   100            01111111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .........+.+++.+||+.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1122344578889999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.8e-38  Score=313.31  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=202.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|++.++||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++.+......++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357999999999999999999964 7889999998766555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999999884   3356889999999999999999999998   99999999999999999999999999986643221


Q ss_pred             CCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          414 LLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                        ......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+....+....  .     ........   .+
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~-----~~~~~~~~---~~  229 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F-----LMSKSNFQ---PP  229 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--e-----eeecCCCC---CC
Confidence              223456889999999874   345788999999999999999999987432211100  0     00000000   00


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ... ........+.+++.+||+.+|++|||+++|+++|
T Consensus       230 ~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000 0112335677889999999999999999999765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.5e-38  Score=316.76  Aligned_cols=256  Identities=23%  Similarity=0.404  Sum_probs=202.4

Q ss_pred             cccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      +|++.++||+|+||.||+|...      ....+++|.+.... ......+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      23568888776543 3345678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCC---------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCC
Q 037160          330 VYEFVQNKSLDRILFDPK---------------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASN  388 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~N  388 (569)
                      ++||+.+++|.+++....                     ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999884321                     1235789999999999999999999998   9999999999


Q ss_pred             eEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 037160          389 ILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDG  467 (569)
Q Consensus       389 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~  467 (569)
                      ||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986544332212223445678999999988889999999999999999998 888875433221


Q ss_pred             hhhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          468 FETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .       +.         .+....... +......+.+++..||+.+|++||++.||++.|++.
T Consensus       238 ~-------~~---------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         238 L-------FN---------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             H-------HH---------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            1       11         111111111 122335678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=314.66  Aligned_cols=258  Identities=24%  Similarity=0.340  Sum_probs=205.4

Q ss_pred             hccccccccccccCceeEEEEEecC------CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQD------GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      .++|.+.+.||+|+||.||+|..+.      +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678899999999999999998652      3689999886443 23446788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCC-------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          328 FVVYEFVQNKSLDRILFDPKQ-------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                      ++||||+++++|.+++.....       ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999854321       234788999999999999999999998   9999999999999999999999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhh
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      |||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.........       +..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-------~~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-------KFV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH-------HHH
Confidence            9999886554432222334456789999999988899999999999999999998 88887543322111       111


Q ss_pred             cccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          480 QAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       480 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .        .......+......+..++..||+.+|++|||+.+|++.|++
T Consensus       235 ~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 I--------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             h--------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1        110101112234577889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.9e-38  Score=310.90  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=202.0

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .++|++.++||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++.+. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356899999999999999999987777899998865332 3457899999999999999999998874 45689999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++... ....+++..+..++.+++.||.|||+.+   ++||||||+||++++++.+||+|||.++........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999999532 2345789999999999999999999998   999999999999999999999999999866543321


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC-
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI-  492 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-  492 (569)
                       ......++..|+|||++.++.++.++||||||+++|||++ |..|+........   .             +.+.... 
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~-------------~~~~~~~~  221 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L-------------DQVERGYR  221 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---H-------------HHHhcCCC
Confidence             2223446678999999988899999999999999999999 7777653322111   0             0000000 


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      ..........+.+++.+|++.+|++||++.++++.|+.
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            01123345567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.4e-38  Score=312.07  Aligned_cols=255  Identities=22%  Similarity=0.367  Sum_probs=197.2

Q ss_pred             ccccccccccCceeEEEEEecC-Cc--eEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC------Cc
Q 037160          258 FDESNKLGHGGYGEIFKGTLQD-GR--EIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------KD  326 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  326 (569)
                      |.+.++||+|+||.||+|++.+ +.  .+|+|.+...  .....+.+.+|+.+++.++|+||+++++.+...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999999764 33  5899987653  344567789999999999999999999987532      24


Q ss_pred             eEEEEeecCCCChhhHhhCC---CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          327 SFVVYEFVQNKSLDRILFDP---KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                      .+++|||+++++|.+++...   .....+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887422   12345889999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      +++...............+++.|++||.+.+..++.++||||||+++|||++ |+.|+.......       .+.....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcC
Confidence            9987654332212223346778999999999899999999999999999999 777775432211       11111111


Q ss_pred             chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      ..       . .........+.+++.+||+.+|++|||+.+|++.|++
T Consensus       231 ~~-------~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NR-------L-KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CC-------C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            10       0 0112233457789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-38  Score=318.84  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=205.8

Q ss_pred             HhccccccccccccCceeEEEEEecC------CceEEEEEEeec-chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCC
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQD------GREIAVKRLFIS-RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKK  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  325 (569)
                      ..++|++.+.||+|+||.||++....      ...+|+|.+... .......+.+|+++++++ +|+||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            44678889999999999999998642      367899988653 233456788999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCC-------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC
Q 037160          326 DSFVVYEFVQNKSLDRILFDP-------------KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD  392 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~  392 (569)
                      ..+++|||+++++|..++...             .....+++..++.++.|++.||.|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998532             23456899999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhh
Q 037160          393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETL  471 (569)
Q Consensus       393 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~  471 (569)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.........  
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--  244 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--  244 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH--
Confidence            999999999999987654432222223345678999999988899999999999999999998 87776533222111  


Q ss_pred             hHhHhhhhcccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          472 VTHTWKHFQAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       472 ~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                           +         .+..... ..+......+.+++.+||+.+|++|||+.||++.|+..
T Consensus       245 -----~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         245 -----K---------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             -----H---------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                 1         1111111 11223345678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.9e-38  Score=315.15  Aligned_cols=258  Identities=28%  Similarity=0.416  Sum_probs=201.8

Q ss_pred             HhccccccccccccCceeEEEEEecC------CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQD------GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      .+++|.+.+.||+|++|.||+|.+.+      +..|++|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35679999999999999999998753      5678888775443 3334568999999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCC----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC---CeEE
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQ----KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKI  399 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~---~~kl  399 (569)
                      .++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999999854321    235889999999999999999999998   99999999999998765   5999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhh
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      +|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||.........         
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---------  231 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---------  231 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---------
Confidence            99999986643222111122234568999999998999999999999999999997 88887643322111         


Q ss_pred             hcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          479 FQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                             +.+...... .+......+.+++.+||+.+|++||++.+|+++|+.
T Consensus       232 -------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         232 -------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             -------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                   111110000 112234567789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.9e-38  Score=311.10  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=204.3

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ..++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++ .....+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence            4567999999999999999999988899999998865433 346789999999999999999999886 45678999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +.+++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            9999999988532 3456889999999999999999999998   99999999999999999999999999976653222


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      . ......++..|+|||++..+.++.++||||||+++|||++ |+.|+........                .+.+....
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~  220 (260)
T cd05067         158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV----------------IQNLERGY  220 (260)
T ss_pred             c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH----------------HHHHHcCC
Confidence            1 1223345678999999998899999999999999999999 8888764332111                00111111


Q ss_pred             CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          493 EIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       493 ~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      ... .......+.+++.+||..+|++||+++++++.|+.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            111 11223468889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-38  Score=331.57  Aligned_cols=253  Identities=23%  Similarity=0.298  Sum_probs=201.7

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ...++|++.++||+|+||.||+++.+ +++.||+|++....   ......+.+|+.+++.++||||+++++++.+....+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34578999999999999999999976 68899999986432   233455789999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999998842    34788888899999999999999998   999999999999999999999999999866


Q ss_pred             CCCCCCCCCcccccCCCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANG----QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      ...... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........       +        
T Consensus       193 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~--------  256 (370)
T cd05596         193 DANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------Y--------  256 (370)
T ss_pred             cCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-------H--------
Confidence            443221 22345799999999998653    478999999999999999999999865432211       0        


Q ss_pred             hhhhcc--cCCC-CCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 037160          485 LEIIDK--SIEI-EDIEEVKRVVWVGLLCTQELPTL--RPSMTNVVQML  528 (569)
Q Consensus       485 ~~~~~~--~l~~-~~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~~L  528 (569)
                      ..++..  .+.. ........+.+++..||+.+|.+  ||++.|++++-
T Consensus       257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         257 SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence            111110  0111 11223456677888999999987  99999998763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.8e-38  Score=324.09  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=196.1

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhcccc-ccceeeeeeeeCCceEEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHK-NLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  331 (569)
                      +|++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999976 57899999986542   33456778899999999765 6888999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999884   3456889999999999999999999998   999999999999999999999999998743222


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.|+........   ....            ....
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i------------~~~~  217 (324)
T cd05587         155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSI------------MEHN  217 (324)
T ss_pred             CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH------------HcCC
Confidence            11  22345789999999999999999999999999999999999999864332211   1100            0000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSM-----TNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~-----~evl~~  527 (569)
                      . ..+......+.+++.+||+.+|++||+.     .+++++
T Consensus       218 ~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 V-SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             C-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            0 0111223456788899999999999986     666654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.8e-38  Score=314.90  Aligned_cols=255  Identities=25%  Similarity=0.344  Sum_probs=202.8

Q ss_pred             ccccccccccccCceeEEEEEec------CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .+|+..++||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999642      356789998876666666789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          330 VYEFVQNKSLDRILFDPKQ------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                      +|||+++++|.+++.....            ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999854321            135789999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |.+|+.........       
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI-------  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH-------
Confidence            9999999876543322112223345688999999999999999999999999999998 88886533221110       


Q ss_pred             hhhcccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          477 KHFQAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                               +.+..... ..+......+.+++.+||+.+|++||++.||++.|+
T Consensus       235 ---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ---------ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ---------HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                     00111000 011122345778999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.7e-38  Score=319.16  Aligned_cols=240  Identities=27%  Similarity=0.350  Sum_probs=190.8

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+++++ +|+.||+|.+....   ......+..|..++..+ +||||+++++.+......++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 68899999987542   23345667788888765 899999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|..++.   ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05620          81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence            99998884   3456889999999999999999999998   99999999999999999999999999874322211  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +.    +.         +.......+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~----~~---------~~~~~~~~~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LF----ES---------IRVDTPHYP  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HH---------HHhCCCCCC
Confidence            335678999999999999999999999999999999999999986443221   11    10         000000001


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSMT-NVV  525 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl  525 (569)
                      ......+.+++..||+.+|++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11234567788999999999999985 665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.6e-38  Score=320.93  Aligned_cols=242  Identities=24%  Similarity=0.360  Sum_probs=194.9

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      +.||+|+||.||++.++ +++.||||++....   ......+.+|..+++.+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 57899999987542   23455677899999888 799999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|..++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  152 (318)
T cd05570          81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T  152 (318)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence            99998884   3346899999999999999999999998   99999999999999999999999999875322221  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||........   .    ...        ...... .+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~----~~i--------~~~~~~-~~  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---F----QSI--------LEDEVR-YP  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---H----HHH--------HcCCCC-CC
Confidence            2345689999999999999999999999999999999999999864432211   0    000        000000 01


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSM-----TNVVQM  527 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~-----~evl~~  527 (569)
                      ......+.+++.+||+.+|++||++     .+++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            1223467788999999999999999     888864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.6e-38  Score=310.02  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=202.3

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .++|++.++||+|+||.||++..+++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            457889999999999999999988888999998865433 3457899999999999999999999875 45689999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++... ....+++..++.++.+++.||.|||+.+   |+||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999998542 2345889999999999999999999998   999999999999999999999999999876543221


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                       ......++..|+|||++.+..++.++||||||+++|||++ |..|+.......   ...             .+.....
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~-------------~~~~~~~  221 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE-------------QVERGYR  221 (260)
T ss_pred             -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-------------HHHcCCC
Confidence             1122335678999999988899999999999999999999 788875432211   111             1111111


Q ss_pred             C-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          494 I-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       494 ~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      . ........+.+++.+|++.+|++|||+.++++.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1 122234568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-38  Score=324.91  Aligned_cols=238  Identities=24%  Similarity=0.309  Sum_probs=191.1

Q ss_pred             ccccccCceeEEEEEe----cCCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          262 NKLGHGGYGEIFKGTL----QDGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++||+|+||.||+++.    .+|+.||+|++.....  .....+.+|++++++++||||+++++.+......++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    2578999999875432  233567789999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--  153 (318)
T cd05582          82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--  153 (318)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence            999999883   3456899999999999999999999998   99999999999999999999999999876543321  


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE  495 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  495 (569)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........   ..            .+...... .
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~------------~i~~~~~~-~  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MT------------MILKAKLG-M  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HH------------HHHcCCCC-C
Confidence            22346789999999999988899999999999999999999999864332111   00            01111111 1


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRPSMTN  523 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~e  523 (569)
                      +......+..++..||+.+|++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1122345677889999999999999444

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.7e-38  Score=314.05  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=199.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCc----eEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGR----EIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|.+.... .....++..|+.++.+++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46888899999999999999874 444    47777765432 234467888899999999999999999875 455789


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ++||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999953  3356899999999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ............++..|+|||++.++.++.++||||||+++|||++ |+.|+..........+                +
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----------------~  224 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL----------------L  224 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----------------H
Confidence            4332212234557788999999998999999999999999999998 8888754332211111                1


Q ss_pred             cccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          489 DKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       489 ~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ....... .......+..++..||..+|++|||+.|+++.|....
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         225 EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1100000 0112235667888999999999999999999987744

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.3e-38  Score=315.66  Aligned_cols=265  Identities=24%  Similarity=0.339  Sum_probs=203.9

Q ss_pred             hccccccccccccCceeEEEEEecC-----------------CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQD-----------------GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQ  316 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  316 (569)
                      .++|++.++||+|+||.||++...+                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999988642                 2458999886543 345678899999999999999999


Q ss_pred             eeeeeeeCCceEEEEeecCCCChhhHhhCCC--------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCC
Q 037160          317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPK--------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASN  388 (569)
Q Consensus       317 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~N  388 (569)
                      +++++..+...+++|||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999985432        1236899999999999999999999998   9999999999


Q ss_pred             eEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCc
Q 037160          389 ILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS--GVQNNKFQSDD  466 (569)
Q Consensus       389 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt--g~~p~~~~~~~  466 (569)
                      |+++.++.++|+|||+++...............++..|+|||++.++.++.++||||||+++|||++  +..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876544332222334456788999999988899999999999999999998  44554322211


Q ss_pred             chhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          467 GFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       467 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                         ..+......+........     ..........+.+++.+||+.+|++|||+.||++.|++
T Consensus       241 ---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 ---QVIENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ---HHHHHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence               111111111111100000     00112223578889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-37  Score=308.01  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=208.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|... +|+.||+|.+...   .....+.+.+|++++++++|+||+++++.+......++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999987 7899999988642   2334567899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          332 EFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ||+++++|.+++... .....+++..++.++.+++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988542 23456889999999999999999999998   99999999999999999999999999886644


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...  ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ..+             .+.+..
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~-------------~~~~~~  222 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSL-------------CKKIEK  222 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-HHH-------------Hhhhhc
Confidence            322  1234568889999999998889999999999999999999999875433110 000             011111


Q ss_pred             c-CCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          491 S-IEIED-IEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       491 ~-l~~~~-~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      . ....+ ......+.+++.+||..+|++|||+.+|+++|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            0 11111 13445677899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.8e-38  Score=313.65  Aligned_cols=249  Identities=23%  Similarity=0.296  Sum_probs=194.8

Q ss_pred             ccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ||+|+||.||+++.+ +|+.||+|.+....   ......+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999876 68999999886432   12234556799999999999999999999999999999999999999


Q ss_pred             hhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcc
Q 037160          340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA  419 (569)
Q Consensus       340 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  419 (569)
                      .+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            9888432 3345889999999999999999999998   9999999999999999999999999987665432   2234


Q ss_pred             cccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHH
Q 037160          420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE  499 (569)
Q Consensus       420 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  499 (569)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.|+...........  ..         ...+...........
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~--~~---------~~~~~~~~~~~~~~~  222 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE--LK---------RRTLEDEVKFEHQNF  222 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH--HH---------HHhhccccccccccC
Confidence            5689999999999988999999999999999999999999864332211000  00         001111111111123


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          500 VKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       500 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      ...+.+++..||+.+|++||++.|+++.+..
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence            4457788999999999999999776654443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.5e-38  Score=309.77  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=206.9

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.+.||+|+||.||+++.. +++.++||.+....   ......+.+|+.+++.++||||+++++++..+...+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999964 78999999876532   334467889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          332 EFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ||+++++|.+++... .....+++..++.++.+|+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 23456899999999999999999999998   99999999999999999999999999886654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...  ......++..|+|||++.+..++.++||||||+++|||++|..|+........ ..             ...+..
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~-------------~~~~~~  222 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL-------------CKKIEQ  222 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HH-------------hhhhhc
Confidence            332  12345688999999999888899999999999999999999998753322110 00             000110


Q ss_pred             cC-CC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          491 SI-EI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       491 ~l-~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .. .. ........+..++.+||+.+|++|||+.+|++++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            00 00 1122445677888999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.6e-38  Score=314.13  Aligned_cols=260  Identities=25%  Similarity=0.344  Sum_probs=206.0

Q ss_pred             hccccccccccccCceeEEEEEecC-----CceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeee-CCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQD-----GREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT-KKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  327 (569)
                      .++|++.+.||+|+||.||+|.+.+     +..|++|++... .......+.+|+.++++++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678899999999999999999765     688999987643 33446778999999999999999999998776 4678


Q ss_pred             EEEEeecCCCChhhHhhCCCCC-----ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQK-----KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                      ++++||+++++|.+++......     ..+++..++.++.+++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998543322     56899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      |+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+.........   .    ....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~----~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA---A----YLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH---H----HHHc
Confidence            99986544332212223456778999999988889999999999999999999 88887543222111   0    0000


Q ss_pred             cchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          482 KTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       482 ~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ..       ... ........+.+++.+||+.+|++|||+.+|++.|++..
T Consensus       235 ~~-------~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         235 GY-------RLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CC-------CCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            00       000 01112346778999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.9e-38  Score=329.19  Aligned_cols=256  Identities=22%  Similarity=0.292  Sum_probs=200.3

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCC
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK  325 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  325 (569)
                      .++...++|++.++||+|+||.||+++.+ +++.+|+|++....   ......+.+|+.+++.++||||+++++.+..+.
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34445678999999999999999999976 68899999886432   233456889999999999999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence            99999999999999999842    35788899999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANG----QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      ......... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........             
T Consensus       190 ~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-------------  255 (370)
T cd05621         190 MKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-------------  255 (370)
T ss_pred             eecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-------------
Confidence            876433221 22356799999999998654    378899999999999999999999864432111             


Q ss_pred             cchhhhhccc--CCCC-CHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 037160          482 KTVLEIIDKS--IEIE-DIEEVKRVVWVGLLCTQELPTL--RPSMTNVVQML  528 (569)
Q Consensus       482 ~~~~~~~~~~--l~~~-~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~~L  528 (569)
                        ...+++..  +... .......+..++..|++.++.+  ||++.|++++-
T Consensus       256 --~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         256 --YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             --HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence              11111111  1111 1122344556777888755543  89999999873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=323.91  Aligned_cols=266  Identities=25%  Similarity=0.343  Sum_probs=213.8

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ......+.++||+|-||.|.++....+..||||.++... +...++|..|+++|.+|+|||||+++|+|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            345667788999999999999999888999999998764 4445899999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      ||++|+|..++....-. .+......+|+.||+.||+||.+.+   +|||||.+.|+|++.++++||+|||+++-+-..+
T Consensus       616 YmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence            99999999999654322 2456667789999999999999998   9999999999999999999999999999777777


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCC--CCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV--QNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ++......+-.+.|||||.+..++++.++|||+||+.|||+++-.  +|++.-.+++.   +...-..+..+....    
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~----  764 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQV----  764 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcce----
Confidence            665555667788999999999999999999999999999988754  45443222221   111111111111000    


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                       .-..++-....+.++++.||..+.++||+++++...|.+.
T Consensus       765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             0111344556788999999999999999999999998764

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.5e-38  Score=309.05  Aligned_cols=245  Identities=26%  Similarity=0.399  Sum_probs=194.8

Q ss_pred             cccccCceeEEEEEec---CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          263 KLGHGGYGEIFKGTLQ---DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      +||+|+||.||+|.++   ++..+|+|++....  ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999753   57889999886443  334567899999999999999999999875 45678999999999


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC-C
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL-P  416 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~  416 (569)
                      +|.+++.   ....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++......... .
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999984   3346889999999999999999999998   9999999999999999999999999998765443211 1


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE  495 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  495 (569)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+........                .+.+.......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----------------~~~i~~~~~~~  218 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV----------------TQMIESGERME  218 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHHCCCCCC
Confidence            122334578999999988889999999999999999998 8888764332211                11111111111


Q ss_pred             -CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          496 -DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       496 -~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                       +......+.+++.+||+.+|++||++.+|++.|++
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence             12234567789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.3e-38  Score=323.48  Aligned_cols=240  Identities=23%  Similarity=0.326  Sum_probs=189.0

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHH-HHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMD-IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+++.. +|+.+|+|++....   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999875 78999999986542   223345555654 46778999999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence            99998883   3457899999999999999999999998   99999999999999999999999999875332211  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........       +..        +....+.. .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-------~~~--------~~~~~~~~-~  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-------YDN--------ILHKPLVL-R  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-------HHH--------HHcCCccC-C
Confidence            3356799999999999999999999999999999999999999864432111       010        11111110 1


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSMTNVV  525 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl  525 (569)
                      +.....+.+++..|++.+|++||++.+.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            12334567788999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.9e-38  Score=315.38  Aligned_cols=261  Identities=25%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             HHhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCC
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK  325 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  325 (569)
                      ...++|++.++||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34678999999999999999999754      24579999875443 233456889999999999999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCC-------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeE
Q 037160          326 DSFVVYEFVQNKSLDRILFDPK-------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPK  398 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  398 (569)
                      ..++||||+++|+|.+++....       ....+++..+..++.|++.||.|||+++   |+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            9999999999999999995322       1234567788999999999999999998   99999999999999999999


Q ss_pred             EeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhh
Q 037160          399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      |+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..|+.......   ...    
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~----  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK----  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----
Confidence            999999886544332212223345678999999998899999999999999999998 676764322211   110    


Q ss_pred             hhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          478 HFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                              .+.+.............+.+++.+||+.+|++|||+.++++.|++.
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 --------FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             --------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                    0111111111112235788899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-38  Score=329.68  Aligned_cols=263  Identities=25%  Similarity=0.317  Sum_probs=198.4

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCC-----ceE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-----DSF  328 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  328 (569)
                      +|++.++||+|+||.||++... +|+.||||++...  .....+.+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999965 7899999988543  2334567889999999999999999999998766     789


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+. ++|.+.+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 57777773   3457899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc------
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA------  481 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  481 (569)
                      ...... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.........      
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            433221 22344678999999998774 5789999999999999999999998654432211111100000000      


Q ss_pred             -cchhhhh-cccCCC--------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 -KTVLEII-DKSIEI--------EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 -~~~~~~~-~~~l~~--------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ......+ ......        ........+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence             0000000 000000        011123567789999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.3e-38  Score=330.83  Aligned_cols=202  Identities=25%  Similarity=0.362  Sum_probs=173.0

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .|++.++||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++++++||||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999975 68899999886542   3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999999843   346788889999999999999999998   9999999999999999999999999975332100


Q ss_pred             C---------------------------------------------CCCCcccccCCCcccccccccCCCCcccchhhHH
Q 037160          413 S---------------------------------------------LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFG  447 (569)
Q Consensus       413 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlG  447 (569)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001234689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCC
Q 037160          448 VLVLEIVSGVQNNKFQS  464 (569)
Q Consensus       448 vil~elltg~~p~~~~~  464 (569)
                      |+||||++|++||....
T Consensus       236 vil~elltG~~Pf~~~~  252 (382)
T cd05625         236 VILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.1e-38  Score=320.00  Aligned_cols=249  Identities=21%  Similarity=0.313  Sum_probs=195.2

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||++... +++.||+|++....   ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 67899999987542   23455688999999888 699999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  152 (327)
T cd05617          81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T  152 (327)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence            99998883   3356899999999999999999999998   99999999999999999999999999875322111  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...............+....        ..... .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~-~p  223 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------EKPIR-IP  223 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------hCCCC-CC
Confidence            2356799999999999999999999999999999999999999864332211111111111111        11111 11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPS------MTNVVQM  527 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt------~~evl~~  527 (569)
                      ......+.+++.+||+.+|++||+      +.+++++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            122345678889999999999998      4677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.2e-38  Score=330.30  Aligned_cols=251  Identities=21%  Similarity=0.280  Sum_probs=194.7

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      +|++.++||+|+||.||+++.. +++.||||++....   ......+.+|+++|++++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999975 68899999886432   2334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999984   3456788888999999999999999998   9999999999999999999999999975332100


Q ss_pred             C-----------------------------------------CCCCcccccCCCcccccccccCCCCcccchhhHHHHHH
Q 037160          413 S-----------------------------------------LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVL  451 (569)
Q Consensus       413 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~  451 (569)
                      .                                         ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                         00011347999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHH
Q 037160          452 EIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRP---SMTNVVQM  527 (569)
Q Consensus       452 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RP---t~~evl~~  527 (569)
                      ||++|+.||...........+    ..+.         ..+... .......+..++.+|+ .+|++|+   ++.|++++
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i----~~~~---------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKV----INWE---------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHH----hccC---------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999998755432211100    0000         000000 1112233444555554 4999999   89999966

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9e-38  Score=316.62  Aligned_cols=263  Identities=22%  Similarity=0.336  Sum_probs=203.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.++||+|+||.||++.+. ++..+|+|.+.... ......+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999976 67888999876542 33446688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      +++++|.+++.   ....+++..+..++.|+++||.|||+ .+   ++||||||+|||++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            99999999984   33568899999999999999999997 46   999999999999999999999999998754332 


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc-----------
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA-----------  481 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------  481 (569)
                         ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....................           
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence               123456889999999998888999999999999999999999998644332222111111110000           


Q ss_pred             ------cchhhhhcccCCC---C--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          482 ------KTVLEIIDKSIEI---E--DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       482 ------~~~~~~~~~~l~~---~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                            ....+..+.....   .  .......+.+++.+||+.+|++|||+.+|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                  0001111111100   0  111334578899999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=308.20  Aligned_cols=252  Identities=24%  Similarity=0.313  Sum_probs=201.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-----hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-----KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|++.+.||+|++|.||++... +++.+++|.+....     ......+.+|++++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999865 68999999886532     2234578899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      |+||+++++|.+++.   ....+++..+..++.+++.||.|||+.+   |+||||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999884   3356888999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCCCCC-CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLP-NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ....... .....++..|+|||++.+..++.++||||||+++|||++|+.|+.......  ..    ......       
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~~-------  222 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--AI----FKIATQ-------  222 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--HH----HHHhcc-------
Confidence            3221111 124567889999999999889999999999999999999999875322111  00    000000       


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ......+......+..++..||..+|++|||+.+++++
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             00000122234467778899999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.4e-38  Score=321.03  Aligned_cols=237  Identities=23%  Similarity=0.327  Sum_probs=187.9

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHH-HHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMD-IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      +.||+|+||.||+++.. +|+.||+|++....   ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999976 78999999986542   222344555554 56778999999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (323)
T cd05575          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T  152 (323)
T ss_pred             CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence            99999884   3456889999999999999999999998   99999999999999999999999999875332221  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........       +.        .++..... ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~--------~i~~~~~~-~~  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-------YD--------NILNKPLR-LK  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-------HH--------HHHcCCCC-CC
Confidence            3356799999999999999999999999999999999999999864332111       00        01111111 11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSMT  522 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~~  522 (569)
                      +.....+.+++..||+.+|++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            22245677888999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3e-38  Score=322.31  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +|++.++||+|+||.||+++.+ +++.||+|++....   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999976 57899999987542   22334567788888877 5899999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+.+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999998884   3356889999999999999999999998   999999999999999999999999998754322


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.|+........   ...            +....
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~~------------i~~~~  217 (323)
T cd05616         155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQS------------IMEHN  217 (323)
T ss_pred             CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HHH------------HHhCC
Confidence            21  22356789999999999999999999999999999999999999865432211   110            00110


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSM-----TNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~-----~evl~~  527 (569)
                      .. .+......+..++.+|++.+|++|++.     .+++++
T Consensus       218 ~~-~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         218 VA-YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             CC-CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            10 112234567788999999999999984     666543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.4e-37  Score=313.42  Aligned_cols=264  Identities=25%  Similarity=0.340  Sum_probs=200.7

Q ss_pred             ccccccccccccCceeEEEEEec-----------------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhcccccccee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-----------------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQF  317 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~  317 (569)
                      ++|++.++||+|+||.||++...                 ++..+|+|++.... ......+.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998533                 23468999886543 3345678999999999999999999


Q ss_pred             eeeeeeCCceEEEEeecCCCChhhHhhCCCC--------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCe
Q 037160          318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQ--------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNI  389 (569)
Q Consensus       318 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NI  389 (569)
                      ++++......++||||+++++|.+++.....        ...+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999854221        134778899999999999999999998   99999999999


Q ss_pred             EECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCcc
Q 037160          390 LLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS--GVQNNKFQSDDG  467 (569)
Q Consensus       390 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt--g~~p~~~~~~~~  467 (569)
                      |++.++.++|+|||+++...............++..|++||....+.++.++||||||+++|||++  |..|+.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999886544322211223344678999999888899999999999999999998  555654322221


Q ss_pred             hhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          468 FETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .   +......+....     ..............+.+++.+||+.+|++||++.+|++.|++
T Consensus       242 ~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 V---IENTGEFFRDQG-----RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHHHhhcc-----ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   110100000000     000001112233677889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.8e-38  Score=320.52  Aligned_cols=237  Identities=22%  Similarity=0.299  Sum_probs=186.8

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHH-HHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMD-IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+++.. +++.||+|++....   ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 68899999986532   222344555554 67889999999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|...+.   ....+.+..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T  152 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence            99988883   3456788889999999999999999998   99999999999999999999999999875322221  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..            .+....+. .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~------------~i~~~~~~-~~  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD------------NILHKPLQ-LP  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH------------HHhcCCCC-CC
Confidence            234578999999999998899999999999999999999999986433211   110            01111111 11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSMT  522 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~~  522 (569)
                      ......+.+++.+||+.+|.+||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            22344677889999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.7e-38  Score=313.73  Aligned_cols=269  Identities=22%  Similarity=0.399  Sum_probs=202.5

Q ss_pred             ccccccccccccCceeEEEEEe-----cCCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeC--Cce
Q 037160          256 DCFDESNKLGHGGYGEIFKGTL-----QDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDS  327 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  327 (569)
                      ..|++.++||+|+||.||++.+     .++..||+|.+.... ......+.+|+.++++++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478889999999999999974     257889999886543 34456799999999999999999999998775  568


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            999999999999999843  2346899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... .......++..|+|||++.+..++.++||||||+++|||++++.|......... ................+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL-KMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh-hhcccccccccHHHHHH
Confidence            6543321 112234567789999999888899999999999999999998765432111000 00000000000001111


Q ss_pred             hhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          487 IIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       487 ~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .+...... ........+.+++.+||+.+|++||++.+|++.|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            11111111 122345678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=305.81  Aligned_cols=250  Identities=30%  Similarity=0.448  Sum_probs=204.1

Q ss_pred             ccccccCceeEEEEEecC----CceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQD----GREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||++....    +..+++|.+...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999763    789999998765433 367899999999999999999999999999999999999999


Q ss_pred             CChhhHhhCCCC------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          337 KSLDRILFDPKQ------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       337 ~~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ++|.+++.....      ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999954321      367899999999999999999999998   99999999999999999999999999987766


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ...........++..|+|||.+....++.++||||||+++|||++ |..|+........       +.....        
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~--------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYLRK--------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHc--------
Confidence            443223345567889999999988899999999999999999999 5888765422211       111110        


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ......+......+..++.+||+.+|++|||+.|+++.|+
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1111112233567888999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-37  Score=306.99  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=200.7

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|++.++||+|++|.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688899999999999999998877789999876443 23467889999999999999999998875 456899999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||+++........ 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999998542 2345789999999999999999999998   999999999999999999999999999866443221 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......   ..    ......        ....
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~--------~~~~  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL----EQVERG--------YRMP  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcC--------CCCC
Confidence            2223346778999999988899999999999999999999 888875432211   00    000000        0001


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      ........+..++.+||+.+|++||++.+|++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            112234567788899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1e-37  Score=312.95  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=202.4

Q ss_pred             hccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      .++|++.++||+|+||.||++..+      ++..||+|++.... ....+.+.+|+.++++++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999864      46789999886543 33456789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCC-------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCC
Q 037160          328 FVVYEFVQNKSLDRILFDPK-------------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASN  388 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~N  388 (569)
                      +++|||+++++|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999985321                   1234788899999999999999999998   9999999999


Q ss_pred             eEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 037160          389 ILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDG  467 (569)
Q Consensus       389 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~  467 (569)
                      |+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876543322212223345678999999988899999999999999999997 766764222111


Q ss_pred             hhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          468 FETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                         ..    ....        +......+......+.+++.+||+.+|++|||+.||++.|++
T Consensus       241 ---~~----~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ---VI----YYVR--------DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HH----HHHh--------cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               10    0000        011111112234567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5e-38  Score=319.51  Aligned_cols=241  Identities=25%  Similarity=0.360  Sum_probs=191.2

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      +.||+|+||.||+|+.. +++.||||++....   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 57899999987542   23345566788888764 999999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      |+|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05619          81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence            99999984   3356889999999999999999999998   99999999999999999999999999875332221  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+........   .    .....      .....   +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~----~~i~~------~~~~~---~  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---F----QSIRM------DNPCY---P  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHh------CCCCC---C
Confidence            2345789999999999988999999999999999999999999864332211   1    00000      00001   1


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSMT-NVVQ  526 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~  526 (569)
                      ......+.+++.+||+.+|++||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            11234567788999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-39  Score=309.72  Aligned_cols=261  Identities=23%  Similarity=0.310  Sum_probs=199.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCC-----ceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-----DSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l  329 (569)
                      -.|...+++|.|.||.||+|+.. ++++||||+.....+-    -.+|+++|+++.|||||+++.+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            34667889999999999999976 5799999998765432    237999999999999999999886533     2357


Q ss_pred             EEeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-CCeEEeccCCCcc
Q 037160          330 VYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLARF  407 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~kl~Dfgla~~  407 (569)
                      |||||+. +|.+.+... ..+..++...+.-+..||++||.|||+.+   |+||||||.|||+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999965 777777431 23567888888889999999999999998   9999999999999976 8999999999998


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ...++   +......|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|......+.-..+-..+......++..
T Consensus       176 L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  176 LVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            87766   34566788999999998775 799999999999999999999998876554433222222222111111111


Q ss_pred             hhc-------ccCCC------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IID-------KSIEI------EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~-------~~l~~------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +-.       +.+..      .......+.++++.++++.+|.+|.++.|++.+
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            111       11100      122334668888999999999999999999943

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.2e-38  Score=315.92  Aligned_cols=260  Identities=25%  Similarity=0.398  Sum_probs=203.6

Q ss_pred             HhccccccccccccCceeEEEEEec--------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ--------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT  323 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  323 (569)
                      ..++|.+.+.||+|+||.||+++..        ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3567889999999999999999742        24578999876432 34456789999999999 89999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeE
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNIL  390 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIl  390 (569)
                      ....++||||+++++|.+++.....             ...+++..+..++.||+.||.|||+++   |+||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            9999999999999999999854321             245788899999999999999999998   999999999999


Q ss_pred             ECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 037160          391 LDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFE  469 (569)
Q Consensus       391 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~  469 (569)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+........ 
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-
Confidence            99999999999999987654332222223445678999999988889999999999999999998 6666543221111 


Q ss_pred             hhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          470 TLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       470 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                            ++......        ...........+..++..||+.+|++||++.||++.|++.
T Consensus       249 ------~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         249 ------FKLLKEGH--------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             ------HHHHHcCC--------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence                  01110000        0001122345677789999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.2e-38  Score=315.63  Aligned_cols=256  Identities=24%  Similarity=0.379  Sum_probs=200.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCc--eEEEEEEeec-chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGR--EIAVKRLFIS-RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.+... .....+.+.+|++++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57888999999999999999875 343  4688877642 334456789999999999 799999999999999999999


Q ss_pred             EeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          331 YEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                      +||+++++|.+++....             ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985322             1235889999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+|||++.......   .......+..|+|||++....++.++|||||||++|||++ |..||.......   .    +
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~----~  228 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L----Y  228 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----H
Confidence            999999986432211   1112223567999999988889999999999999999997 888875433221   1    1


Q ss_pred             hhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          477 KHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                      .         .+...... ........+.+++..||+.+|.+|||+.+|++.|+....
T Consensus       229 ~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         229 E---------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             H---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1         11111111 112233567789999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.7e-38  Score=316.98  Aligned_cols=258  Identities=25%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             hccccccccccccCceeEEEEEec--------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeC
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ--------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK  324 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  324 (569)
                      .++|.+.++||+|+||.||+++..        .+..+|+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467899999999999999999753        23469999887542 33456788999999999 799999999999999


Q ss_pred             CceEEEEeecCCCChhhHhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                      ...++||||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999954321             235889999999999999999999998   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~  470 (569)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+......... 
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~-  252 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-  252 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-
Confidence            9999999999999876543322111222234568999999998899999999999999999998 77776533221111 


Q ss_pred             hhHhHhhhhcccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                                     +.+..... ..+......+.+++..||+.+|++||++.+|++.|+..
T Consensus       253 ---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         253 ---------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             ---------------HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence                           11111111 11222345677789999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=337.18  Aligned_cols=254  Identities=25%  Similarity=0.440  Sum_probs=213.6

Q ss_pred             ccccccccccccCceeEEEEEec-C---CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-D---GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ....+.++||.|.||.|++|+++ .   ...||||.++... ..+...|+.|+.||-++.||||+++.|+.......+||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            34557889999999999999986 2   3579999998753 45567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      .|||++|+|+.||..  +.+++++.+...++.+|+.||.||-+.+   +|||||..+||||+.+...|++||||++.+.+
T Consensus       709 TEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999953  4467999999999999999999999999   99999999999999999999999999997765


Q ss_pred             CCCCCCCcccc--cCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          411 EKSLLPNTAIA--GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       411 ~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      +... ..+...  -...|.|||.+...+++.+|||||||+||||.++ |.+|+..                +..+++..-
T Consensus       784 d~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd----------------mSNQdVIka  846 (996)
T KOG0196|consen  784 DPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----------------MSNQDVIKA  846 (996)
T ss_pred             CCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc----------------cchHHHHHH
Confidence            4311 122222  3578999999999999999999999999999776 7777432                223344555


Q ss_pred             hcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          488 IDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       488 ~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ++....-. +.++...+.+|++.|||++-.+||.+.+|+.+|.+.
T Consensus       847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence            55555443 678888999999999999999999999999888753

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.3e-38  Score=332.29  Aligned_cols=263  Identities=18%  Similarity=0.260  Sum_probs=192.2

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeC--------
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--------  324 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------  324 (569)
                      ..++|++.++||+|+||.||+|+.. +++.||||++....    ....+|+.+|++++|||||++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999975 68899999885432    2345799999999999999998886432        


Q ss_pred             CceEEEEeecCCCChhhHhhC-CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEecc
Q 037160          325 KDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADF  402 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Df  402 (569)
                      ...++||||+++ +|.+++.. ......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            235689999975 66665532 234467899999999999999999999998   99999999999998665 6999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      |+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|.+||...........+.........
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9998665432   22345689999999998764 6899999999999999999999998654332111000000000000


Q ss_pred             cch-------hhhhcccCCCC------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 KTV-------LEIIDKSIEIE------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 ~~~-------~~~~~~~l~~~------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..+       .+..-+.....      +......+.+++.+||+.+|.+|||+.|++++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            000       00000000000      01123467889999999999999999999955

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-37  Score=308.65  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=202.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCc---eEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGR---EIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|+..+.||+|+||.||+|+.+ +++   .+++|.+... .....+.+.+|++++++++||||+++.+++......++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888899999999999999975 333   6899988654 23345678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++..  ....+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999843  2356899999999999999999999998   9999999999999999999999999988665


Q ss_pred             CCCCCCCC-cccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          410 SEKSLLPN-TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       410 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ........ .....+..|+|||++....++.++||||||+++|||++ |+.|+.........       ....       
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~-------~~i~-------  224 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-------KAIN-------  224 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-------HHHh-------
Confidence            43221111 11223457999999988889999999999999999997 99887543321110       0000       


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                       ..............+.+++.+||+.+|++||++.+|++.|++
T Consensus       225 -~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         225 -DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence             000001112234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-37  Score=314.88  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=203.8

Q ss_pred             HhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCC
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKK  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  325 (569)
                      ..++|++.++||+|+||.||++...      .+..||||.+.... ....+.+.+|+.+++++ +||||+++++.+...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3467999999999999999999742      34579999886543 33446789999999999 7999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..+++|||+.+++|.+++.... ...+++..+..++.+++.||.|||+.+   |+|+||||+|||++.++.++|+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999999985322 234899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      +...............++..|+|||.+.++.++.++||||||+++|||++ |..|+.......  ..             
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~-------------  253 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KF-------------  253 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HH-------------
Confidence            86654332111223346788999999999999999999999999999998 888865332211  00             


Q ss_pred             hhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          485 LEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       485 ~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .+.+...... ........+.+++.+||+.+|++|||+.||++.|++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            0111111110 111223567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-37  Score=306.74  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=203.7

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .++|++.+.||+|+||.||++... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999876 78999999876544 5678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            999999998432 2236899999999999999999999998   9999999999999999999999999998664322  


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                         .....+..|+|||++..+.++.++||||||++++||++ |..|+.......   +.             +.+.....
T Consensus       157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~-------------~~~~~~~~  217 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV-------------PHVEKGYR  217 (256)
T ss_pred             ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH-------------HHHhcCCC
Confidence               12334668999999998899999999999999999997 888875432221   11             11111001


Q ss_pred             CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          494 IE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       494 ~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .. .......+.+++.+||..+|++||++.|++++|++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            11 12234567788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-37  Score=310.61  Aligned_cols=256  Identities=23%  Similarity=0.362  Sum_probs=201.6

Q ss_pred             hccccccccccccCceeEEEEEec-CCc----eEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGR----EIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      .++|++.++||+|+||.||+|.+. +|+    .||+|++... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            356888999999999999999864 454    4799988653 33445678899999999999999999999875 4578


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +++||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999999853  2356899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..|+.........                ..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----------------~~  223 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP----------------DL  223 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----------------HH
Confidence            54332211222345678999999998899999999999999999998 88887543222111                11


Q ss_pred             hcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          488 IDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       488 ~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      +..... .........+..++..||+.+|+.||++.++++.|+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            111110 012223456778999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.4e-37  Score=308.93  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=198.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.++||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++++++||||+++++.+......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999864 7889999988654 234456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999996542       4678888999999999999999998   999999999999999999999999999765432  


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|+.|+......................     ....+ 
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-  220 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVL-  220 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCC-
Confidence              2234578999999999998899999999999999999999999986432211100000000000000     00001 


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ........+.+++.+||+.+|+.||++.|++++
T Consensus       221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             011233467788999999999999999999975

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-37  Score=304.12  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=197.0

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCChh
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLD  340 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  340 (569)
                      ++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999998865432 33456889999999999999999999999999999999999999999


Q ss_pred             hHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCccc
Q 037160          341 RILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI  420 (569)
Q Consensus       341 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  420 (569)
                      +++..  ....+++..+..++.+++.+|.|||+.+   ++||||||+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            98843  2346789999999999999999999998   999999999999999999999999998754432211 11223


Q ss_pred             ccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC-CCCHH
Q 037160          421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE-IEDIE  498 (569)
Q Consensus       421 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~  498 (569)
                      .++..|+|||++..+.++.++||||||+++|||++ |..|+.........   ..             +..... .....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~~-------------~~~~~~~~~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---EQ-------------VEKGYRMSCPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HH-------------HHcCCCCCCCCC
Confidence            44678999999998899999999999999999998 88887543222110   00             000000 01122


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          499 EVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       499 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ....+.+++.+||+.+|++||++.|+++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            3457888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-37  Score=325.43  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=203.2

Q ss_pred             HHhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhcc-ccccceeeeeeeeC
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTK  324 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  324 (569)
                      ...++|.+.++||+|+||.||+|++.      .++.||||++.... ......+.+|+.+|.++. |||||++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34456888899999999999999864      34689999997543 233457889999999997 99999999999999


Q ss_pred             CceEEEEeecCCCChhhHhhCCCC--------------------------------------------------------
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQ--------------------------------------------------------  348 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  348 (569)
                      ...++||||+++|+|.+++.....                                                        
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            999999999999999999853211                                                        


Q ss_pred             ---------------------------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCe
Q 037160          349 ---------------------------------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNI  389 (569)
Q Consensus       349 ---------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NI  389 (569)
                                                             ...+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence                                                   124677888999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcch
Q 037160          390 LLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGF  468 (569)
Q Consensus       390 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~  468 (569)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            999999999999999986544322212223456789999999998889999999999999999998 7777653322110


Q ss_pred             hhhhHhHhhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          469 ETLVTHTWKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       469 ~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                        ..             +.+...... .+......+.+++..||+.+|+.||+++||++.|+..
T Consensus       351 --~~-------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 --FY-------------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             --HH-------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              00             001110000 1112235677888899999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-37  Score=322.58  Aligned_cols=263  Identities=25%  Similarity=0.320  Sum_probs=196.7

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCC-----
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-----  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  325 (569)
                      ..++|++.++||+|+||.||++... +|+.||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999875 6899999998643  2344567889999999999999999999986543     


Q ss_pred             -ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          326 -DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       326 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                       ..++||||+.+ +|.+.+.     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46999999976 4555442     24788889999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhHh---------
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVTH---------  474 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~---------  474 (569)
                      ++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......         
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            97543322   22345789999999999999999999999999999999999999875432110 000000         


Q ss_pred             -----Hhhhh-------cccchhhhhcccCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          475 -----TWKHF-------QAKTVLEIIDKSIEI----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       475 -----~~~~~-------~~~~~~~~~~~~l~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                           ....+       ......+........    ........+.+++.+||+.+|++|||+.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                 00000       000000000000000    0111234577899999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.7e-38  Score=308.89  Aligned_cols=253  Identities=29%  Similarity=0.425  Sum_probs=200.3

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecchhhH--HHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      |++.++||+|+||.||+++.. +++.+|+|.+........  ....+|+.++++++||||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677889999999999999977 567899999987654332  23456999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      .+++|.+++.   ....+++..++.++.|+++||.+||+.+   |+|+||||+||+++.++.++|+|||.+.......  
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence            9999999995   4567899999999999999999999998   9999999999999999999999999987642111  


Q ss_pred             CCCcccccCCCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 LPNTAIAGTLGYMAPEYIA-NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                      .......++..|+|||++. +...+.++||||||+++++|++|..|+................    ..   ........
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~----~~---~~~~~~~~  225 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL----KR---PLPSSSQQ  225 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH----HT---HHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc----cc---cccccccc
Confidence            1334567899999999998 7889999999999999999999998877541111111110000    00   00000000


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        .......+.+++..||+.+|++||++.+++++
T Consensus       226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             --cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00112678889999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.4e-38  Score=318.92  Aligned_cols=240  Identities=22%  Similarity=0.302  Sum_probs=187.6

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHH-HHHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEM-DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      +.||+|+||.||+++.. +++.||+|++....   ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999976 67889999986532   12223444444 456778999999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|.+++.   ....+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~  152 (325)
T cd05602          81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T  152 (325)
T ss_pred             CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence            99999884   3455778888899999999999999998   99999999999999999999999999875432221  2


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........       +..        +...... ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~--------i~~~~~~-~~  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------YDN--------ILNKPLQ-LK  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-------HHH--------HHhCCcC-CC
Confidence            3356799999999999999999999999999999999999999864332211       000        1111111 11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSMTNVV  525 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl  525 (569)
                      +.....+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            12334567788899999999999987444

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9e-38  Score=316.78  Aligned_cols=264  Identities=20%  Similarity=0.327  Sum_probs=199.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|.+.++||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999976 67889999886543 22334677899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 77777643  2345788999999999999999999998   99999999999999999999999999876543221


Q ss_pred             CCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhhhhcccch
Q 037160          414 LLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWKHFQAKTV  484 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~  484 (569)
                        ......+++.|+|||++.+ ..++.++||||||+++|||++|++||...........+..        .|..+.....
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              1223467899999998865 4688999999999999999999999875544322111111        1111111100


Q ss_pred             hhhhc-ccCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          485 LEIID-KSIEI-----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       485 ~~~~~-~~l~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+ +....     ..+.....+.+++.+||+.||.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            00000 00000     011223456789999999999999999999964

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-37  Score=318.55  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=203.3

Q ss_pred             hccccccccccccCceeEEEEEec--------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeC
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ--------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK  324 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  324 (569)
                      ..+|.+.++||+|+||.||+++..        .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            356889999999999999999743        12368999776432 34457889999999999 899999999999999


Q ss_pred             CceEEEEeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                      ...+++|||+++++|.+++....             ....+++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999985421             2345788999999999999999999998   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~  470 (569)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......... 
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence            9999999999999986654332212223344578999999999999999999999999999998 77776433221110 


Q ss_pred             hhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                            ....        ..............+..++..||+.+|++||++.||++.|+...
T Consensus       247 ------~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         247 ------KLLK--------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             ------HHHH--------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                  1000        00000112223456778899999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.3e-38  Score=326.15  Aligned_cols=256  Identities=21%  Similarity=0.288  Sum_probs=200.5

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCC
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK  325 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  325 (569)
                      .++...++|++.+.||+|+||.||+++++ +++.+|+|++....   ......+.+|+.+++.++||||+++++.+....
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445689999999999999999999976 68899999886432   233456789999999999999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++||||+++++|.+++..    ..++...+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            99999999999999999842    34788888999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANG----QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      +........ ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........       +.    
T Consensus       190 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~----  257 (371)
T cd05622         190 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YS----  257 (371)
T ss_pred             eEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-------HH----
Confidence            876543221 22356799999999998653    378999999999999999999999864332111       01    


Q ss_pred             cchhhhhcc--cCCCC-CHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 037160          482 KTVLEIIDK--SIEIE-DIEEVKRVVWVGLLCTQELPTL--RPSMTNVVQML  528 (569)
Q Consensus       482 ~~~~~~~~~--~l~~~-~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~~L  528 (569)
                          .+...  .+... .......+..++..|++.++.+  ||++.||+++.
T Consensus       258 ----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         258 ----KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ----HHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                11110  01111 1223445666778898844443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=306.42  Aligned_cols=255  Identities=27%  Similarity=0.420  Sum_probs=205.6

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ..++|.+.++||+|+||.||++..++++.+|||.+..... ..+.+.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4578999999999999999999988888999998865432 346789999999999999999999999988999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999998542 2346899999999999999999999998   99999999999999999999999999886654221


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      . ......++..|+|||.+.+..++.++||||||++++||++ |+.|+.......   ....             +....
T Consensus       159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~-------------~~~~~  221 (261)
T cd05034         159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ-------------VERGY  221 (261)
T ss_pred             h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------HHcCC
Confidence            1 1122334678999999998899999999999999999998 888875332211   1111             11111


Q ss_pred             C-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          493 E-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       493 ~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      . ..+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0 0111224567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-37  Score=314.88  Aligned_cols=254  Identities=25%  Similarity=0.409  Sum_probs=198.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCc--eEEEEEEeec-chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGR--EIAVKRLFIS-RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|++.+.||+|+||.||+|.++ ++.  .+++|.+... .......+.+|++++.++ +||||+++++++......++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57888999999999999999975 454  4577766543 234456788999999999 899999999999999999999


Q ss_pred             EeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          331 YEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                      |||+++++|.+++....             ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999985332             1236789999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+|||+++......   ......++..|+|||++.+..++.++||||||+++|||++ |..||........   .    
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----  233 (303)
T cd05088         164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y----  233 (303)
T ss_pred             EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---H----
Confidence            999999986432111   1112234667999999988889999999999999999998 8888753322211   0    


Q ss_pred             hhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          477 KHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ..         +...... ........+.+++.+||+.+|++||++.+++++|+..
T Consensus       234 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 EK---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HH---------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00         0000000 0111234577899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.9e-37  Score=312.35  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=204.1

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ..+|++.++||+|++|.||+|+.. +++.|++|.+..........+.+|+.+++.++|+||+++++.+......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            357888999999999999999865 6899999998776655567889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++..    ..+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999998832    35788999999999999999999998   99999999999999999999999999876543321


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......  .+.. .   .....      ..+ 
T Consensus       172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~-~---~~~~~------~~~-  236 (296)
T cd06654         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL-I---ATNGT------PEL-  236 (296)
T ss_pred             --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH-H---hcCCC------CCC-
Confidence              1234468899999999988889999999999999999999999986443211  0100 0   00000      000 


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .........+.+++.+||+.+|++|||+.+|+++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0122233557778999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.8e-38  Score=309.44  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=202.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|++.++||+|+||.||+++.. +++.||+|.+..........+.+|+.+++.++||||+++++.+......++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888899999999999999865 6889999998766555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++.   ..+.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            99999999883   3456899999999999999999999998   99999999999999999999999999876543221


Q ss_pred             CCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          414 LLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                        ......|+..|+|||++.   .+.++.++|||||||++|||++|..|+....+...  ............        
T Consensus       162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~~~~~~~--------  229 (267)
T cd06645         162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKSNFQPP--------  229 (267)
T ss_pred             --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhccCCCCC--------
Confidence              223557899999999874   45688999999999999999999998754332111  000000000000        


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... ........+.+++.+||+.+|++||++.+|+++
T Consensus       230 ~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         230 KLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            000 011122456789999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=305.76  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=205.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      ++|++.++||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57889999999999999999975 67889999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++........ 
T Consensus        83 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          83 GGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            99999998843  2356889999999999999999999998   99999999999999999999999999876544221 


Q ss_pred             CCCcccccCCCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          415 LPNTAIAGTLGYMAPEYIANG---QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                       ......++..|+|||.+.+.   .++.++||||||+++|||++|+.|+........  ......         ..+...
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~~---------~~~~~~  224 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLISK---------SNFPPP  224 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh---------ccCCCc
Confidence             22345688899999998776   889999999999999999999998754322111  000000         000000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...........+.+++.+||+.+|.+|||+.+|+.+
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            001123345668889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-37  Score=319.49  Aligned_cols=260  Identities=28%  Similarity=0.406  Sum_probs=199.1

Q ss_pred             hccccccccccccCceeEEEEEe------cCCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeC-C
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTL------QDGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK-K  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~  325 (569)
                      .++|++.++||+|+||.||+|+.      .+++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999973      246889999986543 33456788999999999 789999999988654 4


Q ss_pred             ceEEEEeecCCCChhhHhhCCCC---------------------------------------------------------
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQ---------------------------------------------------------  348 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  348 (569)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998853210                                                         


Q ss_pred             -------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccc
Q 037160          349 -------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA  421 (569)
Q Consensus       349 -------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  421 (569)
                             ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124678888999999999999999998   9999999999999999999999999998654332221222334


Q ss_pred             cCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHH
Q 037160          422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEV  500 (569)
Q Consensus       422 gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  500 (569)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+.......  ...    .....+.       .. ..+....
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~-------~~-~~~~~~~  308 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGT-------RM-RAPDYTT  308 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhccC-------CC-CCCCCCC
Confidence            5678999999988899999999999999999997 887765332110  000    0000000       00 0011122


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          501 KRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       501 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ..+.+++..||+.+|++|||+.||+++|+..
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            4578889999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-37  Score=311.87  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      |+..++||+|+||.||++... +++.||+|.+....   ......+.+|+.++++++|+||+++++.+......++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999876 68899999886532   22235577899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999988432 2345889999999999999999999998   99999999999999999999999999876543322


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                         .....|+..|+|||++.+..++.++||||||+++|||++|+.||..................     .    .... 
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-----~----~~~~-  224 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-----V----QEEY-  224 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----h----hhhc-
Confidence               12347899999999999999999999999999999999999998653321110000000000     0    0000 


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~  527 (569)
                        .......+.+++..||+.+|++|||     +.|++++
T Consensus       225 --~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         225 --SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             --CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence              1122345677889999999999999     8899864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-37  Score=304.68  Aligned_cols=250  Identities=20%  Similarity=0.284  Sum_probs=202.0

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+......+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999976 6899999988653 3344567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++.. .....+++..++.++.+++.||.|||+.+   |+|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            99999988843 23445788999999999999999999998   99999999999999999999999999876644322 


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+.......   .....            .......
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~------------~~~~~~~  219 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LILKV------------CQGSYKP  219 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHHHH------------hcCCCCC
Confidence             1234568899999999988889999999999999999999999986432211   10000            0000111


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+......+.+++.+||+.+|++||++.+|+..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            112233457788999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.9e-38  Score=318.39  Aligned_cols=241  Identities=24%  Similarity=0.339  Sum_probs=192.4

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +|+..+.||+|+||.||++..+ +|+.||+|++....   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999876 68899999887542   233456778999998885 577888999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999883   3456899999999999999999999998   999999999999999999999999998754332


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.|+........   ...            +....
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~------------i~~~~  217 (323)
T cd05615         155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQS------------IMEHN  217 (323)
T ss_pred             Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHH------------HHhCC
Confidence            21  22345689999999999988999999999999999999999999864432211   110            11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSM  521 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~  521 (569)
                      .. .+......+.+++.+||+.+|.+|++.
T Consensus       218 ~~-~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 VS-YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CC-CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            10 011223456778899999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.9e-37  Score=307.76  Aligned_cols=254  Identities=26%  Similarity=0.454  Sum_probs=200.2

Q ss_pred             ccccccccccccCceeEEEEEec-CC---ceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DG---REIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .+|++.+.||+|+||.||+|..+ ++   ..||||.+... .......|..|+.++++++||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35788899999999999999975 33   36999988654 344557899999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999843  2356899999999999999999999998   99999999999999999999999999876544


Q ss_pred             CCCCCCCc-ccc--cCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          411 EKSLLPNT-AIA--GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       411 ~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ........ ...  .+..|+|||++.++.++.++||||||+++|||++ |..|+........   ..             
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~-------------  222 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---IN-------------  222 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HH-------------
Confidence            32211111 111  2457999999998999999999999999999886 8888754322111   00             


Q ss_pred             hhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          487 IIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       487 ~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .+...... ...+....+.+++..||+.+|++||++.+|+..|+.
T Consensus       223 ~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         223 AIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            00000000 112233456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.2e-37  Score=304.20  Aligned_cols=247  Identities=25%  Similarity=0.394  Sum_probs=194.1

Q ss_pred             cccccCceeEEEEEec---CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCC
Q 037160          263 KLGHGGYGEIFKGTLQ---DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKS  338 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  338 (569)
                      .||+|+||.||+|.+.   .+..||+|++.... ....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999864   35579999886553 233467899999999999999999999875 457899999999999


Q ss_pred             hhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC-CC
Q 037160          339 LDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL-PN  417 (569)
Q Consensus       339 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~  417 (569)
                      |.+++..  ....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++......... ..
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999843  3457899999999999999999999998   9999999999999999999999999998654433211 11


Q ss_pred             cccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-
Q 037160          418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-  495 (569)
Q Consensus       418 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-  495 (569)
                      ....++..|+|||.+....++.++||||||+++|||++ |..|+........                ...+....... 
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV----------------MSFIEQGKRLDC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH----------------HHHHHCCCCCCC
Confidence            22234578999999988889999999999999999996 8888754322111                11111111111 


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      +......+.+++..||+.+|++||++.+|.+.|+..
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            223345677789999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-37  Score=302.23  Aligned_cols=247  Identities=27%  Similarity=0.439  Sum_probs=197.9

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCChh
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLD  340 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  340 (569)
                      ++||+|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877999999988654433 5568999999999999999999999999999999999999999999


Q ss_pred             hHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCccc
Q 037160          341 RILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI  420 (569)
Q Consensus       341 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  420 (569)
                      +++...  ...+++..+..++.+++.+|.|||+.+   ++||||||+||+++.++.+||+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998432  346788999999999999999999998   999999999999999999999999998865432221111223


Q ss_pred             ccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC-CCHH
Q 037160          421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI-EDIE  498 (569)
Q Consensus       421 ~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~  498 (569)
                      .++..|+|||++.++.++.++||||||+++|||++ |..|+..........                .+...... .+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE----------------RIESGYRMPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH----------------HHhcCCCCCCCcc
Confidence            34667999999988899999999999999999999 777765433221111                11110000 1122


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          499 EVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       499 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ....+.+++.+||+.+|++|||+.||++.|+
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3346788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3e-37  Score=304.83  Aligned_cols=255  Identities=24%  Similarity=0.375  Sum_probs=203.5

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ..++|++.++||+|+||.||++...++..+++|.+.... .....+.+|+.++++++|+||+++.+.+.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            356789999999999999999998777889999876543 334678899999999999999999999877 778999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++... ....+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            9999999998542 2346788899999999999999999998   99999999999999999999999999986644322


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      . ......++..|+|||++..+.++.++||||||+++|+|++ |+.|+.........   .    .......       .
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~----~~~~~~~-------~  222 (260)
T cd05073         158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R----ALERGYR-------M  222 (260)
T ss_pred             c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---H----HHhCCCC-------C
Confidence            1 2223345678999999998889999999999999999999 88887543221111   0    0000000       0


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                       .........+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0112233567788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.7e-37  Score=310.65  Aligned_cols=265  Identities=21%  Similarity=0.288  Sum_probs=199.5

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|++.++||+|++|.||+|..+ +++.||+|++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999976 68999999886542  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      ++ ++|.+++........+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 588888754444467899999999999999999999998   99999999999999999999999999876543221


Q ss_pred             CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh-hh-------HhHhhhhcc-cc
Q 037160          414 LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET-LV-------THTWKHFQA-KT  483 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~-~~-------~~~~~~~~~-~~  483 (569)
                        ......+++.|+|||++.+. .++.++||||||+++|||++|++|+.......... ..       ...|+.... ..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence              12234568899999988654 57899999999999999999999886443211100 00       001111000 00


Q ss_pred             hhhhhcccCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIE----IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+.....    .........+.+++.+||+.||++|||+.+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000000    0011123456789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-37  Score=309.89  Aligned_cols=270  Identities=21%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             ccccccccccccCceeEEEEEec-----CCceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeee--CCce
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-----DGREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFT--KKDS  327 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  327 (569)
                      +.|++.++||+|+||.||++.+.     .++.+|||.+...... ..+.+.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777889999999999999854     3688999998765443 56789999999999999999999999877  5678


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      +++|||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHh--CccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999943  2335899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... .......++..|++||.+.+..++.++||||||++++||++|+.|+......... .............+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHH
Confidence            7633221 1112234556799999998889999999999999999999999886533221100 0000000001111122


Q ss_pred             hhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          487 IIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       487 ~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .+....... .......+.+++.+||+.+|++|||+.||+++|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            222211111 222335688899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-37  Score=306.25  Aligned_cols=258  Identities=26%  Similarity=0.303  Sum_probs=201.3

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +..++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            445667777789999999999999965 6788999988776666677899999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~~~  409 (569)
                      +||+++++|.+++.........++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999854322212278888899999999999999998   999999999999976 6789999999987654


Q ss_pred             CCCCCCCCcccccCCCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQ--LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ....  ......++..|+|||++....  ++.++||||||+++|+|++|++|+.........     .+..        .
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~~--------~  225 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFKV--------G  225 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hhhh--------h
Confidence            3222  223345789999999986643  788999999999999999999987532211100     0000        0


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ........+......+..++.+||+.+|++|||+.||+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0000000112233457778899999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=317.91  Aligned_cols=202  Identities=22%  Similarity=0.353  Sum_probs=173.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999976 6899999998643   2233456889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999843  2356889999999999999999999998   999999999999999999999999998765443


Q ss_pred             CCCCCCcccccCCCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIAN-----GQLTEKVDIYSFGVLVLEIVSGVQNNKFQ  463 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltg~~p~~~~  463 (569)
                      ... ......||+.|+|||++..     +.++.++|||||||++|||++|+.||...
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            321 2223568999999999863     45788999999999999999999998643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=318.88  Aligned_cols=241  Identities=23%  Similarity=0.321  Sum_probs=187.5

Q ss_pred             ccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc---cccccceeeeeeeeCCceEEEEeecCC
Q 037160          264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA---HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ||+|+||.||+|+.+ +++.||||++....   ......+..|..++.++   +||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999976 68999999986532   12234455677777665   699999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence            99998884   3456899999999999999999999998   99999999999999999999999999875433221  2


Q ss_pred             CcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE  495 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  495 (569)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........       +.....+        .....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~--------~~~~~  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFG--------KVRFP  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcC--------CCCCC
Confidence            2356799999999998765 489999999999999999999999864332211       1111100        01111


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRP----SMTNVVQM  527 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RP----t~~evl~~  527 (569)
                      .......+.+++.+||+.+|++||    ++.+++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            111234566788999999999998    56777653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.4e-37  Score=304.14  Aligned_cols=240  Identities=23%  Similarity=0.314  Sum_probs=187.9

Q ss_pred             ccccccCceeEEEEEecC-------------CceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          262 NKLGHGGYGEIFKGTLQD-------------GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      +.||+|+||.||+|....             ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998542             2358888876655555667889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC-------eEEec
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR-------PKIAD  401 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~-------~kl~D  401 (569)
                      +||||+++++|..++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988842  3356899999999999999999999998   999999999999987664       89999


Q ss_pred             cCCCcccCCCCCCCCCcccccCCCcccccccc-cCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhh
Q 037160          402 FGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA-NGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       402 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      ||++......      ....++..|+|||.+. +..++.++||||||+++|||++ |..|+..........    .    
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~----  221 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----F----  221 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----H----
Confidence            9998654322      2345788999999886 4578999999999999999984 666654322111000    0    


Q ss_pred             cccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          480 QAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       480 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                              ....... .......+..++.+||+.+|++||++.+|++.|+
T Consensus       222 --------~~~~~~~-~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 --------YEGQCML-VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             --------HhcCccC-CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                    0000000 1112345678899999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-37  Score=325.19  Aligned_cols=262  Identities=21%  Similarity=0.238  Sum_probs=200.2

Q ss_pred             HhccccccccccccCceeEEEEEec---CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ---DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ...+|++.++||+|+||.||++...   .+..|++|.+...     ....+|+++|++++||||+++++++......+++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            3467999999999999999999754   3578999977543     2346899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ||++. ++|.+++   .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99995 6787777   34467899999999999999999999998   99999999999999999999999999986655


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhc-------cc-
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ-------AK-  482 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~-  482 (569)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.|+...........+....+...       .. 
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            4333233456799999999999999999999999999999999999999865433221111111111000       00 


Q ss_pred             --chhhhh---cccCCCC--C------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 --TVLEII---DKSIEIE--D------IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 --~~~~~~---~~~l~~~--~------~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        .+...+   .......  .      ......+..++.+||+.+|++|||+.|++.+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000000   0000000  0      0112456678899999999999999999977

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.7e-37  Score=307.95  Aligned_cols=252  Identities=23%  Similarity=0.385  Sum_probs=200.2

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      .|++.++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+......++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3678889999999999999976 577889998876666667788999999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|..++..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........  
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            9999988743  2356899999999999999999999998   99999999999999999999999999876543221  


Q ss_pred             CCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          416 PNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ......++..|+|||++.     +..++.++|||||||++|||++|++|+.......  ......    .. .     ..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~----~~-~-----~~  226 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIA----KS-E-----PP  226 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHh----hc-C-----CC
Confidence            223456889999999984     3457889999999999999999999875432211  010000    00 0     00


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      .+. .+......+.+++..||+.+|.+||++.+++++-
T Consensus       227 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         227 TLA-QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             CCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            000 1112234677888999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.4e-37  Score=313.32  Aligned_cols=261  Identities=25%  Similarity=0.385  Sum_probs=203.0

Q ss_pred             hccccccccccccCceeEEEEEec--------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeC
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ--------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK  324 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  324 (569)
                      .++|.+.++||+|+||.||++...        ....+|+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357888999999999999999742        24568999876432 34456788999999999 699999999999998


Q ss_pred             CceEEEEeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                      ...+++|||+++++|.+++....             ....+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            99999999999999999985432             1245889999999999999999999998   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~  470 (569)
                      +.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+......... 
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-  246 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF-  246 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence            9999999999999986654322211222234567999999998899999999999999999999 77776533222111 


Q ss_pred             hhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                            ........       . .........+.+++.+||+.+|++|||+.++++.|.....
T Consensus       247 ------~~~~~~~~-------~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         247 ------KLLREGHR-------M-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ------HHHHcCCC-------C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                  10000000       0 0112223466788999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.9e-37  Score=302.89  Aligned_cols=251  Identities=27%  Similarity=0.428  Sum_probs=204.1

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|+..++||+|+||.||+++.. +++.+++|.+.....  .+.+.+|++++++++||||+++++.+......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            367899999999999999999987 478999998865533  67899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999843  3457899999999999999999999998   99999999999999999999999999886654321


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......++..|+|||++.+..++.++||||||+++|+|++|+.|+.........  ..     ...     .......
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~-----~~~-----~~~~~~~  220 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FM-----IPN-----KPPPTLS  220 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hh-----hcc-----CCCCCCC
Confidence              223445788999999998889999999999999999999999997643222110  00     000     0000000


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ........+.+++.+||+.+|++|||+.||+++
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence             122233567888999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3e-37  Score=309.21  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=198.6

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      |+..++||+|+||.||++... +++.+|+|.+....   ......+.+|++++++++|+||+++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667788999999999999875 78899999886542   22335578899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            9999999888532 2346899999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......|+..|+|||++.+..++.++||||||+++|||++|..||...........+.            ..+.....
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~------------~~~~~~~~  222 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD------------RRVLETEE  222 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------Hhhhcccc
Confidence              1234568999999999998899999999999999999999999986433221100000            00000000


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~  527 (569)
                      .........+..++..||+.+|++||+     +.+++.+
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            011122345677888999999999999     7777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-37  Score=320.54  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=197.0

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC------
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------  324 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  324 (569)
                      ..++|++.++||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999965 6889999998653  233456788999999999999999999987543      


Q ss_pred             CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999965 6666652     24788899999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh-hhH-------hHh
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET-LVT-------HTW  476 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~-~~~-------~~~  476 (569)
                      ++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||.......... .+.       ..+
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            98654322   2234578999999999999999999999999999999999999986543221100 000       000


Q ss_pred             hhhcc--------------cchhhhhcccCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 KHFQA--------------KTVLEIIDKSIEI----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 ~~~~~--------------~~~~~~~~~~l~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +....              ....+........    ........+.+++.+|++.||.+|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000              0000000000000    011123467789999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-37  Score=320.81  Aligned_cols=261  Identities=25%  Similarity=0.310  Sum_probs=197.0

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC------
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------  324 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  324 (569)
                      ..++|++.+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999865 6889999988653  233456788999999999999999999988643      


Q ss_pred             CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            346999999975 5555552     24788899999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhHh-------Hh
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVTH-------TW  476 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~-------~~  476 (569)
                      ++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ...+..       .+
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            98654332   22345789999999999998999999999999999999999999864432111 000000       00


Q ss_pred             hhhcccchhhhhc---------------ccCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 KHFQAKTVLEIID---------------KSIE----IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 ~~~~~~~~~~~~~---------------~~l~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .... ..+...++               ..+.    .........+.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             Hhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0000 00000000               0000    0011123467789999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.1e-37  Score=305.98  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=200.9

Q ss_pred             ccccccccccccCceeEEEEEec-C---CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-D---GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.+.... ....+.+.+|+.++++++||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999864 2   2368999876532 33456789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..  ....+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999843  2346899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCCC-CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          411 EKSLLP-NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       411 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ...... .....++..|+|||.+.++.++.++||||||+++||+++ |..|+.........       .......     
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~-------~~~~~~~-----  226 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-------KAIEEGY-----  226 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH-------HHHhCCC-----
Confidence            322111 112223568999999998899999999999999999886 98887543322110       0000000     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .   ..........+..++.+|++.+|++||++.++++.|+.
T Consensus       227 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         227 R---LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             c---CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            0   00111233466789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.2e-37  Score=310.73  Aligned_cols=250  Identities=25%  Similarity=0.388  Sum_probs=203.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .+|++.++||.|++|.||+++.. +++.|++|.+........+.+.+|+.+++.++||||+++++.+......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46899999999999999999864 78999999987665555678899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++.    ...+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            9999999883    235899999999999999999999998   99999999999999999999999999876544332 


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       ......++..|+|||.+.+..++.++|||||||++|+|++|+.|+...........+   ...   .      ...+ .
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~~~---~------~~~~-~  236 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATN---G------TPEL-Q  236 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhc---C------Cccc-C
Confidence             123456889999999999888999999999999999999999998654332111000   000   0      0000 0


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ........+.+++.+||+.+|++||++.+|+.+
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            111223456778899999999999999999954

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=295.76  Aligned_cols=249  Identities=23%  Similarity=0.326  Sum_probs=200.8

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++++|++.+.||+|.|+.|+++.+. +|+.+|+|.+...  +....+++.+|+.|-+.|+||||+++.+.+.+....|+
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            35678888999999999999999876 7999999977543  33466889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC---CCeEEeccCCCc
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR  406 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl~Dfgla~  406 (569)
                      |+|+|.|++|..-|.   .+.-+++..+-..+.||+++|.|+|.++   |||||+||+|+||-+.   .-+||+|||+|.
T Consensus        88 vFe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence            999999999965552   3355677778889999999999999999   9999999999999543   348999999999


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ......   ......|||+|||||+++..+++..+|||+.|||||-|+.|.+||........                .+
T Consensus       162 ~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl----------------ye  222 (355)
T KOG0033|consen  162 EVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL----------------YE  222 (355)
T ss_pred             EeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH----------------HH
Confidence            887433   34577899999999999999999999999999999999999999875332211                11


Q ss_pred             hhc-ccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          487 IID-KSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       487 ~~~-~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      .+. .....+   -+...+....++.+||..||.+|.|+.|.|+
T Consensus       223 ~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  223 QIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            111 111111   1122234456778999999999999999884

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-37  Score=302.62  Aligned_cols=249  Identities=27%  Similarity=0.410  Sum_probs=195.7

Q ss_pred             ccccccCceeEEEEEec-C---CceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-D---GREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+|++. .   +..+|+|.+..... ...+.+.+|+.+++++.|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999854 2   26899998875543 34567899999999999999999999875 4568999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|.+++..   ...+++..++.++.|++.+|.|||..+   ++||||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999943   337899999999999999999999998   99999999999999999999999999986654332211


Q ss_pred             -CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          417 -NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       417 -~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |.+|+.......   +......    ..      .  ..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~----~~------~--~~  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLES----GE------R--LP  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----CC------c--CC
Confidence             112234568999999998899999999999999999998 888875433221   1111100    00      0  00


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ........+.+++.+||+.+|++||++.+|++.|+...
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            11223356778999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.8e-37  Score=340.60  Aligned_cols=259  Identities=22%  Similarity=0.309  Sum_probs=200.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999976 68999999986432   233467899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCC--------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          332 EFVQNKSLDRILFDPK--------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                      ||++|++|.+++....        ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1234567788999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCC----------------CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 037160          404 LARFSSSEKS----------------LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG  467 (569)
Q Consensus       404 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~  467 (569)
                      +++.......                ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986622110                001123569999999999999999999999999999999999999986432211


Q ss_pred             hhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhcc
Q 037160          468 FETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRP-SMTNVVQMLKQ  530 (569)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-t~~evl~~L~~  530 (569)
                      ..      ...    .   ...+.......+....+.+++.+|++.+|++|| ++.++++.|+.
T Consensus       239 i~------~~~----~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 IS------YRD----V---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hh------hhh----h---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            10      000    0   000000000112234567788999999999996 56666666654

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.2e-37  Score=307.66  Aligned_cols=254  Identities=23%  Similarity=0.368  Sum_probs=199.0

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeC------
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK------  324 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------  324 (569)
                      ..++.|++.++||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++.+...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678999999999999999999876 68899999886543 3345788999999998 799999999998753      


Q ss_pred             CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                      ...+++|||+.+++|.+++... ....+++..+..++.|++.||.|||+++   |+|+||||+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999998532 3356889999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhh
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      +........  ......|++.|+|||++.     +..++.++|||||||++|||++|+.|+.........      ....
T Consensus       158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~~~~  229 (272)
T cd06637         158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIP  229 (272)
T ss_pred             ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HHHh
Confidence            876543221  233567899999999986     345788999999999999999999987532221100      0000


Q ss_pred             cccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          480 QAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       480 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      . ..     ....  ........+.+++.+||+.+|.+|||+.+|+++
T Consensus       230 ~-~~-----~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         230 R-NP-----APRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             c-CC-----CCCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            0 00     0000  111223457788999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.4e-37  Score=308.45  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=201.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +.|++.++||+|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999976 58899999988776666788999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|..++..  ....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-  165 (292)
T cd06644          92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-  165 (292)
T ss_pred             CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence            99999888743  2346899999999999999999999998   99999999999999999999999999875433211 


Q ss_pred             CCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          415 LPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                       ......++..|+|||++.     ...++.++|||||||++|||++|..|+.......  ....     .....     .
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~-----~~~~~-----~  232 (292)
T cd06644         166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLK-----IAKSE-----P  232 (292)
T ss_pred             -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHH-----HhcCC-----C
Confidence             223456888999999985     3457889999999999999999999875432211  0000     00000     0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +.. .........+..++.+||+.+|++||++.+|+++
T Consensus       233 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 PTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000 0112233467788999999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.9e-37  Score=309.56  Aligned_cols=263  Identities=24%  Similarity=0.297  Sum_probs=193.5

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhc---cccccceeeeeeee-----CC
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRA---HHKNLVQFLGCCFT-----KK  325 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~  325 (569)
                      +|++.+.||+|+||.||+|+.+ +++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999976 688999998865321  2223456777777665   69999999998864     24


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..+++|||+.+ +|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999975 788877432 2345899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-hhhHhH----hhhhc
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE-TLVTHT----WKHFQ  480 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~----~~~~~  480 (569)
                      +......   ......||..|+|||++.+..++.++|||||||++|||++|++||......... ......    ...|.
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8665432   223456899999999999889999999999999999999999988654332111 111000    00000


Q ss_pred             ccc-h-hhhhcccCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          481 AKT-V-LEIIDKSIEI----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       481 ~~~-~-~~~~~~~l~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... . .....+....    ..+.....+.+++.+|++.||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000 0 0000000000    011223456789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=343.93  Aligned_cols=261  Identities=21%  Similarity=0.331  Sum_probs=200.9

Q ss_pred             hhHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC
Q 037160          248 YSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK  324 (569)
Q Consensus       248 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  324 (569)
                      +...+...++|++.++||+|+||.||++.+. .+..+|+|.+...  .......+..|+.+|++|+|||||++++++...
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            3344556678999999999999999999976 5778899988643  233456789999999999999999999988653


Q ss_pred             --CceEEEEeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCC----CCeeeCCCCCCCeEECC----
Q 037160          325 --KDSFVVYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQ----MQIVHRDIKASNILLDL----  393 (569)
Q Consensus       325 --~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivHrDikp~NIll~~----  393 (569)
                        ...+|||||+++++|.++|... .....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.    
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence              5689999999999999998542 223568999999999999999999998542    34999999999999964    


Q ss_pred             -------------CCCeEEeccCCCcccCCCCCCCCCcccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCCC
Q 037160          394 -------------KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGVQ  458 (569)
Q Consensus       394 -------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~~  458 (569)
                                   .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||||++|+.
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                         2348999999998664332   1234578999999999864  458899999999999999999999


Q ss_pred             CCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          459 NNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       459 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      ||......  ..++.             .+..............+..++..||+.+|.+||++.|++.
T Consensus       242 PF~~~~~~--~qli~-------------~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        242 PFHKANNF--SQLIS-------------ELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCcCCcH--HHHHH-------------HHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            98543211  11111             1111111111123456778999999999999999999993

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-37  Score=303.06  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=198.3

Q ss_pred             ccccccCceeEEEEEecC--C--ceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQD--G--REIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  3  3689998876655 566789999999999999999999999988 889999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC-C
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL-L  415 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  415 (569)
                      ++|.+++..... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++........ .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999854322 56899999999999999999999998   999999999999999999999999999876543221 1


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+.......   .......   .       .... .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~-------~~~~-~  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---E-------GERL-E  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---c-------CCcC-C
Confidence            1123457789999999998899999999999999999998 988875332211   1000000   0       0000 0


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ........+.+++.+||+.+|++||++.+|++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11223456788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-37  Score=308.05  Aligned_cols=253  Identities=23%  Similarity=0.415  Sum_probs=201.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.+.||+|+||.||+++.+ +++.||+|.+... .......+.+|++++++++||||+++++.+......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999976 7899999988654 333456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      +++++|..++........+++..+..++.+++.||.|||+. +   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999885433345789999999999999999999974 6   9999999999999999999999999987654321


Q ss_pred             CCCCCcccccCCCcccccccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQ------LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                          .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||..........            .+..
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~------------~~~~  221 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA------------QLSA  221 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH------------HHHH
Confidence                22345788999999986543      4789999999999999999999985432211100            0011


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ................+..++.+||+.+|++||++.+++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         222 IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            11111111123355667789999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.2e-37  Score=300.78  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=204.4

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|+..+.||.|+||.||.++.. +++.+++|.+...  .......+.+|++++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788899999999999999865 6889999988654  244556788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++... ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999998532 2456899999999999999999999998   99999999999999999999999999986654332


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|..|+........   .            .........
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~------------~~~~~~~~~  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---V------------VKIVQGNYT  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH---H------------HHHHcCCCC
Confidence              22345689999999999888899999999999999999999998754322111   0            011111111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      .........+..++.+||+.+|++||++.++++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11223345677888999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.8e-37  Score=303.12  Aligned_cols=252  Identities=24%  Similarity=0.418  Sum_probs=200.6

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35778899999999999999987788999998764432 23578899999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++..  ....+++..++.++.+++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++......... 
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            9999999843  2345789999999999999999999998   999999999999999999999999998765433211 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......++..|+|||.+.++.++.++||||||+++|||++ |..|+........   ..    .....     ...   .
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~-----~~~---~  221 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---VE----TINAG-----FRL---Y  221 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---HH----HHhCC-----CCC---C
Confidence            1223335678999999998899999999999999999998 8888754332211   10    00000     000   0


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      .+......+.+++.+||+.+|++|||+.|+++.|.
T Consensus       222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            01112356888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.3e-37  Score=304.07  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=199.5

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch---------hhHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---------NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+.....         ...+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999875 688999998864321         123568899999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .+++|||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999994   3356888999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCC----CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          407 FSSSEKSLL----PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       407 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      .........    ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+.......  ..           
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~-----------  221 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI-----------  221 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH-----------
Confidence            765322110    1123457889999999998899999999999999999999999986432110  00           


Q ss_pred             chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        ...........+......+..++.+||+.+|.+||++.||+++
T Consensus       222 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         222 --FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             --HHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence              0110110111122234567778899999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.8e-37  Score=302.59  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeee-eCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF-TKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  334 (569)
                      ++|++.+.||+|+||.||++..+ |..+++|.+....  ..+.+.+|+.++++++|+|++++++++. .....+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999876 7889999875432  3467889999999999999999999764 456789999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++... ....+++..++.++.+++.||.|||+.+   ++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999998532 2345889999999999999999999998   9999999999999999999999999987543321  


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                         ....++..|+|||++.+..++.++||||||+++|||++ |+.|+.......   +...             +.....
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~-------------~~~~~~  217 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-------------VEKGYK  217 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------HhcCCC
Confidence               22334568999999998899999999999999999998 888865332211   1110             100000


Q ss_pred             CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          494 IE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       494 ~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .. .......+..++.+||+.+|++|||+.++++.|+.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            01 12234567788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-37  Score=324.83  Aligned_cols=261  Identities=20%  Similarity=0.254  Sum_probs=195.7

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ...|.+.++||+|+||.||++.+. .++.||||...      ...+.+|+++|++++|+|||++++++......++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999976 57889999542      23456899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +. ++|.+++..  ....+++..++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 678777742  2346899999999999999999999998   99999999999999999999999999986644332


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCc--------chhhhhHhHh---hhhc--
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD--------GFETLVTHTW---KHFQ--  480 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~--------~~~~~~~~~~---~~~~--  480 (569)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++......        .....+....   ..+.  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            21223467999999999999999999999999999999999987654322111        0111111100   0000  


Q ss_pred             -ccchhhhhcc-----cCCC---CC----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          481 -AKTVLEIIDK-----SIEI---ED----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       481 -~~~~~~~~~~-----~l~~---~~----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ...+......     ....   ..    ......+..++.+||+.||++|||+.|+|++
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence             0000000000     0000   00    0112356779999999999999999999976

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3e-37  Score=307.83  Aligned_cols=247  Identities=25%  Similarity=0.408  Sum_probs=200.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++.+......++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34667788999999999999865 67889999886443 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++.    ...+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999999883    346889999999999999999999998   99999999999999999999999999876654321


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.|+....+....                ..+.....
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~  218 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL----------------FLIPKNSP  218 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH----------------hhhhcCCC
Confidence              122346788999999999889999999999999999999999987533221110                00000000


Q ss_pred             -CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 -IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 -~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       .........+.+++.+||+.+|++||++.+|+++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence             0112234567788999999999999999999975

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.5e-38  Score=323.47  Aligned_cols=203  Identities=27%  Similarity=0.409  Sum_probs=175.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++....   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999976 68899999986432   334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999984   3456889999999999999999999998   999999999999999999999999998754321


Q ss_pred             CCC---------------------------------CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 037160          412 KSL---------------------------------LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQ  458 (569)
Q Consensus       412 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~  458 (569)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00113469999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 037160          459 NNKFQS  464 (569)
Q Consensus       459 p~~~~~  464 (569)
                      ||....
T Consensus       235 Pf~~~~  240 (360)
T cd05627         235 PFCSET  240 (360)
T ss_pred             CCCCCC
Confidence            986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=315.36  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=210.5

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch---hhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCc
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---NRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKD  326 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  326 (569)
                      +...+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+...   .....+.+|+.+|+++. |||||.+.+++++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            345677889999999999999999987 599999999976543   23468999999999998 9999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC----CCeEEecc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK----HRPKIADF  402 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~----~~~kl~Df  402 (569)
                      .++|||++.||.|.+.+...    .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++||
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            99999999999999999543    3999999999999999999999998   9999999999999643    47999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      |++.......   .....+||+.|+|||++....++..+||||+||++|.|++|.+||..........            
T Consensus       184 Gla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------------  248 (382)
T KOG0032|consen  184 GLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------------  248 (382)
T ss_pred             CCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------------
Confidence            9999887622   4567899999999999999999999999999999999999999988665443211            


Q ss_pred             chhhhhcccC--CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLEIIDKSI--EIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~~~l--~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                         .+.....  ... -.......-+++..++..+|..|+|+.+++++
T Consensus       249 ---~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 ---AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ---HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence               1111111  111 22334556668889999999999999999986

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=304.43  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.+.||.|++|.||+|+.. +++.|++|.+.... ......+.+|+++++.++|+||+++++.+.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888899999999999999976 68899999886543 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++..    ..+++..+..++.|++.+|.|||+.+   ++||||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999999842    27899999999999999999999998   99999999999999999999999999987754321


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......++..|+|||++.+..++.++||||||+++|+|++|+.|+........   ......         ...+.+.
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~---------~~~~~~~  219 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFLIPK---------NNPPSLE  219 (274)
T ss_pred             --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHHhhh---------cCCCCCc
Confidence              23345688899999999988899999999999999999999999854332110   000000         0000010


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        .......+.+++..||+.+|++|||+++++++
T Consensus       220 --~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         220 --GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              01134467788999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7e-37  Score=304.75  Aligned_cols=239  Identities=26%  Similarity=0.354  Sum_probs=187.2

Q ss_pred             cccccCceeEEEEEecC-------------------------CceEEEEEEeecchhhHHHHHHHHHHHHhcccccccee
Q 037160          263 KLGHGGYGEIFKGTLQD-------------------------GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF  317 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  317 (569)
                      .||+|+||.||+|.+..                         ...|++|.+..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13588888866555555678899999999999999999


Q ss_pred             eeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC--
Q 037160          318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH--  395 (569)
Q Consensus       318 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~--  395 (569)
                      ++++......++||||+++++|..++..  ....+++..+..++.||++||.|||+++   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999998843  3456889999999999999999999998   99999999999997654  


Q ss_pred             -----CeEEeccCCCcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHH-hCCCCCCCCCCcch
Q 037160          396 -----RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIV-SGVQNNKFQSDDGF  468 (569)
Q Consensus       396 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~ell-tg~~p~~~~~~~~~  468 (569)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 3799999987543221      22356788999998865 56899999999999999995 68887754332211


Q ss_pred             hhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          469 ETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       469 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ...                +...... +......+.+++..||+.+|++|||+.+|++.|+
T Consensus       231 ~~~----------------~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ERF----------------YEKKHRL-PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHH----------------HHhccCC-CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            100                0100000 1111245778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.5e-37  Score=328.44  Aligned_cols=264  Identities=17%  Similarity=0.217  Sum_probs=194.1

Q ss_pred             HHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcccc------ccceeeeeeee
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHK------NLVQFLGCCFT  323 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~  323 (569)
                      +...+++|++.++||+|+||.||+|.+. .++.||||++.... .....+..|+.++.+++|.      +++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445788999999999999999999875 67889999886432 2234566788888877554      58888888875


Q ss_pred             C-CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCC------
Q 037160          324 K-KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKH------  395 (569)
Q Consensus       324 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~------  395 (569)
                      . ...++|||++ +++|.+++.   ....+++..+..++.||+.||.|||+ .+   ||||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            4 4678899988 778888774   34568999999999999999999997 47   99999999999998765      


Q ss_pred             ----------CeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 037160          396 ----------RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD  465 (569)
Q Consensus       396 ----------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~  465 (569)
                                .+||+|||.+.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      499999998754322     23456799999999999999999999999999999999999999875543


Q ss_pred             cchhhhhHhHhh----hhcc----cchhhhhcc------cC---------C---CCCHHHHHHHHHHHHHhcCCCCCCCC
Q 037160          466 DGFETLVTHTWK----HFQA----KTVLEIIDK------SI---------E---IEDIEEVKRVVWVGLLCTQELPTLRP  519 (569)
Q Consensus       466 ~~~~~~~~~~~~----~~~~----~~~~~~~~~------~l---------~---~~~~~~~~~~~~l~~~Cl~~~P~~RP  519 (569)
                      ......+.....    .|..    ....++++.      ..         .   .........+.+++..||+.||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            222111111100    0000    000001000      00         0   00011234567899999999999999


Q ss_pred             CHHHHHHH
Q 037160          520 SMTNVVQM  527 (569)
Q Consensus       520 t~~evl~~  527 (569)
                      |+.|++++
T Consensus       431 ta~e~L~H  438 (467)
T PTZ00284        431 NARQMTTH  438 (467)
T ss_pred             CHHHHhcC
Confidence            99999975

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=319.31  Aligned_cols=245  Identities=27%  Similarity=0.446  Sum_probs=200.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch---hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .|..++.||.|+||.||.++.. +.+.||||++..+.+   ..+..++.|+.+|++++|||+|.+.|++..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4677888999999999999965 778899999976543   446789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      || -|+-.|++.  ..++++.+.++..|.++.+.||.|||+++   .||||||..||||++.|.|||+|||.|.....  
T Consensus       107 YC-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  107 YC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             HH-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            99 567777773  45678999999999999999999999999   99999999999999999999999999876653  


Q ss_pred             CCCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                          ...++|||.|||||++.   .|+|+-|+||||||+...||.-.++|....+.-.       +.-+....     -.
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQN-----es  242 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQN-----ES  242 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhc-----CC
Confidence                45679999999999874   5789999999999999999999888753221110       00000000     00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +.+  ...+-...+..++..||++-|.+|||..+++.+
T Consensus       243 PtL--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 PTL--QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCC--CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            111  145566678889999999999999999998854

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.4e-37  Score=304.94  Aligned_cols=257  Identities=25%  Similarity=0.370  Sum_probs=201.9

Q ss_pred             ccccccccccccCceeEEEEEec------CCceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ++|++...||+|+||.||+|+.+      +.+.+++|.+...... ....+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999864      2467899988654433 4578999999999999999999999999989999


Q ss_pred             EEEeecCCCChhhHhhCCCCC------ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          329 VVYEFVQNKSLDRILFDPKQK------KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                      +||||+++++|.+++......      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999543322      26899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      |++......... ......++..|+|||.+.+...+.++||||||+++|+|++ |..|+.......   ..    .....
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~----~~~~~  233 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VL----NRLQA  233 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HH----HHHHc
Confidence            998754332211 2233456778999999988889999999999999999999 666764322211   11    01110


Q ss_pred             cchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          482 KTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       482 ~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      +....       .........+.+++.+||+.+|++||++.|++..|+.
T Consensus       234 ~~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         234 GKLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            00000       0011233467789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-36  Score=301.82  Aligned_cols=254  Identities=25%  Similarity=0.363  Sum_probs=190.6

Q ss_pred             ccccccCceeEEEEEec---CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          262 NKLGHGGYGEIFKGTLQ---DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      +.||+|+||.||+|...   .+..+++|.+..... .....+.+|+.++++++||||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999864   345789998865432 33457889999999999999999999999989999999999999


Q ss_pred             ChhhHhhCCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          338 SLDRILFDPK--QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       338 ~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +|.+++....  .....++..+..++.|++.||.|||+.+   ++||||||+||+++.++++||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999985432  2234667788889999999999999998   9999999999999999999999999987544333222


Q ss_pred             CCcccccCCCcccccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          416 PNTAIAGTLGYMAPEYIANG-------QLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~-------~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.|+........   ......    ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~~----~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTVR----EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHhh----cccCCC
Confidence            22345678889999988642       35789999999999999996 9888864432211   111100    000011


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ..+.+..   .....+..++..|| .+|++|||+.||+..|+
T Consensus       231 ~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKL---PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCC---CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111111   12234566778898 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.6e-37  Score=300.70  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=200.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeee-CCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT-KKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  332 (569)
                      +|++.+.||+|++|.||++..+ +++.+|+|++....  ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999976 67899999986542  3345678899999999999999999988764 345789999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.+++... ....+++.+++.++.+++.||.+||+.+   |+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998542 3446899999999999999999999998   9999999999999999999999999998664432


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  ......+++.|+|||++.+..++.++||||||++++||++|+.|+.......   .   ...         .....+
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~---~~~---------~~~~~~  219 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---L---VYR---------IIEGKL  219 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---H---HHH---------HHhcCC
Confidence            2  2234568899999999999999999999999999999999999876332111   0   000         001111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..........+.+++.+|++.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11122344567889999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.4e-37  Score=310.54  Aligned_cols=264  Identities=20%  Similarity=0.316  Sum_probs=198.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.++||+|+||.||+|..+ +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46889999999999999999876 67899999886543 22334677899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      ++ ++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 588887743  2346789999999999999999999998   99999999999999999999999999875443221


Q ss_pred             CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH--------hHhhhhcccch
Q 037160          414 LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT--------HTWKHFQAKTV  484 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~  484 (569)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|++||...........+.        ..|+.+.....
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence              12234568899999988654 57889999999999999999999987544322111111        11111110000


Q ss_pred             hhhhc-ccCC-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          485 LEIID-KSIE-----IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       485 ~~~~~-~~l~-----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+ +...     .........+.+++.+|++.+|.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00000 0000     0011123456779999999999999999999964

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.9e-37  Score=308.97  Aligned_cols=252  Identities=23%  Similarity=0.369  Sum_probs=204.2

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ..++|.+.++||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+......++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            3467999999999999999999964 789999999876655556778899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.+++.    ...+++..+..++.+++.+|.|||+.+   ++||||||+|||++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          97 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             ccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            999999999883    245788999999999999999999998   9999999999999999999999999987654432


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+........  +.. .+.   .+      .+..
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~-~~~---~~------~~~~  235 (297)
T cd06656         170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL-IAT---NG------TPEL  235 (297)
T ss_pred             c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee-ecc---CC------CCCC
Confidence            2  12345688899999999988899999999999999999999999864332111  000 000   00      0000


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       .........+.+++.+||+.+|++||++.+|+++
T Consensus       236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0112223446678899999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-37  Score=303.17  Aligned_cols=249  Identities=26%  Similarity=0.429  Sum_probs=193.0

Q ss_pred             ccccccCceeEEEEEec-CCc--eEEEEEEeec-chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGR--EIAVKRLFIS-RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      +.||+|+||.||+|+.+ ++.  .+++|.+... .......+.+|++++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999976 344  4688877643 234456788999999999 899999999999999999999999999


Q ss_pred             CChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          337 KSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       337 ~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                      ++|.+++....             ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985422             1235789999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      ++.......   .......+..|+|||++....++.++||||||+++|||++ |..||.......   .    +......
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~----~~~~~~~  227 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----YEKLPQG  227 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H----HHHHhCC
Confidence            986322111   1112234567999999988889999999999999999997 888875332211   1    1111100


Q ss_pred             chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .       ... ........+.+++.+||+.+|.+|||+.+++..|+..
T Consensus       228 ~-------~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 Y-------RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             C-------CCC-CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            0       000 1112234577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=307.55  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=212.0

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhh--HHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +..-|+..+.||+|-|+.|-++++- .|+.||||++.+..-+.  ...+..|++.|+.++|||||++|++..+...+|||
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            4566888899999999999999976 89999999997665433  34578899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE-CCCCCeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL-DLKHRPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll-~~~~~~kl~Dfgla~~~~  409 (569)
                      +|.=++|+|.++|..  ....+.+....+++.||++|+.|+|+.+   +|||||||+||++ ..-|-+||+|||++..+.
T Consensus        96 LELGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            999999999999953  4456889999999999999999999998   9999999999887 456889999999998877


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLT-EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      .+.   ..+..+|.+.|.|||++.+..|+ +++||||||||||.|++|++||.-.++.               ..+..++
T Consensus       171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmIm  232 (864)
T KOG4717|consen  171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIM  232 (864)
T ss_pred             Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhh
Confidence            765   34578999999999999998877 6899999999999999999998754432               3344444


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      |-... -+.....++..++..||+.+|++|-+.+||+..
T Consensus       233 DCKYt-vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  233 DCKYT-VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ccccc-CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            43332 244556778889999999999999999999854

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-37  Score=306.33  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=203.2

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|++.++||.|+||.||++... +++.+|+|.+........+.+.+|++++++++||||+++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467899999999999999999975 6889999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999999843  2346899999999999999999999998   99999999999999999999999998875433221


Q ss_pred             CCCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          414 LLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                        ......+++.|+|||.+.     ...++.++||||||+++|||++|+.|+.......  ....     .....     
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~-----~~~~~-----  224 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLK-----ILKSE-----  224 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHH-----HhcCC-----
Confidence              223456889999999875     3457789999999999999999999976432211  0100     00000     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+.+. .+......+.+++..||+.+|.+||++.+|+++
T Consensus       225 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 PPTLD-QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCcC-CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            00000 011223456778899999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.2e-37  Score=303.66  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=187.6

Q ss_pred             ccccccCceeEEEEEecC---CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          262 NKLGHGGYGEIFKGTLQD---GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      ++||+|+||.||+|...+   ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   3568888775443 333467889999999999999999999999999999999999999


Q ss_pred             ChhhHhhCCCC--CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          338 SLDRILFDPKQ--KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       338 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +|.+++.....  ....++.....++.||+.||.|||+.+   |+||||||+|||+++++++||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999854332  234567888899999999999999998   9999999999999999999999999987543332221


Q ss_pred             CCcccccCCCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          416 PNTAIAGTLGYMAPEYIAN-------GQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..|+....+..   .......    ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~----~~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQVVR----EQDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhh----ccCccC
Confidence            2233446778999998743       356789999999999999999 666765332211   1000000    000011


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ..+.+   .......+.+++..|| .+|++|||+++|++.|.
T Consensus       231 ~~~~~---~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQL---DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcc---cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111   1123344556777888 49999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-37  Score=317.59  Aligned_cols=262  Identities=21%  Similarity=0.289  Sum_probs=196.7

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeC----
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK----  324 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----  324 (569)
                      ....++|++.+.||+|+||.||++... +++.||||++....  ....+.+.+|+.++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999865 68899999886532  22345677999999999999999999887543    


Q ss_pred             --CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          325 --KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       325 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                        ...++++|++ +++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence              3468999988 788988773    346899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh-------
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH-------  474 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~-------  474 (569)
                      |+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..       
T Consensus       163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999865432     234578999999999877 5789999999999999999999999864332111000000       


Q ss_pred             -HhhhhcccchhhhhcccCCCCCH--------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          475 -TWKHFQAKTVLEIIDKSIEIEDI--------EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       475 -~~~~~~~~~~~~~~~~~l~~~~~--------~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       .+...........+.. +.....        .....+.+++.+|++.+|.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000000000000000 000000        112346789999999999999999999965

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.2e-37  Score=309.74  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=198.4

Q ss_pred             hccccccccccccCceeEEEEEec-CCc----eEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGR----EIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      .++|+..+.||+|+||.||+|.+. +|.    .+|+|.+..... .....+.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999864 444    468887765432 3344688999999999999999999998654 567


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +++||+++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            99999999999999843  2346789999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..........+                
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~----------------  223 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL----------------  223 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------------
Confidence            54332212223445778999999998899999999999999999997 8888753322111111                


Q ss_pred             hcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          488 IDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       488 ~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      +..... .........+..++..||..+|++||++.++++.|+..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         224 LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            110000 00112234677889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.1e-37  Score=305.46  Aligned_cols=264  Identities=24%  Similarity=0.351  Sum_probs=201.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.++||+|++|.||+++.+ +|+.||+|++....  ....+.+.+|+.++++++|+||+++++.+......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999976 68999999886543  2233567899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|..++.   ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999999988773   3346899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             CCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh--------hcccc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH--------FQAKT  483 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~  483 (569)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...........+......        +....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            2  1223457889999999876 46889999999999999999999998644332111111000000        00000


Q ss_pred             hhh-hhcccCCC-CC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLE-IIDKSIEI-ED-----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~-~~~~~l~~-~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... ...+.... ..     ......+.+++.+||+.+|++||++.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            000 00000000 00     1123567789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.1e-37  Score=308.65  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=200.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +.|....+||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34455567999999999999875 68899999987665556677899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++........ 
T Consensus       102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658         102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            9999999883    235889999999999999999999998   99999999999999999999999999875543221 


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+........   ...         +...+..... 
T Consensus       174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~---------~~~~~~~~~~-  239 (292)
T cd06658         174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRR---------IRDNLPPRVK-  239 (292)
T ss_pred             -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH---------HHhcCCCccc-
Confidence             22345688999999999888899999999999999999999999764322110   000         0011111111 


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ........+..++.+||+.+|++|||+.|++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111223456678889999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.4e-37  Score=314.03  Aligned_cols=255  Identities=17%  Similarity=0.212  Sum_probs=195.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+++.+ +++.||+|.+....   ......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999976 67889999886432   233455888999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999953  2346888999999999999999999998   999999999999999999999999999866543


Q ss_pred             CCCCCCcccccCCCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIAN-----GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ... ......||+.|+|||++.+     +.++.++||||||++||||++|+.||........   ....   ......  
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~i---~~~~~~--  226 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKI---MNHEER--  226 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH---HHHH---HcCCCc--
Confidence            322 2234569999999999875     5688999999999999999999999864332111   0000   000000  


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTL--RPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~~  527 (569)
                         ..+..........+..++.+|+...+++  |+++.+++++
T Consensus       227 ---~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 ---FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ---ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence               0000001112345566677777755543  5688888865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-37  Score=305.91  Aligned_cols=260  Identities=26%  Similarity=0.349  Sum_probs=203.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.++||+|+||.||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++.+......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888899999999999999865 68899999886543 33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      +++++|.+++.   ..+.+++..+..++.+++.+|.|||+ .+   ++||||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            99999999883   33568999999999999999999997 45   9999999999999999999999999986543221


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                          .....|+..|+|||++.++.++.++|||||||++|+|++|+.|+.................    ......+....
T Consensus       159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  230 (284)
T cd06620         159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL----DLLQQIVQEPP  230 (284)
T ss_pred             ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH----HHHHHHhhccC
Confidence                2245689999999999888999999999999999999999999875443211000000000    00011111111


Q ss_pred             CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          493 EIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       493 ~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ... .......+..++.+||+.+|++|||+.||+++..
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            111 1123456778899999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.3e-37  Score=302.81  Aligned_cols=252  Identities=26%  Similarity=0.344  Sum_probs=199.8

Q ss_pred             cccccccccccCceeEEEEEecCCceEEEEEEeecc------hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR------KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +|...+.||+|+||.||+|...+++.+|+|.+....      ......+.+|++++++++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998888999999886432      22345688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      +||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999843   346789999999999999999999998   99999999999999999999999999876532


Q ss_pred             CCCC----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          411 EKSL----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       411 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....    .......|+..|+|||++.+..++.++||||||+++|||++|+.|+.......  .....     ...    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~-----~~~----  223 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYI-----GAH----  223 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHh-----hhc----
Confidence            1111    11224568899999999998889999999999999999999999985332111  00000     000    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        ..............+..++.+||+.+|++||++.|++++
T Consensus       224 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         224 --RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              000000112234556778899999999999999999863

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-36  Score=302.47  Aligned_cols=247  Identities=25%  Similarity=0.409  Sum_probs=203.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ..|+..++||.|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++.+.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777889999999999999976 68899999886543 44567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++.    ...+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999999884    245788899999999999999999998   99999999999999999999999999976644321


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.|+.........                ..+.....
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~  218 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNP  218 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCC
Confidence              223446788999999998888999999999999999999999987543221110                01111111


Q ss_pred             C-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 I-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      . ........+..++..||+.+|++||++.+++.+
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1 123455678889999999999999999999866

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=304.08  Aligned_cols=254  Identities=23%  Similarity=0.369  Sum_probs=202.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCc----eEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGR----EIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|++.++||+|+||.||+|..+ +|+    .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56888899999999999999865 333    58999876553 3345678999999999999999999999987 78899


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999853  2345899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ............++..|+|||.+....++.++||||||+++|||++ |+.|+.........                +.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----------------~~~  224 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP----------------DLL  224 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH----------------HHH
Confidence            4332211122234568999999988899999999999999999998 98887543322111                111


Q ss_pred             cccC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          489 DKSI-EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       489 ~~~l-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .... ...+......+..++..||..+|.+||++.++++.|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         225 EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1110 011122334677888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.7e-37  Score=311.47  Aligned_cols=198  Identities=24%  Similarity=0.452  Sum_probs=160.7

Q ss_pred             cccccccCceeEEEEEec---CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee--CCceEEEEeecC
Q 037160          261 SNKLGHGGYGEIFKGTLQ---DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT--KKDSFVVYEFVQ  335 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  335 (569)
                      .++||+|+||.||+|+.+   +++.+|+|.+....  ....+.+|+.+|++++||||+++++.+..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865   46789999886432  23457789999999999999999998864  456789999985


Q ss_pred             CCChhhHhhCC------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----CCCCCeEEeccCCC
Q 037160          336 NKSLDRILFDP------KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL----DLKHRPKIADFGLA  405 (569)
Q Consensus       336 ~~~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll----~~~~~~kl~Dfgla  405 (569)
                       ++|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +..+.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4777776321      12235889999999999999999999998   9999999999999    45678999999999


Q ss_pred             cccCCCCCC-CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 037160          406 RFSSSEKSL-LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQS  464 (569)
Q Consensus       406 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~  464 (569)
                      +........ .......||+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876543221 122356789999999998764 58999999999999999999999986443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.1e-37  Score=301.53  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=190.3

Q ss_pred             ccccccCceeEEEEEec----CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeee-eCCceEEEEeecC
Q 037160          262 NKLGHGGYGEIFKGTLQ----DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCF-TKKDSFVVYEFVQ  335 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  335 (569)
                      +.||+|+||.||+|.+.    ++..+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999854    2357999987543 3344577889999999999999999999876 4556899999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC-
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL-  414 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  414 (569)
                      +++|.+++...  ...+++..+..++.+++.||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998432  344677888899999999999999998   999999999999999999999999998755432211 


Q ss_pred             -CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          415 -LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV-QNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       415 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                       .......++..|+|||.+.+..++.++||||||+++|||++|. +|+......   .+....+.            ...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~------------~~~  220 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLLQ------------GRR  220 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhc------------CCC
Confidence             0112334577899999998889999999999999999999964 444322111   11111100            000


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ...+......+.+++..||+.+|++||++.+|++.|++.
T Consensus       221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            000111234677899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-36  Score=299.87  Aligned_cols=238  Identities=26%  Similarity=0.390  Sum_probs=187.6

Q ss_pred             ccccccCceeEEEEEecCCc-----------eEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          262 NKLGHGGYGEIFKGTLQDGR-----------EIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999986432           4778876554433 5788999999999999999999999988 788999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-------CeEEeccC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-------RPKIADFG  403 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-------~~kl~Dfg  403 (569)
                      |||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999998532  226889999999999999999999998   99999999999999888       79999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccC--CCCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhhhhHhHhhhhc
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANG--QLTEKVDIYSFGVLVLEIVSG-VQNNKFQSDDGFETLVTHTWKHFQ  480 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  480 (569)
                      ++......      ....++..|+|||++.+.  .++.++||||||+++|||++| ..|+..........    .+.   
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~----~~~---  220 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER----FYQ---  220 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH----HHh---
Confidence            98765431      233466789999999876  789999999999999999995 55554332111100    000   


Q ss_pred             ccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          481 AKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       481 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ..       ....   ......+.+++..||..+|.+|||+.+|++.|+
T Consensus       221 ~~-------~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQ-------HRLP---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cC-------CCCC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00       0000   111167778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-37  Score=316.05  Aligned_cols=192  Identities=23%  Similarity=0.335  Sum_probs=164.3

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ...+|++.++||+|+||.||+|+.. +++.||+|.....      ....|+.++++++||||+++++++......++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999976 5678999964322      23469999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      ++. ++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            995 577777742  3456899999999999999999999998   9999999999999999999999999987543221


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNN  460 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~  460 (569)
                         ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               223456899999999999999999999999999999999976554

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.2e-37  Score=313.80  Aligned_cols=255  Identities=18%  Similarity=0.223  Sum_probs=193.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+++.+ +++.+|+|++....   ......+.+|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999976 57889999885422   233445888999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999953  2346889999999999999999999998   999999999999999999999999998755433


Q ss_pred             CCCCCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ... ......||+.|+|||++.     .+.++.++|||||||++|||++|+.||........   .....   ....   
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~---~~~i~---~~~~---  225 (332)
T cd05623         156 GTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIM---NHKE---  225 (332)
T ss_pred             Ccc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH---HHHHh---CCCc---
Confidence            221 223457999999999986     34688999999999999999999999864332111   00000   0000   


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQE--LPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~--~P~~RPt~~evl~~  527 (569)
                        ..............+.+++.+|+..  ++..||++.|++++
T Consensus       226 --~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 --RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              0000000111233455566666644  44457899999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.4e-37  Score=302.66  Aligned_cols=251  Identities=29%  Similarity=0.452  Sum_probs=196.5

Q ss_pred             ccccccCceeEEEEEecC-------CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQD-------GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +.||+|+||.||+|...+       ++.+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998652       2578999875443 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCC----CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-----CeEEeccCC
Q 037160          334 VQNKSLDRILFDPK----QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-----RPKIADFGL  404 (569)
Q Consensus       334 ~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-----~~kl~Dfgl  404 (569)
                      +++++|.+++....    ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999985422    2244788999999999999999999988   99999999999999877     899999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      ++...............++..|+|||++.++.++.++||||||+++|||++ |+.|+........   ...    .... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~----~~~~-  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH----VTAG-  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH----HhcC-
Confidence            876544332222223345788999999999999999999999999999998 8888753322111   000    0000 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       484 ~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                            ... .........+.+++.+||+.+|++||++.+|++.|++
T Consensus       230 ------~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 ------GRL-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ------Ccc-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                  000 1112234567789999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=299.70  Aligned_cols=248  Identities=28%  Similarity=0.429  Sum_probs=209.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +-|+++.+||+|+||.||++.++ .|+.+|+|++...  ...+++..|+.+|++.+.|++|++||.+.....+++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            34888999999999999999987 7999999988664  35678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ..|++.+++.  .+++++.+.++..++...+.||+|||...   -||||||..||||+.+|..||+|||.+..+..... 
T Consensus       111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-  184 (502)
T KOG0574|consen  111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-  184 (502)
T ss_pred             CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence            9999999994  45688999999999999999999999987   89999999999999999999999999976654322 


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC-
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE-  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-  493 (569)
                       ......||+.|||||++..-.|+.++||||||+...||..|++|+..-.+-.                ..-++..... 
T Consensus       185 -KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMIPT~PPP  247 (502)
T KOG0574|consen  185 -KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMIPTKPPP  247 (502)
T ss_pred             -hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEeccCCCCC
Confidence             3456789999999999999999999999999999999999999976433211                1111111111 


Q ss_pred             -C-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          494 -I-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       494 -~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                       . .+..-...+.+++..||-++|++|-|+.+++++-
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence             1 1344556788899999999999999999998763

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-36  Score=299.69  Aligned_cols=250  Identities=23%  Similarity=0.328  Sum_probs=202.1

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|++.++||+|+||.||++... +|+.|++|.+...  .....+.+.+|+.++++++||||+++++.+......++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999865 7899999998653  233456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +.+++|.+++.. .....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999998843 22345788999999999999999999998   99999999999999999999999999976544321


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......|++.|+|||++.+..++.++||||||+++++|++|+.|+.......   .            ....+.....
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~------------~~~~~~~~~~  219 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---L------------VLKIIRGSYP  219 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---H------------HHHHhcCCCC
Confidence              1223457889999999998899999999999999999999999875432211   0            0111111111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..+......+..++.+||+.+|++||++.+|+++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1122334567889999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-37  Score=302.68  Aligned_cols=240  Identities=25%  Similarity=0.360  Sum_probs=188.8

Q ss_pred             ccccccCceeEEEEEecC--------CceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQD--------GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +.||+|+||.||+|..+.        ..++++|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998642        234888887665555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC--------eEEeccCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR--------PKIADFGLA  405 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~--------~kl~Dfgla  405 (569)
                      +++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998532  336889999999999999999999998   999999999999987765        599999987


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCC-CCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGV-QNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      .....      .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+.........              
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~--------------  215 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL--------------  215 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--------------
Confidence            65432      2234678899999998764 5899999999999999999995 443322111100              


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       484 ~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                        ........ .+......+.+++..||+.+|++|||+.+|++.|+
T Consensus       216 --~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         216 --QFYEDRHQ-LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --HHHHcccc-CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              00000000 01122346778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-36  Score=301.39  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             ccccccccccccCceeEEEEEecC----CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQD----GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|.+.++||+|+||.||+|.+.+    ...|++|...... ....+.+.+|+.++++++||||+++++++.. ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457888999999999999998653    2468999886554 4455689999999999999999999998865 557899


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++...  ...+++..++.++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999432  345899999999999999999999998   99999999999999999999999999886654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      .... ......++..|+|||.+....++.++||||||++++||++ |..||........   ....    ....      
T Consensus       160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~----~~~~------  225 (270)
T cd05056         160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI----ENGE------  225 (270)
T ss_pred             ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH----HcCC------
Confidence            4222 1223334568999999988889999999999999999996 9988754432211   1000    0000      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                       .. .........+.+++.+|+..+|++|||+.++++.|+..
T Consensus       226 -~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         226 -RL-PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             -cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             00 01122334677788999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-36  Score=305.94  Aligned_cols=263  Identities=23%  Similarity=0.287  Sum_probs=198.7

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecchh-----hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN-----RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +|++.++||+|++|.||+|... +++.|+||++......     ....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999975 6899999998765322     345677899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+ +++|.+++....  ..+++..++.++.||++||.|||+++   |+|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999984322  36899999999999999999999998   99999999999999999999999999986654


Q ss_pred             CCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc------
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT------  483 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  483 (569)
                      ...  ......++..|+|||.+.+ ..++.++||||||+++|||++|.+++....+..................      
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            321  1223356788999998865 4678999999999999999999777654332111000000000000000      


Q ss_pred             hhhhhcccCCCC------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIEIE------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~~~------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ............      .......+.+++.+||+.+|++|||+.||+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000000      12234567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-36  Score=299.63  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=193.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-----hhhHHHHHHHHHHHHhccccccceeeeeeeeC--Cce
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-----KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDS  327 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  327 (569)
                      .+|+..+.||+|+||.||++... .+..|++|++....     ......+.+|+.++++++||||+++++.+.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999875 68899999885432     23345788999999999999999999988653  567


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++++||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999843   345789999999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......  .             ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--~-------------~~~  220 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--A-------------IFK  220 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--H-------------HHH
Confidence            5432111 11223458899999999998889999999999999999999999975332110  0             000


Q ss_pred             hhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......... +......+..++ .||..+|++||++.||+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            100000111 111222333344 7888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.3e-36  Score=352.00  Aligned_cols=266  Identities=26%  Similarity=0.463  Sum_probs=211.5

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ..+.....|...+.||+|+||.||+|+.. ++..||||++......    ...|++.+++++|||||++++++.+....+
T Consensus       684 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        684 TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             hHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            34455567888899999999999999974 7899999988643321    235688999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++|+|.+++.      .++|..+..++.|+++||+|||.....+|+||||||+||+++.++.+++. ||.....
T Consensus       760 lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             EEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            9999999999999993      38899999999999999999996655569999999999999999988875 6655433


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ..      .....+|+.|+|||++.+..++.++|||||||++|||++|+.|+...... ...+..+....+........+
T Consensus       833 ~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  905 (968)
T PLN00113        833 CT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWI  905 (968)
T ss_pred             cc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhhee
Confidence            21      12236789999999999999999999999999999999999998533221 223334433333334444455


Q ss_pred             cccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          489 DKSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       489 ~~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                      ++.+...   ..++..++.+++.+||+.+|++||||.||++.|+....
T Consensus       906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            5544322   45677788999999999999999999999999987643

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-36  Score=295.10  Aligned_cols=274  Identities=22%  Similarity=0.285  Sum_probs=220.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +.|+..+.||.|.-|+||++.++ .+..+|+|++.+..   +....+...|-+||+.++||.++.+|..++.+...+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            45778889999999999999987 45889999996653   444567788999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC-
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS-  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~-  410 (569)
                      |||+||+|..+++. ...+.+++..++-++.+++-||+|||-.|   ||.|||||+||||.++|++-|+||.|+..... 
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999998854 45677999999999999999999999999   99999999999999999999999999753211 


Q ss_pred             --------------------------------CCCC---------------------CCCcccccCCCcccccccccCCC
Q 037160          411 --------------------------------EKSL---------------------LPNTAIAGTLGYMAPEYIANGQL  437 (569)
Q Consensus       411 --------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~  437 (569)
                                                      ....                     .....++||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0000                     01124679999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCC
Q 037160          438 TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPT  516 (569)
Q Consensus       438 ~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~  516 (569)
                      +.++|.|+|||+||||+.|.-||......               .++.+++.+.+... .+.....+.+++...|.+||+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999866544               23344444444333 345556777889999999999


Q ss_pred             CCCC----HHHHHHH--hccCCCCCCCCCCCCCccccc
Q 037160          517 LRPS----MTNVVQM--LKQKDITLPTPSKPPFTDECM  548 (569)
Q Consensus       517 ~RPt----~~evl~~--L~~~~~~~~~p~~p~~~~~~~  548 (569)
                      +|.-    +.||-++  ++...+.+-.-.+||+.+...
T Consensus       378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~  415 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV  415 (459)
T ss_pred             hhhccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence            9998    8888754  355555555555666655443

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.4e-36  Score=309.10  Aligned_cols=261  Identities=22%  Similarity=0.378  Sum_probs=187.5

Q ss_pred             cccccccCceeEEEEEec---CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee--CCceEEEEeecC
Q 037160          261 SNKLGHGGYGEIFKGTLQ---DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT--KKDSFVVYEFVQ  335 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  335 (569)
                      ..+||+|+||.||+|+.+   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  ....++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999965   35789999886432  23467789999999999999999998854  456789999986


Q ss_pred             CCChhhHhhCC------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----CCCCCeEEeccCCC
Q 037160          336 NKSLDRILFDP------KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL----DLKHRPKIADFGLA  405 (569)
Q Consensus       336 ~~~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll----~~~~~~kl~Dfgla  405 (569)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 666665321      12335888999999999999999999998   9999999999999    56678999999999


Q ss_pred             cccCCCCCC-CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh------hhh-----
Q 037160          406 RFSSSEKSL-LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE------TLV-----  472 (569)
Q Consensus       406 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~------~~~-----  472 (569)
                      +........ .......||+.|+|||++.+. .++.++|||||||++|||++|++||.....+...      ..+     
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            876543221 122345789999999998764 5899999999999999999999998644322100      000     


Q ss_pred             ------HhHhhhhccc----chhhhhcccC----------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          473 ------THTWKHFQAK----TVLEIIDKSI----------EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       473 ------~~~~~~~~~~----~~~~~~~~~l----------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                            ...|+.....    ..........          ..........+.+++.+|++.||.+|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence                  0011111000    0000000000          00011122457779999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.4e-36  Score=299.82  Aligned_cols=253  Identities=25%  Similarity=0.407  Sum_probs=200.7

Q ss_pred             cccccccccccCceeEEEEEecC--CceEEEEEEeec----------chhhHHHHHHHHHHHHh-ccccccceeeeeeee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQD--GREIAVKRLFIS----------RKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFT  323 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  323 (569)
                      +|++.+.||+|+||.||++..+.  ++.+|+|.+...          .......+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999764  688999987532          22334567788888875 799999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEec
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIAD  401 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~D  401 (569)
                      ....+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+ .+   ++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999887431 234568899999999999999999996 55   99999999999999999999999


Q ss_pred             cCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          402 FGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       402 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      ||++.......   ......|+..|++||.+.++.++.++||||||+++|||++|+.|+.......   ...        
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~--------  223 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LAT--------  223 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHH--------
Confidence            99998665433   2234568899999999998889999999999999999999999875332211   000        


Q ss_pred             cchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          482 KTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       482 ~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                          .......... .......+.+++.+||+.+|++||++.||.+++++
T Consensus       224 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         224 ----KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             ----HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                0001100100 11223567788899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-36  Score=299.26  Aligned_cols=253  Identities=22%  Similarity=0.364  Sum_probs=201.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc------hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR------KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      +|+..+.||+|++|.||++... +++.+|+|++....      ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999864 78999999886432      1235678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCccc
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFS  408 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~~~  408 (569)
                      |+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999843   346889999999999999999999998   99999999999998776 5999999998766


Q ss_pred             CCCCCCC--CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          409 SSEKSLL--PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       409 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      .......  ......++..|+|||.+.+..++.++||||||+++++|++|..|+...........   .         ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~---------~~  222 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---I---------FK  222 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---H---------HH
Confidence            5432110  12245688999999999888899999999999999999999998754332111110   0         01


Q ss_pred             hhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......... +......+.+++.+||+.+|++||++.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            000011111 33445678889999999999999999999854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-36  Score=298.13  Aligned_cols=248  Identities=28%  Similarity=0.417  Sum_probs=200.8

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc-----hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-----KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     ....+.+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999886543     33567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      +||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999984   3346889999999999999999999998   99999999999999999999999999876544


Q ss_pred             CCCCCCCcccccCCCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..   ......++..|++||.+.... ++.++|+||||+++|+|++|+.|+.......  ..    +.....        
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~----~~~~~~--------  217 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AV----FKIGRS--------  217 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HH----HHHHhc--------
Confidence            32   223456889999999987766 8999999999999999999999976433111  01    110000        


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .............+.+++.+||+.+|.+||++.+++.+
T Consensus       218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            00001112234566778899999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.1e-36  Score=298.25  Aligned_cols=257  Identities=26%  Similarity=0.395  Sum_probs=205.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.+.||.|+||.||+|... ++..+++|++.... ......+.+|+++++.++|+||+++++.+......++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999965 67899999886543 23567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++........+++..+..++.|++.||.+||+.+   ++||||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999854333456899999999999999999999998   99999999999999999999999999876655332


Q ss_pred             CC--CCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          414 LL--PNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       414 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..  ......|+..|+|||++... .++.++||||||+++|||++|+.|+.......  ...    +....      ...
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~----~~~~~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLM----LTLQN------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHH----HHhcC------CCC
Confidence            21  22345688999999998877 78999999999999999999999976432211  000    00000      000


Q ss_pred             cCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIE--DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+...  .......+.+++..||+.+|++||++.+|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11111  12334567889999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-36  Score=313.70  Aligned_cols=262  Identities=21%  Similarity=0.273  Sum_probs=203.4

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-c-----cccceeeeeeeeCCceEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-H-----KNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~l  329 (569)
                      +|++.+.||+|.||.|-+|... +++.||||+++.. +....+-..|+.+|..|+ |     -|+|+++++|..+++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7899999999999999999865 7999999988764 445567778999999996 4     389999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC--CeEEeccCCCcc
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH--RPKIADFGLARF  407 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~--~~kl~Dfgla~~  407 (569)
                      |+|.+ ..+|.++|+.. +...++...+..++.||+.||..||+.+   |||+||||+||||.+.+  .+||+|||.+..
T Consensus       266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999 67999999654 4455999999999999999999999998   99999999999997654  699999999986


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh----------
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK----------  477 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----------  477 (569)
                      ....     ......+..|.|||++.+.+|+.+.||||||||+.||++|.+-|....+.+....+.....          
T Consensus       341 ~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  341 ESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            5542     2256678899999999999999999999999999999999776655443322111111100          


Q ss_pred             -----hhcc----------cc---------hhh----hhcccCCC-C--------CHHHHHHHHHHHHHhcCCCCCCCCC
Q 037160          478 -----HFQA----------KT---------VLE----IIDKSIEI-E--------DIEEVKRVVWVGLLCTQELPTLRPS  520 (569)
Q Consensus       478 -----~~~~----------~~---------~~~----~~~~~l~~-~--------~~~~~~~~~~l~~~Cl~~~P~~RPt  520 (569)
                           .+..          ..         ...    ..+..... .        ...+-..+++++++||.+||..|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                 0000          00         000    01111111 0        1244566899999999999999999


Q ss_pred             HHHHHHHhc
Q 037160          521 MTNVVQMLK  529 (569)
Q Consensus       521 ~~evl~~L~  529 (569)
                      ..+.+++--
T Consensus       496 p~qal~Hpf  504 (586)
T KOG0667|consen  496 PAQALNHPF  504 (586)
T ss_pred             HHHHhcCcc
Confidence            999997643

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=314.24  Aligned_cols=259  Identities=27%  Similarity=0.411  Sum_probs=213.0

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ..|-...+....++||-|.||.||.|+|+ -.-.||||.++.. ....++|+.|+.+|+.++|||+|+++|+|..+...|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            33444445566789999999999999987 3567999988654 445689999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      ||+|||..|+|-++|.+. .+..++....+.++.||+.||+||..++   +|||||..+|.|+.++..+||+||||++++
T Consensus       340 IiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999543 4566788888999999999999999998   999999999999999999999999999988


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ..+.+. ......-.+.|.|||-+....++.|+|||+|||+||||.| |..|+...                ....+.++
T Consensus       416 tgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi----------------dlSqVY~L  478 (1157)
T KOG4278|consen  416 TGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYGL  478 (1157)
T ss_pred             cCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc----------------cHHHHHHH
Confidence            765432 3333344678999999999999999999999999999998 55554322                12223344


Q ss_pred             hcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          488 IDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       488 ~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      +.+...-+ +..+..++.++++.||+++|.+||++.||.+.++.
T Consensus       479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            44444433 45567788999999999999999999999987763

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.7e-36  Score=296.89  Aligned_cols=249  Identities=21%  Similarity=0.330  Sum_probs=200.4

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|+..+.||+|+||.||++... +++.+|+|.+...  .....+.+.+|++++++++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999875 6889999988654  233457889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~~~~~~~  412 (569)
                      +++++|.+++... ....+++..+..++.+++.+|.|||+++   ++|+||||+||+++.++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999532 2445889999999999999999999998   99999999999998654 57999999998665432


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......   ...            .......
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~------------~~~~~~~  218 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVL------------KIMSGTF  218 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHH------------HHHhcCC
Confidence               2224568899999999998889999999999999999999998875432211   110            0011111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..........+..++..||+.+|++|||+.|++.+
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11111234567789999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=314.89  Aligned_cols=243  Identities=28%  Similarity=0.391  Sum_probs=201.7

Q ss_pred             cccccCceeEEEEEecC-CceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCChhh
Q 037160          263 KLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDR  341 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~  341 (569)
                      +||+|.||+||.|++.+ ...+|||.+........+.+.+|+.+.++|+|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999774 55789999977777777889999999999999999999999999999999999999999999


Q ss_pred             HhhCCCCCccC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcccCCCCCCCCCc
Q 037160          342 ILFDPKQKKEL--DWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNT  418 (569)
Q Consensus       342 ~l~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~  418 (569)
                      +|.  .+.+++  .+...-...+||++||.|||+..   |||||||-+|||++. .|.+||+|||.++.+..-..  ...
T Consensus       662 LLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TE  734 (1226)
T KOG4279|consen  662 LLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTE  734 (1226)
T ss_pred             HHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--ccc
Confidence            994  345666  67888889999999999999998   999999999999964 68899999999987765432  234


Q ss_pred             ccccCCCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-
Q 037160          419 AIAGTLGYMAPEYIANG--QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-  495 (569)
Q Consensus       419 ~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-  495 (569)
                      .+.||+.|||||++..|  .|..++|||||||.+.||.||++||.--...+-              .+..+-.-...++ 
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------------AMFkVGmyKvHP~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------------AMFKVGMYKVHPPI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------------hhhhhcceecCCCC
Confidence            78899999999999877  488999999999999999999999853221110              0111111122233 


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      +.+...+...++++|+.++|.+||++.++++
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            5566678888999999999999999999994

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=304.67  Aligned_cols=264  Identities=22%  Similarity=0.300  Sum_probs=202.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.++||+|+||.||+|.++ +++.|++|++....  ....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999976 68899999886532  3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |++++.+..++.   ....+++..+..++.+|+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999888876662   3455899999999999999999999998   9999999999999999999999999988765543


Q ss_pred             CCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc--------cc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA--------KT  483 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~  483 (569)
                      .. ......++..|+|||++.+. .++.++||||||+++|+|++|++|+...............+.....        ..
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            21 22345678899999999888 8899999999999999999999888643322111000010000000        00


Q ss_pred             hhhhhcccCCCC---------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIEIE---------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~~~---------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..... ......         .......+.+++..||..+|++||++++|+++
T Consensus       234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGV-AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccc-ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            00000 000000         11124668889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-36  Score=303.52  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=200.4

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeee-----
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCF-----  322 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----  322 (569)
                      .+....++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +||||+++++.+.     
T Consensus        12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            34567789999999999999999999875 68899999875432 2235678899999999 6999999999874     


Q ss_pred             eCCceEEEEeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEec
Q 037160          323 TKKDSFVVYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD  401 (569)
Q Consensus       323 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  401 (569)
                      .+...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence            345689999999999999987432 23456888999999999999999999998   99999999999999999999999


Q ss_pred             cCCCcccCCCCCCCCCcccccCCCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh
Q 037160          402 FGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-----GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       402 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+++.......  ......|++.|+|||++..     ..++.++|||||||++|||++|+.|+.......  .+.    
T Consensus       168 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~----  239 (286)
T cd06638         168 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF----  239 (286)
T ss_pred             CCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh----
Confidence            999876644321  2234568999999998853     457889999999999999999999876432211  000    


Q ss_pred             hhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          477 KHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                       ......     ...+. .+......+..++.+||+.+|++|||+.||++++
T Consensus       240 -~~~~~~-----~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 -KIPRNP-----PPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -hccccC-----CCccc-CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             000000     00000 0111234577899999999999999999999764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-36  Score=308.96  Aligned_cols=264  Identities=18%  Similarity=0.234  Sum_probs=193.4

Q ss_pred             cccccccc--CceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          260 ESNKLGHG--GYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       260 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +.++||+|  +|++||++..+ +|+.||+|++....  ......+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45689999  78999999875 78999999986542  334456788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC-
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS-  413 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~-  413 (569)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.......... 
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999998432 2345889999999999999999999998   99999999999999999999999986543221110 


Q ss_pred             C----CCCcccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-hhhHh-----------H
Q 037160          414 L----LPNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE-TLVTH-----------T  475 (569)
Q Consensus       414 ~----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~-----------~  475 (569)
                      .    .......++..|+|||++.+  ..++.++|||||||++|||++|+.||......... .....           .
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence            0    01122356778999999876  46889999999999999999999998643221100 00000           0


Q ss_pred             hhhhcccchhhhhccc------------------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          476 WKHFQAKTVLEIIDKS------------------IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~------------------l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .............+..                  ...........+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0000000000000000                  000011234567889999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.4e-36  Score=296.26  Aligned_cols=251  Identities=30%  Similarity=0.470  Sum_probs=199.8

Q ss_pred             ccccccccccCceeEEEEEecC-----CceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          258 FDESNKLGHGGYGEIFKGTLQD-----GREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      |++.+.||.|+||.||++...+     +..||+|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999763     378999998655433 5678999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.... ...+++..+..++.|++.||.+||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999985322 122899999999999999999999998   999999999999999999999999999876654


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      .... .....+++.|+|||.+.+..++.++||||||++++||++ |.+|+.......   .....    ..        .
T Consensus       157 ~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~--------~  220 (258)
T smart00219      157 DYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYL----KK--------G  220 (258)
T ss_pred             cccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hc--------C
Confidence            3321 112336789999999988889999999999999999998 677765322111   11100    00        0


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ............+.+++.+|+..+|++|||+.|+++.|
T Consensus       221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      221 YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            00111222445678899999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-36  Score=303.08  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=201.3

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|++.+.||+|++|.||+|... +|+.|++|++....  ......+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999975 78999999987654  33356789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      + +++|.+++...  ...+++..++.++.||+.+|.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 99999988532  356899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH--------hHhhhhcc-cc
Q 037160          414 LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT--------HTWKHFQA-KT  483 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~-~~  483 (569)
                      . ......++..|+|||++.+. .++.++||||||++++||++|++++.............        ..|..... ..
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 R-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             C-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            1 12345688999999998654 46899999999999999999977765433211100000        01111000 00


Q ss_pred             hhhhhcccCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIEI-----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +..+.......     ..++....+.+++.+||+.+|++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000000000     011223677889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.1e-36  Score=299.61  Aligned_cols=256  Identities=23%  Similarity=0.355  Sum_probs=198.5

Q ss_pred             ccccccccccCceeEEEEEec----CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCC------
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK------  325 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  325 (569)
                      |.+.+.||+|+||.||+|.+.    .++.||||++...  .....+.+.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999854    3688999988654  2344667889999999999999999999886532      


Q ss_pred             ceEEEEeecCCCChhhHhhCCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          326 DSFVVYEFVQNKSLDRILFDPK---QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                      ..++++||+.+++|.+++....   ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998874321   2235788999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      |+++...............+++.|++||.+.+..++.++||||||+++|||++ |++|+.......   +....    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~----~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL----IK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHH----Hc
Confidence            99986654332222233445678999999998889999999999999999999 777765332211   11110    00


Q ss_pred             cchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          482 KTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       482 ~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ..       .+ .........+.+++.+||+.+|++||++.++++.|+..
T Consensus       231 ~~-------~~-~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GN-------RL-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CC-------cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00       00 01123345788899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-36  Score=297.53  Aligned_cols=246  Identities=27%  Similarity=0.435  Sum_probs=196.4

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|.+.+.||+|+||.||++.. .++.||+|.+....  ....+.+|+.++++++||||+++++.+.. +..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            4588899999999999999975 57889999886532  23578899999999999999999999865 45799999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999998542 2345789999999999999999999998   9999999999999999999999999987543321   


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                        .....+..|+|||++.++.++.++||||||+++|||++ |+.|+........                .+.+......
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~  216 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV----------------KECVEKGYRM  216 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH----------------HHHHhCCCCC
Confidence              22234568999999998899999999999999999998 8888753322111                0111111111


Q ss_pred             C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          495 E-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       495 ~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      . .......+.+++.+||+.+|+.||++.+|++.|+.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1 12234567789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.2e-37  Score=306.30  Aligned_cols=262  Identities=26%  Similarity=0.367  Sum_probs=200.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.++||+|+||.||++..+ +++.||+|++....  ....+.+.+|+++++.++||||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999976 58999999875432  2234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.++..   ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999988773   2345899999999999999999999998   9999999999999999999999999988654432


Q ss_pred             CCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhHhHhhhhcccchhhh---
Q 037160          413 SLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVTHTWKHFQAKTVLEI---  487 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---  487 (569)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|++|+........ ..+.. ....+.. ...+.   
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~  230 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK-CLGNLIP-RHQEIFQK  230 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH-HhCCCch-hhHHHhcc
Confidence            2  2234567899999999875 4578899999999999999999988764332111 01110 0000000 00000   


Q ss_pred             ---hcccCCCC----------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 ---IDKSIEIE----------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ---~~~~l~~~----------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                         ++......          .+.....+.+++.+||+.+|++||++.+|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence               00000000          11234568889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.9e-36  Score=296.98  Aligned_cols=250  Identities=23%  Similarity=0.308  Sum_probs=195.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-----hhhHHHHHHHHHHHHhccccccceeeeeeeeC--Cce
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-----KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDS  327 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  327 (569)
                      ++|++.++||+|+||.||++... +++.|++|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999975 68999999885421     23356788999999999999999999988663  457


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      +++|||+++++|.+++..   ...+++..++.++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999999842   345788889999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......  ..             ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~-------------~~  220 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AI-------------FK  220 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--HH-------------HH
Confidence            5432111 01223568899999999988889999999999999999999999975321110  00             00


Q ss_pred             hhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ........ .+......+..++..|+. +|++||+++||+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            00000111 123344566677788885 89999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-36  Score=299.83  Aligned_cols=255  Identities=26%  Similarity=0.377  Sum_probs=198.3

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch----------hhHHHHHHHHHHHHhccccccceeeeeeeeCC
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK----------NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK  325 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  325 (569)
                      +|.+.+.||+|+||.||+|... +|+.+|+|.+.....          ...+.+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999865 689999998854211          12346888999999999999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999999843   356889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ--LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      +...............|+..|+|||.+....  ++.++||||||+++|||++|..|+......  ..    .+...... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~----~~~~~~~~-  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AA----MFKLGNKR-  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HH----HHHhhccc-
Confidence            8654332221223456889999999987654  889999999999999999999987532211  00    01100000 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+...   ........+.+++..||+.+|++||++.+|+++
T Consensus       229 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPIPPD---VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcCCcc---ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00000000   112234567778899999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.1e-36  Score=304.89  Aligned_cols=249  Identities=25%  Similarity=0.386  Sum_probs=200.0

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      .|+...+||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++|+||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3445668999999999999875 689999999876555556678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|..++.    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........  
T Consensus       102 ~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--  172 (297)
T cd06659         102 GGALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  172 (297)
T ss_pred             CCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence            999998873    245889999999999999999999998   99999999999999999999999999875544321  


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE  495 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  495 (569)
                      ......|+..|+|||++.+..++.++||||||+++|||++|+.|+...........    ...   ..     ..... .
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~---~~-----~~~~~-~  239 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRD---SP-----PPKLK-N  239 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----Hhc---cC-----CCCcc-c
Confidence            22345688999999999988899999999999999999999999864332211000    000   00     00000 0


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .......+.+++..||+.+|++||++.+|+++
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11123456778899999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.9e-36  Score=305.12  Aligned_cols=256  Identities=22%  Similarity=0.326  Sum_probs=199.9

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.+.||+|+||.||++... .++.|++|.+....   ......+.+|+++++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999976 57899999886543   234467889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999994   3356889999999999999999999998   999999999999999999999999998642111


Q ss_pred             CC-------------CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          412 KS-------------LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       412 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      ..             ........++..|+|||++.+..++.++||||||+++|||++|..|+.......   +..    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~----~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFG----Q  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----H
Confidence            00             001113457889999999988899999999999999999999999975332211   110    0


Q ss_pred             hcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .....    +.  ...........+..++.+||+.+|++||+..++.+.|+.
T Consensus       228 ~~~~~----~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         228 VISDD----IE--WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHhcc----cC--CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            00000    00  000111234457789999999999999997766666655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.7e-36  Score=297.08  Aligned_cols=250  Identities=23%  Similarity=0.361  Sum_probs=201.8

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeee--CCceEEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT--KKDSFVVY  331 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  331 (569)
                      +|++.+.||.|+||.||++... +++.+|+|.+...  .....+.+.+|++++++++||||+++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999865 6889999988653  23445678899999999999999999998764  34578999


Q ss_pred             eecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          332 EFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLH-----KDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       332 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ||+++++|.+++... .....+++..++.++.+|+.||.|||     +.+   ++|+||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999998542 23467899999999999999999999     666   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      .........  .....++..|+|||.+.+..++.++||||||+++++|++|+.|+.......   +.             
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~-------------  219 (265)
T cd08217         158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA-------------  219 (265)
T ss_pred             ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH-------------
Confidence            877654321  234568999999999998889999999999999999999999986543211   11             


Q ss_pred             hhhccc-CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          486 EIIDKS-IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       486 ~~~~~~-l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +.+... ...........+.+++.+|++.+|++||++.+|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         220 SKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            111111 111123344677889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.7e-36  Score=303.16  Aligned_cols=261  Identities=26%  Similarity=0.355  Sum_probs=201.8

Q ss_pred             hhHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeC-
Q 037160          248 YSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK-  324 (569)
Q Consensus       248 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-  324 (569)
                      ...+..++++|++.+.||+|+||.||++... +++.+|+|++..... ....+.+|+.+++++ +|||++++++++... 
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            3445567889999999999999999999975 688999998864322 235677899999999 899999999998754 


Q ss_pred             ----CceEEEEeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEE
Q 037160          325 ----KDSFVVYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI  399 (569)
Q Consensus       325 ----~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  399 (569)
                          ...++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence                3579999999999999988432 23456889999999999999999999998   999999999999999999999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCcccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-----QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH  474 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  474 (569)
                      +|||++........  ......|+..|+|||.+...     .++.++|||||||++|||++|+.|+.......  .+.. 
T Consensus       170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~~-  244 (291)
T cd06639         170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLFK-  244 (291)
T ss_pred             eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHHH-
Confidence            99999886544322  12234688999999987654     36889999999999999999999875432211  1100 


Q ss_pred             HhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          475 TWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       475 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       +.   ....     ..+. ........+..++.+||+.+|++||++.|++++
T Consensus       245 -~~---~~~~-----~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         245 -IP---RNPP-----PTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -Hh---cCCC-----CCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             00   0000     0000 112233457789999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.9e-36  Score=297.01  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=207.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.+.||+|++|.||+++.. +++.|++|++..... .....+.+|+..+.+++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999977 589999999876543 4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      +++++|.+++..   ...+++..++.++.|++++|.|||+ .+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999943   3678999999999999999999999 88   9999999999999999999999999988765433


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...............            .....
T Consensus       155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~------------~~~~~  220 (264)
T cd06623         155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP  220 (264)
T ss_pred             C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH------------hcCCC
Confidence            2  123456889999999999989999999999999999999999997654431111111111            11111


Q ss_pred             CCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIE-EVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~-~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...... ....+.+++..||+.+|++||++.+++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111222 45678889999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.5e-36  Score=296.32  Aligned_cols=253  Identities=20%  Similarity=0.350  Sum_probs=186.1

Q ss_pred             cccccCceeEEEEEecCC---ceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCC
Q 037160          263 KLGHGGYGEIFKGTLQDG---REIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKS  338 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  338 (569)
                      +||+|+||.||++...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999975533   345667665433 3345689999999999999999999999999999999999999999


Q ss_pred             hhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCC
Q 037160          339 LDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN  417 (569)
Q Consensus       339 L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  417 (569)
                      |.+++.... .....++..+..++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999985432 2345667778899999999999999998   999999999999999999999999998643222211122


Q ss_pred             cccccCCCccccccccc-------CCCCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          418 TAIAGTLGYMAPEYIAN-------GQLTEKVDIYSFGVLVLEIVSG-VQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       418 ~~~~gt~~y~aPE~~~~-------~~~~~ksDv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..|+....+..   .......    +......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~----~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHVIK----DQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh----hcccccCC
Confidence            34567889999998743       2457899999999999999975 55654322211   1111111    11111112


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      +.+..   ....++.+++..|| .+|++||++.+|++.|.
T Consensus       232 ~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22211   13345666778899 57999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-36  Score=304.21  Aligned_cols=253  Identities=25%  Similarity=0.321  Sum_probs=202.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch---hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.+.||+|++|.||++... +++.+|+|.+.....   ...+.+.+|++++++++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888999999999999999976 589999999876432   24567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+.+++|.+++.. .....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998853 23457899999999999999999999998   999999999999999999999999998754332


Q ss_pred             CCCC---------------------------CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 037160          412 KSLL---------------------------PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQS  464 (569)
Q Consensus       412 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~  464 (569)
                      ....                           ......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1100                           0113467889999999998889999999999999999999999976433


Q ss_pred             CcchhhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q 037160          465 DDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPS----MTNVVQM  527 (569)
Q Consensus       465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt----~~evl~~  527 (569)
                      ....               ..++........ .......+.+++.+||+.+|++|||    +.|++.+
T Consensus       237 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RDET---------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hHHH---------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            2210               111111111111 1124567888999999999999999    7777764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-36  Score=303.93  Aligned_cols=263  Identities=20%  Similarity=0.279  Sum_probs=195.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|++.++||+|+||.||+++.. +|+.+|+|++.....  .....+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999976 689999998865422  2235677899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++ +|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            974 67776642  2356899999999999999999999998   99999999999999999999999999886543321


Q ss_pred             CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcch--hhhh-------HhHhhhhcc--
Q 037160          414 LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF--ETLV-------THTWKHFQA--  481 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~--~~~~-------~~~~~~~~~--  481 (569)
                        ......++..|+|||++.+. .++.++||||||+++|||++|..|+........  ..+.       ...|.....  
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence              12234578899999998765 478999999999999999999988643222110  0000       000100000  


Q ss_pred             -cchhhhhcccCC--CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 -KTVLEIIDKSIE--IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 -~~~~~~~~~~l~--~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ............  ...+.....+.+++.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence             000000000000  0011234567789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6e-36  Score=299.32  Aligned_cols=265  Identities=22%  Similarity=0.310  Sum_probs=201.3

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +|++.++||.|++|.||+|+.. +|+.||||++..... .....+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999986 688999999876532 23456778999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88888755444567899999999999999999999998   99999999999999999999999999976543221 


Q ss_pred             CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh-----
Q 037160          415 LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII-----  488 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  488 (569)
                       ......++..|++||.+.+. .++.++||||||+++|+|++|+.|+...........+...+.......+..+.     
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             12234578899999988664 57889999999999999999999986544322111111010000000000000     


Q ss_pred             cccCCC--------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEI--------EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~--------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......        ..+.....+.+++..|++.+|.+||++.+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000000        011224567789999999999999999999854

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=310.23  Aligned_cols=271  Identities=23%  Similarity=0.304  Sum_probs=199.3

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeC-----Cc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----KD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  326 (569)
                      ++++|++.++||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3578999999999999999999865 78999999886432 33456688899999999999999999887544     35


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++++||+.+ +|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          83 VYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            7999999964 7777662    346899999999999999999999998   9999999999999999999999999988


Q ss_pred             ccCCCCCCC-CCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          407 FSSSEKSLL-PNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       407 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      ......... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.|+.......................+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            654432211 1224568899999998654 56899999999999999999999988543221110000000000000001


Q ss_pred             hhhhcc-----------cCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hccCC
Q 037160          485 LEIIDK-----------SIEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQKD  532 (569)
Q Consensus       485 ~~~~~~-----------~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~  532 (569)
                      ..+...           .....    .+.....+.+++.+||+.+|++|||+.|++++  ++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            000000           00000    01224567889999999999999999999987  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.1e-36  Score=298.15  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=202.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|+..++||+|++|.||++.++ +++.+++|.+.... ....+.+.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788889999999999999976 68899999887653 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      +++++|.+++...  ...+++..+..++.|++.+|.|||+ .+   ++|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999998532  2678889999999999999999999 77   9999999999999999999999999987554322


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .    ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ......         +...+....
T Consensus       156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~---------~~~~~~~~~  221 (265)
T cd06605         156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFEL---------LQYIVNEPP  221 (265)
T ss_pred             h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHH---------HHHHhcCCC
Confidence            1    12668889999999998899999999999999999999999876442110 001000         001111111


Q ss_pred             CCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIE-EVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~-~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...... ....+.+++..||..+|++|||+.+++.+
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            111111 44567889999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.2e-36  Score=298.34  Aligned_cols=247  Identities=26%  Similarity=0.429  Sum_probs=200.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +-|++.++||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34778889999999999999865 68899999876443 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++.    ...+++..+..++.+++.+|.+||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            99999999883    245889999999999999999999998   99999999999999999999999999876544321


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc-C
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS-I  492 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l  492 (569)
                        ......++..|+|||++.+..++.++||||||+++|+|++|..|+.........                ..+... .
T Consensus       157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----------------~~~~~~~~  218 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL----------------FLIPKNNP  218 (277)
T ss_pred             --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH----------------HHHhcCCC
Confidence              122346788999999998888999999999999999999999987533221100                000000 0


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..........+.+++.+||+.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00112234557778999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.1e-36  Score=301.75  Aligned_cols=245  Identities=24%  Similarity=0.310  Sum_probs=200.9

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.+.||+|+||.||++... +++.+|+|++....   ......+.+|++++++++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999976 68999999886532   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999984   3367899999999999999999999998   999999999999999999999999998876543


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                           .....+++.|+|||.+.+...+.++||||||+++|+|++|+.|+.......       .+..        +....
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~--------~~~~~  214 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEK--------ILEGK  214 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH--------HhcCC
Confidence                 234468899999999988889999999999999999999999976433111       0000        11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      .. .+......+.+++.+||+.+|.+||     ++.|++++
T Consensus       215 ~~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 VR-FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             cc-CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            10 1112245677888999999999999     78888754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.7e-36  Score=294.30  Aligned_cols=252  Identities=30%  Similarity=0.474  Sum_probs=201.1

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|+..++||+|+||.||++... +++.|++|.+.....  ...+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999865 789999999876544  3667899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++.   ....+++..+..++.+++.||.|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999984   3345788999999999999999999998   99999999999999999999999999987655432


Q ss_pred             CCC--CcccccCCCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          414 LLP--NTAIAGTLGYMAPEYIANGQ---LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       414 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ...  .....++..|+|||++.+..   ++.++||||||++++||++|+.|+....... ..    .+... ..     .
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~----~~~~~-~~-----~  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QI----MFHVG-AG-----H  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HH----HHHHh-cC-----C
Confidence            211  12356788999999998766   8899999999999999999999985332111 00    00000 00     0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      ...+. ........+.+++.+||+.+|++|||+.+++.
T Consensus       224 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 KPPIP-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCC-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00010 11112455678889999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-36  Score=298.02  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=201.0

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCC-----
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKK-----  325 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-----  325 (569)
                      ..+++|++.+.||+|++|.||+|..+ +++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            45688999999999999999999976 678999998866543 346789999999999 7999999999997654     


Q ss_pred             -ceEEEEeecCCCChhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          326 -DSFVVYEFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       326 -~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4799999999999999885322 2467899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-----GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      ++........  ......|+..|+|||++..     ..++.++||||||+++++|++|+.|+.......  .+..     
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~-----  229 (275)
T cd06608         159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK-----  229 (275)
T ss_pred             cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH-----
Confidence            9876543221  2234568899999998753     346789999999999999999999985322111  0100     


Q ss_pred             hcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....     ....+. ........+.+++.+||..+|++|||+.+|+++
T Consensus       230 ~~~~-----~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 IPRN-----PPPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             hhcc-----CCCCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0000     000010 112244567889999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=298.95  Aligned_cols=271  Identities=24%  Similarity=0.330  Sum_probs=205.6

Q ss_pred             ccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHh--ccccccceeeeeeeeCC----ceEEEE
Q 037160          258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR--AHHKNLVQFLGCCFTKK----DSFVVY  331 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~  331 (569)
                      .+..++||+|.||.||||++. ++.||||++...   ..+.|.+|-+|...  ++|+||+++++.-....    +.+||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            344567999999999999997 499999988544   44678888888775  58999999999987665    889999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc------CCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD------GQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      +|.+.|+|.++|    +...++|....+|+..+++||+|||+.      .+++|+|||||.+||||.++++..|+|||+|
T Consensus       288 ~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  288 EFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            999999999999    346799999999999999999999975      3678999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccC-CCC-----cccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH-hHhhh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLT-----EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT-HTWKH  478 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~-~~~~~  478 (569)
                      ..+............+||.+|||||++.+. .+.     .+.||||+|.|||||++............++.-.. ..-.+
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            988876665555578999999999999764 233     36899999999999999865443222222211111 11111


Q ss_pred             hcccchhhhhc-ccCCCC------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 037160          479 FQAKTVLEIID-KSIEIE------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLP  536 (569)
Q Consensus       479 ~~~~~~~~~~~-~~l~~~------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  536 (569)
                      ...+.+.+.+- +..++.      ....+.-+.+.+..||.+||+-|.|+.=|.+.+.......+
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            11122222221 111111      12344557778999999999999999999988877654443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.1e-37  Score=330.96  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=194.4

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeC-----
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----  324 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  324 (569)
                      .....+|++...||+||||.|||++.+ ||++||||++... +......+.+|+.+|.+|+|||||+++..|.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            567789999999999999999999988 9999999999655 455567899999999999999999998665420     


Q ss_pred             --------------------------------------------------------------------------------
Q 037160          325 --------------------------------------------------------------------------------  324 (569)
Q Consensus       325 --------------------------------------------------------------------------------  324 (569)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHH
Q 037160          325 ----------------------------------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY  370 (569)
Q Consensus       325 ----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~  370 (569)
                                                        ...||-||||+..+|.+++.+.....  .....++++.+|++||.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                              01367899999888888884322211  467889999999999999


Q ss_pred             HhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC----C--------C----CCCCCCcccccCCCccccccccc
Q 037160          371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS----S--------E----KSLLPNTAIAGTLGYMAPEYIAN  434 (569)
Q Consensus       371 LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~----~--------~----~~~~~~~~~~gt~~y~aPE~~~~  434 (569)
                      +|+++   ||||||||.||+|+++..+||+|||+|....    .        +    ......+..+||.-|+|||.+.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99999   9999999999999999999999999998621    0        0    00113346789999999999976


Q ss_pred             C---CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC---CHHHHHHHHHHHH
Q 037160          435 G---QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE---DIEEVKRVVWVGL  508 (569)
Q Consensus       435 ~---~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~~l~~  508 (569)
                      .   +|+.|+|+|||||||+||+.   ||....+..      ..        +..+-+..+...   ..+....-..++.
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa------~i--------L~~LR~g~iP~~~~f~~~~~~~e~slI~  852 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA------SI--------LTNLRKGSIPEPADFFDPEHPEEASLIR  852 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHH------HH--------HHhcccCCCCCCcccccccchHHHHHHH
Confidence            5   49999999999999999984   443322210      11        111112222222   2344445566888


Q ss_pred             HhcCCCCCCCCCHHHHHH
Q 037160          509 LCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       509 ~Cl~~~P~~RPt~~evl~  526 (569)
                      +++++||.+|||+.|+|.
T Consensus       853 ~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  853 WLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHhcCCCccCCCHHHHhh
Confidence            999999999999999985

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.5e-36  Score=300.80  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=203.4

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|++.+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            367889999999999999999865 6789999998765555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++..    ..+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999842    35788999999999999999999998   99999999999999999999999999876544332


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        ......+++.|++||.+.++.++.++||||||+++|+|++|+.||...........   ..   .        .....
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~---~--------~~~~~  234 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA---T--------NGTPE  234 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hh---c--------CCCCC
Confidence              22334688899999999888899999999999999999999999864432211000   00   0        00000


Q ss_pred             C-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 I-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      . ........+.+++..||+.+|++||++.+++.+
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0 111223457778899999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9.5e-36  Score=298.37  Aligned_cols=249  Identities=25%  Similarity=0.405  Sum_probs=200.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      .|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++......++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555678999999999999865 788999998876555556678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999999843    45889999999999999999999998   99999999999999999999999998875543221  


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE  495 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  495 (569)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+........   ..    ...     ........ .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~----~~~-----~~~~~~~~-~  237 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MK----RIR-----DNLPPKLK-N  237 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HH----HHH-----hcCCCCCc-c
Confidence            12235688999999999888899999999999999999999998754322111   00    000     00000110 1


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .......+.+++.+||+.+|++||++.+++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            11234568889999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=300.58  Aligned_cols=262  Identities=22%  Similarity=0.354  Sum_probs=196.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.++||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57889999999999999999976 689999999865432 2234567899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +.+ +|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            975 898887432  346889999999999999999999998   99999999999999999999999999875432111


Q ss_pred             CCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc---cchhhhh-
Q 037160          414 LLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA---KTVLEII-  488 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-  488 (569)
                        ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+.......  ..+...+.....   ..+.... 
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhh
Confidence              1123346789999998875 458899999999999999999999886443111  111111111000   0000000 


Q ss_pred             -----ccc---CC-----C--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 -----DKS---IE-----I--EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 -----~~~---l~-----~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                           ...   ..     .  ........+.+++..||+.+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                 000   00     0  001112566789999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.4e-36  Score=301.15  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=197.3

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|+..+.||+|++|.||+|+.. +|+.||||++....  ......+.+|++++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999876 68999999886543  22335788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +. ++|..++.. .....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 688888743 23456899999999999999999999998   99999999999999999999999999876543321


Q ss_pred             CCCCcccccCCCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhH-------hHhhhhcc-cc
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVT-------HTWKHFQA-KT  483 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~-------~~~~~~~~-~~  483 (569)
                        ......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+........ .....       ..|..... ..
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence              122345688999999887654 68899999999999999999998865432211 00000       00000000 00


Q ss_pred             hhhhhcccCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIE----IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+.....    ...+.....+.+++.+||+.+|++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0000000000    0011123456788999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.4e-36  Score=299.50  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=199.0

Q ss_pred             HHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeee-----
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT-----  323 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----  323 (569)
                      +....+.|++.++||+|+||.||+|.+. +++.+|+|.+..... ....+..|+.+++++ +|+||+++++++..     
T Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            3445678999999999999999999975 688999998865433 345688999999998 79999999999853     


Q ss_pred             -CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          324 -KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       324 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                       ....+++|||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.++|+||
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeC
Confidence             45679999999999999988542 2345788889999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      |++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|+.|+....+...  ...    
T Consensus       166 g~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~~----  237 (282)
T cd06636         166 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LFL----  237 (282)
T ss_pred             cchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hhh----
Confidence            99876543221  223456889999999875     34678899999999999999999998753321110  000    


Q ss_pred             hhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          478 HFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                            ........  .........+.+++..||+.+|.+||++.||+++
T Consensus       238 ------~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 ------IPRNPPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ------HhhCCCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                  00000000  0112234568889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.8e-36  Score=298.76  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=193.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHH-HHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDI-MSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.+.||+|+||.||+++.+ +|+.||+|++.... ......+..|+.+ ++.++||||+++++++......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999976 68999999886542 2233455566665 566789999999999999999999999


Q ss_pred             ecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          333 FVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       333 ~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |++ ++|.+++... .....+++..++.++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6787777432 2345789999999999999999999987 6   99999999999999999999999999886543


Q ss_pred             CCCCCCCcccccCCCccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIAN----GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ..   ......++..|+|||.+.+    ..++.++||||||+++|||++|+.|+...... ...             +..
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~-------------~~~  219 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQ-------------LKQ  219 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHH-------------HHH
Confidence            22   2233568889999998865    45688999999999999999999987532111 000             111


Q ss_pred             hhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+..... .........+..++..||+.+|++||++.+|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111000 0011233567889999999999999999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-36  Score=303.55  Aligned_cols=267  Identities=19%  Similarity=0.321  Sum_probs=197.7

Q ss_pred             cccccccccccCceeEEEEEec---CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeC--CceE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ---DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSF  328 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  328 (569)
                      .|++.++||+|+||.||+|...   +++.||+|.+....   ......+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3778899999999999999975   47899999987633   33446778899999999999999999999888  7899


Q ss_pred             EEEeecCCCChhhHhhCCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC----CCCeEEecc
Q 037160          329 VVYEFVQNKSLDRILFDPK--QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL----KHRPKIADF  402 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~----~~~~kl~Df  402 (569)
                      +||||+++ +|.+++....  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 5656553222  2236889999999999999999999998   999999999999999    899999999


Q ss_pred             CCCcccCCCCC-CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh------hhHh
Q 037160          403 GLARFSSSEKS-LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET------LVTH  474 (569)
Q Consensus       403 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~------~~~~  474 (569)
                      |++........ ........++..|+|||.+.+. .++.++||||||++++||++|++|+..........      .+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986644332 1122345678999999987664 58899999999999999999999987544332000      0000


Q ss_pred             Hhhhhc------------ccchhhh---hc-ccCC-CCCH-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          475 TWKHFQ------------AKTVLEI---ID-KSIE-IEDI-------EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       475 ~~~~~~------------~~~~~~~---~~-~~l~-~~~~-------~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+.            .......   .. .... ....       ....++.+++.+||+.+|++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000            0000000   00 0000 0000       233568889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-35  Score=297.50  Aligned_cols=252  Identities=29%  Similarity=0.457  Sum_probs=205.5

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..++.|+..+.||+|++|.||++.++ +++.+++|++..... ..+.+.+|++++++++|+|++++++.+......++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45677888999999999999999987 688999999876554 5577889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++....  ..+++..+..++.+++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999995422  47899999999999999999999988   999999999999999999999999988755433


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..  ......++..|++||++.+..++.++||||||+++|+|++|+.|+........  ...             .....
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~-------------~~~~~  232 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFL-------------ITTKG  232 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-------------HHhcC
Confidence            21  12334578899999999888899999999999999999999998764332211  000             00000


Q ss_pred             CC-CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          492 IE-IE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       492 l~-~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .. .. .......+.+++.+||+.+|..||++.+|+++
T Consensus       233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            00 01 11134567789999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-35  Score=296.82  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=200.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeC--CceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  331 (569)
                      ++|+..++||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999975 688999998875432 3456789999999999999999999988654  3679999


Q ss_pred             eecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          332 EFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ||+++++|.+++... .....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887422 23456888999999999999999999998   99999999999999999999999999875543


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..    .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...........-...+  ........ +..
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~  230 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--IVNMPNPE-LKD  230 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH--HhcCCchh-hcc
Confidence            21    123457889999999998899999999999999999999999987543211000000000  00000000 000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... ........+.+++.+||+.+|++|||+.||+++
T Consensus       231 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         231 EPG-NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             CCC-CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            000 011234567889999999999999999999974

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-36  Score=305.21  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=203.5

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEee--cchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFI--SRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ...|+++++||+||-+.||++...+.+.+|+|++..  .+.+....|.+|+.+|.+| .|.+||+++++-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            456889999999999999999988888899887643  3456678899999999999 5899999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||= ..+|..+|... ......| .+..+..|++.++.++|+++   |||.||||.|+|+- .|.+||+|||.|.....+
T Consensus       440 E~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            975 67999999432 2222334 77789999999999999999   99999999999997 789999999999988887


Q ss_pred             CCCCCCcccccCCCcccccccccC-----------CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANG-----------QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ  480 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  480 (569)
                      .+.......+||+.||+||.+...           +.+.++||||||||||+|+.|+.||.....         .|    
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~----  579 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QI----  579 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HH----
Confidence            766666788999999999988532           256799999999999999999999752211         11    


Q ss_pred             ccchhhhhcccCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          481 AKTVLEIIDKSIEIE--DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       481 ~~~~~~~~~~~l~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ..+..+.++.-.++  .......+++++..||+.||.+||++.|+|++
T Consensus       580 -aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 -AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             12334444433222  22222238999999999999999999999965

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.8e-36  Score=294.67  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=200.2

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|++.+.||+|+||.||++..+ +|..+|+|.+....  ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999976 68899999886542  23345788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC-eEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR-PKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~-~kl~Dfgla~~~~~~~  412 (569)
                      +++++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988532 2345789999999999999999999998   999999999999998864 6999999987665432


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  ......|++.|+|||++.+..++.++||||||++++||++|+.|+.......   ..            .+......
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~------------~~~~~~~~  219 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ---LV------------LKICQGYF  219 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HH------------HHHhcccC
Confidence            1  1223458899999999988889999999999999999999999875332111   11            11111111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+.....+.+++.+||+.+|++|||+.||+.+
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11122233567788899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-35  Score=299.18  Aligned_cols=264  Identities=22%  Similarity=0.322  Sum_probs=199.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchh--hHHHHHHHHHHHHhccccccceeeeeeeeC--CceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  330 (569)
                      ++|++.+.||+|+||.||+|..+ +++.+++|.+......  ....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999976 6889999998754322  234567899999999999999999999877  889999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+.+ +|.+++..  ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 88888743  2236899999999999999999999998   99999999999999999999999999986655


Q ss_pred             CCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWKHFQA  481 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~  481 (569)
                      ...  ......+++.|+|||.+.+. .++.++||||||+++|||++|.+|+...........+..        .|..+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            321  22344578899999998764 468999999999999999999999875443221111100        1111100


Q ss_pred             c------chhhhhcccCCCCCHH--HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 K------TVLEIIDKSIEIEDIE--EVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 ~------~~~~~~~~~l~~~~~~--~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      -      .........+...-+.  ....+.+++..||+.+|++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0      0000000000011111  24557788999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1e-35  Score=298.91  Aligned_cols=263  Identities=21%  Similarity=0.332  Sum_probs=195.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      +++|.+.++||+|+||.||+|... +|+.|++|++..... .....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            578999999999999999999865 688999999865432 223467789999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+. ++|.+.+..  ....+.+..+..++.|++.||.|||+.+   |+|+||||+||+++.++++||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          84 YMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             ccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            996 566666532  2345778888999999999999999998   9999999999999999999999999987543322


Q ss_pred             CCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc---------
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK---------  482 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  482 (569)
                      .  ......+++.|+|||++.+. .++.++||||||+++|||++|+.|+...... . ..+...|..+...         
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-F-EQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-H-HHHHHHHHHcCCCChhhhhhhh
Confidence            1  12234578899999998764 5788999999999999999999998643321 1 1111111111000         


Q ss_pred             ---chhhhhcccCCC-------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 ---TVLEIIDKSIEI-------EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ---~~~~~~~~~l~~-------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                         ...+........       ........+.+++.+|++.+|++|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence               000000000000       001113456678899999999999999999854

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-35  Score=288.65  Aligned_cols=250  Identities=30%  Similarity=0.471  Sum_probs=204.2

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      +|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778889999999999999976 788999999977655566789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++...  ...+++..+..++.+++.+|.+||+.+   ++||||+|+||+++.++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999998432  257899999999999999999999988   99999999999999999999999999887655431  


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE  495 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  495 (569)
                       .....++..|+|||.+.+..++.++||||||+++++|++|+.|+........  ... .    ..      ........
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~-~----~~------~~~~~~~~  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFK-I----AT------NGPPGLRN  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHH-H----Hh------cCCCCcCc
Confidence             2355688999999999888899999999999999999999998764322110  000 0    00      00000001


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .......+.+++..||+.+|++|||+.|++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11124568889999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=295.45  Aligned_cols=248  Identities=25%  Similarity=0.416  Sum_probs=199.0

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec-chhhHHHHHHHHHHHHhcc---ccccceeeeeeeeCCceEEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAH---HKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .|++.++||+|+||.||+|.+. +++.+++|.+... .......+.+|+.++++++   |||++++++.+......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4778889999999999999974 7899999988654 3344567889999999996   999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++..    ..+++..++.++.+++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998832    36889999999999999999999998   999999999999999999999999999876554


Q ss_pred             CCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..  ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+..........        .....    ..+
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--------~~~~~----~~~  220 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--------LIPKS----KPP  220 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--------ccccC----CCC
Confidence            32  22345688999999998754 57899999999999999999999986432211100        00000    000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+..  ......+.+++..||+.+|++||++.+++++
T Consensus       221 ~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         221 RLED--NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            1111  1134567788899999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=313.26  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=206.7

Q ss_pred             cccccccccCceeEEEEEec--CCc--eEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          259 DESNKLGHGGYGEIFKGTLQ--DGR--EIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       259 ~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ...++||+|.||.|++|.|+  +|+  .||||.+...... ....|++|+.+|.+|+|+|++++||+..+ ....+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34568999999999999986  344  5799999776544 66789999999999999999999999988 778899999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      ++.|+|-+.|.. ..+..+-......++.|||.||.||..++   +|||||..+||||-....+||+||||.+-+..++.
T Consensus       192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999965 45677888889999999999999999998   99999999999999999999999999998877654


Q ss_pred             CCCCc-ccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          414 LLPNT-AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV-QNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       414 ~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .-... ...-.+.|.|||.++..+++-++|||+|||.||||+++. .|                |.....-.+++.+|..
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEeP----------------W~G~~g~qIL~~iD~~  331 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEP----------------WVGCRGIQILKNIDAG  331 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCC----------------CCCCCHHHHHHhcccc
Confidence            32211 223356799999999999999999999999999999963 34                4444444556666643


Q ss_pred             CCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          492 IEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       492 l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      -.-. +..+.+++.++++.||.++|++|||+..|.+.
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            3222 56778899999999999999999999999743

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.3e-36  Score=295.43  Aligned_cols=247  Identities=23%  Similarity=0.316  Sum_probs=201.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      +|++.++||.|+||.||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999976 68999999886542   2446789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+.+++|.+++..   ...+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999843   357889999999999999999999998   9999999999999999999999999987665432


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                         ......|+..|+|||.+.+..++.++||||||+++|+|++|..|+..........+.             .......
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~~  218 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-------------AKQETAD  218 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-------------HHhcccc
Confidence               223456888999999998888999999999999999999999998754432111110             0111000


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSM--TNVV  525 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~--~evl  525 (569)
                      ...+......+.+++.+||+.+|.+||++  .|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11122233677789999999999999999  6665

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=307.20  Aligned_cols=251  Identities=25%  Similarity=0.417  Sum_probs=205.5

Q ss_pred             ccccccccccccCceeEEEEEecC---Cc--eEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQD---GR--EIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      +.....++||.|.||.||+|++.+   |+  .||||..+.. ..+..+.|+.|..+|++++|||||+++|+|.+ ...+|
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            344456789999999999998642   33  4788988764 34456789999999999999999999999966 56799


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      |||.++.|.|..+|.  ..+..++......++.||+.+|+|||+..   .|||||..+|||+.+..-+||+|||+++...
T Consensus       468 vmEL~~~GELr~yLq--~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQ--QNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHH--hccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            999999999999995  34567888889999999999999999998   9999999999999999999999999999988


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ....+.. +...-...|||||-+.-..++.++|||.|||++||+++ |..||..-..                .++.-.+
T Consensus       543 d~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI~~i  605 (974)
T KOG4257|consen  543 DDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVIGHI  605 (974)
T ss_pred             ccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceEEEe
Confidence            8776633 33445678999999999999999999999999999887 7777654322                2222222


Q ss_pred             cccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          489 DKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       489 ~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      .+.-.. .++.+...+..++.+||..+|.+||++.||...|+
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            222222 25667788889999999999999999999887664

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.8e-35  Score=298.52  Aligned_cols=268  Identities=23%  Similarity=0.330  Sum_probs=198.6

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeC--CceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  329 (569)
                      .++|++.++||+|+||.||+|..+ +|+.||+|++.....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367899999999999999999976 689999998865432  2223566899999999999999999998765  46799


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+.+ +|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999964 78887743  2356899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWKHFQ  480 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~  480 (569)
                      ....  ......++..|+|||.+.+ ..++.++||||||+++|||++|++|+...........+..        .|+.+.
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            4321  1223345788999999865 4678999999999999999999999865443221111111        111110


Q ss_pred             ccchhhhhc---ccCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          481 AKTVLEIID---KSIEI---EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       481 ~~~~~~~~~---~~l~~---~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .......+.   .....   ........+.+++.+|++.||++|||+.|++++---
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence            000000000   00000   001124556779999999999999999999976443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-35  Score=304.23  Aligned_cols=267  Identities=23%  Similarity=0.310  Sum_probs=199.4

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhc-cccccceeeeeeeeC--Cc
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK--KD  326 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~  326 (569)
                      .+.++|++.++||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            35678999999999999999999976 6889999988542  233445677899999999 999999999988653  36


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++||||+. ++|..++..    ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            799999997 588888732    26789999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCC---CCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH-------
Q 037160          407 FSSSEKSL---LPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT-------  475 (569)
Q Consensus       407 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-------  475 (569)
                      ........   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.|+...........+...       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            66543321   12234568999999998755 46889999999999999999999998644322111000000       


Q ss_pred             -hhhhcccchhhhhcccCCC-------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          476 -WKHFQAKTVLEIIDKSIEI-------EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       476 -~~~~~~~~~~~~~~~~l~~-------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       +..+......++++.....       ..+.....+.+++.+||+.+|++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence             0111111111111110000       011134567889999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-35  Score=299.49  Aligned_cols=266  Identities=21%  Similarity=0.284  Sum_probs=195.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhc-cccccceeeeeeeeCCc-----
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKD-----  326 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-----  326 (569)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.+++.+ +||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999976 689999998765432  2345788899999999 46999999999887665     


Q ss_pred             eEEEEeecCCCChhhHhhCCCC--CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccC
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQ--KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFG  403 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfg  403 (569)
                      .++||||+++ +|.+++.....  ...+++..++.++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 78887743222  356899999999999999999999998   999999999999998 8899999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhH-------h
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVT-------H  474 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~-------~  474 (569)
                      +++.+.....  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..|+....+... ..+..       .
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9876543221  1223356889999998865 4578999999999999999999998865432211 00000       0


Q ss_pred             Hhhhhcccchhhhhccc----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          475 TWKHFQAKTVLEIIDKS----IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       475 ~~~~~~~~~~~~~~~~~----l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .|...............    +....+.....+.+++..||+.+|.+||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000000000000000    000011234567789999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.7e-35  Score=298.36  Aligned_cols=247  Identities=28%  Similarity=0.445  Sum_probs=196.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .+.|+..++||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++.+++......++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888999999999999999976 68999999886432   23446788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+. |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 566666532  2346899999999999999999999998   99999999999999999999999999875533


Q ss_pred             CCCCCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .      ....++..|+|||.+.   .+.++.++||||||+++|||++|++|+........  .    .         ..
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~----~---------~~  226 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----Y---------HI  226 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--H----H---------HH
Confidence            2      2346788999999874   45688999999999999999999998753321110  0    0         00


Q ss_pred             hcc-cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          488 IDK-SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       488 ~~~-~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ... ............+..++..||+.+|++||++.+|+.+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            000 00011222345678899999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.1e-35  Score=289.05  Aligned_cols=252  Identities=26%  Similarity=0.355  Sum_probs=205.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeC--CceEEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSFVVY  331 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  331 (569)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999977 789999998866542  4567899999999999999999999999988  8899999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++..   ...+++..++.++.+++++|.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999843   237899999999999999999999988   999999999999999999999999999877665


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..........++..|+|||.+.....+.++||||||+++++|++|+.|+......     ....+.....        ..
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------~~  221 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSS--------GE  221 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhcccc--------CC
Confidence            4311133456889999999998888999999999999999999999998654411     1111111100        00


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+......+.+++.+|++.+|++||++.+++.+
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            111122335678888999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=297.02  Aligned_cols=263  Identities=23%  Similarity=0.317  Sum_probs=196.8

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      |++.++||.|++|.||+|... +|+.||+|++....  ......+.+|++++++++|||++++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999875 79999999886543  223456889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      . ++|.+++... ....+++..++.++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 6898888432 2246899999999999999999999998   99999999999999999999999999876543221 


Q ss_pred             CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhH-------hHhhhhcc-cch
Q 037160          415 LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVT-------HTWKHFQA-KTV  484 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~-------~~~~~~~~-~~~  484 (569)
                       ......++..|+|||++.+. .++.++||||||+++|||++|++|+........ .....       ..|..... ...
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence             12233568899999988664 578999999999999999999998864432111 00000       00100000 000


Q ss_pred             hhhhccc----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          485 LEIIDKS----IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       485 ~~~~~~~----l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...+...    .....+.....+.+++.+||+.+|++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000    000011223567789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-35  Score=319.41  Aligned_cols=270  Identities=20%  Similarity=0.255  Sum_probs=188.7

Q ss_pred             HHHhccccccccccccCceeEEEEEecC--CceEEEE------------------EEeecchhhHHHHHHHHHHHHhccc
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQD--GREIAVK------------------RLFISRKNRIKEICNEMDIMSRAHH  311 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h  311 (569)
                      ..+.++|++.++||+|+||.||++..+.  +...++|                  .+. ........+.+|+.+|++++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence            3456789999999999999999987542  2222222                  111 112234568899999999999


Q ss_pred             cccceeeeeeeeCCceEEEEeecCCCChhhHhhCCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCe
Q 037160          312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPK--QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNI  389 (569)
Q Consensus       312 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NI  389 (569)
                      |||+++++++...+..++|+|++. ++|.+++....  .........+..++.||+.||.|||+++   ||||||||+||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI  298 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI  298 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence            999999999999999999999985 46666653221  1222345667789999999999999998   99999999999


Q ss_pred             EECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC-CCCcch
Q 037160          390 LLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKF-QSDDGF  468 (569)
Q Consensus       390 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~-~~~~~~  468 (569)
                      |++.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..++.. ......
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            9999999999999999876543322 22346799999999999999999999999999999999998754332 221111


Q ss_pred             hhhhHhH------hhhhcc--cchhhhhcccCCC----CCHH------HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          469 ETLVTHT------WKHFQA--KTVLEIIDKSIEI----EDIE------EVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       469 ~~~~~~~------~~~~~~--~~~~~~~~~~l~~----~~~~------~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..+....      ...+..  ..+.+.++.....    ....      ....+..++.+||+.||++|||+.|++.+
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111100      000000  0111111110000    0000      11245567889999999999999999965

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=296.19  Aligned_cols=263  Identities=24%  Similarity=0.336  Sum_probs=198.9

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeC--CceEEEEe
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSFVVYE  332 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  332 (569)
                      |++.++||+|++|.||+|... +++.+|+|++....  ......+.+|++++++++|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999976 58899999997653  33446788999999999999999999999888  88999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++ +|.+++...  ...+++..++.++.||++||.|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888887432  257899999999999999999999998   9999999999999999999999999998665543


Q ss_pred             CCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhhhhcccc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWKHFQAKT  483 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~  483 (569)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+..        .|..+..-.
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            21 1233456788999998765 4688999999999999999999999865443221111110        010000000


Q ss_pred             hhhhhcccCC------CCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIE------IEDIE-EVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~------~~~~~-~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..........      ..... ....+.+++..||+.+|++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0000000000      00001 25678889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=279.40  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=199.9

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec-chhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +.+.+..||.|..|.|++.+++ .|..+|||.+... ++...+++++.++++...+ +|.||+.+|+|..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3445667999999999999987 6889999998664 5666788889999888875 89999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      | ...++.++.  +.++++++.-+-++...+..||.||.+++  .|+|||+||+|||+|+.|++||||||.+..+-... 
T Consensus       173 M-s~C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-  246 (391)
T KOG0983|consen  173 M-STCAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-  246 (391)
T ss_pred             H-HHHHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence            8 456677764  34566888888889999999999999876  59999999999999999999999999997765544 


Q ss_pred             CCCCcccccCCCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          414 LLPNTAIAGTLGYMAPEYIAN---GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                        ..+...|-+.|||||.+.-   .+|+.++||||||+.|+||.||+.|+..-..+ ++ .+.....         -.-+
T Consensus       247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe-~ltkvln---------~ePP  313 (391)
T KOG0983|consen  247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FE-VLTKVLN---------EEPP  313 (391)
T ss_pred             --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HH-HHHHHHh---------cCCC
Confidence              4456789999999999854   46889999999999999999999998753322 11 1111111         0011


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+.. .......+.+++..||++|+.+||...+++++
T Consensus       314 ~L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  314 LLPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            2221 12256788999999999999999999999865

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.1e-35  Score=302.98  Aligned_cols=262  Identities=23%  Similarity=0.314  Sum_probs=197.9

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC------
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------  324 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  324 (569)
                      ..++|++.+.||+|+||.||++... +|+.||+|.+...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999975 7899999988542  233445678899999999999999999988643      


Q ss_pred             CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                      ...++||||+. ++|.+.+..     .++...+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            35699999996 477777632     2788899999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhH----------
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVT----------  473 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~----------  473 (569)
                      ++......   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ..+..          
T Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            98654432   12344678999999999999999999999999999999999999865432111 00000          


Q ss_pred             ----hHhhhhc-------ccchhhhhcccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          474 ----HTWKHFQ-------AKTVLEIIDKSIEIE-----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       474 ----~~~~~~~-------~~~~~~~~~~~l~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                          .....+.       .....+.+...+...     .......+.+++.+||+.+|++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0000000       000111111111000     11234567889999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-35  Score=294.60  Aligned_cols=259  Identities=22%  Similarity=0.280  Sum_probs=192.6

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhcc-ccccceeeeeeeeC--CceEEEEe
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTK--KDSFVVYE  332 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  332 (569)
                      |++.++||+|+||.||++... +++.||+|++.... ........+|+.+++++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999865 68899999886532 222234457899999885 99999999999887  88999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+.+ +|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9974 77777643  2356899999999999999999999998   999999999999999 999999999998664432


Q ss_pred             CCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc-
Q 037160          413 SLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK-  490 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  490 (569)
                         ......++..|+|||++.. +.++.++|||||||++|||++|++|+......+........... ....+...+.. 
T Consensus       154 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  229 (282)
T cd07831         154 ---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT-PDAEVLKKFRKS  229 (282)
T ss_pred             ---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCC-CCHHHHHhhccc
Confidence               2233457889999997644 56789999999999999999999998654332111000000000 00000000000 


Q ss_pred             -------------cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 -------------SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 -------------~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                                   .+..........+.+++.+||+.+|++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                         0000012335678889999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.8e-35  Score=291.96  Aligned_cols=245  Identities=24%  Similarity=0.273  Sum_probs=193.1

Q ss_pred             ccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ||+|+||.||++..+ +|+.+++|.+....   ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 68999999886532   22345677899999999999999999999999999999999999999


Q ss_pred             hhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcc
Q 037160          340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA  419 (569)
Q Consensus       340 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  419 (569)
                      .+++.... ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            99985432 246899999999999999999999998   9999999999999999999999999987654422   2234


Q ss_pred             cccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHH
Q 037160          420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE  499 (569)
Q Consensus       420 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  499 (569)
                      ..++..|+|||.+.++.++.++||||||+++++|++|+.|+...........+            ...............
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL------------KRRTLEMAVEYPDKF  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH------------HhccccccccCCccC
Confidence            46788999999998888999999999999999999999998654331110000            000000000011223


Q ss_pred             HHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          500 VKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       500 ~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      ...+.+++..||+.+|++||     ++.+++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            45677889999999999999     66667753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-35  Score=303.63  Aligned_cols=264  Identities=21%  Similarity=0.286  Sum_probs=199.1

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC-----Cc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----KD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  326 (569)
                      .++|.+.+.||+|+||.||+++.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467899999999999999999965 6899999988643  233345678899999999999999999987644     34


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++|+||+. ++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999995 68888873   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWK  477 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~  477 (569)
                      .......  ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||..............        .+.
T Consensus       157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            6644321  2234467889999998765 4689999999999999999999999864432111111110        000


Q ss_pred             hhcccchhhhhccc---CC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          478 HFQAKTVLEIIDKS---IE----IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       478 ~~~~~~~~~~~~~~---l~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..........+...   ..    ...+.....+.+++.+||+.+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            11111111111100   00    0012334667889999999999999999999977

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.4e-35  Score=296.48  Aligned_cols=247  Identities=28%  Similarity=0.456  Sum_probs=195.9

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .|+..+.||+|+||.||+++.. ++..+|+|++....   ......+.+|++++++++|||++++++++......++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4778889999999999999965 68899999886432   2345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+.+ +|.+++..  ....+++..+..++.+++.||.|||+.+   |+||||+|+||+++.++.+||+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 67666632  2456899999999999999999999998   99999999999999999999999999875433  


Q ss_pred             CCCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                          .....++..|+|||++.   .+.++.++|||||||++|||++|+.|+........  .             .....
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~-------------~~~~~  238 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L-------------YHIAQ  238 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H-------------HHHHh
Confidence                22346788999999873   45789999999999999999999998753221110  0             00001


Q ss_pred             ccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          490 KSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       490 ~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .... .........+.+++.+||+.+|.+||++.+|++++..
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            1011 1112233457788999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.4e-35  Score=295.40  Aligned_cols=245  Identities=24%  Similarity=0.384  Sum_probs=197.0

Q ss_pred             cccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          261 SNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ..+||+|+||.||++..+ +++.||+|++..........+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            457999999999999875 7899999988665555567789999999999999999999999999999999999999999


Q ss_pred             hhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcc
Q 037160          340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA  419 (569)
Q Consensus       340 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  419 (569)
                      .+++.    ...+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++........  ....
T Consensus       105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            99873    235789999999999999999999998   99999999999999999999999999875543221  1234


Q ss_pred             cccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHH
Q 037160          420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE  499 (569)
Q Consensus       420 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  499 (569)
                      ..|++.|+|||++.+..++.++||||||+++|||++|..|+...........+            ...+...+. .....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~------------~~~~~~~~~-~~~~~  242 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------------RDNLPPKLK-NLHKV  242 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------HhhCCcccC-CcccC
Confidence            56889999999998888999999999999999999999997643222110000            000111110 01122


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          500 VKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       500 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...+.+++.+||+.+|.+||++.+|+++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            3456778899999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3e-35  Score=298.05  Aligned_cols=266  Identities=23%  Similarity=0.332  Sum_probs=195.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCc------
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD------  326 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  326 (569)
                      ++|++.++||+|+||.||++... +++.||||.+....  ......+.+|+.++++++||||+++++++.....      
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46899999999999999999976 68999999886543  2223456789999999999999999999876543      


Q ss_pred             --eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          327 --SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       327 --~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                        .++||||+.+ +|.+.+..  ....+++.+++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence              4999999964 77777632  2346899999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCC--CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhc-
Q 037160          405 ARFSSSEKSL--LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ-  480 (569)
Q Consensus       405 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  480 (569)
                      +.........  .......++..|+|||.+.+. .++.++||||||+++|||++|++|+...........+........ 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9866443221  111234578899999988664 478899999999999999999998865443322211111111000 


Q ss_pred             ----ccchhhhhcccC-CCC----------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          481 ----AKTVLEIIDKSI-EIE----------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       481 ----~~~~~~~~~~~l-~~~----------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                          .....+..+... ...          .......+.+++.+||+.+|++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence                000000000000 000          00112456689999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4e-35  Score=300.73  Aligned_cols=267  Identities=21%  Similarity=0.287  Sum_probs=200.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeee----CCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT----KKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  327 (569)
                      .++|++.+.||+|+||.||++..+ +|+.||+|++....  ......+.+|+.+|++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999865 68999999886542  2345677889999999999999999988753    3467


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999995 68888883   3455899999999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCCCC--CCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hh
Q 037160          408 SSSEKSLL--PNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TW  476 (569)
Q Consensus       408 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~  476 (569)
                      ........  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..        .+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            54432211  1124578899999998865 4688999999999999999999999864432211111000        00


Q ss_pred             hhhcccchhhhhcccCCCC-------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          477 KHFQAKTVLEIIDKSIEIE-------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~-------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      .........+.++..-...       .+.....+..++..||+.+|++||++.+++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence            1111111111111110000       122356788899999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-36  Score=307.81  Aligned_cols=244  Identities=23%  Similarity=0.371  Sum_probs=194.1

Q ss_pred             cccccccCceeEEEEEec-CCceEEEEEEeec----chhhHHHHHHHHHHHHhccccccceeeeeeeeCCc--eEEEEee
Q 037160          261 SNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS----RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD--SFVVYEF  333 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~  333 (569)
                      ..+||+|.|-+||+|.+. +|.+||--.+...    .....++|..|+.+|+.|+|||||+++..|.+...  .-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            457999999999999976 6888875544322    33446789999999999999999999999987655  7889999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~~~~~~  412 (569)
                      +..|+|..++   ++.+.++...+..|+.||++||.|||++. +||||||||-+||+|+. -|.+||+|+|||.......
T Consensus       125 ~TSGtLr~Y~---kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYR---KKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHH---HHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999   44567888899999999999999999987 68999999999999985 4899999999999876543


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                          .....|||.|||||+.. ..|++.+||||||++|+||+|+..|+.--..      ....++...++.-..-+.+. 
T Consensus       201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~kV-  268 (632)
T KOG0584|consen  201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSKV-  268 (632)
T ss_pred             ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhcc-
Confidence                34578999999999876 7899999999999999999999888642111      12233333333222222211 


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                            ....+.+++..|+.. .++|||+.|+|..
T Consensus       269 ------~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  269 ------KDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                  123566788899999 9999999999953

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.1e-35  Score=294.43  Aligned_cols=261  Identities=19%  Similarity=0.229  Sum_probs=184.2

Q ss_pred             HhccccccccccccCceeEEEEEecC----CceEEEEEEeecchhhH-----------HHHHHHHHHHHhccccccceee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQD----GREIAVKRLFISRKNRI-----------KEICNEMDIMSRAHHKNLVQFL  318 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~  318 (569)
                      ..++|++.++||+|+||.||+|...+    +..+|+|..........           .....+...+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            44679999999999999999999764    34566665433221110           1122333445567899999999


Q ss_pred             eeeeeCC----ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC
Q 037160          319 GCCFTKK----DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK  394 (569)
Q Consensus       319 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~  394 (569)
                      +.+....    ..++++|++. .++.+.+..   ....++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~  162 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN  162 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence            8765543    3467788764 356555522   233567888999999999999999998   9999999999999999


Q ss_pred             CCeEEeccCCCcccCCCCCC-----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh
Q 037160          395 HRPKIADFGLARFSSSEKSL-----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE  469 (569)
Q Consensus       395 ~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~  469 (569)
                      +.++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ 
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-  241 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-  241 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-
Confidence            99999999999876432211     112245699999999999999999999999999999999999999875532211 


Q ss_pred             hhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          470 TLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       470 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                       ++.....    +.+..+....+..  ......+.+++..|++.+|++||++.+|++.|+
T Consensus       242 -~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 -LIHAAKC----DFIKRLHEGKIKI--KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             -HHHHhHH----HHHHHhhhhhhcc--CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence             1110000    0001111111111  112355778889999999999999999998763

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3e-35  Score=296.02  Aligned_cols=265  Identities=22%  Similarity=0.294  Sum_probs=195.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.++||+|++|.||+|..+ +|+.||+|.+.....  .....+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999976 788999998855422  234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcccCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSE  411 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~~~~~  411 (569)
                      |++ ++|.+++.. .....+++..+..++.||+.||.|||+++   ++||||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 577777633 22334678888899999999999999998   999999999999985 457999999999765432


Q ss_pred             CCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh-hh-------HhHhhhhcc-
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET-LV-------THTWKHFQA-  481 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~-~~-------~~~~~~~~~-  481 (569)
                      ..  ......+++.|+|||++.+. .++.++||||||+++|+|++|++|+......+... ..       ...|..+.. 
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            21  22334578899999988664 57899999999999999999999986543321100 00       000100000 


Q ss_pred             cchhhhhcccCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 KTVLEIIDKSIEI----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 ~~~~~~~~~~l~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .............    ..+.....+.+++.+|++.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000000000    011233457789999999999999999999964

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-35  Score=296.86  Aligned_cols=269  Identities=24%  Similarity=0.350  Sum_probs=198.8

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCC---
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK---  325 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---  325 (569)
                      +...++|++.++||+|+||.||+|..+ +|+.||+|++....  ......+.+|++++++++||||+++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            456678999999999999999999976 68899999986543  223356778999999999999999999987654   


Q ss_pred             -------ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeE
Q 037160          326 -------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPK  398 (569)
Q Consensus       326 -------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  398 (569)
                             ..++|+||+++ ++..++..  ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                   78999999986 66666632  2346899999999999999999999998   99999999999999999999


Q ss_pred             EeccCCCcccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--
Q 037160          399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT--  475 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--  475 (569)
                      |+|||++......... ......++..|+|||.+.+. .++.++|||||||++|||++|++|+...........+...  
T Consensus       157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999999866543321 22233467889999987653 5789999999999999999999988644322111111110  


Q ss_pred             ------hhhhcccchhhhhcc------cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          476 ------WKHFQAKTVLEIIDK------SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       476 ------~~~~~~~~~~~~~~~------~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                            |+...........+.      ............+.+++..||+.+|++||++.+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  000000000000000      0000001123567889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=308.23  Aligned_cols=249  Identities=23%  Similarity=0.394  Sum_probs=202.5

Q ss_pred             ccccccccccccCceeEEEEEecC-CceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +-|++...||.|+||.||+++.++ +-..|.|++...+....+.+.-|++||....||+||++++.+..++.++|..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            457788899999999999999874 3445788888888888899999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      .||-++.++..  -...+.+..+..++++++.||.|||+++   |||||||..|||++-+|.++|+|||.+......  .
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R  184 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence            99999998854  3467899999999999999999999998   999999999999999999999999987533222  1


Q ss_pred             CCCcccccCCCccccccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          415 LPNTAIAGTLGYMAPEYI-----ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      .....+.||+.|||||++     ...+|+.++||||||+.|.||.-+.+|..--.+-  ..++             . +.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVll-------------K-ia  248 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLL-------------K-IA  248 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHH-------------H-Hh
Confidence            134578999999999976     3568999999999999999999998874321110  1111             1 11


Q ss_pred             ccCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEI---EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~---~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +.-.+   .+......+.++...||.+||..||++.+++++
T Consensus       249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            11000   122344567778899999999999999999854

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-36  Score=304.18  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=204.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      -...|.+.++||+|.|+.|.++++. .+.+||+|.+.+..  ......+.+|+++|..|+|||||+++.+.+....+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467899999999999999999976 79999999886653  22334588999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||..+|.+++++.   +.+.+...++..++.|+.++++|||+++   |||||||++||||+.++++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999994   4455666888999999999999999999   99999999999999999999999999998875


Q ss_pred             CCCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..   .....+|++.|.|||.+.+.++ .+++|+||+|++||-|++|..||....-....           ..    .+.
T Consensus       208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~r----vl~  269 (596)
T KOG0586|consen  208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PR----VLR  269 (596)
T ss_pred             cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------ch----hee
Confidence            43   3457899999999999988765 47999999999999999999998744322110           00    011


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ..+.. +.--...+-+++.+++-.+|.+|+++++|.+.-
T Consensus       270 gk~rI-p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  270 GKYRI-PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             eeecc-cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            11111 111223455677788999999999999999643

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.9e-35  Score=287.76  Aligned_cols=241  Identities=26%  Similarity=0.353  Sum_probs=195.6

Q ss_pred             ccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ||.|++|.||+++.. +++.+++|++....   ....+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 58999999886532   23456799999999999999999999999999999999999999999


Q ss_pred             hhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcc
Q 037160          340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA  419 (569)
Q Consensus       340 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  419 (569)
                      .+++.   +...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILR---DRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            99984   3345889999999999999999999998   9999999999999999999999999998665432   1234


Q ss_pred             cccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-CHH
Q 037160          420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIE  498 (569)
Q Consensus       420 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~  498 (569)
                      ..++..|++||.+.+..++.++|+||||+++|+|++|..|+.....+... .            ............ +..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~------------~~~~~~~~~~~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-I------------YNDILKGNGKLEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-H------------HHHHhccCCCCCCCcc
Confidence            46788999999998888999999999999999999999998755431110 0            011111001111 122


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 037160          499 EVKRVVWVGLLCTQELPTLRPS-----MTNVVQ  526 (569)
Q Consensus       499 ~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~  526 (569)
                      ....+..++..||+.+|++||+     +.|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            2467888999999999999999     777776

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-35  Score=285.71  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=202.3

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|++.++||+|++|.||++... +++.|++|.+.....  .....+.+|++++++++|+|++++++++......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999876 678999999876543  4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++..   ...+++..+..++.|++.+|.+||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999999843   367899999999999999999999998   99999999999999999999999999987655432


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                      .  .....++..|+|||.+.+..++.++||||||+++++|++|+.|+......      ...+....         ....
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~~---------~~~~  217 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIVQ---------DDHP  217 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc---------cCCC
Confidence            1  23456788999999998888899999999999999999999987533211      00111100         0000


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .........+..++.+||+.+|++||++.+++..
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            0112223567788899999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.5e-35  Score=294.59  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=193.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|+..++||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            5666788999999999999976 68999999886543 334567889999999996 99999999999999999999999


Q ss_pred             cCCCChhhHhhC--CCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          334 VQNKSLDRILFD--PKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       334 ~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      +.. ++.++...  ......+++..+..++.+++.||.|||+. +   ++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55443311  12335689999999999999999999975 6   99999999999999999999999999876543


Q ss_pred             CCCCCCCcccccCCCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANG---QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ..   ......|+..|+|||++.+.   .++.++||||||+++|||++|+.|+.....     ......... ...    
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~----  227 (288)
T cd06616         161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV-KGD----  227 (288)
T ss_pred             CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc-CCC----
Confidence            22   12334688999999998766   689999999999999999999999764321     000000000 000    


Q ss_pred             hcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       .+.+.. ........+.+++.+||+.+|++|||+.+|+++
T Consensus       228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             011111 112344567889999999999999999999965

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.8e-35  Score=290.79  Aligned_cols=243  Identities=23%  Similarity=0.253  Sum_probs=187.2

Q ss_pred             cccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHh---ccccccceeeeeeeeCCceEEEEeecC
Q 037160          263 KLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSR---AHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      .||+|+||.||++... +++.+|+|.+....   ......+.+|..+++.   .+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 68899999886532   1222334455544443   479999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            999999884   3456899999999999999999999998   9999999999999999999999999987554322   


Q ss_pred             CCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       .....|+..|+|||.+.. ..++.++|||||||++|||++|..||..........+....          ......   
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~---  217 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTVNVE---  217 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh----------hcCCcC---
Confidence             123468999999998864 56899999999999999999999998644322111100000          000001   


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQML  528 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~L  528 (569)
                      .+......+..++..||+.+|++||     ++.|++++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence            1223345677888999999999999     699999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.5e-35  Score=285.62  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=204.8

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|++.+.||+|+||.||++... +++.+++|++.....  .....+.+|++++++++|||++++.+.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999976 689999999876533  4566788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      +++++|.+++.... ....+++..+..++.+++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999985421 2467899999999999999999999998   9999999999999999999999999998765543


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  ......|++.|+|||.+.+..++.++||||+|+++++|++|+.|+.......   +...            ......
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~------------~~~~~~  220 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALK------------ILKGQY  220 (258)
T ss_pred             c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHH------------HhcCCC
Confidence            1  2234568889999999988889999999999999999999999875443211   1100            011111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...+......+..++.+||..+|++|||+.|++++
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11122334567788999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=292.46  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      |++.+.||+|++|.||++... +++.+++|++.....  .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566788999999999999875 788999998865432  24567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++ +|.+++..  ....+++..+..++.+++.||.|||+.+   |+|+||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            75 78777743  2257899999999999999999999998   99999999999999999999999999876655431 


Q ss_pred             CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhhhhcc---c
Q 037160          415 LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWKHFQA---K  482 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~---~  482 (569)
                       ......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+..............        .|..+..   .
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence             12234578899999998776 789999999999999999999988865443211101000        0110000   0


Q ss_pred             chhhhhcc---cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLEIIDK---SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~~---~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ........   ......+.....+.+++..||+.+|.+||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000000   0000012345678889999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.5e-35  Score=286.47  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=203.4

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|++.++||+|++|.||++..+ +++.+++|.+....  ......+.+|++++++++|+||+++.+.+......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999865 78899999886542  33456778999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      +++++|.+++... .....+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988432 22456899999999999999999999998   999999999999999999999999999876554 


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                         ......++..|++||.+.+..++.++|+||||+++|||++|+.|+...........               ......
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~---------------~~~~~~  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK---------------VQRGKY  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------HhcCCC
Confidence               12234578899999999988999999999999999999999999864432211000               001111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..........+..++..|++.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11123445668889999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=285.69  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=196.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec-----chhhHHHHHHHHHHHHhccccccceeeeeeeeC--Cce
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-----RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDS  327 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  327 (569)
                      .+|++.+.||+|+||.||++... +++.+++|.+...     .......+.+|++++++++|+||+++++.+...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999975 6899999987532     233456788999999999999999999998764  457


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++++||+++++|.+++.   ....+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999884   2345788999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... .......++..|+|||++.+..++.++||||||++++||++|+.|+......  ...             .+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~-------------~~  220 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAI-------------FK  220 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHH-------------HH
Confidence            5331111 0112456889999999999888999999999999999999999997532111  000             11


Q ss_pred             hhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......... +......+.+++..||+ +|..||+..+++.+
T Consensus       221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            111101111 22334567778889999 57999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.4e-35  Score=291.78  Aligned_cols=252  Identities=23%  Similarity=0.288  Sum_probs=196.4

Q ss_pred             cccccccccccCceeEEEEEec----CCceEEEEEEeecc----hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCce
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFISR----KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  327 (569)
                      +|++.+.||+|+||.||++...    +|+.||+|++....    ....+.+.+|+.+++++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999863    68899999986532    22346678999999999 699999999999998999


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++++|.+++.   ....+++..+..++.|+++||.|||+.+   ++||||+|+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999984   3456788899999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANG--QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      ....... ......|+..|+|||.+...  .++.++||||||+++|+|++|..|+...........            +.
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~------------~~  221 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE------------IS  221 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH------------HH
Confidence            6443321 22345688999999998753  477899999999999999999999864322111000            00


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          486 EIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       486 ~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      ..+.......+......+..++..||+.+|++||     ++.+++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         222 RRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             HHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            1111111111222345667889999999999997     77888764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-36  Score=293.42  Aligned_cols=264  Identities=25%  Similarity=0.339  Sum_probs=212.2

Q ss_pred             cccccchhHHH-HHhccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccce
Q 037160          242 KFLQFKYSTIE-KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQ  316 (569)
Q Consensus       242 ~~~~~~~~~~~-~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~  316 (569)
                      .++++++-+.. ...+.|..-++||+||||.||-++.+ +|+-+|.|++.+.   .+......++|-.+|.+++.+.||.
T Consensus       170 rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVs  249 (591)
T KOG0986|consen  170 RFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVS  249 (591)
T ss_pred             HHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEE
Confidence            34455543332 33467888999999999999999866 7999999988543   2344566789999999999999999


Q ss_pred             eeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC
Q 037160          317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR  396 (569)
Q Consensus       317 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  396 (569)
                      +-..+++.+.+++|+..|+||+|.-+|...+. ..+++..++-.+.+|+.||++||+..   ||.|||||+|||||+.|+
T Consensus       250 laYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~Gh  325 (591)
T KOG0986|consen  250 LAYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGH  325 (591)
T ss_pred             EeeeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCC
Confidence            99999999999999999999999999976443 67899999999999999999999998   999999999999999999


Q ss_pred             eEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh
Q 037160          397 PKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       397 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ++|+|.|||..+......   ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||......          
T Consensus       326 vRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------  392 (591)
T KOG0986|consen  326 VRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------  392 (591)
T ss_pred             eEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------
Confidence            999999999988887643   4558999999999999999999999999999999999999998643322          


Q ss_pred             hhhcccchhhhhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 037160          477 KHFQAKTVLEIIDKSIEIE----DIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQML  528 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~L  528 (569)
                            .-.+.+|.+....    +.........+....|+.+|++|.     ...+|-++-
T Consensus       393 ------vk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp  447 (591)
T KOG0986|consen  393 ------VKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP  447 (591)
T ss_pred             ------hhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence                  1112222222111    233444555677788899999986     455666543

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-35  Score=291.28  Aligned_cols=262  Identities=22%  Similarity=0.278  Sum_probs=196.3

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEeec
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      |++.+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+++++ |+||+++++.+......++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999976 578899998865422 22234557999999998 999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                       +++|.+.+.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence             788988874322 357899999999999999999999998   9999999999999999999999999998654432  


Q ss_pred             CCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh-----hhcccc-hhhh
Q 037160          415 LPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK-----HFQAKT-VLEI  487 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~  487 (569)
                       ......++..|+|||++.. ..++.++||||||++++||++|++|+.................     .|.... ....
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             2234567889999998754 4689999999999999999999988865543221100000000     000000 0000


Q ss_pred             hcccCC----CC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIE----IE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~----~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ++..+.    ..    .+.....+.+++.+||+.+|++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000    00    11123568899999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-35  Score=299.14  Aligned_cols=283  Identities=24%  Similarity=0.352  Sum_probs=207.1

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCC-
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-  325 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  325 (569)
                      ++....++|++.+.||+|+||.||++... +++.||||++...  .......+.+|+.++++++||||+++++++.... 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            44556788999999999999999999865 7899999988543  2233456889999999999999999999987553 


Q ss_pred             -----ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          326 -----DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       326 -----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                           ..++||||+ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++|+
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence                 358999999 779988873    246889999999999999999999998   9999999999999999999999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhH-----
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVT-----  473 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~-----  473 (569)
                      |||++......     .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+........ .....     
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998765432     234467889999999876 4688999999999999999999999864432111 00000     


Q ss_pred             --hHhhhhcccchhhhhcccC--CCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HhccCCCCCCCCCCCC
Q 037160          474 --HTWKHFQAKTVLEIIDKSI--EIE-----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ--MLKQKDITLPTPSKPP  542 (569)
Q Consensus       474 --~~~~~~~~~~~~~~~~~~l--~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~--~L~~~~~~~~~p~~p~  542 (569)
                        ..+..+........+....  ...     .......+..++.+|++.+|++|||+.+++.  .++........+..|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~  315 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP  315 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC
Confidence              0000111111111111000  000     0122345778999999999999999999994  3444444444445555


Q ss_pred             Ccc
Q 037160          543 FTD  545 (569)
Q Consensus       543 ~~~  545 (569)
                      |..
T Consensus       316 ~~~  318 (343)
T cd07880         316 YDD  318 (343)
T ss_pred             ccc
Confidence            543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7e-35  Score=295.45  Aligned_cols=267  Identities=23%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCC------
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK------  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  325 (569)
                      .++|++.++||+|+||.||+|..+ +++.+|+|++.....  .....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999976 689999998865432  22345778999999999999999998875443      


Q ss_pred             --ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          326 --DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       326 --~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                        ..++|+||+.+ +|...+..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              45999999965 56665532  3456899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCCCC---------CCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH
Q 037160          404 LARFSSSEKSLL---------PNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT  473 (569)
Q Consensus       404 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~  473 (569)
                      +++.........         ..+...+++.|+|||.+.+. .++.++||||||+++|||++|++|+...........+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            997654332110         11234578889999987654 58899999999999999999999986544322111111


Q ss_pred             hHhhhhcccc------hhh----hhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          474 HTWKHFQAKT------VLE----IIDKSIEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       474 ~~~~~~~~~~------~~~----~~~~~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..+.......      +..    .........    .......+.+++.+||+.+|++|||+.|++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1110000000      000    000000000    01122567889999999999999999999854

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-34  Score=296.99  Aligned_cols=267  Identities=22%  Similarity=0.313  Sum_probs=198.9

Q ss_pred             hHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeC-
Q 037160          249 STIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-  324 (569)
Q Consensus       249 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  324 (569)
                      ..+..+.++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            345567789999999999999999999864 78999999886532  23345688899999999999999999988643 


Q ss_pred             -----CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEE
Q 037160          325 -----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI  399 (569)
Q Consensus       325 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  399 (569)
                           ...+++++++ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3467888876 789988773    235889999999999999999999998   999999999999999999999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhH----
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVT----  473 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~----  473 (569)
                      +|||+++....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ .....    
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999875433     2234567889999998866 5688999999999999999999999864332211 00000    


Q ss_pred             ---hHhhhhcccch---hhhhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          474 ---HTWKHFQAKTV---LEIIDKSIEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       474 ---~~~~~~~~~~~---~~~~~~~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                         ..+........   ...+.......    .......+.+++..|++.+|.+||++.+++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence               00011111000   00001000000    001234577899999999999999999999653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.1e-34  Score=285.87  Aligned_cols=247  Identities=21%  Similarity=0.265  Sum_probs=191.0

Q ss_pred             HHHhccccccccc--cccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCce
Q 037160          252 EKATDCFDESNKL--GHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       252 ~~~~~~f~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  327 (569)
                      ....++|++.+.+  |+|+||.||++..+ ++..+|+|.+.......     .|+.....+ +||||+++++.+......
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3445677777777  99999999999975 67889999876432211     122222222 799999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLAR  406 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~  406 (569)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||++.
T Consensus        85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            999999999999999843   347899999999999999999999998   99999999999999998 99999999987


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      .....      ....++..|+|||++.+..++.++||||||+++|||++|+.|+......... .  ..+        ..
T Consensus       159 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~--~~~--------~~  221 (267)
T PHA03390        159 IIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-L--ESL--------LK  221 (267)
T ss_pred             ecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-H--HHH--------HH
Confidence            65432      2345789999999999889999999999999999999999998743332210 0  000        01


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPS-MTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-~~evl~~  527 (569)
                      ...... .........+.+++..||+.+|.+||+ ++|++++
T Consensus       222 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        222 RQQKKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             hhcccC-CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            111111 111234456788889999999999996 6998853

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=287.22  Aligned_cols=267  Identities=22%  Similarity=0.352  Sum_probs=204.9

Q ss_pred             HHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHh--ccccccceeeeeeeeCC----
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR--AHHKNLVQFLGCCFTKK----  325 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----  325 (569)
                      ..+..+..+.+.||+|.||.||+|.++ |+.||||++...+   ...+.+|.+|.+.  |+|+||+.+++.-..+.    
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            445677888899999999999999998 8999999886543   3568889999986  49999999998876543    


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-----DGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                      .++||++|.+.|||.|+|    .+..++....++++..+|.||++||-     +|++.|.|||||+.||||..++...|+
T Consensus       283 QLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            579999999999999999    34789999999999999999999994     578899999999999999999999999


Q ss_pred             ccCCCcccCCCCCC--CCCcccccCCCcccccccccCC----CC--cccchhhHHHHHHHHHhCC----------CCCCC
Q 037160          401 DFGLARFSSSEKSL--LPNTAIAGTLGYMAPEYIANGQ----LT--EKVDIYSFGVLVLEIVSGV----------QNNKF  462 (569)
Q Consensus       401 Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~~--~ksDv~SlGvil~elltg~----------~p~~~  462 (569)
                      |+|||-........  ......+||-.|||||++...-    +.  ..+||||||.|+||+....          .|+..
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999877665322  2344678999999999986532    22  3689999999999998642          33322


Q ss_pred             CCCcchhhhhHhHhhhhcccchhhhhcccCCC--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          463 QSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI--EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ..+.+-      .++....---.+.+.+.+..  ...+....+.+++..||..||.-|-|+-.|-+.|.+..
T Consensus       439 ~Vp~DP------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  439 VVPSDP------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCCC------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            111100      00000000011111222221  25577788999999999999999999999998887655

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-34  Score=290.85  Aligned_cols=256  Identities=23%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             cccccccccccCceeEEEEEec----CCceEEEEEEeecc----hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCce
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFISR----KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  327 (569)
                      +|++.+.||+|++|.||+++..    +++.||||.+....    ....+.+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778889999999999999743    56889999886432    22345688999999999 699999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++++|.+++.   ....+++..+..++.|++++|.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999884   2356889999999999999999999998   99999999999999999999999999886


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQ--LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      +...... ......|+..|+|||.+.+..  .+.++||||||+++|||++|..|+...........       ..    .
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~----~  222 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE-------IS----R  222 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH-------HH----H
Confidence            5543221 122456889999999987654  78899999999999999999999764322111000       00    0


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          486 EIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       486 ~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ..... ....+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       223 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         223 RILKS-KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHcc-CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            00111 1111222334567788999999999999998887777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-34  Score=286.75  Aligned_cols=246  Identities=26%  Similarity=0.427  Sum_probs=195.8

Q ss_pred             ccccCceeEEEEEec-CCceEEEEEEeecch---hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ||+|+||.||+++.. +|+.+++|.+.....   ...+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 589999998865433   4566789999999999999999999999999999999999999999


Q ss_pred             hhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC-----
Q 037160          340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL-----  414 (569)
Q Consensus       340 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-----  414 (569)
                      .+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........     
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            999843   236899999999999999999999998   999999999999999999999999998754433210     


Q ss_pred             -CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 -LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                       .......++..|++||.+.....+.++||||||++++||++|+.|+.........       ..        .......
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------~~--------~~~~~~~  219 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF-------QN--------ILNGKIE  219 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------HH--------HhcCCcC
Confidence             0223456788999999998888999999999999999999999998644322110       00        0000011


Q ss_pred             CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          494 IE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       494 ~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .. .......+..++..||+.+|++|||+.++.+.|+.
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            00 11124567889999999999999999666665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.8e-35  Score=297.62  Aligned_cols=264  Identities=21%  Similarity=0.280  Sum_probs=202.6

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCC-----ceE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-----DSF  328 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  328 (569)
                      +|++.++||+|++|.||+++.. +++.+++|++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999976 58999999886543  344567899999999999999999999988765     789


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      ++|||+. ++|.+++.   ....+++..++.++.+++.||.+||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 58888883   3347899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCC-CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh--------
Q 037160          409 SSEKSL-LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH--------  478 (569)
Q Consensus       409 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------  478 (569)
                      ...... .......++..|+|||++.+. .++.++||||||+++|+|++|++||...........+......        
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            554210 112345678899999999887 8999999999999999999999998655432211111110000        


Q ss_pred             hcccchhhhhcccCCCC-------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          479 FQAKTVLEIIDKSIEIE-------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~-------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .......+.+.......       .+.....+.+++.+||+.+|++||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11111111111100000       11234567889999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=305.18  Aligned_cols=204  Identities=28%  Similarity=0.455  Sum_probs=178.7

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCC------ceE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSF  328 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~  328 (569)
                      .|...+.||+|+||.||+|+++ .|+.||||.+.... ....+...+|+++|++++|+|||+++++-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3556678999999999999966 79999999886643 333466789999999999999999999876554      568


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC--CCCC--eEEeccCC
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD--LKHR--PKIADFGL  404 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~--~~~~--~kl~Dfgl  404 (569)
                      +|||||.+|+|...+.+......+++.+.+.++..+..||.|||+++   |+||||||.||++-  .+|+  -||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999998888889999999999999999999999998   99999999999984  3343  69999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCc
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIA-NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD  466 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~  466 (569)
                      |+..+.+.   .....+||..|++||... .+.|+..+|.|||||++|+.+||..||......
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99888765   457889999999999988 488999999999999999999999999765443

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=287.53  Aligned_cols=262  Identities=24%  Similarity=0.315  Sum_probs=195.4

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhc---cccccceeeeeeeeCCc-----
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRA---HHKNLVQFLGCCFTKKD-----  326 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----  326 (569)
                      |++.++||+|+||.||+++.+ +++.+|+|++.....  .....+.+|+.+++++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999987 589999999864322  2234566788887776   59999999999988776     


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .+++|||+.+ +|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 788877432 2235899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-hhhHhHh----hhhcc
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE-TLVTHTW----KHFQA  481 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~----~~~~~  481 (569)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||++|++|+......... .......    ..+..
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            7654322   22345788999999999989999999999999999999998887654332111 0100000    00000


Q ss_pred             cc--hhhhhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 KT--VLEIIDKSIEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 ~~--~~~~~~~~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..  ............    .+.....+.+++.+||+.+|++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            00  000000000000    12334667789999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=285.34  Aligned_cols=243  Identities=22%  Similarity=0.302  Sum_probs=188.4

Q ss_pred             ccccccCceeEEEEEec-CCceEEEEEEeecch---hhHHHHHHHHHHH-HhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---NRIKEICNEMDIM-SRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      +.||+|+||.||+|... +|+.||+|.+.....   .....+..|..++ ...+|+|++++++.+..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999875 689999998865432   2233445555544 445899999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      ++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||+++....      
T Consensus        82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            99999984   3356889999999999999999999998   99999999999999999999999999875433      


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-  495 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-  495 (569)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..|+........       +........      ..... 
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------~~~~~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------FDNILSRRI------NWPEEV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhccc------CCCCcc
Confidence            2234578899999999888889999999999999999999999864332211       111100000      00000 


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      .......+..++.+||+.+|++||++.++.+.|.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            1123456788999999999999997766555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=298.30  Aligned_cols=264  Identities=23%  Similarity=0.330  Sum_probs=195.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCC------
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK------  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  325 (569)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++....  ......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999965 68999999886432  223456889999999999999999999986543      


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999964 676654     235789999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--------h
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT--------W  476 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~  476 (569)
                      +.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...        +
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            754331     234467889999999876 46889999999999999999999998754321110000000        0


Q ss_pred             hhhcccchhhhhccc--CCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hccCC
Q 037160          477 KHFQAKTVLEIIDKS--IEIE-----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQKD  532 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~--l~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~  532 (569)
                      +..........+...  ....     .+.....+.+++..||+.+|++||++.+++.+  ++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            000000000000000  0000     11233567889999999999999999999955  55443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.1e-34  Score=285.44  Aligned_cols=243  Identities=23%  Similarity=0.234  Sum_probs=187.4

Q ss_pred             cccccCceeEEEEEec-CCceEEEEEEeecch---hhHHHHHHHHHH---HHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          263 KLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---NRIKEICNEMDI---MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      .||+|+||.||++... +++.||+|.+.....   .....+..|..+   ++...||||+++++.+...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 688999998865321   112233444443   444579999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            999999884   3457899999999999999999999998   9999999999999999999999999987654322   


Q ss_pred             CCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.|+............    ...      ......   
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~------~~~~~~---  217 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT------LTMAVE---  217 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHh------hccCCC---
Confidence             2244689999999998754 6899999999999999999999998654322111100    000      000000   


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQML  528 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~L  528 (569)
                      .+......+.+++..|+..+|++||     ++.+++++-
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~  256 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP  256 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence            1112345778888999999999999     999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.8e-35  Score=290.74  Aligned_cols=250  Identities=22%  Similarity=0.295  Sum_probs=202.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|.+.+.||+|+||.||++... +++.|++|++...   .......+.+|++++++++ ||||+++++.+......++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999976 7899999988653   2233467889999999998 99999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ||++++++|.+++.   ....+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999984   3347999999999999999999999998   99999999999999999999999999886654


Q ss_pred             CCCC------------------CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhh
Q 037160          411 EKSL------------------LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV  472 (569)
Q Consensus       411 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~  472 (569)
                      ....                  .......++..|+|||.+....++.++||||||++++++++|+.|+.......  . .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~-~  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--T-F  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--H-H
Confidence            3321                  12224467889999999988889999999999999999999999876443110  0 0


Q ss_pred             HhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 037160          473 THTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSM----TNVVQM  527 (569)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~----~evl~~  527 (569)
                                  ..... .....+......+..++.+||+.+|++||++    .+++.+
T Consensus       232 ------------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         232 ------------QKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ------------HHHHh-cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                        00100 0001122234567889999999999999999    777753

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-34  Score=292.06  Aligned_cols=262  Identities=19%  Similarity=0.213  Sum_probs=192.5

Q ss_pred             ccccccccCceeEEEEEecCCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      +.+.+|.|+++.|+++.. +++.||||++...  .....+.+.+|++++++++|+||+++++.+...+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455566655555554 6899999998754  3455678999999999999999999999999999999999999999


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC----
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS----  413 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~----  413 (569)
                      +|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.+........    
T Consensus        85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999998542 2345888999999999999999999998   99999999999999999999999998865433211    


Q ss_pred             -CCCCcccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh----hcccc---
Q 037160          414 -LLPNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH----FQAKT---  483 (569)
Q Consensus       414 -~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~---  483 (569)
                       ........++..|+|||++..  ..++.++||||||+++|||++|+.||.......  ..+......    +....   
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence             011223457788999999866  358899999999999999999999986433211  111100000    00000   


Q ss_pred             ----hhh----hhcccC-----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          484 ----VLE----IIDKSI-----EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       484 ----~~~----~~~~~l-----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                          ...    ..+...     ..........+.+++.+||+.+|++|||+.+++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence                000    000000     001223345678899999999999999999999653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=297.05  Aligned_cols=266  Identities=21%  Similarity=0.225  Sum_probs=195.8

Q ss_pred             cccc-ccccccccCceeEEEEEec-CCceEEEEEEeecchhh--------------HHHHHHHHHHHHhccccccceeee
Q 037160          256 DCFD-ESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNR--------------IKEICNEMDIMSRAHHKNLVQFLG  319 (569)
Q Consensus       256 ~~f~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~  319 (569)
                      ++|. +.+.||+|+||.||++..+ +++.||||++.......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 3467999999999999966 68999999886543211              124778999999999999999999


Q ss_pred             eeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEE
Q 037160          320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI  399 (569)
Q Consensus       320 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  399 (569)
                      ++..+...++||||+. ++|.+++.   ....+++.....++.|++.||.|||+.+   |+|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999996 58888883   3456889999999999999999999998   999999999999999999999


Q ss_pred             eccCCCcccCCCCC------------CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCc
Q 037160          400 ADFGLARFSSSEKS------------LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD  466 (569)
Q Consensus       400 ~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~  466 (569)
                      +|||+++.......            ........+++.|+|||.+.+. .++.++||||||+++|||++|++|+....+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999986651110            0011233467889999998764 4789999999999999999999998755432


Q ss_pred             chhhhhHhHhhhhcccchhhh--------hcccCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          467 GFETLVTHTWKHFQAKTVLEI--------IDKSIEI----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       467 ~~~~~~~~~~~~~~~~~~~~~--------~~~~l~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      .....+...........+...        .......    ........+.+++..||+.+|++|||+.|++.+-
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            211111000000000000000        0000000    0112235677899999999999999999999654

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.5e-34  Score=293.84  Aligned_cols=262  Identities=23%  Similarity=0.350  Sum_probs=198.8

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeee-CCceE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT-KKDSF  328 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~  328 (569)
                      .++++|++.+.||+|+||.||++... +++.||+|++...  .....+.+.+|++++++++||||+++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            46788999999999999999999865 7899999987542  22344678899999999999999999999865 56789


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +++||+ +++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 568888873    245788888899999999999999998   999999999999999999999999998754


Q ss_pred             CCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH--------hHhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT--------HTWKHF  479 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~  479 (569)
                      ...     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+.        ..+...
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            321     223457889999998766 568999999999999999999999886543321111100        001111


Q ss_pred             cccchhhhhcccCCCC--CH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          480 QAKTVLEIIDKSIEIE--DI-----EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       480 ~~~~~~~~~~~~l~~~--~~-----~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......+.+.......  +.     .....+.+++.+||+.+|++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1111111111111100  11     123577889999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=328.38  Aligned_cols=261  Identities=27%  Similarity=0.386  Sum_probs=203.7

Q ss_pred             HHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      +...+-+|+-..+||.|.||.||-|... +|+-.|+|.+....  ......+.+|..++..++|||+|+++|+-.+++..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            3455668888999999999999999965 78889999876543  44566788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      +|.||||++|+|.+++   ......++-....+..|++.|+.|||++|   ||||||||.||+|+.+|-+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence            9999999999999998   33445566666778899999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCC--CcccccCCCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          408 SSSEKSLLP--NTAIAGTLGYMAPEYIANG---QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       408 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      ...+....+  .....||+.|||||++.+.   ....+.||||||||+.||+||++||.-...+- .  +.+.       
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-a--IMy~------- 1453 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-A--IMYH------- 1453 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-H--HHhH-------
Confidence            765431111  1256799999999999764   35568999999999999999999975332220 0  0000       


Q ss_pred             chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                          +-.......+......-.+++.+||+.||++|.++.|++++=-.+
T Consensus      1454 ----V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1454 ----VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred             ----HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence                000000111222334445577899999999999999999875443

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.2e-34  Score=289.76  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=195.9

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .+.|+..+.||+|+||.||+|+.. +++.+++|.+...   .......+.+|+++++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            345777889999999999999976 6788999988642   233456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+. ++|.+++..  ....+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99996 577776632  2345889999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCCCCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .      ....++..|+|||.+.   .+.++.++|||||||++|||++|+.|+........  ..             ..
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~-------------~~  226 (308)
T cd06634         168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY-------------HI  226 (308)
T ss_pred             c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HH-------------HH
Confidence            2      2346788999999874   35688899999999999999999988643221110  00             00


Q ss_pred             hcccC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          488 IDKSI-EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       488 ~~~~l-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      ..... ..........+..++.+||+.+|++||++.+|+++...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence            00000 01122344567788999999999999999999977443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-34  Score=297.52  Aligned_cols=265  Identities=18%  Similarity=0.259  Sum_probs=195.2

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeC---------
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK---------  324 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------  324 (569)
                      ..+|.+.+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++.+...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            467999999999999999999975 6899999998776666667889999999999999999999776543         


Q ss_pred             -----CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeE
Q 037160          325 -----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPK  398 (569)
Q Consensus       325 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~k  398 (569)
                           ...++||||+. ++|.+++.    ...+++..++.++.||+.||.|||+.+   |+||||||+||+++. ++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 58888773    245889999999999999999999998   999999999999974 55789


Q ss_pred             EeccCCCcccCCCCCCC-CCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH-
Q 037160          399 IADFGLARFSSSEKSLL-PNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT-  475 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-  475 (569)
                      |+|||++.......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.......... 
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999997654322111 1123457889999998754 46888999999999999999999998644322111000000 


Q ss_pred             -------hhhhcccchhhhhccc-CCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          476 -------WKHFQAKTVLEIIDKS-IEIED-----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       476 -------~~~~~~~~~~~~~~~~-l~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                             +............... .....     +.....+.+++.+||+.+|++|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                   0000000000000000 00001     1123567789999999999999999999954

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.3e-34  Score=288.83  Aligned_cols=252  Identities=26%  Similarity=0.428  Sum_probs=193.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.++||+|+||.||++.++ +++.||||.+.... ......+..|+.++.++. ||||+++++++......+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            56888999999999999999987 48999999986543 233456677887777775 9999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      |+. ++|.+++..  ....+++..+..++.+++.||.|||+ .+   |+||||+|+||++++++.+||+|||++..+...
T Consensus        95 ~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            985 467776633  23478899999999999999999997 46   999999999999999999999999998765443


Q ss_pred             CCCCCCcccccCCCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQ----LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ..   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.|+...... ...+ ......    .    
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~-~~~~~~----~----  235 (296)
T cd06618         169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVL-TKILQE----E----  235 (296)
T ss_pred             Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHH-HHHhcC----C----
Confidence            22   22345788999999986543    788999999999999999999997542211 1111 000000    0    


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                       ..... ........+.+++.+||+.+|++||++.+++++.
T Consensus       236 -~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         236 -PPSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             -CCCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence             00000 0112345678889999999999999999999653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.2e-34  Score=291.70  Aligned_cols=262  Identities=19%  Similarity=0.249  Sum_probs=191.6

Q ss_pred             cccccc--CceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHG--GYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ..||+|  +||+||++.+. +|+.||+|.+....  ....+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999975 78999999886532  33457789999999999999999999999999999999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC-
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL-  415 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  415 (569)
                      ++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999885432 345888999999999999999999998   9999999999999999999999998654322211100 


Q ss_pred             ----CCcccccCCCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-hhhHh-Hhhhhc-------
Q 037160          416 ----PNTAIAGTLGYMAPEYIANG--QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE-TLVTH-TWKHFQ-------  480 (569)
Q Consensus       416 ----~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~-~~~~~~-------  480 (569)
                          ......++..|+|||++.++  .++.++||||||+++|||++|+.|+......... ..... .+..+.       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                01112345679999998764  4789999999999999999999998643221110 00000 000000       


Q ss_pred             ----------------ccch-----hhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          481 ----------------AKTV-----LEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       481 ----------------~~~~-----~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                                      ....     ..+....+... .......+.+++.+||+.+|++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                            0000     00000111111 23455678899999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.5e-34  Score=287.81  Aligned_cols=244  Identities=29%  Similarity=0.462  Sum_probs=191.6

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      |...++||+|+||.||+|+.. +++.|++|++....   ......+.+|++++++++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666778999999999999875 68899999886432   23446788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +. ++|.+++..  ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 566666632  3456899999999999999999999998   99999999999999999999999998864322   


Q ss_pred             CCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          414 LLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                         .....|+..|+|||++.   .+.++.++||||||+++|||++|.+|+........  .    .... ....     +
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--~----~~~~-~~~~-----~  238 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHIA-QNDS-----P  238 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--H----HHHH-hcCC-----C
Confidence               23456888999999974   45688999999999999999999998754322110  0    0000 0000     0


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..  ........+.+++.+||+.+|.+||++.+++.+
T Consensus       239 ~~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 TL--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00  011222357778899999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-34  Score=286.00  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=199.5

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      |+..++||+|++|.||+|+.. +++.+++|.+....  ....+.+.+|+.++++++|+||+++++++......++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999976 58999999987653  333467889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      + ++|.+++...  ...+++..+..++.+++.||.+||+.+   |+||||+|+||++++++.++|+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            7 5899998432  246899999999999999999999998   99999999999999999999999999886654322 


Q ss_pred             CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-hhh-------HhHhhhhcccc-h
Q 037160          415 LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE-TLV-------THTWKHFQAKT-V  484 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~-~~~-------~~~~~~~~~~~-~  484 (569)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|++|+......... ...       ...|..+..-. .
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             22234567889999998776 8899999999999999999998887654322110 000       01111111100 0


Q ss_pred             hhhhcccCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          485 LEIIDKSIE----IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       485 ~~~~~~~l~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .........    ...+.....+.+++..||+.+|++||++.+|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000000000    0011224568889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=297.34  Aligned_cols=262  Identities=22%  Similarity=0.340  Sum_probs=199.5

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCc---
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD---  326 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  326 (569)
                      .+.++|++.+.||+|++|.||+|+.. +++.||+|++...  .......+.+|+.++++++||||+++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45678999999999999999999976 6789999988643  23344667889999999999999999988876554   


Q ss_pred             ---eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          327 ---SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       327 ---~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                         .++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 6799888842    46899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh-hhH-------h
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET-LVT-------H  474 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~-~~~-------~  474 (569)
                      ++......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... +..       .
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            99865432     234467889999998865 367899999999999999999999986443321100 000       0


Q ss_pred             HhhhhcccchhhhhcccCCC---C----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          475 TWKHFQAKTVLEIIDKSIEI---E----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       475 ~~~~~~~~~~~~~~~~~l~~---~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+..+........+......   .    .......+.+++.+||+.+|++|||+.||+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            01111111111111110000   0    01124678889999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.9e-34  Score=291.82  Aligned_cols=264  Identities=21%  Similarity=0.242  Sum_probs=192.5

Q ss_pred             cccccccccccCceeEEEEEec-C--CceEEEEEEeec--chhhHHHHHHHHHHHHhc-cccccceeeeeeeeC----Cc
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-D--GREIAVKRLFIS--RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK----KD  326 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~  326 (569)
                      +|++.+.||+|+||.||+++.. .  +..||+|++...  .....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778889999999999999976 4  778999988643  223356788899999999 599999999875432    45


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++++||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688889885 68888883   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCC--CCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH--------hH
Q 037160          407 FSSSEKSLL--PNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT--------HT  475 (569)
Q Consensus       407 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~  475 (569)
                      .........  ......|+..|+|||.+.+ ..++.++||||||+++|+|++|++|+.............        ..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            655432211  1224568999999998765 468999999999999999999999876543211100000        00


Q ss_pred             hhhhcccchhhhhcc---cCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          476 WKHFQAKTVLEIIDK---SIEI----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~---~l~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +..+........+..   ....    ..+.....+.+++.+|++.+|++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            001111110000000   0000    011123567789999999999999999999843

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.9e-34  Score=281.17  Aligned_cols=250  Identities=24%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeec-----chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-----RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +|.+.++||+|+||.||+++.. .+..+++|.+...     .......+..|+.++++++||||+++++.+.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999865 3455656655321     122334567899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      |||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988532 23457899999999999999999999998   999999999999974 679999999987654


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....  ......|+..|+|||.+.+..++.++||||||+++|+|++|..|+.......   ...            ....
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~------------~~~~  219 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVL------------RIVE  219 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH------------HHHc
Confidence            4322  2234567889999999988888999999999999999999999875322110   000            0111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .............+..++.+||+.+|++||++.|++++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            11111123344577789999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=272.46  Aligned_cols=207  Identities=24%  Similarity=0.351  Sum_probs=181.3

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      -.++|+.+++||+|.||.|-+++-+ .++.+|+|++++.   .++....-+.|-++|+..+||.+..+...|...+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3478999999999999999999966 7899999988654   34455566789999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||..||.|.-+|   .....+++.........|..||.|||+++   ||.||||.+|+|||.+|++||+|||+++.--
T Consensus       246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999999888   34566788888889999999999999998   9999999999999999999999999998533


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF  468 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~  468 (569)
                      ....  ..+.++||+.|+|||++....|...+|.|.+||++|||++|+.||.....+..
T Consensus       320 ~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL  376 (516)
T KOG0690|consen  320 KYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL  376 (516)
T ss_pred             cccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH
Confidence            3221  34578999999999999999999999999999999999999999886655543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-36  Score=275.28  Aligned_cols=255  Identities=26%  Similarity=0.396  Sum_probs=196.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++.+.+..||.|.||+|+|-.++ .|+.+|||++..... ...++++.|.+...+- +.||||+++|.+..++..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            45556678999999999999987 799999999976543 4557788888877665 78999999999999999999999


Q ss_pred             ecCCCChhhHhhC--CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          333 FVQNKSLDRILFD--PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       333 ~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      .| ..+|+.+...  ..++..+++.-.-.|.....+||.||.+.-  .|||||+||+||||+..|.+||||||.+..+..
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            99 5677665421  134566888888888889999999998764  599999999999999999999999999876544


Q ss_pred             CCCCCCCcccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      .-   ..+...|-..|||||.+..  ..|+.+|||||||+.|||+.||+-|...... .++.+-.     ...++.    
T Consensus       221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~-----Vv~gdp----  287 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQ-----VVIGDP----  287 (361)
T ss_pred             HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHH-----HHcCCC----
Confidence            32   3455678899999999854  3589999999999999999999888653221 1111100     001111    


Q ss_pred             cccCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEIE--DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       +.+...  ..+....+..++-.|+.++-++||...++.++
T Consensus       288 -p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  288 -PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             111111  23466788889999999999999999998854

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=301.00  Aligned_cols=254  Identities=22%  Similarity=0.370  Sum_probs=208.1

Q ss_pred             ccccccccccCceeEEEEEec-CC----ceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DG----REIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ....++||+|+||+||+|.+- .|    -+||+|++... ..+...+++.|+-+|.+++|||++|+++++.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            345678999999999999863 44    36799988654 4455688999999999999999999999998766 88999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      +||++|+|.++++.  .+..+.....+.|..|||+||.|||++.   ++||||..+||||.+...+||.|||+++....+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999964  5677888999999999999999999998   999999999999999999999999999988776


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...-......-.+.|||=|.+....++.++|||||||.+||++| |..|......+                .+.+++..
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----------------eI~dlle~  915 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----------------EIPDLLEK  915 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------------HhhHHHhc
Confidence            55433334444678999999999999999999999999999998 66665433322                23333333


Q ss_pred             cCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          491 SIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       491 ~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                      ..+- .++....++..++.+||..++..||+++++...+.+...
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            2222 256667788889999999999999999999987765443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5e-33  Score=308.46  Aligned_cols=145  Identities=24%  Similarity=0.424  Sum_probs=130.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|.+.++||+|+||.||+|.+. +++.||||++....   ......+..|+.++..++||||+++++.+......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999976 78999999986532   333467889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ||+.+++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999843   345788999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=268.68  Aligned_cols=267  Identities=21%  Similarity=0.247  Sum_probs=204.8

Q ss_pred             Hhcccccc-ccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeee----CCc
Q 037160          254 ATDCFDES-NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT----KKD  326 (569)
Q Consensus       254 ~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~  326 (569)
                      ++++|.+. ++||-|-.|.|-.+.++ +++.+|+|++.-.     ...++|+++.-.. .|||||.++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45666665 47999999999999877 7899999987543     3456888887666 69999999999864    456


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC---CCeEEeccC
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFG  403 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl~Dfg  403 (569)
                      +.+|||.|+||.|...+.+ +..+.+++.++-.|+.||+.|+.|||+.+   |.||||||+|+|....   -.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            7899999999999999965 34566899999999999999999999999   9999999999999654   459999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      +|+......   .....+-|+.|.|||++...+|+...|+||+||++|-|++|.+||.......+            +..
T Consensus       210 FAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------------spg  274 (400)
T KOG0604|consen  210 FAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPG  274 (400)
T ss_pred             cccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC------------Chh
Confidence            999766533   23456789999999999999999999999999999999999999875543211            122


Q ss_pred             hhhhhcccC-CCC--CHHHH-HHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCCCcc
Q 037160          484 VLEIIDKSI-EIE--DIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTD  545 (569)
Q Consensus       484 ~~~~~~~~l-~~~--~~~~~-~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p~~p~~~~  545 (569)
                      +...|.... ...  .-+++ +..-+++...|..+|.+|.|+.+++.+-- +......|..|.+..
T Consensus       275 Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw-i~~~~~vp~tpl~t~  339 (400)
T KOG0604|consen  275 MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW-INQYEAVPQTPLSTS  339 (400)
T ss_pred             HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch-hcccccCCCCCchhh
Confidence            222222211 111  22333 33445888889999999999999996532 222345566666654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-34  Score=268.21  Aligned_cols=269  Identities=21%  Similarity=0.285  Sum_probs=200.6

Q ss_pred             cchhHHHHHhccccccccccccCceeEEEEE-ecCCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeee
Q 037160          246 FKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT  323 (569)
Q Consensus       246 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  323 (569)
                      .++..+-+.|+     +.||+|+++.|--++ +.+|.++|||++.+......++..+|++++.+. .|+||+.++++|++
T Consensus        73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            34444444443     469999999999987 568999999999888777778899999999999 59999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC---eEEe
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR---PKIA  400 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---~kl~  400 (569)
                      +...|||||-|.||+|-.+|   .+++.+++.++.+++..|+.||.+||.++   |.||||||+|||-.+...   +||+
T Consensus       148 d~~FYLVfEKm~GGplLshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             cceEEEEEecccCchHHHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence            99999999999999999888   45667899999999999999999999999   999999999999976654   7999


Q ss_pred             ccCCCcccCCCCCCCC-----CcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 037160          401 DFGLARFSSSEKSLLP-----NTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET  470 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~  470 (569)
                      ||.|..-........+     ....+|+..|||||+..     ...|+.+.|.||||||||-|++|.+||......+-..
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            9999764433322211     12567889999999763     2368899999999999999999999997654432210


Q ss_pred             hhHhHhhhhcccchhhhhcccCCCCCHHHH----HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEIEDIEEV----KRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~----~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      -...+-+ .-...+.+-|+.....-+..+.    ...-.++...+-.++.+|.++.+++.
T Consensus       302 drGe~Cr-~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  302 DRGEVCR-VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCCccH-HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            0000000 0012223333332222222221    12223555666789999999999986

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=273.10  Aligned_cols=236  Identities=27%  Similarity=0.351  Sum_probs=191.5

Q ss_pred             ccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ||+|+||.||++... +++.+++|.+....   ......+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 58999999886543   23456789999999999999999999999999999999999999999


Q ss_pred             hhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcc
Q 037160          340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA  419 (569)
Q Consensus       340 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  419 (569)
                      .+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence            999843   346899999999999999999999988   99999999999999999999999999876644321  2334


Q ss_pred             cccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHH
Q 037160          420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE  499 (569)
Q Consensus       420 ~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  499 (569)
                      ..++..|++||.+.+...+.++|+||||+++|+|++|+.|+.......   ...            ........ .+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~------------~~~~~~~~-~~~~~  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE------------KILKDPLR-FPEFL  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH------------HHhcCCCC-CCCCC
Confidence            567889999999988889999999999999999999999985433211   100            01111111 11112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHH
Q 037160          500 VKRVVWVGLLCTQELPTLRPSMTN  523 (569)
Q Consensus       500 ~~~~~~l~~~Cl~~~P~~RPt~~e  523 (569)
                      ...+.+++.+||..+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            456778899999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.7e-34  Score=267.68  Aligned_cols=276  Identities=21%  Similarity=0.344  Sum_probs=199.3

Q ss_pred             ccccccccccccCceeEEEEEec---C--CceEEEEEEeecchh--hHHHHHHHHHHHHhccccccceeeeeeee-CCce
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ---D--GREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGCCFT-KKDS  327 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  327 (569)
                      ..|+..++||+|.||.||+|.-+   +  .+++|+|++...+..  ......+|+.+++.++||||+.+..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46888999999999999999643   2  347899998765321  23457789999999999999999999987 7789


Q ss_pred             EEEEeecCCCChhhHhh--CCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC----CCeEEec
Q 037160          328 FVVYEFVQNKSLDRILF--DPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK----HRPKIAD  401 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~--~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~----~~~kl~D  401 (569)
                      ++++||.+. +|..+|.  .....+.++...+..|+.||+.|+.|||++-   |+||||||.||||..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999976 6666663  2233467899999999999999999999998   9999999999999877    8999999


Q ss_pred             cCCCcccCCCCCCC-CCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcc-------hhhh-
Q 037160          402 FGLARFSSSEKSLL-PNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG-------FETL-  471 (569)
Q Consensus       402 fgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~-------~~~~-  471 (569)
                      ||+++.+...-... .....+-|.+|.|||.+.+. .|+++.|||+.|||+.||++-++-|...+..-       ...+ 
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999886643221 33466789999999998875 69999999999999999999877654322110       0000 


Q ss_pred             -----hH----hHhhhhc---cc-chhhhhcccCCCC--CHH-------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          472 -----VT----HTWKHFQ---AK-TVLEIIDKSIEIE--DIE-------EVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       472 -----~~----~~~~~~~---~~-~~~~~~~~~l~~~--~~~-------~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                           +.    ..|+...   +- +...-+......+  ...       ....-.++..++|+.||..|.|+++.+++.-
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence                 00    0111111   00 1111111000000  000       1122566788999999999999999998765


Q ss_pred             cCCCCC
Q 037160          530 QKDITL  535 (569)
Q Consensus       530 ~~~~~~  535 (569)
                      ....++
T Consensus       340 F~~d~l  345 (438)
T KOG0666|consen  340 FTEDPL  345 (438)
T ss_pred             cccCCC
Confidence            444433

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=309.18  Aligned_cols=278  Identities=23%  Similarity=0.281  Sum_probs=212.4

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEee---cchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFI---SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      --.++|++.++||+|+||.|..++++ .++.||+|++.+   -......-|..|-.+|..-+.+-|+.+...|.++.++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            34578999999999999999999987 678899998865   23444567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +|||||+||+|-.++..   ...+++..+..++..|..||.-||+.|   +|||||||+|||||..|++||+|||.+-.+
T Consensus       152 lVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             EEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhc
Confidence            99999999999999943   337899999999999999999999999   999999999999999999999999998877


Q ss_pred             CCCCCCCCCcccccCCCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIAN-----GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      ..+... .....+|||.|.+||++..     +.|++.+|.||+||++|||+.|..||.-..--...              
T Consensus       226 ~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY--------------  290 (1317)
T KOG0612|consen  226 DADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY--------------  290 (1317)
T ss_pred             CCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH--------------
Confidence            765543 4556789999999999853     56899999999999999999999998743321111              


Q ss_pred             hhhhhcc--cCCCC----CHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHhccCCCCC--CCCCCCCCccccccccc
Q 037160          484 VLEIIDK--SIEIE----DIEEVKRVVWVGLLCTQELPTLRPS---MTNVVQMLKQKDITL--PTPSKPPFTDECMELSH  552 (569)
Q Consensus       484 ~~~~~~~--~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt---~~evl~~L~~~~~~~--~~p~~p~~~~~~~~~~~  552 (569)
                       ..+++.  .+..+    ..++...++   ..-+ .+|+.|-.   +.++-.+.-....++  -..+.|||.+.-++...
T Consensus       291 -~KIm~hk~~l~FP~~~~VSeeakdLI---~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~D  365 (1317)
T KOG0612|consen  291 -GKIMNHKESLSFPDETDVSEEAKDLI---EALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDD  365 (1317)
T ss_pred             -HHHhchhhhcCCCcccccCHHHHHHH---HHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCc
Confidence             111111  11111    123333333   3322 35777777   888886653333222  23455677665555555


Q ss_pred             CCCC
Q 037160          553 TSGF  556 (569)
Q Consensus       553 ~~~~  556 (569)
                      .++|
T Consensus       366 TsnF  369 (1317)
T KOG0612|consen  366 TSNF  369 (1317)
T ss_pred             cccc
Confidence            5555

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=304.87  Aligned_cols=263  Identities=26%  Similarity=0.387  Sum_probs=206.8

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec----C----CceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeee
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ----D----GREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLG  319 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~  319 (569)
                      ..|.-.++..+.+.||+|.||.|++|...    .    ...||||.+.... ..+.+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34555566667779999999999999843    1    3568999887543 35567899999999999 6999999999


Q ss_pred             eeeeCCceEEEEeecCCCChhhHhhCCC-----C------C--ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 037160          320 CCFTKKDSFVVYEFVQNKSLDRILFDPK-----Q------K--KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKA  386 (569)
Q Consensus       320 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~------~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp  386 (569)
                      ++..++..++|+||+..|+|.+++...+     .      .  ..+.....+.++.|||.||+||++..   +|||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999996443     0      0  24889999999999999999999998   99999999


Q ss_pred             CCeEECCCCCeEEeccCCCcccCCCCCCCCCcccc--cCCCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCC
Q 037160          387 SNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA--GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV-QNNKFQ  463 (569)
Q Consensus       387 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~-~p~~~~  463 (569)
                      +|||+..+..+||+|||+++......... .+...  -...|||||.+....|+.|+|||||||+||||+|.. .|+...
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999665544432 11122  244699999999999999999999999999999954 444321


Q ss_pred             CCcchhhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          464 SDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ..               ...+.+.+.+....+ +......+..+++.||+.+|++||++.++.+.++..
T Consensus       526 ~~---------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  526 PP---------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             Cc---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            10               111122233333322 333467788999999999999999999999999883

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=284.15  Aligned_cols=194  Identities=29%  Similarity=0.467  Sum_probs=171.3

Q ss_pred             cccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCC
Q 037160          261 SNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      .+.||+|.||+||-|+++ +|+.||||++.+.  .......+++|+.||++++||.||.+...|++.+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            468999999999999976 8999999998653  2344578999999999999999999999999999999999999777


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC---CCeEEeccCCCcccCCCCCC
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl~Dfgla~~~~~~~~~  414 (569)
                      -|+-+|.  ..++.+++.....++.||+.||.|||.++   |+|.||||+||||.+.   .++||||||+|++.++..  
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            7776663  45677888888889999999999999999   9999999999999654   469999999999998764  


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKF  462 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~  462 (569)
                       -....+||+.|+|||+++++.|...-|+||.|||+|--++|.-||.-
T Consensus       722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence             34578899999999999999999999999999999999999776653

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7.5e-33  Score=269.62  Aligned_cols=219  Identities=19%  Similarity=0.138  Sum_probs=174.3

Q ss_pred             cCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCChhhHhhC
Q 037160          267 GGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD  345 (569)
Q Consensus       267 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  345 (569)
                      |.+|.||+++.+ +++.+|+|++....     .+.+|...+....||||+++++++......++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999976 78999999986543     233455555666799999999999999999999999999999998843


Q ss_pred             CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCC
Q 037160          346 PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG  425 (569)
Q Consensus       346 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  425 (569)
                         ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++++|||.+......     .....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence               345899999999999999999999998   999999999999999999999999987655432     123345678


Q ss_pred             cccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHH
Q 037160          426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVW  505 (569)
Q Consensus       426 y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  505 (569)
                      |+|||++.++.++.++||||+|+++|||++|+.|+.......            ...       ..+. .+......+..
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-------~~~~-~~~~~~~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-------TTLN-IPEWVSEEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-------cccC-CcccCCHHHHH
Confidence            999999988889999999999999999999987654221100            000       0000 01122345777


Q ss_pred             HHHHhcCCCCCCCCCH
Q 037160          506 VGLLCTQELPTLRPSM  521 (569)
Q Consensus       506 l~~~Cl~~~P~~RPt~  521 (569)
                      ++.+|++.||++||++
T Consensus       208 li~~~l~~dp~~R~~~  223 (237)
T cd05576         208 LLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHccCCHHHhcCC
Confidence            8899999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-33  Score=273.39  Aligned_cols=259  Identities=25%  Similarity=0.343  Sum_probs=199.0

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch-------hhHHHHHHHHHHHHhccccccceeeeeeeeC
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-------NRIKEICNEMDIMSRAHHKNLVQFLGCCFTK  324 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  324 (569)
                      ...++|-.++.||+|||+.||++.+- ..+.||||+-..+..       ...+...+|.+|.+.|.||.||++++++.-+
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            34567888999999999999999854 678899996543321       1234567899999999999999999999654


Q ss_pred             -CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC---CCCeEEe
Q 037160          325 -KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL---KHRPKIA  400 (569)
Q Consensus       325 -~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~~kl~  400 (569)
                       +..+-|+|||+|.+|+-+|   +..+.+++.++..|+.||..||.||.+.. ++|||-||||.||||.+   -|.+||+
T Consensus       540 tdsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence             5667899999999999999   56678999999999999999999999884 78999999999999954   4679999


Q ss_pred             ccCCCcccCCCCCCC-----CCcccccCCCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhh
Q 037160          401 DFGLARFSSSEKSLL-----PNTAIAGTLGYMAPEYIANG----QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL  471 (569)
Q Consensus       401 Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~  471 (569)
                      ||||++++..+....     ......||.+|++||.+.-+    +.+.|+||||+|||+|+.+.|+.||+......    
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----  691 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----  691 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----
Confidence            999999987754431     22356799999999977543    57789999999999999999999998654321    


Q ss_pred             hHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 037160          472 VTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVV  525 (569)
Q Consensus       472 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl  525 (569)
                           +.+...+++..-.-... ..+........++.+||+..-++|....++.
T Consensus       692 -----dILqeNTIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 -----DILQENTILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -----HHHhhhchhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                 11122222222111111 1233334455677899999999998877765

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-33  Score=284.90  Aligned_cols=241  Identities=24%  Similarity=0.277  Sum_probs=192.4

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +++.|+....+|.|+|+.|-.+.+. +++..+||++.....    ...+|+.++... +||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            5678888999999999999999865 789999998866522    233577666665 7999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE-CCCCCeEEeccCCCcccCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL-DLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll-~~~~~~kl~Dfgla~~~~~  410 (569)
                      |.+.++-+.+.+.   ...... .++..|+.+|+.++.|||+++   ||||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999998877763   222233 778889999999999999999   9999999999999 6899999999999987665


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      .     ....+-|..|.|||++....+++++|+||||++||+|++|+.|+.....+                  .++...
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~  525 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTR  525 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHh
Confidence            4     22345688999999999999999999999999999999999997654433                  011111


Q ss_pred             cCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          491 SIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       491 ~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ..... ....+....+++.+||+.+|.+||+|.++..+-
T Consensus       526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             hcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence            11111 123334455677899999999999999998653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=9.7e-32  Score=261.16  Aligned_cols=235  Identities=26%  Similarity=0.353  Sum_probs=192.6

Q ss_pred             CceeEEEEEec-CCceEEEEEEeecchhh-HHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCChhhHhhC
Q 037160          268 GYGEIFKGTLQ-DGREIAVKRLFISRKNR-IKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD  345 (569)
Q Consensus       268 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  345 (569)
                      +||.||++... +|+.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 58999999987665444 67899999999999999999999999999999999999999999999843


Q ss_pred             CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCC
Q 037160          346 PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG  425 (569)
Q Consensus       346 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  425 (569)
                      .   ..+++..++.++.+++++|.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            2   23889999999999999999999998   9999999999999999999999999998765542   2234567889


Q ss_pred             cccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHH---HHHH
Q 037160          426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIE---EVKR  502 (569)
Q Consensus       426 y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---~~~~  502 (569)
                      |++||.+.+..++.++||||||+++++|++|..|+......  ...             .+.+..........   ....
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~  216 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LEL-------------FKKIGKPKPPFPPPEWKISPE  216 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH-------------HHHHhccCCCCccccccCCHH
Confidence            99999998888999999999999999999999887542111  001             11111111111111   4457


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          503 VVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       503 ~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      +.+++.+|+..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            888999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=9.6e-33  Score=240.28  Aligned_cols=197  Identities=25%  Similarity=0.417  Sum_probs=167.5

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecchh--hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      +|+..++||+|.||+||+|+.+ .++-||+|++...+.+  .-....+|+-+|+.++|.|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556678999999999999976 5788999998765432  345678999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      | ..+|..+..  .-++.++......++.|+++||.++|+++   +.||||||.|+|++.+|++|++|||+++.++-.-.
T Consensus        83 c-dqdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 C-DQDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             h-hHHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            9 457777763  34577899999999999999999999999   99999999999999999999999999997765321


Q ss_pred             CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNK  461 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~  461 (569)
                        -....+-|.+|.+|.++.+. -|+...|+||-|||+.|+....+|..
T Consensus       157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf  203 (292)
T KOG0662|consen  157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_pred             --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence              12244578999999999876 58889999999999999998666643

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-32  Score=285.81  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=205.6

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeee-----CC
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT-----KK  325 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----~~  325 (569)
                      .-++.|++.+.||.|.+|.||+++.+ +++..|+|++..... ..+++..|.++|+.+ +|||++.++|++..     ++
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            44677899999999999999999965 788999998766543 336778899999988 79999999999864     46


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      .+|||||||.+|+..|+++... ...+.|..+..|+..+++||.+||...   ++|||||-.|||++.++.+||+|||++
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence            7899999999999999997655 778999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhc
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANG-----QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ  480 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  480 (569)
                      ........  ......||+.|||||++.-.     .|+..+|+||||++..||.-|.+|+-...+-.             
T Consensus       171 aQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------------  235 (953)
T KOG0587|consen  171 AQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------------  235 (953)
T ss_pred             eeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------------
Confidence            87765433  34567899999999998532     46778999999999999999998865332211             


Q ss_pred             ccchhhhhcccCCC--C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          481 AKTVLEIIDKSIEI--E-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       481 ~~~~~~~~~~~l~~--~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        .+. .+...-..  . +..-..++.+++..||.+|-+.||++.+++++
T Consensus       236 --aLF-~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 --ALF-LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --hhc-cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence              000 01111111  1 34567789999999999999999999998854

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.3e-33  Score=258.05  Aligned_cols=267  Identities=24%  Similarity=0.407  Sum_probs=197.3

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecc-h-hhHHHHHHHHHHHHhccccccceeeeeeeeC--------C
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-K-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--------K  325 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~  325 (569)
                      .|+-..+||+|.||.||+|+.+ .|+.||+|++.... + ..-....+|+++|..|+|+|++.+++.|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4555678999999999999976 67888998765432 2 2224567899999999999999999888542        3


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..|+|+.+|+. +|.-+|.+  ....++..++.+++.++..||.|+|+..   |+|||+||.|+||+.+|.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence            47999999964 67777732  3467889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCC--CCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------
Q 037160          406 RFSSSEKSLL--PNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------  474 (569)
Q Consensus       406 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------  474 (569)
                      +.+.......  ..+..+-|++|.+||.+.+. .++++.|||.-|||+.||+++.+-+....+...-.+++.        
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            8776544321  12345569999999988775 799999999999999999999877665554444444432        


Q ss_pred             Hhhhhcccchhhhhccc-CCCC----CHHHHH------HHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          475 TWKHFQAKTVLEIIDKS-IEIE----DIEEVK------RVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       475 ~~~~~~~~~~~~~~~~~-l~~~----~~~~~~------~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      .|+....-.+.+-+... +...    ..+..+      ..++++..++..||.+|+.+++++.+--
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~  317 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF  317 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence            23322222222211100 1100    111111      4566777889999999999999997643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=1.2e-31  Score=290.43  Aligned_cols=262  Identities=19%  Similarity=0.195  Sum_probs=168.3

Q ss_pred             HhccccccccccccCceeEEEEEec-C----CceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeee------ee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-D----GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC------CF  322 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~  322 (569)
                      ..++|++.++||+|+||.||+|++. +    +..||||++......  +.+.+|  .+++..+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3578999999999999999999976 4    689999987543211  111111  1222222333322221      24


Q ss_pred             eCCceEEEEeecCCCChhhHhhCCCCC-----------------ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 037160          323 TKKDSFVVYEFVQNKSLDRILFDPKQK-----------------KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIK  385 (569)
Q Consensus       323 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDik  385 (569)
                      .....++||||+.+++|.+++......                 .......+..++.||+.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566789999999999999988532210                 01123345679999999999999998   9999999


Q ss_pred             CCCeEECC-CCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccC----------------------CCCcccc
Q 037160          386 ASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG----------------------QLTEKVD  442 (569)
Q Consensus       386 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksD  442 (569)
                      |+|||++. ++.+||+|||+++........ ......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 589999999999866443322 33456789999999965322                      2345679


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh-hhcccchhhhhcccCCCC-------CHHHHHHHHHHHHHhcCCC
Q 037160          443 IYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK-HFQAKTVLEIIDKSIEIE-------DIEEVKRVVWVGLLCTQEL  514 (569)
Q Consensus       443 v~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~-------~~~~~~~~~~l~~~Cl~~~  514 (569)
                      ||||||+||||+++..+...    ....+...... ......+...+......+       .........+++.+||+.|
T Consensus       362 VwSlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            99999999999987544221    11111000000 000001111111110000       0001123447899999999


Q ss_pred             CCCCCCHHHHHHH
Q 037160          515 PTLRPSMTNVVQM  527 (569)
Q Consensus       515 P~~RPt~~evl~~  527 (569)
                      |++|||+.|++++
T Consensus       438 P~kR~ta~e~L~H  450 (566)
T PLN03225        438 GRQRISAKAALAH  450 (566)
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999976

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=2.2e-31  Score=281.33  Aligned_cols=261  Identities=21%  Similarity=0.271  Sum_probs=178.2

Q ss_pred             hccccccccccccCceeEEEEEe-----------------cCCceEEEEEEeecchhhHHHH--------------HHHH
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTL-----------------QDGREIAVKRLFISRKNRIKEI--------------CNEM  303 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~  303 (569)
                      .++|++.++||+|+||.||+|..                 ..++.||||++........++|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999964                 2356899999876543333333              3466


Q ss_pred             HHHHhcccccc-----ceeeeeeee--------CCceEEEEeecCCCChhhHhhCCC---------------------CC
Q 037160          304 DIMSRAHHKNL-----VQFLGCCFT--------KKDSFVVYEFVQNKSLDRILFDPK---------------------QK  349 (569)
Q Consensus       304 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~  349 (569)
                      .++.+++|.++     +++++++..        ....+|||||+++++|.+++....                     ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766554     667777653        356799999999999999885321                     11


Q ss_pred             ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccc
Q 037160          350 KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP  429 (569)
Q Consensus       350 ~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP  429 (569)
                      ..+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            23467788999999999999999998   999999999999999999999999999765443221 11223457899999


Q ss_pred             cccccCCC----------------------CcccchhhHHHHHHHHHhCCC-CCCCCCCc----chhhhhHhHhhhhccc
Q 037160          430 EYIANGQL----------------------TEKVDIYSFGVLVLEIVSGVQ-NNKFQSDD----GFETLVTHTWKHFQAK  482 (569)
Q Consensus       430 E~~~~~~~----------------------~~ksDv~SlGvil~elltg~~-p~~~~~~~----~~~~~~~~~~~~~~~~  482 (569)
                      |.+.....                      ..+.||||+||+++||++|.. |+......    .........|..+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98754321                      135799999999999999875 44211000    0000011112221111


Q ss_pred             chhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHHH
Q 037160          483 TVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELP---TLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P---~~RPt~~evl~~  527 (569)
                      .        .... .........+++..++..+|   .+|+|+.|++++
T Consensus       460 ~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        460 K--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             C--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            1        1111 11223445567777777655   689999999976

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=266.08  Aligned_cols=241  Identities=25%  Similarity=0.316  Sum_probs=191.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  329 (569)
                      ..+|..+.+||+|+||.|.++..+ ..+.+|||++++.-   .+..+--..|-++|... +-|.++.+...+.+.+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            356888999999999999999876 45678999886542   22334445677777766 57889999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+.||+|--.|+   +-+.+.+..+...+..|+-||-+||+++   ||.||||.+||||+.+|++||+|||+++.--
T Consensus       428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            999999999988884   4455667788889999999999999999   9999999999999999999999999997543


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      -...  .....+||+.|+|||++...+|+..+|.||+||+||||+.|++||....++..-..               +.+
T Consensus       502 ~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a---------------I~e  564 (683)
T KOG0696|consen  502 FDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA---------------IME  564 (683)
T ss_pred             cCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---------------HHH
Confidence            3222  34578999999999999999999999999999999999999999986654432111               111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRP  519 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP  519 (569)
                      . ....+...+.+...|...-+.++|.+|.
T Consensus       565 h-nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  565 H-NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             c-cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            1 1112344455666677777888888884

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=263.86  Aligned_cols=269  Identities=17%  Similarity=0.235  Sum_probs=202.2

Q ss_pred             hhHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccc--c----ccceeeee
Q 037160          248 YSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHH--K----NLVQFLGC  320 (569)
Q Consensus       248 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~  320 (569)
                      |+.....+++|.+..+||+|.||.|-.+... .+..||||+++.-.+ ..+..+-|+++|+++.+  |    -+|.+.++
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            3344456889999999999999999999865 578899998865433 23456679999999932  2    36777888


Q ss_pred             eeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-------
Q 037160          321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-------  393 (569)
Q Consensus       321 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-------  393 (569)
                      |.-.++.+||+|.+ |-++.++|.. .+..+++...+..|..|+++++++||+..   ++|-||||+|||+.+       
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEe
Confidence            99999999999998 7799999953 35567889999999999999999999998   999999999999832       


Q ss_pred             -------------CCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 037160          394 -------------KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNN  460 (569)
Q Consensus       394 -------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~  460 (569)
                                   +..++|+|||-|+.-....     ..++.|..|.|||++.+-.++.++||||+||||.||.+|..-|
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence                         2358999999998655432     5678899999999999999999999999999999999998766


Q ss_pred             CCCCCcchhhhhHhHhhhhcccchhh-------------------------hhcccC-----CCCCHHHHHHHHHHHHHh
Q 037160          461 KFQSDDGFETLVTHTWKHFQAKTVLE-------------------------IIDKSI-----EIEDIEEVKRVVWVGLLC  510 (569)
Q Consensus       461 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~l-----~~~~~~~~~~~~~l~~~C  510 (569)
                      ...+..+--.+.......++...+..                         ..+.-.     ......+...+++++..+
T Consensus       310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            54432111011111111111111110                         001000     011345667799999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 037160          511 TQELPTLRPSMTNVVQM  527 (569)
Q Consensus       511 l~~~P~~RPt~~evl~~  527 (569)
                      |..||.+|+|+.|++.+
T Consensus       390 L~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  390 LEFDPARRITLREALSH  406 (415)
T ss_pred             HccCccccccHHHHhcC
Confidence            99999999999999965

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=241.56  Aligned_cols=206  Identities=29%  Similarity=0.430  Sum_probs=171.0

Q ss_pred             HHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCce
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  327 (569)
                      ++...+...-...||+|++|.|-+-++. +|+..|+|++...- .+..++.++|+.+..+. .+|.+|+++|....+...
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            4444555666678999999999999876 79999999986542 34456788898887765 799999999999999999


Q ss_pred             EEEEeecCCCChhhHhhC-CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          328 FVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ++.||.| ..+|+.+-.. ..+.+.+++.-+-+|+..+.+||.|||++-  .+||||+||+|||++.+|++||||||.+.
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 5688776532 245677888899999999999999999964  69999999999999999999999999988


Q ss_pred             ccCCCCCCCCCcccccCCCccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIAN----GQLTEKVDIYSFGVLVLEIVSGVQNNKF  462 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~SlGvil~elltg~~p~~~  462 (569)
                      .+...-   ..+...|--.|||||.+..    ..|+.|+||||||+.+.||.+++.|+..
T Consensus       198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            765432   2334668889999998854    3689999999999999999999988754

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-32  Score=260.83  Aligned_cols=268  Identities=22%  Similarity=0.310  Sum_probs=216.0

Q ss_pred             ccchhHHHHHhccccccccccccCceeEEEEEecC------CceEEEEEEeec-chhhHHHHHHHHHHHHhcccccccee
Q 037160          245 QFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQD------GREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQF  317 (569)
Q Consensus       245 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~  317 (569)
                      ..+.+.+.....+++....+-+|.||.||.|.+++      .++|.+|.++.. +.-+...++.|-.++..+.|||+..+
T Consensus       273 ~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V  352 (563)
T KOG1024|consen  273 NRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSV  352 (563)
T ss_pred             hhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccce
Confidence            34455566666788889999999999999997653      456777766543 34456678899999999999999999


Q ss_pred             eeeeeeC-CceEEEEeecCCCChhhHhh-----CCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          318 LGCCFTK-KDSFVVYEFVQNKSLDRILF-----DPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       318 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                      .+++.++ ...+++++++.-|+|+.||.     +....+.++..+...++.|++.|++|||+++   |||.||..+|.+|
T Consensus       353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvI  429 (563)
T KOG1024|consen  353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVI  429 (563)
T ss_pred             eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhccee
Confidence            9998654 57899999999999999997     5556677888899999999999999999999   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~  470 (569)
                      ++..++||+|=.+++-+-..+.+...........||+||.+.+..|+..+|||||||+||||+| |+.|..--.+.+.. 
T Consensus       430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-  508 (563)
T KOG1024|consen  430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-  508 (563)
T ss_pred             hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-
Confidence            9999999999999997776666655556667789999999999999999999999999999998 56665432222211 


Q ss_pred             hhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                                     ..+....... +.++...+..++.-||...|++||++++++.-|.+.
T Consensus       509 ---------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  509 ---------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ---------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                           1112222222 445566788899999999999999999999988764

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-32  Score=268.25  Aligned_cols=266  Identities=25%  Similarity=0.327  Sum_probs=209.2

Q ss_pred             ccccccccccccCceeEEEEEecCCc-eEEEEEEee---cchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGR-EIAVKRLFI---SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .+++....||-||||.|=+...+... .+|+|.+++   -+..+.+.+..|-.+|...+.|.||++|.-|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34556678999999999998876433 378876643   24455677889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      |-|-||.|...|   +.++.++......++..+.+|+.|||+++   ||.|||||+|++|+.+|-+||.|||+|+....+
T Consensus       500 EaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999999   56678888899999999999999999999   999999999999999999999999999988776


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .   ..-.++||+.|.|||++.+...+.++|.||||+++|||++|.+||....+-....++            +..+|..
T Consensus       574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------------LkGid~i  638 (732)
T KOG0614|consen  574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------------LKGIDKI  638 (732)
T ss_pred             C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------------Hhhhhhh
Confidence            4   234789999999999999999999999999999999999999999876654332222            1111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC--------CCCCCCCCCCCc
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQMLKQKD--------ITLPTPSKPPFT  544 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~L~~~~--------~~~~~p~~p~~~  544 (569)
                      -  -+....+...+++++.+..+|.+|.-     +.+|-++-.-..        ..+++|-.|+..
T Consensus       639 ~--~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va  702 (732)
T KOG0614|consen  639 E--FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVA  702 (732)
T ss_pred             h--cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCC
Confidence            0  02223344566777777889999975     777765543222        234555555544

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=280.83  Aligned_cols=247  Identities=26%  Similarity=0.377  Sum_probs=187.8

Q ss_pred             ccccccccccCce-eEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeecC
Q 037160          258 FDESNKLGHGGYG-EIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       258 f~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      |.-.+.+|.|.-| .||+|.+. |++||||++....   .....+|+..|+.- +|||||++++.-.+++..||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            3445678999987 46999987 7899999885433   34567999999998 6999999999999999999999999 


Q ss_pred             CCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC---C--CCeEEeccCCCcccC
Q 037160          336 NKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL---K--HRPKIADFGLARFSS  409 (569)
Q Consensus       336 ~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~---~--~~~kl~Dfgla~~~~  409 (569)
                      ..+|++++... ...........+.+..|++.||++||+.+   ||||||||.||||+.   +  ..++|+|||+++...
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            67999999542 11111122445778999999999999988   999999999999976   3  468999999999887


Q ss_pred             CCCCCCC-CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          410 SEKSLLP-NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG-VQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       410 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .+..... .....||.+|+|||++....-+.++||||||||+|+.++| .+||+.....+.. ++       ....-   
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-Il-------~~~~~---  731 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-IL-------TGNYT---  731 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-hh-------cCccc---
Confidence            7665432 3467899999999999998888899999999999999987 7888754332110 00       00000   


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +. .+......   ...+++..|+.++|..||++.+|+.+
T Consensus       732 L~-~L~~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  732 LV-HLEPLPDC---EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ee-eeccCchH---HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            00 11111111   55667889999999999999999943

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=245.38  Aligned_cols=249  Identities=23%  Similarity=0.345  Sum_probs=196.2

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  328 (569)
                      .-++|+.+++||+|+|+.|..++++ +.+-+|+|++++.   ..+.+.-...|-.+..+. +||.+|-+..+|.++...+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3468999999999999999999976 5678899987543   334445566777777665 7999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +|.||++||+|--++   .+...++++.+......|..+|.|||+.+   ||.||||.+|+|+|..|++||+|+|+.+.-
T Consensus       328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999997666   34456889999999999999999999999   999999999999999999999999999854


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      -....  ....++||+.|.|||++++..|...+|.|+|||+++||+.|+.||.....+.-+        ...+..+.+++
T Consensus       402 l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d--------~ntedylfqvi  471 (593)
T KOG0695|consen  402 LGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD--------MNTEDYLFQVI  471 (593)
T ss_pred             CCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc--------cchhHHHHHHH
Confidence            33222  345789999999999999999999999999999999999999999754322110        01112222222


Q ss_pred             -cccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 037160          489 -DKSIEIEDIEEVKRVVWVGLLCTQELPTLRP  519 (569)
Q Consensus       489 -~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP  519 (569)
                       .+.+.. +.....+...+...-|.++|.+|.
T Consensus       472 lekqiri-prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  472 LEKQIRI-PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hhhcccc-cceeehhhHHHHHHhhcCCcHHhc
Confidence             222222 333445566677788899999885

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=246.58  Aligned_cols=265  Identities=22%  Similarity=0.298  Sum_probs=197.8

Q ss_pred             ccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC-----CceEEEE
Q 037160          260 ESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----KDSFVVY  331 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~  331 (569)
                      -.+.||.|.||.||...+. +|+.|++|++..-  +-...+.+.+|+.+|..++|.|++..++.....     +++|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            3567999999999999865 8999999988543  334467889999999999999999888776543     3568889


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      |.| ..+|.++|   ...+.++...+.-+++||++||.|||+.+   |.||||||.|+|++++-.+||||||+++.....
T Consensus       137 ELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  137 ELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence            988 56888888   45677888888899999999999999999   999999999999999999999999999976665


Q ss_pred             CCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh--------hccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH--------FQAK  482 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~  482 (569)
                      +.. ..+..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+.-|.-..+-+.-.++......        --++
T Consensus       210 ~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  210 DRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            443 44556678899999999886 6999999999999999999887666655554333333221111        1111


Q ss_pred             chhhhhcccCCC---------C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          483 TVLEIIDKSIEI---------E-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       483 ~~~~~~~~~l~~---------~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      .-..++......         . +...-..-+.+..+++..+|..|.+..+.+..+-...
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence            111111111110         0 1122233455666788999999999999987765433

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.9e-30  Score=261.38  Aligned_cols=207  Identities=24%  Similarity=0.358  Sum_probs=175.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .-|..++.||-|+||.|.+++.. +...+|.|.|.+.+   +.+....+.|-+||.....+-||+++..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            34677889999999999999854 46678999886653   344566889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc---
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS---  408 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~---  408 (569)
                      +|++||++-.+|.   +.+.+.+..++.++.++..|+++.|..|   +|||||||+|||||.+|++||+||||+.-+   
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999998883   4567888888999999999999999999   999999999999999999999999998632   


Q ss_pred             ------CCCCCCC-------------------------------CCcccccCCCcccccccccCCCCcccchhhHHHHHH
Q 037160          409 ------SSEKSLL-------------------------------PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVL  451 (569)
Q Consensus       409 ------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~  451 (569)
                            ..++...                               .....+||+.|+|||++....++...|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                  1111000                               001247999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcch
Q 037160          452 EIVSGVQNNKFQSDDGF  468 (569)
Q Consensus       452 elltg~~p~~~~~~~~~  468 (569)
                      ||+.|++||-...+.+.
T Consensus       863 em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGET  879 (1034)
T ss_pred             HHhhCCCCccCCCCCcc
Confidence            99999999987766543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.6e-28  Score=232.67  Aligned_cols=211  Identities=34%  Similarity=0.583  Sum_probs=183.9

Q ss_pred             ccccCceeEEEEEec-CCceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCChhh
Q 037160          264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDR  341 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~  341 (569)
                      ||+|.+|.||++... +++.+++|++...... ....+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999976 4899999998765432 35678999999999999999999999999999999999999999999


Q ss_pred             HhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcccCCCCCCCCCccc
Q 037160          342 ILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAI  420 (569)
Q Consensus       342 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~  420 (569)
                      ++....  ..+++..+..++.+++++|.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            984321  46889999999999999999999998   999999999999999 89999999999986655321  12335


Q ss_pred             ccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHH
Q 037160          421 AGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE  499 (569)
Q Consensus       421 ~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  499 (569)
                      .+...|++||.+... ..+.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999877 888999999999999999                                              


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          500 VKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       500 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                       ..+.+++..|++.+|++||++.++++.+
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             4677888999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=261.20  Aligned_cols=196  Identities=26%  Similarity=0.461  Sum_probs=170.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch---h-----hHHHHHHHHHHHHhcc---ccccceeeeeeee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---N-----RIKEICNEMDIMSRAH---HKNLVQFLGCCFT  323 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~-----~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  323 (569)
                      .+|...++||+|+||.|+.+.++ +..+|+||.+.+.+-   .     ..-..-.|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35788999999999999999987 678899998876531   1     1123567999999997   9999999999999


Q ss_pred             CCceEEEEeec-CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          324 KKDSFVVYEFV-QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       324 ~~~~~lv~e~~-~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                      ++..||+||-. ++-+|.++|   ..+..+++.++..|+.|++-|+++||+++   |||||||-+|+.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999975 566899998   56788999999999999999999999999   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCC
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT-EKVDIYSFGVLVLEIVSGVQNNK  461 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltg~~p~~  461 (569)
                      |.+.+...+    +...++||..|.|||++.+.+|- ..-|||++|++||.++....|+.
T Consensus       715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            998766554    56688999999999999988765 56899999999999998776653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=7.9e-30  Score=230.29  Aligned_cols=257  Identities=20%  Similarity=0.308  Sum_probs=194.2

Q ss_pred             hccccccccccccCceeEEEEEe-cCCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeeeeeeC--CceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTK--KDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv  330 (569)
                      .++|++.+++|+|.++.||.|+. .+.+.++||.++.-.+   +.+.+|+.+|+.|. ||||+++++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            36788999999999999999984 4788999999865433   67889999999996 99999999998754  467899


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-CCeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~kl~Dfgla~~~~  409 (569)
                      +||+++.+...+.      ..++...+...+.+++.||.|+|++|   |.|||+||.|+++|.. ..++|+|||+|.++-
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998887765      56777888999999999999999999   9999999999999865 469999999999876


Q ss_pred             CCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh------------
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW------------  476 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~------------  476 (569)
                      .....   ...+.+..|--||.+.. ..++..-|+|||||+|..|+..+.||....+.. +.++..+-            
T Consensus       185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHH
Confidence            65432   22345667889998765 568999999999999999999999986554432 22221110            


Q ss_pred             --hhhcccchhhhhcccC--------CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 --KHFQAKTVLEIIDKSI--------EIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 --~~~~~~~~~~~~~~~l--------~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        ..--.....+++....        ..+ ..-...+.++++...|..|-++|||+.|.+.+
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence              0000111111111110        111 11123566777788899999999999999854

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=2.5e-29  Score=250.62  Aligned_cols=273  Identities=20%  Similarity=0.228  Sum_probs=214.6

Q ss_pred             cchhHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc------ccccceee
Q 037160          246 FKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH------HKNLVQFL  318 (569)
Q Consensus       246 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~  318 (569)
                      +.+...|....+|.+....|+|-|++|..|... .|++||||++..+.. ..+.=+.|+++|++|+      --|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            455667888999999999999999999999965 588999999977643 3355568999999995      34899999


Q ss_pred             eeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC-e
Q 037160          319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR-P  397 (569)
Q Consensus       319 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~-~  397 (569)
                      ..|...++++||+|-+ ..+|.++|...+.+..|....+..++.|++-||..|..-+   |+|.||||+|||+++..+ +
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence            9999999999999988 5689999988888889999999999999999999999988   999999999999997654 8


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh-
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW-  476 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-  476 (569)
                      ||||||.|.....++-    +.+.-+..|.|||++.+-.|+...|+||.||.||||.||+.-|+.....+.--+..... 
T Consensus       577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             eeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            9999999987665532    23334567999999999999999999999999999999987766544332211111100 


Q ss_pred             --------------hhhc---------------------------ccchhhhhc--ccCCCCCHHHHHHHHHHHHHhcCC
Q 037160          477 --------------KHFQ---------------------------AKTVLEIID--KSIEIEDIEEVKRVVWVGLLCTQE  513 (569)
Q Consensus       477 --------------~~~~---------------------------~~~~~~~~~--~~l~~~~~~~~~~~~~l~~~Cl~~  513 (569)
                                    .++.                           ..++...+.  +.+..+++.....+..|...|+..
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence                          0000                           011111111  123334566677788899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 037160          514 LPTLRPSMTNVVQM  527 (569)
Q Consensus       514 ~P~~RPt~~evl~~  527 (569)
                      ||+.|.|..+.|.+
T Consensus       733 dP~KRit~nqAL~H  746 (752)
T KOG0670|consen  733 DPEKRITVNQALKH  746 (752)
T ss_pred             ChhhcCCHHHHhcC
Confidence            99999999999865

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-30  Score=261.41  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=205.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|+...++|+|.+|.|||++.+ .++..|+|.++.......+-+..|+-+++..+|||||.+++.+......++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467888999999999999999976 7899999999988888888899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      |.+|+|++.-   ...+.+++.++..+.....+||+|||+.+   -+|||||-.|||+++.|.+|+.|||.+-.+...- 
T Consensus        94 cgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-  166 (829)
T KOG0576|consen   94 CGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-  166 (829)
T ss_pred             cCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence            9999999976   35678899999999999999999999999   8999999999999999999999999987655432 


Q ss_pred             CCCCcccccCCCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          414 LLPNTAIAGTLGYMAPEYI---ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                       ...+.+.||+.|||||+.   +.+.|..++|||++|+...|+---++|...-.+.  ..+..-....         .++
T Consensus       167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~LmTkS~---------~qp  234 (829)
T KOG0576|consen  167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALFLMTKSG---------FQP  234 (829)
T ss_pred             -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHHHhhccC---------CCC
Confidence             245678999999999976   4567999999999999999998777663221111  0000000000         111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      --..+...-..-+-++++.|+.++|++||+++.+|.
T Consensus       235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            111123344556777999999999999999988774

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.4e-27  Score=229.63  Aligned_cols=199  Identities=32%  Similarity=0.501  Sum_probs=172.1

Q ss_pred             ccccccccccCceeEEEEEecC-CceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      |.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667889999999999999874 899999998766544 56789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++....  ..+++..+..++.+++++|.+||+.+   ++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            999999984322  12789999999999999999999998   999999999999999999999999999876554211 


Q ss_pred             CCcccccCCCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 037160          416 PNTAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSGVQNNKF  462 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~SlGvil~elltg~~p~~~  462 (569)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22345678899999998 666788899999999999999999999843

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=231.19  Aligned_cols=261  Identities=25%  Similarity=0.335  Sum_probs=191.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC------Cc
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------KD  326 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  326 (569)
                      .+|..++.+|.|.- .|-.+.+. .++.||+|++...  .....++..+|..++..++|+||++++.++...      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45677788899988 66666544 6899999988543  233456778999999999999999999998644      45


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .|+|||+| ..+|..++.     -.++-..+..|+.|++.|+.|||+.+   |+||||||+||++..+..+||.|||+++
T Consensus        96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            69999999 557777763     34677788899999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhhhHh-----------
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG-FETLVTH-----------  474 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~-----------  474 (569)
                      .....   ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+--|.....-+ +...+..           
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            65543   24567788999999999998889999999999999999999986554221110 0000000           


Q ss_pred             -------Hhhh---hcccchhhhhcccCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          475 -------TWKH---FQAKTVLEIIDKSIE----IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       475 -------~~~~---~~~~~~~~~~~~~l~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                             ....   ...-...+.+...+-    ...+....-...++.+||-.+|++|-++.++|++--
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY  312 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY  312 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence                   0000   000001111111110    001223334556888999999999999999997743

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.7e-27  Score=218.11  Aligned_cols=254  Identities=18%  Similarity=0.227  Sum_probs=185.8

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeee-eeeCCceEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGC-CFTKKDSFVV  330 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv  330 (569)
                      ..+.|.+.+.||+|.||.+-++.++ ..+.+++|.+... ....++|.+|..---.| .|.||+.-+++ |++.+..+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            4567999999999999999999988 5678899976544 33457888887766566 58999987765 5667778899


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC--CCCCeEEeccCCCccc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD--LKHRPKIADFGLARFS  408 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~--~~~~~kl~Dfgla~~~  408 (569)
                      +||++.|+|..-+.    ...+.+....+++.|++.||.|+|+++   +||||||.+||||-  +.-.+||||||+.+..
T Consensus       101 qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999988773    345677888899999999999999999   99999999999994  3347999999998754


Q ss_pred             CCCCCCCCCcccccCCCccccccccc---C--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIAN---G--QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      +..     .....-+..|.+||....   +  ...+.+|||.||+|++.+++|+.||......+.   .-+.|..|..+.
T Consensus       174 g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  174 GTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRK  245 (378)
T ss_pred             Cce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhccc
Confidence            432     123334667999996533   2  356789999999999999999999974333222   223344444333


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       484 ~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ..     .+...-.....+.+.+..+-+.++|++|--+.++-++.
T Consensus       246 ~~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  246 NP-----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             Cc-----cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            22     11111122334566666788899999996666555443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2e-25  Score=221.86  Aligned_cols=131  Identities=22%  Similarity=0.371  Sum_probs=109.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-----c---cccceeeeeeee---
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-----H---KNLVQFLGCCFT---  323 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~---  323 (569)
                      .+|.+.++||-|-|++||++.+. +.+.||+|+.+.. ....+....||++|++++     |   ..||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            78999999999999999999865 6788999977543 333456778999999983     3   379999999974   


Q ss_pred             -CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          324 -KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       324 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                       +.+.++|+|++ |.+|-.+|.. ...+.++...+..|+.||+.||.|||+..  .|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             56889999999 6677677743 34566899999999999999999999986  69999999999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.9e-26  Score=226.43  Aligned_cols=269  Identities=25%  Similarity=0.376  Sum_probs=199.0

Q ss_pred             hhHHHHHhccccccccccccCceeEEEEEec----CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeee
Q 037160          248 YSTIEKATDCFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCF  322 (569)
Q Consensus       248 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  322 (569)
                      ++.+....+.|...++||+|.|++||++.+.    ..+.||+|.+...+..  ..+.+|+++|..+ .+.||+++.+++.
T Consensus        28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhc
Confidence            3455667788999999999999999999854    3678999988765432  4588999999999 5899999999999


Q ss_pred             eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-CCeEEec
Q 037160          323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIAD  401 (569)
Q Consensus       323 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~kl~D  401 (569)
                      .++...+|+||++.....+++      ..++..++...+..++.||.++|.+|   ||||||||+|+|.+.. +.-.|.|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             cCCeeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence            999999999999999999988      34668889999999999999999999   9999999999999854 5679999


Q ss_pred             cCCCcccCCCC------C-------C---------------------C--------CCcccccCCCccccccccc-CCCC
Q 037160          402 FGLARFSSSEK------S-------L---------------------L--------PNTAIAGTLGYMAPEYIAN-GQLT  438 (569)
Q Consensus       402 fgla~~~~~~~------~-------~---------------------~--------~~~~~~gt~~y~aPE~~~~-~~~~  438 (569)
                      ||+|.......      .       .                     .        ..-...||+||.|||++.. +.-+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            99997211000      0       0                     0        0002469999999999866 4578


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCCCCcchh--hhhH---------------h--Hhhhhcccchhhhhcc-------cC
Q 037160          439 EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE--TLVT---------------H--TWKHFQAKTVLEIIDK-------SI  492 (569)
Q Consensus       439 ~ksDv~SlGvil~elltg~~p~~~~~~~~~~--~~~~---------------~--~~~~~~~~~~~~~~~~-------~l  492 (569)
                      .++||||.|||++-+++++.||....++-..  .+..               .  .|+.-....+.+....       .+
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~  336 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI  336 (418)
T ss_pred             CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence            8999999999999999999998765443211  1110               0  1110000011111100       00


Q ss_pred             C--------CC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 E--------IE--DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~--------~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .        ..  ......-++.+..+|+..||.+|.|+++.|++
T Consensus       337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0        00  11112357889999999999999999999966

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=8.7e-27  Score=264.81  Aligned_cols=197  Identities=18%  Similarity=0.244  Sum_probs=137.8

Q ss_pred             hccc-cccceeeeee-------eeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 037160          308 RAHH-KNLVQFLGCC-------FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI  379 (569)
Q Consensus       308 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  379 (569)
                      .++| +||+++++.+       .+....++++|++ +++|.++|..  ....+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            3455 5777777776       2334567788887 6699999953  2456899999999999999999999998   9


Q ss_pred             eeCCCCCCCeEECC-------------------CCCeEEeccCCCcccCCCCC--------C------CCCcccccCCCc
Q 037160          380 VHRDIKASNILLDL-------------------KHRPKIADFGLARFSSSEKS--------L------LPNTAIAGTLGY  426 (569)
Q Consensus       380 vHrDikp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------~------~~~~~~~gt~~y  426 (569)
                      +||||||+||||+.                   ++.+||+|||+++.......        .      .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999965                   34556666666653221000        0      001124578899


Q ss_pred             ccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHH
Q 037160          427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWV  506 (569)
Q Consensus       427 ~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l  506 (569)
                      ||||++.+..++.++|||||||+||||++|.+|+.....    ..     .....    ..    +.............+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~-----~~~~~----~~----~~~~~~~~~~~~~~~  244 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TM-----SSLRH----RV----LPPQILLNWPKEASF  244 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HH-----HHHHH----hh----cChhhhhcCHHHHHH
Confidence            999999999999999999999999999998776431100    00     00000    00    111111223345677


Q ss_pred             HHHhcCCCCCCCCCHHHHHHH
Q 037160          507 GLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       507 ~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +.+||+.+|.+||++.||+++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            889999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=7.7e-25  Score=202.86  Aligned_cols=165  Identities=24%  Similarity=0.300  Sum_probs=123.3

Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCC
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      |+|.+++..  .+..+++..++.++.|++.||.|||+++         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888843  2456999999999999999999999986         999999999999999  99988654422    


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                         ..||+.|||||++.+..++.++|||||||++|||++|+.|+.......  ..+..........      ..... ..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~~~-~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPRDR-SN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Ccccc-cc
Confidence               257899999999999999999999999999999999999975432211  1110000000000      00000 11


Q ss_pred             HHHH---HHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          497 IEEV---KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       497 ~~~~---~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      ....   ..+.+++.+||+.+|++||++.|+++++..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            1222   258889999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2.2e-24  Score=219.03  Aligned_cols=169  Identities=18%  Similarity=0.208  Sum_probs=131.8

Q ss_pred             HHHHhccccccccccccCceeEEEEEec--CCceEEEEEEeec-----chhhHHHHHHHHHHHHhccccccceeeeeeee
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQ--DGREIAVKRLFIS-----RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT  323 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  323 (569)
                      +....++|.+.++||+|+||.||+|+++  +++.+|||++...     .....+.+.+|+++|++++|+|+++.+..   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            3456678999999999999999999875  5777899987532     12235678999999999999999853322   


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCCeEECCCCCeEEecc
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDI-KASNILLDLKHRPKIADF  402 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDi-kp~NIll~~~~~~kl~Df  402 (569)
                      ....++||||++|++|....    ...      ...++.+++++|.|||+.+   |+|||| ||+|||++.++++||+||
T Consensus        90 ~~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             cCCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence            24679999999999996321    111      1457889999999999998   999999 999999999999999999


Q ss_pred             CCCcccCCCCCCC------CCcccccCCCcccccccccC
Q 037160          403 GLARFSSSEKSLL------PNTAIAGTLGYMAPEYIANG  435 (569)
Q Consensus       403 gla~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~  435 (569)
                      |+++.+.......      ..+...+++.|+|||++...
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999765533211      11356688899999998654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4e-23  Score=210.17  Aligned_cols=259  Identities=20%  Similarity=0.258  Sum_probs=192.4

Q ss_pred             cccccccccccCceeEEEEEecCC--ceEEEEEEeecchhhHHHHHHHHHHHHhccc----cccceeeeee-eeCCceEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQDG--REIAVKRLFISRKNRIKEICNEMDIMSRAHH----KNLVQFLGCC-FTKKDSFV  329 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l  329 (569)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997643  4788887766543333378889999999873    5888888888 57778899


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-----CCeEEeccCC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-----HRPKIADFGL  404 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-----~~~kl~Dfgl  404 (569)
                      ||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|.+||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 899999875443 678999999999999999999999999   9999999999999765     3599999999


Q ss_pred             Cc--ccCCCCCC---CC---CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhHhH
Q 037160          405 AR--FSSSEKSL---LP---NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVTHT  475 (569)
Q Consensus       405 a~--~~~~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~  475 (569)
                      ++  .+......   ..   .....||..|.++..+.+...+.+.|+||++.++.|++.|..||........ ..+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            98  33222211   01   1245699999999999999999999999999999999999998854432211 1110000


Q ss_pred             hhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          476 WKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ..        ..... .....+.+...+..   .+-..+..++|....+...|+...
T Consensus       254 ~~--------~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  254 RK--------LLTDR-FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             hh--------hcccc-ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHH
Confidence            00        00000 11223344444443   333478899999999988876543

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.91  E-value=1.8e-24  Score=181.78  Aligned_cols=98  Identities=31%  Similarity=0.613  Sum_probs=76.2

Q ss_pred             ccccc-c--cCC-CCCChHHHHHHHHHHHHHhhhhhc---CceeeecCCCCCceEEEEecCCCCChhhhHHHHHHHHHHh
Q 037160           11 ERHCQ-K--LPP-ENSSNYLHNYHALLNLMRGEMYKK---KFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLL   83 (569)
Q Consensus        11 ~~~c~-~--~~~-~~~~~~~~~~~~ll~~l~~~~~~~---~f~~~~~g~~~~~vygl~qC~~D~~~~~C~~Cl~~a~~~~   83 (569)
                      |+.|+ +  .++ +++++|++|++.||+.|++.++.+   +|++++.|.++++||||+||++|+++.+|..||+.|+..+
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~   80 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI   80 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence            46798 3  466 577889999999999999998764   8999988888999999999999999999999999999999


Q ss_pred             hhhCCC-cceEEEccceeEEEccCcc
Q 037160           84 ADCLPA-ISAHVFLDGCFLRLENYSF  108 (569)
Q Consensus        84 ~~~c~~-~~~~~~~~~C~~ry~~~~f  108 (569)
                      +.+|+. +||+||+++|+||||+++|
T Consensus        81 ~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   81 SSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHhCCCCceEEEECCCEEEEEECCCC
Confidence            999999 9999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-22  Score=193.32  Aligned_cols=199  Identities=20%  Similarity=0.294  Sum_probs=169.9

Q ss_pred             ccccccccccccCceeEEEEEe-cCCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      -.|.+.++||+|.||.++.|.. -+++.||||.-.  .+...-+++.|.+..+.| ..++|...+.+..++.+..||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            3588999999999999999984 479999999432  333446788899999988 568999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-----CeEEeccCCCccc
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-----RPKIADFGLARFS  408 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-----~~kl~Dfgla~~~  408 (569)
                      + |.+|+|+..  -....++..++..++.|++.-++|+|+++   +|.|||||+|+||...+     .+.|+|||+|+.+
T Consensus       106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 889999873  34567899999999999999999999999   99999999999997544     3899999999987


Q ss_pred             CCCCCC-----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 037160          409 SSEKSL-----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKF  462 (569)
Q Consensus       409 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~  462 (569)
                      .+..+.     .-.+...||..||+=..+.+.+-+.+.|+-|||-+++..|-|..||..
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            665432     223467899999999999999999999999999999999999988754

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=1.7e-21  Score=197.16  Aligned_cols=260  Identities=25%  Similarity=0.358  Sum_probs=196.8

Q ss_pred             ccccccccccCceeEEEEEecCCceEEEEEEeecchh---hHHHHHHHHHHHHhcccc-ccceeeeeeeeCCceEEEEee
Q 037160          258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN---RIKEICNEMDIMSRAHHK-NLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  333 (569)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++...+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999987  78899988655332   367899999999999988 799999999777778999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~~~~~~~  412 (569)
                      +.++++.+++........+.......++.+++.++.|+|+.+   ++||||||+||+++..+ .++++|||.++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977732211136888999999999999999999999   99999999999999998 79999999998665544


Q ss_pred             CCC----CCcccccCCCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCc-chhhhhHhHhhhhcccch
Q 037160          413 SLL----PNTAIAGTLGYMAPEYIAN---GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD-GFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       413 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  484 (569)
                      ...    ......|+..|++||.+.+   ...+...|+||+|++++++++|..|+...... .........+.....   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            321    2356789999999999987   57889999999999999999999995544321 011111111111100   


Q ss_pred             hhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          485 LEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       485 ~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        ......... .......+..++..|+..+|..|.+..+....
T Consensus       234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              000000000 01223456778889999999999999988764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.3e-22  Score=182.46  Aligned_cols=202  Identities=20%  Similarity=0.285  Sum_probs=169.4

Q ss_pred             HhccccccccccccCceeEEEEEe-cCCceEEEEEEeecchhhHHHHHHHHHHHHhccc-cccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHH-KNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..+.|.+.++||+|+||.+|.|.. .+|++||||+-....+  ...+..|..+.+.|++ ..|..+..+..++....+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            356799999999999999999985 5899999996644322  3467789999999975 67888888888999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC---CCeEEeccCCCccc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLARFS  408 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl~Dfgla~~~  408 (569)
                      +.+ |.+|++++.-  ....++..+.+.++-|++.-++|+|.++   +|||||||+|+|..-+   ..+.++|||+++.+
T Consensus        91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            998 8999998842  3456788899999999999999999999   9999999999999643   45899999999977


Q ss_pred             CCCCCC-----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 037160          409 SSEKSL-----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQ  463 (569)
Q Consensus       409 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~  463 (569)
                      -+..+.     .......||..|.+-..+.+..-+...|+-|+|.+|+.+.-|..||..-
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            654432     1234678999999988888888889999999999999999999998643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3.5e-23  Score=223.76  Aligned_cols=252  Identities=20%  Similarity=0.246  Sum_probs=186.7

Q ss_pred             cccccccccCceeEEEEEec-CCceEEEEEEee---c--c-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          259 DESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFI---S--R-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       259 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~--~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ...+++|.|.+|.|+..... ..+..+.|....   .  . ......+..|+.+-..++|+|++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678999999988777643 344444443321   1  1 112223667777778889999998888877777776679


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++ +|..++.   ....+...++..++.|+.+|+.|||+.+   |.|||||++|+++..+|.+||+|||.+..+.-.
T Consensus       401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999883   3356888899999999999999999999   999999999999999999999999999866554


Q ss_pred             CCC--CCCcccccCCCcccccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          412 KSL--LPNTAIAGTLGYMAPEYIANGQLTE-KVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       412 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ...  .....+.|+..|+|||.+.+..|++ ..||||.|++++.|++|+.||......+...         .........
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------~~~~~~~~~  544 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------KTNNYSDQR  544 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---------hhhcccccc
Confidence            332  3455788999999999999999887 5899999999999999999988765543221         000000000


Q ss_pred             cccCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          489 DKSIEIE--DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       489 ~~~l~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      .......  ......+...++-++|+.+|..|-|+.+|++
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0000001  1233455677888999999999999999994

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=4.6e-22  Score=188.03  Aligned_cols=173  Identities=14%  Similarity=0.118  Sum_probs=135.3

Q ss_pred             HHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhh---HHH------HHHHHHHHHhccccccceeeeeeee
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR---IKE------ICNEMDIMSRAHHKNLVQFLGCCFT  323 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~~~~~~~~  323 (569)
                      ...++|+..++||.|+||.||+... ++..+|||.+.......   ...      +.+|+..+.+++|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4578999999999999999999655 57799999986443222   122      6799999999999999999888653


Q ss_pred             C--------CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC
Q 037160          324 K--------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH  395 (569)
Q Consensus       324 ~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~  395 (569)
                      .        ...+|+|||++|.+|.++..       ++.    ....+++.+|..||+.+   ++||||||+||+++.+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            3        35789999999999987641       222    24568999999999999   99999999999999988


Q ss_pred             CeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh
Q 037160          396 RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS  455 (569)
Q Consensus       396 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt  455 (569)
                       ++|+|||...........              ..++....+..++|+|+||+.+..+..
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence             999999988755332211              113444556789999999999887653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=2e-21  Score=181.53  Aligned_cols=140  Identities=17%  Similarity=0.154  Sum_probs=109.5

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchh--h------------------------HHHHHHHHHHHHhcccccc
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN--R------------------------IKEICNEMDIMSRAHHKNL  314 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  314 (569)
                      ...||+|+||.||+|...+|+.||||++......  .                        .....+|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998654211  0                        0122459999999988876


Q ss_pred             ceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeCCCCCCCeEECC
Q 037160          315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL-HKDGQMQIVHRDIKASNILLDL  393 (569)
Q Consensus       315 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrDikp~NIll~~  393 (569)
                      .......  ....+|||||++++++...+.   ....+++..+..++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            4433222  223489999999987765432   234688899999999999999999 6888   99999999999998 


Q ss_pred             CCCeEEeccCCCcccC
Q 037160          394 KHRPKIADFGLARFSS  409 (569)
Q Consensus       394 ~~~~kl~Dfgla~~~~  409 (569)
                      ++.++|+|||++....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            5889999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=2.3e-22  Score=216.94  Aligned_cols=251  Identities=20%  Similarity=0.221  Sum_probs=184.2

Q ss_pred             cccccccccccCceeEEEEEecCCceEEEEEEeecch-hhHHHHH---HHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK-NRIKEIC---NEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++...+.||++.|=.|.++++++|. |+||++.+... -..+.|.   .|++ ...++|||.+++..+.+.....|||.+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5677788999999999999999886 99999876652 2233343   4444 445699999999998888889999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc--cCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--SSS  410 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~--~~~  410 (569)
                      |..+ +|.|.|   ..+.-+...+...|+.|++.||..+|+.+   |+|||||.+||||++-..+.|+||.--+.  ++.
T Consensus       102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9954 777777   46677888899999999999999999999   99999999999999999999999987653  222


Q ss_pred             CCCCC---CCcccccCCCcccccccccC-----------CCCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhhhhHhH
Q 037160          411 EKSLL---PNTAIAGTLGYMAPEYIANG-----------QLTEKVDIYSFGVLVLEIVSG-VQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       411 ~~~~~---~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~  475 (569)
                      ++...   -......-..|.|||.+...           ..+++.||||+||++.||++- +++|..++      +..  
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a--  246 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA--  246 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh--
Confidence            22110   00122234579999987431           267899999999999999985 66665332      221  


Q ss_pred             hhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          476 WKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ++.-. ....+.+-..+..      ..+..+++.|++.+|+.|.++++.|+.-...
T Consensus       247 Yr~~~-~~~~e~~Le~Ied------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  247 YRSGN-ADDPEQLLEKIED------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             HhccC-ccCHHHHHHhCcC------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            11111 1111222222211      2577889999999999999999999875543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=4.3e-22  Score=184.57  Aligned_cols=246  Identities=19%  Similarity=0.313  Sum_probs=187.5

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCC
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKS  338 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  338 (569)
                      .-+|.+.-.|..|+|+++ |..+++|++....  ....+.|..|.-.|+.+.||||..+++.|....+..++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            446888999999999998 6688888876543  2334678899999999999999999999999999999999999999


Q ss_pred             hhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCc
Q 037160          339 LDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT  418 (569)
Q Consensus       339 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  418 (569)
                      |..+|.. ...-.++..++.+++..+++|++|||+..+ -|.---|....+++|++.+.+|+ .+-.++.-      +..
T Consensus       274 lynvlhe-~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kfsf------qe~  344 (448)
T KOG0195|consen  274 LYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKFSF------QEV  344 (448)
T ss_pred             HHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cccceeee------ecc
Confidence            9999964 344567888999999999999999999873 23344688999999999988764 12222111      222


Q ss_pred             ccccCCCcccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC
Q 037160          419 AIAGTLGYMAPEYIANGQLT---EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE  495 (569)
Q Consensus       419 ~~~gt~~y~aPE~~~~~~~~---~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  495 (569)
                      ...-.+.||+||.+...+.+   ..+|+|||.++||||.|...||..-.+-+..-               .+.-..+...
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglrv~  409 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLRVH  409 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhcccccc
Confidence            33346889999999876544   57999999999999999998886443322110               1111122222


Q ss_pred             -CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          496 -DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       496 -~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                       ++.....+.+++.-|+..||.+||.+..|+-.|+..
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence             455667788889999999999999999999888763

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=2.1e-20  Score=175.28  Aligned_cols=141  Identities=19%  Similarity=0.216  Sum_probs=111.6

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchh--------------------------hHHHHHHHHHHHHhcccccc
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN--------------------------RIKEICNEMDIMSRAHHKNL  314 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  314 (569)
                      .+.||+|++|.||+|...+|+.||||++......                          ....+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999878999999998754210                          01224678999999999987


Q ss_pred             ceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECC
Q 037160          315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDL  393 (569)
Q Consensus       315 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~  393 (569)
                      .....+...  ..++||||++++++.....   ....++......++.+++.+|.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544433332  3589999999886543321   22457788899999999999999999 88   99999999999999 


Q ss_pred             CCCeEEeccCCCcccCC
Q 037160          394 KHRPKIADFGLARFSSS  410 (569)
Q Consensus       394 ~~~~kl~Dfgla~~~~~  410 (569)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            89999999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.8e-19  Score=166.83  Aligned_cols=188  Identities=14%  Similarity=0.089  Sum_probs=140.2

Q ss_pred             cccccccccCceeEEEEEecCCceEEEEEEeecch----hhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEee
Q 037160          259 DESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK----NRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       259 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .+...|++|+||+|+.+.. ++.+++.+.+.....    .....+.+|+++|++|+ |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4566899999999997665 578888777755432    11235889999999995 5889998886    457999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDI-KASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDi-kp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      +.|.+|...+.    .      ....++.+++++|.++|+.+   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99999875431    0      11347789999999999999   999999 7999999999999999999998654432


Q ss_pred             CC---CC--------CcccccCCCcccccccccC-CCC-cccchhhHHHHHHHHHhCCCCCCCCC
Q 037160          413 SL---LP--------NTAIAGTLGYMAPEYIANG-QLT-EKVDIYSFGVLVLEIVSGVQNNKFQS  464 (569)
Q Consensus       413 ~~---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~ksDv~SlGvil~elltg~~p~~~~~  464 (569)
                      ..   ..        ......++.|++|+...-- ..+ ...+.++.|.-+|.++|+..+...+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            10   00        0112357788888754322 333 56788999999999999988755443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=1.5e-19  Score=176.02  Aligned_cols=232  Identities=19%  Similarity=0.230  Sum_probs=148.1

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhcc----------ccccceeeeeee-
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAH----------HKNLVQFLGCCF-  322 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~~~~~~~-  322 (569)
                      ....+.||.|+++.||.+.+. +|+++|||++....   ....+.+++|.-....+.          |-.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999987 58999999886543   334667777765555532          212222222211 


Q ss_pred             --------eCC--------ceEEEEeecCCCChhhHhh---C-CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 037160          323 --------TKK--------DSFVVYEFVQNKSLDRILF---D-PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR  382 (569)
Q Consensus       323 --------~~~--------~~~lv~e~~~~~~L~~~l~---~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHr  382 (569)
                              ...        ..+++|+-+ .++|.+++.   . ......+....++.+..|+++.+++||..+   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                    111        236778877 668877752   1 112234455566778899999999999999   9999


Q ss_pred             CCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCccccccccc--------CCCCcccchhhHHHHHHHHH
Q 037160          383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN--------GQLTEKVDIYSFGVLVLEIV  454 (569)
Q Consensus       383 Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~SlGvil~ell  454 (569)
                      ||||+|++++.+|.++|+||+.....+....     ....+..|.+||....        -.++.+.|.|+||+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999998765544221     1234578999997643        24788999999999999999


Q ss_pred             hCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 037160          455 SGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLR  518 (569)
Q Consensus       455 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~R  518 (569)
                      +|..|+....+......                   ....-. +....+..++..+|+.||++|
T Consensus       245 C~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999887654432111                   111112 333455567779999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=2.5e-20  Score=192.49  Aligned_cols=225  Identities=27%  Similarity=0.302  Sum_probs=171.8

Q ss_pred             cccccCceeEEEEEe----cCCceEEEEEEeecch--hhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEeecC
Q 037160          263 KLGHGGYGEIFKGTL----QDGREIAVKRLFISRK--NRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      .+|+|.||.|++.+.    +.|.-+|+|+++....  ........|..++...+ ||.+|++...+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998653    3467788888765421  11124567888888886 9999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +|.|...+   ......+..........++-++.++|+.+   |+|||+|++||+++.+|.+++.|||+++..-...   
T Consensus        81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---  151 (612)
T KOG0603|consen   81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---  151 (612)
T ss_pred             cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence            99998877   34445566666777888999999999999   9999999999999999999999999998765432   


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE  495 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  495 (569)
                         ..+||..|||||++.  .....+|.||||++++||++|..||..                   ..+..+....+ ..
T Consensus       152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------------~~~~~Il~~~~-~~  206 (612)
T KOG0603|consen  152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------------DTMKRILKAEL-EM  206 (612)
T ss_pred             ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------------HHHHHHhhhcc-CC
Confidence               228999999999998  567899999999999999999888753                   01111111111 12


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCCH
Q 037160          496 DIEEVKRVVWVGLLCTQELPTLRPSM  521 (569)
Q Consensus       496 ~~~~~~~~~~l~~~Cl~~~P~~RPt~  521 (569)
                      +.+.......++...+..+|..|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            33444445556667777777777644

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=6.7e-19  Score=166.11  Aligned_cols=136  Identities=18%  Similarity=0.233  Sum_probs=105.7

Q ss_pred             cccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhc-----cccccceeeeeeeeCC---ceE-E
Q 037160          259 DESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-----HHKNLVQFLGCCFTKK---DSF-V  329 (569)
Q Consensus       259 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-l  329 (569)
                      .....||+|+||.||.  ++.....+||++........+.+.+|+.+++.+     .||||++++++++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3456899999999996  443333479988765444567899999999999     5799999999998874   323 7


Q ss_pred             EEee--cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeeCCCCCCCeEECC----CCCeEEecc
Q 037160          330 VYEF--VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL-EYLHKDGQMQIVHRDIKASNILLDL----KHRPKIADF  402 (569)
Q Consensus       330 v~e~--~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivHrDikp~NIll~~----~~~~kl~Df  402 (569)
                      |+||  +.+++|.+++.+    ..+++.  ..++.+++.++ .|||+++   |+||||||+|||++.    ++.++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  557999999943    234444  35677888777 9999999   999999999999974    347999995


Q ss_pred             CCC
Q 037160          403 GLA  405 (569)
Q Consensus       403 gla  405 (569)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=1e-19  Score=200.60  Aligned_cols=200  Identities=21%  Similarity=0.205  Sum_probs=160.1

Q ss_pred             HHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc---ccccceeeeeeeeCCce
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH---HKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~  327 (569)
                      .+...+.|.+.+.||+|+||.||+|...+|+.||+|+-.......   |---.+++.+|+   -+-|..+...+.-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            445667899999999999999999998889999999766554321   111123333343   24456666666778889


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-------CCCeEEe
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-------KHRPKIA  400 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-------~~~~kl~  400 (569)
                      +||+||.+.|+|-+++.   ..+.++|.....++.|+++.+.+||..+   |||+||||+|.||..       ..-++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999994   6778999999999999999999999999   999999999999942       3358999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQN  459 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p  459 (569)
                      |||.+--+.--......+..++|-.+-.+|+..+..++.+.|.|.|..+++-||.|+.-
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99988533222222244577889999999999999999999999999999999999653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=2.9e-19  Score=184.85  Aligned_cols=216  Identities=27%  Similarity=0.402  Sum_probs=162.2

Q ss_pred             HHhccccccceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe-eeCCC
Q 037160          306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI-VHRDI  384 (569)
Q Consensus       306 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vHrDi  384 (569)
                      |+.+.|.|+.+++|.+..+...++|.+|+..|+|.+.+..  ....++|.....++..|+.||.|||...   | .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence            4568999999999999999999999999999999999954  4567899999999999999999999875   4 99999


Q ss_pred             CCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccC-------CCCcccchhhHHHHHHHHHhCC
Q 037160          385 KASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-------QLTEKVDIYSFGVLVLEIVSGV  457 (569)
Q Consensus       385 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDv~SlGvil~elltg~  457 (569)
                      ++.|.+++....+||+|||+.................-...|.|||.++..       ..+.+.||||||++++|+++-+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998876531111122223345679999998763       1467899999999999999999


Q ss_pred             CCCCCCCCcch-hhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          458 QNNKFQSDDGF-ETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       458 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      .||........ ..++....+     .....+.+.+.... +....++.++..||..+|++||++.+|-..++...
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            99876433221 122222111     00011111111111 22236888999999999999999999998876544

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=4.1e-20  Score=187.40  Aligned_cols=242  Identities=23%  Similarity=0.295  Sum_probs=161.0

Q ss_pred             ccccccccCceeEEEEEecCC----ceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceee------eeee-----e
Q 037160          260 ESNKLGHGGYGEIFKGTLQDG----REIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFL------GCCF-----T  323 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~------~~~~-----~  323 (569)
                      +.+..+..+++.++..+...+    +.++.|.....+........+++-.+.... |+..+..-      ..+.     .
T Consensus       248 ~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~  327 (516)
T KOG1033|consen  248 ISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGK  327 (516)
T ss_pred             ccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccc
Confidence            344556666666665553322    334444444333233344445555554443 44333221      1111     1


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                      ....+|.|++|...+|.++|.........++...+.++.|++.++.|   ++   .+|||+||.||++..+..+||.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence            23578999999999999999766667778899999999999999999   66   9999999999999999999999999


Q ss_pred             CCcccCCCC----CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhh
Q 037160          404 LARFSSSEK----SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       404 la~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      +........    .....+...||..||+||++.+..|+.|+|||+||+||+||+.-..     .            ...
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~-----T------------~~e  464 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFS-----T------------QFE  464 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhc-----c------------HHH
Confidence            987665544    1113457789999999999999999999999999999999997311     0            001


Q ss_pred             cccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 037160          480 QAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNV  524 (569)
Q Consensus       480 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev  524 (569)
                      ....+.++-+..+......+.+.=..+..+++.+.|.+||++.++
T Consensus       465 r~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  465 RIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             HHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence            112222222333322222222233456678999999999954443

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=5.8e-18  Score=163.68  Aligned_cols=145  Identities=17%  Similarity=0.165  Sum_probs=112.2

Q ss_pred             hccccccccccccCceeEEEEE--ecCCceEEEEEEeecchh------------------------hHHHHHHHHHHHHh
Q 037160          255 TDCFDESNKLGHGGYGEIFKGT--LQDGREIAVKRLFISRKN------------------------RIKEICNEMDIMSR  308 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  308 (569)
                      ..-|++.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+.+|+.++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3357888999999999999998  458999999988653210                        11235689999999


Q ss_pred             ccccc--cceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 037160          309 AHHKN--LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKA  386 (569)
Q Consensus       309 l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp  386 (569)
                      +.+..  +.++++.    ...++||||+++.+|.....   ....+.......++.|++.+|.+||+.+  .|+||||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp  177 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE  177 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence            97633  3344432    24589999999988876542   2234556667889999999999999986  499999999


Q ss_pred             CCeEECCCCCeEEeccCCCcccC
Q 037160          387 SNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       387 ~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      +||+++ +++++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.6e-17  Score=158.52  Aligned_cols=134  Identities=24%  Similarity=0.346  Sum_probs=112.9

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecch--------hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRK--------NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++||+|++|.||+|.+ .|..+++|+......        .....+.+|+.++..++|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 578899997653221        1124578899999999999988777777777888999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++|++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988421      12 77889999999999999998   99999999999999 88999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=2.3e-17  Score=155.83  Aligned_cols=144  Identities=19%  Similarity=0.222  Sum_probs=112.4

Q ss_pred             HHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchh----------------------hHHHHHHHHHHHHh
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN----------------------RIKEICNEMDIMSR  308 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~  308 (569)
                      +......|.+.++||+|+||.||++..++|+.||||++......                      .......|..++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33334458888999999999999999888999999987543210                      11236788999999


Q ss_pred             ccccc--cceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 037160          309 AHHKN--LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKA  386 (569)
Q Consensus       309 l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp  386 (569)
                      +.|++  +.+.++    ....++||||+++++|.++..         ......++.+++.++.++|+.+   |+||||||
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            98874  444443    245689999999999976541         0234568899999999999998   99999999


Q ss_pred             CCeEECCCCCeEEeccCCCcccCC
Q 037160          387 SNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       387 ~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      +||++++++.++|+|||++.....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999865544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.73  E-value=3.7e-18  Score=143.38  Aligned_cols=89  Identities=30%  Similarity=0.647  Sum_probs=72.3

Q ss_pred             hHHHHHHHHHHHHHHHhhhCCCC--CcceeecccccccceeeeeccccCCCHHhHHHHHHHHHHhhhhhcC-CcccEEEe
Q 037160          129 QQDLFRRVVEEVVNKVSKNAPNE--NGFATHKYTLADVSAYAMASCLKTLNHQMCSQCLTKAASTALTCIP-AIEGRVLF  205 (569)
Q Consensus       129 ~~~~f~~~~~~l~~~l~~~a~~~--~~fa~~~~~~~~~~~y~laQC~~dl~~~~C~~Cl~~~~~~~~~~~~-~~~g~vl~  205 (569)
                      +...|..++..||..|+..|+..  .+|+++..+.+..++|||+||++||++.+|..||..++..++.+|+ ..+|+|++
T Consensus        15 ~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~   94 (106)
T PF01657_consen   15 DNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWY   94 (106)
T ss_dssp             TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEE
T ss_pred             CCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEEC
Confidence            34459999999999999887753  6899998765778999999999999999999999999999999887 88899999


Q ss_pred             cccceeeccccc
Q 037160          206 AGCFLRYSRYEF  217 (569)
Q Consensus       206 ~~C~lr~~~~~F  217 (569)
                      .+|+|||+.++|
T Consensus        95 ~~C~lRY~~~~F  106 (106)
T PF01657_consen   95 DSCFLRYENYPF  106 (106)
T ss_dssp             SSEEEEEESS--
T ss_pred             CCEEEEEECCCC
Confidence            999999999887

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=4e-17  Score=154.36  Aligned_cols=130  Identities=23%  Similarity=0.393  Sum_probs=106.7

Q ss_pred             cccccCceeEEEEEecCCceEEEEEEeecc--------hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          263 KLGHGGYGEIFKGTLQDGREIAVKRLFISR--------KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .||+|+||.||+|.+ +|..+++|+.....        ......+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999996 47899999865321        112356789999999999887665555556677789999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      +|++|.+++....   .       .++.+++.+|.+||+.+   ++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH---H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998873211   0       68999999999999998   99999999999999 89999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=3.5e-17  Score=177.79  Aligned_cols=139  Identities=24%  Similarity=0.360  Sum_probs=113.4

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeec--c------hhhHHHHHHHHHHHHhccccccceeeeeeeeCC
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--R------KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  325 (569)
                      ....|...++||+|+||.||++.+.+ ..+++|+....  .      ....+.+.+|++++++++|++++....+.....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            34455678899999999999998764 34555543221  1      112356889999999999999998877777777


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++||||+++++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ +++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            8899999999999999883           35678999999999999998   9999999999999 6889999999998


Q ss_pred             ccc
Q 037160          406 RFS  408 (569)
Q Consensus       406 ~~~  408 (569)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            753

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.9e-16  Score=154.61  Aligned_cols=197  Identities=22%  Similarity=0.279  Sum_probs=133.3

Q ss_pred             cccccceeeeeeee---------------------------CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHH
Q 037160          310 HHKNLVQFLGCCFT---------------------------KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII  362 (569)
Q Consensus       310 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~  362 (569)
                      +|||||+++++|.+                           ....|+||... ..+|..++.    ....+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~----~~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW----TRHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh----cCCCchHHHHHHHH
Confidence            59999999988753                           23458888876 457877773    23445566777999


Q ss_pred             HHHHHHHHHhhcCCCCeeeCCCCCCCeEEC--CCC--CeEEeccCCCcccCCCCCC----CCCcccccCCCccccccccc
Q 037160          363 GTAEGLEYLHKDGQMQIVHRDIKASNILLD--LKH--RPKIADFGLARFSSSEKSL----LPNTAIAGTLGYMAPEYIAN  434 (569)
Q Consensus       363 ~i~~~L~~LH~~~~~~ivHrDikp~NIll~--~~~--~~kl~Dfgla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~  434 (569)
                      |+++|+.|||+++   |.|||+|.+||||.  +++  .+.|+|||.+---....-.    .......|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   99999999999993  333  4789999987432221111    11224567888999998754


Q ss_pred             C--C----CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHH
Q 037160          435 G--Q----LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGL  508 (569)
Q Consensus       435 ~--~----~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~  508 (569)
                      .  +    --.|+|.|+.|.+.||+++...||....+...+           .....+---+.+   +......+.+++.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-----------~r~Yqe~qLPal---p~~vpp~~rqlV~  491 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-----------TRTYQESQLPAL---PSRVPPVARQLVF  491 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-----------hhhhhhhhCCCC---cccCChHHHHHHH
Confidence            3  2    225899999999999999998888753222111           011111001111   2222334566777


Q ss_pred             HhcCCCCCCCCCHHHHHHHh
Q 037160          509 LCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       509 ~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ..|+.||++||+..-....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            88899999999876655544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=6.2e-17  Score=175.42  Aligned_cols=216  Identities=21%  Similarity=0.282  Sum_probs=142.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ...+|+.++.|-.|++|.||..+++ ..+.+|+| +....     .+.+-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-----------------
Confidence            3467888999999999999999987 45677774 32211     11110  22223334333                 


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                          |+=.+.+.   .-+.++...        +.+++|||+.+   |+|||+||+|++|+.-|.+|++|||+++.-....
T Consensus       136 ----gDc~tllk---~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLLK---NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhcc---cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                33333331   222333222        67899999999   9999999999999999999999999987422211


Q ss_pred             C-------------CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhh
Q 037160          413 S-------------LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       413 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      .             ....+..+||+.|.|||++....|...+|.|++|+|+||.+-|+.||..+.++.....+....-.|
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence            1             112345689999999999999999999999999999999999999988776654322211111111


Q ss_pred             cccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 037160          480 QAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVV  525 (569)
Q Consensus       480 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl  525 (569)
                      .++             ......+...++...|+.+|.+|--...-+
T Consensus       278 pE~-------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  278 PEE-------------DEALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             ccc-------------CcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence            111             111223344455677888998885433333

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.65  E-value=1.2e-15  Score=142.69  Aligned_cols=137  Identities=22%  Similarity=0.267  Sum_probs=98.6

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchh--hHHH----------------------HHHHHHHHHhccccc--c
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN--RIKE----------------------ICNEMDIMSRAHHKN--L  314 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i  314 (569)
                      .+.||+|+||.||+|...++++||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999988653211  1111                      135666666664433  3


Q ss_pred             ceeeeeeeeCCceEEEEeecCCCChhhH-hhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEEC
Q 037160          315 VQFLGCCFTKKDSFVVYEFVQNKSLDRI-LFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLD  392 (569)
Q Consensus       315 v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~  392 (569)
                      .+.++.    ...++||||++++.+... +....    .. .....++.+++.++.++|. .+   |+||||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            444433    246899999999544221 11100    11 5677899999999999999 87   99999999999999


Q ss_pred             CCCCeEEeccCCCcccCC
Q 037160          393 LKHRPKIADFGLARFSSS  410 (569)
Q Consensus       393 ~~~~~kl~Dfgla~~~~~  410 (569)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             99999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=2.4e-15  Score=134.84  Aligned_cols=135  Identities=20%  Similarity=0.212  Sum_probs=114.0

Q ss_pred             ccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccc--cccceeeeeeeeCCceEEEEeecCCC
Q 037160          260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHH--KNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  .++++++......+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45679999999999999864 7899998755433  4578899999999977  58899998888888899999999988


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      .+..+          +......++.+++++|.+||......++|+||+|+||+++..+.+++.|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          4566677899999999999986444599999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=7.1e-15  Score=142.41  Aligned_cols=134  Identities=16%  Similarity=0.231  Sum_probs=104.3

Q ss_pred             cccc-ccCceeEEEEEecCCceEEEEEEeecc-------------hhhHHHHHHHHHHHHhcccccc--ceeeeeeeeCC
Q 037160          262 NKLG-HGGYGEIFKGTLQDGREIAVKRLFISR-------------KNRIKEICNEMDIMSRAHHKNL--VQFLGCCFTKK  325 (569)
Q Consensus       262 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~  325 (569)
                      ..|| .||.|+||+.... +..++||++....             ......+.+|++++.+|+|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 8999999998875 6789999885321             1223567889999999998875  66776654332


Q ss_pred             c----eEEEEeecCC-CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          326 D----SFVVYEFVQN-KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       326 ~----~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                      .    .++|||+++| .+|.+++..    ..++..    .+.+|+.+|.+||+.+   |+||||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    3599999997 699888732    234433    3578999999999999   9999999999999999999999


Q ss_pred             ccCCCcc
Q 037160          401 DFGLARF  407 (569)
Q Consensus       401 Dfgla~~  407 (569)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=8.4e-17  Score=174.36  Aligned_cols=254  Identities=22%  Similarity=0.268  Sum_probs=186.6

Q ss_pred             ccccccccccccCceeEEEEEecC--CceEEEEEEeecc--hhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQD--GREIAVKRLFISR--KNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  330 (569)
                      ..|.+.+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            346667779999999998887643  3455666554432  333445556777777776 99999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCccc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH-KDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFS  408 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~~~  408 (569)
                      +++..++++.+.+.. ......+....-..+.|+..++.|+| ..+   +.||||||+|.+++..+ .+++.|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999888742 11224555667779999999999999 887   99999999999999999 9999999999987


Q ss_pred             CC-CCCCCCCccccc-CCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch-
Q 037160          409 SS-EKSLLPNTAIAG-TLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV-  484 (569)
Q Consensus       409 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  484 (569)
                      .. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.........      +..|..... 
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------~~~~~~~~~~  249 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------YSSWKSNKGR  249 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------ceeecccccc
Confidence            76 443334445677 9999999998874 5678899999999999999999998765544311      111111110 


Q ss_pred             -hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          485 -LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       485 -~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                       ....-       .........+...++..+|..|.+.+++-.
T Consensus       250 ~~~~~~-------~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 FTQLPW-------NSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccCcc-------ccCChhhhhcccccccCCchhccccccccc
Confidence             00000       111123444556777789999999988763

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=9.1e-14  Score=146.26  Aligned_cols=146  Identities=21%  Similarity=0.276  Sum_probs=102.1

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhH---------------------------------------
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRI---------------------------------------  296 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------  296 (569)
                      ..|+ .+.||+|++|.||+|++++|+.||||+....-....                                       
T Consensus       118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3344 368999999999999999999999998854321110                                       


Q ss_pred             -HHHHHHHHHHHhcc----ccccceeeeeee-eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHH-HHH
Q 037160          297 -KEICNEMDIMSRAH----HKNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE-GLE  369 (569)
Q Consensus       297 -~~~~~E~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~  369 (569)
                       -.|.+|+..+.+++    |.+-+.+-..+. .....+|||||++|++|.++.....  ...   ....++..+++ .+.
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~  271 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLN  271 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHH
Confidence             02445565555552    333333333332 2445799999999999988763211  112   23446666665 467


Q ss_pred             HHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       370 ~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      .+|..+   ++|+|+||.||+++.+++++++|||++..+..
T Consensus       272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            889988   99999999999999999999999999876654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=6e-13  Score=141.68  Aligned_cols=149  Identities=21%  Similarity=0.255  Sum_probs=96.8

Q ss_pred             HHHhccccccccccccCceeEEEEEecC-CceEEEEEEeecchh----------------------------------hH
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKN----------------------------------RI  296 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~  296 (569)
                      +..-..|+. +.||+|++|.||+|++++ |++||||++...-..                                  ..
T Consensus       116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~  194 (537)
T PRK04750        116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE  194 (537)
T ss_pred             HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence            344556776 789999999999999987 999999998643111                                  01


Q ss_pred             HH------HHHHHHHHHhcc----ccccceeeeeeee-CCceEEEEeecCCCChhhHhhCCCC---CccCCHHHHHHHHH
Q 037160          297 KE------ICNEMDIMSRAH----HKNLVQFLGCCFT-KKDSFVVYEFVQNKSLDRILFDPKQ---KKELDWKKRHVIII  362 (569)
Q Consensus       297 ~~------~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~---~~~l~~~~~~~i~~  362 (569)
                      +.      +.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++-.-...   ...+....+..++.
T Consensus       195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            12      334444444442    3334444444432 4567899999999999875311011   11122222222333


Q ss_pred             HHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC----CeEEeccCCCcccCCC
Q 037160          363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH----RPKIADFGLARFSSSE  411 (569)
Q Consensus       363 ~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~----~~kl~Dfgla~~~~~~  411 (569)
                      |       ++..|   ++|+|+||.||+++.++    .+++.|||++..++..
T Consensus       275 Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        275 Q-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             H-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            3       44566   99999999999999888    9999999999876553

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=3.2e-12  Score=117.35  Aligned_cols=129  Identities=17%  Similarity=0.147  Sum_probs=96.9

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccce-eeeeeeeCCceEEEEeecCCCChh
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ-FLGCCFTKKDSFVVYEFVQNKSLD  340 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~~~L~  340 (569)
                      +.|+.|.++.||++... ++.+++|....... ....+.+|+.+++.+.+.++++ ++...  ....++||||++|.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            56899999999999876 77899997654432 1234678999999997666553 44433  33468999999998886


Q ss_pred             hHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          341 RILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG--QMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       341 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ...        .   ....+..+++++|..||..+  +..++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            431        1   11235678999999999987  23359999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=1.5e-12  Score=135.20  Aligned_cols=251  Identities=22%  Similarity=0.212  Sum_probs=179.4

Q ss_pred             Hhccccccccccc--cCceeEEEEEe--c-CCceEEEEEEeec--chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCC
Q 037160          254 ATDCFDESNKLGH--GGYGEIFKGTL--Q-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKK  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  325 (569)
                      ....|.+...+|.  |.+|.||.+..  . ++..+|+|+-...  .......-.+|+.-.+++ .|+|.++....+++.+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3445677788999  99999999986  3 6888999974332  222223334666666666 5999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeeCCCCCCCeEECCC-CCeEEe
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE----GLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIA  400 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~kl~  400 (569)
                      ..++-+|++. .+|..+..  .....++....+..+.....    ||.++|+.+   ++|-|+||.||++..+ ...+++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cceeeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence            9999999984 77777663  22334666777778888888    999999998   9999999999999999 889999


Q ss_pred             ccCCCcccCCCCCCCCC---cccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          401 DFGLARFSSSEKSLLPN---TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      |||+...+.........   ....|...|++||.++ +-++...|+|++|.++++-.++..........        .|.
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~  336 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWS  336 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------Ccc
Confidence            99999887776532111   1235777899999864 57788999999999999999986654332111        122


Q ss_pred             hhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          478 HFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      ......+...+..       .-...+.....++++.+|..|++...+..
T Consensus       337 ~~r~~~ip~e~~~-------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  337 QLRQGYIPLEFCE-------GGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccccCchhhhc-------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            2222111111110       01122333778899999999999888763

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=3.9e-12  Score=122.05  Aligned_cols=207  Identities=21%  Similarity=0.213  Sum_probs=138.1

Q ss_pred             HHHHHhccccccceeeeeeeeC-----CceEEEEeecCCCChhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 037160          303 MDIMSRAHHKNLVQFLGCCFTK-----KDSFVVYEFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDGQ  376 (569)
Q Consensus       303 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  376 (569)
                      ..-|-++-|.|||++..++.+.     ....++.|||.-|++..+|++.+ ....+......+|+-||..||.|||+-. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            3445566799999999888643     45789999999999999996433 3445777777889999999999999976 


Q ss_pred             CCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC--CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHH
Q 037160          377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIV  454 (569)
Q Consensus       377 ~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ell  454 (569)
                      ++|+|+++.-+-|++..+|-+||.--.-......-....  ......+-++|.+||+=...+.+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            689999999999999999988874322111111100000  111234678999999866667888999999999999998


Q ss_pred             hCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          455 SGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       455 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      -+..-..-.....           ..+......+.. +..      ..-...+..|++..|..||+|++++.+.
T Consensus       277 ilEiq~tnseS~~-----------~~ee~ia~~i~~-len------~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESKV-----------EVEENIANVIIG-LEN------GLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCccee-----------ehhhhhhhheee-ccC------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence            8743211110000           000001111100 000      0111245689999999999999988543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.32  E-value=2.3e-11  Score=127.63  Aligned_cols=166  Identities=18%  Similarity=0.275  Sum_probs=128.2

Q ss_pred             ecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHH
Q 037160          277 LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK  356 (569)
Q Consensus       277 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~  356 (569)
                      ..++.+|.|...............+-++.|+.++||||++++..+++++..|||+|.+.  .|...+..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34788999998877666555678888999999999999999999999999999999873  56666632      33566


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCC
Q 037160          357 RHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ  436 (569)
Q Consensus       357 ~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  436 (569)
                      ....+.||+.||.+||+.+  .++|++|.-..|+|+..|..||++|.++........  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6778999999999999766  499999999999999999999999998764433221  111222223466666543222


Q ss_pred             CCcccchhhHHHHHHHHHhC
Q 037160          437 LTEKVDIYSFGVLVLEIVSG  456 (569)
Q Consensus       437 ~~~ksDv~SlGvil~elltg  456 (569)
                        ...|.|-||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              456999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.31  E-value=5.1e-11  Score=110.56  Aligned_cols=138  Identities=16%  Similarity=0.149  Sum_probs=99.8

Q ss_pred             cccccccCceeEEEEEecC-------CceEEEEEEeecc----------------------hhhHHHHH----HHHHHHH
Q 037160          261 SNKLGHGGYGEIFKGTLQD-------GREIAVKRLFISR----------------------KNRIKEIC----NEMDIMS  307 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~  307 (569)
                      ...||.|--+.||.|...+       +..+|||+.....                      ....+.+.    +|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998553       4799999774221                      01122233    8999999


Q ss_pred             hccc--cccceeeeeeeeCCceEEEEeecCCCChhh-HhhCCCCCccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeCC
Q 037160          308 RAHH--KNLVQFLGCCFTKKDSFVVYEFVQNKSLDR-ILFDPKQKKELDWKKRHVIIIGTAEGLEYL-HKDGQMQIVHRD  383 (569)
Q Consensus       308 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrD  383 (569)
                      ++..  -++.+++.+    ...+|||||+.+..+.. .+.    ...++......+..+++.+|..| |+.+   |||+|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            9854  355566654    56799999997754422 221    12344456667889999999998 8888   99999


Q ss_pred             CCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          384 IKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       384 ikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |++.|||++ ++.++|+|||.+....+
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            999999997 57899999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=5e-12  Score=131.41  Aligned_cols=247  Identities=18%  Similarity=0.122  Sum_probs=176.2

Q ss_pred             HhccccccccccccCceeEEEEEec--CCceEEEEEEeecchhhHH--HHHHHHHHHHhc-cccccceeeeeeeeCCceE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ--DGREIAVKRLFISRKNRIK--EICNEMDIMSRA-HHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  328 (569)
                      ...+|..+..||.|.|+.|++...+  ++..+++|.+.........  .-..|+.+...+ .|.+++++...|......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4567888999999999999998754  6788999987654332222  233566666666 5899999998998888889


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-CCeEEeccCCCcc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLARF  407 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~kl~Dfgla~~  407 (569)
                      +--||++++++...+   .....++...++++..|++.++.++|++.   ++|+|+||+||++..+ +.-++.|||....
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            999999999987766   44566788889999999999999999988   9999999999999886 7889999998864


Q ss_pred             cCCCCCCCCCcccccCCCcc--cccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          408 SSSEKSLLPNTAIAGTLGYM--APEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      +.-..     ....+.-+++  +|+......+-.+.|+||||.-+.|.+++..-....                  ..+.
T Consensus       417 ~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------------------~~~~  473 (524)
T KOG0601|consen  417 LAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG------------------VQSL  473 (524)
T ss_pred             cceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc------------------ccce
Confidence            32211     1222334455  444445567888999999999999999985421100                  0001


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          486 EIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       486 ~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .+.. ......+.....+..+...+...++..||.+.++..+.+.
T Consensus       474 ~i~~-~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  474 TIRS-GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             eeec-ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            1111 1111112222445556667778889999998887765543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1.7e-10  Score=103.36  Aligned_cols=132  Identities=26%  Similarity=0.357  Sum_probs=101.5

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecc--------hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISR--------KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ..+++|+-+.++.+.+. |.++++|.-....        +-....-.+|+.++.+++--.|.-.+-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 4557777432211        12234577899999998766655555556677788999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      ++|..|.+.+...          ...++..+-+-+.-||..+   |+|+||.++||++..+. +.++||||+...
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999988432          2457778888899999999   99999999999998554 999999998744

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.18  E-value=2.3e-10  Score=109.82  Aligned_cols=142  Identities=21%  Similarity=0.288  Sum_probs=109.4

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecch-hhHHHHHHHHHHHHhcccc--ccceeeeeeeeC---CceEEEEeecC
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHK--NLVQFLGCCFTK---KDSFVVYEFVQ  335 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~  335 (569)
                      +.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+++.  ++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887778999998754332 1345788999999999763  456677776553   25689999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG----------------------------------------  375 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  375 (569)
                      |.++.+.+..    ..++......++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988775521    34667777788888888888888531                                        


Q ss_pred             -------------CCCeeeCCCCCCCeEECC--CCCeEEeccCCCcc
Q 037160          376 -------------QMQIVHRDIKASNILLDL--KHRPKIADFGLARF  407 (569)
Q Consensus       376 -------------~~~ivHrDikp~NIll~~--~~~~kl~Dfgla~~  407 (569)
                                   +..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  56689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.16  E-value=6.5e-10  Score=99.09  Aligned_cols=144  Identities=19%  Similarity=0.308  Sum_probs=106.9

Q ss_pred             ccccccccCceeEEEEEecCCceEEEEEEeecc--------hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--------KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ....|-+|+-+.|+++.+. |+...||.-....        +-..++.++|+++|.+++--.|.-..-++.+.....|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5667889999999999987 7777787443221        122456789999999987655554444556667778999


Q ss_pred             eecCC-CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC---eEEeccCCCcc
Q 037160          332 EFVQN-KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR---PKIADFGLARF  407 (569)
Q Consensus       332 e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---~kl~Dfgla~~  407 (569)
                      ||++| .++.+++........ .......++..|-+.+.-||..+   |||+||..+||+|..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 577888754333222 22233678888999999999999   999999999999977664   58999999864


Q ss_pred             c
Q 037160          408 S  408 (569)
Q Consensus       408 ~  408 (569)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.00  E-value=3.7e-09  Score=97.81  Aligned_cols=126  Identities=27%  Similarity=0.305  Sum_probs=83.6

Q ss_pred             eEEEEEecCCceEEEEEEeecch--------------------------hhHHHHHHHHHHHHhcccc--ccceeeeeee
Q 037160          271 EIFKGTLQDGREIAVKRLFISRK--------------------------NRIKEICNEMDIMSRAHHK--NLVQFLGCCF  322 (569)
Q Consensus       271 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~  322 (569)
                      .||.|...+|.++|||.......                          .......+|.+.|.++..-  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999988899999997743210                          0123467899999999765  45555544  


Q ss_pred             eCCceEEEEeecC--CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHH-HhhcCCCCeeeCCCCCCCeEECCCCCeEE
Q 037160          323 TKKDSFVVYEFVQ--NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY-LHKDGQMQIVHRDIKASNILLDLKHRPKI  399 (569)
Q Consensus       323 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivHrDikp~NIll~~~~~~kl  399 (569)
                        ....|||||++  |..+..+...     .++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              25689999998  6666554421     11134455677788875555 57888   9999999999999977 9999


Q ss_pred             eccCCCcccC
Q 037160          400 ADFGLARFSS  409 (569)
Q Consensus       400 ~Dfgla~~~~  409 (569)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.99  E-value=8.7e-09  Score=105.26  Aligned_cols=169  Identities=21%  Similarity=0.330  Sum_probs=128.8

Q ss_pred             ceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee----CCceEEEEeecCC-CChhhH
Q 037160          269 YGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT----KKDSFVVYEFVQN-KSLDRI  342 (569)
Q Consensus       269 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-~~L~~~  342 (569)
                      -.+.||+... +|..|++|++...+.........-++.++++.|+|+|++.+++..    +..+++||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3577999865 899999999954433322233456889999999999999988873    3457899999886 577766


Q ss_pred             hhCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          343 LFDPK------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       343 l~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      -+...            .....++..+|.++.|+..||.++|+.|   +..+-|.|.+||++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            54322            2334677889999999999999999999   99999999999999999999999988766544


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQN  459 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p  459 (569)
                      +..                |-+.+   ..+-|.=-||.+++.|.+|...
T Consensus       446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            321                11111   1356888899999999999654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.94  E-value=2.9e-10  Score=124.39  Aligned_cols=207  Identities=20%  Similarity=0.284  Sum_probs=148.2

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .-+.|.+.+.+-+|.++.++.+.-. .|...+.|.....   ...+.+....+-.++-..++|-+++...-+......+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3466777888899999999887754 3433344433221   12223334444444444456777766555666778899


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      +++|..+++|...+...   ...+.......+..+...+++||...   +.|||++|.|++...++..++.|||......
T Consensus       882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            99999999999888443   24555556667777888999999987   8999999999999999999999998432111


Q ss_pred             CC---------------------CC---C-----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 037160          410 SE---------------------KS---L-----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNN  460 (569)
Q Consensus       410 ~~---------------------~~---~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~  460 (569)
                      .-                     ..   .     .......||+.|.+||.+.+......+|.|++|++++|.++|.+|+
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            00                     00   0     0122456899999999999999999999999999999999999998


Q ss_pred             CCCCCc
Q 037160          461 KFQSDD  466 (569)
Q Consensus       461 ~~~~~~  466 (569)
                      ....+.
T Consensus      1036 na~tpq 1041 (1205)
T KOG0606|consen 1036 NAETPQ 1041 (1205)
T ss_pred             CCcchh
Confidence            765544

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.94  E-value=1.5e-08  Score=99.33  Aligned_cols=133  Identities=20%  Similarity=0.202  Sum_probs=96.0

Q ss_pred             eeEEEEEecCCceEEEEEEeecchh-hHH----------HHHHHHHHHHhcccccc--ceeeeeeee-----CCceEEEE
Q 037160          270 GEIFKGTLQDGREIAVKRLFISRKN-RIK----------EICNEMDIMSRAHHKNL--VQFLGCCFT-----KKDSFVVY  331 (569)
Q Consensus       270 g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~ni--v~~~~~~~~-----~~~~~lv~  331 (569)
                      ..|.+..+ +|+.+.||+....... ..+          .+.+|...+.++...+|  .+++.+.+.     ....+||+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            33556555 4788999977433211 112          37789999988854443  344555543     23578999


Q ss_pred             eecCCC-ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-------CCCeEEeccC
Q 037160          332 EFVQNK-SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-------KHRPKIADFG  403 (569)
Q Consensus       332 e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-------~~~~kl~Dfg  403 (569)
                      |++++. +|.+++.... ....+......++.+++..+..||..|   |+|+|++++|||++.       +..+.|+||+
T Consensus       115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999986 8998874321 234456677789999999999999999   999999999999975       4679999999


Q ss_pred             CCcc
Q 037160          404 LARF  407 (569)
Q Consensus       404 la~~  407 (569)
                      .+..
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.81  E-value=1.2e-07  Score=94.74  Aligned_cols=257  Identities=16%  Similarity=0.137  Sum_probs=155.3

Q ss_pred             ccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccce--------eeeeeeeCCceEEE
Q 037160          260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQ--------FLGCCFTKKDSFVV  330 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------~~~~~~~~~~~~lv  330 (569)
                      ..+.||+|+-+.+|-.--  -...+.|++.........+.   +..|... .||-+-.        ++|-- ......+.
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEe
Confidence            356799999999986431  12346677765544332222   2233333 4554332        11111 11226678


Q ss_pred             EeecCCCC-hhhHhh---CCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          331 YEFVQNKS-LDRILF---DPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       331 ~e~~~~~~-L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      |+.+.+.- +..++.   ........+|...++....++.+.+.||+.|   .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            88887752 233331   1223345789999999999999999999999   9999999999999999999999855433


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCCCC-----cchhhhhHhH
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSG-VQNNKFQSD-----DGFETLVTHT  475 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg-~~p~~~~~~-----~~~~~~~~~~  475 (569)
                      ....+.   .....+|...|.+||.-.     +-.-+..+|.|.|||++++++.| ++|+.....     ...+.-+.  
T Consensus       166 i~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia--  240 (637)
T COG4248         166 INANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA--  240 (637)
T ss_pred             eccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh--
Confidence            222111   223456888999999754     33567789999999999999987 788764322     11111110  


Q ss_pred             hhhhcccchhhhhcc--cCCC----CCHH-HHHHHHHHHHHhcCC--CCCCCCCHHHHHHHhccCCCCC
Q 037160          476 WKHFQAKTVLEIIDK--SIEI----EDIE-EVKRVVWVGLLCTQE--LPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~--~l~~----~~~~-~~~~~~~l~~~Cl~~--~P~~RPt~~evl~~L~~~~~~~  535 (569)
                           .+....--+.  .+..    .+.+ ....+..+..+|+..  ++.-|||.+-.+..|......+
T Consensus       241 -----~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         241 -----HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             -----cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence                 1111111111  1110    0111 123344455677754  4779999999998776544433

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.80  E-value=6.5e-08  Score=92.07  Aligned_cols=138  Identities=22%  Similarity=0.247  Sum_probs=98.0

Q ss_pred             ccccccccccCceeEEEEEecCCceEEEEEEeecch----------------------hhHHHHHHHHHHHHhcccc--c
Q 037160          258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK----------------------NRIKEICNEMDIMSRAHHK--N  313 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n  313 (569)
                      ..+..+||-|--+.||.|....|.++|||.=.....                      -......+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345678999999999999999999999994321110                      0122356889999988654  5


Q ss_pred             cceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC
Q 037160          314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL  393 (569)
Q Consensus       314 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~  393 (569)
                      +.+.++    .+...+|||+++|..|...-        ++....-.++..|++-+..+-..|   |||+|+++-||++++
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            555554    35668999999997775532        122233334444555555555666   999999999999999


Q ss_pred             CCCeEEeccCCCcccCC
Q 037160          394 KHRPKIADFGLARFSSS  410 (569)
Q Consensus       394 ~~~~kl~Dfgla~~~~~  410 (569)
                      +|.+.++||-.+...+.
T Consensus       238 dg~~~vIDwPQ~v~~~h  254 (304)
T COG0478         238 DGDIVVIDWPQAVPISH  254 (304)
T ss_pred             CCCEEEEeCcccccCCC
Confidence            99999999987754433

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=1.3e-07  Score=89.71  Aligned_cols=106  Identities=25%  Similarity=0.313  Sum_probs=83.6

Q ss_pred             HHHHHHHHHHHhccccc--cceeeeeeeeCC----ceEEEEeecCCC-ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHH
Q 037160          297 KEICNEMDIMSRAHHKN--LVQFLGCCFTKK----DSFVVYEFVQNK-SLDRILFDPKQKKELDWKKRHVIIIGTAEGLE  369 (569)
Q Consensus       297 ~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~  369 (569)
                      ....+|...+.+|....  ..+.+++.+...    ..+||+|++++. +|.+++...   ...+......++.++++.+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHHH
Confidence            45778888888885433  455666665432    458999999884 899988432   22566677889999999999


Q ss_pred             HHhhcCCCCeeeCCCCCCCeEECCCC---CeEEeccCCCccc
Q 037160          370 YLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLARFS  408 (569)
Q Consensus       370 ~LH~~~~~~ivHrDikp~NIll~~~~---~~kl~Dfgla~~~  408 (569)
                      -||+.+   |+|+|+++.|||++.++   .+.++||+.++..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999   99999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.69  E-value=4.2e-07  Score=84.69  Aligned_cols=138  Identities=13%  Similarity=0.098  Sum_probs=102.2

Q ss_pred             cccCceeEEEEEecCCceEEEEEEeecc------hhhHHHHHHHHHHHHhccccc--cceeeeeeeeC----CceEEEEe
Q 037160          265 GHGGYGEIFKGTLQDGREIAVKRLFISR------KNRIKEICNEMDIMSRAHHKN--LVQFLGCCFTK----KDSFVVYE  332 (569)
Q Consensus       265 G~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~----~~~~lv~e  332 (569)
                      |+||.+-|+.-.+. |+.+-+|+-...-      +.....|.+|...|.+|..-+  +.++.......    -..+||+|
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            77999999997765 4578999764211      223467899999999985332  44444222221    23689999


Q ss_pred             ecCC-CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC--eEEeccCCCcc
Q 037160          333 FVQN-KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR--PKIADFGLARF  407 (569)
Q Consensus       333 ~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~--~kl~Dfgla~~  407 (569)
                      -+.+ .+|.+++.+. ...+.+...+..++.+++..+.-||+.+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            8764 5898887432 2335677778899999999999999999   999999999999987777  99999987653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=1.4e-07  Score=100.15  Aligned_cols=153  Identities=20%  Similarity=0.282  Sum_probs=98.3

Q ss_pred             HHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhh----------------------------------H
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR----------------------------------I  296 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------~  296 (569)
                      ++..-..|+. +.|+.++-|.||+|++++|++||||+....-...                                  .
T Consensus       121 iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~  199 (517)
T COG0661         121 IEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE  199 (517)
T ss_pred             HHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence            3344444443 6899999999999999999999999885331110                                  0


Q ss_pred             H------HHHHHHHHHHhc----cccccceeeeeee-eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHH
Q 037160          297 K------EICNEMDIMSRA----HHKNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA  365 (569)
Q Consensus       297 ~------~~~~E~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~  365 (569)
                      +      .+.+|...+.++    ++..-+++-.++. -.....|+|||++|..+.++..-  +....+.+.+.....++.
T Consensus       200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f  277 (517)
T COG0661         200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF  277 (517)
T ss_pred             HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH
Confidence            1      133444444444    2222233333333 34567899999999999888521  123344334333333222


Q ss_pred             HHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       366 ~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                        +..+-..+   ++|.|.+|.||+++.+|++.+.|||+...++..
T Consensus       278 --~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         278 --LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              22333355   999999999999999999999999998766553

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.52  E-value=3.6e-08  Score=104.43  Aligned_cols=153  Identities=18%  Similarity=0.257  Sum_probs=97.7

Q ss_pred             HHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC-----C--CCcccccCCCccccccccc
Q 037160          362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL-----L--PNTAIAGTLGYMAPEYIAN  434 (569)
Q Consensus       362 ~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-----~--~~~~~~gt~~y~aPE~~~~  434 (569)
                      .+++.||.++|..-  ++||++|.|++|.++..+.+||+.|+.+.........     +  ..........|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34558999999876  5999999999999999999999999987543331111     0  1112234568999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCC
Q 037160          435 GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQEL  514 (569)
Q Consensus       435 ~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~  514 (569)
                      ...+.++|+||+|+++|.+..|..+........    +.+......       .+........+...++.+=+.+.+..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----~~~~~~~~~-------~~~~~~~~s~~~p~el~~~l~k~l~~~  252 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----LSYSFSRNL-------LNAGAFGYSNNLPSELRESLKKLLNGD  252 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCc----chhhhhhcc-------cccccccccccCcHHHHHHHHHHhcCC
Confidence            888999999999999999995544322111110    011100000       000000011122233444455778999


Q ss_pred             CCCCCCHHHHHHH
Q 037160          515 PTLRPSMTNVVQM  527 (569)
Q Consensus       515 P~~RPt~~evl~~  527 (569)
                      +.-||++.++...
T Consensus       253 ~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  253 SAVRPTLDLLLSI  265 (700)
T ss_pred             cccCcchhhhhcc
Confidence            9999988877644

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.50  E-value=2.1e-06  Score=82.52  Aligned_cols=132  Identities=18%  Similarity=0.183  Sum_probs=84.4

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc--cceeeeeeeeCCceEEEEeecCCCC-
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN--LVQFLGCCFTKKDSFVVYEFVQNKS-  338 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~-  338 (569)
                      .+||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            46899999999984   25567888765432  2345688999999986544  3567777777777789999999963 


Q ss_pred             hhhHhhCCCCCccCCHHHHHHHHHHHHHHH---------------------------------------HHHhh-cCCCC
Q 037160          339 LDRILFDPKQKKELDWKKRHVIIIGTAEGL---------------------------------------EYLHK-DGQMQ  378 (569)
Q Consensus       339 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L---------------------------------------~~LH~-~~~~~  378 (569)
                      +...+..       +......+...+++.+                                       .+|.. .....
T Consensus        82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            2211100       0011111111111111                                       12211 12345


Q ss_pred             eeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          379 IVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       379 ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ++|+|+.|.||++++++ +.|+||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            78999999999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.43  E-value=3.9e-06  Score=79.38  Aligned_cols=151  Identities=21%  Similarity=0.239  Sum_probs=97.1

Q ss_pred             hhHHHHHhccccccc---cccccCceeEEEEEecCCceEEEEEEeecchhh------------------------HHHHH
Q 037160          248 YSTIEKATDCFDESN---KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR------------------------IKEIC  300 (569)
Q Consensus       248 ~~~~~~~~~~f~~~~---~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~  300 (569)
                      ..++....+...+..   .|..|--+.||+|...++..+|||++.......                        ..-..
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            344555555555544   455677789999998889999999886432110                        01123


Q ss_pred             HHHHHHHhcc--ccccceeeeeeeeCCceEEEEeecCCCCh-hhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCC
Q 037160          301 NEMDIMSRAH--HKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQ  376 (569)
Q Consensus       301 ~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~  376 (569)
                      .|...|.++.  +-.+.+.+.+.    ...|||||+....+ .-.|    +...+...+...+..++++.+.-|-. .+ 
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~-  187 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG-  187 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence            4555555553  22333333332    45899999965411 1111    11222333566677888888888876 55 


Q ss_pred             CCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       377 ~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                        +||+||+.-|||+. ++.+.|+||+.+....+
T Consensus       188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             --cccccchhhheEEE-CCeEEEEECccccccCC
Confidence              99999999999999 99999999999876553

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.42  E-value=4.1e-06  Score=78.43  Aligned_cols=138  Identities=13%  Similarity=0.130  Sum_probs=91.3

Q ss_pred             HHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHH---------HHHHHHHHHhcc---ccccceeeee
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE---------ICNEMDIMSRAH---HKNLVQFLGC  320 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~~~~~  320 (569)
                      ...++|...+.+-......|.+-..+ |+.+++|..........+.         ..+++..+.+++   ......++-+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            34678888888888777777666554 7899999776543222222         223344444443   2233333333


Q ss_pred             eee-----CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC
Q 037160          321 CFT-----KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH  395 (569)
Q Consensus       321 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~  395 (569)
                      .+.     ....+++|||++|..|.++..       ++.    .+...+.+.|.-||+.|   ++|+|++|.|++++. +
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~-~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN-N  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC-C
Confidence            322     234568999999998876541       222    24456778899999999   999999999999985 4


Q ss_pred             CeEEeccCCCc
Q 037160          396 RPKIADFGLAR  406 (569)
Q Consensus       396 ~~kl~Dfgla~  406 (569)
                      .++++||+..+
T Consensus       172 ~i~iID~~~k~  182 (229)
T PF06176_consen  172 GIRIIDTQGKR  182 (229)
T ss_pred             cEEEEECcccc
Confidence            49999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.36  E-value=9.1e-08  Score=100.26  Aligned_cols=189  Identities=16%  Similarity=0.142  Sum_probs=139.0

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc-cceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN-LVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~  333 (569)
                      +.-+...+-+++|.++.++|.+....+...++.+...     ....-++++|.+++||| .++.++-+..+...++++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            3334444557999999999998654555556654333     44557899999999999 78888888888889999999


Q ss_pred             cCCC-ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          334 VQNK-SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      +.++ +-....  ......+..-+...+...-.+++++||+..   =+|+|    ||+..+ +..+..||+....+....
T Consensus       316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence            9877 222111  011122333344455666678999999874   58998    777764 778999999987766543


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNK  461 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~  461 (569)
                         ......+++.++|||......+..+.|+|++|+--.++.-|-+|..
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence               3456778999999999999999999999999998888888876654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.30  E-value=5.2e-06  Score=80.04  Aligned_cols=142  Identities=18%  Similarity=0.189  Sum_probs=83.8

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc--cceeeeeeee---CCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN--LVQFLGCCFT---KKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~---~~~~~lv~e~~~~  336 (569)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+....  +.+++.....   ....+++|++++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            568999999999999887 69999976544  44567889999999885443  4566654322   3346899999999


Q ss_pred             CChhh----------------Hhh---CC-CCCccCCHHH---------HHHH------------HHHHHH-HHHHHhh-
Q 037160          337 KSLDR----------------ILF---DP-KQKKELDWKK---------RHVI------------IIGTAE-GLEYLHK-  373 (569)
Q Consensus       337 ~~L~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~i~~-~L~~LH~-  373 (569)
                      ..+..                .+.   .. .......+..         ....            ...+.+ .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                110   00 0001111100         0000            111222 3333332 


Q ss_pred             ---cCCCCeeeCCCCCCCeEEC-CCCCeEEeccCCCc
Q 037160          374 ---DGQMQIVHRDIKASNILLD-LKHRPKIADFGLAR  406 (569)
Q Consensus       374 ---~~~~~ivHrDikp~NIll~-~~~~~kl~Dfgla~  406 (569)
                         ..+..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               2345699999999999999 55666799999764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.28  E-value=1.2e-05  Score=78.52  Aligned_cols=75  Identities=7%  Similarity=0.047  Sum_probs=53.2

Q ss_pred             ccccCc-eeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEeecCCCChhh
Q 037160          264 LGHGGY-GEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDR  341 (569)
Q Consensus       264 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~  341 (569)
                      |-.|.. ..||+.... +..++||......   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 788998765 4788888764432   345678999998884 3445567777766667899999999988764


Q ss_pred             H
Q 037160          342 I  342 (569)
Q Consensus       342 ~  342 (569)
                      .
T Consensus        82 ~   82 (244)
T cd05150          82 L   82 (244)
T ss_pred             h
Confidence            3

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.23  E-value=2e-05  Score=73.65  Aligned_cols=132  Identities=22%  Similarity=0.327  Sum_probs=94.2

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecc----------------hhhHHHHHHHHHHHHhcc------ccccceee
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISR----------------KNRIKEICNEMDIMSRAH------HKNLVQFL  318 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~~  318 (569)
                      ...||+|+.-.||.  +++.....||+.....                ....++..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45799999999885  4445677888876554                223566778887777776      78999999


Q ss_pred             eeeeeCCceEEEEeecCC------CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC
Q 037160          319 GCCFTKKDSFVVYEFVQN------KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD  392 (569)
Q Consensus       319 ~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~  392 (569)
                      |+.+++....+|+|.+.+      .+|.+++.    ...++. .....+   -+-..||-+.+   |+.+||+|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQAL---DEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHH---HHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998743      35677763    233444 333333   34456666666   99999999999995


Q ss_pred             CCC----CeEEec-cCCC
Q 037160          393 LKH----RPKIAD-FGLA  405 (569)
Q Consensus       393 ~~~----~~kl~D-fgla  405 (569)
                      ...    .+.|+| ||-.
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            432    478888 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=9.3e-06  Score=86.19  Aligned_cols=142  Identities=16%  Similarity=0.224  Sum_probs=90.4

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchhh-------------------------------HH------HHHHHHH
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR-------------------------------IK------EICNEMD  304 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~  304 (569)
                      +.||.-+.|.||+|++++|+.||||+-+..-+..                               .+      .|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999999999999999875331110                               11      1334443


Q ss_pred             HHHhc----cccc---cceeeeeeee-CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 037160          305 IMSRA----HHKN---LVQFLGCCFT-KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ  376 (569)
Q Consensus       305 ~l~~l----~h~n---iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  376 (569)
                      ...+.    .|-+   -|++-.++.+ .....|+||||+|..+.++-.  -.+..++...+..-+.+...-+  |=..| 
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~q--If~~G-  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQ--IFKTG-  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHH--HHhcC-
Confidence            33332    3444   1223333322 346789999999998877642  1233455554444333332111  22334 


Q ss_pred             CCeeeCCCCCCCeEECC----CCCeEEeccCCCcccCC
Q 037160          377 MQIVHRDIKASNILLDL----KHRPKIADFGLARFSSS  410 (569)
Q Consensus       377 ~~ivHrDikp~NIll~~----~~~~kl~Dfgla~~~~~  410 (569)
                        ++|.|-+|.||++..    ++.+.+.|||+......
T Consensus       322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence              999999999999984    66899999999876654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.14  E-value=1.7e-05  Score=71.08  Aligned_cols=130  Identities=18%  Similarity=0.259  Sum_probs=90.5

Q ss_pred             cccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCC
Q 037160          259 DESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKS  338 (569)
Q Consensus       259 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  338 (569)
                      +..+.||+|++|.||++.+. |.++|+|+-...+.  ...+..|+++|..++-.++-+=+.++   +..++.|||+.|..
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence            34567999999999999998 56999997665443  35788999999999877665433222   22345599999989


Q ss_pred             hhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC-CCCeEECCCCCeEEeccCCCcc
Q 037160          339 LDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIK-ASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       339 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDik-p~NIll~~~~~~kl~Dfgla~~  407 (569)
                      |.++-...      +.    +-+..+++.-.-|...|   |-|+.|. |...+|..++.+.|+||.-|+.
T Consensus        99 L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            87765211      12    23344555555566667   9999987 4444444455999999998873

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.11  E-value=1.4e-05  Score=74.24  Aligned_cols=105  Identities=24%  Similarity=0.240  Sum_probs=83.5

Q ss_pred             HHHHHHHHhccc-cccceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 037160          300 CNEMDIMSRAHH-KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ  378 (569)
Q Consensus       300 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  378 (569)
                      .+|.-+|+.+++ +++.+++|.|    ..+++.||...+++......-......+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            368888898876 6999999999    44789999987766422100012234689999999999999999999865555


Q ss_pred             eeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          379 IVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       379 ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +.-.|++|+|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            899999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=6.4e-05  Score=86.22  Aligned_cols=79  Identities=13%  Similarity=0.332  Sum_probs=56.8

Q ss_pred             cccccccCceeEEEEEecCC---ceEEEEEEeecc-hhhHHHHHHHHHHHHhcc-cccc--ceeeeeeeeC---CceEEE
Q 037160          261 SNKLGHGGYGEIFKGTLQDG---REIAVKRLFISR-KNRIKEICNEMDIMSRAH-HKNL--VQFLGCCFTK---KDSFVV  330 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  330 (569)
                      ..+|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876643   467777653322 122356889999999995 6665  6777777654   467999


Q ss_pred             EeecCCCCh
Q 037160          331 YEFVQNKSL  339 (569)
Q Consensus       331 ~e~~~~~~L  339 (569)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.01  E-value=5e-05  Score=73.61  Aligned_cols=73  Identities=15%  Similarity=0.237  Sum_probs=46.0

Q ss_pred             ccccccCce-eEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcccc---ccceeeeeeeeC---CceEEEEeec
Q 037160          262 NKLGHGGYG-EIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHK---NLVQFLGCCFTK---KDSFVVYEFV  334 (569)
Q Consensus       262 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~  334 (569)
                      +.|+.||.. .||+.    +..+++|.....  .....+.+|.++|+.+...   .+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777776 58875    245777754332  2235788999999988532   233444433322   2348899999


Q ss_pred             CCCChh
Q 037160          335 QNKSLD  340 (569)
Q Consensus       335 ~~~~L~  340 (569)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            998774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.94  E-value=0.00017  Score=72.37  Aligned_cols=77  Identities=9%  Similarity=-0.024  Sum_probs=56.1

Q ss_pred             ccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccc---cccceeeeeeee---CCceEEEEee
Q 037160          260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHH---KNLVQFLGCCFT---KKDSFVVYEF  333 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~  333 (569)
                      ..+.||.|..+.||+....++ .+++|....  ......+.+|.+.|+.|.-   -.+.++++.+..   .+..+||||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            345799999999999876655 466776432  1122578899999999853   357778877654   3568999999


Q ss_pred             cCCCCh
Q 037160          334 VQNKSL  339 (569)
Q Consensus       334 ~~~~~L  339 (569)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.88  E-value=0.00013  Score=70.56  Aligned_cols=74  Identities=15%  Similarity=0.226  Sum_probs=48.8

Q ss_pred             ccccccCceeEEEEEecC--CceEEEEEEeecchhhHHHHHHHHHHHHhccccccc-eeeeeeeeCCceEEEEeecCCCC
Q 037160          262 NKLGHGGYGEIFKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV-QFLGCCFTKKDSFVVYEFVQNKS  338 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~  338 (569)
                      +.|..|-...+|+....+  ++.+++|....... ......+|+.+++.+...+++ ++++...    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457788888999988664  67888996643322 112345789999988544443 4443322    248999999987


Q ss_pred             hh
Q 037160          339 LD  340 (569)
Q Consensus       339 L~  340 (569)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.87  E-value=8.6e-05  Score=72.94  Aligned_cols=138  Identities=14%  Similarity=0.099  Sum_probs=78.3

Q ss_pred             cccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccc-eeeeeeeeCCceEEEEeecCCCChhh
Q 037160          263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV-QFLGCCFTKKDSFVVYEFVQNKSLDR  341 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~L~~  341 (569)
                      .+..|-.+.+|+... +++.+++|..........-...+|..+++.+....++ +++...    ..++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            356677788998874 4678888865433222112357899999988654443 334332    2478999999977642


Q ss_pred             H-----------------hhCCC-CCccCCHHHH-HHHHHH---------HHHHHHHHhhc-----CCCCeeeCCCCCCC
Q 037160          342 I-----------------LFDPK-QKKELDWKKR-HVIIIG---------TAEGLEYLHKD-----GQMQIVHRDIKASN  388 (569)
Q Consensus       342 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------i~~~L~~LH~~-----~~~~ivHrDikp~N  388 (569)
                      .                 |+... ....++.... .....+         +...+..+-..     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 00100 0111121111 111111         11112222111     12358999999999


Q ss_pred             eEECCCCCeEEeccCCCc
Q 037160          389 ILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       389 Ill~~~~~~kl~Dfgla~  406 (569)
                      |++++++ +.|+||+.+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999877 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.76  E-value=0.00022  Score=80.45  Aligned_cols=201  Identities=17%  Similarity=0.174  Sum_probs=137.6

Q ss_pred             HHHHHHHHHHHHhccccccceeeeeeeeCCceE----EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHH
Q 037160          296 IKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF----VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL  371 (569)
Q Consensus       296 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L  371 (569)
                      .....-|...+.++.|+|++.++.+..++....    +..|++..-++...+   .....++....+.+..++.+||.|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHH
Confidence            444556788888899999999999987665443    345777777777777   3456678888888999999999999


Q ss_pred             hhcCCCCeeeCCCCCC---CeEECCCCCeEEe--ccCCCcccCCCCCCCCCcccccCCCcccccccccCCCC--cccchh
Q 037160          372 HKDGQMQIVHRDIKAS---NILLDLKHRPKIA--DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT--EKVDIY  444 (569)
Q Consensus       372 H~~~~~~ivHrDikp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~ksDv~  444 (569)
                      |+..   +.|.-+..+   +.-.+..+.+.++  ||+..+.+.....   .....-+..+.+||......++  ...|+|
T Consensus       303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHH
Confidence            9986   666555555   5555666777777  8888776655432   2233345567788877665444  447999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 037160          445 SFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNV  524 (569)
Q Consensus       445 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev  524 (569)
                      .+|..+..+..|..+......                  .....+.    ....   .+......|+..++++|++..++
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~------------------~~~~l~~----~~~~---~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAV------------------PVSLLDV----LSTS---ELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccc------------------hhhhhcc----ccch---hhhhhhhhhcchhhhhccchhhh
Confidence            999999999998654322110                  0011111    0000   23445568999999999999999


Q ss_pred             HHHhcc
Q 037160          525 VQMLKQ  530 (569)
Q Consensus       525 l~~L~~  530 (569)
                      +.+.-.
T Consensus       432 l~~~f~  437 (1351)
T KOG1035|consen  432 LTHPFL  437 (1351)
T ss_pred             hhchhc
Confidence            977543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.75  E-value=0.00045  Score=71.60  Aligned_cols=75  Identities=12%  Similarity=0.195  Sum_probs=53.4

Q ss_pred             ccccccCceeEEEEEecCC-ceEEEEEEeec-----c--hhhHHHHHHHHHHHHhcc---ccccceeeeeeeeCCceEEE
Q 037160          262 NKLGHGGYGEIFKGTLQDG-REIAVKRLFIS-----R--KNRIKEICNEMDIMSRAH---HKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  330 (569)
                      +.||.|.+..||+....+| +.++||.-...     .  .........|.+.|+.+.   ..++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999998876 58999974311     1  123456778888888763   2356666666  34567999


Q ss_pred             EeecCCCC
Q 037160          331 YEFVQNKS  338 (569)
Q Consensus       331 ~e~~~~~~  338 (569)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.68  E-value=0.00035  Score=70.21  Aligned_cols=142  Identities=13%  Similarity=0.086  Sum_probs=84.8

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc--cceeeee------eeeCCceEEEEe
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN--LVQFLGC------CFTKKDSFVVYE  332 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e  332 (569)
                      .+.|..|....+|+....+ ..+++|+...   .....+..|+.++..+.+.+  +.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778778999987654 4788887653   22345677888888885433  3444332      123445689999


Q ss_pred             ecCCCChhh----Hh----------h----CCCC----CccCCHHHHH----------HHHHHHHHHHHHHhhc----CC
Q 037160          333 FVQNKSLDR----IL----------F----DPKQ----KKELDWKKRH----------VIIIGTAEGLEYLHKD----GQ  376 (569)
Q Consensus       333 ~~~~~~L~~----~l----------~----~~~~----~~~l~~~~~~----------~i~~~i~~~L~~LH~~----~~  376 (569)
                      +++|..+..    ..          +    ....    .....|....          .....+...+.++.+.    -+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999977632    00          0    0000    0111222111          0111123344454431    12


Q ss_pred             CCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          377 MQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       377 ~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            459999999999999987777899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.66  E-value=0.00058  Score=63.37  Aligned_cols=125  Identities=29%  Similarity=0.364  Sum_probs=88.0

Q ss_pred             ccccccccccccCc-eeEEEEEecCCceEEEEEEee---cch------------------hhHHHHHHHHHHHHhcc---
Q 037160          256 DCFDESNKLGHGGY-GEIFKGTLQDGREIAVKRLFI---SRK------------------NRIKEICNEMDIMSRAH---  310 (569)
Q Consensus       256 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~---  310 (569)
                      .+++..+.||.|.- |.||++.+. |+.+|+|.+..   ...                  .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 999999987 67999998321   100                  11235778888877774   


Q ss_pred             cccc--ceeeeeeeeCC------------------ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHH
Q 037160          311 HKNL--VQFLGCCFTKK------------------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY  370 (569)
Q Consensus       311 h~ni--v~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~  370 (569)
                      +.++  |+.+|+..-..                  ...||.||++...            .+.    ..-+.++.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4566  89999874221                  1246777665432            112    2245566777888


Q ss_pred             HhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       371 LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99998   999999999987     2388999854

>PRK05231 homoserine kinase; Provisional

Probab=97.55  E-value=0.0017  Score=65.92  Aligned_cols=141  Identities=15%  Similarity=0.168  Sum_probs=77.2

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc--cceeeee------eeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN--LVQFLGC------CFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~  333 (569)
                      +.|+.|....+|+....+| .+++|++..   ...+.+..|+.++..|...+  +.+++..      ....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4567777789999886655 788897652   12234455667777664222  2333321      1224557899999


Q ss_pred             cCCCChhh-----------Hh---hCCCC--------CccCCH-HHHHH------------HH-HHHHHHHHHHhhc---
Q 037160          334 VQNKSLDR-----------IL---FDPKQ--------KKELDW-KKRHV------------II-IGTAEGLEYLHKD---  374 (569)
Q Consensus       334 ~~~~~L~~-----------~l---~~~~~--------~~~l~~-~~~~~------------i~-~~i~~~L~~LH~~---  374 (569)
                      ++|..+..           .+   +....        ...+.| .....            .+ ..+...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99975421           11   00000        001111 11111            11 1111122333211   


Q ss_pred             -CCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          375 -GQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       375 -~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                       -+..++|+|+.|.||+++.+...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             23459999999999999866555899999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.43  E-value=0.001  Score=67.06  Aligned_cols=140  Identities=21%  Similarity=0.260  Sum_probs=82.7

Q ss_pred             ccccccCceeEEEEEecC-------CceEEEEEEeecchhhHHHHHHHHHHHHhccccccc-eeeeeeeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQD-------GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV-QFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~  333 (569)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|.+++..+....+. ++++.+.    ..+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            345666667889887654       5789999865433 2234567899999888544443 4455443    2468999


Q ss_pred             cCCCChhhHh-----------------hCCCCCc------cC--CHHHHHH--------------------------HHH
Q 037160          334 VQNKSLDRIL-----------------FDPKQKK------EL--DWKKRHV--------------------------III  362 (569)
Q Consensus       334 ~~~~~L~~~l-----------------~~~~~~~------~l--~~~~~~~--------------------------i~~  362 (569)
                      ++|..+....                 +......      ..  -|.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9987764311                 0100000      00  0111101                          111


Q ss_pred             HHHHHHHHHhh------cCCCCeeeCCCCCCCeEECCC----CCeEEeccCCCc
Q 037160          363 GTAEGLEYLHK------DGQMQIVHRDIKASNILLDLK----HRPKIADFGLAR  406 (569)
Q Consensus       363 ~i~~~L~~LH~------~~~~~ivHrDikp~NIll~~~----~~~kl~Dfgla~  406 (569)
                      .+...+..|..      ..+..++|+|+.|.|||++.+    +.++++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            12222334432      234569999999999999975    889999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.34  E-value=0.0034  Score=62.32  Aligned_cols=69  Identities=9%  Similarity=0.055  Sum_probs=40.4

Q ss_pred             cccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccc--cc-cceeeeeeeeCCceEEEEeecCCCCh
Q 037160          265 GHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHH--KN-LVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       265 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ++|....|+.....+|..+++|.-.  .......+.+|.++|+.+..  +- +.+++.   . ..-.++|+++.|..+
T Consensus        20 ~~g~~~~v~~i~~~~g~~~VlR~p~--~~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~---~-~~~~~~y~~i~G~p~   91 (276)
T cd05152          20 ESGLDFQVVFAKDTDGVPWVLRIPR--RPDVSERAAAEKRVLALVRKHLPVQVPDWRV---H-TPELIAYPKLPGVPA   91 (276)
T ss_pred             CCcceeEEEEEEcCCCCeEEEEecC--CHHHHHHHHHHHHHHHHHHhcCCCCCCceee---e-cCceEEEeccCCCcc
Confidence            4444456665544568899999653  22334567899999999853  21 122221   1 123567777777654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.34  E-value=0.0018  Score=64.32  Aligned_cols=73  Identities=15%  Similarity=0.151  Sum_probs=47.2

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc---ccccceeeeeeeeCCceEEEEeecCCC
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH---HKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      .+.++.|....+|+.. .+++.+.||.-..   .....|..|.+-|+.|.   --.+.+++++....+..+||+||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4568889999999877 5678999997652   22346778888888883   345678888888778889999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.33  E-value=0.0067  Score=61.28  Aligned_cols=143  Identities=17%  Similarity=0.171  Sum_probs=81.3

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc--cceeeeee------eeCCceEEEEe
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN--LVQFLGCC------FTKKDSFVVYE  332 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~------~~~~~~~lv~e  332 (569)
                      .+.++.|....+|+....+| .+++|+.....  ....+..|++++..|....  +.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789998876544 67788764421  1234556778887774322  33433321      12345689999


Q ss_pred             ecCCCChhh-----------Hh---hCCCC----C--c---cCCHHHHHH------------HHHHHHHHHHHHhh----
Q 037160          333 FVQNKSLDR-----------IL---FDPKQ----K--K---ELDWKKRHV------------IIIGTAEGLEYLHK----  373 (569)
Q Consensus       333 ~~~~~~L~~-----------~l---~~~~~----~--~---~l~~~~~~~------------i~~~i~~~L~~LH~----  373 (569)
                      |++|..+..           .+   +....    .  .   .-.|.....            ....+...+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999865421           11   00000    0  0   011111100            01122334555532    


Q ss_pred             cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       374 ~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .-+..++|+|+++.||+++.++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223559999999999999988777899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.28  E-value=0.0039  Score=62.50  Aligned_cols=144  Identities=17%  Similarity=0.195  Sum_probs=97.7

Q ss_pred             ccccccccCceeEEEEEecCCceEEEEEEeec-----chh--------------------hH-HHHHHHHHHHHhccccc
Q 037160          260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFIS-----RKN--------------------RI-KEICNEMDIMSRAHHKN  313 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~--------------------~~-~~~~~E~~~l~~l~h~n  313 (569)
                      +-..|..|--+-||.+.-.+|..+|||+++.+     .+.                    .. .-...|++-|.+|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34567889999999999999999999977421     110                    01 11345777777776544


Q ss_pred             cceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC
Q 037160          314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL  393 (569)
Q Consensus       314 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~  393 (569)
                      |.- -.-..- ....|||+|+.....   -.-..+...++...+..+-.+++.-|.-|.+..  .+||.||.--|+|+- 
T Consensus       228 IP~-PePIlL-k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  228 IPC-PEPILL-KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCC-CCceee-ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence            321 111111 235789999953221   111123456777788888899999999888776  599999999999996 


Q ss_pred             CCCeEEeccCCCcccCCC
Q 037160          394 KHRPKIADFGLARFSSSE  411 (569)
Q Consensus       394 ~~~~kl~Dfgla~~~~~~  411 (569)
                      +|.+.|+|-+.+....+.
T Consensus       300 dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             CCEEEEEEccccccCCCh
Confidence            789999999987655543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.21  E-value=0.00048  Score=67.62  Aligned_cols=136  Identities=17%  Similarity=0.217  Sum_probs=94.0

Q ss_pred             cccccccccccCceeEEEEEecCCceEEEEEEeecc---------h---------hh--H--HHHHHHHHHHHhccc-c-
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR---------K---------NR--I--KEICNEMDIMSRAHH-K-  312 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~---------~~--~--~~~~~E~~~l~~l~h-~-  312 (569)
                      -+.+.++||-|--+.||.+...+|++.++|.-....         +         .+  .  -...+|...|+.|.. - 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            356788999999999999999999999999332110         0         00  0  123467777777743 1 


Q ss_pred             ccceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC
Q 037160          313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD  392 (569)
Q Consensus       313 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~  392 (569)
                      -+.+.++    ....++|||++.+-.|...-      ...+...   +...+..-+.-|..+|   +||+|..--||+++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            2333333    34568999999988875432      1223333   4444555567778888   99999999999999


Q ss_pred             CCCCeEEeccCCCccc
Q 037160          393 LKHRPKIADFGLARFS  408 (569)
Q Consensus       393 ~~~~~kl~Dfgla~~~  408 (569)
                      +++.++++||-..-..
T Consensus       237 dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVST  252 (465)
T ss_pred             cCCCEEEeechHhhcc
Confidence            9999999999865433

>PLN02236 choline kinase

Probab=96.99  E-value=0.0062  Score=62.49  Aligned_cols=140  Identities=19%  Similarity=0.239  Sum_probs=80.5

Q ss_pred             cccccCceeEEEEEecC-----CceEEEEEEeecchhhHHHHHHHHHHHHhccccccc-eeeeeeeeCCceEEEEeecCC
Q 037160          263 KLGHGGYGEIFKGTLQD-----GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV-QFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      .|-.|-...+|+....+     ++.|++|......... -...+|..+++.+...++. ++++.+..    ..|.||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeCC
Confidence            45557777888876532     3678888775543222 2336799999988655554 45555432    258999988


Q ss_pred             CChhhHh-----------------hCCC--C-CccCCHHHHHHHHHHH-----------------HHHHHHH----hh-c
Q 037160          337 KSLDRIL-----------------FDPK--Q-KKELDWKKRHVIIIGT-----------------AEGLEYL----HK-D  374 (569)
Q Consensus       337 ~~L~~~l-----------------~~~~--~-~~~l~~~~~~~i~~~i-----------------~~~L~~L----H~-~  374 (569)
                      .+|...-                 +...  . .....+..+..+..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            7774210                 0100  0 1111223322222111                 1112222    21 2


Q ss_pred             CCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcc
Q 037160          375 GQMQIVHRDIKASNILLDL-KHRPKIADFGLARF  407 (569)
Q Consensus       375 ~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~  407 (569)
                      .+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2345899999999999986 46899999998753

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.96  E-value=0.011  Score=59.21  Aligned_cols=138  Identities=17%  Similarity=0.236  Sum_probs=82.4

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEe-ecchhhHHHHHHHHHHHHhccc--cccceeeeeeeeCC--ceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHH--KNLVQFLGCCFTKK--DSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~  336 (569)
                      +.+-.|.--.+|..... ++++++.+-. ...........+|..+|+.+.-  .-+.+.++.|.++.  ..+.||+|++|
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG  109 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG  109 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence            33433333344544443 6778887211 1223344566788888888743  23445566666655  67999999998


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHH-HHHHHHHHHHhh------------------------------------------
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVII-IGTAEGLEYLHK------------------------------------------  373 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~-~~i~~~L~~LH~------------------------------------------  373 (569)
                      ..+.+-+...      ...  .+.+ ..+++.|.-||+                                          
T Consensus       110 e~~~~~~~~~------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~  181 (321)
T COG3173         110 EVVWSALPPE------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD  181 (321)
T ss_pred             eeccCcCCcc------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence            5443322100      000  1111 244444444443                                          


Q ss_pred             --------c-----CCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          374 --------D-----GQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       374 --------~-----~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                              +     ++..++|+|+++.||+++.++-+=|.||+++..-
T Consensus       182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                    2     2356999999999999999888999999998743

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.77  E-value=0.019  Score=59.48  Aligned_cols=73  Identities=5%  Similarity=0.074  Sum_probs=49.4

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeec----ch---hhHHHHHHHHHHHHhcc---ccccceeeeeeeeCCceEEE
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFIS----RK---NRIKEICNEMDIMSRAH---HKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  330 (569)
                      .+.||.|....||+.... +..++||+-...    ..   ....+-..|.+.|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            457899999999998764 567999965411    11   12334445566666653   246777888776  557889


Q ss_pred             EeecCC
Q 037160          331 YEFVQN  336 (569)
Q Consensus       331 ~e~~~~  336 (569)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.67  E-value=0.00028  Score=81.34  Aligned_cols=160  Identities=13%  Similarity=0.014  Sum_probs=113.4

Q ss_pred             HHHHHHHHHhccccccceeeeeee--eCCceEEEEeecCCCChhhHhhCCCC-CccCCHHHHHHHHHHHHHHHHHHhhcC
Q 037160          299 ICNEMDIMSRAHHKNLVQFLGCCF--TKKDSFVVYEFVQNKSLDRILFDPKQ-KKELDWKKRHVIIIGTAEGLEYLHKDG  375 (569)
Q Consensus       299 ~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~  375 (569)
                      ...|...++...|++++....-..  +..+.+.+++++.+|.+.+.|..... ...++...+.....+......-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555566678998877665543  23456889999999999998854333 333444333333333244555555432


Q ss_pred             --CCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHH
Q 037160          376 --QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI  453 (569)
Q Consensus       376 --~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~el  453 (569)
                        ..-.+|+++|+-|.+|..+-++|+.++|+.++......  ......+++.|+.|++...-+++.++|+|..|+.+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              34579999999999999999999999999984332211  22345677889999998888999999999999999999


Q ss_pred             HhCCCCC
Q 037160          454 VSGVQNN  460 (569)
Q Consensus       454 ltg~~p~  460 (569)
                      --|..++
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8886554

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.65  E-value=0.019  Score=58.42  Aligned_cols=72  Identities=19%  Similarity=0.228  Sum_probs=46.8

Q ss_pred             cccccCceeEEEEEecCC-ceEEEEEEeec------c-hhhHHHHHHHHHHHHhcc--ccccc-eeeeeeeeCCceEEEE
Q 037160          263 KLGHGGYGEIFKGTLQDG-REIAVKRLFIS------R-KNRIKEICNEMDIMSRAH--HKNLV-QFLGCCFTKKDSFVVY  331 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--h~niv-~~~~~~~~~~~~~lv~  331 (569)
                      .||.|....||++...+| +.|+||.-...      + +-...+..-|.+.|+...  .|..| +++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999997754 68999964211      1 222345557777777653  34333 44433  455667999


Q ss_pred             eecCC
Q 037160          332 EFVQN  336 (569)
Q Consensus       332 e~~~~  336 (569)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.51  E-value=0.043  Score=51.74  Aligned_cols=74  Identities=15%  Similarity=0.236  Sum_probs=51.3

Q ss_pred             cccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc---ccccceeeeeeeeCCceEEEEeecCCCCh
Q 037160          263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH---HKNLVQFLGCCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~~L  339 (569)
                      ++--|.--..|.... +..++.||+=   .......|..|+.-|..|.   --.+.+++.+-....+.|+|+||++-+.+
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            444444444444433 3567888842   3444567888888777774   34577888888889999999999998777


Q ss_pred             h
Q 037160          340 D  340 (569)
Q Consensus       340 ~  340 (569)
                      +
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            5

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.25  E-value=0.013  Score=55.70  Aligned_cols=122  Identities=20%  Similarity=0.220  Sum_probs=60.6

Q ss_pred             CceEEEEEEeecchhhHHHHHHHHHHHHhcccccc-ceeeeeeeeCCceEEEEeecCCCChhhH-hh-------------
Q 037160          280 GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL-VQFLGCCFTKKDSFVVYEFVQNKSLDRI-LF-------------  344 (569)
Q Consensus       280 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~-------------  344 (569)
                      ++.|+|++..... ...-...+|..+++.+...++ .++++.+..    ..|+||+++..|..- +.             
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4678888776653 334566789999999876555 445555422    357799977665321 00             


Q ss_pred             ---C--C--CCCccCCHHHHHHH----------------------HHHHHHHHHHHhh----c-CCCCeeeCCCCCCCeE
Q 037160          345 ---D--P--KQKKELDWKKRHVI----------------------IIGTAEGLEYLHK----D-GQMQIVHRDIKASNIL  390 (569)
Q Consensus       345 ---~--~--~~~~~l~~~~~~~i----------------------~~~i~~~L~~LH~----~-~~~~ivHrDikp~NIl  390 (569)
                         .  .  ......-|.....+                      +..+..-+..+.+    . .+.-+.|.||.|.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence               0  0  00111112222222                      0111112222211    1 1234889999999999


Q ss_pred             E-CCCCCeEEeccCCCc
Q 037160          391 L-DLKHRPKIADFGLAR  406 (569)
Q Consensus       391 l-~~~~~~kl~Dfgla~  406 (569)
                      + +.++.++++||..+.
T Consensus       157 ~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             ETSSSSCEEE--GTT-E
T ss_pred             eccCCCeEEEecHHHHh
Confidence            9 889999999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.14  E-value=0.079  Score=53.47  Aligned_cols=29  Identities=28%  Similarity=0.362  Sum_probs=25.3

Q ss_pred             CCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          377 MQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       377 ~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.01  E-value=0.068  Score=53.99  Aligned_cols=32  Identities=25%  Similarity=0.364  Sum_probs=28.3

Q ss_pred             CCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          376 QMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       376 ~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      +..++|+|+.++|||++.++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34599999999999999999999999998753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.01  E-value=0.058  Score=55.07  Aligned_cols=140  Identities=12%  Similarity=0.219  Sum_probs=78.7

Q ss_pred             cccccCceeEEEEEecC----CceEEEEEEeecchhhHHHHHHHHHHHHhccccccc-eeeeeeeeCCceEEEEeecCCC
Q 037160          263 KLGHGGYGEIFKGTLQD----GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV-QFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      .|..|-...+|+....+    +..|++|+...... ..-...+|..+++.+..-++. ++++++. .   .+|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-N---GMIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-C---cEeehhhcCC
Confidence            45556667788876542    23788887754332 223346789999998765554 4555542 2   2589999887


Q ss_pred             ChhhH-------h----------hCCC---CCccCCHHHHHHHHHHH----------------------HHHHHHHh---
Q 037160          338 SLDRI-------L----------FDPK---QKKELDWKKRHVIIIGT----------------------AEGLEYLH---  372 (569)
Q Consensus       338 ~L~~~-------l----------~~~~---~~~~l~~~~~~~i~~~i----------------------~~~L~~LH---  372 (569)
                      .|..-       +          +...   ....-.|..+..+..++                      .+-+..+.   
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            66321       1          1100   01111233222222111                      11111111   


Q ss_pred             -h-cCCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcc
Q 037160          373 -K-DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARF  407 (569)
Q Consensus       373 -~-~~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~  407 (569)
                       . ..+.-+.|.|+.+.|||+++ ++.++++||..+..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence             1 12234799999999999975 57899999998753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.95  E-value=0.11  Score=52.68  Aligned_cols=139  Identities=19%  Similarity=0.232  Sum_probs=81.0

Q ss_pred             ccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcccccc------ceeeee----eeeCCceEEEEee
Q 037160          264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL------VQFLGC----CFTKKDSFVVYEF  333 (569)
Q Consensus       264 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni------v~~~~~----~~~~~~~~lv~e~  333 (569)
                      |.+ .-..+|+....+|+. ++|.....  ....++..|+..|+.|.-..|      ..+-|-    .......+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 456788888877666 78866554  344667788888888842222      111111    1112367889999


Q ss_pred             cCCCChhh-Hh------------------hCC-----CCCccCCHHH-------------HHHHHHHHHHHHHHHhhc--
Q 037160          334 VQNKSLDR-IL------------------FDP-----KQKKELDWKK-------------RHVIIIGTAEGLEYLHKD--  374 (569)
Q Consensus       334 ~~~~~L~~-~l------------------~~~-----~~~~~l~~~~-------------~~~i~~~i~~~L~~LH~~--  374 (569)
                      ++|..+.. .-                  ...     .......|..             ......++...+..+.+.  
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988873 10                  000     0111223330             001122333344444432  


Q ss_pred             --CC---CCeeeCCCCCCCeEECCCCC-eEEeccCCCc
Q 037160          375 --GQ---MQIVHRDIKASNILLDLKHR-PKIADFGLAR  406 (569)
Q Consensus       375 --~~---~~ivHrDikp~NIll~~~~~-~kl~Dfgla~  406 (569)
                        -+   ..+||+|+.|.||+++.+.. .-++||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              11   23999999999999998885 8899999764

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.85  E-value=0.038  Score=56.99  Aligned_cols=74  Identities=19%  Similarity=0.170  Sum_probs=48.6

Q ss_pred             cccccccCceeEEEEEec-CCceEEEEEEee----c-c-hhhHHHHHHHHHHHHhcc--ccccc-eeeeeeeeCCceEEE
Q 037160          261 SNKLGHGGYGEIFKGTLQ-DGREIAVKRLFI----S-R-KNRIKEICNEMDIMSRAH--HKNLV-QFLGCCFTKKDSFVV  330 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----~-~-~~~~~~~~~E~~~l~~l~--h~niv-~~~~~~~~~~~~~lv  330 (569)
                      .+.||.|.-..||++... +++.|+||.-..    . + +-...+..-|.+.|+...  .|..| +++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            457899999999999975 357899996421    1 1 223456667888888763  35444 44443  44556778


Q ss_pred             EeecCC
Q 037160          331 YEFVQN  336 (569)
Q Consensus       331 ~e~~~~  336 (569)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.51  E-value=0.07  Score=50.00  Aligned_cols=152  Identities=16%  Similarity=0.161  Sum_probs=88.5

Q ss_pred             CceeEEEEEecCCceEEEEEEeecchh-hHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCChhhHhhCC
Q 037160          268 GYGEIFKGTLQDGREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDP  346 (569)
Q Consensus       268 ~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  346 (569)
                      +.++.-++.-+- .+..+|++....-. ....|.++.+++++++  .|+++.--  ......++.|+|.....       
T Consensus        74 gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------  141 (308)
T PF07387_consen   74 GNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------  141 (308)
T ss_pred             CceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence            334444443332 24456655433222 3456788899998875  35665522  33345688898843211       


Q ss_pred             CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCc
Q 037160          347 KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY  426 (569)
Q Consensus       347 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y  426 (569)
                           .   ..-.|..+ +..|.-.|+.+ ...+|+|-.|+||+-|..|.+||.|-+..-.              .+.-|
T Consensus       142 -----~---~~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~  197 (308)
T PF07387_consen  142 -----N---FSNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNM  197 (308)
T ss_pred             -----c---hhHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeE
Confidence                 0   11112222 46777888543 3599999999999999999999999774310              01112


Q ss_pred             ccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 037160          427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQ  458 (569)
Q Consensus       427 ~aPE~~~~~~~~~ksDv~SlGvil~elltg~~  458 (569)
                      .--|   ....+.++.+=+|=.-++++....+
T Consensus       198 vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  198 VNIE---YESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             Eeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence            2211   2345667777777777777776543

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.44  E-value=0.37  Score=49.07  Aligned_cols=72  Identities=15%  Similarity=0.098  Sum_probs=45.0

Q ss_pred             cCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc--cceee---e--eeeeCCceEEEEeecCCCCh
Q 037160          267 GGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN--LVQFL---G--CCFTKKDSFVVYEFVQNKSL  339 (569)
Q Consensus       267 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~e~~~~~~L  339 (569)
                      +.-..||+....+|..+++|+..... .....+..|++.+..|....  ++...   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34567899888778889999764322 23456778888888774221  22211   1  12224567789999988654

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.38  E-value=0.1  Score=52.58  Aligned_cols=103  Identities=19%  Similarity=0.233  Sum_probs=70.1

Q ss_pred             CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                      ...|++|++- |++|..       .....+.+...++.+.+..+.-+..+-  +.-|||+.-.||||+ +|++-|+||-+
T Consensus       299 ~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             eEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence            3456667764 555532       234568899999999888888887765  699999999999999 99999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhH
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSF  446 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~Sl  446 (569)
                      ++.-.....       .-....--|-.+. |.-+.+=|||-+
T Consensus       368 sRl~~~q~~-------isy~rldhp~lF~-G~dd~QFeIYrl  401 (488)
T COG5072         368 SRLSYSQGI-------ISYNRLDHPDLFN-GVDDYQFEIYRL  401 (488)
T ss_pred             eecccCCce-------eeccccCchhhhc-CccceeeeHHHH
Confidence            984333221       1111223344444 444667777764

>PRK06148 hypothetical protein; Provisional

Probab=95.27  E-value=0.23  Score=58.42  Aligned_cols=141  Identities=21%  Similarity=0.248  Sum_probs=77.7

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc-------ccccceee-e----eeee-CC--c
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-------HKNLVQFL-G----CCFT-KK--D  326 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~~~-~----~~~~-~~--~  326 (569)
                      +.|+ |..-.+|+....+|..+++|+......  ......|...|..|.       -|.+++.. |    .... .+  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            3464 345778988877888999998865432  234445666666552       22223211 1    1111 12  3


Q ss_pred             eEEEEeecCCCChhhHh---------------------hCCC---CCccCCHHH-----------------HHHHHHHHH
Q 037160          327 SFVVYEFVQNKSLDRIL---------------------FDPK---QKKELDWKK-----------------RHVIIIGTA  365 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l---------------------~~~~---~~~~l~~~~-----------------~~~i~~~i~  365 (569)
                      .+.+++|++|..+.+..                     .+..   ....+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            56789999998775410                     0000   011223321                 112222222


Q ss_pred             HHHH-----HHhhcCCCCeeeCCCCCCCeEECCCC--CeE-EeccCCCc
Q 037160          366 EGLE-----YLHKDGQMQIVHRDIKASNILLDLKH--RPK-IADFGLAR  406 (569)
Q Consensus       366 ~~L~-----~LH~~~~~~ivHrDikp~NIll~~~~--~~k-l~Dfgla~  406 (569)
                      +...     .|.+ -+..+||+|+.+.|||++.++  ++. |+|||.+.
T Consensus       188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            2221     1211 234599999999999999875  565 99999875

>PTZ00384 choline kinase; Provisional

Probab=94.58  E-value=0.28  Score=50.94  Aligned_cols=74  Identities=18%  Similarity=0.338  Sum_probs=44.9

Q ss_pred             ccccccCceeEEEEEecCC--ce-----EEEEEEeecchhhHHHHHHHHHHHHhccccccce-eeeeeeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQDG--RE-----IAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ-FLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~  333 (569)
                      +.|..|-...+|++...++  ..     |.++.. .......-.-.+|+++++.+...++.+ +++.+.    .+++.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            3565677889999876532  23     333322 111111223457899999997666654 455443    3699999


Q ss_pred             cCCCChh
Q 037160          334 VQNKSLD  340 (569)
Q Consensus       334 ~~~~~L~  340 (569)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9998774

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	569
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-45
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-45
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-35
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-33
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-32
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-31
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-27
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-20
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-19
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-15
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-15
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-12
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-10
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		8e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		8e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		9e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 102/290 (35%), Positives = 164/290 (56%), Gaps = 6/290 (2%)
Query: 245 QFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK-EICNEM 303
           +F    ++ A+D F   N LG GG+G+++KG L DG  +AVKRL   R    + +   E+
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIII 362
           +++S A H+NL++  G C T  +  +VY ++ N S+   L + P+ +  LDW KR  I +
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG 422
           G+A GL YLH     +I+HRD+KA+NILLD +    + DFGLA+     K      A+ G
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDXHVXXAVRG 205
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQN---NKFQSDDGFETLVTHTWKHF 479
           T+G++APEY++ G+ +EK D++ +GV++LE+++G +     +  +DD    L        
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 480 QAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
           + K                 V++++ V LLCTQ  P  RP M+ VV+ML+
Sbjct: 266 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 101/290 (34%), Positives = 163/290 (56%), Gaps = 6/290 (2%)
Query: 245 QFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK-EICNEM 303
           +F    ++ A+D F   N LG GG+G+++KG L DG  +AVKRL   R    + +   E+
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIII 362
           +++S A H+NL++  G C T  +  +VY ++ N S+   L + P+ +  LDW KR  I +
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG 422
           G+A GL YLH     +I+HRD+KA+NILLD +    + DFGLA+     K      A+ G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDXHVXXAVRG 197
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQN---NKFQSDDGFETLVTHTWKHF 479
            +G++APEY++ G+ +EK D++ +GV++LE+++G +     +  +DD    L        
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 480 QAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
           + K                 V++++ V LLCTQ  P  RP M+ VV+ML+
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  146 bits (369), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 78/205 (38%), Positives = 124/205 (60%), Gaps = 4/205 (1%)
Query: 251 IEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH 310
           +E+AT+ FD    +GHG +G+++KG L+DG ++A+KR        I+E   E++ +S   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLE 369
           H +LV  +G C  + +  ++Y++++N +L R L+        + W++R  I IG A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      I+HRD+K+ NILLD    PKI DFG+++  +          + GTLGY+ P
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIV 454
           EY   G+LTEK D+YSFGV++ E++
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 78/205 (38%), Positives = 124/205 (60%), Gaps = 4/205 (1%)
Query: 251 IEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH 310
           +E+AT+ FD    +GHG +G+++KG L+DG ++A+KR        I+E   E++ +S   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLE 369
           H +LV  +G C  + +  ++Y++++N +L R L+        + W++R  I IG A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      I+HRD+K+ NILLD    PKI DFG+++  +          + GTLGY+ P
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIV 454
           EY   G+LTEK D+YSFGV++ E++
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 84/226 (37%), Positives = 128/226 (56%), Gaps = 15/226 (6%)
Query: 242 KFLQFKYSTIEKATDCFDE------SNKLGHGGYGEIFKGTLQDGREIAVKRLF----IS 291
           +F  F +  ++  T+ FDE       NK+G GG+G ++KG + +   +AVK+L     I+
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 69
Query: 292 RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE 351
            +   ++   E+ +M++  H+NLV+ LG      D  +VY ++ N SL   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 352 LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE 411
           L W  R  I  G A G+ +LH++     +HRDIK++NILLD     KI+DFGLAR S   
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
              +  + I GT  YMAPE +  G++T K DIYSFGV++LEI++G+
Sbjct: 187 AQTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGL 231

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/226 (37%), Positives = 127/226 (56%), Gaps = 15/226 (6%)
Query: 242 KFLQFKYSTIEKATDCFDE------SNKLGHGGYGEIFKGTLQDGREIAVKRLF----IS 291
           +F  F +  ++  T+ FDE       NK+G GG+G ++KG + +   +AVK+L     I+
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 63
Query: 292 RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE 351
            +   ++   E+ +M++  H+NLV+ LG      D  +VY ++ N SL   L        
Sbjct: 64  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 123
Query: 352 LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE 411
           L W  R  I  G A G+ +LH++     +HRDIK++NILLD     KI+DFGLAR S   
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
              +    I GT  YMAPE +  G++T K DIYSFGV++LEI++G+
Sbjct: 181 AQXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGL 225

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/226 (37%), Positives = 127/226 (56%), Gaps = 15/226 (6%)
Query: 242 KFLQFKYSTIEKATDCFDE------SNKLGHGGYGEIFKGTLQDGREIAVKRLF----IS 291
           +F  F +  ++  T+ FDE       NK+G GG+G ++KG + +   +AVK+L     I+
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 69
Query: 292 RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE 351
            +   ++   E+ +M++  H+NLV+ LG      D  +VY ++ N SL   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 352 LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE 411
           L W  R  I  G A G+ +LH++     +HRDIK++NILLD     KI+DFGLAR S   
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
              +    I GT  YMAPE +  G++T K DIYSFGV++LEI++G+
Sbjct: 187 AQTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGL 231

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 82/226 (36%), Positives = 124/226 (54%), Gaps = 15/226 (6%)
Query: 242 KFLQFKYSTIEKATDCFDE------SNKLGHGGYGEIFKGTLQDGREIAVKRLF----IS 291
           +F  F +  ++  T+ FDE       NK G GG+G ++KG + +   +AVK+L     I+
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 60
Query: 292 RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE 351
            +   ++   E+ + ++  H+NLV+ LG      D  +VY +  N SL   L        
Sbjct: 61  TEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 352 LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE 411
           L W  R  I  G A G+ +LH++     +HRDIK++NILLD     KI+DFGLAR S   
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
              +  + I GT  Y APE +  G++T K DIYSFGV++LEI++G+
Sbjct: 178 AQXVXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGL 222

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 110/195 (56%), Gaps = 6/195 (3%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           K+G G +G + +     G ++AVK L        R+ E   E+ IM R  H N+V F+G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
                +  +V E++   SL R+L     +++LD ++R  +    A+G+ YLH      IV
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           HR++K+ N+L+D K+  K+ DFGL+R  +S  + L + + AGT  +MAPE + +    EK
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 441 VDIYSFGVLVLEIVS 455
            D+YSFGV++ E+ +
Sbjct: 220 SDVYSFGVILWELAT 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 6/195 (3%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           K+G G +G + +     G ++AVK L        R+ E   E+ IM R  H N+V F+G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
                +  +V E++   SL R+L     +++LD ++R  +    A+G+ YLH      IV
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           HRD+K+ N+L+D K+  K+ DFGL+R  +S    L +   AGT  +MAPE + +    EK
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSNEK 219
Query: 441 VDIYSFGVLVLEIVS 455
            D+YSFGV++ E+ +
Sbjct: 220 SDVYSFGVILWELAT 234

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 10/209 (4%)
Query: 249 STIEKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMS 307
           S  ++  + FD   KLG G YG ++K   ++ G+ +A+K++ +  ++ ++EI  E+ IM 
Sbjct: 22  SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQ 79
Query: 308 RAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEG 367
           +    ++V++ G  F   D ++V E+    S+  I+    + K L   +   I+  T +G
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKG 137
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           LEYLH    M+ +HRDIKA NILL+ +   K+ADFG+A        +     + GT  +M
Sbjct: 138 LEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWM 192
Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE I         DI+S G+  +E+  G
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEG 221

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 10/200 (5%)
Query: 258 FDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            D   K+G G  G +        GR++AVK + + ++ R + + NE+ IM    H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   ++ +V+ EF+Q  +L  I+     +  L+ ++   +     + L YLH  G 
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             ++HRDIK+ +ILL L  R K++DFG    +   K +     + GT  +MAPE I+   
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKXLVGTPYWMAPEVISRSL 217
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              +VDI+S G++V+E+V G
Sbjct: 218 YATEVDIWSLGIMVIEMVDG 237

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 263 KLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G +   T +  G+++AVK++ + ++ R + + NE+ IM   HH N+V      
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV EF++  +L  I+   +  +E    +   + +     L YLH  G   ++H
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQG---VIH 164
Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ +ILL    R K++DFG    +   K +     + GT  +MAPE I+      +V
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++V+E++ G
Sbjct: 223 DIWSLGIMVIEMIDG 237

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 112/222 (50%), Gaps = 33/222 (14%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKN-------RIKEICNEMDIMSRAHHKNLVQ 316
           +G GG+G++++     G E+AVK    +R +        I+ +  E  + +   H N++ 
Sbjct: 15  IGIGGFGKVYR-AFWIGDEVAVKA---ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKEL--DWKKRHVIIIGTAEGLEYLHKD 374
             G C  + +  +V EF +   L+R+L   +   ++  +W       +  A G+ YLH +
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA------VQIARGMNYLHDE 124
Query: 375 GQMQIVHRDIKASNILL-------DLKHRP-KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
             + I+HRD+K+SNIL+       DL ++  KI DFGLAR    E       + AG   +
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAW 180
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
           MAPE I     ++  D++S+GVL+ E+++G     F+  DG 
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTG--EVPFRGIDGL 220

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G ++    +  G+E+A++++ + ++ + + I NE+ +M    + N+V +L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV E++   SL  ++ +      +D  +   +     + LE+LH +   Q++H
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ NILL +    K+ DFG     + E+S    + + GT  +MAPE +       KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++ +E++ G
Sbjct: 198 DIWSLGIMAIEMIEG 212

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G ++    +  G+E+A++++ + ++ + + I NE+ +M    + N+V +L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV E++   SL  ++ +      +D  +   +     + LE+LH +   Q++H
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ NILL +    K+ DFG     + E+S    + + GT  +MAPE +       KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++ +E++ G
Sbjct: 198 DIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G ++    +  G+E+A++++ + ++ + + I NE+ +M    + N+V +L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV E++   SL  ++ +      +D  +   +     + LE+LH +   Q++H
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ NILL +    K+ DFG     + E+S    + + GT  +MAPE +       KV
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++ +E++ G
Sbjct: 199 DIWSLGIMAIEMIEG 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G ++    +  G+E+A++++ + ++ + + I NE+ +M    + N+V +L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV E++   SL  ++ +      +D  +   +     + LE+LH +   Q++H
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RDIK+ NILL +    K+ DFG     + E+S    + + GT  +MAPE +       KV
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++ +E++ G
Sbjct: 198 DIWSLGIMAIEMIEG 212

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            D   K+G G  G +   T++  G+ +AVK++ + ++ R + + NE+ IM    H+N+V+
Sbjct: 22  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                    + +VV EF++  +L  I+   +  +E    +   + +   + L  LH  G 
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG- 136
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             ++HRDIK+ +ILL    R K++DFG    +   K +     + GT  +MAPE I+   
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLP 192
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              +VDI+S G++V+E+V G
Sbjct: 193 YGPEVDIWSLGIMVIEMVDG 212

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            D   K+G G  G +   T++  G+ +AVK++ + ++ R + + NE+ IM    H+N+V+
Sbjct: 31  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                    + +VV EF++  +L  I+   +  +E    +   + +   + L  LH  G 
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG- 145
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             ++HRDIK+ +ILL    R K++DFG    +   K +     + GT  +MAPE I+   
Sbjct: 146 --VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLP 201
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              +VDI+S G++V+E+V G
Sbjct: 202 YGPEVDIWSLGIMVIEMVDG 221

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            D   K+G G  G +   T++  G+ +AVK++ + ++ R + + NE+ IM    H+N+V+
Sbjct: 26  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                    + +VV EF++  +L  I+   +  +E    +   + +   + L  LH  G 
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG- 140
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             ++HRDIK+ +ILL    R K++DFG    +   K +     + GT  +MAPE I+   
Sbjct: 141 --VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLP 196
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              +VDI+S G++V+E+V G
Sbjct: 197 YGPEVDIWSLGIMVIEMVDG 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            D   K+G G  G +   T++  G+ +AVK++ + ++ R + + NE+ IM    H+N+V+
Sbjct: 33  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                    + +VV EF++  +L  I+   +  +E    +   + +   + L  LH  G 
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG- 147
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             ++HRDIK+ +ILL    R K++DFG    +   K +     + GT  +MAPE I+   
Sbjct: 148 --VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLP 203
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              +VDI+S G++V+E+V G
Sbjct: 204 YGPEVDIWSLGIMVIEMVDG 223

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            D   K+G G  G +   T++  G+ +AVK++ + ++ R + + NE+ IM    H+N+V+
Sbjct: 76  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                    + +VV EF++  +L  I+   +  +E    +   + +   + L  LH  G 
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG- 190
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             ++HRDIK+ +ILL    R K++DFG    +   K +     + GT  +MAPE I+   
Sbjct: 191 --VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLP 246
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              +VDI+S G++V+E+V G
Sbjct: 247 YGPEVDIWSLGIMVIEMVDG 266

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            D   K+G G  G +   T++  G+ +AVK++ + ++ R + + NE+ IM    H+N+V+
Sbjct: 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                    + +VV EF++  +L  I+   +  +E    +   + +   + L  LH  G 
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG- 267
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             ++HRDIK+ +ILL    R K++DFG    +   K +     + GT  +MAPE I+   
Sbjct: 268 --VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLP 323
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              +VDI+S G++V+E+V G
Sbjct: 324 YGPEVDIWSLGIMVIEMVDG 343

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G  G ++    +  G+E+A++++ + ++ + + I NE+ +M    + N+V +L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               + +VV E++   SL  ++ +      +D  +   +     + LE+LH +   Q++H
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           R+IK+ NILL +    K+ DFG     + E+S    + + GT  +MAPE +       KV
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKV 198
Query: 442 DIYSFGVLVLEIVSG 456
           DI+S G++ +E++ G
Sbjct: 199 DIWSLGIMAIEMIEG 213

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 258 FDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKN---RIKEICNEMDIMSRAHHKN 313
           F +  ++GHG +G + F   +++   +A+K++  S K    + ++I  E+  + +  H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
            +Q+ GC   +  +++V E+    + D +    K  +E++      +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHS 172
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                ++HRD+KA NILL      K+ DFG A        + P     GT  +MAPE I 
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 223
Query: 434 ---NGQLTEKVDIYSFGVLVLEI 453
               GQ   KVD++S G+  +E+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL 246

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           HRD+ A N L+   H  K+ADFGL+R  + +    P  A    + + APE +A  + + K
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGA-KFPIKWTAPESLAYNKFSIK 193
Query: 441 VDIYSFGVLVLEIVS 455
            D+++FGVL+ EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTX----TAHAGAKFPIKWTAPESLAYNKF 194
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 195 SIKSDVWAFGVLLWEIAT 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEK 440
           HRD+ A N L+   H  K+ADFGL+R  + +    P  A    + + APE +A  + + K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGA-KFPIKWTAPESLAYNKFSIK 194
Query: 441 VDIYSFGVLVLEIVS 455
            D+++FGVL+ EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 13/185 (7%)
Query: 282 EIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLD 340
           ++A+KR+ + + +  + E+  E+  MS+ HH N+V +      K + ++V + +   S+ 
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 341 RILFDPKQKKE-----LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH 395
            I+     K E     LD      I+    EGLEYLHK+GQ   +HRD+KA NILL    
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 153
Query: 396 RPKIADFGLARFSSSEKSLLPNTA---IAGTLGYMAPEYIANGQLTE-KVDIYSFGVLVL 451
             +IADFG++ F ++   +  N       GT  +MAPE +   +  + K DI+SFG+  +
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 213
Query: 452 EIVSG 456
           E+ +G
Sbjct: 214 ELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 13/185 (7%)
Query: 282 EIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLD 340
           ++A+KR+ + + +  + E+  E+  MS+ HH N+V +      K + ++V + +   S+ 
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 341 RILFDPKQKKE-----LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH 395
            I+     K E     LD      I+    EGLEYLHK+GQ   +HRD+KA NILL    
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 158
Query: 396 RPKIADFGLARFSSSEKSLLPNTA---IAGTLGYMAPEYIANGQLTE-KVDIYSFGVLVL 451
             +IADFG++ F ++   +  N       GT  +MAPE +   +  + K DI+SFG+  +
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 452 EIVSG 456
           E+ +G
Sbjct: 219 ELATG 223

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 258 FDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKN---RIKEICNEMDIMSRAHHKN 313
           F +  ++GHG +G + F   +++   +A+K++  S K    + ++I  E+  + +  H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
            +Q+ GC   +  +++V E+    + D +    K  +E++      +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHS 133
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                ++HRD+KA NILL      K+ DFG A        + P     GT  +MAPE I 
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 184
Query: 434 ---NGQLTEKVDIYSFGVLVLEI 453
               GQ   KVD++S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 194
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 195 SIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 194
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 195 SIKSDVWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTX----TAHAGAKFPIKWTAPESLAYNKF 190
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 191 SIKSDVWAFGVLLWEIAT 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 137
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 193
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 194 SIKSDVWAFGVLLWEIAT 211

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 189
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 189
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 194
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 195 SIKSDVWAFGVLLWEIAT 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTX----TAHAGAKFPIKWTAPESLAYNKF 187
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 188 SIKSDVWAFGVLLWEIAT 205

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 146
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 202
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 203 SIKSDVWAFGVLLWEIAT 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 191
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 192 SIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 191
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 192 SIKSDVWAFGVLLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 189
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 189
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 189
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 189
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 194
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 195 SIKSDVWAFGVLLWEIAT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTF----TAHAGAKFPIKWTAPESLAYNKF 187
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 188 SIKSDVWAFGVLLWEIAT 205

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G +GE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTX----TAHAGAKFPIKWTAPESLAYNKF 187
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 188 SIKSDVWAFGVLLWEIAT 205

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 19  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK    +V ++ +  SL   L   + K E+  KK   I   TA G++YLH      I+
Sbjct: 77  S-TKPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAK---SII 130
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L   +  KI DFGLA   S          ++G++ +MAPE I    +   
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 191 SFQSDVYAFGIVLYELMTG 209

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ--DGRE---IAVKRL--FISRKNRIKEICNE 302
           T E    C      +G G +GE++KG L+   G++   +A+K L    + K R+ +   E
Sbjct: 38  TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGE 96
Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
             IM +  H N+++  G     K   ++ E+++N +LD+ L +  +  E    +   ++ 
Sbjct: 97  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLR 154
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG 422
           G A G++YL     M  VHRD+ A NIL++     K++DFGL+R    +      T+   
Sbjct: 155 GIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 423 T-LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             + + APE I+  + T   D++SFG+++ E+++
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E++      +    +  +EYL K      +
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 379
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HR++ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 435
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 436 SIKSDVWAFGVLLWEIAT 453

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 110/205 (53%), Gaps = 21/205 (10%)
Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           S ++G G +G ++KG       + + ++      + +   NE+ ++ +  H N++ F+G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG- 99
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQ 378
             TK +  +V ++ +  SL + L      +E  ++   +I I   TA+G++YLH      
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHL----HVQETKFQMFQLIDIARQTAQGMDYLHAK---N 152
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLA----RFSSSEKSLLPNTAIAGTLGYMAPEYIA- 433
           I+HRD+K++NI L      KI DFGLA    R+S S++   P     G++ +MAPE I  
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP----TGSVLWMAPEVIRM 208
Query: 434 --NGQLTEKVDIYSFGVLVLEIVSG 456
             N   + + D+YS+G+++ E+++G
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE++ G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   ++V E++   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAVVLLYMATQISSAMEYLEKK---NFI 152
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HRD+ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A    
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNTF 208
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 209 SIKSDVWAFGVLLWEIAT 226

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L       ++E   E  +M    H NLVQ LG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL K      +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQL 437
           HR++ A N L+   H  K+ADFGL+R  + +      TA AG    + + APE +A  + 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKF 396
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + K D+++FGVL+ EI +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 31  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK    +V ++ +  SL   L   + K E+  KK   I   TA G++YLH      I+
Sbjct: 89  S-TKPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAK---SII 142
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L   +  KI DFGLA   S          ++G++ +MAPE I    +   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 203 SFQSDVYAFGIVLYELMTG 221

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 264 LGHGGYGEIFKGTLQDGREIAV-KRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           LG G +G+  K T ++  E+ V K L    +   +    E+ +M    H N+++F+G  +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
             K    + E+++  +L  I+       +  W +R       A G+ YLH    M I+HR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT------------AIAGTLGYMAPE 430
           D+ + N L+       +ADFGLAR    EK+                  + G   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSGVQ 458
            I      EKVD++SFG+++ EI+  V 
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 21/200 (10%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++  T     ++AVK +     + ++    E ++M    H  LV+ L    
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVK-LHAVV 79
Query: 323 TKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
           TK+  +++ EF+   SL D +  D   K+ L   K        AEG+ ++    Q   +H
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYIH 134
Query: 382 RDIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           RD++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-------IKWTAPEAINFG 187
Query: 436 QLTEKVDIYSFGVLVLEIVS 455
             T K D++SFG+L++EIV+
Sbjct: 188 SFTIKSDVWSFGILLMEIVT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 21/200 (10%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++  T     ++AVK +     + ++    E ++M    H  LV+ L    
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVK-LHAVV 252
Query: 323 TKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
           TK+  +++ EF+   SL D +  D   K+ L   K        AEG+ ++    Q   +H
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYIH 307
Query: 382 RDIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           RD++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-------IKWTAPEAINFG 360
Query: 436 QLTEKVDIYSFGVLVLEIVS 455
             T K D++SFG+L++EIV+
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 31  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T     +V ++ +  SL   L   + K E+  KK   I   TA G++YLH      I+
Sbjct: 89  S-TAPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAK---SII 142
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L   +  KI DFGLA   S          ++G++ +MAPE I    +   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 203 SFQSDVYAFGIVLYELMTG 221

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 83
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 139
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      KIADFGLAR     +     TA  G    + + APE I  G  T 
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYGTFTI 195
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ EIV+
Sbjct: 196 KSDVWSFGILLTEIVT 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 86
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 142
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      KIADFGLAR     +     TA  G    + + APE I  G  T 
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYGTFTI 198
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ EIV+
Sbjct: 199 KSDVWSFGILLTEIVT 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 85
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 141
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      KIADFGLAR     +     TA  G    + + APE I  G  T 
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYGTFTI 197
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ EIV+
Sbjct: 198 KSDVWSFGILLTEIVT 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 83
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 139
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G 
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-------IKWTAPEAINYGT 192
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            T K D++SFG+L+ EIV+
Sbjct: 193 FTIKSDVWSFGILLTEIVT 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 87
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 143
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G 
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-------IKWTAPEAINYGT 196
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            T K D++SFG+L+ EIV+
Sbjct: 197 FTIKSDVWSFGILLTEIVT 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 82
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 138
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G 
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-------IKWTAPEAINYGT 191
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            T K D++SFG+L+ EIV+
Sbjct: 192 FTIKSDVWSFGILLTEIVT 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 77
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      KIADFGLAR     +     TA  G    + + APE I  G  T 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ EIV+
Sbjct: 190 KSDVWSFGILLTEIVT 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 77
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      KIADFGLAR     +     TA  G    + + APE I  G  T 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ EIV+
Sbjct: 190 KSDVWSFGILLTEIVT 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 77
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-------IKWTAPEAINYGT 186
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            T K D++SFG+L+ EIV+
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 79
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 135
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      KIADFGLAR     +     TA  G    + + APE I  G  T 
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYGTFTI 191
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ EIV+
Sbjct: 192 KSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 78
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 134
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      KIADFGLAR     +     TA  G    + + APE I  G  T 
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYGTFTI 190
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ EIV+
Sbjct: 191 KSDVWSFGILLTEIVT 206

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 111/204 (54%), Gaps = 13/204 (6%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNL 314
           D ++   +LG G +G+++K   ++   +A  ++  ++ +  +++   E+DI++   H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L   + + + +++ EF    ++D ++ +   ++ L   +  V+   T + L YLH +
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI-- 432
              +I+HRD+KA NIL  L    K+ADFG++  + + +++    +  GT  +MAPE +  
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMC 209
Query: 433 ---ANGQLTEKVDIYSFGVLVLEI 453
               +     K D++S G+ ++E+
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 72
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 128
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G 
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-------IKWTAPEAINYGT 181
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            T K D++SFG+L+ EIV+
Sbjct: 182 FTIKSDVWSFGILLTEIVT 200

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 264 LGHGGYGEIFKGTLQ-DGRE---IAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +G G +GE+ +G L+  G++   +A+K L   +  R+ R  E  +E  IM +  H N+++
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMGQFEHPNIIR 81
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI-----IIGTAEGLEYL 371
             G         ++ EF++N +LD  L        L+  +  VI     + G A G+ YL
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFL-------RLNDGQFTVIQLVGMLRGIASGMRYL 134
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG---TLGYMA 428
               +M  VHRD+ A NIL++     K++DFGL+RF     S    T+  G    + + A
Sbjct: 135 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTA 191
Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS 455
           PE IA  + T   D +S+G+++ E++S
Sbjct: 192 PEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 27/207 (13%)
Query: 264 LGHGGYGEIFKGTLQ-DGRE---IAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +G G +GE+ +G L+  G++   +A+K L   +  R+ R  E  +E  IM +  H N+++
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMGQFEHPNIIR 79
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI-----IIGTAEGLEYL 371
             G         ++ EF++N +LD  L        L+  +  VI     + G A G+ YL
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFL-------RLNDGQFTVIQLVGMLRGIASGMRYL 132
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF---SSSEKSLLPNTAIAGTLGYMA 428
               +M  VHRD+ A NIL++     K++DFGL+RF   +SS+ +   +      + + A
Sbjct: 133 ---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTA 189
Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS 455
           PE IA  + T   D +S+G+++ E++S
Sbjct: 190 PEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 99/194 (51%), Gaps = 19/194 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++  T     ++AVK +     + ++    E ++M    H  LV+ L    
Sbjct: 189 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVK-LHAVV 246
Query: 323 TKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
           TK+  +++ EF+   SL D +  D   K+ L   K        AEG+ ++    Q   +H
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYIH 301
Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV 441
           RD++A+NIL+      KIADFGLAR  +      P       + + APE I  G  T K 
Sbjct: 302 RDLRAANILVSASLVCKIADFGLARVGAK----FP-------IKWTAPEAINFGSFTIKS 350
Query: 442 DIYSFGVLVLEIVS 455
           D++SFG+L++EIV+
Sbjct: 351 DVWSFGILLMEIVT 364

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ EF+   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSK 221

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 110/204 (53%), Gaps = 13/204 (6%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNL 314
           D ++   +LG G +G+++K   ++   +A  ++  ++ +  +++   E+DI++   H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L   + + + +++ EF    ++D ++ +   ++ L   +  V+   T + L YLH +
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI-- 432
              +I+HRD+KA NIL  L    K+ADFG++  + + + +    +  GT  +MAPE +  
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDSFIGTPYWMAPEVVMC 209
Query: 433 ---ANGQLTEKVDIYSFGVLVLEI 453
               +     K D++S G+ ++E+
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFL 318
             ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   TK    +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      
Sbjct: 71  GYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS--- 124
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NG 435
           I+HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
             + + D+Y+FG+++ E+++G
Sbjct: 185 PYSFQSDVYAFGIVLYELMTG 205

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 20  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK    +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      I+
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAK---SII 131
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I        
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 192 SFQSDVYAFGIVLYELMTG 210

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 17  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK    +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      I+
Sbjct: 75  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 128
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I        
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 189 SFQSDVYAFGIVLYELMTG 207

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 20  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK    +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      I+
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 131
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I        
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 192 SFQSDVYAFGIVLYELMTG 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    ++ + I A+K LF ++  +     ++  E++I S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      DS  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 66  RHPNILRLYGYF---HDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +      A+ GTL Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCGTLDYLPP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 257 CFDESNKLGHGGYGEIFKGTLQ--DGREI--AVKRL--FISRKNRIKEICNEMDIMSRAH 310
           C      +G G +GE+  G L+    REI  A+K L    + K R ++  +E  IM +  
Sbjct: 34  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFD 92
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N++   G         ++ EF++N SLD  L   +   +    +   ++ G A G++Y
Sbjct: 93  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKY 150
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG---TLGYM 427
           L     M  VHRD+ A NIL++     K++DFGL+RF   + S    T+  G    + + 
Sbjct: 151 L---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVS 455
           APE I   + T   D++S+G+++ E++S
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSK 218

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 42  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK    +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      I+
Sbjct: 100 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 153
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I        
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 214 SFQSDVYAFGIVLYELMTG 232

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 109/204 (53%), Gaps = 13/204 (6%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNL 314
           D ++   +LG G +G+++K   ++   +A  ++  ++ +  +++   E+DI++   H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L   + + + +++ EF    ++D ++ +   ++ L   +  V+   T + L YLH +
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI-- 432
              +I+HRD+KA NIL  L    K+ADFG++  + + + +       GT  +MAPE +  
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMC 209
Query: 433 ---ANGQLTEKVDIYSFGVLVLEI 453
               +     K D++S G+ ++E+
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 43  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK    +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      I+
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAK---SII 154
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I        
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 215 SFQSDVYAFGIVLYELMTG 233

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 73
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 129
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           +++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G 
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-------IKWTAPEAINYGT 182
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            T K D++SFG+L+ EIV+
Sbjct: 183 FTIKSDVWSFGILLTEIVT 201

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRAHHKN 313
           FD    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S   H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +++  G      D+  VY  ++   L  +  + ++    D ++    I   A  L Y H 
Sbjct: 74  ILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
               +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ PE I 
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIE 183
Query: 434 NGQLTEKVDIYSFGVLVLEIVSGV 457
                EKVD++S GVL  E + G+
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGM 207

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNR-IKEIC-NEMDIMSRAHHKNLVQFLGC 320
           +G G YG + K   +D GR +A+K+   S  ++ +K+I   E+ ++ +  H+NLV  L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  KK  ++V+EFV +  LD +   P     LD++     +     G+ + H      I+
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSH---NII 146
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE-YIANGQLTE 439
           HRDIK  NIL+      K+ DFG AR  ++   +  +     T  Y APE  + + +  +
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPELLVGDVKYGK 204
Query: 440 KVDIYSFGVLVLEIVSG 456
            VD+++ G LV E+  G
Sbjct: 205 AVDVWAIGCLVTEMFMG 221

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQ--DGRE--IAVKRLFI--SRKNRIKEICNEMDI 305
           E    C      +G G +GE+  G L+    RE  +A+K L +  + K R ++   E  I
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR-RDFLGEASI 76
Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           M +  H N++   G     K   +V E+++N SLD  L   K   +    +   ++ G +
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVIQLVGMLRGIS 134
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G++YL     M  VHRD+ A NIL++     K++DFGL+R    +    P  A     G
Sbjct: 135 AGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGG 187
Query: 426 -----YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                + APE IA  + T   D++S+G+++ E+VS
Sbjct: 188 KIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G  GE++ G      ++AVK L     +       E ++M +  H+ LV+ L    
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR-LYAVV 77
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++    +   +HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      KIADFGLAR     +     TA  G    + + APE I  G  T 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEX----TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ EIV+
Sbjct: 190 KSDVWSFGILLTEIVT 205

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 7/197 (3%)
Query: 261 SNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQFL 318
             ++G G +GE+F G L+ D   +AVK    +    +K +   E  I+ +  H N+V+ +
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G C  K+  ++V E VQ    D + F   +   L  K    ++   A G+EYL       
Sbjct: 179 GVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
            +HRD+ A N L+  K+  KI+DFG++R  +              + + APE +  G+ +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 439 EKVDIYSFGVLVLEIVS 455
            + D++SFG+L+ E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 92  RHPNILRLYGYFH---DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 201
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFL 318
             ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   TK    +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      
Sbjct: 71  GYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS--- 124
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NG 435
           I+HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
             + + D+Y+FG+++ E+++G
Sbjct: 185 PYSFQSDVYAFGIVLYELMTG 205

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 4   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 62
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 63  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 122
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G++YL      + VHRD+ A N +LD K   K+AD
Sbjct: 123 RNETHNPTV----KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 176 FGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGLAR    +    P  A     G     + +PE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDD----PEAAYTTRGGKIPIRWTSPEAI 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG+G +GE++ GT     ++A+K L     +  +    E  IM +  H  LVQ L    
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQ-LYAVV 73
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L D  + + L       +    A G+ Y+ +   M  +HR
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 129
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++++NIL+      KIADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEX----TARQGAKFPIKWTAPEAALYGRFTI 185
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+V+
Sbjct: 186 KSDVWSFGILLTELVT 201

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFISRKN-------RIKEICNEMDI 305
           A +  +   ++G GG+G + KG L +D   +A+K L +           + +E   E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           MS  +H N+V+  G         +V EFV    L   L D  +   + W  +  +++  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDL--KHRP---KIADFGLARFSSSEKSLLPNTAI 420
            G+EY+       IVHRD+++ NI L    ++ P   K+ADFGL     S++S+   + +
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-----SQQSVHSVSGL 186
Query: 421 AGTLGYMAPEYIANGQ--LTEKVDIYSFGVLVLEIVSG 456
            G   +MAPE I   +   TEK D YSF +++  I++G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 69  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 178
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 7/197 (3%)
Query: 261 SNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQFL 318
             ++G G +GE+F G L+ D   +AVK    +    +K +   E  I+ +  H N+V+ +
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G C  K+  ++V E VQ    D + F   +   L  K    ++   A G+EYL       
Sbjct: 179 GVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
            +HRD+ A N L+  K+  KI+DFG++R  +              + + APE +  G+ +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 439 EKVDIYSFGVLVLEIVS 455
            + D++SFG+L+ E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 257 CFDESNKLGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAH 310
           C      +G G +GE+  G L+    R++AV     ++  + K R   +C E  IM +  
Sbjct: 44  CIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLC-EASIMGQFD 102
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V   G     K   +V EF++N +LD  L   K   +    +   ++ G A G+ Y
Sbjct: 103 HPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRY 160
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAP 429
           L     M  VHRD+ A NIL++     K++DFGL+R      +++   T     + + AP
Sbjct: 161 L---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVS 455
           E I   + T   D++S+G+++ E++S
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 162
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSK 249

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 71  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 180
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 43  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK    +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      I+
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAK---SII 154
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I        
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 215 SFQSDVYAFGIVLYELMTG 233

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G 
Sbjct: 35  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TK    +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      I+
Sbjct: 93  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 146
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQL 437
           HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I        
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + + D+Y+FG+++ E+++G
Sbjct: 207 SFQSDVYAFGIVLYELMTG 225

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 135
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 196 SKFSVASDVWSFGVVLYELFTYIEKSK 222

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 130
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 191 SKFSVASDVWSFGVVLYELFTYIEKSK 217

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 69  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +      A+ GTL Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCGTLDYLPP 178
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 67  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T ++GTL Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR----RTTLSGTLDYLPP 176
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 129
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 190 SKFSVASDVWSFGVVLYELFTYIEKSK 216

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTELCGTLDYLPP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 65  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 174
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVG 201

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 197 SKFSVASDVWSFGVVLYELFTYIEKSK 223

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 69  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 178
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 137
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 198 SKFSVASDVWSFGVVLYELFTYIEKSK 224

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 70  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 179
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 199 SKFSVASDVWSFGVVLYELFTYIEKSK 225

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 83  RHPNILRLYGYFH---DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 192
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVG 219

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +      A+ GTL Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCGTLDYLPP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSK 221

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 71  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 180
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVG 207

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFL 318
             ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T     +V ++ +  SL   L   + K E+   K   I   TA+G++YLH      
Sbjct: 71  GYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS--- 124
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NG 435
           I+HRD+K++NI L      KI DFGLA   S          ++G++ +MAPE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
             + + D+Y+FG+++ E+++G
Sbjct: 185 PYSFQSDVYAFGIVLYELMTG 205

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSK 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSK 218

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFI-------SRKNRIKEICNEMDIMSRA 309
           F    K+G G + E+++   L DG  +A+K++ I       +R + IKEI    D++ + 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI----DLLKQL 89
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD-----WKKRHVIIIGT 364
           +H N++++        +  +V E      L R++   K++K L      WK      +  
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFVQL 145
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
              LE++H     +++HRDIK +N+ +      K+ D GL RF SS+ +     ++ GT 
Sbjct: 146 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTP 200
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            YM+PE I       K DI+S G L+ E+ +
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ G   +  ++AVK L     + ++    E ++M    H  LV+      
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  +++ EF+   SL   L   +  K L   K        AEG+ Y+ +      +HR
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERK---NYIHR 133
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D++A+N+L+      KIADFGLAR      +++ E +  P       + + APE I  G 
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-------IKWTAPEAINFGC 186
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            T K +++SFG+L+ EIV+
Sbjct: 187 FTIKSNVWSFGILLYEIVT 205

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTXLCGTLDYLPP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 5   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G++YL      + VHRD+ A N +LD K   K+AD
Sbjct: 124 RNETHNPTV----KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 67  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP 176
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSK 236

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLF---ISRKNRIKEICNEMDIMSRAHH 311
           D FD    LG G +G ++    +  + I A+K LF   + ++    ++  E++I S   H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
            N+++       +K  +++ EF     L + L   ++    D ++    +   A+ L Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 131
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H   + +++HRDIK  N+L+  K   KIADFG +  + S    L    + GTL Y+ PE 
Sbjct: 132 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEM 184
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSGV 457
           I      EKVD++  GVL  E + G+
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGM 210

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 98/180 (54%), Gaps = 9/180 (5%)
Query: 280 GREIAVKRLFI-SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV--VYEFVQN 336
           G ++AVK L   S  N I ++  E++I+   +H+N+V++ G C     + +  + EF+ +
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR 396
            SL   L  PK K +++ K++    +   +G++YL   G  Q VHRD+ A N+L++ +H+
Sbjct: 110 GSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQ 164
Query: 397 PKIADFGLARFSSSEKSLLP-NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            KI DFGL +   ++K            + + APE +   +     D++SFGV + E+++
Sbjct: 165 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 98/180 (54%), Gaps = 9/180 (5%)
Query: 280 GREIAVKRLFI-SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV--VYEFVQN 336
           G ++AVK L   S  N I ++  E++I+   +H+N+V++ G C     + +  + EF+ +
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR 396
            SL   L  PK K +++ K++    +   +G++YL   G  Q VHRD+ A N+L++ +H+
Sbjct: 98  GSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQ 152
Query: 397 PKIADFGLARFSSSEKSLLP-NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            KI DFGL +   ++K            + + APE +   +     D++SFGV + E+++
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSK 236

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFISRKN-------RIKEICNEMDI 305
           A +  +   ++G GG+G + KG L +D   +A+K L +           + +E   E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           MS  +H N+V+  G         +V EFV    L   L D  +   + W  +  +++  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDL--KHRP---KIADFGLARFSSSEKSLLPNTAI 420
            G+EY+       IVHRD+++ NI L    ++ P   K+ADFG     +S++S+   + +
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TSQQSVHSVSGL 186
Query: 421 AGTLGYMAPEYIANGQ--LTEKVDIYSFGVLVLEIVSG 456
            G   +MAPE I   +   TEK D YSF +++  I++G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 4   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 62
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 63  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 122
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G++YL      + VHRD+ A N +LD K   K+AD
Sbjct: 123 RNETHNPTV----KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 176 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 23  VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 81
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 82  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 141
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G++YL      + VHRD+ A N +LD K   K+AD
Sbjct: 142 RNETHNPTV----KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 194
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 195 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 3   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 61
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 62  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 121
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G++YL      + VHRD+ A N +LD K   K+AD
Sbjct: 122 RNETHNPTV----KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 175 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 5   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G++YL      + VHRD+ A N +LD K   K+AD
Sbjct: 124 RNETHNPTV----KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 24  VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 82
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 83  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 142
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G++YL      + VHRD+ A N +LD K   K+AD
Sbjct: 143 RNETHNPTV----KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 195
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 196 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 2   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G++YL      + VHRD+ A N +LD K   K+AD
Sbjct: 121 RNETHNPTV----KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVAD 173
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 174 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 82
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLS---DM 137
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 193
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 71  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP 180
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YGE+++G+ Q G  +AVK +F SR  K+  +E      +M R  H+N++ F+   
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVK-IFSSRDEKSWFRETELYNTVMLR--HENILGFIASD 100
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQ 376
            T + S      + +      L+D  Q   LD      I++  A GL +LH +     G+
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 160
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP--NTAIAGTLGYMAPEYIAN 434
             I HRD+K+ NIL+    +  IAD GLA   S   + L   N    GT  YMAPE +  
Sbjct: 161 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 220
Query: 435 GQLTE------KVDIYSFGVLVLEIVSGVQNNKFQSD 465
               +      +VDI++FG+++ E+   + +N    D
Sbjct: 221 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 257

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 63  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 172
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVG 199

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 99
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLS---DM 154
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 210
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 264 LGHGGYGEIFKGTL--QDGREI--AVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           +G G +G ++ GTL   DG++I  AVK L  I+    + +   E  IM    H N++  L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 319 GCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDG 375
           G C   + S  VV  ++++  L   + +      +    + +I  G   A+G++YL    
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV----KDLIGFGLQVAKGMKYL---A 142
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
             + VHRD+ A N +LD K   K+ADFGLAR  +     S+   T     + +MA E + 
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
             + T K D++SFGVL+ E+++
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMT 224

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 109
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL---SDM 164
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 220
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMS 243

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 116/234 (49%), Gaps = 18/234 (7%)
Query: 232 MDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AVKR 287
           +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AVK 
Sbjct: 2   IDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60
Query: 288 L-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFD 345
           L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   + +
Sbjct: 61  LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 346 PKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG 403
                 +    + +I  G   A+G++YL      + VHRD+ A N +LD K   K+ADFG
Sbjct: 121 ETHNPTV----KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFG 173
Query: 404 LAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           LAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YGE+++G+ Q G  +AVK +F SR  K+  +E      +M R  H+N++ F+   
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-IFSSRDEKSWFRETELYNTVMLR--HENILGFIASD 71
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQ 376
            T + S      + +      L+D  Q   LD      I++  A GL +LH +     G+
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP--NTAIAGTLGYMAPEYIAN 434
             I HRD+K+ NIL+    +  IAD GLA   S   + L   N    GT  YMAPE +  
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 435 GQLTE------KVDIYSFGVLVLEIVSGVQNNKFQSD 465
               +      +VDI++FG+++ E+   + +N    D
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +GE++ G   +  ++AVK L     + ++    E ++M    H  LV+      
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  +++ E++   SL   L   +  K L   K        AEG+ Y+ +      +HR
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERK---NYIHR 134
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D++A+N+L+      KIADFGLAR      +++ E +  P       + + APE I  G 
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-------IKWTAPEAINFGC 187
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            T K D++SFG+L+ EIV+
Sbjct: 188 FTIKSDVWSFGILLYEIVT 206

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YGE+++G+ Q G  +AVK +F SR  K+  +E      +M R  H+N++ F+   
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-IFSSRDEKSWFRETELYNTVMLR--HENILGFIASD 71
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQ 376
            T + S      + +      L+D  Q   LD      I++  A GL +LH +     G+
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP--NTAIAGTLGYMAPEYIAN 434
             I HRD+K+ NIL+    +  IAD GLA   S   + L   N    GT  YMAPE +  
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 435 GQLTE------KVDIYSFGVLVLEIVSGVQNNKFQSD 465
               +      +VDI++FG+++ E+   + +N    D
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL R    +    P  A     G     + +PE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 118/242 (48%), Gaps = 18/242 (7%)
Query: 224 HKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGR 281
           H     + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG+
Sbjct: 4   HMGSNTVHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK 62
Query: 282 EI--AVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNK 337
           +I  AVK L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++ 
Sbjct: 63  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 122
Query: 338 SLDRILFDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKH 395
            L   + +      +    + +I  G   A+G+++L      + VHRD+ A N +LD K 
Sbjct: 123 DLRNFIRNETHNPTV----KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 175
Query: 396 RPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
             K+ADFGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+
Sbjct: 176 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 235
Query: 454 VS 455
           ++
Sbjct: 236 MT 237

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 82
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEX----TARQGAKFPIKWTAPEAALYGRFTI 194
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLF---ISRKNRIKEICNEMDIMSRAHH 311
           D FD    LG G +G ++    +  + I A+K LF   + ++    ++  E++I S   H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
            N+++       +K  +++ EF     L + L   ++    D ++    +   A+ L Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 130
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H   + +++HRDIK  N+L+  K   KIADFG +  + S    L    + GTL Y+ PE 
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEM 183
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSGV 457
           I      EKVD++  GVL  E + G+
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM 209

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 73
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 129
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 185
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 186 KSDVWSFGILLTELTT 201

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 75
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 131
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 187
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 188 KSDVWSFGILLTELTT 203

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 71
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 127
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 183
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 184 KSDVWSFGILLTELTT 199

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRAHHKN 313
           FD    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S   H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +++  G      D+  VY  ++   L  +  + ++    D ++    I   A  L Y H 
Sbjct: 74  ILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
               +++HRDIK  N+LL      KIADFG +  + S +       + GTL Y+ PE I 
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR----RDTLCGTLDYLPPEMIE 183
Query: 434 NGQLTEKVDIYSFGVLVLEIVSGV 457
                EKVD++S GVL  E + G+
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGM 207

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 248
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 360
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 361 KSDVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 248
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 360
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 361 KSDVWSFGILLTELTT 376

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 69  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIA+FG +  + S +     T + GTL Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDYLPP 178
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G        +++ E+     + + L   ++  + D ++    I   A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 180
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 68  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIA+FG +  + S +     T + GTL Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDYLPP 177
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 82
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 194
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 82
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 194
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L   K K+ +D  K         +G+EYL   G
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HR++   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 193 SKFSVASDVWSFGVVLYELFTYIEKSK 219

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQ-LYAVV 82
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 194
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQ-LYAVV 331
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 443
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 444 KSDVWSFGILLTELTT 459

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 257 CFDESNKLGHGGYGEIFKGTLQ--DGREI--AVKRL--FISRKNRIKEICNEMDIMSRAH 310
           C      +G G +GE+  G L+    REI  A+K L    + K R ++  +E  IM +  
Sbjct: 8   CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFD 66
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N++   G         ++ EF++N SLD  L   +   +    +   ++ G A G++Y
Sbjct: 67  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKY 124
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG---TLGYM 427
           L     M  VHR + A NIL++     K++DFGL+RF   + S    T+  G    + + 
Sbjct: 125 L---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVS 455
           APE I   + T   D++S+G+++ E++S
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 79
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEW----TARQGAKFPIKWTAPEAALYGRFTI 191
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 192 KSDVWSFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 79
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 191
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 192 KSDVWSFGILLTELTT 207

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFISRKN-------RIKEICNEMDI 305
           A +  +   ++G GG+G + KG L +D   +A+K L +           + +E   E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           MS  +H N+V+  G         +V EFV    L   L D  +   + W  +  +++  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G+EY+       IVHRD+++ NI L            +A FS S++S+   + + G   
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQ 191
Query: 426 YMAPEYIANGQ--LTEKVDIYSFGVLVLEIVSG 456
           +MAPE I   +   TEK D YSF +++  I++G
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 248
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 360
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 361 KSDVWSFGILLTELTT 376

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 82
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 194
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 67  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +       + GTL Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RDTLCGTLDYLPP 176
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 64  VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 123 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G+++L      + VHRD+ A N +LD K   K+AD
Sbjct: 183 RNETHNPTV----KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 5   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G+++L      + VHRD+ A N +LD K   K+AD
Sbjct: 124 RNETHNPTV----KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 68  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +       + GTL Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPP 177
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 3   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 61
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 62  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 121
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G+++L      + VHRD+ A N +LD K   K+AD
Sbjct: 122 RNETHNPTV----KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 175 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 5   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 63
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 64  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G+++L      + VHRD+ A N +LD K   K+AD
Sbjct: 124 RNETHNPTV----KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 117/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 6   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 64
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 65  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 124
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G+++L      + VHRD+ A N +LD K   K+AD
Sbjct: 125 RNETHNPTV----KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR  +     S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 178 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +       + GTL Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 82
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D+ A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 194
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E ++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 82
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E ++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLS---DM 137
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 193
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 264 LGHGGYGEIFK-GTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           LG G +G++ K      G ++A K +        +E+ NE+ +M++  H NL+Q      
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 323 TKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
           +K D  +V E+V    L DRI+ +     ELD     + +    EG+ ++H   QM I+H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMH---QMYILH 210
Query: 382 RDIKASNIL---LDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
            D+K  NIL    D K + KI DFGLAR     + L  N    GT  ++APE +    ++
Sbjct: 211 LDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFVS 266
Query: 439 EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
              D++S GV+   ++SG+  + F  D+  ETL
Sbjct: 267 FPTDMWSVGVIAYMLLSGL--SPFLGDNDAETL 297

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 69  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +       + GTL Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPP 178
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 249
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 305
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGL R     +     TA  G    + + APE    G+ T 
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 361
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 362 KSDVWSFGILLTELTT 377

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 92  RHPNILRLYGYFH---DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +       + GTL Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RDDLCGTLDYLPP 201
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ--DGREIAVK----RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +G G +GE+  G L+    +EI+V     ++  + K R ++   E  IM +  H N+++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G     K   +V E ++N SLD  L   K   +    +   ++ G A G++YL     M
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A NIL++     K++DFGL+R    +    P  A     G     + +PE I
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD----PEAAYTTRGGKIPIRWTSPEAI 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
           A  + T   D++S+G+++ E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGRE---IAVKRL-FISRKNRIKEICNEMDIMSRAHH 311
           + F +  K+G G +GE+FKG   D R    +A+K +     ++ I++I  E+ ++S+   
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 84
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKS-LDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
             + ++ G        +++ E++   S LD  L +P     LD  +   I+    +GL+Y
Sbjct: 85  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP---LDETQIATILREILKGLDY 139
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH + +   +HRDIKA+N+LL      K+ADFG+A    ++  +  NT + GT  +MAPE
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFV-GTPFWMAPE 194
Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSG 456
            I       K DI+S G+  +E+  G
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARG 220

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMD---------IMSRAHHKNL 314
           LGHG +GE+++G +  G       L ++ K  + E+C+E D         I+S+ +H+N+
Sbjct: 53  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGTAEGLEY 370
           V+ +G        F++ E +    L   L +    P Q   L       +    A G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 371 LHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           L ++     +HRDI A N LL         KI DFG+AR       +     ++LP    
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP---- 223
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 224 ---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 72
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++   +V E++   SL   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 128
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEX----TARQGAKFPIKWTAPEAALYGRFTI 184
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 185 KSDVWSFGILLTELTT 200

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 264 LGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMD---------IMSR 308
           LGHG +GE+++G +          ++AVK L         E+C+E D         I+S+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALIISK 90
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGT 364
            +H+N+V+ +G        F++ E +    L   L +    P Q   L       +    
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSL 414
           A G +YL ++     +HRDI A N LL         KI DFG+AR       +     ++
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           LP       + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 208 LP-------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGRE---IAVKRL-FISRKNRIKEICNEMDIMSRAHH 311
           + F +  K+G G +GE+FKG   D R    +A+K +     ++ I++I  E+ ++S+   
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 64
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKS-LDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
             + ++ G        +++ E++   S LD  L +P     LD  +   I+    +GL+Y
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP---LDETQIATILREILKGLDY 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH + +   +HRDIKA+N+LL      K+ADFG+A    ++  +  NT + GT  +MAPE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFV-GTPFWMAPE 174
Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSG 456
            I       K DI+S G+  +E+  G
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARG 200

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGRE---IAVKRL-FISRKNRIKEICNEMDIMSRAHH 311
           + F +  K+G G +GE+FKG   D R    +A+K +     ++ I++I  E+ ++S+   
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 79
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKS-LDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
             + ++ G        +++ E++   S LD  L +P     LD  +   I+    +GL+Y
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP---LDETQIATILREILKGLDY 134
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH + +   +HRDIKA+N+LL      K+ADFG+A       + +      GT  +MAPE
Sbjct: 135 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPE 189
Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSG 456
            I       K DI+S G+  +E+  G
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARG 215

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 119/256 (46%), Gaps = 51/256 (19%)
Query: 247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDI 305
           KY+  ++    F E   +G GG+G++FK   + DG+   ++R+  + +   +E+      
Sbjct: 3   KYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREV----KA 58
Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII--- 362
           +++  H N+V + GC     D F       + SL+   +DP+  K     K   + I   
Sbjct: 59  LAKLDHVNIVHYNGCW----DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQME 114
Query: 363 ----GTAE-------------------------GLEYLHKDGQMQIVHRDIKASNILLDL 393
               GT E                         G++Y+H     +++HRD+K SNI L  
Sbjct: 115 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVD 171
Query: 394 KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
             + KI DFGL    +S K+    T   GTL YM+PE I++    ++VD+Y+ G+++ E+
Sbjct: 172 TKQVKIGDFGLV---TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 454 V----SGVQNNKFQSD 465
           +    +  + +KF +D
Sbjct: 229 LHVCDTAFETSKFFTD 244

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMD---------IMSRAHHKNL 314
           LGHG +GE+++G +  G       L ++ K  + E+C+E D         I+S+ +H+N+
Sbjct: 38  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGTAEGLEY 370
           V+ +G        F++ E +    L   L +    P Q   L       +    A G +Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 371 LHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           L ++     +HRDI A N LL         KI DFG+AR       +     ++LP    
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP---- 208
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 209 ---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMD---------IMSRAHHKNL 314
           LGHG +GE+++G +  G       L ++ K  + E+C+E D         I+S+ +H+N+
Sbjct: 38  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGTAEGLEY 370
           V+ +G        F++ E +    L   L +    P Q   L       +    A G +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 371 LHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           L ++     +HRDI A N LL         KI DFG+AR       +     ++LP    
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP---- 208
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 209 ---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 264 LGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMD---------IMSR 308
           LGHG +GE+++G +          ++AVK L         E+C+E D         I+S+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALIISK 106
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGT 364
            +H+N+V+ +G        F++ E +    L   L +    P Q   L       +    
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSL 414
           A G +YL ++     +HRDI A N LL         KI DFG+AR       +     ++
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           LP       + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 224 LP-------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMD---------IMSRAHHKNL 314
           LGHG +GE+++G +  G       L ++ K  + E+C+E D         I+S+ +H+N+
Sbjct: 53  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGTAEGLEY 370
           V+ +G        F++ E +    L   L +    P Q   L       +    A G +Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 371 LHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           L ++     +HRDI A N LL         KI DFG+AR       +     ++LP    
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP---- 223
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 224 ---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMD---------IMSRAHHKNL 314
           LGHG +GE+++G +  G       L ++ K  + E+C+E D         I+S+ +H+N+
Sbjct: 56  LGHGAFGEVYEGQV-SGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGTAEGLEY 370
           V+ +G        F++ E +    L   L +    P Q   L       +    A G +Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 371 LHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           L ++     +HRDI A N LL         KI DFG+AR       +     ++LP    
Sbjct: 174 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP---- 226
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 227 ---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I +  +H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INAMLNH 64
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 174
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 264 LGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMD---------IMSR 308
           LGHG +GE+++G +          ++AVK L         E+C+E D         I+S+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALIISK 130
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGT 364
            +H+N+V+ +G        F++ E +    L   L +    P Q   L       +    
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSL 414
           A G +YL ++     +HRDI A N LL         KI DFG+AR       +     ++
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           LP       + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 248 LP-------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGRE---IAVKRL-FISRKNRIKEICNEMDIMSRAHH 311
           + F +  K+G G +GE+FKG   D R    +A+K +     ++ I++I  E+ ++S+   
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 64
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKS-LDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
             + ++ G        +++ E++   S LD  L +P     LD  +   I+    +GL+Y
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP---LDETQIATILREILKGLDY 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH + +   +HRDIKA+N+LL      K+ADFG+A       + +      GT  +MAPE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPE 174
Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSG 456
            I       K DI+S G+  +E+  G
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARG 200

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLV 315
           + +  K+G G YG ++K     GR +A+KR+ +  ++         E+ ++   HH N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
             +    +++   +V+EF++ K L ++L   + K  L   +  + +     G+ + H   
Sbjct: 83  SLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCH--- 136
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI-A 433
           Q +I+HRD+K  N+L++     K+ADFGLAR F    +S    T    TL Y AP+ +  
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY---THEVVTLWYRAPDVLMG 193
Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
           + + +  VDI+S G +  E+++G
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITG 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 109/204 (53%), Gaps = 13/204 (6%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNL 314
           + ++   +LG G +G+++K   ++   +A  ++  ++ +  +++   E++I++   H  +
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 70
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ LG  +     +++ EF    ++D I+ +    + L   +  V+     E L +LH  
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              +I+HRD+KA N+L+ L+   ++ADFG++  + + K+L    +  GT  +MAPE +  
Sbjct: 129 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 435 GQLTE-----KVDIYSFGVLVLEI 453
             + +     K DI+S G+ ++E+
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEM 207

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 264 LGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMD---------IMSR 308
           LGHG +GE+++G +          ++AVK L         E+C+E D         I+S+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALIISK 90
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGT 364
            +H+N+V+ +G        F++ E +    L   L +    P Q   L       +    
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSL 414
           A G +YL ++     +HRDI A N LL         KI DFG+AR       +     ++
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           LP       + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 208 LP-------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLV 315
           + +  K+G G YG ++K     GR +A+KR+ +  ++         E+ ++   HH N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
             +    +++   +V+EF++ K L ++L   + K  L   +  + +     G+ + H   
Sbjct: 83  SLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCH--- 136
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI-A 433
           Q +I+HRD+K  N+L++     K+ADFGLAR F    +S    T    TL Y AP+ +  
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY---THEVVTLWYRAPDVLMG 193
Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
           + + +  VDI+S G +  E+++G
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 82
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++    L   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 194
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G      D+  VY  ++   L  +  + ++  + D ++    I   A  L 
Sbjct: 69  RHPNILRLYGYF---HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +       + GTL Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RDDLCGTLDYLPP 178
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMD---------IMSRAHHKNL 314
           LGHG +GE+++G +  G       L ++ K  + E+C+E D         I+S+ +H+N+
Sbjct: 30  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGTAEGLEY 370
           V+ +G        F++ E +    L   L +    P Q   L       +    A G +Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 371 LHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           L ++     +HRDI A N LL         KI DFG+AR       +     ++LP    
Sbjct: 148 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP---- 200
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 201 ---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 109/204 (53%), Gaps = 13/204 (6%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNL 314
           + ++   +LG G +G+++K   ++   +A  ++  ++ +  +++   E++I++   H  +
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ LG  +     +++ EF    ++D I+ +    + L   +  V+     E L +LH  
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              +I+HRD+KA N+L+ L+   ++ADFG++  + + K+L    +  GT  +MAPE +  
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 435 GQLTE-----KVDIYSFGVLVLEI 453
             + +     K DI+S G+ ++E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 264 LGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMD---------IMSR 308
           LGHG +GE+++G +          ++AVK L         E+C+E D         I+S+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALIISK 96
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGT 364
            +H+N+V+ +G        F++ E +    L   L +    P Q   L       +    
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSL 414
           A G +YL ++     +HRDI A N LL         KI DFG+AR       +     ++
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           LP       + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 214 LP-------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ L    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQ-LYAVV 82
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +++  ++V E++    L   L   +  K L   +   +    A G+ Y+ +   M  VHR
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D++A+NIL+      K+ADFGLAR     +     TA  G    + + APE    G+ T 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTI 194
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFG+L+ E+ +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 116/236 (49%), Gaps = 42/236 (17%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSR 308
           ++  A+D F+E   LG G +G++ K     D R  A+K++  + + ++  I +E+ +++ 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLAS 58
Query: 309 AHHKNLVQFLGCCFTKKD-------------SFVVYEFVQNKSLDRILFDPKQKKELD-- 353
            +H+ +V++      +++              F+  E+ +N++L  ++      ++ D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY 118
Query: 354 WKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS 413
           W+    I+    E L Y+H  G   I+HRD+K  NI +D     KI DFGLA+  +  +S
Sbjct: 119 WRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK--NVHRS 169
Query: 414 L---------LPN-----TAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIV 454
           L         LP      T+  GT  Y+A E +   G   EK+D+YS G++  E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 13/208 (6%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKN 313
           + F + +++G G +GE++KG     +E+   ++      ++ I++I  E+ ++S+     
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKS-LDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           + ++ G        +++ E++   S LD +   P ++  +    R ++     +GL+YLH
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYLH 133
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
            + +   +HRDIKA+N+LL  +   K+ADFG+A       + +      GT  +MAPE I
Sbjct: 134 SERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVI 188
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSGVQNN 460
                  K DI+S G+  +E+  G   N
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPPN 216

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 18/236 (7%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL--QDGREI--AV 285
           + +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL   DG++I  AV
Sbjct: 6   VHIDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 64
Query: 286 KRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRIL 343
           K L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L   +
Sbjct: 65  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 124
Query: 344 FDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
            +      +    + +I  G   A+G+++L      + VHRD+ A N +LD K   K+AD
Sbjct: 125 RNETHNPTV----KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 402 FGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           FGLAR        S+   T     + +MA E +   + T K D++SFGVL+ E+++
Sbjct: 178 FGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 62
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 118
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 119 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 172
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 264 LGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMD---------IMSR 308
           LGHG +GE+++G +          ++AVK L         E+C+E D         I+S+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALIISK 116
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGT 364
            +H+N+V+ +G        F++ E +    L   L +    P Q   L       +    
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSL 414
           A G +YL ++     +HRDI A N LL         KI DFG+AR       +     ++
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           LP       + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 234 LP-------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 64
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 174
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRI---KEICNEMDIMSRA 309
           A + F+    LG G +G ++    +  + I A+K LF ++  +     ++  E++I S  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++  G        +++ E+     + + L   ++  + D ++    I   A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           Y H     +++HRDIK  N+LL      KIADFG +  + S +       + GTL Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLXGTLDYLPP 180
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E I      EKVD++S GVL  E + G
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 64
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 174
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 64
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 174
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 64
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 174
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 64
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 174
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMXGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 64
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 174
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMXGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 263 KLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G +       LQD  G  +AVK+L  S +  +++   E++I+    H N+V++
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 318 LGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            G C++  +++  ++ E++   SL   L      + +D  K         +G+EYL   G
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL---G 134
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT-LGYMAPEYIAN 434
             + +HRD+   NIL++ ++R KI DFGL +    +K          + + + APE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNK 461
            + +   D++SFGV++ E+ + ++ +K
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSK 221

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 111/245 (45%), Gaps = 23/245 (9%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRL---FISRKNRIKEICNEMDIMSRA 309
             D F+    LG G +G++    +++ G   AVK L    I + + ++    E  I+S A
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 310 HHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            +   +  L CCF   D  F V EFV    L   +F  ++ +  D  +           L
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISAL 137
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMA 428
            +LH  G   I++RD+K  N+LLD +   K+ADFG+ +        +      GT  Y+A
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIA 192
Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQS---DDGFETL-----VTHTWKHFQ 480
           PE +        VD ++ GVL+ E++ G  +  F++   DD FE +     V  TW H  
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCG--HAPFEAENEDDLFEAILNDEVVYPTWLHED 250
Query: 481 AKTVL 485
           A  +L
Sbjct: 251 ATGIL 255

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G YGE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMXGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 264 LGHGGYGEIFKGTL----QDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +G G  GE+  G L    Q    +A+K L   +  R+ R  +  +E  IM +  H N+++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--DFLSEASIMGQFDHPNIIR 114
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             G     + + +V E+++N SLD  L       +    +   ++ G   G+ YL   G 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEY 431
              VHRD+ A N+L+D     K++DFGL+R    +    P+ A   T G     + APE 
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD----PDAAXTTTGGKIPIRWTAPEA 225
Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
           IA    +   D++SFGV++ E+++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 110/215 (51%), Gaps = 13/215 (6%)
Query: 249 STIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRL--FISRKNRIKEICNEMDIM 306
           + I    + F +  ++G G +GE+FKG     +++   ++      ++ I++I  E+ ++
Sbjct: 16  NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKS-LDRILFDPKQKKELDWKKRHVIIIGTA 365
           S+     + ++ G        +++ E++   S LD +   P  + ++    + ++     
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL----- 130
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
           +GL+YLH + +   +HRDIKA+N+LL  +   K+ADFG+A    ++  +  NT + GT  
Sbjct: 131 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFV-GTPF 185
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNN 460
           +MAPE I       K DI+S G+  +E+  G   N
Sbjct: 186 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 220

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 264 LGHGGYGEIFKGTL----QDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +G G  GE+  G L    Q    +A+K L   +  R+ R  +  +E  IM +  H N+++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--DFLSEASIMGQFDHPNIIR 114
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             G     + + +V E+++N SLD  L       +    +   ++ G   G+ YL   G 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEY 431
              VHRD+ A N+L+D     K++DFGL+R    +    P+ A   T G     + APE 
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD----PDAAYTTTGGKIPIRWTAPEA 225
Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
           IA    +   D++SFGV++ E+++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 16/219 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRLF---ISRKNRIKEICNEMDIMSRAHH 311
           D F+    LG G +G ++    +    I A+K LF   I ++    ++  E++I +  HH
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
            N+++     + ++  +++ E+     L + L   ++    D ++   I+   A+ L Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H     +++HRDIK  N+LL LK   KIADFG +  + S    L    + GTL Y+ PE 
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPS----LRRKTMCGTLDYLPPEM 192
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET 470
           I      EKVD++  GVL  E++ G  N  F+S    ET
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVG--NPPFESASHNET 229

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 104
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
           C    +  +    + +N  L + +   ++    D              LEYLH  G   I
Sbjct: 105 CFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG---I 158
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +      +
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 218
Query: 440 KVDIYSFGVLVLEIVSGV 457
             D+++ G ++ ++V+G+
Sbjct: 219 SSDLWALGCIIYQLVAGL 236

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 114/248 (45%), Gaps = 26/248 (10%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREI 283
           M+ D   L +  + L +  S  E   D  +    LG G +G++ +            R +
Sbjct: 2   MDPDELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTV 61
Query: 284 AVKRLFI-SRKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSL 339
           AVK L   +  +  + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L
Sbjct: 62  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNL 120
Query: 340 DRIL------FDPKQKKELDWKK----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKAS 387
              L      F P +  E  +K      H+I      A+G+E+L      + +HRD+ A 
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAAR 177
Query: 388 NILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFG 447
           NILL  K+  KI DFGLAR    +   +        L +MAPE I +   T + D++SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 448 VLVLEIVS 455
           VL+ EI S
Sbjct: 238 VLLWEIFS 245

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 15/218 (6%)
Query: 243 FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EIC 300
           FL  K    E   D F++ ++LG G  G +FK + +  G  +A K + +  K  I+ +I 
Sbjct: 55  FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 114
Query: 301 NEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
            E+ ++   +   +V F G  ++  +  +  E +   SLD++L    +  E    K  + 
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 174
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA- 419
           +I   +GL YL +  + +I+HRD+K SNIL++ +   K+ DFG++        L+ + A 
Sbjct: 175 VI---KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMAN 223
Query: 420 -IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
              GT  YM+PE +     + + DI+S G+ ++E+  G
Sbjct: 224 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLV 315
           +D    LG G YGE+     +   E +AVK + + R     E I  E+ I    +H+N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           +F G        ++  E+     L DRI  D    +    +  H ++ G      YLH  
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI 124
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEY 431
           G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+APE 
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMXGTLPYVAPEL 178
Query: 432 IANGQL-TEKVDIYSFGVLVLEIVSG 456
           +   +   E VD++S G+++  +++G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLV 315
           +D    LG G YGE+     +   E +AVK + + R     E I  E+ I    +H+N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           +F G        ++  E+     L DRI  D    +    +  H ++ G      YLH  
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI 123
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEY 431
           G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+APE 
Sbjct: 124 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMXGTLPYVAPEL 177
Query: 432 IANGQL-TEKVDIYSFGVLVLEIVSG 456
           +   +   E VD++S G+++  +++G
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLV 315
           +D    LG G YGE+     +   E +AVK + + R     E I  E+ I    +H+N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           +F G        ++  E+     L DRI  D    +    +  H ++ G      YLH  
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI 123
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEY 431
           G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+APE 
Sbjct: 124 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYVAPEL 177
Query: 432 IANGQL-TEKVDIYSFGVLVLEIVSG 456
           +   +   E VD++S G+++  +++G
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 11/216 (5%)
Query: 243 FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EIC 300
           FL  K    E   D F+  ++LG G  G + K   +  G  +A K + +  K  I+ +I 
Sbjct: 3   FLTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII 62
Query: 301 NEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
            E+ ++   +   +V F G  ++  +  +  E +   SLD++L + K+  E    K   +
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---V 119
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
            I    GL YL +  + QI+HRD+K SNIL++ +   K+ DFG+   S      + N+ +
Sbjct: 120 SIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFV 174
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            GT  YMAPE +     + + DI+S G+ ++E+  G
Sbjct: 175 -GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLVGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S GV++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMD---------IMSRAHHKNL 314
           LGHG +GE+++G +  G       L ++ K  + E+C+E D         I+S+ +H+N+
Sbjct: 39  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGTAEGLEY 370
           V+ +G        F++ E +    L   L +    P Q   L       +    A G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 371 LHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           L ++     +HRDI A N LL         KI DFG+A+       +     ++LP    
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLP---- 209
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 210 ---VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 115/236 (48%), Gaps = 42/236 (17%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSR 308
           ++  A+D F+E   LG G +G++ K     D R  A+K++  + + ++  I +E+ +++ 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLAS 58
Query: 309 AHHKNLVQFLGCCFTKKD-------------SFVVYEFVQNKSLDRILFDPKQKKELD-- 353
            +H+ +V++      +++              F+  E+ +N +L  ++      ++ D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 354 WKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS 413
           W+    I+    E L Y+H  G   I+HRD+K  NI +D     KI DFGLA+  +  +S
Sbjct: 119 WRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK--NVHRS 169
Query: 414 L---------LPN-----TAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIV 454
           L         LP      T+  GT  Y+A E +   G   EK+D+YS G++  E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 116/231 (50%), Gaps = 15/231 (6%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRL 288
           +E+D     +   FL  K    E   D F++ ++LG G  G +FK + +  G  +A K +
Sbjct: 7   LELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI 66
Query: 289 FISRKNRIK-EICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPK 347
            +  K  I+ +I  E+ ++   +   +V F G  ++  +  +  E +   SLD++L    
Sbjct: 67  HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 126
Query: 348 QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF 407
           +  E    K  + +I   +GL YL +  + +I+HRD+K SNIL++ +   K+ DFG++  
Sbjct: 127 RIPEQILGKVSIAVI---KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-- 179
Query: 408 SSSEKSLLPNTA--IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
                 L+ + A    GT  YM+PE +     + + DI+S G+ ++E+  G
Sbjct: 180 ----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFI------SRKNRIKEICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T    G+E AV ++ +      +  +  + + +E+ IMS    H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
             LG C       V+ E+      D + F  ++ + L+      I   TA   + LH   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYG--DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 376 QM----------QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
           Q+            +HRD+ A N+LL   H  KI DFGLAR   ++ + +        + 
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MAPE I +   T + D++S+G+L+ EI S
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLVGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S GV++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFI------SRKNRIKEICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T    G+E AV ++ +      +  +  + + +E+ IMS    H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIIIGT 364
             LG C       V+ E+     L   L           ++P    E     R ++   +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 365 --AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG 422
             A+G+ +L        +HRD+ A N+LL   H  KI DFGLAR   ++ + +       
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            + +MAPE I +   T + D++S+G+L+ EI S
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 97  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 150
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E       A  GT  Y++PE +    
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKS 208
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 209 ACKSSDLWALGCIIYQLVAGL 229

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQ--DGREI--AVKRL---FISRKNRIKEICNEMD 304
           E    C      +G G +GE+  G L+    REI  A+K L   +  ++ R  +  +E  
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEAS 61
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           IM +  H N++   G     K   ++ E+++N SLD  L   K        +   ++ G 
Sbjct: 62  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGI 119
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             G++YL     M  VHRD+ A NIL++     K++DFG++R    +    P  A     
Sbjct: 120 GSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD----PEAAYTTRG 172
Query: 425 G-----YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           G     + APE IA  + T   D++S+G+++ E++S
Sbjct: 173 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 257 CFDESNKLGHGGYGEIFKGTLQ--DGREI--AVKRL---FISRKNRIKEICNEMDIMSRA 309
           C      +G G +GE+  G L+    REI  A+K L   +  ++ R  +  +E  IM + 
Sbjct: 30  CIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQF 87
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N++   G     K   ++ E+++N SLD  L   K        +   ++ G   G++
Sbjct: 88  DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMK 145
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG---- 425
           YL     M  VHRD+ A NIL++     K++DFG++R    +    P  A     G    
Sbjct: 146 YLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD----PEAAYTTRGGKIPI 198
Query: 426 -YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            + APE IA  + T   D++S+G+++ E++S
Sbjct: 199 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLV 315
           F+    LG GG+G +F+   + D    A+KR+ +  +   +E +  E+  +++  H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQ--KKE--LDW---------KKRHV--- 359
           ++      K  +    E +Q  S    L+   Q  +KE   DW         ++R V   
Sbjct: 67  RYFNAWLEKNTT----EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS----LL 415
           I +  AE +E+LH  G M   HRD+K SNI   +    K+ DFGL      ++     L 
Sbjct: 123 IFLQIAEAVEFLHSKGLM---HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 416 PNTAIA------GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIV 454
           P  A A      GT  YM+PE I     + KVDI+S G+++ E++
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQ--DGREI--AVKRL---FISRKNRIKEICNEMD 304
           E    C      +G G +GE+  G L+    REI  A+K L   +  ++ R  +  +E  
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEAS 67
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           IM +  H N++   G     K   ++ E+++N SLD  L   K        +   ++ G 
Sbjct: 68  IMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGI 125
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             G++YL     M  VHRD+ A NIL++     K++DFG++R    +    P  A     
Sbjct: 126 GSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD----PEAAYTTRG 178
Query: 425 G-----YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           G     + APE IA  + T   D++S+G+++ E++S
Sbjct: 179 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 99  --FTFQDDEKLYFGLSYAKNGCLLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 152
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E       +  GT  Y++PE +    
Sbjct: 153 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 210
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
            ++  D+++ G ++ ++V+G+
Sbjct: 211 ASKSSDLWALGCIIYQLVAGL 231

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 114/236 (48%), Gaps = 42/236 (17%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSR 308
           ++  A+D F+E   LG G +G++ K     D R  A+K++  + + ++  I +E+ +++ 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLAS 58
Query: 309 AHHKNLVQFLGCCFTKKD-------------SFVVYEFVQNKSLDRILFDPKQKKELD-- 353
            +H+ +V++      +++              F+  E+ +N++L  ++      ++ D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY 118
Query: 354 WKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS 413
           W+    I+    E L Y+H  G   I+HR++K  NI +D     KI DFGLA+  +  +S
Sbjct: 119 WRLFRQIL----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK--NVHRS 169
Query: 414 L---------LPN-----TAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIV 454
           L         LP      T+  GT  Y+A E +   G   EK+D YS G++  E +
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 264 LGHGGYGEIFKGTLQ-DGREI--AVKRL-FISRKNRIKEICNEMDIMSR-AHHKNLVQFL 318
           +G G +G++ K  ++ DG  +  A+KR+   + K+  ++   E++++ +  HH N++  L
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 319 GCCFTKKDSFVVYEFVQNKSL------DRIL-FDP------KQKKELDWKKRHVIIIGTA 365
           G C  +   ++  E+  + +L       R+L  DP           L  ++        A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G++YL    Q Q +HRD+ A NIL+   +  KIADFGL+R    ++  +  T     + 
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 196
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MA E +     T   D++S+GVL+ EIVS
Sbjct: 197 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 113/250 (45%), Gaps = 27/250 (10%)
Query: 229 GMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGRE 282
            M+ D   L +  + L +  S  E   D       LG G +G++ +            R 
Sbjct: 2   AMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT 61
Query: 283 IAVKRLFI-SRKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKS 338
           +AVK L   +  +  + + +E+ I+    HH N+V  LG C TK      V+ EF +  +
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGN 120
Query: 339 LDRIL------FDPKQKKELDWKK-----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIK 385
           L   L      F P ++   D  K      H+I      A+G+E+L      + +HRD+ 
Sbjct: 121 LSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLA 177
Query: 386 ASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYS 445
           A NILL  K+  KI DFGLAR    +   +        L +MAPE I +   T + D++S
Sbjct: 178 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 237
Query: 446 FGVLVLEIVS 455
           FGVL+ EI S
Sbjct: 238 FGVLLWEIFS 247

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 264 LGHGGYGEIFKGTLQ-DGREI--AVKRLF-ISRKNRIKEICNEMDIMSR-AHHKNLVQFL 318
           +G G +G++ K  ++ DG  +  A+KR+   + K+  ++   E++++ +  HH N++  L
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 319 GCCFTKKDSFVVYEFVQNKSL------DRIL-FDP------KQKKELDWKKRHVIIIGTA 365
           G C  +   ++  E+  + +L       R+L  DP           L  ++        A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G++YL    Q Q +HRD+ A NIL+   +  KIADFGL+R    ++  +  T     + 
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 206
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MA E +     T   D++S+GVL+ EIVS
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 31/220 (14%)
Query: 264 LGHGGYGEIFKGTL--QDGRE----IAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++ K T     GR     +AVK L   +  + ++++ +E +++ + +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIG 363
             G C       ++ E+ +  SL   L + ++                LD      + +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 364 --------TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
                    ++G++YL    +M++VHRD+ A NIL+    + KI+DFGL+R    E S +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             +     + +MA E + +   T + D++SFGVL+ EIV+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLG 319
            ++G G +G +  G   +  ++A+K +   R+  + E     E ++M +  H  LVQ  G
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            C  +    +V+EF+++  L   L    Q+     +    + +   EG+ YL    +  +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EASV 124
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+ A N L+      K++DFG+ RF   ++    +T     + + +PE  +  + + 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFGVL+ E+ S
Sbjct: 184 KSDVWSFGVLMWEVFS 199

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 15/218 (6%)
Query: 243 FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EIC 300
           FL  K    E   D F++ ++LG G  G +FK + +  G  +A K + +  K  I+ +I 
Sbjct: 12  FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 71
Query: 301 NEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
            E+ ++   +   +V F G  ++  +  +  E +   SLD++L    +  E    K  + 
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 131
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA- 419
           +I   +GL YL +  + +I+HRD+K SNIL++ +   K+ DFG++        L+ + A 
Sbjct: 132 VI---KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMAN 180
Query: 420 -IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
              GT  YM+PE +     + + DI+S G+ ++E+  G
Sbjct: 181 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 31/220 (14%)
Query: 264 LGHGGYGEIFKGTL--QDGRE----IAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++ K T     GR     +AVK L   +  + ++++ +E +++ + +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIG 363
             G C       ++ E+ +  SL   L + ++                LD      + +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 364 --------TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
                    ++G++YL    +M++VHRD+ A NIL+    + KI+DFGL+R    E S +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             +     + +MA E + +   T + D++SFGVL+ EIV+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFI------SRKNRIKEICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T    G+E AV ++ +      +  +  + + +E+ IMS    H+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK--------RHVIIIGT--A 365
             LG C       V+ E+     L   L   ++K E D  K        R ++   +  A
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL---RRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
           +G+ +L        +HRD+ A N+LL   H  KI DFGLAR   ++ + +        + 
Sbjct: 163 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MAPE I +   T + D++S+G+L+ EI S
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 115/248 (46%), Gaps = 27/248 (10%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREI 283
           M+ D   L +  + L +  S  E   D       LG G +G++ +            R +
Sbjct: 3   MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTV 62
Query: 284 AVKRLFI-SRKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSL 339
           AVK L   +  +  + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L
Sbjct: 63  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNL 121
Query: 340 DRIL------FDPKQKKELDWKK----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKAS 387
              L      F P + ++L +K      H+I      A+G+E+L      + +HRD+ A 
Sbjct: 122 STYLRSKRNEFVPYKPEDL-YKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAAR 177
Query: 388 NILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFG 447
           NILL  K+  KI DFGLAR    +   +        L +MAPE I +   T + D++SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 448 VLVLEIVS 455
           VL+ EI S
Sbjct: 238 VLLWEIFS 245

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 100 --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 153
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E       +  GT  Y++PE +    
Sbjct: 154 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 211
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 212 ACKSSDLWALGCIIYQLVAGL 232

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 113/225 (50%), Gaps = 21/225 (9%)
Query: 262 NKLGHGGYGEIF--KGTLQDGREIAVKRLFI---SRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +KLG GG   ++  + T+ + + +A+K +FI    ++  +K    E+   S+  H+N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
            +         ++V E+++  +L   +   +    L             +G+++ H    
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           M+IVHRDIK  NIL+D     KI DFG+A+ + SE SL     + GT+ Y +PE  A G+
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQ-AKGE 187
Query: 437 LTEK-VDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ 480
            T++  DIYS G+++ E++ G     F      ET V+   KH Q
Sbjct: 188 ATDECTDIYSIGIVLYEMLVG--EPPFNG----ETAVSIAIKHIQ 226

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFI------SRKNRIKEICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T    G+E AV ++ +      +  +  + + +E+ IMS    H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK--------RHVIIIGT--A 365
             LG C       V+ E+     L   L   ++K E D  K        R ++   +  A
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFL---RRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
           +G+ +L        +HRD+ A N+LL   H  KI DFGLAR   ++ + +        + 
Sbjct: 171 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MAPE I +   T + D++S+G+L+ EI S
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 96  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 149
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E       +  GT  Y++PE +    
Sbjct: 150 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 207
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 208 ACKSSDLWALGCIIYQLVAGL 228

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 258 FDESNK---LGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
           +DE+     LG G YG ++ G  L +   IA+K +        + +  E+ +     HKN
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL---FDPKQKKE--LDWKKRHVIIIGTAEGL 368
           +VQ+LG         +  E V   SL  +L   + P +  E  + +  + ++     EGL
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGL 135
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLARFSSSEKSLLPNT-AIAGTLGY 426
           +YLH +   QIVHRDIK  N+L++      KI+DFG ++  +    + P T    GTL Y
Sbjct: 136 KYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQY 189
Query: 427 MAPEYIANGQ--LTEKVDIYSFGVLVLEIVSG 456
           MAPE I  G     +  DI+S G  ++E+ +G
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 264 LGHGGYGEIF---KGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++F   K +  D R++     +K+  +  ++R++    E DI+   +H  +V+
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVK 90
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T+   +++ +F++   L   L       E D K     +   A  L++LH  G 
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLAELALALDHLHSLG- 146
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I++RD+K  NILLD +   K+ DFGL++ S   +      +  GT+ YMAPE +    
Sbjct: 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG 202
Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            T+  D +SFGVL+ E+++G     FQ  D  ET+ 
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTL--PFQGKDRKETMT 236

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 113/245 (46%), Gaps = 23/245 (9%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREI 283
           M+ D   L +  + L +  S  E   D  +    LG G +G++ +            R +
Sbjct: 1   MDPDELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTV 60
Query: 284 AVKRLFI-SRKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSL 339
           AVK L   +  +  + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNL 119
Query: 340 DRIL------FDPKQKKELDWKK-RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNIL 390
              L      F P +    D+    H+I      A+G+E+L      + +HRD+ A NIL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNIL 176
Query: 391 LDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLV 450
           L  K+  KI DFGLAR    +   +        L +MAPE I +   T + D++SFGVL+
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 451 LEIVS 455
            EI S
Sbjct: 237 WEIFS 241

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 112/249 (44%), Gaps = 27/249 (10%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREI 283
           M+ D   L +  + L +  S  E   D       LG G +G++ +            R +
Sbjct: 1   MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 60
Query: 284 AVKRLFI-SRKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSL 339
           AVK L   +  +  + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNL 119
Query: 340 DRIL------FDPKQKKELDWKK-----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKA 386
              L      F P +    D  K      H+I      A+G+E+L      + +HRD+ A
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 387 SNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSF 446
            NILL  K+  KI DFGLAR    +   +        L +MAPE I +   T + D++SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 447 GVLVLEIVS 455
           GVL+ EI S
Sbjct: 237 GVLLWEIFS 245

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 264 LGHGGYGEIFKGTL--QDGRE----IAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++ K T     GR     +AVK L   +  + ++++ +E +++ + +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIG 363
             G C       ++ E+ +  SL   L + ++                LD      + +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 364 --------TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
                    ++G++YL    +M +VHRD+ A NIL+    + KI+DFGL+R    E S +
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             +     + +MA E + +   T + D++SFGVL+ EIV+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 252 EKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMS 307
           +K  + F     LG G +  +     L   RE A+K L    I ++N++  +  E D+MS
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 308 RAHHKNLVQFLGCCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           R  H   V+     FT +D   +Y    + +N  L + +   ++    D           
Sbjct: 66  RLDHPFFVKLY---FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEI 119
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
              LEYLH  G   I+HRD+K  NILL+     +I DFG A+  S E          GT 
Sbjct: 120 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
            Y++PE +      +  D+++ G ++ ++V+G+
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 209

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 107/231 (46%), Gaps = 23/231 (9%)
Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREIAVKRLFI-SRKNRI 296
           L +  S  E   D  +    LG G +G++ +            R +AVK L   +  +  
Sbjct: 15  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 74
Query: 297 KEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSLDRIL------FDPK 347
           + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L   L      F P 
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 348 QKKELDWKK-RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL 404
           +    D+    H+I      A+G+E+L      + +HRD+ A NILL  K+  KI DFGL
Sbjct: 134 KDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGL 190
Query: 405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           AR    +   +        L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 191 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGE-IFKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +   +    L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 97  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 150
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 209 ACKSSDLWALGCIIYQLVAGL 229

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 101
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 102 --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 155
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 156 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 213
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 214 ACKSSDLWALGCIIYQLVAGL 234

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 109/210 (51%), Gaps = 15/210 (7%)
Query: 251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSR 308
           +E   D F++ ++LG G  G +FK + +  G  +A K + +  K  I+ +I  E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            +   +V F G  ++  +  +  E +   SLD++L    +  E    K  + +I   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI---KGL 117
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA--IAGTLGY 426
            YL +  + +I+HRD+K SNIL++ +   K+ DFG++        L+ + A    GT  Y
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSY 169
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           M+PE +     + + DI+S G+ ++E+  G
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 97  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 150
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 209 ACKSSDLWALGCIIYQLVAGL 229

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           F+P    E     + ++  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR           T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 264 LGHGGYGEIFKGTLQ------DGREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNLV 315
           LGHG +GE+++G +          ++AVK L    S ++ + +   E  I+S+ +H+N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDEL-DFLMEALIISKFNHQNIV 111
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGTAEGLEYL 371
           + +G        F++ E +    L   L +    P Q   L       +    A G +YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 372 HKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLAR-------FSSSEKSLLPNTAIA 421
            ++     +HRDI A N LL         KI DFG+AR       +     ++LP     
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP----- 223
Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             + +M PE    G  T K D +SFGVL+ EI S
Sbjct: 224 --VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT 323
           +G G +G++  G  + G ++AVK   I      +    E  +M++  H NLVQ LG    
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 324 KKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +K   ++V E++   SL   L   + +  L         +   E +EYL  +     VHR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 313
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSL--LPNTAIAGTLGYMAPEYIANGQLTEK 440
           D+ A N+L+   +  K++DFGL + +SS +    LP       + + APE +   + + K
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-------VKWTAPEALREKKFSTK 366
Query: 441 VDIYSFGVLVLEIVS 455
            D++SFG+L+ EI S
Sbjct: 367 SDVWSFGILLWEIYS 381

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 97  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 150
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 209 ACKSSDLWALGCIIYQLVAGL 229

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 252 EKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMS 307
           +K  + F     LG G +  +     L   RE A+K L    I ++N++  +  E D+MS
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 308 RAHHKNLVQFLGCCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           R  H   V+     FT +D   +Y    + +N  L + +   ++    D           
Sbjct: 65  RLDHPFFVKLY---FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEI 118
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
              LEYLH  G   I+HRD+K  NILL+     +I DFG A+  S E          GT 
Sbjct: 119 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
            Y++PE +      +  D+++ G ++ ++V+G+
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           ++   +LG GG+G + +   QD G ++A+K  R  +S KNR +  C E+ IM + +H N+
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR-ERWCLEIQIMKKLNHPNV 75
Query: 315 VQF------LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V        L          +  E+ +   L + L   +    L       ++   +  L
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 135
Query: 369 EYLHKDGQMQIVHRDIKASNILLD-----LKHRPKIADFGLAR-FSSSEKSLLPNTAIAG 422
            YLH++   +I+HRD+K  NI+L      L H  KI D G A+     E      T   G
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIH--KIIDLGYAKELDQGELC----TEFVG 186
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           TL Y+APE +   + T  VD +SFG L  E ++G
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 99  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 152
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 153 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 211 ACKSSDLWALGCIIYQLVAGL 231

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 109/210 (51%), Gaps = 15/210 (7%)
Query: 251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSR 308
           +E   D F++ ++LG G  G +FK + +  G  +A K + +  K  I+ +I  E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            +   +V F G  ++  +  +  E +   SLD++L    +  E    K  + +I   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI---KGL 117
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA--IAGTLGY 426
            YL +  + +I+HRD+K SNIL++ +   K+ DFG++        L+ + A    GT  Y
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSY 169
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           M+PE +     + + DI+S G+ ++E+  G
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           ++   +LG GG+G + +   QD G ++A+K  R  +S KNR +  C E+ IM + +H N+
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR-ERWCLEIQIMKKLNHPNV 74
Query: 315 VQF------LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V        L          +  E+ +   L + L   +    L       ++   +  L
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 369 EYLHKDGQMQIVHRDIKASNILLD-----LKHRPKIADFGLAR-FSSSEKSLLPNTAIAG 422
            YLH++   +I+HRD+K  NI+L      L H  KI D G A+     E      T   G
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIH--KIIDLGYAKELDQGELC----TEFVG 185
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           TL Y+APE +   + T  VD +SFG L  E ++G
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 99  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 152
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 153 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 211 AXKSSDLWALGCIIYQLVAGL 231

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +G +  G  +   ++A+K +     +   E   E  +M    H+ LVQ  G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  F++ E++ N  L   L + + + +   ++   +     E +EYL      Q +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D+ A N L++ +   K++DFGL+R      ++SS  S  P       + +  PE +   +
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFP-------VRWSPPEVLMYSK 182
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + K DI++FGVL+ EI S
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 100 --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 153
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 154 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 211
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 212 ACKSSDLWALGCIIYQLVAGL 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 99  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 152
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 153 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 211 ACKSSDLWALGCIIYQLVAGL 231

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLG 319
            ++G G +G +  G   +  ++A+K +   R+  + E     E ++M +  H  LVQ  G
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            C  +    +V+EF+++  L   L    Q+     +    + +   EG+ YL    +  +
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+ A N L+      K++DFG+ RF   ++    +T     + + +PE  +  + + 
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFGVL+ E+ S
Sbjct: 182 KSDVWSFGVLMWEVFS 197

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 258 FDESNK---LGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
           +DE+     LG G YG ++ G  L +   IA+K +        + +  E+ +     HKN
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 66
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL---FDPKQKKE--LDWKKRHVIIIGTAEGL 368
           +VQ+LG         +  E V   SL  +L   + P +  E  + +  + ++     EGL
Sbjct: 67  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGL 121
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLARFSSSEKSLLPNT-AIAGTLGY 426
           +YLH +   QIVHRDIK  N+L++      KI+DFG ++  +    + P T    GTL Y
Sbjct: 122 KYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQY 175
Query: 427 MAPEYIANGQ--LTEKVDIYSFGVLVLEIVSG 456
           MAPE I  G     +  DI+S G  ++E+ +G
Sbjct: 176 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 207

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLG 319
            ++G G +G +  G   +  ++A+K +   R+  + E     E ++M +  H  LVQ  G
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            C  +    +V+EF+++  L   L    Q+     +    + +   EG+ YL    +  +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 124
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+ A N L+      K++DFG+ RF   ++    +T     + + +PE  +  + + 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFGVL+ E+ S
Sbjct: 184 KSDVWSFGVLMWEVFS 199

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 112/249 (44%), Gaps = 27/249 (10%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREI 283
           M+ D   L +  + L +  S  E   D       LG G +G++ +            R +
Sbjct: 1   MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 60
Query: 284 AVKRLFI-SRKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSL 339
           AVK L   +  +  + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNL 119
Query: 340 DRIL------FDPKQKKELDWKK-----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKA 386
              L      F P +    D  K      H+I      A+G+E+L      + +HRD+ A
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 387 SNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSF 446
            NILL  K+  KI DFGLAR    +   +        L +MAPE I +   T + D++SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 447 GVLVLEIVS 455
           GVL+ EI S
Sbjct: 237 GVLLWEIFS 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 112/249 (44%), Gaps = 27/249 (10%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREI 283
           M+ D   L +  + L +  S  E   D       LG G +G++ +            R +
Sbjct: 1   MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 60
Query: 284 AVKRLFI-SRKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSL 339
           AVK L   +  +  + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNL 119
Query: 340 DRIL------FDPKQKKELDWKK-----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKA 386
              L      F P +    D  K      H+I      A+G+E+L      + +HRD+ A
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 387 SNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSF 446
            NILL  K+  KI DFGLAR    +   +        L +MAPE I +   T + D++SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 447 GVLVLEIVS 455
           GVL+ EI S
Sbjct: 237 GVLLWEIFS 245

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 252 EKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMS 307
           +K  + F     LG G +  +     L   RE A+K L    I ++N++  +  E D+MS
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 308 RAHHKNLVQFLGCCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           R  H   V+     FT +D   +Y    + +N  L + +   ++    D           
Sbjct: 63  RLDHPFFVKLY---FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEI 116
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
              LEYLH  G   I+HRD+K  NILL+     +I DFG A+  S E          GT 
Sbjct: 117 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
            Y++PE +      +  D+++ G ++ ++V+G+
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 206

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 18/215 (8%)
Query: 264 LGHGGYGEIF---KGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++F   K +  D R++     +K+  +  ++R++    E DI+   +H  +V+
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVK 90
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T+   +++ +F++   L   L       E D K     +   A  L++LH  G 
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLAELALALDHLHSLG- 146
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I++RD+K  NILLD +   K+ DFGL++ S   +      +  GT+ YMAPE +    
Sbjct: 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG 202
Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
            T+  D +SFGVL+ E+++G     FQ  D  ET+
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTL--PFQGKDRKETM 235

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 252 EKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMS 307
           +K  + F     LG G +  +     L   RE A+K L    I ++N++  +  E D+MS
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 308 RAHHKNLVQFLGCCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           R  H   V+     FT +D   +Y    + +N  L + +   ++    D           
Sbjct: 64  RLDHPFFVKLY---FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEI 117
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
              LEYLH  G   I+HRD+K  NILL+     +I DFG A+  S E          GT 
Sbjct: 118 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
            Y++PE +      +  D+++ G ++ ++V+G+
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSRA 309
           E   D F++ ++LG G  G +FK + +  G  +A K + +  K  I+ +I  E+ ++   
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           +   +V F G  ++  +  +  E +   SLD++L    +  E    K  + +I   +GL 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI---KGLT 121
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YL +  + +I+HRD+K SNIL++ +   K+ DFG++     E +        GT  YM+P
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA----NEFVGTRSYMSP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E +     + + DI+S G+ ++E+  G
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 18/215 (8%)
Query: 264 LGHGGYGEIF---KGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++F   K +  D R++     +K+  +  ++R++    E DI+   +H  +V+
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVK 91
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T+   +++ +F++   L   L       E D K     +   A  L++LH  G 
Sbjct: 92  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLAELALALDHLHSLG- 147
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I++RD+K  NILLD +   K+ DFGL++ S   +      +  GT+ YMAPE +    
Sbjct: 148 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRG 203
Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
            T+  D +SFGVL+ E+++G     FQ  D  ET+
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTL--PFQGKDRKETM 236

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 99  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 152
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 153 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 211 ACKSSDLWALGCIIYQLVAGL 231

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISR-----KNRIKEICNEMDIMSRAHH 311
           +D    LG G  GE+     +   E +AVK + + R     +N  KEIC    I    +H
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC----INKMLNH 63
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           +N+V+F G        ++  E+     L DRI  D    +    +  H ++ G      Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYM 427
           LH  G   I HRDIK  N+LLD +   KI+DFGLA   R+++ E+ L     + GTL Y+
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---NKMCGTLPYV 173
Query: 428 APEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           APE +   +   E VD++S G+++  +++G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 96  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 149
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 150 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 207
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 208 ACKSSDLWALGCIIYQLVAGL 228

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLG 319
            ++G G +G +  G   +  ++A+K +   R+  + E     E ++M +  H  LVQ  G
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            C  +    +V+EF+++  L   L    Q+     +    + +   EG+ YL    +  +
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 127
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+ A N L+      K++DFG+ RF   ++    +T     + + +PE  +  + + 
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFGVL+ E+ S
Sbjct: 187 KSDVWSFGVLMWEVFS 202

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 109/210 (51%), Gaps = 15/210 (7%)
Query: 251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSR 308
           +E   D F++ ++LG G  G +FK + +  G  +A K + +  K  I+ +I  E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            +   +V F G  ++  +  +  E +   SLD++L    +  E    K  + +I   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI---KGL 117
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA--IAGTLGY 426
            YL +  + +I+HRD+K SNIL++ +   K+ DFG++        L+ + A    GT  Y
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSY 169
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           M+PE +     + + DI+S G+ ++E+  G
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 109/210 (51%), Gaps = 15/210 (7%)
Query: 251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSR 308
           +E   D F++ ++LG G  G +FK + +  G  +A K + +  K  I+ +I  E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            +   +V F G  ++  +  +  E +   SLD++L    +  E    K  + +I   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI---KGL 117
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA--IAGTLGY 426
            YL +  + +I+HRD+K SNIL++ +   K+ DFG++        L+ + A    GT  Y
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSY 169
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           M+PE +     + + DI+S G+ ++E+  G
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 114/229 (49%), Gaps = 26/229 (11%)
Query: 245 QFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEM 303
           +   S +      F+    +G+G YG+++KG  ++ G+  A+K + ++  +  +EI  E+
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEI 71
Query: 304 DIMSR-AHHKNLVQFLGCCFTKKDS-------FVVYEFVQNKSLDRILFDPKQKKELDWK 355
           +++ + +HH+N+  + G  F KK+        ++V EF    S+  ++   K  K    K
Sbjct: 72  NMLKKYSHHRNIATYYGA-FIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLK 127
Query: 356 KRHVIII--GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS 413
           +  +  I      GL +LH   Q +++HRDIK  N+LL      K+ DFG++  +  +++
Sbjct: 128 EEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRT 182
Query: 414 LLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGV 457
           +       GT  +MAPE IA     +     K D++S G+  +E+  G 
Sbjct: 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 99  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 152
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 153 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 211 ACKSSDLWALGCIIYQLVAGL 231

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 109/210 (51%), Gaps = 15/210 (7%)
Query: 251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIK-EICNEMDIMSR 308
           +E   D F++ ++LG G  G +FK + +  G  +A K + +  K  I+ +I  E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            +   +V F G  ++  +  +  E +   SLD++L    +  E    K  + +I   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI---KGL 117
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA--IAGTLGY 426
            YL +  + +I+HRD+K SNIL++ +   K+ DFG++        L+ + A    GT  Y
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSY 169
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           M+PE +     + + DI+S G+ ++E+  G
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 118/229 (51%), Gaps = 32/229 (13%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           F E   +G GG+G++FK   + DG+   +KR+    K   ++   E+  +++  H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVH 68
Query: 317 FLGCC--------FTKKDS--------FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
           + GC          + K+S        F+  EF    +L++ + + ++ ++LD      +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
                +G++Y+H     ++++RD+K SNI L    + KI DFGL    +S K+       
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLV---TSLKNDGKRXRS 181
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIV----SGVQNNKFQSD 465
            GTL YM+PE I++    ++VD+Y+ G+++ E++    +  + +KF +D
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT 323
           +G G +G++  G  + G ++AVK   I      +    E  +M++  H NLVQ LG    
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 324 KKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +K   ++V E++   SL   L   + +  L         +   E +EYL  +     VHR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 132
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSL--LPNTAIAGTLGYMAPEYIANGQLTEK 440
           D+ A N+L+   +  K++DFGL + +SS +    LP       + + APE +     + K
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-------VKWTAPEALREAAFSTK 185
Query: 441 VDIYSFGVLVLEIVS 455
            D++SFG+L+ EI S
Sbjct: 186 SDVWSFGILLWEIYS 200

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFI------SRKNRIKEICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T    G+E AV ++ +      +  +  + + +E+ IMS    H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
             LG C       V+ E+      D + F  ++ + L+      I   T    + LH   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYG--DLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 376 QM----------QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
           Q+            +HRD+ A N+LL   H  KI DFGLAR   ++ + +        + 
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MAPE I +   T + D++S+G+L+ EI S
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +     L   RE A+K L    I ++N++  +  E D+MSR  H   V+   
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 80
Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
             FT +D   +Y    + +N  L + +   ++    D              LEYLH  G 
Sbjct: 81  --FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG- 134
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I+HRD+K  NILL+     +I DFG A+  S E          GT  Y++PE +    
Sbjct: 135 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 192
Query: 437 LTEKVDIYSFGVLVLEIVSGV 457
             +  D+++ G ++ ++V+G+
Sbjct: 193 ACKSSDLWALGCIIYQLVAGL 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 249 STIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEIC------N 301
           +T    +D ++    LG GG  E+     L+D R++AVK L   R +  ++         
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRR 61
Query: 302 EMDIMSRAHHKNLVQFLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKR 357
           E    +  +H  +V        +  +    ++V E+V   +L  I+     +  +  K+ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRA 118
Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLP 416
             +I    + L + H++G   I+HRD+K +NIL+   +  K+ DFG+AR  + S  S+  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ 175
Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             A+ GT  Y++PE      +  + D+YS G ++ E+++G
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT 323
           +G G +G++  G  + G ++AVK   I      +    E  +M++  H NLVQ LG    
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 324 KKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +K   ++V E++   SL   L   + +  L         +   E +EYL  +     VHR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 141
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSL--LPNTAIAGTLGYMAPEYIANGQLTEK 440
           D+ A N+L+   +  K++DFGL + +SS +    LP       + + APE +   + + K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-------VKWTAPEALREKKFSTK 194
Query: 441 VDIYSFGVLVLEIVS 455
            D++SFG+L+ EI S
Sbjct: 195 SDVWSFGILLWEIYS 209

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +G +  G  +   ++A+K +     +   E   E  +M    H+ LVQ  G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  F++ E++ N  L   L + + + +   ++   +     E +EYL      Q +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT---LGYMAPEYIANGQLTE 439
           D+ A N L++ +   K++DFGL+R+   ++     T+  G+   + +  PE +   + + 
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE----ETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 440 KVDIYSFGVLVLEIVS 455
           K DI++FGVL+ EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 106/235 (45%), Gaps = 27/235 (11%)
Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREIAVKRLFI-SRKNRI 296
           L +  S  E   D       LG G +G++ +            R +AVK L   +  +  
Sbjct: 6   LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 297 KEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSLDRIL------FDPK 347
           + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L   L      F P 
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 124
Query: 348 QKKELDWKK-----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA 400
           +    D  K      H+I      A+G+E+L      + +HRD+ A NILL  K+  KI 
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 181
Query: 401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           DFGLAR    +   +        L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 182 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLVGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT 323
           +G G +G++  G  + G ++AVK   I      +    E  +M++  H NLVQ LG    
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 324 KKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
           +K   ++V E++   SL   L   + +  L         +   E +EYL  +     VHR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 126
Query: 383 DIKASNILLDLKHRPKIADFGLARFSSSEKSL--LPNTAIAGTLGYMAPEYIANGQLTEK 440
           D+ A N+L+   +  K++DFGL + +SS +    LP       + + APE +   + + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-------VKWTAPEALREKKFSTK 179
Query: 441 VDIYSFGVLVLEIVS 455
            D++SFG+L+ EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +G +  G  +   ++A+K +     +   E   E  +M    H+ LVQ  G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  F++ E++ N  L   L + + + +   ++   +     E +EYL      Q +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D+ A N L++ +   K++DFGL+R      ++SS  S  P       + +  PE +   +
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-------VRWSPPEVLMYSK 197
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + K DI++FGVL+ EI S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 106/235 (45%), Gaps = 27/235 (11%)
Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREIAVKRLFI-SRKNRI 296
           L +  S  E   D       LG G +G++ +            R +AVK L   +  +  
Sbjct: 6   LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 297 KEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSLDRIL------FDPK 347
           + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L   L      F P 
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 348 QKKELDWKK-----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA 400
           +    D  K      H+I      A+G+E+L      + +HRD+ A NILL  K+  KI 
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 181
Query: 401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           DFGLAR    +   +        L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 182 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           ++P    E     + ++  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 198 RLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +G +  G  +   ++A+K +     +   E   E  +M    H+ LVQ  G C 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  F++ E++ N  L   L + + + +   ++   +     E +EYL      Q +HR
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D+ A N L++ +   K++DFGL+R      ++SS  S  P       + +  PE +   +
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-------VRWSPPEVLMYSK 181
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + K DI++FGVL+ EI S
Sbjct: 182 FSSKSDIWAFGVLMWEIYS 200

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 112/249 (44%), Gaps = 27/249 (10%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREI 283
           M+ D   L +  + L +  S  E   D       LG G +G++ +            R +
Sbjct: 38  MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 97
Query: 284 AVKRLFI-SRKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSL 339
           AVK L   +  +  + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L
Sbjct: 98  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNL 156
Query: 340 DRIL------FDPKQKKELDWKK-----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKA 386
              L      F P +    D  K      H+I      A+G+E+L      + +HRD+ A
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 213
Query: 387 SNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSF 446
            NILL  K+  KI DFGLAR    +   +        L +MAPE I +   T + D++SF
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 447 GVLVLEIVS 455
           GVL+ EI S
Sbjct: 274 GVLLWEIFS 282

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           ++P    E     + ++  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 213 RLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 264 LGHGGYGEIFKGTLQ-DGREI--AVKRLF-ISRKNRIKEICNEMDIMSR-AHHKNLVQFL 318
           +G G +G++ K  ++ DG  +  A+KR+   + K+  ++   E++++ +  HH N++  L
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 319 GCCFTKKDSFVVYEFVQNKSL------DRIL-FDP------KQKKELDWKKRHVIIIGTA 365
           G C  +   ++  E+  + +L       R+L  DP           L  ++        A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G++YL    Q Q +HR++ A NIL+   +  KIADFGL+R    ++  +  T     + 
Sbjct: 150 RGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 203
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           +MA E +     T   D++S+GVL+ EIVS
Sbjct: 204 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           ++P    E     + ++  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 213 RLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           ++P    E     + ++  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 206 RLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +G +  G  +   ++A+K +     +   E   E  +M    H+ LVQ  G C 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  F++ E++ N  L   L + + + +   ++   +     E +EYL      Q +HR
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D+ A N L++ +   K++DFGL+R      ++SS  S  P       + +  PE +   +
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-------VRWSPPEVLMYSK 188
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + K DI++FGVL+ EI S
Sbjct: 189 FSSKSDIWAFGVLMWEIYS 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +G +  G  +   ++A+K +     +   E   E  +M    H+ LVQ  G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  F++ E++ N  L   L + + + +   ++   +     E +EYL      Q +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D+ A N L++ +   K++DFGL+R      ++SS  S  P       + +  PE +   +
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-------VRWSPPEVLMYSK 182
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + K DI++FGVL+ EI S
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           ++P    E     + ++  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 202 RLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           ++P    E     + ++  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 213 RLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           ++P    E     + ++  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 254 RLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +G +  G  +   ++A+K +     +   E   E  +M    H+ LVQ  G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            ++  F++ E++ N  L   L + + + +   ++   +     E +EYL      Q +HR
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 383 DIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D+ A N L++ +   K++DFGL+R      ++SS  S  P       + +  PE +   +
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-------VRWSPPEVLMYSK 177
Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + K DI++FGVL+ EI S
Sbjct: 178 FSSKSDIWAFGVLMWEIYS 196

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K       ++AVK L      + + ++ +EM++M     HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQKKELDWKKRHVIII 362
           ++  LG C      +V+ E+    +L   L           ++P    E     + ++  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 363 G--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +   
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 205 RLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 106/235 (45%), Gaps = 27/235 (11%)
Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREIAVKRLFI-SRKNRI 296
           L +  S  E   D       LG G +G++ +            R +AVK L   +  +  
Sbjct: 6   LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 297 KEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSLDRIL------FDPK 347
           + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L   L      F P 
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 348 QKKELDWKK-----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA 400
           +    D  K      H+I      A+G+E+L      + +HRD+ A NILL  K+  KI 
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 181
Query: 401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           DFGLAR    +   +        L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 182 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 106/235 (45%), Gaps = 27/235 (11%)
Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKG------TLQDGREIAVKRLFI-SRKNRI 296
           L +  S  E   D       LG G +G++ +            R +AVK L   +  +  
Sbjct: 6   LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 297 KEICNEMDIMSR-AHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSLDRIL------FDPK 347
           + + +E+ I+    HH N+V  LG C TK      V+ EF +  +L   L      F P 
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 348 QKKELDWKK-----RHVIIIG--TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA 400
           +    D  K      H+I      A+G+E+L      + +HRD+ A NILL  K+  KI 
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 181
Query: 401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           DFGLAR    +   +        L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 182 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 240 SLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEI 299
           SL  + +K   +E+          +G G +G + K   +  +++A+K+  I  ++  K  
Sbjct: 1   SLHMIDYKEIEVEEV---------VGRGAFGVVCKAKWR-AKDVAIKQ--IESESERKAF 48
Query: 300 CNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
             E+  +SR +H N+V+  G C       +V E+ +  SL  +L   +            
Sbjct: 49  IVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLARFSSSEKSLLPNT 418
             +  ++G+ YLH      ++HRD+K  N+LL       KI DFG A      ++ + N 
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNN 163
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              G+  +MAPE       +EK D++S+G+++ E+++
Sbjct: 164 K--GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 198

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 240 SLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEI 299
           SL  + +K   +E+          +G G +G + K   +  +++A+K+  I  ++  K  
Sbjct: 2   SLHMIDYKEIEVEEV---------VGRGAFGVVCKAKWR-AKDVAIKQ--IESESERKAF 49
Query: 300 CNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
             E+  +SR +H N+V+  G C       +V E+ +  SL  +L   +            
Sbjct: 50  IVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 107
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLARFSSSEKSLLPNT 418
             +  ++G+ YLH      ++HRD+K  N+LL       KI DFG A      ++ + N 
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNN 164
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              G+  +MAPE       +EK D++S+G+++ E+++
Sbjct: 165 K--GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 199

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 249 STIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVK--RLFISRKNRIK-EICNEMD 304
           +T    +D ++    LG GG  E+     L+D R++AVK  R  ++R          E  
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 305 IMSRAHHKNLVQFLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
             +  +H  +V        +  +    ++V E+V   +L  I+     +  +  K+   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEV 121
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTA 419
           I    + L + H++G   I+HRD+K +NI++   +  K+ DFG+AR  + S  S+    A
Sbjct: 122 IADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           + GT  Y++PE      +  + D+YS G ++ E+++G
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFI-SRKNRIKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L   + +  + ++ +EM++M     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKS 413
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       + ++   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 220 RLP-------VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLG 319
            ++G G +G +  G   +  ++A+K +   ++  + E     E ++M +  H  LVQ  G
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTI---KEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            C  +    +V+EF+++  L   L    Q+     +    + +   EG+ YL    +  +
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 144
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+ A N L+      K++DFG+ RF   ++    +T     + + +PE  +  + + 
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSS 203
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFGVL+ E+ S
Sbjct: 204 KSDVWSFGVLMWEVFS 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 249 STIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEIC------N 301
           +T    +D ++    LG GG  E+     L+D R++AVK L   R +  ++         
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRR 61
Query: 302 EMDIMSRAHHKNLVQFLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKR 357
           E    +  +H  +V        +  +    ++V E+V   +L  I+     +  +  K+ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRA 118
Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLP 416
             +I    + L + H++G   I+HRD+K +NI++   +  K+ DFG+AR  + S  S+  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             A+ GT  Y++PE      +  + D+YS G ++ E+++G
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 110 LM-DANLXQVI-----QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 161 SDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 453 IV 454
           +V
Sbjct: 218 MV 219

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG   K   + DG+ +  K L        ++  + +E++++    H N+V++   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 321 CFTKKDS--FVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK--DG 375
              + ++  ++V E+ +   L  ++    K+++ LD +    ++      L+  H+  DG
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
              ++HRD+K +N+ LD K   K+ DFGLAR  + + S     A  GT  YM+PE +   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRM 191
Query: 436 QLTEKVDIYSFGVLVLEI 453
              EK DI+S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 263 KLGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +LG G +G++F          QD   +AVK L  + ++  ++   E ++++   H+++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRIL--FDPKQK----------KELDWKKRHVIIIGT 364
           F G C   +   +V+E++++  L+R L    P  K            L   +   +    
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPN 417
           A G+ YL     +  VHRD+   N L+      KI DFG++R       +    +++LP 
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 194
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQ 463
                 + +M PE I   + T + D++SFGV++ EI +  +   +Q
Sbjct: 195 ------IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 234

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 263 KLGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +LG G +G++F          QD   +AVK L  + ++  ++   E ++++   H+++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRIL--FDPKQK----------KELDWKKRHVIIIGT 364
           F G C   +   +V+E++++  L+R L    P  K            L   +   +    
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPN 417
           A G+ YL     +  VHRD+   N L+      KI DFG++R       +    +++LP 
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 200
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQ 463
                 + +M PE I   + T + D++SFGV++ EI +  +   +Q
Sbjct: 201 ------IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 240

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLG 319
            ++G G +G +  G   +  ++A+K +   R+  + E     E ++M +  H  LVQ  G
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            C  +    +V EF+++  L   L    Q+     +    + +   EG+ YL    +  +
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+ A N L+      K++DFG+ RF   ++    +T     + + +PE  +  + + 
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 440 KVDIYSFGVLVLEIVS 455
           K D++SFGVL+ E+ S
Sbjct: 185 KSDVWSFGVLMWEVFS 200

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKN----RIKEICNEMDIMSRAHHKNLVQFLG 319
           +G G YGE+++G L  G  +AVK +F SR      R  EI N + +     H N++ F+ 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK-IFSSRDEQSWFRETEIYNTVLL----RHDNILGFIA 69
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD----- 374
              T ++S      + +      L+D  Q++ L+      + +  A GL +LH +     
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP--NTAIAGTLGYMAPEYI 432
           G+  I HRD K+ N+L+    +  IAD GLA   S     L   N    GT  YMAPE +
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 433 ANGQLTE------KVDIYSFGVLVLEIVSGVQNNKFQSD 465
                T+        DI++FG+++ EI      N    D
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVED 228

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  +IADFGLAR  ++       T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFI-SRKNRIKEICNEMDIMSRAHH 311
           ++  F +  KLG+G Y  ++KG     G  +A+K + + S +        E+ +M    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQN---KSLD-RILFDPKQKKELDWKKRHVIIIGTAEG 367
           +N+V+      T+    +V+EF+ N   K +D R + +  +  EL+  K     +   +G
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQG 120
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           L + H++   +I+HRD+K  N+L++ + + K+ DFGLAR      +   +  +  TL Y 
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYR 175
Query: 428 APEYIANGQ-LTEKVDIYSFGVLVLEIVSG 456
           AP+ +   +  +  +DI+S G ++ E+++G
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITG 205

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 263 KLGHGGYGE-IFKGTLQDGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFL 318
           K+G G +G+ I   + +DGR+  +K + ISR   K R +E   E+ +++   H N+VQ+ 
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMKHPNIVQYR 89
Query: 319 GCCFTKKDSFVVYEFVQNKSLDR-------ILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
                    ++V ++ +   L +       +LF   Q   LDW       +     L+++
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDW------FVQICLALKHV 141
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H     +I+HRDIK+ NI L      ++ DFG+AR  +S   L    A  GT  Y++PE 
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTPYYLSPEI 196
Query: 432 IANGQLTEKVDIYSFGVLVLEI 453
             N     K DI++ G ++ E+
Sbjct: 197 CENKPYNNKSDIWALGCVLYEL 218

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 263 KLGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +LG G +G++F          QD   +AVK L  + ++  ++   E ++++   H+++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRIL--FDPKQK----------KELDWKKRHVIIIGT 364
           F G C   +   +V+E++++  L+R L    P  K            L   +   +    
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPN 417
           A G+ YL     +  VHRD+   N L+      KI DFG++R       +    +++LP 
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 223
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQ 463
                 + +M PE I   + T + D++SFGV++ EI +  +   +Q
Sbjct: 224 ------IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+ E+    +L   L           +D  +  ++++ +K     
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 251 IEKATDCFDESNKLGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIM 306
           I+   + F+    LG G +G++F    +   +     A+K+  +   + ++    E  ++
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 307 SRAHHKNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           S A     +  + C F TK++ F V E++    L   ++  +   + D  +         
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEII 129
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            GL++LH  G   IV+RD+K  NILLD     KIADFG+ + +    +        GT  
Sbjct: 130 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNEFCGTPD 184
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           Y+APE +   +    VD +SFGVL+ E++ G
Sbjct: 185 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 215

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++F    +   +     A+K+  +   + ++    E  ++S A     +  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 320 CCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           C F TK++ F V E++    L   ++  +   + D  +          GL++LH  G   
Sbjct: 85  CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--- 138
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           IV+RD+K  NILLD     KIADFG+ + +    +        GT  Y+APE +   +  
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNXFCGTPDYIAPEILLGQKYN 196
Query: 439 EKVDIYSFGVLVLEIVSG 456
             VD +SFGVL+ E++ G
Sbjct: 197 HSVDWWSFGVLLYEMLIG 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G +    +  +GR  A+K L    + R  +++   +E  ++S   H  +++  G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                +  F++ ++++   L  +L   ++ +                 LEYLH      I
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEYLHSK---DI 127
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA--IAGTLGYMAPEYIANGQL 437
           ++RD+K  NILLD     KI DFG A++       +P+    + GT  Y+APE ++    
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAKY-------VPDVTYXLCGTPDYIAPEVVSTKPY 180
Query: 438 TEKVDIYSFGVLVLEIVSG 456
            + +D +SFG+L+ E+++G
Sbjct: 181 NKSIDWWSFGILIYEMLAG 199

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 26/223 (11%)
Query: 262 NKLGHGGYGEIFKG------TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
            +LG G +G++F          +D   +AVK L        K+   E ++++   H+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDR----------ILFD--PKQKK-ELDWKKRHVIII 362
           +F G C       +V+E++++  L++          IL D  P+Q K EL   +   I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAI 420
             A G+ YL        VHRD+   N L+      KI DFG++R  +S+    +  +T +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQ 463
              + +M PE I   + T + D++SFGV++ EI +  +   FQ
Sbjct: 198 P--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 238

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEIC--NEMDIMSRAHHKNL 314
           +++  K+G G +GE+FK    + G+++A+K++ +  +     I    E+ I+    H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 315 VQFLGCCFTKKDSF--------VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           V  +  C TK   +        +V++F ++  L  +L +   K  L   KR + ++    
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML--LN 136
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI--AGTL 424
           GL Y+H++   +I+HRD+KA+N+L+      K+ADFGLAR  S  K+  PN       TL
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 425 GYMAPE-YIANGQLTEKVDIYSFGVLVLEI 453
            Y  PE  +        +D++  G ++ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 103 LM-DANLXQVI-----QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 154 SDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 453 IV 454
           +V
Sbjct: 211 MV 212

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 122/252 (48%), Gaps = 24/252 (9%)
Query: 227 DQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIF---KGTLQDGREI 283
           D+G+  ++S+ H        K  + +     F+    LG G +G++F   K T  D   +
Sbjct: 5   DEGVLKEISITH------HVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHL 58
Query: 284 ----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL 339
                +K+  +  ++R++    E DI++  +H  +V+      T+   +++ +F++   L
Sbjct: 59  YAMKVLKKATLKVRDRVRTKM-ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL 117
Query: 340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI 399
              L       E D K     +   A GL++LH  G   I++RD+K  NILLD +   K+
Sbjct: 118 FTRLSKEVMFTEEDVK---FYLAELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKL 171
Query: 400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQN 459
            DFGL++ +   +      +  GT+ YMAPE +     +   D +S+GVL+ E+++G  +
Sbjct: 172 TDFGLSKEAIDHEK--KAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG--S 227
Query: 460 NKFQSDDGFETL 471
             FQ  D  ET+
Sbjct: 228 LPFQGKDRKETM 239

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 264 LGHGGYGEIF--KGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           LG G + E+F  K  L  G+  A+K +  S   R   + NE+ ++ +  H+N+V      
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 322 FTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
            +    ++V + V    L DRIL    ++     K   ++I      ++YLH++G   IV
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 381 HRDIKASNILL---DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
           HRD+K  N+L    +   +  I DFGL++    E++ + +TA  GT GY+APE +A    
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTA-CGTPGYVAPEVLAQKPY 184
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           ++ VD +S GV+   ++ G
Sbjct: 185 SKAVDCWSIGVITYILLCG 203

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           ++G G YGE++ G  + G ++AVK  F + + +  +E      ++ R  H+N++ F+   
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMR--HENILGFIAAD 100
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQ 376
                S+     + +   +  L+D  +   LD K    +   +  GL +LH +     G+
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLA-RFSS--SEKSLLPNTAIAGTLGYMAPEYIA 433
             I HRD+K+ NIL+       IAD GLA +F S  +E  + PNT + GT  YM PE + 
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPPEVLD 219
Query: 434 NG------QLTEKVDIYSFGVLVLEI----VSGVQNNKFQ 463
                   Q     D+YSFG+++ E+    VSG    ++Q
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 263 KLGHGGYGEIFKGTLQDGR-EIAVK----------RLFISRKNRIK---EICNEMDIMSR 308
           KLG G YGE+     ++G  E A+K          R     KN  K   EI NE+ ++  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
             H N+++       KK  ++V EF +   L   + +  +  E D      I+     G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---IMKQILSGI 159
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            YLHK     IVHRDIK  NILL+ K+     KI DFGL+ F S +  L       GT  
Sbjct: 160 CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---GTAY 213
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           Y+APE +   +  EK D++S GV++  ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 25/209 (11%)
Query: 262 NKLGHGGYGEIFKGTLQ-DGREIAVKRL--FISRKNRIKEICNEMDIMSRAHH-KNLVQF 317
            ++G G YG + K   +  G+ +AVKR+   +  K + K++  ++D++ R+     +VQF
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-KQLLMDLDVVMRSSDCPYIVQF 86
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRI------LFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
            G  F + D ++  E +   S D+       + D    +E+  K    I + T + L +L
Sbjct: 87  YGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGK----ITLATVKALNHL 141
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
            ++  ++I+HRDIK SNILLD     K+ DFG+   S      +  T  AG   YMAPE 
Sbjct: 142 KEN--LKIIHRDIKPSNILLDRSGNIKLCDFGI---SGQLVDSIAKTRDAGCRPYMAPER 196
Query: 432 I---ANGQLTE-KVDIYSFGVLVLEIVSG 456
           I   A+ Q  + + D++S G+ + E+ +G
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATG 225

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 110 LM-DANLXQVI-----QMELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 161 SDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 453 IV 454
           +V
Sbjct: 218 MV 219

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 261 SNKLGHGGYGEIFKGTLQ-DGREIAVK---RLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            + LG G +G++  G  +  G ++AVK   R  I   + + +I  E+  +    H ++++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKK-ELDWKKRHVIIIGTAEGLEYLHKDG 375
                 T  D F+V E+V    L    FD   K   LD K+   +      G++Y H+  
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCHRH- 135
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
              +VHRD+K  N+LLD     KIADFGL+   S  + L  +    G+  Y APE I+ G
Sbjct: 136 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVIS-G 189
Query: 436 QL--TEKVDIYSFGVLVLEIVSG 456
           +L    +VDI+S GV++  ++ G
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCG 212

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEI--CNEMDIMSRAH 310
           AT  ++   ++G G YG ++K      G  +A+K + +        I    E+ ++ R  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 311 ---HKNLVQFLGCCFTKKDS-----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
              H N+V+ +  C T +        +V+E V      R   D      L  +    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL--RTYLDKAPPPGLPAETIKDLMR 119
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG 422
               GL++LH +    IVHRD+K  NIL+      K+ADFGLAR  S + +L P   +  
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP---VVV 173
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
           TL Y APE +        VD++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEIC--NEMDIMSRAHHKNL 314
           +++  K+G G +GE+FK    + G+++A+K++ +  +     I    E+ I+    H+N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 315 VQFLGCCFTKKDSF--------VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           V  +  C TK   +        +V++F ++  L  +L +   K  L   KR + ++    
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML--LN 135
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI--AGTL 424
           GL Y+H++   +I+HRD+KA+N+L+      K+ADFGLAR  S  K+  PN       TL
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 425 GYMAPE-YIANGQLTEKVDIYSFGVLVLEI 453
            Y  PE  +        +D++  G ++ E+
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G + ++     +  GRE+A+K +  ++ N   ++++  E+ IM   +H N+V+    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T+K  +++ E+     +   L    + KE + + +   I+     ++Y H   Q +IV
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA---VQYCH---QKRIV 136
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT-E 439
           HRD+KA N+LLD     KIADFG +   +    L    A  G   Y APE     +    
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYDGP 193
Query: 440 KVDIYSFGVLVLEIVSG 456
           +VD++S GV++  +VSG
Sbjct: 194 EVDVWSLGVILYTLVSG 210

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+  +    +L   L           +D  +  ++++ +K     
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEIC--NEMDIMSRAHHKNL 314
           +++  K+G G +GE+FK    + G+++A+K++ +  +     I    E+ I+    H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 315 VQFLGCCFTKKDSF--------VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           V  +  C TK   +        +V++F ++  L  +L +   K  L   KR + ++    
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML--LN 136
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI--AGTL 424
           GL Y+H++   +I+HRD+KA+N+L+      K+ADFGLAR  S  K+  PN       TL
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 425 GYMAPE-YIANGQLTEKVDIYSFGVLVLEI 453
            Y  PE  +        +D++  G ++ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNR-IKEIC-NEMDIMSRAHHKNL 314
           +++  K+G G YG +FK   +D G+ +A+K+   S  +  IK+I   E+ ++ +  H NL
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV-------IIIGTAEG 367
           V  L     K+   +V+E+  +  L           ELD  +R V       I   T + 
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVL----------HELDRYQRGVPEHLVKSITWQTLQA 114
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           + + HK      +HRD+K  NIL+      K+ DFG AR  +       +     T  Y 
Sbjct: 115 VNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYR 169
Query: 428 APE-YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD 465
           +PE  + + Q    VD+++ G +  E++SGV     +SD
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 110 LM-DANLXQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 161 SDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 453 IV 454
           +V
Sbjct: 218 MV 219

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEIC--NEMDIMSRAHHKNL 314
           +++  K+G G +GE+FK    + G+++A+K++ +  +     I    E+ I+    H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 315 VQFLGCCFTKKDSF--------VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           V  +  C TK   +        +V++F ++  L  +L +   K  L   KR + ++    
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML--LN 136
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI--AGTL 424
           GL Y+H++   +I+HRD+KA+N+L+      K+ADFGLAR  S  K+  PN       TL
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 425 GYMAPE-YIANGQLTEKVDIYSFGVLVLEI 453
            Y  PE  +        +D++  G ++ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 117/233 (50%), Gaps = 26/233 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNRIKEICN-----EMDIMSRAHH 311
           +++ + LG G +  ++K   ++  +I A+K++ +  ++  K+  N     E+ ++    H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV--IIIGTAEGLE 369
            N++  L     K +  +V++F++   L+ I+ D      L     H+   ++ T +GLE
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLE 126
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMA 428
           YLH   Q  I+HRD+K +N+LLD     K+ADFGLA+ F S  ++         T  Y A
Sbjct: 127 YLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV---TRWYRA 180
Query: 429 PEYIANGQLTE-KVDIYSFGVLVLEIVSGVQNNKFQSDDG-----FETLVTHT 475
           PE +   ++    VD+++ G ++ E++  V      SD       FETL T T
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG   K   + DG+ +  K L        ++  + +E++++    H N+V++   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 321 CFTKKDS--FVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK--DG 375
              + ++  ++V E+ +   L  ++    K+++ LD +    ++      L+  H+  DG
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
              ++HRD+K +N+ LD K   K+ DFGLAR  + + S        GT  YM+PE +   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRM 191
Query: 436 QLTEKVDIYSFGVLVLEI 453
              EK DI+S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 67/299 (22%)
Query: 263 KLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNL 314
           +LG G +G +++G  +D         +AVK +    S + RI E  NE  +M      ++
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 81
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK-----RHVIIIGT--AEG 367
           V+ LG     + + VV E + +  L   L   + + E +  +     + +I +    A+G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           + YL+     + VHRD+ A N ++      KI DFG+ R       +    K LLP    
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP---- 194
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNN---KFQSDDGFET 470
              + +MAPE + +G  T   D++SFGV++ EI S       G+ N    KF  D G+  
Sbjct: 195 ---VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-- 249
Query: 471 LVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
                                         +RV  +  +C Q  P +RP+   +V +LK
Sbjct: 250 ----------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEI--CNEMDIMSRAH 310
           AT  ++   ++G G YG ++K      G  +A+K + +        I    E+ ++ R  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 311 ---HKNLVQFLGCCFTKKDS-----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
              H N+V+ +  C T +        +V+E V      R   D      L  +    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL--RTYLDKAPPPGLPAETIKDLMR 119
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG 422
               GL++LH +    IVHRD+K  NIL+      K+ADFGLAR  S + +L P   +  
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVV 173
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
           TL Y APE +        VD++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 145
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   ++P      T  Y APE I
Sbjct: 146 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV---TRYYRAPEVI 199
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S G ++ E++ G
Sbjct: 200 LGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 67/299 (22%)
Query: 263 KLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNL 314
           +LG G +G +++G  +D         +AVK +    S + RI E  NE  +M      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 82
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK-----RHVIIIGT--AEG 367
           V+ LG     + + VV E + +  L   L   + + E +  +     + +I +    A+G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           + YL+     + VHRD+ A N ++      KI DFG+ R       +    K LLP    
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLP---- 195
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNN---KFQSDDGFET 470
              + +MAPE + +G  T   D++SFGV++ EI S       G+ N    KF  D G+  
Sbjct: 196 ---VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-- 250
Query: 471 LVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
                                         +RV  +  +C Q  P +RP+   +V +LK
Sbjct: 251 ----------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHK 312
           + +   +G G  G +   F   L  G  +AVK+L    +N+   K    E+ ++   +HK
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 313 NLVQFLGCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           N++  L     +K      D ++V E + + +L +++       ELD ++   ++     
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----HMELDHERMSYLLYQMLC 135
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           G+++LH  G   I+HRD+K SNI++      KI DFGLAR +S+   + P      T  Y
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV---TRYY 189
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            APE I      E VDI+S G ++ E+V G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 67/299 (22%)
Query: 263 KLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNL 314
           +LG G +G +++G  +D         +AVK +    S + RI E  NE  +M      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 82
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK-----RHVIIIGT--AEG 367
           V+ LG     + + VV E + +  L   L   + + E +  +     + +I +    A+G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           + YL+     + VHRD+ A N ++      KI DFG+ R       +    K LLP    
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP---- 195
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNN---KFQSDDGFET 470
              + +MAPE + +G  T   D++SFGV++ EI S       G+ N    KF  D G+  
Sbjct: 196 ---VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-- 250
Query: 471 LVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
                                         +RV  +  +C Q  P +RP+   +V +LK
Sbjct: 251 ----------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 263 KLGHGGYGEIFKGT--LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-----HKNLV 315
           ++G G YG++FK       GR +A+KR+ +        +    ++    H     H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 316 QFLGCCFTKKDS-----FVVYEFVQ---NKSLDRILFDPKQKKELDWKKRHVIIIGTAEG 367
           +    C   +        +V+E V       LD++   P+     +  K   ++     G
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD--MMFQLLRG 132
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           L++LH     ++VHRD+K  NIL+    + K+ADFGLAR  S + +L   T++  TL Y 
Sbjct: 133 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYR 186
Query: 428 APEYIANGQLTEKVDIYSFGVLVLEI 453
           APE +        VD++S G +  E+
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 31/220 (14%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFI------SRKNRIKEICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T    G+E AV ++ +      +  +  + + +E+ IMS    H+N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRIL--------------------FDPKQKKELDWK 355
             LG C       V+ E+     L   L                     D +  + L+ +
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 356 KRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
                    A+G+ +L        +HRD+ A N+LL   H  KI DFGLAR   ++ + +
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                   + +MAPE I +   T + D++S+G+L+ EI S
Sbjct: 216 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 144
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 198
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S G ++ E++ G
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + ++ T  D +E+     V +  + + ++ +++  E+ I     + ++V F G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 320 CCFTKKDSFV--VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
             F + D FV  V E  + +SL  +    K++K +   +    +  T +G++YLH +   
Sbjct: 110 --FFEDDDFVYVVLEICRRRSLLELH---KRRKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           +++HRD+K  N+ L+     KI DFGLA    F    K  L      GT  Y+APE +  
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL-----CGTPNYIAPEVLCK 216
Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
              + +VDI+S G ++  ++ G
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVG 238

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 264 LGHGGYGEIF--------KGTLQDGREIAVKRLFISRKNR-IKEICNEMDIMSR-AHHKN 313
           LG G +G++         K   ++   +AVK L      + + ++ +EM++M     HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----------FDPKQ--KKELDWKKRHVI 360
           ++  LG C      +V+  +    +L   L           +D  +  ++++ +K     
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
               A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR  ++       T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + F+ +  D +E+     V +  + + ++ +++  E+ I     H+++V F G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                   FVV E  + +SL  +    K++K L   +    +     G +YLH++   ++
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 380 VHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           +HRD+K  N+ L+     KI DFGLA    +    K +L      GT  Y+APE ++   
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-----CGTPNYIAPEVLSKKG 217
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
            + +VD++S G ++  ++ G
Sbjct: 218 HSFEVDVWSIGCIMYTLLVG 237

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + F+ +  D +E+     V +  + + ++ +++  E+ I     H+++V F G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                   FVV E  + +SL  +    K++K L   +    +     G +YLH++   ++
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 380 VHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           +HRD+K  N+ L+     KI DFGLA    +    K +L      GT  Y+APE ++   
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-----CGTPNYIAPEVLSKKG 215
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
            + +VD++S G ++  ++ G
Sbjct: 216 HSFEVDVWSIGCIMYTLLVG 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 72
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R       +  
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 190 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G +GE+++G  + G E+AVK +F SR+ R   +E      +M R  H+N++ F+   
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLR--HENILGFIAAD 105
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQ 376
                ++     V +      LFD   +  +  +    + + TA GL +LH +     G+
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKS--LLPNTAIAGTLGYMAPEYIA 433
             I HRD+K+ NIL+       IAD GLA R  S+  +  + PN  + GT  YMAPE + 
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLD 224
Query: 434 NG------QLTEKVDIYSFGVLVLEI 453
           +       +  ++ DIY+ G++  EI
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + ++ T  D +E+     V +  + + ++ +++  E+ I     + ++V F G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 320 CCFTKKDSFV--VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
             F + D FV  V E  + +SL  +    K++K +   +    +  T +G++YLH +   
Sbjct: 110 --FFEDDDFVYVVLEICRRRSLLELH---KRRKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           +++HRD+K  N+ L+     KI DFGLA    F    K  L      GT  Y+APE +  
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-----CGTPNYIAPEVLCK 216
Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
              + +VDI+S G ++  ++ G
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVG 238

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 24/221 (10%)
Query: 249 STIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIM 306
           STI + T    ES  +G G +GE+++G  + G E+AVK +F SR+ R   +E      +M
Sbjct: 5   STIAR-TIVLQES--IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVM 59
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
            R  H+N++ F+        ++     V +      LFD   +  +  +    + + TA 
Sbjct: 60  LR--HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTAS 117
Query: 367 GLEYLHKD-----GQMQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKS--LLPNT 418
           GL +LH +     G+  I HRD+K+ NIL+       IAD GLA R  S+  +  + PN 
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 419 AIAGTLGYMAPEYIANG------QLTEKVDIYSFGVLVLEI 453
            + GT  YMAPE + +       +  ++ DIY+ G++  EI
Sbjct: 178 RV-GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + F+ +  D +E+     V +  + + ++ +++  E+ I     H+++V F G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                   FVV E  + +SL  +    K++K L   +    +     G +YLH++   ++
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 380 VHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           +HRD+K  N+ L+     KI DFGLA    +    K +L      GT  Y+APE ++   
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-----CGTPNYIAPEVLSKKG 191
Query: 437 LTEKVDIYSFGVLVLEIVSG 456
            + +VD++S G ++  ++ G
Sbjct: 192 HSFEVDVWSIGCIMYTLLVG 211

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VDI+S G ++ E++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + F+ +  D +E+     V +  + + ++ +++  E+ I     H+++V F G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                   FVV E  + +SL  +    K++K L   +    +     G +YLH++   ++
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+K  N+ L+     KI DFGLA  +  E        + GT  Y+APE ++    + 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 440 KVDIYSFGVLVLEIVSG 456
           +VD++S G ++  ++ G
Sbjct: 201 EVDVWSIGCIMYTLLVG 217

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 72
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R       +  
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 190 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G +GE+++G  + G E+AVK +F SR+ R   +E      +M R  H+N++ F+   
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLR--HENILGFIAAD 92
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQ 376
                ++     V +      LFD   +  +  +    + + TA GL +LH +     G+
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 152
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKS--LLPNTAIAGTLGYMAPEYIA 433
             I HRD+K+ NIL+       IAD GLA R  S+  +  + PN  + GT  YMAPE + 
Sbjct: 153 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLD 211
Query: 434 NG------QLTEKVDIYSFGVLVLEI 453
           +       +  ++ DIY+ G++  EI
Sbjct: 212 DSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 131/303 (43%), Gaps = 49/303 (16%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 79
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 139
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R       +  
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE 469
             K LLP       + +M+PE + +G  T   D++SFGV++ EI                
Sbjct: 197 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--------------- 234
Query: 470 TLVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVW-VGLLCTQELPTLRPSMTNVVQML 528
           TL    ++    + VL                 +++ +  +C Q  P +RPS   ++  +
Sbjct: 235 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
Query: 529 KQK 531
           K++
Sbjct: 295 KEE 297

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G +GE+++G  + G E+AVK +F SR+ R   +E      +M R  H+N++ F+   
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLR--HENILGFIAAD 67
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQ 376
                ++     V +      LFD   +  +  +    + + TA GL +LH +     G+
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 127
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKS--LLPNTAIAGTLGYMAPEYIA 433
             I HRD+K+ NIL+       IAD GLA R  S+  +  + PN  + GT  YMAPE + 
Sbjct: 128 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLD 186
Query: 434 NG------QLTEKVDIYSFGVLVLEI 453
           +       +  ++ DIY+ G++  EI
Sbjct: 187 DSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 21/226 (9%)
Query: 241 LKFLQFKYSTIEK-ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFI--------- 290
           L+FLQ+K+   +    D F +   LG GG+GE+F   ++     A  +L+          
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRL 223
Query: 291 SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKK 350
            ++   +    E  I+++ H + +V       TK D  +V   +    +   +++  +  
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 351 ELDWKKRHVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS 409
               + R +        GLE+LH   Q  I++RD+K  N+LLD     +I+D GLA    
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           + ++       AGT G+MAPE +   +    VD ++ GV + E+++
Sbjct: 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 263 KLGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +LG G +G++F          QD   +AVK L  +  N  K+   E ++++   H+++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDR----------ILFDPKQKKELDWKKRHVIIIGTAE 366
           F G C       +V+E++++  L++          ++ +     EL   +   I    A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTL 424
           G+ YL        VHRD+   N L+      KI DFG++R  +S+    +  +T +   +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP--I 194
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +M PE I   + T + D++S GV++ EI +
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 74  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           AEG+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 124 AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + F+ +  D +E+     V +  + + ++ +++  E+ I     H+++V F G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                   FVV E  + +SL  +    K++K L   +    +     G +YLH++   ++
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+K  N+ L+     KI DFGLA  +  E        + GT  Y+APE ++    + 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 440 KVDIYSFGVLVLEIVSG 456
           +VD++S G ++  ++ G
Sbjct: 197 EVDVWSIGCIMYTLLVG 213

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 73
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R       +  
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 191 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 263 KLGHGGYGEIFKGT--LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-----HKNLV 315
           ++G G YG++FK       GR +A+KR+ +        +    ++    H     H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 316 QFLGCCFTKKDS-----FVVYEFVQ---NKSLDRILFDPKQKKELDWKKRHVIIIGTAEG 367
           +    C   +        +V+E V       LD++   P+     +  K   ++     G
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD--MMFQLLRG 132
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           L++LH     ++VHRD+K  NIL+    + K+ADFGLAR  S + +L   T++  TL Y 
Sbjct: 133 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYR 186
Query: 428 APEYIANGQLTEKVDIYSFGVLVLEI 453
           APE +        VD++S G +  E+
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            +LG G +G +  G  +   ++AVK +     +   E   E   M +  H  LV+F G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 322 FTKKDSFVVYEFVQNKSLDRIL------FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
             +   ++V E++ N  L   L       +P Q  E+ +           EG+ +L    
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD--------VCEGMAFLESH- 123
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
             Q +HRD+ A N L+D     K++DFG+ R+   ++  + +      + + APE     
Sbjct: 124 --QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYF 180
Query: 436 QLTEKVDIYSFGVLVLEIVS 455
           + + K D+++FG+L+ E+ S
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G +GE+++G  + G E+AVK +F SR+ R   +E      +M R  H+N++ F+   
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLR--HENILGFIAAD 66
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQ 376
                ++     V +      LFD   +  +  +    + + TA GL +LH +     G+
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKS--LLPNTAIAGTLGYMAPEYIA 433
             I HRD+K+ NIL+       IAD GLA R  S+  +  + PN  + GT  YMAPE + 
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLD 185
Query: 434 NG------QLTEKVDIYSFGVLVLEI 453
           +       +  ++ DIY+ G++  EI
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 70
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 71  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 130
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R       +  
Sbjct: 131 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 188 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 21/226 (9%)
Query: 241 LKFLQFKYSTIEK-ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFI--------- 290
           L+FLQ+K+   +    D F +   LG GG+GE+F   ++     A  +L+          
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRL 223
Query: 291 SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKK 350
            ++   +    E  I+++ H + +V       TK D  +V   +    +   +++  +  
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 351 ELDWKKRHVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS 409
               + R +        GLE+LH   Q  I++RD+K  N+LLD     +I+D GLA    
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           + ++       AGT G+MAPE +   +    VD ++ GV + E+++
Sbjct: 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 21/226 (9%)
Query: 241 LKFLQFKYSTIEK-ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFI--------- 290
           L+FLQ+K+   +    D F +   LG GG+GE+F   ++     A  +L+          
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRL 223
Query: 291 SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKK 350
            ++   +    E  I+++ H + +V       TK D  +V   +    +   +++  +  
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 351 ELDWKKRHVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS 409
               + R +        GLE+LH   Q  I++RD+K  N+LLD     +I+D GLA    
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           + ++       AGT G+MAPE +   +    VD ++ GV + E+++
Sbjct: 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G +GE+++G  + G E+AVK +F SR+ R   +E      +M R  H+N++ F+   
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLR--HENILGFIAAD 69
Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQ 376
                ++     V +      LFD   +  +  +    + + TA GL +LH +     G+
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 129
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKS--LLPNTAIAGTLGYMAPEYIA 433
             I HRD+K+ NIL+       IAD GLA R  S+  +  + PN  + GT  YMAPE + 
Sbjct: 130 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLD 188
Query: 434 NG------QLTEKVDIYSFGVLVLEI 453
           +       +  ++ DIY+ G++  EI
Sbjct: 189 DSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + F+ +  D +E+     V +  + + ++ +++  E+ I     H+++V F G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                   FVV E  + +SL  +    K++K L   +    +     G +YLH++   ++
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+K  N+ L+     KI DFGLA  +  E        + GT  Y+APE ++    + 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 440 KVDIYSFGVLVLEIVSG 456
           +VD++S G ++  ++ G
Sbjct: 197 EVDVWSIGCIMYTLLVG 213

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGXLLDYV----REHKDNIGSQYLLNW------CVQI 127
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 263 KLGHGGYGEIFKGT--LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-----HKNLV 315
           ++G G YG++FK       GR +A+KR+ +        +    ++    H     H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 316 QFLGCCFTKKDS-----FVVYEFVQ---NKSLDRILFDPKQKKELDWKKRHVIIIGTAEG 367
           +    C   +        +V+E V       LD++   P+     +  K   ++     G
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD--MMFQLLRG 132
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           L++LH     ++VHRD+K  NIL+    + K+ADFGLAR  S + +L   T++  TL Y 
Sbjct: 133 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYR 186
Query: 428 APEYIANGQLTEKVDIYSFGVLVLEI 453
           APE +        VD++S G +  E+
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R       +  
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 184 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 262 NKLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           ++LG G +G +       L D  G  +AVK+L  S  ++ ++   E+ I+   H   +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 317 FLGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + G  +   ++   +V E++ +  L   L   + +  LD  +  +      +G+EYL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 130
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS-LLPNTAIAGTLGYMAPEYIA 433
           G  + VHRD+ A NIL++ +   KIADFGLA+    +K   +        + + APE ++
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 190
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
           +   + + D++SFGV++ E+ +
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT 212

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 21/226 (9%)
Query: 241 LKFLQFKYSTIEK-ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFI--------- 290
           L+FLQ+K+   +    D F +   LG GG+GE+F   ++     A  +L+          
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRL 223
Query: 291 SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKK 350
            ++   +    E  I+++ H + +V       TK D  +V   +    +   +++  +  
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 351 ELDWKKRHVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS 409
               + R +        GLE+LH   Q  I++RD+K  N+LLD     +I+D GLA    
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           + ++       AGT G+MAPE +   +    VD ++ GV + E+++
Sbjct: 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 110 LM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 161 SDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 453 IV 454
           +V
Sbjct: 218 MV 219

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 91/180 (50%), Gaps = 12/180 (6%)
Query: 280 GREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK 337
           GRE+AVK +  ++ N   ++++  E+ IM   +H N+V+      T+K  ++V E+    
Sbjct: 40  GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGG 99
Query: 338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP 397
            +   L    + KE + + +   I+     ++Y H   Q  IVHRD+KA N+LLD     
Sbjct: 100 EVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCH---QKYIVHRDLKAENLLLDGDMNI 153
Query: 398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT-EKVDIYSFGVLVLEIVSG 456
           KIADFG +   +    L       G+  Y APE     +    +VD++S GV++  +VSG
Sbjct: 154 KIADFGFSNEFTVGNKL---DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR-IKEICNEMDI-MSR 308
           E   D  +   +LG G YG + K   +  G+ +AVKR+  +  ++  K +  ++DI M  
Sbjct: 47  EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 106
Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRI---LFDPKQKKELDWKKRHVIIIGTA 365
                 V F G  F + D ++  E + + SLD+    + D  Q    D   +  I +   
Sbjct: 107 VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIV 163
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
           + LE+LH   ++ ++HRD+K SN+L++   + K+ DFG++ +       +  T  AG   
Sbjct: 164 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDS---VAKTIDAGCKP 218
Query: 426 YMAPEYIANGQLTE-----KVDIYSFGVLVLEI 453
           YMAPE I N +L +     K DI+S G+ ++E+
Sbjct: 219 YMAPERI-NPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 249 STIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEIC------N 301
           +T    +D ++    LG GG  E+     L+  R++AVK L   R +  ++         
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL---RADLARDPSFYLRFRR 61
Query: 302 EMDIMSRAHHKNLVQFLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKR 357
           E    +  +H  +V        +  +    ++V E+V   +L  I+     +  +  K+ 
Sbjct: 62  EAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRA 118
Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLP 416
             +I    + L + H++G   I+HRD+K +NI++   +  K+ DFG+AR  + S  S+  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             A+ GT  Y++PE      +  + D+YS G ++ E+++G
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEI--CNEMDIMSRAH 310
           AT  ++   ++G G YG ++K      G  +A+K + +        I    E+ ++ R  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 311 ---HKNLVQFLGCCFTKKDS-----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
              H N+V+ +  C T +        +V+E V      R   D      L  +    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL--RTYLDKAPPPGLPAETIKDLMR 119
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG 422
               GL++LH +    IVHRD+K  NIL+      K+ADFGLAR  S + +L P   +  
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP---VVV 173
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
           TL Y APE +        VD++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 101
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 102 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 161
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R       +  
Sbjct: 162 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 219 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G + ++     +  GRE+A+K +  ++ N   ++++  E+ IM   +H N+V+    
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T+K  +++ E+     +   L    + KE + + +   I+     ++Y H   Q +IV
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA---VQYCH---QKRIV 133
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT-E 439
           HRD+KA N+LLD     KIADFG +   +    L       G+  Y APE     +    
Sbjct: 134 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DTFCGSPPYAAPELFQGKKYDGP 190
Query: 440 KVDIYSFGVLVLEIVSG 456
           +VD++S GV++  +VSG
Sbjct: 191 EVDVWSLGVILYTLVSG 207

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVK-RLFISRKNRI----KEICNEMDIMSRAHHKNLVQF 317
           LG G +G ++KG  + DG  + +   + + R+N      KEI +E  +M+      + + 
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQ---KKELDWKKRHVIIIGTAEGLEYLHKD 374
           LG C T     V         LD +  +  +   +  L+W       +  A+G+ YL   
Sbjct: 85  LGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLE-- 136
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
             +++VHRD+ A N+L+   +  KI DFGLAR    +++          + +MA E I  
Sbjct: 137 -DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILR 195
Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
            + T + D++S+GV V E+++
Sbjct: 196 RRFTHQSDVWSYGVTVWELMT 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGXLLDYV----REHKDNIGSQYLLNW------CVQI 126
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 116/252 (46%), Gaps = 35/252 (13%)
Query: 230 MEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL------QDGREI 283
           MEM L   HK  K  +   S +      F E  +LG   +G+++KG L      +  + +
Sbjct: 7   MEMPLINQHKQAKLKEISLSAVR-----FME--ELGEDRFGKVYKGHLFGPAPGEQTQAV 59
Query: 284 AVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRI 342
           A+K L    +  ++E   +E  + +R  H N+V  LG     +   +++ +  +  L   
Sbjct: 60  AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 119
Query: 343 LF-------------DPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNI 389
           L              D   K  L+      ++   A G+EYL       +VH+D+   N+
Sbjct: 120 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNV 176
Query: 390 LLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFG 447
           L+  K   KI+D GL R  +++    LL N+ +   + +MAPE I  G+ +   DI+S+G
Sbjct: 177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLL--PIRWMAPEAIMYGKFSIDSDIWSYG 234
Query: 448 VLVLEIVS-GVQ 458
           V++ E+ S G+Q
Sbjct: 235 VVLWEVFSYGLQ 246

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 262 NKLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           ++LG G +G +       L D  G  +AVK+L  S  ++ ++   E+ I+   H   +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 317 FLGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + G  +   ++   +V E++ +  L   L   + +  LD  +  +      +G+EYL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS-LLPNTAIAGTLGYMAPEYIA 433
           G  + VHRD+ A NIL++ +   KIADFGLA+    +K   +        + + APE ++
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
           +   + + D++SFGV++ E+ +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 262 NKLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           ++LG G +G +       L D  G  +AVK+L  S  ++ ++   E+ I+   H   +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 317 FLGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + G  +   ++   +V E++ +  L   L   + +  LD  +  +      +G+EYL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 131
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS-LLPNTAIAGTLGYMAPEYIA 433
           G  + VHRD+ A NIL++ +   KIADFGLA+    +K   +        + + APE ++
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 191
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
           +   + + D++SFGV++ E+ +
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFT 213

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G + ++     +  G+E+AVK +  ++ N   ++++  E+ IM   +H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T+K  ++V E+     +   L    + KE + + +   I+     ++Y H   Q  IV
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCH---QKFIV 135
Query: 381 HRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT- 438
           HRD+KA N+LLD     KIADFG +  F+   K      A  G   Y APE     +   
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL----DAFCGAPPYAAPELFQGKKYDG 191
Query: 439 EKVDIYSFGVLVLEIVSG 456
            +VD++S GV++  +VSG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 67/299 (22%)
Query: 263 KLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNL 314
           +LG G +G +++G  +D         +AVK +    S + RI E  NE  +M      ++
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 83
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK-----RHVIIIGT--AEG 367
           V+ LG     + + VV E + +  L   L   + + E +  +     + +I +    A+G
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           + YL+     + VHR++ A N ++      KI DFG+ R       +    K LLP    
Sbjct: 144 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP---- 196
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNN---KFQSDDGFET 470
              + +MAPE + +G  T   D++SFGV++ EI S       G+ N    KF  D G+  
Sbjct: 197 ---VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-- 251
Query: 471 LVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
                                         +RV  +  +C Q  P +RP+   +V +LK
Sbjct: 252 ----------------------LDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 67/299 (22%)
Query: 263 KLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNL 314
           +LG G +G +++G  +D         +AVK +    S + RI E  NE  +M      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 82
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK-----RHVIIIGT--AEG 367
           V+ LG     + + VV E + +  L   L   + + E +  +     + +I +    A+G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           + YL+     + VHR++ A N ++      KI DFG+ R       +    K LLP    
Sbjct: 143 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP---- 195
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNN---KFQSDDGFET 470
              + +MAPE + +G  T   D++SFGV++ EI S       G+ N    KF  D G+  
Sbjct: 196 ---VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-- 250
Query: 471 LVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
                                         +RV  +  +C Q  P +RP+   +V +LK
Sbjct: 251 ----------------------LDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/309 (23%), Positives = 128/309 (41%), Gaps = 61/309 (19%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 79
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-------------DRILFDPKQKK 350
            +M   +  ++V+ LG     + + V+ E +    L             + +L  P   K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 351 ELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR---- 406
            +            A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R    
Sbjct: 140 MIQMAGE------IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 407 ---FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQ 463
              +    K LLP       + +M+PE + +G  T   D++SFGV++ EI          
Sbjct: 191 TDYYRKGGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--------- 234
Query: 464 SDDGFETLVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVW-VGLLCTQELPTLRPSMT 522
                 TL    ++    + VL                 +++ +  +C Q  P +RPS  
Sbjct: 235 ------TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL 288
Query: 523 NVVQMLKQK 531
            ++  +K++
Sbjct: 289 EIISSIKEE 297

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 262 NKLGHGGYGEI---FKGTLQD--GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           ++LG G +G +       L D  G  +AVK+L  S  ++ ++   E+ I+   H   +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 317 FLGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + G  +   + +  +V E++ +  L   L   + +  LD  +  +      +G+EYL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 127
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS-LLPNTAIAGTLGYMAPEYIA 433
           G  + VHRD+ A NIL++ +   KIADFGLA+    +K   +        + + APE ++
Sbjct: 128 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLS 187
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
           +   + + D++SFGV++ E+ +
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT 209

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE--ICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG   K   + DG+ +  K L        ++  + +E++++    H N+V++   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 321 CFTKKDS--FVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK--DG 375
              + ++  ++V E+ +   L  ++    K+++ LD +    ++      L+  H+  DG
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
              ++HRD+K +N+ LD K   K+ DFGLAR  + ++         GT  YM+PE +   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF--AKEFVGTPYYMSPEQMNRM 191
Query: 436 QLTEKVDIYSFGVLVLEI 453
              EK DI+S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 26/234 (11%)
Query: 234 LSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISR 292
           +SL+ K   + Q    T  +    +     +G G YG +      + G ++A+K+L    
Sbjct: 20  MSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 79
Query: 293 KNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-------FVVYEFVQNKSLDRIL 343
           ++ I  K    E+ ++    H+N++  L   FT   S       ++V  F+Q   L +I+
Sbjct: 80  QSEIFAKRAYRELLLLKHMQHENVIGLLDV-FTPASSLRNFYDFYLVMPFMQT-DLQKIM 137
Query: 344 FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG 403
                  E   +K   ++    +GL+Y+H  G   +VHRD+K  N+ ++     KI DFG
Sbjct: 138 -----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 189
Query: 404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           LAR + +E      T    T  Y APE I +     + VDI+S G ++ E+++G
Sbjct: 190 LARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + ++ T  D +E+     V +  + + ++ +++  E+ I     + ++V F G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 320 CCFTKKDSFV--VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
             F + D FV  V E  + +SL  +    K++K +   +    +  T +G++YLH +   
Sbjct: 110 --FFEDDDFVYVVLEICRRRSLLELH---KRRKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           +++HRD+K  N+ L+     KI DFGLA    F    K  L      GT  Y+APE +  
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-----CGTPNYIAPEVLCK 216
Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
              + +VDI+S G ++  ++ G
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVG 238

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 67/299 (22%)
Query: 263 KLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNL 314
           +LG G +G +++G  +D         +AVK +    S + RI E  NE  +M      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 82
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK-----RHVIIIGT--AEG 367
           V+ LG     + + VV E + +  L   L   + + E +  +     + +I +    A+G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           + YL+     + VHRD+ A N ++      KI DFG+ R            K LLP    
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP---- 195
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNN---KFQSDDGFET 470
              + +MAPE + +G  T   D++SFGV++ EI S       G+ N    KF  D G+  
Sbjct: 196 ---VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-- 250
Query: 471 LVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
                                         +RV  +  +C Q  P +RP+   +V +LK
Sbjct: 251 ----------------------LDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 45/232 (19%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 69
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-------------DRILFDPKQKK 350
            +M   +  ++V+ LG     + + V+ E +    L             + +L  P   K
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 351 ELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR---- 406
            +            A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R    
Sbjct: 130 MIQMAGE------IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 407 ---FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              +    K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 181 TDYYRKGGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 67/299 (22%)
Query: 263 KLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNL 314
           +LG G +G +++G  +D         +AVK +    S + RI E  NE  +M      ++
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 79
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK-----RHVIIIGT--AEG 367
           V+ LG     + + VV E + +  L   L   + + E +  +     + +I +    A+G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           + YL+     + VHRD+ A N ++      KI DFG+ R            K LLP    
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP---- 192
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNN---KFQSDDGFET 470
              + +MAPE + +G  T   D++SFGV++ EI S       G+ N    KF  D G+  
Sbjct: 193 ---VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-- 247
Query: 471 LVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
                                         +RV  +  +C Q  P +RP+   +V +LK
Sbjct: 248 ----------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + ++ T  D +E+     V +  + + ++ +++  E+ I     + ++V F G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 320 CCFTKKDSFV--VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
             F + D FV  V E  + +SL  +    K++K +   +    +  T +G++YLH +   
Sbjct: 94  --FFEDDDFVYVVLEICRRRSLLELH---KRRKAVTEPEARYFMRQTIQGVQYLHNN--- 145
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           +++HRD+K  N+ L+     KI DFGLA    F    K  L      GT  Y+APE +  
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-----CGTPNYIAPEVLCK 200
Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
              + +VDI+S G ++  ++ G
Sbjct: 201 KGHSFEVDIWSLGCILYTLLVG 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 127
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 264 LGHGGYGEIFKGTL----QDGREIAVKRLFISRKNRIKE---ICNEMDIMSR-AHHKNLV 315
           LG G +G++   T     + G  I V    +  K    E   + +E+ +M++   H+N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 316 QFLGCCFTKKDSFVVYEFV-------------QNKSLDRILFDPKQKKE-------LDWK 355
             LG C      ++++E+              +  S D I ++ +++ E       L ++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 356 KRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
                    A+G+E+L        VHRD+ A N+L+      KI DFGLAR   S+ + +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                   + +MAPE +  G  T K D++S+G+L+ EI S
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 130
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 67/299 (22%)
Query: 263 KLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNL 314
           +LG G +G +++G  +D         +AVK +    S + RI E  NE  +M      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 82
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK-----RHVIIIGT--AEG 367
           V+ LG     + + VV E + +  L   L   + + E +  +     + +I +    A+G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           + YL+     + VHRD+ A N ++      KI DFG+ R            K LLP    
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP---- 195
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNN---KFQSDDGFET 470
              + +MAPE + +G  T   D++SFGV++ EI S       G+ N    KF  D G+  
Sbjct: 196 ---VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-- 250
Query: 471 LVTHTWKHFQAKTVLXXXXXXXXXXXXXXVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
                                         +RV  +  +C Q  P +RP+   +V +LK
Sbjct: 251 ----------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 249 STIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVK--RLFISRKNRIK-EICNEMD 304
           +T    +D ++    LG GG  E+     L+  R++AVK  R  ++R          E  
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 305 IMSRAHHKNLVQFLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
             +  +H  +V        +  +    ++V E+V   +L  I+     +  +  K+   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEV 121
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTA 419
           I    + L + H++G   I+HRD+K +NI++   +  K+ DFG+AR  + S  S+    A
Sbjct: 122 IADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           + GT  Y++PE      +  + D+YS G ++ E+++G
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIK-----EICNEMDIMS 307
           AT  ++   ++G G YG ++K      G  +A+K + +                E+ ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 308 RAH---HKNLVQFLGCCFTKKDS-----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
           R     H N+V+ +  C T +        +V+E V      R   D      L  +    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL--RTYLDKAPPPGLPAETIKD 124
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA 419
           ++     GL++LH +    IVHRD+K  NIL+      K+ADFGLAR  S + +L P   
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP--- 178
Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
           +  TL Y APE +        VD++S G +  E+
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 77  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 126
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 128
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L   R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 181
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 235
Query: 433 ANGQLTEKVDIYSFGVLVLEIV 454
                 E VDI+S G ++ E+V
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMV 257

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 31/228 (13%)
Query: 257 CFDESNKLGHGGYGEIFKGTLQDGR---EIAVKRLFISRKNRI--KEICNEMDIMSRAHH 311
            + +   +G G YG +      DGR   ++A+K+L+   ++ +  K    E+ ++    H
Sbjct: 26  VYRDLQPVGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 312 KNLVQFLGCCFTKK-------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           +N++  L   FT         D ++V  F+    L +++    + ++L   +   ++   
Sbjct: 84  ENVIGLLDV-FTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQM 137
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
            +GL Y+H  G   I+HRD+K  N+ ++     KI DFGLAR + SE           T 
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMX-----GXVVTR 189
Query: 425 GYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
            Y APE I N  + T+ VDI+S G ++ E+++G     F+  D  + L
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG--KTLFKGSDHLDQL 235

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 80  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 129
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 132/297 (44%), Gaps = 33/297 (11%)
Query: 255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICN-----EMDIMSRA 309
           ++ +    KLG G YGE+     +D      + + I RK  +    N     E+ ++   
Sbjct: 36  SEMYQRVKKLGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++       K++ ++V E  +   L   +    +  E+D     VII     G+ 
Sbjct: 94  DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD---AAVIIKQVLSGVT 150
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           YLHK     IVHRD+K  N+LL+ K +    KI DFGL+    ++K +       GT  Y
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYY 204
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD--------GFETLVTHTWKH 478
           +APE +   +  EK D++S GV++  +++G      Q+D         G  T  +  WK+
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN 263
Query: 479 FQ--AKTVLXXXXXXXXXXXXXXVKRVV--WVGLLCTQELPTLR-PSMTNVVQMLKQ 530
               AK ++               + +   W+  +C+++   +  PS+ N ++ +++
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 20/205 (9%)
Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFIS-RKNRIKEICNEMDIMSRAHH-KNLVQFL 318
            ++G G  G+++K   +  G  IAVK++  S  K   K I  ++D++ ++H    +VQ  
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 319 GCCFTKKDSFVVYEFVQN--KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
           G   T  D F+  E +    + L + +  P  ++ L   K  V I+   + L YL +  +
Sbjct: 91  GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG--KMTVAIV---KALYYLKE--K 143
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             ++HRD+K SNILLD + + K+ DFG++     +K+       AG   YMAPE I    
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPD 200
Query: 437 LTE-----KVDIYSFGVLVLEIVSG 456
            T+     + D++S G+ ++E+ +G
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATG 225

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR-IKEICNEMDI-M 306
           ++E   D  +   +LG G YG + K   +  G+ +AVKR+  +  ++  K +  ++DI M
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRI---LFDPKQKKELDWKKRHVIIIG 363
                   V F G  F + D ++  E + + SLD+    + D  Q    D   +  I + 
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVS 117
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
             + LE+LH   ++ ++HRD+K SN+L++   + K+ DFG++ +   +   +     AG 
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGC 172
Query: 424 LGYMAPEYIANGQLTE-----KVDIYSFGVLVLEI 453
             YMAPE I N +L +     K DI+S G+ ++E+
Sbjct: 173 KPYMAPERI-NPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 25/202 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIV 454
                 E VDI+S G ++ E+V
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMV 219

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 126
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 128
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 102 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 151
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 152 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 87  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 136
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 137 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 129
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N  +      KI DFG+ R       +  
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 184 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 129
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G + ++     +  G+E+AVK +  ++ N   ++++  E+ IM   +H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T+K  ++V E+     +   L    + KE + + +   I+     ++Y H   Q  IV
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCH---QKFIV 135
Query: 381 HRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT- 438
           HRD+KA N+LLD     KIADFG +  F+   K         G+  Y APE     +   
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL----DTFCGSPPYAAPELFQGKKYDG 191
Query: 439 EKVDIYSFGVLVLEIVSG 456
            +VD++S GV++  +VSG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 129
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G + ++     +  G+E+AVK +  ++ N   ++++  E+ IM   +H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T+K  ++V E+     +   L    + KE + + +   I+     ++Y H   Q  IV
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCH---QKFIV 135
Query: 381 HRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT- 438
           HRD+KA N+LLD     KIADFG +  F+   K         G+  Y APE     +   
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL----DTFCGSPPYAAPELFQGKKYDG 191
Query: 439 EKVDIYSFGVLVLEIVSG 456
            +VD++S GV++  +VSG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 148 LM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 198
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 199 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 453 IV 454
           +V
Sbjct: 256 MV 257

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 73
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R          
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 191 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 83  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 132
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 133 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 15/217 (6%)
Query: 249 STIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVK--RLFISRKNRIK-EICNEMD 304
           +T    +D ++    LG GG  E+     L+  R++AVK  R  ++R          E  
Sbjct: 22  TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 81
Query: 305 IMSRAHHKNLVQFLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
             +  +H  +V        +  +    ++V E+V   +L  I+     +  +  K+   +
Sbjct: 82  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEV 138
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTA 419
           I    + L + H++G   I+HRD+K +NI++   +  K+ DFG+AR  + S  S+    A
Sbjct: 139 IADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 195
Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           + GT  Y++PE      +  + D+YS G ++ E+++G
Sbjct: 196 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           LGHG  G I    + D R++AVKR+     S  +R  ++  E D      H N++++   
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD-----EHPNVIRYF-- 84
Query: 321 CFTKKDSF----------VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           C  K   F           + E+V+ K    +  +P             ++  T  GL +
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI-----------TLLQQTTSGLAH 133
Query: 371 LHKDGQMQIVHRDIKASNILLDL-----KHRPKIADFGLA-RFSSSEKSLLPNTAIAGTL 424
           LH    + IVHRD+K  NIL+ +     K +  I+DFGL  + +    S    + + GT 
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 425 GYMAPEYIANG---QLTEKVDIYSFGVLVLEIVS 455
           G++APE ++       T  VDI+S G +   ++S
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 36/217 (16%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRL-FISRKNRIKEICNEMDI--MSRAHHKNLVQFLG- 319
           +G G YG ++KG+L D R +AVK   F +R+N I    NE +I  +    H N+ +F+  
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFI----NEKNIYRVPLMEHDNIARFIVG 75
Query: 320 ----CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD- 374
                   + +  +V E+  N SL + L         DW     +      GL YLH + 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 375 -----GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP----NTAIA--GT 423
                 +  I HRD+ + N+L+       I+DFGL+   +  + + P    N AI+  GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 424 LGYMAPEYIANG-------QLTEKVDIYSFGVLVLEI 453
           + YMAPE +             ++VD+Y+ G++  EI
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 120
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 121 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 252 EKATDCFDESNKLGHGGYGEIF----KGTLQDGRE--IAVKRL--FISRKNRIKEICNEM 303
           E A +    S +LG G +G ++    KG ++D  E  +A+K +    S + RI E  NE 
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 64
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELD------WKKR 357
            +M   +  ++V+ LG     + + V+ E +    L   L   + + E +         +
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 358 HVIIIG-TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSS 409
            + + G  A+G+ YL+ +   + VHRD+ A N ++      KI DFG+ R          
Sbjct: 125 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             K LLP       + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 182 GGKGLLP-------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 133
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L   R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 33  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 144
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 198
Query: 433 ANGQLTEKVDIYSFGVLVLEIV 454
                 E VDI+S G ++ E+V
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMV 220

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI-----KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++ +    +  +        KEI +E  +M+   +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 111 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 160
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 161 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L   R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIV 454
                 E VDI+S G ++ E+V
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 110
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 111 LM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 161
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 162 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 453 IV 454
           +V
Sbjct: 219 MV 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR-----IKEICNEMDIMSRAHHKNL 314
           E  +LG G +G + KG  Q  + +    + I +          E+  E ++M +  +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL + 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I 
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
             + + K D++SFGVL+ E  S
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR-----IKEICNEMDIMSRAHHKNL 314
           E  +LG G +G + KG  Q  + +    + I +          E+  E ++M +  +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL + 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I 
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
             + + K D++SFGVL+ E  S
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L   R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIV 454
                 E VDI+S G ++ E+V
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 103
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 104 LM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 154
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 155 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 211
Query: 453 IV 454
           +V
Sbjct: 212 MV 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 126
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK------EICNEMDIMSRAHHKN 313
           E  +LG G +G + KG  Q  + +    + I  KN         E+  E ++M +  +  
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPY 87
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL +
Sbjct: 88  IVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE 143
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I
Sbjct: 144 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 103 LM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 453 IV 454
           +V
Sbjct: 211 MV 212

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK------EICNEMDIMSRAHHKN 313
           E  +LG G +G + KG  Q  + +    + I  KN         E+  E ++M +  +  
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPY 73
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL +
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE 129
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I
Sbjct: 130 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 255 TDCFDESNKLGHGGYGEIF--KGTLQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRA 309
           +D +     LG G +GE+   K  +  G+E AVK +    + +K   + +  E+ ++ + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++       K   ++V E      L   +   K+  E+D  +   II     G+ 
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 146
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           Y+HK+   +IVHRD+K  N+LL+ K +    +I DFGL+    + K +       GT  Y
Sbjct: 147 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYY 200
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +APE + +G   EK D++S GV++  ++SG
Sbjct: 201 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 26/234 (11%)
Query: 234 LSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISR 292
           LSL+ K   + Q    T  +    +     +G G YG +      + G ++A+K+L    
Sbjct: 2   LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61
Query: 293 KNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-------FVVYEFVQNKSLDRIL 343
           ++ I  K    E+ ++    H+N++  L   FT   S       ++V  F+Q   L +I+
Sbjct: 62  QSEIFAKRAYRELLLLKHMQHENVIGLLDV-FTPASSLRNFYDFYLVMPFMQT-DLQKIM 119
Query: 344 FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG 403
                  +   +K   ++    +GL+Y+H  G   +VHRD+K  N+ ++     KI DFG
Sbjct: 120 -----GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 171
Query: 404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           LAR + +E      T    T  Y APE I +     + VDI+S G ++ E+++G
Sbjct: 172 LARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 49  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 108
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 109 LM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 159
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 160 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 216
Query: 453 IV 454
           +V
Sbjct: 217 MV 218

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 281 REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSFVVYE 332
           R +A+K+L    +N+   K    E+ +M   +HKN++  L     +K      D ++V E
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 103
Query: 333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
            + + +L +++     + ELD ++   ++     G+++LH  G   I+HRD+K SNI++ 
Sbjct: 104 LM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 154
Query: 393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLE 452
                KI DFGLAR + +   + P      T  Y APE I      E VDI+S G ++ E
Sbjct: 155 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 211
Query: 453 IV 454
           +V
Sbjct: 212 MV 213

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 255 TDCFDESNKLGHGGYGEIF--KGTLQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRA 309
           +D +     LG G +GE+   K  +  G+E AVK +    + +K   + +  E+ ++ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++       K   ++V E      L   +   K+  E+D  +   II     G+ 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           Y+HK+   +IVHRD+K  N+LL+ K +    +I DFGL+    + K +       GT  Y
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYY 194
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +APE + +G   EK D++S GV++  ++SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK------EICNEMDIMSRAHHKN 313
           E  +LG G +G + KG  Q  + +    + I  KN         E+  E ++M +  +  
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPY 73
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL +
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE 129
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I
Sbjct: 130 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 255 TDCFDESNKLGHGGYGEIF--KGTLQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRA 309
           +D +     LG G +GE+   K  +  G+E AVK +    + +K   + +  E+ ++ + 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++       K   ++V E      L   +   K+  E+D  +   II     G+ 
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 163
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           Y+HK+   +IVHRD+K  N+LL+ K +    +I DFGL+    + K +       GT  Y
Sbjct: 164 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYY 217
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +APE + +G   EK D++S GV++  ++SG
Sbjct: 218 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK------EICNEMDIMSRAHHKN 313
           E  +LG G +G + KG  Q  + +    + I  KN         E+  E ++M +  +  
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPY 431
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL +
Sbjct: 432 IVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE 487
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I
Sbjct: 488 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRA-HHK 312
           FD    +G G Y ++    L+    I     VK+  ++    I  +  E  +  +A +H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
            LV    C  T+   F V E+V    L   +F  +++++L  +         +  L YLH
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN---TAIAGTLGYMAP 429
           + G   I++RD+K  N+LLD +   K+ D+G+ +     + L P    +   GT  Y+AP
Sbjct: 171 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 222
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E +        VD ++ GVL+ E+++G
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAG 249

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK------EICNEMDIMSRAHHKN 313
           E  +LG G +G + KG  Q  + +    + I  KN         E+  E ++M +  +  
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPY 432
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL +
Sbjct: 433 IVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE 488
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I
Sbjct: 489 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK------EICNEMDIMSRAHHKN 313
           E  +LG G +G + KG  Q  + +    + I  KN         E+  E ++M +  +  
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL +
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 255 TDCFDESNKLGHGGYGEIF--KGTLQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRA 309
           +D +     LG G +GE+   K  +  G+E AVK +    + +K   + +  E+ ++ + 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+++       K   ++V E      L   +   K+  E+D  +   II     G+ 
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 164
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           Y+HK+   +IVHRD+K  N+LL+ K +    +I DFGL+    + K +       GT  Y
Sbjct: 165 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYY 218
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +APE + +G   EK D++S GV++  ++SG
Sbjct: 219 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK------EICNEMDIMSRAHHKN 313
           E  +LG G +G + KG  Q  + +    + I  KN         E+  E ++M +  +  
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPY 67
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL +
Sbjct: 68  IVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE 123
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I
Sbjct: 124 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 25/202 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 26  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 137
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 138 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 191
Query: 433 ANGQLTEKVDIYSFGVLVLEIV 454
                 E VD++S G ++ E+V
Sbjct: 192 LGMGYKENVDLWSVGCIMGEMV 213

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD--------GREIAVKRLFISRKNRIKEICNEMDIMSRA 309
           F+ES  LG G + +IFKG  ++          E+ +K L  + +N  +       +MS+ 
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            HK+LV   G CF   ++ +V EFV+  SLD  L   K    + WK      +  A+ L 
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK------LEVAKQLA 123
Query: 370 Y-LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL--LPNTAIAGTLGY 426
           + +H   +  ++H ++ A NILL  +   K  +    + S    S+  LP   +   + +
Sbjct: 124 WAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 427 MAPEYIANGQ-LTEKVDIYSFGVLVLEIVSG 456
           + PE I N + L    D +SFG  + EI SG
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G + ++     +  G+E+AVK +  ++ N   ++++  E+ I    +H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T+K  ++V E+     +   L    + KE + + +   I+     ++Y H   Q  IV
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSA---VQYCH---QKFIV 135
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT-E 439
           HRD+KA N+LLD     KIADFG +   +    L    A  G   Y APE     +    
Sbjct: 136 HRDLKAENLLLDADXNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAPELFQGKKYDGP 192
Query: 440 KVDIYSFGVLVLEIVSG 456
           +VD++S GV++  +VSG
Sbjct: 193 EVDVWSLGVILYTLVSG 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK------EICNEMDIMSRAHHKN 313
           E  +LG G +G + KG  Q  + +    + I  KN         E+  E ++M +  +  
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL +
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 VHRD+ A N+LL  +H  KI+DFGL++   + E      T     + + APE I
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+     D    D      +        +    +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G + ++     +  G+E+AV+ +  ++ N   ++++  E+ IM   +H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T+K  ++V E+     +   L    + KE + + +   I+     ++Y H   Q  IV
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCH---QKFIV 135
Query: 381 HRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT- 438
           HRD+KA N+LLD     KIADFG +  F+   K         G+  Y APE     +   
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL----DTFCGSPPYAAPELFQGKKYDG 191
Query: 439 EKVDIYSFGVLVLEIVSG 456
            +VD++S GV++  +VSG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 25/202 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 148
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 149 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 202
Query: 433 ANGQLTEKVDIYSFGVLVLEIV 454
                 E VD++S G ++ E+V
Sbjct: 203 LGMGYKENVDLWSVGCIMGEMV 224

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRA-HHK 312
           FD    +G G Y ++    L+    I     VK+  ++    I  +  E  +  +A +H 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
            LV    C  T+   F V E+V    L   +F  +++++L  +         +  L YLH
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
           + G   I++RD+K  N+LLD +   K+ D+G+ +     + L P    +   GT  Y+AP
Sbjct: 139 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAP 190
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E +        VD ++ GVL+ E+++G
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAG 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G + ++     +  G+E+AVK +  ++ N   ++++  E+ IM   +H N+V+    
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T+K  ++V E+     +   L      KE + + +   I+     ++Y H   Q  IV
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS---AVQYCH---QKFIV 128
Query: 381 HRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT- 438
           HRD+KA N+LLD     KIADFG +  F+   K         G+  Y APE     +   
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL----DTFCGSPPYAAPELFQGKKYDG 184
Query: 439 EKVDIYSFGVLVLEIVSG 456
            +VD++S GV++  +VSG
Sbjct: 185 PEVDVWSLGVILYTLVSG 202

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 25/202 (12%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G  G +   +   L+  R +A+K+L    +N+   K    E+ +M   +HKN++  L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 319 GCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                +K      D ++V E + + +L +++     + ELD ++   ++     G+++LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y APE I
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAPEVI 197
Query: 433 ANGQLTEKVDIYSFGVLVLEIV 454
                 E VD++S G ++ E+V
Sbjct: 198 LGMGYKENVDLWSVGCIMGEMV 219

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 108/225 (48%), Gaps = 31/225 (13%)
Query: 255 TDCFDESNKLGHGGYGEIF--KGTLQDGREIAVKRLFISRKNRIKEICN------EMDIM 306
           +D +    KLG G YGE+   K  L  G E A+K   I +K+ +    N      E+ ++
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIK---IIKKSSVTTTSNSGALLDEVAVL 75
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQK-KELDWKKRHVIIIGT 364
            +  H N+++       K++ ++V E  +   L D I+   +QK  E+D     VI+   
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL--RQKFSEVD---AAVIMKQV 130
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGL-ARFSSSEKSLLPNTAI 420
             G  YLHK     IVHRD+K  N+LL+ K R    KI DFGL A F    K        
Sbjct: 131 LSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM----KER 183
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD 465
            GT  Y+APE +   +  EK D++S GV++  ++ G      Q+D
Sbjct: 184 LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTD 227

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 183
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           K+G G YG ++K     G   A+K++ + +++         E+ I+    H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TKK   +V+E + ++ L ++L     +  L+       ++    G+ Y H     +++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVL 122
Query: 381 HRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI-ANGQLT 438
           HRD+K  N+L++ +   KIADFGLAR F    +     T    TL Y AP+ +  + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---THEVVTLWYRAPDVLMGSKKYS 179
Query: 439 EKVDIYSFGVLVLEIVSG 456
             +DI+S G +  E+V+G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRA-HHK 312
           FD    +G G Y ++    L+    I     VK+  ++    I  +  E  +  +A +H 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
            LV    C  T+   F V E+V    L   +F  +++++L  +         +  L YLH
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
           + G   I++RD+K  N+LLD +   K+ D+G+ +     + L P    +   GT  Y+AP
Sbjct: 124 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAP 175
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E +        VD ++ GVL+ E+++G
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAG 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 176
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G + ++     +  G+E+AV+ +  ++ N   ++++  E+ IM   +H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             T+K  ++V E+     +   L    + KE + + +   I+     ++Y H   Q  IV
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCH---QKFIV 135
Query: 381 HRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT- 438
           HRD+KA N+LLD     KIADFG +  F+   K         G+  Y APE     +   
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL----DEFCGSPPYAAPELFQGKKYDG 191
Query: 439 EKVDIYSFGVLVLEIVSG 456
            +VD++S GV++  +VSG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           K+G G YG ++K     G   A+K++ + +++         E+ I+    H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TKK   +V+E + ++ L ++L     +  L+       ++    G+ Y H     +++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVL 122
Query: 381 HRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI-ANGQLT 438
           HRD+K  N+L++ +   KIADFGLAR F    +     T    TL Y AP+ +  + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---THEVVTLWYRAPDVLMGSKKYS 179
Query: 439 EKVDIYSFGVLVLEIVSG 456
             +DI+S G +  E+V+G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 16/216 (7%)
Query: 247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMD 304
           ++   E   D +D  + LG G + E+     +  +++   +    +    KE  + NE+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIG 363
           ++ +  H N+V       +    +++ + V    L DRI+    +K     +    +I  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQ 124
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNIL---LDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
             + ++YLH  G   IVHRD+K  N+L   LD   +  I+DFGL++       L   +  
Sbjct: 125 VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STA 178
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            GT GY+APE +A    ++ VD +S GV+   ++ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 108/245 (44%), Gaps = 24/245 (9%)
Query: 238 HKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNR 295
           +K +K L     T E+    +     +G+G +G +F+  L +  E+A+K++   +  KNR
Sbjct: 22  NKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR 81
Query: 296 IKEICNEMDIMSRAHHKNLVQFLGCCFT---KKDSF---VVYEFVQNKSLDRILFDPKQK 349
                 E+ IM    H N+V      ++   KKD     +V E+V            K K
Sbjct: 82  ------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK 135
Query: 350 KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLARFS 408
           + +      + +      L Y+H  G   I HRDIK  N+LLD      K+ DFG A+  
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
Query: 409 SSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG 467
            + +   PN +   +  Y APE I      T  +DI+S G ++ E++ G     F  + G
Sbjct: 193 IAGE---PNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG--QPLFPGESG 247
Query: 468 FETLV 472
            + LV
Sbjct: 248 IDQLV 252

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 261 SNKLGHGGYGEIFKGTLQ-DGREIAVK---RLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            + LG G +G++  G  Q  G ++AVK   R  I   + + +I  E+  +    H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T  D F+V E+V    L   +    + +E++ ++    I+     ++Y H+   
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL---SAVDYCHRH-- 130
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             +VHRD+K  N+LLD     KIADFGL+   S  + L  +    G+  Y APE I+ G+
Sbjct: 131 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVIS-GR 185
Query: 437 L--TEKVDIYSFGVLVLEIVSG 456
           L    +VDI+S GV++  ++ G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCG 207

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI----AVKRLFISRKNRIKEICNEMDIMSRA-HHK 312
           FD    +G G Y ++    L+    I     VK+  ++    I  +  E  +  +A +H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
            LV    C  T+   F V E+V    L   +F  +++++L  +         +  L YLH
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
           + G   I++RD+K  N+LLD +   K+ D+G+ +     + L P    +   GT  Y+AP
Sbjct: 128 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAP 179
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E +        VD ++ GVL+ E+++G
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAG 206

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 264 LGHGGYGEIFKGTLQDGRE-----IAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQF 317
           LG G +G ++KG      E     +A+K L  +   +   E  +E  IM+   H +LV+ 
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 318 LGCCFTKKDSFV--------VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           LG C +     V        + E+V     D I      +  L+W       +  A+G+ 
Sbjct: 83  LGVCLSPTIQLVTQLMPHGCLLEYVHEHK-DNI----GSQLLLNW------CVQIAKGMM 131
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YL    + ++VHRD+ A N+L+   +  KI DFGLAR    ++           + +MA 
Sbjct: 132 YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVS 455
           E I   + T + D++S+GV + E+++
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 258 FDESNKLGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHK 312
           + +   +G G  G +   F   L  G  +AVK+L    +N+   K    E+ ++   +HK
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 313 NLVQFLGCCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           N++  L     +K      D ++V E + + +L +++       ELD ++   ++     
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----HMELDHERMSYLLYQMLC 137
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           G+++LH  G   I+HRD+K SNI++      KI DFGLAR + +   + P      T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV---TRYY 191
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            APE I        VDI+S G ++ E+V G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 176
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 183
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 261 SNKLGHGGYGEIFKGTLQ-DGREIAVK---RLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            + LG G +G++  G  Q  G ++AVK   R  I   + + +I  E+  +    H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T  D F+V E+V    L   +    + +E++ ++    I+     ++Y H+   
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL---SAVDYCHRH-- 130
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             +VHRD+K  N+LLD     KIADFGL+   S  + L  +    G+  Y APE I+ G+
Sbjct: 131 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVIS-GR 185
Query: 437 L--TEKVDIYSFGVLVLEIVSG 456
           L    +VDI+S GV++  ++ G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCG 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR-------KNRIKEICNEMD 304
           E     F+    LG G + E+         E A  +LF  +       K +   I NE+ 
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLA-----EEKATGKLFAVKCIPKKALKGKESSIENEIA 72
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIG 363
           ++ +  H+N+V       +    ++V + V    L DRI+    +K     K    +I  
Sbjct: 73  VLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIV----EKGFYTEKDASTLIRQ 128
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILL---DLKHRPKIADFGLARFSSSEKSLLPNTAI 420
             + + YLH+   M IVHRD+K  N+L    D + +  I+DFGL++     K  + +TA 
Sbjct: 129 VLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG--KGDVMSTA- 182
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            GT GY+APE +A    ++ VD +S GV+   ++ G
Sbjct: 183 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 264 LGHGGYGEIFKGTLQDGRE-----IAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQF 317
           LG G +G ++KG      E     +A+K L  +   +   E  +E  IM+   H +LV+ 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 318 LGCCFTKKDSFV--------VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           LG C +     V        + E+V     D I      +  L+W       +  A+G+ 
Sbjct: 106 LGVCLSPTIQLVTQLMPHGCLLEYVHEHK-DNI----GSQLLLNW------CVQIAKGMM 154
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YL    + ++VHRD+ A N+L+   +  KI DFGLAR    ++           + +MA 
Sbjct: 155 YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVS 455
           E I   + T + D++S+GV + E+++
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 175
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLGC 320
           K+G G YG ++K     G   A+K++ + +++         E+ I+    H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             TKK   +V+E + ++ L ++L     +  L+       ++    G+ Y H     +++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVL 122
Query: 381 HRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYI-ANGQLT 438
           HRD+K  N+L++ +   KIADFGLAR F    +     T    TL Y AP+ +  + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---THEIVTLWYRAPDVLMGSKKYS 179
Query: 439 EKVDIYSFGVLVLEIVSG 456
             +DI+S G +  E+V+G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAP 429
            H     +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y AP
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAP 173
Query: 430 EYIANGQ-LTEKVDIYSFGVLVLEIVS 455
           E +   +  +  VDI+S G +  E+V+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 176
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 175
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+     D    D      +        +    +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+      +   D      +        +    +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMD 304
           ++   E   D +D  + LG G + E+     +  +++   +         KE  + NE+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIG 363
           ++ +  H N+V       +    +++ + V    L DRI+    +K     +    +I  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQ 124
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNIL---LDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
             + ++YLH  G   IVHRD+K  N+L   LD   +  I+DFGL++       L   +  
Sbjct: 125 VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STA 178
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            GT GY+APE +A    ++ VD +S GV+   ++ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFIS-RKNR----IKEICNEMDIMSRAH 310
           D F    KLG G +G++    L + R   ++R+  +  K+R    +++I  E++++    
Sbjct: 22  DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H N+++         + ++V E  +   L +RI+    + K L       ++      L 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 370 YLHKDGQMQIVHRDIKASNILLD--LKHRP-KIADFGLAR-FSSSEKSLLPNTAIAGTLG 425
           Y H      +VH+D+K  NIL      H P KI DFGLA  F S E S    T  AGT  
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS----TNAAGTAL 191
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           YMAPE +    +T K DI+S GV++  +++G
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 176
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KXQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+     D    D      +        +    +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 180
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLD-RILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H N+V+ L    T+   ++V+EF+   S+D +   D      +        +    +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           + H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y AP
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 430 EYIANGQ-LTEKVDIYSFGVLVLEIVS 455
           E +   +  +  VDI+S G +  E+V+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLD-RILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H N+V+ L    T+   ++V+EF+   S+D +   D      +        +    +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           + H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y AP
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 430 EYIANGQ-LTEKVDIYSFGVLVLEIVS 455
           E +   +  +  VDI+S G +  E+V+
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE +  
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 176
Query: 435 GQ-LTEKVDIYSFGVLVLEIVS 455
            +  +  VDI+S G +  E+V+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 255 TDCFDESNKLGHGGYGEIF--KGTLQDGREIAVKRLFISRKNRIKEICN------EMDIM 306
           +D +    KLG G YGE+   K  L  G E A+K   I +K+ +    N      E+ ++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIK---IIKKSSVTTTSNSGALLDEVAVL 58
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQK-KELDWKKRHVIIIGT 364
            +  H N+++       K++ ++V E  +   L D I+   +QK  E+D     VI+   
Sbjct: 59  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL--RQKFSEVD---AAVIMKQV 113
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGL-ARFSSSEKSLLPNTAI 420
             G  YLHK     IVHRD+K  N+LL+ K R    KI DFGL A F    K        
Sbjct: 114 LSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM----KER 166
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            GT  Y+APE +   +  EK D++S GV++  ++ G
Sbjct: 167 LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRLF-ISRKNR-IKEICNEMDIMSRAHHKNLVQFLGC 320
           LG G +GE+ K   +   +E AVK +   S KN+    I  E++++ +  H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
                  ++V E      L   +   K+  E D  +   II     G+ Y+HK     IV
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 381 HRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIA---GTLGYMAPEYIAN 434
           HRD+K  NILL+ K +    KI DFGL+           NT +    GT  Y+APE +  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLS------TCFQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 435 GQLTEKVDIYSFGVLVLEIVSGV 457
           G   EK D++S GV++  ++SG 
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGT 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 177
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE +  
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 176
Query: 435 GQ-LTEKVDIYSFGVLVLEIVS 455
            +  +  VDI+S G +  E+V+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR---------KNRIKEICNEMDIM 306
           D +D   +LG G +G + +       E A  R+F+++         K  +K   NE+ IM
Sbjct: 51  DYYDILEELGSGAFGVVHRCV-----EKATGRVFVAKFINTPYPLDKYTVK---NEISIM 102
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIG-- 363
           ++ HH  L+        K +  ++ EF+    L DRI  +       D+K     +I   
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-------DYKMSEAEVINYM 155
Query: 364 --TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTA 419
               EGL+++H   +  IVH DIK  NI+ + K     KI DFGLA   + ++ +   TA
Sbjct: 156 RQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
              T  + APE +    +    D+++ GVL   ++SG+  + F  +D  ETL
Sbjct: 213 ---TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL--SPFAGEDDLETL 259

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE +  
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 178
Query: 435 GQ-LTEKVDIYSFGVLVLEIVS 455
            +  +  VDI+S G +  E+V+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 130
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFG A+   +E+           +
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 128
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFG A+   +E+           +
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMD 304
           ++   E   D +D  + LG G + E+     +  +++   +         KE  + NE+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIG 363
           ++ +  H N+V       +    +++ + V    L DRI+    +K     +    +I  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQ 124
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNIL---LDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
             + ++YLH  G   IVHRD+K  N+L   LD   +  I+DFGL++       L   +  
Sbjct: 125 VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STA 178
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            GT GY+APE +A    ++ VD +S GV+   ++ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE--ICNEMD 304
           ++   E   D +D  + LG G + E+     +  +++   +         KE  + NE+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIG 363
           ++ +  H N+V       +    +++ + V    L DRI+    +K     +    +I  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQ 124
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNIL---LDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
             + ++YLH  G   IVHRD+K  N+L   LD   +  I+DFGL++       L   +  
Sbjct: 125 VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STA 178
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            GT GY+APE +A    ++ VD +S GV+   ++ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 128
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFG A+   +E+           +
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   L  G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     ++        LD +    ++ K+       L+W       +  
Sbjct: 84  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 133
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   L  G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 126
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRLF-ISRKNR-IKEICNEMDIMSRAHHKNLVQFLGC 320
           LG G +GE+ K   +   +E AVK +   S KN+    I  E++++ +  H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
                  ++V E      L   +   K+  E D  +   II     G+ Y+HK     IV
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKH---NIV 143
Query: 381 HRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIA---GTLGYMAPEYIAN 434
           HRD+K  NILL+ K +    KI DFGL+           NT +    GT  Y+APE +  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLS------TCFQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
           G   EK D++S GV++  ++SG
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 264 LGHGGYGEIFKGTLQ-DGREIAVKRLF-ISRKNR-IKEICNEMDIMSRAHHKNLVQFLGC 320
           LG G +GE+ K   +   +E AVK +   S KN+    I  E++++ +  H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
                  ++V E      L   +   K+  E D  +   II     G+ Y+HK     IV
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKH---NIV 143
Query: 381 HRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIA---GTLGYMAPEYIAN 434
           HRD+K  NILL+ K +    KI DFGL+           NT +    GT  Y+APE +  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLS------TCFQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
           G   EK D++S GV++  ++SG
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 242 KFLQFKYSTIEKAT-DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE- 298
           +FLQ+K+   +  T + F +   LG GG+GE+    ++  G+  A K+L   R  + K  
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228
Query: 299 --ICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK 356
               NE  I+ + + + +V       TK    +V   +    L   ++   Q    + + 
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR- 287
Query: 357 RHVIIIGTAE---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS 413
               +   AE   GLE LH++   +IV+RD+K  NILLD     +I+D GLA      ++
Sbjct: 288 ---AVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341
Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +       GT+GYMAPE + N + T   D ++ G L+ E+++G
Sbjct: 342 I---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 128
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFG A+   +E+           +
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 126
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFG A+   +E+           +
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 263 KLGHGGYGEIFKGTL------QDGREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLV 315
           +LG   +G+++KG L      +  + +A+K L    +  ++E   +E  + +R  H N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILF-------------DPKQKKELDWKKRHVIII 362
             LG     +   +++ +  +  L   L              D   K  L+      ++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAI 420
             A G+EYL       +VH+D+   N+L+  K   KI+D GL R  +++    LL N+ +
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQ 458
              + +MAPE I  G+ +   DI+S+GV++ E+ S G+Q
Sbjct: 193 P--IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 21  TIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 81  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 132
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 133 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----- 184
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   LG G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 133
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFG A+   +E+           +
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREI----AVKRLFISRKNRI-KEICNEMDIMSRAHH 311
           F +   L  G +G ++KG  + +G ++    A+K L  +   +  KEI +E  +M+   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGT 364
            ++ + LG C T     +         LD +    ++ K+       L+W       +  
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQI 133
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +MA E I +   T + D++S+GV V E+++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +     ++ G +IAVK+L    ++ I  K    E+ ++
Sbjct: 45  TIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL 104
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFV------QNKSLDRILFDPKQKKELDWKKRHV- 359
               H+N++  L   FT   S   +  V          L+ I+   K +K  D    HV 
Sbjct: 105 KHMKHENVIGLLDV-FTPATSLEEFNDVYLVTHLMGADLNNIV---KCQKLTD---DHVQ 157
Query: 360 -IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
            +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      T
Sbjct: 158 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----T 209
Query: 419 AIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
               T  Y APE + N       VDI+S G ++ E+++G
Sbjct: 210 GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 20/224 (8%)
Query: 242 KFLQFKYSTIEKAT-DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKE- 298
           +FLQ+K+   +  T + F +   LG GG+GE+    ++  G+  A K+L   R  + K  
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228
Query: 299 --ICNEMDIMSRAHHKNLVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWK 355
               NE  I+ + + + +V  L   +  KD+  +V   +    L   ++   Q    + +
Sbjct: 229 AMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR 287
Query: 356 KRHVIIIGTAE---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK 412
                +   AE   GLE LH++   +IV+RD+K  NILLD     +I+D GLA      +
Sbjct: 288 ----AVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340
Query: 413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           ++       GT+GYMAPE + N + T   D ++ G L+ E+++G
Sbjct: 341 TI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 40/223 (17%)
Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSR-AHHKNLVQFL 318
           KLG G YG ++K    + G  +AVK++F + +N    +    E+ I++  + H+N+V  L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 319 GC--CFTKKDSFVVYEFVQNKSLDRI---LFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
                   +D ++V+++++      I   + +P  K+ + ++   VI        +YLH 
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVI--------KYLHS 127
Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN---------------- 417
            G   ++HRD+K SNILL+ +   K+ADFGL+R   + + +  N                
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 418 ---TAIAGTLGYMAPE-YIANGQLTEKVDIYSFGVLVLEIVSG 456
              T    T  Y APE  + + + T+ +D++S G ++ EI+ G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KXQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK----NRIKEICNEMDIMSRAHH 311
           D F+    +G G +G++      D +++   +    +K    N ++ +  E+ IM    H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV        ++D F+V + +    L   L   +Q      +   + I      L+YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYL 131
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
                 +I+HRD+K  NILLD      I DF +A     E  +   T +AGT  YMAPE 
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEM 185
Query: 432 IANGQ---LTEKVDIYSFGVLVLEIVSG 456
            ++ +    +  VD +S GV   E++ G
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 81  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 132
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 133 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----- 184
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 26/228 (11%)
Query: 255 TDCFDESNKLGHGGYGE----IFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR-A 309
           TD ++    +G G Y      I K T     E AVK +  S+++  +EI    +I+ R  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIIDKSKRDPTEEI----EILLRYG 73
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            H N++         K  +VV E ++   L D+IL    ++K    ++   ++    + +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTV 129
Query: 369 EYLHKDGQMQIVHRDIKASNIL-LDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTL 424
           EYLH  G   +VHRD+K SNIL +D    P   +I DFG A+   +E  LL       T 
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY--TA 184
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            ++APE +         DI+S GVL+  +++G        DD  E ++
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+E V      +   D      +        +    +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 175
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 225 KDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFK-GTLQDGREI 283
           +D++G+     LL + LK + ++Y    +         +LG G +GE+ +    Q G + 
Sbjct: 49  EDNEGV-----LLTEKLKPVDYEY---REEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQC 100
Query: 284 AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL 343
           AVK++ +    R++E+     + S      +V   G         +  E ++  SL +++
Sbjct: 101 AVKKVRL-EVFRVEELVACAGLSS----PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 155
Query: 344 FDPKQKKELDWKKRHVIIIGTA-EGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIAD 401
              KQ   L  + R +  +G A EGLEYLH     +I+H D+KA N+LL     R  + D
Sbjct: 156 ---KQMGCLP-EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCD 208
Query: 402 FGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           FG A   +     KSLL    I GT  +MAPE +       KVDI+S   ++L +++G
Sbjct: 209 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 78  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 129
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 130 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----- 181
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 267 GGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMS--RAHHKNLVQFLGC---- 320
           G +G ++K  L +   +AVK   I  K   +   NE ++ S     H+N++QF+G     
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQ---NEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH------KD 374
                D +++  F +  SL   L    +   + W +   I    A GL YLH      KD
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 375 GQM-QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
           G    I HRDIK+ N+LL       IADFGLA    + KS        GT  YMAPE + 
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 434 NGQLTE-----KVDIYSFGVLVLEIVS 455
                +     ++D+Y+ G+++ E+ S
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 82  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 133
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 134 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----- 185
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 83  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 134
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR ++ E      
Sbjct: 135 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----- 186
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 83  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 134
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR ++ E      
Sbjct: 135 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----- 186
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 87  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 138
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 139 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM----- 190
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 191 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 72  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 123
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 175
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 83  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 134
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR ++ E      
Sbjct: 135 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----- 186
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 263 KLGHGGYGEIFKGTLQDGR---EIAVKRLFI-SRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           +LG G +G + +G  +  +   ++A+K L   + K   +E+  E  IM +  +  +V+ +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G C   +   +V E      L + L    +++E+       ++   + G++YL    +  
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKN 130
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL-PNTAIAGTLGYMAPEYIANGQL 437
            VHRD+ A N+LL  +H  KI+DFGL++   ++ S     +A    L + APE I   + 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + + D++S+GV + E +S
Sbjct: 191 SSRSDVWSYGVTMWEALS 208

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 263 KLGHGGYGEIFKGTLQDGR---EIAVKRLFI-SRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           +LG G +G + +G  +  +   ++A+K L   + K   +E+  E  IM +  +  +V+ +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G C   +   +V E      L + L    +++E+       ++   + G++YL    +  
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKN 456
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL-PNTAIAGTLGYMAPEYIANGQL 437
            VHR++ A N+LL  +H  KI+DFGL++   ++ S     +A    L + APE I   + 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 438 TEKVDIYSFGVLVLEIVS 455
           + + D++S+GV + E +S
Sbjct: 517 SSRSDVWSYGVTMWEALS 534

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 82  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 133
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 134 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 185
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 255 TDCFDESNKLGHGGYGEIF--KGTLQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRA 309
           +D +     LG G +GE+   K  +  G+E AVK +    + +K   + +  E+ ++ + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+ +       K   ++V E      L   +   K+  E+D  +   II     G+ 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLA-RFSSSEKSLLPNTAIAGTLG 425
           Y HK+   +IVHRD+K  N+LL+ K +    +I DFGL+  F +S+K         GT  
Sbjct: 141 YXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKX----KDKIGTAY 193
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           Y+APE + +G   EK D++S GV++  ++SG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYE--FVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
               H+N++  L   FT   S   +   ++    +   L +  + ++L       +I   
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      T    T 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATR 186
Query: 425 GYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
            Y APE + N     + VDI+S G ++ E+++G
Sbjct: 187 WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+   RL    +        E+ ++   +H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 176
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNL 314
           F +  K+G G YG ++K   +  G  +A+   RL    +        E+ ++   +H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+ L    T+   ++V+EF+ ++ L + + D      +        +    +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              +++HRD+K  N+L++ +   K+ADFGLAR F    ++    T    TL Y APE + 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILL 175
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
             +  +  VDI+S G +  E+V+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 243 FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR-IKEIC 300
           + Q      E   D  +   +LG G YG + K   +  G+  AVKR+  +  ++  K + 
Sbjct: 21  YFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLL 80
Query: 301 NEMDIMSRAHH-KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRI---LFDPKQKKELDWKK 356
            ++DI  R       V F G  F + D ++  E + + SLD+    + D  Q    D   
Sbjct: 81  XDLDISXRTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILG 139
Query: 357 RHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP 416
           +  I +   + LE+LH   ++ ++HRD+K SN+L++   + K  DFG++ +   +   + 
Sbjct: 140 K--IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD---VA 192
Query: 417 NTAIAGTLGYMAPEYIANGQLTE-----KVDIYSFGVLVLEI 453
               AG   Y APE I N +L +     K DI+S G+  +E+
Sbjct: 193 KDIDAGCKPYXAPERI-NPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFV------QNKSLDRILFDPKQKKELDWKKRHV- 359
               H+N++  L   FT   S   +  V          L+ I+   K +K  D    HV 
Sbjct: 96  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTD---DHVQ 148
Query: 360 -IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
            +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      T
Sbjct: 149 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----T 200
Query: 419 AIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
               T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRL---FISRKNRIKEICNEMDIMS 307
           EK  D F   N LG G +  +++  ++  G E+A+K +    + +   ++ + NE+ I  
Sbjct: 8   EKIED-FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 308 RAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI--IIGTA 365
           +  H ++++           ++V E   N  ++R L + + K   + + RH +  II   
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQII--- 122
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G+ YLH  G   I+HRD+  SN+LL      KIADFGLA  +  +     +  + GT  
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPN 177
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           Y++PE         + D++S G +   ++ G
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVK--RLFISRKNRIKEICNEMDIMSRAH 310
           + + F +  K+G G YG ++K   +  G  +A+K  RL    +        E+ ++   +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+ L    T+   ++V+E V ++ L + + D      +        +    +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
            H     +++HRD+K  N+L++ +   K+ADFGLAR          +  +  TL Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVS 455
            +   +  +  VDI+S G +  E+V+
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 95  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 146
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 147 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 198
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 199 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNR------IKEICNEMDIMSRAH 310
           +++  K+G G YG +FK   ++  EI A+KR+ +   +       ++EIC    ++    
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELK 59
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           HKN+V+      + K   +V+EF  ++ L +  FD     +LD +     +    +GL +
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FD-SCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAP 429
            H      ++HRD+K  N+L++     K+ADFGLAR F    +     +A   TL Y  P
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY---SAEVVTLWYRPP 170
Query: 430 EYIANGQL-TEKVDIYSFGVLVLEIVSGVQ 458
           + +   +L +  +D++S G +  E+ +  +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 78  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 129
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 130 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 181
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD--------GREIAVKRLFISRKNRIKEICNEMDIMSRA 309
           F+ES  LG G + +IFKG  ++          E+ +K L  + +N  +       +MS+ 
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            HK+LV   G C    ++ +V EFV+  SLD  L   K    + WK    +    A  + 
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--VAKQLAAAMH 127
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL--LPNTAIAGTLGYM 427
           +L ++    ++H ++ A NILL  +   K  +    + S    S+  LP   +   + ++
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 428 APEYIANGQ-LTEKVDIYSFGVLVLEIVSG 456
            PE I N + L    D +SFG  + EI SG
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 113/258 (43%), Gaps = 44/258 (17%)
Query: 255 TDCFDESNKLGHGGYGE----IFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR-A 309
           TD ++    +G G Y      I K T     E AVK +  S+++  +EI    +I+ R  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKAT---NXEFAVKIIDKSKRDPTEEI----EILLRYG 73
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            H N++         K  +VV E  +   L D+IL    ++K    ++   ++    + +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL----RQKFFSEREASAVLFTITKTV 129
Query: 369 EYLHKDGQMQIVHRDIKASNIL-LDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTL 424
           EYLH  G   +VHRD+K SNIL +D    P   +I DFG A+   +E  LL       T 
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY--TA 184
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVL------------------EIVSGVQNNKFQSDD 466
            ++APE +         DI+S GVL+                   EI++ + + KF    
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
Query: 467 GFETLVTHTWKHFQAKTV 484
           G+   V+ T K   +K +
Sbjct: 245 GYWNSVSDTAKDLVSKXL 262

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KSQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGL R +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 83  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 134
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 135 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 186
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 73  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 124
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 125 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 176
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 177 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 81  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 132
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 133 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 184
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 73  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 124
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 125 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 176
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 177 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 255 TDCFDESNKLGHGGYGE----IFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR-A 309
           +D +     +G G Y E    + K T     E AVK +  S+++  +EI    +I+ R  
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEI----EILLRYG 78
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            H N++         K  ++V E ++   L D+IL    ++K    ++   ++    + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL----RQKFFSEREASFVLHTIGKTV 134
Query: 369 EYLHKDGQMQIVHRDIKASNIL-LDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTL 424
           EYLH  G   +VHRD+K SNIL +D    P   +I DFG A+   +E  LL       T 
Sbjct: 135 EYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TA 189
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            ++APE +      E  DI+S G+L+  +++G
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 78  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 129
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 130 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 181
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 72  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 123
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 175
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 81  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 132
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 133 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 184
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 225 KDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFK-GTLQDGREI 283
           +D++G+     LL + LK + ++Y    +         ++G G +GE+ +    Q G + 
Sbjct: 35  EDNEGV-----LLTEKLKPVDYEY---REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86
Query: 284 AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL 343
           AVK++ +    R++E+     + S      +V   G         +  E ++  SL +++
Sbjct: 87  AVKKVRL-EVFRVEELVACAGLSS----PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 141
Query: 344 FDPKQKKELDWKKRHVIIIGTA-EGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIAD 401
              KQ   L  + R +  +G A EGLEYLH     +I+H D+KA N+LL     R  + D
Sbjct: 142 ---KQMGCLP-EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCD 194
Query: 402 FGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           FG A   +     KSLL    I GT  +MAPE +       KVDI+S   ++L +++G
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 14  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 74  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 125
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 126 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 177
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 178 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 15  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 75  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 126
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 127 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 178
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 179 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 78  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 129
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 130 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 181
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 88  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 139
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 140 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 191
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 192 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K  K  D    HV
Sbjct: 72  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCAKLTD---DHV 123
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 175
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 88  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 139
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 140 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 191
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 192 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 82  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 133
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 134 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 185
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 88  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 139
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 140 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 191
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 192 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYE--FVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
               H+N++  L   FT   S   +   ++    +   L +  + ++L       +I   
Sbjct: 96  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      T    T 
Sbjct: 155 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATR 206
Query: 425 GYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
            Y APE + N     + VDI+S G ++ E+++G
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 87  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 138
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 139 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 190
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 191 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 82  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 133
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 134 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 185
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYE--FVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
               H+N++  L   FT   S   +   ++    +   L +  + ++L       +I   
Sbjct: 99  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      T    T 
Sbjct: 158 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATR 209
Query: 425 GYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
            Y APE + N     + VDI+S G ++ E+++G
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +     +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 26  TIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 86  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 137
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 138 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 189
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 190 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 264 LGHGGYGEIFKGTL--QDGR--EIAVKRLFI--SRKNRIKEICNEMDIMSRAHHKNLVQF 317
           LG G +G + +G L  +DG   ++AVK + +  S +  I+E  +E   M    H N+++ 
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 318 LGCCFTKKDS-----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHV-------IIIGTA 365
           LG C            V+  F++   L   L   +    L+   +H+        ++  A
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR----LETGPKHIPLQTLLKFMVDIA 157
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G+EYL        +HRD+ A N +L       +ADFGL++   S             + 
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNNKF 462
           ++A E +A+   T K D+++FGV + EI +       GVQN++ 
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYE--FVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
               H+N++  L   FT   S   +   ++    +   L +  + ++L       +I   
Sbjct: 95  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      T    T 
Sbjct: 154 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATR 205
Query: 425 GYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
            Y APE + N     + VDI+S G ++ E+++G
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 225 KDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFK-GTLQDGREI 283
           +D++G+     LL + LK + ++Y    +         ++G G +GE+ +    Q G + 
Sbjct: 51  EDNEGV-----LLTEKLKPVDYEY---REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 102
Query: 284 AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL 343
           AVK++ +    R++E+     + S      +V   G         +  E ++  SL +++
Sbjct: 103 AVKKVRL-EVFRVEELVACAGLSS----PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 157
Query: 344 FDPKQKKELDWKKRHVIIIGTA-EGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIAD 401
              KQ   L  + R +  +G A EGLEYLH     +I+H D+KA N+LL     R  + D
Sbjct: 158 ---KQMGCLP-EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCD 210
Query: 402 FGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           FG A   +     KSLL    I GT  +MAPE +       KVDI+S   ++L +++G
Sbjct: 211 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 255 TDCFDESNKLGHGGYGE----IFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR-A 309
           +D +     +G G Y E    + K T     E AVK +  S+++  +EI    +I+ R  
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEI----EILLRYG 78
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            H N++         K  ++V E ++   L D+IL    ++K    ++   ++    + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL----RQKFFSEREASFVLHTIGKTV 134
Query: 369 EYLHKDGQMQIVHRDIKASNIL-LDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTL 424
           EYLH  G   +VHRD+K SNIL +D    P   +I DFG A+   +E  LL       T 
Sbjct: 135 EYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TA 189
Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            ++APE +      E  DI+S G+L+  +++G
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E +    
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA---- 180
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
                T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 181 -GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E +    
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA---- 180
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
                T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 181 -GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 72  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 123
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E +    
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA---- 176
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
                T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 177 -GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 60/126 (47%), Gaps = 26/126 (20%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS----LL 415
           I I  AE +E+LH  G M   HRD+K SNI   +    K+ DFGL      ++     L 
Sbjct: 169 IFIQIAEAVEFLHSKGLM---HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 416 PNTAIA------GTLGYMAPEYIANGQLTEKVDIYSFGVLVLE-------------IVSG 456
           P  A A      GT  YM+PE I     + KVDI+S G+++ E             I++ 
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITD 285
Query: 457 VQNNKF 462
           V+N KF
Sbjct: 286 VRNLKF 291

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR------ELQIMRKLDHCNI 75
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 233

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR------ELQIMRKLDHCNI 75
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 233

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 18/220 (8%)
Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++     KGT +      +K+  + + + ++    E  +++       +  L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT--AEGLEYLHKDGQ 376
            CF   D  + V E+V    L   ++  +Q      K+ H +      A GL +L   G 
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRF--KEPHAVFYAAEIAIGLFFLQSKG- 462
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I++RD+K  N++LD +   KIADFG+ + +  +   +      GT  Y+APE IA   
Sbjct: 463 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTPDYIAPEIIAYQP 518
Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG-FETLVTHT 475
             + VD ++FGVL+ E+++G    + + +D  F++++ H 
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 75
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 233

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI D+GLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR------ELQIMRKLDHCNI 75
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 233

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 75
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 233

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 76
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 137 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 189
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 234

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 75
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 233

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVK---RLFISRKNR--IKEICNEMDIMSRAHHKNLVQF 317
           LG G +G + KG  + +G  I +    ++   +  R   + + + M  +    H ++V+ 
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGTAEGLEY 370
           LG C       V         LD +    +Q +        L+W       +  A+G+ Y
Sbjct: 99  LGLCPGSSLQLVTQYLPLGSLLDHV----RQHRGALGPQLLLNWG------VQIAKGMYY 148
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           L + G   +VHR++ A N+LL    + ++ADFG+A     +   L  +     + +MA E
Sbjct: 149 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 431 YIANGQLTEKVDIYSFGVLVLEIVS 455
            I  G+ T + D++S+GV V E+++
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 80
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 141 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 193
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 238

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVK---RLFISRKNR--IKEICNEMDIMSRAHHKNLVQF 317
           LG G +G + KG  + +G  I +    ++   +  R   + + + M  +    H ++V+ 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVIIIGTAEGLEY 370
           LG C       V         LD +    +Q +        L+W       +  A+G+ Y
Sbjct: 81  LGLCPGSSLQLVTQYLPLGSLLDHV----RQHRGALGPQLLLNWG------VQIAKGMYY 130
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           L + G   +VHR++ A N+LL    + ++ADFG+A     +   L  +     + +MA E
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 431 YIANGQLTEKVDIYSFGVLVLEIVS 455
            I  G+ T + D++S+GV V E+++
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 103
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 164 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 216
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 261

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 88
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 149 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 201
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 246

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 109
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 222
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 267

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 94
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 155 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 207
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 252

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 83
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 144 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 196
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 241

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 87
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 200
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 245

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 262 NKLGHGGYGEIFKGT--LQDGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQFL 318
           +KLG G Y  ++KG   L D   +A+K + +  +         E+ ++    H N+V   
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
               T+K   +V+E++ +K L + L D      ++     + +     GL Y H+    +
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI--INMHNVKLFLFQLLRGLAYCHRQ---K 120
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE-YIANGQL 437
           ++HRD+K  N+L++ +   K+ADFGLAR  S       N  +  TL Y  P+  + +   
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDY 178
Query: 438 TEKVDIYSFGVLVLEIVSG 456
           + ++D++  G +  E+ +G
Sbjct: 179 STQIDMWGVGCIFYEMATG 197

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 118/242 (48%), Gaps = 34/242 (14%)
Query: 225 KDDQGMEMDLSLLHKSLKFLQFKY-STIEKATDCFDESNKLGHGGYGEIFK-GTLQDGRE 282
           +D++G+     LL + LK + ++Y   +  AT       +LG G +GE+ +    Q G +
Sbjct: 70  EDNEGV-----LLTEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQ 120
Query: 283 IAVKRLFISRKNRIKEICNEMDIMSRAH--HKNLVQFLGCCFTKKDSFVVYEFVQNKSLD 340
            AVK++ +       E+    ++M+ A      +V   G         +  E ++  SL 
Sbjct: 121 CAVKKVRL-------EVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLG 173
Query: 341 RILFDPKQKKELDWKKRHVIIIGTA-EGLEYLHKDGQMQIVHRDIKASNILL--DLKHRP 397
           +++   K++  L  + R +  +G A EGLEYLH     +I+H D+KA N+LL  D  H  
Sbjct: 174 QLV---KEQGCLP-EDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHA- 225
Query: 398 KIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIV 454
            + DFG A   +     KSLL    I GT  +MAPE +       KVD++S   ++L ++
Sbjct: 226 ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 285
Query: 455 SG 456
           +G
Sbjct: 286 NG 287

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 87
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 200
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 245

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 75
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 233

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 109
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 267

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 40/246 (16%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHK 312
           D ++  + +G G YG + +   + + R +A+K++    ++ I  K I  E+ I++R +H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 313 NLVQFLGCCFTKK----DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           ++V+ L     K     D   V   + +    ++   P    EL  K    ++     G+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK---TLLYNLLVGV 169
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR---FSSSEKSLLPN-------- 417
           +Y+H  G   I+HRD+K +N L++     K+ DFGLAR   +  +  S LP         
Sbjct: 170 KYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 418 --------------TAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSGVQNN-K 461
                         T    T  Y APE I      TE +D++S G +  E+++ ++ N  
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 462 FQSDDG 467
           + +D G
Sbjct: 287 YHADRG 292

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 79
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 140 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 192
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 237

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 111
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 172 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 224
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 269

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 256 DCFDESNKLGHGGYGEIFK----GTLQDGREIAVKRL----FISRKNRIKEICNEMDIMS 307
           +CF+    LG GGYG++F+         G+  A+K L     +           E +I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 308 RAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG-TAE 366
              H  +V  +    T    +++ E++    L    F   +++ +  +      +   + 
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISM 132
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
            L +LH+ G   I++RD+K  NI+L+ +   K+ DFGL + S  + ++       GT+ Y
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCGTIEY 187
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
           MAPE +        VD +S G L+ ++++G 
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 18/220 (8%)
Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++     KGT +      +K+  + + + ++    E  +++       +  L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT--AEGLEYLHKDGQ 376
            CF   D  + V E+V    L   ++  +Q      K+ H +      A GL +L   G 
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRF--KEPHAVFYAAEIAIGLFFLQSKG- 141
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             I++RD+K  N++LD +   KIADFG+ + +  +   +      GT  Y+APE IA   
Sbjct: 142 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTPDYIAPEIIAYQP 197
Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG-FETLVTHT 475
             + VD ++FGVL+ E+++G    + + +D  F++++ H 
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYE--FVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
               H+N++  L   FT   S   +   ++    +   L +  + ++L       +I   
Sbjct: 96  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E           T 
Sbjct: 155 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----XGXVATR 206
Query: 425 GYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
            Y APE + N     + VDI+S G ++ E+++G
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 113
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 174 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 226
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 271

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL 314
           + ++  +G+G +G +++  L D G  +A+K++   +  KNR      E+ IM +  H N+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNI 154
Query: 315 VQ---FLGCCFTKKDSF---VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           V+   F      KKD     +V ++V            + K+ L      + +      L
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGY 426
            Y+H  G   I HRDIK  N+LLD    P  A   L  F S+++ +   PN +   +  Y
Sbjct: 215 AYIHSFG---ICHRDIKPQNLLLD----PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 267
Query: 427 MAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
            APE I      T  +D++S G ++ E++ G     F  D G + LV
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIFPGDSGVDQLV 312

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 256 DCFDESNKLGHGGYGEIFK----GTLQDGREIAVKRL----FISRKNRIKEICNEMDIMS 307
           +CF+    LG GGYG++F+         G+  A+K L     +           E +I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 308 RAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG-TAE 366
              H  +V  +    T    +++ E++    L    F   +++ +  +      +   + 
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISM 132
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
            L +LH+ G   I++RD+K  NI+L+ +   K+ DFGL + S  + ++       GT+ Y
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THXFCGTIEY 187
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
           MAPE +        VD +S G L+ ++++G 
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL 314
           +D F+  ++LG G    +++   Q G +       + +    K +  E+ ++ R  H N+
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNI 110
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++      T  +  +V E V    L DRI+    +K     +     +    E + YLH+
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE 166
Query: 374 DGQMQIVHRDIKASNILL--DLKHRP-KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           +G   IVHRD+K  N+L        P KIADFGL++    E  +L  T + GT GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYCAPE 220
Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
            +       +VD++S G++   ++ G +    +  D F
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 122
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 123 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 177
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 178 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 225

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 122
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPK----IADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI+L  ++ PK    I DFGLA    F +  K++   
Sbjct: 123 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 177
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 178 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 225

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 258 FDESNKLGHGGYGEIFKGTLQDGREI-AVKRLFISRKNR------IKEICNEMDIMSRAH 310
           +++  K+G G YG +FK   ++  EI A+KR+ +   +       ++EIC    ++    
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELK 59
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           HKN+V+      + K   +V+EF  ++ L +  FD     +LD +     +    +GL +
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FD-SCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAP 429
            H      ++HRD+K  N+L++     K+A+FGLAR F    +     +A   TL Y  P
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPP 170
Query: 430 EYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           + +   +L +  +D++S G +  E+ + 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANA 198

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 14/218 (6%)
Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++     KGT +      +K+  + + + ++    E  +++       +  L 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
            CF   D  + V E+V    L   ++  +Q  +    +        + GL +LHK G   
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG--- 140
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           I++RD+K  N++LD +   KIADFG+ +    +   +      GT  Y+APE IA     
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG--VTTREFCGTPDYIAPEIIAYQPYG 198
Query: 439 EKVDIYSFGVLVLEIVSGVQNNKFQSDDG-FETLVTHT 475
           + VD +++GVL+ E+++G      + +D  F++++ H 
Sbjct: 199 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 236

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 88/173 (50%), Gaps = 16/173 (9%)
Query: 290 ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS--FVVYEFV-QNKSLDRILFDP 346
           I  +  I+++  E+ I+ +  H N+V+ +       +   ++V+E V Q   ++     P
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 347 KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR 406
             + +  +  + +I     +G+EYLH     +I+HRDIK SN+L+      KIADFG++ 
Sbjct: 134 LSEDQARFYFQDLI-----KGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT---EKVDIYSFGVLVLEIVSG 456
                 +LL NT   GT  +MAPE ++  +     + +D+++ GV +   V G
Sbjct: 186 EFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 99  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 150
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DFGLAR +  E      
Sbjct: 151 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----- 202
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
                T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 203 XGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPK----IADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI+L  ++ PK    I DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPK----IADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI+L  ++ PK    I DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIK-----EICNEMDIMSRAHHKNLVQF 317
           LG G +G++   T  +  +++A+K  FISR+   K      +  E+  +    H ++++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALK--FISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
                T  D  +V E+   +  D I+   K++   D  +R    I  A  +EY H+    
Sbjct: 75  YDVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRFFQQIICA--IEYCHRH--- 127
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
           +IVHRD+K  N+LLD     KIADFGL+   +    L       G+  Y APE I NG+L
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVI-NGKL 183
Query: 438 --TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
               +VD++S G+++  ++ G    +   DD F
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVG----RLPFDDEF 212

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 264 LGHGGYGEIFKGTL----QDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           +G G +G ++ G      Q+  + A+K L  I+   +++    E  +M   +H N++  +
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 319 GCCFTKKD-SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG--TAEGLEYLHKDG 375
           G     +    V+  ++ +  L + +  P++   +    + +I  G   A G+EYL    
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV----KDLISFGLQVARGMEYL---A 141
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
           + + VHRD+ A N +LD     K+ADFGLAR        S+  +      + + A E + 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
             + T K D++SFGVL+ E+++
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLT 223

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 29/187 (15%)
Query: 301 NEMDIMSRAHHKNLVQFLGCCFTKKDSFV--VYEFVQNKSLDRILFDPKQKKELDWKKRH 358
            E++I+   +H+++V++ GCC  + +  V  V E+V   SL             D+  RH
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR------------DYLPRH 106
Query: 359 VIIIG--------TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--S 408
            + +           EG+ YLH       +HR + A N+LLD     KI DFGLA+    
Sbjct: 107 CVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 163
Query: 409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             E   +     +    Y APE +   +     D++SFGV + E+++   +N+      F
Sbjct: 164 GHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCDSNQ-SPHTKF 221
Query: 469 ETLVTHT 475
             L+ HT
Sbjct: 222 TELIGHT 228

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 29/187 (15%)
Query: 301 NEMDIMSRAHHKNLVQFLGCCFTKKDSFV--VYEFVQNKSLDRILFDPKQKKELDWKKRH 358
            E++I+   +H+++V++ GCC  + +  V  V E+V   SL             D+  RH
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR------------DYLPRH 107
Query: 359 VIIIG--------TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--S 408
            + +           EG+ YLH       +HR + A N+LLD     KI DFGLA+    
Sbjct: 108 CVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 164
Query: 409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             E   +     +    Y APE +   +     D++SFGV + E+++   +N+      F
Sbjct: 165 GHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCDSNQ-SPHTKF 222
Query: 469 ETLVTHT 475
             L+ HT
Sbjct: 223 TELIGHT 229

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNI-LLDL---KHRPKIADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI LLD    K R KI DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI DF LAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI  FGLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
            A+G+E+L      + +HRD+ A NILL  K+  KI DFGLAR    +   +        
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
            A+G+E+L      + +HRD+ A NILL  K+  KI DFGLAR    +   +        
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G YG +   +   L+  +++AVK+L    ++ I  +    E+ ++    H+N++  L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 319 GCCFTKKDSFVVYE--FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
              FT   S   +   ++    +   L +  + + L  +    ++     GL+Y+H  G 
Sbjct: 94  DV-FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG- 151
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG- 435
             I+HRD+K SN+ ++     +I DFGLAR +  E      T    T  Y APE + N  
Sbjct: 152 --IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-----TGYVATRWYRAPEIMLNWM 204
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
              + VDI+S G ++ E++ G
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG 225

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK------GTLQDGREIAVKRLFISRKNRIKE-ICNEMD 304
           E   D +D   +LG G +  + K      G     + I  +R   SR+   +E I  E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           I+    H N++        K D  ++ E V    L   L    +K+ L  ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQI 123
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPK----IADFGLAR---FSSSEKSLLPN 417
             G+ YLH    +QI H D+K  NI+L  ++ PK    I DFGLA    F +  K++   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL
Sbjct: 179 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETL 226

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
            A+G+E+L      + +HRD+ A NILL  K+  KI DFGLAR    +   +        
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 50/255 (19%)
Query: 248 YSTIEKATDCFDESNKLGHGGYGEIFKGT--LQDGRE--IAVKRLFISRKNRIKEICNEM 303
           Y  + + ++ F   +K+G G +  ++  T  LQ G E  IA+K L I   + I+ I  E+
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL-IPTSHPIR-IAAEL 70
Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVV-YEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
             ++ A  ++ V  +  CF K D  V+   +++++S   IL        L +++    ++
Sbjct: 71  QCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL------NSLSFQEVREYML 124
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLA-----------RFSSS 410
              + L+ +H+ G   IVHRD+K SN L + +  +  + DFGLA           +F  S
Sbjct: 125 NLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 411 E------------------KSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVL 451
           E                  + + P    AGT G+ APE +      T  +D++S GV+ L
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPR---AGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238
Query: 452 EIVSGVQNNKFQSDD 466
            ++SG       SDD
Sbjct: 239 SLLSGRYPFYKASDD 253

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
            A+G+E+L      + +HRD+ A NILL  K+  KI DFGLAR    +   +        
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 264 LGHGGYGEIFKGTLQD------GREIAVKRLFISRKNRIKE-ICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T            +AVK L  S     +E + +E+ ++S   +H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG------------ 363
             LG C     + V+ E+      D + F  +++      K    I+             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 364 -----TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
                 A+G+ +L        +HRD+ A NILL      KI DFGLAR   ++ + +   
Sbjct: 172 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKG 228
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                + +MAPE I N   T + D++S+G+ + E+ S
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI D GLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 261 SNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFL 318
           S  LG G Y ++    +LQ+G+E AVK +     +    +  E++ + +   +KN+++ +
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 319 GCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
              F + D+  ++V+E +Q  S   IL   +++K  + ++   ++   A  L++LH  G 
Sbjct: 78  E--FFEDDTRFYLVFEKLQGGS---ILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG- 131
Query: 377 MQIVHRDIKASNILLDLKHR---PKIADFGLARFSSSEKSLLPN-----TAIAGTLGYMA 428
             I HRD+K  NIL +   +    KI DF L        S  P      T   G+  YMA
Sbjct: 132 --IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 429 PEYIA--NGQLT---EKVDIYSFGVLVLEIVSG 456
           PE +     Q T   ++ D++S GV++  ++SG
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 229 GMEMDLSLLH-KSLKFLQFKYSTIEKATDC----FDESNKLGHGGYGEIFKGTLQDGREI 283
           G EM+LSLL  +S      + S   +  D      +    +G G +G+++ G      E+
Sbjct: 1   GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EV 58
Query: 284 AVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDR 341
           A++ + I R N  ++K    E+    +  H+N+V F+G C +     ++    + ++L  
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 342 ILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD 401
           ++ D K    LD  K   I     +G+ YLH  G   I+H+D+K+ N+  D   +  I D
Sbjct: 119 VVRDAKIV--LDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITD 172
Query: 402 FGLARFSS-------SEKSLLPNTAIAGTLGYMAPEYI 432
           FGL   S         +K  + N    G L ++APE I
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQN----GWLCHLAPEII 206

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 117/242 (48%), Gaps = 34/242 (14%)
Query: 225 KDDQGMEMDLSLLHKSLKFLQFKY-STIEKATDCFDESNKLGHGGYGEIFK-GTLQDGRE 282
           +D++G+     LL + LK + ++Y   +  AT       +LG G +GE+ +    Q G +
Sbjct: 51  EDNEGV-----LLTEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQ 101
Query: 283 IAVKRLFISRKNRIKEICNEMDIMSRAH--HKNLVQFLGCCFTKKDSFVVYEFVQNKSLD 340
            AVK++ +       E+    ++M+ A      +V   G         +  E ++  SL 
Sbjct: 102 CAVKKVRL-------EVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLG 154
Query: 341 RILFDPKQKKELDWKKRHVIIIGTA-EGLEYLHKDGQMQIVHRDIKASNILL--DLKHRP 397
           +++   K++  L  + R +  +G A EGLEYLH     +I+H D+KA N+LL  D  H  
Sbjct: 155 QLV---KEQGCLP-EDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHA- 206
Query: 398 KIADFGLA---RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIV 454
            + DFG A   +     K LL    I GT  +MAPE +       KVD++S   ++L ++
Sbjct: 207 ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHML 266
Query: 455 SG 456
           +G
Sbjct: 267 NG 268

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI D GLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 250 TIEKATDCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 307 SRAHHKNLVQFLGCCFTK-------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
               H+N++  L   FT         D ++V   +    L+ I+   K +K  D    HV
Sbjct: 76  KHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTD---DHV 127
Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN 417
             +I     GL+Y+H      I+HRD+K SN+ ++     KI D GLAR +  E      
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM----- 179
Query: 418 TAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSG 456
           T    T  Y APE + N     + VDI+S G ++ E+++G
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 264 LGHGGYGEIFKGTLQD------GREIAVKRLFISRKNRIKE-ICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T            +AVK L  S     +E + +E+ ++S   +H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG------------ 363
             LG C     + V+ E+      D + F  +++      K    I+             
Sbjct: 91  NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 364 -----TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
                 A+G+ +L        +HRD+ A NILL      KI DFGLAR   ++ + +   
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                + +MAPE I N   T + D++S+G+ + E+ S
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 258 FDESNKLGHGGYGEIFK-GTLQDGREIAVKR---LFISRKNRIKEICNEMDIMSRAHHKN 313
           F   ++LGHG YGE+FK  + +DGR  AVKR    F   K+R +++           H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP- 117
Query: 314 LVQFLGCCFTKKDSF----VVYEFVQNKSLDRILFDPKQKKELD-WKKR--HVIIIG--- 363
                 CC   + ++    ++Y       L   L  P  ++  + W        + G   
Sbjct: 118 ------CCVRLEQAWEEGGILY-------LQTELCGPSLQQHCEAWGASLPEAQVWGYLR 164
Query: 364 -TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG 422
            T   L +LH  G   +VH D+K +NI L  + R K+ DFGL     +  +        G
Sbjct: 165 DTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEG 218
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIV 454
              YMAPE +  G      D++S G+ +LE+ 
Sbjct: 219 DPRYMAPELL-QGSYGTAADVFSLGLTILEVA 249

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 262 NKLGHGG--YGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
            KLG GG  Y ++ +G L DG   A+KR+    +   +E   E D+    +H N+++ + 
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 320 CCF----TKKDSFVVYEFVQNKSLDRILFDPKQKKE-LDWKKRHVIIIGTAEGLEYLHKD 374
            C      K +++++  F +  +L   +   K K   L   +   +++G   GLE +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFG-----LARFSSSEKSLLPNTAIAG--TLGYM 427
           G     HRD+K +NILL  + +P + D G           S ++L      A   T+ Y 
Sbjct: 154 G---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 428 APEYI---ANGQLTEKVDIYSFGVLVLEIVSG 456
           APE     ++  + E+ D++S G ++  ++ G
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 13/166 (7%)
Query: 290 ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL---DRILF-- 344
           IS K++  +  NE+ I++   ++  +   G      + +++YE+++N S+   D   F  
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 345 DPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL 404
           D      +  +    II        Y+H   +  I HRD+K SNIL+D   R K++DFG 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE--KVDIYSFGV 448
           + +   +K         GT  +M PE+ +N       KVDI+S G+
Sbjct: 199 SEYMVDKKI----KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 264 LGHGGYGEIFKGTLQD------GREIAVKRLFISRKNRIKE-ICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T            +AVK L  S     +E + +E+ ++S   +H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG------------ 363
             LG C     + V+ E+      D + F  +++      K    I+             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 364 -----TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
                 A+G+ +L        +HRD+ A NILL      KI DFGLAR   ++ + +   
Sbjct: 172 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 228
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                + +MAPE I N   T + D++S+G+ + E+ S
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 264 LGHGGYGEIFKGTLQD------GREIAVKRLFISRKNRIKE-ICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T            +AVK L  S     +E + +E+ ++S   +H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG------------ 363
             LG C     + V+ E+      D + F  +++      K    I+             
Sbjct: 107 NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 364 -----TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
                 A+G+ +L        +HRD+ A NILL      KI DFGLAR   ++ + +   
Sbjct: 165 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 221
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                + +MAPE I N   T + D++S+G+ + E+ S
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 264 LGHGGYGEIFKGTLQD------GREIAVKRLFISRKNRIKE-ICNEMDIMSR-AHHKNLV 315
           LG G +G++ + T            +AVK L  S     +E + +E+ ++S   +H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG------------ 363
             LG C     + V+ E+      D + F  +++      K    I+             
Sbjct: 109 NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 364 -----TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
                 A+G+ +L        +HRD+ A NILL      KI DFGLAR   ++ + +   
Sbjct: 167 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 223
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                + +MAPE I N   T + D++S+G+ + E+ S
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE-----ICNEMDIMSRAHHKNLVQFL 318
           +G G +GE+     +  R++   +L +S+   IK         E DIM+ A+   +VQ  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 +  ++V E++    L  ++  +D  +K    W + +     TAE +  L     
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHS 191
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI---- 432
           M  +HRD+K  N+LLD     K+ADFG     + E  +  +TA+ GT  Y++PE +    
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 250
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
            +G    + D +S GV + E++ G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L     AGT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----AGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 258 FDESNKLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
           FD    LG G +G++     K T   GR  A+K L    I  K+ +     E  ++    
Sbjct: 10  FDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 311 HKNLVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H  L   L   F   D    V E+     L    F   +++    ++           LE
Sbjct: 67  HPFLTA-LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 122
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      +V+RDIK  N++LD     KI DFGL +   S+ + +      GT  Y+AP
Sbjct: 123 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 177
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E + +      VD +  GV++ E++ G
Sbjct: 178 EVLEDNDYGRAVDWWGLGVVMYEMMCG 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 258 FDESNKLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
           FD    LG G +G++     K T   GR  A+K L    I  K+ +     E  ++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 311 HKNLVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H  L   L   F   D    V E+     L    F   +++    ++           LE
Sbjct: 64  HPFLTA-LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      +V+RDIK  N++LD     KI DFGL +   S+ + +      GT  Y+AP
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E + +      VD +  GV++ E++ G
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE-----ICNEMDIMSRAHHKNLVQFL 318
           +G G +GE+     +  R++   +L +S+   IK         E DIM+ A+   +VQ  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 +  ++V E++    L  ++  +D  +K    W + +     TAE +  L     
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHS 191
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI---- 432
           M  +HRD+K  N+LLD     K+ADFG     + E  +  +TA+ GT  Y++PE +    
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 250
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
            +G    + D +S GV + E++ G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE-----ICNEMDIMSRAHHKNLVQFL 318
           +G G +GE+     +  R++   +L +S+   IK         E DIM+ A+   +VQ  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 +  ++V E++    L  ++  +D  +K    W + +     TAE +  L     
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHS 186
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI---- 432
           M  +HRD+K  N+LLD     K+ADFG     + E  +  +TA+ GT  Y++PE +    
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
            +G    + D +S GV + E++ G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 17/193 (8%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++        G+++A+K +    +++ +    I  E+  +    H ++++   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
              +K +  +V E+  N+  D I+    Q+ ++  ++           +EY H+    +I
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KI 124
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-- 437
           VHRD+K  N+LLD     KIADFGL+   +    L       G+  Y APE I+ G+L  
Sbjct: 125 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVIS-GKLYA 180
Query: 438 TEKVDIYSFGVLV 450
             +VD++S GV++
Sbjct: 181 GPEVDVWSCGVIL 193

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 258 FDESNKLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
           FD    LG G +G++     K T   GR  A+K L    I  K+ +     E  ++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 311 HKNLVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H  L   L   F   D    V E+     L    F   +++    ++           LE
Sbjct: 64  HPFLTA-LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      +V+RDIK  N++LD     KI DFGL +   S+ + +      GT  Y+AP
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E + +      VD +  GV++ E++ G
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 264 LGHGGYGEI---FKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G YG +   +   L+  +++AVK+L    ++ I  +    E+ ++    H+N++  L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 319 GCCFTKKDSFVVYE--FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
              FT   S   +   ++    +   L +  + + L  +    ++     GL+Y+H  G 
Sbjct: 94  DV-FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG- 151
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG- 435
             I+HRD+K SN+ ++     +I DFGLAR +  E      T    T  Y APE + N  
Sbjct: 152 --IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-----TGYVATRWYRAPEIMLNWM 204
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
              + VDI+S G ++ E++ G
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG 225

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 17/193 (8%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++        G+++A+K +    +++ +    I  E+  +    H ++++   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
              +K +  +V E+  N+  D I+    Q+ ++  ++           +EY H+    +I
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KI 128
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-- 437
           VHRD+K  N+LLD     KIADFGL+   +    L       G+  Y APE I+ G+L  
Sbjct: 129 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVIS-GKLYA 184
Query: 438 TEKVDIYSFGVLV 450
             +VD++S GV++
Sbjct: 185 GPEVDVWSCGVIL 197

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 258 FDESNKLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
           FD    LG G +G++     K T   GR  A+K L    I  K+ +     E  ++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 311 HKNLVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H  L   L   F   D    V E+     L    F   +++    ++           LE
Sbjct: 64  HPFLTA-LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      +V+RDIK  N++LD     KI DFGL +   S+ + +      GT  Y+AP
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXFCGTPEYLAP 174
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E + +      VD +  GV++ E++ G
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 17/193 (8%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++        G+++A+K +    +++ +    I  E+  +    H ++++   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
              +K +  +V E+  N+  D I+    Q+ ++  ++           +EY H+    +I
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KI 133
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-- 437
           VHRD+K  N+LLD     KIADFGL+   +    L       G+  Y APE I+ G+L  
Sbjct: 134 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVIS-GKLYA 189
Query: 438 TEKVDIYSFGVLV 450
             +VD++S GV++
Sbjct: 190 GPEVDVWSCGVIL 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 258 FDESNKLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
           FD    LG G +G++     K T   GR  A+K L    I  K+ +     E  ++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 311 HKNLVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H  L   L   F   D    V E+     L    F   +++    ++           LE
Sbjct: 64  HPFLTA-LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      +V+RDIK  N++LD     KI DFGL +   S+ + +      GT  Y+AP
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXFCGTPEYLAP 174
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E + +      VD +  GV++ E++ G
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 17/193 (8%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++        G+++A+K +    +++ +    I  E+  +    H ++++   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
              +K +  +V E+  N+  D I+    Q+ ++  ++           +EY H+    +I
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KI 134
Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-- 437
           VHRD+K  N+LLD     KIADFGL+   +    L       G+  Y APE I+ G+L  
Sbjct: 135 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVIS-GKLYA 190
Query: 438 TEKVDIYSFGVLV 450
             +VD++S GV++
Sbjct: 191 GPEVDVWSCGVIL 203

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 258 FDESNKLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
           FD    LG G +G++     K T   GR  A+K L    I  K+ +     E  ++    
Sbjct: 12  FDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 311 HKNLVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H  L   L   F   D    V E+     L    F   +++    ++           LE
Sbjct: 69  HPFLTA-LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 124
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      +V+RDIK  N++LD     KI DFGL +   S+ + +      GT  Y+AP
Sbjct: 125 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXFCGTPEYLAP 179
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E + +      VD +  GV++ E++ G
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    +G G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   K+ADFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 258 FDESNKLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
           FD    LG G +G++     K T   GR  A+K L    I  K+ +     E  ++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 311 HKNLVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H  L   L   F   D    V E+     L    F   +++    ++           LE
Sbjct: 64  HPFLTA-LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YLH      +V+RDIK  N++LD     KI DFGL +   S+ + +      GT  Y+AP
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXFCGTPEYLAP 174
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E + +      VD +  GV++ E++ G
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 26/237 (10%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFI----SRKNRI----KEICNE 302
           +K  D +D   +LG G +  + K   +  G E A K  FI    SR +R     +EI  E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVCREEIERE 65
Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
           + I+ +  H N++        + D  ++ E V    L   L    QK+ L  ++    I 
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIK 122
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNT 418
              +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFGLA      +  +   
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFK 176
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT 475
            I GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL   T
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETLANIT 231

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 31/230 (13%)
Query: 232 MDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFI 290
           MDL ++H S               D ++    +G G +G        Q    +AVK  +I
Sbjct: 10  MDLPIMHDS---------------DRYELVKDIGAGNFGVARLMRDKQANELVAVK--YI 52
Query: 291 SRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQK 349
            R  +I E      I  R+  H N+V+F     T     +V E+     L   + +  + 
Sbjct: 53  ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 112
Query: 350 KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP--KIADFGLARF 407
            E + +     +I    G+ Y H    MQ+ HRD+K  N LLD    P  KIADFG ++ 
Sbjct: 113 SEDEARFFFQQLIS---GVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA 166
Query: 408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV-DIYSFGVLVLEIVSG 456
           S       P +A+ GT  Y+APE +   +   KV D++S GV +  ++ G
Sbjct: 167 SVLHSQ--PKSAV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 14/202 (6%)
Query: 262 NKLGHGGYGEIFKGTLQ--DGREIAV-----KRLFISRKNRIKEICNEMDIMSRAHHKNL 314
            KLG G +G + +G      G+ ++V     K   +S+   + +   E++ M    H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           ++  G   T     V         LDR+    K +            +  AEG+ YL   
Sbjct: 84  IRLYGVVLTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              + +HRD+ A N+LL  +   KI DFGL R    ++   +          + APE + 
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
               +   D + FGV + E+ +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 26/237 (10%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFI----SRKNRI----KEICNE 302
           +K  D +D   +LG G +  + K   +  G E A K  FI    SR +R     +EI  E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVSREEIERE 65
Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
           + I+ +  H N++        + D  ++ E V    L   L    QK+ L  ++    I 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIK 122
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNT 418
              +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFGLA      +  +   
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFK 176
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT 475
            I GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL   T
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETLANIT 231

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 263 KLGHGGYGEIFKGTLQ--DGREIAV-----KRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
           KLG G +G + +G      G+ ++V     K   +S+   + +   E++ M    H+NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +  G   T     V         LDR+    K +            +  AEG+ YL    
Sbjct: 79  RLYGVVLTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK- 134
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
             + +HRD+ A N+LL  +   KI DFGL R    ++   +          + APE +  
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
              +   D + FGV + E+ +
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 263 KLGHGGYGEIFKGTLQ--DGREIAV-----KRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
           KLG G +G + +G      G+ ++V     K   +S+   + +   E++ M    H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +  G   T     V         LDR+    K +            +  AEG+ YL    
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
             + +HRD+ A N+LL  +   KI DFGL R    ++   +          + APE +  
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
              +   D + FGV + E+ +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 14/202 (6%)
Query: 262 NKLGHGGYGEIFKGTLQ--DGREIAV-----KRLFISRKNRIKEICNEMDIMSRAHHKNL 314
            KLG G +G + +G      G+ ++V     K   +S+   + +   E++ M    H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           ++  G   T     V         LDR+    K +            +  AEG+ YL   
Sbjct: 84  IRLYGVVLTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIA 433
              + +HRD+ A N+LL  +   KI DFGL R    ++   +          + APE + 
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
               +   D + FGV + E+ +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 264 LGHGGYGEIFKGTLQDGR---EIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
           +G G YG +      D R   ++AVK+L    ++ I  +    E+ ++    H+N++  L
Sbjct: 28  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 319 GCCFTKKDSFVVYE--FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
              FT   S   +   ++    +   L +  + + L  +    ++     GL+Y+H  G 
Sbjct: 86  DV-FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG- 143
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG- 435
             I+HRD+K SN+ ++     +I DFGLAR +  E      T    T  Y APE + N  
Sbjct: 144 --IIHRDLKPSNVAVNEDCELRILDFGLARQADEEM-----TGYVATRWYRAPEIMLNWM 196
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
              + VDI+S G ++ E++ G
Sbjct: 197 HYNQTVDIWSVGCIMAELLQG 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 263 KLGHGGYGEIFKGTLQ--DGREIAV-----KRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
           KLG G +G + +G      G+ ++V     K   +S+   + +   E++ M    H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +  G   T     V         LDR+    K +            +  AEG+ YL    
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
             + +HRD+ A N+LL  +   KI DFGL R    ++   +          + APE +  
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
              +   D + FGV + E+ +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++KEI    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+     +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   K+ DFGLA+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 253 KATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE-----ICNEMDIMS 307
           KA D +D    +G G +GE+     +  +++   +L +S+   IK         E DIM+
Sbjct: 73  KAED-YDVVKVIGRGAFGEVQLVRHKASQKVYAMKL-LSKFEMIKRSDSAFFWEERDIMA 130
Query: 308 RAHHKNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGT 364
            A+   +VQ   C F   K  ++V E++    L  ++  +D  +K    W K +     T
Sbjct: 131 FANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----T 180
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           AE +  L     M ++HRD+K  N+LLD     K+ADFG       E  ++      GT 
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHCDTAVGTP 239
Query: 425 GYMAPEYI----ANGQLTEKVDIYSFGVLVLEIVSG 456
            Y++PE +     +G    + D +S GV + E++ G
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 28/167 (16%)
Query: 301 NEMDIMSRAHHKNLVQFLGCCFTKKDSFV--VYEFVQNKSLDRILFDPKQKKELDWKKRH 358
            E+DI+   +H++++++ GCC     + +  V E+V   SL             D+  RH
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR------------DYLPRH 129
Query: 359 VIIIG--------TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--S 408
            I +           EG+ YLH       +HRD+ A N+LLD     KI DFGLA+    
Sbjct: 130 SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186
Query: 409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             E   +     +    Y APE +   +     D++SFGV + E+++
Sbjct: 187 GHEXYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 249 STIEKATDCFD-ESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIK-EICNEMDIM 306
           S  E+  D F+ E  K+G G YG ++K   +DG++     L       I    C E+ ++
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALL 72
Query: 307 SRAHHKNLVQFLGCCFTKKDS--FVVYEFVQNKSLDRILF---DPKQKKELDWKKRHV-- 359
               H N++       +  D   ++++++ ++     I F       KK +   +  V  
Sbjct: 73  RELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILL----DLKHRPKIADFGLAR-FSSSEKSL 414
           ++    +G+ YLH +    ++HRD+K +NIL+      + R KIAD G AR F+S  K L
Sbjct: 133 LLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 415 LPNTAIAGTLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVS 455
                +  T  Y APE +   +  T+ +DI++ G +  E+++
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 26/237 (10%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFI----SRKNRI----KEICNE 302
           +K  D +D   +LG G +  + K   +  G E A K  FI    SR +R     +EI  E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVSREEIERE 65
Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
           + I+ +  H N++        + D  ++ E V    L   L    QK+ L  ++    I 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIK 122
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNT 418
              +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFGLA      +  +   
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFK 176
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT 475
            I GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL   T
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETLANIT 231

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 26/237 (10%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFI----SRKNRI----KEICNE 302
           +K  D +D   +LG G +  + K   +  G E A K  FI    SR +R     +EI  E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVSREEIERE 65
Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
           + I+ +  H N++        + D  ++ E V    L   L    QK+ L  ++    I 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIK 122
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNT 418
              +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFGLA      +  +   
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFK 176
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT 475
            I GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL   T
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETLANIT 231

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 28/167 (16%)
Query: 301 NEMDIMSRAHHKNLVQFLGCCFTK--KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH 358
            E+DI+   +H++++++ GCC  +  K   +V E+V   SL             D+  RH
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLR------------DYLPRH 112
Query: 359 VIIIG--------TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--S 408
            I +           EG+ YLH       +HR++ A N+LLD     KI DFGLA+    
Sbjct: 113 SIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE 169
Query: 409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             E   +     +    Y APE +   +     D++SFGV + E+++
Sbjct: 170 GHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 106/237 (44%), Gaps = 26/237 (10%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK-GTLQDGREIAVKRLFI----SRKNRI----KEICNE 302
           +K  D +D   +LG G +  + K      G E A K  FI    SR +R     +EI  E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVSREEIERE 65
Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
           + I+ +  H N++        + D  ++ E V    L   L    QK+ L  ++    I 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIK 122
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNT 418
              +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFGLA      +  +   
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFK 176
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT 475
            I GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL   T
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETLANIT 231

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 263 KLGHGGYGEIFKGTLQ--DGREIAV-----KRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
           KLG G +G + +G      G+ ++V     K   +S+   + +   E++ M    H+NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +  G   T     V         LDR+    K +            +  AEG+ YL    
Sbjct: 79  RLYGVVLTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK- 134
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
             + +HRD+ A N+LL  +   KI DFGL R    ++   +          + APE +  
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
              +   D + FGV + E+ +
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 263 KLGHGGYGEIFKGTLQ--DGREIAV-----KRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
           KLG G +G + +G      G+ ++V     K   +S+   + +   E++ M    H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +  G   T     V         LDR+    K +            +  AEG+ YL    
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
             + +HRD+ A N+LL  +   KI DFGL R    ++   +          + APE +  
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
              +   D + FGV + E+ +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 264 LGHGGYGEIFKG------TLQDGREIAVKRLFISRKNRIK-EICNEMDIMSRAHHKNLVQ 316
           +G G +G +F+         +    +AVK L       ++ +   E  +M+   + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRIL---------------------FDPKQKKELDWK 355
            LG C   K   +++E++    L+  L                             L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 356 KRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
           ++  I    A G+ YL    + + VHRD+   N L+      KIADFGL+R   S     
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQ 458
            +   A  + +M PE I   + T + D++++GV++ EI S G+Q
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 26/237 (10%)
Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFI----SRKNRI----KEICNE 302
           +K  D +D   +LG G +  + K   +  G E A K  FI    SR +R     +EI  E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVSREEIERE 65
Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
           + I+ +  H N++        + D  ++ E V    L   L    QK+ L  ++    I 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIK 122
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNT 418
              +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFGLA      +  +   
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFK 176
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT 475
            I GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL   T
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGDTKQETLANIT 231

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 245 QFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICN 301
           +F  +   K +D +D   +LG G +  + +   +  G E A K +   +      +++  
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 302 EMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVII 361
           E  I  +  H N+V+       +   ++V++ V    L   +   +   E D    H I 
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD--ASHCIQ 135
Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNT 418
               E + Y H +G   IVHR++K  N+LL  K +    K+ADFGLA   +  ++     
Sbjct: 136 -QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---H 188
Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             AGT GY++PE +     ++ VDI++ GV++  ++ G
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 17/156 (10%)
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII--------GTAEGLEYLHKD 374
           T  +SF    F ++KSL     D +++++ D   +  I +          A G+E+L   
Sbjct: 163 TSSESFASSGFQEDKSLS----DVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFL--- 215
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
              + +HRD+ A NILL   +  KI DFGLAR        +        L +MAPE I +
Sbjct: 216 SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFD 275
Query: 435 GQLTEKVDIYSFGVLVLEIVS--GVQNNKFQSDDGF 468
              + K D++S+GVL+ EI S  G      Q D+ F
Sbjct: 276 KIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDF 311

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 28/167 (16%)
Query: 301 NEMDIMSRAHHKNLVQFLGCCFTK--KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH 358
            E+DI+   +H++++++ GCC  +  K   +V E+V   SL             D+  RH
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLR------------DYLPRH 112
Query: 359 VIIIG--------TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--S 408
            I +           EG+ YLH       +HR++ A N+LLD     KI DFGLA+    
Sbjct: 113 SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE 169
Query: 409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             E   +     +    Y APE +   +     D++SFGV + E+++
Sbjct: 170 GHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 253 KATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRA 309
           K +D +D   +LG G +  + +   +  G E A K +   +      +++  E  I  + 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+V+       +   ++V++ V    L   +   +   E D    H I     E + 
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD--ASHCIQ-QILESIA 119
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           Y H +G   IVHR++K  N+LL  K +    K+ADFGLA   +  ++       AGT GY
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGY 173
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           ++PE +     ++ VDI++ GV++  ++ G
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 253 KATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRA 309
           K +D +D   +LG G +  + +   +  G E A K +   +      +++  E  I  + 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+V+       +   ++V++ V    L   +   +   E D    H I     E + 
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD--ASHCIQ-QILESIA 119
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           Y H +G   IVHR++K  N+LL  K +    K+ADFGLA   +  ++       AGT GY
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGY 173
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           ++PE +     ++ VDI++ GV++  ++ G
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 253 KATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISR--KNRIKEICNEMDIMSRA 309
           K +D +D   +LG G +  + +   +  G E A K +   +      +++  E  I  + 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+V+       +   ++V++ V    L   +   +   E D    H I     E + 
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD--ASHCIQ-QILESIA 118
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           Y H +G   IVHR++K  N+LL  K +    K+ADFGLA   +  ++       AGT GY
Sbjct: 119 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGY 172
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           ++PE +     ++ VDI++ GV++  ++ G
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQDGRE----IAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 212
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 213 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 247

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    +G G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E++    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   K+ADFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 84/176 (47%), Gaps = 25/176 (14%)
Query: 302 EMDIMSRAHHKNLVQFLGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
           E+ ++ R  HKN++Q +   +   K+  ++V E+      +  + D   +K     + H 
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHG 113
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA 419
                 +GLEYLH  G   IVH+DIK  N+LL      KI+  G+A      ++L P  A
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA------EALHPFAA 164
Query: 420 ------IAGTLGYMAPEYIANGQLT---EKVDIYSFGVLVLEIVSGVQNNKFQSDD 466
                   G+  +  PE IANG  T    KVDI+S GV +  I +G+    F+ D+
Sbjct: 165 DDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGLY--PFEGDN 217

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    +G G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E++    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   K+ADFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQD----GREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 184
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQD----GREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 184
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----XGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQDGRE----IAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 189
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 42/223 (18%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEICN----EMDIMSRAH-HKNLVQF 317
           LG+G  G + F+G+ Q GR +AVKR+ I       + C+    E+ +++ +  H N++++
Sbjct: 23  LGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRY 74
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH---VIIIGTAEGLEYLHKD 374
                T +  ++  E       D +       + L  +K +    ++   A G+ +LH  
Sbjct: 75  YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 375 GQMQIVHRDIKASNILLDLKHRPK-------------IADFGL-ARFSSSEKSLLPN-TA 419
             ++I+HRD+K  NIL+    R               I+DFGL  +  S + S   N   
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 420 IAGTLGYMAPEYIANG-------QLTEKVDIYSFGVLVLEIVS 455
            +GT G+ APE +          +LT  +DI+S G +   I+S
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 178
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 179 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 230
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 178
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+             + GT  Y+APE 
Sbjct: 179 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAPEI 230
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQD----GREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP-------IKWMAPESI 184
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQDGRE----IAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 184
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+             + GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQDGRE----IAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 181
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQDGRE----IAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 186
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 187 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 221

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++KEI    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+     +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   ++ DFGLA+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQDGRE----IAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 187
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 188 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 222

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGR-EIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YG +        +  +A+K++     +   +    E+ I+ R  H+N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 322 FTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   KD ++V + ++       L+   + + L        +     GL+Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYIA 433
             ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE + 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIML 200
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSG 456
           N +  T+ +DI+S G ++ E++S 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 152
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 153 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 204
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 143
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+             + GT  Y+APE 
Sbjct: 144 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYLAPEI 195
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 252 EKATDCFDESNKLGHGGYGEIFK----GTLQDGREIAVK-----RLFISRKNRIKE-ICN 301
           E   D ++   +LG G +  + K    GT   G+E A K     RL  SR+   +E I  
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSSSRRGVSREEIER 64
Query: 302 EMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVII 361
           E++I+    H N++        K D  ++ E V    L   L    +K+ L   +    +
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFL 121
Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPN 417
               +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFG+A    +       
Sbjct: 122 KQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--- 175
Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             I GT  ++APE +    L  + D++S GV+   ++SG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDI 93
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 203
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 144
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 145 H---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 196
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 203
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGR-EIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YG +        +  +A+K++     +   +    E+ I+ R  H+N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 322 FTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   KD ++V + ++       L+   + + L        +     GL+Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYIA 433
             ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE + 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIML 200
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSG 456
           N +  T+ +DI+S G ++ E++S 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 13/219 (5%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL 314
           D +D   +LG G +G + + T +  G   A K +    ++  + +  E+  MS   H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V          +  ++YEF+    L   + D   K   D    ++  +   +GL ++H++
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV--CKGLCHMHEN 274
Query: 375 GQMQIVHRDIKASNILLDLK--HRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
                VH D+K  NI+   K  +  K+ DFGL      ++S+   T   GT  + APE  
Sbjct: 275 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 328
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               +    D++S GVL   ++SG+     ++DD  ETL
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETL 365

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 302 EMDIMSR-AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
           E+DI+ + + H N++Q      T    F+V++ ++   L   L    +K  L  K+   I
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKI 129
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTA 419
           +    E +  LHK   + IVHRD+K  NILLD     K+ DFG + +    EK      +
Sbjct: 130 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----RS 182
Query: 420 IAGTLGYMAPEYIA------NGQLTEKVDIYSFGVLVLEIVSG 456
           + GT  Y+APE I       +    ++VD++S GV++  +++G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 264 LGHGGYGEIFKGTLQDGR-EIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YG +        +  +A+K++     +   +    E+ I+ R  H+N++      
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 322 FTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   +D ++V + ++       L+   + ++L        +     GL+Y+H    
Sbjct: 111 RASTLEAMRDVYIVQDLMETD-----LYKLLKSQQLSNDHICYFLYQILRGLKYIHS--- 162
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE---KSLLPNTAIAGTLGYMAPEYIA 433
             ++HRD+K SN+L++     KI DFGLAR +  E      L  T    T  Y APE + 
Sbjct: 163 ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFL--TEXVATRWYRAPEIML 220
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVS 455
           N +  T+ +DI+S G ++ E++S
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEICN----EMDIMSRAH-HKNLVQF 317
           LG+G  G + F+G+ Q GR +AVKR+ I       + C+    E+ +++ +  H N++++
Sbjct: 41  LGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRY 92
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH---VIIIGTAEGLEYLHKD 374
                T +  ++  E       D +       + L  +K +    ++   A G+ +LH  
Sbjct: 93  YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 150
Query: 375 GQMQIVHRDIKASNILLDLKHRPK-------------IADFGL-ARFSSSEKSLLPN-TA 419
             ++I+HRD+K  NIL+    R               I+DFGL  +  S +     N   
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 420 IAGTLGYMAPEYIANG---QLTEKVDIYSFGVLVLEIVS 455
            +GT G+ APE +      +LT  +DI+S G +   I+S
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGR-EIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YG +        +  +A+K++     +   +    E+ I+ R  H+N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 322 FTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   KD ++V + ++       L+   + + L        +     GL+Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYIA 433
             ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE + 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIML 200
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSG 456
           N +  T+ +DI+S G ++ E++S 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEICN----EMDIMSRAH-HKNLVQF 317
           LG+G  G + F+G+ Q GR +AVKR+ I       + C+    E+ +++ +  H N++++
Sbjct: 41  LGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRY 92
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH---VIIIGTAEGLEYLHKD 374
                T +  ++  E       D +       + L  +K +    ++   A G+ +LH  
Sbjct: 93  YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 150
Query: 375 GQMQIVHRDIKASNILLDLKHRPK-------------IADFGL-ARFSSSEKSLLPN-TA 419
             ++I+HRD+K  NIL+    R               I+DFGL  +  S +     N   
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 420 IAGTLGYMAPEYIANG---QLTEKVDIYSFGVLVLEIVS 455
            +GT G+ APE +      +LT  +DI+S G +   I+S
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 13/219 (5%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL 314
           D +D   +LG G +G + + T +  G   A K +    ++  + +  E+  MS   H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V          +  ++YEF+    L   + D   K   D    ++  +   +GL ++H++
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV--CKGLCHMHEN 168
Query: 375 GQMQIVHRDIKASNILLDLK--HRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
                VH D+K  NI+   K  +  K+ DFGL      ++S+       GT  + APE  
Sbjct: 169 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVA 222
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               +    D++S GVL   ++SG+     ++DD  ETL
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETL 259

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
            EYLH    + +++RD+K  N+L+D +   K+ADFG A+        L      GT  Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL-----CGTPEYL 206
Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           APE I +    + VD ++ GVL+ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGR-EIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YG +        +  +A+K++     +   +    E+ I+ R  H+N++      
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 322 FTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   KD ++V + ++       L+   + + L        +     GL+Y+H    
Sbjct: 93  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 144
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYIA 433
             ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE + 
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIML 202
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSG 456
           N +  T+ +DI+S G ++ E++S 
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGR-EIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YG +        +  +A+K++     +   +    E+ I+ R  H+N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 322 FTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   KD ++V + ++       L+   + + L        +     GL+Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYIA 433
             ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE + 
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIML 200
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSG 456
           N +  T+ +DI+S G ++ E++S 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ ++ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 29  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 139
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 197
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 29  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 139
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 197
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGR-EIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YG +        +  +A+K++     +   +    E+ I+ R  H+N++      
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 322 FTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   KD ++V + ++       L+   + + L        +     GL+Y+H    
Sbjct: 99  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 150
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYIA 433
             ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE + 
Sbjct: 151 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIML 208
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSG 456
           N +  T+ +DI+S G ++ E++S 
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSN 232

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGR-EIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YG +        +  +A+K++     +   +    E+ I+ R  H+N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 322 FTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   KD ++V + ++       L+   + + L        +     GL+Y+H    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYIA 433
             ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE + 
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIML 200
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSG 456
           N +  T+ +DI+S G ++ E++S 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 264 LGHGGYGEIFKGTLQDGR-EIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +G G YG +        +  +A+K++     +   +    E+ I+ R  H+N++      
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 322 FTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                   KD ++V + ++       L+   + + L        +     GL+Y+H    
Sbjct: 111 RAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 162
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYIA 433
             ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE + 
Sbjct: 163 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIML 220
Query: 434 NGQ-LTEKVDIYSFGVLVLEIVSG 456
           N +  T+ +DI+S G ++ E++S 
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 18/163 (11%)
Query: 302 EMDIMSR-AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
           E+DI+ + + H N++Q      T    F+V++ ++   L   L    +K  L  K+   I
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKI 116
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTA 419
           +    E +  LHK   + IVHRD+K  NILLD     K+ DFG + +    EK       
Sbjct: 117 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----RE 169
Query: 420 IAGTLGYMAPEYIA------NGQLTEKVDIYSFGVLVLEIVSG 456
           + GT  Y+APE I       +    ++VD++S GV++  +++G
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 36  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 146
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 204
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 37  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 95
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 147
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 205
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEMLSN 230

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 28  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 86
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 138
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 196
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEMLSN 221

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 203
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 108/238 (45%), Gaps = 22/238 (9%)
Query: 235 SLLHKSLKFLQFK-YSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRL--FI 290
           S+  K+L  L+ + +       D ++    +G+G YG +     +  G+++A+K++    
Sbjct: 33  SVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF 92
Query: 291 SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------KDSFVVYEFVQNKSLDRILF 344
                 K    E+ I+    H N++               K  +VV + +++  L +I+ 
Sbjct: 93  DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQII- 150
Query: 345 DPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL 404
                + L  +     +     GL+Y+H     Q++HRD+K SN+L++     KI DFG+
Sbjct: 151 --HSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM 205
Query: 405 AR---FSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQ 458
           AR    S +E      T    T  Y APE + +  + T+ +D++S G +  E+++  Q
Sbjct: 206 ARGLCTSPAEHQYF-MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 18/163 (11%)
Query: 302 EMDIMSR-AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
           E+DI+ + + H N++Q      T    F+V++ ++   L   L    +K  L  K+   I
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKI 129
Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA-RFSSSEKSLLPNTA 419
           +    E +  LHK   + IVHRD+K  NILLD     K+ DFG + +    EK       
Sbjct: 130 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----RE 182
Query: 420 IAGTLGYMAPEYIA------NGQLTEKVDIYSFGVLVLEIVSG 456
           + GT  Y+APE I       +    ++VD++S GV++  +++G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+     +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   K+ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQD----GREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 564
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+     +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   K+ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 256 DCFDESNKLGHGGYGEIFK----GTLQDGREIAVK-----RLFISRKNRIKE-ICNEMDI 305
           D ++   +LG G +  + K    GT   G+E A K     RL  SR+   +E I  E++I
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           +    H N++        K D  ++ E V    L   L    +K+ L   +    +    
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQIL 139
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNTAIA 421
           +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFG+A    +         I 
Sbjct: 140 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF 193
Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           GT  ++APE +    L  + D++S GV+   ++SG
Sbjct: 194 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H N+V+       +  +F+V E +    L +RI    K+KK     +   I+      + 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI----KKKKHFSETEASYIMRKLVSAVS 120
Query: 370 YLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           ++H  G   +VHRD+K  N+L   ++     KI DFG AR    +   L       TL Y
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHY 175
Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD 466
            APE +      E  D++S GV++  ++SG     FQS D
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSG--QVPFQSHD 213

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 150
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 151 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 202
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 150
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 151 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 202
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 90/184 (48%), Gaps = 19/184 (10%)
Query: 282 EIAVKRLFISRKNRIKEICN-EMDIMSR-AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL 339
           E+  +RL   +   ++E    E  I+ + A H +++  +    +    F+V++ ++   L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI 399
              L    +K  L  K+   I+    E + +LH +    IVHRD+K  NILLD   + ++
Sbjct: 188 FDYL---TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241
Query: 400 ADFGLA-RFSSSEKSLLPNTAIAGTLGYMAPEYI------ANGQLTEKVDIYSFGVLVLE 452
           +DFG +      EK       + GT GY+APE +       +    ++VD+++ GV++  
Sbjct: 242 SDFGFSCHLEPGEKL----RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297
Query: 453 IVSG 456
           +++G
Sbjct: 298 LLAG 301

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 264 LGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIK-------------EICNEMDIMSRA 309
           LG GG+G +F G  L D  ++A+K   +  +NR+              E+     + +  
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIK---VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGL 368
            H  +++ L   F  ++ F++   ++     + LFD   +K  L               +
Sbjct: 96  GHPGVIRLLDW-FETQEGFML--VLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHR-PKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           ++ H  G   +VHRDIK  NIL+DL+    K+ DFG       E    P T   GT  Y 
Sbjct: 153 QHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYS 205
Query: 428 APEYIANGQLTE-KVDIYSFGVLVLEIVSGVQNNKFQSD 465
            PE+I+  Q       ++S G+L+ ++V G  +  F+ D
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCG--DIPFERD 242

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 264 LGHGGYGEIFKGTLQD----GREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFL 318
           +G G +G++ +G           +A+K       + ++E    E   M +  H ++V+ +
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G   T+   +++ E      L   L    +K  LD     +     +  L YL      +
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSS------SEKSLLPNTAIAGTLGYMAPEYI 432
            VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE I
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPESI 564
Query: 433 ANGQLTEKVDIYSFGVLVLEIV-------SGVQNN 460
              + T   D++ FGV + EI+        GV+NN
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 256 DCFDESNKLGHGGYGEIFK----GTLQDGREIAVK-----RLFISRKNRIKE-ICNEMDI 305
           D ++   +LG G +  + K    GT   G+E A K     RL  SR+   +E I  E++I
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           +    H N++        K D  ++ E V    L   L    +K+ L   +    +    
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQIL 118
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNTAIA 421
           +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFG+A    +         I 
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF 172
Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           GT  ++APE +    L  + D++S GV+   ++SG
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 178
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 179 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 230
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGY 426
           LE+LHK G   I++RDIK  NILLD      + DFGL++ F + E     +    GT+ Y
Sbjct: 172 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEY 226
Query: 427 MAPEYIANGQL--TEKVDIYSFGVLVLEIVSG 456
           MAP+ +  G     + VD +S GVL+ E+++G
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 108/238 (45%), Gaps = 22/238 (9%)
Query: 235 SLLHKSLKFLQFK-YSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRL--FI 290
           S+  K+L  L+ + +       D ++    +G+G YG +     +  G+++A+K++    
Sbjct: 32  SVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF 91
Query: 291 SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------KDSFVVYEFVQNKSLDRILF 344
                 K    E+ I+    H N++               K  +VV + +++  L +I+ 
Sbjct: 92  DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQII- 149
Query: 345 DPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL 404
                + L  +     +     GL+Y+H     Q++HRD+K SN+L++     KI DFG+
Sbjct: 150 --HSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM 204
Query: 405 AR---FSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQ 458
           AR    S +E      T    T  Y APE + +  + T+ +D++S G +  E+++  Q
Sbjct: 205 ARGLCTSPAEHQYF-MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 42/223 (18%)
Query: 264 LGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEICN----EMDIMSRAH-HKNLVQF 317
           LG+G  G + F+G+ Q GR +AVKR+ I       + C+    E+ +++ +  H N++++
Sbjct: 23  LGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRY 74
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH---VIIIGTAEGLEYLHKD 374
                T +  ++  E       D +       + L  +K +    ++   A G+ +LH  
Sbjct: 75  YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 375 GQMQIVHRDIKASNILLDLKHRPK-------------IADFGL-ARFSSSEKSLLPN-TA 419
             ++I+HRD+K  NIL+    R               I+DFGL  +  S +     N   
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 420 IAGTLGYMAPEYIANG-------QLTEKVDIYSFGVLVLEIVS 455
            +GT G+ APE +          +LT  +DI+S G +   I+S
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A++++     +   +    E+ I+ R  H+N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 203
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKCQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGTLGYMAPEYI 432
              ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T  Y APE +
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 203
Query: 433 ANGQ-LTEKVDIYSFGVLVLEIVSG 456
            N +  T+ +DI+S G ++ E++S 
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF----- 317
           LG GG G +F     D  + +A+K++ ++    +K    E+ I+ R  H N+V+      
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 318 ---------LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
                    +G        ++V E+++   L  +L   +Q   L+   R + +     GL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHAR-LFMYQLLRGL 133
Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLARFSS---SEKSLLPNTAIAGTL 424
           +Y+H      ++HRD+K +N+ ++ +    KI DFGLAR      S K  L    +  T 
Sbjct: 134 KYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV--TK 188
Query: 425 GYMAPE-YIANGQLTEKVDIYSFGVLVLEIVSG 456
            Y +P   ++    T+ +D+++ G +  E+++G
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLF--ISRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           S+ LG G    +F+G  +   ++   ++F  IS    +     E +++ + +HKN+V+  
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 319 GCC--FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T +   ++ EF    SL  +L +P     L   +  +++     G+ +L ++G 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 377 MQIVHRDIKASNILL----DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             IVHR+IK  NI+     D +   K+ DFG AR    ++  +   ++ GT  Y+ P+  
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYLHPDMY 187
Query: 433 ANGQLTE--------KVDIYSFGVLVLEIVSG 456
               L +         VD++S GV      +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT  Y+AP  
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPAI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLVQFLGCC 321
           L  GG+  +++   +  GRE A+KRL  + + + + I  E+  M + + H N+VQF    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 322 FTKKDS-------FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
              K+        F++   +    L   L   + +  L       I   T   ++++H+ 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLA---------RFSSSEKSLLPNTAIAGTLG 425
            +  I+HRD+K  N+LL  +   K+ DFG A          +S+  ++L+       T  
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 426 -YMAPEYI---ANGQLTEKVDIYSFGVLV 450
            Y  PE I   +N  + EK DI++ G ++
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE---KSLLPNTAIAGT 423
           GL+Y+H      ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T
Sbjct: 138 GLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFL--TEYVAT 192
Query: 424 LGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSG 456
             Y APE + N +  T+ +DI+S G ++ E++S 
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI----AGTLGYMAPEY 431
              ++HRD+K SN+LL+     KI DFGLAR +  +     +T        T  Y APE 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD---HTGFLXEXVATRWYRAPEI 202
Query: 432 IANGQ-LTEKVDIYSFGVLVLEIVSG 456
           + N +  T+ +DI+S G ++ E++S 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLF-ISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG +      L   R +A+K++     +   +    E+ I+ R  H+N++     
Sbjct: 36  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 321 CFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                    KD ++V + ++       L+   + + L        +     GL+Y+H   
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 146
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI----AGTLGYMAPEY 431
              ++HRD+K SN+LL+     KI DFGLAR +  +     +T        T  Y APE 
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD---HTGFLXEXVATRWYRAPEI 203
Query: 432 IANGQ-LTEKVDIYSFGVLVLEIVSG 456
           + N +  T+ +DI+S G ++ E++S 
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 19/201 (9%)
Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++     K T   GR  A+K L    I  K+ +     E  ++  + H  L  
Sbjct: 18  LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 74
Query: 317 FLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            L   F   D    V E+     L    F   +++     +           L+YLH   
Sbjct: 75  -LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--S 128
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           +  +V+RD+K  N++LD     KI DFGL +    + + +      GT  Y+APE + + 
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KXFCGTPEYLAPEVLEDN 186
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
                VD +  GV++ E++ G
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCG 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 19/201 (9%)
Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++     K T   GR  A+K L    I  K+ +     E  ++  + H  L  
Sbjct: 16  LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 72
Query: 317 FLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            L   F   D    V E+     L    F   +++     +           L+YLH   
Sbjct: 73  -LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--S 126
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           +  +V+RD+K  N++LD     KI DFGL +    + + +      GT  Y+APE + + 
Sbjct: 127 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KXFCGTPEYLAPEVLEDN 184
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
                VD +  GV++ E++ G
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCG 205

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 19/201 (9%)
Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++     K T   GR  A+K L    I  K+ +     E  ++  + H  L  
Sbjct: 17  LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 73
Query: 317 FLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            L   F   D    V E+     L    F   +++     +           L+YLH   
Sbjct: 74  -LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--S 127
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           +  +V+RD+K  N++LD     KI DFGL +    + + +      GT  Y+APE + + 
Sbjct: 128 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KXFCGTPEYLAPEVLEDN 185
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
                VD +  GV++ E++ G
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCG 206

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+     +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   ++ DFG A+        L      GT  Y+APE 
Sbjct: 158 H---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGT 423
           GL+Y+H      ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL--TEYVAT 210
Query: 424 LGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSG 456
             Y APE + N +  T+ +DI+S G ++ E++S 
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             L +         + ++V E+     +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   K+ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             L +         + ++V E+     +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   K+ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 261 SNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIK---------EICNEMDIMSRAH 310
           S  LG G  GE+      +  +++A+ R+   RK  I           +  E++I+ + +
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAI-RIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H  +++ +   F  +D ++V E ++   L   +   K+ KE   K   +        ++Y
Sbjct: 199 HPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---LYFYQMLLAVQY 254
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           LH++G   I+HRD+K  N+LL  +      KI DFG ++    E SL+    + GT  Y+
Sbjct: 255 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM--RTLCGTPTYL 308
Query: 428 APEY---IANGQLTEKVDIYSFGVLVLEIVSG 456
           APE    +        VD +S GV++   +SG
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREI-----AVKRLFISRKNRIKE 298
           L F+ ST       +   N +G G +GE+ K  +Q G  I      + + F+   +R K+
Sbjct: 14  LYFQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ 72
Query: 299 ICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH 358
              E++IM    H N+++         D ++V E      L   +   +  +E D  +  
Sbjct: 73  ---EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR-- 127
Query: 359 VIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL--DLKHRP-KIADFGL-ARFSSSEKSL 414
            I+      + Y HK   + + HRD+K  N L   D    P K+ DFGL ARF   +   
Sbjct: 128 -IMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--- 180
Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +  T + GT  Y++P+ +  G    + D +S GV++  ++ G
Sbjct: 181 MMRTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             L +         + ++V E+     +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   K+ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +G GG+GE++     D G+  A+K L    K RIK    E   ++     +LV    C F
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE----------GLEYLH 372
                 + Y F     L  IL D     +L +      +   A+          GLE++H
Sbjct: 254 I---VCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 +V+RD+K +NILLD     +I+D GLA   S +K   P+ ++ GT GYMAPE +
Sbjct: 310 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVL 362
Query: 433 ANG-QLTEKVDIYSFGVLVLEIVSG 456
             G       D +S G ++ +++ G
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 256 DCFDESNKLGHGGYGEI-----FKGTLQDGREIAVKRLFISRKNRIKE----ICNEMDIM 306
           D +  S  LG G  GE+      K   +   +I  KR F     R  +    +  E++I+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
            + +H  +++ +   F  +D ++V E ++   L   +   K+ KE   K   +       
Sbjct: 70  KKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---LYFYQMLL 125
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGT 423
            ++YLH++G   I+HRD+K  N+LL  +      KI DFG ++    E SL+    + GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM--RTLCGT 179
Query: 424 LGYMAPEY---IANGQLTEKVDIYSFGVLVLEIVSG 456
             Y+APE    +        VD +S GV++   +SG
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 256 DCFDESNKLGHGGYGEI-----FKGTLQDGREIAVKRLFISRKNRIKE----ICNEMDIM 306
           D +  S  LG G  GE+      K   +   +I  KR F     R  +    +  E++I+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
            + +H  +++ +   F  +D ++V E ++   L   +   K+ KE   K   +       
Sbjct: 70  KKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---LYFYQMLL 125
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGT 423
            ++YLH++G   I+HRD+K  N+LL  +      KI DFG ++    E SL+    + GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM--RTLCGT 179
Query: 424 LGYMAPEY---IANGQLTEKVDIYSFGVLVLEIVSG 456
             Y+APE    +        VD +S GV++   +SG
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 256 DCFDESNKLGHGGYGEI-----FKGTLQDGREIAVKRLFISRKNRIKE----ICNEMDIM 306
           D +  S  LG G  GE+      K   +   +I  KR F     R  +    +  E++I+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
            + +H  +++ +   F  +D ++V E ++   L   +   K+ KE   K   +       
Sbjct: 70  KKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---LYFYQMLL 125
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGT 423
            ++YLH++G   I+HRD+K  N+LL  +      KI DFG ++    E SL+    + GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM--RTLCGT 179
Query: 424 LGYMAPEY---IANGQLTEKVDIYSFGVLVLEIVSG 456
             Y+APE    +        VD +S GV++   +SG
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +G GG+GE++     D G+  A+K L    K RIK    E   ++     +LV    C F
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE----------GLEYLH 372
                 + Y F     L  IL D     +L +      +   A+          GLE++H
Sbjct: 254 I---VCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 +V+RD+K +NILLD     +I+D GLA   S +K   P+ ++ GT GYMAPE +
Sbjct: 310 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVL 362
Query: 433 ANG-QLTEKVDIYSFGVLVLEIVSG 456
             G       D +S G ++ +++ G
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +G GG+GE++     D G+  A+K L    K RIK    E   ++     +LV    C F
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE----------GLEYLH 372
                 + Y F     L  IL D     +L +      +   A+          GLE++H
Sbjct: 254 I---VCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 +V+RD+K +NILLD     +I+D GLA   S +K   P+ ++ GT GYMAPE +
Sbjct: 310 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVL 362
Query: 433 ANG-QLTEKVDIYSFGVLVLEIVSG 456
             G       D +S G ++ +++ G
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D F+    LG G +G +     ++ G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+     +   L    +  E   +     I+ T    EYL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 158
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+++D +   K+ DFG A+        L      GT  Y+APE 
Sbjct: 159 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL-----CGTPEYLAPEI 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 19/201 (9%)
Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++     K T   GR  A+K L    I  K+ +     E  ++  + H  L  
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 317 FLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            L   F   D    V E+     L    F   +++     +           L+YLH   
Sbjct: 213 -LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--S 266
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           +  +V+RD+K  N++LD     KI DFGL +    + + +      GT  Y+APE + + 
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAPEVLEDN 324
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
                VD +  GV++ E++ G
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCG 345

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 264 LGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +G GG+GE++     D G+  A+K L    K RIK    E   ++     +LV    C F
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 252
Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE----------GLEYLH 372
                 + Y F     L  IL D     +L +      +   A+          GLE++H
Sbjct: 253 I---VCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 308
Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 +V+RD+K +NILLD     +I+D GLA   S +K   P+ ++ GT GYMAPE +
Sbjct: 309 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVL 361
Query: 433 ANG-QLTEKVDIYSFGVLVLEIVSG 456
             G       D +S G ++ +++ G
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 256 DCFDESNKLGHGGYGEI-----FKGTLQDGREIAVKRLFISRKNRIKE----ICNEMDIM 306
           D +  S  LG G  GE+      K   +   +I  KR F     R  +    +  E++I+
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
            + +H  +++ +   F  +D ++V E ++   L   +   K+ KE   K   +       
Sbjct: 69  KKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---LYFYQMLL 124
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGT 423
            ++YLH++G   I+HRD+K  N+LL  +      KI DFG ++    E SL+    + GT
Sbjct: 125 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM--RTLCGT 178
Query: 424 LGYMAPEY---IANGQLTEKVDIYSFGVLVLEIVSG 456
             Y+APE    +        VD +S GV++   +SG
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 256 DCFDESNKLGHGGYGEI-----FKGTLQDGREIAVKRLFISRKNRIKE----ICNEMDIM 306
           D +  S  LG G  GE+      K   +   +I  KR F     R  +    +  E++I+
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
            + +H  +++ +   F  +D ++V E ++   L   +   K+ KE   K   +       
Sbjct: 76  KKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---LYFYQMLL 131
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGT 423
            ++YLH++G   I+HRD+K  N+LL  +      KI DFG ++    E SL+    + GT
Sbjct: 132 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM--RTLCGT 185
Query: 424 LGYMAPEY---IANGQLTEKVDIYSFGVLVLEIVSG 456
             Y+APE    +        VD +S GV++   +SG
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 261 SNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIK---------EICNEMDIMSRAH 310
           S  LG G  GE+      +  +++A+ R+   RK  I           +  E++I+ + +
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAI-RIISKRKFAIGSAREADPALNVETEIEILKKLN 212
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H  +++ +   F  +D ++V E ++   L   +   K+ KE   K   +        ++Y
Sbjct: 213 HPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---LYFYQMLLAVQY 268
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           LH++G   I+HRD+K  N+LL  +      KI DFG ++    E SL+    + GT  Y+
Sbjct: 269 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLM--RTLCGTPTYL 322
Query: 428 APEY---IANGQLTEKVDIYSFGVLVLEIVSG 456
           APE    +        VD +S GV++   +SG
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 255 TDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHK 312
           +D ++    +G G +G        Q    +AVK  +I R  +I E      I  R+  H 
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVK--YIERGEKIDENVKREIINHRSLRHP 74
Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           N+V+F     T     +V E+     L   + +  +  E + +     +I    G+ Y H
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS---GVSYCH 131
Query: 373 KDGQMQIVHRDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
               MQ+ HRD+K  N LLD    P  KI DFG ++  SS     P + + GT  Y+APE
Sbjct: 132 A---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTV-GTPAYIAPE 185
Query: 431 YIANGQLTEKV-DIYSFGVLVLEIVSG 456
            +   +   KV D++S GV +  ++ G
Sbjct: 186 VLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 19/201 (9%)
Query: 264 LGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           LG G +G++     K T   GR  A+K L    I  K+ +     E  ++  + H  L  
Sbjct: 159 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 317 FLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            L   F   D    V E+     L    F   +++     +           L+YLH   
Sbjct: 216 -LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--S 269
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           +  +V+RD+K  N++LD     KI DFGL +    + + +      GT  Y+APE + + 
Sbjct: 270 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAPEVLEDN 327
Query: 436 QLTEKVDIYSFGVLVLEIVSG 456
                VD +  GV++ E++ G
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCG 348

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 264 LGHGGYGEIFKGTLQDGR----EIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           LG G +GE+++G   + +     +AVK  +   +  N+ ++  +E  IM    H ++V+ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIVKL 74
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
           +G    ++ ++++ E      L   L   + K  L      +  +   + + YL     +
Sbjct: 75  IGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
             VHRDI   NIL+      K+ DFGL+R+   E      +     + +M+PE I   + 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESINFRRF 187
Query: 438 TEKVDIYSFGVLVLEIVS 455
           T   D++ F V + EI+S
Sbjct: 188 TTASDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 264 LGHGGYGEIFKGTLQDGR----EIAVK--RLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           LG G +GE+++G   + +     +AVK  +   +  N+ ++  +E  IM    H ++V+ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIVKL 78
Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
           +G    ++ ++++ E      L   L   + K  L      +  +   + + YL     +
Sbjct: 79  IGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
             VHRDI   NIL+      K+ DFGL+R+   E      +     + +M+PE I   + 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESINFRRF 191
Query: 438 TEKVDIYSFGVLVLEIVS 455
           T   D++ F V + EI+S
Sbjct: 192 TTASDVWMFAVCMWEILS 209

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 261 SNKLGHGGYGEIFKGTLQDGREIAVKRLF--ISRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           S+ LG G    +F+G  +   ++   ++F  IS    +     E +++ + +HKN+V+  
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 319 GCC--FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T +   ++ EF    SL  +L +P     L   +  +++     G+ +L ++G 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 377 MQIVHRDIKASNILL----DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             IVHR+IK  NI+     D +   K+ DFG AR    ++  +    + GT  Y+ P+  
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---XLYGTEEYLHPDMY 187
Query: 433 ANGQLTEK--------VDIYSFGVLVLEIVSG 456
               L +         VD++S GV      +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK---SLLPNTAIAGT 423
           GL+Y+H      ++HRD+K SN+LL+     KI DFGLAR +  +      L  T    T
Sbjct: 138 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVAT 192
Query: 424 LGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSG 456
             Y APE + N +  T+ +DI+S G ++ E++S 
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 264 LGHGGYGEIFKG--TLQDGREIAVKRLFISRK---NRIKEICNEMDIMSRAHHKNLVQFL 318
           LG G +GE+++G  T   G +I V      +    +  ++  +E  IM    H ++V+ +
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G    ++ ++++ E      L   L   + K  L      +  +   + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLE---SIN 145
Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
            VHRDI   NIL+      K+ DFGL+R+   E      +     + +M+PE I   + T
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESINFRRFT 204
Query: 439 EKVDIYSFGVLVLEIVS 455
              D++ F V + EI+S
Sbjct: 205 TASDVWMFAVCMWEILS 221

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 50/219 (22%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLF-----------ISRKNRIKEICNEMDIMSRAHHK 312
           +  G YG +  G   +G  +A+KR+F           +S     K +  E+ +++  HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 313 NLVQFLGCCFTKKDSFVVYE-----------------FVQNKSLDRILFDPKQKKELDWK 355
           N+   LG     +D FV +E                   Q     RI+  P+    + + 
Sbjct: 90  NI---LGL----RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH---IQYF 139
Query: 356 KRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
             H+++     GL  LH+ G   +VHRD+   NILL   +   I DF LAR  +++ +  
Sbjct: 140 MYHILL-----GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN-- 189
Query: 416 PNTAIAGTLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEI 453
             T       Y APE +   +  T+ VD++S G ++ E+
Sbjct: 190 -KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 256 DCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFISRKNRIKEI---CNEMDIMSRAHH 311
           D FD    LG G +G +      + G   A+K L   +  ++K+I    NE  I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             LV+         + ++V E+V    +   L    +  E   +     I+ T    EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT---FEYL 157
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + +++RD+K  N+L+D +   ++ DFG A+        L      GT   +APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL-----CGTPEALAPEI 209
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           I +    + VD ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 50/219 (22%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLF-----------ISRKNRIKEICNEMDIMSRAHHK 312
           +  G YG +  G   +G  +A+KR+F           +S     K +  E+ +++  HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 313 NLVQFLGCCFTKKDSFVVYE-----------------FVQNKSLDRILFDPKQKKELDWK 355
           N+   LG     +D FV +E                   Q     RI+  P+    + + 
Sbjct: 90  NI---LGL----RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH---IQYF 139
Query: 356 KRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL 415
             H+++     GL  LH+ G   +VHRD+   NILL   +   I DF LAR  +++ +  
Sbjct: 140 MYHILL-----GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN-- 189
Query: 416 PNTAIAGTLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEI 453
             T       Y APE +   +  T+ VD++S G ++ E+
Sbjct: 190 -KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 110/242 (45%), Gaps = 23/242 (9%)
Query: 238 HKSLKFLQFKYSTIEKAT-DCFDESNKLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNR 295
           H+  ++  +    +E    D +    KLG G Y E+F+   + +  ++ VK L   +KN+
Sbjct: 18  HRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNK 77
Query: 296 IKEICNEMDIMSRAHH-KNLVQFLGCCF--TKKDSFVVYEFVQNKSLDRILFDPKQKKEL 352
           IK    E+ I+       N++           +   +V+E V N    ++      +   
Sbjct: 78  IKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLT 129
Query: 353 DWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLARFSSSE 411
           D+  R   +    + L+Y H    M I+HRD+K  N+++D +HR  ++ D+GLA F    
Sbjct: 130 DYDIR-FYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 412 KSLLPNTAIAGTLGYMAPEYIANGQLTE-KVDIYSFGVLVLEIVSGVQNNKFQSDDGFET 470
           +    N  +A    +  PE + + Q+ +  +D++S G ++  ++   +   F   D ++ 
Sbjct: 186 QEY--NVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFR-KEPFFHGHDNYDQ 241
Query: 471 LV 472
           LV
Sbjct: 242 LV 243

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 39/234 (16%)
Query: 232 MDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFI 290
           MDL ++H S               D ++    +G G +G        Q    +AVK  +I
Sbjct: 10  MDLPIMHDS---------------DRYELVKDIGSGNFGVARLMRDKQSNELVAVK--YI 52
Query: 291 SRKNRI-----KEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD 345
            R  +I     +EI N   +     H N+V+F     T     +V E+     L   + +
Sbjct: 53  ERGEKIAANVKREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 108
Query: 346 PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP--KIADFG 403
             +  E + +     +I    G+ Y H    MQ+ HRD+K  N LLD    P  KI DFG
Sbjct: 109 AGRFSEDEARFFFQQLIS---GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFG 162
Query: 404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKV-DIYSFGVLVLEIVSG 456
            ++  SS     P + + GT  Y+APE +   +   KV D++S GV +  ++ G
Sbjct: 163 YSK--SSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 255 TDCFDESNKLGHGGYG--EIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HH 311
           +D +D    +G G +G   + +  L     +AVK  +I R   I E      I  R+  H
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVK--YIERGAAIDENVQREIINHRSLRH 75
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
            N+V+F     T     ++ E+     L   + +  +  E    +          G+ Y 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE---DEARFFFQQLLSGVSYC 132
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           H    MQI HRD+K  N LLD    P  KI DFG ++  SS     P + + GT  Y+AP
Sbjct: 133 HS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTV-GTPAYIAP 186
Query: 430 EYIANGQLTEKV-DIYSFGVLVLEIVSG 456
           E +   +   K+ D++S GV +  ++ G
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 253 KATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHH 311
           K  D F      G G +G +  G  +  G  +A+K++    + R +E+   M  ++  HH
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHH 78
Query: 312 KNLVQFLGCCFT-----KKDSF--VVYEFVQNKSLDRILFDPKQKKELDWKKR-HVIIIG 363
            N+VQ     +T     ++D +  VV E+V + +L R   +  +++         V +  
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILL-DLKHRPKIADFGLA-RFSSSEKSLLPNTAIA 421
               +  LH    + + HRDIK  N+L+ +     K+ DFG A + S SE    PN A  
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE----PNVAYI 192
Query: 422 GTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSG 456
            +  Y APE I  N   T  VDI+S G +  E++ G
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 262 NKLGHGGYGEIFKGTLQDGREI-----AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           N +G G +GE+ K  +Q G  I      + + F+   +R K+   E++IM    H N+++
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDHPNIIR 70
Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                    D ++V E      L   +   +  +E D  +   I+      + Y HK   
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCHK--- 124
Query: 377 MQIVHRDIKASNILL--DLKHRP-KIADFGL-ARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
           + + HRD+K  N L   D    P K+ DFGL ARF   +   +  T + GT  Y++P+ +
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKV-GTPYYVSPQ-V 179
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
             G    + D +S GV++  ++ G
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 249 STIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKE---ICNEMDI 305
           +T  + TD +    +LG G +  + +   +   +    ++  ++K   ++   +  E  I
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
                H N+V+       +   ++V++ V    L   +   +   E D    H I     
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD--ASHCI----H 137
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAG 422
           + LE ++   Q  IVHRD+K  N+LL  K +    K+ADFGLA     E+        AG
Sbjct: 138 QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW--FGFAG 195
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           T GY++PE +      + VDI++ GV++  ++ G
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 232 MDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFI 290
           MDL ++H S               D ++    +G G +G        Q    +AVK  +I
Sbjct: 10  MDLPIMHDS---------------DRYELVKDIGSGNFGVARLMRDKQSNELVAVK--YI 52
Query: 291 SRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQK 349
            R  +I E      I  R+  H N+V+F     T     +V E+     L   + +  + 
Sbjct: 53  ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 112
Query: 350 KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS 409
            E + +     +I    G+ Y H    MQ+ HRD+K  N LLD    P++    +  F  
Sbjct: 113 SEDEARFFFQQLIS---GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLK---ICAFGY 163
Query: 410 SEKSLL---PNTAIAGTLGYMAPEYIANGQLTEKV-DIYSFGVLVLEIVSG 456
           S+ S+L   P + + GT  Y+APE +   +   KV D++S GV +  ++ G
Sbjct: 164 SKSSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 267 GGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRA--HHKNLVQFLGCCFTK 324
           G +G ++K  L +   +AVK   +  K   +   +E +I S     H+NL+QF+     K
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQ---SEREIFSTPGMKHENLLQFIAA--EK 79
Query: 325 KDS------FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD---- 374
           + S      +++  F    SL   L    +   + W +   +    + GL YLH+D    
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 375 ----GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
                +  I HRD K+ N+LL       +ADFGLA      K         GT  YMAPE
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE 195
Query: 431 YIANGQLTE-----KVDIYSFGVLVLEIVS 455
            +      +     ++D+Y+ G+++ E+VS
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 127 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 181
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 182 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 230

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 126 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 180
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 181 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 229

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 128 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 182
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 183 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 231

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 121 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 175
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 176 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 224

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 174
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 175 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 223

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 24/213 (11%)
Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGRE-IAVKRLFISRKNR--IKEICNEMDIMSRAH 310
           + D +    KLG G YGE++K       E +A+KR+ +  +          E+ ++    
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQN---KSLDRILFDPKQKKELDWKKRHVIIIGTAEG 367
           H+N+++            +++E+ +N   K +D+         ++  +     +     G
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK-------NPDVSMRVIKSFLYQLING 144
Query: 368 LEYLHKDGQMQIVHRDIKASNILL---DLKHRP--KIADFGLARFSSSEKSLLPNTAIAG 422
           + + H     + +HRD+K  N+LL   D    P  KI DFGLAR          +  I  
Sbjct: 145 VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-- 199
Query: 423 TLGYMAPE-YIANGQLTEKVDIYSFGVLVLEIV 454
           TL Y  PE  + +   +  VDI+S   +  E++
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 48/84 (57%), Gaps = 5/84 (5%)
Query: 376 QMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
           QM +VHRD+K  N+LL  K +    K+ADFGLA     E+        AGT GY++PE +
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVL 196
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 + VD+++ GV++  ++ G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 33/231 (14%)
Query: 232 MDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEI-FKGTLQDGREIAVKRLFI 290
           MDL ++H S               D ++    +G G +G        Q    +AVK  +I
Sbjct: 10  MDLPIMHDS---------------DRYELVKDIGSGNFGVARLMRDKQSNELVAVK--YI 52
Query: 291 SRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQK 349
            R  +I E      I  R+  H N+V+F     T     +V E+     L   + +  + 
Sbjct: 53  ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 112
Query: 350 KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS 409
            E + +     +I    G+ Y H    MQ+ HRD+K  N LLD    P++    +  F  
Sbjct: 113 SEDEARFFFQQLIS---GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLK---ICAFGY 163
Query: 410 SEKSLL---PNTAIAGTLGYMAPEYIANGQLTEKV-DIYSFGVLVLEIVSG 456
           S+ S+L   P   + GT  Y+APE +   +   KV D++S GV +  ++ G
Sbjct: 164 SKSSVLHSQPKDTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 122 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 176
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 177 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 264 LGHGGYGEIFKGTLQDGREI--AVKRL---FISRKNRIKEICNEMDIMSR-AHHKNLVQF 317
           +G G +G++         E+  AVK L    I +K   K I +E +++ +   H  LV  
Sbjct: 46  IGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 318 LGCCFTKKDSFVVYEFVQNKSL------DRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
                T    + V +++    L      +R   +P+ +               A  L YL
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR---------FYAAEIASALGYL 155
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H    + IV+RD+K  NILLD +    + DFGL + +    S    +   GT  Y+APE 
Sbjct: 156 H---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEV 210
Query: 432 IANGQLTEKVDIYSFGVLVLEIVSGV 457
           +        VD +  G ++ E++ G+
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 166 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 220
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 221 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 269

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 122 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 176
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 177 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 225

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 136 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 190
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 191 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 239

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 18/217 (8%)
Query: 258 FDESNKLGHGGYGEIFKGTL--QDGR--EIAVKRLF--ISRKNRIKEICNEMDIMSRAHH 311
           F     LG G +G + +  L  +DG   ++AVK L   I   + I+E   E   M    H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 312 KNLVQFLGCCFTKKDS------FVVYEFVQNKSLDRILFDPKQKKE---LDWKKRHVIII 362
            ++ + +G     +         V+  F+++  L   L   +  +    L  +     ++
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG 422
             A G+EYL        +HRD+ A N +L       +ADFGL+R   S        A   
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQN 459
            + ++A E +A+   T   D+++FGV + EI++  Q 
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 174
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 175 --TEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLL 415
           I+    E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL 
Sbjct: 172 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL- 226
Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
             T    T  Y+APE +   +  +  D++S GV++  ++ G     F S+ G 
Sbjct: 227 --TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGL 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 48/84 (57%), Gaps = 5/84 (5%)
Query: 376 QMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
           QM +VHRD+K  N+LL  K +    K+ADFGLA     ++        AGT GY++PE +
Sbjct: 121 QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPEVL 178
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 + VDI++ GV++  ++ G
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVG 202

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 105/235 (44%), Gaps = 21/235 (8%)
Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNR-----IKEICNEMDIMSRA 309
           D ++    +G G +  + +   ++ G++ AVK + +++         +++  E  I    
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI----IIGTA 365
            H ++V+ L    +    ++V+EF+    L    F+  ++ +  +     +    +    
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAG 422
           E L Y H +    I+HRD+K  N+LL  K      K+ DFG+A     E  L+    + G
Sbjct: 141 EALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVAGGRV-G 195
Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK 477
           T  +MAPE +      + VD++  GV++  ++SG        +  FE ++   +K
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK 250

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 23/206 (11%)
Query: 264 LGHGGYGEIFKGTLQDGREIAVKRLFISRK--NRIKEIC--NEMDIMSRAHHKNLVQFLG 319
           +G G +GE+    L++  ++   ++    +   R +  C   E D++     K +     
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 320 CCFTKKDSFVVYEFVQNKSLDRIL--FDPKQKKELD--WKKRHVIIIGTAEGLEYLHKDG 375
                 + ++V ++     L  +L  F+ +  +E+   +    VI I +   L Y     
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY----- 196
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI--- 432
               VHRDIK  NIL+D+    ++ADFG +     E   + ++   GT  Y++PE +   
Sbjct: 197 ----VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 433 --ANGQLTEKVDIYSFGVLVLEIVSG 456
               G+   + D +S GV + E++ G
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 255 TDCFDESNKLGHGGYGEIFK-GTLQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRAH 310
           TD +    +LG G +  + +   +  G+E A K +    +S ++  +++  E  I     
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH-QKLEREARICRLLK 61
Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N+V+       +   ++V++ V    L   +   +   E D    H I     E + +
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD--ASHCIQ-QILESVNH 118
Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
            H +G   IVHRD+K  N+LL  K +    K+ADFGLA     ++        AGT GY+
Sbjct: 119 CHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYL 173
Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +PE +      + VD+++ GV++  ++ G
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 255 TDCFDESNKLGHGGYGEIFK-GTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHH 311
           TD +    +LG G +  + +   +  G+E A K +   +      +++  E  I     H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
            N+V+       +   ++V++ V    L   +   +   E D    H I     E + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD--ASHCIQ-QILESVNHC 119
Query: 372 HKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYMA 428
           H +G   IVHRD+K  N+LL  K +    K+ADFGLA     ++        AGT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLS 174
Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           PE +      + VD+++ GV++  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKN----------R 295
           KYST+          + LG G +G ++    ++  +E+ VK  FI ++           +
Sbjct: 25  KYSTM----------SPLGSGAFGFVWTAVDKEKNKEVVVK--FIKKEKVLEDCWIEDPK 72
Query: 296 IKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWK 355
           + ++  E+ I+SR  H N+++ L   F  +  F +        LD   F  +  + LD  
Sbjct: 73  LGKVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEP 130
Query: 356 KRHVIIIGTAEGLEYLH-KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL 414
               I       + YL  KD    I+HRDIK  NI++      K+ DFG A +    K  
Sbjct: 131 LASYIFRQLVSAVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF 186
Query: 415 LPNTAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIV 454
                  GT+ Y APE +  N     +++++S GV +  +V
Sbjct: 187 Y---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 40/220 (18%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKR-------LFISRKNRIKEICNEMDIMSRA 309
           F   + LG G YG +   T +  G  +A+K+       LF  R  R      E+ I+   
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR------EIKILKHF 66
Query: 310 HHKNLVQFLGCCFTKKDSF-------VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
            H+N++        + DSF       ++ E +Q   L R++      + L        I 
Sbjct: 67  KHENIITIFN--IQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQYFIY 119
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--SSSEKSLLPN--- 417
            T   ++ LH      ++HRD+K SN+L++     K+ DFGLAR    S+  +  P    
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 418 ---TAIAGTLGYMAPEY-IANGQLTEKVDIYSFGVLVLEI 453
              T    T  Y APE  + + + +  +D++S G ++ E+
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 40/220 (18%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKR-------LFISRKNRIKEICNEMDIMSRA 309
           F   + LG G YG +   T +  G  +A+K+       LF  R  R      E+ I+   
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR------EIKILKHF 66
Query: 310 HHKNLVQFLGCCFTKKDSF-------VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
            H+N++        + DSF       ++ E +Q   L R++      + L        I 
Sbjct: 67  KHENIITIFN--IQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQYFIY 119
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--SSSEKSLLPN--- 417
            T   ++ LH      ++HRD+K SN+L++     K+ DFGLAR    S+  +  P    
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 418 ---TAIAGTLGYMAPEY-IANGQLTEKVDIYSFGVLVLEI 453
              T    T  Y APE  + + + +  +D++S G ++ E+
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 48/84 (57%), Gaps = 5/84 (5%)
Query: 376 QMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
           QM +VHR++K  N+LL  K +    K+ADFGLA     E+        AGT GY++PE +
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVL 185
Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 + VD+++ GV++  ++ G
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVG 209

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 258 FDESNKLGHGGYGEIFKGTLQD-GREIAVKR-------LFISRKNRIKEICNEMDIMSRA 309
           F   + LG G YG +   T +  G  +A+K+       LF  R  R      E+ I+   
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR------EIKILKHF 66
Query: 310 HHKNLVQFLGCCFTKKDSF-------VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
            H+N++        + DSF       ++ E +Q   L R++      + L        I 
Sbjct: 67  KHENIITIFN--IQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQYFIY 119
Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--SSSEKSLLPNTAI 420
            T   ++ LH      ++HRD+K SN+L++     K+ DFGLAR    S+  +  P    
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 421 AG------TLGYMAPEY-IANGQLTEKVDIYSFGVLVLEI 453
           +G      T  Y APE  + + + +  +D++S G ++ E+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 106/239 (44%), Gaps = 41/239 (17%)
Query: 253 KATDCFDESNKLGHGGYGEIFKGTLQDG-REIAVKRLFISRKNRI--KEICNEMDIMSRA 309
           K  D ++  + +G G YG ++    ++  + +A+K++    ++ I  K I  E+ I++R 
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 310 HHKNLVQFLGCC----FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV--IIIG 363
               +++           K D   +   + +  L ++   P     +   ++HV  I+  
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTP-----IFLTEQHVKTILYN 139
Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL--------- 414
              G +++H+ G   I+HRD+K +N LL+     KI DFGLAR  +S+K +         
Sbjct: 140 LLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEK 196
Query: 415 ----LPN----------TAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSGVQ 458
                P           T+   T  Y APE I      T  +DI+S G +  E+++ ++
Sbjct: 197 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMK 255

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 263 KLGHGGYGEIFKGTLQDGR------EIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           ++G G +  ++KG   +        E+  ++L  S + R KE   E + +    H N+V+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQHPNIVR 89
Query: 317 FLGCCFT----KKDSFVVYEFVQNKSLDRIL--FDPKQKKELDWKKRHVIIIGTAEGLEY 370
           F     +    KK   +V E   + +L   L  F   + K L    R ++     +GL++
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQIL-----KGLQF 144
Query: 371 LHKDGQMQIVHRDIKASNILL-DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           LH      I+HRD+K  NI +       KI D GLA    +  +     A+ GT  + AP
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFXAP 199
Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVS 455
           E     +  E VD+Y+FG   LE  +
Sbjct: 200 EXYEE-KYDESVDVYAFGXCXLEXAT 224

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNTAI 420
            E ++YLH    + I HRD+K  N+L   K RP    K+ DFG A+ ++S  SL   T  
Sbjct: 171 GEAIQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSL---TTP 223
Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             T  Y+APE +   +  +  D +S GV+   ++ G
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCG 259

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 5/86 (5%)
Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEK-SLLPNTAIAGTLGYMAPEYIANGQLTE 439
           HRD+K  NIL+       + DFG+A  ++ EK + L NT   GTL Y APE  +    T 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT--VGTLYYXAPERFSESHATY 214
Query: 440 KVDIYSFGVLVLEIVSGVQNNKFQSD 465
           + DIY+   ++ E ++G  +  +Q D
Sbjct: 215 RADIYALTCVLYECLTG--SPPYQGD 238

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 48/86 (55%), Gaps = 6/86 (6%)
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI--- 432
           Q+  VHRDIK  N+LLD+    ++ADFG     + + ++  + A+ GT  Y++PE +   
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQAM 251
Query: 433 --ANGQLTEKVDIYSFGVLVLEIVSG 456
               G+   + D +S GV + E++ G
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 48/86 (55%), Gaps = 6/86 (6%)
Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI--- 432
           Q+  VHRDIK  N+LLD+    ++ADFG     + + ++  + A+ GT  Y++PE +   
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQAM 267
Query: 433 --ANGQLTEKVDIYSFGVLVLEIVSG 456
               G+   + D +S GV + E++ G
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 264 LGHGGYGEIFKGTLQDG-REIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLGC 320
           +G G YG ++    ++  + +A+K++    ++ I  K I  E+ I++R     +++    
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 321 C----FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                  K D   +   + +  L ++   P    E   K    I+     G  ++H+ G 
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK---TILYNLLLGENFIHESG- 149
Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK------SLLPN------------- 417
             I+HRD+K +N LL+     K+ DFGLAR  +SEK       L  N             
Sbjct: 150 --IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 418 -TAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSGVQ 458
            T+   T  Y APE I      T+ +DI+S G +  E+++ +Q
Sbjct: 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSR--AHHKNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +  +    +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 72  IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 129 XG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 178
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 105 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 162 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 211
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 104 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 161 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 210
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 105 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 162 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 211
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 105 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 162 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 211
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 104 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 161 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 210
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 104 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 161 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 210
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 105 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 162 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 211
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 119 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 175
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 176 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 225
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 104 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 161 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 210
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 119 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 175
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 176 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 225
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 91  IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 147
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 148 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 197
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 91  IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 147
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 148 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 197
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 92  IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 149 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 198
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 124 IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 180
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 181 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 230
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN------EMDIMSRAHH--KNL 314
           LG GG+G ++ G  + D   +A+K +   R +   E+ N      E+ ++ +       +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ L   F + DSFV+   ++     + LFD   ++  L  +          E + + H 
Sbjct: 92  IRLLDW-FERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIA---GTLGYMAP 429
            G   ++HRDIK  NIL+DL +   K+ DFG         +LL +T      GT  Y  P
Sbjct: 149 CG---VLHRDIKDENILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPP 198
Query: 430 EYIANGQLTEK-VDIYSFGVLVLEIVSG 456
           E+I   +   +   ++S G+L+ ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	569
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-122
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-111
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-106
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-75
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-62
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-53
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-47
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-39
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-38
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-37
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-36
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-35
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-32
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-32
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-31
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-30
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-30
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-30
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-30
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-29
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-29
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-29
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-29
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-29
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-29
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-28
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-28
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-27
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-14
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	3e-14
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	5e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-06

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  363 bits (933), Expect = e-122
 Identities = 103/289 (35%), Positives = 173/289 (59%), Gaps = 6/289 (2%)

Query: 246 FKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFI-SRKNRIKEICNEMD 304
           F    ++ A+D F   N LG GG+G+++KG L DG  +AVKRL     +    +   E++
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIG 363
           ++S A H+NL++  G C T  +  +VY ++ N S+   L + P+ +  LDW KR  I +G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
           +A GL YLH     +I+HRD+KA+NILLD +    + DFGLA+    + + +  TA+ GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGT 198

Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG--VQNNKFQSDDGFETLVTHTWKHFQA 481
           +G++APEY++ G+ +EK D++ +GV++LE+++G    +    ++D    L+       + 
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 482 KTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
           K +  ++D  ++     EEV++++ V LLCTQ  P  RP M+ VV+ML+
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  334 bits (859), Expect = e-111
 Identities = 101/309 (32%), Positives = 157/309 (50%), Gaps = 18/309 (5%)

Query: 233 DLSLLHKSLKFLQFKYSTIEKATDCFDE------SNKLGHGGYGEIFKGTLQDGREIAVK 286
           + SL     +F  F +  ++  T+ FDE       NK+G GG+G ++KG + +   +AVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 287 RLFISRKNRI----KEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRI 342
           +L            ++   E+ +M++  H+NLV+ LG      D  +VY ++ N SL   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 343 LFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF 402
           L        L W  R  I  G A G+ +LH++     +HRDIK++NILLD     KI+DF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDF 177

Query: 403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKF 462
           GLAR S      +  + I GT  YMAPE +  G++T K DIYSFGV++LEI++G+     
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 463 QSDDGFETLVTHTWKHFQ-AKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSM 521
             +   + L+    +     KT+ + IDK +   D   V+ +  V   C  E    RP +
Sbjct: 237 HREP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 294

Query: 522 TNVVQMLKQ 530
             V Q+L++
Sbjct: 295 KKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  321 bits (824), Expect = e-106
 Identities = 90/287 (31%), Positives = 152/287 (52%), Gaps = 5/287 (1%)

Query: 245 QFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMD 304
           +     +E+AT+ FD    +GHG +G+++KG L+DG ++A+KR        I+E   E++
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87

Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIG 363
            +S   H +LV  +G C  + +  ++Y++++N +L R L+        + W++R  I IG
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
            A GL YLH      I+HRD+K+ NILLD    PKI DFG+++  +       +T + GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204

Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT 483
           LGY+ PEY   G+LTEK D+YSFGV++ E++                L     +      
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264

Query: 484 VLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
           + +I+D ++  +   E +++     + C       RPSM +V+  L+
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  240 bits (615), Expect = 4e-75
 Identities = 65/310 (20%), Positives = 110/310 (35%), Gaps = 29/310 (9%)

Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEM 303
           +      +   +           G +G ++K  L     +AVK     +  +  +   E+
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFP-IQDKQSWQNEYEV 69

Query: 304 DIMSRAHHKNLVQFLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
             +    H+N++QF+G            +++  F +  SL   L    +   + W +   
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCH 125

Query: 360 IIIGTAEGLEYLHKDGQMQ-------IVHRDIKASNILLDLKHRPKIADFGLARFSSSEK 412
           I    A GL YLH+D           I HRDIK+ N+LL       IADFGLA    + K
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 413 SLLPNTAIAGTLGYMAPEYIANG-----QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG 467
           S        GT  YMAPE +            ++D+Y+ G+++ E+ S         D+ 
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 468 FETLVTHTWKH-----FQAKTVLEIIDKSI--EIEDIEEVKRVVWVGLLCTQELPTLRPS 520
                    +H      Q   V +     +    +    +  +      C       R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 521 MTNVVQMLKQ 530
              V + + Q
Sbjct: 306 AGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  206 bits (527), Expect = 4e-62
 Identities = 63/338 (18%), Positives = 119/338 (35%), Gaps = 44/338 (13%)

Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEM 303
           ++   S      D       +G G YG ++KG+L D R +AVK    + +   +   NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEK 56

Query: 304 DI--MSRAHHKNLVQFLGCCFTKKDS-----FVVYEFVQNKSLDRILFDPKQKKELDWKK 356
           +I  +    H N+ +F+               +V E+  N SL + L         DW  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVS 112

Query: 357 RHVIIIGTAEGLEYLHKD------GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS 410
              +      GL YLH +       +  I HRD+ + N+L+       I+DFGL+   + 
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 411 EKSL------LPNTAIAGTLGYMAPEYIAN-------GQLTEKVDIYSFGVLVLEIVSGV 457
            + +          +  GT+ YMAPE +             ++VD+Y+ G++  EI    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 458 QNNKFQSDDG-----FETLVTHTWKHFQAKTVLEIIDKSIEIED---IEEVKRVVWVGLL 509
            +             F+T V +       + ++    +  +  +      +        +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 510 --CTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTD 545
             C  +    R +     + + +  +          T 
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  205 bits (523), Expect = 1e-61
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 31/290 (10%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLG 319
            K+G G +G + +     G ++AVK L        R+ E   E+ IM R  H N+V F+G
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                 +  +V E++   SL R+L     +++LD ++R  +    A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-I 160

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           VHR++K+ N+L+D K+  K+ DFGL+R  +S        + AGT  +MAPE + +    E
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNE 218

Query: 440 KVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI--EI-ED 496
           K D+YSFGV++ E+ +            +  L        Q   V  +  K    EI  +
Sbjct: 219 KSDVYSFGVILWELATL--------QQPWGNL-----NPAQV--VAAVGFKCKRLEIPRN 263

Query: 497 IEEVKRVVWVGLL--CTQELPTLRPSMTNVVQMLKQ-KDITLPTPSKPPF 543
           +          ++  C    P  RPS   ++ +L+      +P P++   
Sbjct: 264 LNP----QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (522), Expect = 1e-61
 Identities = 61/290 (21%), Positives = 123/290 (42%), Gaps = 34/290 (11%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
            +    +G G +G + K   +  +++A+K++    ++  K    E+  +SR +H N+V+ 
Sbjct: 10  IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKL 66

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G C       +V E+ +  SL  +L   +              +  ++G+ YLH     
Sbjct: 67  YGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 378 QIVHRDIKASNILLDLKHR-PKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
            ++HRD+K  N+LL       KI DFG A    +       T   G+  +MAPE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSN 179

Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI--EI 494
            +EK D++S+G+++ E+++            F+ +         A  ++  +       +
Sbjct: 180 YSEKCDVFSWGIILWEVITR--------RKPFDEI------GGPAFRIMWAVHNGTRPPL 225

Query: 495 -EDIEEVKRVVWVGLL--CTQELPTLRPSMTNVVQMLKQKDITLPTPSKP 541
            +++ +        L+  C  + P+ RPSM  +V+++       P   +P
Sbjct: 226 IKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  195 bits (499), Expect = 1e-58
 Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 47/293 (16%)

Query: 258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN-------RIKEICNEMDIMSRA 309
            +   ++G GG+G + KG L  D   +A+K L +           + +E   E+ IMS  
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           +H N+V+  G         +V EFV    L   L    +   + W  +  +++  A G+E
Sbjct: 81  NHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIE 136

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHR-----PKIADFGLARFSSSEKSLLPNTAIAGTL 424
           Y+       IVHRD+++ NI L           K+ADFGL++ S         + + G  
Sbjct: 137 YMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNF 190

Query: 425 GYMAPEYIA--NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK 482
            +MAPE I       TEK D YSF +++  I++G        +  F+        + + K
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTG--------EGPFDEY-----SYGKIK 237

Query: 483 TVLEIIDKSI--EI-EDIEEVKRVVWVGLL--CTQELPTLRPSMTNVVQMLKQ 530
            +  I ++ +   I ED           ++  C    P  RP  + +V+ L +
Sbjct: 238 FINMIREEGLRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  193 bits (493), Expect = 8e-58
 Identities = 74/283 (26%), Positives = 118/283 (41%), Gaps = 39/283 (13%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFIS----RKNRIKEICNEMDIMSRAHHKNLVQF 317
             +G GG+G++++     G E+AVK             I+ +  E  + +   H N++  
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G C  + +  +V EF +   L+R+L      K +         +  A G+ YLH +  +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 378 QIVHRDIKASNILLDLKHRP--------KIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
            I+HRD+K+SNIL+  K           KI DFGLAR            + AG   +MAP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAP 183

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID 489
           E I     ++  D++S+GVL+ E+++G     F+  DG                 L I  
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEV--PFRGIDGLAVAYGVAMNKLA----LPIPS 237

Query: 490 KSIEIEDIEEVKRVVWVGLL--CTQELPTLRPSMTNVVQMLKQ 530
              E           +  L+  C    P  RPS TN++  L  
Sbjct: 238 TCPE----------PFAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (481), Expect = 1e-55
 Identities = 72/325 (22%), Positives = 117/325 (36%), Gaps = 59/325 (18%)

Query: 262 NKLGHGGYGEIFKGTL-QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
             LG G +G+  K T  + G  + +K L    +   +    E+ +M    H N+++F+G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
            +  K    + E+++  +L  I+     +    W +R       A G+ YLH    M I+
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNII 130

Query: 381 HRDIKASNILLDLKHRPKIADFGLARFSSSEKSL------------LPNTAIAGTLGYMA 428
           HRD+ + N L+       +ADFGLAR    EK+                  + G   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVSGVQ----NNKFQSDDGFETLVTHTWKHFQAKT- 483
           PE I      EKVD++SFG+++ EI+  V           D           + F  +  
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------FGLNVRGFLDRYC 244

Query: 484 -------VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ----KD 532
                     I                    + C    P  RPS   +   L+       
Sbjct: 245 PPNCPPSFFPIT-------------------VRCCDLDPEKRPSFVKLEHWLETLRMHLA 285

Query: 533 ITLPTPSKPPFTDECMELSHTSGFS 557
             LP   +    D     ++  G S
Sbjct: 286 GHLPLGPQLEQLDRGFWETYRRGES 310

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (467), Expect = 5e-54
 Identities = 52/281 (18%), Positives = 105/281 (37%), Gaps = 41/281 (14%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLG 319
            KL     GE++KG  Q G +I VK L +      + ++   E   +    H N++  LG
Sbjct: 16  TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 320 CCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            C +       ++  ++   SL  +L +      +D  +     +  A G+ +LH    +
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
            I    + + ++++D     +I+   +     S               ++APE +     
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPE 185

Query: 438 ---TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI-- 492
                  D++SF VL+ E+V+         +  F  L      + +    +++  + +  
Sbjct: 186 DTNRRSADMWSFAVLLWELVTR--------EVPFADL-----SNMEI--GMKVALEGLRP 230

Query: 493 EI-EDIEEVKRVVWVGLL--CTQELPTLRPSMTNVVQMLKQ 530
            I   I          L+  C  E P  RP    +V +L++
Sbjct: 231 TIPPGISP----HVSKLMKICMNEDPAKRPKFDMIVPILEK 267

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  182 bits (465), Expect = 2e-53
 Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 13/200 (6%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLG 319
            ++G G +G ++KG      ++AVK L ++     +++   NE+ ++ +  H N++ F+G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
              T     +V ++ +  SL   L   + K   + KK   I   TA G++YLH      I
Sbjct: 88  YS-TAPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLH---AKSI 141

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-- 437
           +HRD+K++NI L   +  KI DFGLA   S          ++G++ +MAPE I       
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 438 -TEKVDIYSFGVLVLEIVSG 456
            + + D+Y+FG+++ E+++G
Sbjct: 202 YSFQSDVYAFGIVLYELMTG 221

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (464), Expect = 4e-53
 Identities = 57/285 (20%), Positives = 117/285 (41%), Gaps = 40/285 (14%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLG 319
             +G G +G+++ G      E+A++ + I R  ++++K    E+    +  H+N+V F+G
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
            C +     ++    + ++L  ++ D K    LD  K   I     +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN---TAIAGTLGYMAPEYIANGQ 436
           +H+D+K+ N+  D   +  I DFGL   S   ++           G L ++APE I    
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 437 L---------TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI 487
                     ++  D+++ G +  E+ +                    +K   A+ ++  
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREW----------------PFKTQPAEAIIWQ 254

Query: 488 IDKSIEIEDIEEVKRVVWVGLL--CTQELPTLRPSMTNVVQMLKQ 530
           +   ++    +         +L  C       RP+ T ++ ML++
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  178 bits (452), Expect = 4e-51
 Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 31/293 (10%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
            ++G G YGE++ G  + G ++AVK  F +   +  +E   E+       H+N++ F+  
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAA 99

Query: 321 CFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-- 374
                 S    +++ ++ +N SL   L    +   LD K    +   +  GL +LH +  
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 375 ---GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL--LPNTAIAGTLGYMAP 429
              G+  I HRD+K+ NIL+       IAD GLA    S+ +   +P     GT  YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 430 E------YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD--DGFETLVTH--TWKHF 479
           E         + Q     D+YSFG+++ E+     +     +    +  LV    +++  
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 480 QAKTVLEIIDKSIEIEDIEEVKRVVWVGLL--CTQELPTLRPSMTNVVQMLKQ 530
           +    ++ +  S       +        L+  C    P  R +   V + L +
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  174 bits (444), Expect = 2e-50
 Identities = 71/296 (23%), Positives = 126/296 (42%), Gaps = 37/296 (12%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
             +G G YGE+++G+ Q G  +AVK       K+  +E   E+       H+N++ F+  
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRET--ELYNTVMLRHENILGFIAS 70

Query: 321 CFTKKDSFVVY----EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-- 374
             T + S         + +  SL   L    Q   LD      I++  A GL +LH +  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 375 ---GQMQIVHRDIKASNILLDLKHRPKIADFGLARF--SSSEKSLLPNTAIAGTLGYMAP 429
              G+  I HRD+K+ NIL+    +  IAD GLA     S+ +  + N    GT  YMAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 430 E------YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG--FETLVTHTWKHFQA 481
           E       +      ++VDI++FG+++ E+   + +N    D    F  +V +       
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 482 KTV-------LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
           + V         I ++      +  + +++     C  + P+ R +   + + L +
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  167 bits (425), Expect = 3e-47
 Identities = 64/300 (21%), Positives = 120/300 (40%), Gaps = 45/300 (15%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDI--MSRAHHKNLVQFLG 319
             +G G +GE+++G  + G E+AVK      +        E +I       H+N++ F+ 
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103

Query: 320 CCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD- 374
                  +    ++V ++ ++ SL   L     +  +  +    + + TA GL +LH + 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 375 ----GQMQIVHRDIKASNILLDLKHRPKIADFGLARF--SSSEKSLLPNTAIAGTLGYMA 428
               G+  I HRD+K+ NIL+       IAD GLA    S+++   +      GT  YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 429 PE------YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD--DGFETLVTHTWKHFQ 480
           PE       + + +  ++ DIY+ G++  EI           D    +  LV       +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279

Query: 481 AKTV-------LEIIDKSIEIEDIEEVKRVV---WVGLLCTQELPTLRPSMTNVVQMLKQ 530
            + V         I ++    E +  + +++   W            R +   + + L Q
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW------YANGAARLTALRIKKTLSQ 333

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  146 bits (371), Expect = 4e-40
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 21/204 (10%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLG 319
           ++G G +  ++KG   +   E+A   L   +  K+  +    E +++    H N+V+F  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 320 CCF---TKKDSFVVY-EFVQNKSLDRILFDPKQKKELDWKK--RHVIIIGTAEGLEYLHK 373
                   K   V+  E + + +L   L   K  K    +   R ++     +GL++LH 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL-----KGLQFLHT 147

Query: 374 DGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
                I+HRD+K  NI +       KI D GLA    +  +     A+ GT  +MAPE  
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMY 202

Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                 E VD+Y+FG+ +LE+ + 
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATS 225

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  143 bits (362), Expect = 9e-39
 Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 21/203 (10%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           LG G YG ++ G  L +   IA+K +        + +  E+ +     HKN+VQ+LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 323 TKKDSFVVYEFVQNKSLDRIL---FDPKQKKELDWKKRHVIIIGTA---EGLEYLHKDGQ 376
                 +  E V   SL  +L   + P +  E        I   T    EGL+YLH +  
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE------QTIGFYTKQILEGLKYLHDNQ- 142

Query: 377 MQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
             IVHRDIK  N+L++      KI+DFG ++  +            GTL YMAPE I  G
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKG 198

Query: 436 QL--TEKVDIYSFGVLVLEIVSG 456
                +  DI+S G  ++E+ +G
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATG 221

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  143 bits (361), Expect = 4e-38
 Identities = 62/235 (26%), Positives = 115/235 (48%), Gaps = 13/235 (5%)

Query: 225 KDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL-QDGREI 283
           K  + +E+D     +   FL  K    E   D F++ ++LG G  G +FK +    G  +
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61

Query: 284 AVKRLFISRKNR-IKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRI 342
           A K + +  K     +I  E+ ++   +   +V F G  ++  +  +  E +   SLD++
Sbjct: 62  ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121

Query: 343 LFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF 402
           L   K+   +  +    + I   +GL YL +  +  I+HRD+K SNIL++ +   K+ DF
Sbjct: 122 L---KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 176

Query: 403 GLA-RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           G++ +   S    + N+   GT  YM+PE +     + + DI+S G+ ++E+  G
Sbjct: 177 GVSGQLIDS----MANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  139 bits (353), Expect = 1e-37
 Identities = 54/203 (26%), Positives = 105/203 (51%), Gaps = 10/203 (4%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
              +    K+G G  G ++    +  G+E+A++++ + ++ + + I NE+ +M    + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V +L       + +VV E++   SL  ++     +  +D  +   +     + LE+LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 134

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
           +    ++HRDIK+ NILL +    K+ DFG     + E+S   +T + GT  +MAPE + 
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMV-GTPYWMAPEVVT 189

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
                 KVDI+S G++ +E++ G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  142 bits (359), Expect = 3e-37
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 19/209 (9%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLVQ 316
           F   + LGHG  G I    + D R++AVKR+             E+ ++     H N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
           +      ++  ++  E       + +         L+      ++  T  GL +LH    
Sbjct: 83  YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT---LLQQTTSGLAHLH---S 136

Query: 377 MQIVHRDIKASNILLDLKH-----RPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPE 430
           + IVHRD+K  NIL+ + +     +  I+DFGL +  +    S    + + GT G++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 431 YI---ANGQLTEKVDIYSFGVLVLEIVSG 456
            +        T  VDI+S G +   ++S 
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  139 bits (351), Expect = 3e-37
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 27/220 (12%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR-IKEICNEMDIMSRAHHKNLV 315
           F+    LG GG+G +F+     D    A+KR+ +  +    +++  E+  +++  H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 316 QFLGCCFTKKDS------------FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
           ++      K  +            ++  +  + ++L   +      +E +      I + 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL--------- 414
            AE +E+LH      ++HRD+K SNI   +    K+ DFGL      ++           
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 415 -LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI 453
              +T   GT  YM+PE I     + KVDI+S G+++ E+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  138 bits (349), Expect = 9e-37
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 10/203 (4%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
               D   K+G G  G +        GR++AVK + + ++ R + + NE+ IM    H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+        ++ +V+ EF+Q  +L  I+     +  L+ ++   +     + L YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
            G   ++HRDIK+ +ILL L  R K++DFG     S +      + + GT  +MAPE I+
Sbjct: 160 QG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLV-GTPYWMAPEVIS 214

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
                 +VDI+S G++V+E+V G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  137 bits (347), Expect = 2e-36
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 16/200 (8%)

Query: 262 NKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
            ++G G +GE+ +    Q G + AVK++ +           E+   +      +V   G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGA 118

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
                   +  E ++  SL +++   KQ   L   +    +    EGLEYLH      I+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRR---IL 172

Query: 381 HRDIKASNILLDLK-HRPKIADFGLAR---FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           H D+KA N+LL     R  + DFG A         KSLL    I GT  +MAPE +    
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 437 LTEKVDIYSFGVLVLEIVSG 456
              KVDI+S   ++L +++G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNG 252

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  135 bits (343), Expect = 4e-36
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 35/227 (15%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           F+E   LG G +G++ K     D R  A+K++  + +     I +E+ +++  +H+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVVR 66

Query: 317 FLGC-------------CFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIII 362
           +                   K   F+  E+ +N +L D I     +       +   +  
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFR 123

Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA- 421
              E L Y+H  G   I+HRD+K  NI +D     KI DFGLA+       +L   +   
Sbjct: 124 QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 422 -----------GTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSG 456
                      GT  Y+A E +   G   EK+D+YS G++  E++  
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  137 bits (348), Expect = 4e-36
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)

Query: 263 KLGHGGYGEIFKGTLQ-DGREIAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           ++G G +GE+F G L+ D   +AVK        +   +   E  I+ +  H N+V+ +G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  K+  ++V E VQ       L    +   L  K    ++   A G+EYL        +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235

Query: 381 HRDIKASNILLDLKHRPKIADFGLARF-------SSSEKSLLPNTAIAGTLGYMAPEYIA 433
           HRD+ A N L+  K+  KI+DFG++R        +S     +P       + + APE + 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP-------VKWTAPEALN 288

Query: 434 NGQLTEKVDIYSFGVLVLEIVS 455
            G+ + + D++SFG+L+ E  S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (342), Expect = 9e-36
 Identities = 49/216 (22%), Positives = 94/216 (43%), Gaps = 21/216 (9%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           +    KLG GG+  +     L DG   A+KR+    +   +E   E D+    +H N+++
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 317 FLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHV--IIIGTAEGLEY 370
            +  C  ++ +    +++  F +  +L   +   K K      +  +  +++G   GLE 
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEA 149

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS-------LLPNTAIAGT 423
           +H        HRD+K +NILL  + +P + D G    +            L    A   T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 424 LGYMAPEYI---ANGQLTEKVDIYSFGVLVLEIVSG 456
           + Y APE     ++  + E+ D++S G ++  ++ G
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (341), Expect = 1e-35
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 22/218 (10%)

Query: 248 YSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE---ICNEM 303
           Y+T+      F    K+G G + E+++   L DG  +A+K++ I      K       E+
Sbjct: 28  YNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83

Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKK-----ELDWKKRH 358
           D++ + +H N++++        +  +V E      L R++   K++K        WK   
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK--- 140

Query: 359 VIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
              +     LE++H     +++HRDIK +N+ +      K+ D GL RF SS+ +   ++
Sbjct: 141 -YFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HS 195

Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            + GT  YM+PE I       K DI+S G L+ E+ + 
Sbjct: 196 LV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  134 bits (338), Expect = 2e-35
 Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 10/203 (4%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
            + FD   KLG G YG ++K    + G+ +A+K   +  ++ ++EI  E+ IM +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPH 85

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V++ G  F   D ++V E+    S+  I+    + K L   +   I+  T +GLEYLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                 +HRDIKA NILL+ +   K+ADFG+A   +   +   NT I GT  +MAPE I 
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVI-GTPFWMAPEVIQ 198

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
                   DI+S G+  +E+  G
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEG 221

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (340), Expect = 2e-35
 Identities = 47/210 (22%), Positives = 94/210 (44%), Gaps = 23/210 (10%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMS--RAHHKNLVQF 317
            ++G GG  ++F+   +  +  A+K + +       +    NE+  ++  + H   +++ 
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
                T +  ++V E   N  L+  L   K+KK +D  +R        E +  +H+ G  
Sbjct: 75  YDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 128

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN--- 434
            IVH D+K +N L+      K+ DFG+A     + + +   +  GT+ YM PE I +   
Sbjct: 129 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 435 --------GQLTEKVDIYSFGVLVLEIVSG 456
                    +++ K D++S G ++  +  G
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYG 216

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (336), Expect = 5e-35
 Identities = 46/210 (21%), Positives = 93/210 (44%), Gaps = 23/210 (10%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNL--VQF 317
            ++G GG  ++F+   +  +  A+K + +       +    NE+  +++    +   ++ 
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
                T +  ++V E   N  L+  L   K+KK +D  +R        E +  +H+ G  
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 147

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN--- 434
            IVH D+K +N L+      K+ DFG+A     + + +   +  GT+ YM PE I +   
Sbjct: 148 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 435 --------GQLTEKVDIYSFGVLVLEIVSG 456
                    +++ K D++S G ++  +  G
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYG 235

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (343), Expect = 6e-35
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            KLG G +GE++  T     ++AVK +     +  +    E ++M    H  LV+     
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
            TK+  +++ EF+   SL   L   +   +    K        AEG+ ++    Q   +H
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 382 RDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           RD++A+NIL+      KIADFGLAR       ++ E +  P       + + APE I  G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-------IKWTAPEAINFG 360

Query: 436 QLTEKVDIYSFGVLVLEIVS 455
             T K D++SFG+L++EIV+
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  132 bits (333), Expect = 9e-35
 Identities = 50/208 (24%), Positives = 103/208 (49%), Gaps = 13/208 (6%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
            + ++   +LG G +G+++K    + G   A K +    +  +++   E++I++   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ LG  +     +++ EF    ++D I+   +  + L   +  V+     E L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                I+HRD+KA N+L+ L+   ++ADFG++  +        ++ I GT  +MAPE + 
Sbjct: 136 KR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFI-GTPYWMAPEVVM 190

Query: 434 NGQLTE-----KVDIYSFGVLVLEIVSG 456
              + +     K DI+S G+ ++E+   
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQI 218

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (334), Expect = 9e-35
 Identities = 54/206 (26%), Positives = 83/206 (40%), Gaps = 16/206 (7%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKEICNEMDIMSR-AH 310
             F   ++LGHG YGE+FK    +DGR  AVKR    F   K+R +++  E+    +   
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQ 115

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H   V+           ++  E                   L   +    +  T   L +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCE---AWGASLPEAQVWGYLRDTLLALAH 172

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH      +VH D+K +NI L  + R K+ DFGL     +  +        G   YMAPE
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT--AGAGEVQE-GDPRYMAPE 226

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSG 456
            +  G      D++S G+ +LE+   
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACN 251

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  133 bits (336), Expect = 1e-34
 Identities = 53/222 (23%), Positives = 104/222 (46%), Gaps = 17/222 (7%)

Query: 240 SLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--I 296
            L      + ++EK    +    K+G G +G+       +DGR+  +K + ISR +    
Sbjct: 12  DLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67

Query: 297 KEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKK 356
           +E   E+ +++   H N+VQ+          ++V ++ +   L + +     +K + +++
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQE 124

Query: 357 RHV--IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL 414
             +    +     L+++H     +I+HRDIK+ NI L      ++ DFG+AR  +S   L
Sbjct: 125 DQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181

Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
                I GT  Y++PE   N     K DI++ G ++ E+ + 
Sbjct: 182 A-RACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  131 bits (331), Expect = 2e-34
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 11/204 (5%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFI-SRKNRIKEICNEMDIMSRAHHK 312
            + F +  K+G G +GE+FKG   +  + +A+K + +   ++ I++I  E+ ++S+    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
            + ++ G        +++ E++   S   +L    +   LD  +   I+    +GL+YLH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH 136

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
            +     +HRDIKA+N+LL      K+ADFG+A       + +      GT  +MAPE I
Sbjct: 137 SEK---KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
                  K DI+S G+  +E+  G
Sbjct: 192 KQSAYDSKADIWSLGITAIELARG 215

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  132 bits (334), Expect = 4e-34
 Identities = 45/212 (21%), Positives = 93/212 (43%), Gaps = 27/212 (12%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR----IKEICNEMDIMSRAHHKNL--V 315
            ++G GG  ++F+   +  +  A+K   ++ +      +    NE+  +++    +   +
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKY--VNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +      T +  ++V E   N  L+  L   K+KK +D  +R        E +  +H+ G
Sbjct: 120 RLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG 175

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN- 434
              IVH D+K +N L+      K+ DFG+A     + + +   +  G + YM PE I + 
Sbjct: 176 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 435 ----------GQLTEKVDIYSFGVLVLEIVSG 456
                      +++ K D++S G ++  +  G
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  133 bits (337), Expect = 4e-34
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 21/199 (10%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFLG 319
             +G G +G++  G  + G ++AVK +    KN    +    E  +M++  H NLVQ LG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 320 CCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
               +K    +V E++   SL   L     +  L         +   E +EYL       
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYL---EGNN 309

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
            VHRD+ A N+L+   +  K++DFGL +   S+ +   LP       + + APE +   +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-------VKWTAPEALREKK 362

Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + K D++SFG+L+ EI S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  129 bits (327), Expect = 7e-34
 Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 46/294 (15%)

Query: 262 NKLGHGGYGEIFKGTL-----QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            +LG G +G +            G  +AVK+L  S +  +++   E++I+    H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 317 FLGCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + G C++       ++ E++   SL   L   K K+ +D  K         +G+EYL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARF--------SSSEKSLLPNTAIAGTLGY 426
              + +HRD+   NIL++ ++R KI DFGL +            E    P       + +
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP-------IFW 183

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE 486
            APE +   + +   D++SFGV++ E+ + ++ +K    +    +            ++E
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 487 IIDK----------SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
           ++              EI  I            C       RPS  ++   + Q
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIM---------TECWNNNVNQRPSFRDLALRVDQ 288

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (324), Expect = 1e-33
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 19/200 (9%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV+     
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
            T++  +++ E+++N SL   L  P    +L   K   +    AEG+ ++    +   +H
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 382 RDIKASNILLDLKHRPKIADFGLAR------FSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           RD++A+NIL+      KIADFGLAR      +++ E +  P       + + APE I  G
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-------IKWTAPEAINYG 185

Query: 436 QLTEKVDIYSFGVLVLEIVS 455
             T K D++SFG+L+ EIV+
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  132 bits (335), Expect = 2e-33
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 262 NKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L        +E   E  +M    H NLVQ LG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL    +   +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFI 340

Query: 381 HRDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           HR++ A N L+   H  K+ADFGL+R       ++   +  P       + + APE +A 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-------IKWTAPESLAY 393

Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
            + + K D+++FGVL+ EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  127 bits (322), Expect = 2e-33
 Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            ++G G +G +  G   +  ++A+K +     +  ++   E ++M +  H  LVQ  G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
             +    +V EF+++  L   L    Q+     +    + +   EG+ YL    +  ++H
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 382 RDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           RD+ A N L+      K++DFG+ RF      +SS  +  P       + + +PE  +  
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-------VKWASPEVFSFS 180

Query: 436 QLTEKVDIYSFGVLVLEIVS 455
           + + K D++SFGVL+ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  133 bits (335), Expect = 2e-33
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ     
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
            +++  ++V E++   SL   L      K L   +   +    A G+ Y+ +   M  VH
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386

Query: 382 RDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           RD++A+NIL+      K+ADFGLAR       ++ + +  P       + + APE    G
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-------IKWTAPEAALYG 439

Query: 436 QLTEKVDIYSFGVLVLEIVS 455
           + T K D++SFG+L+ E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (325), Expect = 2e-33
 Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 46/294 (15%)

Query: 262 NKLGHGGYGEIFKGTL-----QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
            +LG G +G +            G  +AVK+L  S +  +++   E++I+    H N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 317 FLGCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + G C++       ++ E++   SL   L   K K+ +D  K         +G+EYL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLG-- 162

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARF--------SSSEKSLLPNTAIAGTLGY 426
              + +HRD+   NIL++ ++R KI DFGL +            E    P       + +
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP-------IFW 214

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE 486
            APE +   + +   D++SFGV++ E+ + ++ +K    +    +            ++E
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 487 IIDK----------SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
           ++              EI  I            C       RPS  ++   + Q
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIM---------TECWNNNVNQRPSFRDLALRVDQ 319

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  127 bits (321), Expect = 2e-33
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 19/199 (9%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
           +LG G +G +  G  +   ++AVK +     +   E   E   M +  H  LV+F G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR 382
            +   ++V E++ N  L   L      K L+  +   +     EG+ +L      Q +HR
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 383 DIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
           D+ A N L+D     K++DFG+ R+       SS  +  P       + + APE     +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-------VKWSAPEVFHYFK 181

Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + K D+++FG+L+ E+ S
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (332), Expect = 2e-33
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LVQ     
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
            +++  ++V E++   SL   L      K L   +   +    A G+ Y+ +   M  VH
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303

Query: 382 RDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           RD++A+NIL+      K+ADFGLAR       ++ + +  P       + + APE    G
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-------IKWTAPEAALYG 356

Query: 436 QLTEKVDIYSFGVLVLEIVS 455
           + T K D++SFG+L+ E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  127 bits (322), Expect = 2e-33
 Identities = 66/302 (21%), Positives = 131/302 (43%), Gaps = 56/302 (18%)

Query: 248 YSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIM 306
           ++  ++    F E   +G GG+G++FK     DG+   +KR+  + +        E+  +
Sbjct: 3   HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK----AEREVKAL 58

Query: 307 SRAHHKNLVQFLGC----------------CFTKKDSFVVYEFVQNKSLDRILFDPKQKK 350
           ++  H N+V + GC                    K  F+  EF    +L++ +   ++++
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRR 115

Query: 351 ELDWKKRHV--IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS 408
                K     +     +G++Y+H     ++++RD+K SNI L    + KI DFGL    
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

Query: 409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
            ++      T   GTL YM+PE I++    ++VD+Y+ G+++ E                
Sbjct: 173 KNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE---------------- 213

Query: 469 ETLVTHTWKHFQAKTVLEIIDKSIEIEDI--EEVKRVVWVGLLCTQELPTLRPSMTNVVQ 526
             L+      F+       + +   I DI  ++ K ++   LL  +  P  RP+ + +++
Sbjct: 214 --LLHVCDTAFETSKFFTDL-RDGIISDIFDKKEKTLL-QKLLSKK--PEDRPNTSEILR 267

Query: 527 ML 528
            L
Sbjct: 268 TL 269

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  129 bits (326), Expect = 2e-33
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR---IKEICNEMDIMSRAH 310
              F +  ++GHG +G ++    +++   +A+K++  S K      ++I  E+  + +  
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N +Q+ GC   +  +++V E+    + D +    K  +E    +   +  G  +GL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE---VEIAAVTHGALQGLAY 169

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH      ++HRD+KA NILL      K+ DFG A        + P  +  GT  +MAPE
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPE 220

Query: 431 YIANGQLTE---KVDIYSFGVLVLEIVSG 456
            I      +   KVD++S G+  +E+   
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (321), Expect = 3e-33
 Identities = 61/286 (21%), Positives = 117/286 (40%), Gaps = 51/286 (17%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLG 319
            +G G YG   K     DG+ +  K L          + + +E++++    H N+V++  
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 320 CCFTKKDSFVVY---EFVQNKSLDRILFDPKQKKELD-----WKKRHVIIIGTAEGLEYL 371
                + +  +Y   E+ +   L  ++    ++++        +    ++      L+  
Sbjct: 73  R-IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR----VMTQLTLALKEC 127

Query: 372 H--KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           H   DG   ++HRD+K +N+ LD K   K+ DFGLAR  + + S    T + GT  YM+P
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFV-GTPYYMSP 185

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH-FQAKTVLEII 488
           E +      EK DI+S G L+ E+ +                        F A +  E+ 
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCAL--------------------MPPFTAFSQKELA 225

Query: 489 DK--SIEIEDI-----EEVKRVVWVGLLCTQELPTLRPSMTNVVQM 527
            K    +   I     +E+  ++   +L  +     RPS+  +++ 
Sbjct: 226 GKIREGKFRRIPYRYSDELNEIIT-RMLNLK--DYHRPSVEEILEN 268

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  127 bits (321), Expect = 3e-33
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            +LG G +G +  G  +   ++A+K +     +   E   E  +M    H+ LVQ  G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
             ++  F++ E++ N  L   L   + +     ++   +     E +EYL      Q +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 382 RDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           RD+ A N L++ +   K++DFGL+R+      +SS  S  P       + +  PE +   
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-------VRWSPPEVLMYS 196

Query: 436 QLTEKVDIYSFGVLVLEIVS 455
           + + K DI++FGVL+ EI S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  127 bits (321), Expect = 3e-33
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 21/199 (10%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKN--RIKEICNEMDIMSRAHHKNLVQFLG 319
             +G G +G++  G  + G ++AVK +    KN    +    E  +M++  H NLVQ LG
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 320 CCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
               +K   ++V E++   SL   L     +  L         +   E +EYL       
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNN 137

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLAR--FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
            VHRD+ A N+L+   +  K++DFGL +   S+ +   LP       + + APE +   +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-------VKWTAPEALREKK 190

Query: 437 LTEKVDIYSFGVLVLEIVS 455
            + K D++SFG+L+ EI S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  127 bits (322), Expect = 5e-33
 Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 26/219 (11%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE---ICNEMDIMSRAHH 311
             +  S+ LG G    +F+G   + G   A+K    +  + ++       E +++ + +H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 312 KNLVQFLGC--CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           KN+V+        T +   ++ EF    SL  +L +P     L   +  +++     G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNTAIAGTLG 425
           +L ++G   IVHR+IK  NI+  +        K+ DFG AR    ++      ++ GT  
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEE 180

Query: 426 YMAPEYIANGQL--------TEKVDIYSFGVLVLEIVSG 456
           Y+ P+      L           VD++S GV      +G
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  127 bits (322), Expect = 5e-33
 Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 32/216 (14%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE----IAVKRL--FISRKNRIKEICNEMDIMSRAHHKNLV 315
             LG G +G + +  L+        +AVK L   I   + I+E   E   M    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 316 QFLGCCF------TKKDSFVVYEFVQNKSLD---RILFDPKQKKELDWKKRHVIIIGTAE 366
           + +G               V+  F+++  L          +    L  +     ++  A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTA 419
           G+EYL        +HRD+ A N +L       +ADFGL+R       +     S LP   
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP--- 202

Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
               + ++A E +A+   T   D+++FGV + EI++
Sbjct: 203 ----VKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  127 bits (322), Expect = 5e-33
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 21/206 (10%)

Query: 262 NKLGHGGYGEIFKGTL-----QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           ++LG G +G +            G  +AVK+L  S  ++ ++   E+ I+   H   +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 317 FLGCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           + G  +        +V E++ +  L   L   + +  LD  +  +      +G+EYL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG-- 144

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAP 429
              + VHRD+ A NIL++ +   KIADFGLA+    +K    +  +    G     + AP
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 199

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVS 455
           E +++   + + D++SFGV++ E+ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  127 bits (322), Expect = 6e-33
 Identities = 76/322 (23%), Positives = 123/322 (38%), Gaps = 70/322 (21%)

Query: 262 NKLGHGGYGEIFKGTLQDGR------EIAVKRL--FISRKNRIKEICNEMDIMSRAHHKN 313
             LGHG +GE+++G +          ++AVK L    S ++   +   E  I+S+ +H+N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIISKFNHQN 94

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL----FDPKQKKELDWKKRHVIIIGTAEGLE 369
           +V+ +G        F++ E +    L   L      P Q   L       +    A G +
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLAR-------FSSSEKSLLPNTA 419
           YL    +   +HRDI A N LL         KI DFG+AR       +     ++LP   
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP--- 208

Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNNKFQSDDGFETLV 472
               + +M PE    G  T K D +SFGVL+ EI S          N +           
Sbjct: 209 ----VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----------- 253

Query: 473 THTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVW-VGLLCTQELPTLRPSMTNVVQMLKQ- 530
                      VLE +     ++  +     V+ +   C Q  P  RP+   +++ ++  
Sbjct: 254 -----------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

Query: 531 ------KDITLPTPSKPPFTDE 546
                  +  LP    P   +E
Sbjct: 303 TQDPDVINTALPIEYGPLVEEE 324

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  128 bits (323), Expect = 1e-32
 Identities = 76/322 (23%), Positives = 123/322 (38%), Gaps = 70/322 (21%)

Query: 262 NKLGHGGYGEIFKGTLQDGR------EIAVKRL--FISRKNRIKEICNEMDIMSRAHHKN 313
             LGHG +GE+++G +          ++AVK L    S ++   +   E  I+S+ +H+N
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIISKFNHQN 135

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL----FDPKQKKELDWKKRHVIIIGTAEGLE 369
           +V+ +G        F++ E +    L   L      P Q   L       +    A G +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLAR-------FSSSEKSLLPNTA 419
           YL    +   +HRDI A N LL         KI DFG+AR       +     ++LP   
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP--- 249

Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNNKFQSDDGFETLV 472
               + +M PE    G  T K D +SFGVL+ EI S          N +           
Sbjct: 250 ----VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----------- 294

Query: 473 THTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVW-VGLLCTQELPTLRPSMTNVVQMLKQ- 530
                      VLE +     ++  +     V+ +   C Q  P  RP+   +++ ++  
Sbjct: 295 -----------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343

Query: 531 ------KDITLPTPSKPPFTDE 546
                  +  LP    P   +E
Sbjct: 344 TQDPDVINTALPIEYGPLVEEE 365

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  127 bits (320), Expect = 1e-32
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + F+ +        A K +    + + ++ +++  E+ I     H+++V F G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                   FVV E  + +SL  +    K++K L   +    +     G +YLH++    +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNR---V 162

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+K  N+ L+     KI DFGLA     +        + GT  Y+APE ++    + 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-KV-LCGTPNYIAPEVLSKKGHSF 220

Query: 440 KVDIYSFGVLVLEIVSG 456
           +VD++S G ++  ++ G
Sbjct: 221 EVDVWSIGCIMYTLLVG 237

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  125 bits (317), Expect = 2e-32
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 28/210 (13%)

Query: 262 NKLGHGGYGEIFKGTL-----QDGREIAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLV 315
             LG G +G++            G ++AVK L   S  N I ++  E++I+   +H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 316 QFLGCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ G C     +   ++ EF+ + SL   L  PK K +++ K++    +   +G++YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG- 143

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--------SSSEKSLLPNTAIAGTLG 425
               Q VHRD+ A N+L++ +H+ KI DFGL +         +  +    P       + 
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP-------VF 194

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           + APE +   +     D++SFGV + E+++
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (316), Expect = 2e-32
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 12/197 (6%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISR--KNRIKE-ICNEMDIMSRAHHKNLVQFLG 319
           LG GG+ + F+ +        A K +  S   K   +E +  E+ I     H+++V F G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                   FVV E  + +SL  +    K++K L   +    +     G +YLH++    +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNR---V 136

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+K  N+ L+     KI DFGLA     +        + GT  Y+APE ++    + 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-KV-LCGTPNYIAPEVLSKKGHSF 194

Query: 440 KVDIYSFGVLVLEIVSG 456
           +VD++S G ++  ++ G
Sbjct: 195 EVDVWSIGCIMYTLLVG 211

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  125 bits (317), Expect = 2e-32
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 31/215 (14%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE----IAVKRL--FISRKNRIKEICNEMDIMSRAHHKNLV 315
             LG G +G + +G L+        +AVK +    S +  I+E  +E   M    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 316 QFLGCCF-----TKKDSFVVYEFVQNKSLD---RILFDPKQKKELDWKKRHVIIIGTAEG 367
           + LG C            V+  F++   L             K +  +     ++  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTAI 420
           +EYL        +HRD+ A N +L       +ADFGL++       +     + +P    
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP---- 212

Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
              + ++A E +A+   T K D+++FGV + EI +
Sbjct: 213 ---VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  126 bits (318), Expect = 2e-32
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE-----IAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLV 315
             LG G +G ++KG      E     +A+K L   +     KEI +E  +M+   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           + LG C       ++ + +    L   +   + K  +  +      +  A+G+ YL    
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE--- 134

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARF-------SSSEKSLLPNTAIAGTLGYMA 428
             ++VHRD+ A N+L+      KI DFGLA+          +E   +P       + +MA
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP-------IKWMA 187

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS 455
            E I +   T + D++S+GV V E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  125 bits (315), Expect = 2e-32
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 262 NKLGHGGYGEIFKGTLQDGR-EIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGC 320
           +KLG G YGE+++G  +     +AVK L        +E   E  +M    H NLVQ LG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
           C  +   +++ EF+   +L   L +   ++E+       +    +  +EYL    +   +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 381 HRDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           HRD+ A N L+   H  K+ADFGL+R       ++   +  P       + + APE +A 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-------IKWTAPESLAY 186

Query: 435 GQLTEKVDIYSFGVLVLEIVS 455
            + + K D+++FGVL+ EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  125 bits (317), Expect = 3e-32
 Identities = 51/219 (23%), Positives = 100/219 (45%), Gaps = 35/219 (15%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE------IAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
            +LG G +G++F     +         +AVK L  + ++  ++   E ++++   H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRIL------------FDPKQKKELDWKKRHVIIIG 363
           +F G C   +   +V+E++++  L+R L             +      L   +   +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLP 416
            A G+ YL     +  VHRD+   N L+      KI DFG++R       +    +++LP
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223

Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                  + +M PE I   + T + D++SFGV++ EI +
Sbjct: 224 -------IRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  124 bits (314), Expect = 3e-32
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRAHHKN 313
           F+    LG G +G ++     Q    +A+K LF   + +     ++  E++I S   H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +++  G        +++ E+    ++ R L   ++  + D ++    I   A  L Y H 
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 127

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                ++HRDIK  N+LL      KIADFG +  + S +       + GTL Y+ PE I 
Sbjct: 128 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TD-LCGTLDYLPPEMIE 180

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
                EKVD++S GVL  E + G
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVG 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  124 bits (314), Expect = 3e-32
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 16/223 (7%)

Query: 232 MDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFI 290
           M     H S +   +   TI+   D F    KLG G +G++        G E  +K +  
Sbjct: 1   MHHHHHHSSGRENLYFQGTID---DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINK 57

Query: 291 SR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQ 348
            R +  +++I  E++++    H N+++         + ++V E  +   L +RI+    +
Sbjct: 58  DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 349 KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLA 405
            K L       ++      L Y H      +VH+D+K  NIL          KI DFGLA
Sbjct: 118 GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174

Query: 406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGV 448
               S++     T  AGT  YMAPE +    +T K DI+S GV
Sbjct: 175 ELFKSDEHS---TNAAGTALYMAPE-VFKRDVTFKCDIWSAGV 213

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  124 bits (313), Expect = 4e-32
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 24/220 (10%)

Query: 250 TIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFI-SRKNRIKEICNEMDI-M 306
           ++E   D  +   +LG G YG + K   +  G+ +AVKR+         K +  ++DI M
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH------VI 360
                   V F G  F + D ++  E + + SLD+       K+ +D  +         I
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114

Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI 420
            +   + LE+LH   ++ ++HRD+K SN+L++   + K+ DFG++ +      +  +   
Sbjct: 115 AVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDA 170

Query: 421 AGTLGYMAPEYIANGQL----TEKVDIYSFGVLVLEIVSG 456
            G   YMAPE I         + K DI+S G+ ++E+   
Sbjct: 171 -GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  124 bits (313), Expect = 5e-32
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 36/220 (16%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE------IAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
            +LG G +G++F     +         +AVK L        K+   E ++++   H+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRIL-------------FDPKQKKELDWKKRHVIII 362
           +F G C       +V+E++++  L++ L                + K EL   +   I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLL 415
             A G+ YL        VHRD+   N L+      KI DFG++R       +     ++L
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197

Query: 416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           P       + +M PE I   + T + D++SFGV++ EI +
Sbjct: 198 P-------IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  127 bits (320), Expect = 5e-32
 Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 32/227 (14%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNL 314
           +       LG+G  G +       GR +AVKR+     +       E+ +++    H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71

Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRIL---FDPKQKKELDWKKRHVIIIGTAEGLEYL 371
           +++     T +  ++  E       D +       +  K         ++   A G+ +L
Sbjct: 72  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 372 HKDGQMQIVHRDIKASNILLDLKH-------------RPKIADFGLARFSSSEKSLLPNT 418
           H      I+HRD+K  NIL+                 R  I+DFGL +   S +S     
Sbjct: 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 419 A--IAGTLGYMAPEYI-------ANGQLTEKVDIYSFGVLVLEIVSG 456
               +GT G+ APE +          +LT  +DI+S G +   I+S 
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  123 bits (312), Expect = 6e-32
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 260 ESNKLGHGGYGEIFKGTLQDGRE----IAVKRL-FISRKNRIKEICNEMDIMSRAHHKNL 314
               +G G +G ++ G   D  +     A+K L  I+   +++    E  +M   +H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 315 VQFLGCCFTKKD--SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           +  +G      +    V+  ++ +  L + +  P+  +    K      +  A G+EYL 
Sbjct: 85  LALIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLA 141

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR---------FSSSEKSLLPNTAIAGT 423
              + + VHRD+ A N +LD     K+ADFGLAR               + LP       
Sbjct: 142 ---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP------- 191

Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           + + A E +   + T K D++SFGVL+ E+++
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (314), Expect = 7e-32
 Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 34/217 (15%)

Query: 262 NKLGHGGYGEIFKGTL-QDGREI--AVKRL--FISRKNRIKEICNEMDIMSR-AHHKNLV 315
           + +G G +G++ K  + +DG  +  A+KR+  + S+ +  ++   E++++ +  HH N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNII 89

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRIL-------------FDPKQKKELDWKKRHVIII 362
             LG C  +   ++  E+  + +L   L                     L  ++      
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS----SSEKSLLPNT 418
             A G++YL    Q Q +HRD+ A NIL+   +  KIADFGL+R            LP  
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 204

Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                + +MA E +     T   D++S+GVL+ EIVS
Sbjct: 205 -----VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  124 bits (313), Expect = 7e-32
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 262 NKLGHGGYGEIFKGTL---QDGREI--AVKRL-FISRKNRIKEICNEMDIMSRAHHKNLV 315
             LG G +G++         DG     AVK L   +          E+DI+   +H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 316 QFLGCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           ++ GCC     +   +V E+V   SL   L     +  +   +  +      EG+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH- 151

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--------FSSSEKSLLPNTAIAGTLG 425
                 +HRD+ A N+LLD     KI DFGLA+        +   E    P       + 
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-------VF 202

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           + APE +   +     D++SFGV + E+++
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  125 bits (315), Expect = 8e-32
 Identities = 44/278 (15%), Positives = 91/278 (32%), Gaps = 24/278 (8%)

Query: 238 HKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLF---ISRKN 294
              L  ++ K +  +  +      + LG G + ++++ T  D  +   K+ F   + +  
Sbjct: 48  QCKLPAIKPK-TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA 106

Query: 295 RIKEI---CNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRI-LFDPKQK 349
              E       M+ +  +     ++F      +  S +V E     +L + I L+    +
Sbjct: 107 NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166

Query: 350 KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP-----------K 398
           K +         +     +E +H      I+H DIK  N +L                  
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223

Query: 399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQ 458
           + D G +            TA   T G+   E ++N     ++D +     V  ++ G  
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-T 282

Query: 459 NNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED 496
             K +++ G         +        E     + I D
Sbjct: 283 YMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPD 320

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  123 bits (311), Expect = 1e-31
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 27/209 (12%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE----IAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
             +G G +G ++ GTL D        AVK L  I+    + +   E  IM    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 317 FLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            LG C   + S  VV  ++++  L   +    +      K      +  A+G++YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLA--- 145

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARF---------SSSEKSLLPNTAIAGTLGY 426
             + VHRD+ A N +LD K   K+ADFGLAR           +   + LP       + +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP-------VKW 198

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           MA E +   + T K D++SFGVL+ E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  123 bits (310), Expect = 1e-31
 Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 39/222 (17%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE------IAVKRL--FISRKNRIKEICNEMDIMSRAHHKN 313
            +LG   +G+++KG L           +A+K L        R +E  +E  + +R  H N
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQHPN 73

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-------------FDPKQKKELDWKKRHVI 360
           +V  LG     +   +++ +  +  L   L              D   K  L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 361 IIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF-------SSSEKS 413
           +   A G+EYL       +VH+D+   N+L+  K   KI+D GL R             S
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           LLP       + +MAPE I  G+ +   DI+S+GV++ E+ S
Sbjct: 191 LLP-------IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  123 bits (312), Expect = 1e-31
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 17/211 (8%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR-IKEICNEMDI-MSRAHHK 312
           +   +  ++G G YG + K      G+ +AVKR+  +   +  K++  ++D+ M  +   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH--VIIIGTAEGLEY 370
            +VQF G  F + D ++  E + + S D+         +    +     I + T + L +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL-ARFSSSEKSLLPNTAIAGTLGYMAP 429
           L ++ +  I+HRDIK SNILLD     K+ DFG+  +   S    +  T  AG   YMAP
Sbjct: 141 LKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS----IAKTRDAGCRPYMAP 194

Query: 430 EYIANGQL----TEKVDIYSFGVLVLEIVSG 456
           E I           + D++S G+ + E+ +G
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  125 bits (315), Expect = 2e-31
 Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE---ICNEMDIMSRAHHKNLVQFL 318
            LG G    +F+G   + G   A+K    +  + ++       E +++ + +HKN+V+  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIK--VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 319 GC--CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T +   ++ EF    SL  +L +P     L   +  +++     G+ +L ++G 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132

Query: 377 MQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             IVHR+IK  NI+  +        K+ DFG AR    ++      ++ GT  Y+ P+  
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMY 187

Query: 433 ANGQL--------TEKVDIYSFGVLVLEIVSG 456
               L           VD++S GV      +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  125 bits (314), Expect = 2e-31
 Identities = 41/214 (19%), Positives = 81/214 (37%), Gaps = 16/214 (7%)

Query: 255 TDCFDESNKLGHG--GYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIMSRA 309
             C++    +G G      +        G  + V+R+ +   +   +  +  E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           +H N+V +        + +VV  F+   S  + L        ++      I+ G  + L+
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS-----LLPNTAIAGTL 424
           Y+H  G    VHR +KAS+IL+ +  +  ++         S                  L
Sbjct: 143 YIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 425 GYMAPEYIANGQL--TEKVDIYSFGVLVLEIVSG 456
            +++PE +         K DIYS G+   E+ +G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  123 bits (311), Expect = 2e-31
 Identities = 69/329 (20%), Positives = 118/329 (35%), Gaps = 54/329 (16%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLVQFLGC 320
            L  GG+  +++   +  GRE A+KRL  + + + + I  E+  M + + H N+VQF   
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 321 CFTKKDS-------FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
               K+        F++   +    L   L   + +  L       I   T   ++++H+
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA----------GT 423
                I+HRD+K  N+LL  +   K+ DFG A   S       +               T
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 424 LGYMAPEYI---ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH-F 479
             Y  PE I   +N  + EK DI++ G ++  +                       +H F
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR--------------------QHPF 253

Query: 480 QAKTVLEIIDKSIEIEDI----EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL 535
           +    L I++    I            ++       Q  P  R S+  VV  L++     
Sbjct: 254 EDGAKLRIVNGKYSIPPHDTQYTVFHSLI---RAMLQVNPEERLSIAEVVHQLQEIAAAR 310

Query: 536 PTPSKPPFTDECMELSHTSGFSRRQSSSA 564
               K P T+    L    G+     S  
Sbjct: 311 NVNPKSPITE---LLEQNGGYGSATLSRG 336

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  122 bits (308), Expect = 2e-31
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)

Query: 263 KLGHGGYGEIFKGTLQDGR---EIAVKRL--FISRKNRIKEICNEMDIMSRAHHKNLVQF 317
           +LG G +G + KG  Q  +    +AVK L    +      E+  E ++M +  +  +V+ 
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
           +G C   +   +V E  +   L++ L   +Q + +  K    ++   + G++YL    + 
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPEYI 432
             VHRD+ A N+LL  +H  KI+DFGL++   ++     N   A T G     + APE I
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD----ENYYKAQTHGKWPVKWYAPECI 192

Query: 433 ANGQLTEKVDIYSFGVLVLEIVS 455
              + + K D++SFGVL+ E  S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (307), Expect = 2e-31
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 11/197 (5%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +  +++   +  G E+A+K +    + +   ++ + NE+ I  +  H ++++   
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                   ++V E   N  ++R L    + K     +    +     G+ YLH  G   I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLHSHG---I 133

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
           +HRD+  SN+LL      KIADFGLA            T + GT  Y++PE         
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPEIATRSAHGL 191

Query: 440 KVDIYSFGVLVLEIVSG 456
           + D++S G +   ++ G
Sbjct: 192 ESDVWSLGCMFYTLLIG 208

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  124 bits (312), Expect = 2e-31
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 27/209 (12%)

Query: 262 NKLGHGGYGEIFKGTLQ--DGREI--AVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
             +G G +G ++ GTL   DG++I  AVK L  I+    + +   E  IM    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 317 FLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
            LG C   + S  VV  ++++  L   +    +      K      +  A+G+++L    
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLA--- 209

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARF---------SSSEKSLLPNTAIAGTLGY 426
             + VHRD+ A N +LD K   K+ADFGLAR           +   + LP       + +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP-------VKW 262

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           MA E +   + T K D++SFGVL+ E+++
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT 291

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  121 bits (306), Expect = 3e-31
 Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 25/205 (12%)

Query: 263 KLGHGGYGEIFKGTLQDGRE---IAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFL 318
           +LG G +G + +G  +  ++   +A+K L   + K   +E+  E  IM +  +  +V+ +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
           G C   +   +V E      L + L    +++E+       ++   + G++YL    +  
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARF--------SSSEKSLLPNTAIAGTLGYMAPE 430
            VHRD+ A N+LL  +H  KI+DFGL++         ++      P       L + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP-------LKWYAPE 183

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVS 455
            I   + + + D++S+GV + E +S
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  121 bits (306), Expect = 3e-31
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 24/204 (11%)

Query: 263 KLGHGGYGEIFKGTLQ--DGREI--AVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQF 317
            +G G +G++ +G     +   +  A+K     +  +  ++   E   M +  H ++V+ 
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
           +G   T+   +++ E      L   L    +K  LD     +     +  L YL      
Sbjct: 82  IGVI-TENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE---SK 135

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEY 431
           + VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE 
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPES 188

Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
           I   + T   D++ FGV + EI+ 
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILM 212

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  122 bits (309), Expect = 4e-31
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 33/216 (15%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE------IAVKRL--FISRKNRIKEICNEMDIMSRAHHKN 313
            +LG G +G +++G  +   +      +A+K +    S + RI E  NE  +M   +  +
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 89

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-------FDPKQKKELDWKKRHVIIIGTAE 366
           +V+ LG     + + V+ E +    L   L        +          K   +    A+
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPNTA 419
           G+ YL+     + VHRD+ A N ++      KI DFG+ R       +    K LLP   
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--- 203

Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
               + +M+PE + +G  T   D++SFGV++ EI +
Sbjct: 204 ----VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  122 bits (307), Expect = 4e-31
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 18/214 (8%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKN-RIKEICNEMDIMSRAHHKN 313
           D ++    +G G    +          ++A+KR+ + +    + E+  E+  MS+ HH N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 314 LVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG-----TAEG 367
           +V +    F  KD  ++V + +   S+  I+     K E          I        EG
Sbjct: 75  IVSYY-TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG----LARFSSSEKSLLPNTAIAGT 423
           LEYLHK+GQ   +HRD+KA NILL      +IADFG    LA      ++ +  T + GT
Sbjct: 134 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GT 189

Query: 424 LGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
             +MAPE +   +    K DI+SFG+  +E+ +G
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  121 bits (305), Expect = 5e-31
 Identities = 49/228 (21%), Positives = 80/228 (35%), Gaps = 36/228 (15%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKEICNEMDIMSR-A 309
           T  F E  K+G G +G +FK     DG   A+KR         +    +  E+   +   
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL-REVYAHAVLG 68

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            H ++V++           +  E+    SL D I  + +        +   +++    GL
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRP-------------------KIADFGLARFSS 409
            Y+H    M +VH DIK SNI +     P                   KI D G     S
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           S +         G   ++A E +        K DI++  + V+     
Sbjct: 186 SPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  126 bits (318), Expect = 5e-31
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 15/224 (6%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH 310
           +   D +D   +LG G +G + + T    G   A K +    ++  + +  E+  MS   
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
           H  LV          +  ++YEF+    L +++  +  +  E +  +    +    +GL 
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE---YMRQVCKGLC 269

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           ++H   +   VH D+K  NI+   K     K+ DFGL      ++S+       GT  + 
Sbjct: 270 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFA 323

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
           APE      +    D++S GVL   ++SG+  + F  ++  ETL
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGL--SPFGGENDDETL 365

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  120 bits (303), Expect = 9e-31
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 24/204 (11%)

Query: 263 KLGHGGYGEIFKGTLQ--DGREI--AVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQF 317
            LG G +GE+++G      G +I  AVK        +  ++  +E  IM    H ++V+ 
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
           +G    ++ ++++ E      L   L   + K  L      +  +   + + YL     +
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEY 431
             VHRDI   NIL+      K+ DFGL+R+        +  + LP       + +M+PE 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-------IKWMSPES 185

Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
           I   + T   D++ F V + EI+S
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  121 bits (305), Expect = 1e-30
 Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE-----IAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLV 315
             LG G +G + KG      E     + +K +   S +   + + + M  +    H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           + LG C       +V +++   SL   +   + +  L  +      +  A+G+ YL    
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLE--- 132

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARF-------SSSEKSLLPNTAIAGTLGYMA 428
           +  +VHR++ A N+LL    + ++ADFG+A             ++  P       + +MA
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP-------IKWMA 185

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS 455
            E I  G+ T + D++S+GV V E+++
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMT 212

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  121 bits (305), Expect = 1e-30
 Identities = 40/203 (19%), Positives = 83/203 (40%), Gaps = 16/203 (7%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFIS-RKNRIKEICNEMDIMSRA 309
           ++  + +  +  LG G +G + +       +    K  F+  +      +  E+ I++ A
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIA 58

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            H+N++       + ++  +++EF+    + +RI     +  E +       +    E L
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVS---YVHQVCEAL 115

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLK--HRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           ++LH      I H DI+  NI+   +     KI +FG AR      +      +     Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEY 169

Query: 427 MAPEYIANGQLTEKVDIYSFGVL 449
            APE   +  ++   D++S G L
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTL 192

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  121 bits (305), Expect = 1e-30
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE-----IAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLV 315
             LG G +G ++KG      E     +A+K L   +     KEI +E  +M+   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           + LG C       ++ + +    L   +   + K  +  +      +  A+G+ YL    
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLE--- 134

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARF-------SSSEKSLLPNTAIAGTLGYMA 428
             ++VHRD+ A N+L+      KI DFGLA+          +E   +P       + +MA
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP-------IKWMA 187

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVS 455
            E I +   T + D++S+GV V E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  120 bits (302), Expect = 1e-30
 Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 22/205 (10%)

Query: 263 KLGHGGYGEIFKGTLQ--DGREI--AVKRL---FISRKNRIKEICNEMDIMSRAHHKNLV 315
           KLG G +G + +G      G+ +  AVK L    +S+   + +   E++ M    H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +  G         +V E     SL   L   K +            +  AEG+ YL    
Sbjct: 85  RLYGVV-LTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLE--- 138

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPE 430
             + +HRD+ A N+LL  +   KI DFGL R          +  +          + APE
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWCAPE 194

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVS 455
            +     +   D + FGV + E+ +
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT 219

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  122 bits (307), Expect = 1e-30
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 21/205 (10%)

Query: 262 NKLGHGGYGEIFKGTLQ--DGREI--AVKRL--FISRKNRIKEICNEMDIMSRAHHKNLV 315
             +G G +GE+  G L+    +EI  A+K L    + K R ++   E  IM +  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNII 109

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +  G     K   +V E+++N SLD  L   K   +    +   ++ G A G++YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPE 430
            M  VHRD+ A NIL++     K++DFGL R    +    P  A     G     + +PE
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD----PEAAYTTRGGKIPIRWTSPE 220

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVS 455
            IA  + T   D++S+G+++ E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  119 bits (301), Expect = 2e-30
 Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 40/216 (18%)

Query: 263 KLGHGGYGEIFKGTLQDGR--------EIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL 314
            LG G + +IFKG  ++          E+ +K L  + +N  +       +MS+  HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V   G C    ++ +V EFV+  SLD  L   K    + WK    +    A  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--VAKQLAAAMHFLE-- 130

Query: 375 GQMQIVHRDIKASNILLDLKHRP--------KIADFGLARFSSSEKSLLPNTAIAGTLGY 426
            +  ++H ++ A NILL  +           K++D G++              +      
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177

Query: 427 ------MAPEYIANGQL-TEKVDIYSFGVLVLEIVS 455
                 + PE I N +      D +SFG  + EI S
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  120 bits (302), Expect = 3e-30
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 21/205 (10%)

Query: 262 NKLGHGGYGEIFKGTLQ--DGREI--AVKRL--FISRKNRIKEICNEMDIMSRAHHKNLV 315
             +G G  GE+  G L+    R++  A+K L    + + R ++  +E  IM +  H N++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASIMGQFDHPNII 113

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +  G     + + +V E+++N SLD  L       +    +   ++ G   G+ YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG-----YMAPE 430
            +  VHRD+ A N+L+D     K++DFGL+R    +    P+ A   T G     + APE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD----PDAAYTTTGGKIPIRWTAPE 224

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVS 455
            IA    +   D++SFGV++ E+++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  123 bits (310), Expect = 3e-30
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 22/223 (9%)

Query: 243 FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKE 298
           F+Q   +      D +     LG G +GE+        G+E AVK +    + +K   + 
Sbjct: 16  FVQHSTAIFS---DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72

Query: 299 ICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKR 357
           +  E+ ++ +  H N+++       K   ++V E      L D I+     +K       
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDA 128

Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLARFSSSEKSL 414
             II     G+ Y+H   + +IVHRD+K  N+LL+ K      +I DFGL+    + K +
Sbjct: 129 ARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185

Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
                  GT  Y+APE + +G   EK D++S GV++  ++SG 
Sbjct: 186 ---KDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGC 224

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  118 bits (299), Expect = 4e-30
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)

Query: 258 FDESNKLGHGGYGEIFKG-TLQDGREIAVKRLF---ISRKNRIKEICNEMDIMSRAHHKN 313
           FD    LG G +G ++     Q+   +A+K LF   + ++    ++  E++I S   H N
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +++       +K  +++ EF     L + L   ++    D ++    +   A+ L Y H+
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHE 132

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                ++HRDIK  N+L+  K   KIADFG +  + S +     T + GTL Y+ PE I 
Sbjct: 133 RK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR---RT-MCGTLDYLPPEMIE 185

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
                EKVD++  GVL  E + G
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVG 208

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (300), Expect = 4e-30
 Identities = 72/301 (23%), Positives = 128/301 (42%), Gaps = 42/301 (13%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRL---------FISRKNRIKEICNEMDIMSRAHHK 312
            LG GG  E+     L+D R++AVK L         F  R  R      E    +  +H 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR------EAQNAAALNHP 72

Query: 313 NLVQFL--GCCFTKKDS--FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            +V     G   T      ++V E+V   +L  I+     +  +  K+   +I    + L
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL 129

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT-AIAGTLGYM 427
            + H++G   I+HRD+K +NI++   +  K+ DFG+AR  +   + +  T A+ GT  Y+
Sbjct: 130 NFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI 487
           +PE      +  + D+YS G ++ E+++G     F  D    + V+  ++H +     + 
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEP--PFTGD----SPVSVAYQHVRE----DP 236

Query: 488 IDKSIEIEDI-EEVKRVVWVGLLCTQELPTLRP-SMTNVVQMLKQKDITLPTPSKPPFTD 545
           I  S   E +  ++  VV   L    + P  R  +   +   L +     P  +    TD
Sbjct: 237 IPPSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTD 293

Query: 546 E 546
            
Sbjct: 294 A 294

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (299), Expect = 5e-30
 Identities = 68/278 (24%), Positives = 113/278 (40%), Gaps = 40/278 (14%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRL---------FISRKNRIKEICNEMDIMSRAHHK 312
           KLG GG   ++         ++A+K +          + R  R      E+   S+  H+
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFER------EVHNSSQLSHQ 71

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           N+V  +         ++V E+++  +L   +   +    L             +G+++ H
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH 128

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
                 IVHRDIK  NIL+D     KI DFG+A+  S       N  + GT+ Y +PE  
Sbjct: 129 DMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQA 184

Query: 433 ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK--TVLEIIDK 490
                 E  DIYS G+++ E++ G     F   +G ET V+   KH Q     V   + K
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEP--PF---NG-ETAVSIAIKHIQDSVPNVTTDVRK 238

Query: 491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML 528
            I     + +  V+   L  T++    R     + +M 
Sbjct: 239 DIP----QSLSNVI---LRATEKDKANRYK--TIQEMK 267

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  123 bits (311), Expect = 6e-30
 Identities = 46/208 (22%), Positives = 76/208 (36%), Gaps = 36/208 (17%)

Query: 263 KLGHGGYGEIFKG--TLQDGREIAVKRL-------FISRKNRIKEICNEMDIMSRAHHKN 313
            + HGG G I+       +GR + +K L         +          E   ++   H +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMA------ERQFLAEVVHPS 140

Query: 314 LVQFL-----GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
           +VQ                ++V E+V  +SL R          L   +    ++     L
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPAL 195

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMA 428
            YLH  G   +V+ D+K  NI+L  + + K+ D G          +     + GT G+ A
Sbjct: 196 SYLHSIG---LVYNDLKPENIMLT-EEQLKLIDLGAVS------RINSFGYLYGTPGFQA 245

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           PE I     T   DIY+ G  +  +   
Sbjct: 246 PE-IVRTGPTVATDIYTVGRTLAALTLD 272

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  119 bits (299), Expect = 6e-30
 Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 18/227 (7%)

Query: 239 KSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR-I 296
           K   +L       +   +  +   ++G G  G+++K    + G  IAVK++  S      
Sbjct: 8   KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN 67

Query: 297 KEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWK 355
           K I  ++D++ ++H    +VQ  G   T  D F+  E +   +            E    
Sbjct: 68  KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG 127

Query: 356 KRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL-ARFSSSEKSL 414
           K   + +   + L YL +  +  ++HRD+K SNILLD + + K+ DFG+  R        
Sbjct: 128 K---MTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---- 178

Query: 415 LPNTAIAGTLGYMAPEYIANGQLTE-----KVDIYSFGVLVLEIVSG 456
                 AG   YMAPE I     T+     + D++S G+ ++E+ +G
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  120 bits (302), Expect = 8e-30
 Identities = 62/254 (24%), Positives = 109/254 (42%), Gaps = 18/254 (7%)

Query: 222 KPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDG 280
            P  +D     +        + ++ K  ++    D +D   +LG G +G + +      G
Sbjct: 20  GPKINDYDKFYEDIWKKYVPQPVEVKQGSVY---DYYDILEELGSGAFGVVHRCVEKATG 76

Query: 281 REIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL- 339
           R    K +          + NE+ IM++ HH  L+        K +  ++ EF+    L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 340 DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK--HRP 397
           DRI  +  +  E +       +    EGL+++H   +  IVH DIK  NI+ + K     
Sbjct: 137 DRIAAEDYKMSEAEVIN---YMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSV 190

Query: 398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
           KI DFGLA   + ++ +        T  + APE +    +    D+++ GVL   ++SG+
Sbjct: 191 KIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247

Query: 458 QNNKFQSDDGFETL 471
             + F  +D  ETL
Sbjct: 248 --SPFAGEDDLETL 259

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  123 bits (309), Expect = 1e-29
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 21/207 (10%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE---ICNEMDIMSRAHHKNLVQFL 318
           +LG GG+G + +      G ++A+K     ++   K     C E+ IM + +H N+V   
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 319 GCCFTKKD------SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                 +         +  E+ +   L + L   +    L       ++   +  L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 373 KDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           ++    I+HRD+K  NI+L    +    KI D G A+     +       + GTL Y+AP
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFV-GTLQYLAP 192

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSG 456
           E +   + T  VD +SFG L  E ++G
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITG 219

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  118 bits (298), Expect = 1e-29
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 28/208 (13%)

Query: 263 KLGHGGYGEIFKGTLQDGRE-----IAVKRL--FISRKNRIKEICNEMDIMSRAHHKNLV 315
            +G G +GE++KG L+         +A+K L    + K R  +   E  IM +  H N++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNII 109

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +  G     K   ++ E+++N +LD+ L   ++  E    +   ++ G A G++YL    
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLA--- 164

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFS--------SSEKSLLPNTAIAGTLGYM 427
            M  VHRD+ A NIL++     K++DFGL+R          ++    +P       + + 
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP-------IRWT 217

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVS 455
           APE I+  + T   D++SFG+++ E+++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  118 bits (297), Expect = 1e-29
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 20/215 (9%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHK 312
              F+    +G+G YG+++KG  ++ G+  A+K + ++  +  +EI  E++++ +  HH+
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHR 81

Query: 313 NLVQFLGCCFTKKDSF------VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           N+  + G    K          +V EF    S+  ++    +   L  +    I      
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILR 140

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           GL +LH+     ++HRDIK  N+LL      K+ DFG++           NT I GT  +
Sbjct: 141 GLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFI-GTPYW 195

Query: 427 MAPEYIANGQLTE-----KVDIYSFGVLVLEIVSG 456
           MAPE IA  +  +     K D++S G+  +E+  G
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  122 bits (308), Expect = 1e-29
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 24/204 (11%)

Query: 263 KLGHGGYGEIFKGTLQ--DGREI--AVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQF 317
            +G G +G++ +G     +   +  A+K     +  +  ++   E   M +  H ++V+ 
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
           +G   T+   +++ E      L   L    +K  LD     +     +  L YL      
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE---SK 510

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARF------SSSEKSLLPNTAIAGTLGYMAPEY 431
           + VHRDI A N+L+      K+ DFGL+R+        + K  LP       + +MAPE 
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-------IKWMAPES 563

Query: 432 IANGQLTEKVDIYSFGVLVLEIVS 455
           I   + T   D++ FGV + EI+ 
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILM 587

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  116 bits (294), Expect = 1e-29
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 26/209 (12%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--------IKEICNEMDI 305
            D ++   +LG G +  + K      G+E A K  FI ++           +EI  E++I
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAK--FIKKRRLSSSRRGVSREEIEREVNI 61

Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGT 364
           +    H N++        K D  ++ E V    L D +     +K+ L   +    +   
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA----EKESLTEDEATQFLKQI 117

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPNTAI 420
            +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFG+A    +         I
Sbjct: 118 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNI 171

Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVL 449
            GT  ++APE +    L  + D++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  117 bits (296), Expect = 1e-29
 Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 42/225 (18%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE------IAVKRL--FISRKNRIKEICNEMDIMSR-AHHK 312
             LG G +G++ + T     +      +AVK L        R + + +E+ ++S   +H 
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYLGNHM 87

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSL---------------DRILFDPKQKKELDWKKR 357
           N+V  LG C     + V+ E+     L                        +  LD +  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSS 410
                  A+G+ +L        +HRD+ A NILL      KI DFGLAR       +   
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             + LP       + +MAPE I N   T + D++S+G+ + E+ S
Sbjct: 205 GNARLP-------VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  117 bits (295), Expect = 2e-29
 Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 37/211 (17%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRL---------FISRKNRIKEICNEMDIMSRAHHK 312
            +G GG G++++       R +A+K +         F +R  R      E     R    
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQR------EARTAGRLQEP 94

Query: 313 NLVQFLGCCFTKKDS-------FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           ++V          D        +V    +    L  +L   +++  L   +   I+    
Sbjct: 95  HVVPIH-------DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIG 144

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
             L+  H  G     HRD+K  NIL+       + DFG+A  ++ EK       + GTL 
Sbjct: 145 SALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLY 200

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           YMAPE  +    T + DIY+   ++ E ++G
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTG 231

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  119 bits (299), Expect = 2e-29
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 14/212 (6%)

Query: 242 KFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEIC 300
           + +  K   +        ++  LG G +G++ K      G ++A K +        +E+ 
Sbjct: 76  RIVTAKQGAVNSFYT-VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK 134

Query: 301 NEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHV 359
           NE+ +M++  H NL+Q      +K D  +V E+V    L DRI+    +   L      +
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTIL 191

Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK--HRPKIADFGLARFSSSEKSLLPN 417
            +    EG+ ++H   QM I+H D+K  NIL   +   + KI DFGLAR     + L   
Sbjct: 192 FMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--- 245

Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVL 449
               GT  ++APE +    ++   D++S GV+
Sbjct: 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  116 bits (294), Expect = 3e-29
 Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 43/225 (19%)

Query: 262 NKLGHGGYGEIFKGTLQD------GREIAVKRL--FISRKNRIKEICNEMDIMSR-AHHK 312
             LG G +G++ +            R +AVK L    +     + + +E+ I+    HH 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHL 91

Query: 313 NLVQFLGCCFTKKDS--FVVYEFVQNKSL-------------DRILFDPKQKKELDWKKR 357
           N+V  LG C TK      V+ EF +  +L              ++  +   K  L  +  
Sbjct: 92  NVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSS 410
                  A+G+E+L      + +HRD+ A NILL  K+  KI DFGLAR       +   
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207

Query: 411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             + LP       L +MAPE I +   T + D++SFGVL+ EI S
Sbjct: 208 GDARLP-------LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  115 bits (291), Expect = 3e-29
 Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 16/205 (7%)

Query: 249 STIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMS 307
           ST       +   N +G G +GE+            A K++       +     E++IM 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 308 RAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAE 366
              H N+++         D ++V E      L +R++     K+         I+     
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLS 117

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLARFSSSEKSLLPNTAIAGT 423
            + Y H   ++ + HRD+K  N L          K+ DFGLA      K +       GT
Sbjct: 118 AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171

Query: 424 LGYMAPEYIANGQLTEKVDIYSFGV 448
             Y++P+ +  G    + D +S GV
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGV 195

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  120 bits (302), Expect = 3e-29
 Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 21/243 (8%)

Query: 222 KPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDG 280
                 + +     L      F+  K   +    + +    KLG G YGE+         
Sbjct: 6   HHSSGRENLYFQGDLQATPGMFITSKKGHLS---EMYQRVKKLGSGAYGEVLLCRDKVTH 62

Query: 281 REIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKS 338
            E A+K +  +    +   ++  E+ ++    H N+++       K++ ++V E  +   
Sbjct: 63  VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122

Query: 339 L-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-- 395
           L D I+     + + +     VII     G+ YLH   +  IVHRD+K  N+LL+ K   
Sbjct: 123 LFDEII----HRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKD 175

Query: 396 -RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIV 454
              KI DFGL+    ++K +       GT  Y+APE +   +  EK D++S GV++  ++
Sbjct: 176 ALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILL 231

Query: 455 SGV 457
           +G 
Sbjct: 232 AGY 234

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  121 bits (304), Expect = 3e-29
 Identities = 51/219 (23%), Positives = 100/219 (45%), Gaps = 25/219 (11%)

Query: 249 STIEKATDCFDESNKLGHGGYGEIFKGTLQDGRE---IAVKRL-FISRKNRIKEICNEMD 304
               K  +      +LG G +G + +G  +  ++   +A+K L   + K   +E+  E  
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388

Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           IM +  +  +V+ +G C   +   +V E      L + L    +++E+       ++   
Sbjct: 389 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQV 445

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF--------SSSEKSLLP 416
           + G++YL    +   VHR++ A N+LL  +H  KI+DFGL++         ++      P
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502

Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
                  L + APE I   + + + D++S+GV + E +S
Sbjct: 503 -------LKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  116 bits (292), Expect = 3e-29
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 22/220 (10%)

Query: 238 HKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI 296
           H      +          + ++    LG G +GE+ K       +E AVK   I++ +  
Sbjct: 4   HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKV--INKASAK 61

Query: 297 KE----ICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKE 351
            +    I  E++++ +  H N+++           ++V E      L D I+    ++K 
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKR 117

Query: 352 LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLARFS 408
                   II     G+ Y+H   +  IVHRD+K  NILL+ K      KI DFGL+   
Sbjct: 118 FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGV 448
                +       GT  Y+APE +  G   EK D++S GV
Sbjct: 175 QQNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  116 bits (294), Expect = 4e-29
 Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 38/221 (17%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE------IAVKRL--FISRKNRIKEICNEMDIMSR-AHHK 312
             LG G +G++ + T     +      +AVK L        + + + +E+ IMS    H+
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK-EALMSELKIMSHLGQHE 110

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSL-----------DRILFDPKQKKELDWKKRHVII 361
           N+V  LG C       V+ E+     L           +              +      
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSL 414
              A+G+ +L        +HRD+ A N+LL   H  KI DFGLAR       +     + 
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
           LP       + +MAPE I +   T + D++S+G+L+ EI S
Sbjct: 228 LP-------VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  116 bits (293), Expect = 4e-29
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKN--------RIKEICNE 302
           E   D +D   +LG G +  + K      G + A K  FI ++           ++I  E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAK--FIKKRRTKSSRRGVSREDIERE 64

Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVII 361
           + I+    H N++        K D  ++ E V    L D +     +K+ L  ++    +
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFL 120

Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPN 417
                G+ YLH    +QI H D+K  NI+L  ++ P    KI DFGLA            
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 174

Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVL 449
             I GT  ++APE +    L  + D++S GV+
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  119 bits (301), Expect = 5e-29
 Identities = 66/254 (25%), Positives = 110/254 (43%), Gaps = 32/254 (12%)

Query: 222 KPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDG 280
             H   +       +      +++ K   I    + + +  KLG G YGE+         
Sbjct: 5   HHHSSGRENLYFQGIAINPGMYVRKKEGKIG---ESYFKVRKLGSGAYGEVLLCKEKNGH 61

Query: 281 REIAVKRL-------------FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS 327
            E A+K +               + +   +EI NE+ ++    H N+++       KK  
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121

Query: 328 FVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKA 386
           ++V EF +   L ++I+     + + D      I+     G+ YLH   +  IVHRDIK 
Sbjct: 122 YLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKP 174

Query: 387 SNILLDLKH---RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDI 443
            NILL+ K+     KI DFGL+ F S +  L       GT  Y+APE +   +  EK D+
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVL-KKKYNEKCDV 230

Query: 444 YSFGVLVLEIVSGV 457
           +S GV++  ++ G 
Sbjct: 231 WSCGVIMYILLCGY 244

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  116 bits (292), Expect = 5e-29
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 26/212 (12%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--------IKEICNE 302
           +K  D +D   +LG G +  + K      G E A K  FI ++           +EI  E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVSREEIERE 65

Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVII 361
           + I+ +  H N++        + D  ++ E V    L D +     QK+ L  ++    I
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFI 121

Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPN 417
               +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFGLA            
Sbjct: 122 KQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175

Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVL 449
             I GT  ++APE +    L  + D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  119 bits (300), Expect = 6e-29
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 22/229 (9%)

Query: 238 HKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKN-- 294
           H      +          + ++    LG G +GE+ K       +E AVK   I++ +  
Sbjct: 4   HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKV--INKASAK 61

Query: 295 --RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKE 351
                 I  E++++ +  H N+++           ++V E      L D I+    ++K 
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKR 117

Query: 352 LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLARFS 408
                   II     G+ Y+H   +  IVHRD+K  NILL+ K      KI DFGL+   
Sbjct: 118 FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
                +       GT  Y+APE +  G   EK D++S GV++  ++SG 
Sbjct: 175 QQNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  116 bits (293), Expect = 6e-29
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 17/206 (8%)

Query: 248 YSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIM 306
            S  +  +D F+  ++LG G    +++       +  A+K   + +    K +  E+ ++
Sbjct: 45  GSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVL 102

Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTA 365
            R  H N+++      T  +  +V E V    L DRI+    +K     +     +    
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQIL 158

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAG 422
           E + YLH   +  IVHRD+K  N+L          KIADFGL++    +  +     + G
Sbjct: 159 EAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCG 212

Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGV 448
           T GY APE +       +VD++S G+
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGI 238

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  116 bits (292), Expect = 7e-29
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 42/225 (18%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE--------IAVKRL--FISRKNRIKEICNEMDIMSR-AH 310
             LG G +G++         +        +AVK L    + K+   ++ +EM++M     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGK 99

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-------------FDPKQKKELDWKKR 357
           HKN++  LG C      +V+ E+    +L   L              +   ++++ +K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSS 410
                  A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
               LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 217 TNGRLP-------VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  115 bits (291), Expect = 8e-29
 Identities = 53/230 (23%), Positives = 102/230 (44%), Gaps = 47/230 (20%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE------IAVKRL--FISRKNRIKEICNEMDIMSRAHHKN 313
             LG G +G++ K T    +       +AVK L    S     +++ +E +++ + +H +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSEFNVLKQVNHPH 87

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSL---------------------DRILFDPKQKKEL 352
           +++  G C       ++ E+ +  SL                     +    D   ++ L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 353 DWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR------ 406
                       ++G++YL    +M++VHRD+ A NIL+    + KI+DFGL+R      
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 407 -FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +    +  +P       + +MA E + +   T + D++SFGVL+ EIV+
Sbjct: 205 SYVKRSQGRIP-------VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  116 bits (292), Expect = 8e-29
 Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 47/230 (20%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE------IAVKRL--FISRKNRIKEICNEMDIMSR-AHHK 312
             LG G +G++   T     +      +AVK L        R + + +E+ +M++   H+
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSELKMMTQLGSHE 109

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSL------------DRILFDPKQKKELDWKKRHVI 360
           N+V  LG C      ++++E+     L            +  +    QK+  + +  +V+
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 361 IIGT--------AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR------ 406
                       A+G+E+L        VHRD+ A N+L+      KI DFGLAR      
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 407 -FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            +     + LP       + +MAPE +  G  T K D++S+G+L+ EI S
Sbjct: 227 NYVVRGNARLP-------VKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  116 bits (293), Expect = 8e-29
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 26/212 (12%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--------IKEICNE 302
           +K  D +D   +LG G +  + K      G E A K  FI ++           +EI  E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK--FIKKRQSRASRRGVCREEIERE 65

Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVII 361
           + I+ +  H N++        + D  ++ E V    L D +     QK+ L  ++    I
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFI 121

Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLARFSSSEKSLLPN 417
               +G+ YLH     +I H D+K  NI+L  K+ P    K+ DFGLA            
Sbjct: 122 KQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175

Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVL 449
             I GT  ++APE +    L  + D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  116 bits (292), Expect = 1e-28
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 47/230 (20%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE------IAVKRL--FISRKNRIKEICNEMDIMSRAHHKN 313
             +G G +G +F+              +AVK L    S   +  +   E  +M+   + N
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPN 111

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSL---------------------DRILFDPKQKKEL 352
           +V+ LG C   K   +++E++    L                      R          L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 353 DWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR------ 406
              ++  I    A G+ YL    + + VHRD+   N L+      KIADFGL+R      
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 407 -FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
            + +     +P       + +M PE I   + T + D++++GV++ EI S
Sbjct: 229 YYKADGNDAIP-------IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  114 bits (287), Expect = 2e-28
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 16/191 (8%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            LG G + E+F       G+  A+K +  S   R   + NE+ ++ +  H+N+V      
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 322 FTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
            +    ++V + V    L DRIL    ++     K   ++I      ++YLH+     IV
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHE---NGIV 128

Query: 381 HRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
           HRD+K  N+L           I DFGL++   +       +   GT GY+APE +A    
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPY 184

Query: 438 TEKVDIYSFGV 448
           ++ VD +S GV
Sbjct: 185 SKAVDCWSIGV 195

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (290), Expect = 2e-28
 Identities = 21/228 (9%), Positives = 60/228 (26%), Gaps = 43/228 (18%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR---IKEICNEMDIMSRAHHKNLVQFLG 319
           L  G    +F    ++   + A+K   +  +N    ++ +       +R   ++  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 320 CC--------------------------FTKKDSFVVYEFVQ---NKSLDRILFDPKQKK 350
                                       +   +  ++              + F    + 
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 351 ELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS 410
           +      H++          L   G   +VH      N+ +    R  + D        +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 411 EKSLLPNTAIAGTLGYMAPEYI--ANGQLTEKVDIYSFGVLVLEIVSG 456
                   A +  + Y   E++  +    T  ++ +  G+ +  +   
Sbjct: 247 RG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  114 bits (288), Expect = 2e-28
 Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 18/209 (8%)

Query: 247 KYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDI 305
           K S   +  D   +   LG G +    K    +  +  AVK   I  K        E+  
Sbjct: 2   KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITA 58

Query: 306 MSR-AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIG 363
           +     H N+V+       +  +F+V E +    L +RI     +KK     +   I+  
Sbjct: 59  LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRK 114

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAI 420
               + ++H  G   +VHRD+K  N+L   ++     KI DFG AR    +   L     
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTP 169

Query: 421 AGTLGYMAPEYIANGQLTEKVDIYSFGVL 449
             TL Y APE +      E  D++S GV+
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVI 198

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  115 bits (290), Expect = 3e-28
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 42/225 (18%)

Query: 262 NKLGHGGYGEIFKGTLQDGRE--------IAVKRL--FISRKNRIKEICNEMDIMSR-AH 310
             LG G +G++         +        +AVK L    + K+   ++ +EM++M     
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGK 145

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-------------FDPKQKKELDWKKR 357
           HKN++  LG C      +V+ E+    +L   L              +   ++++ +K  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSS 410
                  A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
               LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 263 TNGRLP-------VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  113 bits (284), Expect = 3e-28
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE----ICNEMDIMSRA 309
           +D +D   +LG G +  + +      G E A K   I+ K         +  E  I  + 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKLEREARICRKL 62

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            H N+V+       +   ++V++ V    L + I+     ++          I    E +
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESI 118

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLG 425
            Y H +G   IVHR++K  N+LL  K +    K+ADFGLA   +  ++       AGT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPG 172

Query: 426 YMAPEYIANGQLTEKVDIYSFGV 448
           Y++PE +     ++ VDI++ GV
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGV 195

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  113 bits (285), Expect = 6e-28
 Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 26/200 (13%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE----ICNEMDIMSR-AHHKNLVQ 316
           +LG G +  + +      G+E A K  F+ ++ R ++    I +E+ ++        ++ 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 317 FLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQK-KELDWKK--RHVIIIGTAEGLEYLH 372
                    +  ++ E+     +    L +  +   E D  +  + ++     EG+ YLH
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL-----EGVYYLH 148

Query: 373 KDGQMQIVHRDIKASNILL---DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
              Q  IVH D+K  NILL         KI DFG++R       L     I GT  Y+AP
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIMGTPEYLAP 202

Query: 430 EYIANGQLTEKVDIYSFGVL 449
           E +    +T   D+++ G++
Sbjct: 203 EILNYDPITTATDMWNIGII 222

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  114 bits (287), Expect = 9e-28
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 42/225 (18%)

Query: 262 NKLGHGGYGEIFKGTLQD--------GREIAVKRL--FISRKNRIKEICNEMDIMSR-AH 310
             LG G +G++                 ++AVK L    + K+   ++ +EM++M     
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGK 133

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSL-----------DRILFDPKQKKELDWKKRHV 359
           HKN++  LG C      +V+ E+    +L               ++P    E     + +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 360 IIIGT--AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSS 410
           +      A G+EYL      + +HRD+ A N+L+   +  KIADFGLAR       +  +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
               LP       + +MAPE + +   T + D++SFGVL+ EI +
Sbjct: 251 TNGRLP-------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  113 bits (285), Expect = 9e-28
 Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 29/217 (13%)

Query: 263 KLGHGGYGE---------------IFKGTLQDGREIA-VKRLFISRKNRIKEICNEMDIM 306
            L  G + +                 K  L+  R+        IS K++  +  NE+ I+
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-----DRILFDPKQKKELDWKKRHVII 361
           +   ++  +   G      + +++YE+++N S+        + D      +  +    II
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA 421
                   Y+H   +  I HRD+K SNIL+D   R K++DFG + +   +K      +  
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI---KGS-R 211

Query: 422 GTLGYMAPEYIANGQLT--EKVDIYSFGVLVLEIVSG 456
           GT  +M PE+ +N       KVDI+S G+ +  +   
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  113 bits (284), Expect = 1e-27
 Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 15/205 (7%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVK-----RLFISRKNRIKEICNEMDIMSR 308
            D ++    +G G +  + +    + G++ AVK     +   S     +++  E  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEG 367
             H ++V+ L    +    ++V+EF+    L   I+                 +    E 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTL 424
           L Y H      I+HRD+K   +LL  K      K+  FG+A        +       GT 
Sbjct: 143 LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTP 197

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVL 449
            +MAPE +      + VD++  GV+
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVI 222

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  112 bits (281), Expect = 2e-27
 Identities = 50/250 (20%), Positives = 98/250 (39%), Gaps = 34/250 (13%)

Query: 290 ISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQK 349
           +S  + +     ++  M     KN V  L     K   ++  +  + ++L   +      
Sbjct: 99  LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158

Query: 350 KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR--- 406
           ++ +      I I  AE +E+LH      ++HRD+K SNI   +    K+ DFGL     
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215

Query: 407 -------FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQN 459
                    +   +   +T   GT  YM+PE I     + KVDI+S G+++ E++     
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---- 271

Query: 460 NKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLL--CTQELPTL 517
                   F T         +   ++  + ++++   +   K      ++       PT 
Sbjct: 272 -------SFST-------QMERVRIITDV-RNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316

Query: 518 RPSMTNVVQM 527
           RP  T++++ 
Sbjct: 317 RPEATDIIEN 326

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  112 bits (281), Expect = 2e-27
 Identities = 51/269 (18%), Positives = 85/269 (31%), Gaps = 52/269 (19%)

Query: 238 HKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVK-----RLFIS 291
               + L F+  ++ +    +     +G G YG +      Q     A+K     ++   
Sbjct: 8   SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67

Query: 292 RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKK 350
               ++ I  E+ +M + HH N+ +       ++   +V E      L D++        
Sbjct: 68  NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127

Query: 351 ELDWKKRHVIIIGTA------------------------------------EGLEYLHKD 374
                      I                                         L YLH  
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-- 185

Query: 375 GQMQIVHRDIKASNILLDLKH--RPKIADFGLARFSSSEKSLLPN--TAIAGTLGYMAPE 430
               I HRDIK  N L         K+ DFGL++      +      T  AGT  ++APE
Sbjct: 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

Query: 431 YIANGQL--TEKVDIYSFGVLVLEIVSGV 457
            +         K D +S GVL+  ++ G 
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  113 bits (285), Expect = 2e-27
 Identities = 54/240 (22%), Positives = 104/240 (43%), Gaps = 34/240 (14%)

Query: 234 LSLLHKSLKFLQFKYSTIEKAT-------DCFDESNKLGHGGYGEIFKGT-LQDGREIAV 285
           ++L     K   F   T++  +       D +  S  LG G  GE+      +  +++A+
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165

Query: 286 K----RLFISRKNRIKE----ICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK 337
           +    R F     R  +    +  E++I+ + +H  +++     F  +D ++V E ++  
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 224

Query: 338 SL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR 396
            L D+++      K L      +        ++YLH++G   I+HRD+K  N+LL  +  
Sbjct: 225 ELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277

Query: 397 P---KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL---TEKVDIYSFGVLV 450
               KI DFG ++       +     + GT  Y+APE + +         VD +S GV++
Sbjct: 278 DCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  111 bits (280), Expect = 3e-27
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 25/226 (11%)

Query: 232 MDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFI 290
           M    +H  ++ L          TD ++    +G G Y    +        E AVK   I
Sbjct: 1   MQTVGVHSIVQQLHRNSIQF---TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK--II 55

Query: 291 S-RKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPK 347
              K    E   E++I+ R   H N++         K  +VV E ++   L D+IL    
Sbjct: 56  DKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---- 108

Query: 348 QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFG 403
           ++K    ++   ++    + +EYLH  G   +VHRD+K SNIL   +       +I DFG
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165

Query: 404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVL 449
            A+   +E  LL       T  ++APE +         DI+S GVL
Sbjct: 166 FAKQLRAENGLL--MTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  110 bits (277), Expect = 4e-27
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 28/204 (13%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE---------ICNEMDIMSR-AHH 311
            LG G    + +       +E AVK + ++                   E+DI+ + + H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
            N++Q      T    F+V++ ++   L D +     +K  L  K+   I+    E +  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICA 139

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LHK     IVHRD+K  NILLD     K+ DFG +      + L     + GT  Y+APE
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPE 193

Query: 431 YIANGQL------TEKVDIYSFGV 448
            I            ++VD++S GV
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGV 217

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  111 bits (280), Expect = 5e-27
 Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 21/219 (9%)

Query: 239 KSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIK 297
           +  +  +F  +   K +D +D   +LG G +  + +      G E A K   I+ K    
Sbjct: 12  QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSA 69

Query: 298 E----ICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKEL 352
                +  E  I  +  H N+V+       +   ++V++ V    L + I+     ++  
Sbjct: 70  RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFY 125

Query: 353 DWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSS 409
                   I    E + Y H      IVHR++K  N+LL  K +    K+ADFGLA   +
Sbjct: 126 SEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGV 448
             ++       AGT GY++PE +     ++ VDI++ GV
Sbjct: 183 DSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  111 bits (279), Expect = 2e-26
 Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 16/201 (7%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHH 311
           T+ +    +LG G +  + +   +  G+E A   +   + +    +++  E  I     H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
            N+V+       +   +++++ V    L + I+     ++          I    E + +
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLH 125

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
            H   QM +VHR++K  N+LL  K +    K+ADFGLA     E+        AGT GY+
Sbjct: 126 CH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYL 180

Query: 428 APEYIANGQLTEKVDIYSFGV 448
           +PE +      + VD+++ GV
Sbjct: 181 SPEVLRKDPYGKPVDLWACGV 201

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (275), Expect = 2e-26
 Identities = 33/238 (13%), Positives = 65/238 (27%), Gaps = 54/238 (22%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEI----------------------- 299
           LG        + T  + G    V   + + +     I                       
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 300 -----CNEMDIMSRAHHKNLVQFLGCC--FTKKDSFVVYEFVQNKSLDRI--LFD-PKQK 349
                    D++     K +++             F +Y  +Q+        L       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 350 KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS 409
           K L    R  + +     L  LH  G   +VH  ++  +I+LD +    +  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 410 SEKSLLPNTAIAGTLGYMAPEYIA-----------NGQLTEKVDIYSFGVLVLEIVSG 456
           +          + + G+  PE  A              +T   D ++ G+++  I   
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (272), Expect = 3e-26
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 27/202 (13%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVK----RLFISRKNRIKE----ICNEMDIMSRAHHKN 313
            LG G  GE+      +  +++A+K    R F     R  +    +  E++I+ + +H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           +++     F  +D ++V E ++   L D++       K L      +        ++YLH
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 373 KDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           ++G   I+HRD+K  N+LL  +      KI DFG ++       +     + GT  Y+AP
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAP 185

Query: 430 EYIANGQL---TEKVDIYSFGV 448
           E + +         VD +S GV
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGV 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  109 bits (274), Expect = 3e-26
 Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 27/203 (13%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISR--------KNRIKEICNEMDIMSR-AHHK 312
            +G G    + +      G E AVK + ++         +   +    E  I+ + A H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
           +++  +    +    F+V++ ++   L D +     +K  L  K+   I+    E + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFL 216

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H +    IVHRD+K  NILLD   + +++DFG +      + L     + GT GY+APE 
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEI 270

Query: 432 IANGQL------TEKVDIYSFGV 448
           +            ++VD+++ GV
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGV 293

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  109 bits (274), Expect = 5e-26
 Identities = 33/238 (13%), Positives = 68/238 (28%), Gaps = 53/238 (22%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR---IKEICNEMDIMSR----------- 308
           LG        + T  + G    V   + + +     IK++  E+  +             
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 309 -----------AHHKNLVQFLGCCFTKKDSFVVYEFV-------QNKSLDRILFD-PKQK 349
                             + +     ++D +V+  F          ++   +L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 350 KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS 409
           K L    R  + +     L  LH  G   +VH  ++  +I+LD +    +  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 410 SEKSLLPNTAIAGTLGYMAPEYIA----------NGQLTEKVDIYSFGVLVLEIVSGV 457
           +      +       G+  PE  A             +T   D ++ G+ +  I    
Sbjct: 263 A------SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  105 bits (265), Expect = 7e-25
 Identities = 63/247 (25%), Positives = 106/247 (42%), Gaps = 36/247 (14%)

Query: 222 KPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGR 281
            P  D   +   L+   K+ +  +  Y+  +           +G+G +G +F+  L +  
Sbjct: 16  NPLDDPNKVIKVLASDGKTGEQREIAYTNCKV----------IGNGSFGVVFQAKLVESD 65

Query: 282 EIAVKRLFI--SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS------FVVYEF 333
           E+A+K++      KNR      E+ IM    H N+V      ++  D        +V E+
Sbjct: 66  EVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119

Query: 334 VQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD 392
           V  +++ R      K K+ +      + +      L Y+H  G   I HRDIK  N+LLD
Sbjct: 120 VP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLD 175

Query: 393 -LKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVL 449
                 K+ DFG A+   + E    PN +   +  Y APE I      T  +DI+S G +
Sbjct: 176 PPSGVLKLIDFGSAKILIAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCV 231

Query: 450 VLEIVSG 456
           + E++ G
Sbjct: 232 MAELMQG 238

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  103 bits (258), Expect = 2e-24
 Identities = 45/202 (22%), Positives = 89/202 (44%), Gaps = 23/202 (11%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLVQFLGCC 321
           LG G +  +     L   +E AVK +     +    +  E++++ +   H+N+++ +   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 322 FTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
             +   ++V+E ++  S+   I     +++  +  +  V++   A  L++LH  G   I 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHNKG---IA 133

Query: 381 HRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTA-----IAGTLGYMAPEYI 432
           HRD+K  NIL +  ++    KI DF L           P +        G+  YMAPE +
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193

Query: 433 ANGQLT-----EKVDIYSFGVL 449
                      ++ D++S GV+
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVI 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  104 bits (260), Expect = 4e-24
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 25/217 (11%)

Query: 243 FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN 301
            LQ K + I        +   LG G  G++ +    +   + A+K   +    + +    
Sbjct: 51  GLQIKKNAIIDDYKVTSQ--VLGLGINGKVLQIFNKRTQEKFALKM--LQDCPKARR--- 103

Query: 302 EMDIMSR-AHHKNLVQFLG----CCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWK 355
           E+++  R +   ++V+ +         +K   +V E +    L  RI    +  +    +
Sbjct: 104 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTER 161

Query: 356 KRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEK 412
           +   I+    E ++YLH    + I HRD+K  N+L   K      K+ DFG A+ ++S  
Sbjct: 162 EASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

Query: 413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVL 449
           SL   T    T  Y+APE +   +  +  D++S GV+
Sbjct: 219 SL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (255), Expect = 4e-24
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN-------EMDIMSRAHHKNLV 315
           LG G YG++ +    +     AVK   I +K +++ I N       E+ ++ R  HKN++
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 316 QFLGCCF--TKKDSFVVYEFVQNKSLDRILFDPKQKKELD-WKKRHV---IIIGTAEGLE 369
           Q +   +   K+  ++V E+      +  + D   +K     +       +I    +GLE
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLI----DGLE 123

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK--SLLPNTAIAGTLGYM 427
           YLH  G   IVH+DIK  N+LL      KI+  G+A              T+  G+  + 
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC-RTS-QGSPAFQ 178

Query: 428 APEYIANGQLTE--KVDIYSFGVLVLEIVSG 456
            PE           KVDI+S GV +  I +G
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  100 bits (251), Expect = 9e-24
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 17/200 (8%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN---EMDIMSRAHHKNLVQFLG 319
           LG G YGE+           +AVK   +  K  +    N   E+ I    +H+N+V+F G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 320 CCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
                   ++  E+     L DRI  D    +    +  H ++     G+ YLH  G   
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGIG--- 125

Query: 379 IVHRDIKASNILLDLKHRPKIADFGL-ARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQ 436
           I HRDIK  N+LLD +   KI+DFGL   F  + +  L N    GTL Y+APE +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREF 184

Query: 437 LTEKVDIYSFGVLVLEIVSG 456
             E VD++S G+++  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  104 bits (260), Expect = 1e-23
 Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 35/233 (15%)

Query: 242 KFLQFKYSTIEKAT-DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRI 296
           +FLQ+K+   +    D F +   LG GG+GE+F   ++   ++ A K+L    + ++   
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229

Query: 297 KEICNEMDIMSRAHHKNLVQFLGCCF-TKKDSFVVYEFV---------QNKSLDRILFDP 346
           +    E  I+++ H + +V  L   F TK D  +V   +          N   D   F  
Sbjct: 230 QGAMVEKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288

Query: 347 KQKKELDWKKRHVIIIGTAE---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG 403
            +               TA+   GLE+LH+     I++RD+K  N+LLD     +I+D G
Sbjct: 289 PRAI-----------FYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLG 334

Query: 404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           LA    + ++       AGT G+MAPE +   +    VD ++ GV + E+++ 
Sbjct: 335 LAVELKAGQT-KTKG-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (260), Expect = 1e-23
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 20/224 (8%)

Query: 242 KFLQFKYSTIEKAT-DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRI 296
           +FLQ+K+   +  T + F +   LG GG+GE+    ++   ++ A K+L    I ++   
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228

Query: 297 KEICNEMDIMSRAHHKNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWK 355
               NE  I+ + + + +V  L   + TK    +V   +    L    F      +  + 
Sbjct: 229 AMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDL---KFHIYHMGQAGFP 284

Query: 356 KRHVIIIGTAE---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK 412
           +   +    AE   GLE LH++    IV+RD+K  NILLD     +I+D GLA      +
Sbjct: 285 EARAVFY-AAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340

Query: 413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
                    GT+GYMAPE + N + T   D ++ G L+ E+++G
Sbjct: 341 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  100 bits (251), Expect = 3e-23
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 24/194 (12%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE-ICNEMDIMSRAHHKNLVQFLGCC 321
           +G G +G             +AVK  +I R   I E +  E+       H N+V+F    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 322 FTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
            T     ++ E+     L +RI    +  ++        ++ G    + Y H    MQI 
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG----VSYCHS---MQIC 138

Query: 381 HRDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN---- 434
           HRD+K  N LLD    P  KI DFG ++ S       P + + GT  Y+APE +      
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTV-GTPAYIAPEVLLRQEYD 195

Query: 435 GQLTEKVDIYSFGV 448
           G+     D++S GV
Sbjct: 196 GK---IADVWSCGV 206

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 23/202 (11%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE-----ICNEMDIMSRAHHKNLVQF 317
           +G G + ++     +  GRE+A+K   I  K ++       +  E+ IM   +H N+V+ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 318 LGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                T+K  +++ E+     + D ++   + K++    K   I+      ++Y H+   
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR- 134

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             IVHRD+KA N+LLD     KIADFG +   +    L  +    G   Y APE    G+
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAF-CGAPPYAAPELF-QGK 188

Query: 437 LTE--KVDIYSFGVLVLEIVSG 456
             +  +VD++S GV++  +VSG
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSG 210

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 60/192 (31%), Positives = 88/192 (45%), Gaps = 17/192 (8%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN---EMDIMSRAHHKNLVQFLG 319
           LG G YGE+           +AVK   +  K  +    N   E+ I    +H+N+V+F G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 320 CCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
                   ++  E+     L DRI  D    +    +  H ++     G+ YLH    + 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125

Query: 379 IVHRDIKASNILLDLKHRPKIADFGL-ARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQ 436
           I HRDIK  N+LLD +   KI+DFGL   F  + +  L N    GTL Y+APE +     
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREF 184

Query: 437 LTEKVDIYSFGV 448
             E VD++S G+
Sbjct: 185 HAEPVDVWSCGI 196

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.0 bits (247), Expect = 6e-23
 Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 36/212 (16%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE---------ICNEMDIMSRAHHK- 312
           LG GG+G ++ G  + D   +A+K      K+RI +         +  E+ ++ +     
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIK---HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107

Query: 313 -NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKK-RHV---IIIGTAE 366
             +++ L          ++ E  +     + LFD   ++  L  +  R     ++    E
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVL----E 160

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            + + H  G   ++HRDIK  NIL+DL     K+ DFG       + ++       GT  
Sbjct: 161 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVY-TDF-DGTRV 213

Query: 426 YMAPEYIANGQLT-EKVDIYSFGVLVLEIVSG 456
           Y  PE+I   +       ++S G+L+ ++V G
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 99.8 bits (249), Expect = 1e-22
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 31/209 (14%)

Query: 263 KLGHGGYGEIFKGTLQD-GREIAVKRLFI--SRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
            +G+G +G +++  L D G  +A+K++      KNR      E+ IM +  H N+V+   
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRY 114

Query: 320 CCFTKKDSF------VVYEFVQNKSLDRIL-FDPKQKKELDWKKRHV--IIIGTAEGLEY 370
             ++  +        +V ++V  +++ R+     + K+ L     +V   +      L Y
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLP--VIYVKLYMYQLFRSLAY 171

Query: 371 LHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMA 428
           +H  G   I HRDIK  N+LLD      K+ DFG A+     E    PN +   +  Y A
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRA 224

Query: 429 PEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           PE I      T  +D++S G ++ E++ G
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLG 253

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 41/197 (20%), Positives = 84/197 (42%), Gaps = 24/197 (12%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLVQFLGC 320
            LG G  G++ +    + G++ A+K   +    + ++   E+D   + +   ++V  L  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKL--LYDSPKARQ---EVDHHWQASGGPHIVCILDV 90

Query: 321 C----FTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                  K+   ++ E ++   L  RI    +  +    ++   I+      +++LH   
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTEREAAEIMRDIGTAIQFLH--- 145

Query: 376 QMQIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
              I HRD+K  N+L   K +    K+ DFG A+ ++             T  Y+APE +
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVL 201

Query: 433 ANGQLTEKVDIYSFGVL 449
              +  +  D++S GV+
Sbjct: 202 GPEKYDKSCDMWSLGVI 218

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 45/219 (20%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE------------------------ 298
           +G G YG +       D    A+K   +S+K  I++                        
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMK--VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 299 ----ICNEMDIMSRAHHKNLVQFLG--CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKEL 352
               +  E+ I+ +  H N+V+ +       +   ++V+E V    +  +       ++ 
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138

Query: 353 DWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK 412
                  +I G    +EYLH      I+HRDIK SN+L+      KIADFG++       
Sbjct: 139 ARFYFQDLIKG----IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 413 SLLPNTAIAGTLGYMAPEYIANGQLT---EKVDIYSFGV 448
           +LL NT   GT  +MAPE ++  +     + +D+++ GV
Sbjct: 192 ALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 97.9 bits (244), Expect = 4e-22
 Identities = 56/231 (24%), Positives = 104/231 (45%), Gaps = 34/231 (14%)

Query: 249 STIEKATDCFD-ESNKLGHGGYGEIFKG---TLQDGREIAVKRLFISRKNRIKEICNEMD 304
           S  E+  D F+ E  K+G G YG ++K      +D ++ A+K+  I         C E+ 
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQ--IEGTGISMSACREIA 70

Query: 305 IMSRAHHKNLVQFLGCCFTKKDS--FVVYEFVQN---KSLDRILFDPKQKKELDWKKRHV 359
           ++    H N++       +  D   ++++++ ++     +         KK +   +  V
Sbjct: 71  LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130

Query: 360 --IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP----KIADFGLAR-FSSSEK 412
             ++    +G+ YLH +    ++HRD+K +NIL+  +       KIAD G AR F+S  K
Sbjct: 131 KSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 413 SLLPNTAIAGTLGYMAPE-------YIANGQLTEKVDIYSFGVLVLEIVSG 456
            L     +  T  Y APE       Y      T+ +DI++ G +  E+++ 
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS 232

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 95.7 bits (239), Expect = 7e-22
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 41/219 (18%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR------IKEICNEMDIMSRA 309
           + + +  K+G G YG ++K     GR +A+KR+ +  ++       I+EI     ++   
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKEL 76

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQN---KSLD--RILFDPKQKKELDWKKRHVIIIGT 364
           HH N+V  +    +++   +V+EF++    K LD  +      Q K          +   
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIY--------LYQL 128

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             G+ + H+     I+HRD+K  N+L++     K+ADFGLAR          +  +  TL
Sbjct: 129 LRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TL 183

Query: 425 GYMAPE-------YIANGQLTEKVDIYSFGVLVLEIVSG 456
            Y AP+       Y      +  VDI+S G +  E+++G
Sbjct: 184 WYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITG 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 96.2 bits (240), Expect = 8e-22
 Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 23/223 (10%)

Query: 248 YSTIEKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLF--ISRKNRIKEICNEMD 304
                K  D F      G G +G +  G  +  G  +A+K++      +NR  +    M 
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQ 71

Query: 305 IMSRAHHKNLVQFLGCCFTKKDS-------FVVYEFVQNKSLDRIL-FDPKQKKELDWKK 356
            ++  HH N+VQ     +T  +         VV E+V   +L R      +++       
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPIL 130

Query: 357 RHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLAR-FSSSEKSL 414
             V +      +  LH      + HRDIK  N+L++      K+ DFG A+  S SE   
Sbjct: 131 IKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--- 186

Query: 415 LPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
            PN A   +  Y APE I   Q  T  VDI+S G +  E++ G
Sbjct: 187 -PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.9 bits (237), Expect = 8e-22
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 33/215 (15%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR------IKEICNEMDIMSRA 309
           + +    K+G G YG ++K     G   A+K++ + +++       I+EI     I+   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            H N+V+      TKK   +V+E +  + L ++L   +   E    K    ++    G+ 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKS--FLLQLLNGIA 114

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMA 428
           Y H      ++HRD+K  N+L++ +   KIADFGLAR F    +     T    TL Y A
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY---THEIVTLWYRA 168

Query: 429 PE-------YIANGQLTEKVDIYSFGVLVLEIVSG 456
           P+       Y      +  +DI+S G +  E+V+G
Sbjct: 169 PDVLMGSKKY------STTIDIWSVGCIFAEMVNG 197

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 38/214 (17%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN---------EMDIMSRAH--- 310
           LG GG+G +F G  L D  ++A+K   +  +NR+              E+ ++ +     
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIK---VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95

Query: 311 -HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD-PKQKKELDWKK-RHV---IIIGT 364
            H  +++ L    T++   +V E     + D  LFD   +K  L     R     ++   
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLP-AQD--LFDYITEKGPLGEGPSRCFFGQVV--- 149

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEKSLLPNTAIAGT 423
              +++ H  G   +VHRDIK  NIL+DL+    K+ DFG                  GT
Sbjct: 150 -AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPY-TDF-DGT 201

Query: 424 LGYMAPEYIANGQLT-EKVDIYSFGVLVLEIVSG 456
             Y  PE+I+  Q       ++S G+L+ ++V G
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 24/203 (11%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE------ICNEMDIMSRAHHKNLVQ 316
           LG G +G++  G     G ++AVK   I  + +I+       I  E+  +    H ++++
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 317 FLGCCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
                 T  D F+V E+V    L D I    + ++    +    I+      ++Y H+  
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCHRHM 131

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
              +VHRD+K  N+LLD     KIADFGL+   S  + L   T+  G+  Y APE I+ G
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTS-CGSPNYAAPEVIS-G 184

Query: 436 QLTE--KVDIYSFGVLVLEIVSG 456
           +L    +VDI+S GV++  ++ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCG 207

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRL---FISRKNRIKEICNEMDIMSRAHH 311
           + F     LG G +  +         RE A+K L    I ++N++  +  E D+MSR  H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----FDPKQKKELDWKKRHVIIIGTAE 366
              V+        +  +    + +N  L + +     FD    +             TAE
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR-----------FYTAE 138

Query: 367 ---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGT 423
               LEYLH  G   I+HRD+K  NILL+     +I DFG A+  S E       +  GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             Y++PE +      +  D+++ G ++ ++V+G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 30/209 (14%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN-----------EMDIMSRAHH 311
           LG G +G ++     +  +E+ VK     +K ++ E C            E+ I+SR  H
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVK---FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKS--LDRILFDPKQKKELDWKKRHVIIIGTAEGLE 369
            N+++ L     +    +V E   +       I   P+  + L       ++      + 
Sbjct: 89  ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVG 144

Query: 370 YLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           YL       I+HRDIK  NI++      K+ DFG A +    K     T   GT+ Y AP
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTF-CGTIEYCAP 198

Query: 430 EYIANGQLTE--KVDIYSFGVLVLEIVSG 456
           E +  G      +++++S GV +  +V  
Sbjct: 199 EVLM-GNPYRGPELEMWSLGVTLYTLVFE 226

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 50/219 (22%), Positives = 96/219 (43%), Gaps = 41/219 (18%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRK-----NRIKEICNEMDIMSRA 309
           + + + +KLG G Y  ++KG        +A+K + +  +       I+E+     ++   
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQN---KSLD--RILFDPKQKKELDWKKRHVIIIGT 364
            H N+V       T+K   +V+E++     + LD    + +    K        + +   
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK--------LFLFQL 109

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             GL Y H   + +++HRD+K  N+L++ +   K+ADFGLAR  S       N  +  TL
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TL 164

Query: 425 GYMAPE-------YIANGQLTEKVDIYSFGVLVLEIVSG 456
            Y  P+       Y      + ++D++  G +  E+ +G
Sbjct: 165 WYRPPDILLGSTDY------STQIDMWGVGCIFYEMATG 197

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 46/224 (20%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEICNEMDIMSR 308
           D +    KLG G YGE++K         +A+KR+ +  +        I+E+     ++  
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQN---KSLDR-ILFDPKQKKELDWKKRHVIIIGT 364
             H+N+++            +++E+ +N   K +D+      +  K   ++         
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ--------L 141

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP-----KIADFGLARFSSSEKSLLPNTA 419
             G+ + H       +HRD+K  N+LL +         KI DFGLAR          +  
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198

Query: 420 IAGTLGYMAPE-------YIANGQLTEKVDIYSFGVLVLEIVSG 456
           I  TL Y  PE       Y      +  VDI+S   +  E++  
Sbjct: 199 I--TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMK 234

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 57/230 (24%), Positives = 106/230 (46%), Gaps = 50/230 (21%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEICNEMDIMSR 308
             +++  K+G G +GE+FK    + G+++A+K++ +  +        ++EI     I+  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQL 72

Query: 309 AHHKNLVQFLGCCFTKKDS--------FVVYEFVQN---KSLD--RILFDPKQKKELDWK 355
             H+N+V  +  C TK           ++V++F ++     L    + F   + K +   
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--- 129

Query: 356 KRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSL 414
                +     GL Y+H++    I+HRD+KA+N+L+      K+ADFGLAR FS ++ S 
Sbjct: 130 -----MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

Query: 415 LPN-TAIAGTLGYMAPE-------YIANGQLTEKVDIYSFGVLVLEIVSG 456
               T    TL Y  PE       Y         +D++  G ++ E+ + 
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTR 225

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 92.2 bits (230), Expect = 8e-21
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 44/220 (20%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEICNEMDIMSR 308
             +++  K+G G YG +FK    +    +A+KR+ +   +       ++EIC    ++  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQN---KSLD--RILFDPKQKKELDWKKRHVIIIG 363
             HKN+V+      + K   +V+EF      K  D      DP+  K          +  
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF--------LFQ 109

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAG 422
             +GL + H      ++HRD+K  N+L++     K+A+FGLAR F    +     +A   
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVV 163

Query: 423 TLGYMAPE-------YIANGQLTEKVDIYSFGVLVLEIVS 455
           TL Y  P+       Y      +  +D++S G +  E+ +
Sbjct: 164 TLWYRPPDVLFGAKLY------STSIDMWSAGCIFAELAN 197

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 39/221 (17%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICN-----EMDIMSRA 309
             +++ + LG G +  ++K       + +A+K++ +  ++  K+  N     E+ ++   
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 310 HHKNLVQFLGCCFTKKDSFVVYEFVQN--KSL---DRILFDPKQKKELDWKKRHVIIIGT 364
            H N++  L     K +  +V++F++   + +   + ++  P   K          ++ T
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY--------MLMT 121

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGT 423
            +GLEYLH+     I+HRD+K +N+LLD     K+ADFGLA+ F S  ++    T    T
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY---THQVVT 175

Query: 424 LGYMAPE-------YIANGQLTEKVDIYSFGVLVLEIVSGV 457
             Y APE       Y         VD+++ G ++ E++  V
Sbjct: 176 RWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)

Query: 253 KATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR---------IKEICNE 302
            AT  ++   ++G G YG ++K      G  +A+K + +              ++E+   
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV-AL 64

Query: 303 MDIMSRAHHKNLVQFLGCCFTKKDS-----FVVYEFVQN------KSLDRILFDPKQKKE 351
           +  +    H N+V+ +  C T +        +V+E V                  +  K+
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124

Query: 352 LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE 411
           L        +     GL++LH +    IVHRD+K  NIL+      K+ADFGLAR  S +
Sbjct: 125 L--------MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173

Query: 412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
            +L   T +  TL Y APE +        VD++S G +  E+   
Sbjct: 174 MAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 30/218 (13%)

Query: 254 ATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRK-----NRIKEICNEMDIMS 307
           ++  F +  KLG+G Y  ++KG     G  +A+K + +  +       I+EI     +M 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LMK 58

Query: 308 RAHHKNLVQFLGCCFTKKDSFVVYEFVQN--KSLDRILFDPKQKKELDWKKRHVIIIGTA 365
              H+N+V+      T+    +V+EF+ N  K            + L+            
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
           +GL + H++    I+HRD+K  N+L++ + + K+ DFGLAR      +   +  +  TL 
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173

Query: 426 YMAPE-------YIANGQLTEKVDIYSFGVLVLEIVSG 456
           Y AP+       Y      +  +DI+S G ++ E+++G
Sbjct: 174 YRAPDVLMGSRTY------STSIDIWSCGCILAEMITG 205

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 32/215 (14%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEICNEMDIMSR 308
           + ++    +G G YG + K      GR +A+K+   S  ++      ++EI     ++ +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK----LLKQ 80

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQN---KSLDRI--LFDPKQKKELDWKKRHVIIIG 363
             H+NLV  L  C  KK  ++V+EFV +     L+      D +  ++  ++        
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-------- 132

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAG 422
              G+ + H      I+HRDIK  NIL+      K+ DFG AR  ++  +          
Sbjct: 133 IINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---DDEVA 186

Query: 423 TLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSG 456
           T  Y APE +  + +  + VD+++ G LV E+  G
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 23/202 (11%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE------ICNEMDIMSRAHHKNLVQ 316
           LG G +G++   T  +  +++A+K      +  +K+      +  E+  +    H ++++
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
                 T  D  +V E+   +  D I+   +  ++   +    II      +EY H+   
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRHK- 128

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             IVHRD+K  N+LLD     KIADFGL+   +    L   T+  G+  Y APE I  G+
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTS-CGSPNYAAPEVIN-GK 182

Query: 437 LTE--KVDIYSFGVLVLEIVSG 456
           L    +VD++S G+++  ++ G
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVG 204

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 90.0 bits (224), Expect = 7e-20
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 253 KATDCFDESNKLGHGGYGEIFKG--TLQDGREIAVKRLFISRKNR------IKEICNEMD 304
           +A   ++   ++G G YG++FK       GR +A+KR+ +           I+E+   + 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLR 66

Query: 305 IMSRAHHKNLVQFLGCCFTKKDS-----FVVYEFVQN------KSLDRILFDPKQKKELD 353
            +    H N+V+    C   +        +V+E V          +       +  K++ 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126

Query: 354 WKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS 413
           ++           GL++LH      +VHRD+K  NIL+    + K+ADFGLAR  S + +
Sbjct: 127 FQ--------LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175

Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           L   T++  TL Y APE +        VD++S G +  E+   
Sbjct: 176 L---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.2 bits (222), Expect = 9e-20
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 34/216 (15%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEICNEMDIMSR 308
           + +++  K+G G YG +FK      G+ +A+K+   S  +       ++EI     ++ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR----MLKQ 58

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
             H NLV  L     K+   +V+E+  + ++   L   ++       K   I   T + +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKS--ITWQTLQAV 115

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYM 427
            + HK      +HRD+K  NIL+      K+ DFG AR  +              T  Y 
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY---DDEVATRWYR 169

Query: 428 APE-------YIANGQLTEKVDIYSFGVLVLEIVSG 456
           +PE       Y         VD+++ G +  E++SG
Sbjct: 170 SPELLVGDTQY------GPPVDVWAIGCVFAELLSG 199

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 91.0 bits (226), Expect = 1e-19
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 18/200 (9%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVK---RLFISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++  G     G ++AVK   R  I   + + +I  E+  +    H ++++   
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 320 CCFTKKDSFVVYEFVQNKSL-DRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ 378
              T  D F+V E+V    L D I  + +  ++   +    I+     G++Y H+     
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCHRHM--- 136

Query: 379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT 438
           +VHRD+K  N+LLD     KIADFGL+   S  + L   T+  G+  Y APE I +G+L 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTS-CGSPNYAAPEVI-SGRLY 192

Query: 439 E--KVDIYSFGVLVLEIVSG 456
              +VDI+S GV++  ++ G
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.2 bits (224), Expect = 2e-19
 Identities = 47/216 (21%), Positives = 92/216 (42%), Gaps = 25/216 (11%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHH 311
           D F+    +G G + E+    ++   ++ A+K +    + ++  +     E D++     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 312 KNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---G 367
           + + Q L   F  +   ++V E+     L  +L    ++   +  +        AE    
Sbjct: 121 RWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR-----FYLAEIVMA 174

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           ++ +H+ G    VHRDIK  NILLD     ++ADFG      ++ ++    A+ GT  Y+
Sbjct: 175 IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYL 230

Query: 428 APEYI-------ANGQLTEKVDIYSFGVLVLEIVSG 456
           +PE +         G    + D ++ GV   E+  G
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.1 bits (226), Expect = 2e-19
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 28/232 (12%)

Query: 239 KSLKFLQFK-YSTIEKAT-DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISR 292
           K  +F Q+K        T + F     +G GG+GE++     D  ++ A+K L    I  
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM 229

Query: 293 KNRIKEICNEMDIMSRAHHKN---LVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQ 348
           K       NE  ++S     +   +V  +   F T      + + +    L   L     
Sbjct: 230 KQGETLALNERIMLSLVSTGDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV 288

Query: 349 KKELDWKKRHVIIIGTAE---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA 405
             E        +    AE   GLE++H      +V+RD+K +NILLD     +I+D GLA
Sbjct: 289 FSE------ADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339

Query: 406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
              S +K      A  GT GYMAPE +  G       D +S G ++ +++ G
Sbjct: 340 CDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 45/204 (22%), Positives = 87/204 (42%), Gaps = 27/204 (13%)

Query: 262 NKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLVQFLG 319
            KLG G Y E+F+   + +  ++ VK L   +  + K+I  E+ I+       N++    
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLA- 97

Query: 320 CCFTKKDSFV---VYEFVQNKSLDRILFDPKQKKELDWKKRHV--IIIGTAEGLEYLHKD 374
                  S     V+E V N    ++     Q          +   +    + L+Y H  
Sbjct: 98  DIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDY----DIRFYMYEILKALDYCH-- 147

Query: 375 GQMQIVHRDIKASNILLDLKHRP-KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
             M I+HRD+K  N+++D +HR  ++ D+GLA F    +          +  +  PE + 
Sbjct: 148 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLV 203

Query: 434 NGQL-TEKVDIYSFGVLVLEIVSG 456
           + Q+    +D++S G ++  ++  
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFR 227

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 89.8 bits (223), Expect = 3e-19
 Identities = 46/214 (21%), Positives = 94/214 (43%), Gaps = 23/214 (10%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHH 311
           + F+    +G G +GE+    L++  ++ A+K L    + ++        E D++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 312 KNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---G 367
           K +   L   F    + ++V ++     L  +L   + +   +  +        AE    
Sbjct: 134 KWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR-----FYLAEMVIA 187

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           ++ +H+      VHRDIK  NIL+D+    ++ADFG       + ++  + A+ GT  Y+
Sbjct: 188 IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 243

Query: 428 APEYIANGQLTEK-----VDIYSFGVLVLEIVSG 456
           +PE +   +  +       D +S GV + E++ G
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.0 bits (216), Expect = 9e-19
 Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 35/254 (13%)

Query: 218 ANDFKPHKDDQGMEMDLSLLHKSLKFLQ-FKYSTIEKAT-DCFDESNKLGHGGYGEIFKG 275
            N     K  +   +   L      FL+ ++  +   A  D FD    LG G +G +   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60

Query: 276 TLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY 331
             ++     A+K L    + +  +I+   NE  I+   +   LV+         + ++V 
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120

Query: 332 EFVQNKSLDRIL-----FDPKQKKELDWKKRHVIIIGTAE---GLEYLHKDGQMQIVHRD 383
           E+V    +   L     F     +              A+     EYLH      +++RD
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHAR-----------FYAAQIVLTFEYLHSLD---LIYRD 166

Query: 384 IKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT-AIAGTLGYMAPEYIANGQLTEKVD 442
           +K  N+L+D +   ++ DFG A      K +   T  + GT   +APE I +    + VD
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFA------KRVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220

Query: 443 IYSFGVLVLEIVSG 456
            ++ GVL+ E+ +G
Sbjct: 221 WWALGVLIYEMAAG 234

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 256 DCFDESNKLGHGGYGEIF----KGTLQDGREIAVKRL---FISRKNRIKEICNEMDIMSR 308
           + ++    +G G +GE+     K T    +  A+K L    + +++       E DIM+ 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 309 AHHKNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE- 366
           A+   +VQ L   F   +  ++V E++    L  ++       ++           TAE 
Sbjct: 126 ANSPWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVP---EKWARFYTAEV 177

Query: 367 --GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
              L+ +H    M  +HRD+K  N+LLD     K+ADFG     + E  +  +TA+ GT 
Sbjct: 178 VLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTP 233

Query: 425 GYMAPEYIAN----GQLTEKVDIYSFGVLVLEIVSG 456
            Y++PE + +    G    + D +S GV + E++ G
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 34/209 (16%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           +G G +G++      D +++ A+K +       +N ++ +  E+ IM    H  LV  L 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN-LW 81

Query: 320 CCF-TKKDSFVVYEFVQNKSL-----DRILFDPKQKKELDWKKRHVIIIGTAE---GLEY 370
             F  ++D F+V + +    L       + F  +  K           +   E    L+Y
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVK-----------LFICELVMALDY 130

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           L       I+HRD+K  NILLD      I DF +A     E  +   T +AGT  YMAPE
Sbjct: 131 LQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPE 184

Query: 431 YIANGQL---TEKVDIYSFGVLVLEIVSG 456
             ++ +    +  VD +S GV   E++ G
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 48/248 (19%), Positives = 88/248 (35%), Gaps = 55/248 (22%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFI--SRKNRIKEICNEMDIMSR 308
           E ++  +     LG G +G + +    + G+  A+K++      KNR      E+DIM  
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR------ELDIMKV 56

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKR----------- 357
             H N+++ +   +T  D         +        +                       
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 358 --------HVIIIGTAE-------------------GLEYLHKDGQMQIVHRDIKASNIL 390
                   H ++                         + ++H  G   I HRDIK  N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLL 173

Query: 391 LDLK-HRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGV 448
           ++ K +  K+ DFG A+     +   P+ A   +  Y APE +      T  +D++S G 
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230

Query: 449 LVLEIVSG 456
           +  E++ G
Sbjct: 231 VFGELILG 238

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 86.1 bits (213), Expect = 4e-18
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHH 311
              +     +G G  G +         R +A+K+L    +N+   K    E+ +M   +H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 312 KNLVQFL------GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           KN++  L            +D ++V E +    L +++     + ELD ++   ++    
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-----QMELDHERMSYLLYQML 174

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            G+++LH  G   I+HRD+K SNI++      KI DFGLAR + +   +   T    T  
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRY 228

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           Y APE I      E VDI+S G ++ E+V  
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL-- 318
           +G G  G +         R +A+K+L    +N+   K    E+ +M   +HKN++  L  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92

Query: 319 ----GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
                     +D ++V E +   +L +++     + ELD ++   ++     G+++LH  
Sbjct: 93  FTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSA 146

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           G   I+HRD+K SNI++      KI DFGLAR + +   +   T    T  Y APE I  
Sbjct: 147 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILG 200

Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
               E VDI+S G ++ E++ G
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKG 222

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.1 bits (201), Expect = 6e-17
 Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 35/222 (15%)

Query: 252 EKAT-DCFDESNKLGHGGYGEIF---KGTLQDGREI-AVKRL---FISRKNRIKEICNEM 303
           EKA    F+    LG G +G++F   K +  D R++ A+K L    +  ++R+     E 
Sbjct: 19  EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMER 77

Query: 304 DIMSRAHHKNLVQFLGCCF-TKKDSFVVYEFVQNKSL-----DRILFDPKQKKELDWKKR 357
           DI+   +H  +V+ L   F T+   +++ +F++   L       ++F  +  K       
Sbjct: 78  DILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK------- 129

Query: 358 HVIIIGTAE---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL 414
                  AE    L++LH  G   I++RD+K  NILLD +   K+ DFGL++ S   +  
Sbjct: 130 ----FYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182

Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
               +  GT+ YMAPE +     T+  D +SFGVL+ E+++G
Sbjct: 183 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 30/206 (14%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           LG G +G++     +      A+K L    I  K+ +     E  ++    H  L   L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA-LK 71

Query: 320 CCF-TKKDSFVVYEFVQNKSL-----DRILFDPKQKKELDWKKRHVIIIGTAE---GLEY 370
             F T      V E+     L        +F  ++ +              AE    LEY
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR-----------FYGAEIVSALEY 120

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH      +V+RDIK  N++LD     KI DFGL +   S+ + +  T   GT  Y+APE
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KT-FCGTPEYLAPE 175

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSG 456
            + +      VD +  GV++ E++ G
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 24/205 (11%)

Query: 262 NKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL 318
             +G G YG +      + G ++A+K+L    ++ I  K    E+ ++    H+N++  L
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 319 ------GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                        D ++V  F+Q   L +I+       +   +K   ++    +GL+Y+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIH 143

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
             G   +VHRD+K  N+ ++     KI DFGLAR + +E      T    T  Y APE I
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVI 195

Query: 433 ANGQL-TEKVDIYSFGVLVLEIVSG 456
            +     + VDI+S G ++ E+++G
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTG 220

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 31/215 (14%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHH 311
           + F+    LG G +G++     +      A+K L    I  K+ +     E  ++  + H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 312 KNLVQFLGCCF-TKKDSFVVYEFVQNKSL------DRILFDPKQKKELDWKKRHVIIIGT 364
             L   L   F T      V E+     L      +R+ F   + +              
Sbjct: 208 PFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRAR-----------FYG 254

Query: 365 AE---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA 421
           AE    L+YLH   +  +V+RD+K  N++LD     KI DFGL +    + +        
Sbjct: 255 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFC 310

Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           GT  Y+APE + +      VD +  GV++ E++ G
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 48/213 (22%), Positives = 93/213 (43%), Gaps = 30/213 (14%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRI-----------KEICNEMDIMSRAHH 311
            +  G YG +  G   +G  +A+KR+F +  +             K +  E+ +++  HH
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 312 KNLVQFLGC-CFTKKDSF----VVYEFVQNKSLDRILFDPKQKKELDWKKRHV--IIIGT 364
            N++         ++ +     +V E ++   L +++      + +    +H+   +   
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI----HDQRIVISPQHIQYFMYHI 143

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
             GL  LH+ G   +VHRD+   NILL   +   I DF LAR  +++ +    T      
Sbjct: 144 LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHR 197

Query: 425 GYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSG 456
            Y APE +      T+ VD++S G ++ E+ + 
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.1 bits (196), Expect = 3e-16
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 34/210 (16%)

Query: 264 LGHGGYGEIF---KGTLQDGREI-AVKRL----FISRKNRIKEICNEMDIMSRAHHKNLV 315
           LG GGYG++F   K T  +  +I A+K L     +           E +I+    H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 316 QFLGCCF-TKKDSFVVYEFVQNKSL-----DRILFDPKQKKELDWKKRHVIIIGTAE--- 366
             L   F T    +++ E++    L        +F                    AE   
Sbjct: 85  D-LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTAC-----------FYLAEISM 132

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
            L +LH+ G   I++RD+K  NI+L+ +   K+ DFGL + S  + ++  +T   GT+ Y
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HT-FCGTIEY 187

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           MAPE +        VD +S G L+ ++++G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 34/291 (11%), Positives = 79/291 (27%), Gaps = 57/291 (19%)

Query: 263 KLGHGGYGEIFKGTLQD---GREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQ 316
             G     + ++    D    R++A+  +    +   + ++E  +    +SR     + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 317 FLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
            L    T+    VV E+++  SL  +                  +   A   +  H+ G 
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG- 149

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
             +       S + + +     +A                          M         
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------ 179

Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED 496
              + DI   G  +  ++                L     +        + I+ +    D
Sbjct: 180 -NPQDDIRGIGASLYALLVNRW--PLPEAGVRSGLAPAE-RDTAG----QPIEPADIDRD 231

Query: 497 I-EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDE 546
           I  ++  V        Q    +R + T ++ +++Q              DE
Sbjct: 232 IPFQISAVA---ARSVQGDGGIRSAST-LLNLMQQATAVADRTEVLGPIDE 278

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 47/212 (22%), Positives = 95/212 (44%), Gaps = 26/212 (12%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFL--- 318
            LG GG G +F        + +A+K++ ++    +K    E+ I+ R  H N+V+     
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77

Query: 319 -----------GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEG 367
                      G        ++V E+++   L  +L    ++  L  +   + +     G
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL----EQGPLLEEHARLFMYQLLRG 132

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEKSLLPN-TAIAGTLG 425
           L+Y+H      ++HRD+K +N+ ++ +    KI DFGLAR      S   + +    T  
Sbjct: 133 LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 426 YMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
           Y +P  + +    T+ +D+++ G +  E+++G
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 37/226 (16%)

Query: 252 EKAT-DCFDESNKLGHGGYGEIF---KGTLQDGREI-AVKRL----FISRKNRIKEICNE 302
           EK   + F+    LG G YG++F   K +  D  ++ A+K L     + +    +    E
Sbjct: 49  EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108

Query: 303 MDIMSRA-HHKNLVQFLGCCF-TKKDSFVVYEFVQNKSL-----DRILFDPKQKKELDWK 355
             ++        LV  L   F T+    ++ +++    L      R  F   + +     
Sbjct: 109 RQVLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ----- 162

Query: 356 KRHVIIIGTAE---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK 412
                 I   E    LE+LHK G   I++RDIK  NILLD      + DFGL++   +++
Sbjct: 163 ------IYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213

Query: 413 SLLPNTAIAGTLGYMAPEYIANGQL--TEKVDIYSFGVLVLEIVSG 456
           +        GT+ YMAP+ +  G     + VD +S GVL+ E+++G
Sbjct: 214 TERAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.4 bits (193), Expect = 7e-16
 Identities = 41/111 (36%), Positives = 59/111 (53%), Gaps = 24/111 (21%)

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-------FSSSEKSLLPN 417
           A+G+E+L      + +HRD+ A NILL  K+  KI DFGLAR       +     + LP 
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP- 258

Query: 418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-------GVQNNK 461
                 L +MAPE I +   T + D++SFGVL+ EI S       GV+ ++
Sbjct: 259 ------LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 30/157 (19%), Positives = 56/157 (35%), Gaps = 19/157 (12%)

Query: 262 NKLGHGGYGEIFKGTL------QDGREIAVKRL-FISRKNRIKEICNEMDIMSRA-HHKN 313
             LG G +G++ +            R +AVK L   +  +  + + +E+ I+    HH N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 314 LVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           +V  LG C        V+ EF +  +L   L            KR+  +    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS 409
               +  +  D+K     +        + F   +  S
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 33/214 (15%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRAHH 311
             F     LG G +G +     +      A+K L    + R  +++   +E  ++S   H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-----FDPKQKKELDWKKRHVIIIGTAE 366
             +++  G     +  F++ ++++   L  +L     F     K              AE
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK-----------FYAAE 114

Query: 367 ---GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA-IAG 422
               LEYLH      I++RD+K  NILLD     KI DFG A      K +   T  + G
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFA------KYVPDVTYTLCG 165

Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           T  Y+APE ++     + +D +SFG+L+ E+++G
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL-- 318
           +G G YG +      + G ++A+K+L+   ++ +  K    E+ ++    H+N++  L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 319 ----GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
                      D ++V  F+    L +++    + ++L   +   ++    +GL Y+H  
Sbjct: 93  FTPDETLDDFTDFYLVMPFMG-TDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAA 147

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           G   I+HRD+K  N+ ++     KI DFGLAR + SE      T    T  Y APE I N
Sbjct: 148 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILN 199

Query: 435 GQL-TEKVDIYSFGVLVLEIVSG 456
               T+ VDI+S G ++ E+++G
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITG 222

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRA-HHKNLVQFL 318
           +G G Y ++    L+    I A+K +    ++    I  +  E  +  +A +H  LV  L
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG-L 75

Query: 319 GCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKD 374
             CF T+   F V E+V    L   +F  +++++L   + H     +AE    L YLH+ 
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP--EEHARFY-SAEISLALNYLHER 129

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           G   I++RD+K  N+LLD +   K+ D+G+ +           +   GT  Y+APE +  
Sbjct: 130 G---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRG 184

Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
                 VD ++ GVL+ E+++G
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAG 206

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 29/214 (13%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRA-H 310
             F+    LG G +G++     +   E+ AVK L    + + + ++    E  +++    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 311 HKNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE--- 366
              L Q L  CF T    + V E+V    L   ++  +Q      +   V     AE   
Sbjct: 80  PPFLTQ-LHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFK-EPHAVFYA--AEIAI 132

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA----G 422
           GL +L   G   I++RD+K  N++LD +   KIADFG+       K  + +        G
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC------KENIWDGVTTKTFCG 183

Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           T  Y+APE IA     + VD ++FGVL+ E+++G
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 29/206 (14%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRA-HHKNLVQFL 318
           +G G Y ++    L+    I A++ +    ++    I  +  E  +  +A +H  LV  L
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG-L 118

Query: 319 GCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKD 374
             CF T+   F V E+V    L   +F  +++++L   + H     +AE    L YLH+ 
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP--EEHARFY-SAEISLALNYLHER 172

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA----GTLGYMAPE 430
           G   I++RD+K  N+LLD +   K+ D+G+       K  L          GT  Y+APE
Sbjct: 173 G---IIYRDLKLDNVLLDSEGHIKLTDYGMC------KEGLRPGDTTSTFCGTPNYIAPE 223

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSG 456
            +        VD ++ GVL+ E+++G
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAG 249

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.8 bits (191), Expect = 3e-15
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 21/210 (10%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRA-H 310
             F+    LG G +G++     +   E+ AVK L    + + + ++    E  +++    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 311 HKNLVQFLGCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE--- 366
              L Q L  CF T    + V E+V    L   ++  +Q      +   V     AE   
Sbjct: 401 PPFLTQ-LHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFK-EPHAVFYA--AEIAI 453

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
           GL +L   G   I++RD+K  N++LD +   KIADFG+ + +  +      T   GT  Y
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKT-FCGTPDY 508

Query: 427 MAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +APE IA     + VD ++FGVL+ E+++G
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 42/231 (18%), Positives = 81/231 (35%), Gaps = 54/231 (23%)

Query: 229 GMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKR 287
           G  +   L  K    +   Y    +          LG G  G++ +    +   + A+K 
Sbjct: 1   GPHVKSGLQIKKNAIID-DYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKM 50

Query: 288 LFISRKNRIKEICNEMDIMSR-AHHKNLVQFLGCC----FTKKDSFVVYEFVQNKSL-DR 341
             +    + +    E+++  R +   ++V+ +         +K   +V E +    L  R
Sbjct: 51  --LQDCPKARR---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 105

Query: 342 ILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP---K 398
           I    +  +    ++   I+    E ++YLH    + I HRD+K  N+L   K      K
Sbjct: 106 IQ--DRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK 160

Query: 399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVL 449
           + DFG                        A E     +  +  D++S GV+
Sbjct: 161 LTDFGF-----------------------AKE-TTGEKYDKSCDMWSLGVI 187

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 57/250 (22%), Positives = 96/250 (38%), Gaps = 32/250 (12%)

Query: 222 KPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKAT-DCFDESNKLGHGGYGEIFKGTLQDG 280
              ++ + M  + +      + +    S+   A    F     +G G +G++     +  
Sbjct: 3   SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62

Query: 281 REI-AVKRL---FISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCF-TKKDSFVVYEFV 334
               AVK L    I +K   K I +E +++ +   H  LV  L   F T    + V +++
Sbjct: 63  EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-LHFSFQTADKLYFVLDYI 121

Query: 335 QNKSL-----DRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKDGQMQIVHRDIKA 386
               L         F   + +              AE    L YLH      IV+RD+K 
Sbjct: 122 NGGELFYHLQRERCFLEPRAR-----------FYAAEIASALGYLHSLN---IVYRDLKP 167

Query: 387 SNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSF 446
            NILLD +    + DFGL + +    S    +   GT  Y+APE +        VD +  
Sbjct: 168 ENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225

Query: 447 GVLVLEIVSG 456
           G ++ E++ G
Sbjct: 226 GAVLYEMLYG 235

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.7 bits (187), Expect = 5e-15
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 21/202 (10%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRA-HHKNLVQFL 318
           LG G +G++    +++  ++ AVK L    I + + ++    E  I+S A +H  L Q L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ-L 89

Query: 319 GCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKD 374
            CCF T    F V EFV    L        QK     + R       AE    L +LH  
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFY--AAEIISALMFLHDK 143

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           G   I++RD+K  N+LLD +   K+ADFG+ +               GT  Y+APE +  
Sbjct: 144 G---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQE 198

Query: 435 GQLTEKVDIYSFGVLVLEIVSG 456
                 VD ++ GVL+ E++ G
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCG 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.9 bits (187), Expect = 6e-15
 Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 15/187 (8%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL- 318
            +G G YG ++        + +A+K++    ++ I  K I  E+ I++R     +++   
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92

Query: 319 ----GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
                      + ++V E      L ++    K    L  +    I+     G  ++H+ 
Sbjct: 93  LIIPDDLLKFDELYIVLEIAD-SDLKKLF---KTPIFLTEEHIKTILYNLLLGENFIHES 148

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           G   I+HRD+K +N LL+     K+ DFGLAR  +SEK       +              
Sbjct: 149 G---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205

Query: 435 GQLTEKV 441
            QLT  V
Sbjct: 206 KQLTSHV 212

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.9 bits (185), Expect = 8e-15
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 25/204 (12%)

Query: 264 LGHGGYGEIFKGTLQDGREI-AVKRL---FISRKNRIKEICNEMDIMSRA-HHKNLVQFL 318
           LG G +G++F    +   +  A+K L    +   + ++    E  ++S A  H  L   +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH-M 83

Query: 319 GCCF-TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE---GLEYLHKD 374
            C F TK++ F V E++    L   ++  +   + D   R       AE   GL++LH  
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFD-LSRATFYA--AEIILGLQFLHSK 137

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA--GTLGYMAPEYI 432
           G   IV+RD+K  NILLD     KIADFG+ +    E  L         GT  Y+APE +
Sbjct: 138 G---IVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNTFCGTPDYIAPEIL 190

Query: 433 ANGQLTEKVDIYSFGVLVLEIVSG 456
              +    VD +SFGVL+ E++ G
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIG 214

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 23/203 (11%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL-- 318
           +G G YG +      + G  +AVK+L    ++ I  K    E+ ++    H+N++  L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96

Query: 319 ----GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
                      D ++V   +    L+ I+    + ++L       +I     GL+Y+H  
Sbjct: 97  FTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIHSA 151

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
               I+HRD+K SN+ ++     KI DFGLAR ++ E      T    T  Y APE + N
Sbjct: 152 D---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRAPEIMLN 203

Query: 435 GQL-TEKVDIYSFGVLVLEIVSG 456
                + VDI+S G ++ E+++G
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTG 226

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 23/214 (10%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRL--FISRKNRI--KEICNEMDIMSRA 309
              +   + +G G YG +       +   +A+K++  F   +++   +    E+ I+ R 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRF 82

Query: 310 HHKNLVQFL-----GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
            H+N++              KD ++V + ++   L ++L    + + L        +   
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQI 137

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN-TAIAGT 423
             GL+Y+H      ++HRD+K SN+LL+     KI DFGLAR +  +       T    T
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194

Query: 424 LGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
             Y APE + N +  T+ +DI+S G ++ E++S 
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.9 bits (179), Expect = 7e-14
 Identities = 54/241 (22%), Positives = 102/241 (42%), Gaps = 45/241 (18%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSRAHHKNLVQFL- 318
            +G G YG + +     + R +A+K++    ++ I  K I  E+ I++R +H ++V+ L 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119

Query: 319 ----GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV--IIIGTAEGLEYLH 372
                      + +VV E        ++    +    L   + H+  ++     G++Y+H
Sbjct: 120 IVIPKDVEKFDELYVVLEIAD-SDFKKLF---RTPVYL--TELHIKTLLYNLLVGVKYVH 173

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG---------- 422
             G   I+HRD+K +N L++     K+ DFGLAR     ++      I+           
Sbjct: 174 SAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 423 ---------------TLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDD 466
                          T  Y APE I   +  TE +D++S G +  E+++ ++ N     D
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

Query: 467 G 467
            
Sbjct: 291 R 291

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 46/213 (21%), Positives = 83/213 (38%), Gaps = 30/213 (14%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRL--FISRKNRI--KEICNEMDIMSRAHHKNLVQF 317
            LG G YG +   T    G  +A+K++  F      +       E+ I+    H+N++  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITI 74

Query: 318 L-----GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
                        + +++ E +Q   L R++      + L        I  T   ++ LH
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQYFIYQTLRAVKVLH 129

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAG--------TL 424
                 ++HRD+K SN+L++     K+ DFGLAR      +                 T 
Sbjct: 130 GSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186

Query: 425 GYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
            Y APE +      +  +D++S G ++ E+   
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 55/221 (24%), Positives = 108/221 (48%), Gaps = 34/221 (15%)

Query: 262 NKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIMSR-AHHKNLVQF 317
            KLG G YG ++K    + G  +AVK++F + +N    +    E+ I++  + H+N+V  
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 318 LGCCFTK--KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           L        +D ++V+++++   L  ++    +   L+   +  ++    + ++YLH  G
Sbjct: 75  LNVLRADNDRDVYLVFDYME-TDLHAVI----RANILEPVHKQYVVYQLIKVIKYLHSGG 129

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG---------- 425
              ++HRD+K SNILL+ +   K+ADFGL+R   + + +  N  ++              
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 426 ---------YMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
                    Y APE +      T+ +D++S G ++ EI+ G
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 37/190 (19%), Positives = 69/190 (36%), Gaps = 28/190 (14%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGC 320
            +G GG+G I+   +     +      + +   +    +  E+    RA     +Q    
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 321 CFTKKDSFV--VYEFVQNKSLDRI-------LFDPKQKKELDWKKRH-----VIIIGT-- 364
               K   V   +    +    +         F    +K  +   +      V+ +    
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI--ADFGLA-RFSSSEK----SLLPN 417
            + LEY+H+      VH DIKASN+LL+ K+  ++   D+GLA R+         +  P 
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218

Query: 418 TAIAGTLGYM 427
               GT+ + 
Sbjct: 219 RCHDGTIEFT 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 31/196 (15%), Positives = 68/196 (34%), Gaps = 38/196 (19%)

Query: 262 NKLGHGGYGEIFKGT---------LQDGREIAVK-----------RLFISRKNRIKEICN 301
           +       G +++               ++ ++K           + F  R  +  ++  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 302 EMDIMSRAHHKNLVQFLGCCFTKKD-SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVI 360
               +       +   +G    +    F+V      +SL     D   K  L  +   V+
Sbjct: 108 WK-KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-LGRSLQS-ALDVSPKHVLSER--SVL 162

Query: 361 IIGT--AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI--ADFGLA-RFSSSEK--- 412
            +     + LE+LH++     VH ++ A NI +D + + ++  A +G A R+  S K   
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219

Query: 413 -SLLPNTAIAGTLGYM 427
                 +   G L ++
Sbjct: 220 YVEGSRSPHEGDLEFI 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.3 bits (145), Expect = 5e-10
 Identities = 38/277 (13%), Positives = 77/277 (27%), Gaps = 63/277 (22%)

Query: 254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFI--------SRKNRIKEICNEMDI 305
            T+      K+G G +GE+F+    D   +A+K + I        S +   +EI  E+ I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 306 M---------SRAHHKNLVQFLGCC------------------------------FTKKD 326
                          +  +                                    F    
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKA 386
            F+V EF           +  + K         I+      L        ++  HRD+  
Sbjct: 137 LFIVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 387 SNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSF 446
            N+LL      K+      + S+     L        + Y       +G +     ++  
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGL----QVSIIDYTLSRLERDGIV-----VFCD 241

Query: 447 GVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT 483
             +  ++ +G  + +F      +    + W  +   +
Sbjct: 242 VSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYS 278

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 50/263 (19%), Positives = 86/263 (32%), Gaps = 86/263 (32%)

Query: 263 KLGHGGYGEIFKG-TLQDGREIAVKRLFISRKNRIKEICNEMDIMSR------AH--HKN 313
           KLG G +  ++    +Q  + +A+K +  S ++  +   +E+ ++             + 
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 314 LVQFLGCCFTKKDSFV-----------VYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
           +VQ L       D F            V+E +    L + +     +  L       II 
Sbjct: 103 VVQLL-------DDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQG-LPLPCVKKIIQ 153

Query: 363 GTAEGLEYLHKDGQMQIVHRDIKASNILLDL----------------------------- 393
              +GL+YLH   + +I+H DIK  NILL +                             
Sbjct: 154 QVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 394 --------------------KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                               K + KIAD G A +          T    T  Y + E + 
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLI 266

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
                   DI+S   +  E+ +G
Sbjct: 267 GSGYNTPADIWSTACMAFELATG 289

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 30/153 (19%), Positives = 63/153 (41%), Gaps = 19/153 (12%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV-QFLGC 320
           ++G G +G IF+GT L + +++A+K     R++   ++ +E            +      
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT--AEGLEYLHKDGQMQ 378
                 + +V +     SL+  L D    ++   K   V +        ++ +H+     
Sbjct: 75  GQEGLHNVLVIDL-LGPSLED-LLD-LCGRKFSVK--TVAMAAKQMLARVQSIHEKS--- 126

Query: 379 IVHRDIKASNILLDLKHRPK-----IADFGLAR 406
           +V+RDIK  N L+   +        + DFG+ +
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 46/238 (19%), Positives = 81/238 (34%), Gaps = 76/238 (31%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKEI-----CNEMDIMSRAH 310
           KLG G +  ++    + +   +A+K   I R ++        EI      N+ D      
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82

Query: 311 --HKNLVQFLGCCFTKKDSFV-------------------VYEFVQNK-----SLDRILF 344
               ++++ L       D F                    +   ++        L  +  
Sbjct: 83  MGANHILKLL-------DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV-- 133

Query: 345 DPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP------K 398
                          I      GL+Y+H+  +  I+H DIK  N+L+++   P      K
Sbjct: 134 -------------KQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIK 178

Query: 399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           IAD G A +          T    T  Y +PE +         DI+S   L+ E+++G
Sbjct: 179 IADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 37/153 (24%), Positives = 61/153 (39%), Gaps = 19/153 (12%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHH-KNLVQFLGC 320
           K+G G +GE+  G  L     +A+K      K+R  ++  E     +      + Q    
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT--AEGLEYLHKDGQMQ 378
               K + +V E     SL+  LFD    +    K   V++I       +EY+H      
Sbjct: 74  GPCGKYNAMVLEL-LGPSLE-DLFD-LCDRTFSLK--TVLMIAIQLISRMEYVHSKN--- 125

Query: 379 IVHRDIKASNILLDLKHRPK-----IADFGLAR 406
           +++RD+K  N L+            I DF LA+
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 43/194 (22%), Positives = 77/194 (39%), Gaps = 39/194 (20%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV------ 315
           K+G GG+G I+         + A   + +  +     + +E+    R   K+ +      
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDCIKKWIER 102

Query: 316 ---------QFLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIII 362
                     F G   T+       F+V E      L + +          +KK  V+ +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMER-LGIDLQK-ISGQNGT----FKKSTVLQL 156

Query: 363 GT--AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI--ADFGLA-RFSSSEK----S 413
           G    + LEY+H++     VH DIKA+N+LL  K+  ++  AD+GL+ R+  +       
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213

Query: 414 LLPNTAIAGTLGYM 427
             P     GT+ + 
Sbjct: 214 ENPRKGHNGTIEFT 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 17/151 (11%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLVQFLGC 320
           K+G G +G+I+ GT +  G E+A+K      K +  ++  E  I         +     C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT--AEGLEYLHKDGQMQ 378
                 + +V E     SL+  LF+    ++   K   V+++       +EY+H      
Sbjct: 74  GAEGDYNVMVMEL-LGPSLED-LFN-FCSRKFSLK--TVLLLADQMISRIEYIHSKN--- 125

Query: 379 IVHRDIKASNILLDLKHRPK---IADFGLAR 406
            +HRD+K  N L+ L  +     I DFGLA+
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.0 bits (134), Expect = 3e-08
 Identities = 55/352 (15%), Positives = 95/352 (26%), Gaps = 76/352 (21%)

Query: 224 HKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREI 283
           H D +  E      ++    L           DC D                 +QD    
Sbjct: 6   HMDFETGEHQ----YQYKDILSVFEDAFVDNFDCKD-----------------VQD---- 40

Query: 284 AVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDR-- 341
             K +    +  I  I    D +S          L      K   +V +FV+   L    
Sbjct: 41  MPKSILSKEE--IDHIIMSKDAVSG------TLRLFWTLLSKQEEMVQKFVEE-VLRINY 91

Query: 342 -ILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI---VHRDIKASNI---LLDLK 394
             L  P + ++        + I   E  + L+ D Q+     V R      +   LL+L+
Sbjct: 92  KFLMSPIKTEQRQPSMMTRMYI---EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR 148

Query: 395 HRPKIADFGLARFSSSEKSLLPNTAIA--GTLGYMAPE--YIANGQLTEKVDI------- 443
               +   G+       K+ +             M  +  ++          +       
Sbjct: 149 PAKNVLIDGVLGSG---KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205

Query: 444 -YSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKR 502
            Y              N K +       L     K    +  L ++       +++  K 
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAEL-RRLLKSKPYENCLLVLL------NVQNAK- 257

Query: 503 VVW--VGLLCTQELPTLR-PSMTNVVQMLKQKDITLPTPSKPPFT-DECMEL 550
             W    L C + L T R   +T+ +       I+L        T DE   L
Sbjct: 258 -AWNAFNLSC-KILLTTRFKQVTDFLSAATTTHISL-DHHSMTLTPDEVKSL 306

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.6 bits (133), Expect = 4e-08
 Identities = 60/526 (11%), Positives = 131/526 (24%), Gaps = 187/526 (35%)

Query: 4   DARTNIIERHCQKLPPENSSNYLHNY--HALLNLMRGEMYKKKFASKE-FGIPP--SRTY 58
           D  T   +   + +       ++ N+    + ++ +  + K++             S T 
Sbjct: 8   DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI--DHIIMSKDAVSGTL 65

Query: 59  MLSQCMEDLTLTECNTCFAQMNHLLADCLPAISAHVFLDGCFLRLENYSFYGEPFAPFDD 118
            L   +                              F++   LR  NY F   P      
Sbjct: 66  RLFWTLLSK--------------------QEEMVQKFVEEV-LR-INYKFLMSPIK---- 99

Query: 119 MKCGVDAEQEQQDLFRRVVEEVVNK-------VSK-NAPNENGFATHKYTL------ADV 164
                  EQ Q  +  R+  E  ++        +K N      +   +  L       +V
Sbjct: 100 ------TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153

Query: 165 SAYAMASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVL---FAGCFLRYSRYEFANDF 221
               +    KT         +      +      ++ ++       C             
Sbjct: 154 LIDGVLGSGKT--------WVALDVCLSYKVQCKMDFKIFWLNLKNC------------- 192

Query: 222 KPHKDDQGMEMDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGR 281
             +  +  +EM   LL+      Q   +   ++    D S+ +            +   +
Sbjct: 193 --NSPETVLEMLQKLLY------QIDPNWTSRS----DHSSNIKL---------RIHSIQ 231

Query: 282 EIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ-F-LGC--CFTKKDSFVVYEFVQNK 337
              ++RL  S+        N + ++    +      F L C    T +   V  +F+   
Sbjct: 232 A-ELRRLLKSKPYE-----NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT-DFLSAA 284

Query: 338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP 397
                               H+ +   +  L     D    +                  
Sbjct: 285 -----------------TTTHISLDHHSMTLT---PDEVKSL------------------ 306

Query: 398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG- 456
                 L ++       LP   +        P                     L I++  
Sbjct: 307 ------LLKYLDCRPQDLPREVLTT-----NP-------------------RRLSIIAES 336

Query: 457 VQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKR 502
           +++     D          WKH     +  II+ S+ + +  E ++
Sbjct: 337 IRDGLATWD---------NWKHVNCDKLTTIIESSLNVLEPAEYRK 373

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 3e-06
 Identities = 60/434 (13%), Positives = 121/434 (27%), Gaps = 127/434 (29%)

Query: 3   ADARTNIIERHCQKLPP------ENSSNYLHNYH----ALLNLMRGEMYKK--------- 43
            +    ++++   ++ P      ++SSN     H     L  L++ + Y+          
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254

Query: 44  -KFASKEFGIPPSRTYMLSQCMEDLTLTECNTCFAQMNHLLADCLPAISA-HVFLDGCFL 101
              A   F +          C + L  T            + D L A +  H+ LD    
Sbjct: 255 NAKAWNAFNL---------SC-KILLTTR--------FKQVTDFLSAATTTHISLD---- 292

Query: 102 RLENYSFYGEPFAPFDDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPNENGFATHKYTL 161
                                     E + L  + ++     + +     N        L
Sbjct: 293 ---------HHSMTLT--------PDEVKSLLLKYLDCRPQDLPREVLTTNPRR-----L 330

Query: 162 ADVSAYA--MASCLKTLNHQMCSQCLTKAASTALTCIPAIEGRVLFAGCFLRYSRYEFAN 219
           + ++       +      H  C + LT    ++L  +   E R +F    +      F  
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDK-LTTIIESSLNVLEPAEYRKMFDRLSV------FPP 383

Query: 220 DFK-PHK---------DDQGMEMDLSLLH-KSLKFLQFKYSTIEKATDCFDESNKLGHGG 268
               P               + + ++ LH  SL   Q K STI            +    
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS-----------I-PSI 431

Query: 269 YGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF 328
           Y    +  ++   E A+ R  +   N  K   ++ D++     +     +G         
Sbjct: 432 Y---LELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQYFYSHIG--------- 478

Query: 329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASN 388
             +     +  +R+        +  + ++ +    TA                      N
Sbjct: 479 --HHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASG--------------SILN 522

Query: 389 ILLDLK-HRPKIAD 401
            L  LK ++P I D
Sbjct: 523 TLQQLKFYKPYICD 536

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.9 bits (129), Expect = 9e-08
 Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 13/149 (8%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLVQFLGC 320
           K+G G +GEI+ GT +Q   E+A+K    + K +  ++  E  I         +      
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIV 380
                 + +V +     SL+  LF+    ++L  K   ++       +E++H       +
Sbjct: 72  GVEGDYNVLVMDL-LGPSLE-DLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS---FL 125

Query: 381 HRDIKASNILLDLKHRPK---IADFGLAR 406
           HRDIK  N L+ L  R     I DFGLA+
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 10/93 (10%)

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTAIAGT 423
           + L+ LHK    +I+H D+K  NILL  + R   K+ DFG + +          T I  +
Sbjct: 211 QCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY----TYIQ-S 262

Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             Y APE I   +    +D++S G ++ E+++G
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 8/93 (8%)

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTAIAGT 423
             L +L    ++ I+H D+K  NILL    R   KI DFG +                 +
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQS 221

Query: 424 LGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
             Y +PE +        +D++S G +++E+ +G
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	569
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.94
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.74
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.74
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.97
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.73
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.54
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.38
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.37
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.18
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.05
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.99
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.99
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.76
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.54
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.49
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.4
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.33
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.28
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.19
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.13
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.07
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.73
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.45
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.4
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.65
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.31
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.0
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.85

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.7e-55  Score=438.60  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=213.3

Q ss_pred             ccccccccccccCceeEEEEEec------CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|.+.++||+|+||.||+|++.      +++.||||++........++|.+|+++|++++|||||++++++.+.+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56888899999999999999864      477899999987777777889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCC----------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEE
Q 037160          330 VYEFVQNKSLDRILFDP----------KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI  399 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  399 (569)
                      |||||++|+|.++|...          .....++|..++.|+.||++||.|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999999542          23457999999999999999999999998   999999999999999999999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhh
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      +|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+   +....   
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i---  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI---  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHH---
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---
Confidence            99999987665443323345679999999999999999999999999999999998 899986443221   11111   


Q ss_pred             hcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                               ........+......+.+++.+||+.||++|||+.||++.|++..
T Consensus       244 ---------~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          244 ---------TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             ---------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                     011111112233456788999999999999999999999998753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.2e-55  Score=441.46  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=205.8

Q ss_pred             ccccccccccccCceeEEEEEec------CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|.+.++||+|+||.||+|+++      +++.||||++........+.|.+|+++|++++|||||++++++.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46778889999999999999864      478899999987777777889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          330 VYEFVQNKSLDRILFDPK------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                      |||||++|+|.+++....            ....++|.+++.|+.||++||.|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999996532            2346899999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||.......   ++.   
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~---  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AID---  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHH---
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHH---
Confidence            9999999997765544434456789999999999999999999999999999999999 899986433221   111   


Q ss_pred             hhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          477 KHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                                .+...... .+......+.+++.+||+.||++|||+.||+++|+...
T Consensus       272 ----------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          272 ----------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             ----------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence                      11111111 12233456778999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-54  Score=432.53  Aligned_cols=265  Identities=23%  Similarity=0.402  Sum_probs=205.6

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .+++++.++||+|+||.||+|++++  .||||++...  .....+.|.+|+.+|++++|||||++++++.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3567888999999999999999763  6999988643  34556789999999999999999999998754 56899999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      ||++|+|.++|..  ....++|..++.|+.||++||.|||+++   ||||||||+||||++++++||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999953  3456999999999999999999999998   9999999999999999999999999998766544


Q ss_pred             CCCCCcccccCCCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIAN---GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      .........||+.|||||++.+   +.++.++|||||||+||||+||+.||.......  .+.........        .
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~~~~~~~~~--------~  256 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIFMVGRGYA--------S  256 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHTTCC--------C
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCC--------C
Confidence            3334456789999999999864   468999999999999999999999986433221  11111111111        1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCC
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPT  537 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  537 (569)
                      +.+..........+.+++.+||+.+|++|||+.||+++|+....++|.
T Consensus       257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            111111223345677889999999999999999999999876655543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-54  Score=435.74  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=211.1

Q ss_pred             ccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      .++++.++||+|+||.||+|++.      +++.||||++.... ....++|.+|+.+|++++|||||+++|++.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34667889999999999999863      46789999986543 334578999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC
Q 037160          329 VVYEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH  395 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~  395 (569)
                      ||||||++|+|.++|....             ....++|..++.|+.||++||.|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999995432             1346899999999999999999999998   99999999999999999


Q ss_pred             CeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHh
Q 037160          396 RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTH  474 (569)
Q Consensus       396 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  474 (569)
                      ++||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+   +.  
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~--  257 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VV--  257 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HH--
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HH--
Confidence            999999999987765544334456789999999999999999999999999999999998 888876443221   11  


Q ss_pred             Hhhhhcccchhhhhccc-CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          475 TWKHFQAKTVLEIIDKS-IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       475 ~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                                 +.+... ....+......+.+++..||+.+|++|||+.||+++|+..
T Consensus       258 -----------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 -----------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                       111111 1111233445678899999999999999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-53  Score=433.42  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=202.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.++||+|+||.||+|+++ +|+.||||++....  ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999976 79999999997542  3445789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |++||+|.++|.. .....+++..++.++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+++......
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999953 23456789999999999999999999999   9999999999999999999999999998765422


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  .....+||+.|||||++.+..++.++|||||||+||||++|+.||.......   ++..            ++....
T Consensus       180 ~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~------------i~~~~~  242 (350)
T 4b9d_A          180 E--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLK------------IISGSF  242 (350)
T ss_dssp             H--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH------------HHHTCC
T ss_pred             c--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH------------HHcCCC
Confidence            1  1235679999999999999999999999999999999999999986543221   1111            111111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..........+.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11122233567788999999999999999999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-53  Score=429.45  Aligned_cols=250  Identities=24%  Similarity=0.379  Sum_probs=209.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999976 79999999997766555667889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      +||+|.+++.    +..+++..+..++.||+.||.|||+++   ||||||||+||||+.+|++||+|||+++....... 
T Consensus       154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            9999999984    246899999999999999999999999   99999999999999999999999999987755432 


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       .....+||+.|||||++.+..|+.++|||||||+||||++|++||........   ......         .....+. 
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~---------~~~~~~~-  291 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRD---------NLPPRLK-  291 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHH---------SSCCCCS-
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHc---------CCCCCCC-
Confidence             33567899999999999999999999999999999999999999864332211   110000         0000111 


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ........+.+++.+||+.||++|||+.|++++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            112233567788999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.6e-53  Score=422.51  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=208.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|+++ +|+.||||++...   .....+.+.+|+++|++++|||||++++++++++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999976 7899999999754   2344678999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||++||+|.+++.   ..+.+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999994   3467999999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .........+||+.|||||++.+..++.++|||||||+||||++|+.||........   ....            ....
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i------------~~~~  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---FAKI------------IKLE  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH------------HHTC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH------------HcCC
Confidence            443345577899999999999999999999999999999999999999865432211   1111            0101


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVV  525 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl  525 (569)
                      ... +......+.+++.+||+.||++|||+.|++
T Consensus       251 ~~~-p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 YDF-PEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCC-CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCC-CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            110 112234567789999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-52  Score=422.54  Aligned_cols=253  Identities=21%  Similarity=0.249  Sum_probs=204.1

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .+.|++.++||+|+||.||+|+++ +|+.||||++.....     ..+|+.+|++++|||||++++++.+++..||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356888899999999999999976 789999999865432     24799999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCcccCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEK  412 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~~~~~~~  412 (569)
                      ++||+|.++|.   ..+.+++..+..++.||+.||.|||+++   ||||||||+||||+.+| .+||+|||+|+......
T Consensus       132 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999994   3457999999999999999999999998   99999999999999988 59999999999775533


Q ss_pred             CC---CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          413 SL---LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       413 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..   ......+||+.|||||++.+..++.++|||||||+||||++|++||...........+.   ..  ....     
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~---~~--~~~~-----  275 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA---SE--PPPI-----  275 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH---HS--CCGG-----
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---cC--CCCc-----
Confidence            21   12234679999999999999999999999999999999999999987544332211111   00  0000     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                         ...++.....+.+++.+||+.||++|||+.||+++|...
T Consensus       276 ---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          276 ---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             ---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence               001122335677788999999999999999999888654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-52  Score=411.87  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=197.4

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeee----CCceEEE
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT----KKDSFVV  330 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  330 (569)
                      |++.++||+|+||.||+|+++ +++.||+|++...  .....+.|.+|+++|++++|||||++++++..    +...+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            356678999999999999976 6899999998654  23445779999999999999999999999875    3457999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~~~  409 (569)
                      ||||++|+|.+++.   ....+++..+..++.||+.||.|||+++ ++||||||||+||||+. ++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999994   3467899999999999999999999975 35999999999999984 7999999999998644


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..    .....+||+.|||||++.+ +++.++|||||||+||||++|+.||.......  .+..    ....+.....++
T Consensus       184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~----~i~~~~~~~~~~  252 (290)
T 3fpq_A          184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR----RVTSGVKPASFD  252 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH----HHTTTCCCGGGG
T ss_pred             CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHH----HHHcCCCCCCCC
Confidence            32    2346789999999998864 69999999999999999999999986432211  1111    111110000011


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .       .....+.+++.+||+.||++|||+.|++++
T Consensus       253 ~-------~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          253 K-------VAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             G-------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             c-------cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1       112356778899999999999999999974

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-52  Score=427.21  Aligned_cols=272  Identities=27%  Similarity=0.375  Sum_probs=217.6

Q ss_pred             ccccccchhHHHHHhccccccccccccCceeEEEEEecC------CceEEEEEEeecc-hhhHHHHHHHHHHHHhccc-c
Q 037160          241 LKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQD------GREIAVKRLFISR-KNRIKEICNEMDIMSRAHH-K  312 (569)
Q Consensus       241 ~~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~  312 (569)
                      ...+.++....|.-.++|++.++||+|+||.||+|.+..      ++.||||++.... ....+.|.+|+.+|.+++| |
T Consensus        49 ~~~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhp  128 (353)
T 4ase_A           49 CERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL  128 (353)
T ss_dssp             GGGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             hhcCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCC
Confidence            344455555566667899999999999999999998652      3579999987543 3445779999999999965 8


Q ss_pred             ccceeeeeeeeC-CceEEEEeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 037160          313 NLVQFLGCCFTK-KDSFVVYEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQ  378 (569)
Q Consensus       313 niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  378 (569)
                      |||+++++|.+. ...+||||||++|+|.++|....             .+..+++..++.++.||++||.|||+++   
T Consensus       129 nIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---  205 (353)
T 4ase_A          129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---  205 (353)
T ss_dssp             TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             cEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---
Confidence            999999999764 56899999999999999995422             1345899999999999999999999998   


Q ss_pred             eeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CC
Q 037160          379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GV  457 (569)
Q Consensus       379 ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~  457 (569)
                      ||||||||+||||++++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+
T Consensus       206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~  285 (353)
T 4ase_A          206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  285 (353)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence            99999999999999999999999999997765544333446779999999999999999999999999999999998 89


Q ss_pred             CCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          458 QNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       458 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .||.......  .+             ...+....... +......+.+++..||+.||++|||+.||+++|++
T Consensus       286 ~Pf~~~~~~~--~~-------------~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          286 SPYPGVKIDE--EF-------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CSSTTCCCSH--HH-------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCHHH--HH-------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            9986443221  01             11111111111 22234567788999999999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.7e-52  Score=430.16  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=209.9

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .+.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            356999999999999999999976 7999999999776655566789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      |+||+|.+++.    ...+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+++.+.....
T Consensus       230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            99999999984    345899999999999999999999999   99999999999999999999999999987755432


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                        .....+||+.|||||++.+..|+.++|||||||++|||++|++||...........   .         .......+.
T Consensus       303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~---i---------~~~~~~~~~  368 (423)
T 4fie_A          303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---I---------RDNLPPRLK  368 (423)
T ss_dssp             --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---H---------HHSCCCCCS
T ss_pred             --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH---H---------HcCCCCCCc
Confidence              34567899999999999999999999999999999999999999864332211100   0         000011111


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ........+.+++.+||+.||++|||+.|++++
T Consensus       369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             111233567788899999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.9e-52  Score=406.82  Aligned_cols=246  Identities=21%  Similarity=0.280  Sum_probs=190.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|+++ +|+.||||++....   ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999976 79999999986542   334567999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+ +|+|.+++.   .++.+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 678988884   3467999999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      .   .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......   +....    .        ..
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i----~--------~~  227 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNI----S--------NG  227 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----H--------HT
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----H--------cC
Confidence            3   2345789999999999988776 579999999999999999999986433221   11111    0        00


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... .+......+.+++.+||+.||++|||+.|++++
T Consensus       228 ~~~-~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          228 VYT-LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             CCC-CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             CCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            000 011123456778899999999999999999974

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.3e-52  Score=417.85  Aligned_cols=269  Identities=22%  Similarity=0.305  Sum_probs=199.7

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCC----ceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK----DSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  331 (569)
                      ++|.+.++||+|+||.||+|+++ |+.||||++...... ...+..|+..+.+++|||||++++++.+..    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            46778899999999999999985 899999998654322 223345666667889999999999998754    579999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      |||++|+|.++|.    ...++|..+.+++.|+++||.|||++     ..++||||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999994    34689999999999999999999987     12349999999999999999999999999998


Q ss_pred             ccCCCCCC--CCCcccccCCCcccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          407 FSSSEKSL--LPNTAIAGTLGYMAPEYIANG------QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       407 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      ........  .......||+.|||||++.+.      .++.++|||||||+||||+||++|+........... ......
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~-~~~~~~  235 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVPSD  235 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSCSS
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch-hccccc
Confidence            76554322  122356799999999998754      467899999999999999999887754433211000 000000


Q ss_pred             hcccchhh-hhcccCCCC------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          479 FQAKTVLE-IIDKSIEIE------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       479 ~~~~~~~~-~~~~~l~~~------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .....+.. +....+...      ..+....+.+++.+||+.||++|||+.||++.|++.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            00001111 111222111      234566788899999999999999999999999764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1e-51  Score=411.94  Aligned_cols=248  Identities=23%  Similarity=0.295  Sum_probs=196.4

Q ss_pred             ccccccccccccCceeEEEEEec----CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|++.++||+|+||.||+|+..    .++.||||++....  ......+.+|+++|++++|||||++++++.+++..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999863    46889999986432  2223468899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||++||+|.+++.   ..+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999994   3457999999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....  .....+||+.|||||++.+..++.++|||||||+||||++|+.||........   ....            ..
T Consensus       178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i------------~~  240 (304)
T 3ubd_A          178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET---MTMI------------LK  240 (304)
T ss_dssp             ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH------------HH
T ss_pred             CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH---HHHH------------Hc
Confidence            4332  23467899999999999999999999999999999999999999864432211   1111            11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~  527 (569)
                      .... .+......+.+++.+||+.||++|||     ++|++++
T Consensus       241 ~~~~-~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          241 AKLG-MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             CCCC-CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             CCCC-CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            1111 11122345778889999999999998     5788754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-50  Score=404.69  Aligned_cols=253  Identities=22%  Similarity=0.369  Sum_probs=191.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCC-------
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-------  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  325 (569)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356999999999999999999976 789999999976543 34567899999999999999999999987654       


Q ss_pred             -----ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          326 -----DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       326 -----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                           ..|+||||+++|+|.+++.........++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                 36899999999999999976555556777888999999999999999999   9999999999999999999999


Q ss_pred             ccCCCcccCCCCCCC----------CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 037160          401 DFGLARFSSSEKSLL----------PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET  470 (569)
Q Consensus       401 Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~  470 (569)
                      |||+|+.........          ..+..+||+.|||||++.+..++.++|||||||+||||++   ||..  ......
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~--~~~~~~  235 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST--QMERVR  235 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS--HHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC--ccHHHH
Confidence            999998775543211          1234679999999999999999999999999999999996   4421  100000


Q ss_pred             hhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                                  .+..+..................++.+||+.||++|||+.|++++
T Consensus       236 ------------~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 ------------TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             ------------HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                        001111111111112233455678999999999999999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=396.93  Aligned_cols=266  Identities=21%  Similarity=0.290  Sum_probs=203.2

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeee------CC
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT------KK  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~  325 (569)
                      .++|++.++||+|+||.||+|+++ +|+.||||++....  ....+.+.+|+++|++++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            467999999999999999999976 79999999996532  3345678899999999999999999998764      35


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..|||||||+ |+|.+++.   ..+.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 67999883   4567999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCC--CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh------
Q 037160          406 RFSSSEKS--LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW------  476 (569)
Q Consensus       406 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~------  476 (569)
                      +.+.....  .......+||+.|||||++.+. .++.++||||+|||+|||++|++||...........+....      
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            87654321  1133467899999999998775 57999999999999999999999997554332221111110      


Q ss_pred             --hhhcccchhhhhcccCCC--CCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 --KHFQAKTVLEIIDKSIEI--EDI-----EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 --~~~~~~~~~~~~~~~l~~--~~~-----~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        ...........+......  ...     .....+.+++.+||+.||++|||+.|++++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              000011111111111000  011     123457788999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-46  Score=382.66  Aligned_cols=282  Identities=32%  Similarity=0.576  Sum_probs=237.0

Q ss_pred             chhHHHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       247 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      .+..++..+++|++.+.||+|+||.||+|++++|+.||||++........+.+.+|+.++++++||||+++++++...+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            34445667899999999999999999999988899999999877666667889999999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          327 SFVVYEFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      .++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999985432 2346899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      +...............||+.|+|||++.++.++.++||||||+++|||++|+.|+....+........+.........+.
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            86554333223345668999999999999999999999999999999999999987665554444444443334444444


Q ss_pred             hhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          486 EIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       486 ~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ..+++.+... ..+....+.+++.+||+.+|++|||+.||+++|+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            4555544433 677888899999999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.3e-47  Score=388.29  Aligned_cols=207  Identities=27%  Similarity=0.447  Sum_probs=175.7

Q ss_pred             hhHHHHHhccccccccccccCceeEEEEEec----CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeee
Q 037160          248 YSTIEKATDCFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCF  322 (569)
Q Consensus       248 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  322 (569)
                      +..+....+.|++.++||+|+||.||+|+.+    .++.||||++....  ....+.+|+++|+.+ +|||||++++++.
T Consensus        13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            3445567889999999999999999999864    46789999886543  335678999999998 6999999999999


Q ss_pred             eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-CCeEEec
Q 037160          323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIAD  401 (569)
Q Consensus       323 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~kl~D  401 (569)
                      +.+..++||||+++++|.+++      +.+++.++..++.||+.||.|||+++   |+||||||+|||++.+ +.+||+|
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             ECCEEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence            999999999999999999998      24889999999999999999999999   9999999999999877 7999999


Q ss_pred             cCCCcccCCCCCC--------------------------CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHH
Q 037160          402 FGLARFSSSEKSL--------------------------LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIV  454 (569)
Q Consensus       402 fgla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~ell  454 (569)
                      ||+|+........                          ......+||+.|||||++.+. .++.++||||+||++|||+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            9999865432210                          011245799999999999775 5899999999999999999


Q ss_pred             hCCCCCCCCCC
Q 037160          455 SGVQNNKFQSD  465 (569)
Q Consensus       455 tg~~p~~~~~~  465 (569)
                      +|+.||....+
T Consensus       242 ~G~~Pf~~~~~  252 (361)
T 4f9c_A          242 SGRYPFYKASD  252 (361)
T ss_dssp             HTCSSSSCCSS
T ss_pred             HCCCCCCCCCC
Confidence            99999865443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-46  Score=404.02  Aligned_cols=251  Identities=22%  Similarity=0.239  Sum_probs=201.1

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHH---HHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEIC---NEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      -++|++.++||+|+||.||+|+.+ +|+.||||++....   ......+.   .++.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            468999999999999999999976 79999999996532   22223333   446666777999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ||||||++||+|.++|.   ..+.+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999994   3467999999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      +....    ....+||+.|||||++.. ..++.++|||||||+||||++|++||..........+....           
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i-----------  406 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----------  406 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH-----------
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-----------
Confidence            75543    345689999999999975 57999999999999999999999998643322211111111           


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQML  528 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~L  528 (569)
                       ...... .+......+.+++..||+.||++|++     +.||+++-
T Consensus       407 -~~~~~~-~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp  451 (689)
T 3v5w_A          407 -LTMAVE-LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  451 (689)
T ss_dssp             -HHCCCC-CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred             -cCCCCC-CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence             011111 11223456778889999999999998     68888543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.3e-46  Score=406.03  Aligned_cols=252  Identities=21%  Similarity=0.287  Sum_probs=209.6

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|++.++||+|+||.||+|+++ +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+....+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999976 7999999999876666667899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC--CCeEEeccCCCcccCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK--HRPKIADFGLARFSSSE  411 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~--~~~kl~Dfgla~~~~~~  411 (569)
                      |+||+|.++|..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999843  3457899999999999999999999999   9999999999999854  89999999999987654


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .   .....+||+.|||||++.+..++.++|||||||+||||++|++||...........+   ..    .      +..
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i---~~----~------~~~  374 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV---KS----C------DWN  374 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---HT----T------CCC
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---Hh----C------CCC
Confidence            3   234568999999999999999999999999999999999999998654332211100   00    0      000


Q ss_pred             CCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          492 IEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       492 l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +... .......+.+++.+||+.||++|||+.|++++
T Consensus       375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 11123456778899999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.4e-45  Score=375.33  Aligned_cols=288  Identities=36%  Similarity=0.656  Sum_probs=234.8

Q ss_pred             ccchhHHHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeee
Q 037160          245 QFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFT  323 (569)
Q Consensus       245 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  323 (569)
                      .+.+..++...++|++.++||+|+||.||+|..++|+.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus        19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   98 (326)
T 3uim_A           19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT   98 (326)
T ss_dssp             ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred             eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence            4677889999999999999999999999999988899999999865432 222368899999999999999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                      ....++||||+++++|.+++.... ....+++..++.++.|++.||.|||+....+|+||||||+|||++.++.+||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df  178 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF  178 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence            999999999999999999996543 3445999999999999999999999992222999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC--CcchhhhhHhHhhhhc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQS--DDGFETLVTHTWKHFQ  480 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~  480 (569)
                      |+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....  .........+......
T Consensus       179 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          179 GLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             SSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             ccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            999876544322 2335569999999999999999999999999999999999999985321  1111122333333444


Q ss_pred             ccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          481 AKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       481 ~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                      ........+..+... .......+.+++.+||+.+|++|||+.||+++|+....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            444555555544433 67788899999999999999999999999999987543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-43  Score=357.46  Aligned_cols=284  Identities=34%  Similarity=0.558  Sum_probs=233.5

Q ss_pred             ccccchhHHHHHhcccccc------ccccccCceeEEEEEecCCceEEEEEEeec----chhhHHHHHHHHHHHHhcccc
Q 037160          243 FLQFKYSTIEKATDCFDES------NKLGHGGYGEIFKGTLQDGREIAVKRLFIS----RKNRIKEICNEMDIMSRAHHK  312 (569)
Q Consensus       243 ~~~~~~~~~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~  312 (569)
                      ...+.+..++.++++|...      ++||+|+||.||+|.. +++.||||++...    .....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3457788899999999887      8999999999999987 4789999998653    234457799999999999999


Q ss_pred             ccceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC
Q 037160          313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD  392 (569)
Q Consensus       313 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~  392 (569)
                      ||+++++++......++||||+++++|.+++........+++..++.++.|++.||.|||+.+   |+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999965555567999999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhh
Q 037160          393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV  472 (569)
Q Consensus       393 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~  472 (569)
                      .++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|++|+...........+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            999999999999987655332222335678999999998764 5899999999999999999999998765433221111


Q ss_pred             HhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          473 THTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      .... ......+.+.++..+..........+.+++..||+.+|++|||+.+|+++|++..
T Consensus       247 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          247 KEEI-EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHH-HTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHh-hhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1110 1112334555666665557778888999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.8e-44  Score=362.97  Aligned_cols=267  Identities=28%  Similarity=0.430  Sum_probs=204.7

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..++|++.++||+|+||.||+|+. +|+.||||++....  ....+.+.+|+.++++++||||+++++++......++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356799999999999999999987 47899999986543  344567999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++........+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999965444456999999999999999999999985 34999999999999999999999999999855443


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.  .            ...
T Consensus       193 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~--~------------~~~  256 (309)
T 3p86_A          193 FL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG--F------------KCK  256 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--H------------SCC
T ss_pred             cc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h------------cCC
Confidence            21  2345679999999999999999999999999999999999999986443221110000  0            000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTP  538 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p  538 (569)
                      ....+......+.+++.+||+.+|++|||+.+|++.|+.......+|
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence            00012223346778999999999999999999999998865544333

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.5e-44  Score=357.40  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=209.3

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ..++|++.++||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            4568999999999999999999964 789999999987666666789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999843    35899999999999999999999998   9999999999999999999999999998765543


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+  . ..         ....+
T Consensus       171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~-~~---------~~~~~  236 (297)
T 3fxz_A          171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--A-TN---------GTPEL  236 (297)
T ss_dssp             C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--H-HH---------CSCCC
T ss_pred             c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-hC---------CCCCC
Confidence            2  234567999999999999999999999999999999999999998644322111000  0 00         00000


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       .........+.+++.+||+.||++|||+.|++++
T Consensus       237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             0122233457788999999999999999999965

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.2e-44  Score=363.91  Aligned_cols=268  Identities=25%  Similarity=0.307  Sum_probs=208.9

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCc----eEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD----SFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv  330 (569)
                      .++|++.++||+|+||.||+|++. ++.||||++...... .....+|+.++++++||||+++++++.....    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            357889999999999999999876 789999998655433 3456679999999999999999999987543    6999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD----------GQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                      |||+++|+|.+++..    ..+++..++.++.|++.||.|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999943    4589999999999999999999998          7   9999999999999999999999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-----GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  475 (569)
                      |||+++...............||+.|+|||++.+     ..++.++||||||+++|||++|+.||...............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999987766544333445679999999999976     35667899999999999999999998754433221111111


Q ss_pred             hhhhcccchhhhhc-c----cCCC--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          476 WKHFQAKTVLEIID-K----SIEI--EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       476 ~~~~~~~~~~~~~~-~----~l~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ........+.+.+. .    .+..  ........+.+++.+||+.||++|||+.||++.|+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111111111111 1    1111  1234556788999999999999999999999999764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-43  Score=366.41  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=210.9

Q ss_pred             hccccccccccccCceeEEEEEec--------CCceEEEEEEeec-chhhHHHHHHHHHHHHhc-cccccceeeeeeeeC
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ--------DGREIAVKRLFIS-RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK  324 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  324 (569)
                      .++|++.+.||+|+||.||+|.+.        ++..||||++... .....+.+.+|+.+|+++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            367889999999999999999853        3457999998654 334567899999999999 899999999999999


Q ss_pred             CceEEEEeecCCCChhhHhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999954321             245889999999999999999999998   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~  470 (569)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......... 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence            9999999999999987665443333445567889999999999999999999999999999999 88887654332211 


Q ss_pred             hhHhHhhhhcccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                                     ..+..... ..+......+..++..||+.+|++|||+.||++.|+..
T Consensus       316 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          316 ---------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             ---------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                           11111111 11223345677899999999999999999999999764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-43  Score=360.50  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=206.2

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .++|++.++||+|+||.||+|++. +|+.||||++...  .....+.+.+|+++|++++||||+++++++......++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            467999999999999999999974 7999999998654  3345677889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++++||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999843   356899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCCCcccccCCCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLT-EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      .   ......||+.|+|||++.+..++ .++|||||||++|||++|+.||.........   ...            ...
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i------------~~~  229 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR---ERV------------LRG  229 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH------------HHC
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH---HHH------------HhC
Confidence            3   23456799999999999888765 7999999999999999999998654322111   100            001


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... .+......+.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 KYR-IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCC-CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCC-CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            010 111233457788899999999999999999975

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=354.08  Aligned_cols=263  Identities=25%  Similarity=0.415  Sum_probs=213.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|.+.++||+|+||.||++.+. +++.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357889999999999999999976 6899999998776677778899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999953  2456899999999999999999999999   99999999999999999999999999987654332


Q ss_pred             CC------------CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          414 LL------------PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       414 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+...........          
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------  233 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------  233 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------
Confidence            11            01145799999999999999999999999999999999999988765433321110          


Q ss_pred             cchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          482 KTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       482 ~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                      .......+....   ......+.+++..||+.+|++|||+.+|++.|+.....+
T Consensus       234 ~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          234 LNVRGFLDRYCP---PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             BCHHHHHHHTCC---TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhhhccccccCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            001111111111   112235777899999999999999999999998765443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.9e-43  Score=357.77  Aligned_cols=250  Identities=23%  Similarity=0.287  Sum_probs=206.2

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|++.++||+|+||.||+++.+ +|+.||+|++...   .......+.+|+.+|++++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367999999999999999999976 6899999999754   234456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999984   3456899999999999999999999998   99999999999999999999999999986433


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........   ..            +...
T Consensus       158 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~------------i~~~  220 (337)
T 1o6l_A          158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---EL------------ILME  220 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH------------HHHC
T ss_pred             CCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH---HH------------HHcC
Confidence            221  234568999999999999999999999999999999999999998643322111   00            0011


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQML  528 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~L  528 (569)
                      .+. .+......+.+++..||+.+|++||     ++.||+++-
T Consensus       221 ~~~-~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~  262 (337)
T 1o6l_A          221 EIR-FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             CCC-CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             CCC-CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence            111 0112234677788999999999999     899998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.8e-43  Score=357.93  Aligned_cols=255  Identities=25%  Similarity=0.320  Sum_probs=205.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +.++|++.++||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            3468999999999999999999976 789999999865432 23456889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        85 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999999983   4456899999999999999999999998   999999999999999999999999999866543


Q ss_pred             CCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..........||+.|+|||++.+..+ +.++||||||+++|||++|+.||..........      ..+..        .
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~~~~~--------~  224 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKE--------K  224 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH------HHHHT--------T
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHhc--------c
Confidence            33223345679999999999987765 789999999999999999999987544321110      00000        0


Q ss_pred             cCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          491 SIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       491 ~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      .... ........+.+++.+||+.||++|||+.|++++-
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence            0000 0112234567889999999999999999999764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.2e-43  Score=355.09  Aligned_cols=261  Identities=25%  Similarity=0.367  Sum_probs=212.9

Q ss_pred             cchhHHHHHhcc----------ccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcccccc
Q 037160          246 FKYSTIEKATDC----------FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL  314 (569)
Q Consensus       246 ~~~~~~~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni  314 (569)
                      +.+..++.+++.          |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni  104 (321)
T 2c30_A           25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV  104 (321)
T ss_dssp             CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred             CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence            445555555543          777889999999999999976 799999999987666667789999999999999999


Q ss_pred             ceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC
Q 037160          315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK  394 (569)
Q Consensus       315 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~  394 (569)
                      +++++++...+..++||||+++++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          105 VEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD  177 (321)
T ss_dssp             CCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             ceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence            999999999999999999999999999983    246899999999999999999999998   9999999999999999


Q ss_pred             CCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh
Q 037160          395 HRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH  474 (569)
Q Consensus       395 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  474 (569)
                      +.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........   ...
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~~  252 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKR  252 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH
T ss_pred             CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence            9999999999987654332  23456799999999999999999999999999999999999999864432211   000


Q ss_pred             HhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          475 TWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       475 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                               +.....+.+. ........+.+++.+||+.+|++|||+.|++++-
T Consensus       253 ---------~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          253 ---------LRDSPPPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             ---------HHHSSCCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             ---------HhcCCCCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                     0000001110 1112234577888999999999999999999753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.6e-44  Score=360.56  Aligned_cols=273  Identities=21%  Similarity=0.389  Sum_probs=207.7

Q ss_pred             hccccccccccccCceeEEEEEe-----cCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeC--Cce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTL-----QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  327 (569)
                      .++|++.++||+|+||.||++++     .+++.||||++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46789999999999999999984     26889999999877777778899999999999999999999998653  568


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHH--CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHh--cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            999999999999999953  2345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.......................+.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6554322 122344577889999999999999999999999999999999888653221100000000000000011112


Q ss_pred             hhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          487 IIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       487 ~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      .+...... .+......+.+++..||+.+|++|||+.||++.|+...
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            22211111 13334467888999999999999999999999998654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-43  Score=364.16  Aligned_cols=270  Identities=28%  Similarity=0.383  Sum_probs=214.9

Q ss_pred             cccchhHHHHHhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccc
Q 037160          244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLV  315 (569)
Q Consensus       244 ~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv  315 (569)
                      +.+.....+...++|++.++||+|+||.||+|++.      +++.||||++.... ....+.+.+|++++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            34555666677889999999999999999999732      46889999997643 34456799999999999 899999


Q ss_pred             eeeeeeeeCCc-eEEEEeecCCCChhhHhhCCCC----------------------------------------------
Q 037160          316 QFLGCCFTKKD-SFVVYEFVQNKSLDRILFDPKQ----------------------------------------------  348 (569)
Q Consensus       316 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------  348 (569)
                      ++++++..... .++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999987654 8999999999999999965432                                              


Q ss_pred             -----------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          349 -----------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       349 -----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                                       +..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             122899999999999999999999998   999999999999999999999999999876554


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..........||+.|+|||++.+..++.++||||||+++|||++ |+.|+........  +.             ..+..
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~-------------~~~~~  311 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC-------------RRLKE  311 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HH-------------HHHHH
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HH-------------HHHHc
Confidence            33323345678999999999999999999999999999999998 9999865433211  00             00000


Q ss_pred             cCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          491 SIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       491 ~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ... ..+......+.+++..||+.+|++|||+.||+++|+..
T Consensus       312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            000 01122334677889999999999999999999999753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-43  Score=348.60  Aligned_cols=254  Identities=23%  Similarity=0.381  Sum_probs=209.1

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|++.++||+|+||.||++.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            57889999999999999999998889999999875433 33678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++........ 
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  162 (269)
T 4hcu_A           89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  162 (269)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred             CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence            9999999953  3456899999999999999999999999   999999999999999999999999999866543221 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.........   ..            +.......
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~---~~------------~~~~~~~~  227 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---ED------------ISTGFRLY  227 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HH------------HHTTCCCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH---HH------------HhcCccCC
Confidence            2334557788999999999999999999999999999999 88887644322111   00            00000011


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .+......+.+++..||+.+|++|||+.|++++|++.
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            1222345677889999999999999999999999764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=357.72  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=207.0

Q ss_pred             hccccccccccccCceeEEEEEec----CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|+||.||+|.+.    .+..||||++... .....+.+.+|+.++++++||||+++++++......++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467899999999999999999975    3446999998754 34445779999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999953  3356899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          410 SEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       410 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||........                ...
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------~~~  266 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV----------------ISS  266 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----------------HHH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH----------------HHH
Confidence            543221 1223456788999999999999999999999999999999 9988754332211                111


Q ss_pred             hcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          488 IDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       488 ~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      +..... .........+.+++..||+.+|++|||+.+|++.|+...
T Consensus       267 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            111111 112233456788999999999999999999999998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.1e-43  Score=354.77  Aligned_cols=254  Identities=21%  Similarity=0.388  Sum_probs=203.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCc-----
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD-----  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  326 (569)
                      +.++|++.++||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+...     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999987 79999999997543 3355789999999999999999999999865432     


Q ss_pred             ----------------------------------------------------eEEEEeecCCCChhhHhhCCCCCccCCH
Q 037160          327 ----------------------------------------------------SFVVYEFVQNKSLDRILFDPKQKKELDW  354 (569)
Q Consensus       327 ----------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~l~~  354 (569)
                                                                          .++||||+++++|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                                7999999999999999977666667788


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC----------CCCcccccCC
Q 037160          355 KKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL----------LPNTAIAGTL  424 (569)
Q Consensus       355 ~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~  424 (569)
                      ..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            889999999999999999998   999999999999999999999999999877654321          1223457999


Q ss_pred             CcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHH
Q 037160          425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVV  504 (569)
Q Consensus       425 ~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  504 (569)
                      .|+|||++.+..++.++||||||+++|||++|..|+.     ....            ....................+.
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~------------~~~~~~~~~~~~~~~~~~~~~~  303 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVR------------IITDVRNLKFPLLFTQKYPQEH  303 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHH------------HHHHHHTTCCCHHHHHHCHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHH------------HHHHhhccCCCcccccCChhHH
Confidence            9999999999999999999999999999999865421     0000            0001111111111233445677


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHH
Q 037160          505 WVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       505 ~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +++..||+.+|++|||+.|++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            89999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=350.36  Aligned_cols=273  Identities=19%  Similarity=0.231  Sum_probs=215.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCC--ceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK--DSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv  330 (569)
                      .++|.+.++||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999976 58999999987543 334567889999999999999999999998765  67999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----CCCCCeEEeccCCCc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL----DLKHRPKIADFGLAR  406 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll----~~~~~~kl~Dfgla~  406 (569)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976555555999999999999999999999998   9999999999999    778889999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhhhHhHhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIA--------NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG-FETLVTHTWK  477 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~  477 (569)
                      .......   .....||+.|+|||++.        +..++.++||||||+++|||++|+.||....... ..........
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            7655432   23457999999999986        5688999999999999999999999986443322 1111111111


Q ss_pred             hhcccchhhh-------h--cccCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          478 HFQAKTVLEI-------I--DKSIE---IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       478 ~~~~~~~~~~-------~--~~~l~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                      ......+...       +  ...+.   .........+..++..||+.||++|||+.|++++..+...
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            1111000000       0  00011   1145666778889999999999999999999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-42  Score=358.15  Aligned_cols=251  Identities=24%  Similarity=0.302  Sum_probs=206.7

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchh------hHHHHHHHHHHHHhccccccceeeeeeeeCC
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN------RIKEICNEMDIMSRAHHKNLVQFLGCCFTKK  325 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  325 (569)
                      .+.+.|++.++||+|+||.||+++.+ +|+.||+|.+......      ..+.+.+|+.+|++++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            35678999999999999999999976 6899999998764322      3467899999999999999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC----CeEEec
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH----RPKIAD  401 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~----~~kl~D  401 (569)
                      ..++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            9999999999999999993   3467999999999999999999999998   99999999999998877    799999


Q ss_pred             cCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          402 FGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       402 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      ||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........   .        
T Consensus       163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~---~--------  228 (361)
T 2yab_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---A--------  228 (361)
T ss_dssp             CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H--------
T ss_pred             cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---H--------
Confidence            99998765533   234567999999999999999999999999999999999999998654322111   0        


Q ss_pred             cchhhhhcccCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 KTVLEIIDKSIEIED---IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 ~~~~~~~~~~l~~~~---~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                          .+.........   ......+.+++..||+.||++|||+.|++++
T Consensus       229 ----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          229 ----NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             ----HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----HHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                00000000000   0123456778999999999999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.3e-43  Score=345.92  Aligned_cols=257  Identities=22%  Similarity=0.360  Sum_probs=210.6

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .++|++.++||+|+||.||++.++++..||+|++..... ..+.+.+|+.++++++||||+++++++......++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467999999999999999999998888999999876543 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            99999999943  2346899999999999999999999998   999999999999999999999999999876554322


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                       ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...........               .......
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---------------~~~~~~~  224 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---------------VSQGHRL  224 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---------------HHTTCCC
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH---------------HHcCCCC
Confidence             2234456778999999999899999999999999999999 9888764432211100               0000000


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       494 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                      ..+......+.+++..||+.+|++|||+.|+++.|+....
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            1111123467789999999999999999999999987653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9e-43  Score=362.56  Aligned_cols=256  Identities=22%  Similarity=0.321  Sum_probs=202.7

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|+||.||+++.+ +++.||+|++....   ......+.+|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999976 67899999997543   22334578899999887 89999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++|+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999984   3456899999999999999999999999   9999999999999999999999999998533


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh--hhhHhHhhhhcccchhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE--TLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  487 (569)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ......+        ..+
T Consensus       205 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~--------~~i  274 (396)
T 4dc2_A          205 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVI  274 (396)
T ss_dssp             CTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH--------HHH
T ss_pred             cCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH--------HHH
Confidence            3221  334678999999999999999999999999999999999999999643321110  0000000        011


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSM------TNVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~------~evl~~  527 (569)
                      ....+. .+......+..++..||+.||++||++      .||+++
T Consensus       275 ~~~~~~-~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          275 LEKQIR-IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHCCCC-CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             hccccC-CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            111111 122234567788999999999999995      677754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-43  Score=360.17  Aligned_cols=255  Identities=23%  Similarity=0.367  Sum_probs=200.2

Q ss_pred             hccccccccccccCceeEEEEEec-CCce----EEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGRE----IAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      .++|++.++||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++... ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            356899999999999999999965 4444    577776443 234557899999999999999999999999875 478


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +|+||+.+|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999853  3456899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........                ..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------~~  231 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------------SI  231 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------HH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----------------HH
Confidence            65544333345567889999999999999999999999999999999 99988654433221                11


Q ss_pred             hcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          488 IDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       488 ~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      +..... .........+..++.+||+.+|++||++.||+++|+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111 11233445688899999999999999999999998654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.1e-43  Score=359.35  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=201.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|+||.||+++++ +|+.||||++...   .....+.+.+|..+++.+ +||||+++++++.+....++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999976 6899999999754   234456788999999998 79999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999984   3456899999999999999999999998   9999999999999999999999999998543


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........   .            .+..
T Consensus       176 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~------------~i~~  238 (353)
T 3txo_A          176 CNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF---E------------AILN  238 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H------------HHHH
T ss_pred             cCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH---H------------HHHc
Confidence            3221  234568999999999999989999999999999999999999998654332111   0            1111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSM------TNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~------~evl~~  527 (569)
                      .... .+......+..++..||+.+|++||++      .||+++
T Consensus       239 ~~~~-~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          239 DEVV-YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             CCCC-CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CCCC-CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            1111 111233457778899999999999999      888854

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=358.34  Aligned_cols=249  Identities=25%  Similarity=0.366  Sum_probs=205.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67999999999999999999976 68899999986542   344577889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+.+|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999994   3456899999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCCCcccccCCCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIAN---GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      .   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+....             
T Consensus       169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-------------  232 (384)
T 4fr4_A          169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF-------------  232 (384)
T ss_dssp             C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-------------
T ss_pred             C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-------------
Confidence            3   3346689999999999864   45899999999999999999999998755443322221111             


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPS-MTNVVQ  526 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-~~evl~  526 (569)
                      .......+......+..++..||+.+|++||+ +.+|++
T Consensus       233 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          233 ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11111112223456788899999999999998 777775

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-43  Score=354.78  Aligned_cols=251  Identities=18%  Similarity=0.254  Sum_probs=206.8

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      +.++|++.++||+|+||.||++... +++.+|+|.+.... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            4578999999999999999999976 68899999886543 344678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC--CCCeEEeccCCCcccCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL--KHRPKIADFGLARFSSS  410 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~--~~~~kl~Dfgla~~~~~  410 (569)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++....
T Consensus        82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999999943  3346899999999999999999999998   999999999999987  78999999999987754


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..   ......||+.|+|||++.+..++.++||||||+++|||++|..||.........   .            .+...
T Consensus       157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~------------~i~~~  218 (321)
T 1tki_A          157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---E------------NIMNA  218 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H------------HHHHT
T ss_pred             CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH---H------------HHHcC
Confidence            33   234567999999999999888999999999999999999999998654322111   1            01111


Q ss_pred             cCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          491 SIEIED---IEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       491 ~l~~~~---~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ......   ......+.+++.+||+.||++|||+.|++++-
T Consensus       219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            111000   11234677899999999999999999999743

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.5e-43  Score=350.44  Aligned_cols=262  Identities=23%  Similarity=0.331  Sum_probs=205.7

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ..++|++.++||+|+||.||++++. +++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            3567999999999999999999975 78999999986532   3445778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++.   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        89 v~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999994   3356899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........      ........ ..... 
T Consensus       163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~~~~-  233 (294)
T 4eqm_A          163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-VPNVT-  233 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-CCCHH-
T ss_pred             ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-CCCcc-
Confidence            43322 23356799999999999999999999999999999999999999864432211      00110000 00000 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhccCCC
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRP-SMTNVVQMLKQKDI  533 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-t~~evl~~L~~~~~  533 (569)
                      ...   .......+.+++.+||+.+|++|| ++.++.+.|+....
T Consensus       234 ~~~---~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          234 TDV---RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHS---CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             hhc---ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            000   112234677889999999999998 99999999987543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=351.72  Aligned_cols=250  Identities=24%  Similarity=0.295  Sum_probs=206.0

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchh------hHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN------RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      ..+.|++.+.||+|+||.||+++.+ +|+.||+|++......      ..+.+.+|+.+|++++||||+++++++.....
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4567999999999999999999976 6899999998754321      35779999999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC----CeEEecc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH----RPKIADF  402 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~----~~kl~Df  402 (569)
                      .++||||+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999993   3467899999999999999999999998   99999999999999887    7999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      |+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||........   ....       
T Consensus       163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~-------  229 (326)
T 2y0a_A          163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANV-------  229 (326)
T ss_dssp             TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH-------
T ss_pred             CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHH-------
Confidence            9998765433   22356799999999999989999999999999999999999999864332211   0000       


Q ss_pred             chhhhhcccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLEIIDKSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                           ........   .......+.+++..||+.+|++|||+.|++++
T Consensus       230 -----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          230 -----SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             -----HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----HhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 00000000   01123456788999999999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.4e-43  Score=363.48  Aligned_cols=256  Identities=25%  Similarity=0.417  Sum_probs=196.9

Q ss_pred             hccccccccccccCceeEEEEEec----CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|+||.||+|+++    ++..||||++... .....+.+.+|+.++++++||||+++++++......++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            457999999999999999999875    5678999998754 33445689999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999953  3456899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          410 SEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       410 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+........                ...
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~----------------~~~  262 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----------------IKA  262 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH----------------HHH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHH
Confidence            433211 1123345788999999999999999999999999999998 9988754332211                111


Q ss_pred             hcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          488 IDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       488 ~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      +..... .........+.+++..||+.+|++||++.+|++.|+..
T Consensus       263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            111111 11223345678899999999999999999999998754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.2e-43  Score=367.18  Aligned_cols=266  Identities=17%  Similarity=0.209  Sum_probs=210.0

Q ss_pred             cchhHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeee
Q 037160          246 FKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCC  321 (569)
Q Consensus       246 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~  321 (569)
                      .++..++...++|++.++||+|+||.||+++++ +++.||+|++....   ......+.+|+.++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345556667789999999999999999999987 57899999986532   12223488999999999999999999999


Q ss_pred             eeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEec
Q 037160          322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD  401 (569)
Q Consensus       322 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  401 (569)
                      .+....++||||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence            999999999999999999999953  2456899999999999999999999998   99999999999999999999999


Q ss_pred             cCCCcccCCCCCCCCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh
Q 037160          402 FGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       402 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+++........ ......||+.|+|||++.     .+.++.++|||||||++|||++|+.||...........+....
T Consensus       219 FGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  297 (437)
T 4aw2_A          219 FGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK  297 (437)
T ss_dssp             CTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             hhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence            9999876544322 233468999999999987     4678999999999999999999999987543322111110000


Q ss_pred             hhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 037160          477 KHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTL--RPSMTNVVQML  528 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~~L  528 (569)
                      .           ..............+.+++.+||..+|++  ||++.||+++-
T Consensus       298 ~-----------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          298 E-----------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             H-----------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             c-----------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence            0           00000001112345667788999888888  99999999753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.1e-42  Score=356.88  Aligned_cols=254  Identities=22%  Similarity=0.315  Sum_probs=206.1

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .+.++|++.++||+|+||.||++.++ +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45678999999999999999999976 68999999986542  3445678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC---CeEEeccCCCc
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLAR  406 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~---~~kl~Dfgla~  406 (569)
                      ||||+++++|.+.+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999999884   3456899999999999999999999998   99999999999998654   59999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|++||........   ....    ..+..  
T Consensus       180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i----~~~~~--  247 (362)
T 2bdw_A          180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YAQI----KAGAY--  247 (362)
T ss_dssp             CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCC--
T ss_pred             EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----HhCCC--
Confidence            765433   22356799999999999998999999999999999999999999864332211   1000    00000  


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        . ............+.+++.+||+.||++|||+.|++++
T Consensus       248 --~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          248 --D-YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             --C-CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --C-CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0 0000011223457788999999999999999999865

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=365.20  Aligned_cols=256  Identities=19%  Similarity=0.242  Sum_probs=206.2

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ..+.++|++.++||+|+||.||++... +|+.+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            356788999999999999999999875 78999999986543  334567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC---CCCCeEEeccCCC
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD---LKHRPKIADFGLA  405 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~---~~~~~kl~Dfgla  405 (569)
                      +||||+++|+|.+.+..   +..+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||++
T Consensus        87 lv~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EEECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            99999999999998843   456899999999999999999999998   99999999999998   4678999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.........   .    ....+.. 
T Consensus       161 ~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~---~----~i~~~~~-  230 (444)
T 3soa_A          161 IEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY---Q----QIKAGAY-  230 (444)
T ss_dssp             BCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H----HHHHTCC-
T ss_pred             EEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH---H----HHHhCCC-
Confidence            87655332  234567999999999999999999999999999999999999998644322111   0    0000000 


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          486 EIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       486 ~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                          .............+.+++..||+.||++|||+.|++++
T Consensus       231 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 ----DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                00000011223567788999999999999999999975

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-42  Score=349.01  Aligned_cols=266  Identities=22%  Similarity=0.313  Sum_probs=203.6

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..++|++.++||+|+||.||+|++.+|+.||+|++....  ......+.+|+.++++++||||+++++++......++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            457899999999999999999999889999999986543  233467889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99985 77777743  3456899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh----
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE----  486 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  486 (569)
                      ..  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...........+..    
T Consensus       173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            22  2334578999999999876 5689999999999999999999999876544332111111000000000000    


Q ss_pred             --hhc---ccCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 --IID---KSIEIED-----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 --~~~---~~l~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        ..+   .......     +.....+.+++.+||+.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence              000   0000001     1123467789999999999999999999974

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-43  Score=366.68  Aligned_cols=257  Identities=26%  Similarity=0.387  Sum_probs=208.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..++|.+.++||+|+||.||+|+++ +++.||||.+.... ......+.+|+.+|++++||||+++++++...+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3467899999999999999999986 78999999886542 334457889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999953  2346899999999999999999999998   999999999999999999999999999865443


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..........+++.|+|||.+.++.++.++||||||+++|||++ |..|+........                .+.+..
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~----------------~~~~~~  330 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT----------------REFVEK  330 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH----------------HHHHHT
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHHc
Confidence            22211223345778999999999999999999999999999998 8888764332211                111111


Q ss_pred             cCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          491 SIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       491 ~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ..... +......+.+++..||+.+|++|||+.+|++.|+..
T Consensus       331 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          331 GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            11111 122334677889999999999999999999999764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=347.58  Aligned_cols=263  Identities=23%  Similarity=0.398  Sum_probs=202.4

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|++.++||+|+||.||++++. ++.||||++...  ...+.+.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            56888999999999999999986 789999988543  34577899999999999999999999886  45899999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC-eEEeccCCCcccCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR-PKIADFGLARFSSSEKSL  414 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~-~kl~Dfgla~~~~~~~~~  414 (569)
                      +++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976554456889999999999999999999933223999999999999998887 799999999755432   


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.|+..........    .+....         .....
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~---------~~~~~  224 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHN---------GTRPP  224 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HHHHHT---------TCCCC
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HHHHhc---------CCCCC
Confidence              234468999999999999999999999999999999999999986443321110    111000         00000


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCC
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKP  541 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p~~p  541 (569)
                      ........+.+++.+||+.+|++|||+.+|++.|+.....++.+..|
T Consensus       225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence            11122345778899999999999999999999998776555544433

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=360.19  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=214.0

Q ss_pred             HhccccccccccccCceeEEEEEec--------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ--------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT  323 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  323 (569)
                      ..++|.+.++||+|+||.||+|+..        .+..||||++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            4578999999999999999999863        23579999986543 34457899999999999 99999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeE
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNIL  390 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIl  390 (569)
                      .+..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999954321             245899999999999999999999998   999999999999


Q ss_pred             ECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 037160          391 LDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFE  469 (569)
Q Consensus       391 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~  469 (569)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+........ 
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~-  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999987765443334445667899999999999999999999999999999999 8888764432211 


Q ss_pred             hhhHhHhhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          470 TLVTHTWKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       470 ~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                                     .+.+...... ........+.+++..||+.+|++|||+.||++.|+......
T Consensus       303 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          303 ---------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             ---------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ---------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                           1111111111 12223456778999999999999999999999998765433

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-42  Score=346.60  Aligned_cols=255  Identities=22%  Similarity=0.365  Sum_probs=206.9

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ..++|++.++||+|+||.||++.++++..||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3567899999999999999999998888999999875433 236789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.......
T Consensus       101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            999999999953  2456899999999999999999999998   99999999999999999999999999986654322


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      . ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........                +.+....
T Consensus       176 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~----------------~~~~~~~  238 (283)
T 3gen_A          176 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------EHIAQGL  238 (283)
T ss_dssp             H-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------------HHHHTTC
T ss_pred             c-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH----------------HHHhccc
Confidence            1 2234456788999999999999999999999999999998 98887644322111                1111111


Q ss_pred             C-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          493 E-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       493 ~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      . ..+......+.+++..||+.+|++|||+.+++++|+..
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1 11122235677899999999999999999999999753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-43  Score=356.69  Aligned_cols=267  Identities=24%  Similarity=0.352  Sum_probs=213.4

Q ss_pred             HHHHhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeee
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT  323 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  323 (569)
                      ++...++|++.+.||+|+||.||+|++.      +++.||||++.... ....+.+.+|+.++++++||||+++++++..
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445688999999999999999999975      34789999987543 3445779999999999999999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCC---------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQ---------------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHR  382 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHr  382 (569)
                      .+..++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+++   |+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            9999999999999999999954321                     257899999999999999999999998   9999


Q ss_pred             CCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 037160          383 DIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNK  461 (569)
Q Consensus       383 Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~  461 (569)
                      ||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999987654433223345668899999999999999999999999999999999 988876


Q ss_pred             CCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          462 FQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                      .......   ..            .+.+......+......+.+++..||+.+|++||++.+|++.|++.....
T Consensus       279 ~~~~~~~---~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          279 GMAHEEV---IY------------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TSCHHHH---HH------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CCChHHH---HH------------HHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            4332211   10            00111111112223356788999999999999999999999999866443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-43  Score=361.77  Aligned_cols=259  Identities=26%  Similarity=0.361  Sum_probs=208.7

Q ss_pred             hccccccccccccCceeEEEEEec------CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      .++|++.++||+|+||.||+|++.      +++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467899999999999999999843      4678999998643 344456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCC----CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC---CeEEe
Q 037160          328 FVVYEFVQNKSLDRILFDPK----QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKIA  400 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~---~~kl~  400 (569)
                      ++||||+++++|.+++....    ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999995432    2246899999999999999999999999   99999999999999655   49999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhh
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|+.........          
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~----------  296 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----------  296 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------
Confidence            9999986544333323445678999999999999999999999999999999998 88887654322111          


Q ss_pred             cccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          480 QAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       480 ~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                            +.+..... .........+.+++..||+.+|++|||+.+|++.|+...
T Consensus       297 ------~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          297 ------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             ------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                  11111111 112223345778999999999999999999999997643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.9e-43  Score=358.45  Aligned_cols=276  Identities=22%  Similarity=0.337  Sum_probs=212.2

Q ss_pred             ccccccccccccCceeEEEEEe-----cCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeee--eCCceE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTL-----QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF--TKKDSF  328 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~  328 (569)
                      ++|++.++||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788999999999999999984     368899999998777677788999999999999999999999887  445689


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            99999999999999943  2346899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+........... ...........+.+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHHH
Confidence            544321 122345688889999999999999999999999999999999988653221110000 000000000112222


Q ss_pred             hcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCC
Q 037160          488 IDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPT  537 (569)
Q Consensus       488 ~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  537 (569)
                      +....... .......+.+++..||+.+|++|||+.||+++|+........
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            22222211 334456788899999999999999999999999877554433

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.5e-42  Score=351.98  Aligned_cols=255  Identities=23%  Similarity=0.331  Sum_probs=203.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|++.++||+|+||.||+++++ +++.||+|++...   .....+.+.+|..++.++ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57899999999999999999976 6889999999754   234456788999999988 899999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999984   3356899999999999999999999998   99999999999999999999999999986433


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh--hhhHhHhhhhcccchhhhh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE--TLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  488 (569)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ......+.        .+.
T Consensus       163 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~i~  232 (345)
T 3a8x_A          163 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VIL  232 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--------HHH
T ss_pred             CCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--------HHH
Confidence            221  234568999999999999999999999999999999999999998643221100  00000000        111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSM------TNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~------~evl~~  527 (569)
                      ..... .+......+..++..||+.+|++||++      .||+++
T Consensus       233 ~~~~~-~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          233 EKQIR-IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HCCCC-CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             cCCCC-CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            11111 112234567788899999999999995      677754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-42  Score=347.41  Aligned_cols=245  Identities=22%  Similarity=0.322  Sum_probs=204.4

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+++.+ +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            67999999999999999999976 78999999987542   234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999994   3456899999999999999999999998   999999999999999999999999999876442


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                           .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   .            ..++...
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~------------~~i~~~~  219 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---Y------------EKILNAE  219 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H------------HHHHHCC
T ss_pred             -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H------------HHHHhCC
Confidence                 2356799999999999999999999999999999999999999864332111   0            0111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      +.. +......+.+++..||+.+|++||     ++.||+++
T Consensus       220 ~~~-p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          220 LRF-PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CCC-CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCC-CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            110 112234677888999999999999     89999954

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.7e-42  Score=353.02  Aligned_cols=253  Identities=19%  Similarity=0.261  Sum_probs=204.3

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecch-----hhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-----NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      +.+.|++.++||+|+||.||+++.+ +|+.||||++.....     ...+.+.+|+.++++++||||+++++++...+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3567999999999999999999976 789999999865321     1357789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC---eEEeccC
Q 037160          328 FVVYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR---PKIADFG  403 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---~kl~Dfg  403 (569)
                      ++||||+++++|.+.+... .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999998877432 22345899999999999999999999998   999999999999987665   9999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    +..          
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~----------  242 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFE----------  242 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHH----------
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHH----------
Confidence            9987765332  233567999999999999999999999999999999999999998643211    110          


Q ss_pred             hhhhhcccCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIEIED---IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~~~~---~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        .+.........   ......+.+++.+||+.||++|||+.|++++
T Consensus       243 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          243 --GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              01111111110   1123467789999999999999999999953

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.6e-42  Score=352.49  Aligned_cols=247  Identities=21%  Similarity=0.254  Sum_probs=205.7

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|++.+.||+|+||.||+++.+ +|+.||||++....   ....+.+.+|+.+|++++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999976 78999999986542   23456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999943   356899999999999999999999999   99999999999999999999999999987644


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      .     .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   .    ..        +...
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~----~~--------i~~~  253 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---Y----EK--------IVSG  253 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HH--------HHHC
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---H----HH--------HHcC
Confidence            2     2356799999999999999999999999999999999999999864432211   0    00        1111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQML  528 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~L  528 (569)
                      ... .+......+..++..||+.||++||+     +.||+++-
T Consensus       254 ~~~-~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          254 KVR-FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             CCC-CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             CCC-CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence            111 01122346778889999999999998     89998654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.7e-42  Score=350.23  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=211.3

Q ss_pred             hccccccccccccCceeEEEEEec------CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      .++|.+.+.||+|+||.||++...      +++.||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            567999999999999999999862      4578999998654 344567899999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCC---------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 037160          328 FVVYEFVQNKSLDRILFDPKQ---------------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKA  386 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp  386 (569)
                      ++||||+++++|.+++.....                     ...+++..++.++.||+.||.|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999964332                     234889999999999999999999998   99999999


Q ss_pred             CCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 037160          387 SNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSD  465 (569)
Q Consensus       387 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~  465 (569)
                      +||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987755443323345567889999999999999999999999999999999 9888865443


Q ss_pred             cchhhhhHhHhhhhcccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          466 DGFETLVTHTWKHFQAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       466 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ......                +..... .........+.+++..||+.+|++|||+.||++.|+..
T Consensus       259 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          259 ERLFNL----------------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GGHHHH----------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHH----------------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            321111                111110 11222345678899999999999999999999999763

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=360.60  Aligned_cols=264  Identities=19%  Similarity=0.249  Sum_probs=207.6

Q ss_pred             chhHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeee
Q 037160          247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCF  322 (569)
Q Consensus       247 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  322 (569)
                      .+..++...++|++.++||+|+||.||+++.+ +|+.||||++....   ....+.+.+|..++.+++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34445556789999999999999999999986 78999999986532   223345889999999999999999999999


Q ss_pred             eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       323 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                      +.+..++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++++||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            999999999999999999999532  246899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIA-------NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  475 (569)
                      |+++........ ......||+.|+|||++.       .+.++.++|||||||++|||++|+.||...........+...
T Consensus       207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  285 (412)
T 2vd5_A          207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY  285 (412)
T ss_dssp             TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            999876554321 223468999999999987       357899999999999999999999998654332211111000


Q ss_pred             hhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHh
Q 037160          476 WKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLR---PSMTNVVQML  528 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~R---Pt~~evl~~L  528 (569)
                      ...         +  .+..........+.+++.+||+ +|++|   |++.||+++-
T Consensus       286 ~~~---------~--~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          286 KEH---------L--SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             HHH---------C--CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             ccC---------c--CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            000         0  0000011223467778889999 99988   6999999654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-42  Score=361.76  Aligned_cols=262  Identities=20%  Similarity=0.245  Sum_probs=207.9

Q ss_pred             hHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeC
Q 037160          249 STIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK  324 (569)
Q Consensus       249 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  324 (569)
                      ..++...++|++.++||+|+||.||+++++ +++.||+|++....   ......+.+|+.+++.++|||||++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344456789999999999999999999987 68899999986532   12234578999999999999999999999999


Q ss_pred             CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                      ...++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999842    35889999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhc
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ----LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ  480 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  480 (569)
                      ++........ ......||+.|+|||++.+..    ++.++|||||||++|||++|+.||...........+.   .   
T Consensus       215 a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~---  287 (410)
T 3v8s_A          215 CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---N---  287 (410)
T ss_dssp             CEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---T---
T ss_pred             eEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH---h---
Confidence            9876543321 233568999999999997655    7899999999999999999999987543221111100   0   


Q ss_pred             ccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhcc
Q 037160          481 AKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTL--RPSMTNVVQMLKQ  530 (569)
Q Consensus       481 ~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~--RPt~~evl~~L~~  530 (569)
                       ..     ..............+..++..||+.+|.+  ||++.||+++---
T Consensus       288 -~~-----~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f  333 (410)
T 3v8s_A          288 -HK-----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  333 (410)
T ss_dssp             -HH-----HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred             -cc-----ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence             00     00000001122345677888999999988  9999999977543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.6e-42  Score=346.69  Aligned_cols=261  Identities=25%  Similarity=0.326  Sum_probs=200.0

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHh--ccccccceeeeeeeeC----Cce
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR--AHHKNLVQFLGCCFTK----KDS  327 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~  327 (569)
                      ..++|++.++||+|+||.||+|++ +++.||||++...   ....+..|.+++..  ++||||+++++++...    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            467899999999999999999988 5899999988643   33456677777776  7999999999987653    457


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeCCCCCCCeEECCCCCeEE
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH--------KDGQMQIVHRDIKASNILLDLKHRPKI  399 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivHrDikp~NIll~~~~~~kl  399 (569)
                      ++||||+++++|.+++.    ...+++..++.++.|++.||.|||        +.+   |+||||||+|||++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            99999999999999993    346899999999999999999999        777   999999999999999999999


Q ss_pred             eccCCCcccCCCCCCC--CCcccccCCCcccccccccC------CCCcccchhhHHHHHHHHHhC----------CCCCC
Q 037160          400 ADFGLARFSSSEKSLL--PNTAIAGTLGYMAPEYIANG------QLTEKVDIYSFGVLVLEIVSG----------VQNNK  461 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~SlGvil~elltg----------~~p~~  461 (569)
                      +|||+++.........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998655433211  12345799999999999876      455799999999999999999          66654


Q ss_pred             CCCCcchhhhhHhHhhhhcccchhhhhcccCCC--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          462 FQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI--EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       462 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .........  .........    ......+..  ........+.+++..||+.+|++|||+.||++.|++.
T Consensus       235 ~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPSF--EDMRKVVCV----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCCH--HHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcch--hhhhHHHhc----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            332211100  000000000    000011110  0234567788999999999999999999999999764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-42  Score=369.63  Aligned_cols=261  Identities=25%  Similarity=0.373  Sum_probs=211.9

Q ss_pred             HHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .+...++|++.++||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++. .+..++|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            344567899999999999999999999888999999987543 34578999999999999999999999986 6678999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            9999999999999532 2236789999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      .... ......+++.|+|||++..+.++.++||||||++||||++ |+.|+.........                ..+.
T Consensus       337 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~----------------~~i~  399 (454)
T 1qcf_A          337 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI----------------RALE  399 (454)
T ss_dssp             HHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----------------HHHH
T ss_pred             Ccee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHHH
Confidence            3211 2233456788999999999999999999999999999999 99888643322111                1111


Q ss_pred             ccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 037160          490 KSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDIT  534 (569)
Q Consensus       490 ~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  534 (569)
                      .... ..+......+.+++.+||+.+|++|||+.+|++.|+.....
T Consensus       400 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          400 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            1111 11222345677899999999999999999999999986543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-42  Score=368.82  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=206.3

Q ss_pred             HHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ...++|++.++||+|+||.||+|.++++..||||++..... ..+.+.+|+.+|++++||||+++++++.+ +..++|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            34577899999999999999999998888899999875432 34679999999999999999999999876 67899999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++|+|.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       259 ~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          259 YMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CCTTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hhcCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999999999942 12345899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .. ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+........   .             +.+...
T Consensus       335 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~-------------~~i~~~  397 (452)
T 1fmk_A          335 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L-------------DQVERG  397 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H-------------HHHHTT
T ss_pred             ee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---H-------------HHHHcC
Confidence            21 2234457789999999999999999999999999999999 8888764332211   1             111111


Q ss_pred             CCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCC
Q 037160          492 IEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPT  537 (569)
Q Consensus       492 l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  537 (569)
                      ... .+......+.+++..||+.+|++|||+.+|++.|+.......+
T Consensus       398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            111 1223345677899999999999999999999999987654443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.5e-42  Score=348.48  Aligned_cols=259  Identities=17%  Similarity=0.200  Sum_probs=207.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .++|++.++||+|+||.||+|+.. +|+.||||++.....  ...+.+|+.+++++ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            467999999999999999999964 789999998865432  24588999999999 99999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC-----eEEeccCCCcc
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR-----PKIADFGLARF  407 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~-----~kl~Dfgla~~  407 (569)
                      |+ +++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998532  457999999999999999999999998   999999999999998887     99999999987


Q ss_pred             cCCCCCCC-----CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          408 SSSEKSLL-----PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       408 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      ........     ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            65433211     1245679999999999999999999999999999999999999987654433222111110000000


Q ss_pred             chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      . .+.    +...    ...+..++..||+.+|.+||++.+|++.|++
T Consensus       240 ~-~~~----~~~~----~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          240 P-IEV----LCEN----FPEMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             C-HHH----HTTT----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             C-HHH----Hhcc----ChHHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            0 000    0001    1278889999999999999999999998864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=354.79  Aligned_cols=263  Identities=25%  Similarity=0.397  Sum_probs=209.2

Q ss_pred             HhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCC
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKK  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  325 (569)
                      ..++|++.+.||+|+||.||+|.+.      ++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4578999999999999999999862      45689999986542 33446789999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCC--------------------ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQK--------------------KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIK  385 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDik  385 (569)
                      ..++||||+++++|.+++......                    ..+++..++.++.||+.||.|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999653321                    34799999999999999999999998   9999999


Q ss_pred             CCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 037160          386 ASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQS  464 (569)
Q Consensus       386 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~  464 (569)
                      |+|||++.++.+||+|||++................||+.|+|||.+.++.++.++||||||+++|||++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987655433222335567889999999999999999999999999999998 998886543


Q ss_pred             CcchhhhhHhHhhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 037160          465 DDGFETLVTHTWKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDIT  534 (569)
Q Consensus       465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  534 (569)
                      ....  .             ...+...... .+......+..++..||+.+|.+|||+.+|+++|+.....
T Consensus       280 ~~~~--~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          280 VDAN--F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CSHH--H-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cHHH--H-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            3211  0             0111111111 1222345677889999999999999999999999876543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.2e-42  Score=340.75  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=196.0

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecch----hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK----NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|++.++||+|+||.||+|.+. ++.||||++.....    ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357899999999999999999976 88999998865432    3356789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC--------CCCeEEecc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL--------KHRPKIADF  402 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~--------~~~~kl~Df  402 (569)
                      |||+++++|.+++.    ...+++..++.++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983    356899999999999999999999998556899999999999986        778999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      |++.......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+.........      +      
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~------  224 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------Y------  224 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------H------
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H------
Confidence            9998655432    22457899999999999999999999999999999999999998643322110      0      


Q ss_pred             chhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          483 TVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       483 ~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                         ......... ........+.+++..||+.+|++|||+.|++++|++
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          225 ---GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ---HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence               000111111 122233567789999999999999999999999975

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.8e-42  Score=351.81  Aligned_cols=262  Identities=23%  Similarity=0.332  Sum_probs=194.1

Q ss_pred             HHhccccccccccccCceeEEEEEecC-Cc---eEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQD-GR---EIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      ...++|++.+.||+|+||.||+|.+.. +.   .||||++...  .....+.+.+|+.++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999999763 32   7999988654  34456789999999999999999999999987765


Q ss_pred             e------EEEEeecCCCChhhHhhCCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          327 S------FVVYEFVQNKSLDRILFDPK---QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       327 ~------~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                      .      ++||||+++++|.+++....   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence            5      99999999999999984322   2236899999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...........     
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-----  251 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY-----  251 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH-----
Confidence            9999999987655443333345567889999999999999999999999999999999 8888765433221110     


Q ss_pred             hhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          477 KHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                                +...............+.+++..||+.+|++|||+.++++.|++.-
T Consensus       252 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          252 ----------LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             ----------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      1111111112233456788999999999999999999999998653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-42  Score=354.65  Aligned_cols=251  Identities=25%  Similarity=0.318  Sum_probs=204.3

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCce
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  327 (569)
                      ...++|++.++||+|+||.||+|+++ +|+.||||++....   ......+.+|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999986 68999999997542   33456788999999987 999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999994   3356899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........   .    ..        
T Consensus       168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~----~i--------  230 (345)
T 1xjd_A          168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---H----SI--------  230 (345)
T ss_dssp             CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HH--------
T ss_pred             cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH---H----HH--------
Confidence            433222  234668999999999999999999999999999999999999998644322111   0    00        


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMT-NVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~~  527 (569)
                      ...... .+......+.+++..||+.+|++||++. +|+++
T Consensus       231 ~~~~~~-~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          231 RMDNPF-YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             HHCCCC-CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             HhCCCC-CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            000000 0111234577888999999999999998 77643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-42  Score=345.31  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=196.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch--------------------------hhHHHHHHHHHHHH
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--------------------------NRIKEICNEMDIMS  307 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  307 (569)
                      .++|++.++||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999975 688999999865431                          12356889999999


Q ss_pred             hccccccceeeeeeee--CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 037160          308 RAHHKNLVQFLGCCFT--KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIK  385 (569)
Q Consensus       308 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDik  385 (569)
                      +++||||+++++++..  ....++||||+++++|.+++    ....+++..++.++.||+.||.|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  56789999999999998865    3457899999999999999999999998   9999999


Q ss_pred             CCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCC
Q 037160          386 ASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ---LTEKVDIYSFGVLVLEIVSGVQNNKF  462 (569)
Q Consensus       386 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~SlGvil~elltg~~p~~~  462 (569)
                      |+|||++.++.+||+|||+++.......  ......||+.|+|||.+.+..   .+.++||||||+++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987654332  123457999999999997765   47889999999999999999999864


Q ss_pred             CCCcchhhhhHhHhhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          463 QSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .....   +..    .        +....... ........+.+++.+||+.||++|||+.||+++
T Consensus       243 ~~~~~---~~~----~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          243 ERIMC---LHS----K--------IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSHHH---HHH----H--------HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             ccHHH---HHH----H--------HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            32211   100    0        00000110 112233467788999999999999999999853

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.1e-42  Score=343.44  Aligned_cols=262  Identities=20%  Similarity=0.271  Sum_probs=201.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.++||+|+||.||+|++. +++.||||++....  ......+.+|+.++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999976 68999999987543  3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |++++.+..+.   .....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            99865444444   23456899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCCCCcccccCCCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhc---ccchhhhh
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ---AKTVLEII  488 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  488 (569)
                      .  ......||+.|+|||++.+.. ++.++||||||+++|||++|..|+.......  ..+........   ...+....
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred             c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhc
Confidence            2  234567899999999997765 8999999999999999999988864332211  11111111100   00000000


Q ss_pred             ---c----------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 ---D----------KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ---~----------~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                         +          ..+....+.....+.+++..||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence               0          00000112334567789999999999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6e-43  Score=353.55  Aligned_cols=256  Identities=22%  Similarity=0.348  Sum_probs=195.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCce--
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS--  327 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--  327 (569)
                      +.++|++.++||+|+||.||++++. +++.||||++...   .......+.+|+.++++++||||+++++++......  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            4578999999999999999999974 7899999998654   233456789999999999999999999998776544  


Q ss_pred             --EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          328 --FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       328 --~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                        ++||||+++++|.+++..   ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence              999999999999999943   356899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          406 RFSSSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       406 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      +........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||........      .+........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCC
Confidence            876543321 122346789999999999999999999999999999999999999864432211      1111000000


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          485 LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       485 ~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....      ........+..++.+||+.||++||+..+++..
T Consensus       238 ~~~~------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          238 PPSA------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             CHHH------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             Cccc------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence            0000      011123467788999999999999987776643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-42  Score=371.18  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=212.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ..++|++.++||+|+||.||+|+++ .+..||||.+.... ...+.+.+|+.+|++++||||+++++++......++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            4567899999999999999999987 48899999986543 345789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999999542 3456899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .. ......+++.|+|||.+.++.++.++||||||++||||++ |+.|+........                .+.+...
T Consensus       373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~----------------~~~~~~~  435 (495)
T 1opk_A          373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YELLEKD  435 (495)
T ss_dssp             EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----------------HHHHHTT
T ss_pred             ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHHcC
Confidence            22 2234456789999999999999999999999999999999 8888764432211                1111111


Q ss_pred             CCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          492 IEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       492 l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      .... +......+.+++.+||+.+|++|||+.+|++.|+...
T Consensus       436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1111 2233456778899999999999999999999998754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.8e-42  Score=348.90  Aligned_cols=274  Identities=27%  Similarity=0.372  Sum_probs=216.0

Q ss_pred             ccccccchhHHHHHhccccccccccccCceeEEEEEe------cCCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-ccc
Q 037160          241 LKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL------QDGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHK  312 (569)
Q Consensus       241 ~~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~  312 (569)
                      .+.+.+.....+...++|++.++||+|+||.||+|++      .+++.||||++.... ....+.+.+|+.++.++ +||
T Consensus        12 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp   91 (316)
T 2xir_A           12 CERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL   91 (316)
T ss_dssp             GGGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             hhhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCC
Confidence            3444555566666778999999999999999999984      256889999987543 33456789999999999 799


Q ss_pred             ccceeeeeeeeCC-ceEEEEeecCCCChhhHhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 037160          313 NLVQFLGCCFTKK-DSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQ  378 (569)
Q Consensus       313 niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  378 (569)
                      ||+++++++...+ ..++||||+++++|.+++.....             +..+++..++.++.|++.||.|||+.+   
T Consensus        92 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---  168 (316)
T 2xir_A           92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---  168 (316)
T ss_dssp             TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             CeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---
Confidence            9999999987754 48999999999999999965332             223789999999999999999999998   


Q ss_pred             eeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CC
Q 037160          379 IVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GV  457 (569)
Q Consensus       379 ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~  457 (569)
                      |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |.
T Consensus       169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~  248 (316)
T 2xir_A          169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  248 (316)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987655433223335567899999999999999999999999999999998 98


Q ss_pred             CCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          458 QNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       458 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .|+........  +..    .....        ............+.+++..||+.+|.+|||+.||+++|+..
T Consensus       249 ~p~~~~~~~~~--~~~----~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          249 SPYPGVKIDEE--FCR----RLKEG--------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CSSTTCCCSHH--HHH----HHHHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccchhHH--HHH----HhccC--------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            88865432211  100    00000        00001122334677889999999999999999999999753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-42  Score=355.36  Aligned_cols=253  Identities=21%  Similarity=0.266  Sum_probs=207.6

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ..++|++.++||+|+||.||+|..+ +|+.||+|++..........+.+|+.+|++++||||+++++++.+....++|||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            3578999999999999999999976 688999999877655556789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC--CCCeEEeccCCCcccCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL--KHRPKIADFGLARFSSS  410 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~--~~~~kl~Dfgla~~~~~  410 (569)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++....
T Consensus       129 ~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          129 FLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999999843  3346899999999999999999999998   999999999999974  47799999999987654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   +.....    .      ..
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i~~----~------~~  267 (387)
T 1kob_A          204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKR----C------DW  267 (387)
T ss_dssp             TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHH----C------CC
T ss_pred             Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHHHh----C------CC
Confidence            33   22345799999999999999999999999999999999999999865432111   100000    0      00


Q ss_pred             cCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .... ........+.+++..||+.||++|||+.|++++
T Consensus       268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            0000 011233567788999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4e-42  Score=347.35  Aligned_cols=259  Identities=25%  Similarity=0.389  Sum_probs=210.3

Q ss_pred             hccccccccccccCceeEEEEEe------cCCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTL------QDGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  326 (569)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46789999999999999999985      256789999987543 23457799999999999 99999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCC---------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQ---------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                      .++||||+++++|.+++.....               ...+++..++.++.||+.||.|||+.+   |+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999954322               225899999999999999999999998   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~  470 (569)
                      +.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence            9999999999999987765443322334567889999999999999999999999999999999 8888765433211  


Q ss_pred             hhHhHhhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .             ...+...... ........+.+++.+||+.+|.+|||+.||+++|++.
T Consensus       257 ~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 F-------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             H-------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-------------HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            0             0111111111 1122335677889999999999999999999999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.6e-42  Score=343.85  Aligned_cols=264  Identities=22%  Similarity=0.314  Sum_probs=199.8

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.++||+|+||.||+|+..+|+.||+|++.....  .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999999998899999999865432  2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            975 88888843  3356899999999999999999999998   99999999999999999999999999986643221


Q ss_pred             CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh-----hhcccchhhh
Q 037160          414 LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK-----HFQAKTVLEI  487 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~  487 (569)
                        ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+.....     .|........
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence              22345789999999998764 589999999999999999999999865433211111100000     0000000000


Q ss_pred             hcccCCC--------CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEI--------EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~--------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .++....        ........+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0110000        001123567789999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.9e-42  Score=353.12  Aligned_cols=247  Identities=20%  Similarity=0.254  Sum_probs=202.1

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999974 78999999986532   22345788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+ +|+|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 678888874   3456899999999999999999999999   99999999999999999999999999987655


Q ss_pred             CCCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..   ......||+.|+|||++.+..+ ++++||||||+++|+|++|+.||.........                ..+.
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~  221 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVN  221 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCC
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHH
Confidence            43   2345679999999999988775 68999999999999999999998643322110                0001


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......+......+.+++.+||+.||.+|||+.|++++
T Consensus       222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            10111112233457788999999999999999999964

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-41  Score=340.65  Aligned_cols=267  Identities=14%  Similarity=0.160  Sum_probs=212.0

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..++|++.+.||+|+||.||+|... +|+.||||++....  ....+.+|+.+++++ +|+|++++++++......++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            3567999999999999999999964 78999999886443  234678899999999 8999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC-----eEEeccCCCc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR-----PKIADFGLAR  406 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~-----~kl~Dfgla~  406 (569)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||+++
T Consensus        86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 99999999532  345899999999999999999999998   999999999999987776     9999999998


Q ss_pred             ccCCCCCC-----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          407 FSSSEKSL-----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       407 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      ........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            76554321     1234567999999999999999999999999999999999999998765433222221111111111


Q ss_pred             cchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 037160          482 KTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLP  536 (569)
Q Consensus       482 ~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  536 (569)
                      ....+..        ......+.+++..||+.+|++||++.+|++.|++....+.
T Consensus       240 ~~~~~~~--------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          240 TPLRELC--------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             SCHHHHT--------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHH--------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            1111110        1123467788999999999999999999999987654443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-42  Score=352.71  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=202.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCce----EEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGRE----IAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|++.++||+|+||.||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57889999999999999999965 4554    7777764432 233356778999999999999999999886 567899


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+.+++|.+++..  .+..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999999953  3457899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ............+|..|+|||++.++.++.++||||||+++|||++ |+.||...........+.               
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------------  231 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---------------  231 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH---------------
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH---------------
Confidence            6544434456678889999999999999999999999999999999 999987544332211111               


Q ss_pred             cccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          489 DKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       489 ~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                       .... ..+......+..++..||+.+|++|||+.||++.|+...
T Consensus       232 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          232 -KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             -TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             -cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             1000 001112234667889999999999999999999997654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-41  Score=360.15  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=205.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|.+.+.||+|+||.||+|++. +|+.||||++....   ......+.+|+.+++.++||||+++++++......++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999976 79999999986542   234567899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++++||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999994   4567999999999999999999999998   999999999999999999999999999876553


Q ss_pred             CCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      .   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........   ..            .+.+.
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~------------~i~~~  231 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---FK------------KICDG  231 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---HH------------HHHTT
T ss_pred             c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---HH------------HHhcC
Confidence            3   2235679999999999988765 6899999999999999999999864432211   11            01111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... .+......+.+++..||+.||++|||+.||+++
T Consensus       232 ~~~-~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          232 IFY-TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             CCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CcC-CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            111 111123457788999999999999999999963

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.5e-42  Score=353.66  Aligned_cols=272  Identities=24%  Similarity=0.303  Sum_probs=209.8

Q ss_pred             ccchhHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-----ccccceee
Q 037160          245 QFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-----HKNLVQFL  318 (569)
Q Consensus       245 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~  318 (569)
                      .+.+.....+.++|++.++||+|+||.||+|++. +++.||||++... ......+..|+.++++++     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            3455555667889999999999999999999975 7889999988643 334466788999999996     99999999


Q ss_pred             eeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-----
Q 037160          319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-----  393 (569)
Q Consensus       319 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-----  393 (569)
                      +++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.     
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence            9999999999999999 99999998542 3345899999999999999999999998   999999999999975     


Q ss_pred             --------------------CCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHH
Q 037160          394 --------------------KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEI  453 (569)
Q Consensus       394 --------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~el  453 (569)
                                          ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                789999999999865442     2356789999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh--------hcc-----cCCCC--CH---------------HHHHHH
Q 037160          454 VSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI--------IDK-----SIEIE--DI---------------EEVKRV  503 (569)
Q Consensus       454 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~-----~l~~~--~~---------------~~~~~~  503 (569)
                      ++|+.||...........+.............+.        +..     .....  ..               .....+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            9999998754433221111111100000000000        000     00000  00               011456


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          504 VWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       504 ~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+++..||+.||++|||+.|++++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcC
Confidence            789999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-42  Score=351.32  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=197.7

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeec--chhhHHHHHHHHHHHHhccc--cccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHH--KNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~l  329 (569)
                      ..++|++.++||+|+||.||++...+++.||||++...  .....+.+.+|+.+|.+++|  |||+++++++......++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            35679999999999999999999988999999998754  33445778999999999976  999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||| +.+++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++...
T Consensus        87 v~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 56889999994   3457899999999999999999999998   99999999999997 6889999999998776


Q ss_pred             CCCCCCCCcccccCCCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIAN-----------GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      ............||+.|+|||++.+           ..++.++||||||+++|||++|+.||.......           
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----------  227 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----------  227 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----------
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----------
Confidence            5443323346679999999999865           678999999999999999999999986432210           


Q ss_pred             hcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          479 FQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                         ..+...++...... +......+.+++..||+.+|++|||+.|++++.
T Consensus       228 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          228 ---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             ---HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ---HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence               01111222111111 111224577888999999999999999999653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1e-41  Score=345.08  Aligned_cols=267  Identities=19%  Similarity=0.235  Sum_probs=200.5

Q ss_pred             Hhcccccc-ccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEE
Q 037160          254 ATDCFDES-NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       254 ~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +.+.|++. ++||+|+||.||+++.. +++.||||++..........+.+|+.++.++ +||||+++++++...+..++|
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            34678874 78999999999999965 7899999999776656667899999999995 799999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC---eEEeccCCCcc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR---PKIADFGLARF  407 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---~kl~Dfgla~~  407 (569)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||++..
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999943   356899999999999999999999998   999999999999998776   99999999876


Q ss_pred             cCCCCCC-----CCCcccccCCCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          408 SSSEKSL-----LPNTAIAGTLGYMAPEYIAN-----GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       408 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      .......     .......||+.|+|||++.+     ..++.++||||||+++|||++|+.||.................
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            5432211     01224569999999999875     5688999999999999999999999876543221000000000


Q ss_pred             hhcccchhhhhcccCCCCCH----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          478 HFQAKTVLEIIDKSIEIEDI----EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~~~----~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .. ...+.+.+.......+.    .....+.+++.+||+.||++|||+.|++++
T Consensus       244 ~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          244 AC-QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HH-HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hH-HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00 00011111111111111    123567889999999999999999999985

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9e-42  Score=347.45  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=195.0

Q ss_pred             hccccccccccccCceeEEEEEe----cCCceEEEEEEeecc----hhhHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTL----QDGREIAVKRLFISR----KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      .++|++.++||+|+||.||+++.    .+|+.||+|++....    ......+.+|+.+|++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999987    478999999986542    2334568899999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999984   3456889999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      .......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||........   ..            .
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~------------~  232 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---ID------------K  232 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH------------H
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HH------------H
Confidence            5443222  23356799999999999999999999999999999999999999864432211   11            1


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQML  528 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~L  528 (569)
                      +...... .+......+.+++.+||+.+|++||     ++.|++++-
T Consensus       233 i~~~~~~-~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          233 ILKCKLN-LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             HHHTCCC-CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             HHhCCCC-CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence            1111111 1122335677888999999999999     788998754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.3e-42  Score=351.27  Aligned_cols=253  Identities=23%  Similarity=0.289  Sum_probs=190.4

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .+.++|++.++||+|+||.||+|+.+ +++.||||++....  ..+.+.+|+.++++++||||+++++++......++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            45678999999999999999999987 57899999987543  3356889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC---CCCeEEeccCCCccc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL---KHRPKIADFGLARFS  408 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~~kl~Dfgla~~~  408 (569)
                      ||+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999984   3456899999999999999999999998   999999999999975   889999999999866


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||++|+.|+........  ...    .......    
T Consensus       202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~----~i~~~~~----  268 (349)
T 2w4o_A          202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR----RILNCEY----  268 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH----HHHTTCC----
T ss_pred             Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH----HHHhCCC----
Confidence            5432   22356789999999999999999999999999999999999999864433211  110    0000000    


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       .............+.+++.+||+.||++|||+.|++++
T Consensus       269 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          269 -YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00000012234567788999999999999999999975

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-41  Score=338.20  Aligned_cols=250  Identities=19%  Similarity=0.264  Sum_probs=206.3

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .+.++|++.++||+|+||.||+|..+ ++..+|+|++........+.+.+|++++++++||||+++++++......++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            45678999999999999999999976 57899999998766666788999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---CCCCCeEEeccCCCccc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL---DLKHRPKIADFGLARFS  408 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~~kl~Dfgla~~~  408 (569)
                      ||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++...
T Consensus        86 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           86 ELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999998843   456899999999999999999999999   9999999999999   78899999999999876


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ....   ......||+.|+|||.+.+ .++.++||||||+++|||++|+.|+.........   .            .+.
T Consensus       160 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~------------~~~  220 (277)
T 3f3z_A          160 KPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM---L------------KIR  220 (277)
T ss_dssp             CTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H------------HHH
T ss_pred             cCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH---H------------HHH
Confidence            5433   2335579999999999865 4899999999999999999999998654322110   0            000


Q ss_pred             cccCCCCCH---HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEIEDI---EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~---~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .........   .....+.+++..||+.+|++|||+.+++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          221 EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111111100   123567789999999999999999999853

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.6e-42  Score=365.51  Aligned_cols=250  Identities=22%  Similarity=0.281  Sum_probs=195.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|++.++||+|+||.||+++.. +|+.||||++...   .......+.+|+.++++++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999976 7899999998754   233456678999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      |||+++++|.+++.   ....+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999984   34568999999999999999999998 77   9999999999999999999999999998643


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+               ..
T Consensus       301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---------------~~  363 (446)
T 4ejn_A          301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------------LM  363 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------------HH
T ss_pred             CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---------------Hh
Confidence            3222  234568999999999999999999999999999999999999998644322111110               00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQML  528 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~L  528 (569)
                      .... .+......+.+++..||+.||++||     ++.|++++-
T Consensus       364 ~~~~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          364 EEIR-FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             CCCC-CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             CCCC-CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence            1110 1112234677889999999999999     999999653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.5e-42  Score=343.58  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=211.6

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ...++|++.++||+|+||.||+|.++ ++..||+|.+.... ...+.+.+|+.++++++||||+++++++......++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            34678999999999999999999987 58899999886543 34578899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.. .....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHH-CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHh-cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999999954 23456899999999999999999999999   999999999999999999999999999876544


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|+.........                +.+..
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~----------------~~~~~  227 (288)
T 3kfa_A          165 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------ELLEK  227 (288)
T ss_dssp             SSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----------------HHHHT
T ss_pred             ccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHHhc
Confidence            322 2334567889999999999999999999999999999999 88887654332211                11111


Q ss_pred             cCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          491 SIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       491 ~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .... .+......+.+++..||+.+|++|||+.+|++.|+.
T Consensus       228 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence            1111 122234567889999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-42  Score=351.28  Aligned_cols=270  Identities=22%  Similarity=0.352  Sum_probs=209.5

Q ss_pred             ccccccccccCceeEEEEEec-----CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeC--CceEE
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-----DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSFV  329 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  329 (569)
                      |++.++||+|+||.||++.++     +++.||||++.... ....+.+.+|++++++++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999888643     67899999987643 34457799999999999999999999999874  56799


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++..    ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999943    34899999999999999999999999   9999999999999999999999999998776


Q ss_pred             CCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ..... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+....... ...............+.+.+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHH
Confidence            54321 12234567888999999999999999999999999999999998865321110 00000111111112222333


Q ss_pred             cccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          489 DKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       489 ~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                      ....... .......+.+++.+||+.+|++|||+.||++.|+.....+
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            3222222 3344567888999999999999999999999998764433

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.9e-42  Score=338.52  Aligned_cols=254  Identities=23%  Similarity=0.373  Sum_probs=207.8

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|++.+.||+|+||.||++.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++......++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57889999999999999999998889999999876543 33678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......... 
T Consensus        87 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  160 (267)
T 3t9t_A           87 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  160 (267)
T ss_dssp             TCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred             CCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc-
Confidence            9999999953  2356899999999999999999999998   999999999999999999999999999866442211 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........   ....            .......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~i------------~~~~~~~  225 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDI------------STGFRLY  225 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH------------HTTCCCC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HHHH------------hcCCcCC
Confidence            2234457789999999998999999999999999999999 8888764332211   1000            0000001


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .+......+.+++.+||+.+|++|||+.+++++|+..
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1122335677899999999999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.1e-42  Score=352.12  Aligned_cols=251  Identities=21%  Similarity=0.276  Sum_probs=193.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|++.++||+|+||.||+++.. +++.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999986 7899999998754332 35688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC--eEEeccCCCcccCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR--PKIADFGLARFSSSE  411 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~--~kl~Dfgla~~~~~~  411 (569)
                      +++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999984   3456899999999999999999999998   999999999999987765  999999998744332


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCCcc-hhhhhHhHhhhhcccchhhhhc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEK-VDIYSFGVLVLEIVSGVQNNKFQSDDG-FETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      .   ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....... ....+.            .+..
T Consensus       172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~------------~~~~  236 (361)
T 3uc3_A          172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ------------RILS  236 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH------------HHHT
T ss_pred             C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH------------HHhc
Confidence            2   2345579999999999988877665 899999999999999999987543321 111111            1111


Q ss_pred             ccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...... .......+.+++.+||+.+|++|||+.|++++
T Consensus       237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            111111 11223567789999999999999999999965

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.2e-41  Score=343.08  Aligned_cols=264  Identities=22%  Similarity=0.364  Sum_probs=191.2

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .++|++.++||+|+||.||+|..+ +|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467899999999999999999976 689999999875432 334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCC---CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          333 FVQNKSLDRILFDP---KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       333 ~~~~~~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      |++ ++|.+++...   .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5898887432   12345899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--------hhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT--------WKHFQ  480 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~  480 (569)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...        |....
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            4322  23355789999999998764 6899999999999999999999998755433221111100        00000


Q ss_pred             -------------ccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          481 -------------AKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       481 -------------~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                                   ...+.+.+.+....   .....+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKE---PLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSS---CCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccchhHHHhhcccccc---cCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                         00011111111111   123467889999999999999999999964

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.4e-42  Score=347.30  Aligned_cols=272  Identities=22%  Similarity=0.333  Sum_probs=202.5

Q ss_pred             ccccchhHHHHHhccccccccccccCceeEEEEEec----CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccce
Q 037160          243 FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQ  316 (569)
Q Consensus       243 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~  316 (569)
                      .++-+...+....++|.+.+.||+|+||.||+|...    .++.||||++...  .....+.+.+|+.++++++||||++
T Consensus        21 el~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~  100 (313)
T 3brb_A           21 ELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR  100 (313)
T ss_dssp             ---CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeee
Confidence            334444555556788999999999999999999864    3457999988654  3444577999999999999999999


Q ss_pred             eeeeeeeCC-----ceEEEEeecCCCChhhHhhCC---CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCC
Q 037160          317 FLGCCFTKK-----DSFVVYEFVQNKSLDRILFDP---KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASN  388 (569)
Q Consensus       317 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~N  388 (569)
                      +++++....     ..++||||+++++|.+++...   .....+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N  177 (313)
T 3brb_A          101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN  177 (313)
T ss_dssp             CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGG
T ss_pred             eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence            999998755     349999999999999998432   23467899999999999999999999998   9999999999


Q ss_pred             eEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 037160          389 ILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDG  467 (569)
Q Consensus       389 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~  467 (569)
                      |+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus       178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  257 (313)
T 3brb_A          178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE  257 (313)
T ss_dssp             EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence            9999999999999999987655443323345567889999999999999999999999999999999 888876543322


Q ss_pred             hhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          468 FETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ....   .            ...............+.+++..||+.+|++|||+.+|+++|+...
T Consensus       258 ~~~~---~------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          258 MYDY---L------------LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             HHHH---H------------HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH---H------------HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1110   0            011011112223356788999999999999999999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-41  Score=349.96  Aligned_cols=249  Identities=24%  Similarity=0.321  Sum_probs=204.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|+||.||+++.+ +|+.||||++....   ....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999987 57899999987542   33456788999999988 89999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999994   3356899999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..            .+..
T Consensus       173 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~------------~i~~  235 (353)
T 2i0e_A          173 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQ------------SIME  235 (353)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH------------HHHH
T ss_pred             cCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---HH------------HHHh
Confidence            3221  23456899999999999999999999999999999999999999864432211   11            0111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~  527 (569)
                      .... .+......+..++..||+.+|++||+     +.+|+++
T Consensus       236 ~~~~-~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          236 HNVA-YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             CCCC-CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CCCC-CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1111 11223356778889999999999995     5888755

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.9e-41  Score=345.02  Aligned_cols=264  Identities=19%  Similarity=0.246  Sum_probs=208.6

Q ss_pred             chhHHHHHhcccccc-ccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhc-cccccceeeeee
Q 037160          247 KYSTIEKATDCFDES-NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRA-HHKNLVQFLGCC  321 (569)
Q Consensus       247 ~~~~~~~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  321 (569)
                      .++..+.+.+.|.+. ++||+|+||.||+++.. +++.||+|++....  ......+.+|+.+++++ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            345667888889988 89999999999999976 68999999986543  23357889999999999 569999999999


Q ss_pred             eeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC---CCCeE
Q 037160          322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL---KHRPK  398 (569)
Q Consensus       322 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~~k  398 (569)
                      ......++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            999999999999999999999843 33467899999999999999999999998   999999999999998   78999


Q ss_pred             EeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.     
T Consensus       175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-----  246 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS-----  246 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred             EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH-----
Confidence            99999998765432   2234679999999999999999999999999999999999999986543221110000     


Q ss_pred             hcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                             .................+.+++..||+.+|++|||+.|++++--
T Consensus       247 -------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          247 -------QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             -------HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             -------hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence                   00000000111223455778899999999999999999997643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.3e-41  Score=347.41  Aligned_cols=261  Identities=25%  Similarity=0.369  Sum_probs=209.8

Q ss_pred             HhccccccccccccCceeEEEEEec--------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeee
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ--------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT  323 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  323 (569)
                      ..++|++.+.||+|+||.||+|.+.        ++..||||++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999863        46789999986543 34567799999999999 89999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeE
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQ-------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNIL  390 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIl  390 (569)
                      .+..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999965332             235899999999999999999999998   999999999999


Q ss_pred             ECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 037160          391 LDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFE  469 (569)
Q Consensus       391 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~  469 (569)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.........
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            99999999999999987665443323344567889999999998899999999999999999999 98887644322111


Q ss_pred             hhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          470 TLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       470 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                         .....            .............+..++..||+.+|.+|||+.||++.|+...
T Consensus       270 ---~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          270 ---KLLKE------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             ---HHHHH------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHhc------------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               10000            0000112223356778899999999999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.8e-42  Score=362.27  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=204.0

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCC-ceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-DSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e  332 (569)
                      ..++|++.++||+|+||.||+|.++ |+.||||++....  ..+.+.+|+.+|++++||||+++++++.... ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3567899999999999999999986 7899999987543  4467999999999999999999999987765 7899999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            99999999999542 2334789999999999999999999998   999999999999999999999999999854332 


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                          .....+++.|+|||.+.+..++.++||||||++||||++ |+.|+.........                ..+...
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~----------------~~i~~~  402 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----------------PRVEKG  402 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH----------------HHHHTT
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHHHcC
Confidence                123357889999999999999999999999999999998 99988654332211                111111


Q ss_pred             CCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          492 IEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       492 l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ... .+......+.+++..||+.+|++|||+.+|++.|+..
T Consensus       403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111 1223345677889999999999999999999999764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.7e-42  Score=340.92  Aligned_cols=261  Identities=24%  Similarity=0.435  Sum_probs=195.4

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..++|++.++||+|+||.||+|++.  ..||||++....  ....+.+.+|+.++++++||||++++++. .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3567999999999999999999875  369999986543  44567899999999999999999999965 556789999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999999843  3456899999999999999999999998   999999999999999999999999999866543


Q ss_pred             CCCCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ..........||+.|+|||.+.   +..++.++||||||+++|||++|+.||.......  .+......    ...    
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~----~~~----  243 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGR----GSL----  243 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHH----TSC----
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhcc----ccc----
Confidence            3322334567999999999986   5678899999999999999999999986543321  11111100    000    


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ...+..........+.+++..||+.+|++|||+.+|++.|++..
T Consensus       244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            01111111233456888999999999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.1e-41  Score=334.48  Aligned_cols=255  Identities=25%  Similarity=0.322  Sum_probs=206.8

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4578999999999999999999976 78999999986543 344577899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999983   3456899999999999999999999998   999999999999999999999999999866443


Q ss_pred             CCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.........      +..+.....      
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~------  226 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKT------  226 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTCT------
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhccc------
Confidence            32223345678999999999987765 78999999999999999999998754432111      011111000      


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ...........+.+++..||+.+|++|||+.||+++
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             000011223456789999999999999999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=341.30  Aligned_cols=267  Identities=24%  Similarity=0.277  Sum_probs=200.4

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch-----hhHHHHHHHHHHHHhcc---ccccceeeeeeee
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-----NRIKEICNEMDIMSRAH---HKNLVQFLGCCFT  323 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  323 (569)
                      ...++|++.++||+|+||.||+|++. +++.||||++.....     .....+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            35678999999999999999999975 789999999875431     11245667888877775   9999999999987


Q ss_pred             CC-----ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeE
Q 037160          324 KK-----DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPK  398 (569)
Q Consensus       324 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  398 (569)
                      ..     ..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            65     4799999997 5999988543 2344899999999999999999999999   99999999999999999999


Q ss_pred             EeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|++||...........+......
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999998765432   334667999999999999999999999999999999999999998654433221111111000


Q ss_pred             hcccchhh-------hhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          479 FQAKTVLE-------IIDKSIEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       479 ~~~~~~~~-------~~~~~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .....+..       .+.......    .++....+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            00000000       000000000    11223567789999999999999999999964

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=352.09  Aligned_cols=248  Identities=23%  Similarity=0.282  Sum_probs=197.3

Q ss_pred             ccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCCCC
Q 037160          260 ESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKS  338 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  338 (569)
                      ..+.||+|+||.||+|... +|+.||+|++........+.+.+|+.+|++++||||+++++++...+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3568999999999999975 789999999987666667789999999999999999999999999999999999999999


Q ss_pred             hhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE--CCCCCeEEeccCCCcccCCCCCCCC
Q 037160          339 LDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL--DLKHRPKIADFGLARFSSSEKSLLP  416 (569)
Q Consensus       339 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~  416 (569)
                      |.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            9988843  3456899999999999999999999998   9999999999999  5678899999999987755432   


Q ss_pred             CcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCC
Q 037160          417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED  496 (569)
Q Consensus       417 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  496 (569)
                      .....||+.|+|||++.++.++.++||||||+++|||++|+.||........   +......    .+     .......
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~~~----~~-----~~~~~~~  312 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET---LNNILAC----RW-----DLEDEEF  312 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHT----CC-----CSCSGGG
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhc----cC-----CCChhhh
Confidence            2345699999999999999999999999999999999999999865432211   1000000    00     0000001


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          497 IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       497 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......+.+++.+||+.+|++|||+.|++++
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1223567788999999999999999999963

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.3e-42  Score=343.11  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=203.8

Q ss_pred             hccccccccccccCceeEEEEEec-CC-------ceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DG-------REIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      .++|.+.++||+|+||.||+|+.. ++       ..||+|++........+.+.+|+.++++++||||+++++++.....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467899999999999999999876 33       4799999977766777889999999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC--------eE
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR--------PK  398 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~--------~k  398 (569)
                      .++||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999953  2344899999999999999999999999   999999999999998887        99


Q ss_pred             EeccCCCcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      |+|||++.....      .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+........  ... .+.
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~~-~~~  232 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQ-FYE  232 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH-HHH
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HHH-Hhh
Confidence            999999865432      234568899999999987 6799999999999999999997555432222110  000 000


Q ss_pred             hhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          478 HFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                      .          ...+   +......+.+++..||+.+|++|||+.|+++.|++...
T Consensus       233 ~----------~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 D----------RHQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             T----------TCCC---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             c----------cCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0          0000   01112346778899999999999999999999998654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-41  Score=354.89  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=197.7

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecc--hhhHHHHHHHHHHHHhcc--ccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAH--HKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|++.++||+|+||.||++...+++.||||++....  ......+.+|+.+|++++  ||||+++++++......++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            35699999999999999999998889999999986543  445678999999999996  59999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      || +.+++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++....
T Consensus       135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 568899999943   347889999999999999999999998   99999999999995 68999999999987765


Q ss_pred             CCCCCCCcccccCCCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIAN-----------GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      ...........||+.|+|||++.+           ..++.++|||||||+||||++|+.||....... .          
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~----------  275 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-S----------  275 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-H----------
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-H----------
Confidence            433323345679999999999865           468899999999999999999999986432210 0          


Q ss_pred             cccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          480 QAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       480 ~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                         .+..+++...... +......+.+++..||+.+|++|||+.||+++
T Consensus       276 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          276 ---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence               1111222211111 11113457788899999999999999999965

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.7e-42  Score=340.18  Aligned_cols=256  Identities=21%  Similarity=0.302  Sum_probs=194.4

Q ss_pred             HhccccccccccccCceeEEEEEecC----CceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQD----GREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ..++|++.++||+|+||.||+|.+..    +..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence            34678999999999999999998752    456999987653 334456799999999999999999999997 456789


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999999953  2346899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.........   ...            
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i------------  230 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI------------  230 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH------------
T ss_pred             Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHH------------
Confidence            543322 2234456789999999998999999999999999999997 88888654332211   000            


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ...............+.+++..||+.+|++|||+.||++.|+..
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00000011222345677889999999999999999999999753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=344.15  Aligned_cols=247  Identities=23%  Similarity=0.319  Sum_probs=194.2

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  329 (569)
                      ..++|++.++||+|+||.||+|++. +|+.||||++....  ......+..|+..+.++ +||||+++++++.+....++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            4578999999999999999999987 79999999886532  23334555666666665 99999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++++||+|||++....
T Consensus       135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 67888887432  356999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ...   ......||+.|+|||++.+ .++.++||||||+++|||++|..++...          ..+...........+.
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~~~~  274 (311)
T 3p1a_A          209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPPEFT  274 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCHHHH
T ss_pred             cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCcccc
Confidence            433   2345569999999999875 7899999999999999999997664321          0111111111111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                             ......+.+++..||+.+|++|||+.|++++
T Consensus       275 -------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          275 -------AGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             -------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                   1123567889999999999999999999964

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.4e-42  Score=339.36  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=206.9

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .++|++.+.||+|+||.||+|..++++.||||.+..... ..+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            467889999999999999999988888999999865432 3567899999999999999999999876 45689999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            999999998431 1236899999999999999999999998   999999999999999999999999999876554322


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                       ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+........   ...             +.....
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~-------------~~~~~~  228 (279)
T 1qpc_A          166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQN-------------LERGYR  228 (279)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHH-------------HHTTCC
T ss_pred             -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHH-------------HhcccC
Confidence             2234557889999999998899999999999999999999 8888764332211   110             000000


Q ss_pred             -CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          494 -IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       494 -~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                       .........+.+++..||+.+|++|||+.+|++.|+...
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence             011223356778999999999999999999999998754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.7e-41  Score=337.16  Aligned_cols=253  Identities=28%  Similarity=0.471  Sum_probs=202.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchh-------hHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN-------RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      .++|++.++||+|+||.||+|++. +++.||||++......       ..+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            467899999999999999999975 7899999998654321       1267899999999999999999999986544 


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC-----eEEec
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR-----PKIAD  401 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~-----~kl~D  401 (569)
                       ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999888853  3457899999999999999999999985 34999999999999988876     99999


Q ss_pred             cCCCcccCCCCCCCCCcccccCCCcccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhh
Q 037160          402 FGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA--NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       402 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      ||+++....     ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||..............     
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-----  242 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-----  242 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH-----
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH-----
Confidence            999975433     234567899999999984  45678999999999999999999999875443322111100     


Q ss_pred             cccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          480 QAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       480 ~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                              ....... ........+.+++..||+.+|++|||+.||++.|++
T Consensus       243 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          243 --------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             --------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                    0011111 122234567889999999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-41  Score=348.18  Aligned_cols=260  Identities=21%  Similarity=0.209  Sum_probs=203.7

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-----hhhHHHHHHHHHHHHhccccccceeeeeeee
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-----KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT  323 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  323 (569)
                      .+..+.++|++.++||+|+||.||+|+.. +++.||+|++....     ....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            45677889999999999999999999975 68899999986542     3455789999999999999999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCC-------------------------------------CCccCCHHHHHHHHHHHHH
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPK-------------------------------------QKKELDWKKRHVIIIGTAE  366 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~  366 (569)
                      ....++||||+++++|.+++....                                     ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999884110                                     0223456778889999999


Q ss_pred             HHHHHhhcCCCCeeeCCCCCCCeEECCCC--CeEEeccCCCcccCCCCCC--CCCcccccCCCccccccccc--CCCCcc
Q 037160          367 GLEYLHKDGQMQIVHRDIKASNILLDLKH--RPKIADFGLARFSSSEKSL--LPNTAIAGTLGYMAPEYIAN--GQLTEK  440 (569)
Q Consensus       367 ~L~~LH~~~~~~ivHrDikp~NIll~~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~k  440 (569)
                      ||.|||+.+   |+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999998   99999999999998777  8999999999865432211  12345679999999999875  678999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC---CHHHHHHHHHHHHHhcCCCCCC
Q 037160          441 VDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE---DIEEVKRVVWVGLLCTQELPTL  517 (569)
Q Consensus       441 sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~  517 (569)
                      +||||||+++|||++|+.||........   .            ..++.......   .......+.+++..||+.+|++
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~---~------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT---I------------SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH---H------------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH---H------------HHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence            9999999999999999999864432211   0            11111111111   1112356778999999999999


Q ss_pred             CCCHHHHHHH
Q 037160          518 RPSMTNVVQM  527 (569)
Q Consensus       518 RPt~~evl~~  527 (569)
                      |||+.|++++
T Consensus       322 Rps~~~~l~h  331 (345)
T 3hko_A          322 RFDAMRALQH  331 (345)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999974

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.6e-41  Score=352.49  Aligned_cols=269  Identities=18%  Similarity=0.255  Sum_probs=204.8

Q ss_pred             hcccccccccccc--CceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHG--GYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|  +||.||+++.+ +|+.||||++....  ....+.+.+|+.++++++|||||++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999987 78999999997653  3445778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998542 2356899999999999999999999998   9999999999999999999999999886543


Q ss_pred             CCCC-----CCCCcccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh-hhhHhHhhhhcc
Q 037160          410 SEKS-----LLPNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE-TLVTHTWKHFQA  481 (569)
Q Consensus       410 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~  481 (569)
                      ....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||......... ......+.....
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            2211     111223578999999999987  57999999999999999999999998654332211 000000000000


Q ss_pred             ------c-------------chhhhhccc----------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 ------K-------------TVLEIIDKS----------IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 ------~-------------~~~~~~~~~----------l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                            .             ...+.+...          ...........+.+++.+||+.||++|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                  0             000000000          000011233568889999999999999999999965

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.3e-41  Score=336.96  Aligned_cols=253  Identities=22%  Similarity=0.308  Sum_probs=205.6

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +.++|++.++||+|+||.||+|.++ +++.||+|++....  ....+.+.+|+.++++++||||+++++++......++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4678999999999999999999976 68999999986543  34457788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC---eEEeccCCCcc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR---PKIADFGLARF  407 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---~kl~Dfgla~~  407 (569)
                      |||+++++|.+.+.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999988884   3356899999999999999999999998   999999999999987665   99999999987


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .....   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+...........+       ....    
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~----  223 (284)
T 3kk8_A          158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------KAGA----  223 (284)
T ss_dssp             CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTC----
T ss_pred             cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH-------Hhcc----
Confidence            65433   223467899999999999999999999999999999999999998644322111000       0000    


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ..............+.+++..||+.+|++|||+.|++++
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          224 -YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             -CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             000000011223457788999999999999999999964

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=341.86  Aligned_cols=265  Identities=23%  Similarity=0.321  Sum_probs=200.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .++|++.++||+|+||.||+|++. +|+.||||++....  ....+.+.+|+.++++++||||+++++++......++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            367999999999999999999986 68999999886543  233567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999999884   3456899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh--------hhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK--------HFQAK  482 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~  482 (569)
                      ..  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+.....        .+...
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            22  2235578999999999876 5789999999999999999999999876544322111111100        00000


Q ss_pred             chhhhhc-ccCCC-C-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLEIID-KSIEI-E-----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~-~~l~~-~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....... +.... .     .+.....+.+++..||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000 00000 0     01233457889999999999999999999965

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.2e-42  Score=346.37  Aligned_cols=269  Identities=22%  Similarity=0.375  Sum_probs=205.8

Q ss_pred             ccccccccccccCceeEEEEEe-----cCCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeC--Cce
Q 037160          256 DCFDESNKLGHGGYGEIFKGTL-----QDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDS  327 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  327 (569)
                      +.|++.++||+|+||.||++++     .+++.||||++.... ....+.+.+|+.++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588899999999999999983     368899999987543 34457889999999999999999999999876  668


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            999999999999999843  2345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... .......||..|+|||.+.+..++.++||||||+++|||++|..|+....... ...............+..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF-LKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCGGGHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH-hhccCCcccccCHHHHHH
Confidence            6654321 12335568888999999999999999999999999999999988743211000 000000000011111112


Q ss_pred             hhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          487 IIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       487 ~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .+...... ........+.+++..||+.+|++|||+.++++.|+.
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            22211111 123344678889999999999999999999999975

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.5e-42  Score=346.98  Aligned_cols=263  Identities=22%  Similarity=0.337  Sum_probs=210.8

Q ss_pred             HHhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCC
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK  325 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  325 (569)
                      ...++|++.++||+|+||.||+|++.      .++.||||.+.... ......+.+|+.++++++||||+++++++....
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            45678999999999999999999864      36789999886543 334567899999999999999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCC-------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeE
Q 037160          326 DSFVVYEFVQNKSLDRILFDPK-------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPK  398 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  398 (569)
                      ..++||||+++++|.+++....       ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence            9999999999999999985321       1245789999999999999999999998   99999999999999999999


Q ss_pred             EeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhh
Q 037160          399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      |+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+........   ...   
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~---  252 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRF---  252 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHH---
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---HHH---
Confidence            999999986654433222334567889999999999999999999999999999999 7788754332211   110   


Q ss_pred             hhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          478 HFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                               +...............+.+++.+||+.+|++|||+.|+++.|+....
T Consensus       253 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          253 ---------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                     01111111122334567788999999999999999999999987643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.2e-41  Score=343.87  Aligned_cols=269  Identities=19%  Similarity=0.225  Sum_probs=201.0

Q ss_pred             hccccccccccccCceeEEEEEec----CCceEEEEEEeecchh-----------hHHHHHHHHHHHHhccccccceeee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFISRKN-----------RIKEICNEMDIMSRAHHKNLVQFLG  319 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~  319 (569)
                      .++|++.++||+|+||.||+|...    .+..+|||++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999975    5788999988764321           1123667888999999999999999


Q ss_pred             eeee----CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC
Q 037160          320 CCFT----KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH  395 (569)
Q Consensus       320 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~  395 (569)
                      ++..    ....++||||+ +++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9987    67889999999 9999999843   347999999999999999999999998   99999999999998887


Q ss_pred             --CeEEeccCCCcccCCCCCCC-----CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 037160          396 --RPKIADFGLARFSSSEKSLL-----PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF  468 (569)
Q Consensus       396 --~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~  468 (569)
                        .+||+|||+++.........     ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              99999999998765432211     12355799999999999999999999999999999999999999853222111


Q ss_pred             hhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          469 ETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       469 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                      ..  ........ ......+.....  .......+.+++..||+.+|++||++.+|++.|+.....+
T Consensus       269 ~~--~~~~~~~~-~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  330 (345)
T 2v62_A          269 AV--QTAKTNLL-DELPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL  330 (345)
T ss_dssp             HH--HHHHHHHH-HTTTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred             HH--HHHHHhhc-ccccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence            00  00000000 001111111000  0022346788889999999999999999999999876533

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.6e-41  Score=358.75  Aligned_cols=261  Identities=25%  Similarity=0.291  Sum_probs=196.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC------C
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------K  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  325 (569)
                      .++|++.++||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999876 6899999999754  344567788999999999999999999999654      3


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++||||++++ |.+.+.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999765 555552     24889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWK  477 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~  477 (569)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..        .+.
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8765432   23456899999999999999999999999999999999999999865432211111100        000


Q ss_pred             hhc--------------ccchhhhhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          478 HFQ--------------AKTVLEIIDKSIEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       478 ~~~--------------~~~~~~~~~~~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...              ...+...+...+...    .......+.+++.+||+.||++|||+.|++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000              000111111111111    11225668889999999999999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9e-42  Score=347.12  Aligned_cols=248  Identities=22%  Similarity=0.284  Sum_probs=179.2

Q ss_pred             cccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEeecCCCC
Q 037160          261 SNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYEFVQNKS  338 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~  338 (569)
                      .++||+|+||.||+++++ +++.||||++...   ....+.+|+.+++++. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999976 6899999998543   3456789999999997 9999999999999999999999999999


Q ss_pred             hhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC---CeEEeccCCCcccCCCCCCC
Q 037160          339 LDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       339 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~  415 (569)
                      |.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++.......  
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence            9999943   457899999999999999999999998   99999999999998766   799999999986654322  


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE  495 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  495 (569)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||..................        +........
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------i~~~~~~~~  236 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK--------IKKGDFSFE  236 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH--------HTTTCCCCC
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH--------HHcCCCCCC
Confidence            234557899999999999999999999999999999999999998754332110000001111        111111111


Q ss_pred             C---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          496 D---IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       496 ~---~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .   ......+.+++..||+.||++|||+.|++++
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            1   1234567889999999999999999999855

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.1e-41  Score=348.72  Aligned_cols=271  Identities=18%  Similarity=0.208  Sum_probs=205.4

Q ss_pred             HhccccccccccccCceeEEEEEecC------CceEEEEEEeecchhhH-----------HHHHHHHHHHHhccccccce
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQD------GREIAVKRLFISRKNRI-----------KEICNEMDIMSRAHHKNLVQ  316 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  316 (569)
                      ..++|++.++||+|+||.||+|.++.      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45689999999999999999998764      47899999865542111           12344556677778999999


Q ss_pred             eeeeeeeC----CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC
Q 037160          317 FLGCCFTK----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD  392 (569)
Q Consensus       317 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~  392 (569)
                      +++++...    ...++||||+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998765    4579999999 9999999953  3356999999999999999999999998   99999999999999


Q ss_pred             --CCCCeEEeccCCCcccCCCCCCC-----CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 037160          393 --LKHRPKIADFGLARFSSSEKSLL-----PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD  465 (569)
Q Consensus       393 --~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~  465 (569)
                        .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999998765433211     12345699999999999999999999999999999999999999874322


Q ss_pred             cchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          466 DGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       466 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                      ...  ....... .....+.+.++..+...  .....+..++..||+.+|++||++.+|++.|++.-...
T Consensus       267 ~~~--~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          267 DPK--YVRDSKI-RYRENIASLMDKCFPAA--NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             CHH--HHHHHHH-HHHHCHHHHHHHHSCTT--CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CHH--HHHHHHH-HhhhhHHHHHHHhcccc--cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            211  1111111 11122333444333211  12345677888999999999999999999987654333

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.3e-41  Score=341.50  Aligned_cols=250  Identities=23%  Similarity=0.295  Sum_probs=205.9

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchh------hHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN------RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      ..++|++.+.||+|+||.||+++.. +|+.||||.+......      ..+.+.+|+.++++++||||+++++++.....
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            4577999999999999999999976 6899999998754321      35679999999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC----CeEEecc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH----RPKIADF  402 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~----~~kl~Df  402 (569)
                      .++||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999943   456899999999999999999999998   99999999999999888    7999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      |++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........   ...        
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~--------  229 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LAN--------  229 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHH--------
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---HHH--------
Confidence            9998765533   22455789999999999999999999999999999999999999864332211   000        


Q ss_pred             chhhhhcccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLEIIDKSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                          +........   .......+.+++..||+.+|++|||+.|++++
T Consensus       230 ----i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          230 ----ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ----HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ----HHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                000000000   01122457788999999999999999999975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=342.26  Aligned_cols=265  Identities=20%  Similarity=0.306  Sum_probs=206.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee----CCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT----KKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l  329 (569)
                      .++|++.++||+|+||.||+++.. +++.||||++........+.+.+|+.++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            467999999999999999999974 789999999987766777889999999999999999999999873    346799


Q ss_pred             EEeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          330 VYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      ||||+++++|.+++... .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999988532 23467899999999999999999999998   999999999999999999999999998755


Q ss_pred             CCCCCCC-------CCcccccCCCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          409 SSEKSLL-------PNTAIAGTLGYMAPEYIANGQ---LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       409 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      .......       ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||......            
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------  252 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------------  252 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT------------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc------------
Confidence            3321100       011345799999999987553   789999999999999999999987421000            


Q ss_pred             hcccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 037160          479 FQAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLP  536 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  536 (569)
                        .......+..... .........+.+++..||+.+|.+|||+.+|++.|+......+
T Consensus       253 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          253 --GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             --TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             --cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence              0001111111111 1122234567889999999999999999999999998764433

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=350.85  Aligned_cols=258  Identities=23%  Similarity=0.295  Sum_probs=204.6

Q ss_pred             hccccccccccccCceeEEEEEe----cCCceEEEEEEeecc----hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCC
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTL----QDGREIAVKRLFISR----KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKK  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  325 (569)
                      .++|++.++||+|+||.||+++.    .+++.||||++....    ....+.+.+|+++|+++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999987    368999999986432    23345677899999999 6999999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999943   356899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANG--QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      +.+...... ......||+.|+|||++.++  .++.++||||||+++|||++|+.||...........+..         
T Consensus       207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------  276 (355)
T 1vzo_A          207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------  276 (355)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---------
T ss_pred             eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---------
Confidence            866443322 23356799999999999863  578999999999999999999999875443221111100         


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccC
Q 037160          484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQMLKQK  531 (569)
Q Consensus       484 ~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~L~~~  531 (569)
                         .+.......+......+.+++.+||+.||++||     ++.|++++.--.
T Consensus       277 ---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          277 ---RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             ---HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             ---HHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence               000000111222334567889999999999999     999999876543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.6e-42  Score=370.61  Aligned_cols=261  Identities=24%  Similarity=0.360  Sum_probs=210.8

Q ss_pred             HHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +...++|++.++||+|+||.||+|.++++..||||++..... ..+.|.+|+++|++++||||+++++++.+ +..+|||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            345678999999999999999999998888899999875432 34679999999999999999999999866 6789999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       341 e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          341 EYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCCTTEEHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             ehhcCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            99999999999942 12345899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ... ......++..|+|||++.++.++.++||||||++||||++ |+.|+........   .             +.+..
T Consensus       417 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~-------------~~i~~  479 (535)
T 2h8h_A          417 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L-------------DQVER  479 (535)
T ss_dssp             HHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---H-------------HHHHT
T ss_pred             cee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-------------HHHHc
Confidence            211 2233456789999999999999999999999999999999 8888754332211   1             11111


Q ss_pred             cCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          491 SIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       491 ~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                      .... ........+.+++..||+.+|++|||+.+|++.|+......
T Consensus       480 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            1111 12233456778999999999999999999999999865443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-41  Score=353.60  Aligned_cols=267  Identities=23%  Similarity=0.340  Sum_probs=194.2

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCC--c
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKK--D  326 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~  326 (569)
                      ...++|++.++||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            45678999999999999999999975 7899999998543  3445567889999999997 999999999997544  6


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++||||++ ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 589888842    46889999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCC-------------------CCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCc
Q 037160          407 FSSSEKS-------------------LLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD  466 (569)
Q Consensus       407 ~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~  466 (569)
                      .......                   ........||+.|+|||++.+ ..++.++|||||||++|||++|++||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            6543211                   111234679999999999876 67899999999999999999999998754432


Q ss_pred             chhhhhHhHhh--------hhcccchhhhhc----------ccCCCC-------------CHHHHHHHHHHHHHhcCCCC
Q 037160          467 GFETLVTHTWK--------HFQAKTVLEIID----------KSIEIE-------------DIEEVKRVVWVGLLCTQELP  515 (569)
Q Consensus       467 ~~~~~~~~~~~--------~~~~~~~~~~~~----------~~l~~~-------------~~~~~~~~~~l~~~Cl~~~P  515 (569)
                      .....+.....        ..........+.          ......             .......+.+++.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            21111110000        000000000000          000000             00123467889999999999


Q ss_pred             CCCCCHHHHHHH
Q 037160          516 TLRPSMTNVVQM  527 (569)
Q Consensus       516 ~~RPt~~evl~~  527 (569)
                      ++|||+.|++++
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999999977

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.6e-41  Score=351.73  Aligned_cols=251  Identities=21%  Similarity=0.291  Sum_probs=193.5

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch--------hhHHHHHHHHHHHHhccccccceeeeeee
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--------NRIKEICNEMDIMSRAHHKNLVQFLGCCF  322 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~  322 (569)
                      ....++|.+.++||+|+||.||+|... +++.||||++.....        .....+.+|+.+|++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            456789999999999999999999976 689999999865421        12235789999999999999999999975


Q ss_pred             eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC---CeEE
Q 037160          323 TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKI  399 (569)
Q Consensus       323 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~---~~kl  399 (569)
                       .+..++||||+++++|.+++.   ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++   .+||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence             456899999999999999883   4567899999999999999999999998   99999999999997554   5999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN---GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  476 (569)
                      +|||+++......   ......||+.|+|||++.+   ..++.++||||||+++|||++|+.||........  +     
T Consensus       284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~-----  353 (419)
T 3i6u_A          284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L-----  353 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H-----
T ss_pred             eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H-----
Confidence            9999998765432   2345679999999999853   5788999999999999999999999864332210  1     


Q ss_pred             hhhcccchhhhhcccCCCCCH----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 KHFQAKTVLEIIDKSIEIEDI----EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~~~----~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                              .+.+........+    .....+.+++.+||+.+|++|||+.|++++
T Consensus       354 --------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          354 --------KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             --------HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --------HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                    0111111000111    123567889999999999999999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-41  Score=337.70  Aligned_cols=254  Identities=25%  Similarity=0.340  Sum_probs=199.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +.++|.+.++||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++......++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            4467999999999999999999975 68999999987653 334578899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---CCCCCeEEeccCCCcc
Q 037160          332 EFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL---DLKHRPKIADFGLARF  407 (569)
Q Consensus       332 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~~kl~Dfgla~~  407 (569)
                      ||+++++|.+++... .....+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999988432 22356899999999999999999999998   9999999999999   4567899999999986


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .....   ......||+.|+|||++. +.++.++||||||+++|||++|+.||.............             .
T Consensus       177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~-------------~  239 (285)
T 3is5_A          177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-------------Y  239 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------------H
T ss_pred             cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc-------------c
Confidence            65432   234567899999999875 568999999999999999999999986543221110000             0


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...............+.+++..||+.+|++|||+.||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          240 KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0001111111123467788999999999999999999964

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-41  Score=351.80  Aligned_cols=247  Identities=22%  Similarity=0.295  Sum_probs=191.9

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHH-HHhccccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDI-MSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|+||.||+++.+ +++.||||++....   ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999986 68899999997543   2334556677776 467899999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999984   3456889999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..            .++.
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~------------~i~~  253 (373)
T 2r5t_A          191 EHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD------------NILN  253 (373)
T ss_dssp             CCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---HH------------HHHH
T ss_pred             cCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HH------------HHHh
Confidence            3221  33467899999999999999999999999999999999999999864332211   10            1111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVV  525 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl  525 (569)
                      ..+.. .......+.+++..||+.+|++||++.+.+
T Consensus       254 ~~~~~-~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          254 KPLQL-KPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             SCCCC-CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             cccCC-CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            11111 112234567788999999999999985433

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=346.38  Aligned_cols=244  Identities=21%  Similarity=0.300  Sum_probs=202.9

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch--------hhHHHHHHHHHHHHhccccccceeeeeeee
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--------NRIKEICNEMDIMSRAHHKNLVQFLGCCFT  323 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  323 (569)
                      ...++|++.++||+|+||.||+|++. +++.||||++.....        .....+.+|+.++++++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            45678999999999999999999965 789999999875431        123457789999999999999999999999


Q ss_pred             CCceEEEEeecCCC-ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEecc
Q 037160          324 KKDSFVVYEFVQNK-SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADF  402 (569)
Q Consensus       324 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Df  402 (569)
                      ....++||||+.+| +|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999776 9999984   3456899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      |++.......   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....                
T Consensus       175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------  235 (335)
T 3dls_A          175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------  235 (335)
T ss_dssp             TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------
T ss_pred             ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------
Confidence            9998765543   2345679999999999988776 8899999999999999999999753110                


Q ss_pred             cchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 KTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 ~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                           .+..... .+......+.+++..||+.+|++|||+.|++++
T Consensus       236 -----~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 -----TVEAAIH-PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----GTTTCCC-CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----HHhhccC-CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0011110 011123457788899999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.9e-42  Score=347.84  Aligned_cols=262  Identities=25%  Similarity=0.386  Sum_probs=209.0

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CC-----ceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeee
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DG-----REIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT  323 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  323 (569)
                      +...++|++.+.||+|+||.||+|... .+     ..||+|.+.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            344578999999999999999999965 23     479999986543 34456799999999999 89999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCC-----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPK-----------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD  392 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~  392 (569)
                      ....++||||+++++|.+++....           ....+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence            999999999999999999985321           1345789999999999999999999998   99999999999999


Q ss_pred             CCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhh
Q 037160          393 LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETL  471 (569)
Q Consensus       393 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~  471 (569)
                      .++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..|+........  .
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~  276 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F  276 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H
Confidence            999999999999986654433222334567889999999999999999999999999999998 8888764432211  0


Q ss_pred             hHhHhhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          472 VTHTWKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       472 ~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                                   ...+...... .+......+..++..||+.+|.+|||+.||++.|+..
T Consensus       277 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 -------------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence                         0111111110 1112235677899999999999999999999999753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.5e-41  Score=336.00  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=200.7

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ..++|++.+.||+|+||.||++.+. +++.||||++....   ......+.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3467999999999999999999876 67899999986542   2235678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999999843   356899999999999999999999998   9999999999999999999999999986544


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..    ......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+...........                +.
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------------~~  220 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----------------IS  220 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----------------HH
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH----------------HH
Confidence            32    22355789999999999999999999999999999999999999864332211100                00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......+......+.+++..||+.+|++|||+.||+++
T Consensus       221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          221 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000111223456788899999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-41  Score=338.01  Aligned_cols=262  Identities=24%  Similarity=0.365  Sum_probs=210.1

Q ss_pred             ccccccc-cccccCceeEEEEEec---CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESN-KLGHGGYGEIFKGTLQ---DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|.+.+ +||+|+||.||+|.+.   ++..||||++... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 8999999999999854   5788999998764 344567899999999999999999999999 56678999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999843  3456899999999999999999999998   99999999999999999999999999987754


Q ss_pred             CCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          411 EKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       411 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...........                +
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----------------i  226 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----------------I  226 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----------------H
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----------------H
Confidence            4322 12234457889999999998899999999999999999998 9999865443221111                1


Q ss_pred             cccC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCC
Q 037160          489 DKSI-EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPS  539 (569)
Q Consensus       489 ~~~l-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p~  539 (569)
                      .... ...+......+.+++..||+.+|++||++.+|+++|+..-.....+.
T Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          227 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence            1100 01122334567889999999999999999999999987654444443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=345.85  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=198.7

Q ss_pred             hccccccccccccCceeEEEEEec-CCce----EEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGRE----IAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      .++|++.++||+|+||.||+|++. +++.    |++|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999965 4554    466666433 3345678999999999999999999999998754 88


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +|+||+.+++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999999853  2456899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........                ..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~----------------~~  231 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------------SI  231 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------HH
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----------------HH
Confidence            55443323345567889999999999999999999999999999999 99998654433221                11


Q ss_pred             hcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          488 IDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       488 ~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      +..... .........+..++..||+.+|++|||+.||++.|+...
T Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111111 112223446778999999999999999999999998754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=351.89  Aligned_cols=271  Identities=18%  Similarity=0.233  Sum_probs=211.4

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCC--ceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK--DSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv  330 (569)
                      .++|.+.++||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999976 58999999987543 334567889999999999999999999998765  67999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----CCCCCeEEeccCCCc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL----DLKHRPKIADFGLAR  406 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll----~~~~~~kl~Dfgla~  406 (569)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965444455999999999999999999999998   9999999999999    777889999999998


Q ss_pred             ccCCCCCCCCCcccccCCCccccccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCc-chhhhhHhHhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIAN--------GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD-GFETLVTHTWK  477 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~SlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~  477 (569)
                      ......   ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||...... ...........
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            765543   2234579999999999865        56788999999999999999999998643322 11111111111


Q ss_pred             hhcccchhhhh---------cccCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          478 HFQAKTVLEII---------DKSIE---IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       478 ~~~~~~~~~~~---------~~~l~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ......+....         ...+.   .........+..++..||+.||++||++.|+++.+++.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            11110000000         00011   11356667788899999999999999999999888654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-41  Score=341.55  Aligned_cols=267  Identities=23%  Similarity=0.357  Sum_probs=200.6

Q ss_pred             hHHHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhc--cccccceeeeeeeeC--
Q 037160          249 STIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRA--HHKNLVQFLGCCFTK--  324 (569)
Q Consensus       249 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~--  324 (569)
                      .......++|++.++||+|+||.||+|++. ++.||||++....   ...+.+|.+++..+  +||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            334556789999999999999999999986 8999999986443   23445566666554  999999999999887  


Q ss_pred             --CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc--------CCCCeeeCCCCCCCeEECCC
Q 037160          325 --KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD--------GQMQIVHRDIKASNILLDLK  394 (569)
Q Consensus       325 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------~~~~ivHrDikp~NIll~~~  394 (569)
                        ...++||||+++++|.+++..    ..+++..++.++.|++.||.|||+.        +   |+||||||+|||++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN  178 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred             CCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence              678999999999999999942    3689999999999999999999998        6   9999999999999999


Q ss_pred             CCeEEeccCCCcccCCCCCCC--CCcccccCCCcccccccccCCCCcc------cchhhHHHHHHHHHhCCCC-------
Q 037160          395 HRPKIADFGLARFSSSEKSLL--PNTAIAGTLGYMAPEYIANGQLTEK------VDIYSFGVLVLEIVSGVQN-------  459 (569)
Q Consensus       395 ~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------sDv~SlGvil~elltg~~p-------  459 (569)
                      +.+||+|||+++.........  ......||+.|+|||++.+...+.+      +||||||+++|||++|..|       
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999997665433221  1224579999999999988766665      9999999999999999444       


Q ss_pred             ---CCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          460 ---NKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE--DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       460 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                         +.........      +.............+.....  .......+.+++.+||+.+|++|||+.||+++|+...
T Consensus       259 ~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          259 QLPYHDLVPSDPS------YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CCTTTTTSCSSCC------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccHhhhcCCCCc------hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence               3322111100      00000000000001111100  2256677889999999999999999999999998643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.8e-41  Score=336.63  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=205.6

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ..++|.+.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.++++++||||+++++++...+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            3467899999999999999999976 5788999988654   23445678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++.   ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999999884   3456899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........       +..        +..
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~--------~~~  229 (294)
T 2rku_A          167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLR--------IKK  229 (294)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHH--------HHT
T ss_pred             cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH--------Hhh
Confidence            4322  23346789999999999988999999999999999999999999864432211       000        000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .... .+......+.+++.+||+.+|++|||+.|++++
T Consensus       230 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          230 NEYS-IPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             TCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccCC-CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000 011223457778899999999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-42  Score=347.47  Aligned_cols=272  Identities=21%  Similarity=0.383  Sum_probs=208.9

Q ss_pred             hccccccccccccCceeEEEEEe-----cCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCC--ce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTL-----QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK--DS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~  327 (569)
                      .++|++.++||+|+||.||++++     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46789999999999999999984     368899999998766666788999999999999999999999987644  78


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999532  346899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+......-................+.+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            75543211 12234577889999999998999999999999999999999887642210000000000000000011112


Q ss_pred             hhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          487 IIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       487 ~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .+...... ........+..++..||+.+|++|||+.||++.|+..
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            22211111 1223345678899999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4e-41  Score=363.34  Aligned_cols=255  Identities=24%  Similarity=0.306  Sum_probs=208.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ..++|++.++||+|+||.||+++++ +|+.||||++....   ......+.+|+.+|++++||||+++++++.+....++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3567999999999999999999976 78999999996542   2345678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999998543 2345899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+            ...+.
T Consensus       338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i------------~~~i~  402 (576)
T 2acx_A          338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV------------ERLVK  402 (576)
T ss_dssp             TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH------------HHHHH
T ss_pred             cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH------------HHHhh
Confidence            5432   23458999999999999989999999999999999999999998754332111111            01111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      ......+......+..++..||+.||++||     ++.||+++
T Consensus       403 ~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          403 EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            000001122335677888999999999999     78999865

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.2e-41  Score=332.27  Aligned_cols=252  Identities=19%  Similarity=0.274  Sum_probs=203.2

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeC--CceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK--KDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|+++ ++.||||++....  ....+.+.+|+.++++++||||+++++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57889999999999999999986 8899999987643  34456799999999999999999999999877  7789999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ .+|+||||||+||+++.++.++|+|||++....  
T Consensus        89 e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--  164 (271)
T ss_dssp             ECCTTCBHHHHHHS-CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred             cccCCCcHHHHHhh-cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence            99999999999954 23346899999999999999999999875 359999999999999999999999999875432  


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTE---KVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                           .....||+.|+|||.+.+...+.   ++||||||+++|||++|+.|+.........   .            ...
T Consensus       165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~------------~~~  224 (271)
T 3kmu_A          165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG---M------------KVA  224 (271)
T ss_dssp             -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH---H------------HHH
T ss_pred             -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH---H------------HHH
Confidence                 23456899999999998765544   899999999999999999998643322110   0            001


Q ss_pred             cccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          489 DKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       489 ~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ...... .+......+.+++..||+.+|++|||+.||++.|+...
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            111111 12223456778889999999999999999999998643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=333.22  Aligned_cols=250  Identities=22%  Similarity=0.327  Sum_probs=184.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.++++++||||+++++++......++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            367999999999999999999974 78999999986542   22346789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999953  3356899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.........       .        .....
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~--------~~~~~  227 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------N--------KVVLA  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------H--------HHhhc
Confidence            322  223457899999999999989999999999999999999999998654322110       0        00000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... .+......+.+++.+||+.+|++|||+.+++++
T Consensus       228 ~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          228 DYE-MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CCC-CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccC-CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            000 011223467788999999999999999999964

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=346.13  Aligned_cols=269  Identities=22%  Similarity=0.283  Sum_probs=196.0

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeeeee--------e
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGCCF--------T  323 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~  323 (569)
                      ...+|++.++||+|+||.||++++. +++.||||++........+.+.+|+.+++++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            4467999999999999999999975 78999999997777777788999999999996 999999999984        3


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                      ....++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            344799999995 788888854444567999999999999999999999875 359999999999999999999999999


Q ss_pred             CCcccCCCCCCC----------CCcccccCCCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 037160          404 LARFSSSEKSLL----------PNTAIAGTLGYMAPEYI---ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET  470 (569)
Q Consensus       404 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~  470 (569)
                      +++.........          ......||+.|+|||++   .+..++.++||||||+++|||++|+.|+........  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--  261 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--  261 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence            998765533211          11144689999999998   566789999999999999999999999853322110  


Q ss_pred             hhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCCC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPF  543 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p~~p~~  543 (569)
                                       +....... .......+..++..||+.+|++|||+.|+++.|+........+..++.
T Consensus       262 -----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~  318 (337)
T 3ll6_A          262 -----------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI  318 (337)
T ss_dssp             ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred             -----------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccH
Confidence                             00000000 111112366788999999999999999999999887655444444333

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.4e-41  Score=333.48  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=204.7

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee--------
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT--------  323 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  323 (569)
                      .+.++|++.+.||+|+||.||++++. +++.||+|++....    ..+.+|++++++++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            45678999999999999999999986 78999999987654    246689999999999999999998864        


Q ss_pred             --------CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC
Q 037160          324 --------KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH  395 (569)
Q Consensus       324 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~  395 (569)
                              ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                    44579999999999999999532 2356899999999999999999999998   99999999999999999


Q ss_pred             CeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH
Q 037160          396 RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       396 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  475 (569)
                      .+||+|||++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|..|+...         ...
T Consensus       160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~  227 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKF  227 (284)
T ss_dssp             EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHH
T ss_pred             CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHH
Confidence            99999999998765533   223456899999999999999999999999999999999998764210         001


Q ss_pred             hhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 037160          476 WKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTP  538 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p  538 (569)
                      +..        .....+..   .....+..++..||+.+|++|||+.|++++|+.........
T Consensus       228 ~~~--------~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          228 FTD--------LRDGIISD---IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             HHH--------HHTTCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             HHH--------hhcccccc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence            111        11111111   12234677889999999999999999999998776554433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.8e-41  Score=356.52  Aligned_cols=195  Identities=27%  Similarity=0.448  Sum_probs=155.7

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC-----Cc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----KD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  326 (569)
                      .++|++.++||+|+||.||+|+++ +++.||||++...  .....+.+.+|+.+|++++|||||++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999976 7899999998653  334567899999999999999999999998543     56


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++||||+ +++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 578988884   3456999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCC-------------------------CCCcccccCCCccccccc-ccCCCCcccchhhHHHHHHHHHhC
Q 037160          407 FSSSEKSL-------------------------LPNTAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSG  456 (569)
Q Consensus       407 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~SlGvil~elltg  456 (569)
                      ........                         ...+...||+.|+|||++ ....++.++||||||||||||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            76532211                         122356789999999976 556799999999999999999994

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.2e-41  Score=334.75  Aligned_cols=256  Identities=23%  Similarity=0.306  Sum_probs=201.9

Q ss_pred             HhccccccccccccCceeEEEEEecC----CceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQD----GREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ..++|.+.+.||+|+||.||+|++.+    +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34679999999999999999998652    235999988654 33456789999999999999999999999764 5678


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999953  2345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...........+.   .          
T Consensus       164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~----------  229 (281)
T 3cc6_A          164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---K----------  229 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---H----------
T ss_pred             cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---c----------
Confidence            553322 2234567889999999998999999999999999999998 999986543332111110   0          


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                        .............+.+++..||+.+|++|||+.|+++.|+..
T Consensus       230 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          230 --GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence              000001112234577889999999999999999999999753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-40  Score=332.18  Aligned_cols=264  Identities=18%  Similarity=0.241  Sum_probs=202.1

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeee-eeCCceEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC-FTKKDSFVV  330 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv  330 (569)
                      ...++|++.++||+|+||.||+|++. +++.||||++......  ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            35678999999999999999999974 7899999986554322  3578899999999988877776665 566778999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---CCCCCeEEeccCCCcc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL---DLKHRPKIADFGLARF  407 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~~kl~Dfgla~~  407 (569)
                      |||+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus        84 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 9999999852  2346899999999999999999999999   9999999999999   7889999999999987


Q ss_pred             cCCCCCC-----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          408 SSSEKSL-----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       408 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      .......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            6554321     12235679999999999999999999999999999999999999987644332221111111100000


Q ss_pred             chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      .. +.+.       ......+.+++..||+.+|++|||+.+|++.|++..
T Consensus       238 ~~-~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          238 PI-EVLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             CH-HHHT-------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hh-hhhh-------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            00 0000       111346788999999999999999999999997643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-41  Score=335.76  Aligned_cols=259  Identities=21%  Similarity=0.303  Sum_probs=204.2

Q ss_pred             ccccccccccccCceeEEEEEec-CC---ceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCce-EE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DG---REIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~l  329 (569)
                      -.|...++||+|+||.||+|.+. ++   ..+|+|.+... .....+.+.+|+.++++++||||+++++++...+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            34667789999999999999864 22   36999988653 334567899999999999999999999999876665 99


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+.+++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999954  3456889999999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCC--CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC-CCcchhhhhHhHhhhhcccchhh
Q 037160          410 SEKS--LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQ-SDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       410 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....  ........+++.|+|||.+.+..++.++||||||+++|||++|..|+... .....                ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~----------------~~  239 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL----------------TH  239 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH----------------HH
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH----------------HH
Confidence            4331  11233556889999999999999999999999999999999966654322 22111                11


Q ss_pred             hhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          487 IIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       487 ~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                      .+...... ........+.+++..||+.+|.+|||+.++++.|++....+
T Consensus       240 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          240 FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            11111111 11223346778999999999999999999999998754333

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.7e-41  Score=344.76  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=201.6

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .+.++|++.+.||+|+||.||+++++ +|+.||||++.....    ...+|++++.++ +||||+++++++.+....++|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            45678999999999999999999976 689999999865433    234688889888 799999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-C---CeEEeccCCCc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-H---RPKIADFGLAR  406 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-~---~~kl~Dfgla~  406 (569)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+.++ +   .+||+|||+++
T Consensus        95 ~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           95 TELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             ECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999999999999843   456899999999999999999999998   9999999999998543 3   49999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+....    ..+..  
T Consensus       169 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~--  240 (342)
T 2qr7_A          169 QLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKF--  240 (342)
T ss_dssp             ECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCC--
T ss_pred             cCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCc--
Confidence            7654332  233567899999999998888999999999999999999999998754332222121111    00000  


Q ss_pred             hhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                          .+.. ........+.+++..||+.||++|||+.|++++
T Consensus       241 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          241 ----SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             ----CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ----ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                0000 012233567788899999999999999999964

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-41  Score=341.86  Aligned_cols=256  Identities=24%  Similarity=0.437  Sum_probs=199.4

Q ss_pred             hccccccccccccCceeEEEEEecC-----CceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQD-----GREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      .++|.+.++||+|+||.||+|.+..     +..||||.+.... ......+.+|+.++++++||||+++++++......+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567888999999999999998652     2359999987542 334567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999953  3456899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          409 SSEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       409 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........   .             .
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~-------------~  261 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M-------------K  261 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-------------H
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H-------------H
Confidence            5432211 1223456788999999999999999999999999999999 9988754332211   1             1


Q ss_pred             hhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          487 IIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       487 ~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .+..... .........+.+++.+||+.+|++||++.+|++.|+..
T Consensus       262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          262 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111100 11222345677899999999999999999999999764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-40  Score=358.90  Aligned_cols=255  Identities=22%  Similarity=0.332  Sum_probs=207.4

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|++.++||+|+||.||+++++ +|+.||+|++....   ......+.+|+.+|++++||||+++++++......++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999986 68999999996543   23456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      |||++||+|.+++.... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999986533 2456899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...            +.
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~------------i~  406 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR------------VL  406 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH------------HH
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH------------Hh
Confidence            5432  22345899999999999999999999999999999999999999875432211 111110            11


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSM-----TNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~-----~evl~~  527 (569)
                      ..... .+......+..++..||+.+|++||++     .+|+++
T Consensus       407 ~~~~~-~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          407 EQAVT-YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             HCCCC-CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             hcccC-CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            11111 112234567778899999999999975     677743

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.3e-41  Score=345.23  Aligned_cols=248  Identities=26%  Similarity=0.429  Sum_probs=199.7

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .+.|+..++||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++......++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            456999999999999999999964 78999999986542   33456789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+. |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 577777632  2456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCCCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .      ....||+.|+|||++.   .+.++.++||||||+++|||++|+.|+........  +    +.... .     
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~----~~~~~-~-----  268 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHIAQ-N-----  268 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHHHH-S-----
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H----HHHHh-c-----
Confidence            2      3457899999999984   56789999999999999999999999754322110  0    00000 0     


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ..+..  ........+.+++..||+.+|++|||+.+++++.
T Consensus       269 ~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          269 ESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             CCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCCCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            00001  1112234567788999999999999999999654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.9e-41  Score=342.10  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=205.5

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ..++|.+.+.||+|+||.||++.+. +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3467899999999999999999976 5789999988654   23455678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       119 v~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999999884   3456899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........       ..        +..
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~--------~~~  255 (335)
T 2owb_A          193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LR--------IKK  255 (335)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HH--------HHH
T ss_pred             cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-------HH--------Hhc
Confidence            4322  234567899999999999989999999999999999999999998644322110       00        000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .... .+......+.+++.+||+.||++|||+.|++++
T Consensus       256 ~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          256 NEYS-IPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             TCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCC-CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 011123456778899999999999999999964

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.2e-41  Score=353.84  Aligned_cols=200  Identities=26%  Similarity=0.418  Sum_probs=168.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC-----C
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----K  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~  325 (569)
                      +.++|++.++||+|+||.||+|++. +++.||||++...  .....+.+.+|+.+|++++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3578999999999999999999976 6889999999653  334557889999999999999999999999776     5


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++||||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            6899999986 59999984   3456899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCC--------------------CCCcccccCCCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCC
Q 037160          406 RFSSSEKSL--------------------LPNTAIAGTLGYMAPEYI-ANGQLTEKVDIYSFGVLVLEIVSGVQNN  460 (569)
Q Consensus       406 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~SlGvil~elltg~~p~  460 (569)
                      +........                    ...+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            876543221                    112466899999999986 5567999999999999999999865554

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.6e-40  Score=347.45  Aligned_cols=251  Identities=22%  Similarity=0.262  Sum_probs=191.2

Q ss_pred             hcccccc-ccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHh-ccccccceeeeeeee----CCce
Q 037160          255 TDCFDES-NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKNLVQFLGCCFT----KKDS  327 (569)
Q Consensus       255 ~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~  327 (569)
                      .++|.+. ++||+|+||.||++.++ +|+.||||++...     ..+.+|+.++.+ .+||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3456665 68999999999999976 6899999988532     356788888755 489999999999875    5678


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC---CCCeEEeccCC
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL---KHRPKIADFGL  404 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~~kl~Dfgl  404 (569)
                      ++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999999542 2346899999999999999999999998   999999999999998   78899999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............           
T Consensus       211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-----------  276 (400)
T 1nxk_A          211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-----------  276 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH-----------
T ss_pred             ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH-----------
Confidence            98665432   2345678999999999999999999999999999999999999987544322110000           


Q ss_pred             hhhhcccCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          485 LEIIDKSIEI---EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       485 ~~~~~~~l~~---~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ..+.......   ........+.+++..||+.||++|||+.||+++-
T Consensus       277 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          277 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             HHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0000000000   0112335677899999999999999999999763

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-41  Score=342.69  Aligned_cols=267  Identities=22%  Similarity=0.297  Sum_probs=199.0

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchh-----hHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN-----RIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      ...++|++.+.||+|+||.||+|++. +|+.||||++......     ..+.+.+|+.++++++||||+++++++.....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999976 6899999998653221     12467899999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++||||+++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 88888743  3456888999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhc---cc
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ---AK  482 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~  482 (569)
                      .......  ......||+.|+|||++.+. .++.++||||||+++|||++|.+|+........   +...+....   ..
T Consensus       161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEE  235 (346)
T ss_dssp             TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTT
T ss_pred             eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChh
Confidence            7654322  23456789999999998764 589999999999999999999988765433211   111111100   00


Q ss_pred             chhh------hhcc-cCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          483 TVLE------IIDK-SIEIED-----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       483 ~~~~------~~~~-~l~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      .+.+      .+.. .....+     ......+.+++..||+.||++|||+.|++++---
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f  295 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  295 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence            0000      0000 000001     1223568889999999999999999999987543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=333.34  Aligned_cols=253  Identities=25%  Similarity=0.316  Sum_probs=199.7

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      +|.....||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3555568999999999999975 688999999977666666789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccCCCcccCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      +++|.+++........+++..+..++.|++.||.|||+.+   |+||||||+||+++. ++.+||+|||++........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999965444456778899999999999999999998   999999999999987 89999999999987654322 


Q ss_pred             CCCcccccCCCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQ--LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                       ......||+.|+|||++.++.  ++.++||||||+++|||++|+.|+......... .    +..        ......
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~----~~~--------~~~~~~  244 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-M----FKV--------GMFKVH  244 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-H----HHH--------HHHCCC
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-H----Hhh--------cccccc
Confidence             223557899999999987654  889999999999999999999997532221110 0    000        000000


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..........+..++.+||+.+|++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            01122233567788899999999999999999964

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.9e-41  Score=332.58  Aligned_cols=247  Identities=26%  Similarity=0.390  Sum_probs=203.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++......++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999976 67899999986542   22346789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999999843   346899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      .    ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.........       .        .+...
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~--------~~~~~  227 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-------R--------RIVNV  227 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------H--------HHHTT
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-------H--------HHhcc
Confidence            2    223457899999999999999999999999999999999999998644322110       0        00010


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... .+......+.+++..||+.+|++|||+.+++++
T Consensus       228 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 DLK-FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CCC-CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ccC-CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            010 111223456788999999999999999999963

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.2e-41  Score=348.05  Aligned_cols=264  Identities=22%  Similarity=0.333  Sum_probs=206.3

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..++|++.++||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++......++||
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            3578999999999999999999976 7899999998765 3444577899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ||+++++|.+++..   ...+++..+..++.+++.||.|||+. +   |+||||||+|||++.++.+||+|||++.....
T Consensus       111 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          111 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             ECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999943   34689999999999999999999996 7   99999999999999999999999999875533


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh----------------
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH----------------  474 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----------------  474 (569)
                      .    ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............                
T Consensus       185 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             H----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             c----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            2    22345789999999999999999999999999999999999999875443322111100                


Q ss_pred             -------Hhhhhcccchhhhhccc----CCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          475 -------TWKHFQAKTVLEIIDKS----IEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       475 -------~~~~~~~~~~~~~~~~~----l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                             ...........+.++..    ... ........+.+++..||+.||++|||+.|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                   00000001111111110    000 011234567889999999999999999999954

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.1e-41  Score=336.68  Aligned_cols=253  Identities=21%  Similarity=0.309  Sum_probs=203.2

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .+.++|.+.++||+|+||.||+++.. +|+.||+|++........+.+.+|+.++++++||||+++++++......++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            34578999999999999999999976 78999999998665555567889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---CCCCCeEEeccCCCccc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL---DLKHRPKIADFGLARFS  408 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~~kl~Dfgla~~~  408 (569)
                      ||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++...
T Consensus        86 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           86 QLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999998843   356899999999999999999999998   9999999999999   78899999999998754


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ...    ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........   ....    .....    
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i----~~~~~----  224 (304)
T 2jam_A          160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FEKI----KEGYY----  224 (304)
T ss_dssp             CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----HHCCC----
T ss_pred             CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----HcCCC----
Confidence            432    22345689999999999999999999999999999999999999864432211   1100    00000    


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       .............+.+++..||+.+|++|||+.|++++
T Consensus       225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             00000012233567789999999999999999999964

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.7e-41  Score=332.29  Aligned_cols=252  Identities=23%  Similarity=0.286  Sum_probs=201.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch------hhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK------NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      .++|++.++||+|+||.||+++.. +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999987 689999999865432      1357899999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC----CeEEeccC
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH----RPKIADFG  403 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~----~~kl~Dfg  403 (569)
                      ++||||+++++|.+++.   ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999994   3456899999999999999999999998   99999999999998877    89999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      ++.......   ......|++.|+|||.+.+..++.++||||||+++|+|++|+.|+.........   ... .......
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~-~~~~~~~  230 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---TNI-SAVNYDF  230 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHH-HTTCCCC
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH---HHh-HhcccCC
Confidence            998765432   223456899999999999999999999999999999999999998654322110   000 0000000


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..+.        .......+.+++.+||+.+|++|||+.|++++
T Consensus       231 ~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          231 DEEY--------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CHHH--------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             cchh--------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            0000        01123457789999999999999999999963

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.7e-40  Score=343.19  Aligned_cols=256  Identities=21%  Similarity=0.333  Sum_probs=207.4

Q ss_pred             hhHHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch--------hhHHHHHHHHHHHHhc-ccccccee
Q 037160          248 YSTIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--------NRIKEICNEMDIMSRA-HHKNLVQF  317 (569)
Q Consensus       248 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~  317 (569)
                      +.....+.++|++.++||+|+||.||+|++. +|+.||||++.....        ...+.+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3445667789999999999999999999986 799999999865431        2245688999999999 89999999


Q ss_pred             eeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       318 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                      ++++......++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence            999999999999999999999999984   3456899999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN------GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL  471 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~  471 (569)
                      ||+|||++.......   ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||........   
T Consensus       240 kl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---  313 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM---  313 (365)
T ss_dssp             EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---
T ss_pred             EEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH---
Confidence            999999998765543   2345679999999999863      3588999999999999999999999864322111   


Q ss_pred             hHhHhhhhcccchhhhhcccCCCCCH---HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          472 VTHTWKHFQAKTVLEIIDKSIEIEDI---EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       472 ~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....            .........+   .....+..++.+||+.+|++|||+.|++++
T Consensus       314 ~~~i------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          314 LRMI------------MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHH------------HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHH------------HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1000            0000100000   123457789999999999999999999974

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.4e-41  Score=335.80  Aligned_cols=260  Identities=25%  Similarity=0.334  Sum_probs=202.0

Q ss_pred             HhccccccccccccCceeEEEEEecC----CceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeee-eCCce
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQD----GREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCF-TKKDS  327 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~  327 (569)
                      ...+|++.++||+|+||.||+|.+.+    ...+|+|.+... .....+.+.+|+.++++++||||+++++++. .+...
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            34578889999999999999998642    235889988653 3345578999999999999999999999864 45678


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence            999999999999999953  3456889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCCC--CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          408 SSSEKSL--LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV-QNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       408 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      .......  .......+|+.|+|||.+.+..++.++||||||+++|||++|. +|+...........   .         
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~---------  245 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---L---------  245 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---H---------
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---H---------
Confidence            6543321  1223456788999999999999999999999999999999954 45443322211100   0         


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          485 LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       485 ~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                         ........+......+.+++..||+.+|++|||+.|+++.|+..-.
T Consensus       246 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          246 ---LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             ---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---hcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               0000011111223467788999999999999999999999987543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.3e-41  Score=338.37  Aligned_cols=265  Identities=23%  Similarity=0.371  Sum_probs=199.6

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|++.++||+|+||.||+|... +|+.||||++...   .......+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            457999999999999999999975 7899999998652   344557789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      |||+++++|.+++... .....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998432 23456899999999999999999999998   9999999999999999999999999998665


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ....  ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+........ .+..    .......     
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~~~~~~~-----  255 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCK----KIEQCDY-----  255 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHH----HHHTTCS-----
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHH----HhhcccC-----
Confidence            4322  22345789999999999999999999999999999999999999864322211 0100    0000000     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLP  536 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  536 (569)
                      ...  ........+.+++..||+.||++|||+.+|++.|++......
T Consensus       256 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          256 PPL--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             CCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCC--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            000  011233467788999999999999999999999987654433

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.6e-41  Score=333.79  Aligned_cols=248  Identities=21%  Similarity=0.286  Sum_probs=199.6

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  328 (569)
                      ...++|++.++||+|+||.||+|+.. +++.||||++...  .......+.+|+..+.++ +||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            35678999999999999999999986 7899999998754  234456788999999999 9999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-------------
Q 037160          329 VVYEFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-------------  394 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-------------  394 (569)
                      +||||+++++|.+++.... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            9999999999999995321 1256899999999999999999999998   9999999999999844             


Q ss_pred             ------CCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 037160          395 ------HRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG  467 (569)
Q Consensus       395 ------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~  467 (569)
                            ..+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++...  ..
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~  236 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--DQ  236 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS--HH
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch--hH
Confidence                  479999999998765432      33589999999999776 6678999999999999999998764321  10


Q ss_pred             hhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          468 FETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                              +..        +........+......+.+++..||+.+|++|||+.|++++
T Consensus       237 --------~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 --------WHE--------IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             --------HHH--------HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --------HHH--------HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                    111        11111111112233567788899999999999999999965

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=344.17  Aligned_cols=260  Identities=23%  Similarity=0.333  Sum_probs=196.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCC------
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK------  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  325 (569)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.+|++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999975 7899999998543  2344567899999999999999999999997653      


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++||||+ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899999843    46899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TW  476 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~  476 (569)
                      +.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..        .+
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            876542     345678999999999877 6899999999999999999999999875443221111100        01


Q ss_pred             hhhcccchhhhhccc-------CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 KHFQAKTVLEIIDKS-------IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~-------l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...........+...       +..........+.+++.+||+.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            111111111111100       000012234567788999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.9e-41  Score=341.36  Aligned_cols=261  Identities=25%  Similarity=0.354  Sum_probs=203.8

Q ss_pred             HhccccccccccccCceeEEEEEec------CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      ..++|++.+.||+|+||.||+|++.      +++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            3578999999999999999999842      5778999998643 34455678999999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCC----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC---CCeEE
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQ----KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKI  399 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl  399 (569)
                      .++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+   ..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999954321    245889999999999999999999998   9999999999999854   46999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhh
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      +|||++................||+.|+|||++.+..++.++||||||+++|||++ |+.|+........   ....   
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~---  258 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFV---  258 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHH---
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHH---
Confidence            99999976544333223345668899999999999999999999999999999998 8888764432211   1000   


Q ss_pred             hcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                       .        ..............+.+++..||+.+|.+||++.+|+++|+...
T Consensus       259 -~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          259 -T--------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             -H--------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -h--------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence             0        00000112223346778999999999999999999999997643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=344.86  Aligned_cols=264  Identities=20%  Similarity=0.298  Sum_probs=195.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhh-HHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNR-IKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|.+.++||+|+||.||+|+.. +++.||||++....... ...+.+|+.++++++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999976 78999999986543221 12455799999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      ++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 588888743  2346899999999999999999999998   99999999999999999999999999986543322


Q ss_pred             CCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh----
Q 037160          414 LLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII----  488 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  488 (569)
                        ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...........+....    
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence              2234578999999999876 568999999999999999999999987654332221111111110011000000    


Q ss_pred             ----c-ccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 ----D-KSIEIE-----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ----~-~~l~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                          . +.....     .+.....+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                0 000000     11223567789999999999999999999974

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4e-40  Score=329.92  Aligned_cols=265  Identities=18%  Similarity=0.237  Sum_probs=206.6

Q ss_pred             HhccccccccccccCceeEEEEEe-cCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeee-eeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC-FTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  331 (569)
                      ..++|++.+.||+|+||.||+|++ .+|+.||||++......  ..+.+|+.++++++|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            457899999999999999999997 47899999988654332  4688999999999998877666665 5667779999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---CCCCCeEEeccCCCccc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL---DLKHRPKIADFGLARFS  408 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~~kl~Dfgla~~~  408 (569)
                      ||+ +++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 9999999852  2356899999999999999999999998   9999999999999   48899999999999876


Q ss_pred             CCCCCCC-----CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          409 SSEKSLL-----PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       409 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      .......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            6543211     22456799999999999999999999999999999999999999876443222111111111000000


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 037160          484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDIT  534 (569)
Q Consensus       484 ~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  534 (569)
                      . +.+.       ......+.+++..||+.+|++|||+.+|++.|+.....
T Consensus       239 ~-~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          239 I-EVLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             H-HHHT-------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             h-HHHH-------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            0 0000       11224678899999999999999999999999865433

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.3e-41  Score=338.43  Aligned_cols=261  Identities=19%  Similarity=0.199  Sum_probs=198.3

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .-++|++.++||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999976 78899999986542   2334778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999943   356899999999999999999999998   9999999999999999999999999998665


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......   +.. ....  ......   
T Consensus       186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~-~~~~--~~~~~~---  255 (309)
T 2h34_A          186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGA-HINQ--AIPRPS---  255 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHH-HHHS--CCCCGG---
T ss_pred             ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHH-Hhcc--CCCCcc---
Confidence            43321 2335578999999999999999999999999999999999999986432211   000 0000  000000   


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhccCCCC
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRP-SMTNVVQMLKQKDIT  534 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-t~~evl~~L~~~~~~  534 (569)
                          .........+.+++.+||+.+|++|| ++.++++.|+..-..
T Consensus       256 ----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          256 ----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             ----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             ----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence                00112234577789999999999999 999999999875443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-40  Score=334.37  Aligned_cols=250  Identities=25%  Similarity=0.408  Sum_probs=206.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .+.|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            456899999999999999999875 68999999986543 3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999983    356899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             CCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.........   .....         .....+
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~---------~~~~~~  239 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIPK---------NNPPTL  239 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH---------SCCCCC
T ss_pred             c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHhhc---------CCCCCC
Confidence            2  234567899999999999999999999999999999999999997643322110   00000         000111


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                         .......+..++..||+.+|++|||+.||+++.
T Consensus       240 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          240 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             ---CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ---ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence               112234577889999999999999999999653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.5e-41  Score=341.69  Aligned_cols=265  Identities=26%  Similarity=0.392  Sum_probs=200.9

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .++|++.++||+|+||.||+++.. +|+.||||++....  ....+.+.+|+.++++++||||+++++++......++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357899999999999999999976 58999999986543  233456889999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999998873   3356899999999999999999999998   999999999999999999999999999866543


Q ss_pred             CCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--------hhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT--------WKHFQAK  482 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~  482 (569)
                      ..  ......||+.|+|||++.+. .++.++||||||+++|||++|++||...........+...        +..+...
T Consensus       178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            22  22345789999999998775 7899999999999999999999998765433211111000        0000000


Q ss_pred             chhh-hhcccCCC-CC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLE-IIDKSIEI-ED-----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~-~~~~~l~~-~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .... ...+.+.. ..     +.....+.+++.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000 00011110 11     1234568889999999999999999999964

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-40  Score=339.63  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=202.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceE--EEEEEeec-chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREI--AVKRLFIS-RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|++.+.||+|+||.||+|++. ++..+  |+|.+... .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57899999999999999999975 56644  99988643 234456789999999999 999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          331 YEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996432             2357899999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.........       
T Consensus       182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-------  251 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------  251 (327)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------
T ss_pred             EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH-------
Confidence            999999987433221   2234457889999999998889999999999999999998 99988644322110       


Q ss_pred             hhhcccchhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          477 KHFQAKTVLEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      .         .+..... .........+.+++.+||+.+|++|||+.|+++.|+...
T Consensus       252 ~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          252 E---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             H---------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H---------HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0         0111111 112223356778999999999999999999999987643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-41  Score=354.12  Aligned_cols=242  Identities=16%  Similarity=0.134  Sum_probs=187.6

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHH---HHHhccccccceee-------ee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMD---IMSRAHHKNLVQFL-------GC  320 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~  320 (569)
                      .++|++.++||+|+||.||+|++. +|+.||||++...   .....+.+.+|+.   ++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467889999999999999999974 6899999999743   3445678999994   55556899999998       55


Q ss_pred             eeeCC-----------------ceEEEEeecCCCChhhHhhCCC----CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 037160          321 CFTKK-----------------DSFVVYEFVQNKSLDRILFDPK----QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI  379 (569)
Q Consensus       321 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  379 (569)
                      +...+                 ..++||||+ +|+|.+++....    ....+++..++.++.||+.||.|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 378999999 689999985321    1123445888899999999999999998   9


Q ss_pred             eeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccC-----------CCCcccchhhHHH
Q 037160          380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-----------QLTEKVDIYSFGV  448 (569)
Q Consensus       380 vHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~SlGv  448 (569)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985433     2234567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          449 LVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       449 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      ++|||++|+.||...........               +.. ..    ......+.+++.+||+.||++|||+.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~---------------~~~-~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEW---------------IFR-SC----KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGG---------------GGS-SC----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchhh---------------hhh-hc----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999864332211100               000 00    111245777889999999999999999995

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-41  Score=347.02  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=194.5

Q ss_pred             ccccccccccccCceeEEEEEec--CC--ceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeee-CCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ--DG--REIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT-KKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l  329 (569)
                      ..|++.++||+|+||.||+|.+.  ++  ..||||.+... .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            45777889999999999999864  22  35899988543 33456789999999999999999999998754 567899


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999953  3456789999999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCCCC--CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          410 SEKSLL--PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       410 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ......  ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+...........+              
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~--------------  309 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------------  309 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH--------------
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH--------------
Confidence            432211  1234567889999999999999999999999999999999 56666543332211110              


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                       ........+......+.+++..||+.+|++|||+.||++.|+.....+
T Consensus       310 -~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          310 -LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             -HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             000000111222346778899999999999999999999998765444

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=367.03  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=199.9

Q ss_pred             cccccc-cccccCceeEEEEEec---CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          257 CFDESN-KLGHGGYGEIFKGTLQ---DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       257 ~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++.+.+ +||+|+||.||+|.++   ++..||||++.... ....+.+.+|+++|++++|||||++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            334444 7999999999999864   45679999987643 3456789999999999999999999999876 5689999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999943  3456899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          412 KSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       412 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ... .......+++.|+|||++.++.++.++|||||||+||||++ |+.|+.........                +.+.
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~----------------~~i~  553 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----------------AFIE  553 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH----------------HHHH
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----------------HHHH
Confidence            321 11223346789999999999999999999999999999998 99998754433211                1111


Q ss_pred             ccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          490 KSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       490 ~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ..... .+......+.+++..||+.+|++||++.+|++.|+..
T Consensus       554 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          554 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11111 1223445678899999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=330.71  Aligned_cols=253  Identities=23%  Similarity=0.260  Sum_probs=198.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc----hhhHHHHHHHHHHHHhccccccceeeeeee--eCCc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR----KNRIKEICNEMDIMSRAHHKNLVQFLGCCF--TKKD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~  326 (569)
                      ..++|++.+.||+|+||.||++... +++.||+|++....    ......+.+|+.++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4578999999999999999999975 68899999986543    234577999999999999999999999984  4567


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++||||+.++ |.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999877 6666643 23457899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQ--LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      ...............||+.|+|||++.+..  .+.++||||||+++|||++|+.|+........   .    .....   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~----~~i~~---  227 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---F----ENIGK---  227 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H----HHHHH---
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH---H----HHHhc---
Confidence            765433222333566899999999987643  47899999999999999999999864332111   0    10000   


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          485 LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       485 ~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                           ... .........+.+++.+||+.||++|||+.|++++
T Consensus       228 -----~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          228 -----GSY-AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----CCC-CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----CCC-CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 000 0111223456788899999999999999999965

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.4e-40  Score=335.12  Aligned_cols=256  Identities=20%  Similarity=0.307  Sum_probs=200.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeeeeee--CCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFT--KKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  330 (569)
                      .++|++.++||+|+||.||+|+.. +++.||||++....   .+.+.+|+.++++++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            367999999999999999999865 78999999986433   367889999999997 9999999999987  5678999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~~~~  409 (569)
                      |||+.+++|.+++      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            9999999999988      24889999999999999999999998   99999999999999777 89999999998765


Q ss_pred             CCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ....   .....||..|+|||++.+ ..++.++||||||+++|||++|+.|+........ .+. ............+.+
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~-~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLV-RIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHH-HHHHHHCHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHH-HHHHhcCCchhhhHH
Confidence            5432   234578999999999877 6799999999999999999999999854433211 111 000100011111111


Q ss_pred             cc-----------------------cCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DK-----------------------SIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~-----------------------~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +.                       ..... .......+.+++..||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00                       00000 11134678889999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-40  Score=355.43  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=202.6

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .+.++|++.++||+|+||.||+++.+ +++.||||++....  ......+.+|+.+|++++||||+++++++......++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            35678999999999999999999976 78999999986532  2345778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC---CCCCeEEeccCCCc
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD---LKHRPKIADFGLAR  406 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~---~~~~~kl~Dfgla~  406 (569)
                      ||||+.+++|.+.+..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            9999999999988843   356899999999999999999999999   99999999999995   45679999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ......   ......||+.|+|||++.+ .++.++|||||||++|+|++|++||........   +...           
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i-----------  234 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRV-----------  234 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH-----------
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH-----------
Confidence            765433   2335579999999999875 589999999999999999999999865432211   1100           


Q ss_pred             hhcccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ........   .......+.+++..||+.+|++|||+.|++++
T Consensus       235 -~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          235 -ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -HHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -HhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00000000   11223457789999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.9e-40  Score=356.84  Aligned_cols=252  Identities=25%  Similarity=0.320  Sum_probs=198.8

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +.+.|++.++||+|+||.||+|+.+ ++..||+|++....  ......+.+|+.++++++||||+++++++......++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999976 78899999987543  23356789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC---CCeEEeccCCCcc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLARF  407 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl~Dfgla~~  407 (569)
                      |||+++|+|.+.+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++..   +.+||+|||++..
T Consensus       115 ~e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999998884   3456899999999999999999999998   9999999999999764   4599999999987


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .....   ......||+.|+|||++. +.++.++|||||||++|+|++|.+||...........+.   .    ...   
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~----~~~---  254 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE---K----GKY---  254 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----TCC---
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h----CCC---
Confidence            65543   234567999999999886 569999999999999999999999987543322111100   0    000   


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        .............+.+++..||+.+|++|||+.|++++
T Consensus       255 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          255 --TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             --CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence              00000001223457788999999999999999999954

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.1e-41  Score=334.53  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=202.3

Q ss_pred             hccccccc-cccccCceeEEEEEec---CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          255 TDCFDESN-KLGHGGYGEIFKGTLQ---DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       255 ~~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      .++|.+.+ .||+|+||.||+|.+.   .++.||||++....  ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 9999999999999643   46889999986543  23357799999999999999999999999 667889


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999943   356899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          409 SSEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       409 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.........                .
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------------~  231 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----------------A  231 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----------------H
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----------------H
Confidence            5543221 1223456788999999998889999999999999999999 99988654332111                1


Q ss_pred             hhcccC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          487 IIDKSI-EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       487 ~~~~~l-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .+.... ...+......+..++..||+.+|++||++.+|++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          232 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111100 011223345678899999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.9e-41  Score=341.73  Aligned_cols=265  Identities=20%  Similarity=0.268  Sum_probs=193.8

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ...++|++.++||+|+||.||+++.. +++.||||++.....  ...+.+.+|+.++++++||||+++++++......++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            44578999999999999999999865 789999999865432  234567899999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC-----CCCCeEEeccCC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD-----LKHRPKIADFGL  404 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~-----~~~~~kl~Dfgl  404 (569)
                      ||||+++ +|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++     .++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999974 8998884   3346899999999999999999999998   99999999999994     445599999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      ++.......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...........
T Consensus       184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            987654322  23455789999999999875 589999999999999999999999865443221111100000000000


Q ss_pred             ---------hhhhhcccCCCCCHH------HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 ---------VLEIIDKSIEIEDIE------EVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ---------~~~~~~~~l~~~~~~------~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                               +..... ........      ....+.+++..||+.||++|||+.|++++
T Consensus       262 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          262 WPGVTALPDWKQSFP-KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             STTGGGSTTCCTTCC-CCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhh-hhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence                     000000 00000111      23567789999999999999999999974

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-40  Score=342.68  Aligned_cols=268  Identities=22%  Similarity=0.346  Sum_probs=202.3

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeC-------
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-------  324 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  324 (569)
                      .++|++.++||+|+||.||+|+.. +|+.||||++.....  .....+.+|+.++++++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            367999999999999999999975 789999998865432  2345678999999999999999999999873       


Q ss_pred             -CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          325 -KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       325 -~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                       +..++||||+++ +|.+.+..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             467999999975 66666643  3356899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCCC--CCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH-----
Q 037160          404 LARFSSSEKSL--LPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT-----  475 (569)
Q Consensus       404 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-----  475 (569)
                      +++........  .......||+.|+|||++.+ ..++.++||||||+++|||++|++|+...........+...     
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99876533221  12235678999999999876 46899999999999999999999998765433222221111     


Q ss_pred             ---hhhhcccchhhhhcccCCCC-C-HHH------HHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          476 ---WKHFQAKTVLEIIDKSIEIE-D-IEE------VKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       476 ---~~~~~~~~~~~~~~~~l~~~-~-~~~------~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                         |.........+.+....... . .+.      ...+.+++.+||+.||++|||+.|++++-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  313 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  313 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence               11111111111111000000 1 111      23477899999999999999999999764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4e-41  Score=334.32  Aligned_cols=260  Identities=21%  Similarity=0.313  Sum_probs=203.7

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeee--CCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT--KKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l  329 (569)
                      .++|++.+.||+|+||.||+++.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999976 78999999987543  3445679999999999999999999998854  567899


Q ss_pred             EEeecCCCChhhHhhCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          330 VYEFVQNKSLDRILFDPK-QKKELDWKKRHVIIIGTAEGLEYLHKDG--QMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999985322 2345899999999999999999999976  2349999999999999999999999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      .......  ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+........   ...    ..      
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----i~------  229 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGK----IR------  229 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH----HH------
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HHH----Hh------
Confidence            6654321  12245689999999999998999999999999999999999999865432211   100    00      


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                        .......+......+.+++.+||+.+|++|||+.||++.+...
T Consensus       230 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          230 --EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             --HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             --hcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence              0001011122335677889999999999999999999876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.3e-40  Score=366.31  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=205.4

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  328 (569)
                      ..++|++.++||+|+||.||+++++ +++.||||++...   .....+.+..|..+|..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3468999999999999999999976 6888999998753   233456788899999987 7999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      |||||+++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999943   356899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      .....  ......||+.|+|||++.+..++.++|||||||+||||++|+.||........   ..            .++
T Consensus       493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~---~~------------~i~  555 (674)
T 3pfq_A          493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQ------------SIM  555 (674)
T ss_dssp             CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH------------HHH
T ss_pred             ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH---HH------------HHH
Confidence            33222  33467899999999999999999999999999999999999999865432211   11            111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSM-----TNVVQM  527 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~-----~evl~~  527 (569)
                      ...+. .+......+.+++..||+.||++||++     .||+++
T Consensus       556 ~~~~~-~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          556 EHNVA-YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             SSCCC-CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             hCCCC-CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            11111 122234567788899999999999998     788754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.4e-40  Score=338.72  Aligned_cols=268  Identities=23%  Similarity=0.305  Sum_probs=206.4

Q ss_pred             chhHHHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHh--ccccccceeeeeeeeC
Q 037160          247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSR--AHHKNLVQFLGCCFTK  324 (569)
Q Consensus       247 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~  324 (569)
                      .......+.++|++.++||+|+||.||+|++. |+.||||++...   ....+.+|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            33445667789999999999999999999985 899999998543   34567789999988  7999999999999877


Q ss_pred             C----ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeCCCCCCCeEEC
Q 037160          325 K----DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH--------KDGQMQIVHRDIKASNILLD  392 (569)
Q Consensus       325 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivHrDikp~NIll~  392 (569)
                      .    ..++||||+++++|.+++..    ..+++..++.++.|++.||.|||        +.+   |+||||||+|||++
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK  181 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence            6    78999999999999999942    46899999999999999999999        677   99999999999999


Q ss_pred             CCCCeEEeccCCCcccCCCCCCC--CCcccccCCCcccccccccC------CCCcccchhhHHHHHHHHHhC--------
Q 037160          393 LKHRPKIADFGLARFSSSEKSLL--PNTAIAGTLGYMAPEYIANG------QLTEKVDIYSFGVLVLEIVSG--------  456 (569)
Q Consensus       393 ~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~SlGvil~elltg--------  456 (569)
                      .++++||+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999998665443211  12345799999999998775      234789999999999999999        


Q ss_pred             --CCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          457 --VQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI--EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       457 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                        ..|+.........  ..........    ....+.+..  ...+....+.+++.+||+.+|++|||+.||+++|+..
T Consensus       262 ~~~~p~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPS--VEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCTTTTTSCSSCC--HHHHHHHHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCccccCcCccc--HHHHHHHHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence              4555432211100  0000000000    000111111  1235567788999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.6e-40  Score=329.52  Aligned_cols=248  Identities=24%  Similarity=0.343  Sum_probs=195.5

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .++|.+.++||+|+||.||+|.+. +|+.||||++....   ....+.+.+|+.++++++||||+++++++......++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367899999999999999999986 78999999986542   23456789999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999843   346899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..   ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.|+.......   ..    ..         +.
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~----~~---------~~  224 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LF----KK---------IR  224 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HH---------HH
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HH----HH---------hh
Confidence            32   1234568999999999987765 689999999999999999999986432211   11    00         00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......+......+..++.+||+.+|++|||+.||+++
T Consensus       225 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          225 GGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00000111123457788999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.2e-40  Score=341.15  Aligned_cols=262  Identities=23%  Similarity=0.321  Sum_probs=186.6

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC------
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------  324 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  324 (569)
                      ..++|++.++||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+|++++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3478999999999999999999865 7899999998653  334456788999999999999999999998654      


Q ss_pred             CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                      ...++|+|++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            5679999999 789998883    256899999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------H
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------T  475 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~  475 (569)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..        .
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9865432     345678999999999877 6799999999999999999999999875443221111110        1


Q ss_pred             hhhhcccchhhhhcccCCC--CCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          476 WKHFQAKTVLEIIDKSIEI--EDI-----EEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~--~~~-----~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      +...........+......  ...     .....+.+++.+||+.||++|||+.|++++-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence            1111111111111111110  011     1234577899999999999999999999753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.6e-40  Score=339.95  Aligned_cols=271  Identities=23%  Similarity=0.260  Sum_probs=192.6

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCc--
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD--  326 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--  326 (569)
                      ......++|++.++||+|+||.||+|++. +|+.||||++..... ....+.+|++.+..++||||+++++++.....  
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            34566789999999999999999999976 689999998865432 23456678888999999999999999976443  


Q ss_pred             -----eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeeCCCCCCCeEECC-CCCeE
Q 037160          327 -----SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH--KDGQMQIVHRDIKASNILLDL-KHRPK  398 (569)
Q Consensus       327 -----~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivHrDikp~NIll~~-~~~~k  398 (569)
                           .++||||++++.+..+.........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+|
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence                 7899999987543333222245567889999999999999999999  887   999999999999996 89999


Q ss_pred             EeccCCCcccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          399 IADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      |+|||+++......   ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+.....
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            99999998765543   23355789999999998665 489999999999999999999999876543322111110000


Q ss_pred             hhcccchhhhhcc-----------------cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          478 HFQAKTVLEIIDK-----------------SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       478 ~~~~~~~~~~~~~-----------------~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      .. .......+.+                 ............+.+++..||+.||++|||+.|++++-
T Consensus       250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  316 (360)
T 3e3p_A          250 CP-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP  316 (360)
T ss_dssp             CC-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred             CC-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence            00 0000000000                 00111122456788899999999999999999999753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.4e-41  Score=332.02  Aligned_cols=249  Identities=25%  Similarity=0.358  Sum_probs=195.7

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeC-CceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-KDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~  333 (569)
                      .++|++.+.||+|+||.||++..+ |+.||||++....  ..+.+.+|+.++++++||||+++++++.+. ...++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467899999999999999999875 7899999886543  456789999999999999999999997654 478999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999998432 2234789999999999999999999998   999999999999999999999999998755432  


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                         .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.........                ..+....
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~----------------~~~~~~~  231 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----------------PRVEKGY  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH----------------HHHTTTC
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHHhcCC
Confidence               223457889999999999999999999999999999998 98887654322111                1111111


Q ss_pred             C-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          493 E-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       493 ~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      . .........+.+++..||+.+|++|||+.|+++.|+..
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            1 11222345677888999999999999999999998764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=343.15  Aligned_cols=251  Identities=16%  Similarity=0.128  Sum_probs=199.7

Q ss_pred             HhccccccccccccCceeEEEEE------ecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc---ccccceeeeeeeeC
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGT------LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH---HKNLVQFLGCCFTK  324 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~  324 (569)
                      ..++|.+.++||+|+||.||+|.      ...++.||||++....   ...+.+|++++.+++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45779999999999999999994      3468999999986543   346777888888876   99999999999999


Q ss_pred             CceEEEEeecCCCChhhHhhCCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC---------
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPK--QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL---------  393 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~---------  393 (569)
                      +..++||||+++|+|.+++....  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999995321  3467999999999999999999999998   999999999999998         


Q ss_pred             --CCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhh
Q 037160          394 --KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL  471 (569)
Q Consensus       394 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~  471 (569)
                        ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.|+........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence              899999999999765432222233456799999999999999999999999999999999999998743222110   


Q ss_pred             hHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHhcc
Q 037160          472 VTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLR-PSMTNVVQMLKQ  530 (569)
Q Consensus       472 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~R-Pt~~evl~~L~~  530 (569)
                              .       +...+...  .....+.+++..|++.+|.+| |++.++.+.|++
T Consensus       294 --------~-------~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          294 --------K-------PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             --------E-------ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             --------e-------echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                    0       01111111  112345567789999999988 677877777764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=339.92  Aligned_cols=270  Identities=22%  Similarity=0.353  Sum_probs=197.0

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHH--HHhccccccceeeeeeee-----CCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDI--MSRAHHKNLVQFLGCCFT-----KKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~~~  327 (569)
                      .++|++.++||+|+||.||+|+. +++.||||++.....   ..+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36789999999999999999987 579999999865433   334444444  445899999999986542     2356


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc---------CCCCeeeCCCCCCCeEECCCCCeE
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD---------GQMQIVHRDIKASNILLDLKHRPK  398 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------~~~~ivHrDikp~NIll~~~~~~k  398 (569)
                      ++||||+++++|.+++..    ...++..++.++.||+.||.|||+.         +   |+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            899999999999999943    3458899999999999999999998         7   99999999999999999999


Q ss_pred             EeccCCCcccCCCCCC------CCCcccccCCCccccccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 037160          399 IADFGLARFSSSEKSL------LPNTAIAGTLGYMAPEYIAN-------GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD  465 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~SlGvil~elltg~~p~~~~~~  465 (569)
                      |+|||+++........      .......||+.|+|||++.+       ..++.++||||||+++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            9999999876543221      12224579999999999976       4567899999999999999999776543322


Q ss_pred             -cchhhhhHhHhhhhc-ccchhhhhc-----ccCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          466 -DGFETLVTHTWKHFQ-AKTVLEIID-----KSIEI---EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       466 -~~~~~~~~~~~~~~~-~~~~~~~~~-----~~l~~---~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                       ............... ...+...+.     +.+..   ........+.+++.+||+.+|++|||+.||++.|+..-...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence             111111110000000 000111111     11111   12345667899999999999999999999999998754333

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=342.39  Aligned_cols=266  Identities=15%  Similarity=0.161  Sum_probs=204.0

Q ss_pred             hccccccccccccCceeEEEEEecC---------CceEEEEEEeecchhhHHHHHHHHHHHHhccccccce---------
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQD---------GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ---------  316 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  316 (569)
                      .++|++.++||+|+||.||+|+...         ++.||||++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999999763         789999988644     35779999999999999998         


Q ss_pred             ------eeeeeee-CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCe
Q 037160          317 ------FLGCCFT-KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNI  389 (569)
Q Consensus       317 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NI  389 (569)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5666665 67889999999 99999999532 2467999999999999999999999998   99999999999


Q ss_pred             EECCCC--CeEEeccCCCcccCCCCCCC-----CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 037160          390 LLDLKH--RPKIADFGLARFSSSEKSLL-----PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKF  462 (569)
Q Consensus       390 ll~~~~--~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~  462 (569)
                      |++.++  .+||+|||+++.........     ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  89999999998765433211     12345799999999999999999999999999999999999999875


Q ss_pred             CCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 037160          463 QSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITL  535 (569)
Q Consensus       463 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  535 (569)
                      ...... .+.. ....+. ............  .......+.+++..||+.+|++|||+.+|++.|+......
T Consensus       271 ~~~~~~-~~~~-~~~~~~-~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          271 CLPNTE-DIMK-QKQKFV-DKPGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             GTTCHH-HHHH-HHHHHH-HSCCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CCcCHH-HHHH-HHHhcc-CChhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            432211 1111 000000 000000010000  0112356778889999999999999999999998654433

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-40  Score=357.23  Aligned_cols=249  Identities=24%  Similarity=0.333  Sum_probs=204.8

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      +.++|++.++||+|+||.||+++.+ +|+.||||++....   ......+.+|+.++++++||||+++++++......++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4578999999999999999999976 78999999986532   3456789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---CCCCCeEEeccCCCc
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL---DLKHRPKIADFGLAR  406 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~~kl~Dfgla~  406 (569)
                      ||||+.+++|.+.+.   ....+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999884   3456899999999999999999999998   9999999999999   567899999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ......   ......||+.|+|||++.+ .++.++|||||||++|+|++|++||........   ....           
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i-----------  239 (484)
T 3nyv_A          178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---LKKV-----------  239 (484)
T ss_dssp             HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH-----------
T ss_pred             Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH-----------
Confidence            765433   2345679999999999865 689999999999999999999999865432211   1100           


Q ss_pred             hhcccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ........   .......+.+++.+||+.+|++|||+.|++++
T Consensus       240 -~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          240 -EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             -HHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence             00000000   11223467789999999999999999999964

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.5e-40  Score=328.23  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=198.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeee----CCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT----KKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  327 (569)
                      .+.|.+.++||+|+||.||+|.+. ++..||+|.+....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            345788889999999999999975 68899999986542  4456778999999999999999999999875    3557


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC-CCCCeEEeccCCCc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD-LKHRPKIADFGLAR  406 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~~kl~Dfgla~  406 (569)
                      ++||||+++++|.+++.   ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999999994   3356899999999999999999999875 3499999999999997 78999999999997


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      .....    ......||+.|+|||++. +.++.++||||||+++|+|++|+.|+.......  ...    ..........
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~----~~~~~~~~~~  249 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY----RRVTSGVKPA  249 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH----HHHTTTCCCG
T ss_pred             ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHH----HHHhccCCcc
Confidence            55432    233557899999999876 468999999999999999999999986433221  111    1111100000


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..       .......+.+++..||+.+|++|||+.||+++
T Consensus       250 ~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          250 SF-------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GG-------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            00       11112457788999999999999999999964

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.9e-40  Score=354.41  Aligned_cols=250  Identities=27%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch-------------hhHHHHHHHHHHHHhccccccceee
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-------------NRIKEICNEMDIMSRAHHKNLVQFL  318 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~  318 (569)
                      .+.++|.+.++||+|+||.||+|+.+ +++.||||++.....             ...+.+.+|+.+|++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            35678999999999999999999976 688999999865421             2356789999999999999999999


Q ss_pred             eeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC---
Q 037160          319 GCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH---  395 (569)
Q Consensus       319 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~---  395 (569)
                      +++.+....++||||+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence            99999999999999999999999884   3456899999999999999999999998   99999999999998776   


Q ss_pred             CeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH
Q 037160          396 RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       396 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  475 (569)
                      .+||+|||++.......   ......||+.|+|||++. +.++.++|||||||++|+|++|.+||.........   ...
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i  259 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII---KKV  259 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH
Confidence            69999999998775543   234567999999999986 56899999999999999999999998754332211   100


Q ss_pred             hhhhcccchhhhhcccCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          476 WKHFQAKTVLEIIDKSIEIED---IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~~~---~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                                  .........   ......+.+++..||+.+|.+|||+.|++++
T Consensus       260 ------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          260 ------------EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             ------------HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------------HcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                        000000000   1123467789999999999999999999964

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.9e-40  Score=333.20  Aligned_cols=253  Identities=21%  Similarity=0.302  Sum_probs=196.2

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--------hhhHHHHHHHHHHHHhccccccceeeeeeee
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--------KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT  323 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  323 (569)
                      ...++|++.++||+|+||.||+|+.. +++.||||++....        ......+.+|++++++++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            45678999999999999999999976 68899999986432        1223458899999999999999999999866


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC---eEEe
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR---PKIA  400 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---~kl~  400 (569)
                      .. .++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             Cc-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence            54 899999999999999883   4467899999999999999999999998   999999999999987665   9999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      |||+++......   ......||+.|+|||++.   ...++.++||||||+++|||++|..||........  +......
T Consensus       160 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~  234 (322)
T 2ycf_A          160 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS  234 (322)
T ss_dssp             CCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH
T ss_pred             cCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh
Confidence            999998764422   123456899999999974   46789999999999999999999999864432210  1000000


Q ss_pred             hhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          478 HFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      . ......+.        .......+.+++.+||+.||++|||+.|+++
T Consensus       235 ~-~~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          235 G-KYNFIPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             T-CCCCCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C-ccccCchh--------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0 00000000        0112356778999999999999999999984

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-39  Score=340.59  Aligned_cols=262  Identities=20%  Similarity=0.256  Sum_probs=202.1

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc--------ccccceeeeeee--
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH--------HKNLVQFLGCCF--  322 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~--  322 (569)
                      +.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++        |+||+++++.+.  
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            4578999999999999999999865 6889999998644 334567889999999995        788999999987  


Q ss_pred             --eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCC----
Q 037160          323 --TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKH----  395 (569)
Q Consensus       323 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~----  395 (569)
                        .....++||||+. ++|.+.+.. .....+++..++.++.||+.||.|||++ +   |+||||||+|||++.++    
T Consensus       114 ~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          114 GVNGTHICMVFEVLG-HHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             ETTEEEEEEEECCCC-CBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             CCCCceEEEEEeccC-ccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence              4567899999995 455554432 2335689999999999999999999998 8   99999999999999775    


Q ss_pred             ---------------------------------------------CeEEeccCCCcccCCCCCCCCCcccccCCCccccc
Q 037160          396 ---------------------------------------------RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE  430 (569)
Q Consensus       396 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE  430 (569)
                                                                   .+||+|||++......     .....||+.|+|||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence                                                         8999999999876542     23457899999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh---hhHhHhhhhcc--------cc----------------
Q 037160          431 YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET---LVTHTWKHFQA--------KT----------------  483 (569)
Q Consensus       431 ~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~--------~~----------------  483 (569)
                      ++.+..++.++|||||||+||||++|+.||..........   .+.........        ..                
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            9999999999999999999999999999997654332111   01100000000        00                


Q ss_pred             ------hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 ------VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ------~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                            ..+.+... ..........+.+++.+||+.||++|||+.||+++
T Consensus       344 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          344 KLKPWGLFEVLVEK-YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCCHHHHHHHT-SCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccCCcchhHhhhhh-cccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                  00000000 01245667788999999999999999999999964

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-40  Score=366.40  Aligned_cols=247  Identities=26%  Similarity=0.372  Sum_probs=196.7

Q ss_pred             ccccccCceeEEEEEec---CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ---DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+|.+.   .++.||||++....  ....+.+.+|+++|++++|||||++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999653   46789999987543  334678999999999999999999999986 4568999999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC-C
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL-L  415 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  415 (569)
                      |+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++........ .
T Consensus       454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999994   3456899999999999999999999998   999999999999999999999999999877554322 1


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||........                .+.+......
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~----------------~~~i~~~~~~  591 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----------------TAMLEKGERM  591 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------HHHHHTTCCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHHcCCCC
Confidence            2234457889999999999999999999999999999998 9999864433211                1111111111


Q ss_pred             -CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          495 -EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       495 -~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                       .+......+.+++..||+.+|++||++.+|++.|+..
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             1223345678899999999999999999999999753

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-39  Score=346.58  Aligned_cols=262  Identities=18%  Similarity=0.226  Sum_probs=205.2

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccc-cccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHH-KNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..++|++.++||+|+||.||+|++. +++.||||++......  ..+.+|+++++.++| +++..+..++......+|||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            3578999999999999999999974 7899999987654332  357899999999987 55556666667788889999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE---CCCCCeEEeccCCCccc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL---DLKHRPKIADFGLARFS  408 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~~kl~Dfgla~~~  408 (569)
                      ||+ +++|.+++..  ....+++..++.|+.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++..
T Consensus        83 e~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           83 DLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ECC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            999 9999999953  2456899999999999999999999998   9999999999999   68899999999999876


Q ss_pred             CCCCCC-----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          409 SSEKSL-----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       409 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      ......     .......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+...........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            654321     122366799999999999999999999999999999999999999876544332222111111111111


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       484 ~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ...+..        .....+.+++..||+.+|++||++.+|+++|+..
T Consensus       237 ~~~l~~--------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          237 IEALCR--------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHHHT--------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHhc--------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            111101        1134678899999999999999999999988653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-40  Score=343.04  Aligned_cols=273  Identities=19%  Similarity=0.262  Sum_probs=201.7

Q ss_pred             chhHHHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecch-----------hhHHHHHHHHHHHHhccccccc
Q 037160          247 KYSTIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK-----------NRIKEICNEMDIMSRAHHKNLV  315 (569)
Q Consensus       247 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv  315 (569)
                      ....++.+.++|.+.++||+|+||.||+|...+|+.||||++.....           ...+.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            35567788999999999999999999999988899999999854321           2247899999999999999999


Q ss_pred             eeeeeeeeC-----CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeE
Q 037160          316 QFLGCCFTK-----KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNIL  390 (569)
Q Consensus       316 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIl  390 (569)
                      ++++++...     ...++||||+. ++|.+++.  .....+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            999998543     35799999997 57777774  33457899999999999999999999998   999999999999


Q ss_pred             ECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh
Q 037160          391 LDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE  469 (569)
Q Consensus       391 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~  469 (569)
                      ++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999997544332   2345678999999999877 67999999999999999999999998754322211


Q ss_pred             hhhHh--------HhhhhcccchhhhhcccCCCC--------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          470 TLVTH--------TWKHFQAKTVLEIIDKSIEIE--------DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       470 ~~~~~--------~~~~~~~~~~~~~~~~~l~~~--------~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ..+..        .+..+......+.+...+...        .+.....+.+++..||+.+|++|||+.|++++-
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  318 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP  318 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence            11100        000011111111111111110        112235578899999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7e-40  Score=328.58  Aligned_cols=255  Identities=23%  Similarity=0.253  Sum_probs=204.1

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---------hhhHHHHHHHHHHHHhcc-ccccceeeee
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---------KNRIKEICNEMDIMSRAH-HKNLVQFLGC  320 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~  320 (569)
                      ....++|++.++||+|+||.||++.++ +|+.||||++....         ....+.+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            345678999999999999999999986 68999999986542         123456889999999995 9999999999


Q ss_pred             eeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       321 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                      +......++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence            9999999999999999999999943   456899999999999999999999998   9999999999999999999999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCcccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA------NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH  474 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  474 (569)
                      |||++.......   ......|++.|+|||++.      ...++.++||||||+++|||++|+.|+.........   ..
T Consensus       167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~  240 (298)
T 1phk_A          167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RM  240 (298)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH
T ss_pred             cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH---HH
Confidence            999998765433   223457899999999885      456889999999999999999999998643322110   00


Q ss_pred             HhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          475 TWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       475 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .    ....     ..............+.+++..||+.+|++|||+.|++++
T Consensus       241 ~----~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          241 I----MSGN-----YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             H----HHTC-----CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             H----hcCC-----cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            0    0000     000000112234567889999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=332.80  Aligned_cols=265  Identities=19%  Similarity=0.289  Sum_probs=196.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeee-----------
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF-----------  322 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----------  322 (569)
                      .++|++.++||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467999999999999999999987 58999999998777777788999999999999999999998873           


Q ss_pred             ---eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC-CCCCeE
Q 037160          323 ---TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD-LKHRPK  398 (569)
Q Consensus       323 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~~k  398 (569)
                         +....++||||++ ++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++ .++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467799999997 69999883    356889999999999999999999998   99999999999997 567899


Q ss_pred             EeccCCCcccCCCCCC-CCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh
Q 037160          399 IADFGLARFSSSEKSL-LPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       399 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  476 (569)
                      |+|||+++........ .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999876543221 12234567999999998865 678999999999999999999999987554322111111100


Q ss_pred             hhhcccchhhhh-------cccCC--CCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 KHFQAKTVLEII-------DKSIE--IED-----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 ~~~~~~~~~~~~-------~~~l~--~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .........+..       .....  ...     ......+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            000000000000       00000  001     1224567889999999999999999999964

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-39  Score=337.91  Aligned_cols=262  Identities=24%  Similarity=0.280  Sum_probs=193.4

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCC------
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK------  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  325 (569)
                      .++|++.++||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999876 6899999998753  2344567889999999999999999999997654      


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      ..++||||+++ +|.+.+.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 6777773     34889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH--------hHhh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT--------HTWK  477 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~  477 (569)
                      +......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.        ..+.
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            8665432   2235678999999999999999999999999999999999999986543221100000        0000


Q ss_pred             hh--------------cccchhhhhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          478 HF--------------QAKTVLEIIDKSIEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       478 ~~--------------~~~~~~~~~~~~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ..              ....+...+.......    .......+.+++.+||+.||++|||+.|++++-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            00              0000111111111111    122356788899999999999999999999753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-39  Score=332.09  Aligned_cols=263  Identities=17%  Similarity=0.260  Sum_probs=205.7

Q ss_pred             HhccccccccccccCceeEEEEEe-c-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccc------cceeeeeeeeCC
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTL-Q-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN------LVQFLGCCFTKK  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~  325 (569)
                      ..++|++.++||+|+||.||++.. . +++.||||++.... ...+.+.+|+.++++++|++      ++++++++...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            456899999999999999999986 3 68899999886543 34567889999999998765      999999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC------------
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL------------  393 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~------------  393 (569)
                      ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            999999999 88999988532 3346889999999999999999999998   999999999999987            


Q ss_pred             -------CCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCc
Q 037160          394 -------KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD  466 (569)
Q Consensus       394 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~  466 (569)
                             ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.|+......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                   678999999999865432     23457899999999999999999999999999999999999998765443


Q ss_pred             chhhhhHhHhhhhcccc--------------------------hhhhhccc--CCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 037160          467 GFETLVTHTWKHFQAKT--------------------------VLEIIDKS--IEIEDIEEVKRVVWVGLLCTQELPTLR  518 (569)
Q Consensus       467 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~--l~~~~~~~~~~~~~l~~~Cl~~~P~~R  518 (569)
                      .....+...........                          ........  ...........+.+++.+||+.||++|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            22111111100000000                          00000000  011134556778899999999999999


Q ss_pred             CCHHHHHHH
Q 037160          519 PSMTNVVQM  527 (569)
Q Consensus       519 Pt~~evl~~  527 (569)
                      ||+.||+++
T Consensus       321 pt~~ell~h  329 (339)
T 1z57_A          321 ITLREALKH  329 (339)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4e-40  Score=343.89  Aligned_cols=264  Identities=22%  Similarity=0.309  Sum_probs=197.8

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCc------e
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD------S  327 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~  327 (569)
                      ...+|.+.++||+|+||.||+|++..+..+|+|++......    ..+|+++++.++||||+++++++.....      .
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            45679999999999999999999987778999988654322    2369999999999999999999965443      7


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC-CCCCeEEeccCCCc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD-LKHRPKIADFGLAR  406 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~~kl~Dfgla~  406 (569)
                      ++||||++++.+..+.........+++..+..++.||++||.|||+.+   |+||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            899999987655544422234567899999999999999999999998   99999999999999 79999999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      ......   ......||+.|+|||++.+. .++.++|||||||++|||++|++||...........+...........+.
T Consensus       191 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          191 ILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             ECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            765443   23456789999999998765 58999999999999999999999987544322111111000000000000


Q ss_pred             hh----hc---ccCCCCC------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          486 EI----ID---KSIEIED------IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       486 ~~----~~---~~l~~~~------~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..    ..   +......      ......+.+++.+||+.+|++|||+.|++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00    00   0000001      1123568889999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-40  Score=334.09  Aligned_cols=254  Identities=22%  Similarity=0.387  Sum_probs=198.8

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4578999999999999999999986 689999999877666667889999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999998843  2356899999999999999999999998   9999999999999999999999999875332211


Q ss_pred             CCCCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          413 SLLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .  ......||+.|+|||++.     +..++.++||||||+++|||++|+.|+........  . ......    .    
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~~~~~~----~----  238 (302)
T 2j7t_A          172 Q--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L-LKIAKS----D----  238 (302)
T ss_dssp             H--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H-HHHHHS----C----
T ss_pred             c--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--H-HHHhcc----C----
Confidence            0  123456899999999983     56789999999999999999999999764432111  0 000000    0    


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       .... .........+..++..||+.+|++|||+.+++++
T Consensus       239 -~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 -PPTL-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -CCCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -Cccc-CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             0000 0112223467789999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.1e-40  Score=331.18  Aligned_cols=254  Identities=27%  Similarity=0.410  Sum_probs=199.8

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      +...++|++.++||+|+||.||+|.+. +|+.||||.+....  ..+.+.+|+.++++++||||+++++++......++|
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            345678999999999999999999976 68999999886543  346788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..  ....+++..++.++.+++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       103 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          103 MEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             eecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            999999999999842  3456899999999999999999999998   99999999999999999999999999986654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+........  .. .. .        .....
T Consensus       178 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~-~~-~--------~~~~~  243 (314)
T 3com_A          178 TMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IF-MI-P--------TNPPP  243 (314)
T ss_dssp             TBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH-HH-H--------HSCCC
T ss_pred             hcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HH-HH-h--------cCCCc
Confidence            322  23355789999999999999999999999999999999999999864332110  00 00 0        00000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ... ........+.+++..||+.+|++|||+.+++++
T Consensus       244 ~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          244 TFR-KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             CCS-SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            000 011223567789999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.1e-40  Score=331.04  Aligned_cols=257  Identities=22%  Similarity=0.328  Sum_probs=196.7

Q ss_pred             hccccccccccccCceeEEEEEec--CCc--eEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ--DGR--EIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      .++|++.++||+|+||.||+|++.  +++  .||||++...   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357899999999999999999864  333  6899988653   2345678999999999999999999999997754 8


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            999999999999999853  2356899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          408 SSSEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       408 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      ........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........   ....          
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~----------  237 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKI----------  237 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH----------
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---HHHH----------
Confidence            65543211 2234567889999999998889999999999999999999 9998864432211   1100          


Q ss_pred             hhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          486 EIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       486 ~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                        ...... .........+.+++..||+.+|++|||+.++++.|++..
T Consensus       238 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          238 --DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             --HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             --HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence              000000 112223456788999999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.9e-40  Score=329.90  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=186.8

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ..++|++.++||+|+||.||+++.. +|+.||||++....  ....+.+.++...++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999975 78999999986542  22333455555667888999999999999999999999


Q ss_pred             EeecCCCChhhHhhC-CCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          331 YEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      |||+++ +|.+++.. ......+++..++.++.|++.||.|||++ +   |+||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999974 88777632 12346799999999999999999999998 8   999999999999999999999999999866


Q ss_pred             CCCCCCCCCcccccCCCccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYI----ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.|+........ .+             
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-------------  223 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QL-------------  223 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HH-------------
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HH-------------
Confidence            5432   22345789999999996    556789999999999999999999999864322110 00             


Q ss_pred             hhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          485 LEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       485 ~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      ...+...... ........+.+++..||+.+|++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          224 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            0111111111 11223456788999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.2e-40  Score=340.22  Aligned_cols=267  Identities=20%  Similarity=0.253  Sum_probs=203.7

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeC-----Cc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----KD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  326 (569)
                      ..++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3467999999999999999999976 78899999987543 34457789999999999999999999998754     36


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++||||+. ++|.+++.    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            899999997 58988884    245899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCC-CCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--------h
Q 037160          407 FSSSEKSLL-PNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT--------W  476 (569)
Q Consensus       407 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~  476 (569)
                      ......... ......||+.|+|||++.++ .++.++||||||+++|||++|+.||...........+...        +
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            765543221 12456799999999987654 5899999999999999999999998755433221111110        0


Q ss_pred             hhhcccchhhhhcccCCCC--C-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          477 KHFQAKTVLEIIDKSIEIE--D-----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~--~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      ..+................  .     +.....+.+++.+||+.||++|||+.|++++-
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            0000000000000000000  1     12235678899999999999999999999753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.5e-40  Score=346.01  Aligned_cols=201  Identities=20%  Similarity=0.325  Sum_probs=173.5

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc------cccccceeeeeeeeCCc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA------HHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~  326 (569)
                      ...+|++.++||+|+||.||+|... +++.||||++... ......+.+|+.+++.+      +|+||+++++.+.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            4567999999999999999999876 6899999998654 33346778899998887      56799999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC--eEEeccCC
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR--PKIADFGL  404 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~--~kl~Dfgl  404 (569)
                      .++||||+. ++|.+++.. .....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKK-NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999996 688888853 23345899999999999999999999998   999999999999999987  99999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD  465 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~  465 (569)
                      +.....     ......||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus       249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            976543     22345789999999999999999999999999999999999999875543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.7e-40  Score=344.14  Aligned_cols=252  Identities=9%  Similarity=0.053  Sum_probs=181.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhc--cccccceee-------eeee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRA--HHKNLVQFL-------GCCF  322 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~  322 (569)
                      .+|.+.++||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888999999999999999976 78999999997753   23456778886666555  599988755       3333


Q ss_pred             eC-----------------CceEEEEeecCCCChhhHhhCCCCCccCCHHHH------HHHHHHHHHHHHHHhhcCCCCe
Q 037160          323 TK-----------------KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKR------HVIIIGTAEGLEYLHKDGQMQI  379 (569)
Q Consensus       323 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~i  379 (569)
                      ..                 ...++||||++ ++|.+++...  ...+.+..+      +.++.||+.||.|||+++   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            32                 33799999998 8999999532  223455555      678899999999999998   9


Q ss_pred             eeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCC
Q 037160          380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGV  457 (569)
Q Consensus       380 vHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~  457 (569)
                      +||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||+||||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999866432     124557799999999987  67999999999999999999999


Q ss_pred             CCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          458 QNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       458 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      .||..........        +................ .......+.+++.+||+.||++|||+.|+++
T Consensus       291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9987554332110        00000000000011100 1223456778899999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-39  Score=335.27  Aligned_cols=266  Identities=19%  Similarity=0.238  Sum_probs=200.8

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeC-----Cc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----KD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  326 (569)
                      +.++|++.+.||+|+||.||+|++. +|+.||||++.... ......+.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4578999999999999999999976 68999999986533 34456788999999999999999999988654     67


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .++||||+. ++|.+++..    ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999997 589888843    46899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCC--------CCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          407 FSSSEKSLL--------PNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       407 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      .........        ......||+.|+|||++.+ ..++.++||||||+++|||++|++||...........+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            765432210        1123578999999998765 6789999999999999999999999875443211111100000


Q ss_pred             ---------hhcccchhhhhcccCC--CC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          478 ---------HFQAKTVLEIIDKSIE--IE-----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       478 ---------~~~~~~~~~~~~~~l~--~~-----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                               ........+.+.....  ..     .+.....+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                     0000111111111000  00     11233567789999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.6e-40  Score=335.89  Aligned_cols=264  Identities=20%  Similarity=0.302  Sum_probs=204.3

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhh-----------------HHHHHHHHHHHHhcccccccee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR-----------------IKEICNEMDIMSRAHHKNLVQF  317 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~~  317 (569)
                      .++|++.++||+|+||.||++.. +|+.||||++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999986543221                 1789999999999999999999


Q ss_pred             eeeeeeCCceEEEEeecCCCChhhH------hhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeE
Q 037160          318 LGCCFTKKDSFVVYEFVQNKSLDRI------LFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNIL  390 (569)
Q Consensus       318 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIl  390 (569)
                      ++++...+..++||||+++++|.++      +.. .....+++..++.++.|++.||.|||+ .+   |+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      522 225679999999999999999999999 88   999999999999


Q ss_pred             ECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCCCCC-cc
Q 037160          391 LDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTE-KVDIYSFGVLVLEIVSGVQNNKFQSD-DG  467 (569)
Q Consensus       391 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDv~SlGvil~elltg~~p~~~~~~-~~  467 (569)
                      ++.++.+||+|||++......    ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.|+..... ..
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999876443    22355789999999999887 6666 99999999999999999999875543 11


Q ss_pred             hhhhhHhHhhhhccc---chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          468 FETLVTHTWKHFQAK---TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       468 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+......+...   ....................+.+++.+||+.+|++|||+.|++++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            110000000000000   000000000000012234567889999999999999999999974

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-40  Score=333.86  Aligned_cols=266  Identities=26%  Similarity=0.394  Sum_probs=186.9

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ...++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999965 68999999886543 33456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhC-----CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          331 YEFVQNKSLDRILFD-----PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                      |||+++++|.+++..     ......+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999842     113456899999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCCC---CCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcc
Q 037160          406 RFSSSEKSL---LPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA  481 (569)
Q Consensus       406 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  481 (569)
                      .........   .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+.........   .........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~  245 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQNDPP  245 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHTSSCC
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhccCCC
Confidence            766543221   11234578999999999876 56899999999999999999999998754432211   111111000


Q ss_pred             cchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          482 KTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       482 ~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .......+...   .......+.+++.+||+.+|++|||+.|++++
T Consensus       246 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          246 SLETGVQDKEM---LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CTTC-----CC---CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccccccccchh---hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00000000000   11123457788899999999999999999964

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.8e-40  Score=346.17  Aligned_cols=261  Identities=21%  Similarity=0.304  Sum_probs=193.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCC------ceE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK------DSF  328 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~  328 (569)
                      .+|++.++||+|+||.||+|++. +|+.||||++.....    ...+|+++|++++|||||++++++....      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999986 689999999865432    2347999999999999999999986422      367


Q ss_pred             EEEeecCCCChhhHhhC-CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-CCeEEeccCCCc
Q 037160          329 VVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLAR  406 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~kl~Dfgla~  406 (569)
                      +||||+++ +|.+++.. ......+++..++.++.||++||.|||+.+   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 55555422 123567899999999999999999999998   9999999999999965 568999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      ......   ......||+.|+|||++.+. .++.++|||||||+||||++|++||...........+...........+.
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            765433   23456789999999998765 79999999999999999999999987543221110000000000000010


Q ss_pred             hhh-------cccCCCCC------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          486 EII-------DKSIEIED------IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       486 ~~~-------~~~l~~~~------~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+-       .+.+....      ......+.+++.+||+.||++|||+.|++++
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            000       00000001      1123567889999999999999999999964

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-40  Score=341.96  Aligned_cols=265  Identities=20%  Similarity=0.289  Sum_probs=195.6

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeC------
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------  324 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  324 (569)
                      +...++|++.++||+|+||.||+|++. +|+.||||++......    ..+|+.+|+.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            456788999999999999999999975 7899999988654322    23799999999999999999998543      


Q ss_pred             --------------------------------CceEEEEeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHH
Q 037160          325 --------------------------------KDSFVVYEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYL  371 (569)
Q Consensus       325 --------------------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~L  371 (569)
                                                      ...++||||++ ++|.+.+... .....+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            33789999998 4777766421 2346789999999999999999999


Q ss_pred             hhcCCCCeeeCCCCCCCeEEC-CCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHH
Q 037160          372 HKDGQMQIVHRDIKASNILLD-LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVL  449 (569)
Q Consensus       372 H~~~~~~ivHrDikp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvi  449 (569)
                      |+.+   |+||||||+|||++ .++.+||+|||+++......   ......||+.|+|||.+.+. .++.++||||||++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9998   99999999999997 68899999999998765443   23455789999999998765 58999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh-------hcccCCCC------CHHHHHHHHHHHHHhcCCCCC
Q 037160          450 VLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI-------IDKSIEIE------DIEEVKRVVWVGLLCTQELPT  516 (569)
Q Consensus       450 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~~------~~~~~~~~~~l~~~Cl~~~P~  516 (569)
                      +|||++|+.||...........+...........+...       .-+.....      +......+.+++.+||+.+|+
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999998754432211111000000000000000       00000000      111234578899999999999


Q ss_pred             CCCCHHHHHHH
Q 037160          517 LRPSMTNVVQM  527 (569)
Q Consensus       517 ~RPt~~evl~~  527 (569)
                      +|||+.|++++
T Consensus       312 ~R~t~~e~l~h  322 (383)
T 3eb0_A          312 LRINPYEAMAH  322 (383)
T ss_dssp             GSCCHHHHHTS
T ss_pred             hCCCHHHHhcC
Confidence            99999999943

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-39  Score=329.49  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=196.4

Q ss_pred             HHhccccccccccccCceeEEEEEecCCceEEEEEEeec--chhhHHHHHHHHHHHHhcc--ccccceeeeeeeeCCceE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAH--HKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~  328 (569)
                      ...++|++.++||+|+||.||++...+++.||||++...  .......+.+|+.++.+++  ||||+++++++......+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            345779999999999999999999888999999998654  3445678999999999997  499999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||| +.+++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||++...
T Consensus       105 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred             EEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeeccccccc
Confidence            9999 668899999843   357899999999999999999999998   99999999999996 589999999999876


Q ss_pred             CCCCCCCCCcccccCCCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIAN-----------GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      .............||+.|+|||.+.+           ..++.++||||||+++|||++|+.|+....... .        
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~--------  247 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-S--------  247 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-H--------
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-H--------
Confidence            55433223345678999999999865           478889999999999999999999986432211 0        


Q ss_pred             hhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          478 HFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                           .+...++...... +......+.+++.+||+.+|++|||+.|++++
T Consensus       248 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          248 -----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                 0111112111111 11113467788899999999999999999964

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.4e-39  Score=333.38  Aligned_cols=262  Identities=19%  Similarity=0.256  Sum_probs=199.7

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-----------ccccceeeeeee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-----------HKNLVQFLGCCF  322 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~  322 (569)
                      .++|++.++||+|+||.||+|+.. +++.||||++.... .....+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357999999999999999999975 78999999986432 34467889999999886           899999999998


Q ss_pred             eCC----ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEEC-----
Q 037160          323 TKK----DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLD-----  392 (569)
Q Consensus       323 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~-----  392 (569)
                      ...    ..++|||++ +++|.+++... ....+++..++.++.||+.||.|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 89999998542 234589999999999999999999998 8   99999999999994     


Q ss_pred             -CCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchh--
Q 037160          393 -LKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFE--  469 (569)
Q Consensus       393 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~--  469 (569)
                       ..+.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........  
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4447999999999876542     23457899999999999999999999999999999999999998754432111  


Q ss_pred             -hhhHhHhhhhc--------cc----------------------chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 037160          470 -TLVTHTWKHFQ--------AK----------------------TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLR  518 (569)
Q Consensus       470 -~~~~~~~~~~~--------~~----------------------~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~R  518 (569)
                       ..+........        ..                      ...+.+... ..........+.+++..||+.||++|
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK-YKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT-TCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhc-ccCCcchHHHHHHHHHHHhccCcccc
Confidence             00000000000        00                      000111111 11245667788899999999999999


Q ss_pred             CCHHHHHHHh
Q 037160          519 PSMTNVVQML  528 (569)
Q Consensus       519 Pt~~evl~~L  528 (569)
                      ||+.||+++-
T Consensus       326 pt~~ell~hp  335 (373)
T 1q8y_A          326 ADAGGLVNHP  335 (373)
T ss_dssp             BCHHHHHTCG
T ss_pred             CCHHHHhhCh
Confidence            9999999753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=334.25  Aligned_cols=257  Identities=23%  Similarity=0.366  Sum_probs=197.3

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeee----
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT----  323 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----  323 (569)
                      .+....++|++.+.||+|+||.||+|++. +|+.||||++..... ....+.+|+.+++++ +||||+++++++..    
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            33456788999999999999999999975 789999999865433 346788999999999 89999999999987    


Q ss_pred             --CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEec
Q 037160          324 --KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD  401 (569)
Q Consensus       324 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  401 (569)
                        ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence              46789999999999999999542 3456899999999999999999999998   99999999999999999999999


Q ss_pred             cCCCcccCCCCCCCCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh
Q 037160          402 FGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       402 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  476 (569)
                      ||++........  ......||+.|+|||++.     +..++.++||||||+++|||++|+.|+........  . ....
T Consensus       173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~~~~  247 (326)
T 2x7f_A          173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--L-FLIP  247 (326)
T ss_dssp             CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H-HHHH
T ss_pred             CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--H-HHhh
Confidence            999986644321  223457899999999987     56789999999999999999999999854332111  0 0000


Q ss_pred             hhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 KHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .    ..     .+..  ........+..++..||+.+|++|||+.+++++
T Consensus       248 ~----~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          248 R----NP-----APRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             H----SC-----CCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             c----Cc-----cccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0    00     0000  011223467788899999999999999999974

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=335.17  Aligned_cols=271  Identities=23%  Similarity=0.383  Sum_probs=199.4

Q ss_pred             HHhccccccccccccCceeEEEEEecCCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ...++|++.++||+|+||.||+|.+++  .+|+|++....  ....+.+.+|+.++++++||||+++++++......++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345789999999999999999999763  59999886542  22345677899999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++....
T Consensus       108 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             eecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            999999999999943  3346899999999999999999999998   99999999999998 78999999999876533


Q ss_pred             CCC---CCCCcccccCCCccccccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          411 EKS---LLPNTAIAGTLGYMAPEYIAN---------GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       411 ~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      ...   ........||+.|+|||.+.+         ..++.++||||||+++|||++|+.|+........   ....   
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~---  255 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---IWQM---  255 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH---HHHH---
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHh---
Confidence            211   112234568999999999864         3578899999999999999999999864432211   1000   


Q ss_pred             hcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCCCCCCCcc
Q 037160          479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTD  545 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~p~~p~~~~  545 (569)
                       ...     ..+...  .......+..++..||+.+|++|||+.+|+++|+.........+.|..+.
T Consensus       256 -~~~-----~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          256 -GTG-----MKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             -HTT-----CCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred             -ccC-----CCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence             000     001010  11122357788999999999999999999999999877666655555544

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.6e-39  Score=334.11  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=198.3

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCce---
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS---  327 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---  327 (569)
                      ..++|.+.++||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.++++++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3568999999999999999999976 7899999998754  233457788999999999999999999999877655   


Q ss_pred             ---EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          328 ---FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       328 ---~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                         ++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999997 68887772     34899999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------H
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------T  475 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~  475 (569)
                      ++.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+..        .
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            9865432     234578999999999887 6899999999999999999999999865432211111000        0


Q ss_pred             hhhhcccchhhhhcccC---CCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          476 WKHFQAKTVLEIIDKSI---EIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l---~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                      +..+........+....   ...    .+.....+.+++..||+.+|++|||+.|++++-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  325 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  325 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence            00111111111111100   000    112245688899999999999999999999763

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-39  Score=329.81  Aligned_cols=267  Identities=24%  Similarity=0.333  Sum_probs=200.8

Q ss_pred             HHhccccccccccccCceeEEEEEec--CCceEEEEEEeecch--hhHHHHHHHHHHHHhc---cccccceeeeeee---
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ--DGREIAVKRLFISRK--NRIKEICNEMDIMSRA---HHKNLVQFLGCCF---  322 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---  322 (569)
                      .+.++|++.++||+|+||.||++++.  +|+.||+|++.....  .....+.+|+.+++++   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            35678999999999999999999973  688999999865432  1223566788887776   8999999999987   


Q ss_pred             --eCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          323 --TKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       323 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                        .....++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              4567899999997 6999988532 2345899999999999999999999998   9999999999999999999999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh----
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW----  476 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----  476 (569)
                      |||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+....    
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999998665432   2235678999999999999999999999999999999999999987544322111110000    


Q ss_pred             -hhhcccch--hhhhc----ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 -KHFQAKTV--LEIID----KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 -~~~~~~~~--~~~~~----~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                       ..|.....  ...+.    ..+..........+.+++.+||+.+|++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             00000000  00000    00000011233456788999999999999999999964

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.3e-39  Score=334.16  Aligned_cols=204  Identities=20%  Similarity=0.276  Sum_probs=173.3

Q ss_pred             HHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-cc-----ccceeeeeeee
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HK-----NLVQFLGCCFT  323 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~  323 (569)
                      .+.+.++|++.++||+|+||.||+|+.. +++.||||++... ......+.+|+.+++.++ |+     +|+++++++..
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3456788999999999999999999976 6889999998643 334567788999998885 44     49999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh--cCCCCeeeCCCCCCCeEEC--CCCCeEE
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK--DGQMQIVHRDIKASNILLD--LKHRPKI  399 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~--~~~~~ivHrDikp~NIll~--~~~~~kl  399 (569)
                      ....++||||+. ++|.+++... ....+++..+..++.|++.||.|||.  .+   |+||||||+|||++  .++.+||
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred             CCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence            999999999996 5999988542 23458999999999999999999995  45   99999999999994  4788999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSD  465 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~  465 (569)
                      +|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus       203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999876542     2356789999999999999999999999999999999999999875543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.7e-39  Score=323.56  Aligned_cols=253  Identities=24%  Similarity=0.392  Sum_probs=192.2

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee---------
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT---------  323 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------  323 (569)
                      +.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4678999999999999999999975 7899999998653 3445788999999999999999999998865         


Q ss_pred             ----CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEE
Q 037160          324 ----KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKI  399 (569)
Q Consensus       324 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  399 (569)
                          ....++||||+++++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                3567999999999999999953  3356788999999999999999999998   999999999999999999999


Q ss_pred             eccCCCcccCCCCC------------CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCc
Q 037160          400 ADFGLARFSSSEKS------------LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD  466 (569)
Q Consensus       400 ~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~  466 (569)
                      +|||++........            ........||+.|+|||++.+. .++.++||||||+++|||+++   +...  .
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p---~~~~--~  232 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTG--M  232 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC---CSSH--H
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc---cCCc--h
Confidence            99999986643211            0122345689999999998764 789999999999999999983   2211  0


Q ss_pred             chhhhhHhHhhhhcccchhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          467 GFETLVTHTWKHFQAKTVLEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       467 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .....    ......      ....... ........+.+++..||+.||++|||+.+++++
T Consensus       233 ~~~~~----~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          233 ERVNI----LKKLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHH----HHHHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hHHHH----HHhccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            00000    000000      0000111 122334557788999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=339.73  Aligned_cols=273  Identities=20%  Similarity=0.350  Sum_probs=185.1

Q ss_pred             HHhccccc-cccccccCceeEEEEEec---CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee--CCc
Q 037160          253 KATDCFDE-SNKLGHGGYGEIFKGTLQ---DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT--KKD  326 (569)
Q Consensus       253 ~~~~~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~  326 (569)
                      ...+.|++ .++||+|+||.||+|+++   +++.||||++.....  ...+.+|+.+|++++||||+++++++..  ...
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            34556776 458999999999999965   578999998864432  2467899999999999999999999964  667


Q ss_pred             eEEEEeecCCCChhhHhhCC------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE----CCCCC
Q 037160          327 SFVVYEFVQNKSLDRILFDP------KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL----DLKHR  396 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll----~~~~~  396 (569)
                      .++||||+.+ +|.+++...      .....+++..++.++.||+.||.|||+.+   |+||||||+||||    +.++.
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence            8999999965 777666321      12235899999999999999999999999   9999999999999    67889


Q ss_pred             eEEeccCCCcccCCCCCC-CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcch------
Q 037160          397 PKIADFGLARFSSSEKSL-LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF------  468 (569)
Q Consensus       397 ~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~------  468 (569)
                      +||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|++||........      
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999999876543221 123456799999999998874 589999999999999999999999965433210      


Q ss_pred             hhhhHhH-----------hhhhccc----chhhhhc-ccCCCCCH---------HHHHHHHHHHHHhcCCCCCCCCCHHH
Q 037160          469 ETLVTHT-----------WKHFQAK----TVLEIID-KSIEIEDI---------EEVKRVVWVGLLCTQELPTLRPSMTN  523 (569)
Q Consensus       469 ~~~~~~~-----------~~~~~~~----~~~~~~~-~~l~~~~~---------~~~~~~~~l~~~Cl~~~P~~RPt~~e  523 (569)
                      ...+...           |......    .....+. ........         .....+.+++..||+.||++|||+.|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            0000000           1100000    0000000 00000000         01345778999999999999999999


Q ss_pred             HHHHhccC
Q 037160          524 VVQMLKQK  531 (569)
Q Consensus       524 vl~~L~~~  531 (569)
                      ++++---.
T Consensus       331 ~L~hp~f~  338 (405)
T 3rgf_A          331 AMQDPYFL  338 (405)
T ss_dssp             HHTSGGGT
T ss_pred             HhcChhhc
Confidence            99765433

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.3e-39  Score=321.29  Aligned_cols=254  Identities=23%  Similarity=0.318  Sum_probs=203.0

Q ss_pred             HHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          252 EKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       252 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ..+.++|++.++||+|+||.||+++.. +++.||||++....  ......+.+|++++++++||||+++++++......+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345678999999999999999999976 78999999986543  234678899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC---CCeEEeccCCC
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGLA  405 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl~Dfgla  405 (569)
                      +||||+++++|.+.+..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999999988843   346899999999999999999999998   9999999999999764   46999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      .......   ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.|+........   ..    ........
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~  240 (287)
T 2wei_A          172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LK----RVETGKYA  240 (287)
T ss_dssp             GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHCCCC
T ss_pred             eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHcCCCC
Confidence            8765433   2234568999999998865 589999999999999999999999865432211   11    00000000


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          486 EIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       486 ~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                          ... .........+.+++.+||+.+|++|||+.|++++
T Consensus       241 ----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 ----FDL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             ----CCS-GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----CCc-hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence                000 0001223467789999999999999999999973

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.4e-39  Score=328.19  Aligned_cols=263  Identities=18%  Similarity=0.258  Sum_probs=201.3

Q ss_pred             HhccccccccccccCceeEEEEEec-CC-ceEEEEEEeecchhhHHHHHHHHHHHHhccccc------cceeeeeeeeCC
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DG-REIAVKRLFISRKNRIKEICNEMDIMSRAHHKN------LVQFLGCCFTKK  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~  325 (569)
                      +.++|++.++||+|+||.||++... ++ +.||+|++... ....+.+.+|+.++++++|++      ++.+++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            3578999999999999999999975 44 68999988653 334567889999999998876      899999999999


Q ss_pred             ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE--------------
Q 037160          326 DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL--------------  391 (569)
Q Consensus       326 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll--------------  391 (569)
                      ..++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+.+   |+||||||+|||+              
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eEEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            999999999 5556555533 23356899999999999999999999998   9999999999999              


Q ss_pred             -----CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCc
Q 037160          392 -----DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDD  466 (569)
Q Consensus       392 -----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~  466 (569)
                           +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 56789999999999865432     23457899999999999999999999999999999999999998755433


Q ss_pred             chhhhhHhHhhhhcccc--------------------------hhhhhcc--cCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 037160          467 GFETLVTHTWKHFQAKT--------------------------VLEIIDK--SIEIEDIEEVKRVVWVGLLCTQELPTLR  518 (569)
Q Consensus       467 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~--~l~~~~~~~~~~~~~l~~~Cl~~~P~~R  518 (569)
                      .....+...........                          ..+....  ............+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            22111111100000000                          0000000  0001133445678899999999999999


Q ss_pred             CCHHHHHHH
Q 037160          519 PSMTNVVQM  527 (569)
Q Consensus       519 Pt~~evl~~  527 (569)
                      ||+.|++++
T Consensus       326 pt~~e~l~h  334 (355)
T 2eu9_A          326 ITLAEALLH  334 (355)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999854

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.6e-39  Score=330.97  Aligned_cols=259  Identities=22%  Similarity=0.311  Sum_probs=196.9

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCc-----
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD-----  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  326 (569)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467899999999999999999976 7899999998653  23345678899999999999999999999987654     


Q ss_pred             -eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          327 -SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       327 -~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                       .++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 58887762     34899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TW  476 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~  476 (569)
                      +.....     .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..        .+
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            865432     234578999999999877 6789999999999999999999999865432211100000        00


Q ss_pred             hhhcccchhhhhcc-------cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 KHFQAKTVLEIIDK-------SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 ~~~~~~~~~~~~~~-------~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..+........+..       .+..........+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            01111111111110       0001112335677889999999999999999999965

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=328.53  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=191.5

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchh------hHHHHHHHHHHHHhc----cccccceee
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN------RIKEICNEMDIMSRA----HHKNLVQFL  318 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~  318 (569)
                      ..+...++|++.++||+|+||.||+|+.. +++.||||++......      ....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34567789999999999999999999875 7889999998654321      223466799999999    899999999


Q ss_pred             eeeeeCCceEEEEee-cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC-CCCC
Q 037160          319 GCCFTKKDSFVVYEF-VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD-LKHR  396 (569)
Q Consensus       319 ~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~  396 (569)
                      +++...+..++|||+ +.+++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++ .++.
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence            999999999999999 789999999943   456899999999999999999999998   99999999999999 8899


Q ss_pred             eEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH
Q 037160          397 PKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLT-EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT  475 (569)
Q Consensus       397 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  475 (569)
                      +||+|||++.......    .....||..|+|||++.+..+. .++||||||+++|||++|+.|+....     .     
T Consensus       179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~-----  244 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E-----  244 (312)
T ss_dssp             EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-----
T ss_pred             EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H-----
Confidence            9999999998765432    2345689999999998877664 58999999999999999999875211     0     


Q ss_pred             hhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          476 WKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       476 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                                 ....... ........+.+++.+||+.+|++|||+.|++++-
T Consensus       245 -----------~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          245 -----------ILEAELH-FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             -----------HHHTCCC-CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             -----------HhhhccC-CcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                       0000010 0112234577889999999999999999999853

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.7e-39  Score=356.80  Aligned_cols=257  Identities=21%  Similarity=0.298  Sum_probs=202.1

Q ss_pred             HHhccccccccccccCceeEEEEEecC----CceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQD----GREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      ...++|++.+.||+|+||.||+|.+..    +..||||.+... .....+.+.+|+.++++++||||+++++++. .+..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            345789999999999999999998752    457899987653 3344577999999999999999999999984 5678


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      ++||||+++|+|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       466 ~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence            999999999999999953  2346899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........   ....           
T Consensus       541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i-----------  605 (656)
T 2j0j_A          541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI-----------  605 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH-----------
T ss_pred             cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH-----------
Confidence            6544322 2234557889999999999999999999999999999997 8888764332211   1100           


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          487 IIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       487 ~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                       ........+......+.+++..||+.+|++|||+.||++.|+..
T Consensus       606 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          606 -ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             00000011222345677899999999999999999999998753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.6e-39  Score=326.66  Aligned_cols=254  Identities=25%  Similarity=0.375  Sum_probs=177.6

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHH-HHHhccccccceeeeeeeeCCceEEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMD-IMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .++|++.+.||+|+||.||++..+ +|+.||||++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367889999999999999999986 78999999987643 333445666666 677789999999999999999999999


Q ss_pred             eecCCCChhhHhhC--CCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          332 EFVQNKSLDRILFD--PKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       332 e~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 77777632  12246789999999999999999999998 8   999999999999999999999999999866


Q ss_pred             CCCCCCCCCcccccCCCccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYI----ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.|+....... ..+     ....... 
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~-----~~~~~~~-  246 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-DQL-----TQVVKGD-  246 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSC-
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-HHH-----HHHhcCC-
Confidence            5432   22344789999999998    45678999999999999999999999986432110 000     0000000 


Q ss_pred             hhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          485 LEIIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       485 ~~~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                          ...+.. ........+.+++.+||+.+|++|||+.||++
T Consensus       247 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          247 ----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                000110 01123456788999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-38  Score=326.02  Aligned_cols=254  Identities=20%  Similarity=0.253  Sum_probs=173.6

Q ss_pred             Hhccccccc-cccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee----CCce
Q 037160          254 ATDCFDESN-KLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT----KKDS  327 (569)
Q Consensus       254 ~~~~f~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  327 (569)
                      ..++|.+.+ .||+|+||.||+|+++ +|+.||||++.....    ...+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            457788855 6999999999999987 789999999865321    12223334566799999999999876    4458


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC---CCeEEeccCC
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK---HRPKIADFGL  404 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl~Dfgl  404 (569)
                      ++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999999642 3356899999999999999999999998   9999999999999864   4599999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      ++.....    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............   ....    
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~----  246 (336)
T 3fhr_A          178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIR----  246 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhh----
Confidence            9865532    2234578999999999988899999999999999999999999986543322100000   0000    


Q ss_pred             hhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          485 LEIIDKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       485 ~~~~~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                       . ...... .........+.+++..||+.+|++|||+.|++++-
T Consensus       247 -~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          247 -L-GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             -c-cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence             0 000000 00122345677899999999999999999999743

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2e-39  Score=329.10  Aligned_cols=246  Identities=20%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             HHHHhccccccccccccCceeEEEEEec-CCceEEEEEEeecchh------hHHHHHHHHHHHHhcc--ccccceeeeee
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKN------RIKEICNEMDIMSRAH--HKNLVQFLGCC  321 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~  321 (569)
                      .+...++|++.++||+|+||.||+|+.. +++.||||++......      ....+.+|+.++++++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            3456778999999999999999999865 7899999998654321      2245678999999996  59999999999


Q ss_pred             eeCCceEEEEeecCC-CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC-CCCCeEE
Q 037160          322 FTKKDSFVVYEFVQN-KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD-LKHRPKI  399 (569)
Q Consensus       322 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~~kl  399 (569)
                      ...+..++|||++.+ ++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++ .++.+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence            999999999999976 899999843   456899999999999999999999998   99999999999999 7899999


Q ss_pred             eccCCCcccCCCCCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          400 ADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       400 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      +|||+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.....     .       
T Consensus       192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~-------  255 (320)
T 3a99_A          192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------  255 (320)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------
T ss_pred             eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-------
Confidence            9999998765432    234568999999999987765 6889999999999999999999753210     0       


Q ss_pred             hcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 037160          479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQML  528 (569)
Q Consensus       479 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  528 (569)
                               ...... ........+.+++.+||+.+|++|||+.||+++-
T Consensus       256 ---------~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          256 ---------IRGQVF-FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             ---------HHCCCC-CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ---------hccccc-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence                     000000 0111234577888999999999999999999753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.2e-38  Score=334.83  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=187.4

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +.|...++||+|+||+||.+...+|+.||||++....   .+.+.+|+.+|+++ +||||+++++++.+....++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4456678899999999987766679999999886532   35678999999987 8999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCcc----CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC-------------CCe
Q 037160          335 QNKSLDRILFDPKQKKE----LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK-------------HRP  397 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~-------------~~~  397 (569)
                      . |+|.+++........    ..+..++.++.||+.||.|||+.+   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 699999954322111    133356789999999999999998   9999999999999754             479


Q ss_pred             EEeccCCCcccCCCCCCC--CCcccccCCCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 037160          398 KIADFGLARFSSSEKSLL--PNTAIAGTLGYMAPEYIAN-------GQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDG  467 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~  467 (569)
                      ||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.|+.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999998776543221  1234579999999999875       578999999999999999999 888885432221


Q ss_pred             hhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          468 FETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       468 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      . .+..   ....       ...............+.+++.+||+.+|++|||+.||+++
T Consensus       248 ~-~i~~---~~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 S-NIIR---GIFS-------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             H-HHHH---TCCC-------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             H-HHhc---CCCC-------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            0 0000   0000       0000111234566788899999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=319.49  Aligned_cols=252  Identities=22%  Similarity=0.351  Sum_probs=179.4

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      .++|++.++||+|+||.||+|++. +|+.||||++.....  ...+.+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467889999999999999999986 789999999875432  22334455556778889999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ||+ ++.+..+...  ....+++..++.++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 5566655532  235689999999999999999999995 8   99999999999999999999999999976654


Q ss_pred             CCCCCCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      ..   ......||+.|+|||++.     ...++.++||||||+++|||++|+.|+.......  .........       
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~-------  245 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLTKVLQE-------  245 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHHS-------
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHHHHhcc-------
Confidence            32   223457899999999984     4578899999999999999999999986432211  111100000       


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          486 EIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       486 ~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        ....+. ........+..++..||+.+|.+||++.||+++
T Consensus       246 --~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          246 --EPPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             --CCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             --CCCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              000010 011223467788899999999999999999853

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=332.06  Aligned_cols=251  Identities=24%  Similarity=0.305  Sum_probs=185.9

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ..+|++.++||+|+||+|+.....+|+.||||++.....   ..+.+|+.+|+++ +|||||++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            456888999999999997655556789999999865432   2356899999999 899999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-----CCCeEEeccCCCccc
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-----KHRPKIADFGLARFS  408 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-----~~~~kl~Dfgla~~~  408 (569)
                      +. ++|.+++...  .....+..++.++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 5999998543  233445567789999999999999998   999999999999953     235889999999876


Q ss_pred             CCCCCC-CCCcccccCCCcccccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccc
Q 037160          409 SSEKSL-LPNTAIAGTLGYMAPEYIA---NGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKT  483 (569)
Q Consensus       409 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  483 (569)
                      ...... .......||+.|+|||++.   ...++.++|||||||++|||++ |..|+...........        ....
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--------~~~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--------LGAC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--------TTCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--------hccC
Confidence            543221 1234567999999999997   4567889999999999999999 8888753322211100        0000


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       484 ~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                           ..............+.+++.+||+.||++|||+.||+++
T Consensus       246 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          246 -----SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             -----CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                 000001122344557789999999999999999999953

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.6e-38  Score=344.84  Aligned_cols=264  Identities=22%  Similarity=0.279  Sum_probs=198.9

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeee------CCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT------KKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~  326 (569)
                      .++|++.++||+|+||.||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999975 6899999988654 34456779999999999999999999998765      667


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCC---eEEeccC
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHR---PKIADFG  403 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---~kl~Dfg  403 (569)
                      .++||||+++++|.+++........+++..++.++.+++.||.|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555557899999999999999999999998   999999999999997775   8999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhh-HhHhhh-hc
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLV-THTWKH-FQ  480 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~-~~~~~~-~~  480 (569)
                      ++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+ ...... ..
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            998765543   23456799999999999999999999999999999999999999864321100 0000 000000 00


Q ss_pred             ccchhhh--hcccC---CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 037160          481 AKTVLEI--IDKSI---EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNV  524 (569)
Q Consensus       481 ~~~~~~~--~~~~l---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev  524 (569)
                      .......  ....+   ..........+.+++..||+.||++|||+.|+
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            0000000  00000   01133456778889999999999999999763

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.6e-37  Score=341.11  Aligned_cols=237  Identities=23%  Similarity=0.320  Sum_probs=190.2

Q ss_pred             HhccccccccccccCceeEEEEEec--CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCc----
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ--DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD----  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  326 (569)
                      ..++|++.++||+|+||.||++.+.  +|+.||||++... .......+.+|+.++++++||||+++++++.....    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3478999999999999999999975  6899999988654 33445678999999999999999999999987765    


Q ss_pred             -eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          327 -SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       327 -~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                       .+|||||+++++|.+++.     ..+++..++.++.||+.||.|||+++   |+||||||+|||++.+ .+||+|||++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eeEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence             699999999999998773     26899999999999999999999998   9999999999999875 9999999999


Q ss_pred             cccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchh
Q 037160          406 RFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL  485 (569)
Q Consensus       406 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  485 (569)
                      +.....      ....||+.|+|||++.++. +.++||||||+++|||++|.+|+........                 
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------  284 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------  284 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------
T ss_pred             hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------
Confidence            876542      3457999999999987654 8999999999999999999877542111100                 


Q ss_pred             hhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHhc
Q 037160          486 EIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSM-TNVVQMLK  529 (569)
Q Consensus       486 ~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~-~evl~~L~  529 (569)
                            .... .......+..++.+||+.+|++||+. .++...|.
T Consensus       285 ------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          285 ------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                  0000 11223567789999999999999964 44444443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-36  Score=303.94  Aligned_cols=232  Identities=13%  Similarity=0.058  Sum_probs=182.9

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ..++|++.++||+|+||.||+|++. +++.||||++....   ....+.+.+|+.++.+++||||+++++++...+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3467999999999999999999976 58999999986542   3345789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++++|.+++..    + ....++..++.|++.||.|||+++   |+||||||+|||++.++.+||++++      
T Consensus       109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999999832    1 355678889999999999999999   9999999999999999999998543      


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc-chhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK-TVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  488 (569)
                                      |++       .++.++||||||+++|||++|+.||...........   ........ .....+
T Consensus       175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~  228 (286)
T 3uqc_A          175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAGQPIEPADI  228 (286)
T ss_dssp             ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTTSCBCCHHHH
T ss_pred             ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhccCCCChhhc
Confidence                            333       368899999999999999999999875443211000   00000000 000000


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                             .......+..++.+||+.||++| |+.|+++.|+....
T Consensus       229 -------~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          229 -------DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             -------CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             -------ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence                   01123457788999999999999 99999999987543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-35  Score=298.63  Aligned_cols=228  Identities=19%  Similarity=0.248  Sum_probs=177.1

Q ss_pred             hcccccc-ccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHH-Hhccccccceeeeeeee----CCce
Q 037160          255 TDCFDES-NKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIM-SRAHHKNLVQFLGCCFT----KKDS  327 (569)
Q Consensus       255 ~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~  327 (569)
                      .++|.+. +.||+|+||.||++... +++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3556666 77999999999999975 7899999988542     3567888888 55599999999999987    6778


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC---CCCeEEeccCC
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL---KHRPKIADFGL  404 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~~kl~Dfgl  404 (569)
                      ++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999999542 3346899999999999999999999998   999999999999998   78899999998


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      +....                        +..++.++||||||+++|||++|+.||..........            ..
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------------~~  210 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------GM  210 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------------CS
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------------HH
Confidence            86432                        2456789999999999999999999986433221100            00


Q ss_pred             hhhhcccCCCCC----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          485 LEIIDKSIEIED----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       485 ~~~~~~~l~~~~----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ...+.......+    ......+..++..||+.+|++|||+.|++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000000000001    1124567889999999999999999999974

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-36  Score=311.04  Aligned_cols=241  Identities=17%  Similarity=0.203  Sum_probs=182.4

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecc--------hhhHHHHHHHHHHHHhcc---------cccccee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--------KNRIKEICNEMDIMSRAH---------HKNLVQF  317 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~~  317 (569)
                      .++|++.++||+|+||.||+|++ +|+.||||++....        ....+.+.+|+.++++++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 58999999997653        223477889999999986         5555555


Q ss_pred             eee-----------------eee-------------CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHH
Q 037160          318 LGC-----------------CFT-------------KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEG  367 (569)
Q Consensus       318 ~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~  367 (569)
                      .+.                 +.+             ....++||||+++|++.+.+.    +..+++..++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence            554                 433             678999999999997666552    2568999999999999999


Q ss_pred             HHHHh-hcCCCCeeeCCCCCCCeEECCCC--------------------CeEEeccCCCcccCCCCCCCCCcccccCCCc
Q 037160          368 LEYLH-KDGQMQIVHRDIKASNILLDLKH--------------------RPKIADFGLARFSSSEKSLLPNTAIAGTLGY  426 (569)
Q Consensus       368 L~~LH-~~~~~~ivHrDikp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y  426 (569)
                      |.||| +.+   |+||||||+|||++.++                    .+||+|||+++....       ....||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence            99999 898   99999999999999887                    899999999986643       234799999


Q ss_pred             ccccccccCCCCcccchhhHHHH-HHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCC---CHHHHHH
Q 037160          427 MAPEYIANGQLTEKVDIYSFGVL-VLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE---DIEEVKR  502 (569)
Q Consensus       427 ~aPE~~~~~~~~~ksDv~SlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~  502 (569)
                      +|||++.+.. +.++||||||++ .+++++|..|+.           ...|.......+...........   .......
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS-----------NVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH-----------HHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc-----------chhhhhHHHHhhhhhhccCcccchhhhhhcCHH
Confidence            9999998766 899999998777 777888887752           11111111111111111111111   2345677


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHH-HH
Q 037160          503 VVWVGLLCTQELPTLRPSMTNVV-QM  527 (569)
Q Consensus       503 ~~~l~~~Cl~~~P~~RPt~~evl-~~  527 (569)
                      +.+++.+||+.+     |+.|++ ++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHhccC-----CHHHHHhcC
Confidence            889999999965     999998 54

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-36  Score=318.42  Aligned_cols=241  Identities=17%  Similarity=0.137  Sum_probs=178.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch---hhHHHHHHHHHHHHhccc-ccccee---------e--
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---NRIKEICNEMDIMSRAHH-KNLVQF---------L--  318 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~---------~--  318 (569)
                      ...|...++||+|+||.||+|++. +|+.||||++.....   ...+.+.+|+.+++.++| +|...+         .  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777889999999999999965 789999998874322   235779999999999976 222111         1  


Q ss_pred             ----------eeeee-----CCceEEEEeecCCCChhhHhhC----CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 037160          319 ----------GCCFT-----KKDSFVVYEFVQNKSLDRILFD----PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI  379 (569)
Q Consensus       319 ----------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  379 (569)
                                .+...     ....+++|+++ +++|.+++..    ......+++..++.++.||++||.|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                      11111     12346667755 7899988831    123456888899999999999999999998   9


Q ss_pred             eeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCccccccc----------ccCCCCcccchhhHHHH
Q 037160          380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI----------ANGQLTEKVDIYSFGVL  449 (569)
Q Consensus       380 vHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDv~SlGvi  449 (569)
                      +||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998865443     234567 999999999          55568889999999999


Q ss_pred             HHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 037160          450 VLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVV  525 (569)
Q Consensus       450 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl  525 (569)
                      +|||++|+.||.........               ..++....     .....+.+++..||+.+|++||++.+++
T Consensus       307 l~elltg~~Pf~~~~~~~~~---------------~~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGS---------------EWIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCS---------------GGGGSSCC-----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhhhH---------------HHHHhhcc-----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999998644322110               01111100     1124577888999999999999977775

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.3e-30  Score=283.23  Aligned_cols=183  Identities=17%  Similarity=0.174  Sum_probs=130.6

Q ss_pred             cccccCceeEEEEEe-cCCceEEEEEEeecc----------hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEE
Q 037160          263 KLGHGGYGEIFKGTL-QDGREIAVKRLFISR----------KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ..+.|++|.+..++. -.|+.++||.+....          ....++|.+|+++|+++ +|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            467777777776653 368999999986431          22346799999999999 799999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||++|++|.++|..   .+.++..   .|+.||+.||.|||+++   ||||||||+||||+.+|++||+|||+++....
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999953   3456554   48899999999999999   99999999999999999999999999987655


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCC
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV  457 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~  457 (569)
                      ...  .....+||++|||||++.+ .+..++|+||+|+++++|.++.
T Consensus       392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             --C--CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence            432  3446789999999999875 5677899999999988876653

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.94  E-value=2.5e-27  Score=197.54  Aligned_cols=103  Identities=20%  Similarity=0.419  Sum_probs=94.8

Q ss_pred             ccccccccccccCCCCCChHHHHHHHHHHHHHhhhhhc--CceeeecCC-CCCceEEEEecCCCCChhhhHHHHHHHHHH
Q 037160            6 RTNIIERHCQKLPPENSSNYLHNYHALLNLMRGEMYKK--KFASKEFGI-PPSRTYMLSQCMEDLTLTECNTCFAQMNHL   82 (569)
Q Consensus         6 ~~~~~~~~c~~~~~~~~~~~~~~~~~ll~~l~~~~~~~--~f~~~~~g~-~~~~vygl~qC~~D~~~~~C~~Cl~~a~~~   82 (569)
                      ++.++++.|++++|+++++|++||+.||++|+++++.+  +|+++..|. ++++||||+|||||+++++|..||+.|+..
T Consensus         2 ~t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~   81 (108)
T 3a2e_A            2 NTAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNR   81 (108)
T ss_dssp             CCCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred             CcceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence            57789999998899999999999999999999998765  567766654 458999999999999999999999999999


Q ss_pred             hhhhCCC-cceEEEccceeEEEccCcc
Q 037160           83 LADCLPA-ISAHVFLDGCFLRLENYSF  108 (569)
Q Consensus        83 ~~~~c~~-~~~~~~~~~C~~ry~~~~f  108 (569)
                      +.++|++ +||+||+++|+||||+++|
T Consensus        82 ~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           82 IFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            9999999 9999999999999999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.5e-27  Score=256.05  Aligned_cols=185  Identities=16%  Similarity=0.166  Sum_probs=145.7

Q ss_pred             cccccccccCceeEEEEEecCCceEEEEEEeecch--------hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          259 DESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK--------NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       259 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ...++||+|+||.||++.. .++.+++|+......        ...+.+.+|+++|++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999954 478999998754321        1235589999999999999999766666678888999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++++|.+++..           +..++.|+++||.|||+++   |+||||||+|||++.  ++||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           5579999999999999998   999999999999998  999999999997765


Q ss_pred             CCCCC-----CCcccccCCCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 037160          411 EKSLL-----PNTAIAGTLGYMAPEYIAN--GQLTEKVDIYSFGVLVLEIVSGVQNN  460 (569)
Q Consensus       411 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~SlGvil~elltg~~p~  460 (569)
                      .....     ......||+.|||||++..  ..|+..+|+|+..+-.++.+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32210     1135679999999999987  56888999999999988888776543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=7.2e-24  Score=210.19  Aligned_cols=152  Identities=17%  Similarity=0.152  Sum_probs=122.2

Q ss_pred             HHHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecch------------------hhHHHHHHHHHHHHhccc
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK------------------NRIKEICNEMDIMSRAHH  311 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h  311 (569)
                      ++......|.+.++||+|+||.||+|.+.+|+.||||.+.....                  .....+.+|+.+|++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            34444566778899999999999999997799999999864321                  13456889999999999 


Q ss_pred             cccceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       312 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                       | +++.+++. .+..++||||+++++|.+ +.         ......++.|++.||.|||+.+   |+||||||+|||+
T Consensus       163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl  226 (282)
T 1zar_A          163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV  226 (282)
T ss_dssp             -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence             4 66666543 356799999999999988 41         1234569999999999999999   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCccccccccc
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN  434 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  434 (569)
                      + ++.+||+|||+++.               +..++|||++..
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            9 99999999999863               335789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=6.2e-20  Score=179.57  Aligned_cols=137  Identities=20%  Similarity=0.186  Sum_probs=107.5

Q ss_pred             cccccccccccCceeEEEEEe-cCCce--EEEEEEeecch------------------------hhHHHHHHHHHHHHhc
Q 037160          257 CFDESNKLGHGGYGEIFKGTL-QDGRE--IAVKRLFISRK------------------------NRIKEICNEMDIMSRA  309 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l  309 (569)
                      -|++.+.||+|+||.||+|.. .+|+.  ||||++.....                        .....+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367788999999999999998 67889  99998754311                        1123678999999999


Q ss_pred             ccccc--ceeeeeeeeCCceEEEEeecCC-C----ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHh-hcCCCCeee
Q 037160          310 HHKNL--VQFLGCCFTKKDSFVVYEFVQN-K----SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH-KDGQMQIVH  381 (569)
Q Consensus       310 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH  381 (569)
                      +|+++  ..++..    ...+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            98864  334432    467899999942 3    66665421      234567789999999999999 888   999


Q ss_pred             CCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          382 RDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       382 rDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.74  E-value=2.5e-18  Score=143.08  Aligned_cols=100  Identities=20%  Similarity=0.449  Sum_probs=83.5

Q ss_pred             CCcccCCCcchhhHHHHHHHHHHHHHHHhhhCCC-CCcceeecccc-cccceeeeeccccCCCHHhHHHHHHHHHHhhhh
Q 037160          117 DDMKCGVDAEQEQQDLFRRVVEEVVNKVSKNAPN-ENGFATHKYTL-ADVSAYAMASCLKTLNHQMCSQCLTKAASTALT  194 (569)
Q Consensus       117 ~~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~-~~~fa~~~~~~-~~~~~y~laQC~~dl~~~~C~~Cl~~~~~~~~~  194 (569)
                      ....|+..+. .+...|.++++.||..|+..++. +.+|+++..+. +..+||||+||++|+++.+|..||..++..++.
T Consensus         6 v~~~Cn~~~~-t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~   84 (108)
T 3a2e_A            6 VSSACNTQKI-PSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFS   84 (108)
T ss_dssp             EEEEECSSBC-CTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHH
T ss_pred             eeeecCCCcc-CCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHH
Confidence            4456764433 23556999999999999987764 44677766554 557999999999999999999999999999999


Q ss_pred             hcC-CcccEEEecccceeeccccc
Q 037160          195 CIP-AIEGRVLFAGCFLRYSRYEF  217 (569)
Q Consensus       195 ~~~-~~~g~vl~~~C~lr~~~~~F  217 (569)
                      +|+ .++|+|++.+|++||+.+.|
T Consensus        85 ~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           85 ICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HCCCCceEEEECCCEEEEEeCCcC
Confidence            998 78899999999999999887

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=4.7e-18  Score=173.08  Aligned_cols=139  Identities=16%  Similarity=0.188  Sum_probs=100.1

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecch--------------hhHHHH--------HHHHHHHHhccccc
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK--------------NRIKEI--------CNEMDIMSRAHHKN  313 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~h~n  313 (569)
                      .-|++.++||+|++|.||+|...+|+.||||++.....              ......        .+|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34899999999999999999998999999998743210              011122        24555555554433


Q ss_pred             cceeeeeeeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC
Q 037160          314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL  393 (569)
Q Consensus       314 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~  393 (569)
                      +.- ...+. ....+|||||++|++|.++..         ......++.||+.+|.+||+.+   ||||||||.|||+++
T Consensus       175 v~v-p~p~~-~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPV-PEPIA-QSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSC-CCEEE-EETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred             CCC-Ceeee-ccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence            321 11111 123479999999999876541         1234568899999999999998   999999999999988


Q ss_pred             CCC----------eEEeccCCCccc
Q 037160          394 KHR----------PKIADFGLARFS  408 (569)
Q Consensus       394 ~~~----------~kl~Dfgla~~~  408 (569)
                      ++.          +.|+||+.+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            773          899999987644

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=2.8e-12  Score=125.17  Aligned_cols=144  Identities=15%  Similarity=0.063  Sum_probs=112.9

Q ss_pred             HhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .-+.|.+...++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. +..+.+++++....+..++|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3456888888999999999999865 6899999886532222345889999999994 6778889999988889999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG-------------------------------------  375 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  375 (569)
                      |++|.+|.+.+.        +......++.+++++|..||+..                                     
T Consensus        91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999987641        11223468889999999999811                                     


Q ss_pred             -------------------CCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          376 -------------------QMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       376 -------------------~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                                         +..++|+|++|.|||+++++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               1349999999999999876556799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.4e-11  Score=119.78  Aligned_cols=136  Identities=15%  Similarity=0.131  Sum_probs=100.5

Q ss_pred             cccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc--cceeeeeeeeCCceEEEEeec
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN--LVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .+.+....+.|..+.||+....+|+.+++|.....   ....+.+|+.+++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44444333456669999998777888999986543   2245778999999996545  456888887777889999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG---------------------------------------  375 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------  375 (569)
                      +|.+|.  ...      .+   ...++.++++.|..||+..                                       
T Consensus        98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999884  311      11   2256778888888888743                                       


Q ss_pred             ----------------CCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          376 ----------------QMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       376 ----------------~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                                      +..++|+|++|.|||+++++.+.|+||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            1229999999999999876666799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=4.3e-10  Score=115.00  Aligned_cols=142  Identities=16%  Similarity=0.206  Sum_probs=106.9

Q ss_pred             ccccccccCceeEEEEEecCCceEEEEEEe--ecc-hhhHHHHHHHHHHHHhcc--ccccceeeeeeeeC---CceEEEE
Q 037160          260 ESNKLGHGGYGEIFKGTLQDGREIAVKRLF--ISR-KNRIKEICNEMDIMSRAH--HKNLVQFLGCCFTK---KDSFVVY  331 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~  331 (569)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35678999999999988764 688888765  322 122346788999999997  45578888888766   4489999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG------------------------------------  375 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------  375 (569)
                      ||++|..+.+..     ...++...+..++.++++.|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998885422     234677888899999999999999731                                    


Q ss_pred             -------------------CCCeeeCCCCCCCeEECCCCC--eEEeccCCCcc
Q 037160          376 -------------------QMQIVHRDIKASNILLDLKHR--PKIADFGLARF  407 (569)
Q Consensus       376 -------------------~~~ivHrDikp~NIll~~~~~--~kl~Dfgla~~  407 (569)
                                         +..++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997764  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.97  E-value=1.1e-09  Score=109.07  Aligned_cols=182  Identities=19%  Similarity=0.242  Sum_probs=121.1

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccc--cceeeeeeeeCC---ceEEEEeec
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKN--LVQFLGCCFTKK---DSFVVYEFV  334 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  334 (569)
                      .+.++.|....||+..    ..+++|.....  .....+.+|..+|+.+. +..  +.+++.......   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3468999999999864    57889975432  34567889999999883 333  334444443332   358999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG---------------------------------------  375 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------  375 (569)
                      +|.+|.+...     ..++..++..++.++++.|..||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998875431     34667777888888888888888621                                       


Q ss_pred             ----------------CCCeeeCCCCCCCeEECC--CCCeEEeccCCCcccCCCCCCCCCcccccCCCc---cccccccc
Q 037160          376 ----------------QMQIVHRDIKASNILLDL--KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY---MAPEYIAN  434 (569)
Q Consensus       376 ----------------~~~ivHrDikp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~  434 (569)
                                      +..++|+|++|.||+++.  ...+.|+||+.+..-.....      .......   ..|+....
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHH
Confidence                            235899999999999998  45678999999865332110      0111111   22322110


Q ss_pred             -----CC---------CCcccchhhHHHHHHHHHhCCCC
Q 037160          435 -----GQ---------LTEKVDIYSFGVLVLEIVSGVQN  459 (569)
Q Consensus       435 -----~~---------~~~ksDv~SlGvil~elltg~~p  459 (569)
                           +.         .....+.|++|.++|.+.+|..+
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence                 11         11236899999999999999554

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=6.8e-07  Score=88.97  Aligned_cols=136  Identities=20%  Similarity=0.190  Sum_probs=95.3

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcccc---ccceeeeeee-eCCceEEEEeecCCC
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHK---NLVQFLGCCF-TKKDSFVVYEFVQNK  337 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~~  337 (569)
                      +.++.|....||+.    |..+++|+..  .......+.+|..+|+.+.+.   .+.+++.+.. ..+..++|||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            45788888899987    5788999742  233456788999999999653   3455666653 345678999999999


Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-------------------------------------------  374 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------  374 (569)
                      .|.+...     ..++......+..++++.|..||+.                                           
T Consensus        99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            8876321     1234455555666666666666643                                           


Q ss_pred             --------------CCCCeeeCCCCCCCeEECC---CCCe-EEeccCCCccc
Q 037160          375 --------------GQMQIVHRDIKASNILLDL---KHRP-KIADFGLARFS  408 (569)
Q Consensus       375 --------------~~~~ivHrDikp~NIll~~---~~~~-kl~Dfgla~~~  408 (569)
                                    .+..++|+|++|.|||++.   ++.+ .|+||+.+..-
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          2234799999999999987   4564 89999987643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.45  E-value=1.8e-06  Score=84.01  Aligned_cols=133  Identities=18%  Similarity=0.127  Sum_probs=96.6

Q ss_pred             ccccCce-eEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEEEEeecCCCChh
Q 037160          264 LGHGGYG-EIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFVVYEFVQNKSLD  340 (569)
Q Consensus       264 lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  340 (569)
                      +..|..+ .||+.... ++..+++|+-...   ....+.+|..+|+.+. +-.+.+++.++...+..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            3445444 68987765 5678999975432   3456788999999884 334667888888888999999999999887


Q ss_pred             hHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 037160          341 RILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG---------------------------------------------  375 (569)
Q Consensus       341 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------------  375 (569)
                      +....       .......+..++++.|..||...                                             
T Consensus       109 ~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          109 QVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            76521       12233456677777777777521                                             


Q ss_pred             ----------CCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          376 ----------QMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       376 ----------~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                                +..++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      1238999999999999987767799999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.37  E-value=8.5e-07  Score=90.17  Aligned_cols=81  Identities=7%  Similarity=0.025  Sum_probs=56.0

Q ss_pred             cccc-cccCceeEEEEEec-------CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccc---cccceeeeeeeeC--
Q 037160          261 SNKL-GHGGYGEIFKGTLQ-------DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHH---KNLVQFLGCCFTK--  324 (569)
Q Consensus       261 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~--  324 (569)
                      .+.| +.|....+|+....       +++.+++|......   ......+.+|+.+++.+..   -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999988754       26788898654322   0012457789999998853   2466777776554  


Q ss_pred             -CceEEEEeecCCCChhh
Q 037160          325 -KDSFVVYEFVQNKSLDR  341 (569)
Q Consensus       325 -~~~~lv~e~~~~~~L~~  341 (569)
                       +..++|||+++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999987754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.18  E-value=7.6e-06  Score=84.44  Aligned_cols=75  Identities=19%  Similarity=0.199  Sum_probs=50.0

Q ss_pred             cccccccCceeEEEEEec-CCceEEEEEEeecch-------hhHHHHHHHHHHHHhccc--cccc-eeeeeeeeCCceEE
Q 037160          261 SNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-------NRIKEICNEMDIMSRAHH--KNLV-QFLGCCFTKKDSFV  329 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~~~~~~~~~~~~~l  329 (569)
                      .+.||.|..+.||++... +++.++||.......       .....+..|.++|+.+..  +..+ +++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999765 568899997643211       122456789999988742  4444 55543  4556789


Q ss_pred             EEeecCCC
Q 037160          330 VYEFVQNK  337 (569)
Q Consensus       330 v~e~~~~~  337 (569)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.05  E-value=1.7e-05  Score=77.99  Aligned_cols=80  Identities=18%  Similarity=0.130  Sum_probs=58.1

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcccc---ccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHK---NLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e  332 (569)
                      ........+|.|..+.||+....+|+.|+||+...........+..|+..|+.|.-.   .+.+++..    +..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence            345556789999999999999999999999976544333334678899999988422   33444543    24588999


Q ss_pred             ecCCCCh
Q 037160          333 FVQNKSL  339 (569)
Q Consensus       333 ~~~~~~L  339 (569)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.99  E-value=3e-05  Score=77.93  Aligned_cols=140  Identities=16%  Similarity=0.208  Sum_probs=80.1

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcccc--ccceeee------eeeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHK--NLVQFLG------CCFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e~  333 (569)
                      +.|+.|..+.||+....+| .+++|+.... .   ..+..|+.+++.|...  .+.+++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999887654 5899987652 1   3344566666666321  2333332      11245667899999


Q ss_pred             cCCCChh-----------hHh---h----CCC-C------CccCCHHHHH------------------------------
Q 037160          334 VQNKSLD-----------RIL---F----DPK-Q------KKELDWKKRH------------------------------  358 (569)
Q Consensus       334 ~~~~~L~-----------~~l---~----~~~-~------~~~l~~~~~~------------------------------  358 (569)
                      ++|..+.           +.+   +    ... .      .....|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9987653           001   0    000 0      0011232110                              


Q ss_pred             -HHHHHHHHHHHHHhh----------cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          359 -VIIIGTAEGLEYLHK----------DGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       359 -~i~~~i~~~L~~LH~----------~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                       .+...+..++.+|++          ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             111123345666653          123569999999999999888899999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.99  E-value=5.5e-05  Score=75.10  Aligned_cols=138  Identities=17%  Similarity=0.087  Sum_probs=91.7

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc---ccccceeeeeeeeCCceEEEEeecCCC
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH---HKNLVQFLGCCFTKKDSFVVYEFVQNK  337 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~  337 (569)
                      .+.|+.|....+|+.... +..+++|+....   ....+..|...|+.|.   ...+.+++.+....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            457899999999998864 678999976533   3466889999999884   256778888887778899999999998


Q ss_pred             Chhh--------Hh---hCCCC---C----------------ccCCHHHHH---HHHH----------------HHHHH-
Q 037160          338 SLDR--------IL---FDPKQ---K----------------KELDWKKRH---VIII----------------GTAEG-  367 (569)
Q Consensus       338 ~L~~--------~l---~~~~~---~----------------~~l~~~~~~---~i~~----------------~i~~~-  367 (569)
                      .+..        .|   .....   .                -.-+|....   ++..                .+..- 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521        11   11100   0                012454322   1111                11111 


Q ss_pred             HHHHhh-cCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          368 LEYLHK-DGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       368 L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                      ...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            223432 2356799999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.76  E-value=0.00012  Score=75.97  Aligned_cols=78  Identities=10%  Similarity=0.135  Sum_probs=48.1

Q ss_pred             CCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCccc-ccCCCcccccccccC---CCCcccchhhHHHHHH
Q 037160          376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAI-AGTLGYMAPEYIANG---QLTEKVDIYSFGVLVL  451 (569)
Q Consensus       376 ~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~ksDv~SlGvil~  451 (569)
                      +..++|+|++|.|||++.++ ++|+||+.+..-......  .... .-...|.+|+.....   ......++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            34599999999999998776 999999988643321110  0000 011346666655311   1122355668888888


Q ss_pred             HHHhC
Q 037160          452 EIVSG  456 (569)
Q Consensus       452 elltg  456 (569)
                      +.+.+
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88776

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.54  E-value=0.00034  Score=69.59  Aligned_cols=142  Identities=13%  Similarity=0.100  Sum_probs=79.1

Q ss_pred             ccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcccccc--ceeeee------eeeCCceEEEEee
Q 037160          262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL--VQFLGC------CFTKKDSFVVYEF  333 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~------~~~~~~~~lv~e~  333 (569)
                      +.|+.|....+|+....+| .+++|......  ....+..|+.+++.+....+  .+++..      ....+..+++++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            4567788889999887655 78899775421  12345678888887743222  333321      1223557899999


Q ss_pred             cCCCChhh-----------H---hh----CCCCC--cc---CCHHHHHH------------HHHHHHHHHHHHhhc----
Q 037160          334 VQNKSLDR-----------I---LF----DPKQK--KE---LDWKKRHV------------IIIGTAEGLEYLHKD----  374 (569)
Q Consensus       334 ~~~~~L~~-----------~---l~----~~~~~--~~---l~~~~~~~------------i~~~i~~~L~~LH~~----  374 (569)
                      ++|..+..           .   ++    .....  ..   ..|...+.            +...+.+.+..+++.    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            99876421           0   00    00000  00   11222110            001133445555532    


Q ss_pred             CCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          375 GQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       375 ~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            23459999999999999876656899999764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.49  E-value=0.00044  Score=68.16  Aligned_cols=128  Identities=16%  Similarity=0.155  Sum_probs=77.3

Q ss_pred             cccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccc-eeeeeeeeCCceEEEEeec-CCCC
Q 037160          261 SNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV-QFLGCCFTKKDSFVVYEFV-QNKS  338 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~-~~~~  338 (569)
                      .+.|+.|....+|+.     ..+++|+....... .....+|+.+++.+...++. ++++.  ..+..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            567889999999998     57888877543211 11235688888887544443 55543  344568899999 7665


Q ss_pred             hhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh---------------------------------------------
Q 037160          339 LDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK---------------------------------------------  373 (569)
Q Consensus       339 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~---------------------------------------------  373 (569)
                      +.......          ...+..++++.|..||+                                             
T Consensus        95 l~~~~~~~----------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  164 (301)
T 3dxq_A           95 MSPEKFKT----------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS  164 (301)
T ss_dssp             CCHHHHHH----------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred             CCHhhHhh----------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence            53210000          00012222222222222                                             


Q ss_pred             -----cCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          374 -----DGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       374 -----~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                           ..+..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                 12345899999999999 5677899999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.40  E-value=0.00041  Score=72.12  Aligned_cols=73  Identities=14%  Similarity=0.226  Sum_probs=50.0

Q ss_pred             cccccccCceeEEEEEecC--------CceEEEEEEeecchhhHHHHHHHHHHHHhcccccc-ceeeeeeeeCCceEEEE
Q 037160          261 SNKLGHGGYGEIFKGTLQD--------GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL-VQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  331 (569)
                      .+.|+.|....||+....+        ++.+++|+....  .....+.+|..+++.+...++ .++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4567888889999998653        478899977432  111445579999998864444 456665432    3899


Q ss_pred             eecCCCCh
Q 037160          332 EFVQNKSL  339 (569)
Q Consensus       332 e~~~~~~L  339 (569)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.33  E-value=0.0022  Score=63.82  Aligned_cols=141  Identities=17%  Similarity=0.162  Sum_probs=81.2

Q ss_pred             cccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc--cceeeee-----eeeCCceEEEEeecC
Q 037160          263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN--LVQFLGC-----CFTKKDSFVVYEFVQ  335 (569)
Q Consensus       263 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~~  335 (569)
                      .|+ |....||+....+|+.+++|...... .....+..|..+++.+....  +++++..     ....+..+++||+++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            466 77889999887777789999875321 12346677888888884322  3344432     122445678999998


Q ss_pred             CCChhh-----------Hh-------hCC--CCCccCCHHHH----HHH---------------HHHHHHHHHHHhhc--
Q 037160          336 NKSLDR-----------IL-------FDP--KQKKELDWKKR----HVI---------------IIGTAEGLEYLHKD--  374 (569)
Q Consensus       336 ~~~L~~-----------~l-------~~~--~~~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~--  374 (569)
                      |..+..           .+       ...  ......++...    ..+               ...+.+.+..+.+.  
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            865421           00       000  01112222211    001               00111222333221  


Q ss_pred             --CCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          375 --GQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       375 --~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                        .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              234589999999999999 4 899999998753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.28  E-value=0.001  Score=67.67  Aligned_cols=140  Identities=16%  Similarity=0.202  Sum_probs=81.6

Q ss_pred             ccccccCceeEEEEEec--------CCceEEEEEEeecchhhHHHHHHHHHHHHhcccccc-ceeeeeeeeCCceEEEEe
Q 037160          262 NKLGHGGYGEIFKGTLQ--------DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL-VQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  332 (569)
                      +.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.|.-.++ .++++.+..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            46777888899998864        2478899875332 1234566789999998854333 456665533    39999


Q ss_pred             ecCCCChhhH-h----------------hCC--CCCccC--CHHHHHHHHHHHHH-------------------HHHHH-
Q 037160          333 FVQNKSLDRI-L----------------FDP--KQKKEL--DWKKRHVIIIGTAE-------------------GLEYL-  371 (569)
Q Consensus       333 ~~~~~~L~~~-l----------------~~~--~~~~~l--~~~~~~~i~~~i~~-------------------~L~~L-  371 (569)
                      |++|..|..- +                +..  ......  -|..+.++..++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998766421 0                000  001111  13444444433321                   22233 


Q ss_pred             ---hhc-CCCCeeeCCCCCCCeEECCC----CCeEEeccCCCc
Q 037160          372 ---HKD-GQMQIVHRDIKASNILLDLK----HRPKIADFGLAR  406 (569)
Q Consensus       372 ---H~~-~~~~ivHrDikp~NIll~~~----~~~kl~Dfgla~  406 (569)
                         ... .+..++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               221 23459999999999999876    789999999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.0014  Score=65.50  Aligned_cols=142  Identities=13%  Similarity=0.118  Sum_probs=72.6

Q ss_pred             ccccccCcee-EEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccc--cceeeeeeeeCCceEEEEeecCCCC
Q 037160          262 NKLGHGGYGE-IFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN--LVQFLGCCFTKKDSFVVYEFVQNKS  338 (569)
Q Consensus       262 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~~  338 (569)
                      +.|+.|.... +|+....+|+.+++|.......   ..+..|+.+++.+....  +.+++.+..  ...+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence            4565554444 6676654467787775432211   23456777777774323  445666532  23378999998766


Q ss_pred             hhhHhhCCC-----------------------CCccCCHHHHH-------HH-------------HHHHHHHHHHHh---
Q 037160          339 LDRILFDPK-----------------------QKKELDWKKRH-------VI-------------IIGTAEGLEYLH---  372 (569)
Q Consensus       339 L~~~l~~~~-----------------------~~~~l~~~~~~-------~i-------------~~~i~~~L~~LH---  372 (569)
                      +.+.+....                       ....++.....       .+             ...+...+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654331100                       00111111000       00             001111222221   


Q ss_pred             hcCCCCeeeCCCCCCCeEECCC----CCeEEeccCCCccc
Q 037160          373 KDGQMQIVHRDIKASNILLDLK----HRPKIADFGLARFS  408 (569)
Q Consensus       373 ~~~~~~ivHrDikp~NIll~~~----~~~kl~Dfgla~~~  408 (569)
                      ...+..++|||+.+.|||++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1123469999999999999874    67899999988643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.19  E-value=0.0024  Score=66.74  Aligned_cols=74  Identities=12%  Similarity=-0.016  Sum_probs=47.9

Q ss_pred             cccccccCceeEEEEEecC-CceEEEEEEeecchhhHHHHHHHHHHHHhcccccc-ceeeeeeeeCCceEEEEeecCCCC
Q 037160          261 SNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL-VQFLGCCFTKKDSFVVYEFVQNKS  338 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~~  338 (569)
                      .+.|+.|-...+|+....+ +..+++|+........ -...+|..+++.|...++ .++++.+.    ..+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence            3467888889999998764 4788888764322111 112589999999965555 45666652    236999999865


Q ss_pred             h
Q 037160          339 L  339 (569)
Q Consensus       339 L  339 (569)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.13  E-value=0.0011  Score=67.28  Aligned_cols=74  Identities=11%  Similarity=0.167  Sum_probs=45.1

Q ss_pred             cccccccCceeEEEEEecC---------CceEEEEEEeecchhhHHHHHHHHHHHHhcccccc-ceeeeeeeeCCceEEE
Q 037160          261 SNKLGHGGYGEIFKGTLQD---------GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL-VQFLGCCFTKKDSFVV  330 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  330 (569)
                      ...|+.|....+|+....+         +..+++|+...... .......|..+++.+...++ .++++..    ..++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            3467888888999988653         26788886543222 11234678888888854444 3566543    24789


Q ss_pred             EeecCCCCh
Q 037160          331 YEFVQNKSL  339 (569)
Q Consensus       331 ~e~~~~~~L  339 (569)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.07  E-value=0.0023  Score=64.24  Aligned_cols=68  Identities=12%  Similarity=0.139  Sum_probs=44.1

Q ss_pred             cccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccc---cccceeeee------eeeCCceEEEEeecC
Q 037160          265 GHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHH---KNLVQFLGC------CFTKKDSFVVYEFVQ  335 (569)
Q Consensus       265 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~------~~~~~~~~lv~e~~~  335 (569)
                      |.|....||+....+| .+++|+......      ..|+.+++.|..   |++.+.+..      ....+..+++|+|++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            4444689999987767 899997654331      356677776632   224444432      123466789999999


Q ss_pred             CCCh
Q 037160          336 NKSL  339 (569)
Q Consensus       336 ~~~L  339 (569)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8766

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.73  E-value=0.004  Score=57.28  Aligned_cols=99  Identities=18%  Similarity=0.118  Sum_probs=65.0

Q ss_pred             ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCC
Q 037160          338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN  417 (569)
Q Consensus       338 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  417 (569)
                      +|.++|.  ....+++++++|.++.|.+..|.-+-... . -..+=+.|..|+|..+|++.+.+ ..+.           
T Consensus        34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc-----------
Confidence            7888884  34578999999999999999987762211 0 11333457899999999998764 1110           


Q ss_pred             cccccCCCcccccccccCCCCcccchhhHHHHHHHHHhC
Q 037160          418 TAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG  456 (569)
Q Consensus       418 ~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg  456 (569)
                         .....+.|||... ...+.+.=|||||++||.-+--
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence               1123466888763 3556788999999999998853

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.40  E-value=0.061  Score=55.35  Aligned_cols=74  Identities=12%  Similarity=0.136  Sum_probs=48.5

Q ss_pred             cccccccCceeEEEEEecC--------CceEEEEEEeecchhhHHHHHHHHHHHHhcccccc-ceeeeeeeeCCceEEEE
Q 037160          261 SNKLGHGGYGEIFKGTLQD--------GREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL-VQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  331 (569)
                      .+.|..|-...+|+....+        ++.+++|+...... ..-...+|..+++.+...++ .++++.+    ..++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence            3467778888999988653        57888887643321 11234578888888854344 3455432    247899


Q ss_pred             eecCCCCh
Q 037160          332 EFVQNKSL  339 (569)
Q Consensus       332 e~~~~~~L  339 (569)
                      ||++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99999765

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.65  E-value=0.3  Score=49.81  Aligned_cols=28  Identities=32%  Similarity=0.519  Sum_probs=24.4

Q ss_pred             eeeCCCCCCCeEE------CCCCCeEEeccCCCc
Q 037160          379 IVHRDIKASNILL------DLKHRPKIADFGLAR  406 (569)
Q Consensus       379 ivHrDikp~NIll------~~~~~~kl~Dfgla~  406 (569)
                      ++|+|+.+.|||+      +++..+.++||.++.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456779999999875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.31  E-value=1.3  Score=40.58  Aligned_cols=82  Identities=9%  Similarity=0.051  Sum_probs=59.0

Q ss_pred             cccccceeeeeeeeCCceEEEEeecCCC-ChhhHhhCCCCCccCCHHHHHHHHHHHHHHHH-HHhhcCCCCeeeCCCCCC
Q 037160          310 HHKNLVQFLGCCFTKKDSFVVYEFVQNK-SLDRILFDPKQKKELDWKKRHVIIIGTAEGLE-YLHKDGQMQIVHRDIKAS  387 (569)
Q Consensus       310 ~h~niv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivHrDikp~  387 (569)
                      .||++  -...-.+++...+.++--+++ ++. -+      ..++..++++++..|+.... +++.     -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            57777  344446666666667655333 333 23      45778899999999887666 4543     588889999


Q ss_pred             CeEECCCCCeEEeccCCC
Q 037160          388 NILLDLKHRPKIADFGLA  405 (569)
Q Consensus       388 NIll~~~~~~kl~Dfgla  405 (569)
                      ||+++.++.++|.-.|+-
T Consensus       114 NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             GEEECTTCCEEESCCEET
T ss_pred             eEEEeCCCcEEEEEcCCc
Confidence            999999999999888864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.00  E-value=1.1  Score=41.13  Aligned_cols=83  Identities=10%  Similarity=0.117  Sum_probs=60.5

Q ss_pred             cccccceeeeeeeeCCceEEEEeecC-CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCC
Q 037160          310 HHKNLVQFLGCCFTKKDSFVVYEFVQ-NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASN  388 (569)
Q Consensus       310 ~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~N  388 (569)
                      .||+++.. .+-.+++...+.++.-+ +.++.. +      ..++...+++++..|+....+++.     -+|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            68888866 45555666666665543 223332 2      457889999999999888755554     4788999999


Q ss_pred             eEECCCCCeEEeccCCC
Q 037160          389 ILLDLKHRPKIADFGLA  405 (569)
Q Consensus       389 Ill~~~~~~kl~Dfgla  405 (569)
                      |+++.++.++|.--|+-
T Consensus       110 L~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             EEECTTSCEEESCCEET
T ss_pred             EEEcCCCCEEEEEccCc
Confidence            99999999999887764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.85  E-value=0.2  Score=52.22  Aligned_cols=61  Identities=5%  Similarity=0.049  Sum_probs=18.5

Q ss_pred             cccccccccCceeEEEEEecC-CceEEE------EEEeec--chhhHHHHHHHHHHHHhccccccceeeeeee
Q 037160          259 DESNKLGHGGYGEIFKGTLQD-GREIAV------KRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCF  322 (569)
Q Consensus       259 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  322 (569)
                      .+.++||   ||.||+|.+.. ..+|||      |.....  ..+....+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456776   99999999863 468888      765432  2333456888999999999999999887764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	569
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-59
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-57
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (537), Expect = 8e-65
 Identities = 60/278 (21%), Positives = 129/278 (46%), Gaps = 19/278 (6%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            ++G G +G ++KG       + +  +      +++   NE+ ++ +  H N++ F+G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
            T     +V ++ +  SL   L   + K   +  K   I   TA+G++YLH      I+H
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIH 127

Query: 382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI---ANGQLT 438
           RD+K++NI L      KI DFGLA   S          ++G++ +MAPE I        +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 439 EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIE 498
            + D+Y+FG+++ E+++G     + + +  + ++    + + +  + ++          +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRS-----NCPK 240

Query: 499 EVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLP 536
            +KR++     C ++    RP    ++  ++    +LP
Sbjct: 241 AMKRLM---AECLKKKRDERPLFPQILASIELLARSLP 275

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-59
 Identities = 67/302 (22%), Positives = 127/302 (42%), Gaps = 27/302 (8%)

Query: 251 IEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI-KEICNEMDIMSR 308
           +E   D F++ ++LG G  G +FK +    G  +A K + +  K  I  +I  E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
            +   +V F G  ++  +  +  E +   SLD++L   K+   +  +    + I   +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMA 428
            YL +  + +I+HRD+K SNIL++ +   K+ DFG++       +     +  GT  YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 171

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII 488
           PE +     + + DI+S G+ ++E+  G                 +      AK +  + 
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVG----------------RYPIPPPDAKELELMF 215

Query: 489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECM 548
              +E +  E   R    G   +      RP M     +    +   P      F+ E  
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275

Query: 549 EL 550
           + 
Sbjct: 276 DF 277

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-59
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 23/275 (8%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
           +      +LG G +GE++ G      ++AVK L     +       E ++M +  H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +      T++  +++ E+++N SL   L  P   K L   K   +    AEG+ ++ +  
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
               +HRD++A+NIL+      KIADFGLAR     +           + + APE I  G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYG 185

Query: 436 QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE 495
             T K D++SFG+L+ EIV+  +                 +       V++ +++   + 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR---------------IPYPGMTNPEVIQNLERGYRMV 230

Query: 496 DIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLK 529
             +   + +  +  LC +E P  RP+   +  +L+
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 5e-58
 Identities = 57/274 (20%), Positives = 114/274 (41%), Gaps = 23/274 (8%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
                +LG G +G +  G  +   ++A+K +     +   E   E  +M    H+ LVQ 
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQL 64

Query: 318 LGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
            G C  ++  F++ E++ N  L   L + + +     ++   +     E +EYL      
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQ-- 120

Query: 378 QIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL 437
             +HRD+ A N L++ +   K++DFGL+R+   ++    +      + +  PE +   + 
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKF 178

Query: 438 TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDI 497
           + K DI++FGVL+ EI                +L    ++ F      E I + + +   
Sbjct: 179 SSKSDIWAFGVLMWEIY---------------SLGKMPYERFTNSETAEHIAQGLRLYRP 223

Query: 498 EEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
               ++V  +   C  E    RP+   ++  +  
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 9e-58
 Identities = 57/276 (20%), Positives = 119/276 (43%), Gaps = 23/276 (8%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
                  ++G G +G +  G   +  ++A+K +     +  ++   E ++M +  H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           Q  G C  +    +V+EF+++  L    +   Q+     +    + +   EG+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
              ++HRD+ A N L+      K++DFG+ RF   ++    +T     + + +PE  +  
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177

Query: 436 QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE 495
           + + K D++SFGVL+ E+ S  +                 +++     V+E I     + 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK---------------IPYENRSNSEVVEDISTGFRLY 222

Query: 496 DIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
                   V  +   C +E P  RP+ + +++ L +
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 4e-57
 Identities = 64/287 (22%), Positives = 120/287 (41%), Gaps = 23/287 (8%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV 315
           +      KLG G +GE++ GT      +A+K L     +  +    E  +M +  H+ LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           Q      +++  ++V E++   SL   L     K      +   +    A G+ Y+    
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
           +M  VHRD++A+NIL+      K+ADFGLAR     +           + + APE    G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYG 189

Query: 436 QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIE 495
           + T K D++SFG+L+ E+ +  +                 +     + VL+ +++   + 
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR---------------VPYPGMVNREVLDQVERGYRMP 234

Query: 496 DIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKP 541
              E  + +  +   C ++ P  RP+   +   L+    +     +P
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-55
 Identities = 62/291 (21%), Positives = 118/291 (40%), Gaps = 29/291 (9%)

Query: 263 KLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCF 322
            +G G +GE+++G    G E+AVK    SR+ R      E+       H+N++ F+    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 323 TKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG--- 375
               +    ++V ++ ++ SL   L     +  +  +    + + TA GL +LH +    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 376 --QMQIVHRDIKASNILLDLKHRPKIADFGLARF--SSSEKSLLPNTAIAGTLGYMAPEY 431
             +  I HRD+K+ NIL+       IAD GLA    S+++   +      GT  YMAPE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 432 I------ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF----ETLVTHTWKHFQA 481
           +       + +  ++ DIY+ G++  EI           D             + +  + 
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 482 KTVLEIIDKSI--EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
               + +  +I    +  E ++ +  +   C       R +   + + L Q
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (474), Expect = 2e-55
 Identities = 66/315 (20%), Positives = 122/315 (38%), Gaps = 45/315 (14%)

Query: 244 LQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTL------QDGREIAVKRLFI-SRKNRI 296
           L  K  ++E   +  +    +G G +G +F+         +    +AVK L   +  +  
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 297 KEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFD----------- 345
            +   E  +M+   + N+V+ LG C   K   +++E++    L+  L             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 346 ----------PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH 395
                           L   ++  I    A G+ YL    + + VHRD+   N L+    
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENM 177

Query: 396 RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS 455
             KIADFGL+R   S      +   A  + +M PE I   + T + D++++GV++ EI S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 456 GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELP 515
                 +      E +               + D +I          +  +  LC  +LP
Sbjct: 238 Y-GLQPYYGMAHEEVI-------------YYVRDGNILACPENCPLELYNLMRLCWSKLP 283

Query: 516 TLRPSMTNVVQMLKQ 530
             RPS  ++ ++L++
Sbjct: 284 ADRPSFCSIHRILQR 298

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-55
 Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 29/275 (10%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF 317
                 +G G +G++  G    G ++AVK   I      +    E  +M++  H NLVQ 
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 318 LGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQ 376
           LG    +K   ++V E++   SL   L   + +  L         +   E +EYL  +  
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 123

Query: 377 MQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQ 436
              VHRD+ A N+L+   +  K++DFGL + +SS +           + + APE +   +
Sbjct: 124 --FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKK 176

Query: 437 LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIED 496
            + K D++SFG+L+ EI S  +                 +     K V+  ++K  +++ 
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGR---------------VPYPRIPLKDVVPRVEKGYKMDA 221

Query: 497 IEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
            +     V  V   C      +RPS   + + L+ 
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (475), Expect = 3e-55
 Identities = 69/308 (22%), Positives = 131/308 (42%), Gaps = 38/308 (12%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
              F +  ++GHG +G ++    +++   +A+K++         + ++I  E+  + +  
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H N +Q+ GC   +  +++V E+    + D +      KK L   +   +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH      ++HRD+KA NILL      K+ DFG A   +      P  +  GT  +MAPE
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPE 181

Query: 431 YIA---NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI 487
            I     GQ   KVD++S G+  +E+          + +    L            + + 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP--PLFNMNAMSAL----------YHIAQN 229

Query: 488 IDKSIEIEDI-EEVKRVVWVGLLCTQELPTLRPSMTNVVQ---MLKQKDITLPTPSKPPF 543
              +++     E  +  V     C Q++P  RP+   +++   +L+++  T+        
Sbjct: 230 ESPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRT 286

Query: 544 TDECMELS 551
            D   EL 
Sbjct: 287 KDAVRELD 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 5e-55
 Identities = 64/289 (22%), Positives = 129/289 (44%), Gaps = 28/289 (9%)

Query: 250 TIEKATDCFDESNKLGHGGYGEIFKGTLQDG-----REIAVKRLFISRKNR-IKEICNEM 303
           T E    C      +G G +GE++KG L+         +A+K L      +   +   E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 304 DIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIG 363
            IM +  H N+++  G     K   ++ E+++N +LD+  F  ++  E    +   ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRG 118

Query: 364 TAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAG 422
            A G++YL     M  VHRD+ A NIL++     K++DFGL+R      ++    +    
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK 482
            + + APE I+  + T   D++SFG+++ E+++  +   ++  +                
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---------------H 220

Query: 483 TVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
            V++ I+    +    +    +  + + C Q+    RP   ++V +L +
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (469), Expect = 1e-54
 Identities = 67/303 (22%), Positives = 127/303 (41%), Gaps = 38/303 (12%)

Query: 246 FKYSTIEKATDCFDES---------NKLGHGGYGEIFKGTL----QDGREIAVKRLFISR 292
           F +    +A   F +            +G G +GE+  G L    +    +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 293 -KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE 351
            + + ++  +E  IM +  H N++   G         ++ EF++N SLD   F  +   +
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124

Query: 352 LDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE 411
               +   ++ G A G++YL     M  VHRD+ A NIL++     K++DFGL+RF   +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 412 KSLLPNTA---IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF 468
            S    T+       + + APE I   + T   D++S+G+++ E++S  +          
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 469 ETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQM 527
                  +     + V+  I++   +    +    +  + L C Q+    RP    +V  
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 528 LKQ 530
           L +
Sbjct: 287 LDK 289

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (465), Expect = 3e-54
 Identities = 71/281 (25%), Positives = 123/281 (43%), Gaps = 23/281 (8%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGTLQD-GREIAVKRLFISRKNRIKEICNEMDIMSRAH 310
           E         +KLG G YGE+++G  +     +AVK L        +E   E  +M    
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIK 71

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H NLVQ LG C  +   +++ EF+   +L   L +   ++E+       +    +  +EY
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEY 130

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           L    +   +HRD+ A N L+   H  K+ADFGL+R  + +     +      + + APE
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPE 186

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK 490
            +A  + + K D+++FGVL+ EI +   +                +       V E+++K
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLEK 231

Query: 491 SIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
              +E  E   ++V  +   C Q  P+ RPS   + Q  + 
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 4e-54
 Identities = 66/295 (22%), Positives = 124/295 (42%), Gaps = 37/295 (12%)

Query: 243 FLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQD---GREIAVKRLFISRKNR--IK 297
           +L  K  T+E          +LG G +G + KG  Q     + +AVK L     +     
Sbjct: 2   YLDRKLLTLE--------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD 53

Query: 298 EICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKR 357
           E+  E ++M +  +  +V+ +G C   +   +V E  +   L++ L    Q + +  K  
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNI 109

Query: 358 HVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLP- 416
             ++   + G++YL    +   VHRD+ A N+LL  +H  KI+DFGL++   ++++    
Sbjct: 110 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166

Query: 417 NTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW 476
            T     + + APE I   + + K D++SFGVL+ E                 +     +
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF---------------SYGQKPY 211

Query: 477 KHFQAKTVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
           +  +   V  +++K   +       + +  +  LC       RP    V   L+ 
Sbjct: 212 RGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 3e-53
 Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 30/308 (9%)

Query: 232 MDLSLLHKSLKFLQFKYSTIEKATDCFDESNKLGHGGYGEIFKGTLQD----GREIAVKR 287
           +DLS L+  L     ++  I  ++     +  +G G +G ++ GTL D        AVK 
Sbjct: 4   IDLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62

Query: 288 L-FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFD 345
           L  I+    + +   E  IM    H N++  LG C   + S  VV  ++++  L    F 
Sbjct: 63  LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FI 120

Query: 346 PKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA 405
             +      K      +  A+G+++L      + VHRD+ A N +LD K   K+ADFGLA
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 177

Query: 406 RF--SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQ 463
           R        S+   T     + +MA E +   + T K D++SFGVL+ E+++        
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA----- 232

Query: 464 SDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMT 522
                       +       +   + +   +   E     +  V L C      +RPS +
Sbjct: 233 ----------PPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 282

Query: 523 NVVQMLKQ 530
            +V  +  
Sbjct: 283 ELVSRISA 290

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 6e-53
 Identities = 64/282 (22%), Positives = 123/282 (43%), Gaps = 26/282 (9%)

Query: 253 KATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIMSRA 309
           +A D ++    +G G YG   K     DG+ +  K L          + + +E++++   
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 310 HHKNLVQFLGCCFTKKDS--FVVYEFVQNKSLDRILFD-PKQKKELDWKKRHVIIIGTAE 366
            H N+V++      + ++  ++V E+ +   L  ++    K+++ LD +    ++     
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 367 GLEYLHK--DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
            L+  H+  DG   ++HRD+K +N+ LD K   K+ DFGLAR  + + S     A  GT 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTP 178

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV 484
            YM+PE +      EK DI+S G L+ E+ + +    F +    E              +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELA----------GKI 226

Query: 485 LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ 526
            E   + I     +E+  ++             RPS+  +++
Sbjct: 227 REGKFRRIPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 8e-53
 Identities = 63/285 (22%), Positives = 122/285 (42%), Gaps = 27/285 (9%)

Query: 260 ESNKLGHGGYGEIFKGTLQ---DGREIAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLV 315
              +LG G +G + +G  +      ++A+K L   + K   +E+  E  IM +  +  +V
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           + +G C  +    +V E      L + L    +++E+       ++   + G++YL    
Sbjct: 73  RLIGVCQAEA-LMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLE--- 126

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARF-SSSEKSLLPNTAIAGTLGYMAPEYIAN 434
           +   VHRD+ A N+LL  +H  KI+DFGL++   + +      +A    L + APE I  
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186

Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI 494
            + + + D++S+GV + E +S  Q                 +K  +   V+  I++   +
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAFIEQGKRM 231

Query: 495 EDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTP 538
           E   E    +  +   C       RP    V Q ++    +L + 
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-52
 Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 34/275 (12%)

Query: 258 FDESNKLGHGGYGEIFKGTL-QDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKN 313
           F+    LG G +G ++     Q    +A+K L    + +     ++  E++I S   H N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +++  G        +++ E+    ++ R L   ++  + D ++    I   A  L Y H 
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH- 123

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
               +++HRDIK  N+LL      KIADFG +  + S +     T + GTL Y+ PE I 
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIE 177

Query: 434 NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE 493
                EKVD++S GVL  E + G     F+++   ET                I      
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVG--KPPFEANTYQETYK-------------RISRVEFT 222

Query: 494 IEDI--EEVKRVVWVGLLCTQELPTLRPSMTNVVQ 526
             D   E  + ++       +  P+ RP +  V++
Sbjct: 223 FPDFVTEGARDLI---SRLLKHNPSQRPMLREVLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-52
 Identities = 63/273 (23%), Positives = 115/273 (42%), Gaps = 30/273 (10%)

Query: 262 NKLGHGGYGEIFKGTL-QDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFL 318
            ++G G +  ++KG   +   E+A   L   +  K+  +    E +++    H N+V+F 
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 319 GCCFT----KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
               +    KK   +V E + + +L   L   K+ K +  K          +GL++LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 375 GQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
               I+HRD+K  NI +       KI D GLA    +  +     A+ GT  +MAPE   
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMY- 185

Query: 434 NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE 493
             +  E VD+Y+FG+ +LE+ +      +        +    ++   +       DK   
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQI----YRRVTSGVKPASFDKVA- 238

Query: 494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ 526
              I EVK ++     C ++    R S+ +++ 
Sbjct: 239 ---IPEVKEII---EGCIRQNKDERYSIKDLLN 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-52
 Identities = 69/320 (21%), Positives = 128/320 (40%), Gaps = 43/320 (13%)

Query: 251 IEKATDCFDESNKLGHGGYGEIFKGT-LQDGRE----IAVKRL-FISRKNRIKEICNEMD 304
           I K T+ F +   LG G +G ++KG  + +G +    +A+K L   +     KEI +E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 305 IMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           +M+   + ++ + LG C T     +         LD   +  + K  +  +      +  
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLD---YVREHKDNIGSQYLLNWCVQI 120

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
           A+G+ YL      ++VHRD+ A N+L+      KI DFGLA+   +E+           +
Sbjct: 121 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 425 GYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV 484
            +MA E I +   T + D++S+GV V E++               T  +  +    A  +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELM---------------TFGSKPYDGIPASEI 222

Query: 485 LEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ------------- 530
             I++K   +         V  + + C       RP    ++    +             
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

Query: 531 -KDITLPTPSKPPFTDECME 549
            + + LP+P+   F    M+
Sbjct: 283 DERMHLPSPTDSNFYRALMD 302

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-51
 Identities = 57/278 (20%), Positives = 121/278 (43%), Gaps = 26/278 (9%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKN 313
            D ++   +LG G +G+++K    +     A K +    +  +++   E+DI++   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +V+ L   + + + +++ EF    ++D ++   + ++ L   +  V+   T + L YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLH- 127

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
               +I+HRD+KA NIL  L    K+ADFG++  ++         +  GT  +MAPE + 
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVM 183

Query: 434 NGQL-----TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII 488
                      K D++S G+ ++E+            +    L     K  +++      
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEI--EPPHHELNPMRVL----LKIAKSEPPTLAQ 237

Query: 489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ 526
                    + +K+       C ++    R + + ++Q
Sbjct: 238 PSRWSSNFKDFLKK-------CLEKNVDARWTTSQLLQ 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 3e-51
 Identities = 68/305 (22%), Positives = 131/305 (42%), Gaps = 28/305 (9%)

Query: 250 TIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR 308
           ++      +    K+G G  G ++    +  G+E+A++++ + ++ + + I NE+ +M  
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGL 368
             + N+V +L       + +VV E++   SL  ++ +       D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQAL 129

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMA 428
           E+LH     Q++HRDIK+ NILL +    K+ DFG     + E+S    + + GT  +MA
Sbjct: 130 EFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMA 184

Query: 429 PEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII 488
           PE +       KVDI+S G++ +E++ G     + +++    L    +      T     
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG--EPPYLNENPLRAL----YLIATNGTPELQN 238

Query: 489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQKDITLPTPSKPPFTDE 546
            + +     + + R       C       R S   ++Q   LK   I  P  S  P    
Sbjct: 239 PEKLSAIFRDFLNR-------CLDMDVEKRGSAKELLQHQFLK---IAKPLSSLTPLIAA 288

Query: 547 CMELS 551
             E +
Sbjct: 289 AKEAT 293

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 4e-51
 Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 22/272 (8%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLV 315
           +D    LG G YGE+           +AVK + + R  +  + I  E+ I    +H+N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
           +F G        ++  E+     L   +   +    +              G+ YLH   
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
            + I HRDIK  N+LLD +   KI+DFGLA              + GTL Y+APE +   
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 436 QL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI 494
           +   E VD++S G+++  +++G       SD   E      +  ++ K       K I+ 
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYLNPWKKIDS 234

Query: 495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ 526
             +  + +          E P+ R ++ ++ +
Sbjct: 235 APLALLHK-------ILVENPSARITIPDIKK 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 5e-51
 Identities = 63/293 (21%), Positives = 112/293 (38%), Gaps = 41/293 (13%)

Query: 262 NKLGHGGYGEIFKGTL------QDGREIAVKRLFISRK-NRIKEICNEMDIMSR-AHHKN 313
             LG G +G++ + T            +AVK L  S      + + +E+ ++S   +H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE---------------LDWKKRH 358
           +V  LG C     + V+ E+     L   L   +                   LD +   
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 359 VIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNT 418
                 A+G+ +L        +HRD+ A NILL      KI DFGLAR   ++ + +   
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 419 AIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH 478
                + +MAPE I N   T + D++S+G+ + E+ S   +                   
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYPGM 251

Query: 479 FQAKTVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
                  ++I +   +   E     +  +   C    P  RP+   +VQ++++
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 6e-51
 Identities = 67/302 (22%), Positives = 120/302 (39%), Gaps = 44/302 (14%)

Query: 256 DCFDESNKLGHGGYGEIFKGTLQD------GREIAVKRLF-ISRKNRIKEICNEMDIMSR 308
           +  +    LG G +G++   T           ++AVK L   +  +  + + +E+ +M++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 309 -AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQK------------------ 349
              H+N+V  LG C      ++++E+     L   L   ++K                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 350 --KELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF 407
               L ++         A+G+E+L        VHRD+ A N+L+      KI DFGLAR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDG 467
             S+ + +        + +MAPE +  G  T K D++S+G+L+ EI S    N +     
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272

Query: 468 FETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM 527
                   +K  Q    ++    +      EE+  ++     C       RPS  N+   
Sbjct: 273 DANF----YKLIQNGFKMDQPFYA-----TEEIYIIM---QSCWAFDSRKRPSFPNLTSF 320

Query: 528 LK 529
           L 
Sbjct: 321 LG 322

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 2e-50
 Identities = 64/283 (22%), Positives = 101/283 (35%), Gaps = 31/283 (10%)

Query: 258 FDESNKLGHGGYGEIFKGTL----QDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
                KLG G +G + +G           +AVK L    +S+   + +   E++ M    
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H+NL++  G   T     +V E     SL       K +            +  AEG+ Y
Sbjct: 70  HRNLIRLYGVVLTP-PMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLGYMAP 429
           L        +HRD+ A N+LL  +   KI DFGL R    ++   +          + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID 489
           E +     +   D + FGV + E+                T     W       +L  ID
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMF---------------TYGQEPWIGLNGSQILHKID 228

Query: 490 KSIEIEDIEE--VKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
           K  E     E   + +  V + C    P  RP+   +   L +
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 6e-50
 Identities = 64/292 (21%), Positives = 117/292 (40%), Gaps = 40/292 (13%)

Query: 258 FDESNKLGHGGYGEIFKGTLQDG---REIAVKRL-FISRKNRIKEICNEMDIMSR-AHHK 312
               + +G G +G++ K  ++      + A+KR+   + K+  ++   E++++ +  HH 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRIL-------------FDPKQKKELDWKKRHV 359
           N++  LG C  +   ++  E+  + +L   L                     L  ++   
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA 419
                A G++YL    Q Q +HRD+ A NIL+   +  KIADFGL+R           T 
Sbjct: 132 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTM 185

Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHF 479
               + +MA E +     T   D++S+GVL+ EIVS                    +   
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---------------TPYCGM 230

Query: 480 QAKTVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
               + E + +   +E        V  +   C +E P  RPS   ++  L +
Sbjct: 231 TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-48
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 12/224 (5%)

Query: 252 EKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKEICNEMDIMS 307
           +K  + F     LG G +  +     L   RE A+K L    I ++N++  +  E D+MS
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 308 RAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEG 367
           R  H   V+        +  +    + +N  L + +         D              
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSA 120

Query: 368 LEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           LEYLH      I+HRD+K  NILL+     +I DFG A+  S E       +  GT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
           +PE +      +  D+++ G ++ ++V+G+    F++ + +   
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYLIF 219

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-47
 Identities = 60/303 (19%), Positives = 118/303 (38%), Gaps = 35/303 (11%)

Query: 256 DCFDESNKLGHGGYGEIFKGTL------QDGREIAVKRLFISRKNR-IKEICNEMDIMSR 308
           +    S +LG G +G +++G        +    +A+K +  +   R   E  NE  +M  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 309 AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKE-------LDWKKRHVII 361
            +  ++V+ LG     + + V+ E +    L   L   +               K   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 362 IGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIA 421
              A+G+ YL+ +     VHRD+ A N ++      KI DFG+ R               
Sbjct: 140 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 422 GTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQA 481
             + +M+PE + +G  T   D++SFGV++ EI +  +                 ++    
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSN 241

Query: 482 KTVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSK 540
           + VL  + +   ++  +     +  +  +C Q  P +RPS   ++  +K+     P   +
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE--EMEPGFRE 299

Query: 541 PPF 543
             F
Sbjct: 300 VSF 302

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  163 bits (413), Expect = 4e-46
 Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 30/294 (10%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           +LG G +G + + T    G   A K +    ++  + +  E+  MS   H  LV      
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
               +  ++YEF+    L   +    +  ++   +    +    +GL ++H++     VH
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVH 147

Query: 382 RDIKASNILLDLKH--RPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
            D+K  NI+   K     K+ DFGL      ++S+   T   GT  + APE      +  
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGY 204

Query: 440 KVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE 499
             D++S GVL   ++SG+  + F  ++  ETL          K+    +D S      E+
Sbjct: 205 YTDMWSVGVLSYILLSGL--SPFGGENDDETL-------RNVKSCDWNMDDSAFSGISED 255

Query: 500 VKRVVWVGLLCTQELPTLRPSMTNVVQM-------LKQKDITLPTPSKPPFTDE 546
            K  +          P  R ++   ++           +D  +P+       D 
Sbjct: 256 GKDFI---RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 4e-45
 Identities = 74/297 (24%), Positives = 119/297 (40%), Gaps = 38/297 (12%)

Query: 256 DCFDESNKLGHGGYGEIFKGT------LQDGREIAVKRLFISRKN-RIKEICNEMDIMSR 308
           D       LG G +G++ +            R +AVK L     +   + + +E+ I+  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 309 -AHHKNLVQFLGCCFTKKDS-FVVYEFVQNKSLDRILFDPKQ-------------KKELD 353
             HH N+V  LG C        V+ EF +  +L   L   +              K  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 354 WKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS 413
            +         A+G+E+L      + +HRD+ A NILL  K+  KI DFGLAR    +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT 473
            +        L +MAPE I +   T + D++SFGVL+ EI S        S      +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDE 244

Query: 474 HTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
              +  +  T +   D +       E+ + +   L C    P+ RP+ + +V+ L  
Sbjct: 245 EFCRRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 293

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 7e-45
 Identities = 56/281 (19%), Positives = 103/281 (36%), Gaps = 28/281 (9%)

Query: 256 DCFDESNKLGHGGYGEIFKGTL----QDGREIAVKRLFISRKNRIKE-ICNEMDIMSRAH 310
           +  +    +G G +G++ +G           +A+K       + ++E    E   M +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H ++V+ +G   T+   +++ E      L    F   +K  LD     +     +  L Y
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           L        VHRDI A N+L+      K+ DFGL+R+          +     + +MAPE
Sbjct: 124 LESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPE 179

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK 490
            I   + T   D++ FGV + EI+                     ++  +   V+  I+ 
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIEN 224

Query: 491 SIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
              +         +  +   C    P+ RP  T +   L  
Sbjct: 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-44
 Identities = 64/299 (21%), Positives = 118/299 (39%), Gaps = 42/299 (14%)

Query: 256 DCFDESNKLGHGGYGEIFKGTL--------QDGREIAVKRLFISRKNR-IKEICNEMDIM 306
           D       LG G +G++                 ++AVK L      + + ++ +EM++M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 307 SR-AHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQ-------------KKEL 352
                HKN++  LG C      +V+ E+    +L   L   +              +++L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 353 DWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK 412
             K         A G+EYL        +HRD+ A N+L+   +  KIADFGLAR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 413 SLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLV 472
                T     + +MAPE + +   T + D++SFGVL+ EI +                 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-------------- 235

Query: 473 THTWKHFQAKTVLEIIDKSIEIEDIEEV-KRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
              +     + + +++ +   ++        +  +   C   +P+ RP+   +V+ L +
Sbjct: 236 -SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  156 bits (395), Expect = 2e-43
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 13/219 (5%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNL 314
           D +D   +LG G +G + +      GR    K +          + NE+ IM++ HH  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           +        K +  ++ EF+    L   +    +  ++   +    +    EGL+++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 375 GQMQIVHRDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
            +  IVH DIK  NI+ + K     KI DFGLA   + ++ +   T    T  + APE +
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 200

Query: 433 ANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
               +    D+++ GVL   ++SG+    F  +D  ETL
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS--PFAGEDDLETL 237

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  148 bits (375), Expect = 2e-41
 Identities = 64/287 (22%), Positives = 122/287 (42%), Gaps = 30/287 (10%)

Query: 255 TDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAH 310
           +D ++    LG GG  E+     L+  R++AVK L        +       E    +  +
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 311 HKNLVQFLGCCFTKKDS----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           H  +V        +  +    ++V E+V   +L  I+     +  +  K+   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQ 122

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR-FSSSEKSLLPNTAIAGTLG 425
            L + H++G   I+HRD+K +NI++   +  K+ DFG+AR  + S  S+    A+ GT  
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 426 YMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVL 485
           Y++PE      +  + D+YS G ++ E+++G     F  D          ++H +     
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE--PPFTGDSPVSVA----YQHVRE---- 229

Query: 486 EIIDKSIEIEDI-EEVKRVVWVGLLCTQELPTLRP-SMTNVVQMLKQ 530
           + I  S   E +  ++  VV   L    + P  R  +   +   L +
Sbjct: 230 DPIPPSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVR 273

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (374), Expect = 7e-41
 Identities = 61/330 (18%), Positives = 130/330 (39%), Gaps = 33/330 (10%)

Query: 248 YSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISR-KNRIKEICNEMDI 305
           +   E   D +D  + LG G + E+      +  + +A+K +     + +   + NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 306 MSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
           + +  H N+V       +    +++ + V    L   +    +K     +    +I    
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKH---RPKIADFGLARFSSSEKSLLPNTAIAG 422
           + ++YLH    + IVHRD+K  N+L        +  I+DFGL++       L   +   G
Sbjct: 118 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACG 171

Query: 423 TLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK 482
           T GY+APE +A    ++ VD +S GV+   ++ G     F  ++  +         ++  
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG--YPPFYDENDAKLFEQILKAEYEFD 229

Query: 483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK----QKDITLPTP 538
           +     D S   +D   ++          ++ P  R +     Q L+      D  L   
Sbjct: 230 S-PYWDDISDSAKDF--IRH-------LMEKDPEKRFTCE---QALQHPWIAGDTALDKN 276

Query: 539 SKPPFTDECMELSHTSGFSRRQSSSAKILR 568
                +++  +    S + +  +++A +  
Sbjct: 277 IHQSVSEQIKKNFAKSKWKQAFNATAVVRH 306

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 58/286 (20%), Positives = 114/286 (39%), Gaps = 26/286 (9%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
            LG G +G + +       +    K + +   ++   +  E+ I++ A H+N++      
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
            + ++  +++EF+    +   +       EL+ ++    +    E L++LH      I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHN---IGH 125

Query: 382 RDIKASNILLDLKHRP--KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTE 439
            DI+  NI+   +     KI +FG AR      +      +     Y APE   +  ++ 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVST 182

Query: 440 KVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEE 499
             D++S G LV  ++SG+  N F ++   + +       +   T  E   K I IE ++ 
Sbjct: 183 ATDMWSLGTLVYVLLSGI--NPFLAETNQQIIENIMNAEY---TFDEEAFKEISIEAMDF 237

Query: 500 VKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQKDITLPTPSKPPF 543
           V R          +    R + +  +Q   LKQK   + T      
Sbjct: 238 VDR-------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 4e-40
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 15/230 (6%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKEICNEMDIMSRA-H 310
           + F     LG G +G++F     +  +  A+K L    +   + ++    E  ++S A  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
           H  L        TK++ F V E++    L   +   +   + D  +          GL++
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           LH  G   IV+RD+K  NILLD     KIADFG+ + +    +        GT  Y+APE
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPE 173

Query: 431 YIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQ 480
            +   +    VD +SFGVL+ E++ G   + F   D  E   +    +  
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEELFHSIRMDNPF 221

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (366), Expect = 6e-40
 Identities = 48/278 (17%), Positives = 97/278 (34%), Gaps = 26/278 (9%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           K+G G +G+I+ GT +  G E+A+K      K +  ++  E  I         +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
             + D  V+   +   SL+         ++   K   ++       +EY+H       +H
Sbjct: 72  GAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 382 RDIKASNILLDLK---HRPKIADFGLARFSSSEKS-----LLPNTAIAGTLGYMAPEYIA 433
           RD+K  N L+ L    +   I DFGLA+     ++        N  + GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 434 NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK-SI 492
             + + + D+ S G +++    G    +               +   +  +  +      
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 246

Query: 493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
           E      +         C       +P  + + Q+ + 
Sbjct: 247 EFATY--LNF-------CRSLRFDDKPDYSYLRQLFRN 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  145 bits (367), Expect = 8e-40
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 15/203 (7%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHHKN 313
           F     LG G +G +       +GR  A+K L    + R  +++   +E  ++S   H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +++  G     +  F++ ++++   L  +L   ++      K     +      LEYLH 
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV---CLALEYLHS 122

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                I++RD+K  NILLD     KI DFG A++            + GT  Y+APE ++
Sbjct: 123 ---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVS 174

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
                + +D +SFG+L+ E+++G
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAG 197

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (368), Expect = 1e-39
 Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 42/298 (14%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISR------KNRIKEICNEMDIMSRAH 310
           F     +G GG+GE++       G+  A+K L   R      +         + ++S   
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 311 HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
              +V       T      + + +    L   L       E D +           GLE+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGLEH 122

Query: 371 LHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           +H      +V+RD+K +NILLD     +I+D GLA   S +K      A  GT GYMAPE
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPE 175

Query: 431 YIANGQ-LTEKVDIYSFGVLVLEIVSGVQ-------NNKFQSDDGFETLVTHTWKHFQAK 482
            +  G       D +S G ++ +++ G          +K + D    T+       F + 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF-SP 234

Query: 483 TVLEIIDK----------SIEIEDIEEVKR------VVWVGLLCTQELPTLRPSMTNV 524
            +  +++                  +EVK       + W  +   +  P L P    V
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEV 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (360), Expect = 3e-39
 Identities = 42/280 (15%), Positives = 99/280 (35%), Gaps = 28/280 (10%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCC 321
           ++G G +G IF+GT L + +++A+K  F  R++   ++ +E            +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 322 FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH 381
             +    V+   +   SL+ +L      ++   K   +        ++ +H+     +V+
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 124

Query: 382 RDIKASNILLDLKHRP-----KIADFGLARFSSSEKS-----LLPNTAIAGTLGYMAPEY 431
           RDIK  N L+   +        + DFG+ +F     +           ++GT  YM+   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 432 IANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS 491
               + + + D+ + G + +  + G    +           T+  K+ +     +     
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA------ATNKQKYERIGEKKQSTPLR 238

Query: 492 IEIEDI-EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ 530
                  EE  + +              P    +  +  +
Sbjct: 239 ELCAGFPEEFYKYM---HYARNLAFDATPDYDYLQGLFSK 275

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  141 bits (357), Expect = 7e-39
 Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 38/288 (13%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI---------KEICNEMDI 305
           + ++    LG G    + +       +E AVK + ++              +    E+DI
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 306 MSRAH-HKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGT 364
           + +   H N++Q      T    F+V++ ++   L   L    +K  L  K+   I+   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 365 AEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTL 424
            E +  LHK     IVHRD+K  NILLD     K+ DFG +      + L     + GT 
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTP 173

Query: 425 GYMAPEYIANGQL------TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH 478
            Y+APE I            ++VD++S GV++  +++G  +  F        L      +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--SPPFWHRKQMLMLRMIMSGN 231

Query: 479 FQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ 526
           +Q  +  E  D S  ++D+  V R            P  R +    + 
Sbjct: 232 YQFGS-PEWDDYSDTVKDL--VSR-------FLVVQPQKRYTAEEALA 269

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-38
 Identities = 59/295 (20%), Positives = 117/295 (39%), Gaps = 26/295 (8%)

Query: 262 NKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE-----ICNEMDIMSRAHHKNLV 315
           + LG G +  ++K       + +A+K++ +  ++  K+        E+ ++    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 316 QFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG 375
             L     K +  +V++F++      I         L        ++ T +GLEYLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQ-- 118

Query: 376 QMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANG 435
              I+HRD+K +N+LLD     K+ADFGLA+   S       T    T  Y APE +   
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175

Query: 436 QL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI 494
           ++    VD+++ G ++ E++  V       D   + L     + F+              
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVP--FLPGDSDLDQL----TRIFETLGTPTEEQWPDMC 229

Query: 495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECME 549
              + V    + G+            + +++Q L   +     P       + ++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN-----PCARITATQALK 279

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 4e-38
 Identities = 53/292 (18%), Positives = 108/292 (36%), Gaps = 15/292 (5%)

Query: 262 NKLGHGGYGEIFKGT-LQDGREIAVKRL-FISRKNRIKEICNEMDIMSRAHHKNLVQFLG 319
           + +G G YG +       +   +A+K++     +   +    E+ I+ R  H+N++    
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
                    +   ++    +   L+   + + L        +     GL+Y+H      +
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARF-SSSEKSLLPNTAIAGTLGYMAPEYIANGQL- 437
           +HRD+K SN+LL+     KI DFGLAR            T    T  Y APE + N +  
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 438 TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDI 497
           T+ +DI+S G ++ E++S      F      + L  H      + +  ++          
Sbjct: 191 TKSIDIWSVGCILAEMLSN--RPIFPGKHYLDQL-NHILGILGSPSQEDLNCIINLKARN 247

Query: 498 EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECME 549
             +       +   +  P       +++  +   +     P K    ++ + 
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN-----PHKRIEVEQALA 294

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-37
 Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 24/301 (7%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHK 312
           + F +  K+G G YG ++K      G  +A+K++ +  +          E+ ++   +H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 313 NLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLH 372
           N+V+ L    T+   ++V+EF+          D      +        +    +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 373 KDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE-Y 431
                +++HRD+K  N+L++ +   K+ADFGLAR           T    TL Y APE  
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 174

Query: 432 IANGQLTEKVDIYSFGVLVLEIVSGV-----QNNKFQSDDGFETLVTHTWKHFQAKTVLE 486
           +     +  VDI+S G +  E+V+        +   Q    F TL T     +   T + 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 487 IIDKSIEIEDIEEVKRVV------WVGLL--CTQELPTLRPSMTNVVQMLKQKDITLPTP 538
               S      ++  +VV         LL       P  R S    +     +D+T P P
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294

Query: 539 S 539
            
Sbjct: 295 H 295

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  137 bits (346), Expect = 3e-37
 Identities = 59/291 (20%), Positives = 117/291 (40%), Gaps = 21/291 (7%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLG 319
            K+G G YG ++K     G   A+K++ + +++         E+ I+    H N+V+   
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 320 CCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQI 379
              TKK   +V+E +       +      +  L+       ++    G+ Y H      +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---V 121

Query: 380 VHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN-GQLT 438
           +HRD+K  N+L++ +   KIADFGLAR          +  +  TL Y AP+ +    + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKYS 179

Query: 439 EKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIE 498
             +DI+S G +  E+V+G       S+      +        +K    + +      +  
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 499 EVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECME 549
             + + W        L  L  S  +++  + + D     P++     + +E
Sbjct: 240 VYEPLPW-----ESFLKGLDESGIDLLSKMLKLD-----PNQRITAKQALE 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 6e-37
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 22/217 (10%)

Query: 253 KATDCFDESNKLGHGGYGEIFKGT--LQDGREIAVKRLFIS------RKNRIKEICNEMD 304
           +A   ++   ++G G YG++FK       GR +A+KR+ +         + I+E+   + 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLR 62

Query: 305 IMSRAHHKNLVQFLGCCFTKKDS-----FVVYEFVQNKSLDRILFDPKQKKELDWKKRHV 359
            +    H N+V+    C   +        +V+E V          D   +  +  +    
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKD 120

Query: 360 IIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTA 419
           ++     GL++LH      +VHRD+K  NIL+    + K+ADFGLAR  S +      T+
Sbjct: 121 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTS 174

Query: 420 IAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG 456
           +  TL Y APE +        VD++S G +  E+   
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 7e-37
 Identities = 46/222 (20%), Positives = 91/222 (40%), Gaps = 19/222 (8%)

Query: 258 FDESNKLGHGGYGEIFKGTL-QDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQ 316
           + ++  +G+G +G +++  L   G  +A+K++   ++ + +E+     IM +  H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNIVR 77

Query: 317 FLGCCFTKKDS------FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEY 370
                ++  +        +V ++V            + K+ L      + +      L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 371 LHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAP 429
           +H      I HRDIK  N+LLD      K+ DFG A+     +     + I         
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPE 192

Query: 430 EYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
                   T  +D++S G ++ E++ G     F  D G + L
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQL 232

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 1e-36
 Identities = 73/312 (23%), Positives = 125/312 (40%), Gaps = 39/312 (12%)

Query: 246 FKYSTIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR------IKE 298
           F+   ++   D +D   +LG G +  + K      G + A K +   R          ++
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 299 ICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRH 358
           I  E+ I+    H N++        K D  ++ E V    L        +K+ L  ++  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD---FLAEKESLTEEEAT 116

Query: 359 VIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD----LKHRPKIADFGLARFSSSEKSL 414
             +     G+ YLH    +QI H D+K  NI+L      K R KI DFGLA         
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173

Query: 415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH 474
                I GT  ++APE +    L  + D++S GV+   ++SG   + F  D   ETL   
Sbjct: 174 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--ASPFLGDTKQETLANV 228

Query: 475 TWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQKD 532
           +  +++ +      + S   +D   ++R          + P  R ++ + +Q   +K KD
Sbjct: 229 SAVNYEFEDEY-FSNTSALAKDF--IRR-------LLVKDPKKRMTIQDSLQHPWIKPKD 278

Query: 533 I--TLPTPSKPP 542
               L +    P
Sbjct: 279 TQQALSSAWSHP 290

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-35
 Identities = 57/291 (19%), Positives = 107/291 (36%), Gaps = 46/291 (15%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKE------ICNEMDIMSRAH--HKN 313
            LG GG+G ++ G  + D   +A+K +   R +   E      +  E+ ++ +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 314 LVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
           +++ L          ++ E  +            ++  L  +          E + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 374 DGQMQIVHRDIKASNILLDL-KHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYI 432
            G   ++HRDIK  NIL+DL +   K+ DFG              T   GT  Y  PE+I
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181

Query: 433 ANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS 491
              +       ++S G+L+ ++V G  +  F+ D+                   EII   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE-------------------EIIRGQ 220

Query: 492 IEIEDI--EEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSK 540
           +        E + ++     C    P+ RP+   +      +D+ LP  + 
Sbjct: 221 VFFRQRVSSECQHLI---RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 268

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (328), Expect = 3e-34
 Identities = 57/263 (21%), Positives = 101/263 (38%), Gaps = 20/263 (7%)

Query: 225 KDDQGMEMDLSLLHKSLKFLQFKYSTIEKAT---DCFDESNKLGHGGYGEIFKGT-LQDG 280
           K     E     L K+ +    K+ T  + T   D FD    LG G +G +      + G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 281 REIAVKRL---FISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQNK 337
              A+K L    + +  +I+   NE  I+   +   LV+         + ++V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 338 SLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP 397
            +   L    +                    EYLH    + +++RD+K  N+L+D +   
Sbjct: 127 EMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180

Query: 398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV 457
           ++ DFG A+             + GT   +APE I +    + VD ++ GVL+ E+ +G 
Sbjct: 181 QVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG- 234

Query: 458 QNNKFQSDDGFETLVTHTWKHFQ 480
               F +D   +          +
Sbjct: 235 -YPPFFADQPIQIYEKIVSGKVR 256

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-34
 Identities = 59/273 (21%), Positives = 112/273 (41%), Gaps = 31/273 (11%)

Query: 264 LGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCC 321
           LG G  G++ +    +   + A+K L         +   E+++  RA    ++V+ +   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74

Query: 322 FT----KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQM 377
                 +K   +V E +    L   + D +  +    ++   I+    E ++YLH     
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131

Query: 378 QIVHRDIKASNILLDLKHRP---KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
            I HRD+K  N+L   K      K+ DFG A+ ++S  S    T    T  Y+APE +  
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGP 187

Query: 435 GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI 494
            +  +  D++S GV++  ++ G     F S+ G                + +    + E 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCG--YPPFYSNHGLAIS----PGMKTRIRMGQYEFPNPEW 241

Query: 495 EDI-EEVKRVVWVGLLCTQELPTLRPSMTNVVQ 526
            ++ EEVK ++       +  PT R ++T  + 
Sbjct: 242 SEVSEEVKMLI---RNLLKTEPTQRMTITEFMN 271

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-34
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 20/213 (9%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNL 314
           +++  K+G G +GE+FK    + G+++A+K++ +  +          E+ I+    H+N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 315 VQFLGCCFTKKDS--------FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
           V  +  C TK           ++V++F ++     +        +    +   ++     
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLN 128

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPN--TAIAGTL 424
           GL Y+H++    I+HRD+KA+N+L+      K+ADFGLAR  S  K+  PN  T    TL
Sbjct: 129 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 425 GYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSG 456
            Y  PE +   +     +D++  G ++ E+ + 
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-33
 Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 12/205 (5%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRL---FISRKNRIKEICNEMDIMSRAHH 311
           + FD    LG G +G++        GR  A+K L    I  K+ +     E  ++    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
             L        T      V E+     L   L    +++    ++           LEYL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEY 431
           H      +V+RDIK  N++LD     KI DFGL +   S+ + +      GT  Y+APE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176

Query: 432 IANGQLTEKVDIYSFGVLVLEIVSG 456
           + +      VD +  GV++ E++ G
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCG 201

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 6e-33
 Identities = 58/296 (19%), Positives = 118/296 (39%), Gaps = 21/296 (7%)

Query: 258 FDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNL 314
           +++  K+G G YG +FK    +    +A+KR+ +   +         E+ ++    HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 315 VQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD 374
           V+      + K   +V+EF          +      +LD +     +    +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118

Query: 375 GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIAN 434
               ++HRD+K  N+L++     K+A+FGLAR           +A   TL Y  P+ +  
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFG 175

Query: 435 GQ-LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE 493
            +  +  +D++S G +  E+ +      F  +D  + L              E      +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANA-GRPLFPGNDVDDQL--KRIFRLLGTPTEEQWPSMTK 232

Query: 494 IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPFTDECME 549
           + D +          L    +P L  +  +++Q L + +     P +    +E ++
Sbjct: 233 LPDYKPYPMYPATTSL-VNVVPKLNATGRDLLQNLLKCN-----PVQRISAEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 4e-31
 Identities = 65/326 (19%), Positives = 125/326 (38%), Gaps = 30/326 (9%)

Query: 250 TIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIM 306
           T  +    + +   +G G YG +      + G ++A+K+L+   ++    K    E+ ++
Sbjct: 12  TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71

Query: 307 SRAHHKNLVQFLGCCFTKKDSFVVYEF-VQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
               H+N++  L      +      +F +    +   L    + ++L   +   ++    
Sbjct: 72  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 131

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
           +GL Y+H  G +   HRD+K  N+ ++     KI DFGLAR + SE      T    T  
Sbjct: 132 KGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRW 183

Query: 426 YMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSGV-----QNNKFQSDDGFETLVT---HTW 476
           Y APE I N    T+ VDI+S G ++ E+++G       ++  Q  +  +   T      
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243

Query: 477 KHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQEL-------PTLRPSMTNVVQM-- 527
           +  Q+      +    E+E  +    +     L    L          R +    +    
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303

Query: 528 LKQKDITLPTPSKPPFTDECMELSHT 553
            +    T   P    + D   ++  T
Sbjct: 304 FESLHDTEDEPQVQKYDDSFDDVDRT 329

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (300), Expect = 1e-30
 Identities = 61/306 (19%), Positives = 121/306 (39%), Gaps = 34/306 (11%)

Query: 256 DCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSR-AHHKN 313
           D +    KLG G Y E+F+   + +  ++ VK L   +  + K+I  E+ I+       N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPN 91

Query: 314 LVQFLGCC--FTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
           ++           +   +V+E V N    ++       + L        +    + L+Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRP-KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPE 430
           H  G   I+HRD+K  N+++D +HR  ++ D+GLA F    +          +  +  PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPE 199

Query: 431 YIANGQL-TEKVDIYSFGVLVLEIVSGVQ------NNKFQSDDGFETLVTHTWKHFQAKT 483
            + + Q+    +D++S G ++  ++   +      +N  Q     + L T     +  K 
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259

Query: 484 VLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLPTPSKPPF 543
            +E+  +  +I      KR  W   + ++    + P   + +  L + D           
Sbjct: 260 NIELDPRFNDILGRHSRKR--WERFVHSENQHLVSPEALDFLDKLLRYD-----HQSRLT 312

Query: 544 TDECME 549
             E ME
Sbjct: 313 AREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-27
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 21/203 (10%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNR--IKEICNEMDIMSRAHHKNLVQFLG 319
            +G G  G +         R +A+K+L    +N+   K    E+ +M   +HKN++  L 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 320 CCFTKK------DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK 373
               +K      D ++V E +       I      + ELD ++   ++     G+++LH 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH- 136

Query: 374 DGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIA 433
                I+HRD+K SNI++      KI DFGLAR + +   +   T    T  Y APE I 
Sbjct: 137 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVIL 191

Query: 434 NGQLTEKVDIYSFGVLVLEIVSG 456
                E VDI+S G ++ E+V  
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRH 214

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-27
 Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 15/227 (6%)

Query: 250 TIEKATDCFDESNKLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRI--KEICNEMDIM 306
           TI +  + +   + +G G YG +      + G  +AVK+L    ++ I  K    E+ ++
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71

Query: 307 SRAHHKNLVQFLGCCFTKKDSF-VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTA 365
               H+N++  L      +        ++    +   L +  + ++L       +I    
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131

Query: 366 EGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLG 425
            GL+Y+H    +   HRD+K SN+ ++     KI DFGLAR +         T    T  
Sbjct: 132 RGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 183

Query: 426 YMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETL 471
           Y APE + N     + VDI+S G ++ E+++G     F   D  + L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG--RTLFPGTDHIDQL 228

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 2e-26
 Identities = 68/315 (21%), Positives = 126/315 (40%), Gaps = 43/315 (13%)

Query: 256 DCFDESNKLGHGGYGEIFKGTL----QDGREIAVKRL----FISRKNRIKEICNEMDIMS 307
           + F+    LG G YG++F          G+  A+K L     + +    +    E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 308 RA-HHKNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAE 366
                  LV       T+    ++ +++    L   L    Q++     +  + +     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVL 140

Query: 367 GLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGY 426
            LE+LHK G   I++RDIK  NILLD      + DFGL++   ++++        GT+ Y
Sbjct: 141 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEY 196

Query: 427 MAPEYIANGQ--LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV 484
           MAP+ +  G     + VD +S GVL+ E+++G   + F  D    +    + +  +++  
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG--ASPFTVDGEKNSQAEISRRILKSEPP 254

Query: 485 LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSM-TNVVQMLKQ----KDI------ 533
               + S   +D+  ++R          + P  R          +K+    + I      
Sbjct: 255 YP-QEMSALAKDL--IQR-------LLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA 304

Query: 534 --TLPTPSKPPFTDE 546
              +P P KP   DE
Sbjct: 305 AKKVPAPFKPVIRDE 319

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (252), Expect = 5e-24
 Identities = 42/223 (18%), Positives = 90/223 (40%), Gaps = 20/223 (8%)

Query: 263 KLGHGGYGEIFKGT-LQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHH---------- 311
           KLG G +  ++    + +   +A+K +   +    +   +E+ ++ R +           
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 312 -KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHV--IIIGTAEGL 368
             ++++ L     K  + V    V     + +L   K+ +       +V  I      GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 369 EYLHKDGQMQIVHRDIKASNILLDLK-HRPKIADFGLARFSSSEKSLLPNTAIAGTLGYM 427
           +Y+H+  +  I+H DIK  N+L+++      +    +A   ++       T    T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 428 APEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET 470
           +PE +         DI+S   L+ E+++G  +  F+ D+G   
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITG--DFLFEPDEGHSY 237

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.8 bits (214), Expect = 2e-20
 Identities = 31/202 (15%), Positives = 59/202 (29%), Gaps = 27/202 (13%)

Query: 262 NKLGHGGYGEIFKGTLQDGREIAVKRLFIS----------RKNRIKEICNEMDIMSRAHH 311
             +G G    +F    +   E  VK   +           R              +R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 312 KNLVQFLGCCFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYL 371
           + L +  G    K      Y +  N  L  ++   +  +         ++    E +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE-VLDMILEEVAKF 119

Query: 372 HKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL-LPNTAIAGTLGYMAPE 430
           +      IVH D+   N+L+  +    I DF  +     E    +    +   + Y +  
Sbjct: 120 Y---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175

Query: 431 YIANGQLTEKVDIYSFGVLVLE 452
           Y        + DI S    +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	569
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.62
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.07
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.73
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.27
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.75
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.12

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=410.49  Aligned_cols=253  Identities=25%  Similarity=0.330  Sum_probs=205.4

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .++|++.++||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            467999999999999999999976 78999999986543 2334678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||+++++++||+|||+++......
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999983   4567999999999999999999999998   9999999999999999999999999999776544


Q ss_pred             CCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .........||+.|||||++.+..+ +.++|||||||++|||++|++||...........      ...        ...
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------~~~--------~~~  223 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------DWK--------EKK  223 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH------HHH--------TTC
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH------HHh--------cCC
Confidence            3334456789999999999988776 5789999999999999999999865433221100      000        000


Q ss_pred             CCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          492 IEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       492 l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .... .......+.+++.+||+.||++|||++|++++
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000 11223456678899999999999999999753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=410.46  Aligned_cols=253  Identities=23%  Similarity=0.397  Sum_probs=198.0

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|++.++||+|+||.||+|++++++.||||++.... ...++|.+|++++++++|||||++++++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4688899999999999999999888899999987543 334679999999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||+++++++||+|||+++........ 
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            9999999853  3466899999999999999999999998   999999999999999999999999999877654332 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQN-NKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......||+.|+|||++.++.++.++|||||||++|||+|+..| +.......   +..             .+......
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~-------------~i~~~~~~  221 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE-------------DISTGFRL  221 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHH-------------HHHHTCCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHH-------------HHHhcCCC
Confidence            23356789999999999999999999999999999999996544 33222111   111             11111111


Q ss_pred             -CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          495 -EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       495 -~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                       .+......+.+++..||+.||++|||++||+++|++.
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             1122335677899999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=411.44  Aligned_cols=264  Identities=23%  Similarity=0.402  Sum_probs=204.4

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .++|++.++||+|+||.||+|+++  ..||||++...  .....+.|.+|+.+|++++|||||++++++. .+..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            367889999999999999999875  36999998654  3456678999999999999999999999875 456899999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+++|+|.+++..  .+..+++..++.++.||++||.|||+++   ||||||||+||||+.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999953  3456999999999999999999999998   9999999999999999999999999998776544


Q ss_pred             CCCCCcccccCCCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          413 SLLPNTAIAGTLGYMAPEYIAN---GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      .........||+.|||||++.+   +.++.++|||||||+||||+||+.||........  +............      
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~p~------  230 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVGRGYLSPD------  230 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHHTSCCCC------
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHHhcCCCCCc------
Confidence            4334456789999999999864   3589999999999999999999999864433211  1111111111111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLP  536 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  536 (569)
                        +..........+.+++.+||+.+|++|||+.||+++|+.....+|
T Consensus       231 --~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         231 --LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             --GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence              111112233567788999999999999999999999987654443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-52  Score=408.79  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=206.1

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      .++|++.++||+|+||.||+|++++++.||||++.... ...+.|.+|+++|++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            35788899999999999999999888999999986543 334679999999999999999999998754 5679999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++|+|.+++.. .....+++..++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+++........
T Consensus        90 ~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99999998743 23345899999999999999999999998   999999999999999999999999999987654432


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       ......||+.|||||++.++.++.++|||||||++|||+||..|+.......  .+.             ..+......
T Consensus       166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~-------------~~i~~~~~~  229 (272)
T d1qpca_         166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVI-------------QNLERGYRM  229 (272)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH-------------HHHHTTCCC
T ss_pred             -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHH-------------HHHHhcCCC
Confidence             3345678999999999999999999999999999999999766543222111  111             111111111


Q ss_pred             C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          495 E-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       495 ~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      . +......+.+++.+||+.+|++|||++||+++|++
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            1 22233467788999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=407.61  Aligned_cols=250  Identities=23%  Similarity=0.377  Sum_probs=208.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      ++|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999975 79999999998766566678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++|+|.+++.    +..+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++.+..... 
T Consensus       100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            9999999874    246899999999999999999999999   99999999999999999999999999987755432 


Q ss_pred             CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          415 LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                       ......||+.|+|||++.++.++.++|||||||++|||++|+.||........  + ......   .      ...+. 
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~-~~~~~~---~------~~~~~-  237 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L-YLIATN---G------TPELQ-  237 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H-HHHHHH---C------SCCCS-
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--H-HHHHhC---C------CCCCC-
Confidence             23466799999999999999999999999999999999999999864332111  1 000000   0      00000 


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+......+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112233567788999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-52  Score=412.31  Aligned_cols=256  Identities=28%  Similarity=0.415  Sum_probs=211.1

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|++.++||+|+||.||+|+++ +|+.||||++.... ...++|.+|+.+|++++|||||++++++.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467888999999999999999986 68899999886543 3457899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++|+|.+++.. .....+++..++.++.||++||.|||+++   |+||||||+||||++++++||+|||+++.......
T Consensus        95 ~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            999999999854 33467899999999999999999999998   99999999999999999999999999987665432


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIE  493 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  493 (569)
                      . ......|++.|+|||++.++.++.++|||||||++|||++|..|+.......  .             +.+.+.....
T Consensus       171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~-------------~~~~i~~~~~  234 (287)
T d1opja_         171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q-------------VYELLEKDYR  234 (287)
T ss_dssp             E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H-------------HHHHHHTTCC
T ss_pred             e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--H-------------HHHHHhcCCC
Confidence            2 2334568899999999999999999999999999999999877654322211  1             1111111111


Q ss_pred             CC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          494 IE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       494 ~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .. +......+.+++..||+.||++|||+.||++.|+..
T Consensus       235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11 222345678899999999999999999999999764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=402.44  Aligned_cols=245  Identities=25%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++....   ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999986 68999999986532   334567899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999994   3456899999999999999999999998   999999999999999999999999999866543


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                          ......||+.|||||++.+..++.++|||||||+||||++|+.||........   ....            ....
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i------------~~~~  220 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRI------------SRVE  220 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH------------HTTC
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH---HHHH------------HcCC
Confidence                23456799999999999999999999999999999999999999864332211   1100            0000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQ  526 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  526 (569)
                      .. .+......+.+++.+||+.||++|||+.||++
T Consensus       221 ~~-~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 FT-FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC-CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            00 01122345677889999999999999999996

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=398.17  Aligned_cols=252  Identities=22%  Similarity=0.372  Sum_probs=212.0

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|++.++||+|+||.||+|+++++++||||++..... ..+.|.+|+.++++++|||||++++++.+....++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57899999999999999999999888999999876543 34689999999999999999999999999999999999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +|+|..++..  ....+++..+++++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++........ 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999999743  4567899999999999999999999998   999999999999999999999999999877655433 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||...........                +......
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~----------------i~~~~~~  220 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----------------IAQGLRL  220 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----------------HHTTCCC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH----------------HHhCCCC
Confidence            3345679999999999999999999999999999999998 7888765443221111                1111111


Q ss_pred             -CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          495 -EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       495 -~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                       .+......+.+++.+||+.+|++|||+.||+++|.+
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             112233567789999999999999999999999865

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=405.37  Aligned_cols=255  Identities=22%  Similarity=0.330  Sum_probs=194.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeee--CCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT--KKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  330 (569)
                      ++|++.+.||+|+||.||+|+.+ +|+.||||++....  ....+.+.+|+++|++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999976 78999999986543  3445678999999999999999999999865  4568999


Q ss_pred             EeecCCCChhhHhhCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          331 YEFVQNKSLDRILFDP-KQKKELDWKKRHVIIIGTAEGLEYLHKDG--QMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      |||+++|+|.+++... ..+..+++..++.++.||+.||.|||+++  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998532 23457999999999999999999999875  23599999999999999999999999999987


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ......  ......||+.|||||++.+..++.++|||||||++|||++|++||........   ..    ..        
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~~----~i--------  226 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG----KI--------  226 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH----HH--------
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---HH----HH--------
Confidence            765432  23457899999999999999999999999999999999999999864332211   11    00        


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ........+......+.+++.+||+.||++|||+.||+++
T Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0111111112233467788899999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-51  Score=406.71  Aligned_cols=255  Identities=25%  Similarity=0.430  Sum_probs=195.9

Q ss_pred             ccccccccccccCceeEEEEEec-CCc---eEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGR---EIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|++.++||+|+||.||+|+++ +++   .||||.+... .....+.|.+|+++|++++|||||++++++...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            46777899999999999999975 332   5888887653 344557899999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++|+|.+++..  ....+++.+++.++.||++||.|||+++   |+||||||+||||+.++++||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998853  3456899999999999999999999998   99999999999999999999999999987765


Q ss_pred             CCCCC---CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          411 EKSLL---PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       411 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      .....   ......||+.|||||.+.++.++.++|||||||+||||+| |++|+........   .             .
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~-------------~  244 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---I-------------N  244 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-------------H
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---H-------------H
Confidence            43321   1223467899999999999999999999999999999998 8888764332211   1             1


Q ss_pred             hhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          487 IIDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       487 ~~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .+...... .+.+....+.+++.+||+.+|++|||+.||++.|++.
T Consensus       245 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         245 AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11111111 1233445677899999999999999999999998753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=403.38  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=203.7

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecC
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQ  335 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  335 (569)
                      ++|++.++||+|+||.||+|++++++.||||++.... ...+.|.+|+.+|++++|||||++++++. .+..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            5799999999999999999999988899999986543 33477999999999999999999999985 456899999999


Q ss_pred             CCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCCC
Q 037160          336 NKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSLL  415 (569)
Q Consensus       336 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  415 (569)
                      +|+|..++.. .....++|..++.++.||+.||+|||+.+   |+||||||+||||+.++++||+|||+++........ 
T Consensus        95 ~g~l~~~~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-  169 (285)
T d1fmka3          95 KGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  169 (285)
T ss_dssp             TCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhh-cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence            9999988843 22346899999999999999999999998   999999999999999999999999999876554332 


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC-
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI-  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-  494 (569)
                      ......||+.|+|||++..+.++.++||||||+++|||++|..|+.......  .++             ..+...... 
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~-------------~~i~~~~~~~  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVL-------------DQVERGYRMP  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH-------------HHHHTTCCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHH-------------HHHHhcCCCC
Confidence            3345678999999999999999999999999999999999776654332211  111             111111111 


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 037160          495 EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDITLP  536 (569)
Q Consensus       495 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  536 (569)
                      ........+.+++.+||+.||++|||+++|+++|++.-....
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            122334567789999999999999999999999988654443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=413.06  Aligned_cols=264  Identities=22%  Similarity=0.335  Sum_probs=207.2

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ..++|++.++||+|+||.||+|++. +|+.||+|++.... ......+.+|+.+|++++|||||++++++.+....++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4678999999999999999999976 78999999987643 344567899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      ||+++|+|.+++.   +...+++..+..++.|++.||.|||++ +   |+||||||+||||+.++++||+|||+|+....
T Consensus        84 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999999994   345689999999999999999999974 7   99999999999999999999999999986644


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh--------------
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW--------------  476 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------------  476 (569)
                      .    ......||+.|+|||++.+.+++.++|||||||++|||++|+.||................              
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            2    2345689999999999999999999999999999999999999997654332111100000              


Q ss_pred             ---------hhhcccchhhhhcccCC---C--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 ---------KHFQAKTVLEIIDKSIE---I--EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 ---------~~~~~~~~~~~~~~~l~---~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                               .........+..+....   .  ........+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                     00000000111110000   0  011123567789999999999999999999974

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=404.59  Aligned_cols=252  Identities=22%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeec
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFV  334 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  334 (569)
                      +.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56899999999999999999976 78999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++|+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++....... 
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            99999998743  2356999999999999999999999999   99999999999999999999999999976543211 


Q ss_pred             CCCcccccCCCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          415 LPNTAIAGTLGYMAPEYIA-----NGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       415 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                       ......||+.|+|||++.     +..++.++|||||||++|||++|+.||........   .......    .     .
T Consensus       166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~~~----~-----~  232 (288)
T d2jfla1         166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIAKS----E-----P  232 (288)
T ss_dssp             -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHHS----C-----C
T ss_pred             -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHHHcC----C-----C
Confidence             123567999999999984     45689999999999999999999999865433221   1100000    0     0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +.+ ..+......+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         233 PTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             CCC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000 0112234567788999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-51  Score=402.32  Aligned_cols=248  Identities=22%  Similarity=0.316  Sum_probs=202.8

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.+.||+|+||.||+|+++ +|+.||||++....   ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 78999999986532   344577999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++.   ..+.+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999884   4467999999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..    .        +....
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~----~--------i~~~~  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQ----K--------IIKLE  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----H--------HHTTC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---HH----H--------HHcCC
Confidence            433344466899999999999999999999999999999999999999875432211   10    0        01111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVV  525 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl  525 (569)
                      ... +......+.+++.+||+.||++|||++|++
T Consensus       227 ~~~-p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 YDF-PEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CCC-CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CCC-CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            110 112234577889999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=399.56  Aligned_cols=256  Identities=23%  Similarity=0.445  Sum_probs=199.6

Q ss_pred             ccccccccccccCceeEEEEEecCC-----ceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDG-----REIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      +.|++.++||+|+||.||+|.++..     ..||||++.... ......|.+|+.+|++++|||||++++++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688889999999999999997632     369999986543 3345679999999999999999999999999999999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+.++++.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999988743  3457999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ...... ......||+.|||||++.++.++.++|||||||++|||++|..|+.......  .+             .+.+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~-------------~~~i  226 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EV-------------MKAI  226 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH-------------HHHH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HH-------------HHHH
Confidence            543221 2234568999999999999999999999999999999999766654332211  11             1111


Q ss_pred             cccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          489 DKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       489 ~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ....... +......+.+++.+||+.+|++|||+.||+++|+..
T Consensus       227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence            1111111 223445678899999999999999999999999753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=408.57  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=206.4

Q ss_pred             hccccccccccccCceeEEEEEecC-C-----ceEEEEEEeec-chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQD-G-----REIAVKRLFIS-RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  326 (569)
                      .++|++.++||+|+||.||+|++.. +     ..||+|.+... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3679999999999999999998753 2     36899988653 233446789999999998 89999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCC--------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQ--------------------KKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKA  386 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp  386 (569)
                      .++||||+++|+|.++|.....                    ...+++..++.++.||+.||.|||+++   ||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999964332                    245899999999999999999999998   99999999


Q ss_pred             CCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 037160          387 SNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSD  465 (569)
Q Consensus       387 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~  465 (569)
                      +|||++.++++||+|||+++...............||+.|||||++.++.++.++|||||||+||||++ |++||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987665544323345678999999999999999999999999999999998 8998864433


Q ss_pred             cchhhhhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 037160          466 DGFETLVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLK  529 (569)
Q Consensus       466 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  529 (569)
                      ...  +             .+++....... +......+.+++.+||+.+|++|||++||+++|.
T Consensus       273 ~~~--~-------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DAN--F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHH--H-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH--H-------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            211  1             11111111111 2223356778999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=398.27  Aligned_cols=254  Identities=25%  Similarity=0.387  Sum_probs=205.9

Q ss_pred             ccccccc-cccccCceeEEEEEec---CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESN-KLGHGGYGEIFKGTLQ---DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|.+.+ +||+|+||.||+|.++   ++..||||++... .....+.|.+|+++|++++|||||++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999864   3557999998654 34456789999999999999999999999864 568999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++|+|.+++.  ..+..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        87 mE~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999884  33467999999999999999999999998   99999999999999999999999999997765


Q ss_pred             CCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          411 EKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       411 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      .... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||..........                .+
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----------------~i  225 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----------------FI  225 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----------------HH
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH----------------HH
Confidence            4432 12335568999999999999999999999999999999998 899986543322111                11


Q ss_pred             cccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          489 DKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       489 ~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ....... +......+.+++.+||+.+|++|||+.+|++.|+..
T Consensus       226 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1111111 223345677899999999999999999999998753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-50  Score=392.72  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=196.5

Q ss_pred             ccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeee----CCceEEE
Q 037160          258 FDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT----KKDSFVV  330 (569)
Q Consensus       258 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  330 (569)
                      |++.++||+|+||.||+|+++ +++.||+|++...  .....+.+.+|+++|++++|||||++++++..    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            356678999999999999976 6889999998654  33445679999999999999999999999875    3457999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC-CCCCeEEeccCCCcccC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD-LKHRPKIADFGLARFSS  409 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~~kl~Dfgla~~~~  409 (569)
                      |||+++|+|.+++.   ....+++..++.++.||+.||.|||+++ .+|+||||||+|||++ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999994   3457899999999999999999999875 4599999999999996 57899999999998654


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhc
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIID  489 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  489 (569)
                      ..    ......||+.|||||++.+ +++.++|||||||++|||++|+.||.......  .+.    .....+.....++
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~----~~i~~~~~~~~~~  235 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY----RRVTSGVKPASFD  235 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH----HHHTTTCCCGGGG
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHH----HHHHcCCCCcccC
Confidence            32    2345689999999999865 69999999999999999999999986432211  111    1111110000011


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          490 KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       490 ~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                             ......+.+++.+||+.||++|||+.|++++
T Consensus       236 -------~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         236 -------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                   1122346778899999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-50  Score=404.29  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=191.9

Q ss_pred             HHhccccccccccccCceeEEEEEec-CCceEEEEEEeecch-hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEE
Q 037160          253 KATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK-NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       253 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      .+.+.|++.++||+|+||.||+|+++ +|+.||||++..... .....+.+|+.+|++++|||||++++++.+++..++|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45677999999999999999999976 689999999875432 2345688999999999999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC---CCCCeEEeccCCCcc
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD---LKHRPKIADFGLARF  407 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~---~~~~~kl~Dfgla~~  407 (569)
                      |||++||+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||+.   +++.+||+|||+++.
T Consensus        86 mE~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          86 MQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             ECCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EeccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999994   3467999999999999999999999998   99999999999994   578999999999987


Q ss_pred             cCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          408 SSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       408 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      .....   ......||+.|||||++.+..++.++|||||||++|||++|+.||.........   .....    ..    
T Consensus       160 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i~~----~~----  225 (307)
T d1a06a_         160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQILK----AE----  225 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHT----TC----
T ss_pred             ccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHhc----cC----
Confidence            65433   234567999999999999999999999999999999999999998643322111   10000    00    


Q ss_pred             hcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        ..... ........+.+++.+||+.||++|||+.|++++
T Consensus       226 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 --YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             --CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              00000 112234567889999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-49  Score=402.98  Aligned_cols=252  Identities=20%  Similarity=0.284  Sum_probs=208.9

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      -++|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999975 7899999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC--CCCeEEeccCCCcccCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL--KHRPKIADFGLARFSSSE  411 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~--~~~~kl~Dfgla~~~~~~  411 (569)
                      +++|+|.+++..  ....+++..+..++.||+.||.|||+++   ||||||||+|||++.  ++.+||+|||+++.....
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999843  3456999999999999999999999999   999999999999964  678999999999877654


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .   ......||+.|||||++.+..++.++|||||||++|||++|+.||........   ......    ..      ..
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~----~~------~~  243 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKS----CD------WN  243 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----TC------CC
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHh----CC------CC
Confidence            3   23467899999999999999999999999999999999999999864432211   110000    00      00


Q ss_pred             CCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          492 IEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       492 l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .... .......+.+++.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 11223467788999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=396.90  Aligned_cols=246  Identities=26%  Similarity=0.381  Sum_probs=197.0

Q ss_pred             ccccccCceeEEEEEec---CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEeecCC
Q 037160          262 NKLGHGGYGEIFKGTLQ---DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEFVQN  336 (569)
Q Consensus       262 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  336 (569)
                      ++||+|+||.||+|.++   .++.||||++...  +....+.+.+|+++|++++|||||++++++.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999865   3468999998643  23345679999999999999999999999864 567899999999


Q ss_pred             CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC-C
Q 037160          337 KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL-L  415 (569)
Q Consensus       337 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  415 (569)
                      |+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++........ .
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999984   3456999999999999999999999998   999999999999999999999999999876554332 1


Q ss_pred             CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccCCC
Q 037160          416 PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEI  494 (569)
Q Consensus       416 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  494 (569)
                      ......||+.|||||.+.++.++.++|||||||++|||++ |+.||........                ...+......
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~----------------~~~i~~~~~~  229 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----------------TAMLEKGERM  229 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------HHHHHTTCCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH----------------HHHHHcCCCC
Confidence            2235678999999999999999999999999999999998 8999864332211                1111111111


Q ss_pred             C-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          495 E-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       495 ~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      . +......+.+++.+||+.+|++|||+++|++.|+.
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            1 22234567789999999999999999999988865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=394.33  Aligned_cols=250  Identities=24%  Similarity=0.293  Sum_probs=206.5

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc------hhhHHHHHHHHHHHHhccccccceeeeeeeeCCc
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR------KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  326 (569)
                      +.++|++.++||+|+||.||+|+++ +|+.||||++....      ....+.+.+|+.+|++++|||||++++++.+...
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4578999999999999999999975 78999999986532      1235789999999999999999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC----CeEEecc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH----RPKIADF  402 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~----~~kl~Df  402 (569)
                      .++||||+++|+|.+++.   ..+.+++..++.++.|++.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        88 ~~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          88 VILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence            999999999999999994   3457999999999999999999999999   99999999999998777    4999999


Q ss_pred             CCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          403 GLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       403 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      |+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..    .    
T Consensus       162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~----~----  227 (293)
T d1jksa_         162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA----N----  227 (293)
T ss_dssp             TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----H----
T ss_pred             hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---HH----H----
Confidence            9998775543   23456789999999999999999999999999999999999999864432211   00    0    


Q ss_pred             chhhhhcccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLEIIDKSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                          +........   .......+.+++.+||+.||++|||+.|++++
T Consensus       228 ----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         228 ----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ----HHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----HHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000000000   01123457788999999999999999999974

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3e-49  Score=402.22  Aligned_cols=256  Identities=22%  Similarity=0.274  Sum_probs=210.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.++...++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999975 7999999999876655667889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEEC--CCCCeEEeccCCCcccCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLD--LKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~--~~~~~kl~Dfgla~~~~~~  411 (569)
                      +++|+|.+++.  .....+++.+++.++.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+++.....
T Consensus       108 ~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99999988773  23456999999999999999999999999   99999999999998  6789999999999887654


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   +.....    .      ...
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~----~------~~~  246 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKR----C------DWE  246 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHH----C------CCC
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----C------CCC
Confidence            3   33456799999999999999999999999999999999999999864332211   110000    0      000


Q ss_pred             CCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hccC
Q 037160          492 IEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQK  531 (569)
Q Consensus       492 l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~  531 (569)
                      .... .......+.+++.+||+.||.+|||+.|++++  ++..
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            0000 12234567788999999999999999999975  5443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-50  Score=399.36  Aligned_cols=245  Identities=25%  Similarity=0.436  Sum_probs=201.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      +.|+..++||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999999975 78899999987543   344567899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+.+|+|..++.   .+..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            9999999987763   3467999999999999999999999999   999999999999999999999999999865432


Q ss_pred             CCCCCCcccccCCCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIAN---GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                            ....||+.|||||++.+   +.++.++|||||||++|||++|+.||.......   .+.            .+.
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~---~~~------------~i~  227 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALY------------HIA  227 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH------------HHH
T ss_pred             ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH---HHH------------HHH
Confidence                  34579999999999864   468999999999999999999999986432211   000            011


Q ss_pred             cccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 DKSIE-IEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~~~l~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..... .........+.+++.+||+.||++|||+.|++++
T Consensus       228 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            11000 0111223467788899999999999999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-50  Score=399.63  Aligned_cols=265  Identities=24%  Similarity=0.336  Sum_probs=211.8

Q ss_pred             HHHHHhccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeee
Q 037160          250 TIEKATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCF  322 (569)
Q Consensus       250 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  322 (569)
                      .+|.-.++|++.++||+|+||.||+|+++      +++.||||++.... ....+.|.+|+++|++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999864      35789999986543 334567999999999999999999999999


Q ss_pred             eCCceEEEEeecCCCChhhHhhCCC---------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 037160          323 TKKDSFVVYEFVQNKSLDRILFDPK---------------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVH  381 (569)
Q Consensus       323 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  381 (569)
                      .....+++|||+++|+|.+++....                     ....+++..++.++.|++.||+|||+++   |||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence            9999999999999999999985322                     2335889999999999999999999998   999


Q ss_pred             CCCCCCCeEECCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCC-CC
Q 037160          382 RDIKASNILLDLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQ-NN  460 (569)
Q Consensus       382 rDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~-p~  460 (569)
                      |||||+||||+.++++||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|.. |+
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999987665544434456778999999999999999999999999999999999964 55


Q ss_pred             CCCCCcchhhhhHhHhhhhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          461 KFQSDDGFETLVTHTWKHFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       461 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                      ........   ...            +.+......+......+.+++.+||+.+|++||||.||+++|++..
T Consensus       244 ~~~~~~e~---~~~------------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEEV---IYY------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHHH---HHH------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHHH---HHH------------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            43322211   111            0111111112223356788999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-48  Score=391.92  Aligned_cols=245  Identities=22%  Similarity=0.328  Sum_probs=205.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|+++ +|+.||||++...   .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975 7899999998653   2344678999999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||++||+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.+|.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999883   4556788899999999999999999998   999999999999999999999999999876542


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||........   ..            .+....
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~------------~i~~~~  217 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YE------------KILNAE  217 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH------------HHHHCC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH---HH------------HHHcCC
Confidence                 3456899999999999999999999999999999999999999864332211   00            011111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                      .. .+......+.+++.+||+.||++||     |++|++++
T Consensus       218 ~~-~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 LR-FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CC-CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC-CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            11 1122234577888999999999996     99999865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=393.55  Aligned_cols=248  Identities=23%  Similarity=0.299  Sum_probs=206.9

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|+.+ +|+.||||++...   .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            67999999999999999999975 7999999999754   2344677899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++.....
T Consensus        85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999984   3457899999999999999999999999   999999999999999999999999999866543


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|++||........   ...            +....
T Consensus       159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~------------i~~~~  221 (337)
T d1o6la_         159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FEL------------ILMEE  221 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH------------HHHCC
T ss_pred             Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---HHH------------HhcCC
Confidence            22  23467899999999999999999999999999999999999999875443221   110            00011


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~  527 (569)
                      +. .+......+.+++..||+.||++||+     +.|++++
T Consensus       222 ~~-~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 IR-FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CC-CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC-CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            11 01123345677889999999999995     8888864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=393.65  Aligned_cols=254  Identities=23%  Similarity=0.373  Sum_probs=200.7

Q ss_pred             ccccccccccccCceeEEEEEec-CCc----eEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGR----EIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      ++|++.++||+|+||.||+|.+. +|+    +||+|++... .....+.+.+|+.+|++++|||||++++++.+ +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            46999999999999999999875 444    5888888643 34456789999999999999999999999976 45778


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ++||+.+++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999888743  4567899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ............||+.|+|||++.++.++.++|||||||+||||+| |.+|+.........                ..+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~----------------~~i  226 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------------SIL  226 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH----------------HHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH----------------HHH
Confidence            6554433445678999999999999999999999999999999998 67777544332221                111


Q ss_pred             cccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          489 DKSIEI-EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       489 ~~~l~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ...... .+......+.+++.+||+.+|++|||+.||+++|+..
T Consensus       227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            111111 1223345677899999999999999999999988653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=387.78  Aligned_cols=259  Identities=27%  Similarity=0.381  Sum_probs=197.8

Q ss_pred             HhccccccccccccCceeEEEEEec------CCceEEEEEEeec-chhhHHHHHHHHHHHHhc-cccccceeeeeeeeC-
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFIS-RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK-  324 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-  324 (569)
                      -.++|++.++||+|+||.||+|++.      +++.||||++... .....+.+.+|..++.++ +|+|||++++++.+. 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3478999999999999999999864      2468999998653 334456788888888887 689999999998664 


Q ss_pred             CceEEEEeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                      ...++||||+++|+|.+++....             ....+++..++.++.||++||.|||+++   ||||||||+||||
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence            46899999999999999995322             2345899999999999999999999998   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQ-NNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~-p~~~~~~~~~~~  470 (569)
                      ++++++||+|||+++...............||+.|+|||++.++.++.++|||||||++|||++|.. |+.......  .
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~  245 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E  245 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--H
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--H
Confidence            9999999999999987665554434456789999999999999999999999999999999999754 554332211  1


Q ss_pred             hhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                      +.             ..+....... +......+.+++.+||+.||++|||+.||+++|++
T Consensus       246 ~~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         246 FC-------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             HH-------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH-------------HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            11             1111111111 12233467789999999999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-49  Score=382.93  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=195.8

Q ss_pred             hccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeee-CCceEEEEee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFT-KKDSFVVYEF  333 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  333 (569)
                      .++|++.++||+|+||.||+|+++ |+.||||++...  ...+.+.+|++++++++|||||++++++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            356888999999999999999986 789999998654  344679999999999999999999999865 4568999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence            9999999999532 2345899999999999999999999998   999999999999999999999999999865442  


Q ss_pred             CCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          414 LLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                         .....+|..|+|||++.++.+++++||||||+++|||+| |++|+......+..                ..+....
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~----------------~~i~~~~  217 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----------------PRVEKGY  217 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH----------------HHHTTTC
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH----------------HHHHcCC
Confidence               234467899999999999999999999999999999998 67776544332211                1111111


Q ss_pred             CCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          493 EIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       493 ~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ... +......+.+++.+||+.||++|||+.||+++|+..
T Consensus       218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            111 222335677889999999999999999999999764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=383.95  Aligned_cols=254  Identities=21%  Similarity=0.297  Sum_probs=194.2

Q ss_pred             hccccccccccccCceeEEEEEecC----CceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEE
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQD----GREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  329 (569)
                      .++|++.++||+|+||.||+|++..    +..||||.+... .....+.+.+|+.+|++++|||||++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3679999999999999999998752    346888887543 3344567999999999999999999999985 567899


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccC
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSS  409 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~  409 (569)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||+++...
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999998742  3457899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhhhh
Q 037160          410 SEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII  488 (569)
Q Consensus       410 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  488 (569)
                      ..... ......||+.|+|||.+.++.++.++|||||||++|||++ |.+|+.........   .....    +      
T Consensus       160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~i~~----~------  225 (273)
T d1mp8a_         160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIEN----G------  225 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHT----T------
T ss_pred             CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HHHHc----C------
Confidence            54332 3345678999999999999999999999999999999998 78887654433211   11100    0      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          489 DKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       489 ~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                        .....+......+.+++..||+.||++|||+.||++.|+.
T Consensus       226 --~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         226 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              0001122334567788999999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-47  Score=388.61  Aligned_cols=245  Identities=21%  Similarity=0.261  Sum_probs=205.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  331 (569)
                      ++|++.++||+|+||.||+|+++ +|+.||||++....   ....+.+.+|+.+|++++|||||++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999976 79999999986532   344567899999999999999999999999999999999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSE  411 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~  411 (569)
                      ||+.+|+|..++.   ..+.+++..++.++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999984   3457899999999999999999999999   999999999999999999999999999876542


Q ss_pred             CCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhccc
Q 037160          412 KSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKS  491 (569)
Q Consensus       412 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  491 (569)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||.......   +....            ....
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i------------~~~~  254 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKI------------VSGK  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH------------HHCC
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHH------------hcCC
Confidence                 335689999999999999999999999999999999999999986433211   11111            1111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCC-----CCHHHHHHH
Q 037160          492 IEIEDIEEVKRVVWVGLLCTQELPTLR-----PSMTNVVQM  527 (569)
Q Consensus       492 l~~~~~~~~~~~~~l~~~Cl~~~P~~R-----Pt~~evl~~  527 (569)
                      .. .+......+.+++..||+.||.+|     ||++|++++
T Consensus       255 ~~-~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         255 VR-FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CC-CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC-CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            11 112233467788899999999999     499999964

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=387.84  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=202.0

Q ss_pred             ccccccccccccCceeEEEEEec-CCc--eEEEEEEeec-chhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGR--EIAVKRLFIS-RKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|++.++||+|+||.||+|+++ +|.  .||||++... .....+.+.+|+++|.++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67888999999999999999976 444  4678877543 344556799999999998 799999999999999999999


Q ss_pred             EeecCCCChhhHhhCC-------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCe
Q 037160          331 YEFVQNKSLDRILFDP-------------KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRP  397 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  397 (569)
                      |||+++|+|.++|...             .....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999643             23467999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCCCcchhhhhHhHh
Q 037160          398 KIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQ-NNKFQSDDGFETLVTHTW  476 (569)
Q Consensus       398 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~-p~~~~~~~~~~~~~~~~~  476 (569)
                      ||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|.. |+.......   +.    
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~----  236 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY----  236 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HH----
Confidence            999999998654432   2234568999999999999999999999999999999999765 444322211   11    


Q ss_pred             hhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 037160          477 KHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKD  532 (569)
Q Consensus       477 ~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  532 (569)
                               +.+....... +......+..++.+||+.+|++||||.||+++|++.-
T Consensus       237 ---------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         237 ---------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             ---------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                     1111111111 2223456778889999999999999999999987653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=382.03  Aligned_cols=254  Identities=22%  Similarity=0.333  Sum_probs=195.6

Q ss_pred             ccccccccccccCceeEEEEEec--CC--ceEEEEEEeec---chhhHHHHHHHHHHHHhccccccceeeeeeeeCCceE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ--DG--REIAVKRLFIS---RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ++|++.+.||+|+||.||+|+++  ++  .+||||++...   .....+.|.+|+.+|++++|||||++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56899999999999999999864  22  36899988643   33456789999999999999999999999965 4678


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++++|.+.+..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++++||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999988743  3456999999999999999999999998   999999999999999999999999999977


Q ss_pred             CCCCCCC-CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHhhhhcccchhh
Q 037160          409 SSEKSLL-PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFETLVTHTWKHFQAKTVLE  486 (569)
Q Consensus       409 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  486 (569)
                      ....... ......|+..|+|||.+.++.++.++||||||+++|||++ |+.||.......   .....           
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i-----------  227 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKI-----------  227 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH-----------
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHH-----------
Confidence            5543321 2234568889999999999999999999999999999998 888876433221   11111           


Q ss_pred             hhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 037160          487 IIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQ  530 (569)
Q Consensus       487 ~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  530 (569)
                       ........ .......+.+++.+||+.||++|||+.||++.|++
T Consensus       228 -~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         228 -DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             -HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence             11111111 12233467789999999999999999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.6e-47  Score=376.88  Aligned_cols=252  Identities=23%  Similarity=0.259  Sum_probs=205.6

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch---------hhHHHHHHHHHHHHhcc-ccccceeeeeeee
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK---------NRIKEICNEMDIMSRAH-HKNLVQFLGCCFT  323 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  323 (569)
                      .++|++.++||+|+||+||+|++. +|+.||||++.....         ...+.+.+|+.+|++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            468999999999999999999975 789999999865421         22346889999999997 9999999999999


Q ss_pred             CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccC
Q 037160          324 KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFG  403 (569)
Q Consensus       324 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfg  403 (569)
                      ++..+|||||+++|+|.++|.   ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            999999999999999999994   3457999999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhh
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIAN------GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWK  477 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  477 (569)
                      +++......   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.........       .
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~  225 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------R  225 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------H
T ss_pred             heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------H
Confidence            998776543   2345679999999999863      34788999999999999999999998754322111       1


Q ss_pred             hhcccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          478 HFQAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ....+..     .............+.+++.+||+.+|++|||+.||+++
T Consensus       226 ~i~~~~~-----~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         226 MIMSGNY-----QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHHTCC-----CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhCCC-----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            0000000     00001112334567889999999999999999999865

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=382.26  Aligned_cols=260  Identities=23%  Similarity=0.272  Sum_probs=197.1

Q ss_pred             ccccccccCceeEEEEEec-CCceEEEEEEeecchhh-----HHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          260 ESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNR-----IKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       260 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      .+++||+|+||+||+|+++ +|+.||||++.......     .+.+.+|+.+|++++|||||++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3568999999999999976 68999999986543221     24688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +.++++..++   ..+..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9998887766   34567889999999999999999999999   99999999999999999999999999987655432


Q ss_pred             CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhh----
Q 037160          414 LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEII----  488 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  488 (569)
                        ......||+.|+|||++..+ .++.++|||||||++|||++|++||......+....+...........+....    
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence              23456799999999998755 57999999999999999999999986544332111111000000000000000    


Q ss_pred             ---cccCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 ---DKSIEIEDI-----EEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ---~~~l~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                         .........     .....+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence               000000011     123567889999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.2e-48  Score=380.11  Aligned_cols=259  Identities=22%  Similarity=0.338  Sum_probs=199.9

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHHhccccccceeeeeeeeCCc---
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKD---  326 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  326 (569)
                      ..++|++.+.||+|+||.||+|++. +|+.||||++....   ......+.+|+++|++++|||||++++++.....   
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            3578999999999999999999975 79999999996542   3445679999999999999999999999986543   


Q ss_pred             -eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCC
Q 037160          327 -SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLA  405 (569)
Q Consensus       327 -~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla  405 (569)
                       .|+||||++|++|.+++.   ..+.+++.+++.++.||+.||.|||+++   |+||||||+|||++.++..+|+|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence             789999999999999884   3457999999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCCC-CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          406 RFSSSEKSL-LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       406 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      ......... .......||+.|+|||++.+..++.++|||||||++|||++|++||........      .+........
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCC
Confidence            765443321 133456799999999999999999999999999999999999999864332211      1111111100


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhcc
Q 037160          485 LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRP-SMTNVVQMLKQ  530 (569)
Q Consensus       485 ~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-t~~evl~~L~~  530 (569)
                      ..   ..   ........+.+++.+||+.||++|| |++++++.|.+
T Consensus       233 ~~---~~---~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         233 PP---SA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CG---GG---TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CC---ch---hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            00   00   0112234677888999999999999 89999888764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=382.39  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=205.9

Q ss_pred             hccccccccccccCceeEEEEEecC--------CceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeC
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQD--------GREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTK  324 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  324 (569)
                      .++|++.++||+|+||.||+|+...        +..||||++.... .....++.+|+..+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578889999999999999998642        2479999986654 34457889999999988 899999999999999


Q ss_pred             CceEEEEeecCCCChhhHhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPK-------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                      ...++||||+++|+|.++|....             ....+++..++.++.||+.||.|||+.+   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999996433             2346899999999999999999999999   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVS-GVQNNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~ellt-g~~p~~~~~~~~~~~  470 (569)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||++ |.+|+.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            9999999999999997766554434456789999999999999999999999999999999998 677765433221   


Q ss_pred             hhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      +    +.         .+....... +......+.+++.+||+.+|++|||+.||+++|++.
T Consensus       246 ~----~~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         246 L----FK---------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             H----HH---------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HH---------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1    11         111111111 122335678899999999999999999999999764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=384.86  Aligned_cols=259  Identities=24%  Similarity=0.365  Sum_probs=210.1

Q ss_pred             hccccccccccccCceeEEEEEec------CCceEEEEEEeecc-hhhHHHHHHHHHHHHhc-cccccceeeeeeeeCCc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFISR-KNRIKEICNEMDIMSRA-HHKNLVQFLGCCFTKKD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  326 (569)
                      .++|++.++||+|+||.||+|++.      +++.||||++.... ......+.+|+.+++++ +|||||++++++.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            367888999999999999999853      45789999997543 34456789999999999 79999999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCC---------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEE
Q 037160          327 SFVVYEFVQNKSLDRILFDPK---------------QKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILL  391 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll  391 (569)
                      .++||||+++|+|.+++....               ....+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999985432               2336899999999999999999999999   9999999999999


Q ss_pred             CCCCCeEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCcchhh
Q 037160          392 DLKHRPKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSG-VQNNKFQSDDGFET  470 (569)
Q Consensus       392 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg-~~p~~~~~~~~~~~  470 (569)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+++ .+|+........  
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            99999999999999977665444344567899999999999999999999999999999999995 444433322211  


Q ss_pred             hhHhHhhhhcccchhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          471 LVTHTWKHFQAKTVLEIIDKSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                                   +.+++....... +......+.+++.+||+.||++|||+.||+++|++.
T Consensus       257 -------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         257 -------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             -------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                         111122212111 222345678899999999999999999999999763

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=383.97  Aligned_cols=250  Identities=18%  Similarity=0.265  Sum_probs=205.6

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      +.++|++.++||+|+||.||+|+++ +|+.||||++...... ...+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3577999999999999999999976 7889999999765433 3568899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCC--CCeEEeccCCCcccCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLK--HRPKIADFGLARFSSS  410 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~--~~~kl~Dfgla~~~~~  410 (569)
                      |++||+|.+++..  ....+++.++..++.||+.||.|||+++   |+||||||+|||++.+  ..+||+|||+++....
T Consensus        82 ~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999999943  2346899999999999999999999999   9999999999999854  4799999999987654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ..   ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.........   .            .+...
T Consensus       157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~---~------------~i~~~  218 (321)
T d1tkia_         157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---E------------NIMNA  218 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H------------HHHHT
T ss_pred             CC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH---H------------HHHhC
Confidence            33   234567899999999999999999999999999999999999998754332111   1            11111


Q ss_pred             cCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          491 SIEIED---IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       491 ~l~~~~---~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......   ......+.+++.+||+.||++|||+.|++++
T Consensus       219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111110   0123457789999999999999999999974

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=383.54  Aligned_cols=269  Identities=22%  Similarity=0.293  Sum_probs=198.2

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeCC----ceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK----DSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  331 (569)
                      ++|.+.++||+|+||.||+|+++ |+.||||++...... ......|+..+.+++|||||++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            56778889999999999999974 889999988654322 122334555556789999999999998654    578999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD-----GQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ||+++|+|.++|..    ..++|..++.++.+++.||.|||+.     ...+|+||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999943    4689999999999999999999974     12349999999999999999999999999998


Q ss_pred             ccCCCCCCC--CCcccccCCCcccccccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh
Q 037160          407 FSSSEKSLL--PNTAIAGTLGYMAPEYIANGQ------LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH  478 (569)
Q Consensus       407 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  478 (569)
                      .........  ......||+.|+|||++.+..      ++.++|||||||+||||++|..|+............... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~-~~  235 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP-SD  235 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC-SS
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc-cc
Confidence            775543221  233567999999999987642      677999999999999999998887544332211000000 00


Q ss_pred             hcccchh-hhhcccCC----CC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          479 FQAKTVL-EIIDKSIE----IE--DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       479 ~~~~~~~-~~~~~~l~----~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ....... ...+..+.    ..  ..+....+..++.+||+.||++|||+.||+++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            0000011 11111221    11  234556688899999999999999999999999754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.8e-47  Score=387.88  Aligned_cols=249  Identities=22%  Similarity=0.228  Sum_probs=199.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHH---HHHHHHhccccccceeeeeeeeCCceE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICN---EMDIMSRAHHKNLVQFLGCCFTKKDSF  328 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~  328 (569)
                      ++|++.++||+|+||.||+|++. +|+.||||++....   ......+.+   |+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999976 78999999986432   122233444   466677778999999999999999999


Q ss_pred             EEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCccc
Q 037160          329 VVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFS  408 (569)
Q Consensus       329 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~  408 (569)
                      +||||+++|+|.++|.   ....+++..++.++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+++.+
T Consensus        84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999994   3456889999999999999999999999   999999999999999999999999999877


Q ss_pred             CCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEI  487 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  487 (569)
                      ....    .....||+.|+|||++.. ..++.++|||||||+||||++|+.||..........+..             .
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-------------~  220 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------------M  220 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-------------H
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------h
Confidence            6542    335679999999999875 468999999999999999999999987544332211111             0


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 037160          488 IDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPS-----MTNVVQM  527 (569)
Q Consensus       488 ~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-----~~evl~~  527 (569)
                      ........+......+.+++.+||+.||++|||     ++|++++
T Consensus       221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            000000011123346778899999999999999     6888854

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=383.94  Aligned_cols=259  Identities=22%  Similarity=0.338  Sum_probs=209.6

Q ss_pred             hccccccccccccCceeEEEEEec------CCceEEEEEEeec-chhhHHHHHHHHHHHHhccccccceeeeeeeeCCce
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ------DGREIAVKRLFIS-RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDS  327 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  327 (569)
                      .++|++.++||+|+||.||+|.++      +++.||||++... .......|.+|++++++++|||||++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            367888999999999999999864      3578999998654 334446789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhHhhCC-------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          328 FVVYEFVQNKSLDRILFDP-------KQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                      ++||||+++|+|.+++...       .....+++..+..++.|+++||.|||+++   |+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999988422       22345789999999999999999999998   9999999999999999999999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCcchhhhhHhHhhhh
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGV-QNNKFQSDDGFETLVTHTWKHF  479 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~  479 (569)
                      |||+++...............||+.|+|||.+.++.++.++||||||+++|||++|. +|+.......   ...      
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~------  246 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLR------  246 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHH------
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HHH------
Confidence            999998776654433344567899999999999999999999999999999999996 4543322111   111      


Q ss_pred             cccchhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          480 QAKTVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       480 ~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                            .+.+......+......+.+++.+||+.+|++|||+.+|+++|++.
T Consensus       247 ------~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         247 ------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ------HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                  1111111111223345688899999999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-47  Score=380.29  Aligned_cols=254  Identities=25%  Similarity=0.339  Sum_probs=201.3

Q ss_pred             cccccccCceeEEEEEecCC----ceEEEEEEee-cchhhHHHHHHHHHHHHhccccccceeeeeeeeC-CceEEEEeec
Q 037160          261 SNKLGHGGYGEIFKGTLQDG----REIAVKRLFI-SRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-KDSFVVYEFV  334 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~  334 (569)
                      .++||+|+||+||+|++.++    ..||||++.. ......+.|.+|+++|++++|||||++++++... ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999997532    2589999864 3455668899999999999999999999998764 5789999999


Q ss_pred             CCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCCC
Q 037160          335 QNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKSL  414 (569)
Q Consensus       335 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  414 (569)
                      ++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999853  4456788899999999999999999998   999999999999999999999999999876554332


Q ss_pred             C--CCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcccC
Q 037160          415 L--PNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDKSI  492 (569)
Q Consensus       415 ~--~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  492 (569)
                      .  ......||+.|+|||.+..+.++.++||||||+++|||++|..|+.......  .+.......            ..
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~g------------~~  252 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQG------------RR  252 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTT------------CC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC------------CC
Confidence            1  2234578999999999999999999999999999999999887765432211  111111110            00


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 037160          493 EIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQKDI  533 (569)
Q Consensus       493 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  533 (569)
                      ...+......+.+++.+||+.+|++||++.||+++|++...
T Consensus       253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            00112223467788999999999999999999999987643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=384.18  Aligned_cols=247  Identities=25%  Similarity=0.342  Sum_probs=202.6

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc---hhhHHHHHHHHHHHH-hccccccceeeeeeeeCCceEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR---KNRIKEICNEMDIMS-RAHHKNLVQFLGCCFTKKDSFVV  330 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv  330 (569)
                      ++|++.++||+|+||+||+|+++ +|+.||||++....   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999976 78999999997532   334556777777765 68999999999999999999999


Q ss_pred             EeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCC
Q 037160          331 YEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSS  410 (569)
Q Consensus       331 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~  410 (569)
                      |||+++|+|.+++.   ....+++.++..++.||+.||.|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999994   3456889999999999999999999999   99999999999999999999999999986654


Q ss_pred             CCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccchhhhhcc
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTVLEIIDK  490 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (569)
                      ...  ..+...||+.|+|||++.++.++.++|||||||++|||++|+.||.........       ......      ..
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~------~~  220 (320)
T d1xjda_         156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMD------NP  220 (320)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC------CC
T ss_pred             ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcC------CC
Confidence            332  334568999999999999999999999999999999999999998754332211       110000      00


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 037160          491 SIEIEDIEEVKRVVWVGLLCTQELPTLRPSMT-NVVQ  526 (569)
Q Consensus       491 ~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~  526 (569)
                      ..   +......+.+++.+||+.||++|||+. |+++
T Consensus       221 ~~---p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 FY---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CC---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CC---CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            01   112234577888999999999999995 7764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-47  Score=376.88  Aligned_cols=265  Identities=22%  Similarity=0.289  Sum_probs=200.9

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecch--hhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK--NRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.++||+|+||.||+|++. +|+.||||++.....  ...+.+.+|+++|++++|||||++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999975 789999999865432  235678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      |+.++.+.....  .....+++..+..++.||+.||.|||+++   ||||||||+|||++.++++||+|||+++......
T Consensus        82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            997665554432  34556999999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCCCCcccccCCCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccc---hhhhh
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKT---VLEII  488 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  488 (569)
                      .  ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...........+...........   .....
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            2  344568999999999876654 57899999999999999999999875432211100000000000000   00000


Q ss_pred             c--cc---CCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          489 D--KS---IEIED-----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       489 ~--~~---l~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      +  ..   .....     ......+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0  00   00001     1223567788999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=379.75  Aligned_cols=250  Identities=22%  Similarity=0.260  Sum_probs=198.4

Q ss_pred             hccccccc-cccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhc-cccccceeeeeeee----CCce
Q 037160          255 TDCFDESN-KLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRA-HHKNLVQFLGCCFT----KKDS  327 (569)
Q Consensus       255 ~~~f~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~  327 (569)
                      .++|++.+ .||+|+||.||+|++. +++.||||++...     ..+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788875 5999999999999975 7899999998542     4567899987665 89999999999875    4568


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC---CCCeEEeccCC
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL---KHRPKIADFGL  404 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~~kl~Dfgl  404 (569)
                      |+|||||+||+|.++|... ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.   .+.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999999642 2356999999999999999999999999   999999999999985   45799999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      ++......   ......||+.|||||++.+..++.++|||||||+||||++|+.||...........+   ...      
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~------  228 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTR------  228 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------C------
T ss_pred             eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHH------
Confidence            98766543   234567999999999999999999999999999999999999998644322111000   000      


Q ss_pred             hhhhcccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          485 LEIIDKSIEIE---DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       485 ~~~~~~~l~~~---~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                        +........   .......+.+++.+||+.||++|||+.|++++
T Consensus       229 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         229 --IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              000001111   12234568889999999999999999999984

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.3e-46  Score=371.51  Aligned_cols=264  Identities=22%  Similarity=0.293  Sum_probs=202.0

Q ss_pred             ccccccccccccCceeEEEEEecCCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYEF  333 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  333 (569)
                      ++|++.++||+|+||+||+|++++|+.||||++....  ....+.+.+|+.+|++++|||||++++.+...+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5799999999999999999999999999999996543  23357899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCCC
Q 037160          334 VQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEKS  413 (569)
Q Consensus       334 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~~  413 (569)
                      +.++.+..+.   ...+.+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9888887776   34577999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             CCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh-----hhhcccchhhh
Q 037160          414 LLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW-----KHFQAKTVLEI  487 (569)
Q Consensus       414 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~  487 (569)
                        ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+....     ..+........
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence              23355689999999998754 57899999999999999999999986543222111100000     00000000000


Q ss_pred             hcccCC---C-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 IDKSIE---I-----EDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~~~l~---~-----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ......   .     ........+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000   0     011223567788999999999999999999854

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-47  Score=371.42  Aligned_cols=241  Identities=20%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecch------hhHHHHHHHHHHHHhcc--ccccceeeeeeeeCC
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRK------NRIKEICNEMDIMSRAH--HKNLVQFLGCCFTKK  325 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  325 (569)
                      .++|++.++||+|+||.||+|+.. +|+.||||++.....      .....+.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            467999999999999999999975 789999999864321      12234678999999996  899999999999999


Q ss_pred             ceEEEEeecCC-CChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-CCCeEEeccC
Q 037160          326 DSFVVYEFVQN-KSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-KHRPKIADFG  403 (569)
Q Consensus       326 ~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~Dfg  403 (569)
                      ..++||||+.+ +++.+++.   .+..+++..++.++.||+.||.|||+++   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 57777773   3467899999999999999999999999   999999999999985 4789999999


Q ss_pred             CCcccCCCCCCCCCcccccCCCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          404 LARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQL-TEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       404 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      +++.....    ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||....     ..           
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-----------  216 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-----------  216 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-----------
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-----------
Confidence            99865443    2345679999999999987765 577999999999999999999985321     00           


Q ss_pred             chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                           ...... ........+.+++.+||+.||++|||++|++++
T Consensus       217 -----~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         217 -----IRGQVF-FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -----HHCCCC-CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----hhcccC-CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                 000000 011123456778899999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-46  Score=370.55  Aligned_cols=266  Identities=23%  Similarity=0.315  Sum_probs=199.1

Q ss_pred             HhccccccccccccCceeEEEEEec-C-CceEEEEEEeecch--hhHHHHHHHHHHHHhc---cccccceeeeeeee---
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-D-GREIAVKRLFISRK--NRIKEICNEMDIMSRA---HHKNLVQFLGCCFT---  323 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---  323 (569)
                      ..++|++.++||+|+||+||+|++. + ++.||||++.....  .....+.+|+.+|+.|   +||||+++++++..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            3578999999999999999999974 4 56799999865432  2233566788887776   79999999999853   


Q ss_pred             --CCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEec
Q 037160          324 --KKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIAD  401 (569)
Q Consensus       324 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  401 (569)
                        ....+++|||+.++++.....  .....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence              346799999999887765543  34567899999999999999999999999   99999999999999999999999


Q ss_pred             cCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHh-----
Q 037160          402 FGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTW-----  476 (569)
Q Consensus       402 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-----  476 (569)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|++||...........+....     
T Consensus       160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            99988654433   3346789999999999999999999999999999999999999987554322111111000     


Q ss_pred             hhhcccch--hhhhccc----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          477 KHFQAKTV--LEIIDKS----IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       477 ~~~~~~~~--~~~~~~~----l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..+.....  .......    ...........+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000000  0000000    000011223456678899999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=363.03  Aligned_cols=266  Identities=21%  Similarity=0.321  Sum_probs=198.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeee--------C
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFT--------K  324 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~  324 (569)
                      ++|++.++||+|+||+||+|++. +|+.||||++....  ......+.+|+++|++++||||+++++.+..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67999999999999999999975 79999999885542  3345678899999999999999999999855        3


Q ss_pred             CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          325 KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       325 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                      ...++||||+.++.+....   .....++...+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            4679999999888777655   44567889999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCC--CCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhh---
Q 037160          405 ARFSSSEKSL--LPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKH---  478 (569)
Q Consensus       405 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---  478 (569)
                      ++........  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....+......+......   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876543322  122346799999999998765 6899999999999999999999998654332222221111111   


Q ss_pred             -----hcccchhhhhcccCCCC-CHH-------HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          479 -----FQAKTVLEIIDKSIEIE-DIE-------EVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       479 -----~~~~~~~~~~~~~l~~~-~~~-------~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                           .........+....... ...       ....+++++.+||+.||++|||++|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence                 11111111111111111 111       12345678999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=366.61  Aligned_cols=272  Identities=19%  Similarity=0.224  Sum_probs=201.5

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeecc-hhhHHHHHHHHHHHHhccccccceeeeeeeeCC----ce
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK----DS  327 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~  327 (569)
                      ++++|++.++||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            3467999999999999999999865 89999999996543 344567899999999999999999999997653    23


Q ss_pred             EEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcc
Q 037160          328 FVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARF  407 (569)
Q Consensus       328 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~  407 (569)
                      +++++++.+++|.+++..    ..+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            566677789999999842    46899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCCC-CCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc---
Q 037160          408 SSSEKSLL-PNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK---  482 (569)
Q Consensus       408 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  482 (569)
                      ........ ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......................   
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            65543321 2345679999999999855 467899999999999999999999986544322211111110000000   


Q ss_pred             -----chhhhhc--ccCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hccCC
Q 037160          483 -----TVLEIID--KSIEIEDI-----EEVKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQKD  532 (569)
Q Consensus       483 -----~~~~~~~--~~l~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~  532 (569)
                           .......  +.......     .....+.+++.+||+.||++|||+.|++++  |+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence                 0000000  00000011     112467889999999999999999999976  44443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=369.00  Aligned_cols=266  Identities=22%  Similarity=0.325  Sum_probs=197.9

Q ss_pred             HhccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeCC-----
Q 037160          254 ATDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKK-----  325 (569)
Q Consensus       254 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  325 (569)
                      +.++|++.++||+|+||+||+|+++ +|+.||||++...  .....+.+.+|+++|++++|||||++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3568999999999999999999975 6999999998653  3344567899999999999999999999997654     


Q ss_pred             -ceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCC
Q 037160          326 -DSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGL  404 (569)
Q Consensus       326 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgl  404 (569)
                       +.++||||+ +.+|..++.    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence             469999999 667877763    356999999999999999999999999   99999999999999999999999999


Q ss_pred             CcccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------H
Q 037160          405 ARFSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------T  475 (569)
Q Consensus       405 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~  475 (569)
                      ++.....     .+...||+.|+|||.+.+. .++.++||||+||++|||++|++|+..............        .
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            9876542     3456799999999998764 578999999999999999999999865533221111100        0


Q ss_pred             hhhhcccchh---hhhccc----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hccCC
Q 037160          476 WKHFQAKTVL---EIIDKS----IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQKD  532 (569)
Q Consensus       476 ~~~~~~~~~~---~~~~~~----l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~  532 (569)
                      +.........   ..+...    +..........+.+++.+||+.||++|||+.|++++  +++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0110000000   000000    000011223456788999999999999999999986  55543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=368.50  Aligned_cols=261  Identities=20%  Similarity=0.283  Sum_probs=195.1

Q ss_pred             cccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccccccceeeeeeeeC------CceEE
Q 037160          257 CFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------KDSFV  329 (569)
Q Consensus       257 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  329 (569)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    ...+|+++|++++|||||++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4778889999999999999976 789999999866432    234799999999999999999998643      24689


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCccc
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFS  408 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~~~  408 (569)
                      ||||++++.+..+.........+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755554432345567999999999999999999999998   99999999999999775 8999999999877


Q ss_pred             CCCCCCCCCcccccCCCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHh--------Hhhhh
Q 037160          409 SSEKSLLPNTAIAGTLGYMAPEYIAN-GQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTH--------TWKHF  479 (569)
Q Consensus       409 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~  479 (569)
                      ....   ......||..|+|||.+.+ ..++.++|||||||++|||++|++||...........+..        .+...
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            5543   2345679999999998765 4789999999999999999999999875543221111100        11110


Q ss_pred             cccchhhhhccc-----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          480 QAKTVLEIIDKS-----IEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       480 ~~~~~~~~~~~~-----l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ........+...     ...........+.+++.+||+.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000000000     000012234467788999999999999999999964

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-43  Score=352.91  Aligned_cols=261  Identities=18%  Similarity=0.223  Sum_probs=195.8

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcccccccee-eeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLVQF-LGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e  332 (569)
                      .++|++.++||+|+||.||+|++. +|+.||||++.....  ..++..|++++++++|+|++.. ..+..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            357999999999999999999975 689999998866433  2457889999999987765555 555567788899999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC---CCCeEEeccCCCcccC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL---KHRPKIADFGLARFSS  409 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~~kl~Dfgla~~~~  409 (569)
                      |+. ++|.+.+.  .....+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+++.+.
T Consensus        84 ~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLG-PSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCC-CBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcC-Cchhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            994 55555553  23456899999999999999999999999   999999999999864   4579999999999776


Q ss_pred             CCCCC-----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          410 SEKSL-----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       410 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      .....     .......||+.|||||.+.+..++.++|||||||++|||++|+.||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            54332     1234567999999999999999999999999999999999999998765443222111111000000000


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          485 LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       485 ~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      .. +.       ......+.+++..||+.+|++||+++++.+.|+..
T Consensus       238 ~~-~~-------~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         238 EV-LC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HH-HT-------TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             hH-hc-------cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            00 00       11224577788999999999999999998877653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=352.50  Aligned_cols=264  Identities=20%  Similarity=0.239  Sum_probs=205.5

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeCCceEEEEe
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  332 (569)
                      ++|++.++||+|+||+||+|++. +|+.||||++....  ....+.+.+|+.+|++++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999975 78999999986543  3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCcccCCCC
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLARFSSSEK  412 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~~~~~~~  412 (569)
                      ++.+++|..++.   ..+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988874   4467889999999999999999999998   9999999999999999999999999998776543


Q ss_pred             CCCCCcccccCCCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCcch-hhhhHhHhhhhcccch---hhh
Q 037160          413 SLLPNTAIAGTLGYMAPEYIANGQ-LTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGF-ETLVTHTWKHFQAKTV---LEI  487 (569)
Q Consensus       413 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~  487 (569)
                      .  ......+++.|+|||.+.... ++.++|||||||++|||++|+.|+........ ...+...+........   ...
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            2  233456788999999987664 68999999999999999999998754332211 1111111000000000   000


Q ss_pred             hc----------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          488 ID----------KSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       488 ~~----------~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      .+          .............+.+++.+||+.||++|||++||+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00          00001122334567788999999999999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.2e-43  Score=347.06  Aligned_cols=261  Identities=14%  Similarity=0.170  Sum_probs=204.0

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhccc-cccceeeeeeeeCCceEEEEe
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAHH-KNLVQFLGCCFTKKDSFVVYE  332 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  332 (569)
                      .++|++.++||+|+||.||+|++. +|+.||||++.....  ...+.+|+++++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999976 789999998755432  2457789999999965 899999999999999999999


Q ss_pred             ecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECC-----CCCeEEeccCCCcc
Q 037160          333 FVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDL-----KHRPKIADFGLARF  407 (569)
Q Consensus       333 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~-----~~~~kl~Dfgla~~  407 (569)
                      |+ +++|.+++..  ....+++..+..++.|++.||.|||+++   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 7899888843  3356899999999999999999999999   999999999999964     57899999999987


Q ss_pred             cCCCCCC-----CCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhccc
Q 037160          408 SSSEKSL-----LPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAK  482 (569)
Q Consensus       408 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  482 (569)
                      +......     .......||+.|||||++.+..++.++|||||||++|||++|+.||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6543221     12335679999999999999999999999999999999999999997554433222111111110001


Q ss_pred             chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 037160          483 TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSMTNVVQMLKQK  531 (569)
Q Consensus       483 ~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  531 (569)
                      ...++.     ..   ....+..++..|+..+|++||+++.+.+.|++.
T Consensus       236 ~~~~l~-----~~---~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         236 PLRELC-----AG---FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             CHHHHT-----TT---SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ChHHhc-----CC---CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            111110     11   123567788899999999999999888777653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.9e-43  Score=356.13  Aligned_cols=257  Identities=18%  Similarity=0.298  Sum_probs=198.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeeeeeeC--CceEEEE
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTK--KDSFVVY  331 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~  331 (569)
                      ++|++.++||+|+||+||+|++. +|+.||||++....   .+.+.+|+++|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            68999999999999999999975 78999999986543   457889999999995 99999999998744  5689999


Q ss_pred             eecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCC-CeEEeccCCCcccCC
Q 037160          332 EFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKH-RPKIADFGLARFSSS  410 (569)
Q Consensus       332 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~Dfgla~~~~~  410 (569)
                      ||+.+++|..+.      +.+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997764      45899999999999999999999999   99999999999998765 589999999987665


Q ss_pred             CCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh-hhHh--------Hh-hhh
Q 037160          411 EKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET-LVTH--------TW-KHF  479 (569)
Q Consensus       411 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~-~~~~--------~~-~~~  479 (569)
                      ..   ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+.......... .+..        .+ ...
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            43   23456789999999998765 57999999999999999999999987654432110 0000        00 000


Q ss_pred             cc---cchhhhhc--------ccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          480 QA---KTVLEIID--------KSIEIE-DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       480 ~~---~~~~~~~~--------~~l~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                      ..   ........        ...... .......+.+++.+||+.||++|||++|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   00000000        000000 12223567789999999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-44  Score=357.49  Aligned_cols=253  Identities=22%  Similarity=0.304  Sum_probs=201.8

Q ss_pred             ccccccccccccCceeEEEEEec----CCceEEEEEEeec----chhhHHHHHHHHHHHHhccc-cccceeeeeeeeCCc
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ----DGREIAVKRLFIS----RKNRIKEICNEMDIMSRAHH-KNLVQFLGCCFTKKD  326 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  326 (569)
                      ++|++.++||+|+||+||+|+..    +|+.||||++...    +....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999852    4789999988543    22334668899999999976 899999999999999


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .+++|||+.+++|.+++.   ....+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999984   3446678889999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHhhhhcccch
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANG--QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHTWKHFQAKTV  484 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  484 (569)
                      .+...... ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........+....        
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--------  248 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--------  248 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--------
Confidence            76554332 23456799999999998764  47889999999999999999999987654433221111110        


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 037160          485 LEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRP-----SMTNVVQM  527 (569)
Q Consensus       485 ~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~~  527 (569)
                         ..... ..+......+.+++.+||+.||++||     |++|++++
T Consensus       249 ---~~~~~-~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         249 ---LKSEP-PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ---HHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ---ccCCC-CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence               00000 01223446777888999999999999     48899864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-43  Score=357.76  Aligned_cols=260  Identities=25%  Similarity=0.284  Sum_probs=192.8

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeec--chhhHHHHHHHHHHHHhccccccceeeeeeeeC------Cc
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFIS--RKNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK------KD  326 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  326 (569)
                      ++|++.++||+|+||+||+|++. +|+.||||++...  .....+.+.+|+.+|++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999976 6999999999754  234456789999999999999999999998643      57


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .|+||||+.++.+..+.      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            79999999776665442      35789999999999999999999999   9999999999999999999999999988


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhH--------hHhhh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVT--------HTWKH  478 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~  478 (569)
                      ......   ......||+.|+|||++.+..+++++||||+||+++||++|+.||...........+.        ..|..
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            665543   3346679999999999999999999999999999999999999986543221111100        00100


Q ss_pred             --------------hcccchhhhhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 037160          479 --------------FQAKTVLEIIDKSIEIE----DIEEVKRVVWVGLLCTQELPTLRPSMTNVVQM  527 (569)
Q Consensus       479 --------------~~~~~~~~~~~~~l~~~----~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  527 (569)
                                    .........+.......    .......+.+++.+||+.||++|||++||+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                          00011111111111111    23445678889999999999999999999966

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=358.77  Aligned_cols=278  Identities=22%  Similarity=0.292  Sum_probs=204.1

Q ss_pred             hccccccccccccCceeEEEEEec-CCceEEEEEEeecc--hhhHHHHHHHHHHHHhccccccceeeeeeeeC-----Cc
Q 037160          255 TDCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR--KNRIKEICNEMDIMSRAHHKNLVQFLGCCFTK-----KD  326 (569)
Q Consensus       255 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  326 (569)
                      .++|++.++||+|+||+||+|++. +|+.||||++....  ....+.+.+|+++|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            567999999999999999999975 79999999986543  33456788999999999999999999998643     34


Q ss_pred             eEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          327 SFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       327 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      .+++++|+.+|+|.+++.    .+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            577788889999999983    346999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCCCCCCCcccccCCCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--------hh
Q 037160          407 FSSSEKSLLPNTAIAGTLGYMAPEYIANG-QLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFETLVTHT--------WK  477 (569)
Q Consensus       407 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~  477 (569)
                      ....     ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+...        +.
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            6543     23456789999999987665 5689999999999999999999998654432221111100        00


Q ss_pred             hhcccchhhhhcccCCC--CC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hccCCCCCCCCCCCCCc
Q 037160          478 HFQAKTVLEIIDKSIEI--ED-----IEEVKRVVWVGLLCTQELPTLRPSMTNVVQM--LKQKDITLPTPSKPPFT  544 (569)
Q Consensus       478 ~~~~~~~~~~~~~~l~~--~~-----~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~~~~~~p~~p~~~  544 (569)
                      .................  ..     ......+.+++.+||+.||++|||+.|++++  +.+.......|..+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~~  320 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD  320 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCCC
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCCC
Confidence            01111111111110000  01     1123456788999999999999999999974  44444333444444443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.8e-38  Score=322.08  Aligned_cols=262  Identities=19%  Similarity=0.243  Sum_probs=193.2

Q ss_pred             ccccccccccccCceeEEEEEec-CCceEEEEEEeecchhhHHHHHHHHHHHHhcc-----------ccccceeeeeeee
Q 037160          256 DCFDESNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISRKNRIKEICNEMDIMSRAH-----------HKNLVQFLGCCFT  323 (569)
Q Consensus       256 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  323 (569)
                      ++|++.++||+|+||+||+|+.. +|+.||||++..... ..+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999975 799999999875432 3457788999998875           5789999988865


Q ss_pred             C--CceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCCeEECCCCC----
Q 037160          324 K--KDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHK-DGQMQIVHRDIKASNILLDLKHR----  396 (569)
Q Consensus       324 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~----  396 (569)
                      .  ...+++++++..+..............+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            3  4566777776665544443334556778899999999999999999998 76   999999999999987654    


Q ss_pred             --eEEeccCCCcccCCCCCCCCCcccccCCCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCcchhh---h
Q 037160          397 --PKIADFGLARFSSSEKSLLPNTAIAGTLGYMAPEYIANGQLTEKVDIYSFGVLVLEIVSGVQNNKFQSDDGFET---L  471 (569)
Q Consensus       397 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~SlGvil~elltg~~p~~~~~~~~~~~---~  471 (569)
                        ++++|||.+.....     ......||+.|+|||++....++.++||||+||+++||++|+.||..........   .
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              89999999876543     2345679999999999999999999999999999999999999986543221110   0


Q ss_pred             hHhHhhhhc---------cc---------------------chhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 037160          472 VTHTWKHFQ---------AK---------------------TVLEIIDKSIEIEDIEEVKRVVWVGLLCTQELPTLRPSM  521 (569)
Q Consensus       472 ~~~~~~~~~---------~~---------------------~~~~~~~~~l~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~  521 (569)
                      +......+.         ..                     ...+.... ...........+.+++.+||+.||++|||+
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE-KYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH-TTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhccc-ccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            000000000         00                     00000000 111245667788999999999999999999


Q ss_pred             HHHHHH
Q 037160          522 TNVVQM  527 (569)
Q Consensus       522 ~evl~~  527 (569)
                      +|+|++
T Consensus       323 ~e~L~H  328 (362)
T d1q8ya_         323 GGLVNH  328 (362)
T ss_dssp             HHHHTC
T ss_pred             HHHhcC
Confidence            999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=5.4e-24  Score=196.45  Aligned_cols=163  Identities=18%  Similarity=0.169  Sum_probs=121.3

Q ss_pred             cccccccccCceeEEEEEecCCceEEEEEEeecch------------------hhHHHHHHHHHHHHhccccccceeeee
Q 037160          259 DESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRK------------------NRIKEICNEMDIMSRAHHKNLVQFLGC  320 (569)
Q Consensus       259 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~~  320 (569)
                      .+.++||+|+||.||+|+..+|++||||++.....                  .......+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            46789999999999999988899999998643210                  112345678899999999999988765


Q ss_pred             eeeCCceEEEEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCCeEECCCCCeEEe
Q 037160          321 CFTKKDSFVVYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDGQMQIVHRDIKASNILLDLKHRPKIA  400 (569)
Q Consensus       321 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  400 (569)
                      .    ..+++|||+++..+.+          ++......++.|++++|.|||+++   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    3479999998866543          334455679999999999999999   9999999999999965 49999


Q ss_pred             ccCCCcccCCCCCCCCCcccccCCCcccc------cccccCCCCcccchhhHHHHH
Q 037160          401 DFGLARFSSSEKSLLPNTAIAGTLGYMAP------EYIANGQLTEKVDIYSFGVLV  450 (569)
Q Consensus       401 Dfgla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~ksDv~SlGvil  450 (569)
                      |||+|.........          .|...      |. ....++.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99999765432210          11111      11 135678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.62  E-value=1.1e-07  Score=89.95  Aligned_cols=147  Identities=15%  Similarity=0.089  Sum_probs=101.9

Q ss_pred             HHHHhccccccccccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcc-ccccceeeeeeeeCCceEE
Q 037160          251 IEKATDCFDESNKLGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAH-HKNLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       251 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  329 (569)
                      +.+.-+.|+..+..+.+..+.||+... +++.++||+...........+.+|...++.+. +--+.+++.+....+..++
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            344445677666655555678998764 46678889776554444445778999988874 3345677888888888999


Q ss_pred             EEeecCCCChhhHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 037160          330 VYEFVQNKSLDRILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKDG----------------------------------  375 (569)
Q Consensus       330 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  375 (569)
                      ||++++|.++.+.....        .....++.++++.|..||+..                                  
T Consensus        88 v~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999886654211        112335566666677777421                                  


Q ss_pred             ----------------------CCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          376 ----------------------QMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       376 ----------------------~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                                            +..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  1227999999999999977666799999765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.07  E-value=8e-06  Score=76.17  Aligned_cols=129  Identities=16%  Similarity=0.115  Sum_probs=86.4

Q ss_pred             ccccC-ceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhcccc--ccceeeeeeeeCCceEEEEeecCCCChh
Q 037160          264 LGHGG-YGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHK--NLVQFLGCCFTKKDSFVVYEFVQNKSLD  340 (569)
Q Consensus       264 lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~~L~  340 (569)
                      +..|. -+.||+...+++..+++|.......   ..+..|...|+.+...  .+.+++.+....+..++||++++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            34444 3678999888888899997644332   3466788888877433  3566788778888899999999987764


Q ss_pred             hHhhCCCCCccCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 037160          341 RILFDPKQKKELDWKKRHVIIIGTAEGLEYLHKD----------------------------------------------  374 (569)
Q Consensus       341 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------------  374 (569)
                      +..        ...   ..++.++++.|..||+.                                              
T Consensus        95 ~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          95 SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            321        111   11223344444444421                                              


Q ss_pred             ---------CCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          375 ---------GQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       375 ---------~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                               .+..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                     11238999999999999977667899999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.73  E-value=5.7e-05  Score=75.22  Aligned_cols=77  Identities=16%  Similarity=0.164  Sum_probs=49.0

Q ss_pred             cccccccCceeEEEEEec-CCceEEEEEEeecc-------hhhHHHHHHHHHHHHhcc-c-c-ccceeeeeeeeCCceEE
Q 037160          261 SNKLGHGGYGEIFKGTLQ-DGREIAVKRLFISR-------KNRIKEICNEMDIMSRAH-H-K-NLVQFLGCCFTKKDSFV  329 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h-~-niv~~~~~~~~~~~~~l  329 (569)
                      .+.||.|....||+.... +++.++||.-...-       .....+...|.+.|+.+. + | .+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            346899999999999865 46789999653211       112234556888887763 2 3 34455543  4567789


Q ss_pred             EEeecCCCCh
Q 037160          330 VYEFVQNKSL  339 (569)
Q Consensus       330 v~e~~~~~~L  339 (569)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.27  E-value=0.00083  Score=64.61  Aligned_cols=134  Identities=17%  Similarity=0.147  Sum_probs=77.9

Q ss_pred             eeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccc--eee-----eeeeeCCceEEEEeecCCCChhh-
Q 037160          270 GEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV--QFL-----GCCFTKKDSFVVYEFVQNKSLDR-  341 (569)
Q Consensus       270 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~~-----~~~~~~~~~~lv~e~~~~~~L~~-  341 (569)
                      -.||+....+|+.+++|+.... ....+++..|...+..|....+.  ..+     ......+..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            5799999999999999976543 22346688899999888533221  111     11234556788999998754421 


Q ss_pred             ----------Hh-------h--CCCCCccCCHH-------------------HHHHHHHHHHHHHHHHhh----cCCCCe
Q 037160          342 ----------IL-------F--DPKQKKELDWK-------------------KRHVIIIGTAEGLEYLHK----DGQMQI  379 (569)
Q Consensus       342 ----------~l-------~--~~~~~~~l~~~-------------------~~~~i~~~i~~~L~~LH~----~~~~~i  379 (569)
                                .+       .  ....+..+++.                   ....+...+.+.+..+..    ..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                      00       0  00111122211                   111112222223333322    224558


Q ss_pred             eeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          380 VHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       380 vHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ||+|+.|.|||+++ + ..++||+-+.
T Consensus       195 iHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         195 LHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             CCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             ecCCCCcccEEEeC-C-ceEEechhcc
Confidence            99999999999974 3 5689999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.75  E-value=0.0023  Score=63.18  Aligned_cols=73  Identities=14%  Similarity=0.229  Sum_probs=49.5

Q ss_pred             cccccccCceeEEEEEecCC--------ceEEEEEEeecchhhHHHHHHHHHHHHhccccccc-eeeeeeeeCCceEEEE
Q 037160          261 SNKLGHGGYGEIFKGTLQDG--------REIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV-QFLGCCFTKKDSFVVY  331 (569)
Q Consensus       261 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~  331 (569)
                      .++|+.|-.-.+|+....++        +.|++++.. .. .......+|..+++.+.-.+++ ++++++.    -.+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            35788888899999886532        456666544 22 2234566899999988544554 6777663    37899


Q ss_pred             eecCCCCh
Q 037160          332 EFVQNKSL  339 (569)
Q Consensus       332 e~~~~~~L  339 (569)
                      ||++|..|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99988655

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.12  E-value=0.02  Score=54.04  Aligned_cols=156  Identities=12%  Similarity=-0.003  Sum_probs=80.5

Q ss_pred             hhHHHHHhcccccccc-----ccccCceeEEEEEecCCceEEEEEEeecchhhHHHHHHHHHHHHhccccccc--eee--
Q 037160          248 YSTIEKATDCFDESNK-----LGHGGYGEIFKGTLQDGREIAVKRLFISRKNRIKEICNEMDIMSRAHHKNLV--QFL--  318 (569)
Q Consensus       248 ~~~~~~~~~~f~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~~--  318 (569)
                      ...++.+..+|.+.+.     |..|---+.|+....+| .+++|+.....  ...++..|++++..|...++.  ..+  
T Consensus         5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~   81 (316)
T d2ppqa1           5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR   81 (316)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence            3556666777776443     34555577899887755 58999875432  223455677788877433221  111  


Q ss_pred             ----eeeeeCCceEEEEeecCCCChhhHh------------------hCCC--CCcc------------------CCHHH
Q 037160          319 ----GCCFTKKDSFVVYEFVQNKSLDRIL------------------FDPK--QKKE------------------LDWKK  356 (569)
Q Consensus       319 ----~~~~~~~~~~lv~e~~~~~~L~~~l------------------~~~~--~~~~------------------l~~~~  356 (569)
                          .+.........++.++.+......-                  ....  ....                  .....
T Consensus        82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (316)
T d2ppqa1          82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  161 (316)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence                1112234456677777664432100                  0000  0000                  00111


Q ss_pred             HHHHHHHHHHHHHHHhhc-CCCCeeeCCCCCCCeEECCCCCeEEeccCCCc
Q 037160          357 RHVIIIGTAEGLEYLHKD-GQMQIVHRDIKASNILLDLKHRPKIADFGLAR  406 (569)
Q Consensus       357 ~~~i~~~i~~~L~~LH~~-~~~~ivHrDikp~NIll~~~~~~kl~Dfgla~  406 (569)
                      ....+..+...+...+.. -+..+||+|+.++||+++.+...-|.||+.+.
T Consensus       162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222222222222221 13459999999999999988777899999864